Citrus Sinensis ID: 002717
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 888 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LRT1 | 1016 | Probably inactive leucine | yes | no | 0.961 | 0.840 | 0.616 | 0.0 | |
| C0LGE4 | 882 | Probable LRR receptor-lik | no | no | 0.865 | 0.871 | 0.357 | 1e-124 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.911 | 0.798 | 0.335 | 1e-114 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.922 | 0.687 | 0.329 | 1e-113 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.913 | 0.736 | 0.345 | 1e-111 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.945 | 0.672 | 0.328 | 1e-108 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.932 | 0.725 | 0.312 | 1e-107 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.914 | 0.715 | 0.313 | 1e-106 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.914 | 0.809 | 0.318 | 1e-106 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.924 | 0.754 | 0.325 | 1e-105 |
| >sp|Q9LRT1|Y3804_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At3g28040 OS=Arabidopsis thaliana GN=At3g28040 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1045 bits (2702), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 552/896 (61%), Positives = 686/896 (76%), Gaps = 42/896 (4%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L++L+ SHN+LSGQIP SL ++ +++ LDL+ N SG + LF NC+SLRYLSL+ N
Sbjct: 126 LQKLDLSHNNLSGQIPSSLGSI--TSLQHLDLTGNSFSGTLSDDLFNNCSSLRYLSLSHN 183
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
L+G I CS LN+LNLS N FSG+ F SG IW L+RLR LDLS N SGSIP
Sbjct: 184 HLEGQIPSTLFRCSVLNSLNLSRNRFSGNPSFVSG--IWRLERLRALDLSSNSLSGSIPL 241
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
G+ +LH LKEL LQ NQFSG LP+DIG CPHL +DLS+N F+G+LP +L+ L S+
Sbjct: 242 GILSLHNLKELQLQRNQFSGALPSDIGLCPHLNRVDLSSNHFSGELPRTLQKLKSLNHFD 301
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFN-------------------- 242
VSNN L+GD P WIG+++ L LDFS+N LTG LPSS+ N
Sbjct: 302 VSNNLLSGDFPPWIGDMTGLVHLDFSSNELTGKLPSSISNLRSLKDLNLSENKLSGEVPE 361
Query: 243 ----CKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQT 298
CK+L +++L+GN +GNIP+G FDLGL+E+D S NG GSIP GSS LF++
Sbjct: 362 SLESCKELMIVQLKGNDFSGNIPDGFFDLGLQEMDFSGNGLTGSIPRGSSR-----LFES 416
Query: 299 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY 358
L LDLS N+L G IP E+GLF ++RYLNLS NH +R+PPE+ + +L LDLRN+AL
Sbjct: 417 LIRLDLSHNSLTGSIPGEVGLFIHMRYLNLSWNHFNTRVPPEIEFLQNLTVLDLRNSALI 476
Query: 359 GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 418
GS+P ++CES+SL ILQLDGNSLTG IP+ I NC+SL LLSLSHN+L+G IPKS+SNL +
Sbjct: 477 GSVPADICESQSLQILQLDGNSLTGSIPEGIGNCSSLKLLSLSHNNLTGPIPKSLSNLQE 536
Query: 419 LKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGIC 478
LKILKLE N+LSGEIP+ELG L +LL VNVS+NRLIGRLP+G VF +LDQS++QGNLGIC
Sbjct: 537 LKILKLEANKLSGEIPKELGDLQNLLLVNVSFNRLIGRLPLGDVFQSLDQSAIQGNLGIC 596
Query: 479 SPLLKGPCKMNVPKPLVLDPDAY-NSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAIL 537
SPLL+GPC +NVPKPLV++P++Y N N M G+ S + H MF SVS IVAI AAIL
Sbjct: 597 SPLLRGPCTLNVPKPLVINPNSYGNGNNMPGNRASGGSGTFHRRMFLSVSVIVAISAAIL 656
Query: 538 IAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRS-VNLAAGKVILFDSRSSSL----- 591
I GV++I+LLN S RRRL FV+ LES+ S SS+S +L GK++L +SR+S
Sbjct: 657 IFSGVIIITLLNASVRRRLAFVDNALESIFSGSSKSGRSLMMGKLVLLNSRTSRSSSSSQ 716
Query: 592 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 651
+ +PE+LL KA+ +GEGVFGTVYK G QGR LAVKKLV S I+Q EDF+REVR+L
Sbjct: 717 EFERNPESLLNKASRIGEGVFGTVYKAPLGEQGRNLAVKKLVPSPILQNLEDFDREVRIL 776
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
KA+HPNL+S++GY+WTP L LLVS+Y PNG+LQ+KLHER PSTPPLSW R+K+ILGTA
Sbjct: 777 AKAKHPNLVSIKGYFWTPDLHLLVSEYIPNGNLQSKLHEREPSTPPLSWDVRYKIILGTA 836
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM-SNRFQSAL 770
KGLA+LHH+FRP IH+NLKP+NILLD+ NP+ISDFGL+RLLT D + M +NRFQ+AL
Sbjct: 837 KGLAYLHHTFRPTTIHFNLKPTNILLDEKNNPKISDFGLSRLLTTQDGNTMNNNRFQNAL 896
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830
GYVAPEL CQ+LRVNEKCD+YGFGVLILELVTGRRPVEYGED+ VILS+HVRV+LE+GNV
Sbjct: 897 GYVAPELECQNLRVNEKCDVYGFGVLILELVTGRRPVEYGEDSFVILSDHVRVMLEQGNV 956
Query: 831 LDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRM 885
L+C+DP M + Y EDEVLPVLKLALVCT IPS+RP+MAE+VQILQVI +P+P R+
Sbjct: 957 LECIDPVMEEQYSEDEVLPVLKLALVCTSQIPSNRPTMAEIVQILQVINSPVPHRI 1012
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGE4|Y1124_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g12460 OS=Arabidopsis thaliana GN=At1g12460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 311/870 (35%), Positives = 455/870 (52%), Gaps = 101/870 (11%)
Query: 76 YLSLAGNILQGPIGKIFNYCSS-----LNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLD 130
Y SLA + G + FN + ++ + L N +G L G+ +LK +R L+
Sbjct: 42 YNSLASWVSDGDLCNSFNGITCNPQGFVDKIVLWNTSLAGTL----APGLSNLKFIRVLN 97
Query: 131 LSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPV 190
L N F+G++P L L + + N SGP+P I L LDLS N FTG++PV
Sbjct: 98 LFGNRFTGNLPLDYFKLQTLWTINVSSNALSGPIPEFISELSSLRFLDLSKNGFTGEIPV 157
Query: 191 SL-RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 249
SL + + F+S+++N + G IP I N + L DFS N+L G LP + + L I
Sbjct: 158 SLFKFCDKTKFVSLAHNNIFGSIPASIVNCNNLVGFDFSYNNLKGVLPPRICDIPVLEYI 217
Query: 250 RLRGNSLNGNIPEG--------LFDLG--------------------------------- 268
+R N L+G++ E L DLG
Sbjct: 218 SVRNNLLSGDVSEEIQKCQRLILVDLGSNLFHGLAPFAVLTFKNITYFNVSWNRFGGEIG 277
Query: 269 --------LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 320
LE +D S N G IP G S L++LDL SN L G IP +G
Sbjct: 278 EIVDCSESLEFLDASSNELTGRIPTGVMGCKS------LKLLDLESNKLNGSIPGSIGKM 331
Query: 321 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 380
+L + L +N + IP ++G L L+L N L G +P+++ R L L + GN
Sbjct: 332 ESLSVIRLGNNSIDGVIPRDIGSLEFLQVLNLHNLNLIGEVPEDISNCRVLLELDVSGND 391
Query: 381 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 440
L G I + + N T++ +L L N L+GSIP + NL+K++ L L N LSG IP LG L
Sbjct: 392 LEGKISKKLLNLTNIKILDLHRNRLNGSIPPELGNLSKVQFLDLSQNSLSGPIPSSLGSL 451
Query: 441 ASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDA 500
+L NVSYN L G +P + S+ N +C L PC
Sbjct: 452 NTLTHFNVSYNNLSGVIPPVPMIQAFGSSAFSNNPFLCGDPLVTPCNSR----------- 500
Query: 501 YNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVE 560
+ + S N + SV ++ A IL GV ++ LN+ R+R E
Sbjct: 501 ----------GAAAKSRNSDALSISVIIVIIAAAVILF--GVCIVLALNLRARKRRKDEE 548
Query: 561 T-TLESM-CSSSSRSVNLAAGKVILFDSR--SSSLDCSIDPETLLEKAAEVGEGVFGTVY 616
T+E+ +SS S + GK++LF S D + LL+K +G G G+VY
Sbjct: 549 ILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALLDKENIIGMGSIGSVY 608
Query: 617 KVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676
+ SF G +AVKKL T I+ E+FE+E+ LG +HPNL S +GYY++ ++L++S
Sbjct: 609 RASF-EGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLSSFQGYYFSSTMQLILS 667
Query: 677 DYAPNGSLQAKLHERL-PSTPP------LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYN 729
++ PNGSL LH R+ P T L+W RF++ LGTAK L+ LH+ +P I+H N
Sbjct: 668 EFVPNGSLYDNLHLRIFPGTSSSYGNTDLNWHRRFQIALGTAKALSFLHNDCKPAILHLN 727
Query: 730 LKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCD 789
+K +NILLD+ Y ++SD+GL + L +D ++ +F +A+GY+APEL QSLR +EKCD
Sbjct: 728 VKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIAPELAQQSLRASEKCD 787
Query: 790 IYGFGVLILELVTGRRPVEY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLP 848
+Y +GV++LELVTGR+PVE E+ V+IL ++VR LLE G+ DC D + ++ E+E++
Sbjct: 788 VYSYGVVLLELVTGRKPVESPSENQVLILRDYVRDLLETGSASDCFDRRLREFEENELIQ 847
Query: 849 VLKLALVCTCHIPSSRPSMAEVVQILQVIK 878
V+KL L+CT P RPSMAEVVQ+L+ I+
Sbjct: 848 VMKLGLLCTSENPLKRPSMAEVVQVLESIR 877
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1063), Expect = e-114, Method: Compositional matrix adjust.
Identities = 300/895 (33%), Positives = 468/895 (52%), Gaps = 86/895 (9%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L LN S N+LSG + L NL ++++ LDL N G +P F+N LR+L L+GN
Sbjct: 142 LVHLNASGNNLSGNLTEDLGNL--VSLEVLDLRGNFFQGSLPSS-FKNLQKLRFLGLSGN 198
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
L G + + SL T L N F G + G ++ L+ LDL+ SG IP
Sbjct: 199 NLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFG----NINSLKYLDLAIGKLSGEIPS 254
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
+ L L+ LLL N F+G +P +IG L LD S+N TG++P+ + L ++ ++
Sbjct: 255 ELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLN 314
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
+ N L+G IP I +++ L+ L+ NN L+G LPS L L + + NS +G IP
Sbjct: 315 LMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPS 374
Query: 263 GLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTL------------------FQTLRILD 303
L + G L ++ L N F G IP S+ S + L+ L+
Sbjct: 375 TLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLE 434
Query: 304 LSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 363
L+ N L G IP ++ +L +++ S N +RS +P + H+L + +N + G +P
Sbjct: 435 LAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPD 494
Query: 364 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILK 423
+ + SL L L N+LTG IP I +C L L+L +N+L+G IP+ I+ ++ L +L
Sbjct: 495 QFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLD 554
Query: 424 LEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLK 483
L N L+G +P+ +G +L +NVSYN+L G +P+ G T++ L+GN G+C +L
Sbjct: 555 LSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLP 614
Query: 484 GPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIA-GGV 542
PC ++ SHS S H I+A LI V
Sbjct: 615 -PC-----------------SKFQRATSSHS--SLHGKR---------IVAGWLIGIASV 645
Query: 543 LVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFD----SRSSSLDCSIDPE 598
L + +L + TR + + C + S +++ F + S L C
Sbjct: 646 LALGILTIVTRT--LYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILAC----- 698
Query: 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS--DIIQ-YPEDFEREVRVLGKAR 655
++++ +G G G VYK +LAVKKL S DI DF EV +LGK R
Sbjct: 699 --IKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLR 756
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPL-SWTNRFKVILGTAKGL 714
H N++ L G+ + + ++V ++ NG+L +H + + L W +R+ + LG A GL
Sbjct: 757 HRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGL 816
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
A+LHH PP+IH ++K +NILLD N + RI+DFGLAR++ R + V + + GY+A
Sbjct: 817 AYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETV--SMVAGSYGYIA 874
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPV--EYGEDNVVILSEHVRVLLEEGNVL- 831
PE +L+V+EK DIY +GV++LEL+TGRRP+ E+GE V + E VR + + L
Sbjct: 875 PEYG-YTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGES--VDIVEWVRRKIRDNISLE 931
Query: 832 DCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR 884
+ +DP++G+ Y ++E+L VL++AL+CT +P RPSM +V+ +L K P+R
Sbjct: 932 EALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAK---PRR 983
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1052), Expect = e-113, Method: Compositional matrix adjust.
Identities = 303/919 (32%), Positives = 455/919 (49%), Gaps = 100/919 (10%)
Query: 13 AIPS-MVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENC 71
++PS M +++L+ L ++N SG+IP + + M+ K L L++NLLSG +P +L
Sbjct: 320 SLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPML--KHLSLASNLLSGSIPRELC-GS 376
Query: 72 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSG--------------DLDFASG 117
SL + L+GN+L G I ++F+ CSSL L L+NN +G DLD +
Sbjct: 377 GSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMALDLDSNNF 436
Query: 118 YG-----IWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCP 172
G +W L S+N G +P + LK L+L NQ +G +P +IG
Sbjct: 437 TGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLT 496
Query: 173 HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHL 232
L+ L+L+ N+F G++PV L S+ + + +N L G IP I ++ L+ L S N+L
Sbjct: 497 SLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNL 556
Query: 233 TGSLPSS------LFNCKKLSVIRLRG------NSLNGNIPEGLFD-LGLEEIDLSENGF 279
+GS+PS LS ++ G N L+G IPE L + L L EI LS N
Sbjct: 557 SGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHL 616
Query: 280 MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPP 339
G IP +S + L ILDLS N L G IP EMG L+ LNL++N L IP
Sbjct: 617 SGEIP------ASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPE 670
Query: 340 ELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 399
G SL+ L+L N L G +P + + L + L N+L+G + + L L
Sbjct: 671 SFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLY 730
Query: 400 LSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPV 459
+ N +G IP + NL +L+ L + N LSGEIP ++ L +L +N++ N L G +P
Sbjct: 731 IEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPS 790
Query: 460 GGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNH 519
GV ++ L GN +C ++ CK+ K
Sbjct: 791 DGVCQDPSKALLSGNKELCGRVVGSDCKIEGTK--------------------------- 823
Query: 520 HHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLT---------------FVETTLE 564
S I ++ I V V SL + +R+ FV+ L
Sbjct: 824 ---LRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLY 880
Query: 565 SMCSSSSR---SVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFG 621
+ S SR S+N+A + L R + ++ K +G+G FGTVYK
Sbjct: 881 FLSGSRSREPLSINIAMFEQPLLKVRLGDI---VEATDHFSKKNIIGDGGFGTVYKACLP 937
Query: 622 TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 681
+ + +AVKKL + Q +F E+ LGK +HPNL+SL GY + KLLV +Y N
Sbjct: 938 GE-KTVAVKKLSEAK-TQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVN 995
Query: 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 741
GSL L + L W+ R K+ +G A+GLA LHH F P IIH ++K SNILLD ++
Sbjct: 996 GSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDF 1055
Query: 742 NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELV 801
P+++DFGLARL++ + HV S GY+ PE QS R K D+Y FGV++LELV
Sbjct: 1056 EPKVADFGLARLISACESHV-STVIAGTFGYIPPEYG-QSARATTKGDVYSFGVILLELV 1113
Query: 802 TGRRPV--EYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP-EDEVLPVLKLALVCTC 858
TG+ P ++ E L + +G +D +DP + ++ L +L++A++C
Sbjct: 1114 TGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLA 1173
Query: 859 HIPSSRPSMAEVVQILQVI 877
P+ RP+M +V++ L+ I
Sbjct: 1174 ETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 402 bits (1033), Expect = e-111, Method: Compositional matrix adjust.
Identities = 300/869 (34%), Positives = 437/869 (50%), Gaps = 58/869 (6%)
Query: 15 PSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASL 74
PS+ LE L N +G IP + L MK L L N L+G +P ++ N
Sbjct: 253 PSVGNISRLEVLALHENYFTGSIPREIGKLT--KMKRLYLYTNQLTGEIPREI-GNLIDA 309
Query: 75 RYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
+ + N L G I K F + +L L+L N G + G L L LDLS N
Sbjct: 310 AEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELG----ELTLLEKLDLSIN 365
Query: 135 LFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL 194
+G+IPQ + L YL +L L NQ G +P IGF + + LD+S N +G +P
Sbjct: 366 RLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCR 425
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 254
++I +S+ +N L+G+IP + +L L +N LTGSLP LFN + L+ + L N
Sbjct: 426 FQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQN 485
Query: 255 SLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDI 313
L+GNI L L LE + L+ N F G IPP + + F ++SSN L G I
Sbjct: 486 WLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGF------NISSNQLTGHI 539
Query: 314 PAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGI 373
P E+G ++ L+LS N I ELG L L L +N L G IP + L
Sbjct: 540 PKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLME 599
Query: 374 LQLDGNSLTGPIPQVIRNCTSLYL-LSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE 432
LQL GN L+ IP + TSL + L++SHN+LSG+IP S+ NL L+IL L N+LSGE
Sbjct: 600 LQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGE 659
Query: 433 IPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPK 492
IP +G L SLL N+S N L+G +P VF +D S+ GN G+C+ + C +
Sbjct: 660 IPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNS-QRSHC-----Q 713
Query: 493 PLVLDPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVS- 551
PLV D+ + ++G + +++ IV G V +I+ L +
Sbjct: 714 PLVPHSDSKLNWLING---------SQRQKILTITCIV--------IGSVFLITFLGLCW 756
Query: 552 --TRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGE 609
RR FV LE F + + +D + +G
Sbjct: 757 TIKRREPAFV--ALEDQTKPD-------VMDSYYFPKKGFTYQGLVDATRNFSEDVVLGR 807
Query: 610 GVFGTVYKVSFGTQGRMLAVKKLVT-SDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT 668
G GTVYK + G ++AVKKL + + F E+ LGK RH N++ L G+ +
Sbjct: 808 GACGTVYKAEM-SGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYH 866
Query: 669 PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHY 728
LL+ +Y GSL +L +R L W R+++ LG A+GL +LHH RP I+H
Sbjct: 867 QNSNLLLYEYMSKGSLGEQL-QRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHR 925
Query: 729 NLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKC 788
++K +NILLD+ + + DFGLA+L+ MS + GY+APE +++V EKC
Sbjct: 926 DIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS-AVAGSYGYIAPEYA-YTMKVTEKC 983
Query: 789 DIYGFGVLILELVTGR---RPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 845
DIY FGV++LEL+TG+ +P+E G D V + +R ++ + D + E
Sbjct: 984 DIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHE 1043
Query: 846 VLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
+ VLK+AL CT + P+SRP+M EVV ++
Sbjct: 1044 MSLVLKIALFCTSNSPASRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 392 bits (1008), Expect = e-108, Method: Compositional matrix adjust.
Identities = 315/959 (32%), Positives = 467/959 (48%), Gaps = 119/959 (12%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ L+ S N+L+G+IP N M + L L+NN LSG +P + N +L L L+G
Sbjct: 289 LQTLDLSANNLTGEIPEEFWN--MSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGT 346
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDL--------DFASGY------------GIWS 122
L G I + C SL L+LSNN +G + + Y I +
Sbjct: 347 QLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISN 406
Query: 123 LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNN 182
L L+ L L HN G +P+ ++AL L+ L L N+FSG +P +IG C L +D+ N
Sbjct: 407 LTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGN 466
Query: 183 LFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFN 242
F G++P S+ L + + + N L G +P +GN L LD ++N L+GS+PSS
Sbjct: 467 HFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGF 526
Query: 243 CKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTL------ 295
K L + L NSL GN+P+ L L L I+LS N G+I P SSS +
Sbjct: 527 LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNG 586
Query: 296 -----------------------------------FQTLRILDLSSNNLVGDIPAEMGLF 320
+ L +LD+SSN L G IP ++ L
Sbjct: 587 FEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLC 646
Query: 321 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 380
L +++L++N L IPP LG L L L +N S+P E+ L +L LDGNS
Sbjct: 647 KKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNS 706
Query: 381 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 440
L G IPQ I N +L +L+L N SGS+P+++ L+KL L+L N L+GEIP E+G+L
Sbjct: 707 LNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQL 766
Query: 441 ASLL-AVNVSYNRLIGRLP--VGGV--FPTLDQSSLQ------GNLGICSPL-------- 481
L A+++SYN G +P +G + TLD S Q G++G L
Sbjct: 767 QDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFN 826
Query: 482 -LKGPCKMNVPKPLVLDPDAYNSNQ-MDGHIHS--HSFSSNHHHMFFSVSAIVAIIAAIL 537
L G K + D++ N + G S + SN+ S ++V I A
Sbjct: 827 NLGGKLKKQFSR---WPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISA 883
Query: 538 IAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDP 597
+ L+I ++ + ++R F + + +S S + A LF + +S D I
Sbjct: 884 LTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSD--IRW 941
Query: 598 ETLLEKAAE------VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 651
E ++E +G G G VYK G +AVKK++ D + + F REV+ L
Sbjct: 942 EDIMEATHNLSEEFMIGSGGSGKVYKAEL-ENGETVAVKKILWKDDLMSNKSFSREVKTL 1000
Query: 652 GKARHPNLISLEGYYWTPQ--LKLLVSDYAPNGSLQAKLHERLP----STPPLSWTNRFK 705
G+ RH +L+ L GY + L LL+ +Y NGS+ LHE P L W R +
Sbjct: 1001 GRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLR 1060
Query: 706 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSN 764
+ +G A+G+ +LHH PPI+H ++K SN+LLD N + DFGLA++LT D + SN
Sbjct: 1061 IAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSN 1120
Query: 765 R-FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE--YGE--DNVVILSE 819
F + GY+APE SL+ EK D+Y G++++E+VTG+ P + +G D V +
Sbjct: 1121 TWFACSYGYIAPEY-AYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVET 1179
Query: 820 HVRVLLEEGNVLD-CVDPSMG---DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
H+ V G+ D +DP + + ED VL++AL CT P RPS + L
Sbjct: 1180 HLEV---AGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 390 bits (1002), Expect = e-107, Method: Compositional matrix adjust.
Identities = 304/973 (31%), Positives = 463/973 (47%), Gaps = 145/973 (14%)
Query: 16 SMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLR 75
S+ R LE L + N L+G+IPP + + +K L L +NLL+G +P +L + + L
Sbjct: 148 SLSKLRNLETLILNSNQLTGKIPPDISKCS--KLKSLILFDNLLTGSIPTELGK-LSGLE 204
Query: 76 YLSLAGNI-LQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLD---- 130
+ + GN + G I CS+L L L+ SG+L + G LK+L TL
Sbjct: 205 VIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLG----KLKKLETLSIYTT 260
Query: 131 --------------------LSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGF 170
L N SGSIP+ + L L++L L N G +P +IG
Sbjct: 261 MISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGN 320
Query: 171 CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNN 230
C +L +DLS NL +G +P S+ L+ + +S+N +G IP I N S+L L N
Sbjct: 321 CSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKN 380
Query: 231 HLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPG--- 286
++G +PS L KL++ N L G+IP GL D L+ +DLS N G+IP G
Sbjct: 381 QISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFM 440
Query: 287 ---------SSSSSSSTLFQ------TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSN 331
S+S S + Q +L L L N + G+IP+ +G + +L+ SSN
Sbjct: 441 LRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSN 500
Query: 332 HLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRN 391
L ++P E+G L +DL NN+L GS+P V L +L + N +G IP +
Sbjct: 501 RLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGR 560
Query: 392 CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELG------------- 438
SL L LS N SGSIP S+ + L++L L NELSGEIP ELG
Sbjct: 561 LVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSS 620
Query: 439 ---------KLASL--------------------------LAVNVSYNRLIGRLPVGGVF 463
K+ASL +++N+SYN G LP +F
Sbjct: 621 NRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLF 680
Query: 464 PTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMF 523
L L+GN +CS + C + K L D +S +
Sbjct: 681 RQLSPQDLEGNKKLCSST-QDSCFLTYRKGNGLGDDGD--------------ASRTRKLR 725
Query: 524 FSVSAIVAIIAAILIAGGVLVI-SLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVI 582
+++ ++ + ++I G V VI + N+ R ET + + +N + ++I
Sbjct: 726 LTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQF--TPFQKLNFSVDQII 783
Query: 583 LFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI----- 637
C ++P +G+G G VY+ G ++AVKKL + +
Sbjct: 784 ---------RCLVEPNV-------IGKGCSGVVYRADV-DNGEVIAVKKLWPAMVNGGHD 826
Query: 638 ---IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPS 694
+ F EV+ LG RH N++ G W +LL+ DY PNGSL + LHER S
Sbjct: 827 EKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGS 886
Query: 695 TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754
+ L W R++++LG A+GLA+LHH PPI+H ++K +NIL+ ++ P I+DFGLA+L+
Sbjct: 887 S--LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLV 944
Query: 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
D SN + GY+APE S+++ EK D+Y +GV++LE++TG++P++
Sbjct: 945 DEGDIGRCSNTVAGSYGYIAPEYG-YSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEG 1003
Query: 815 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
+ L + VR VLD S + DE++ VL AL+C P RP+M +V +L
Sbjct: 1004 IHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAML 1063
Query: 875 QVIKTPLPQRMEV 887
+ IK + +V
Sbjct: 1064 KEIKQEREEYAKV 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (993), Expect = e-106, Method: Compositional matrix adjust.
Identities = 284/905 (31%), Positives = 448/905 (49%), Gaps = 93/905 (10%)
Query: 21 RILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLA 80
R L+ L + +SG +P SL L+ ++ L + + +LSG +P +L NC+ L L L
Sbjct: 227 RNLKVLGLAATKISGSLPVSLGQLS--KLQSLSVYSTMLSGEIPKEL-GNCSELINLFLY 283
Query: 81 GNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
N L G + K +L + L N+ G + G+ +K L +DLS N FSG+I
Sbjct: 284 DNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGF----MKSLNAIDLSMNYFSGTI 339
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200
P+ L L+EL+L N +G +P+ + C L + N +G +P + LL +
Sbjct: 340 PKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNI 399
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF------------------- 241
N L G+IP + L+ LD S N+LTGSLP+ LF
Sbjct: 400 FLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVI 459
Query: 242 -----NCKKLSVIRLRGNSLNGNIPEGL-FDLGLEEIDLSENGFMGSIPPGSSSSSSSTL 295
NC L +RL N + G IP+G+ F L +DLSEN G +P S+
Sbjct: 460 PLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNC----- 514
Query: 296 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN 355
+ L++L+LS+N L G +P + L+ L++SSN L +IP LG+ SL L L N
Sbjct: 515 -RQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKN 573
Query: 356 ALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYL-LSLSHNHLSGSIPKSIS 414
+ G IP + +L +L L N+++G IP+ + + L + L+LS N L G IP+ IS
Sbjct: 574 SFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERIS 633
Query: 415 NLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 474
LN+L +L + N LSG++ L L +L+++N+S+NR G LP VF L + ++GN
Sbjct: 634 ALNRLSVLDISHNMLSGDL-SALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGN 692
Query: 475 LGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIA 534
G+CS + C ++ NS+Q+ HS H + ++ ++++ A
Sbjct: 693 NGLCSKGFRS-CFVS------------NSSQLTTQRGVHS-----HRLRIAIGLLISVTA 734
Query: 535 AILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCS 594
+ + G + VI + + L + + + +N V L C
Sbjct: 735 VLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHV---------LKCL 785
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED---------FE 645
++ +G+G G VYK + ++AVKKL + E F
Sbjct: 786 VEGNV-------IGKGCSGIVYKAEMPNR-EVIAVKKLWPVTVPNLNEKTKSSGVRDSFS 837
Query: 646 REVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK 705
EV+ LG RH N++ G W +LL+ DY NGSL + LHER L W R+K
Sbjct: 838 AEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHER-SGVCSLGWEVRYK 896
Query: 706 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 765
+ILG A+GLA+LHH PPI+H ++K +NIL+ ++ P I DFGLA+L+ D SN
Sbjct: 897 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNT 956
Query: 766 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 825
+ GY+APE S+++ EK D+Y +GV++LE++TG++P+ D + H+ +
Sbjct: 957 IAGSYGYIAPEYG-YSMKITEKSDVYSYGVVVLEVLTGKQPI----DPTIPDGLHIVDWV 1011
Query: 826 EEGNVLDCVDPSMGDYPEDEV---LPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882
++ + +D + PE EV + L +AL+C IP RP+M +V +L I
Sbjct: 1012 KKIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEICQERE 1071
Query: 883 QRMEV 887
+ M+V
Sbjct: 1072 ESMKV 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 385 bits (989), Expect = e-106, Method: Compositional matrix adjust.
Identities = 302/947 (31%), Positives = 449/947 (47%), Gaps = 135/947 (14%)
Query: 15 PSMVVFRILERLNFSHNSLSGQIPPSL--------LNLN---------------MMNMKF 51
P + R+L+ L+ + N +SG IPP + LNL+ ++N++
Sbjct: 87 PDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRV 146
Query: 52 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 111
LD+ NN L+G +P + N LR+L L GN G I + + L +S N G
Sbjct: 147 LDVYNNNLTGDLPVSV-TNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGK 205
Query: 112 L-----------DFASGY----------GIWSLKRLRTLDLSHNLFSGSIPQGVAALHYL 150
+ + GY I +L L D ++ +G IP + L L
Sbjct: 206 IPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKL 265
Query: 151 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG 210
L LQ N FSGPL ++G L ++DLSNN+FTG++P S L ++ +++ N L G
Sbjct: 266 DTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHG 325
Query: 211 DIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP--------- 261
+IP +IG++ LE L N+ TGS+P L KL+++ L N L G +P
Sbjct: 326 EIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKL 385
Query: 262 EGLFDLG----------------LEEIDLSENGFMGSIPPGSSSSSSSTLFQ--TLRILD 303
E L LG L I + EN GSIP G LF L ++
Sbjct: 386 ETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKG--------LFGLPKLTQVE 437
Query: 304 LSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 363
L N L G++P G+ NL ++LS+N L +PP +G F + L L N G IP
Sbjct: 438 LQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPS 497
Query: 364 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILK 423
EV + + L + N +G I I C L + LS N LSG IP I+ + L L
Sbjct: 498 EVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLN 557
Query: 424 LEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLK 483
L N L G IP + + SL +++ SYN L G +P G F + +S GN +C P L
Sbjct: 558 LSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYL- 616
Query: 484 GPCKMNVPKPLVLDPDAYNSNQMDGHIHSHS---FSSNHHHMFFSVSAIVAIIAAILIAG 540
GPCK V K GH SHS S++ + + +I A
Sbjct: 617 GPCKDGVAK--------------GGH-QSHSKGPLSASMKLLLVLGLLVCSIAFA----- 656
Query: 541 GVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETL 600
V++++ + ++ +S SR+ L A + + F + D +D
Sbjct: 657 ---VVAIIKARSLKK------------ASESRAWRLTAFQRLDF-----TCDDVLDS--- 693
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVT-SDIIQYPEDFEREVRVLGKARHPNL 659
L++ +G+G G VYK G ++AVK+L S + F E++ LG+ RH ++
Sbjct: 694 LKEDNIIGKGGAGIVYK-GVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHI 752
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
+ L G+ + LLV +Y PNGSL LH + L W R+K+ L AKGL +LHH
Sbjct: 753 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGK--KGGHLHWDTRYKIALEAAKGLCYLHH 810
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
P I+H ++K +NILLD N+ ++DFGLA+ L + + GY+APE
Sbjct: 811 DCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEY-A 869
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE--EGNVLDCVDPS 837
+L+V+EK D+Y FGV++LELVTGR+PV D V I+ + VR + + + +VL +DP
Sbjct: 870 YTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIV-QWVRKMTDSNKDSVLKVLDPR 928
Query: 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR 884
+ P EV V +A++C RP+M EVVQIL I P +
Sbjct: 929 LSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKLPPSK 975
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 384 bits (986), Expect = e-105, Method: Compositional matrix adjust.
Identities = 284/873 (32%), Positives = 430/873 (49%), Gaps = 52/873 (5%)
Query: 21 RILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLS-- 78
+ L L+ S N G +PP + N + ++ + N L+G +P + LR +S
Sbjct: 244 KKLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCN--LTGTIPSSM----GMLRKVSVI 297
Query: 79 -LAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS 137
L+ N L G I + CSSL TL L++N G++ A + LK+L++L+L N S
Sbjct: 298 DLSDNRLSGNIPQELGNCSSLETLKLNDNQLQGEIPPA----LSKLKKLQSLELFFNKLS 353
Query: 138 GSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNS 197
G IP G+ + L ++L+ N +G LP ++ HL L L NN F G +P+SL L S
Sbjct: 354 GEIPIGIWKIQSLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRS 413
Query: 198 MIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 257
+ + + N TG+IP + + L +N L G +P+S+ CK L +RL N L+
Sbjct: 414 LEEVDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERVRLEDNKLS 473
Query: 258 GNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM 317
G +PE L L ++L N F GSIP S + L +DLS N L G IP E+
Sbjct: 474 GVLPEFPESLSLSYVNLGSNSFEGSIPRSLGSC------KNLLTIDLSQNKLTGLIPPEL 527
Query: 318 GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 377
G +L LNLS N+L +P +L L++ D+ +N+L GSIP +SL L L
Sbjct: 528 GNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVLS 587
Query: 378 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKI-LKLEFNELSGEIPQE 436
N+ G IPQ + L L ++ N G IP S+ L L+ L L N +GEIP
Sbjct: 588 DNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPTT 647
Query: 437 LGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVL 496
LG L +L +N+S N+L G L V +L+Q + N GP +P L+
Sbjct: 648 LGALINLERLNISNNKLTGPLSVLQSLKSLNQVDVSYNQ------FTGP----IPVNLLS 697
Query: 497 DPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRL 556
+ ++ N S+S S+ F S V + I+L+ + +
Sbjct: 698 NSSKFSGNPDLCIQASYSVSAIIRKEFKSCKGQVKL--------STWKIALIAAGSSLSV 749
Query: 557 TFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVY 616
+ L + R ++ + S L+ + L+ +G G G VY
Sbjct: 750 LALLFALFLVLCRCKRGTKTEDANILAEEGLSLLLNKVLAATDNLDDKYIIGRGAHGVVY 809
Query: 617 KVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676
+ S G+ G AVKKL+ ++ I+ ++ +RE+ +G RH NLI LE ++ + L++
Sbjct: 810 RASLGS-GEEYAVKKLIFAEHIRANQNMKREIETIGLVRHRNLIRLERFWMRKEDGLMLY 868
Query: 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 736
Y PNGSL LH L W+ RF + LG + GLA+LHH PPIIH ++KP NIL
Sbjct: 869 QYMPNGSLHDVLHRGNQGEAVLDWSARFNIALGISHGLAYLHHDCHPPIIHRDIKPENIL 928
Query: 737 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVL 796
+D + P I DFGLAR+L D V + GY+APE +++R E D+Y +GV+
Sbjct: 929 MDSDMEPHIGDFGLARILD--DSTVSTATVTGTTGYIAPENAYKTVRSKES-DVYSYGVV 985
Query: 797 ILELVTGRRPVEYGEDNVVILSEHVRVLL-----EEGNVLDCVDPSMGDYPED-----EV 846
+LELVTG+R ++ + + VR +L E+ VDP + D D +
Sbjct: 986 LLELVTGKRALDRSFPEDINIVSWVRSVLSSYEDEDDTAGPIVDPKLVDELLDTKLREQA 1045
Query: 847 LPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
+ V LAL CT P +RPSM +VV+ L +++
Sbjct: 1046 IQVTDLALRCTDKRPENRPSMRDVVKDLTDLES 1078
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 888 | ||||||
| 255554367 | 1007 | receptor protein kinase, putative [Ricin | 0.983 | 0.866 | 0.702 | 0.0 | |
| 224131472 | 1006 | predicted protein [Populus trichocarpa] | 0.961 | 0.848 | 0.720 | 0.0 | |
| 225433686 | 1012 | PREDICTED: probably inactive leucine-ric | 0.971 | 0.852 | 0.697 | 0.0 | |
| 224069080 | 985 | predicted protein [Populus trichocarpa] | 0.961 | 0.867 | 0.714 | 0.0 | |
| 356499695 | 1007 | PREDICTED: probably inactive leucine-ric | 0.970 | 0.856 | 0.672 | 0.0 | |
| 356568921 | 1007 | PREDICTED: probably inactive leucine-ric | 0.981 | 0.865 | 0.667 | 0.0 | |
| 449469172 | 1007 | PREDICTED: probably inactive leucine-ric | 0.975 | 0.859 | 0.665 | 0.0 | |
| 449484810 | 1007 | PREDICTED: LOW QUALITY PROTEIN: probably | 0.975 | 0.859 | 0.664 | 0.0 | |
| 357502883 | 1016 | Probably inactive leucine-rich repeat re | 0.986 | 0.862 | 0.660 | 0.0 | |
| 297815072 | 1014 | hypothetical protein ARALYDRAFT_484589 [ | 0.962 | 0.843 | 0.615 | 0.0 |
| >gi|255554367|ref|XP_002518223.1| receptor protein kinase, putative [Ricinus communis] gi|223542628|gb|EEF44166.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1229 bits (3181), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 642/914 (70%), Positives = 745/914 (81%), Gaps = 41/914 (4%)
Query: 5 LVHGNSYNAI-PSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPV 63
L H N I P + + LE LN SHNSLSG IP S +N M ++FLDLS N LSGP+
Sbjct: 105 LSHNNFSGEISPDLPLIPSLESLNLSHNSLSGLIPSSFVN--MTTVRFLDLSENSLSGPL 162
Query: 64 PYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSL 123
P LF+NC SLRY+SLAGN LQGP+ CSSLNTLNLS+NHFSG+ DF SG IWSL
Sbjct: 163 PDNLFQNCLSLRYISLAGNSLQGPLPSTLARCSSLNTLNLSSNHFSGNPDFFSG--IWSL 220
Query: 124 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL 183
KRLRTLDLS+N FSGS+P GV++LH LK+L LQGN+FSG LP D G C HL LDLSNNL
Sbjct: 221 KRLRTLDLSNNEFSGSLPIGVSSLHNLKDLQLQGNRFSGTLPVDTGLCTHLLRLDLSNNL 280
Query: 184 FTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC 243
FTG LP SL+ L S+ FIS+SNN T D P WIGNI LE+LDFS+N LTGSLPSS+ +
Sbjct: 281 FTGALPDSLKWLGSLTFISLSNNMFTDDFPQWIGNIRNLEYLDFSSNLLTGSLPSSISDL 340
Query: 244 K------------------------KLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGF 279
K KLSVIRLRGNS G IPEGLF+LGLEE+D S+N
Sbjct: 341 KSLYFINLSNNKFTGQIPTSMVQFSKLSVIRLRGNSFIGTIPEGLFNLGLEEVDFSDNKL 400
Query: 280 MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPP 339
+GSIP GSS + +L+ILDLS NNL G+I AEMGL +NLRYLNLS N+L+SR+P
Sbjct: 401 IGSIPAGSSK-----FYGSLQILDLSRNNLTGNIRAEMGLSSNLRYLNLSWNNLQSRMPQ 455
Query: 340 ELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 399
ELGYF +L LDLRN+A+ GSIP ++CES SL ILQLDGNS+ G IP+ I NC+++YLLS
Sbjct: 456 ELGYFQNLTVLDLRNSAISGSIPADICESGSLSILQLDGNSIVGSIPEEIGNCSTMYLLS 515
Query: 400 LSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPV 459
LSHN+LSG IPKSI+ LN LKILKLEFN+LSGEIP ELGKL +LLAVN+SYN LIGRLP
Sbjct: 516 LSHNNLSGPIPKSIAKLNNLKILKLEFNKLSGEIPLELGKLENLLAVNISYNMLIGRLPS 575
Query: 460 GGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHI---HSHSFS 516
GG+FP+LDQS+LQGNLGICSPLLKGPCKMNVPKPLVLDP AY NQM+GH S +
Sbjct: 576 GGIFPSLDQSALQGNLGICSPLLKGPCKMNVPKPLVLDPFAY-GNQMEGHRPRNESPDST 634
Query: 517 SNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNL 576
+H+HM SVS+I+AI AA+ I GV++ISLLN+S R+RL FV+ LES+ SSSSRS NL
Sbjct: 635 RSHNHMLLSVSSIIAISAAVFIVFGVIIISLLNISARKRLAFVDHALESLFSSSSRSGNL 694
Query: 577 AA-GKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFG-TQGRMLAVKKLVT 634
AA GK++LFDS+SS + + +PE+LL KAAE+GEGVFGTVYKVS G + GRM+A+KKLV+
Sbjct: 695 AAAGKLVLFDSKSSPDEIN-NPESLLNKAAEIGEGVFGTVYKVSLGGSHGRMVAIKKLVS 753
Query: 635 SDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPS 694
S+IIQYPEDFEREV++LGKARHPNLISL GYYWTPQL+LLVS++AP+GSLQAKLH R PS
Sbjct: 754 SNIIQYPEDFEREVQILGKARHPNLISLTGYYWTPQLQLLVSEFAPSGSLQAKLHGRPPS 813
Query: 695 TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754
TPPLSW NRFK++LGTAKGLAHLHHSFRPPIIHYN+KPSNILLD+N NP+ISDFGL+RLL
Sbjct: 814 TPPLSWANRFKIVLGTAKGLAHLHHSFRPPIIHYNIKPSNILLDENNNPKISDFGLSRLL 873
Query: 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
T+LDKHV++NRFQSALGYVAPEL CQSLRVNEKCD+YGFG+LILELVTGRRP+EYGEDNV
Sbjct: 874 TKLDKHVINNRFQSALGYVAPELACQSLRVNEKCDVYGFGILILELVTGRRPIEYGEDNV 933
Query: 815 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
VIL++HVRVLLE+GN LDCVDPSMGDYPEDEVLPVLKLALVCT IPSSRPSM EVVQIL
Sbjct: 934 VILNDHVRVLLEQGNALDCVDPSMGDYPEDEVLPVLKLALVCTSQIPSSRPSMGEVVQIL 993
Query: 875 QVIKTPLPQRMEVF 888
QVIKTP+PQRME+F
Sbjct: 994 QVIKTPVPQRMEIF 1007
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224131472|ref|XP_002321093.1| predicted protein [Populus trichocarpa] gi|222861866|gb|EEE99408.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1214 bits (3140), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 644/894 (72%), Positives = 740/894 (82%), Gaps = 40/894 (4%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
LE LN SHNSLSG IP S L+ NM ++KFLDLS N +GP+P LF N SLRYLSLAGN
Sbjct: 125 LESLNLSHNSLSGLIP-SFLD-NMSSLKFLDLSENSFTGPLPDDLFRNSFSLRYLSLAGN 182
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+LQGPI CSSLNT+NLSNN FSGD DF +G WSL+RLR LDLSHN FSGS+PQ
Sbjct: 183 LLQGPIPSSLFSCSSLNTINLSNNQFSGDPDFVTG--TWSLERLRKLDLSHNEFSGSVPQ 240
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
GV+A+H LKEL LQGN+FSGPLP DIG C HL LDLS+NLF+G LP SL+ L+S+ + S
Sbjct: 241 GVSAIHNLKELHLQGNRFSGPLPVDIGLCRHLNRLDLSSNLFSGALPESLQGLSSINYFS 300
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSL------------------------PS 238
+S N LTG+ P WIG++S LE+LD S+N LTGS+ P+
Sbjct: 301 LSKNMLTGEFPRWIGSLSNLEYLDLSSNALTGSISSSIGDLKSLRYLSLSNNKLLGNIPA 360
Query: 239 SLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQT 298
S+ +C LS IRLRGNS NG+IPEGLFDLGLEE+D S NG +GSIP GSS T F +
Sbjct: 361 SIVSCTMLSAIRLRGNSFNGSIPEGLFDLGLEEVDFSHNGLIGSIPSGSS-----TFFTS 415
Query: 299 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY 358
L LDLS NNL G IPAEMGL ++LRYLNLS N+L SR+PPELGYF +L LDLR+NAL
Sbjct: 416 LHTLDLSRNNLTGHIPAEMGLSSDLRYLNLSWNNLESRMPPELGYFQNLTVLDLRSNALA 475
Query: 359 GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 418
GSIP ++CES SL ILQLDGNSL G +P+ I NC+SLYLLSLS N+LSGSIPKSIS L+K
Sbjct: 476 GSIPADICESGSLNILQLDGNSLVGQVPEEIGNCSSLYLLSLSQNNLSGSIPKSISRLDK 535
Query: 419 LKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGIC 478
LKILKLEFNEL+GE+PQELGKL +LLAVN+SYN+LIGRLPV G+FP+LDQS+LQGNLGIC
Sbjct: 536 LKILKLEFNELTGEVPQELGKLENLLAVNISYNKLIGRLPVRGIFPSLDQSALQGNLGIC 595
Query: 479 SPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSN----HHHMFFSVSAIVAIIA 534
SPLLKGPCKMNVPKPLVLDP+AY NQ DG S SS HHHMF SVSAI+AI A
Sbjct: 596 SPLLKGPCKMNVPKPLVLDPNAY-GNQGDGQ-KPRSASSRPARFHHHMFLSVSAIIAISA 653
Query: 535 AILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCS 594
AI I GV++ISLLNVS R+RL FV+ LESMCSSSS+S NL GK++LFDS+SS D
Sbjct: 654 AIFIMFGVILISLLNVSVRKRLAFVDHALESMCSSSSKSGNLVTGKLVLFDSKSSP-DWI 712
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
PE+LL KAAE+G+GVFGTVYKVS G++ RM+A+KKL+TS+IIQYPEDF+REVRVLGKA
Sbjct: 713 NSPESLLNKAAEIGQGVFGTVYKVSLGSEARMVAIKKLITSNIIQYPEDFDREVRVLGKA 772
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
RHPNL+SL+GYYWTPQL+LLVS+YAPNGSLQ+KLHERL STPPLSW NR K++LGTAKGL
Sbjct: 773 RHPNLLSLKGYYWTPQLQLLVSEYAPNGSLQSKLHERLTSTPPLSWANRLKIVLGTAKGL 832
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
AHLHHSFRPPIIHYN+KPSNILLD+N+NP+ISDFGLARLLT+LD+HVMS+RFQSALGYVA
Sbjct: 833 AHLHHSFRPPIIHYNIKPSNILLDENFNPKISDFGLARLLTKLDRHVMSSRFQSALGYVA 892
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
PEL CQSLR+NEKCDIYGFGVLILELVTGRRPVEYGEDNVVI ++HVRVLLE+GN LDCV
Sbjct: 893 PELACQSLRINEKCDIYGFGVLILELVTGRRPVEYGEDNVVIQNDHVRVLLEQGNALDCV 952
Query: 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEVF 888
DPSMGDYPEDEV+PVLKLALVCT IPSSRPSMAEVVQILQVI+TP+PQRME+F
Sbjct: 953 DPSMGDYPEDEVMPVLKLALVCTSQIPSSRPSMAEVVQILQVIRTPVPQRMEIF 1006
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225433686|ref|XP_002265846.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1192 bits (3083), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 629/902 (69%), Positives = 735/902 (81%), Gaps = 39/902 (4%)
Query: 15 PSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASL 74
P + + LERLN SHNSLSG+IP SL N M +++FLDLS+N L+GP+P ++FEN +SL
Sbjct: 122 PELALITGLERLNLSHNSLSGRIPSSLSN--MTSIRFLDLSHNSLAGPIPDEMFENYSSL 179
Query: 75 RYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
R LSL+ N L+GPI C++L+ LNLS+N FSG+LDF+SG IW+L RLRTLDLSHN
Sbjct: 180 RSLSLSMNFLEGPIPSALLRCTTLSNLNLSSNQFSGNLDFSSG--IWTLNRLRTLDLSHN 237
Query: 135 LFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL 194
+FSGS+P GVAA+H LKEL LQGN+FSGPLP DIG CPHL LD +NLFTG LP SL+
Sbjct: 238 VFSGSVPDGVAAIHNLKELQLQGNRFSGPLPVDIGLCPHLRRLDFCHNLFTGSLPDSLQR 297
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS------------------------NN 230
LNS++F VSNN L GD P WIG++S++E++DFS +N
Sbjct: 298 LNSLVFFGVSNNLLAGDFPQWIGSMSSVEYVDFSGNGFTGSLPASMGNLKSLQFLSLSDN 357
Query: 231 HLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSS 290
LTGS+P SLF C KLSVIRLRGN +G+IPEGLFDLGL+E+DLS N G IPPGSS
Sbjct: 358 RLTGSIPGSLFYCPKLSVIRLRGNGFSGSIPEGLFDLGLDEVDLSGNELEGPIPPGSSR- 416
Query: 291 SSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL 350
LF++L LDLS N L G IPAE+GLF++LRYLNLS N LRSR+PPELGYF +L L
Sbjct: 417 ----LFESLHSLDLSRNKLTGSIPAEIGLFSSLRYLNLSWNSLRSRMPPELGYFQNLTVL 472
Query: 351 DLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP 410
DLRN L+GSIP ++C+S SLGILQLDGNSLTGPIP NC+SLYLLS+SHN L+GSIP
Sbjct: 473 DLRNTFLFGSIPGDICDSGSLGILQLDGNSLTGPIPDEFGNCSSLYLLSMSHNELNGSIP 532
Query: 411 KSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSS 470
KS + L KL+IL+LEFNELSGEIP+ELG L +LLAVNVSYNRLIGRLPVGG+F +LDQS+
Sbjct: 533 KSFAMLKKLEILRLEFNELSGEIPRELGSLENLLAVNVSYNRLIGRLPVGGIFQSLDQSA 592
Query: 471 LQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSN----HHHMFFSV 526
LQGNLGICSPLLKGPCK+NV KPLVLDP + ++G + ++ HHMF SV
Sbjct: 593 LQGNLGICSPLLKGPCKLNVSKPLVLDPYDF-GKPINGQNRRNESTTTPMRFRHHMFLSV 651
Query: 527 SAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDS 586
SAI+AI AA I GV+VISLLNVS RRRL F++T LESMCSSSSRS + GK+ILFDS
Sbjct: 652 SAIIAITAAAFILIGVVVISLLNVSARRRLAFIDTALESMCSSSSRSGSPPTGKLILFDS 711
Query: 587 RSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER 646
R+S D +PE LL KAAE+G GVFGTVYKVS G RM+A+KKLVTS+IIQYPEDF+R
Sbjct: 712 RASQ-DWIANPENLLNKAAEIGGGVFGTVYKVSLGGGARMVAIKKLVTSNIIQYPEDFDR 770
Query: 647 EVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV 706
EVR+LGKARH NLISL+GYYWTPQL+LLV+DYAPNGSLQA+LHER P+TPPLSW NRF++
Sbjct: 771 EVRILGKARHQNLISLKGYYWTPQLQLLVTDYAPNGSLQARLHERPPTTPPLSWPNRFRI 830
Query: 707 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 766
ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD+N NP ISD+GLARLLT+LDKHV+S+RF
Sbjct: 831 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDENCNPMISDYGLARLLTKLDKHVISSRF 890
Query: 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826
QSALGYVAPEL CQSLRVNEKCDIYGFGV+ILE+VTGRRPVEYGEDNVVIL++HVRVLLE
Sbjct: 891 QSALGYVAPELACQSLRVNEKCDIYGFGVMILEIVTGRRPVEYGEDNVVILNDHVRVLLE 950
Query: 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRME 886
+GNVL+CVDPSM +YPE+EVLPVLKLALVCT IPSSRP+MAEVVQILQVIKTP+PQRME
Sbjct: 951 QGNVLECVDPSMNEYPEEEVLPVLKLALVCTSQIPSSRPTMAEVVQILQVIKTPIPQRME 1010
Query: 887 VF 888
F
Sbjct: 1011 AF 1012
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069080|ref|XP_002302895.1| predicted protein [Populus trichocarpa] gi|222844621|gb|EEE82168.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1180 bits (3052), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 639/894 (71%), Positives = 734/894 (82%), Gaps = 40/894 (4%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
LERLN SHNSLSG IP S L+ NM ++KFLDLS N SGP+P LF N SLRYLSLAGN
Sbjct: 104 LERLNLSHNSLSGLIP-SFLD-NMSSIKFLDLSENSFSGPLPDNLFRNSQSLRYLSLAGN 161
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+LQGPI CSSLNT+NLSNNHFSGD DF+SG IWSLKRLR LDLSHN FSGS+PQ
Sbjct: 162 LLQGPIPSSLLSCSSLNTINLSNNHFSGDPDFSSG--IWSLKRLRKLDLSHNEFSGSVPQ 219
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
GV+A+H+LKEL LQGN+FSGPLP DIG CPHL LDLS NLF+G LP SL+ L+SM S
Sbjct: 220 GVSAIHFLKELQLQGNRFSGPLPGDIGLCPHLNRLDLSRNLFSGALPESLQRLSSMSLFS 279
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS----------------------- 239
+S N L G+ P WIG+++ LE+LD S+N LTGS+PSS
Sbjct: 280 LSKNMLAGEFPRWIGSLTNLEYLDLSSNALTGSIPSSIGDLKSLRYLSLSNNKLFGIIPT 339
Query: 240 -LFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQT 298
+ +C LSVIRLRGNS NG+IPEGLFDL LEE+D S+NG +GSIP GS T F +
Sbjct: 340 SMVSCTMLSVIRLRGNSFNGSIPEGLFDLRLEEVDFSDNGLVGSIPSGSI-----TFFSS 394
Query: 299 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY 358
L LDLS NNL G IPAE GL +NLRYLNLS N+L SR+P ELGYF +L LDLRN+AL
Sbjct: 395 LHTLDLSKNNLTGHIPAERGLSSNLRYLNLSWNNLESRMPLELGYFQNLTVLDLRNSALV 454
Query: 359 GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 418
G IP ++CES SL ILQLDGNSL G IP+ I NC+SLYLLSLS N+LSGSIP+SIS LNK
Sbjct: 455 GLIPADICESGSLNILQLDGNSLVGQIPEEIGNCSSLYLLSLSQNNLSGSIPESISRLNK 514
Query: 419 LKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGIC 478
LKILKLEFNEL+GEIPQELGKL +LLAVNVSYN+L+GRLPVGG+FP+LD+S+LQGNLG+C
Sbjct: 515 LKILKLEFNELTGEIPQELGKLENLLAVNVSYNKLVGRLPVGGIFPSLDRSALQGNLGLC 574
Query: 479 SPLLKGPCKMNVPKPLVLDPDAYNSNQMDG----HIHSHSFSSNHHHMFFSVSAIVAIIA 534
SPLLKGPCKMNVPKPLVLDP AY+ NQ DG ++ SH + HHHMF SVS I+AI A
Sbjct: 575 SPLLKGPCKMNVPKPLVLDPYAYD-NQGDGKKPRNVSSHP-ARFHHHMFLSVSTIIAISA 632
Query: 535 AILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCS 594
AI I GV+++SLLNVS R+RL FV+ LESMCSSSSRS NL+ GK++LFDS+SS D
Sbjct: 633 AIFILFGVILVSLLNVSVRKRLAFVDHALESMCSSSSRSGNLSTGKLVLFDSKSSP-DWI 691
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
+PE LL KAAE+G GVFGTVYKVS G++ RM+A+KKL T +IIQYPEDF+REV+VLGKA
Sbjct: 692 SNPEALLNKAAEIGHGVFGTVYKVSLGSEARMVAIKKLFTLNIIQYPEDFDREVQVLGKA 751
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
RHPNL+SL+GYYWTPQL+LLVS+YAPNGSLQAKLHER+PS P LSW NR K++LGTAKGL
Sbjct: 752 RHPNLLSLKGYYWTPQLQLLVSEYAPNGSLQAKLHERIPSAPRLSWANRLKIVLGTAKGL 811
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
AHLHHSFRPPIIH ++KPSNILLD+N+NP+ISDFGLAR L +LD+HV+S RFQSALGYVA
Sbjct: 812 AHLHHSFRPPIIHCDIKPSNILLDENFNPKISDFGLARFLAKLDRHVISTRFQSALGYVA 871
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
PEL+CQSLR+NEKCDIYGFG+LILELVTGRRPVEYGEDNV+IL +HVR LLE+GNV DCV
Sbjct: 872 PELSCQSLRINEKCDIYGFGILILELVTGRRPVEYGEDNVLILKDHVRFLLEQGNVFDCV 931
Query: 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEVF 888
DPSMGDYPEDEVLPVLKLALVCT HIPSSRPSMAEVVQILQVIKTP+PQR E F
Sbjct: 932 DPSMGDYPEDEVLPVLKLALVCTSHIPSSRPSMAEVVQILQVIKTPVPQRTEFF 985
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499695|ref|XP_003518672.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1154 bits (2984), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/901 (67%), Positives = 721/901 (80%), Gaps = 39/901 (4%)
Query: 15 PSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASL 74
PS+ + LERLN SHN+LSG IP S +N+N +++FLDLS N SGPVP FE+C+SL
Sbjct: 119 PSLTLSNSLERLNLSHNALSGSIPTSFVNMN--SIRFLDLSENSFSGPVPESFFESCSSL 176
Query: 75 RYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
++SLA NI GPI + CSSLN++NLSNN FSG++DF+ GIWSL RLRTLDLS+N
Sbjct: 177 HHISLARNIFDGPIPGSLSRCSSLNSINLSNNRFSGNVDFS---GIWSLNRLRTLDLSNN 233
Query: 135 LFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL 194
SGS+P G++++H KE+LLQGNQFSGPL DIGFC HL+ LD S+N +G+LP SL +
Sbjct: 234 ALSGSLPNGISSIHNFKEILLQGNQFSGPLSTDIGFCLHLSRLDFSDNQLSGELPESLGM 293
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLP----------------- 237
L+S+ + SNN + P WIGN++ LE+L+ SNN TGS+P
Sbjct: 294 LSSLSYFKASNNHFNSEFPQWIGNMTNLEYLELSNNQFTGSIPQSIGELRSLTHLSISNN 353
Query: 238 -------SSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSS 290
SSL +C KLSV++LRGN NG IPE LF LGLE+IDLS NG GSIPPGSS
Sbjct: 354 KLVGTIPSSLSSCTKLSVVQLRGNGFNGTIPEALFGLGLEDIDLSHNGLSGSIPPGSS-- 411
Query: 291 SSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL 350
L +TL LDLS N+L G+IPAE GL + LRYLNLS N L S++PPE G +L L
Sbjct: 412 ---RLLETLTNLDLSDNHLQGNIPAETGLLSKLRYLNLSWNDLHSQMPPEFGLLQNLTVL 468
Query: 351 DLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP 410
DLRN+AL+GSIP ++C+S +L +LQLDGNS G IP I NC+SLYLLS SHN+L+GSIP
Sbjct: 469 DLRNSALHGSIPADICDSGNLAVLQLDGNSFEGNIPSEIGNCSSLYLLSSSHNNLTGSIP 528
Query: 411 KSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSS 470
KS++ LNKLKILKLEFNELSGEIP ELG L SLLAVN+SYNRL GRLP +F LD+SS
Sbjct: 529 KSMAKLNKLKILKLEFNELSGEIPMELGMLQSLLAVNISYNRLTGRLPTSSIFQNLDKSS 588
Query: 471 LQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSN---HHHMFFSVS 527
L+GNLG+CSPLLKGPCKMNVPKPLVLDP+AYN NQ+ + S + H H F SVS
Sbjct: 589 LEGNLGLCSPLLKGPCKMNVPKPLVLDPNAYN-NQISPQRQRNESSESGQVHRHRFLSVS 647
Query: 528 AIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSR 587
AIVAI A+ +I GV+ +SLLNVS RRRLTFV+ LESMCSSSSRS + A GK+ILFDS
Sbjct: 648 AIVAISASFVIVLGVIAVSLLNVSVRRRLTFVDNALESMCSSSSRSGSPATGKLILFDSH 707
Query: 588 SSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFERE 647
SS D +PE+LL KA+E+GEGVFGT+YKV G+QGRM+A+KKL++S+IIQYPEDF+RE
Sbjct: 708 SSP-DWISNPESLLNKASEIGEGVFGTLYKVPLGSQGRMVAIKKLISSNIIQYPEDFDRE 766
Query: 648 VRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVI 707
VR+LGKARHPNLI+L+GYYWTPQL+LLV+++APNGSLQAKLHERLPS+PPLSW RFK++
Sbjct: 767 VRILGKARHPNLIALKGYYWTPQLQLLVTEFAPNGSLQAKLHERLPSSPPLSWAIRFKIL 826
Query: 708 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 767
LGTAKGLAHLHHSFRPPIIHYN+KPSNILLD+NYN +ISDFGLARLLT+LD+HVMSNRFQ
Sbjct: 827 LGTAKGLAHLHHSFRPPIIHYNIKPSNILLDENYNAKISDFGLARLLTKLDRHVMSNRFQ 886
Query: 768 SALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827
SALGYVAPEL CQSLRVNEKCD+YGFGV+ILELVTGRRPVEYGEDNV+IL++HVRVLLE
Sbjct: 887 SALGYVAPELACQSLRVNEKCDVYGFGVMILELVTGRRPVEYGEDNVLILNDHVRVLLEH 946
Query: 828 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEV 887
GNVL+CVD SM +YPEDEVLPVLKLA+VCT IPSSRP+MAEVVQILQVIKTP+PQRMEV
Sbjct: 947 GNVLECVDQSMSEYPEDEVLPVLKLAMVCTSQIPSSRPTMAEVVQILQVIKTPVPQRMEV 1006
Query: 888 F 888
F
Sbjct: 1007 F 1007
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568921|ref|XP_003552656.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1150 bits (2975), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 609/912 (66%), Positives = 729/912 (79%), Gaps = 40/912 (4%)
Query: 5 LVHGNSYNAI-PSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPV 63
L H N +I PS+ + LERLN SHN LSG IP S +N+N ++KFLDLS N SGP+
Sbjct: 108 LSHNNLSGSISPSLTLSNSLERLNLSHNVLSGSIPTSFVNMN--SIKFLDLSENSFSGPM 165
Query: 64 PYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSL 123
P FE+C+SL ++SLA N+ GP+ + CSSLN++NLSNNHFSG++DF+ GIWSL
Sbjct: 166 PESFFESCSSLHHISLARNMFDGPVPGSLSRCSSLNSINLSNNHFSGNVDFS---GIWSL 222
Query: 124 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL 183
RLRTLDLS+N SGS+P G++++H KE+LLQGNQFSGPL DIGFC HL LD S+N
Sbjct: 223 NRLRTLDLSNNALSGSLPNGISSVHNFKEILLQGNQFSGPLSTDIGFCLHLNRLDFSDNQ 282
Query: 184 FTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLP------ 237
F+G+LP SL +L+S+ + SNN + P WIGN+++LE+L+ SNN TGS+P
Sbjct: 283 FSGELPESLGMLSSLSYFKASNNHFNSEFPQWIGNMTSLEYLELSNNQFTGSIPQSIGEL 342
Query: 238 ------------------SSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGF 279
SSL C KLSV++LRGN NG IPEGLF LGLEEIDLS N
Sbjct: 343 RSLTHLSISNNMLVGTIPSSLSFCTKLSVVQLRGNGFNGTIPEGLFGLGLEEIDLSHNEL 402
Query: 280 MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPP 339
GSIPPGSS L +TL LDLS N+L G+IPAE GL + L +LNLS N L S++PP
Sbjct: 403 SGSIPPGSS-----RLLETLTHLDLSDNHLQGNIPAETGLLSKLTHLNLSWNDLHSQMPP 457
Query: 340 ELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 399
E G +L LDLRN+AL+GSIP ++C+S +L +LQLDGNS G IP I NC+SLYLLS
Sbjct: 458 EFGLLQNLAVLDLRNSALHGSIPADICDSGNLAVLQLDGNSFEGNIPSEIGNCSSLYLLS 517
Query: 400 LSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPV 459
LSHN+L+GSIPKS+S LNKLKILKLEFNELSGEIP ELG L SLLAVN+SYNRL GRLP
Sbjct: 518 LSHNNLTGSIPKSMSKLNKLKILKLEFNELSGEIPMELGMLQSLLAVNISYNRLTGRLPT 577
Query: 460 GGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSN- 518
+F LD+SSL+GNLG+CSPLLKGPCKMNVPKPLVLDP+AYN NQ+ ++ S +
Sbjct: 578 SSIFQNLDKSSLEGNLGLCSPLLKGPCKMNVPKPLVLDPNAYN-NQISPQRQTNESSESG 636
Query: 519 --HHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNL 576
H H F SVSAIVAI A+ +I GV+ +SLLNVS RRRLTF++ LESMCSSSSRS +
Sbjct: 637 PVHRHRFLSVSAIVAISASFVIVLGVIAVSLLNVSVRRRLTFLDNALESMCSSSSRSGSP 696
Query: 577 AAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD 636
A GK+ILFDS+SS D +PE+LL KA+E+GEGVFGT+YKV G+QGRM+A+KKL++++
Sbjct: 697 ATGKLILFDSQSSP-DWISNPESLLNKASEIGEGVFGTLYKVPLGSQGRMVAIKKLISTN 755
Query: 637 IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP 696
IIQYPEDF+REVR+LGKARHPNLI+L+GYYWTPQL+LLV+++APNGSLQAKLHERLPS+P
Sbjct: 756 IIQYPEDFDREVRILGKARHPNLIALKGYYWTPQLQLLVTEFAPNGSLQAKLHERLPSSP 815
Query: 697 PLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756
PLSW RFK++LGTAKGLAHLHHSFRPPIIHYN+KPSNILLD+NYN +ISDFGLARLLT+
Sbjct: 816 PLSWAIRFKILLGTAKGLAHLHHSFRPPIIHYNIKPSNILLDENYNAKISDFGLARLLTK 875
Query: 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 816
LD+HVMSNRFQSALGYVAPEL CQSLRVNEKCD+YGFGV+ILELVTGRRPVEYGEDNV+I
Sbjct: 876 LDRHVMSNRFQSALGYVAPELACQSLRVNEKCDVYGFGVMILELVTGRRPVEYGEDNVLI 935
Query: 817 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876
L++HVRVLLE+GNVL+CVD SM +YPEDEVLPVLKLA+VCT IPSSRP+MAEVVQILQV
Sbjct: 936 LNDHVRVLLEQGNVLECVDQSMSEYPEDEVLPVLKLAMVCTSQIPSSRPTMAEVVQILQV 995
Query: 877 IKTPLPQRMEVF 888
IKTP+PQRMEVF
Sbjct: 996 IKTPVPQRMEVF 1007
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469172|ref|XP_004152295.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1142 bits (2953), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/911 (66%), Positives = 721/911 (79%), Gaps = 45/911 (4%)
Query: 8 GNSY--NAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPY 65
GN++ N P +V+ L+R+NFS NSLSG+IP SL++ M +++FLD S+NLLSGP+P
Sbjct: 109 GNNFTGNLSPQLVLPPSLDRVNFSGNSLSGRIPVSLIS--MSSIRFLDFSDNLLSGPLPD 166
Query: 66 QLFENCASLRYLSLAGNILQGPIGKIF-NYCSSLNTLNLSNNHFSGDLDFASGYGIWSLK 124
++F NC+SL YLSLA N+LQGP+ C LNTLNLS N FSG L+FA G IWSL
Sbjct: 167 EMFVNCSSLHYLSLASNMLQGPVPNTLPTRCLYLNTLNLSTNQFSGSLNFAPG--IWSLA 224
Query: 125 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLF 184
RLRTLDLS N FSG +PQG++A+H LKEL LQ NQFSGPLP+D+G C HL TLD+S N
Sbjct: 225 RLRTLDLSKNDFSGVLPQGISAIHNLKELKLQNNQFSGPLPSDLGLCVHLATLDVSGNRL 284
Query: 185 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS---------------- 228
TG LP S+RLL S+ F+++ N+ + ++P WIGN+ LE++DFS
Sbjct: 285 TGPLPNSMRLLTSLTFLNIGFNSFSDELPQWIGNMGRLEYMDFSSNGFTGSLPLTMGGLR 344
Query: 229 --------NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFM 280
NN LTG++P +L C +LSVI+L GNSLNG +PEGLF+LGLEE+DLS+N +
Sbjct: 345 SVKYMSFSNNKLTGNIPETLMECSELSVIKLEGNSLNGRVPEGLFELGLEEMDLSKNELI 404
Query: 281 GSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE 340
GSIP GSS L++ L +DLSSN L G+ PAEMGL+ NLRYLNLS N +++IPPE
Sbjct: 405 GSIPVGSS-----RLYEKLTRMDLSSNRLEGNFPAEMGLYRNLRYLNLSWNEFKAKIPPE 459
Query: 341 LGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSL 400
+G F +L LD+R++ LYGSIP E+C+S SL ILQLDGNSL GPIP I NC SLYLLSL
Sbjct: 460 MGLFENLNVLDIRSSDLYGSIPGELCDSGSLKILQLDGNSLVGPIPDEIGNCLSLYLLSL 519
Query: 401 SHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG 460
SHN+LSG IPKSIS L+KL+IL+LE NELSGEIPQELG L +LLAVN+SYN L GRLPVG
Sbjct: 520 SHNNLSGEIPKSISKLSKLEILRLESNELSGEIPQELGILQNLLAVNISYNMLTGRLPVG 579
Query: 461 GVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFS--SN 518
G+FP+LDQS+LQGNLG+CSPLLKGPCKMNVPKPLVLDP+AY NQM G + S SN
Sbjct: 580 GIFPSLDQSALQGNLGLCSPLLKGPCKMNVPKPLVLDPNAY-PNQMGGQSSRNRPSQLSN 638
Query: 519 H--HHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRR-LTFVETTLESMCSSSSRSVN 575
H HH+FFSVSAIVAI AA LIA GVLVI+LLNVS RRR L FV+ LES SSS
Sbjct: 639 HSSHHVFFSVSAIVAISAATLIALGVLVITLLNVSARRRSLAFVDNALESCSSSSKSGT- 697
Query: 576 LAAGKVILFDSRS-SSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVT 634
+ AGK+ILFDS S +SL+ + E LL KA+E+G GVFGTVYKVS G G + A+KKLV
Sbjct: 698 VTAGKLILFDSNSKASLNWVSNHEALLNKASEIGGGVFGTVYKVSLGDGGDV-AMKKLVK 756
Query: 635 SDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPS 694
SDIIQ PEDF+RE+RVLGK +HPNLISL+GYYWT Q +LLV +YA NGSLQ +LH RLPS
Sbjct: 757 SDIIQNPEDFDREIRVLGKVKHPNLISLKGYYWTVQTQLLVMEYANNGSLQTQLHGRLPS 816
Query: 695 TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754
PPLSW NRFK++LGTAKGLAHLHHSFRPPI+HYNLKP+NILLD+N+NP+ISD+GLARLL
Sbjct: 817 APPLSWDNRFKIVLGTAKGLAHLHHSFRPPIVHYNLKPTNILLDENFNPKISDYGLARLL 876
Query: 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
T+LDKHVM+NRFQSALGYVAPEL CQS+RVNEKCD++GFGV+ILE+VTGRRPVEYGEDNV
Sbjct: 877 TKLDKHVMNNRFQSALGYVAPELACQSIRVNEKCDVHGFGVMILEIVTGRRPVEYGEDNV 936
Query: 815 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
VIL++HVR LLE GNVLDCVDPSM Y EDEV+P+LKLALVCT IPSSRPSMAEVVQIL
Sbjct: 937 VILTDHVRYLLERGNVLDCVDPSMTQYSEDEVVPILKLALVCTSQIPSSRPSMAEVVQIL 996
Query: 875 QVIKTPLPQRM 885
QVIK PLPQR+
Sbjct: 997 QVIKAPLPQRI 1007
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449484810|ref|XP_004156987.1| PREDICTED: LOW QUALITY PROTEIN: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1139 bits (2946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 605/911 (66%), Positives = 720/911 (79%), Gaps = 45/911 (4%)
Query: 8 GNSY--NAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPY 65
GN++ N P +V+ L+R+NFS NSLSG+IP SL++ M +++FLD S+NLLSGP+P
Sbjct: 109 GNNFTGNLSPQLVLPPSLDRVNFSGNSLSGRIPVSLIS--MSSIRFLDFSDNLLSGPLPD 166
Query: 66 QLFENCASLRYLSLAGNILQGPIGKIF-NYCSSLNTLNLSNNHFSGDLDFASGYGIWSLK 124
++F NC+SL YLSLA N+LQGP+ C LNTLNLS N FSG L+FA G IWSL
Sbjct: 167 EMFVNCSSLHYLSLASNMLQGPVPNTLPTRCLYLNTLNLSTNQFSGSLNFAPG--IWSLA 224
Query: 125 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLF 184
RLRTLDLS N FSG +PQG++A+H LKEL LQ NQFSGPLP+D+G C HL TLD+S N
Sbjct: 225 RLRTLDLSKNDFSGVLPQGISAIHNLKELKLQNNQFSGPLPSDLGLCVHLATLDVSGNRL 284
Query: 185 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS---------------- 228
TG LP S+RLL S+ F+++ N+ + ++P WIGN+ LE++DFS
Sbjct: 285 TGPLPNSMRLLTSLTFLNIGFNSFSDELPQWIGNMGRLEYMDFSSNGFTGSLPLTMGGLR 344
Query: 229 --------NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFM 280
NN LTG++P +L C +LSVI+L GNSLNG +PEGLF+LGLEE+DLS+N +
Sbjct: 345 SVKYMSFSNNKLTGNIPETLMECSELSVIKLEGNSLNGRVPEGLFELGLEEMDLSKNELI 404
Query: 281 GSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE 340
GSIP GSS L++ L +DLSSN L G+ PAEMGL+ NLRYLNLS N +++IPPE
Sbjct: 405 GSIPVGSS-----RLYEKLTRMDLSSNRLEGNFPAEMGLYRNLRYLNLSWNEFKAKIPPE 459
Query: 341 LGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSL 400
+G F +L LD+R++ LYGSIP E+C+S SL ILQLDGNSL GPIP I NC SLYLLSL
Sbjct: 460 MGLFENLNVLDIRSSDLYGSIPGELCDSGSLKILQLDGNSLVGPIPDEIGNCLSLYLLSL 519
Query: 401 SHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG 460
SHN+LSG IPKSIS L+KL+IL+LE NELSGEIPQELG L +LLAVN+SYN L GRLPVG
Sbjct: 520 SHNNLSGEIPKSISKLSKLEILRLESNELSGEIPQELGILQNLLAVNISYNMLTGRLPVG 579
Query: 461 GVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFS--SN 518
G+FP+LDQS+LQGNLG+CSPLLKGPCKMNVPKPLVLDP+AY NQM G + S SN
Sbjct: 580 GIFPSLDQSALQGNLGLCSPLLKGPCKMNVPKPLVLDPNAY-PNQMGGQSSRNRPSQLSN 638
Query: 519 H--HHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRR-LTFVETTLESMCSSSSRSVN 575
H HH+FFSVSAIVAI AA LIA GVLVI+LLNVS RRR L FV+ LES SSS
Sbjct: 639 HSSHHVFFSVSAIVAISAATLIALGVLVITLLNVSARRRSLAFVDNALESCSSSSKSGT- 697
Query: 576 LAAGKVILFDSRS-SSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVT 634
+ AGK+ILFDS S +SL+ + E LL KA+E+G GVFGTVYKVS G G + A+KKLV
Sbjct: 698 VTAGKLILFDSNSKASLNWVSNHEALLNKASEIGGGVFGTVYKVSLGDGGDV-AMKKLVK 756
Query: 635 SDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPS 694
SDIIQ PEDF+RE+RVLGK +HPNLISL+GYYWT Q +LLV +YA NGSLQ +LH RLPS
Sbjct: 757 SDIIQNPEDFDREIRVLGKVKHPNLISLKGYYWTVQTQLLVMEYANNGSLQTQLHGRLPS 816
Query: 695 TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754
PPLSW NRFK++LGTAKGLAHLHHSF PPI+HYNLKP+NILLD+N+NP+ISD+GLARLL
Sbjct: 817 APPLSWDNRFKIVLGTAKGLAHLHHSFXPPIVHYNLKPTNILLDENFNPKISDYGLARLL 876
Query: 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
T+LDKHVM+NRFQSALGYVAPEL CQS+RVNEKCD++GFGV+ILE+VTGRRPVEYGEDNV
Sbjct: 877 TKLDKHVMNNRFQSALGYVAPELACQSIRVNEKCDVHGFGVMILEIVTGRRPVEYGEDNV 936
Query: 815 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
VIL++HVR LLE GNVLDCVDPSM Y EDEV+P+LKLALVCT IPSSRPSMAEVVQIL
Sbjct: 937 VILTDHVRYLLERGNVLDCVDPSMTQYSEDEVVPILKLALVCTSQIPSSRPSMAEVVQIL 996
Query: 875 QVIKTPLPQRM 885
QVIK PLPQR+
Sbjct: 997 QVIKAPLPQRI 1007
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357502883|ref|XP_003621730.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355496745|gb|AES77948.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1115 bits (2884), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 591/895 (66%), Positives = 719/895 (80%), Gaps = 19/895 (2%)
Query: 1 MTTPLVHGNSYNAI-PSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLL 59
+T L H N I PS+ + L++LN SHNS SG +P S +N M +++F+DLS+N
Sbjct: 134 VTLSLSHNNFSGTISPSLTLSNTLQKLNLSHNSFSGPLPLSFVN--MSSIRFIDLSHNSF 191
Query: 60 SGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYG 119
+G +P FENC SLR +SL+ N+ +G I + CS LN+++LSNNHFSG++DF+
Sbjct: 192 AGQMPDGFFENCFSLRRVSLSMNLFEGQIPTTLSKCSLLNSVDLSNNHFSGNVDFSR--- 248
Query: 120 IWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDL 179
+WSL RLR+LDLS+N SG++ G+++LH LKELLL+ NQFSG LP DIGFC HL +DL
Sbjct: 249 VWSLNRLRSLDLSNNALSGNLVNGISSLHNLKELLLENNQFSGQLPNDIGFCLHLNRVDL 308
Query: 180 SNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS 239
S N F+G+LP S LNS+ ++ VSNN L G+ P WIGN+ +LE LD S+N G++P S
Sbjct: 309 STNQFSGELPESFGRLNSLSYLRVSNNLLFGEFPQWIGNLISLEDLDLSHNQFYGNIPLS 368
Query: 240 LFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 299
L +C KLS I LRGNS NG IPEGLF LGLEEID S N +GSIP GS+ L +TL
Sbjct: 369 LVSCTKLSKIFLRGNSFNGTIPEGLFGLGLEEIDFSHNELIGSIPAGSNR-----LLETL 423
Query: 300 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 359
LDLS N+L G+IPAE+GL + LR+LNLS N L S+IPPE G +L LDLRN+AL+G
Sbjct: 424 TKLDLSVNHLQGNIPAEIGLLSKLRFLNLSWNDLHSQIPPEFGLLQNLEVLDLRNSALFG 483
Query: 360 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKL 419
SIP++ C+S +L +LQLDGNSL G IP+ I NC+SLYLL LSHN+L+G +PKS+SNLNKL
Sbjct: 484 SIPEDTCDSGNLAVLQLDGNSLKGSIPEKIGNCSSLYLLGLSHNNLTGPVPKSMSNLNKL 543
Query: 420 KILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICS 479
KILKLEFNELSGE+P ELGKL +LLAVN+S+N L GRLP+G +F LD+SSL+GN G+CS
Sbjct: 544 KILKLEFNELSGELPMELGKLQNLLAVNISHNSLTGRLPIGSIFQNLDKSSLEGNYGLCS 603
Query: 480 PLLKGPCKMNVPKPLVLDPDAYNSNQMDGHI----HSHSFSSNHHHMFFSVSAIVAIIAA 535
PLL GPCKMNVPKPLVLDP YN +QM+ I S S S HHH F S+SAI+AI A
Sbjct: 604 PLLTGPCKMNVPKPLVLDPHGYN-DQMNPRIPRNESSESSSPIHHHRFLSISAIIAISAI 662
Query: 536 ILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSI 595
I+I GV+ ISL+N S RR+L FVE LESMCSSSSRS A GK+ILFDS+SS D
Sbjct: 663 IVIVIGVIAISLVNASVRRKLAFVENALESMCSSSSRSGAPATGKLILFDSQSSP-DWIS 721
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQ-GRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
+PE LL KA+E+GEGVFGTV+KV G+Q GR +A+KKL+TS+I+QYPEDF+REVR+LG A
Sbjct: 722 NPENLLNKASEIGEGVFGTVFKVPLGSQQGRNVAIKKLITSNILQYPEDFDREVRILGNA 781
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
RHPNLI+L+GYYWTPQL+LLVS++APNG+LQ+KLHE+LPS+PPLSW NRFK++LGTAKGL
Sbjct: 782 RHPNLIALKGYYWTPQLQLLVSEFAPNGNLQSKLHEKLPSSPPLSWPNRFKILLGTAKGL 841
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
AHLHHSFRPPIIHYN+KPSNILLD+N+N +ISDFGLARLLT+LDKHVMSNRFQSALGYVA
Sbjct: 842 AHLHHSFRPPIIHYNIKPSNILLDENFNAKISDFGLARLLTKLDKHVMSNRFQSALGYVA 901
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
PEL CQSLRVNEKCD+YGFGV+ILE+VTGRRPVEYGEDNV+IL++HVRVLLE GN L+CV
Sbjct: 902 PELACQSLRVNEKCDVYGFGVMILEIVTGRRPVEYGEDNVLILNDHVRVLLEHGNALECV 961
Query: 835 DPS-MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEVF 888
DPS M +YPEDEVLPVLKLA+VCT IPSSRP+MAEVVQILQVIKTP+PQRMEVF
Sbjct: 962 DPSLMNEYPEDEVLPVLKLAMVCTSQIPSSRPTMAEVVQILQVIKTPVPQRMEVF 1016
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297815072|ref|XP_002875419.1| hypothetical protein ARALYDRAFT_484589 [Arabidopsis lyrata subsp. lyrata] gi|297321257|gb|EFH51678.1| hypothetical protein ARALYDRAFT_484589 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1047 bits (2707), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 554/900 (61%), Positives = 692/900 (76%), Gaps = 45/900 (5%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L++L+ SHN+LSGQIP SL +++ +++ LDL+ N SG + F NC+SLRYLSL+ N
Sbjct: 126 LQKLDLSHNNLSGQIPSSLGSIS--SLQHLDLTGNSFSGTLSDDFFNNCSSLRYLSLSHN 183
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
L+G I CS LN+LNLS N FSG F SG+ W L+RLR LDLS N SGSIP
Sbjct: 184 HLEGQIPSTLFQCSVLNSLNLSRNRFSGS--FVSGF--WRLERLRALDLSSNSLSGSIPL 239
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
G+ +LH LKEL LQ NQFSG LP+DIG CPHL +DLS NLF+G+LP +L+ L S+
Sbjct: 240 GILSLHNLKELQLQRNQFSGSLPSDIGLCPHLNRVDLSFNLFSGELPRTLQKLRSLNHFD 299
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPS------------------------ 238
+S N L+GD P WIG+++ L LDFS+N LTG LPS
Sbjct: 300 LSKNLLSGDFPAWIGDMTGLVHLDFSSNELTGELPSLIGNLRSLKDLILSENKISGEIPE 359
Query: 239 SLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQT 298
SL +C++L +++L+GN +G+IP+GLFDLGL+E+D S NGF GSIP GSS LF++
Sbjct: 360 SLESCQELMIVQLKGNGFSGSIPDGLFDLGLQEMDFSGNGFTGSIPRGSS-----RLFES 414
Query: 299 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY 358
L+ LDLS NNL G IP E+GLF N+RYLNLS NH +R+PPE+ + +LI LDLR +AL
Sbjct: 415 LKRLDLSRNNLTGSIPGEVGLFINMRYLNLSWNHFNTRVPPEIEFLQNLIVLDLRYSALI 474
Query: 359 GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 418
GS+P ++CES+SL ILQLDGNSLTG IP+ I NC+SL LLSLSHN+L+G IPKS+SNL +
Sbjct: 475 GSVPADICESQSLQILQLDGNSLTGSIPEGIGNCSSLKLLSLSHNNLTGPIPKSLSNLQE 534
Query: 419 LKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGIC 478
LKILKLE N+LSGEIP+ELG+L +LL VNVS+NRLIGRLPVGGVF +LDQS++QGNLGIC
Sbjct: 535 LKILKLEANKLSGEIPKELGELQNLLLVNVSFNRLIGRLPVGGVFQSLDQSAIQGNLGIC 594
Query: 479 SPLLKGPCKMNVPKPLVLDPDAY-NSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAIL 537
SPLL+GPC +NVPKPLV+DP++Y + N M G+ S HH MF SVS IVAI AAIL
Sbjct: 595 SPLLRGPCTLNVPKPLVIDPNSYGHGNNMPGNRGSSGSGKFHHRMFLSVSVIVAISAAIL 654
Query: 538 IAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRS-VNLAAGKVILFDSRSSSL----- 591
I GV++I+LLN S RRRL FV+ LES+ S SS+S +L GK++L +SR+S
Sbjct: 655 IFSGVIIITLLNASVRRRLAFVDNALESIFSGSSKSGRSLMMGKLVLLNSRTSRSSSSSQ 714
Query: 592 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 651
+ +P++LL KA+ +GEGVFGTVYK G QGR LAVKKLV S I+Q EDF+REVR+L
Sbjct: 715 EFERNPDSLLNKASRIGEGVFGTVYKAPLGEQGRNLAVKKLVPSPILQNLEDFDREVRIL 774
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
KA+HPNL+S++GY+WTP+L LLVS+Y PNG+LQ+KLHER PSTPPLSW R+++ILGTA
Sbjct: 775 AKAKHPNLVSIKGYFWTPELHLLVSEYIPNGNLQSKLHEREPSTPPLSWDVRYRIILGTA 834
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM-SNRFQSAL 770
KGLA+LHH+FRP IH+NLKP+NILLD+ NP+ISDFGL+RLLT D + M +NRFQ+AL
Sbjct: 835 KGLAYLHHTFRPATIHFNLKPTNILLDEKNNPKISDFGLSRLLTTQDGNTMNNNRFQNAL 894
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830
GYVAPEL CQ+LRVNEKCD+YGFGVLILELVTGRRPVEYGED+ VILS+HVRV+LE+GNV
Sbjct: 895 GYVAPELECQNLRVNEKCDVYGFGVLILELVTGRRPVEYGEDSFVILSDHVRVMLEQGNV 954
Query: 831 LDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP-QRMEVF 888
L+C+DP M + Y EDEVLPVLKLALVCT IPS+RP+MAE+VQILQVI +P+P Q M+ F
Sbjct: 955 LECIDPVMEEQYSEDEVLPVLKLALVCTSQIPSNRPTMAEIVQILQVINSPVPHQIMDSF 1014
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 888 | ||||||
| TAIR|locus:2091353 | 1016 | AT3G28040 [Arabidopsis thalian | 0.985 | 0.861 | 0.517 | 3.6e-231 | |
| TAIR|locus:2102499 | 964 | AT3G56370 [Arabidopsis thalian | 0.958 | 0.882 | 0.384 | 3.1e-154 | |
| TAIR|locus:2181042 | 967 | AT5G01890 [Arabidopsis thalian | 0.942 | 0.865 | 0.364 | 8.3e-138 | |
| TAIR|locus:2034725 | 882 | AT1G12460 [Arabidopsis thalian | 0.371 | 0.374 | 0.440 | 1.6e-111 | |
| TAIR|locus:2015504 | 890 | AT1G62950 [Arabidopsis thalian | 0.359 | 0.358 | 0.428 | 7.1e-109 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.506 | 0.444 | 0.303 | 3.2e-96 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.352 | 0.262 | 0.371 | 8e-94 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.521 | 0.420 | 0.329 | 2.7e-91 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.514 | 0.472 | 0.313 | 5.2e-90 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.515 | 0.474 | 0.315 | 7.1e-90 |
| TAIR|locus:2091353 AT3G28040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2230 (790.1 bits), Expect = 3.6e-231, P = 3.6e-231
Identities = 463/895 (51%), Positives = 592/895 (66%)
Query: 5 LVHGNSYNAIPSMV-VFRILERLNFSHNSLSGQIPPSXXXXXXXXXKFLDLSNNLLSGPV 63
L H N IPS + L+ L+ + NS SG + ++L LS+N L G +
Sbjct: 131 LSHNNLSGQIPSSLGSITSLQHLDLTGNSFSGTLSDDLFNNCSSL-RYLSLSHNHLEGQI 189
Query: 64 PYQLFENCASLRYLSLAGNILQGPIGKIFNYCXXXXXXXXXXXHFSGDLDFASGYGIWSL 123
P LF C+ L L+L+ N G + S L + GI SL
Sbjct: 190 PSTLFR-CSVLNSLNLSRNRFSGNPSFVSGIWRLERLRALDLS--SNSLSGSIPLGILSL 246
Query: 124 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL 183
L+ L L N FSG++P + +L + L N FSG LP + L D+SNNL
Sbjct: 247 HNLKELQLQRNQFSGALPSDIGLCPHLNRVDLSSNHFSGELPRTLQKLKSLNHFDVSNNL 306
Query: 184 FTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC 243
+G P + + ++ + S+N LTG +P I N+ +L+ L+ S N L+G +P SL +C
Sbjct: 307 LSGDFPPWIGDMTGLVHLDFSSNELTGKLPSSISNLRSLKDLNLSENKLSGEVPESLESC 366
Query: 244 KKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGXXXXXXXTLFQTLRILD 303
K+L +++L+GN +GNIP+G FDLGL+E+D S NG GSIP G LF++L LD
Sbjct: 367 KELMIVQLKGNDFSGNIPDGFFDLGLQEMDFSGNGLTGSIPRGSSR-----LFESLIRLD 421
Query: 304 LSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 363
LS N+L G IP E+GLF ++RYLNLS NH +R+PPE+ + +L LDLRN+AL GS+P
Sbjct: 422 LSHNSLTGSIPGEVGLFIHMRYLNLSWNHFNTRVPPEIEFLQNLTVLDLRNSALIGSVPA 481
Query: 364 EVCESRSLGILQLDGNSLTGPIPQVIRNCTXXXXXXXXXXXXXXXIPXXXXXXXXXXXXX 423
++CES+SL ILQLDGNSLTG IP+ I NC+ IP
Sbjct: 482 DICESQSLQILQLDGNSLTGSIPEGIGNCSSLKLLSLSHNNLTGPIPKSLSNLQELKILK 541
Query: 424 XEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLK 483
E N+LSGEIP+ELG L +LL VNVS+NRLIGRLP+G VF +LDQS++QGNLGICSPLL+
Sbjct: 542 LEANKLSGEIPKELGDLQNLLLVNVSFNRLIGRLPLGDVFQSLDQSAIQGNLGICSPLLR 601
Query: 484 GPCKMNVPKPLVLDPDAY-NSNQMDGXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 542
GPC +NVPKPLV++P++Y N N M G
Sbjct: 602 GPCTLNVPKPLVINPNSYGNGNNMPGNRASGGSGTFHRRMFLSVSVIVAISAAILIFSGV 661
Query: 543 XXXSLLNVSTRRRLTFVETTLESMCSSSSRSV-NLAAGKVILFDSR-----SSSLDCSID 596
+LLN S RRRL FV+ LES+ S SS+S +L GK++L +SR SSS + +
Sbjct: 662 IIITLLNASVRRRLAFVDNALESIFSGSSKSGRSLMMGKLVLLNSRTSRSSSSSQEFERN 721
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 656
PE+LL KA+ +GEGVFGTVYK G QGR LAVKKLV S I+Q EDF+REVR+L KA+H
Sbjct: 722 PESLLNKASRIGEGVFGTVYKAPLGEQGRNLAVKKLVPSPILQNLEDFDREVRILAKAKH 781
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
PNL+S++GY+WTP L LLVS+Y PNG+LQ+KLHER PSTPPLSW R+K+ILGTAKGLA+
Sbjct: 782 PNLVSIKGYFWTPDLHLLVSEYIPNGNLQSKLHEREPSTPPLSWDVRYKIILGTAKGLAY 841
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN-RFQSALGYVAP 775
LHH+FRP IH+NLKP+NILLD+ NP+ISDFGL+RLLT D + M+N RFQ+ALGYVAP
Sbjct: 842 LHHTFRPTTIHFNLKPTNILLDEKNNPKISDFGLSRLLTTQDGNTMNNNRFQNALGYVAP 901
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835
EL CQ+LRVNEKCD+YGFGVLILELVTGRRPVEYGED+ VILS+HVRV+LE+GNVL+C+D
Sbjct: 902 ELECQNLRVNEKCDVYGFGVLILELVTGRRPVEYGEDSFVILSDHVRVMLEQGNVLECID 961
Query: 836 PSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR-MEVF 888
P M + Y EDEVLPVLKLALVCT IPS+RP+MAE+VQILQVI +P+P R M+ F
Sbjct: 962 PVMEEQYSEDEVLPVLKLALVCTSQIPSNRPTMAEIVQILQVINSPVPHRIMDSF 1016
|
|
| TAIR|locus:2102499 AT3G56370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1504 (534.5 bits), Expect = 3.1e-154, P = 3.1e-154
Identities = 338/879 (38%), Positives = 480/879 (54%)
Query: 17 MVVFRILERLNFSHNSLSGQIPPSXXXXXXXXXKFLDLSNNLLSGPVPYQLFENCASLRY 76
++ + L +L+ S+N+L+G I P+ K +DLS+N LSG +P + F C SLR
Sbjct: 89 LLQLQFLHKLSLSNNNLTGIINPNMLLSLVNL-KVVDLSSNGLSGSLPDEFFRQCGSLRV 147
Query: 77 LSLAGNILQGPIGKIFNYCXXXXXXXXXXXHFSGDLDFASGYGIWSLKRLRTLDLSHNLF 136
LSLA N L G I + C FSG + GIWSL LR+LDLS N
Sbjct: 148 LSLAKNKLTGKIPVSISSCSSLAALNLSSNGFSGSMPL----GIWSLNTLRSLDLSRNEL 203
Query: 137 SGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLN 196
G P+ + L+ L+ L L N+ SGP+P++IG C L T+DLS N +G LP + + L+
Sbjct: 204 EGEFPEKIDRLNNLRALDLSRNRLSGPIPSEIGSCMLLKTIDLSENSLSGSLPNTFQQLS 263
Query: 197 SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSL 256
+++ N L G++P WIG + +LE LD S N +G +P S+ N L V+ GN L
Sbjct: 264 LCYSLNLGKNALEGEVPKWIGEMRSLETLDLSMNKFSGQVPDSIGNLLALKVLNFSGNGL 323
Query: 257 NGNIPEGLFD-LGLEEIDLSENGFMGSIPPGXXXXXXXTL-----------FQTLRILDL 304
G++P + + L +DLS N G +P + + +++LDL
Sbjct: 324 IGSLPVSTANCINLLALDLSGNSLTGKLPMWLFQDGSRDVSALKNDNSTGGIKKIQVLDL 383
Query: 305 SSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQE 364
S N G+I A +G +L L+LS N L IP +G L LD+ +N L G IP+E
Sbjct: 384 SHNAFSGEIGAGLGDLRDLEGLHLSRNSLTGPIPSTIGELKHLSVLDVSHNQLNGMIPRE 443
Query: 365 VCESRSLGILQLDGNSLTGPIPQVIRNCTXXXXXXXXXXXXXXXIPXXXXXXXXXXXXXX 424
+ SL L+L+ N L G IP I+NC+ IP
Sbjct: 444 TGGAVSLEELRLENNLLEGNIPSSIKNCSSLRSLILSHNKLLGSIPPELAKLTRLEEVDL 503
Query: 425 EFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKG 484
FNEL+G +P++L L L N+S+N L G LP GG+F L SS+ GN GIC ++
Sbjct: 504 SFNELAGTLPKQLANLGYLHTFNISHNHLFGELPAGGIFNGLSPSSVSGNPGICGAVVNK 563
Query: 485 PCKMNVPKPLVLDPDAYNSNQMDGXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 544
C PKP+VL+P+A + +G
Sbjct: 564 SCPAISPKPIVLNPNA-TFDPYNGEIVPPGAGHKRILLSISSLIAISAAAAIVVGVIAIT 622
Query: 545 XSLLNV--STRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLE 602
L V ST R T S S + + +GK+++F S D S LL
Sbjct: 623 VLNLRVRASTVSRSAVPLTFSGGDDFSRSPTTDSNSGKLVMF---SGEPDFSTGTHALLN 679
Query: 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
K E+G G FG VY+ G +A+KKL S +++ ++FEREV+ LGK RH NL+ L
Sbjct: 680 KDCELGRGGFGAVYRTVI-RDGYPVAIKKLTVSSLVKSQDEFEREVKKLGKLRHSNLVKL 738
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
EGYYWT L+LL+ ++ GSL +LHE LSW +RF +ILGTAK LA+LH S
Sbjct: 739 EGYYWTTSLQLLIYEFLSGGSLYKQLHEAPGGNSSLSWNDRFNIILGTAKCLAYLHQS-- 796
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
IIHYN+K SN+LLD + P++ D+GLARLL LD++V+S++ QSALGY+APE C+++
Sbjct: 797 -NIIHYNIKSSNVLLDSSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 855
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM-GDY 841
++ EKCD+YGFGVL+LE+VTG++PVEY ED+VV+L + VR LE+G +C+DP + G +
Sbjct: 856 KITEKCDVYGFGVLVLEVVTGKKPVEYMEDDVVVLCDMVREALEDGRADECIDPRLQGKF 915
Query: 842 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880
P +E + V+KL L+CT +PSSRP M E V IL++I+ P
Sbjct: 916 PVEEAVAVIKLGLICTSQVPSSRPHMGEAVNILRMIRCP 954
|
|
| TAIR|locus:2181042 AT5G01890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1349 (479.9 bits), Expect = 8.3e-138, P = 8.3e-138
Identities = 316/866 (36%), Positives = 465/866 (53%)
Query: 23 LERLNFSHNSLSGQIPPSXXXXXXXXXKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ ++FS N+LSG+IP + + L+NN L+G +P L C++L +L+L+ N
Sbjct: 118 LQVVDFSGNNLSGRIPDGFFEQCGSL-RSVSLANNKLTGSIPVSL-SYCSTLTHLNLSSN 175
Query: 83 ILQGPIGKIFNYCXXXXXXXXXXXHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
L G + + + GD+ G G++ L R ++LS N FSG +P
Sbjct: 176 QLSGRLPRDIWFLKSLKSLDFSHNFLQGDIPDGLG-GLYDL---RHINLSRNWFSGDVPS 231
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
+ LK L L N FSG LP + +++ L N G++P + + ++ +
Sbjct: 232 DIGRCSSLKSLDLSENYFSGNLPDSMKSLGSCSSIRLRGNSLIGEIPDWIGDIATLEILD 291
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
+S N TG +P +GN+ L+ L+ S N L G LP +L NC L I + NS G++ +
Sbjct: 292 LSANNFTGTVPFSLGNLEFLKDLNLSANMLAGELPQTLSNCSNLISIDVSKNSFTGDVLK 351
Query: 263 GLFDLGLEEIDLSENGFMGSIPPGXXXXXXXTLF-QTLRILDLSSNNLVGDIPAEMGLFA 321
+F E LS F G F Q LR+LDLSSN G++P+ + +
Sbjct: 352 WMFTGNSESSSLSR--FSLHKRSGNDTIMPIVGFLQGLRVLDLSSNGFTGELPSNIWILT 409
Query: 322 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 381
+L LN+S+N L IP +G LDL +N L G++P E+ + SL L L N L
Sbjct: 410 SLLQLNMSTNSLFGSIPTGIGGLKVAEILDLSSNLLNGTLPSEIGGAVSLKQLHLHRNRL 469
Query: 382 TGPIPQVIRNCTXXXXXXXXXXXXXXXIPXXXXXXXXXXXXXXEFNELSGEIPQELGKLA 441
+G IP I NC+ IP N LSG +P+E+ KL+
Sbjct: 470 SGQIPAKISNCSALNTINLSENELSGAIPGSIGSLSNLEYIDLSRNNLSGSLPKEIEKLS 529
Query: 442 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDAY 501
LL N+S+N + G LP GG F T+ S++ GN +C ++ C PKP+VL+P++
Sbjct: 530 HLLTFNISHNNITGELPAGGFFNTIPLSAVTGNPSLCGSVVNRSCLSVHPKPIVLNPNS- 588
Query: 502 NSNQMDGXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXSLLNVSTRRRLTFVET 561
SN +G +LLNV R ++ +
Sbjct: 589 -SNPTNGPALTGQIRKSVLSISALIAIGAAAVIAIGVVAV----TLLNVHARSSVSRHDA 643
Query: 562 TLESMCS-----SSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVY 616
S S S S + GK+++F D + + LL K +E+G G FG VY
Sbjct: 644 AAALALSVGETFSCSPSKDQEFGKLVMFSGEVDVFDTT-GADALLNKDSELGRGGFGVVY 702
Query: 617 KVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676
K S GR +AVKKL S +I+ E+FERE+R LGK RH N++ ++GYYWT L+LL+
Sbjct: 703 KTSL-QDGRPVAVKKLTVSGLIKSQEEFEREMRKLGKLRHKNVVEIKGYYWTQSLQLLIH 761
Query: 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 736
++ GSL LH + L+W RF +ILG A+GLA LH S I HYN+K +N+L
Sbjct: 762 EFVSGGSLYRHLHG--DESVCLTWRQRFSIILGIARGLAFLHSS---NITHYNMKATNVL 816
Query: 737 LDDNYNPRISDFGLARLL-TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGV 795
+D ++SDFGLARLL + LD+ V+S + QSALGY APE C+++++ ++CD+YGFG+
Sbjct: 817 IDAAGEAKVSDFGLARLLASALDRCVLSGKVQSALGYTAPEFACRTVKITDRCDVYGFGI 876
Query: 796 LILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM-GDYPEDEVLPVLKLAL 854
L+LE+VTG+RPVEY ED+VV+L E VR LEEG V +CVDP + G++P +E +PV+KL L
Sbjct: 877 LVLEVVTGKRPVEYAEDDVVVLCETVREGLEEGRVEECVDPRLRGNFPAEEAIPVIKLGL 936
Query: 855 VCTCHIPSSRPSMAEVVQILQVIKTP 880
VC +PS+RP M EVV+IL++I+ P
Sbjct: 937 VCGSQVPSNRPEMEEVVKILELIQCP 962
|
|
| TAIR|locus:2034725 AT1G12460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 708 (254.3 bits), Expect = 1.6e-111, Sum P(2) = 1.6e-111
Identities = 151/343 (44%), Positives = 223/343 (65%)
Query: 548 LNVSTRRRLTFVET-TLESM-CSSSSRSVNLAAGKVILFDSRSSSL--DCSIDPETLLEK 603
LN+ R+R E T+E+ +SS S + GK++LF S D + LL+K
Sbjct: 536 LNLRARKRRKDEEILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALLDK 595
Query: 604 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
+G G G+VY+ SF G +AVKKL T I+ E+FE+E+ LG +HPNL S +
Sbjct: 596 ENIIGMGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLSSFQ 654
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERL-PSTPP------LSWTNRFKVILGTAKGLAH 716
GYY++ ++L++S++ PNGSL LH R+ P T L+W RF++ LGTAK L+
Sbjct: 655 GYYFSSTMQLILSEFVPNGSLYDNLHLRIFPGTSSSYGNTDLNWHRRFQIALGTAKALSF 714
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
LH+ +P I+H N+K +NILLD+ Y ++SD+GL + L +D ++ +F +A+GY+APE
Sbjct: 715 LHNDCKPAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIAPE 774
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN-VVILSEHVRVLLEEGNVLDCVD 835
L QSLR +EKCD+Y +GV++LELVTGR+PVE +N V+IL ++VR LLE G+ DC D
Sbjct: 775 LAQQSLRASEKCDVYSYGVVLLELVTGRKPVESPSENQVLILRDYVRDLLETGSASDCFD 834
Query: 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878
+ ++ E+E++ V+KL L+CT P RPSMAEVVQ+L+ I+
Sbjct: 835 RRLREFEENELIQVMKLGLLCTSENPLKRPSMAEVVQVLESIR 877
|
|
| TAIR|locus:2015504 AT1G62950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 7.1e-109, Sum P(2) = 7.1e-109
Identities = 144/336 (42%), Positives = 215/336 (63%)
Query: 556 LTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSL--DCSIDPETLLEKAAEVGEGVFG 613
+TF +TT + S+ S + + GK++LF S D + LL+K +G G G
Sbjct: 554 VTF-DTTTPTQASTESGNGGVTFGKLVLFSKSLPSKYEDWEAGTKALLDKDNIIGIGSIG 612
Query: 614 TVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673
VY+ SF G +AVKKL T I+ E+FE+E+ LG HPNL S +GYY++ ++L
Sbjct: 613 AVYRASF-EGGVSIAVKKLETLGRIRNQEEFEQEIGRLGSLSHPNLASFQGYYFSSTMQL 671
Query: 674 LVSDYAPNGSLQAKLHERLP----------STPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
++S++ NGSL LH R+ L+W RF++ +GTAK L+ LH+ +P
Sbjct: 672 ILSEFVTNGSLYDNLHPRVSHRTSSSSSSHGNTELNWHRRFQIAVGTAKALSFLHNDCKP 731
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
I+H N+K +NILLD+ Y ++SD+GL + L L+ ++ +F +A+GY+APEL QSLR
Sbjct: 732 AILHLNVKSTNILLDERYEAKLSDYGLEKFLPVLNSSGLT-KFHNAVGYIAPELA-QSLR 789
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDN-VVILSEHVRVLLEEGNVLDCVDPSMGDYP 842
V++KCD+Y +GV++LELVTGR+PVE +N VVIL +HVR LLE G+ DC D + +
Sbjct: 790 VSDKCDVYSYGVVLLELVTGRKPVESPSENEVVILRDHVRNLLETGSASDCFDRRLRGFE 849
Query: 843 EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878
E+E++ V+KL L+CT P RPS+AEVVQ+L++I+
Sbjct: 850 ENELIQVMKLGLICTTENPLKRPSIAEVVQVLELIR 885
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 527 (190.6 bits), Expect = 3.2e-96, Sum P(2) = 3.2e-96
Identities = 141/465 (30%), Positives = 219/465 (47%)
Query: 23 LERLNFSHNSLSGQIPPSXXXXXXXXXKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
LE L+ N G +P S +FL LS N L+G +P L + SL L N
Sbjct: 166 LEVLDLRGNFFQGSLPSSFKNLQKL--RFLGLSGNNLTGELPSVLGQ-LPSLETAILGYN 222
Query: 83 ILQGPIGKIFNYCXXXXXXXXXXXHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+GPI F SG++ G LK L TL L N F+G+IP+
Sbjct: 223 EFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELG----KLKSLETLLLYENNFTGTIPR 278
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
+ ++ LK L N +G +P +I +L L+L N +G +P ++ L + +
Sbjct: 279 EIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLE 338
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
+ NNTL+G++P +G S L++LD S+N +G +PS+L N L+ + L N+ G IP
Sbjct: 339 LWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPA 398
Query: 263 GLFDL-GLEEIDLSENGFMGSIPPGXXXXXXXTLFQTLRILDLSSNNLVGDIPAEMGLFA 321
L L + + N GSIP G + L+ L+L+ N L G IP ++
Sbjct: 399 TLSTCQSLVRVRMQNNLLNGSIPIGFGK------LEKLQRLELAGNRLSGGIPGDISDSV 452
Query: 322 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 381
+L +++ S N +RS +P + H+L + +N + G +P + + SL L L N+L
Sbjct: 453 SLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTL 512
Query: 382 TGPIPQVIRNCTXXXXXXXXXXXXXXXIPXXXXXXXXXXXXXXEFNELSGEIPQELGKLA 441
TG IP I +C IP N L+G +P+ +G
Sbjct: 513 TGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSP 572
Query: 442 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPC 486
+L +NVSYN+L G +P+ G T++ L+GN G+C +L PC
Sbjct: 573 ALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVLP-PC 616
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 507 (183.5 bits), Expect = 8.0e-94, Sum P(2) = 8.0e-94
Identities = 121/326 (37%), Positives = 181/326 (55%)
Query: 558 FVETTLESMCSSSSR---SVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGT 614
FV+ L + S SR S+N+A + L R + ++ K +G+G FGT
Sbjct: 874 FVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDI---VEATDHFSKKNIIGDGGFGT 930
Query: 615 VYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674
VYK + + +AVKKL + Q +F E+ LGK +HPNL+SL GY + KLL
Sbjct: 931 VYKACLPGE-KTVAVKKLSEAKT-QGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLL 988
Query: 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSN 734
V +Y NGSL L + L W+ R K+ +G A+GLA LHH F P IIH ++K SN
Sbjct: 989 VYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASN 1048
Query: 735 ILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFG 794
ILLD ++ P+++DFGLARL++ + HV S GY+ PE QS R K D+Y FG
Sbjct: 1049 ILLDGDFEPKVADFGLARLISACESHV-STVIAGTFGYIPPEYG-QSARATTKGDVYSFG 1106
Query: 795 VLILELVTGRRPV--EYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP-EDEVLPVLK 851
V++LELVTG+ P ++ E L + +G +D +DP + ++ L +L+
Sbjct: 1107 VILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQ 1166
Query: 852 LALVCTCHIPSSRPSMAEVVQILQVI 877
+A++C P+ RP+M +V++ L+ I
Sbjct: 1167 IAMLCLAETPAKRPNMLDVLKALKEI 1192
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 529 (191.3 bits), Expect = 2.7e-91, Sum P(2) = 2.7e-91
Identities = 158/479 (32%), Positives = 215/479 (44%)
Query: 15 PSMVVFRILERLNFSHNSLSGQIPPSXXXXXXXXXKFLDLSNNLLSGPVPYQLFENCASL 74
PS+ LE L N +G IP K L L N L+G +P ++ N
Sbjct: 253 PSVGNISRLEVLALHENYFTGSIPREIGKLTKM--KRLYLYTNQLTGEIPREI-GNLIDA 309
Query: 75 RYLSLAGNILQGPIGKIFNYCXXXXXXXXXXXHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
+ + N L G I K F + G + G L L LDLS N
Sbjct: 310 AEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELG----ELTLLEKLDLSIN 365
Query: 135 LFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL 194
+G+IPQ + L YL +L L NQ G +P IGF + + LD+S N +G +P
Sbjct: 366 RLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCR 425
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 254
++I +S+ +N L+G+IP + +L L +N LTGSLP LFN + L+ + L N
Sbjct: 426 FQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQN 485
Query: 255 SLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGXXXXXXXTLFQTLRILDLSSNNLVGDI 313
L+GNI L L LE + L+ N F G IPP F ++SSN L G I
Sbjct: 486 WLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGF------NISSNQLTGHI 539
Query: 314 PAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGI 373
P E+G ++ L+LS N I ELG L L L +N L G IP + L
Sbjct: 540 PKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLME 599
Query: 374 LQLDGNSLTGPIPQVIRNCTXXXXXXXXXXXXXX-XIPXXXXXXXXXXXXXXEFNELSGE 432
LQL GN L+ IP + T IP N+LSGE
Sbjct: 600 LQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGE 659
Query: 433 IPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVP 491
IP +G L SLL N+S N L+G +P VF +D S+ GN G+C+ + C+ VP
Sbjct: 660 IPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQ-RSHCQPLVP 717
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 514 (186.0 bits), Expect = 5.2e-90, Sum P(2) = 5.2e-90
Identities = 149/476 (31%), Positives = 217/476 (45%)
Query: 23 LERLNFSHNSLSGQIPPSXXXXXXXXXKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L ++FS N L G IP S +FL+L NN L+GP+P L + +L+ L LA N
Sbjct: 123 LAYVDFSTNLLFGDIPFSISKLKQL--EFLNLKNNQLTGPIPATLTQ-IPNLKTLDLARN 179
Query: 83 ILQGPIGKIFNYCXXXXXXXXXXXHFSGDL--DFASGYGIWSLKRLRTLDLSHNLFSGSI 140
L G I ++ + +G L D G+W D+ N +G+I
Sbjct: 180 QLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPDMCQLTGLWYF------DVRGNNLTGTI 233
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200
P+ + + L + NQ +G +P +IGF + TL L N TG++P + L+ ++
Sbjct: 234 PESIGNCTSFEILDVSYNQITGVIPYNIGFL-QVATLSLQGNKLTGRIPEVIGLMQALAV 292
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 260
+ +S+N LTG IP +GN+S L N LTG +P L N +LS ++L N L G I
Sbjct: 293 LDLSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKI 352
Query: 261 PEGLFDLG-LEEIDLSENGFMGSIPPGXXXXXXXTLFQTLRILDLSSNNLVGDIPAEMGL 319
P L L L E++L+ N +G IP F ++ N L G +P E
Sbjct: 353 PPELGKLEQLFELNLANNNLVGLIPSNISSCAALNQF------NVHGNFLSGAVPLEFRN 406
Query: 320 FANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGN 379
+L YLNLSSN + +IP ELG+ +L LDL N GSIP + + L IL L N
Sbjct: 407 LGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRN 466
Query: 380 SLTGPIPQVIRNCTXXXXXXXXXXXXXXXIPXXXXXXXXXXXXXXEFNELSGEIPQELGK 439
L G +P N IP N++ G+IP +L
Sbjct: 467 HLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTN 526
Query: 440 LASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLV 495
SL +N+S+N L G +P F +S GN +C + C ++PK V
Sbjct: 527 CFSLANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSICGPSLPKSQV 582
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 7.1e-90, Sum P(2) = 7.1e-90
Identities = 151/478 (31%), Positives = 216/478 (45%)
Query: 26 LNFSHNSLSGQIPPSXXXXXXXXXKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85
L+ S N L G IP S L+L NN L+GPVP L + +L+ L LAGN L
Sbjct: 124 LDLSENLLYGDIPFSISKLKQLET--LNLKNNQLTGPVPATLTQ-IPNLKRLDLAGNHLT 180
Query: 86 GPIGKIFNYCXXXXXXXXXXXHFSGDL--DFASGYGIWSLKRLRTLDLSHNLFSGSIPQG 143
G I ++ + +G L D G+W D+ N +G+IP+
Sbjct: 181 GEISRLLYWNEVLQYLGLRGNMLTGTLSSDMCQLTGLWYF------DVRGNNLTGTIPES 234
Query: 144 VAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 203
+ + L + NQ +G +P +IGF + TL L N TG++P + L+ ++ + +
Sbjct: 235 IGNCTSFQILDISYNQITGEIPYNIGFL-QVATLSLQGNRLTGRIPEVIGLMQALAVLDL 293
Query: 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 263
S+N L G IP +GN+S L N LTG +PS L N +LS ++L N L G IP
Sbjct: 294 SDNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPE 353
Query: 264 LFDLG-LEEIDLSENGFMGSIPPGXXXXXXXTLFQTLRILDLSSNNLVGDIPAEMGLFAN 322
L L L E++L+ N +G IP F ++ N L G IP +
Sbjct: 354 LGKLEQLFELNLANNRLVGPIPSNISSCAALNQF------NVHGNLLSGSIPLAFRNLGS 407
Query: 323 LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLT 382
L YLNLSSN+ + +IP ELG+ +L LDL N GSIP + + L IL L N L+
Sbjct: 408 LTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLS 467
Query: 383 GPIPQVIRNCTXXXXXXXXXXXXXXXIPXXXXXXXXXXXXXXEFNELSGEIPQELGKLAS 442
G +P N IP N+L G+IP +L +
Sbjct: 468 GQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFT 527
Query: 443 LLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDPDA 500
L+ +NVS+N L G +P F +S GN +C + C +PK V A
Sbjct: 528 LVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGP-LPKSRVFSRGA 584
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LRT1 | Y3804_ARATH | No assigned EC number | 0.6160 | 0.9617 | 0.8405 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 888 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-96 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-60 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-52 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.004 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.004 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 323 bits (829), Expect = 3e-96
Identities = 268/869 (30%), Positives = 408/869 (46%), Gaps = 93/869 (10%)
Query: 19 VFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLS 78
F L+ L+ N L G+IP SL NL +++FL L++N L G +P +L + SL+++
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNLT--SLEFLTLASNQLVGQIPRELGQ-MKSLKWIY 218
Query: 79 LAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG 138
L N L G I +SLN L+L N+ +G + + G +LK L+ L L N SG
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG----NLKNLQYLFLYQNKLSG 274
Query: 139 SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM 198
IP + +L L L L N SG +P + +L L L +N FTG++PV+L L +
Sbjct: 275 PIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRL 334
Query: 199 IFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 258
+ + +N +G+IP +G + L LD S N+LTG +P L + L + L NSL G
Sbjct: 335 QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG 394
Query: 259 NIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM 317
IP+ L L + L +N F G +P S T + LD+S+NNL G I +
Sbjct: 395 EIPKSLGACRSLRRVRLQDNSFSGELP------SEFTKLPLVYFLDISNNNLQGRINSRK 448
Query: 318 GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 377
+L+ L+L+ N +P G L +LDL N G++P+++ L L+L
Sbjct: 449 WDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLS 507
Query: 378 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQEL 437
N L+G IP + +C L L LSHN LSG IP S S + L L L N+LSGEIP+ L
Sbjct: 508 ENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567
Query: 438 GKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKG---PCKMNVPKPL 494
G + SL+ VN+S+N L G LP G F ++ S++ GN+ +C PCK P
Sbjct: 568 GNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPS 627
Query: 495 VLDPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRR 554
F+ + A + L+A G + I N +
Sbjct: 628 --------------------------WWFYITCTLGAFLVLALVAFGFVFIRGRNNLELK 661
Query: 555 RLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAE---VGEGV 611
R+ + T E FDS+ S SI +L E + G
Sbjct: 662 RVENEDGTWELQ----------------FFDSKVSK---SITINDILSSLKEENVISRGK 702
Query: 612 FGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 671
G YK G VK++ + I P + +GK +HPN++ L G + +
Sbjct: 703 KGASYKGKSIKNGMQFVVKEINDVNSI--PSSEIAD---MGKLQHPNIVKLIGLCRSEKG 757
Query: 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLK 731
L+ +Y +L L LSW R K+ +G AK L LH P ++ NL
Sbjct: 758 AYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810
Query: 732 PSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIY 791
P I++D P + L LL + + YVAPE T ++ + EK DIY
Sbjct: 811 PEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFISSAYVAPE-TRETKDITEKSDIY 862
Query: 792 GFGVLILELVTGRRP--VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP---EDEV 846
GFG++++EL+TG+ P E+G ++ E R + ++ +DPS+ ++E+
Sbjct: 863 GFGLILIELLTGKSPADAEFGVHGSIV--EWARYCYSDCHLDMWIDPSIRGDVSVNQNEI 920
Query: 847 LPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ V+ LAL CT P++RP +V++ L+
Sbjct: 921 VEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 1e-60
Identities = 152/446 (34%), Positives = 208/446 (46%), Gaps = 65/446 (14%)
Query: 16 SMVVFRI--LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCAS 73
S +FR+ ++ +N S+N LSG IP
Sbjct: 86 SSAIFRLPYIQTINLSNNQLSGPIP----------------------------------- 110
Query: 74 LRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSH 133
IF SSL LNLSNN+F+G + G S+ L TLDLS+
Sbjct: 111 ---------------DDIFTTSSSLRYLNLSNNNFTGSI--PRG----SIPNLETLDLSN 149
Query: 134 NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR 193
N+ SG IP + + LK L L GN G +P + L L L++N GQ+P L
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG 209
Query: 194 LLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRG 253
+ S+ +I + N L+G+IP+ IG +++L LD N+LTG +PSSL N K L + L
Sbjct: 210 QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269
Query: 254 NSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGD 312
N L+G IP +F L L +DLS+N G IP Q L IL L SNN G
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP------ELVIQLQNLEILHLFSNNFTGK 323
Query: 313 IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLG 372
IP + L+ L L SN IP LG ++L LDL N L G IP+ +C S +L
Sbjct: 324 IPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF 383
Query: 373 ILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE 432
L L NSL G IP+ + C SL + L N SG +P + L + L + N L G
Sbjct: 384 KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGR 443
Query: 433 IPQELGKLASLLAVNVSYNRLIGRLP 458
I + SL ++++ N+ G LP
Sbjct: 444 INSRKWDMPSLQMLSLARNKFFGGLP 469
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 6e-52
Identities = 124/373 (33%), Positives = 188/373 (50%), Gaps = 60/373 (16%)
Query: 89 GKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALH 148
G N S + +++LS + SG + A I+ L ++T++LS+N SG IP +
Sbjct: 62 GITCNNSSRVVSIDLSGKNISGKISSA----IFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 149 Y-LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 207
L+ L L N F+G +P G P+L TLDLSNN+ +G++P + +S+ + + N
Sbjct: 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
Query: 208 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL 267
L G IP+ + N+++LEFL ++N L G +P L K L I L N+L+G IP + L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 268 GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLN 327
+L LDL NNL G IP+ +G NL+YL
Sbjct: 236 -----------------------------TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266
Query: 328 LSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQ 387
L N L IPP + LI LDL +N+L G IP+ V + ++L IL L N+ TG
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTG---- 322
Query: 388 VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVN 447
IP ++++L +L++L+L N+ SGEIP+ LGK +L ++
Sbjct: 323 --------------------KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD 362
Query: 448 VSYNRLIGRLPVG 460
+S N L G +P G
Sbjct: 363 LSTNNLTGEIPEG 375
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 2e-50
Identities = 134/406 (33%), Positives = 193/406 (47%), Gaps = 59/406 (14%)
Query: 70 NCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 129
N + + + L+G + G I + T+NLSNN SG + S LR L
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSS---LRYL 123
Query: 130 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLP 189
+LS+N F+GSIP+ G P+L TLDLSNN+ +G++P
Sbjct: 124 NLSNNNFTGSIPR--------------------------GSIPNLETLDLSNNMLSGEIP 157
Query: 190 VSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 249
+ +S+ + + N L G IP+ + N+++LEFL ++N L G +P L K L I
Sbjct: 158 NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI 217
Query: 250 RLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL 309
L N+L+G IP + L +L LDL NNL
Sbjct: 218 YLGYNNLSGEIPYEIGGL-----------------------------TSLNHLDLVYNNL 248
Query: 310 VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESR 369
G IP+ +G NL+YL L N L IPP + LI LDL +N+L G IP+ V + +
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308
Query: 370 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 429
+L IL L N+ TG IP + + L +L L N SG IPK++ N L +L L N L
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 430 SGEIPQELGKLASLLAVNVSYNRLIGRLPVG-GVFPTLDQSSLQGN 474
+GEIP+ L +L + + N L G +P G +L + LQ N
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 69/195 (35%), Positives = 101/195 (51%), Gaps = 9/195 (4%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+GEG FGTVY G+ +A+K + D E+ RE+ +L K HPN++ L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 667 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 726
LV +Y GSL+ L E LS +++L +GL +LH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 727 HYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
H +LKP NILLD DN +++DFGL++LLT + Y+APE+ +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 786 EKCDIYGFGVLILEL 800
EK DI+ GV++ EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 74/267 (27%), Positives = 121/267 (45%), Gaps = 22/267 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
++GEG FG VY G+++A+K + I + E RE+++L K +HPN++ L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
+ LV +Y G L L +R + + + L +LH I
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQILSALEYLHSKG---I 118
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
+H +LKP NILLD++ + +++DFGLAR LD F Y+APE+
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEV-LLGKGYG 174
Query: 786 EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 845
+ DI+ GV++ EL+TG+ P G+D ++ L + + P D E
Sbjct: 175 KAVDIWSLGVILYELLTGKPPF-PGDDQLLELFKKIGKPKPP------FPPPEWDIS-PE 226
Query: 846 VLPVLKLALVCTCHIPSSRPSMAEVVQ 872
+++ LV P R + E +Q
Sbjct: 227 AKDLIRKLLVKD---PEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 18/267 (6%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGY 665
+G G FGTVYK G+++AVK L + + RE+R+L + HPN++ L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
+ LV +Y G L L PLS K+ L +GL +LH + I
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
IH +LKP NILLD+N +I+DFGLA+ L + + + F Y+APE+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYG 177
Query: 786 EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 845
K D++ GV++ EL+TG+ P + +N++ + +R +L
Sbjct: 178 PKVDVWSLGVILYELLTGKPP--FSGENILDQLQLIR------RILGPPLEFDEPKWSSG 229
Query: 846 VLPVLKLALVCTCHIPSSRPSMAEVVQ 872
L C PS RP+ E++Q
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 27/279 (9%)
Query: 606 EVGEGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
++GEG FG VYK + +AVK L + +DF +E RV+ K HPN++ L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHER-----LPSTPPLSWTNRFKVILGTAKGLAHL 717
G + LV +Y G L L + P LS + + AKG+ +L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
+H +L N L+ ++ +ISDFGL+R + D + + + ++APE
Sbjct: 122 ASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE- 177
Query: 778 TCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836
+ + K D++ FGVL+ E+ T G P Y + +E V L +G L P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPG----LSNEEVLEYLRKGYRLPK--P 229
Query: 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
P++ + +L L C P RP+ +E+V+ L+
Sbjct: 230 E--YCPDE----LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-38
Identities = 117/349 (33%), Positives = 166/349 (47%), Gaps = 39/349 (11%)
Query: 15 PSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASL 74
PS+ + L L+ S NSLSG+IP L + + N++ L L +N +G +P L SL
Sbjct: 278 PSIFSLQKLISLDLSDNSLSGEIPE--LVIQLQNLEILHLFSNNFTGKIPVAL----TSL 331
Query: 75 RYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
L L L +N FSG++ G L LDLS N
Sbjct: 332 ---------------------PRLQVLQLWSNKFSGEIPKNLG----KHNNLTVLDLSTN 366
Query: 135 LFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL 194
+G IP+G+ + L +L+L N G +P +G C L + L +N F+G+LP
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 254
L + F+ +SNN L G I ++ +L+ L + N G LP S F K+L + L N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSRN 485
Query: 255 SLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDI 313
+G +P L L L ++ LSEN G IP SS + L LDLS N L G I
Sbjct: 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC------KKLVSLDLSHNQLSGQI 539
Query: 314 PAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 362
PA L L+LS N L IP LG SL+ +++ +N L+GS+P
Sbjct: 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 7e-38
Identities = 85/281 (30%), Positives = 132/281 (46%), Gaps = 29/281 (10%)
Query: 599 TLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
TL +K +GEG FG VYK + +AVK L Q E+F RE R++ K
Sbjct: 2 TLGKK---LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
HPN++ L G + ++V +Y P G L L + P LS ++ L A+G+
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGM 116
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
+L IH +L N L+ +N +ISDFGL+R L D + + + + ++A
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMA 172
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833
PE + + + K D++ FGVL+ E+ T G P Y + + V L++G L
Sbjct: 173 PE-SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--YPG----MSNAEVLEYLKKGYRLPK 225
Query: 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
P + + KL L C P RP+ +E+V+IL
Sbjct: 226 --------PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 85/281 (30%), Positives = 130/281 (46%), Gaps = 30/281 (10%)
Query: 599 TLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
TL +K +GEG FG VYK G + +AVK L Q E+F RE R++ K
Sbjct: 2 TLGKK---LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
HPN++ L G + +V +Y G L + L + P LS ++ L A+G+
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGM 115
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
+L IH +L N L+ +N +ISDFGL+R L D + + + ++A
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMA 171
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833
PE + + + K D++ FGVL+ E+ T G +P Y + E V L+ G L
Sbjct: 172 PE-SLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSN----EEVLEYLKNGYRLPQ 224
Query: 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
P + + L L C P RP+ +E+V+IL
Sbjct: 225 --------PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 79/274 (28%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 606 EVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
++GEG FG VYK +AVK L + E+F E ++ K HPN++
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
L G + +V++Y P G L L + L+ + ++ L AKG+ +L
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLE--- 119
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
+H +L N L+ +N +ISDFGL+R + D + + + ++APE +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL-KD 178
Query: 782 LRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840
+ K D++ FGVL+ E+ T G +P G N E V LLE+G L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSN-----EEVLELLEDGYRLPR------- 225
Query: 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
PE+ + +L L C + P RP+ +E+V+ L
Sbjct: 226 -PENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+G G FG+VY G ++AVK + ++ D + E ERE+R+L +HPN++ G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 666 YWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPL--SWTNRFKVILGTAKGLAHLHHSF 721
+ + +Y GSL + L + P+ +T + IL +GLA+LH
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ---IL---EGLAYLH--- 118
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
I+H ++K +NIL+D + +++DFG A+ L ++ + + ++APE+ +
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRG 177
Query: 782 LRVNEKCDIYGFGVLILELVTGRRP 806
DI+ G ++E+ TG+ P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 17/216 (7%)
Query: 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNL 659
L E ++G+G FG VYK G+ +A+K + + E E+++L K +HPN+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK-EKIINEIQILKKCKHPNI 59
Query: 660 ISLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
+ G Y + +L +V ++ GSL+ L L+ + V KGL +LH
Sbjct: 60 VKYYGSY-LKKDELWIVMEFCSGGSLKDLLKSTNQ---TLTESQIAYVCKELLKGLEYLH 115
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 777
S IIH ++K +NILL + ++ DFGL+ +L N ++APE +
Sbjct: 116 -SNG--IIHRDIKAANILLTSDGEVKLIDFGLS---AQLSDTKARNTMVGTPYWMAPEVI 169
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN 813
+ + K DI+ G+ +EL G+ P Y E
Sbjct: 170 NGK--PYDYKADIWSLGITAIELAEGKPP--YSELP 201
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 7/202 (3%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISLEG 664
++G+G FG VY V + G++ +K++ +++ + ED EV++L K HPN+I
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ +V +YA G L K+ ++ P + L +LH S +
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-SRK-- 123
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 784
I+H ++KP NI L N ++ DFG++++L+ ++ Y++PEL CQ+
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVVGTPYYLSPEL-CQNKPY 180
Query: 785 NEKCDIYGFGVLILELVTGRRP 806
N K DI+ G ++ EL T + P
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 9/212 (4%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+G+G FG V+KV R+ A+K++ ++ + E+ E RVL K +I
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
+ +V +YA NG L L + PL ++ + GLAHLH I
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGR--PLPEDQVWRFFIQILLGLAHLHSK---KI 122
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
+H ++K N+ LD N +I D G+A+LL+ D +N Y++PEL C+ N
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPEL-CEDKPYN 179
Query: 786 EKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
EK D++ GV++ E TG+ P + +IL
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 22/219 (10%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLI 660
EK A++GEG +G VYK G ++A+KK+ + + +P RE+++L K RHPN++
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 661 SLEGYYWTPQLK--LLVSDYAP---NGSLQAKLHERLPSTPPL--SWTNRFKVILGTAKG 713
L+ + +V +Y G L + T + K +L +G
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLL---DSPEVKFTESQIKCY---MKQLL---EG 112
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
L +LH + I+H ++K SNIL++++ +++DFGLAR T+ + +NR + L Y
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT-LWYR 168
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
PEL + R + D++ G ++ EL G +P+ G
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
LE+ +G+G G VYKV G++ A+KK+ ++ + RE++ L P ++
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
G ++ +V +Y GSL A L +++ P + IL KGL +LH
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEPVLAYIARQIL---KGLDYLHTK 118
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
IIH ++KPSN+L++ +I+DFG++++L N F + Y++PE
Sbjct: 119 RH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQCNTFVGTVTYMSPE---- 170
Query: 781 SLRVNEK-----CDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835
R+ + DI+ G+ +LE G+ P L++ + D
Sbjct: 171 --RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF------ELMQA--ICDGPP 220
Query: 836 PSMGDYPEDEVLPVLK--LALVCTCHIPSSRPSMAEVVQ 872
PS+ P +E P + ++ C P RPS AE++Q
Sbjct: 221 PSL---PAEEFSPEFRDFISA-CLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 6e-23
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 21/216 (9%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 664
+G+G FG V V G++ A+K L II+ E E +L + HP ++ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 665 YYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHS 720
Y + + KL LV +YAP G L + L + + + RF +++L L +LH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA---RFYAAEIVLA----LEYLH-- 110
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
II+ +LKP NILLD + + +++DFGLA+ L+ + F Y+APE+
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVL-L 166
Query: 781 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 816
+ D + GVL+ E++TG+ P Y ED I
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 101 bits (251), Expect = 9e-23
Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 19/277 (6%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHP-NLISL 662
++GEG FG VY +++A+K L + E F RE+++L HP N++ L
Sbjct: 7 KLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
++ LV +Y GSL+ L +++ PLS + ++ L +LH
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFILAQILSALEYLHSK-- 120
Query: 723 PPIIHYNLKPSNILLDDNYN-PRISDFGLARLLTRLDKHVMSNRFQSA----LGYVAPEL 777
IIH ++KP NILLD + ++ DFGLA+LL S GY+APE+
Sbjct: 121 -GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 778 T--CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835
+ DI+ G+ + EL+TG P E GE N S+ ++++LE
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-GEKNSSATSQTLKIILELPTPSLASP 238
Query: 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
S PE L P +R S + +
Sbjct: 239 LSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 38/300 (12%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRM----LAVKKLVTSDIIQYPEDFEREVRV 650
I ET LEK +G G FGTVYK + +G +A+K L + ++ E V
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62
Query: 651 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVI 707
+ HP+++ L G + Q+ L++ P G L + + S L+W +
Sbjct: 63 MASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI--- 118
Query: 708 LGTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 765
AKG+++L ++H +L N+L+ + +I+DFGLA+LL +K +
Sbjct: 119 ---AKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
Query: 766 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 824
+ + ++A E + K D++ +GV + EL+T G +P E G V I L
Sbjct: 171 GKVPIKWMALE-SILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPD-----L 223
Query: 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR 884
LE+G L P + V + + C SRP+ E++ + PQR
Sbjct: 224 LEKGERL--------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD-PQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 80/297 (26%), Positives = 131/297 (44%), Gaps = 37/297 (12%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
+ L+ ++GEG FG V + G +AVK L S Q+ DFERE+ +L
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILR 61
Query: 653 KARHPNLISLEGYYWTPQLK--LLVSDYAPNGSLQA---KLHERLPSTPPLSWTNRFKVI 707
H N++ +G P + L+ +Y P+GSL+ + +++ L ++
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS------ 115
Query: 708 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNRF 766
KG+ +L IH +L NIL++ +ISDFGLA++L D + +
Sbjct: 116 SQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP---------VEYGEDNVVIL 817
+S + + APE S + + D++ FGV + EL T P G ++
Sbjct: 173 ESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231
Query: 818 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
+ LL+EG L DEV ++KL C P RPS A+++ I+
Sbjct: 232 VTRLLELLKEGERLPRPPSC-----PDEVYDLMKL---CWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVLGKA 654
P+ E +G G +G VYK G ++A+K KL D E ++E+ +L +
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF---EIIQQEISMLKEC 57
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
RHPN+++ G Y +V +Y GSLQ + PLS V T KGL
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGL 114
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 771
A+LH + + IH ++K +NILL ++ + +++DFG++ LT ++ R +S +G
Sbjct: 115 AYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKR-KSFIGTPY 166
Query: 772 YVAPELTCQSLRV--NEKCDIYGFGVLILELVTGRRP 806
++APE+ + + KCDI+ G+ +EL + P
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 78/275 (28%), Positives = 130/275 (47%), Gaps = 27/275 (9%)
Query: 606 EVGEGVFGTVYKVSFGTQ-GRML--AVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
++G+G FG V + + T G+++ AVK L + + +DF +E ++ H NLI L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
G T L +V++ AP GSL +L + +S + V + A G+ +L
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI--ANGMRYLESK-- 116
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNRFQSALGYVAPELTCQS 781
IH +L NILL + +I DFGL R L + + H VM + + APE + ++
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SLRT 174
Query: 782 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS--EHVRVLLEEGNVLDCVDPSMG 839
+ D++ FGV + E+ T YGE+ LS + ++ + +EG L
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT------YGEEPWAGLSGSQILKKIDKEGERL-------- 220
Query: 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
+ PE + + L C H P+ RP+ A + + L
Sbjct: 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 34/221 (15%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKAR 655
PE + + ++GEG +G+VYK G+++A+K + V D+ ++ +E+ +L +
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL----QEIIKEISILKQCD 56
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSL-------QAKLHERLPSTPPLSWTNRFKVIL 708
P ++ G Y+ +V +Y GS+ L E + ++
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA----------ILY 106
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
T KGL +LH + IH ++K NILL++ +++DFG++ LT M+ R +
Sbjct: 107 QTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT----DTMAKR-NT 158
Query: 769 ALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+G ++APE+ Q + N K DI+ G+ +E+ G+ P
Sbjct: 159 VIGTPFWMAPEVI-QEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEG 664
+G G FG VYK G +A+K++ I + + +E+ +L +HPN++ G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 665 YYWTPQLKLLVSDYAPNGSLQ--AKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
T ++ +YA NGSL+ K P + L ++V+ +GLA+LH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPES--LVAVYVYQVL----QGLAYLH---E 117
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTC 779
+IH ++K +NIL + +++DFG+A T+L+ +S S +G ++APE+
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVA---TKLND--VSKDDASVVGTPYWMAPEVIE 172
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRP 806
S + DI+ G ++EL+TG P
Sbjct: 173 MS-GASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 68/230 (29%), Positives = 100/230 (43%), Gaps = 45/230 (19%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK-ARHPNLISL 662
+GEG F TV + A+K L +I+ + + E VL + HP +I L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 663 EGYYWTPQ--LKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
Y+T Q L V +YAPNG L + + S L L +LH
Sbjct: 68 ---YYTFQDEENLYFVLEYAPNGELLQYIR-KYGS---LDEKCTRFYAAEILLALEYLH- 119
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN--------------- 764
IIH +LKP NILLD + + +I+DFG A++L +
Sbjct: 120 --SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 765 RFQSALG---YVAPELTCQSLRVNEKC-----DIYGFGVLILELVTGRRP 806
RF S +G YV+PEL +NEK D++ G +I +++TG+ P
Sbjct: 178 RFASFVGTAEYVSPEL------LNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
++P + E E+G+G FG VYK G A K + + EDF E+ +L +
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL-EDFMVEIDILSEC 59
Query: 655 RHPNLISL-EGYYWTPQLKLLVSDYAPNGSLQA---KLHERLPSTPPLSWTNRFKVILGT 710
+HPN++ L E Y++ +L +L+ ++ G+L + +L ER + P + + R
Sbjct: 60 KHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQ-----M 112
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL-ARLLTRLDKHVMSNRFQSA 769
+ L LH +IH +LK NILL + + +++DFG+ A+ + L K + F
Sbjct: 113 LEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGT 166
Query: 770 LGYVAPELT-CQSLR---VNEKCDIYGFGVLILELVTGRRP 806
++APE+ C++ + + K DI+ G+ ++EL P
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEGYY 666
G+G +G+VYKV + + A+K++ + Q ED E+R+L HPN+IS + +
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 667 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 726
+V +YAP G L + +R + +++ + +GL LH I+
Sbjct: 69 LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KIL 125
Query: 727 HYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
H +LK +NILL N +I D G++++L + K + Y+APE+ + +
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH-----YMAPEV-WKGRPYS 179
Query: 786 EKCDIYGFGVLILELVTGRRPVE 808
K DI+ G L+ E+ T P E
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 24/218 (11%)
Query: 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--------FEREVRVLGKA 654
K A +G G FG+VY + G ++AVK++ + +D RE+ +L +
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
+H N++ G + +Y P GS+ A L+ L N + IL KGL
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV-RNFVRQIL---KGL 119
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR------LLTRLDKHVMSNRFQS 768
+LH+ IIH ++K +NIL+D+ +ISDFG+++ L T+ + S Q
Sbjct: 120 NYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS--LQG 174
Query: 769 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++ ++APE+ Q+ K DI+ G L++E++TG+ P
Sbjct: 175 SVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE------REVRVLGKAR 655
E VGEG +G V K G ++A+KK S+ +D + REV+VL + R
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-----DDEDVKKTALREVKVLRQLR 58
Query: 656 HPNLISL-EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
H N+++L E + +L LV +Y L+ L E P P + I + +
Sbjct: 59 HENIVNLKEAFRRKGRL-YLVFEYVERTLLE--LLEASPGGLPPDAVRSY--IWQLLQAI 113
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-----RLDKHVMSNRFQSA 769
A+ H IIH ++KP NIL+ ++ ++ DFG AR L L +V + R+
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRW--- 166
Query: 770 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
Y APEL + D++ G ++ EL+ G
Sbjct: 167 --YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 34/227 (14%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 654
EK ++GEG + VYK GR++A+KK+ + + E + RE+++L +
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQEL 59
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHER-LPSTPP--LSWTNRFKVILGTA 711
+HPN+I L + LV ++ L+ + ++ + TP S+ +L T
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSY------MLMTL 112
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS--- 768
+GL +LH ++ I+H +LKP+N+L+ + +++DFGLAR NR +
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR------SFGSPNRKMTHQV 163
Query: 769 -ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
Y APEL + D++ G + EL+ R P G+ ++
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVLGKARHPNLISLEG 664
+G G FG VY G ++AVK ++ +D E E++VL +HPNL+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVKYYG 66
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ + +Y G+L+ L + + L +GLA+LH
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQL--LEGLAYLHSH---G 119
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTCQS 781
I+H ++KP+NI LD N ++ DFG A L + M QS G Y+APE+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN-NTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 782 LRVNE--KCDIYGFGVLILELVTGRRP 806
DI+ G ++LE+ TG+RP
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 72/287 (25%), Positives = 130/287 (45%), Gaps = 30/287 (10%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVL 651
IDP + + +G G FG V + G+ +A+K L + DF E ++
Sbjct: 1 IDP-SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIM 59
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
G+ HPN+I LEG + +++++Y NGSL L E + ++ G A
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIA 116
Query: 712 KGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
G+ +L ++ +H +L NIL++ N ++SDFGL+R L + + + +
Sbjct: 117 SGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGE-DNVVILSEHVRVLLEEG 828
+ APE + D++ FG+++ E+++ G RP Y + N ++ +E+G
Sbjct: 173 RWTAPE-AIAYRKFTSASDVWSFGIVMWEVMSYGERP--YWDMSNQDVIKA-----VEDG 224
Query: 829 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
L P D P + +L L C + RP+ +++V L
Sbjct: 225 YRL----PPPMDCPS----ALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 27/278 (9%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
DPE L K ++G+G FG V+K +++A+K + + ED ++E+ VL +
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 715
P + G Y ++ +Y GS L P PL T ++ KGL
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PG--PLDETQIATILREILKGLD 115
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 775
+LH + IH ++K +N+LL ++ +++DFG+A LT D + N F ++AP
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835
E+ QS + K DI+ G+ +EL G P + + V L+ + N
Sbjct: 171 EVIKQS-AYDSKADIWSLGITAIELAKGEPP------HSELHPMKVLFLIPKNN-----P 218
Query: 836 PSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
P++ G+Y + P+ + C PS RP+ E+++
Sbjct: 219 PTLEGNYSK----PLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 79/280 (28%), Positives = 125/280 (44%), Gaps = 47/280 (16%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKK-LVTSDIIQYPE---DFEREVRVLGKARHPNLISL 662
+G G FG+VY+ G AVK+ + D E E+E+ +L K +HPN++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66
Query: 663 EGYYWTPQL--KLLVS-DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
Y T + L + + P GSL AKL ++ S P + IL GL +LH
Sbjct: 67 --YLGTEREEDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQIL---LGLEYLHD 120
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF-QSALG---YVAP 775
+H ++K +NIL+D N +++DFG+A K V+ F +S G ++AP
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAP 170
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835
E+ Q DI+ G +LE+ TG+ P + + E V + + G
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPP--WSQ------LEGVAAVFKIGRS----- 217
Query: 836 PSMGDYPE--DEVLPVLKL-ALVCTCHIPSSRPSMAEVVQ 872
+ P D + K L C PS RP+ AE+++
Sbjct: 218 ---KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 654
EK ++GEG +G VYK G ++A+KK I E+ E RE+ +L +
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKK-----IRLDNEE-EGIPSTALREISLLKEL 55
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF-KVILGTAKG 713
+HPN++ L T + LV +Y L+ K ++ P + +L +G
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLK-KYLDKRPGPLSPNLIKSIMYQLL---RG 110
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT----RLDKHVMSNRFQSA 769
LA+ H I+H +LKP NIL++ + +++DFGLAR V++
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT------ 161
Query: 770 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
L Y APE+ S + DI+ G + E++TG+
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKK-LVTSD------IIQYPEDFEREVRVLGK 653
LE E+G G G V KV G+++AVK + + I+ RE+ +L K
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQIL-------RELDILHK 55
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVILGT 710
P ++ G ++ + +Y GSL L E R+P L K+ +
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIP-ERILG-----KIAVAV 109
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
KGL +LH + IIH ++KPSNIL++ ++ DFG++ L + ++ F
Sbjct: 110 LKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV----NSLAKTFVGTS 163
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 807
Y+APE Q + K DI+ G+ ++EL TGR P
Sbjct: 164 SYMAPE-RIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEG 664
+G G FG V V ++ R A+K + I++ E E +L + HP ++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHER--LPSTPPLSWTNRF---KVILGTAKGLAHLHH 719
+ + ++ +Y G L L +R +T RF V+L +LH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-----YTARFYIACVVLA----FEYLHN 111
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
II+ +LKP N+LLD N ++ DFG A+ L K + F YVAPE+
Sbjct: 112 R---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEI-I 164
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN 813
+ + D + G+L+ EL+TGR P +GED+
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP--FGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFER--------EVRVLGKARHP 657
+G+G +G VY T G M+AVK++ + + I + ++ E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPL--SWTNRFKVILGTAKGLA 715
N++ G+ T + + +Y P GS+ + L L +T + +GLA
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ------VLEGLA 122
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 775
+LH I+H +LK N+L+D + +ISDFG+++ + + + Q ++ ++AP
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 776 E-LTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
E + S + K DI+ G ++LE+ GRRP
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 25/246 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKL----VTSDIIQYPEDFEREVRVLGKARHPNLISL 662
+GEG G V+K G +A+KK+ + I P RE++ L +HP ++ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI---PNQALREIKALQACQHPYVVKL 64
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ +LV +Y P L L + P + +++L KG+A++H +
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN-- 118
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
I+H +LKP+N+L+ + +I+DFGLARL + + + S++ + Y APEL +
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT-RWYRAPELLYGAR 176
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 842
+ + D++ G + EL+ G P+ GE+++ L+ R L G P+ +P
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRTL---GT------PNEETWP 226
Query: 843 EDEVLP 848
LP
Sbjct: 227 GLTSLP 232
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 68/269 (25%), Positives = 111/269 (41%), Gaps = 21/269 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G+G FG VYK +AVK ++ F +E +L + HPN++ L G
Sbjct: 3 IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 667 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 726
Q +V + P GSL L + L+ ++ L A G+ +L I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCI 115
Query: 727 HYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNE 786
H +L N L+ +N +ISDFG++R V Q + + APE R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE-ALNYGRYTS 174
Query: 787 KCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEV 846
+ D++ +G+L+ E + G N + R +E G + P+
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSN-----QQTRERIESGYRMPA--------PQLCP 221
Query: 847 LPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ +L L C + P +RPS +E+ LQ
Sbjct: 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 48/289 (16%)
Query: 606 EVGEGVFGTVYKVSFGTQGRML-----AVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+GEG FG VYK L A+K L + + ++F +E ++ +HPN++
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---------------WTNRF- 704
L G Q ++ +Y +G L HE L P S + F
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDL----HEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 705 KVILGTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 762
+ + A G+ +L HH +H +L N L+ + +ISDFGL+R + D + +
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHV 821
++ + ++ PE + + DI+ FGV++ E+ + G +P YG N + V
Sbjct: 183 QSKSLLPVRWMPPE-AILYGKFTTESDIWSFGVVLWEIFSYGLQPY-YGFSN-----QEV 235
Query: 822 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 870
++ +L C PED V L + C IP+ RP ++
Sbjct: 236 IEMIRSRQLLPC--------PEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 580 KVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS--DI 637
K ++ D + L DPE + E+G G FG VY + ++AVKK+ S
Sbjct: 2 KGVVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT 61
Query: 638 IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA-PNGSLQAKLHERLPSTP 696
+ +D +EV+ L + +HPN I +G Y LV +Y + S ++H++
Sbjct: 62 NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKK----- 116
Query: 697 PLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756
PL + G +GLA+LH +IH ++K NILL + +++DFG A +
Sbjct: 117 PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173
Query: 757 LDKHVMSNRFQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPV 807
+N F ++APE L + + K D++ G+ +EL + P+
Sbjct: 174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLI 660
+K ++GEG +G VYK G ++A+KK+ + P+ RE+++L + HPN+I
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHH 719
L + LV ++ + + K L +GLA H
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPES-----LIKSYLYQLLQGLAFCH- 115
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL---TRLDKHVMSNRFQSALGYVAPE 776
I+H +LKP N+L++ +++DFGLAR R H + R+ Y APE
Sbjct: 116 --SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPE 168
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGR 804
L + DI+ G + EL++ R
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 11/211 (5%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
DPE L K +G+G FG VYK ++A+K + + ED ++E+ VL +
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 715
P + G Y ++ +Y GS L PL T ++ KGL
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLD 115
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 775
+LH + IH ++K +N+LL + + +++DFG+A LT D + N F ++AP
Sbjct: 116 YLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
E+ QS + K DI+ G+ +EL G P
Sbjct: 171 EVIKQS-AYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 74/286 (25%), Positives = 127/286 (44%), Gaps = 38/286 (13%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
L+ A +G+G FG V G +G+ +AVK L D + F E V+ R
Sbjct: 4 NSKELKLGATIGKGEFGDVML---GDYRGQKVAVKCL--KDDSTAAQAFLAEASVMTTLR 58
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 715
HPNL+ L G +V++Y GSL L R + ++ + L +G+
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGME 116
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 775
+L +H +L N+L+ ++ ++SDFGLA+ + + S + + + AP
Sbjct: 117 YLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS---QGQDSGKL--PVKWTAP 168
Query: 776 ELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
E +LR + K D++ FG+L+ E+ + GR P Y + + HV E+G +
Sbjct: 169 E----ALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPHV----EKGYRM 218
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
+ PE V K+ C P+ RP+ ++ + L +I
Sbjct: 219 EA--------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 42/303 (13%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 651
P +E ++G+G FG V++ M+AVK L DF+RE ++
Sbjct: 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALM 62
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST---------------- 695
+ HPN++ L G + L+ +Y G L L R P
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 696 --PPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753
PLS T + + A G+A+L +H +L N L+ +N +I+DFGL+R
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGED 812
+ D + S + ++ PE + R + D++ +GV++ E+ + G +P YG
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPY-YGMA 237
Query: 813 NVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
+ E V + +GNVL C P++ L + L +C +PS RPS A + +
Sbjct: 238 H-----EEVIYYVRDGNVLSC--------PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284
Query: 873 ILQ 875
ILQ
Sbjct: 285 ILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 72/275 (26%), Positives = 118/275 (42%), Gaps = 53/275 (19%)
Query: 607 VGEGVFGTVYKVSFGTQGRM-----LAVKKLV--TSDIIQYPEDFEREVRVLGKARHPNL 659
+G G FG V+ +G +AVK L T D P+DF E +++ K RHP L
Sbjct: 14 LGAGQFGEVW------EGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKL 63
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH- 718
I L + +V++ GSL L L + A G+A+L
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEA 121
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG------Y 772
++ IH +L N+L+ +N +++DFGLAR++ + +++ G +
Sbjct: 122 QNY----IHRDLAARNVLVGENNICKVADFGLARVI-------KEDIYEAREGAKFPIKW 170
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
APE R + K D++ FG+L+ E+VT GR P G N +L + +++G +
Sbjct: 171 TAPE-AALYNRFSIKSDVWSFGILLTEIVTYGRMPYP-GMTNAEVLQQ-----VDQGYRM 223
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS 866
C P + + L C P RP+
Sbjct: 224 PC--------PPGCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 19/228 (8%)
Query: 585 DSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS--DIIQYPE 642
D + L DPE L E+G G FG VY ++A+KK+ S + +
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 60
Query: 643 DFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA-PNGSLQAKLHERLPSTPPLSWT 701
D +EVR L K RHPN I G Y LV +Y + S ++H++ PL
Sbjct: 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEV 115
Query: 702 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761
V G +GLA+LH +IH ++K NILL + ++ DFG A ++
Sbjct: 116 EIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167
Query: 762 MSNRFQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPV 807
+N F ++APE L + + K D++ G+ +EL + P+
Sbjct: 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 38/225 (16%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER-------EVRVLGKA 654
E +G+G FGTV KV + G++L K+ I Y E+ EV +L +
Sbjct: 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKE------IDYGNMTEKEKQQLVSEVNILREL 56
Query: 655 RHPNLISLEGYY-----WTPQLKLLVSDYAPNGSLQA------KLHERLPSTPPLSWTNR 703
+HPN++ YY + Q +V +Y G L K + + W
Sbjct: 57 KHPNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEE--EFIW--- 108
Query: 704 FKVILGTAKGLAHLHH--SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761
+++ L H+ ++H +LKP+NI LD N N ++ DFGLA++L
Sbjct: 109 -RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG--HDSS 165
Query: 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ + Y++PE + +EK DI+ G LI EL P
Sbjct: 166 FAKTYVGTPYYMSPEQ-LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 6e-17
Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 38/226 (16%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 663
+G G +G V GR +A+KK+ S++ D + RE+++L RH N+I L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 664 GYYWTPQLKL------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA-KGLAH 716
P +V++ ++ LH+ + S PL+ + + L +GL +
Sbjct: 66 DIL-RPPSPEDFNDVYIVTEL-----METDLHKVIKSPQPLT-DDHIQYFLYQILRGLKY 118
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT--RLDKHVMSNRFQSALGYV- 773
LH + +IH +LKPSNIL++ N + +I DFGLAR + +K ++ YV
Sbjct: 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT-------EYVV 168
Query: 774 -----APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
APEL S R + DI+ G + EL+T R+P+ G D +
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYI 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 16/216 (7%)
Query: 594 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS---DIIQYPEDFEREVRV 650
T EK +GEG +G VY+ T G ++A+KK+ D I P RE+ +
Sbjct: 2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI--PISSLREITL 59
Query: 651 LGKARHPNLISLEGYYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL 708
L RHPN++ L+ L LV +Y A L + +P+ P S + ++L
Sbjct: 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQD--LASLLDNMPT--PFSESQVKCLML 115
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
+GL +LH +F IIH +LK SN+LL D +I+DFGLAR K M+ + +
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-MTPKVVT 171
Query: 769 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
L Y APEL D++ G ++ EL+ +
Sbjct: 172 -LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 28/275 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
+G G FG V++ GR +A+K L + +DF E ++G+ H N+I LE
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
G + +++++Y NG+L L + + I K L+ +++
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY---- 128
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR-FQSALGYVAPELTCQSL 782
+H +L NIL++ N ++SDFGL+R+L + + + + + APE
Sbjct: 129 --VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR- 185
Query: 783 RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH-VRVLLEEGNVLDCVDPSMGD 840
+ D++ FG+++ E+++ G RP Y + +S H V + +G L P+ D
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP--YWD-----MSNHEVMKAINDGFRL----PAPMD 234
Query: 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
P V +L L C + RP ++V +L
Sbjct: 235 CPS----AVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 78/289 (26%), Positives = 139/289 (48%), Gaps = 39/289 (13%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
+DP + E E+G+G FG VYK G LA K++ + + ED+ E+ +L
Sbjct: 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATC 66
Query: 655 RHPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTA 711
HP ++ L G +YW +L +++ ++ P G++ A + E R + P + +VI
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP------QIQVICRQM 119
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL-ARLLTRLDKHVMSNRFQSAL 770
HS + IIH +LK N+LL + + +++DFG+ A+ + L + + F
Sbjct: 120 LEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR---DSFIGTP 174
Query: 771 GYVAPELT-CQSLR---VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826
++APE+ C++++ + K DI+ G+ ++E+ P + E N +RVLL+
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP--HHELN------PMRVLLK 226
Query: 827 EGNVLDCVDPSMGDYPED---EVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
+P P E LK AL P +RPS A++++
Sbjct: 227 IAK----SEPPTLSQPSKWSMEFRDFLKTALD---KHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 11/211 (5%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
DPE L K +G+G FG V+K +++A+K + + ED ++E+ VL +
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 715
P + G Y ++ +Y GS L R K IL KGL
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEIL---KGLD 115
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 775
+LH + IH ++K +N+LL + + +++DFG+A LT D + N F ++AP
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
E+ QS + K DI+ G+ +EL G P
Sbjct: 171 EVIQQS-AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 42/281 (14%)
Query: 606 EVGEGVFGTVYKVSFGTQGRM---LAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
E+G G FG+V K + + +AVK L I ++F RE V+ + HP ++ L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
G L +LV + AP G L + L + ++ ++ A G+A+L
Sbjct: 62 IGVCKGEPL-MLVMELAPLGPL----LKYLKKRREIPVSDLKELAHQVAMGMAYLESK-- 114
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG------YVAPE 776
+H +L N+LL + + +ISDFG++R L S+ +++ + APE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRAL-----GAGSDYYRATTAGRWPLKWYAPE 168
Query: 777 LTCQSL-RVNEKCDIYGFGVLILELVT-GRRPVEYGE-DNVVILSEHVRVLLEEGNVLDC 833
C + + + K D++ +GV + E + G +P YGE +++ +LE G L
Sbjct: 169 --CINYGKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVIA-----MLESGERLPR 219
Query: 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
PE+ + + L C + P RP+ +E+
Sbjct: 220 --------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 32/288 (11%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS--DIIQYPEDFEREVRVLGK 653
DPE L E+G G FG VY ++A+KK+ S + +D +EV+ L +
Sbjct: 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYA-PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
+HPN I +G Y LV +Y + S ++H++ PL + G +
Sbjct: 82 IKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQ 136
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
GLA+LH +IH ++K NILL + +++DFG A + + +N F +
Sbjct: 137 GLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYW 187
Query: 773 VAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830
+APE L + + K D++ G+ +EL R+P + N+ +S + E
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLF---NMNAMSALYHIAQNESPT 243
Query: 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878
L + S DY + V C IP RP+ E+++ + V++
Sbjct: 244 LQSNEWS--DYFRNFVDS-------CLQKIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISL 662
+G G VY +A+K++ D+ + + +EV+ + + HPN++
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 663 EGYYWTPQLKLLVSDYAPNGSL---------QAKLHERLPSTPPLSWTNRFKVILGTAKG 713
+ LV Y GSL + L E + +T V+ KG
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT----------VLKEVLKG 114
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL-ARLLTRLD-KHVMSNRFQSALG 771
L +LH IH ++K NILL ++ + +I+DFG+ A L D + F
Sbjct: 115 LEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++APE+ Q + K DI+ FG+ +EL TG P
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 660
K ++GEG +G VYK G+++A+KK+ + S+ P RE+ +L + +HPN++
Sbjct: 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
L+ L+ ++ L L + L S P + + V + L +
Sbjct: 63 CLQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL---TRLDKHVMSNRFQSALGYVAPEL 777
++H +LKP N+L+D+ +++DFGLAR R+ H + L Y APE+
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV-----VTLWYRAPEV 172
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
S R + DI+ G + E+ T ++P+ +G+ + L R+L
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRIL 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 17/210 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVT--SDIIQYPEDFEREVRVLGKARHPNLISLEG 664
VG G FG V G+ +A+KK++ S + + RE+++L RH N+ISL
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSD 76
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ +P L Y L LH RL ++ PL + +GL ++H +
Sbjct: 77 IFISP----LEDIYFVTELLGTDLH-RLLTSRPLEKQFIQYFLYQILRGLKYVHSA---G 128
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 784
++H +LKPSNIL+++N + +I DFGLAR+ +S R+ Y APE+ +
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKY 183
Query: 785 NEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
+ + DI+ G + E++ G +P+ G+D+V
Sbjct: 184 DVEVDIWSAGCIFAEMLEG-KPLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 28/222 (12%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDF---EREVRV 650
+P+ E VG G +G VYK G + AVK KL D DF ++E+ +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD------DFSLIQQEIFM 59
Query: 651 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
+ + +H N+++ G Y + + + +Y GSLQ H T PLS V T
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRET 115
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
+GLA+LH + +H ++K +NILL DN + +++DFG+A +T ++ R +S +
Sbjct: 116 LQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITA----TIAKR-KSFI 167
Query: 771 G---YVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPV 807
G ++APE+ ++ N+ CDI+ G+ +EL + P+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE----DFEREVRVLGKARHPNLIS 661
+ +G FG+VY + G A+K L SD+I + ER + ++ + P +
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAK 61
Query: 662 LEGYYWTPQLK---LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
L Y++ Q K LV +Y G A L + L P W ++ I G+ LH
Sbjct: 62 L---YYSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLP-EDWAKQY--IAEVVLGVEDLH 114
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 778
IIH ++KP N+L+D + +++DFGL+R + + +F Y+APE T
Sbjct: 115 QR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPE-T 164
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRPVE 808
+ ++ D + G +I E + G P
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 23/238 (9%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLEG 664
+G+G FG V V +M A+K + ++ + E R+L + HP L++L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ + LV D G L+ L +++ + +F I L +LH
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKF-WICEIVLALEYLHSK---G 120
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ---S 781
IIH ++KP NILLD+ + I+DF +A +T ++ GY+APE+ C+ S
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 782 LRVNEKCDIYGFGVLILELVTGRRPVEY----GEDNVVILSEHVRVLLEEGNVLDCVD 835
+ V D + GV E + G+RP D + E VL + +D
Sbjct: 178 VAV----DWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED-FEREVRVLGKARHPNLI 660
EK VG G FG V+ +++ +K++ + + + E +VL HPN+I
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII 62
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
+ + ++V +YAP G+L + +R S F V + L LHH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI-----LLALHHV 117
Query: 721 FRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 776
I+H +LK NILLD + +I DFG++++L+ K + +G Y++PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA------YTVVGTPCYISPE 171
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 808
L C+ N+K DI+ G ++ EL + +R E
Sbjct: 172 L-CEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-16
Identities = 52/143 (36%), Positives = 70/143 (48%), Gaps = 18/143 (12%)
Query: 350 LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI 409
L L N L G IP ++ + R L + L GNS+ G IP + + TSL +L LS+N +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 410 PKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQS 469
P+S+ L L+IL L N LSG +P LG GRL F D +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG----------------GRLLHRASFNFTDNA 526
Query: 470 SLQGNLGI--CSPLLKGPCKMNV 490
L G G+ C P L K+ +
Sbjct: 527 GLCGIPGLRACGPHLSVGAKIGI 549
|
Length = 623 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS---------DIIQYPEDFER 646
DPE L E+G G FG VY ++A+KK+ S DII +
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII-------K 64
Query: 647 EVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA-PNGSLQAKLHERLPSTPPLSWTNRFK 705
EVR L + RHPN I +G Y LV +Y + S ++H++ PL
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK-----PLQEVEIAA 119
Query: 706 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 765
+ G +GLA+LH R IH ++K NILL + +++DFG A L++ +N
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANS 170
Query: 766 FQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
F ++APE L + + K D++ G+ +EL R+P
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF---EREVRVLG 652
+P+ E +G G +G VYK G + A+K + ++ EDF ++E+ ++
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQEIIMMK 61
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
+H N+++ G Y + ++ GSLQ H T PLS + V T +
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQ 117
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 771
GL +LH + +H ++K +NILL DN + +++DFG++ +T ++ R +S +G
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA----TIAKR-KSFIGT 169
Query: 772 --YVAPELTCQSLR--VNEKCDIYGFGVLILELVTGRRPV 807
++APE+ + N+ CDI+ G+ +EL + P+
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 36/219 (16%)
Query: 600 LLEKAAEVGEGVFGTVYKVSF-GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN 658
L K +G G FG V+ ++ GT +AVK L + PE F +E +++ K RH
Sbjct: 10 LERK---LGAGQFGEVWMGTWNGTT--KVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDK 62
Query: 659 LISL-------EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
L+ L E Y +V++Y GSL L L + A
Sbjct: 63 LVQLYAVCSEEEPIY-------IVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIA 113
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA-- 769
+G+A+L IH +L NIL+ +N +I+DFGLARL+ D + + A
Sbjct: 114 EGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE--DDEYTAR--EGAKF 166
Query: 770 -LGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 806
+ + APE R K D++ FG+L+ E+VT GR P
Sbjct: 167 PIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 87/311 (27%), Positives = 134/311 (43%), Gaps = 66/311 (21%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGK- 653
E+ AE+GEG +GTVYK GR +A+KK ++ P E RE+ +L +
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKK------VRVPLSEEGIPLSTLREIALLKQL 55
Query: 654 --ARHPNLISL----EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPST--PPLSWTNRF 704
HPN++ L G +LKL LV ++ + L L + P PP + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLM 113
Query: 705 KVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764
+ +L +G+ L HS R I+H +LKP NIL+ + +I+DFGLAR+ +
Sbjct: 114 RQLL---RGVDFL-HSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYS--------- 158
Query: 765 RFQSALG-------YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
F+ AL Y APE+ QS D++ G + EL RRP+ G L
Sbjct: 159 -FEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQL 215
Query: 818 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
+ V+ G PS ++P + LP + + S V +
Sbjct: 216 DKIFDVI---GL------PSEEEWPRNVSLPR-------SSFPSYTPRSFKSFVPEICEE 259
Query: 878 KTPLPQRMEVF 888
L ++M F
Sbjct: 260 GLDLLKKMLTF 270
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF----EREVRV-LGKARHPNLIS 661
+G+G FG VY+V R+ A+K L +I+ E ER + V P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKV-ILGTAKGLAHLH 718
L+ + T LV+DY G L L + R +R K I L HLH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE-------DRAKFYIAELVLALEHLH 113
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 778
+ I++ +LKP NILLD + + DFGL++ L + +N F Y+APE+
Sbjct: 114 ---KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+ D + GVL+ E+ G P Y ED
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPF-YAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKL--VTSDIIQYPEDFEREVRVLGKARHPNLISLEG 664
+G G FG V+ V+ G+ +A+KK+ V +++ F RE+++L +H N++S
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHSFRP 723
P + Y +Q+ LH+ + S PLS ++ KV L +GL +LH +
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSA--- 122
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
I+H ++KP N+L++ N +I DFGLAR+ + M+ + Y APE+ S
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSRH 181
Query: 784 VNEKCDIYGFGVLILELVTGR 804
DI+ G + EL+ R
Sbjct: 182 YTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKA 654
DP L + ++GEG G VYK + G+ +A+KK+ + + E+ ++
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL---IINEILIMKDC 72
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF-------KVI 707
+HPN++ Y +V +Y GSL T ++ V
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSL----------TDIITQNFVRMNEPQIAYVC 122
Query: 708 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 767
+GL +LH S +IH ++K NILL + + +++DFG A LT+ S R
Sbjct: 123 REVLQGLEYLH-SQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE----KSKR-N 174
Query: 768 SALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
S +G ++APE+ + K DI+ G++ +E+ G P
Sbjct: 175 SVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/219 (26%), Positives = 113/219 (51%), Gaps = 19/219 (8%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
++PE E E+G+G FG VYK + +LA K++ + + ED+ E+ +L
Sbjct: 1 LNPEEFWEIIGELGDGAFGKVYKAQ-NKETGVLAAAKVIDTKSEEELEDYMVEIDILASC 59
Query: 655 RHPNLIS-LEGYYWTPQLKLLVSDYAPNGSLQAKLHE-RLPSTPPLSWTNRFKVILG-TA 711
HPN++ L+ +Y+ L +L+ ++ G++ A + E P T P + +V+ T
Sbjct: 60 DHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELERPLTEP-----QIRVVCKQTL 113
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+ L +LH + IIH +LK NIL + + +++DFG++ TR + + F
Sbjct: 114 EALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPY 168
Query: 772 YVAPELT-CQSLR---VNEKCDIYGFGVLILELVTGRRP 806
++APE+ C++ + + K D++ G+ ++E+ P
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 69/239 (28%), Positives = 113/239 (47%), Gaps = 35/239 (14%)
Query: 586 SRSSSLDCSIDPETL--LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED 643
S S+S ++L LE+ +G G GTVYKV GR+ A+K + +
Sbjct: 59 SSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ 118
Query: 644 FEREVRVLGKARHPNLISLEGYY-WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTN 702
RE+ +L HPN++ + ++++L+ ++ GSL+ + L+
Sbjct: 119 ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGT---HIADEQFLADVA 174
Query: 703 RFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHV 761
R IL G+A+LH R I+H ++KPSN+L++ N +I+DFG++R+L + +D
Sbjct: 175 R--QIL---SGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP-- 224
Query: 762 MSNRFQSALGYVAPELTCQSLRVNEKC----------DIYGFGVLILELVTGRRPVEYG 810
N + Y++PE R+N DI+ GV ILE GR P G
Sbjct: 225 -CNSSVGTIAYMSPE------RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276
|
Length = 353 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE------REVRVLGKAR 655
EK +++GEG +G V+K G+++A+KK V S+ +D RE+R+L + +
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE-----DDPVIKKIALREIRMLKQLK 58
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 715
HPNL++L + + LV +Y + ++ +L + P K+I T + +
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK---KIIWQTLQAVN 114
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV---MSNRFQSALGY 772
H IH ++KP NIL+ ++ DFG AR+LT ++ R+ Y
Sbjct: 115 FCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-----Y 166
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTG 803
APEL + D++ G + EL+TG
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 70/243 (28%), Positives = 120/243 (49%), Gaps = 27/243 (11%)
Query: 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLGK 653
ET L++ +G G FGTVYK + +G + A+K L + + +F E ++
Sbjct: 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHER---LPSTPPLSWTNRFKVILGT 710
HP+L+ L G +P ++L V+ P+G L +HE + S L+W +
Sbjct: 66 MDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWC------VQI 118
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
AKG+ +L ++H +L N+L+ + +I+DFGLARLL +K ++ + +
Sbjct: 119 AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175
Query: 771 GYVAPELTCQSLR-VNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEG 828
++A L C R + D++ +GV I EL+T G +P + I + + LLE+G
Sbjct: 176 KWMA--LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG------IPTREIPDLLEKG 227
Query: 829 NVL 831
L
Sbjct: 228 ERL 230
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 40/279 (14%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
++G G +G VY+ + +AVK L D ++ E+F +E V+ + +HPNL+ L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-----GTAKGLAHLHHS 720
+++++ G+L L E V+L + + +L
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVN-------AVVLLYMATQISSAMEYLE-- 121
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
+ IH +L N L+ +N+ +++DFGL+RL+T D + + + + APE
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE---- 175
Query: 781 SLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836
SL N+ K D++ FGVL+ E+ T G P G D LS V LLE+G +
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-GID----LS-QVYELLEKGYRM----- 224
Query: 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ PE V +L C PS RPS AE+ Q +
Sbjct: 225 ---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 656
P L ++G+G FG V+ ++ R +A+K L + PE F +E +V+ K RH
Sbjct: 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM--SPEAFLQEAQVMKKLRH 60
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGT 710
L+ L + + +V++Y GSL + + RLP ++
Sbjct: 61 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ--------I 111
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
A G+A++ R +H +L+ +NIL+ +N +++DFGLARL+ +++ + +
Sbjct: 112 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPI 167
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 806
+ APE R K D++ FG+L+ EL T GR P
Sbjct: 168 KWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 13/215 (6%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
I P L E+G G FG V+ + + R +A+K + + + EDF E +V+ K
Sbjct: 1 IHPSEL-TLVQEIGSGQFGLVWLGYW-LEKRKVAIKTIREGAMSE--EDFIEEAQVMMKL 56
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
HP L+ L G LV ++ +G L L + S + L +G+
Sbjct: 57 SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGM 113
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
A+L S +IH +L N L+ +N ++SDFG+ R + D++ S + + + +
Sbjct: 114 AYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSS 169
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVE 808
PE+ S + + K D++ FGVL+ E+ + G+ P E
Sbjct: 170 PEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPN 658
LE+ VG G FG V+ V A+K + ++I + + E RVL + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 659 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
+I L + ++ +Y P G L + L + + T F ++ + L
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFS---NSTGLFY----ASEIVCALE 115
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAP 775
+ I++ +LKP NILLD + +++DFG A+ L +R + G Y+AP
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL--------RDRTWTLCGTPEYLAP 167
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
E+ QS N+ D + G+LI E++ G P
Sbjct: 168 EVI-QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 41/292 (14%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRM---LAVKKLVTSDIIQYPEDFEREVRV 650
ID + +EK +G G FG V G+ +A+K L + DF E +
Sbjct: 1 IDASCIKIEKV--IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASI 58
Query: 651 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-- 708
+G+ HPN+I LEG + ++V++Y NGSL A L + +F VI
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH---------DGQFTVIQLV 109
Query: 709 ----GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764
G A G+ +L +H +L NIL++ N ++SDFGL+R+L + +
Sbjct: 110 GMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166
Query: 765 R-FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 822
R + + + APE + D++ +G+++ E+++ G RP + VI +
Sbjct: 167 RGGKIPIRWTAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA---- 221
Query: 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
+EEG L P+ D P + +L L C + RP ++V IL
Sbjct: 222 --IEEGYRL----PAPMDCP----AALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVLGKARH 656
+L ++ +G G +G VY+ GR++A+K L T D D +REV +L + R
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQ 58
Query: 657 ---PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
PN+ G Y ++ +YA GS++ L P++ +I
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-----LMKAGPIAEKYISVIIREVLVA 113
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-- 771
L ++H +IH ++K +NIL+ + N ++ DFG+A LL S++ + +G
Sbjct: 114 LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN-----QNSSKRSTFVGTP 165
Query: 772 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++APE+ + + K DI+ G+ I E+ TG P
Sbjct: 166 YWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 42/278 (15%)
Query: 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN 658
TL K +G G FG V++ + + R +A+K ++ SD + +DF++EV+ L + RH +
Sbjct: 9 TLERK---LGSGYFGEVWEGLWKNRVR-VAIK-ILKSDDLLKQQDFQKEVQALKRLRHKH 63
Query: 659 LISL-------EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
LISL E Y ++++ GSL A L R P L + + A
Sbjct: 64 LISLFAVCSVGEPVY-------IITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVA 114
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+G+A+L IH +L NIL+ ++ +++DFGLARL+ + +S+ +
Sbjct: 115 EGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYK 169
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 830
+ APE + K D++ FG+L+ E+ T G+ P G +N V + G
Sbjct: 170 WTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYP-GMNN-----HEVYDQITAGYR 222
Query: 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA 868
+ P P++ + K+ L C P RPS
Sbjct: 223 M----PCPAKCPQE----IYKIMLECWAAEPEDRPSFK 252
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 62/207 (29%), Positives = 88/207 (42%), Gaps = 21/207 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 662
+G+G FG V G+M A KKL + + + E+++ L K ++SL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHH 719
+ T LV G L K H P + I A+ GL HLH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEA---RAIFYAAQIICGLEHLHQ 113
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
I++ +LKP N+LLDD+ N RISD GLA L K GY+APE+
Sbjct: 114 RR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVL- 166
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRP 806
Q + D + G + E++ GR P
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 72/282 (25%), Positives = 127/282 (45%), Gaps = 29/282 (10%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
I+P L E+G G FG V+ + Q + +A+K + + EDF E +V+ K
Sbjct: 1 INPSEL-TFMKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAM--SEEDFIEEAKVMMKL 56
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
HP L+ L G + +V+++ NG L L +R LS + +G+
Sbjct: 57 SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGM 113
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
+L R IH +L N L+ ++SDFG+ R + D++ S+ + + +
Sbjct: 114 EYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSP 169
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833
PE+ S + + K D++ FGVL+ E+ T G+ P E + N ++ + G L
Sbjct: 170 PEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFE-KKSNYEVVEM-----ISRGFRL-- 220
Query: 834 VDPSMGDY-PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
Y P+ + V ++ C P RP+ AE+++ +
Sbjct: 221 -------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 75/295 (25%), Positives = 127/295 (43%), Gaps = 44/295 (14%)
Query: 607 VGEGVFGTVYK-VSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
+GEG FG V K +F +GR +AVK L + D E +L + HP++I
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERL--------------------PSTPPLSWT 701
L G LL+ +YA GSL++ L E P L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 702 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761
+ ++G+ +L ++H +L N+L+ + +ISDFGL+R + D +V
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 820
++ + + ++A E + + D++ FGVL+ E+VT G P I E
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLWEIVTLGGNPYPG------IAPER 237
Query: 821 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ LL+ G + + PE+ + L L C P RP+ A++ + L+
Sbjct: 238 LFNLLKTGYRM--------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 84/293 (28%), Positives = 142/293 (48%), Gaps = 41/293 (13%)
Query: 607 VGEGVFGTVYKVSFG----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
+G+G FG+V + G ++AVKKL S ++ DFERE+ +L +H N++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKY 70
Query: 663 EGYYWTP-QLKL-LVSDYAPNGSLQAKL---HERLPSTPPLSWTNRFKVILGTAKGLAHL 717
+G ++ + L LV +Y P GSL+ L ERL L + ++ KG+ +L
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGMEYL 124
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK--HVMSNRFQSALGYVAP 775
S R +H +L NIL++ +I DFGL ++L DK + + +S + + AP
Sbjct: 125 G-SKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWYAP 180
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVT-----GRRPVEY----GED-NVVILSEHVRVLL 825
E +S + + D++ FGV++ EL T P E+ G D ++ H+ LL
Sbjct: 181 ESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239
Query: 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878
+ L P+ P E+ ++K C + PS RPS +E+ ++ I+
Sbjct: 240 KNNGRL----PAPPGCP-AEIYAIMKE---CWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
EK ++GEG + TVYK G+++A+K + + P RE +L +H N++
Sbjct: 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHS 720
L T + LV +Y + L + + P K+ L +GL+++H
Sbjct: 68 LHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
+ I+H +LKP N+L+ D +++DFGLAR + + H SN + L Y P++
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLARAKS-VPSHTYSNEVVT-LWYRPPDVLLG 177
Query: 781 SLRVNEKCDIYGFGVLILELVTG 803
S + D++G G + +E++ G
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 79/286 (27%), Positives = 132/286 (46%), Gaps = 38/286 (13%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 656
P L+ ++G G FG V+ ++ + +AVK L + PE F E +++ K RH
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTM--SPESFLEEAQIMKKLRH 60
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE------RLPSTPPLSWTNRFKVILGT 710
L+ L + + +V++Y GSL L + +LP N +
Sbjct: 61 DKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLP--------NLVDMAAQV 111
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
A G+A++ R IH +L+ +NIL+ D +I+DFGLARL+ +++ + +
Sbjct: 112 AAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED-NEYTARQGAKFPI 167
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 829
+ APE R K D++ FG+L+ ELVT GR P G +N +L + +E G
Sbjct: 168 KWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYP-GMNNREVLEQ-----VERGY 220
Query: 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ C P+D + + +L L C P RP+ + L+
Sbjct: 221 RMPC--------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 656
P L ++G+G FG V+ ++ + +A+K L ++ PE F +E +++ K RH
Sbjct: 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMM--PEAFLQEAQIMKKLRH 60
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE------RLPSTPPLSWTNRFKVILGT 710
L+ L + + +V+++ GSL L E +LP ++
Sbjct: 61 DKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ--------I 111
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
A G+A++ R IH +L+ +NIL+ DN +I+DFGLARL+ +++ + +
Sbjct: 112 ADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPI 167
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 806
+ APE R K D++ FG+L+ ELVT GR P
Sbjct: 168 KWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 52/210 (24%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 607 VGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
+G G FG V + G+ +A+K L + + DF E ++G+ HPN+I LE
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
G + ++++++ NG+L + L + + + I K L+ +++
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY---- 127
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG------YVAPEL 777
+H +L NIL++ N ++SDFGL+R L+ + S+LG + APE
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSSLGGKIPIRWTAPE- 181
Query: 778 TCQSLRVNEKCDIYGFGVLILELVT-GRRP 806
+ D++ +G+++ E+++ G RP
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 67/221 (30%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVL---GKARHPNL 659
A +G G FG V + G + A+K L DII E E R+ RHP L
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAH 716
++L + T V +YA G L +H + S P F V+L GL +
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP----RAVFYAACVVL----GLQY 116
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM--SNRFQSALG--- 771
LH + I++ +LK N+LLD +I+DFGL K M +R + G
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGTPE 166
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
++APE+ ++ D +G GVLI E++ G P G+D
Sbjct: 167 FLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFP-GDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 65/291 (22%), Positives = 130/291 (44%), Gaps = 26/291 (8%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
+ E L E +++G G G+V KV G ++A K + + RE++++ +
Sbjct: 2 LRNEDL-ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC 60
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
R P ++S G + + ++ GSL + P + K+ + +GL
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG----KIAVAVVEGL 116
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
+L++ R I+H ++KPSNIL++ ++ DFG++ L + +++ F Y++
Sbjct: 117 TYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMS 170
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
PE Q + K D++ G+ I+EL G+ P + + + + +L ++L +
Sbjct: 171 PE-RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL----DLLQQI 225
Query: 835 --DPS----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
+P D+PED V C P+ RP+ ++ + I+
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVDA----CLLKDPTERPTPQQLCAMPPFIQA 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 74/286 (25%), Positives = 121/286 (42%), Gaps = 42/286 (14%)
Query: 606 EVGEGVFGTVYKVS-FGT----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+GE FG VYK FGT Q + +A+K L E+F+ E + + +HPN++
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------PPLSWTNRFKVIL 708
L G Q ++ Y + L L R P + L + ++
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 709 GTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 766
A G+ L HH ++H +L N+L+ D N +ISD GL R + D + +
Sbjct: 132 QIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP-VEYGEDNVVILSEHVRVL 824
+ +++PE + + DI+ +GV++ E+ + G +P Y +V+ E +R
Sbjct: 187 LLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI---EMIR-- 240
Query: 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 870
VL C P+D V L L C PS RP ++
Sbjct: 241 --NRQVLPC--------PDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
VGEG FG V + A+K++ ED +E +L K +HPN+++ + +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 667 WTPQLKLLVSDYAPNGSLQAKLHER----LPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+V +Y G L K+ + P L W + + G+ H+H
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH---E 118
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
++H ++K NI L N ++ DFG ARLLT + + + YV PE+ +++
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEI-WENM 175
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
N K DI+ G ++ EL T + P + +IL
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 16/204 (7%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW 667
GEG G+V K G + A+K + T + RE+ + + P ++ G +
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 668 TPQ---LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ + + +Y GSL + + + K+ KGL++LH
Sbjct: 70 DESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---K 125
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLA-RLLTRLDKHVMSNRFQSALGYVAPE-LTCQSL 782
IIH ++KPSNILL ++ DFG++ L+ L F Y+APE + +
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF-----YMAPERIQGKPY 180
Query: 783 RVNEKCDIYGFGVLILELVTGRRP 806
+ D++ G+ +LE+ R P
Sbjct: 181 SI--TSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 67/283 (23%), Positives = 121/283 (42%), Gaps = 36/283 (12%)
Query: 606 EVGEGVFGTVYKVSFGTQG----RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
E+GE FG +YK G +++A+K L + Q +F++E ++ + HPN++
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST-------------PPLSWTNRFKVIL 708
L G Q ++ +Y G L L R P + L + + +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
A G+ +L F +H +L NIL+ + + +ISD GL+R + D + + +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 769 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEE 827
+ ++ PE + + DI+ FGV++ E+ + G +P YG N + V ++ +
Sbjct: 189 PIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPY-YGFSN-----QEVIEMVRK 241
Query: 828 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 870
+L C ED + L C PS RP ++
Sbjct: 242 RQLLPC--------SEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPNLISLEG 664
+G G FG V V G+ A+K L + I++ E E R+L RHP L++L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHSF 721
+ LV +Y P G L + L R P RF +V+L L +LH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVA-RFYAAQVVLA----LEYLHSL- 120
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELT 778
I++ +LKP N+LLD + +I+DFG A K V R + G Y+APE+
Sbjct: 121 --DIVYRDLKPENLLLDSDGYIKITDFGFA-------KRV-KGRTYTLCGTPEYLAPEII 170
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRP 806
S + D + G+LI E++ G P
Sbjct: 171 -LSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 67/242 (27%), Positives = 113/242 (46%), Gaps = 25/242 (10%)
Query: 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLGK 653
ET L K +G GVFGTV+K + +G + A+K + Q ++ + +G
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVILGT 710
H ++ L G L+L V+ +P GSL + + S P L+W +
Sbjct: 66 LDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWC------VQI 118
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
AKG+ +L ++H NL NILL + +I+DFG+A LL DK + ++ +
Sbjct: 119 AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH-VRVLLEEGN 829
++A E + R + D++ +GV + E+++ YG + + H V LLE+G
Sbjct: 176 KWMALE-SILFGRYTHQSDVWSYGVTVWEMMS------YGAEPYAGMRPHEVPDLLEKGE 228
Query: 830 VL 831
L
Sbjct: 229 RL 230
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 44/235 (18%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGK- 653
DP + E +GEG +G VYK G+++A+K + + D E+ + E +L K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKY 59
Query: 654 ARHPNLISLEGYY-----WTPQLKL-LVSDYAPNGS---LQAKLHERLPSTPPLSWTNRF 704
+ HPN+ + G + +L LV + GS L L ++ R
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK---------GKRL 110
Query: 705 K------VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758
K ++ T +GLA+LH +IH ++K NILL N ++ DFG++ L
Sbjct: 111 KEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-- 165
Query: 759 KHVMSNRFQSALG---YVAPE-LTC-QSLRV--NEKCDIYGFGVLILELVTGRRP 806
R + +G ++APE + C + + + D++ G+ +EL G+ P
Sbjct: 166 ---TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLI 660
K ++GEG FG V G+ +K++ S + + E+ +EV VL +HPN++
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHER----LPSTPPLSWTNRFKVILGTAKGLAH 716
+ + +V DY G L K++ + P L W + L H
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKH 116
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YV 773
+H I+H ++K NI L + ++ DFG+AR+L + ++ +G Y+
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCIGTPYYL 168
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG 810
+PE+ C++ N K DI+ G ++ E+ T + E G
Sbjct: 169 SPEI-CENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 660
+K ++GEG +G VYK G ++A+KK+ + ++ P RE+ +L + HPN++
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
L T LV ++ + L+ + S PL + L +GLA H S
Sbjct: 63 KLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH-S 118
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLAR---LLTRLDKHVMSNRFQSALGYVAPEL 777
R ++H +LKP N+L++ +++DFGLAR + R H + L Y APE+
Sbjct: 119 HR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-----VTLWYRAPEI 171
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGR 804
+ DI+ G + E+VT R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 59/240 (24%), Positives = 106/240 (44%), Gaps = 40/240 (16%)
Query: 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE----------------R 646
K A +GEG +G V K G+++A+KK+ II+ D R
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKV---KIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 647 EVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV 706
E++++ + +H N++ L Y LV D + + L + + L+ + +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDI-----MASDLKKVVDRKIRLTESQVKCI 124
Query: 707 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL--------TRLD 758
+L GL LH + +H +L P+NI ++ +I+DFGLAR D
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 759 KHVMSNRFQSA----LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
+ + ++ L Y APEL + + + D++ G + EL+TG +P+ GE+ +
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEI 240
|
Length = 335 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-14
Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 663
VG G +G V GR +A+KKL S Q + RE+R+L H N+I L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL--SRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 664 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV--ILGTAKGL 714
+ TP L LV+ A L+ + +F V IL +GL
Sbjct: 81 DVF-TPASSLEDFQDVYLVTHLM-----GADLNNIVKCQKLSDDHIQFLVYQIL---RGL 131
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV- 773
++H + IIH +LKPSNI ++++ +I DFGLAR M+ GYV
Sbjct: 132 KYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT----DDEMT-------GYVA 177
Query: 774 -----APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
APE+ + N+ DI+ G ++ EL+TG+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 18/216 (8%)
Query: 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLV--TSDIIQYPEDFER---EVRVLGKA 654
K +G+G +GTVY QG+++AVK++ TS+++ +++E+ EV +L
Sbjct: 1 EWTKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
+H N++ G + ++ P GS+ + L R P + K IL G+
Sbjct: 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQIL---DGV 115
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM-SNRFQSALG-- 771
A+LH++ ++H ++K +N++L N ++ DFG AR L + H SN +S G
Sbjct: 116 AYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 772 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++APE+ +S K DI+ G + E+ TG+ P
Sbjct: 173 YWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 9e-14
Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLV-TSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+G G +G V G+ +A+KK+ D+ + RE+++L +H N+I++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA-KGLAHLHHSFRPP 724
P Y +++ LH + S PL+ + L +GL ++H +
Sbjct: 73 LRPPG-ADFKDVYVVMDLMESDLHHIIHSDQPLT-EEHIRYFLYQLLRGLKYIHSA---N 127
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLL-TRLDKH--VMSNRFQSALGYVAPELTCQS 781
+IH +LKPSN+L++++ RI DFG+AR L + +H M+ + + Y APEL
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT-EYVATRWYRAPELLLSL 186
Query: 782 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
D++ G + E++ GRR + G++ V
Sbjct: 187 PEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYV 218
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+GEG FG +Y + +K++ +T ++ E ++EV +L K +HPN+++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHER----LPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
+ +V +Y G L +++ + LSW + + GL H+H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIHDR- 120
Query: 722 RPPIIHYNLKPSNILLDDN-YNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
I+H ++K NI L N ++ DFG+AR L D ++ Y++PE+ CQ
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEI-CQ 175
Query: 781 SLRVNEKCDIYGFGVLILELVTGRRPVE 808
+ N K DI+ G ++ EL T + P E
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 36/219 (16%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL--------VTSDIIQYPEDFEREVRVLGK 653
+K ++GEG +G VYK G ++A+KK+ V S I RE+ +L +
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-------REISLLKE 54
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF--KVILGTA 711
HPN++ L + LV ++ L L + + S+P +
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR---LLTRLDKH-VMSNRFQ 767
+G+A+ H S R ++H +LKP N+L+D +++DFGLAR + R H V++
Sbjct: 110 QGIAYCH-SHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT---- 162
Query: 768 SALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
L Y APE+ S + + DI+ G + E+V RRP
Sbjct: 163 --LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 47/298 (15%)
Query: 601 LEKAAEVGEGVFGTV----YKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 656
L+K +GEG FG V Y + G M+AVK L Q +++E+ +L H
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65
Query: 657 PNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL---GTA 711
N++ +G + L+ +Y P GSL+ L P N +++L
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--------PKHKLNLAQLLLFAQQIC 117
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL-TRLDKHVMSNRFQSAL 770
+G+A+LH IH +L N+LLD++ +I DFGLA+ + + + + S +
Sbjct: 118 EGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP-------------VEYGEDNVVIL 817
+ A E + + + D++ FGV + EL+T + G+ VV L
Sbjct: 175 FWYAVE-CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233
Query: 818 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
E LLE G L C P++ V L C RP+ ++ IL+
Sbjct: 234 IE----LLERGMRLPC--------PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 34/231 (14%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKL---VTSDIIQYPEDFEREVRVLGKARHPNLISL 662
+VG G +GTV G +A+KKL S++ + + RE+R+L +H N+I L
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL--FAKRAYRELRLLKHMKHENVIGL 79
Query: 663 EGYYWTPQLKL-------LVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFK-VILGTAK 712
+ TP L L LV + G+ KL HE+L +R + ++ K
Sbjct: 80 LDVF-TPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSE-------DRIQFLVYQMLK 129
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
GL ++H + IIH +LKP N+ ++++ +I DFGLAR + R+ Y
Sbjct: 130 GLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW-----Y 181
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV 823
APE+ + + DI+ G ++ E++TG +P+ G D++ L E ++V
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHDHLDQLMEIMKV 231
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE------REVRVLGKARHPNLI 660
VGEG +G V K G+++A+KK + S +D RE+R+L + RH NL+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLES-----EDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR--FKVILGTAKGLAHLH 718
+L + + LV ++ + L E+ P+ S + F+++ G H H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGI--EFCHSH 119
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT---RLDKHVMSNRFQSALGYVAP 775
+ IIH ++KP NIL+ + ++ DFG AR L + ++ R+ Y AP
Sbjct: 120 N-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW-----YRAP 169
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTG 803
EL + DI+ G L+ E++TG
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 68/230 (29%), Positives = 100/230 (43%), Gaps = 32/230 (13%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKA-RHPNLISL 662
+G+G FG V + AVK L I+Q +D E E RVL A +HP L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRF---KVILGTAKGLAHL 717
+ T V +Y G L + R RF +++LG L L
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLG----LQFL 112
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR--LLTRLDKHVMSNRFQSALGYVAP 775
H II+ +LK N+LLD + +I+DFG+ + +L V ++ F Y+AP
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTTSTFCGTPDYIAP 165
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE-YGEDNV--VILSEHVR 822
E+ D + GVL+ E++ G+ P E ED + IL + VR
Sbjct: 166 EIL-SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
K ++GEG + TV+K ++A+K++ P REV +L +H N+++L
Sbjct: 9 KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHSF 721
T + LV +Y L + L + L + L + K+ + +GL++ H
Sbjct: 69 HDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR- 122
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
I+H +LKP N+L+++ +++DFGLAR + K SN + L Y P++ S
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVT-LWYRPPDVLLGS 178
Query: 782 LRVNEKCDIYGFGVLILELVTGR 804
+ D++G G ++ E+ TGR
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 73/284 (25%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 607 VGEGVFGTVYK------VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+G G FG VY+ + G+ +AVK L Q ++F +E ++ HPN++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHE-RLPSTPP--LSWTNRFKVILGTAKGLAHL 717
L G + + ++ + G L + L + R+ P L+ + L AKG +L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 718 HHSFRPPIIHYNLKPSNILLD--DNYNPR---ISDFGLARLLTRLDKHVMSNRFQSALGY 772
+ IH +L N L+ R I DFGLAR + + D + + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
+APE + D++ FGVL+ E++T G++P +N +L +HV G L
Sbjct: 180 MAPESLLDGKFTTQS-DVWSFGVLMWEILTLGQQPYP-ALNNQEVL-QHVT----AGGRL 232
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
P P+ + +L C PS RP+ + +ILQ
Sbjct: 233 Q--KPEN--CPDK----IYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G+G +G VY + +A+K++ D +Y + E+ + +H N++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 667 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF--KVILGTAKGLAHLHHSFRPP 724
+ + P GSL A L + T F K IL +GL +LH +
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL---EGLKYLHDN---Q 128
Query: 725 IIHYNLKPSNILLDDNYNP--RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
I+H ++K N+L++ Y+ +ISDFG ++ L ++ + F L Y+APE+ +
Sbjct: 129 IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGP 185
Query: 783 R-VNEKCDIYGFGVLILELVTGRRP-VEYGE 811
R DI+ G I+E+ TG+ P +E GE
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPFIELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
K ++GEG + TVYK ++A+K++ P REV +L +H N+++L
Sbjct: 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHSF 721
T + LV +Y L L + L + K+ L +GL + H
Sbjct: 70 HDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
R ++H +LKP N+L+++ +++DFGLAR + + SN + L Y P++ S
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYSNEVVT-LWYRPPDILLGS 179
Query: 782 LRVNEKCDIYGFGVLILELVTGR 804
+ + D++G G + E+ TGR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 52/295 (17%)
Query: 606 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+GEG FG V+ + ++AVK L + +DFERE +L +H N++
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSL---------QAKLHERLPSTP-PLSWTNRFKVILGT 710
G ++V +Y +G L A + S L+ + ++ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 711 AKG---LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 767
A G LA H +H +L N L+ + +I DFG++R + D + +
Sbjct: 132 ASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 768 SALGYVAPE------LTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 820
+ ++ PE T +S D++ FGV++ E+ T G++P YG N E
Sbjct: 186 LPIRWMPPESIMYRKFTTES-------DVWSFGVVLWEIFTYGKQPW-YGLSN-----EE 232
Query: 821 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
V + +G +L P V + L C P R ++ ++ + LQ
Sbjct: 233 VIECITQGRLLQR--------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 43/262 (16%)
Query: 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLE 663
++GEG +G VYK G ++A+KK+ + + +P RE+++L + H N+++L+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 664 GYYWTPQLKL----------LVSDYAPN---GSLQAKL----HERLPSTPPLSWTNRFKV 706
Q L LV +Y + G L++ L + + S K
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF--------MKQ 124
Query: 707 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 766
+L +GL + H + +H ++K SNILL++ +++DFGLARL + +N+
Sbjct: 125 LL---EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826
+ L Y PEL R D++ G ++ EL T ++P+ + L R+
Sbjct: 179 IT-LWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLELISRL--- 233
Query: 827 EGNVLDCVDPSMGDYPEDEVLP 848
C P +P+ LP
Sbjct: 234 ------CGSPCPAVWPDVIKLP 249
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISLEG 664
+G+G FG V G+M A KKL I + + E ++L K ++SL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHHSF 721
Y T LV G L+ ++ + + A+ GL LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE-----RAVFYAAEITCGLEDLH--- 119
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
R I++ +LKP NILLDD + RISD GLA + + + R +GY+APE+ ++
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIP--EGETIRGRV-GTVGYMAPEVV-KN 175
Query: 782 LRVNEKCDIYGFGVLILELVTGRRP 806
R D +G G LI E++ G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 75/302 (24%), Positives = 134/302 (44%), Gaps = 39/302 (12%)
Query: 597 PETLLEKAAEVGEGVFGTVYKV-SFGT------QGRMLAVKKLVTSDIIQYPEDFEREVR 649
P L +GEG FG V + ++G Q +AVK L + + D E+
Sbjct: 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEME 69
Query: 650 VLG-KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP------------ 696
++ +H N+I+L G ++ +YA G+L+ L R P P
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 697 PLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756
LS+ + A+G+ +L S R IH +L N+L+ ++ +I+DFGLAR +
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLE-SRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
Query: 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVV 815
+D + ++ + + ++APE + ++ D++ FG+L+ E+ T G P
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQS-DVWSFGILMWEIFTLGGSPYP------G 239
Query: 816 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
I E + LL EG+ +D P + + L C +P+ RP+ ++V+ L
Sbjct: 240 IPVEELFKLLREGHRMDK--------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
Query: 876 VI 877
+
Sbjct: 292 KV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 606 EVGEGVFGTVYKV--SFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKARH 656
+G G +G VYK G G+ A+KK E + RE+ +L + +H
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-----KEQYTGISQSACREIALLRELKH 61
Query: 657 PNLISLEGYYWTPQLKL--LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKG 713
N++SL + K L+ DYA + Q R + + K +L G
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP-PSMVKSLLWQILNG 120
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPR----ISDFGLARL-------LTRLDKHVM 762
+ +LH ++ ++H +LKP+NIL+ R I D GLARL L LD V+
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
+ + Y APEL + + DI+ G + EL+T
Sbjct: 178 T------IWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 35/226 (15%)
Query: 595 IDPE--TLLEKAAEVGEGVFGTVYKVSFGT-QGRM-LAVKKLVTSDIIQYPEDFEREVRV 650
IDP+ T L+ E+G G FG V +G +G+ +A+K + + + ++F E +V
Sbjct: 1 IDPKDLTFLK---ELGTGQFGVV---KYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKV 52
Query: 651 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
+ K H L+ L G + +V++Y NG L L E P K +
Sbjct: 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV--- 109
Query: 711 AKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 769
+G+A+L F IH +L N L+DD ++SDFGL+R +V+ + + S+
Sbjct: 110 CEGMAYLESKQF----IHRDLAARNCLVDDQGCVKVSDFGLSR-------YVLDDEYTSS 158
Query: 770 LG------YVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVE 808
+G + PE+ S + + K D++ FGVL+ E+ + G+ P E
Sbjct: 159 VGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 36/290 (12%)
Query: 601 LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
+ E+G+G FG VY+ V G +A+K + + ++ +F E V+ +
Sbjct: 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN 67
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------PPLSWTNRFKVILG 709
+++ L G T Q L+V + G L++ L R P P + ++
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 710 TAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 769
A G+A+L +H +L N ++ ++ +I DFG+ R + D + +
Sbjct: 128 IADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 770 LGYVAPELTCQSLR---VNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 825
+ ++APE SL+ K D++ FGV++ E+ T +P + G N E V +
Sbjct: 185 VRWMAPE----SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ-GLSN-----EEVLKFV 234
Query: 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+G L D PE+ +L+L +C + P RP+ E+V L+
Sbjct: 235 IDGGHL--------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 72/281 (25%), Positives = 116/281 (41%), Gaps = 30/281 (10%)
Query: 607 VGEGVFGTVYKVSF----GTQGRM-LAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
+G G FG VY+ + G + +AVK L S Q DF E ++ K H N++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST---PPLSWTNRFKVILGTAKGLAHLH 718
L G + + ++ + G L++ L E P L+ + AKG +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL- 132
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPR---ISDFGLARLLTRLDKHVMSNRFQSALGYVAP 775
IH ++ N LL R I+DFG+AR + R + R + ++ P
Sbjct: 133 EENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
E + K D++ FGVL+ E+ + G P G N + V + G L
Sbjct: 191 EAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYP-GRTN-----QEVMEFVTGGGRL--- 240
Query: 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
D P+ PV ++ C H P RP+ A +++ +Q
Sbjct: 241 -----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 33/218 (15%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLA-------VKKLVTSDIIQYPEDFEREVRVLGK 653
EK E+G G G V KV G ++A +K + + II RE++VL +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQII-------RELKVLHE 55
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTA 711
P ++ G +++ + ++ GSL L + R+P L K+ +
Sbjct: 56 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-NILG-----KISIAVL 109
Query: 712 KGLAHLH--HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 769
+GL +L H I+H ++KPSNIL++ ++ DFG++ L +D M+N F
Sbjct: 110 RGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS--MANSFVGT 161
Query: 770 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 807
Y++PE Q + DI+ G+ ++E+ GR P+
Sbjct: 162 RSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-13
Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 28/230 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G G FG VY+ +A+KK ++Q P+ RE+ ++ H N+I L+ YY
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKK-----VLQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 667 WTPQLKL--------LVSDYAPNGSLQ-AKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 717
+T K +V ++ P + K + R PL + L + LA++
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYI 186
Query: 718 HHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGLARLLTRLDKHV--MSNRFQSALGYVA 774
H F I H +LKP N+L+D N + ++ DFG A+ L + V + +RF Y A
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRA 238
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
PEL + D++ G +I E++ G P+ G+ +V L ++VL
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQLVRIIQVL 287
|
Length = 440 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 38/85 (44%), Positives = 52/85 (61%)
Query: 302 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSI 361
L L + L G IP ++ +L+ +NLS N +R IPP LG SL LDL N+ GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 362 PQEVCESRSLGILQLDGNSLTGPIP 386
P+ + + SL IL L+GNSL+G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 66/230 (28%), Positives = 112/230 (48%), Gaps = 21/230 (9%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 660
EK ++GEG +G VYK +A+KK+ + + P RE+ +L + +H N++
Sbjct: 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF-KVIL-GTAKGLAHLH 718
L+ + + LV +Y L L + + S+P + R K L +G+A+
Sbjct: 65 RLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC- 118
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLL---TRLDKHVMSNRFQSALGYVA 774
HS R ++H +LKP N+L+D N +++DFGLAR R H + L Y A
Sbjct: 119 HSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEV-----VTLWYRA 171
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
PE+ S + DI+ G + E+V ++P+ G+ + L + R+L
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKIFRIL 220
|
Length = 294 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 36/213 (16%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVT-----SDIIQYPEDFEREVRVLGK-ARHPNL 659
++G+G FG+VY G ++A+KK+ + + REV+ L K HPN+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLNEHPNI 60
Query: 660 ISL-EGYYWTPQLKLLVSDYAPNGSL--QAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
+ L E + +L V +Y G+L K + P + + +I +GLAH
Sbjct: 61 VKLKEVFRENDEL-YFVFEYM-EGNLYQLMKDRKGKPFSESVI----RSIIYQILQGLAH 114
Query: 717 LH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR----FQSALG 771
+H H F H +LKP N+L+ +I+DFGLAR + S + S
Sbjct: 115 IHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRW 163
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
Y APE+ +S + DI+ G ++ EL T R
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 67/228 (29%), Positives = 100/228 (43%), Gaps = 23/228 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLISLE 663
+G+G FG V G++ A KKL ++ + +E E R+L K ++SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKL-NKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHHS 720
+ T LV G L+ ++ P + TA+ GL HLH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQIISGLEHLHQR 116
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
II+ +LKP N+LLD++ N RISD GLA L D + + G++APEL Q
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELL-Q 170
Query: 781 SLRVNEKCDIYGFGVLILELVTGRRP-------VEYGEDNVVILSEHV 821
+ D + GV + E++ R P VE E IL++ V
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 14/212 (6%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 656
P L+ ++G G FG V+ + + +A+K L + PE F E ++ + +H
Sbjct: 4 PRETLKLVKKLGAGQFGEVW-MGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQH 60
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
P L+ L T + ++++Y NGSL L + P L+ + A+G+A
Sbjct: 61 PRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
+ R IH +L+ +NIL+ + +I+DFGLARL+ +++ + + + APE
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE 173
Query: 777 -LTCQSLRVNEKCDIYGFGVLILELVT-GRRP 806
+ + + K D++ FG+L+ E+VT GR P
Sbjct: 174 AINYGTFTI--KSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL---VTSDIIQYPEDFEREVRVLGKARH 656
L +G+G FG VYK +++A+K + D I ED ++E++ L + R
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI---EDIQQEIQFLSQCRS 58
Query: 657 PNLISLEGYYWTPQLKL-LVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVILGT 710
P + G + KL ++ +Y GS KL E + ++
Sbjct: 59 PYITKYYGSF-LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF----------ILREV 107
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
GL +LH + IH ++K +NILL + + +++DFG++ LT MS R + +
Sbjct: 108 LLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLT----STMSKR-NTFV 159
Query: 771 G---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
G ++APE+ QS +EK DI+ G+ +EL G P
Sbjct: 160 GTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 21/215 (9%)
Query: 606 EVGEGVFGTVY--KVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
E+G G FG V + G + VK+L S F +EV+ + HPN++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKL-----HERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
G LLV ++ P G L+ L + + ++ A GL LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV----LQRMACEVASGLLWLH 117
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 778
+ IH +L N L + + +I D+GLA D ++ + L ++APEL
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 779 C---QSLRV---NEKCDIYGFGVLILELVT-GRRP 806
Q L +K +I+ GV + EL T +P
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 31/229 (13%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEG 664
+G+G FG V V G+ A+K L II E E RVL RHP L +L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKL-HERLPSTPPLSWTNRF---KVILGTAKGLAHLHHS 720
+ T V +YA G L L ER+ S RF +++ L +LH
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGAEIVSA----LGYLH-- 112
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
+++ +LK N++LD + + +I+DFGL + + F Y+APE+
Sbjct: 113 -SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV--- 166
Query: 781 SLRVNE---KCDIYGFGVLILELVTGRRPVEYGEDNVV----ILSEHVR 822
L N+ D +G GV++ E++ GR P Y +D+ IL E +R
Sbjct: 167 -LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 64/283 (22%), Positives = 123/283 (43%), Gaps = 36/283 (12%)
Query: 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-----VTSDIIQYPEDFEREVRVLGKARHP 657
K ++G G F + Y+ G ++AVK++ +S+ + E +E+R++ + HP
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 717
++I + G L ++ GS+ L + + +GL++L
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSYL 119
Query: 718 HHSFRPPIIHYNLKPSNILLDDN-YNPRISDFG----LARLLTRLDKHVMSNRFQSALGY 772
H + IIH ++K +N+L+D RI+DFG LA T + + + +
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAF 174
Query: 773 VAPELTCQSLR---VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829
+APE+ LR CD++ G +I+E+ T + P + + S H+ ++ + +
Sbjct: 175 MAPEV----LRGEQYGRSCDVWSVGCVIIEMATAKPP--WNAEKH---SNHLALIFKIAS 225
Query: 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
PS+ PE + + L C P RP E+++
Sbjct: 226 ATT--APSI---PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 11/223 (4%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISLEG 664
+G+G FG V G+M A K+L I + + E ++L K +++L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
Y T LV G L K H P + + A+ L L R
Sbjct: 68 AYETKDALCLVLTIMNGGDL--KFHIYNMGNPGFE---EERALFYAAEILCGLEDLHREN 122
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 784
++ +LKP NILLDD + RISD GLA + + + R +GY+APE+ + R
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRV-GTVGYMAPEVL-NNQRY 178
Query: 785 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827
D +G G LI E++ G+ P ++ V RVL E
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED-FEREVRVLGKARHPNL 659
E+ +E+G G G V KV G ++A +KL+ +I + RE++VL + P +
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMA-RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKGLAHL 717
+ G +++ + ++ GSL L E R+P KV + +GLA+L
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI------LGKVSIAVLRGLAYL 119
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
+ I+H ++KPSNIL++ ++ DFG++ L +D M+N F Y++PE
Sbjct: 120 REKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS--MANSFVGTRSYMSPE- 172
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPV 807
Q + + DI+ G+ ++EL GR P+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 17/210 (8%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED-FEREVRVLGKARHPNL 659
EK +E+G G G V+KVS G ++A +KL+ +I + RE++VL + P +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKGLAHL 717
+ G +++ + ++ GSL L + R+P KV + KGL +L
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI------LGKVSIAVIKGLTYL 119
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
+ I+H ++KPSNIL++ ++ DFG++ L +D M+N F Y++PE
Sbjct: 120 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDS--MANSFVGTRSYMSPE- 172
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPV 807
Q + + DI+ G+ ++E+ GR P+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 34/88 (38%), Positives = 51/88 (57%)
Query: 177 LDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSL 236
L L N G +P + L + I++S N++ G+IP +G+I++LE LD S N GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 237 PSSLFNCKKLSVIRLRGNSLNGNIPEGL 264
P SL L ++ L GNSL+G +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKK-LVTSDIIQYPEDFEREVRVLGKARHPNLI 660
EK A++G+G FG V+K +++A+KK L+ ++ +P RE+++L +H N++
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVV 74
Query: 661 SLEGYYWTPQLK--------LLVSDYAPNGSLQAKLHE--RLPSTPPLSWT--NRFKVIL 708
+L T LV ++ H+ L S + +T KV+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR---LLTRLDKHVMSNR 765
GL ++H R I+H ++K +NIL+ + +++DFGLAR L + +NR
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 766 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG 810
+ L Y PEL D++G G ++ E+ T R P+ G
Sbjct: 184 VVT-LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQG 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 662
+G+G FG V A+K L D++ +D E E RVL A HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKAL-KKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ T + V +Y G L + + ++I G L LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKKG- 116
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
II+ +LK N+LLD + + +I+DFG+ + + ++ F Y+APE+ +
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEIL-KGQ 171
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+ NE D + FGVL+ E++ G+ P +GED
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPF-HGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 73/258 (28%), Positives = 114/258 (44%), Gaps = 32/258 (12%)
Query: 602 EKAAEVGEGVFGTVYKV-SFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKAR---H 656
E AE+GEG +G V+K GR +A+K++ V + P REV VL H
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63
Query: 657 PNLISLEGYYWTP----QLKLLVSDYAPNGSLQAKLHERL-PSTPPLSWTNRFKVILGTA 711
PN++ L + KL + + L L + P P + + ++
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD---MMFQLL 120
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+GL LH S R ++H +LKP NIL+ + +++DFGLAR+ + + L
Sbjct: 121 RGLDFLH-SHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLW 174
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
Y APE+ QS D++ G + E+ R+P+ G +V L G +L
Sbjct: 175 YRAPEVLLQSSYAT-PVDLWSVGCIFAEMFR-RKPLFRGSSDVDQL----------GKIL 222
Query: 832 DCVD-PSMGDYPEDEVLP 848
D + P D+P D LP
Sbjct: 223 DVIGLPGEEDWPRDVALP 240
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
K ++GEG + TV+K ++A+K++ P REV +L +H N+++L
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHSF 721
T + LV +Y L L + + + + K+ L +GLA+ H
Sbjct: 70 HDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--- 121
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
R ++H +LKP N+L+++ +++DFGLAR + K SN + L Y P++ S
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVT-LWYRPPDVLLGS 179
Query: 782 LRVNEKCDIYGFGVLILELVTGR 804
+ + D++G G + E+ +GR
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 34/277 (12%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
L +GEG FG V + + G+ +AVK + D+ + F E V+ K H NL+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEY--TGQKVAVK-NIKCDVTA--QAFLEETAVMTKLHHKNLV 62
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
L G L + V + G+L L R + + +F L A+G+ +L
Sbjct: 63 RLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYLESK 119
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNRFQSALGYVAPELTC 779
++H +L NIL+ ++ ++SDFGLAR+ + +D + + + APE
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL------PVKWTAPE-AL 169
Query: 780 QSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838
+ + + K D++ +GVL+ E+ + GR P Y + ++ + E V E+G + +P
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAP--YPKMSLKEVKECV----EKGYRM---EP-- 218
Query: 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
PE V L C P RPS ++ + L+
Sbjct: 219 ---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 72/249 (28%), Positives = 112/249 (44%), Gaps = 44/249 (17%)
Query: 579 GKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII 638
GK I+FDS DP E +G+G +G V+KV G AVK L I
Sbjct: 5 GKTIIFDSFP-------DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIH 55
Query: 639 QYPEDFEREVRVLGK-ARHPNLISLEGYYWTPQLK-----LLVSDYAPNGSLQ------A 686
E+ E E +L + HPN++ G Y+ +K LV + GS+
Sbjct: 56 DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115
Query: 687 KLHERLPSTPPLSWTNRFKVILGTA-KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRI 745
K ER+ P +++ IL A GL HLH + IH ++K +NILL ++
Sbjct: 116 KRGERM-EEPIIAY------ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165
Query: 746 SDFGLARLLTRLDKHVMSNRFQSALG---YVAPE-LTCQS---LRVNEKCDIYGFGVLIL 798
DFG++ LT R +++G ++APE + C+ + +CD++ G+ +
Sbjct: 166 VDFGVSAQLTS-----TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAI 220
Query: 799 ELVTGRRPV 807
EL G P+
Sbjct: 221 ELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-12
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVT--SDIIQYPEDFEREVRVLGKARHPNLISLEG 664
VG G +G+V G +AVKKL II + RE+R+L +H N+I L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 665 YYWTP--QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ TP L+ Y + A L+ + +F +I +GL ++H +
Sbjct: 84 VF-TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIHSA-- 139
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
IIH +LKPSN+ ++++ +I DFGLAR ++ R+ Y APE+ +
Sbjct: 140 -DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YRAPEIMLNWM 193
Query: 783 RVNEKCDIYGFGVLILELVTGR 804
N+ DI+ G ++ EL+TGR
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 59/303 (19%)
Query: 607 VGEGVFGTVYKV-SFGTQGR----MLAVKKLVTSDIIQYPEDF--EREV-RVLGKARHPN 658
+GEG FG V K + G +AVK L + D E E+ +++GK H N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 659 LISLEGYYWTPQLKL-LVSDYAPNGSLQAKLHER------------LPSTPPLSWTNRFK 705
+I+L G T + L +V +YA +G+L+ L R P L+ +
Sbjct: 78 IINLLGVC-TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 706 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 765
A+G+ L IH +L N+L+ +++ +I+DFGLAR + +D + +
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 766 FQSALGYVAPE------LTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILS 818
+ + ++APE T QS D++ FGVL+ E+ T G P I
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLLWEIFTLGGSPYP------GIPV 240
Query: 819 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTC--HIPSSRPSMAEVVQILQV 876
E + LL+EG ++ P E+ L+ C +PS RP+ ++V+ L
Sbjct: 241 EELFKLLKEGYRME--KPQ---NCTQEL-----YHLMRDCWHEVPSQRPTFKQLVEDLDR 290
Query: 877 IKT 879
+ T
Sbjct: 291 MLT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 34/298 (11%)
Query: 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLGK 653
ET L+K +G G FGTVYK + G + A+K L + + ++ E V+
Sbjct: 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG 65
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVILGT 710
P + L G T ++L V+ P G L + E R+ S L+W +
Sbjct: 66 VGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWC------VQI 118
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
AKG+++L ++H +L N+L+ + +I+DFGLARLL + ++ + +
Sbjct: 119 AKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 829
++A E R + D++ +GV + EL+T G +P + I + + LLE+G
Sbjct: 176 KWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDG------IPAREIPDLLEKGE 228
Query: 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEV 887
L P + V + + C RP E+V + P R V
Sbjct: 229 RL--------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD-PSRFVV 277
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 607 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARH-PNL 659
+G G +G V+ KVS G++ A+K L + I+Q + E E +VL R P L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG-TAKGLAHLH 718
++L + T L+ DY G L L +R ++ G L HLH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLALEHLH 122
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 778
+ II+ ++K NILLD N + ++DFGL++ D+ + F + Y+AP++
Sbjct: 123 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIV 178
Query: 779 CQSLRVNEKC-DIYGFGVLILELVTGRRPVEY-GEDN 813
++K D + GVL+ EL+TG P GE N
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVL----GKARHPNLIS 661
+G G FG VY G+M A+K L I ++ E R++ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
+ + TP + D G L L + + ++ILG L H+H+ F
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG----LEHMHNRF 117
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
+++ +LKP+NILLD++ + RISD GLA ++ H GY+APE+ +
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH----GYMAPEVLQKG 170
Query: 782 LRVNEKCDIYGFGVLILELVTGRRP 806
+ D + G ++ +L+ G P
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVT----SDIIQYPEDFEREVRVLGKARHPNLISL 662
+G+G FG VY GR LAVK++ + + E E+++L +H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
G + + +Y P GS+ ++L + L+ T K +G+ +LH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEGVEYLH---S 122
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG----YVAPELT 778
I+H ++K +NIL D N ++ DFG + RL S ++ +++PE+
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGAS---KRLQTICSSGTGMKSVTGTPYWMSPEV- 178
Query: 779 CQSLRVN-----EKCDIYGFGVLILELVTGRRP 806
++ K D++ G ++E++T + P
Sbjct: 179 -----ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 72/294 (24%), Positives = 127/294 (43%), Gaps = 39/294 (13%)
Query: 607 VGEGVFGTVYKV-SFG------TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPN 658
+GEG FG V + G + +AVK L + D E+ ++ +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 659 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKV 706
+I+L G ++ +YA G+L+ L R P +++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 707 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 766
A+G+ +L IH +L N+L+ +N +I+DFGLAR + +D + +
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 825
+ + ++APE + ++ D++ FGVL+ E+ T G P I E + LL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGGSPYPG------IPVEELFKLL 252
Query: 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
+EG+ + D P + + + C IPS RP+ ++V+ L I T
Sbjct: 253 KEGHRM--------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 610 GVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE----DFEREVRVLGKARHPNLISLEGY 665
G +G V+ + G + A+K + +D+I+ + ER++ L +A+ P ++ L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL--- 58
Query: 666 YWTPQLK---LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
Y++ Q K LV +Y P G L A L E + S I+ L +LH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIAEIV---LALEYLH---S 111
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLA------RLLTRLDKHVMSNRFQSALGYVAPE 776
IIH +LKP NIL+D N + +++DFGL+ R + D R Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 777 -LTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ Q ++ D + G ++ E + G P
Sbjct: 172 VILGQG--HSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 77/285 (27%), Positives = 131/285 (45%), Gaps = 42/285 (14%)
Query: 607 VGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
+G+G FG VY + Q AVK L ++ E F +E ++ HPN++SL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 664 GYYWTPQ-LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG----TAKGLAHLH 718
G + L+V Y +G L+ + R + P K ++G AKG+ +L
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNP-----TVKDLIGFGLQVAKGMEYLA 115
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--GYVAPE 776
+H +L N +LD+++ +++DFGLAR + + + + N + L ++A E
Sbjct: 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE----DNVVILSEHVRVLLEEGNVLD 832
+ Q+ + K D++ FGVL+ EL+T R Y + D V L + R+L E
Sbjct: 173 -SLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRLLQPEY---- 226
Query: 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
C D P+ ++ L C P RP+ +E+V ++ I
Sbjct: 227 CPD------------PLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 57/228 (25%), Positives = 102/228 (44%), Gaps = 26/228 (11%)
Query: 597 PETLLEKAAEVGEGVFGTVY--------------KVSFGTQGRMLAVKKLVTSDIIQYPE 642
P L ++GEG FG V+ F Q ++AVK L
Sbjct: 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN 62
Query: 643 DFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHER-LPST------ 695
DF +E++++ + ++PN+I L G + ++++Y NG L L +R + ST
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 696 -PPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754
P +S N + + A G+ +L +H +L N L+ ++Y +I+DFG++R L
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
D + + R + ++A E + D++ FGV + E+ T
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 19/227 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISLEG 664
+G+G FG V G+M A KKL I + + E ++L K ++SL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHHSF 721
Y T LV G L+ ++ + + + A+ GL LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG-----RAVFYAAEICCGLEDLH--- 119
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
+ I++ +LKP NILLDD+ + RISD GLA + + + R +GY+APE+ ++
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRV-GTVGYMAPEVV-KN 175
Query: 782 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 828
R D + G L+ E++ G+ P + + I E V L++E
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--IKREEVERLVKEV 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 71/288 (24%), Positives = 121/288 (42%), Gaps = 47/288 (16%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPN 658
+EK +G+G F VYK GR++A+KK+ +++ + +D +E+ +L + HPN
Sbjct: 6 IEKK--IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 659 LIS-LEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVILGTAK 712
+I L + +L +V + A G L K +RL + W K +
Sbjct: 64 VIKYLASFIENNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTI-W----KYFVQLCS 117
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 771
L H+H S R I+H ++KP+N+ + ++ D GL R + + S +G
Sbjct: 118 ALEHMH-SKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSS-----KTTAAHSLVGT 169
Query: 772 --YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829
Y++PE N K DI+ G L+ E+ + P + N+ L
Sbjct: 170 PYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL------------ 216
Query: 830 VLDCVDPSMGDYP----EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873
C DYP + + L C P RP ++ V+Q+
Sbjct: 217 ---CKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 69/282 (24%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLGK 653
ET +K +G G FGTVYK + +G + A+K+L + + ++ E V+
Sbjct: 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 65
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVILGT 710
+P++ L G T ++L ++ P G L + E + S L+W +
Sbjct: 66 VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQI 118
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
AKG+ +L ++H +L N+L+ + +I+DFGLA+LL +K + + +
Sbjct: 119 AKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 829
++A E + ++ D++ +GV + EL+T G +P + I + + +LE+G
Sbjct: 176 KWMALESILHRIYTHQS-DVWSYGVTVWELMTFGSKPYDG------IPASEISSILEKGE 228
Query: 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVV 871
L P P + V + + C SRP E++
Sbjct: 229 RL----PQ----PPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKA-RHPNLISL 662
+G+G FG V+ + A+K L D++ +D E E RVL A HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKAL-KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ T + V +Y G L + P + ++I G L LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSK-- 115
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
I++ +LK NILLD + + +I+DFG+ + + + F Y+APE+
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQ- 171
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+ N D + FGVL+ E++ G+ P +G D
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPF-HGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 66/271 (24%), Positives = 107/271 (39%), Gaps = 22/271 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+G G FG V+ +AVK + F +E R+L + HPN++ L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
Q +V + G L P L +++ A G+ +L
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
IH +L N L+ + +ISDFG++R Q + + APE R +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE-ALNYGRYS 174
Query: 786 EKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844
+ D++ FG+L+ E + G P + ++ R +E+G L C + P+
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPY------ANLSNQQTREAIEQGVRLPCPE----LCPDA 224
Query: 845 EVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
V +L C + P RPS + V Q LQ
Sbjct: 225 ----VYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 29/228 (12%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-A 654
DP E +G+G +G VYKV+ G + AVK + I E+ E E +L
Sbjct: 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK--ILDPISDVDEEIEAEYNILQSLP 76
Query: 655 RHPNLISLEGYYWTP------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL 708
HPN++ G ++ QL LV + GS+ + L L ++
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT--RLDKHVMSNRF 766
G GL HLH++ IIH ++K +NILL ++ DFG++ LT RL R
Sbjct: 136 GALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-------RR 185
Query: 767 QSALG---YVAPE-LTCQS---LRVNEKCDIYGFGVLILELVTGRRPV 807
+++G ++APE + C+ + +CD++ G+ +EL G P+
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 43/230 (18%)
Query: 595 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
IDP T L+ E+G G FG V+ + + +A+K + + + +DF E +V+
Sbjct: 1 IDPSELTFLK---ELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSE--DDFIEEAKVMM 54
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK--VILGT 710
K HPNL+ L G + +V++Y NG L L ER + +L
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER---------KGKLGTEWLLDM 105
Query: 711 A----KGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 765
+ + +L + F IH +L N L+ ++ ++SDFGLAR +V+ ++
Sbjct: 106 CSDVCEAMEYLESNGF----IHRDLAARNCLVGEDNVVKVSDFGLAR-------YVLDDQ 154
Query: 766 FQSALG------YVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVE 808
+ S+ G + PE+ S R + K D++ FGVL+ E+ + G+ P E
Sbjct: 155 YTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 66/247 (26%), Positives = 115/247 (46%), Gaps = 22/247 (8%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
LEK +GEG + TVYK T G ++A+K++ P RE+ ++ + +H N++
Sbjct: 5 LEK---LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHER-LPSTPPLSWTNRFKVILGTAKGLAHLHH 719
L T +LV +Y + L+ + + + F L KG+A H
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCHE 118
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS---ALGYVAPE 776
+ ++H +LKP N+L++ +++DFGLAR + N F + L Y AP+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG-----IPVNTFSNEVVTLWYRAPD 170
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836
+ S + DI+ G ++ E++TG RP+ G +N L + R++ G + P
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLKIFRIM---GTPTESTWP 226
Query: 837 SMGDYPE 843
+ PE
Sbjct: 227 GISQLPE 233
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGK- 653
DP + E VG G +G VYK G++ A+K + VT D E+ ++E+ +L K
Sbjct: 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKY 59
Query: 654 ARHPNLISLEGYYWT---PQLK---LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF-KV 706
+ H N+ + G + P + LV ++ GS+ + +T W +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 707 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV-MSNR 765
IL +GL+HLH +IH ++K N+LL +N ++ DFG++ +LD+ V N
Sbjct: 120 IL---RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRNT 170
Query: 766 FQSALGYVAPE-LTCQS---LRVNEKCDIYGFGVLILELVTGRRPV 807
F ++APE + C + K D++ G+ +E+ G P+
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 31/246 (12%)
Query: 597 PETLLEKAAEVGEGVFGTVY-KVSFGTQG---------------RMLAVKKLVTSDIIQY 640
P L ++GEG FG V+ + G Q ++AVK L
Sbjct: 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA 62
Query: 641 PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST----- 695
EDF +EV++L + PN+ L G ++ +Y NG L L + + T
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 696 --PPLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752
LS++ + A G+ +L +F +H +L N L+ NY +I+DFG++R
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNF----VHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 753 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GRRPVEYG 810
L D + + R + ++A E + K D++ FGV + E++T +P E+
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
Query: 811 EDNVVI 816
D VI
Sbjct: 238 TDQQVI 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
DP T L+ ++GEG G V + + G+++AVKK+ Q E EV ++ +
Sbjct: 17 DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQ 75
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVILGT 710
H N++ + Y +V ++ G+L +++E + V L
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA----------VCLAV 125
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
K L+ LH +IH ++K +ILL + ++SDFG ++ K V R +S +
Sbjct: 126 LKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFC---AQVSKEV--PRRKSLV 177
Query: 771 G---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
G ++APEL + L + DI+ G++++E+V G P
Sbjct: 178 GTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 662
+G+G FG V V G+M A KKL + + + E+E+ L K P +++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHH 719
+ + LV G L K H L +VI +A+ G+ HLH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDL--KYHIYNVGERGLEME---RVIHYSAQITCGILHLHS 113
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
I++ ++KP N+LLDD N R+SD GLA L D ++ R + GY+APE+
Sbjct: 114 M---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTN-GYMAPEILK 167
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRP 806
+ + D + G I E+V GR P
Sbjct: 168 EEP-YSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-11
Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 26/191 (13%)
Query: 644 FEREVRVLGKARHPNLISL--EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 701
F RE + + HPN+++L G P L V +Y P +L+ E L + L
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLR----EVLAADGALPAG 79
Query: 702 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLL--TR 756
+++L LA H I+H +LKP NI++ + ++ DFG+ LL R
Sbjct: 80 ETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136
Query: 757 LDKHVMSNRFQSALG---YVAPELTCQSLR---VNEKCDIYGFGVLILELVTGRRPVEYG 810
R LG Y APE LR V D+Y +G++ LE +TG+R V+ G
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPE----QLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ-G 191
Query: 811 EDNVVILSEHV 821
IL + +
Sbjct: 192 ASVAEILYQQL 202
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 607 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISL 662
+G+G FG V+ K++ G++ A+K L + + ++ + E +L + HP ++ L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT-AKGLAHLHHSF 721
+ T L+ D+ G L +L + + T K L A L HLH
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----EEDVKFYLAELALALDHLH--- 115
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
II+ +LKP NILLD+ + +++DFGL++ +K S F + Y+APE+
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV---- 169
Query: 782 LRVNEK-----CDIYGFGVLILELVTGRRPVEYGED 812
VN + D + FGVL+ E++TG P + G+D
Sbjct: 170 --VNRRGHTQSADWWSFGVLMFEMLTGSLPFQ-GKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH-PNL 659
L+ E+G G FGTV K+ G ++AVK++ ++ + + ++ V+ ++ P +
Sbjct: 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 660 ISL------EGYYWT-PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
+ EG W +L + D ++E L S P K+ + T K
Sbjct: 66 VKFYGALFREGDCWICMELMDISLD-----KFYKYVYEVLKSVIPEEILG--KIAVATVK 118
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
L +L + IIH ++KPSNILLD N N ++ DFG++ +L + R Y
Sbjct: 119 ALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---GQLVDSIAKTRDAGCRPY 173
Query: 773 VAPELTCQSLR--VNEKCDIYGFGVLILELVTGRRP 806
+APE S R + + D++ G+ + E+ TG+ P
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 17/213 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISLEG 664
+G+G FG V G+M A KKL I + + E R+L K ++SL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK---GLAHLHHSF 721
Y T LV G L K H P + + I A+ GL L
Sbjct: 68 AYETKDALCLVLTIMNGGDL--KFHIYNMGNPGF---DEQRAIFYAAELCCGLEDLQ--- 119
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
R I++ +LKP NILLDD + RISD GLA + + + R +GY+APE+ +
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRV-GTVGYMAPEVI-NN 175
Query: 782 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
+ D +G G LI E++ G+ P ++ V
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 27/212 (12%)
Query: 607 VGEGVFG--TVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISL 662
+G+G FG T+Y+ T+ L V K V + E D E+ +L +HPN+I+
Sbjct: 8 LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHER---LPSTPPLSWTNRFKVILGTAKGLAHLHH 719
++ L+ +YA G+L K+ + L + W + ++++H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHK 119
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 776
+ I+H ++K NI L ++ DFG++++L ++ M+ ++ +G Y++PE
Sbjct: 120 A---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG--SEYSMA---ETVVGTPYYMSPE 171
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 808
L CQ ++ N K DI+ G ++ EL+T +R +
Sbjct: 172 L-CQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 32/224 (14%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLEG 664
VG G FG V V G + A+K + S ++ FE E +L + P + L+
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT-------AKGLAHL 717
+ LV +Y P G L LS NR++ A+ + +
Sbjct: 69 AFQDKDNLYLVMEYQPGGDL-------------LSLLNRYEDQFDEDMAQFYLAELVLAI 115
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
H + +H ++KP N+L+D + +++DFG A LT +K V S Y+APE+
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGTPDYIAPEV 174
Query: 778 TCQSLRVNEK------CDIYGFGVLILELVTGRRPVEYGEDNVV 815
++ + K CD + GV+ E++ GR P E
Sbjct: 175 L-TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH--EGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 79/281 (28%), Positives = 122/281 (43%), Gaps = 37/281 (13%)
Query: 607 VGEGVFGTVYKVSFGTQG-RM-LAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLE 663
+GEG FG V K G RM A+K++ DF E+ VL K HPN+I+L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHER--LPSTPPLSWTNRFKVILGT----------A 711
G L +YAP+G+L L + L + P + N L + A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+G+ +L IH +L NIL+ +NY +I+DFGL+R K M + +
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG---RLPVR 188
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 830
++A E S+ D++ +GVL+ E+V+ G P Y L E +
Sbjct: 189 WMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP--YCGMTCAELYEKLPQGYRLEKP 245
Query: 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVV 871
L+C +DEV +++ C P RPS A+++
Sbjct: 246 LNC---------DDEVYDLMRQ---CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVL----GKARHPNLIS 661
+G G FG VY G+M A+K L I ++ E R++ P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTN-RF---KVILGTAKGLAHL 717
+ + TP + D G L H L S RF ++ILG L H+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEAEMRFYAAEIILG----LEHM 113
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
H+ F +++ +LKP+NILLD++ + RISD GLA ++ H GY+APE+
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH----GYMAPEV 166
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ + + D + G ++ +L+ G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 608 GEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARH-PNLI 660
G G +G V+ KV G++ A+K L + I+Q + E E +VL R P L+
Sbjct: 9 GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLV 68
Query: 661 SLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK------VILGTAKG 713
+L Y + KL L+ DY G L L++R F I
Sbjct: 69 TLH-YAFQTDTKLHLILDYVNGGELFTHLYQR----------EHFTESEVRVYIAEIVLA 117
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
L HLH + II+ ++K NILLD + ++DFGL++ ++ + F + Y+
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 774 APELTCQSLRVNEKC-DIYGFGVLILELVTGRRP 806
APE+ ++K D + GVL EL+TG P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 80/243 (32%), Positives = 111/243 (45%), Gaps = 19/243 (7%)
Query: 92 FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLK 151
L +L+L+ N ++ L L +LDL +N + P LK
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISELL-----ELTNLTSLDLDNNNITDIPPLIGLLKSNLK 143
Query: 152 ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 211
EL L N+ LP+ + P+L LDLS N + LP L L+++ + +S N ++ D
Sbjct: 144 ELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-D 200
Query: 212 IPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLE 270
+P I +S LE LD SNN + L SSL N K LS + L N L ++PE + +L LE
Sbjct: 201 LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLE 258
Query: 271 EIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSS 330
+DLS N SS SS LR LDLS N+L +P L L L
Sbjct: 259 TLDLSNN--------QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLL 310
Query: 331 NHL 333
L
Sbjct: 311 LTL 313
|
Length = 394 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 60/231 (25%), Positives = 92/231 (39%), Gaps = 52/231 (22%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYY 666
GEG FG VYK GR++A+KK++ + +P RE+++L K +HPN++ L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID-- 74
Query: 667 WTPQLKLLVSDYAPNGSLQAKLHERLPS----TP-------PLSWTNRFKVILGTAK--- 712
+ + K + S TP L K+ K
Sbjct: 75 -------MAVERPD------KSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 713 -----GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 767
G+ +LH + I+H ++K +NIL+D+ +I+DFGLAR
Sbjct: 122 LQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYD--GPPPNPKGGG 176
Query: 768 SALG-----------YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 807
Y PEL R DI+G G + E+ T RRP+
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 38/272 (13%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVK-KLVTSDIIQYPED----FEREVRVLGKARHPNLIS 661
+G+G FG V+K GT V K D+ P++ F E R+L + HPN++
Sbjct: 3 LGKGNFGEVFK---GTLKDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVK 56
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
L G Q +V + P G + L ++ L K L A G+A+L
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK- 112
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR--FQSALGYVAPELTC 779
IH +L N L+ +N +ISDFG++R + D + S+ Q + + APE
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPE-AL 166
Query: 780 QSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838
R + + D++ +G+L+ E + G P G N + R +E+G + C
Sbjct: 167 NYGRYSSESDVWSYGILLWETFSLGVCPYP-GMTN-----QQAREQVEKGYRMSCPQKC- 219
Query: 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 870
P+D V K+ C + P +RP +E+
Sbjct: 220 ---PDD----VYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 37/107 (34%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 77 LSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLF 136
L L L+G I + L ++NLS N G++ + G S+ L LDLS+N F
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG----SITSLEVLDLSYNSF 478
Query: 137 SGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCP-HLTTLDLSNN 182
+GSIP+ + L L+ L L GN SG +PA +G H + + ++N
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 32/221 (14%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGK 653
DP + L+ ++GEG G V + + GR +AVKK+ D+ Q E EV ++
Sbjct: 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRD 72
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVIL 708
+HPN++ + Y +V ++ G+L +++E +T V L
Sbjct: 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT----------VCL 122
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
K L+ LH +IH ++K +ILL + ++SDFG ++ K V R +S
Sbjct: 123 AVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC---AQVSKEV--PRRKS 174
Query: 769 ALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+G ++APE+ + E DI+ G++++E+V G P
Sbjct: 175 LVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLG-KARHPNLISL 662
+G+G FG V + A+K L I+Q +D + E R+L A+HP L +L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ T V +Y G L ++ P S +V L L LH R
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA----LMFLH---R 114
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
+I+ +LK NILLD + +++DFG+ + + V + F Y+APE+ Q L
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEIL-QEL 171
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVE 808
D + GVL+ E++ G+ P E
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 40/118 (33%), Positives = 52/118 (44%), Gaps = 29/118 (24%)
Query: 225 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 284
L N L G +P+ + + L I L GNS+ GNIP L GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL----------------GSIT 466
Query: 285 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELG 342
+L +LDLS N+ G IP +G +LR LNL+ N L R+P LG
Sbjct: 467 -------------SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 45/291 (15%)
Query: 607 VGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPNLI 660
+GEG FG+V + G+Q + +AVK + DI Y E+F E + HPN++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLK-VAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 661 SLEGYYWT------PQLKLLVSDYAPNGSLQAKL-HERLPSTP---PLSWTNRFKVILGT 710
L G + +++ + +G L + L + RL P PL +F ++
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF--MVDI 122
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
A G+ +L S R IH +L N +L ++ ++DFGL++ + D + + +
Sbjct: 123 ALGMEYL--SNRN-FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 771 GYVAPELTCQSLRVN---EKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLE 826
++A E SL K D++ FGV + E+ T G+ P G +N I L
Sbjct: 180 KWIAIE----SLADRVYTSKSDVWAFGVTMWEIATRGQTPYP-GVENHEIYD-----YLR 229
Query: 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
GN L PED + + L C P RP+ ++ ++L+ I
Sbjct: 230 HGNRL--------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---------REVRVLGKARHP 657
+G G +G V +A+KK+ + F+ RE+++L H
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA--------FDNRIDAKRTLREIKLLRHLDHE 64
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 717
N+I+++ P + Y + LH+ + S+ LS + + +GL ++
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
H + ++H +LKPSN+LL+ N + +I DFGLAR T +K + Y APEL
Sbjct: 125 HSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPEL 179
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
D++ G + EL+ GR+P+ G+D V
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYV 215
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
DP +LLE ++GEG G V GR +AV K++ Q E EV ++ +
Sbjct: 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAV-KMMDLRKQQRRELLFNEVVIMRDYQ 76
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVILGT 710
H N++ + Y + ++ ++ G+L Q +L+E +T V
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT----------VCESV 126
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
+ L +LH +IH ++K +ILL + ++SDFG ++ K V +
Sbjct: 127 LQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRKSLVGT 180
Query: 771 GY-VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
Y +APE+ ++ E DI+ G++++E+V G P
Sbjct: 181 PYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEG 664
+G+G FG V V G+ A+K L II E E RVL RHP L SL+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKL-HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
+ T V +Y G L L ER+ S RF A+ ++ L +
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSED----RTRFY----GAEIVSALDYLHSG 114
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
I++ +LK N++LD + + +I+DFGL + + F Y+APE+ +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVL-EDND 171
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDN 813
D +G GV++ E++ GR P Y +D+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF-YNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 57/212 (26%), Positives = 86/212 (40%), Gaps = 17/212 (8%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKK-LVTSDIIQYPEDFEREVRVLGKARHPNLI 660
EK ++GEG +G VYK G+++A+KK + D P RE+ +L I
Sbjct: 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 661 -------SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAK 712
+E P L L+ + + R P P P F L K
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--LK 121
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSALG 771
G+AH H + ++H +LKP N+L+D +I+D GL R + K L
Sbjct: 122 GVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLW 176
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTG 803
Y APE+ S + DI+ G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 32/272 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISL-EG 664
VG+G +G V V T G+ +KKL + + + + E+E ++L + +HPN+++ E
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHER----LPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
+ L +V + G L KL E+ LP + W + A L +LH
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYLHEK 121
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
I+H +LK N+ L ++ D G+AR+L ++ M++ Y++PEL
Sbjct: 122 H---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMSPELFSN 176
Query: 781 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840
N K D++ G + E+ T + + N ++ R++ EG + P M
Sbjct: 177 K-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY----RII--EGKL-----PPM-- 222
Query: 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
P+D + +L P RPS+ +++
Sbjct: 223 -PKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 606 EVGEGVFGTVYKVS----FGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
E+GEG FG V+ Q +ML K + +DF+RE +L +H +++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-----------PLSWTNRFKVILGT 710
G + L+V +Y +G L L P L+ +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 711 AKG---LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 767
A G LA LH +H +L N L+ +I DFG++R + D + + R
Sbjct: 132 ASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 768 SALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 806
+ ++ PE + + + DI+ FGV++ E+ T G++P
Sbjct: 186 LPIRWMPPE-SILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 607 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARH-PNL 659
+G G +G V+ KV+ G++ A+K L + ++Q + E E VL R P L
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 660 ISLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
++L Y + + KL L+ DY G + L++R + ++IL L HLH
Sbjct: 68 VTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHLH 122
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR-LLTRLDKHVMSNRFQSALGYVAPEL 777
+ I++ ++K NILLD + ++DFGL++ L+ + S F + Y+APE+
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEYMAPEI 177
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEY-GEDN 813
+ D + G+LI EL+TG P GE N
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 18/223 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEG 664
+G+G FG V V GR A+K L I+ E E RVL +RHP L +L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKL-HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
+ T V +YA G L L ER+ S + V L +LH
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV-----SALDYLHS--EK 115
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
+++ +LK N++LD + + +I+DFGL + + D M F Y+APE+ +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-FCGTPEYLAPEVL-EDND 172
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDN----VVILSEHVR 822
D +G GV++ E++ GR P Y +D+ +IL E +R
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 67/228 (29%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEG 664
+G+G FG V V GR A+K L II E E RVL RHP L +L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKL-HERLPSTPPLSWTNRFKVILGT--AKGLAHLHHSF 721
+ T V +YA G L L ER+ +T G L +LH
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSALEYLHSR- 114
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
+++ ++K N++LD + + +I+DFGL + + F Y+APE+
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV---- 166
Query: 782 LRVNE---KCDIYGFGVLILELVTGRRPVEYGEDN----VVILSEHVR 822
L N+ D +G GV++ E++ GR P Y +D+ +IL E +R
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 49/223 (21%)
Query: 607 VGEGVFGTVYKVSFGTQG-RMLAVKKLVTSDIIQYPEDFER---------EVRVLGKA-R 655
+G G FG VYKV G +LA+K++ + + ER EV ++ + R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 656 HPNLIS-----LEGYYWTPQLKLLVSDYAPNG----SLQAKLH----ERLPSTPPLSWTN 702
HPN++ LE + L+ + AP G SL+ K ER+ W
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLI--EGAPLGEHFNSLKEKKQRFTEERI-------WNI 118
Query: 703 RFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 762
+++L L +LH R I+H +L P+NI+L ++ I+DFGLA+ K
Sbjct: 119 FVQMVLA----LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--- 169
Query: 763 SNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
S +G Y PE+ ++ EK D++ FG ++ ++ T
Sbjct: 170 ---LTSVVGTILYSCPEIV-KNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLE 663
+GEG FG V + G + A+K L DF E+ VL K HPN+I+L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHE-RLPSTPP-----------LSWTNRFKVILGTA 711
G + +YAP G+L L + R+ T P L+ + A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
G+ +L IH +L N+L+ +N +I+DFGL+R K M + +
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG---RLPVR 183
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
++A E S+ K D++ FGVL+ E+V+
Sbjct: 184 WMAIESLNYSVYTT-KSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 660
EK + EG +G VY+ G ++A+KKL + + +P RE+ +L K +HPN++
Sbjct: 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 661 SLEGYYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
+++ L +V +Y + L++ L E + P + ++L G+AHLH
Sbjct: 68 TVKEVVVGSNLDKIYMVMEYVEH-DLKS-LMETMK--QPFLQSEVKCLMLQLLSGVAHLH 123
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL----LTRLDKHVMSNRFQSALGYVA 774
++ I+H +LK SN+LL++ +I DFGLAR L + V++ L Y A
Sbjct: 124 DNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT------LWYRA 174
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGR 804
PEL + + D++ G + EL+T +
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 18/222 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKAR-HPNLISL 662
+G+G FG V GR+ AVK L D+I +D E E R+L AR HP L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVL-KKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ TP V ++ G L + + + ++ L LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SALMFLHDK-- 115
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
II+ +LK N+LLD + +++DFG+ + + ++ F Y+APE+ Q +
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEIL-QEM 171
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEY-GEDNV--VILSEHV 821
D + GVL+ E++ G P E ED++ IL++ V
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKA-RHPNLISL 662
+G+G FG V +G AVK L D++ +D E E RVL A +P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKAL-KKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT------AKGLAH 716
+ T + V ++ G L + ++ RF + T GL
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDK----------GRFDLYRATFYAAEIVCGLQF 111
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YV 773
LH II+ +LK N++LD + + +I+DFG+ + + NR + G Y+
Sbjct: 112 LHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNRASTFCGTPDYI 163
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
APE+ Q L+ D + FGVL+ E++ G+ P +G+D
Sbjct: 164 APEIL-QGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 67/254 (26%), Positives = 113/254 (44%), Gaps = 41/254 (16%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH-PNL 659
LE E+G G G VYK+ F G ++AVK++ + + + ++ V+ K+ P +
Sbjct: 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYI 76
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQA----KLHERLPSTPPLSWTNRFKVILG-----T 710
+ GY+ T SD L + KL +R+ P + ILG
Sbjct: 77 VKCYGYFITD------SDVFICMELMSTCLDKLLKRIQGPIP-------EDILGKMTVAI 123
Query: 711 AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
K L +L H +IH ++KPSNILLD + N ++ DFG++ L R
Sbjct: 124 VKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAG 176
Query: 769 ALGYVAPE-LTCQSLRVNE--KCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 825
Y+APE + + D++ G+ ++EL TG+ P + + +L+ ++L
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT---KILQ 233
Query: 826 EEGNVLDCVDPSMG 839
EE + P+ G
Sbjct: 234 EE---PPSLPPNEG 244
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-10
Identities = 31/89 (34%), Positives = 49/89 (55%)
Query: 129 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL 188
L L + G IP ++ L +L+ + L GN G +P +G L LDLS N F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 189 PVSLRLLNSMIFISVSNNTLTGDIPHWIG 217
P SL L S+ ++++ N+L+G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 28/227 (12%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGK- 653
DP + E VG G +G VYK G++ A+K + VT D E+ + E+ +L K
Sbjct: 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEIKLEINMLKKY 69
Query: 654 ARHPNLISLEGYYW--TP-----QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF-K 705
+ H N+ + G + +P QL LV ++ GS+ + + W +
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQL-WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 706 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV-MSN 764
IL +GLAHLH +IH ++K N+LL +N ++ DFG++ +LD+ V N
Sbjct: 129 EIL---RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRN 179
Query: 765 RFQSALGYVAPE-LTCQS---LRVNEKCDIYGFGVLILELVTGRRPV 807
F ++APE + C + + DI+ G+ +E+ G P+
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 72/260 (27%), Positives = 114/260 (43%), Gaps = 37/260 (14%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKAR---HP 657
E AE+G G +GTVYK G +A+K + V ++ P REV +L + HP
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHP 62
Query: 658 NLISLEGYYWTP----QLKLLVSDYAPNGSLQAKLHERLPSTPPL-SWTNRFKVILGTAK 712
N++ L T + K+ + + L+ L + P P + + + L +
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL---R 119
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT---RLDKHVMSNRFQSA 769
GL LH + I+H +LKP NIL+ +++DFGLAR+ + L V++
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT------ 170
Query: 770 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829
L Y APE+ QS D++ G + E+ R+P+ G L G
Sbjct: 171 LWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFR-RKPLFCGNSEADQL----------GK 218
Query: 830 VLDCVD-PSMGDYPEDEVLP 848
+ D + P D+P D LP
Sbjct: 219 IFDLIGLPPEDDWPRDVTLP 238
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 606 EVGEGVFGTVY--KVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
E+G G FG V +V+ G + VK+L S +Q F E + +H NL+
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPS---TPPLSWTNRFKVILGTAKGLAHLH-H 719
G LLV ++ P G L+ L + TP + R + A GL HLH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHKN 119
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
+F IH +L N LL + +I D+GL+ + D +V ++ L ++APEL
Sbjct: 120 NF----IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 780 Q---SLRV---NEKCDIYGFGVLILELVT-GRRPVEYGEDNVVI 816
+ +L V ++ +++ GV I EL G +P + D V+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER--EVRVLGKARHPNLISLEG 664
+G+G FG V +V R+ A+K + + I+ E E VL + P ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ +P+ LV + G L L + + TA+ L L + +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQRE-------GRFDLSRARFYTAELLCALENLHKFN 113
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARL-LTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
+I+ +LKP NILLD + + DFGL +L + DK +N F Y+APEL
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---TNTFCGTPEYLAPELLL-GHG 169
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827
+ D + GVL+ E++TG P Y E+ ++E R +L+E
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPF-YDEN----VNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRM-LAVKKLVT--SDIIQYPEDFEREVRVLGKARHPNLISLE 663
VG G +G+V ++ T+ R +AVKKL +I + RE+R+L +H N+I L
Sbjct: 23 VGSGAYGSVCS-AYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGLL 80
Query: 664 GYYWTPQLKL--LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
+ TP + Y + A L+ + LS + +I +GL ++H +
Sbjct: 81 DVF-TPATSIENFNEVYLVTNLMGADLNN-IVKCQKLSDEHVQFLIYQLLRGLKYIHSA- 137
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
IIH +LKPSN+ ++++ RI DFGLAR ++ R+ Y APE+
Sbjct: 138 --GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRW-----YRAPEIMLNW 190
Query: 782 LRVNEKCDIYGFGVLILELVTGR 804
+ N+ DI+ G ++ EL+ G+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 65/280 (23%), Positives = 123/280 (43%), Gaps = 48/280 (17%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKARHPN 658
E+G G FGTV K + +M +K V I++ + RE V+ + +P
Sbjct: 2 ELGSGNFGTVKKGMY----KMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPY 57
Query: 659 LISL----EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
++ + E W +LV + A G L ++ L ++ N +++ + G+
Sbjct: 58 IVRMIGICEAESW-----MLVMELAELGPL----NKFLQKNKHVTEKNITELVHQVSMGM 108
Query: 715 AHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF-QSALGY 772
+L +F +H +L N+LL + +ISDFGL++ L + + + + + +
Sbjct: 109 KYLEETNF----VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 773 VAPELTCQS-LRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 830
APE C + + + K D++ FGVL+ E + G++P + + N V ++E G
Sbjct: 165 YAPE--CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT------QMIESGER 216
Query: 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEV 870
++C P+ + L +C + RP A V
Sbjct: 217 MEC--------PQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---------REVRVLGKARHP 657
+GEG +G V + G +A+KK+ FE RE+++L + +H
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKI---------SPFEHQTFCQRTLREIKILRRFKHE 63
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 717
N+I + P + Y ++ L+ +L T LS + + +GL ++
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLY-KLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV-MSNRFQSALGYVAPE 776
H + ++H +LKPSN+LL+ N + +I DFGLAR+ H + + Y APE
Sbjct: 123 HSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGR 804
+ S + DI+ G ++ E+++ R
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
+K ++GEG + TVYK G+++A+K++ P RE +L +H N+++
Sbjct: 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHHS 720
L T + LV +Y L L + + + ++ L +GLA+ H
Sbjct: 68 LHDIIHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS---ALGYVAPEL 777
++H +LKP N+L+ + +++DFGLAR K V S + + L Y P++
Sbjct: 123 R---VLHRDLKPQNLLISERGELKLADFGLARA-----KSVPSKTYSNEVVTLWYRPPDV 174
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGR 804
S + D++G G + E+ TGR
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 664
+G G FG V V ++ A+K L ++++ E F E VL + + +L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 665 YYWTPQLKLLVSDYAPNG---SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
+ LV DY G +L +K +RLP + + + + + LH+
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS---VHQLHY-- 123
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
+H ++KP NIL+D N + R++DFG L D V S+ Y++PE+ Q+
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEIL-QA 177
Query: 782 L-----RVNEKCDIYGFGVLILELVTGRRP 806
+ + +CD + GV + E++ G P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 606 EVGEGVFGTV-----YKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+GEG FG V Y +S T+ +ML K + + +DF+RE +L +H +++
Sbjct: 12 ELGEGAFGKVFLAECYNLS-PTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVIL 708
G ++V +Y +G L L P + L + +
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
A G+ +L +H +L N L+ N +I DFG++R + D + +
Sbjct: 131 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 769 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 806
+ ++ PE + + + D++ FGV++ E+ T G++P
Sbjct: 188 PIRWMPPE-SIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED------FEREVRVLGKARHPNLI 660
+G+G FG VY GR LAVK++ + PE E E+++L H ++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDP--ESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 661 SLEGYYWTPQLKLL--VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
G P + L ++ P GS++ ++L S L+ K +G+++LH
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR-FQSALG---YVA 774
+ I+H ++K +NIL D N ++ DFG ++ RL +S +S G +++
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSGTGMKSVTGTPYWMS 177
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
PE+ K DI+ G ++E++T + P
Sbjct: 178 PEVISGE-GYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 59/194 (30%), Positives = 85/194 (43%), Gaps = 6/194 (3%)
Query: 296 FQTLRILDLSSNNLVG--DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 353
L LDL S + + D + L L+L+ N LRS I L +L LDL
Sbjct: 66 LSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLE-LTNLTSLDLD 124
Query: 354 NNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI 413
NN + P +L L L N + +P +RN +L L LS N LS +PK +
Sbjct: 125 NNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLL 182
Query: 414 SNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQG 473
SNL+ L L L N++S ++P E+ L++L +++S N +I L L L
Sbjct: 183 SNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSN 241
Query: 474 NLGICSPLLKGPCK 487
N P G
Sbjct: 242 NKLEDLPESIGNLS 255
|
Length = 394 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 66/287 (22%), Positives = 125/287 (43%), Gaps = 40/287 (13%)
Query: 606 EVGEGVFGTVYK------VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNL 659
E+G+G FG VY+ V + R +A+K + + ++ +F E V+ + ++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLH------ERLPSTPPLSWTNRFKVILGTAKG 713
+ L G Q L++ + G L++ L E P P S ++ A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
+A+L+ + +H +L N ++ +++ +I DFG+ R + D + + + ++
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 774 APELTCQSLR---VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830
+PE SL+ D++ FGV++ E+ T G N E V + EG +
Sbjct: 189 SPE----SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----EQVLRFVMEGGL 239
Query: 831 LDCVD--PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
LD D P M + +L +C + P RPS E++ ++
Sbjct: 240 LDKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
++GEG + TVYK G+++A+K + P RE +L +H N++ L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP-LSWTNRFKVILGTAKGLAHLHHSFRPP 724
T + V +Y + L + + P L N + +GLA++H
Sbjct: 72 IHTKETLTFVFEY-----MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--- 123
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS---ALGYVAPELTCQS 781
I+H +LKP N+L+ +++DFGLAR K + S + S L Y P++ +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR-----AKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 782 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
+ DI+G G + +E++ G +P G +V
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G G GTVYK R+LAVK + ++ + E+ +L K P +I G +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 667 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 726
+ + +++ GSL ++ ++P L ++ + KGL +L + I+
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPE-HVLG-----RIAVAVVKGLTYL---WSLKIL 117
Query: 727 HYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNE 786
H ++KPSN+L++ ++ DFG++ L + ++ + Y+APE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGE-QYGI 172
Query: 787 KCDIYGFGVLILELVTGRRP 806
D++ G+ +EL GR P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLE 663
+GEG FG V K G + A+K++ DF E+ VL K HPN+I+L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHE-RLPSTPP-----------LSWTNRFKVILGTA 711
G L +YAP+G+L L + R+ T P LS A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+G+ +L IH +L NIL+ +NY +I+DFGL+R K M + +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG---RLPVR 176
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
++A E S+ D++ +GVL+ E+V+
Sbjct: 177 WMAIESLNYSVYTT-NSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 664
+G G FG V V R+ A+K L ++++ E F E VL + +L
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 665 YYWTPQLKLLVSDYAPNG---SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
+ LV DY G +L +K +RLP RF + A+ + +H
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED-----MARFYI----AEMVLAIHSIH 119
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
+ +H ++KP N+LLD N + R++DFG + L D V S+ Y++PE+ Q+
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEIL-QA 177
Query: 782 L-----RVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
+ + +CD + GV + E++ G P Y E V
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPF-YAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKL---VTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
VG G +G+V G +A+KKL S+I + + RE+ +L +H N+I L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI--FAKRAYRELTLLKHMQHENVIGLL 80
Query: 664 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
+ T + LV Y +Q L + + PLS ++ GL +
Sbjct: 81 DVF-TSAVSGDEFQDFYLVMPY-----MQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKY 132
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
+H + IIH +LKP N+ ++++ +I DFGLAR + R+ Y APE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPE 184
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGR 804
+ + N+ DI+ G ++ E++TG+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 67/280 (23%), Positives = 127/280 (45%), Gaps = 27/280 (9%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 656
P ++ ++G G FG V+ + + +AVK L + + F E ++ +H
Sbjct: 4 PRESIKLVKKLGAGQFGEVW-MGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQH 60
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
L+ L + ++++Y GSL L L F + A+G+A+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAY 118
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
+ R IH +L+ +N+L+ ++ +I+DFGLAR++ +++ + + + APE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPE 174
Query: 777 -LTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
+ S + K D++ FG+L+ E+VT G+ P G N ++S L+ G +
Sbjct: 175 AINFGSFTI--KSDVWSFGILLYEIVTYGKIPYP-GMSNSDVMSA-----LQRGYRM--- 223
Query: 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
P M + P DE+ ++K C RP+ + +L
Sbjct: 224 -PRMENCP-DELYDIMKT---CWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 34/284 (11%)
Query: 606 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+G+G FG VY+ + G +AVK + S ++ +F E V+ +++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLH------ERLPSTPPLSWTNRFKVILGTAKGL 714
L G Q L+V + +G L++ L E P PP + ++ A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
A+L+ +H +L N ++ ++ +I DFG+ R + D + + + ++A
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 775 PELTCQSLR---VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
PE SL+ D++ FGV++ E+ + G N E V + +G L
Sbjct: 190 PE----SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVMDGGYL 240
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
D P++ V L +C P RP+ E+V +L+
Sbjct: 241 --------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 600 LLEKAAEVGEGVFGTV----YKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
L++ ++GEG FG V Y G +AVK L + D ++E+ +L
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 656 HPNLISLEGYY---WTPQLKLLVSDYAPNGSLQAKLHERLP-STPPLSWTNRFKVILGTA 711
H N++ +G +KL++ ++ P+GSL+ E LP + ++ + K +
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIM-EFLPSGSLK----EYLPRNKNKINLKQQLKYAVQIC 119
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL-TRLDKHVMSNRFQSAL 770
KG+ +L +H +L N+L++ + +I DFGL + + T + + + + S +
Sbjct: 120 KGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
+ APE QS + D++ FGV + EL+T
Sbjct: 177 FWYAPECLIQS-KFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 18/225 (8%)
Query: 606 EVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
E+GEG FG V+ Q ++L K + +DF RE +L +H +++
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST-------PP--LSWTNRFKVILGTAK 712
G ++V +Y +G L L P P L+ + + A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
G+ +L +H +L N L+ +N +I DFG++R + D + + + +
Sbjct: 132 GMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVI 816
+ PE + + + D++ GV++ E+ T G++P +N VI
Sbjct: 189 MPPE-SIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+E E+G+G +G+VYKV G +A+K++ E+ +L KA P ++
Sbjct: 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIV 62
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
G ++ + +Y GSL KL+ +T + ++ KGL L
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLA-RLLTRLDK-------HVMSNRFQSALGY 772
IIH ++KP+N+L++ N ++ DFG++ L+ L K ++ R +S
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
P T QS D++ G+ ILE+ GR P
Sbjct: 180 QNPTYTVQS-------DVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 21/271 (7%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLE 663
++G G F VY+ + G +A+KK+ D++ + D +E+ +L + HPN+I
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
+ +V + A G L + + +K + L H+H S R
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH-SRR- 126
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
++H ++KP+N+ + ++ D GL R + K ++ Y++PE ++
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHEN-G 182
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 843
N K DI+ G L+ E+ + P + N+ L + + C P + P
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------QCDYPPL---PS 230
Query: 844 DEVLPVL-KLALVCTCHIPSSRPSMAEVVQI 873
D L +L +C P RP + V +
Sbjct: 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 70/281 (24%), Positives = 129/281 (45%), Gaps = 28/281 (9%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH 656
P L+ ++G G FG V+ ++ + +AVK + + E F E V+ +H
Sbjct: 4 PRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM--SVEAFLAEANVMKTLQH 60
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
L+ L T + +++++ GSL L S PL F + A+G+A
Sbjct: 61 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAF 117
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
+ + IH +L+ +NIL+ + +I+DFGLAR++ +++ + + + APE
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPE 173
Query: 777 -LTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
+ S + K D++ FG+L++E+VT GR P + VI + LE G +
Sbjct: 174 AINFGSFTI--KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA------LERGYRM--- 222
Query: 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
P + PE+ + + + C + P RP+ + +L
Sbjct: 223 -PRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 55/176 (31%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 662
+G+G FG V G+ AVK L I++ E ER V +L +HP L+ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLH-ERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
+ T V DY G L L ER P RF A L +LH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP----RARFYAA-EIASALGYLHSL- 115
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
II+ +LKP NILLD + ++DFGL + ++ ++ F Y+APE+
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 662
+G+G FG V + G AVK L I++ E ER V +L +HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLH-ERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
+ T + V DY G L L ER P RF A + +LH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP----RARFYAA-EVASAIGYLHSL- 115
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
II+ +LKP NILLD + ++DFGL + ++ ++ F Y+APE+ +
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVL-RK 170
Query: 782 LRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+ D + G ++ E++ G P Y D
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPF-YSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLV----TSDIIQYPEDFEREVRVLGKARHPNLISL 662
+G G FG VY GR LAVK++ + + + E E+++L RH ++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 663 EGYYWTPQLKLL--VSDYAPNGSLQAKLHERLPSTPPLSWTNRF-KVILGTAKGLAHLHH 719
G P+ K L +Y P GS++ +L T + T R+ + IL +G+++LH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV--TRRYTRQIL---QGVSYLHS 124
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR-FQSALG---YVAP 775
+ I+H ++K +NIL D N ++ DFG ++ R+ MS +S G +++P
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSGTGIKSVTGTPYWMSP 178
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
E+ K D++ ++E++T + P
Sbjct: 179 EVI-SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 70/277 (25%), Positives = 118/277 (42%), Gaps = 29/277 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
+GEG FG VY+ + + +AVK E F +E ++ + HP+++ L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
G T +V + AP G L++ L S S + LA+L S R
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLI---LYSYQLSTALAYLE-SKR- 127
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
+H ++ N+L+ ++ DFGL+R L + + +++ + + ++APE + R
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAPE-SINFRR 184
Query: 784 VNEKCDIYGFGVLILE-LVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 842
D++ FGV + E L+ G +P + ++N VI +E G L P
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR------IENGERLPM--------P 230
Query: 843 EDEVLPVL-KLALVCTCHIPSSRPSMAEVVQILQVIK 878
+ P L L C + PS RP E+ L I
Sbjct: 231 PN-CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 660
EK ++GEG +GTV+K ++A+K++ + D P RE+ +L + +H N++
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
L + + LV +Y + L+ K + F L KGLA H
Sbjct: 63 RLYDVLHSDKKLTLVFEYC-DQDLK-KYFDSCNGDIDPEIVKSFMFQL--LKGLAFCHSH 118
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA----LGYVAPE 776
++H +LKP N+L++ N +++DFGLAR + R SA L Y P+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFG------IPVRCYSAEVVTLWYRPPD 169
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+ + + D++ G + EL RP+ G D
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-09
Identities = 27/79 (34%), Positives = 47/79 (59%)
Query: 162 GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST 221
G +P DI HL +++LS N G +P SL + S+ + +S N+ G IP +G +++
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 222 LEFLDFSNNHLTGSLPSSL 240
L L+ + N L+G +P++L
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 53/214 (24%), Positives = 103/214 (48%), Gaps = 13/214 (6%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED---FEREVRVLGKARHPNLISLE 663
+G+G +G V G +A+KK+ +D+ ++ D RE+++L RHP+++ ++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKI--NDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
P + Y +++ LH+ + + L+ + + + L ++H +
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA--- 122
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARL-LTRLDKHVMSNRFQSALGYVAPELTCQSL 782
+ H +LKP NIL + + +I DFGLAR+ + + + Y APEL C S
Sbjct: 123 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL-CGSF 181
Query: 783 --RVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
+ DI+ G + E++TG +P+ G++ V
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 214
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
DP L+ ++GEG G V + G+ +AVKK+ Q E EV ++
Sbjct: 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYH 77
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTNRFKVILGT 710
H N++ + Y +V ++ G+L +++E +T V L
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT----------VCLSV 127
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
+ L++LH+ +IH ++K +ILL + ++SDFG ++ K V +
Sbjct: 128 LRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFC---AQVSKEVPKRKSLVGT 181
Query: 771 GY-VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
Y +APE+ + L + DI+ G++++E++ G P
Sbjct: 182 PYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 73/299 (24%), Positives = 130/299 (43%), Gaps = 33/299 (11%)
Query: 599 TLLEKAAEVGEGVFGTVYKV-SFG------TQGRMLAVKKLVTSDIIQYPEDFEREVRVL 651
T L +GEG FG V + G + +AVK L + D E+ ++
Sbjct: 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMM 71
Query: 652 GK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSW--------TN 702
+H N+I+L G ++ +YA G+L+ L R P S+
Sbjct: 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131
Query: 703 RFKVILGTAKGLAH-LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761
FK ++ A +A + + IH +L N+L+ ++ +I+DFGLAR + +D +
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 820
+ + + ++APE + ++ D++ FGVL+ E+ T G P I E
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLLWEIFTLGGSPYPG------IPVEE 244
Query: 821 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
+ LL+EG+ + D P + + + C +PS RP+ ++V+ L + T
Sbjct: 245 LFKLLKEGHRM--------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF----EREVRVLGKARHPNLISL 662
+G G FG V V G++ A+K L ++++ E ER+V V G R I+
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR---WITN 65
Query: 663 EGYYWTPQLKL-LVSDYAPNG---SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
Y + + L LV DY G +L +K +RLP RF + A+ + +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-----MARFYL----AEMVLAID 116
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 778
+ +H ++KP N+LLD N + R++DFG + L D V SN Y++PE+
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 779 CQSL-----RVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
Q++ R +CD + GV + E++ G P Y E V
Sbjct: 176 -QAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 41/236 (17%)
Query: 597 PETLLEKAAEVGEGVFGTVY-----------KVSF-----GTQGRMLAVKKLVTSDIIQY 640
P L ++GEG FG V+ F G Q ++AVK L
Sbjct: 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA 62
Query: 641 PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP--- 697
DF +E++++ + + PN+I L T ++++Y NG L L P
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 698 ----LSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752
+S++ + A G+ +L +F +H +L N L+ NY +I+DFG++R
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNF----VHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 753 LLTRLD------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
L D + V+ R+ S + + T S D++ FGV + E++T
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS-------DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLG-KARHPNLISL 662
+G+G FG V + A+K ++ D++ +D E E RVL + + P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ T V +Y G L + + P + ++ + GL LH R
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEI----SVGLFFLH---R 119
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
II+ +LK N++LD + +I+DFG+ + + V + F Y+APE+
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQ- 176
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+ D + +GVL+ E++ G+ P + GED
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFD-GED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 607 VGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDF---EREVRVLGKARHPNLI 660
+G+G +G V++V T G++ A+K L + I++ +D + E +L +HP ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHL 717
L + T L+ +Y G L L ER + T F ++ L L HL
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-ER--EGIFMEDTACFYLSEISLA----LEHL 116
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
H II+ +LKP NILLD + +++DFGL + + + +++ F + Y+APE+
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEI 171
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+S + D + G L+ +++TG P
Sbjct: 172 LMRSGH-GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 73/277 (26%), Positives = 121/277 (43%), Gaps = 40/277 (14%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G+G FG V + +G +AVK + Q F E V+ + RH NL+ L G
Sbjct: 14 IGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVI 68
Query: 667 WTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH-HSFRPP 724
+ L +V++Y GSL L R S L K L + + +L ++F
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEANNF--- 123
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--GYVAPELTCQSL 782
+H +L N+L+ ++ ++SDFGL K S + L + APE +
Sbjct: 124 -VHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPE-ALREK 174
Query: 783 RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHV-RVLLEEGNVLDCVDPSMGD 840
+ + K D++ FG+L+ E+ + GR P + L + V RV E+G +D D
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPR-----IPLKDVVPRV--EKGYKMDAPDGC--- 224
Query: 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
P V + C ++RPS ++ + L+ I
Sbjct: 225 -PP----VVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 49/213 (23%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 653
DP+ + ++G+G GTVY G+ +A++++ ++ Q P E E+ V+ +
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 73
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
++PN+++ Y +V +Y GSL + E ++ R +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQA 128
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
L LH + +IH ++K NILL + + +++DFG +T + + ++
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWM 183
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
APE+ + K DI+ G++ +E++ G P
Sbjct: 184 APEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 75/298 (25%), Positives = 132/298 (44%), Gaps = 51/298 (17%)
Query: 607 VGEGVFGTVYKV-SFGTQGRM------LAVKKLVT-------SDIIQYPEDFEREVRVLG 652
+GEG FG V + G +AVK L + SD+I E ++++G
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME----MMKMIG 81
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP---------STPP---LSW 700
K H N+I+L G ++ +YA G+L+ L R P + P LS+
Sbjct: 82 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 701 TNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760
+ A+G+ +L IH +L N+L+ ++ +I+DFGLAR + +D +
Sbjct: 140 KDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSE 819
+ + + ++APE + ++ D++ FGVL+ E+ T G P + E
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGGSPYPG------VPVE 249
Query: 820 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
+ LL+EG+ + D P + + + C +PS RP+ ++V+ L I
Sbjct: 250 ELFKLLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLV----TSDIIQYPEDFEREVRVLGKARHPNLISL 662
+G+G FG VY GR LA K++ + + + E E+++L +H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 663 EGYYWTPQLKLLV--SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
G K L +Y P GS++ ++L + L+ + K +G+++LH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR-FQSALG---YVAPE 776
I+H ++K +NIL D N ++ DFG ++ RL MS +S G +++PE
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRP-VEY 809
+ K D++ G ++E++T + P EY
Sbjct: 180 VISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 664
+G G FG V V + ++ A+K L ++I+ + F E ++ A ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHSF 721
+ + +V +Y P G L + P W RF +V+L L +H
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWA-RFYTAEVVLA----LDAIHSM- 161
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELT 778
IH ++KP N+LLD + + +++DFG ++D + M R +A+G Y++PE+
Sbjct: 162 --GFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMDANGMV-RCDTAVGTPDYISPEVL 215
Query: 779 CQSLRVN----EKCDIYGFGVLILELVTGRRP 806
+S + +CD + GV + E++ G P
Sbjct: 216 -KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 603 KAAEVGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+ +VG G +G VYK G + A+K++ + I RE+ +L + +HPN+I
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISM---SACREIALLRELKHPNVI 61
Query: 661 SLEGYYWTPQLK--LLVSDYAPNGSLQ-AKLHE-----RLPSTPPLSWTNRFKVILGTAK 712
+L+ + + + L+ DYA + K H + P P S ++
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK--SLLYQILD 119
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLARL-------LTRLDKHV 761
G+ +LH ++ ++H +LKP+NIL+ + +I+D G ARL L LD V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
++ Y APEL + + DI+ G + EL+T
Sbjct: 177 VT------FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 32/248 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLE 663
+GEG FG+V + +L AVK + + + EDF E + + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 664 GY---------YWTPQLKLLVSDYAPNGSLQA-KLHERLPSTPPLSWTNRF-KVILGTAK 712
G Y +P +++ + +G L + L+ RL P T K + A
Sbjct: 67 GVCLQTVESEGYPSP---VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
G+ +L IH +L N +L++N N ++DFGL++ + D + + + +
Sbjct: 124 GMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
+A E + K D++ FGV + E+ T G+ P G +N I L +GN L
Sbjct: 181 IAIESLADRVYTT-KSDVWSFGVTMWEIATRGQTPYP-GVENSEIYD-----YLRQGNRL 233
Query: 832 ----DCVD 835
DC+D
Sbjct: 234 KQPPDCLD 241
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 653
DP+ + ++G+G GTVY G+ +A+K++ ++ Q P E E+ V+ +
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRE 72
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
++PN+++ Y +V +Y GSL + E ++ R +
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQA 127
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
L LH + +IH ++K NILL + + +++DFG +T + + ++
Sbjct: 128 LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWM 182
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
APE+ + K DI+ G++ +E+V G P
Sbjct: 183 APEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 63/286 (22%), Positives = 123/286 (43%), Gaps = 31/286 (10%)
Query: 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHP 657
+EK ++G G F VY+ + + +A+KK+ +++ + +D +E+ +L + HP
Sbjct: 5 QIEK--KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 658 NLIS-LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
N+I L+ + +L + V + A G L + + +K + + H
Sbjct: 63 NVIKYLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
+H S R ++H ++KP+N+ + ++ D GL R + K ++ Y++PE
Sbjct: 122 MH-SRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPE 176
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836
++ N K DI+ G L+ E+ + P + N+ L + + C
Sbjct: 177 RIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE---------QC--- 223
Query: 837 SMGDYP----EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878
DYP E + +L +C P RP + V QI + +
Sbjct: 224 ---DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLG-KARHPNLISL 662
+G+G FG V + A+K ++ D++ +D E E RVL + P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK---VILGTAK---GLAH 716
+ T V +Y G L ++ + RFK + A+ GL
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQ----------VGRFKEPHAVFYAAEIAIGLFF 116
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
LH II+ +LK N++LD + +I+DFG+ + + V + F Y+APE
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPE 171
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+ + D + FGVL+ E++ G+ P E GED
Sbjct: 172 IIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFE-GED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 58/236 (24%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS-------------DIIQYPEDFERE 647
LE E+G G +G V K+ G ++AVK++ + DI D
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 648 VRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL-----QAKLHERLPSTPPLSWTN 702
V G + EG W + + V D SL + L
Sbjct: 63 VTFYGA------LFREGDVW---ICMEVMD----TSLDKFYKKVYDKGLTIPEDILG--- 106
Query: 703 RFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA-RLLTRLDKHV 761
K+ + K L +LH +IH ++KPSN+L++ N ++ DFG++ L+ + K +
Sbjct: 107 --KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI 162
Query: 762 MSNRFQSALGYVAPELTCQSLRVNE---------KCDIYGFGVLILELVTGRRPVE 808
+ Y+APE R+N K D++ G+ ++EL TGR P +
Sbjct: 163 DA----GCKPYMAPE------RINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 603 KAAEVGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+ +VG G +G VYK G R A+K++ + I RE+ +L + +HPN+I
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISM---SACREIALLRELKHPNVI 61
Query: 661 SLEGYYWTPQLK--LLVSDYAPNGSLQ-AKLHE-----RLPSTPPLSWTNRFKVILGTAK 712
SL+ + + + L+ DYA + K H + P P ++
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK--SLLYQILD 119
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLARL-------LTRLDKHV 761
G+ +LH ++ ++H +LKP+NIL+ + +I+D G ARL L LD V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
++ Y APEL + + DI+ G + EL+T
Sbjct: 177 VT------FWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLG-KARHPNLISL 662
+G+G FG V + A+K L IIQ +D E E RVL + P L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT------AKGLAH 716
+ T V +Y G L + + +FK A GL
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ----------VGKFKEPHAVFYAAEIAIGLFF 116
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR----FQSALGY 772
LH II+ +LK N++LD + +I+DFG+ + +++ + F Y
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK------ENIFGGKTTRTFCGTPDY 167
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+APE+ + D + FGVL+ E++ G+ P + GED
Sbjct: 168 IAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFD-GED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 43/290 (14%)
Query: 607 VGEGVFGTVYKVSFGTQ---GRMLAVKKL-----VTSDIIQYPEDFEREVRVLGKARHPN 658
+G+G FG+V + ++ + +AVK L +SDI E+F RE + + HPN
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDI----EEFLREAACMKEFDHPN 62
Query: 659 LISLEGYYWTPQLK------LLVSDYAPNGSLQA-KLHERL---PSTPPLSWTNRFKVIL 708
+I L G + K +++ + +G L L R+ P T PL RF ++
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF--MI 120
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
A G+ +L IH +L N +L++N ++DFGL++ + D + +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 769 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEE 827
+ ++A E ++ D++ FGV + E++T G+ P G +N I + L +
Sbjct: 178 PVKWLALESLADNVYTTHS-DVWAFGVTMWEIMTRGQTPYA-GVENSEIYN-----YLIK 230
Query: 828 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
GN L P D + V +L C P RPS + L++I
Sbjct: 231 GNRL--------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 63/258 (24%), Positives = 114/258 (44%), Gaps = 33/258 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 664
+G G FG V V + ++ A+K L ++I+ + F E ++ A P ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ + +V +Y P G L + P W + TA+ + L
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFY-----TAEVVLALDAIHSMG 162
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE-LTCQ 780
+IH ++KP N+LLD + + +++DFG ++D+ M R +A+G Y++PE L Q
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMV-RCDTAVGTPDYISPEVLKSQ 218
Query: 781 SLR--VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838
+CD + GV + E++ G P Y + V S+ +++ N L
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF-YADSLVGTYSK----IMDHKNSL------- 266
Query: 839 GDYPEDEVLPVLKLALVC 856
++PED + L+C
Sbjct: 267 -NFPEDVEISKHAKNLIC 283
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPN 658
E +G G FG V G A+K L +I++ + +E +L + HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 659 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRF---KVILGTAKG 713
++++ + + ++ G L L + R P+ +F +++L
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPND-----VAKFYHAELVLA---- 130
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-- 771
+LH II+ +LKP N+LLD+ + +++DFG A+ + +R + G
Sbjct: 131 FEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--------DRTFTLCGTP 179
Query: 772 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
Y+APE+ QS + D + GVL+ E + G P
Sbjct: 180 EYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 47/213 (22%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 653
DP+ + ++G+G GTV+ G+ +A+K++ ++ + P E E+ V+ +
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKE 72
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
++PN+++ + +V +Y GSL + E ++ R +
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----ECLQA 127
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
L LH + +IH ++K N+LL + + +++DFG +T + + ++
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWM 182
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
APE+ + K DI+ G++ +E+V G P
Sbjct: 183 APEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-08
Identities = 41/139 (29%), Positives = 69/139 (49%), Gaps = 5/139 (3%)
Query: 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPS 733
LV DYA G L+ ++ R + + L + L +HH +IH ++K +
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFR---EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172
Query: 734 NILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGF 793
NILL N ++ DFG +++ + F YVAPE+ + ++K D++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI-WRRKPYSKKADMFSL 231
Query: 794 GVLILELVTGRRPVEYGED 812
GVL+ EL+T +RP + GE+
Sbjct: 232 GVLLYELLTLKRPFD-GEN 249
|
Length = 496 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 15/216 (6%)
Query: 597 PETLLEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 651
P + L++ +G G FG V+ + ++ VK L + +F RE+ +
Sbjct: 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMF 62
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ-----AKLHERLPSTPPLSWTNRFKV 706
K H N++ L G + ++ +Y G L+ K + PPLS + +
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 707 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 766
A G+ HL ++ +H +L N L+ ++S L++ + + + + N
Sbjct: 123 CTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
L ++APE Q + K D++ FGVL+ E+ T
Sbjct: 180 -IPLRWLAPE-AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF---EREVRVLGKA-RHPNLISL 662
+G G + V V R+ A+K +V +++ ED + E V +A HP L+ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMK-VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
+ T V +Y G L + +LP ++ + L +LH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER 115
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
II+ +LK N+LLD + +++D+G+ + R ++ F Y+APE+
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEI--- 167
Query: 781 SLRVNE---KCDIYGFGVLILELVTGRRPVE 808
LR + D + GVL+ E++ GR P +
Sbjct: 168 -LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 653
DP+ + ++G+G GTVY G+ +A+K++ ++ Q P E E+ V+ +
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRE 72
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
+HPN+++ Y +V +Y GSL + E ++ R +
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQA 127
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-- 771
L LH + +IH ++K NILL + + +++DFG +T ++ + +G
Sbjct: 128 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTP 179
Query: 772 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++APE+ + K DI+ G++ +E+V G P
Sbjct: 180 YWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 54/233 (23%), Positives = 108/233 (46%), Gaps = 20/233 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
E+G G FG V K + + + + A+K L + ++ RE ++ + +P ++ +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
G L +LV + A G L L + +N +++ + G+ +L
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITV---SNVVELMHQVSMGMKYLEGK--- 114
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF-QSALGYVAPELTCQSL 782
+H +L N+LL + + +ISDFGL++ L D + + + L + APE C +
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE--CINF 172
Query: 783 R-VNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833
R + + D++ +G+ + E + G++P + + V+ +E+G LDC
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM------SFIEQGKRLDC 219
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 43/232 (18%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLEG 664
+G G FG V+ V G++ A+K L SD+I+ + E +L A P ++ L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 665 YYWTPQLKL-LVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
Y + + L LV +Y P G L L + P RF A+ + L
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETA-RFY----IAELVLALDSVH 118
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLA------------------------RLLTRL 757
+ IH ++KP NIL+D + + +++DFGL L+ R
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 758 DKHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
D R S +G Y+APE+ +CD + GV++ E++ G P
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 1e-07
Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 11/87 (12%)
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-YVA------PEL 777
+IH +LKPSNILL+ + +++DFGLAR L+ L+ N L YVA PE+
Sbjct: 128 VIHRDLKPSNILLNSDCRVKLADFGLARSLSELE----ENPENPVLTDYVATRWYRAPEI 183
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGR 804
S R + D++ G ++ E++ G+
Sbjct: 184 LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 65/257 (25%), Positives = 109/257 (42%), Gaps = 16/257 (6%)
Query: 191 SLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIR 250
+L L + + ++ N L +I + ++ L LD NN++T P L +
Sbjct: 88 NLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELD 146
Query: 251 LRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL 309
L N + ++P L +L L+ +DLS N S + L LDLS N +
Sbjct: 147 LSDNKI-ESLPSPLRNLPNLKNLDLSFN-------DLSDLPKLLSNLSNLNNLDLSGNKI 198
Query: 310 VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESR 369
D+P E+ L + L L+LS+N + + L +L L+L NN L +P+ +
Sbjct: 199 -SDLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKL-EDLPESIGNLS 255
Query: 370 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 429
+L L L N ++ + + T+L L LS N LS + I+ L L L L
Sbjct: 256 NLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLS-NALPLIALLLLLLELLLNLLLT 312
Query: 430 SGEIPQELGKLASLLAV 446
+ +L + +
Sbjct: 313 LKALELKLNSILLNNNI 329
|
Length = 394 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF---EREVRVLGKA-RHPNLISL 662
+G G + V V R+ A+K ++ +++ ED + E V A HP L+ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMK-VIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRF---KVILGTAKGLAHL 717
+ T V ++ G L + +LP RF ++ L L L
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHA-----RFYSAEISLA----LNFL 112
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
H II+ +LK N+LLD + +++D+G+ + + ++ F Y+APE+
Sbjct: 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEI 167
Query: 778 TCQSLRVNE---KCDIYGFGVLILELVTGRRP 806
LR + D + GVL+ E++ GR P
Sbjct: 168 ----LRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 51/220 (23%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKL------VTSDIIQYPEDFEREVRVLGKARHPNLI 660
+G G G V G+ +A+KKL VT Y RE+ ++ H N+I
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-----RELVLMKLVNHKNII 78
Query: 661 SLEGYYWTPQLKL-------LVSDYAPNGSL----QAKL-HERLPSTPPLSWTNRFKVIL 708
L + TPQ L LV + + +L Q L HER+ S+ ++
Sbjct: 79 GLLNVF-TPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERM------SY-----LLY 125
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS----N 764
G+ HLH + IIH +LKPSNI++ + +I DFGLAR T +M+
Sbjct: 126 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVT 180
Query: 765 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
R+ Y APE+ + E DI+ G ++ E++ G
Sbjct: 181 RY-----YRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 25/155 (16%)
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
IH +L NILL +N +I DFGLAR + + +V + L ++APE +
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV-YT 253
Query: 786 EKCDIYGFGVLILELVT-GRRP---VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG-- 839
+ D++ FGVL+ E+ + G P V+ E+ L E R M
Sbjct: 254 TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---------------MRAP 298
Query: 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
+Y E+ ++ L C + P RP+ +E+V+IL
Sbjct: 299 EYATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 662
+G+G FG V + + AVK L I++ E+ ER V +L +HP L+ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ T V DY G L L P + RF A L +LH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA---RFYAA-EIASALGYLHSL-- 115
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
I++ +LKP NILLD + ++DFGL + ++ + ++ F Y+APE+ +
Sbjct: 116 -NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQ- 171
Query: 783 RVNEKCDIYGFGVLILELVTGRRP 806
+ D + G ++ E++ G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 59/232 (25%), Positives = 103/232 (44%), Gaps = 27/232 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF---EREVRVLGKAR-HPNLISL 662
+G G + V V ++ A+K +V +++ ED + E V +A +P L+ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMK-VVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
+ T LV +Y G L + +LP + + L LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFLHER 115
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
II+ +LK N+LLD + + +++D+G+ + L ++ F Y+APE+
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEI--- 167
Query: 781 SLRVNE---KCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH--VRVLLEE 827
LR E D + GVL+ E++ GR P + DN + +E +V+LE+
Sbjct: 168 -LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 59/275 (21%), Positives = 89/275 (32%), Gaps = 56/275 (20%)
Query: 88 IGKIFNYCSSLNTLNLSNNHFSGDLDF--ASGYGIWSLKRLRTLDLSHNLFSGSIPQGVA 145
+ SL L LS N + G+ L+ LDLS N +
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102
Query: 146 ALH---YLKELLLQGNQFSGPLPADIGFC------PHLTTLDLSNNLFTGQLPVSLRLLN 196
+L L+EL L N G + P L L L N G
Sbjct: 103 SLLRSSSLQELKLNNNGL-GDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA--------- 152
Query: 197 SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-----NCKKLSVIRL 251
S L + L+ L+ +NN + + +L NC L V+ L
Sbjct: 153 -------SCEALAKALRA----NRDLKELNLANNGIGDAGIRALAEGLKANC-NLEVLDL 200
Query: 252 RGNSLNGNIPEGLFDLG--------LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILD 303
N L EG L LE ++L +N + + +S+ + +L L
Sbjct: 201 NNNGLT---DEGASALAETLASLKSLEVLNLGDNN-LTDAGAAALASALLSPNISLLTLS 256
Query: 304 LSSNNLVGDIPAEMGL-----FANLRYLNLSSNHL 333
LS N++ D A+ +L L+L N
Sbjct: 257 LSCNDI-TDDGAKDLAEVLAEKESLLELDLRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 664
+G G FG V V + ++ A+K L ++I+ + F E ++ A P ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ + +V +Y P G L + P W RF TA+ + L
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWA-RFY----TAEVVLALDAIHSMG 162
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE-LTCQ 780
IH ++KP N+LLD + + +++DFG +++K M R +A+G Y++PE L Q
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMV-RCDTAVGTPDYISPEVLKSQ 218
Query: 781 SLR--VNEKCDIYGFGVLILELVTGRRP 806
+CD + GV + E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 65/239 (27%), Positives = 111/239 (46%), Gaps = 39/239 (16%)
Query: 606 EVGEGVFGTVYKVSF--GTQGRMLAVKKL--VTSDIIQYPEDFEREVRVLGKAR-HPNLI 660
E+G+G +G V ++ +A+KK+ V S I RE+++L R H N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNIT 65
Query: 661 SLEGYYWTPQLKLLVSDYAPNGS------LQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
L Y +V N ++A LH+ + S PL+ + I GL
Sbjct: 66 CL---YDMD----IVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA---LG 771
++H + ++H +LKP N+L++ + +I DFGLAR + N ++A
Sbjct: 119 KYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS-------ENPGENAGFMTE 168
Query: 772 YV------APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
YV APE+ + D++ G ++ EL+ GR+PV G+D V L++ ++VL
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVL 226
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 64/254 (25%), Positives = 108/254 (42%), Gaps = 39/254 (15%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGT--------------QGR--MLAVKKLVTSDIIQY 640
P L ++GEG FG V+ +GR ++AVK L
Sbjct: 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNA 62
Query: 641 PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERL-------- 692
DF +EV++L + + PN+I L G ++++Y NG L L
Sbjct: 63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 693 -PSTPP------LSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPR 744
+ PP +S+++ V L A G+ +L +F +H +L N L+ +N +
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF----VHRDLATRNCLVGENLTIK 178
Query: 745 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
I+DFG++R L D + + R + ++A E + D++ FGV + E++
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLC 237
Query: 805 RPVEYGE--DNVVI 816
+ YGE D VI
Sbjct: 238 KEQPYGELTDEQVI 251
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 272 IDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSN 331
+ L G G IP S + L+ ++LS N++ G+IP +G +L L+LS N
Sbjct: 423 LGLDNQGLRGFIPNDISK------LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476
Query: 332 HLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 365
IP LG SL L+L N+L G +P +
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 11/209 (5%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGY 665
VGEG +G V K ++A+KK S+ + E RE+++L + N++ L+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
+ LV +Y L+ L E +P+ P + L A +H + I
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKA-----IHWCHKNDI 121
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
+H ++KP N+L+ N ++ DFG AR L+ + + + Y +PEL +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRSPELLLGA-PYG 179
Query: 786 EKCDIYGFGVLILELVTGRRPVEYGEDNV 814
+ D++ G ++ EL G +P+ GE +
Sbjct: 180 KAVDMWSVGCILGELSDG-QPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 29/67 (43%), Positives = 41/67 (61%), Gaps = 3/67 (4%)
Query: 20 FRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSL 79
R L+ +N S NS+ G IPPSL ++ +++ LDLS N +G +P L + SLR L+L
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSL--GSITSLEVLDLSYNSFNGSIPESLGQ-LTSLRILNL 497
Query: 80 AGNILQG 86
GN L G
Sbjct: 498 NGNSLSG 504
|
Length = 623 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 62/209 (29%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGY 665
+G G G V G +AVKKL Q + + RE+ +L H N+ISL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 666 YWTPQ--LKLLVSDYAPNGSLQAKL---------HERLPSTPPLSWTNRFKVILGTAKGL 714
+ TPQ L+ Y + A L HER+ ++ G+
Sbjct: 89 F-TPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSY-----------LLYQMLCGI 136
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
HLH + IIH +LKPSNI++ + +I DFGLAR + M + Y A
Sbjct: 137 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRA 190
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTG 803
PE+ + E DI+ G ++ ELV G
Sbjct: 191 PEVIL-GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 29/118 (24%)
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 260
+ + N L G IP+ I + L+ ++ S N + G++P SL + L V+ L NS NG+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 261 PEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG 318
PE L L +LRIL+L+ N+L G +PA +G
Sbjct: 483 PESLGQL-----------------------------TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED----FEREVRVLGKARHPNLISL 662
+G+G FG V G+ AVK L ++ E ER V +L +HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ T + V D+ G L L P + RF A L +LH S
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA---RF-YAAEIASALGYLH-SIN 116
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
I++ +LKP NILLD + ++DFGL + + + + F Y+APE+ +
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVI-RKQ 171
Query: 783 RVNEKCDIYGFGVLILELVTGRRP 806
+ D + G ++ E++ G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 40/174 (22%), Positives = 75/174 (43%), Gaps = 20/174 (11%)
Query: 642 EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPST 695
+ E E++ L + N++ + G+ + + D P SL + L E L
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFI------IDIVDDLPRLSLILEYCTRGYLREVLDKE 116
Query: 696 PPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755
LS+ + + + KGL +L+ P + NL + L+ +NY +I GL ++L+
Sbjct: 117 KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILS 174
Query: 756 RLDKHVMSNRFQSALGYVAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVE 808
+ + + Y + ++ K DIY GV++ E+ TG+ P E
Sbjct: 175 -----SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 7/115 (6%)
Query: 101 LNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF 160
L L N G + I L+ L++++LS N G+IP + ++ L+ L L N F
Sbjct: 423 LGLDNQGLRGFI----PNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 161 SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSL--RLLNSMIFISVSNNTLTGDIP 213
+G +P +G L L+L+ N +G++P +L RLL+ F N L G IP
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IP 532
|
Length = 623 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 21/153 (13%)
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
IH +L NILL +N +I DFGLAR + + +V + L ++APE +
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 786 EKCDIYGFGVLILELVT-GRRP---VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841
+ D++ FGVL+ E+ + G P V+ E+ L + R+
Sbjct: 256 QS-DVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM----------------RA 298
Query: 842 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
PE+ + ++ L C P RP+ + +V+IL
Sbjct: 299 PENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 27/112 (24%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 693 PSTPPLSWTNRFKVILGT--AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750
+ P + + + V + A G+++LH + +IH ++ N ++D+ +I+D L
Sbjct: 107 EANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNAL 163
Query: 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
+R L +D H + + + ++A E + + + D++ FGVL+ EL+T
Sbjct: 164 SRDLFPMDYHCLGDNENRPVKWMALE-SLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 27/239 (11%)
Query: 575 NLAAGKVILFDSRSSSLDCSIDPETLL---EKAAEVGEGVFGTVYK-VSFGTQGRMLAVK 630
+++ G + D S+S D + L+ +KA EV + TV K ++ G++GR+
Sbjct: 27 DISDGDLEYSDDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT 86
Query: 631 K-----LVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 685
K V I Q E +L HP++I ++ + + +V + + L
Sbjct: 87 KPGQPDPVVLKIGQKGTTL-IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLY 144
Query: 686 AKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRI 745
L +R + PL + +GL +LH IIH ++K NI ++D I
Sbjct: 145 TYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCI 198
Query: 746 SDFGLARLLTRLDKHVMSNRFQSALGYV---APELTCQSLRVNEKCDIYGFGVLILELV 801
D G A+ V++ F G V APE+ + + N K DI+ G+++ E++
Sbjct: 199 GDLGAAQF------PVVAPAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 62/245 (25%), Positives = 104/245 (42%), Gaps = 60/245 (24%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFERE----VR----VLGKARHPN 658
+G G FG V V G + A+KKL S+++ E+E VR +L +A +P
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML------EKEQVAHVRAERDILAEADNPW 62
Query: 659 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
++ L + L+ +Y P G + L ++ T + RF I T + +H
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET---RF-YIAETILAIDSIH 118
Query: 719 -HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA--------RLLTRLDKHVMSNRFQ-- 767
+ IH ++KP N+LLD + ++SDFGL R+ H + + F
Sbjct: 119 KLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 768 -----------------------SALG---YVAPELTCQSLRVNEKCDIYGFGVLILELV 801
S +G Y+APE+ Q+ N++CD + GV++ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEML 233
Query: 802 TGRRP 806
G P
Sbjct: 234 VGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 15/150 (10%)
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
IH +L NILL +N +I DFGLAR + + +V + L ++APE +
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 786 EKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844
+ D++ FGVL+ E+ + G P V I E R L+EG + DY
Sbjct: 261 QS-DVWSFGVLLWEIFSLGASPYP----GVKIDEEFCR-RLKEGTRM-----RAPDYTTP 309
Query: 845 EVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
E+ + L C PS RP+ +E+V+ L
Sbjct: 310 EMYQTM---LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 62/247 (25%), Positives = 97/247 (39%), Gaps = 59/247 (23%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE----DFEREVRVLGKARH 656
+K +G+G G V+ V G++ A+K L ++I+ + E+E+ L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDH 60
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL----HERLPSTPPLSWTNRF---KVILG 709
P L +L + T LV DY P G L L + L RF +V+L
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVA-----RFYAAEVLL- 114
Query: 710 TAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM------- 762
L +LH I++ +LKP NILL ++ + +SDF L++ V
Sbjct: 115 ---ALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 763 --------------------SNRFQSALGYVAPELTC---QSLRVNEKCDIYGFGVLILE 799
SN F Y+APE+ V D + G+L+ E
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYE 224
Query: 800 LVTGRRP 806
++ G P
Sbjct: 225 MLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 61/280 (21%), Positives = 112/280 (40%), Gaps = 42/280 (15%)
Query: 607 VGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
+G G FG + + + +A+ L + F E LG+ H N++ LE
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
G ++V++Y NG+L + L HE L ++ G A G+ +L
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEM- 126
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-----YVAPE 776
+H L +L++ + +IS F RL + + + G + APE
Sbjct: 127 --GYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVT-GRRPV-EYGEDNVVILSEHVRVLLEEGNVLDCV 834
Q + D++ FG+++ E+++ G RP + +V+ +E+G L
Sbjct: 179 -AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-------KAVEDGFRL--- 227
Query: 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
P+ + P + +L L C RP +++ IL
Sbjct: 228 -PAPRNCPN----LLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 59/244 (24%), Positives = 103/244 (42%), Gaps = 49/244 (20%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPN 658
E +G G FG V V G + A+K L +D+++ + E +L +A
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 659 LISLEGYYWTPQLKL---LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 715
++ + +++ Q KL L+ ++ P G + L ++ T +F I T +
Sbjct: 63 VVKM---FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE---ETQF-YIAETVLAID 115
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK--------HVM----- 762
+H + IH ++KP N+LLD + ++SDFGL L + + H +
Sbjct: 116 SIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 763 --------------SNRFQSALG------YVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
NR Q A Y+APE+ Q+ N+ CD + GV++ E++
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLI 231
Query: 803 GRRP 806
G P
Sbjct: 232 GYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGY 665
+G G G V R +A+KKL Q + + RE+ ++ H N+ISL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 666 YWTPQ----------LKLLVSDYAPNGSLQAKL-HERLPSTPPLSWTNRFKVILGTAKGL 714
+ TPQ L + + D +Q +L HER+ ++ G+
Sbjct: 85 F-TPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----------LLYQMLCGI 132
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
HLH + IIH +LKPSNI++ + +I DFGLAR M + Y A
Sbjct: 133 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRA 186
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELV 801
PE+ + E DI+ G ++ E+V
Sbjct: 187 PEVIL-GMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 63/247 (25%), Positives = 102/247 (41%), Gaps = 55/247 (22%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E +G G FG V V G + A+K L +D++ E+E +A L+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML------EKEQVAHIRAERDILV 56
Query: 661 SLEG-----YYWTPQLK---LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
+G +++ Q K L+ ++ P G + L ++ LS I T
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVL 112
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA------------RLLT----- 755
+ +H + IH ++KP N+LLD + ++SDFGL R LT
Sbjct: 113 AIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 756 ----------RLDKHVMSNRFQ---SALG---YVAPELTCQSLRVNEKCDIYGFGVLILE 799
R + NR Q S +G Y+APE+ Q+ N+ CD + GV++ E
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE 228
Query: 800 LVTGRRP 806
++ G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 607 VGEGVFGTVYKVS--FGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISL 662
+G+G FGTVY V L V K + + E + +E ++L K HP ++
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHE------RLPSTPPLSWTNRFKVILGTAKGLAH 716
+ ++++Y L KL E L W +++LG H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF--IQLLLGV-----H 120
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
H R I+H +LK NI L +N +I DFG++RLL + ++ F Y++PE
Sbjct: 121 YMHQRR--ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPE 175
Query: 777 -LTCQSLRVNEKCDIYGFGVLILEL 800
L Q + K DI+ G ++ E+
Sbjct: 176 ALKHQGY--DSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 29/250 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL---- 662
+G G G V+ + +AVKK+V +D RE++++ + H N++ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVYEVL 71
Query: 663 --EGYYWTPQLKLLV---SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 717
G T + L S Y ++ L + PLS + + +GL ++
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDL-ANVLEQGPLSEEHARLFMYQLLRGLKYI 130
Query: 718 HHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQS----ALGY 772
H + ++H +LKP+N+ ++ ++ +I DFGLAR++ D H + S Y
Sbjct: 131 HSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTKWY 184
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG----EDNVVILSEHVRVLLEEG 828
+P L + D++ G + E++TG +P+ G E +IL E V V+ EE
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLIL-ESVPVVREED 242
Query: 829 -NVLDCVDPS 837
N L V PS
Sbjct: 243 RNELLNVIPS 252
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 28/212 (13%)
Query: 607 VGEGVFGTVYK------VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+G+G F ++K +G + + K++ Y E F ++ + H +L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH-LHH 719
G ++V +Y GSL L + + +SW L AK LA LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWK------LEVAKQLAWALHF 115
Query: 720 SFRPPIIHYNLKPSNILL-----DDNYNP---RISDFGLARLLTRLDKHVMSNRFQSALG 771
+ H N+ N+LL NP ++SD G++ +T L K ++ R +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLER----IP 169
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTG 803
+V PE ++ D + FG + E+ +G
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
RHPN+++ + T ++S + GS + L P +S ++ G +GL
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG--MSEALIGNILFGALRGL 114
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG-LARLLTRLDKHVMSNRF----QSA 769
+LH + IH N+K S+IL+ + +S L L+ K + F S
Sbjct: 115 NYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV 171
Query: 770 LGYVAPELTCQSLR-VNEKCDIYGFGVLILELVTGRRP 806
L +++PEL Q L N K DIY G+ EL TGR P
Sbjct: 172 LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-05
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 13/160 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEG 664
+ G FG VY ++ AVK + +D+I + E L ++ P ++ L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL-- 69
Query: 665 YYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
YY LV +Y G +++ LH ++ K I A L +LH R
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYLH---R 122
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 762
IIH +LKP N+L+ + + +++DFGL+++ + ++M
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMM 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 4/134 (2%)
Query: 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 732
LL+ +Y G L ++ +RL P ++V L + + L ++H +LK
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPF---QEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197
Query: 733 SNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYG 792
+NI L ++ DFG ++ + +++ F Y+APEL + R ++K D++
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL-WERKRYSKKADMWS 256
Query: 793 FGVLILELVTGRRP 806
GV++ EL+T RP
Sbjct: 257 LGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 61/251 (24%), Positives = 92/251 (36%), Gaps = 50/251 (19%)
Query: 172 PHLTTLDLSNNLFTGQLPVSLRLLNSMI-------FISVSNNTLTGDIPHWIGNI---ST 221
P L L LS N TG++P L+ L + + +S+N L D + ++ S+
Sbjct: 51 PSLKELCLSLN-ETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSS 109
Query: 222 LEFLDFSNN--------HLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG----- 268
L+ L +NN L L L + L N L G L
Sbjct: 110 LQELKLNNNGLGDRGLRLLAKGLKD---LPPALEKLVLGRNRLEG---ASCEALAKALRA 163
Query: 269 ---LEEIDLSENGFMGS-IPPGSSSSSSSTLFQTLRILDLSSNNL--VGDIPAEMGL--F 320
L+E++L+ NG + I + + L +LDL++N L G L
Sbjct: 164 NRDLKELNLANNGIGDAGIR---ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220
Query: 321 ANLRYLNLSSNHLRSRIPPEL-----GYFHSLIHLDLRNNALYGSIPQEVCE----SRSL 371
+L LNL N+L L SL+ L L N + +++ E SL
Sbjct: 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESL 280
Query: 372 GILQLDGNSLT 382
L L GN
Sbjct: 281 LELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 31/210 (14%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGY 665
+G G G V R +A+KKL Q + + RE+ ++ H N+I L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 666 YWTPQ--LKLLVSDYAPNGSLQAKL---------HERLPSTPPLSWTNRFKVILGTAKGL 714
+ TPQ L+ Y + A L HER+ ++ G+
Sbjct: 92 F-TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----------LLYQMLCGI 139
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
HLH + IIH +LKPSNI++ + +I DFGLAR M + Y A
Sbjct: 140 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRA 193
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGR 804
PE+ + E DI+ G ++ E++ G
Sbjct: 194 PEVIL-GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 49/208 (23%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 607 VGEGVFGTVYKVSFGTQG-RMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLE 663
+G G FG V ++ + +A+K+ S II+ + E ++L HP ++L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
G + LV ++ G L ++R P+ + + +I + L
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN------ 151
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELT 778
I++ +LKP N+LLD + +++DFG A+ V+ R + G Y+APE+
Sbjct: 152 ---IVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRTYTLCGTPEYIAPEIL 200
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRP 806
++ + D + G+ I E++ G P
Sbjct: 201 L-NVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 6e-05
Identities = 21/64 (32%), Positives = 28/64 (43%), Gaps = 4/64 (6%)
Query: 73 SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 132
+L+ L L+ N L F +L L+LS N+ L S L LR+LDLS
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNN----LTSISPEAFSGLPSLRSLDLS 56
Query: 133 HNLF 136
N
Sbjct: 57 GNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 57/180 (31%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ L+ S N LS +P L NL+ N+ LDLS N +S +P ++ E ++L L L+ N
Sbjct: 165 LKNLDLSFNDLS-DLPKLLSNLS--NLNNLDLSGNKIS-DLPPEI-ELLSALEELDLSNN 219
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+ + + N +L+ L LSNN + L L TLDLS+N S
Sbjct: 220 SIIELLSSLSN-LKNLSGLELSNNKLEDLPESIGN-----LSNLETLDLSNNQ--ISSIS 271
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ-LPVSLRLLNSMIFI 201
+ +L L+EL L GN S LP L L N L T + L + L + I
Sbjct: 272 SLGSLTNLRELDLSGNSLSNALPLIAL--LLLLLELLLNLLLTLKALELKLNSILLNNNI 329
|
Length = 394 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 65/252 (25%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR----VLGKARHPNLISL 662
+G+G FG V V G++ A+K L+ S++ + +D V+ VL ++ P ++SL
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHH 719
+ Q L+ ++ P G L L + + ++ RF + +L + +H
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---RFYMAECVLA----IEAVH- 118
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLA-------------RLLT------RLDKH 760
+ IH ++KP NIL+D + ++SDFGL+ +LL R+D
Sbjct: 119 --KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 761 ----------VMSNRFQ-------------SALG---YVAPELTCQSLRVNEKCDIYGFG 794
MS++ Q S +G Y+APE+ Q E CD + G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLG 235
Query: 795 VLILELVTGRRP 806
++ E + G P
Sbjct: 236 AIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 23/171 (13%)
Query: 643 DFEREVRVLGKARHPNLISL-EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 701
RE+ +L H +I+L Y W + +++ Y + L + + PL
Sbjct: 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY------KCDLFTYVDRSGPLPLE 185
Query: 702 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761
+ + LA+LH IIH ++K NI LD+ N + DFG A +LD H
Sbjct: 186 QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHP 239
Query: 762 MSNRFQSALGYV---APELTCQSLRVNEKC---DIYGFGVLILELVTGRRP 806
+ + G + +PEL L ++ C DI+ G+++ E+
Sbjct: 240 DTPQCYGWSGTLETNSPEL----LALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 370 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 429
+L L L N LT + +L +L LS N+L+ P++ S L L+ L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 58/260 (22%), Positives = 101/260 (38%), Gaps = 69/260 (26%)
Query: 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARH 656
++ K +G G FG V V + A+K L +D++ + + E +L +A +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 657 PNLISLEGYYWTPQLK---LLVSDYAPNGSLQAKL------HERLPSTPPLSWTNRFKVI 707
++ L Y++ Q K V DY P G + + L E L RF I
Sbjct: 61 EWVVKL---YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA---------RF-YI 107
Query: 708 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL------------- 754
+ +H + IH ++KP NIL+D + + +++DFGL
Sbjct: 108 AELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164
Query: 755 -TRLDKHVMSNRF------------------------QSALG---YVAPELTCQSLRVNE 786
R D S + S +G Y+APE+ ++ +
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQ 223
Query: 787 KCDIYGFGVLILELVTGRRP 806
CD + GV++ E++ G+ P
Sbjct: 224 LCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 46/227 (20%), Positives = 87/227 (38%), Gaps = 52/227 (22%)
Query: 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARH 656
+L + VG+G +G V+ G ++A+K++ S + + E E +L +
Sbjct: 4 QILTQ---VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
L+ L + + L +Y P G + L G+
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---------------------NNLGVLS 99
Query: 717 LHHS--------------FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 762
H+ IH +LKP N L+D + + +++DFGL+ K ++
Sbjct: 100 EDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS-------KGIV 152
Query: 763 SNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ S +G Y+APE+ + + D + G ++ E + G P
Sbjct: 153 T-YANSVVGSPDYMAPEVL-RGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 1/61 (1%)
Query: 48 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 107
N+K LDLSNN L+ +P F+ +L+ L L+GN L + F+ SL +L+LS N+
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 108 F 108
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 19/155 (12%)
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKGL 714
PN++ L Y + LV +A G L + + + +P W V L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG-LARLLTRLDKHVMSNRFQSALGYV 773
LH R I+ +L P+NILLDD + +++ F + + D + N Y
Sbjct: 101 --LH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 808
APE+ S E CD + G ++ EL+TG+ VE
Sbjct: 150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 7e-04
Identities = 23/60 (38%), Positives = 33/60 (55%), Gaps = 3/60 (5%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ L+ S+N L+ IP + N+K LDLS N L+ + + F SLR L L+GN
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFK-GLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 173 HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHL 232
+L +LDLSNN T + + L ++ + +S N LT P + +L LD S N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 46/203 (22%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD 739
+ S +K E + PL + + A+G+ L IH ++ N+LL D
Sbjct: 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTD 247
Query: 740 NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE------LTCQSLRVNEKCDIYGF 793
+I DFGLAR + +V+ + + ++APE T QS D++ +
Sbjct: 248 GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQS-------DVWSY 300
Query: 794 GVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKL 852
G+L+ E+ + G+ P +++ S+ + +++ G + P D+ E+ ++K+
Sbjct: 301 GILLWEIFSLGKSPYP----GILVNSKFYK-MVKRGYQMSR--P---DFAPPEIYSIMKM 350
Query: 853 ALVCTCHIPSSRPSMAEVVQILQ 875
C P+ RP+ +++ Q++Q
Sbjct: 351 ---CWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 30/151 (19%), Positives = 48/151 (31%), Gaps = 18/151 (11%)
Query: 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEG 664
+ G+ VY + + +K + + D EREV +L L +
Sbjct: 4 KLLKGGLTNRVYLLGTKDED--YVLKINPSR---EKGADREREVAILQLLARKGLPVPKV 58
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT--AKGLAHLHHSFR 722
+ L E + + K + A+ LA LH
Sbjct: 59 LA-----------SGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPL 107
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARL 753
+ H +L P NIL+DD I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 20/60 (33%), Positives = 31/60 (51%)
Query: 394 SLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
+L L LS+N L+ + L LK+L L N L+ P+ L SL ++++S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 29/62 (46%), Positives = 34/62 (54%), Gaps = 6/62 (9%)
Query: 299 LRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNN 355
L+ LDLS+N L IP GL NL+ L+LS N+L S I PE SL LDL N
Sbjct: 2 LKSLDLSNNRL-TVIPDGAFKGL-PNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGN 58
Query: 356 AL 357
L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.004
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 19/97 (19%)
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH----VMSNRFQ 767
K L H+H + I H ++KP NIL+ D+ +++DFG R K +S R+
Sbjct: 111 KSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRW- 163
Query: 768 SALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVT 802
Y APE LT K DI+ G + E+++
Sbjct: 164 ----YRAPECLLTDG--YYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 12/212 (5%)
Query: 597 PETLLEKAAEVGEGVFGTVYK-VSFG---TQGRM-LAVKKLVTSDIIQYPEDFEREVRVL 651
P L +G G FG V + ++G + M +AVK L + E E++++
Sbjct: 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM 92
Query: 652 GK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
H N+++L G L++++Y G L L + S L+ +
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQV 150
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
AKG+A L IH +L N+LL +I DFGLAR + +V+ + +
Sbjct: 151 AKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVT 802
++APE + E D++ +G+L+ E+ +
Sbjct: 208 KWMAPESIFNCVYTFES-DVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII---QYPEDF-EREVRVLGKARHPNLISL 662
+ G +G VY V + A+KK+ ++I Q + F ER++ L A +P ++S+
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVSM 66
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ T + +V +Y G A L L + L T L +LH+
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDC-ATL---LKNIGALPVDMARMYFAETVLALEYLHNY-- 120
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLAR-----LLTRLDKHVMSNRFQSALG------ 771
I+H +LKP N+L+ + +++DFGL++ L T L + + + L
Sbjct: 121 -GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 772 --YVAPELTCQSLR--VNEKCDIYGFGVLILELVTGRRPVEYGE 811
Y+APE+ LR + D + G+++ E + G P +G+
Sbjct: 180 PEYIAPEVI---LRQGYGKPVDWWAMGIILYEFLVGCVPF-FGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 888 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.25 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.24 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.23 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.21 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.9 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.88 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.71 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.71 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.52 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.51 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.51 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.48 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.44 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.44 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.4 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-98 Score=937.61 Aligned_cols=812 Identities=31% Similarity=0.501 Sum_probs=577.7
Q ss_pred CCccccccccccccCcccccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEcC
Q 002717 1 MTTPLVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLA 80 (888)
Q Consensus 1 ~~~l~l~~n~~~~ip~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~ 80 (888)
|+.|++++|.++.......+++|++|+|++|.+++.+|..++.+ ++|++|+|++|.+.+.+|.. |.++++|++|+|+
T Consensus 120 L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l--~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~ 196 (968)
T PLN00113 120 LRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSF--SSLKVLDLGGNVLVGKIPNS-LTNLTSLEFLTLA 196 (968)
T ss_pred CCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcC--CCCCEEECccCcccccCChh-hhhCcCCCeeecc
Confidence 46777777777633223556777777777777777777777765 67777777777776566643 5677777777777
Q ss_pred CccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCCEEEccCccc
Q 002717 81 GNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF 160 (888)
Q Consensus 81 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 160 (888)
+|.+.+..+..|..+++|++|+|++|++++..+ ..+..+++|++|+|++|.+++..|..+.++++|++|++++|.+
T Consensus 197 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p----~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 272 (968)
T PLN00113 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP----YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272 (968)
T ss_pred CCCCcCcCChHHcCcCCccEEECcCCccCCcCC----hhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCee
Confidence 777776666667777777777777777664322 2456677777777777777666677777777777777777777
Q ss_pred cccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCCCCC
Q 002717 161 SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSL 240 (888)
Q Consensus 161 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 240 (888)
++..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..|..+.++++|+.|++++|.+++.+|..+
T Consensus 273 ~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l 352 (968)
T PLN00113 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352 (968)
T ss_pred eccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHH
Confidence 66666666677777777777777766666667777777777777777766666666677777777777777766666666
Q ss_pred CCCCCCcEEEeeCCcCCCCCCcccccc-CCceEEcccCcccccCCCCCCC------------------CCCCcccCCCCE
Q 002717 241 FNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSS------------------SSSSTLFQTLRI 301 (888)
Q Consensus 241 ~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~N~l~~~~p~~~~~------------------~~~~~~l~~L~~ 301 (888)
..+++|+.|++++|++++.+|..+... .++.|++++|.+.+.+|..... ...+..+++|+.
T Consensus 353 ~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 432 (968)
T PLN00113 353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432 (968)
T ss_pred hCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCE
Confidence 666667777777666666666555543 3555555555555444432111 001233556666
Q ss_pred EeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceEEccCCcC
Q 002717 302 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 381 (888)
Q Consensus 302 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 381 (888)
|++++|++++.+|..+..+++|+.|++++|++.+..|..+ ..++|+.|+|++|++++..|..+..+++|+.|+|++|++
T Consensus 433 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 511 (968)
T PLN00113 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511 (968)
T ss_pred EECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcc
Confidence 6666666666666666666777777777777766666544 347788899999999989999999999999999999999
Q ss_pred CCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeeccCCcceecCCCCC
Q 002717 382 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGG 461 (888)
Q Consensus 382 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~ 461 (888)
++.+|..+.++++|+.|+|++|.+++.+|..|..+++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|..+
T Consensus 512 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~ 591 (968)
T PLN00113 512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591 (968)
T ss_pred eeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcCCCcCCCCCCCCC---CCCCCCCCCCccCCCCCCCCCCCCCcCCCCCCCCCcchhHHHHHHHHHHHHHHH
Q 002717 462 VFPTLDQSSLQGNLGICSPLLKG---PCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAILI 538 (888)
Q Consensus 462 ~~~~l~~~~~~~n~~~c~~~~~~---~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~vl~ 538 (888)
++.++...++.||+++|+++... +|.. ..+.... ++++++++ ++++++
T Consensus 592 ~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~--------------------------~~~~~~~-~~~~~~~~--~~~~~~ 642 (968)
T PLN00113 592 AFLAINASAVAGNIDLCGGDTTSGLPPCKR--------------------------VRKTPSW-WFYITCTL--GAFLVL 642 (968)
T ss_pred hhcccChhhhcCCccccCCccccCCCCCcc--------------------------cccccee-eeehhHHH--HHHHHH
Confidence 99999999999999999865311 1110 0001111 11122111 111222
Q ss_pred HHHHHHHHHHHHHHHhhccccccccccccCCCCcccccccCeeEEeccCCCCccccCChhhhhhhcCeeccccceEEEEE
Q 002717 539 AGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKV 618 (888)
Q Consensus 539 ~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~ 618 (888)
++++++++ ++++|++.+..+ .+.. .+. .....++..........+....+...+.||+|+||.||+|
T Consensus 643 ~~~~~~~~--~~~~~~~~~~~~--~~~~-~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~ 709 (968)
T PLN00113 643 ALVAFGFV--FIRGRNNLELKR--VENE-DGT--------WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKG 709 (968)
T ss_pred HHHHHHHH--HHHhhhcccccc--cccc-ccc--------ccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEE
Confidence 22222222 222222111111 0100 000 0000111000000000011122445568999999999999
Q ss_pred EECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCHHHHHhhcCCCCCCC
Q 002717 619 SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPL 698 (888)
Q Consensus 619 ~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l 698 (888)
++..+++.||||++..... ....|++++++++|||||+++|+|.+++..++||||+++|+|.++++. +
T Consensus 710 ~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l 777 (968)
T PLN00113 710 KSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------L 777 (968)
T ss_pred EECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------C
Confidence 9988999999998854321 223568899999999999999999999999999999999999999963 7
Q ss_pred ChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccccccccccccCcccc
Q 002717 699 SWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 778 (888)
Q Consensus 699 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~ 778 (888)
+|.++.+++.|+|+||+|||+.++++|+|||+||+||+++.++.+++. ||....... .....+++.|+|||++
T Consensus 778 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~ 850 (968)
T PLN00113 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETR 850 (968)
T ss_pred CHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccc
Confidence 899999999999999999997777799999999999999999888876 665543211 1223678899999988
Q ss_pred cCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCC---CChhhHHHHHHHHHH
Q 002717 779 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD---YPEDEVLPVLKLALV 855 (888)
Q Consensus 779 ~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~---~~~~~~~~l~~li~~ 855 (888)
.+..++.++|||||||++|||+||+.||+..........+|++...........+|+.+.. .+..+..++.+++.+
T Consensus 851 -~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 929 (968)
T PLN00113 851 -ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALH 929 (968)
T ss_pred -cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHh
Confidence 5567899999999999999999999999655444445566666555444444556665533 345566778899999
Q ss_pred ccCCCCCCCCCHHHHHHHHHhhcCCCC
Q 002717 856 CTCHIPSSRPSMAEVVQILQVIKTPLP 882 (888)
Q Consensus 856 cl~~dp~~RPs~~evl~~L~~~~~~~~ 882 (888)
||+.||++||||+||++.|+++....+
T Consensus 930 Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 930 CTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred hCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 999999999999999999999866443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=543.21 Aligned_cols=471 Identities=33% Similarity=0.529 Sum_probs=413.5
Q ss_pred CCcccccccccc-ccCc--ccccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEE
Q 002717 1 MTTPLVHGNSYN-AIPS--MVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYL 77 (888)
Q Consensus 1 ~~~l~l~~n~~~-~ip~--~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L 77 (888)
|++|++++|.++ .+|. +..+.+|++|+|++|++++.+|.. .+ ++|++|+|++|.+++.+|.. |+++++|++|
T Consensus 95 L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~--~l--~~L~~L~Ls~n~~~~~~p~~-~~~l~~L~~L 169 (968)
T PLN00113 95 IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG--SI--PNLETLDLSNNMLSGEIPND-IGSFSSLKVL 169 (968)
T ss_pred CCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc--cc--CCCCEEECcCCcccccCChH-HhcCCCCCEE
Confidence 578999999997 7885 338999999999999999888863 23 78999999999999777765 6999999999
Q ss_pred EcCCccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCCEEEccC
Q 002717 78 SLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQG 157 (888)
Q Consensus 78 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 157 (888)
+|++|.+.+..+..|..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++.+|..+..+++|++|++++
T Consensus 170 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p----~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 245 (968)
T PLN00113 170 DLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP----RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245 (968)
T ss_pred ECccCcccccCChhhhhCcCCCeeeccCCCCcCcCC----hHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcC
Confidence 999999998888889999999999999999986433 3678899999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCC
Q 002717 158 NQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLP 237 (888)
Q Consensus 158 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 237 (888)
|.+++..|..+..+++|++|+|++|.+++..|..+..+++|+.|++++|.+.+.+|..+.++++|++|++++|.+++..|
T Consensus 246 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~ 325 (968)
T PLN00113 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325 (968)
T ss_pred ceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcEEEeeCCcCCCCCCcccccc-CCceEEcccCcccccCCCCCCCC------------------CCCcccCC
Q 002717 238 SSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSS------------------SSSTLFQT 298 (888)
Q Consensus 238 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~N~l~~~~p~~~~~~------------------~~~~~l~~ 298 (888)
..+..+++|+.|++++|.+.+.+|..+... .|+.|++++|.+.+.+|...... ..+..+++
T Consensus 326 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~ 405 (968)
T PLN00113 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405 (968)
T ss_pred hhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCC
Confidence 999999999999999999999999888776 79999999999999888754321 11233556
Q ss_pred CCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceEEccC
Q 002717 299 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDG 378 (888)
Q Consensus 299 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 378 (888)
|+.|++++|++++.+|..+..+++|+.|++++|.+++.++..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++
T Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~ 484 (968)
T PLN00113 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSR 484 (968)
T ss_pred CCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcC
Confidence 7777777777777777777777777777777777777777777777788888888888877777655 457888999999
Q ss_pred CcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeeccCCcceecCC
Q 002717 379 NSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 458 (888)
Q Consensus 379 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 458 (888)
|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|.++|.+|..+..+++|+.|+|++|+++|.+|
T Consensus 485 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 564 (968)
T PLN00113 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564 (968)
T ss_pred CccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred C-CCCCCCCCCCCcCCCcCCCCCC
Q 002717 459 V-GGVFPTLDQSSLQGNLGICSPL 481 (888)
Q Consensus 459 ~-~~~~~~l~~~~~~~n~~~c~~~ 481 (888)
. ...+..+..+++.+|+..+.-|
T Consensus 565 ~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 565 KNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred hhHhcCcccCEEeccCCcceeeCC
Confidence 4 3556778888899998766544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=428.43 Aligned_cols=283 Identities=42% Similarity=0.712 Sum_probs=241.8
Q ss_pred CCccccCChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEc
Q 002717 589 SSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT 668 (888)
Q Consensus 589 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 668 (888)
++.++..+++++-... .||+|+||.||+|... +|+.||||++......+ ..+|..|+.++.+++|||+|+++|||.+
T Consensus 66 s~~el~~AT~~Fs~~~-~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 66 SYDELRKATNNFSESN-LIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred eHHHHHHHHhCCchhc-ceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 5566666776665544 8999999999999997 66999999886554332 4669999999999999999999999999
Q ss_pred CC-eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEec
Q 002717 669 PQ-LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD 747 (888)
Q Consensus 669 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 747 (888)
.+ +.++|||||++|+|.++++..... +++|..|++||.++|+||+|||+.+.|+|+||||||+|||+|+++++||+|
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 98 499999999999999999986433 789999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccc-cccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-CchhhHHHHHHHHH
Q 002717 748 FGLARLLTRLDKHVMSNRF-QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE-DNVVILSEHVRVLL 825 (888)
Q Consensus 748 fgla~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~-~~~~~l~~~~~~~~ 825 (888)
||+|+..+..+.. .... .||.+|+|||+. ..+..+.|+|||||||++.|++||+.|.+... .....+..|+...+
T Consensus 221 FGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~-~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 221 FGLAKLGPEGDTS--VSTTVMGTFGYLAPEYA-STGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCcccCCccccc--eeeecCCCCccCChhhh-ccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 9999765431111 1222 899999999998 45689999999999999999999999987654 33444888998889
Q ss_pred hcCCcccccCCCCC--CCCh-hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 826 EEGNVLDCVDPSMG--DYPE-DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 826 ~~~~~~~~~d~~~~--~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
..+...+++|+++. .++. .+..++.+++.+|++.+|++||+|.||+++|+.+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 99999999999986 3454 678889999999999999999999999999976654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=399.55 Aligned_cols=261 Identities=32% Similarity=0.462 Sum_probs=222.0
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
.+.+.++..+.||+|.||+||.|.|. ....||+|.++... ...++|.+|+++|++++|++||+++|+|..++..+||
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 34566777889999999999999996 44489999997653 3458899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
||||+.|+|.++|+.. .+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..|||+|||+|+...
T Consensus 280 tE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence 9999999999999983 456788899999999999999999999 99999999999999999999999999999544
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
+ +.+.......-++.|.|||.+ ....++.|||||||||+||||+| |+.||..+...+ +-..++.|..+.+
T Consensus 355 d-~~Y~~~~~~kfPIkWtAPEa~-~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------v~~~le~GyRlp~- 425 (468)
T KOG0197|consen 355 D-DEYTASEGGKFPIKWTAPEAL-NYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------VLELLERGYRLPR- 425 (468)
T ss_pred C-CceeecCCCCCCceecCHHHH-hhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------HHHHHhccCcCCC-
Confidence 3 444444556667899999998 66789999999999999999999 888887654321 1123344554433
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
|..++..++++|..||+.+|++|||++.+...++.+...
T Consensus 426 -------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 -------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 778888999999999999999999999999999887653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=398.67 Aligned_cols=259 Identities=32% Similarity=0.482 Sum_probs=213.8
Q ss_pred hhcCeeccccceEEEEEEECCCCeE-EEEEEeecCCccC-ChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-eeeEEEec
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRM-LAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQ-LKLLVSDY 678 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~-vavK~l~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 678 (888)
+..+.||+|+||+||+|.|+ |+. ||||++....... ..++|.+|+.++.+++|||||+++|+|.++. ..++||||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34446999999999999995 665 9999986543221 1568999999999999999999999999988 78999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCC-eEecCCCCCcEEecCCC-CcEEecccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP-IIHYNLKPSNILLDDNY-NPRISDFGLARLLTR 756 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~~~ 756 (888)
+++|+|.++++.. ....+++..++++|.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999884 356799999999999999999999998 6 99999999999999997 999999999986553
Q ss_pred cccccccccccccccccCcccccC-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQ-SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.. .......||+.|||||++.. ...++.|+|||||||++|||+||+.||..... ...... + ...
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~-v---~~~-------- 261 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASA-V---VVG-------- 261 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHH-H---Hhc--------
Confidence 21 22244789999999999953 46799999999999999999999999987654 222211 1 111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCC
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 882 (888)
......+..+...+..+|.+||+.||+.||++.|++..|+.+.....
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 12223455577889999999999999999999999999998866444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=377.24 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=217.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-eeeEEEe
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-LKLLVSD 677 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 677 (888)
...+..+.||+|..|+||++.++.+++.+|+|.+.........+++.+|+++++..+||+||+++|.|.... ...++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 445667799999999999999999999999999955444455678999999999999999999999999988 4999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
||++|+|++.+... .++++....+++.+|++||.|||+.. +||||||||+|+|++..|+|||||||.++.+...
T Consensus 159 YMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999999875 56899999999999999999999632 9999999999999999999999999999876542
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.+.+..||..|||||.+ .+..|+.++||||||++++|+++|+.||...........+.+... ++..
T Consensus 233 ----~a~tfvGT~~YMsPERi-~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---------v~~p 298 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERI-SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---------VDEP 298 (364)
T ss_pred ----hcccccccccccChhhh-cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---------hcCC
Confidence 44778999999999999 667899999999999999999999999976523222222322222 2222
Q ss_pred CCCCChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 838 MGDYPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 838 ~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
-+..|.. ...++..++..|+++||.+|||+.|++++-.-
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 2334554 77789999999999999999999999987544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=415.33 Aligned_cols=269 Identities=28% Similarity=0.438 Sum_probs=232.5
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCe
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 671 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 671 (888)
+....+..+.||+|+||.||+|+... +...||||.+++....+..++|++|++++..++|||||+++|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 33444556689999999999999842 4567999999888777678999999999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhcCCC----------CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPS----------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 741 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 741 (888)
.++|+|||..|+|.++|..+.+. .++++..+.+.||.|||.||.||-++ .+|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 99999999999999999865432 23488899999999999999999998 999999999999999999
Q ss_pred CcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHH
Q 002717 742 NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 820 (888)
Q Consensus 742 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~ 820 (888)
.|||+|||+++.+...|++.......-+++|||||.+ ...++|.+||||||||+|||+++ |+.||.....++
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI-ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------ 713 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI-LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------ 713 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHh-hcCcccchhhhhhhhhhhhhhhccccCcccccchHH------
Confidence 9999999999998888888776666778999999988 67799999999999999999999 999997654422
Q ss_pred HHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002717 821 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883 (888)
Q Consensus 821 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 883 (888)
|-..++.+.... .|+.++..+++||..||+..|++||+++||-..|+......+.
T Consensus 714 VIe~i~~g~lL~--------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 714 VIECIRAGQLLS--------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred HHHHHHcCCccc--------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 223345555544 4889999999999999999999999999999999998776654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=371.52 Aligned_cols=268 Identities=23% Similarity=0.290 Sum_probs=214.9
Q ss_pred CccccCChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC------ChHHHHHHHHHHhhcCCCCcceee
Q 002717 590 SLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ------YPEDFEREVRVLGKARHPNLISLE 663 (888)
Q Consensus 590 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~ 663 (888)
.........+.|...+.+|+|+||.|-+|..+.+|+.||||.+.+..... ......+|+++|++++|||||+++
T Consensus 163 ~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~ 242 (475)
T KOG0615|consen 163 SKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK 242 (475)
T ss_pred ccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence 33344456778888999999999999999999999999999997654332 122357999999999999999999
Q ss_pred eEEEcCCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC---
Q 002717 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN--- 740 (888)
Q Consensus 664 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~--- 740 (888)
+++..++..|+|+||++||+|.+++-.. ..+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAED 315 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcc
Confidence 9999999999999999999999998764 4567777788999999999999999 99999999999999755
Q ss_pred CCcEEecccccccccccccccccccccccccccCcccccCcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHH
Q 002717 741 YNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL--RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 818 (888)
Q Consensus 741 ~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~ 818 (888)
..+||+|||+|+..++. ....+.+||+.|.|||++...+ .+..+.|+||+||++|-+++|.+||.....+.. +.
T Consensus 316 ~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l~ 391 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-LK 391 (475)
T ss_pred eEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-HH
Confidence 77999999999987632 2336789999999999985432 234588999999999999999999976433321 11
Q ss_pred HHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 819 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 819 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
+++ ..++.. + -+.......++...+|.+|+..||++|||+.|++++-|--
T Consensus 392 eQI----~~G~y~--f---~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 392 EQI----LKGRYA--F---GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred HHH----hcCccc--c---cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 211 122211 1 1123456667788999999999999999999999877653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=355.34 Aligned_cols=265 Identities=24% Similarity=0.390 Sum_probs=217.9
Q ss_pred CChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeE-EEcCCe-
Q 002717 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGY-YWTPQL- 671 (888)
Q Consensus 595 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~- 671 (888)
..+...|++.++||+|.||+||++.+..+|..||.|.+.-.... +..++...|+.++++++|||||+++++ +.++..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 34567789999999999999999999999999999998633322 234567899999999999999999993 444444
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCC-CeEecCCCCCcEEecCCCCcEEecccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP-PIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
.++|||||.+|+|...++........+++..+|+++.|+++||.++|+..+. -|+||||||.||++|.+|.||++|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 7899999999999999998877888999999999999999999999984322 389999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCc
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
++.+.. .........|||.||+||.+ ....|+.||||||+||++|||+.-+.||... +...+.+ .+..+.
T Consensus 175 ~r~l~s--~~tfA~S~VGTPyYMSPE~i-~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~----KI~qgd- 244 (375)
T KOG0591|consen 175 GRFLSS--KTTFAHSLVGTPYYMSPERI-HESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCK----KIEQGD- 244 (375)
T ss_pred HhHhcc--hhHHHHhhcCCCcccCHHHH-hcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHH----HHHcCC-
Confidence 998764 22334678899999999998 7778999999999999999999999999754 3333333 223332
Q ss_pred ccccCCCCCCCC-hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 831 LDCVDPSMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 831 ~~~~d~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.+..| ...+.++.+||..|+..||+.||+...+++.++.
T Consensus 245 -------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 -------YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -------CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 12234 5677889999999999999999996666665554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=395.11 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=221.5
Q ss_pred hhhcCeeccccceEEEEEEECCCC---eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQG---RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.++.+.||.|.||+||+|+++..| ..||||.++.....+...+|..|+.||.++.||||+++.|+.......++|+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 355678999999999999998766 46999999888777778899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
||++|+|+.+|+.+ ..++++.+...+.++||.||.||-+. ++|||||.++|||++.+..+|++|||++|.+.+.
T Consensus 711 yMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999987 35699999999999999999999999 9999999999999999999999999999977543
Q ss_pred c-cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 758 D-KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 758 ~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
. ....+....-+++|.|||.+ ...+++.+||||||||++||.++ |.+||.++...+.+ ..++++..+
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAI-a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI------kaIe~gyRL---- 853 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI------KAIEQGYRL---- 853 (996)
T ss_pred CCccccccCCccceeecChhHh-hhcccCchhhccccceEEEEecccCCCcccccchHHHH------HHHHhccCC----
Confidence 3 22333334456889999998 77789999999999999999887 99999877553322 123333332
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
..|.+++..+++||..||++|-.+||.+.|++..|+++
T Consensus 854 ----PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 854 ----PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred ----CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 23789999999999999999999999999999999876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=364.98 Aligned_cols=201 Identities=29% Similarity=0.456 Sum_probs=179.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-ccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
..|+..++||+|+||+||+|+++.++..||||.+.+.. ..+..+....|+.+++.++|||||.++++++.++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 34566677999999999999999999999999997664 33455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC------CCcEEeccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN------YNPRISDFGLA 751 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~------~~~kl~Dfgla 751 (888)
||.||+|.+|++.+ ..+++..+..++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999986 4789999999999999999999999 99999999999999854 45899999999
Q ss_pred ccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG 810 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~ 810 (888)
+.+.+. ....+.+|++.|||||++ ...+|+.|+|+||+|+++|+|++|+.||+..
T Consensus 163 R~L~~~---~~a~tlcGSplYMAPEV~-~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 163 RFLQPG---SMAETLCGSPLYMAPEVI-MSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhCCch---hHHHHhhCCccccCHHHH-HhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 988743 334678999999999998 6778999999999999999999999999753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=380.36 Aligned_cols=260 Identities=24% Similarity=0.329 Sum_probs=218.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
..|++++.||+|||+.||++++..+|+.||+|++.+.... ...+...+|++|.++++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999999889999999999765332 34567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
|+|+.|+|..+++.+ .++++.++..+..||+.||.|||+. +|+|||||..|+++++++++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999854 6799999999999999999999999 999999999999999999999999999998764
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.+ ....+.+|||.|+|||++. ....+..+||||+||++|-|++|++||+.....+ ..+.+... +.
T Consensus 171 ~~--Erk~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-----ty~~Ik~~-------~Y 235 (592)
T KOG0575|consen 171 DG--ERKKTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-----TYNKIKLN-------EY 235 (592)
T ss_pred cc--cccceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-----HHHHHHhc-------Cc
Confidence 32 2346789999999999994 5578999999999999999999999997542211 11111111 11
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 883 (888)
.+|........+||..+++.||.+|||+++|+.+=.--.-..|.
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCC
Confidence 23556667788999999999999999999999875443333333
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=406.13 Aligned_cols=270 Identities=29% Similarity=0.416 Sum_probs=228.0
Q ss_pred ccCChhhhhhhcCeeccccceEEEEEEECCC-C----eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEE
Q 002717 593 CSIDPETLLEKAAEVGEGVFGTVYKVSFGTQ-G----RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW 667 (888)
Q Consensus 593 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~-~----~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 667 (888)
+..-+....+..+.||+|+||.||+|..... | ..||||.+.+....+...+|.+|..+|++++|||||+++|+|.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 3444556677788999999999999999643 2 3499999988777778899999999999999999999999999
Q ss_pred cCCeeeEEEecCCCCCHHHHHhhcCC---CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcE
Q 002717 668 TPQLKLLVSDYAPNGSLQAKLHERLP---STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 744 (888)
Q Consensus 668 ~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 744 (888)
+....++++|||++|+|..+|++.++ ....++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++...||
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence 99999999999999999999998533 245688899999999999999999999 999999999999999999999
Q ss_pred EecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHH
Q 002717 745 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRV 823 (888)
Q Consensus 745 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~ 823 (888)
|+|||+|+.+.+.+++.......-++.|||||.+ .+..++.|+|||||||++||++| |..||..... .+.+..
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl-~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~v~~~---- 916 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESL-KDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FEVLLD---- 916 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHH-hhcccccccchhhhHHHHHHHHhCCCCCCCCcch-HHHHHH----
Confidence 9999999987776666554554566899999999 66789999999999999999999 7788865433 222222
Q ss_pred HHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 824 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 824 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
..+.+ + -+.|..++..++++|..||+.+|++||++..+++.+..+.+.
T Consensus 917 ~~~gg-R--------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 917 VLEGG-R--------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHhCC-c--------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 22233 2 145888999999999999999999999999999999887553
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=380.14 Aligned_cols=384 Identities=23% Similarity=0.232 Sum_probs=200.4
Q ss_pred ccccccccccccCc--c--cccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEE
Q 002717 3 TPLVHGNSYNAIPS--M--VVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLS 78 (888)
Q Consensus 3 ~l~l~~n~~~~ip~--~--~~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~ 78 (888)
.||++++.+.++.. + ..+...+.||||+|+++.+-+..|.++ ++|++++|.+|.++ .||... ....+|+.|+
T Consensus 56 lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl--~nLq~v~l~~N~Lt-~IP~f~-~~sghl~~L~ 131 (873)
T KOG4194|consen 56 LLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNL--PNLQEVNLNKNELT-RIPRFG-HESGHLEKLD 131 (873)
T ss_pred eeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcC--Ccceeeeeccchhh-hccccc-ccccceeEEe
Confidence 34555555555421 1 123344555555555555555445444 55555555555555 555421 2222355555
Q ss_pred cCCccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCCEEEccCc
Q 002717 79 LAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGN 158 (888)
Q Consensus 79 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 158 (888)
|.+|.|+.+....++.++.|+.||||.|.|+.++. ..|..-.++++|+|++|.|+......|..+.+|..|.|++|
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~----~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrN 207 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPK----PSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRN 207 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhchhhcccC----CCCCCCCCceEEeeccccccccccccccccchheeeecccC
Confidence 55555555555555555555555555555554332 23444445555555555555555555555555555555555
Q ss_pred cccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCCC
Q 002717 159 QFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPS 238 (888)
Q Consensus 159 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 238 (888)
+|+...+..|.++++|+.|+|..|+|.-.-...|.+|++|+.|.|..|.|.......|..|.++++|+|+.|+++..-..
T Consensus 208 rittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g 287 (873)
T KOG4194|consen 208 RITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEG 287 (873)
T ss_pred cccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcc
Confidence 55554445555555555555555555533344555555555555555555555555555555555555555555544455
Q ss_pred CCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCcccccCCCCCCCCCCCcccCCCCEEeCCCCcCcccCChhhh
Q 002717 239 SLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG 318 (888)
Q Consensus 239 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 318 (888)
++.++++|+.|+|++|.|..+-++.+ .--++|+.|+|++|+|+...+..|.
T Consensus 288 ~lfgLt~L~~L~lS~NaI~rih~d~W-----------------------------sftqkL~~LdLs~N~i~~l~~~sf~ 338 (873)
T KOG4194|consen 288 WLFGLTSLEQLDLSYNAIQRIHIDSW-----------------------------SFTQKLKELDLSSNRITRLDEGSFR 338 (873)
T ss_pred cccccchhhhhccchhhhheeecchh-----------------------------hhcccceeEeccccccccCChhHHH
Confidence 55555555555555555542211111 1124566666666666655556666
Q ss_pred hccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCc---cccccCCCceEEccCCcCCCccCccccccccc
Q 002717 319 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ---EVCESRSLGILQLDGNSLTGPIPQVIRNCTSL 395 (888)
Q Consensus 319 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 395 (888)
.+..|++|+|++|.|..+-...|.++.+|++|||++|.|+..+.+ .|..+++|+.|+|.+|+|..+...+|.++.+|
T Consensus 339 ~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~L 418 (873)
T KOG4194|consen 339 VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEAL 418 (873)
T ss_pred HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccc
Confidence 666666666666666555555555666666666666665544332 24445555555555555554333455555555
Q ss_pred cEEEccCCcccccCCccccCCCCCCeEEc
Q 002717 396 YLLSLSHNHLSGSIPKSISNLNKLKILKL 424 (888)
Q Consensus 396 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 424 (888)
+.|||.+|.|..+-|.+|..| .|+.|.+
T Consensus 419 E~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 419 EHLDLGDNAIASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred ceecCCCCcceeecccccccc-hhhhhhh
Confidence 555555555555555555555 4554443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=373.79 Aligned_cols=271 Identities=27% Similarity=0.422 Sum_probs=217.1
Q ss_pred cccCChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCC
Q 002717 592 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ 670 (888)
Q Consensus 592 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 670 (888)
+....+-+.....+.||+|.||+||+|.|. | .||||.+.-.... +..++|+.|+.++++-||.||+-+.|||..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 334445566677889999999999999995 3 4999999655432 34578999999999999999999999999888
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
. .+|+.+|+|.+|+.+++.. ...++..+...||.|||+||.|||.+ +|||||+|+.||++.+++.|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 7 9999999999999999986 36789999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQS--LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 828 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 828 (888)
+..-.............|...|||||++... ..|++++||||||+|+|||+||..||. ....+.++-. ...|
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifm-----VGrG 608 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFM-----VGRG 608 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEE-----eccc
Confidence 9754332222222334567889999988543 468999999999999999999999998 3333322211 1112
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCC
Q 002717 829 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882 (888)
Q Consensus 829 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 882 (888)
.. -+.+......++.++.+|+..||..++++||.+.+++..|+.+....|
T Consensus 609 ~l----~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 609 YL----MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred cc----CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 11 122223456777889999999999999999999999999988877544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=362.80 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=216.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCC-eeeE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQ-LKLL 674 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 674 (888)
..+.|...++||.|+||.||+|+-..+|+.||||++++.........-.+|++.+++++ |||||++..++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 45778999999999999999999999999999999976654322233468999999998 999999999999888 8999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
|||||+ .+|++.++++ +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.+
T Consensus 88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999995 5899999987 57899999999999999999999999 9999999999999999999999999999987
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC-----
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN----- 829 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~----- 829 (888)
.....+ +....|.+|+|||++.+...|+.+.||||+||+++|+.+-++-|.+.. +.+++.+....+.....
T Consensus 161 ~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-E~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 161 RSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-EIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-HHHHHHHHHHHhCCCccccchh
Confidence 643333 345678999999999999999999999999999999999888776543 33333333322211110
Q ss_pred ---cccccCC--------CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 830 ---VLDCVDP--------SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 830 ---~~~~~d~--------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
+...+.- .+...-.....+..++|.+|+++||++||||.|++++-
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0111111 11222234677889999999999999999999999865
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.75 Aligned_cols=264 Identities=25% Similarity=0.314 Sum_probs=208.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCCh-HHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
+.|+...++|+|+||.||+++++.+|+.||||++..++..... +-..+|+.++++++|||+|.++.+|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3577788999999999999999999999999999877654433 456899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc-c
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-R 756 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~-~ 756 (888)
||+. ++.+-+... ...++...+.++++|++.|+.|.|++ +++||||||+|||++.++.+|+||||+|+.+. +
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9976 555555554 34578889999999999999999999 99999999999999999999999999999886 3
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH----------h
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL----------E 826 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~----------~ 826 (888)
++.+ +....|.+|+|||.+.+...|....||||+||++.||++|.+-|. +..+.+++....+.+. .
T Consensus 155 gd~Y---TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P-G~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 155 GDNY---TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP-GRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred cchh---hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC-CcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 3332 345678899999999888899999999999999999999987765 4444444443332211 1
Q ss_pred c-CCcccccCCCCCCC------ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 827 E-GNVLDCVDPSMGDY------PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 827 ~-~~~~~~~d~~~~~~------~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
. ..+.-..-|..... -+.....+.+++..|++.||++|++-+|++.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1 11111111111110 01223357899999999999999999998864
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=372.68 Aligned_cols=396 Identities=24% Similarity=0.240 Sum_probs=318.8
Q ss_pred cCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEcCCccccccccccccCC-CCCCEE
Q 002717 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYC-SSLNTL 101 (888)
Q Consensus 23 L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L 101 (888)
-+-||.+++.+..+.-..+.+.--..-+.|||++|+|+ .+....|.++++|++++|.+|.++.|+. |.+. .+|+.|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt~IP~--f~~~sghl~~L 130 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELTRIPR--FGHESGHLEKL 130 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccc-cCcHHHHhcCCcceeeeeccchhhhccc--ccccccceeEE
Confidence 45678888887754334444332234567888888887 6776777888888888888888887775 4444 458888
Q ss_pred ECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEccC
Q 002717 102 NLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181 (888)
Q Consensus 102 ~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 181 (888)
+|.+|.|+++ .+..+..++.|+.||||.|.|+.+.-..|..=.++++|+|++|+|+..-.+.|..+.+|..|.|+.
T Consensus 131 ~L~~N~I~sv----~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsr 206 (873)
T KOG4194|consen 131 DLRHNLISSV----TSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSR 206 (873)
T ss_pred eeeccccccc----cHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeeccc
Confidence 8888888753 334677778888888888888866666777777888888888888877777888888888888888
Q ss_pred CccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCC
Q 002717 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 261 (888)
Q Consensus 182 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 261 (888)
|+|+.+++..|.+|++|+.|+|..|+|.-..--.|.++++|+.|.|..|.|......+|..|.++++|+|+.|+++..-.
T Consensus 207 NrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~ 286 (873)
T KOG4194|consen 207 NRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNE 286 (873)
T ss_pred CcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhc
Confidence 88887777888888888888888888874445677888888888888888887777788888888888888888874333
Q ss_pred ccccccCCceEEcccCcccccCCCCCCCCCCCcccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCc
Q 002717 262 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL 341 (888)
Q Consensus 262 ~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 341 (888)
.++| .++.|+.|+||+|.|..+-++.+....+|++|+|++|+|+...+..|
T Consensus 287 g~lf-----------------------------gLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf 337 (873)
T KOG4194|consen 287 GWLF-----------------------------GLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSF 337 (873)
T ss_pred cccc-----------------------------ccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHH
Confidence 3333 36789999999999998889999999999999999999999999999
Q ss_pred ccCCcceEEEcccCcccccCCccccccCCCceEEccCCcCCCccCc---cccccccccEEEccCCcccccCCccccCCCC
Q 002717 342 GYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQ---VIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 418 (888)
Q Consensus 342 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 418 (888)
..+..|++|+|++|.|.......|..+++|+.|||++|.|++.+.+ .|..+++|+.|.|.+|+|..+.-.+|.++..
T Consensus 338 ~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~ 417 (873)
T KOG4194|consen 338 RVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEA 417 (873)
T ss_pred HHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcc
Confidence 9999999999999999988888899999999999999999876543 5888999999999999999655578999999
Q ss_pred CCeEEccCCcceecCCccccccCCCCeeeccCCccee
Q 002717 419 LKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 455 (888)
Q Consensus 419 L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~ 455 (888)
|+.|||.+|.|....|.+|..| .|++|-+..-.+-.
T Consensus 418 LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflC 453 (873)
T KOG4194|consen 418 LEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLC 453 (873)
T ss_pred cceecCCCCcceeecccccccc-hhhhhhhcccceEE
Confidence 9999999999999999999999 89988876655443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=322.49 Aligned_cols=270 Identities=27% Similarity=0.360 Sum_probs=221.9
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC-ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
.|...+++|+|.||.||+|++..+|+.||||+++.....+ ......+|++.++.++|+||+.++++|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4777789999999999999999999999999997765443 235678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
|+. +|...++.. ...++..++..++.++.+|++|+|.+ .|+|||+||.|+|++++|.+||+|||+|+.+....
T Consensus 83 m~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 965 899999875 46789999999999999999999999 89999999999999999999999999999886544
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
... ....-|.+|+|||.+.+...|+...||||.||++.||+-| .||-.++.+-+++....+.+.... +-..|.+
T Consensus 156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~~LGTP~---~~~WP~~ 229 (318)
T KOG0659|consen 156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFRALGTPT---PDQWPEM 229 (318)
T ss_pred ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHHHcCCCC---cccCccc
Confidence 322 2236788999999988888999999999999999999975 567677777777777666542211 1111111
Q ss_pred CC-----------------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCC
Q 002717 839 GD-----------------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882 (888)
Q Consensus 839 ~~-----------------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 882 (888)
.. .-..+..++.+++..++..||.+|+|++|++++=.--..|.|
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 11 123445567999999999999999999999998765544444
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=359.91 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=210.6
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
.|-+.+...+.+|+|+.|.||+|++ .++.||||+++.- -..+|+-|++++||||+.+.|+|.....++||
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 3444444556999999999999999 5899999987422 23578889999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
||||+.|-|...|+.. .++.......|..+||.||.|||.+ .|||||||+-|||++.+..|||+|||-++...
T Consensus 191 MEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 9999999999999874 5678888999999999999999998 99999999999999999999999999998765
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
+. .+...+.||+.|||||++ .....++|.||||||||||||+||..||.+......++ .+.
T Consensus 264 ~~---STkMSFaGTVaWMAPEvI-rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw---------------GVG 324 (904)
T KOG4721|consen 264 DK---STKMSFAGTVAWMAPEVI-RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW---------------GVG 324 (904)
T ss_pred hh---hhhhhhhhhHhhhCHHHh-hcCCcccccceehhHHHHHHHHhcCCCccccchheeEE---------------ecc
Confidence 43 334678999999999999 66789999999999999999999999997543221111 111
Q ss_pred CCC--CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCC
Q 002717 836 PSM--GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882 (888)
Q Consensus 836 ~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 882 (888)
... ...|..++..+.-|++.||+..|..||+|++++.+|+-..+.+.
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 111 13678889999999999999999999999999999987655443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=352.10 Aligned_cols=268 Identities=23% Similarity=0.315 Sum_probs=224.2
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
-|.+.....++||+|.||+|.++... .+..||||.++.........+|.+|+++|.+++|||||+++|+|..++.+++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 35566667789999999999999985 46999999998776666668999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
+|||++|+|.+++...... ......-.+|+.|||+||+||.+. ++||||+.++|+|+|+++++||+|||+++.+.
T Consensus 614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999886322 245566778999999999999998 99999999999999999999999999999888
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt--g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.++++...+...-+.+|||||.+.. .+++.++|||+|||++||+++ ...||....+ ++..+....+...+....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~~~~~~~- 764 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFRDQGRQV- 764 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcCCCCcce-
Confidence 7888877777788899999998744 479999999999999999866 7889876533 223333333333222111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
....|.-++..++++|.+||+.+-++|||++++...|++.
T Consensus 765 ----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1235777888899999999999999999999999998764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=342.91 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=213.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+.|+..+.||.|..++||+|+....++.||||++.-.+.....+.+.+|++.++.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 44777889999999999999999999999999997776666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
|.+|++.+.+....+.+ +++..+..|.+++++||.|||.+ |.||||||+.|||++++|.|||+|||.+..+.+..
T Consensus 106 Ma~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999876554 89999999999999999999999 99999999999999999999999999876654432
Q ss_pred -ccccc-ccccccccccCccc-ccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 759 -KHVMS-NRFQSALGYVAPEL-TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 759 -~~~~~-~~~~g~~~y~aPE~-~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
..... ....||++|||||+ ..+-..|+.|+||||||++..|+.+|..||.....-. .+... ++.. ....+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-vLl~t----Lqn~--pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-VLLLT----LQND--PPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-HHHHH----hcCC--CCCcc
Confidence 22222 45689999999999 4444568999999999999999999999997643321 11111 1111 11111
Q ss_pred CCCC--CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 836 PSMG--DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 836 ~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.... +........+.+++..|+..||++|||+++++++=
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 0000 11122334688999999999999999999998753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.10 Aligned_cols=261 Identities=27% Similarity=0.403 Sum_probs=210.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC--eeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ--LKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 676 (888)
..+...+.||+|+||+||++....+|+..|||......... .+.+.+|+.++++++|||||+++|...... .+++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 34667889999999999999998889999999886553332 567899999999999999999999855544 588999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC-CCCcEEeccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLT 755 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~ 755 (888)
||+++|+|.+++.... + .+++..+..++.||++||+|||++ +||||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999862 2 699999999999999999999998 9999999999999999 7999999999998765
Q ss_pred c-cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 756 R-LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 756 ~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
. ...........||+.|||||++..+.....++||||+||++.||+||+.||....... .... ..+ .
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~---~~~~----~ig-----~ 237 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA---EALL----LIG-----R 237 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH---HHHH----HHh-----c
Confidence 3 1122223457899999999998544334469999999999999999999997531111 1111 111 1
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
....+.+|...+.+..+++.+|+..+|++||||+|++++.....
T Consensus 238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 11223456667778889999999999999999999999876544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=349.96 Aligned_cols=271 Identities=25% Similarity=0.328 Sum_probs=214.5
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-ccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC--Cee
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLK 672 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 672 (888)
...+.|+..++||+|.||.||+|++..+|+.||+|++.-.. ..+...-..+||.+|++++||||+++.+...+. ...
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 45567888889999999999999999999999999986554 334556677999999999999999999998876 688
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
|+|+|||++ +|.-++... +..+++.++..++.|++.||+|+|++ +|+|||||.+|||+|.+|.+||+|||+|+
T Consensus 194 YlVFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 999999976 777777653 46799999999999999999999999 99999999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC--Cc
Q 002717 753 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--NV 830 (888)
Q Consensus 753 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--~~ 830 (888)
++....... -+...-|.+|+|||++.+...|+.+.|+||.||||.||++|++.|. +..+..++..+.+-..... .+
T Consensus 267 ~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~-G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 267 FYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ-GRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC-CccHHHHHHHHHHHhCCCChhcc
Confidence 876533322 2455678999999999899999999999999999999999988775 4455555555443321110 00
Q ss_pred c-------cccCCCCCCCCh-------hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 831 L-------DCVDPSMGDYPE-------DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 831 ~-------~~~d~~~~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
. ..+.+. ..+.. ..+....+|+..++..||++|.|+.++++.=.-
T Consensus 345 ~~~kLP~~~~~kp~-~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQ-QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred ccccCCcccccCCC-CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 0 000000 00111 223346789999999999999999999985433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=340.89 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=208.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCC--hHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
.+.++..+.||+|+||.||.++.+.+++.+|+|++.+...... .+....|..++.+++||.||++.-.|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4557788899999999999999999999999999987765543 56788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
+||+.||.|...|++. ..+++..+.-++..|+.||.|||+. +|||||+||+|||+|.+|.++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999874 5699999999999999999999999 99999999999999999999999999998543
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
. ....+.+.+||+.|||||++ .+..++.++|.||+||++|||++|.+||..... .++.+...+..
T Consensus 177 ~--~~~~t~tfcGT~eYmAPEil-~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~I~~~k------- 241 (357)
T KOG0598|consen 177 K--DGDATRTFCGTPEYMAPEIL-LGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDKILKGK------- 241 (357)
T ss_pred c--CCCccccccCCccccChHHH-hcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHHHhcCc-------
Confidence 2 22234668999999999998 555899999999999999999999999975432 12222222221
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRP----SMAEVVQ 872 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~evl~ 872 (888)
+...+.....+..+++...+..||++|. ++.++.+
T Consensus 242 --~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 242 --LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred --CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1222333455678899999999999995 4555443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=351.18 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=211.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCC--hHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 675 (888)
..|..++.||+|+|++|++|+...+++.||||++.+...... .+...+|-.+|.++ .||.|++++-.|.++...|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 345677899999999999999999999999999966654332 34577899999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
+||+++|+|.++|+.. +.+++.-...+|.+|+.|++|||++ |||||||||+|||+|++|.+||+|||-|+.+.
T Consensus 153 Le~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999986 5689999999999999999999999 99999999999999999999999999998875
Q ss_pred ccccc-----------cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH
Q 002717 756 RLDKH-----------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824 (888)
Q Consensus 756 ~~~~~-----------~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~ 824 (888)
+.... .....+.||-.|++||++ .+...+..+|+|+|||++|+|+.|.+||....+- ....+ +
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL-~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqk----I 299 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL-NDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQK----I 299 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHh-cCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHH----H
Confidence 42211 112457899999999998 6778899999999999999999999999765331 11111 1
Q ss_pred HhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 825 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
+. ++. ++++..+..+.+|+.+.+..||.+|+|..|+.++.
T Consensus 300 ~~-------l~y---~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 300 QA-------LDY---EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HH-------hcc---cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 122 23445556788999999999999999999998864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=361.02 Aligned_cols=263 Identities=27% Similarity=0.393 Sum_probs=226.4
Q ss_pred CChhhhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC
Q 002717 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ 670 (888)
Q Consensus 595 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 670 (888)
+..+...++.++||+|+||+||+|.|-.+|+ +||+|++......+..+++.+|+.+|.+++|||+++++|+|..+.
T Consensus 692 I~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 692 ILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred echhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 3444556677899999999999999976664 689999988777777889999999999999999999999998776
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
..+|++||+.|+|.++++.. +..+.....+.|..|||+||.|||++ ++|||||.++||||.+-..+||.|||+
T Consensus 772 -~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgl 844 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGL 844 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecch
Confidence 78999999999999999986 46688899999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
++.....+.........-++.|||-|.+ ....++.++|||||||++||++| |..||+.... +.+..+++.+.
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i-~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------~eI~dlle~ge 917 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESI-RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------EEIPDLLEKGE 917 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHh-hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------HHhhHHHhccc
Confidence 9988776666655666677889999988 66689999999999999999999 9999976543 23334445444
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
.+ ..|+.+..+++.+|.+||..|++.||+++++...+.++..
T Consensus 918 RL--------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 RL--------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cC--------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 33 3588899999999999999999999999999999987643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=362.94 Aligned_cols=266 Identities=26% Similarity=0.381 Sum_probs=208.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCC
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 670 (888)
+.+.|+..+.||+|+||.||+|.+. .+++.||||++.........+.+.+|+.+++.+ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4466788889999999999999852 245689999986544333446789999999999 8999999999987654
Q ss_pred -eeeEEEecCCCCCHHHHHhhcCCC-------------------------------------------------------
Q 002717 671 -LKLLVSDYAPNGSLQAKLHERLPS------------------------------------------------------- 694 (888)
Q Consensus 671 -~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 694 (888)
..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999999753210
Q ss_pred ---CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccccccccccccc
Q 002717 695 ---TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771 (888)
Q Consensus 695 ---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~ 771 (888)
..++++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 13478889999999999999999998 999999999999999999999999999986543333233334456788
Q ss_pred ccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHH
Q 002717 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVL 850 (888)
Q Consensus 772 y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~ 850 (888)
|+|||++ .+..++.++|||||||++|||++ |..||.......... . ....+.. ...+...+..+.
T Consensus 242 y~aPE~~-~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~-~----~~~~~~~--------~~~~~~~~~~l~ 307 (338)
T cd05102 242 WMAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC-Q----RLKDGTR--------MRAPENATPEIY 307 (338)
T ss_pred ccCcHHh-hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH-H----HHhcCCC--------CCCCCCCCHHHH
Confidence 9999988 45578999999999999999997 999997643322111 1 1111111 112344556789
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 851 KLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 851 ~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.15 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=210.1
Q ss_pred hhcCeeccccceEEEEEEECCCCe---E-EEEEEeecC--CccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGR---M-LAVKKLVTS--DIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~---~-vavK~l~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
+..++||+|+||.||+|++...+. . ||||..+.. .......+|.+|++++++++|||||+++|++......++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 345799999999999999965422 3 899988642 2233457899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
||+|.||+|.++|+... ..++..++..++.++|.||+|||+. +++||||.++|+|++.++.+||+|||+++...
T Consensus 240 mEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999999862 3689999999999999999999999 99999999999999999999999999997543
Q ss_pred ccccccccc-cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHH-hcCCccc
Q 002717 756 RLDKHVMSN-RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL-EEGNVLD 832 (888)
Q Consensus 756 ~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~-~~~~~~~ 832 (888)
.+.... ...-+..|+|||.+ ....+++++|||||||++||+++ |..||...... .++..+ ..+...
T Consensus 314 ---~~~~~~~~~klPirWLAPEtl-~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~~r~- 382 (474)
T KOG0194|consen 314 ---QYVMKKFLKKLPIRWLAPETL-NTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNGYRM- 382 (474)
T ss_pred ---ceeeccccccCcceecChhhh-ccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcCccC-
Confidence 122212 23467889999999 44589999999999999999999 78898765432 222222 333322
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCC
Q 002717 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882 (888)
Q Consensus 833 ~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 882 (888)
..+...+..+..++..||..+|++||||.++.+.++.+.....
T Consensus 383 -------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 -------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 2355667788899999999999999999999999988866543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.67 Aligned_cols=256 Identities=21% Similarity=0.338 Sum_probs=216.3
Q ss_pred cCChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 594 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 594 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
..++...|+..++||+|+.|.||.|....+++.||||++..... ...+-+.+|+.+|+..+|+|||++++.|...++.|
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 45688889999999999999999999999999999999965542 33466789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|||||++|+|.+.+... .+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..
T Consensus 347 VVMEym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred EEEeecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeec
Confidence 999999999999999874 489999999999999999999999 999999999999999999999999999987
Q ss_pred ccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
+..... ...+..||+.|||||+. ....|.+|.||||+|++++||+-|++||-....-... .-+...+.
T Consensus 419 i~~~~~--KR~TmVGTPYWMAPEVv-trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl-----yLIa~ng~---- 486 (550)
T KOG0578|consen 419 ISEEQS--KRSTMVGTPYWMAPEVV-TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNGT---- 486 (550)
T ss_pred cccccC--ccccccCCCCccchhhh-hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH-----HHHhhcCC----
Confidence 754332 23667899999999998 6668999999999999999999999999653221111 11111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+.+ ..++.....+.+++.+|+..||++||++.|++++
T Consensus 487 --P~l-k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 487 --PKL-KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --CCc-CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 111 2356667789999999999999999999999986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.33 Aligned_cols=264 Identities=23% Similarity=0.387 Sum_probs=203.4
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc--CCCCcceeeeEEEcCC----eeeEE
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA--RHPNLISLEGYYWTPQ----LKLLV 675 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~lv 675 (888)
+..+.||+|+||.||+|.+ +++.||||++... ..+.|+.|-.+++.. +|+||++++++-.... ++++|
T Consensus 213 ~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhc--cCceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3445789999999999999 5799999998543 457788888887765 7999999999876544 78999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcC------CCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF------RPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
+||.+.|+|.+||..+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||..|+++.|+|||
T Consensus 287 t~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 9999999999999975 5999999999999999999999764 7899999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccCcCCCC-----CcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHH-----
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN-----EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE----- 819 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-----~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~----- 819 (888)
+|..+..+..........||.+|||||++.+...+. .+.||||+|.|+|||+++...+..+......+..
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999887665555455678999999999985554444 4789999999999999976544322111111111
Q ss_pred ------HHHH-HHhcCCcccccCCCCCCC--ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCC
Q 002717 820 ------HVRV-LLEEGNVLDCVDPSMGDY--PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 881 (888)
Q Consensus 820 ------~~~~-~~~~~~~~~~~d~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 881 (888)
.++. ..++. --|.+++. .-.....+.+.+..||..||+.|.|+.=|-+++..+...-
T Consensus 442 ~hPt~e~mq~~VV~kK-----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKK-----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCCHHHHHHHHHhhc-----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1111 11111 11222220 1144556789999999999999999999999887765443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.61 Aligned_cols=254 Identities=28% Similarity=0.386 Sum_probs=218.6
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
....++|-|.||.||.|.|+...-.||||.++... ...++|..|+.+|+.++|||+|+++|+|......|||+|||..
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 34458999999999999999888899999986544 3468999999999999999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|.+|+++.. ...++.--.+.+|.||++||+||..+ ++|||||.++|+||.++..|||+|||+++.+.. +.+.
T Consensus 348 GNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-DTYT 421 (1157)
T KOG4278|consen 348 GNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-DTYT 421 (1157)
T ss_pred ccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcC-Ccee
Confidence 99999999863 34566677889999999999999988 999999999999999999999999999998864 5554
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 840 (888)
......-++.|.|||-+ ....++.|+|||+|||++||+.| |..||...+- .++-.+++.+..++
T Consensus 422 AHAGAKFPIKWTAPEsL-AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------SqVY~LLEkgyRM~-------- 486 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESL-AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYGLLEKGYRMD-------- 486 (1157)
T ss_pred cccCccCcccccCcccc-cccccccchhhHHHHHHHHHHHhcCCCCCCCccH------HHHHHHHhcccccc--------
Confidence 44555667889999987 66688999999999999999998 8888865322 34445566665543
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 841 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
.|+.|+..+++||+.||+++|.+||+++|+-+.++.+-
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 37888899999999999999999999999999998764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.68 Aligned_cols=273 Identities=25% Similarity=0.350 Sum_probs=218.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEc--CCeeeE
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLL 674 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 674 (888)
-+.|++...|++|+||.||+|+++.+++.||+|+++.... ...+-.-.+|+.++.+++|||||.+..+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4557788899999999999999999999999999965432 2344566899999999999999999888764 356899
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
|||||+. +|.+.+... .+++...++..+..|+++|+.|||+. .|+|||+|++|+|+...|.+||+|||+||.+
T Consensus 155 VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999976 899999886 36799999999999999999999999 8999999999999999999999999999988
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
+..... -+...-|.+|+|||++.....|+.+.|+||+|||+.||+++++-|. +.....++...++.+ |...+.+
T Consensus 228 gsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~-G~sE~dQl~~If~ll---GtPte~i 301 (419)
T KOG0663|consen 228 GSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP-GKSEIDQLDKIFKLL---GTPSEAI 301 (419)
T ss_pred cCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC-CCchHHHHHHHHHHh---CCCcccc
Confidence 754322 2455678999999999899999999999999999999999887765 444455555554433 2222222
Q ss_pred CCCCCC--------------------CChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002717 835 DPSMGD--------------------YPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883 (888)
Q Consensus 835 d~~~~~--------------------~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 883 (888)
.|.... ++.. ....-.+++...+..||.+|.|++|.+++=.--..|.|.
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 222211 1111 234567899999999999999999999987665555543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=361.98 Aligned_cols=451 Identities=29% Similarity=0.410 Sum_probs=322.7
Q ss_pred CCccccccccccccCc-ccccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEc
Q 002717 1 MTTPLVHGNSYNAIPS-MVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSL 79 (888)
Q Consensus 1 ~~~l~l~~n~~~~ip~-~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L 79 (888)
+|+|++|+|.+..+|+ +..+..+..|+.|+|+++ ++|.++..+ .+|..|+.++|++. ++|+++ +.+..|..|+.
T Consensus 70 l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~--~~l~~l~~s~n~~~-el~~~i-~~~~~l~dl~~ 144 (565)
T KOG0472|consen 70 LTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSL--ISLVKLDCSSNELK-ELPDSI-GRLLDLEDLDA 144 (565)
T ss_pred eeEEEeccchhhhCCHHHHHHHHHHHhhcccchHh-hccHHHhhh--hhhhhhhcccccee-ecCchH-HHHhhhhhhhc
Confidence 4667777777777774 556777777777777776 567777665 66777777777776 666654 45777777777
Q ss_pred CCccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCCEEEccCcc
Q 002717 80 AGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQ 159 (888)
Q Consensus 80 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 159 (888)
.+|+|+..+++ +..+.+|..|++.+|+++..++ ..-+++.|+.||+.+|-++ .+|..++.+.+|+.|||.+|+
T Consensus 145 ~~N~i~slp~~-~~~~~~l~~l~~~~n~l~~l~~-----~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nk 217 (565)
T KOG0472|consen 145 TNNQISSLPED-MVNLSKLSKLDLEGNKLKALPE-----NHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNK 217 (565)
T ss_pred cccccccCchH-HHHHHHHHHhhccccchhhCCH-----HHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcc
Confidence 77777776665 4456777777777777775544 1223777888888888886 677778888888888888888
Q ss_pred ccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCCCC
Q 002717 160 FSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS 239 (888)
Q Consensus 160 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 239 (888)
|. ..| .|..+..|++|+++.|+|.....+....+.++..|||..|+++ ..|+.+.-+++|++||+|+|.|+ .+|..
T Consensus 218 i~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~s 293 (565)
T KOG0472|consen 218 IR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYS 293 (565)
T ss_pred cc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcc
Confidence 87 556 5788888888888888888554455568888888888888888 67777888888888888888888 56777
Q ss_pred CCCCCCCcEEEeeCCcCCCCCCccccccC----CceEE-------cccCcc----cccCCCCCCCCCCCcccCCCCEEeC
Q 002717 240 LFNCKKLSVIRLRGNSLNGNIPEGLFDLG----LEEID-------LSENGF----MGSIPPGSSSSSSSTLFQTLRILDL 304 (888)
Q Consensus 240 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~----L~~L~-------l~~N~l----~~~~p~~~~~~~~~~~l~~L~~L~L 304 (888)
++++ .|+.|-+.||++. ++...+...+ |++|. ++.-+- .+..|.+. .......-+.++|++
T Consensus 294 Lgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~--~~~~~~~i~tkiL~~ 369 (565)
T KOG0472|consen 294 LGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSES--FPDIYAIITTKILDV 369 (565)
T ss_pred cccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCc--ccchhhhhhhhhhcc
Confidence 8888 7888888888886 3433333221 12111 111100 00111111 112233456788888
Q ss_pred CCCcCcccCChhhhhccC---CcEeeccCCccccCCCCCcccCCcce-EEEcccCcccccCCccccccCCCceEEccCCc
Q 002717 305 SSNNLVGDIPAEMGLFAN---LRYLNLSSNHLRSRIPPELGYFHSLI-HLDLRNNALYGSIPQEVCESRSLGILQLDGNS 380 (888)
Q Consensus 305 ~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 380 (888)
+.-+++ .+|+....... .+..+++.|++. .+|..+..+..+. .+.+++|.+. .+|..++.+++|..|+|++|-
T Consensus 370 s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~ 446 (565)
T KOG0472|consen 370 SDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNL 446 (565)
T ss_pred cccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccch
Confidence 888888 56666544444 778888888886 5676666666544 4566666665 778888888888888888888
Q ss_pred CCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeeccCCcceecCCCC
Q 002717 381 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG 460 (888)
Q Consensus 381 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~ 460 (888)
+. .+|..++.+..|+.||+|+|+|. .+|..+..+..|+.+-.++|++....|+.+.+|.+|..|||.+|.+...+|..
T Consensus 447 Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~L 524 (565)
T KOG0472|consen 447 LN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPIL 524 (565)
T ss_pred hh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhh
Confidence 87 67888888888888888888887 78888888888888888888887666666888888888888888888888888
Q ss_pred CCCCCCCCCCcCCCcC
Q 002717 461 GVFPTLDQSSLQGNLG 476 (888)
Q Consensus 461 ~~~~~l~~~~~~~n~~ 476 (888)
|.+.++..+.+.|||.
T Consensus 525 gnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 525 GNMTNLRHLELDGNPF 540 (565)
T ss_pred ccccceeEEEecCCcc
Confidence 8888888888888876
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.97 Aligned_cols=253 Identities=27% Similarity=0.383 Sum_probs=214.6
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
.+...|...+.||+|.||.||+|.+..+++.||+|++.-.......+++++|+.++.+++++||.+++|.+..+...+++
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 34455666779999999999999999999999999997777666778899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
||||.+|++.+.++.. ..+++..+..+..++..|+.|||++ +.+|||||+.||++..+|.+|++|||.+..+.
T Consensus 90 Mey~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHHhcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee
Confidence 9999999999999864 3457888888999999999999999 99999999999999999999999999998765
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
... ....++.||+.|||||++. ...|+.|+||||+|++.+||++|.+|+.....- +.+-.+.
T Consensus 163 ~~~--~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------rvlflIp 224 (467)
T KOG0201|consen 163 NTV--KRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------RVLFLIP 224 (467)
T ss_pred chh--hccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------eEEEecc
Confidence 432 3337789999999999994 667999999999999999999999999764321 1111122
Q ss_pred CCC-CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 836 PSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 836 ~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
... +.........+.+++..|+..||+.||||.+++++
T Consensus 225 k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 225 KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 211 12334666679999999999999999999999885
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.89 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=212.5
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----CChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCe
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQL 671 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 671 (888)
....|+.++.||+|+||.|+.|.+..+++.||+|.+.+.... ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 345577888999999999999999989999999976543111 23456678999999998 9999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC-CCcEEecccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGL 750 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgl 750 (888)
.++||||+.+|+|.+++... .++.+..+..++.|+++|++|+|+. +|+||||||+|+++|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999884 5688899999999999999999998 99999999999999999 9999999999
Q ss_pred cccccccccccccccccccccccCcccccCcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
+.... .........+|++.|+|||++.... +...++||||+||++|.|++|+.||++... ..+. +. +..+.
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--~~l~---~k-i~~~~ 239 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--PNLY---RK-IRKGE 239 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--HHHH---HH-HhcCC
Confidence 98764 2223346789999999999996655 446899999999999999999999986322 1111 11 11111
Q ss_pred cccccCCCCCCCChhh-HHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 830 VLDCVDPSMGDYPEDE-VLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~-~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
-.+|... ..++..++.+|+..||.+|+|+.|++.+=+-..
T Consensus 240 ---------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 ---------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1234444 677899999999999999999999997666554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=345.60 Aligned_cols=268 Identities=24% Similarity=0.329 Sum_probs=205.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECC----------------CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcce
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGT----------------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~----------------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 661 (888)
.+.|+..++||+|+||.||+|.+.. .+..||+|.+...........|.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4556777899999999999998632 344799999865433333467899999999999999999
Q ss_pred eeeEEEcCCeeeEEEecCCCCCHHHHHhhcCC---------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeE
Q 002717 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP---------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPII 726 (888)
Q Consensus 662 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 726 (888)
+++++.+.+..++||||+++|+|.+++..... ....+++..+++++.|++.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999865321 123578889999999999999999998 999
Q ss_pred ecCCCCCcEEecCCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh--CC
Q 002717 727 HYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GR 804 (888)
Q Consensus 727 Hrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt--g~ 804 (888)
||||||+||++++++.+||+|||+++.....+.........++..|+|||++ ....++.++|||||||++|||++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI-LMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH-hcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999866543333333344567889999987 44568999999999999999987 45
Q ss_pred CCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 805 RPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 805 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.||..... ......+.......... . ....+..++..+.+++.+||+.||++|||+.|+.+.|++
T Consensus 240 ~p~~~~~~--~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTD--EQVIENAGEFFRDQGRQ-V----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCH--HHHHHHHHHHhhhcccc-c----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 56654322 22222222222211100 0 011234455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=358.55 Aligned_cols=458 Identities=24% Similarity=0.320 Sum_probs=302.1
Q ss_pred ccccccccccccC-cccccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEcCC
Q 002717 3 TPLVHGNSYNAIP-SMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG 81 (888)
Q Consensus 3 ~l~l~~n~~~~ip-~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~~ 81 (888)
.+++.+|.++.+- ...++.-+.+|++++|+++ ..|++++.+ ..++.|+.++|+++ .+|... ..+.+|+.|++++
T Consensus 49 ~lils~N~l~~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l--~~l~~l~vs~n~ls-~lp~~i-~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 49 KLILSHNDLEVLREDLKNLACLTVLNVHDNKLS-QLPAAIGEL--EALKSLNVSHNKLS-ELPEQI-GSLISLVKLDCSS 123 (565)
T ss_pred hhhhccCchhhccHhhhcccceeEEEeccchhh-hCCHHHHHH--HHHHHhhcccchHh-hccHHH-hhhhhhhhhhccc
Confidence 4555555555554 3455666666666666665 466666665 45666666666666 566554 4566666666666
Q ss_pred ccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCCEEEccCcccc
Q 002717 82 NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFS 161 (888)
Q Consensus 82 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (888)
|.+..++++ +..+..|+.|+..+|++++.+. .+.++.+|..|++.+|+++...|..+. ++.|++||..+|-+.
T Consensus 124 n~~~el~~~-i~~~~~l~dl~~~~N~i~slp~-----~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 124 NELKELPDS-IGRLLDLEDLDATNNQISSLPE-----DMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE 196 (565)
T ss_pred cceeecCch-HHHHhhhhhhhccccccccCch-----HHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh
Confidence 666666555 3445566666666666665543 344566666666666666644443333 666666666666665
Q ss_pred ccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcC-cccCCcccEEEeeccccCCCCCCCC
Q 002717 162 GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHW-IGNISTLEFLDFSNNHLTGSLPSSL 240 (888)
Q Consensus 162 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~ 240 (888)
.+|..++.+.+|.-|||..|+|. ..| .|.++..|++|+++.|+|. .+|.. ..++++|..|||..|+++ ..|+.+
T Consensus 197 -tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~ 271 (565)
T KOG0472|consen 197 -TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEI 271 (565)
T ss_pred -cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHH
Confidence 55556666666666666666666 334 5666666666666666666 33333 336666666666666666 566666
Q ss_pred CCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCccccc----CCCCCCCCCCCcccCCCCE----EeCCCC-----
Q 002717 241 FNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGS----IPPGSSSSSSSTLFQTLRI----LDLSSN----- 307 (888)
Q Consensus 241 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~----~p~~~~~~~~~~~l~~L~~----L~L~~N----- 307 (888)
.-+++|..||+++|.|+ .+|..+..+.|+.|-+.+|.+... +..+ .-..++.|+. =-++.-
T Consensus 272 clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPlrTiRr~ii~~g-----T~~vLKyLrs~~~~dglS~se~~~e 345 (565)
T KOG0472|consen 272 CLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPLRTIRREIISKG-----TQEVLKYLRSKIKDDGLSQSEGGTE 345 (565)
T ss_pred HHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCchHHHHHHHHccc-----HHHHHHHHHHhhccCCCCCCccccc
Confidence 66666666666666666 566666666666666666665310 0000 0000000000 000000
Q ss_pred ----cCcccCChhhhhccCCcEeeccCCccccCCCCCcccC--CcceEEEcccCcccccCCccccccCCCce-EEccCCc
Q 002717 308 ----NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF--HSLIHLDLRNNALYGSIPQEVCESRSLGI-LQLDGNS 380 (888)
Q Consensus 308 ----~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~Ls~N~ 380 (888)
...+..| ....+.+.+.|++++-+++.+..+.|..- .-....+++.|++. .+|..+..+..+.. +++++|.
T Consensus 346 ~~~t~~~~~~~-~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~ 423 (565)
T KOG0472|consen 346 TAMTLPSESFP-DIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNK 423 (565)
T ss_pred ccCCCCCCccc-chhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCc
Confidence 0000111 22345678999999999985443334322 23789999999998 78988888776654 5666666
Q ss_pred CCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeeccCCcceecCCC-
Q 002717 381 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPV- 459 (888)
Q Consensus 381 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~- 459 (888)
++ -+|..++.+++|..|+|++|-+. .+|.+++.+..|+.||+++|++. .+|..+..+..|+.+-.++|++....|.
T Consensus 424 is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~ 500 (565)
T KOG0472|consen 424 IS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSG 500 (565)
T ss_pred cc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHH
Confidence 66 88999999999999999999998 89999999999999999999998 8999999999999998899999877775
Q ss_pred CCCCCCCCCCCcCCCcCCCCCCCCCCCCC
Q 002717 460 GGVFPTLDQSSLQGNLGICSPLLKGPCKM 488 (888)
Q Consensus 460 ~~~~~~l~~~~~~~n~~~c~~~~~~~c~~ 488 (888)
.+.+.++..+++.+|...-.||.-+.|..
T Consensus 501 l~nm~nL~tLDL~nNdlq~IPp~Lgnmtn 529 (565)
T KOG0472|consen 501 LKNMRNLTTLDLQNNDLQQIPPILGNMTN 529 (565)
T ss_pred hhhhhhcceeccCCCchhhCChhhccccc
Confidence 46788899999999999999988888753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.60 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=212.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
.|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+... .+..+...+|++++++++|||||.++++|+...+.++|+||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 35566789999999999999999999999999865543 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+.| +|..++... ..++++.+..++.|+++||.|||+. +|.|||+||.||+++.++.+|+||||+|+.+..
T Consensus 83 a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-- 152 (808)
T KOG0597|consen 83 AVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-- 152 (808)
T ss_pred hhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc--
Confidence 977 999999874 5799999999999999999999999 999999999999999999999999999997764
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
...+.....||+-|||||+. .+..|+..+|.||+||++||+++|++||... ...+.++.+..+.
T Consensus 153 ~t~vltsikGtPlYmAPElv-~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~---------- 216 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELV-EEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDP---------- 216 (808)
T ss_pred CceeeeeccCcccccCHHHH-cCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCC----------
Confidence 33444678999999999988 6778999999999999999999999999632 1223333322221
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..+|......+..++...+.+||..|.|..+++.+-
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 123556677889999999999999999999988753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=352.58 Aligned_cols=263 Identities=24% Similarity=0.353 Sum_probs=207.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEE-----CCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCC
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 670 (888)
+.+.|+..+.||+|+||.||+|++ ..++..||||++.........+.+.+|+.+++.+ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 456688889999999999999975 2346689999986544344456788999999999 8999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhcCC---------------------------------------------------------
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLP--------------------------------------------------------- 693 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 693 (888)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999975321
Q ss_pred --------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 694 --------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 694 --------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
....+++..+.+++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 112578899999999999999999998 999999999999999999999999999986643332
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
........++..|+|||.+ ....++.++|||||||++|||++ |..||......... .+. +..+...
T Consensus 270 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~-~~~----~~~~~~~------- 336 (375)
T cd05104 270 YVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-YKM----IKEGYRM------- 336 (375)
T ss_pred ccccCCCCCCcceeChhHh-cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH-HHH----HHhCccC-------
Confidence 2222334456789999988 55578999999999999999998 88888654332211 111 1111110
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..+...+.++.+++.+||+.||++|||+.|+++.|++
T Consensus 337 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 -LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1122334578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=343.77 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=216.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-c-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-I-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~-~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
-.-|+.++.+|.|+.|.|-.|++..+|+.+|||.+.+.. . ......+.+|+-+|+-+.||||+++++++....+.|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 344678889999999999999999999999999986552 1 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
.||+++|-|.+++-.+ +++++.++.+++.||..|+.|.|.. +|+|||+||+|+|+|..+++||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 9999999999999875 5789999999999999999999998 99999999999999999999999999997644
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
++ ..-.+.+|++.|.|||++.+..+...++||||+|||||.++||+.||++. +-..+-..|+ .|.
T Consensus 164 ~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--Nir~LLlKV~----~G~------ 228 (786)
T KOG0588|consen 164 PG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--NIRVLLLKVQ----RGV------ 228 (786)
T ss_pred CC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--cHHHHHHHHH----cCc------
Confidence 32 23356799999999999977767789999999999999999999999743 3222222222 222
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
-++|...+.++..|+++|+..||++|.|++||++|-.-.
T Consensus 229 ---f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 229 ---FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred ---ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 135777778899999999999999999999999987544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=311.57 Aligned_cols=238 Identities=28% Similarity=0.358 Sum_probs=203.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.++..+.+|.|+||.|..++.+.+|..+|+|++.+.+... ..+...+|..+++.+.||.++++++.+.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 34667779999999999999999999999999997655432 2356778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||++||-|.++++.. +++++..+.-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999985 5799999999999999999999999 999999999999999999999999999987653
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
. +-+.+||+.|+|||++ +...+..++|.|||||++|||+.|..||..... .....+.+. +.
T Consensus 197 r-----T~TlCGTPeYLAPEii-~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~-----~~------- 257 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEII-QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILE-----GK------- 257 (355)
T ss_pred c-----EEEecCCccccChHHh-hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHh-----Cc-------
Confidence 2 3567999999999998 666789999999999999999999999976544 222222221 11
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCC
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSR 864 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~R 864 (888)
-.+|.....++..|+...++.|-.+|
T Consensus 258 --v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 --VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 13566666678889999999998888
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=322.15 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=204.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc--CCCCcceeeeEEEcCC----eeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA--RHPNLISLEGYYWTPQ----LKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~l 674 (888)
....+.||+|.||+||+|.|+ |+.||||++...+ .+.+.+|.++++.+ +|+||+.+++.-..+. ..++
T Consensus 213 I~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred eEEEEEecCccccceeecccc--CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 455678999999999999994 9999999996544 46788888888876 9999999998765443 4589
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhc-----CCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS-----FRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
|++|.+.|+|.+||... .++....++++..+|+||+|||.. .+|.|+|||||+.||||.+++.+.|+|+|
T Consensus 287 vTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999874 588999999999999999999965 38999999999999999999999999999
Q ss_pred cccccccccc--ccccccccccccccCcccccCcCCC-----CCcchHHHHHHHHHHHHhC----------CCCCCCCCC
Q 002717 750 LARLLTRLDK--HVMSNRFQSALGYVAPELTCQSLRV-----NEKCDIYGFGVLILELVTG----------RRPVEYGED 812 (888)
Q Consensus 750 la~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~-----~~~sDvwS~Gv~l~elltg----------~~p~~~~~~ 812 (888)
+|-....... ........||.+|||||++...... -..+||||||.|+||++.+ +.||.+...
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9976544322 2334567899999999998554332 2478999999999999863 467766433
Q ss_pred chhhHHHHHHHHHhcCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 813 NVVILSEHVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 813 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
.+-...+. +..+ ..+.+-|..+. ...+....+.++|+.||..+|..|.|+-.+.+.|.++.+
T Consensus 442 ~DPs~eeM-rkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEEM-RKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHHH-hcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 33322221 1111 11112222222 234566778899999999999999999999999988865
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=334.32 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=200.2
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCCCcceeeeEEEc----CCeeeEEEec
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWT----PQLKLLVSDY 678 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 678 (888)
..||+|++|.||+|.+ +|+.||||++....... ..+.|.+|+.++++++||||++++|++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 4799999999999999 68999999986543221 13677899999999999999999999876 3467899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++.....++.|++.|+.|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999999864 46889999999999999999999732 78899999999999999999999999997654211
Q ss_pred cccccccccccccccCcccccC-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQ-SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
....++..|+|||++.. ...++.++|||||||++|||++|+.||...... .. .......+..
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~~----~~~i~~~~~~------- 240 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-EI----YDLIINKNNS------- 240 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-HH----HHHHHhcCCC-------
Confidence 23457889999998843 257899999999999999999999999754321 11 1111111111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
...+...+..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 241 -~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 -LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11233456678999999999999999999999999998754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=338.27 Aligned_cols=259 Identities=26% Similarity=0.376 Sum_probs=218.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCC--C--eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQ--G--RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~--~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
.+..+..+.||+|.||.||+|.+... | -.||||..+........+.|..|..+|++++|||||+++|+|.+. ..+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 34556677899999999999998432 2 368999987766667788999999999999999999999999775 468
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|||.++-|.|.+|++.. ...++......++.|++.||+|||+. .+|||||.++|||+.+...||++|||+++.
T Consensus 467 ivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred EEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 999999999999999986 35578888899999999999999999 999999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccc
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (888)
+.+.+.+.. +...-+..|||||-+ ...+++.++|||-|||.+||++. |..||..-...+.+.. ++.|.
T Consensus 541 ~ed~~yYka-S~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~------iEnGe--- 609 (974)
T KOG4257|consen 541 LEDDAYYKA-SRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH------IENGE--- 609 (974)
T ss_pred ccccchhhc-cccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE------ecCCC---
Confidence 987666554 455567889999988 66789999999999999999987 9999976544332211 12222
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 833 ~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
....|+.++..++.||.+||..+|.+||++.|+...|..+..
T Consensus 610 -----RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 610 -----RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 234588999999999999999999999999999998866543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=337.63 Aligned_cols=252 Identities=36% Similarity=0.584 Sum_probs=197.3
Q ss_pred hcCeeccccceEEEEEEEC----CCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 603 KAAEVGEGVFGTVYKVSFG----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 603 ~~~~ig~G~~g~V~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
..+.||+|+||.||+|.+. ..+..|+||.+.........+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3458999999999999997 346789999995543333467899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ....+++..++.|+.|+|+||+|||+. +++|+||+++||++++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999986 245689999999999999999999998 99999999999999999999999999998763333
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.............|+|||.+ ....++.++||||||+++||+++ |+.||... .... ..... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~-~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~----~~~~~-~~~~~~------ 224 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVL-KDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEE----IIEKL-KQGQRL------ 224 (259)
T ss_dssp SEEESTTSESGGGGS-HHHH-HHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHH----HHHHH-HTTEET------
T ss_pred cccccccccccccccccccc-cccccccccccccccccccccccccccccccc-cccc----ccccc-cccccc------
Confidence 33333445567889999987 44568999999999999999999 67888654 2221 11111 222211
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..+...+..+.+++..||+.+|++|||+.|+++.|
T Consensus 225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22445567789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=349.99 Aligned_cols=265 Identities=23% Similarity=0.352 Sum_probs=207.9
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCC-----CeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcC
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQ-----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP 669 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 669 (888)
-+.+.|+..+.||+|+||.||+|++... +..||+|++.........+.+.+|+.+++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3556788888999999999999986433 3579999986544333446788999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhcCC--------------------------------------------------------
Q 002717 670 QLKLLVSDYAPNGSLQAKLHERLP-------------------------------------------------------- 693 (888)
Q Consensus 670 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 693 (888)
+..++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999865310
Q ss_pred ----------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccccc
Q 002717 694 ----------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS 763 (888)
Q Consensus 694 ----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 763 (888)
...++++..+++++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 123578889999999999999999998 9999999999999999999999999999765433222222
Q ss_pred ccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCC
Q 002717 764 NRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 842 (888)
Q Consensus 764 ~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 842 (888)
....++..|+|||++ ....++.++|||||||++|||++ |+.||......... .. ....+. .+ ..+
T Consensus 272 ~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~-~~----~~~~~~-----~~---~~~ 337 (374)
T cd05106 272 GNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF-YK----MVKRGY-----QM---SRP 337 (374)
T ss_pred cCCCCccceeCHHHh-cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH-HH----HHHccc-----Cc---cCC
Confidence 333456789999988 45578999999999999999997 99999764332211 11 111111 01 112
Q ss_pred hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 843 EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 843 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
...+.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 23346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=322.95 Aligned_cols=260 Identities=25% Similarity=0.344 Sum_probs=207.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCe-----eeEE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL-----KLLV 675 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv 675 (888)
|+..+.+|+|+||.||+|....+++.||||+..... +.-.+|+++|+.+.|||||++.-+|....+ ..+|
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 455678999999999999999899999999875443 223479999999999999999988864332 2489
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC-CCcEEecccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGLARLL 754 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgla~~~ 754 (888)
||||+. +|.++++........++...+.-+..|+++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 89999987555567788899999999999999999997 99999999999999954 99999999999987
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC------
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG------ 828 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~------ 828 (888)
.+++.. .....|..|+|||.+.+...|+.+.||||.|||+.||+-|++-|.. +....++...++.+....
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHHHhh
Confidence 665443 3345678899999998889999999999999999999999888864 555666666665432211
Q ss_pred ---CcccccCCCCCC------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 ---NVLDCVDPSMGD------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ---~~~~~~d~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
...+.-.+.+.. +......+..+++.+++..+|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111111122211 234556678999999999999999999999874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.32 Aligned_cols=258 Identities=27% Similarity=0.402 Sum_probs=214.2
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCC-C--eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCee
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQ-G--RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~-~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 672 (888)
.+++.+...++||+|.||.|++|.|... | ..||||.+.....-...++|.+|+.+|.+++|||++++||+..+ ...
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 3566677778999999999999999653 2 46899999766555567899999999999999999999999987 667
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
.+|+|.++.|+|.+.|+.. ....+-......++.|||.||.||..+ ++||||+.++|+++.....|||+|||+.+
T Consensus 186 mMV~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hHHhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccccee
Confidence 8999999999999999983 355678888899999999999999999 99999999999999999999999999999
Q ss_pred ccccccccc-ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCc
Q 002717 753 LLTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 753 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
-+...+.+. +.....-++.|.|||.+ ....++.++|||+|||++|||+| |+.||..... ..++. .+.++
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsL-rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-~qIL~-----~iD~~-- 331 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESL-RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-IQILK-----NIDAG-- 331 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHh-ccccccccchhhhhhhhHHhhhccCCCCCCCCCH-HHHHH-----hcccc--
Confidence 887765543 33445567789999998 66689999999999999999999 7788864332 11111 11122
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 831 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
+...-|..++++++++|..||..+|++||||..+.+.+
T Consensus 332 ------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22234788999999999999999999999999998554
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=304.69 Aligned_cols=268 Identities=23% Similarity=0.276 Sum_probs=213.8
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC-----Ce
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-----QL 671 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 671 (888)
.++.|...+.+|+|||+.||.++...+++.+|+|++.... .+..+..++|++..++++||||++++++...+ .+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3556778889999999999999988899999999987655 34567789999999999999999999987543 34
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 751 (888)
.|+++.|...|+|.+.+......+..+++.++++|+.++++||.+||+. .|+++||||||.||++.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 7999999999999999998877777899999999999999999999987 556999999999999999999999999998
Q ss_pred cccccccc-------ccccccccccccccCccccc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHH
Q 002717 752 RLLTRLDK-------HVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822 (888)
Q Consensus 752 ~~~~~~~~-------~~~~~~~~g~~~y~aPE~~~--~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~ 822 (888)
+...-.-. .........|..|+|||.+. .+...++++|||||||++|+|+.|..||+.....+..++-
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL--- 253 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL--- 253 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE---
Confidence 75432110 00011234678899999873 2445789999999999999999999999754332222211
Q ss_pred HHHhcCCcccccCCCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 823 VLLEEGNVLDCVDPSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 823 ~~~~~~~~~~~~d~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
........ ......++.+.+++..|++.||.+||++.|++..++.+.
T Consensus 254 ---------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 ---------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111111 012236778999999999999999999999999988753
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.52 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=204.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+.|+..+.||+|+||.||+|....+++.||+|++...........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 44677889999999999999998889999999986554434445678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
++ +++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 85 VH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 95 6788887654 24578899999999999999999998 99999999999999999999999999987543211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC-------Ccc
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG-------NVL 831 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~-------~~~ 831 (888)
.......+++.|+|||++.....++.++||||+||++|||++|..||....+....+........... ...
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 11234567899999998755566889999999999999999999999765433322222211110000 000
Q ss_pred cccCCC-CCC-CCh---------hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 832 DCVDPS-MGD-YPE---------DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 832 ~~~d~~-~~~-~~~---------~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
...++. ... .+. .....+.+++.+|++.||++|||+.|++++-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 000000 000 000 11245778999999999999999999998543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=334.44 Aligned_cols=253 Identities=27% Similarity=0.342 Sum_probs=202.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.++++++|++|+++++++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 34566899999999999999889999999998654322 2234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999888654 234589999999999999999999998 99999999999999999999999999997654322
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. .....|+..|+|||++ ....++.++|||||||++|||++|+.||........ ...+....... .
T Consensus 157 ~---~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~---------~ 221 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKED---------Q 221 (285)
T ss_pred e---ecCCCCCCCccCHhhh-cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhcc---------c
Confidence 1 1345689999999998 455789999999999999999999999976433211 11111111110 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 873 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 873 (888)
..++......+.+++.+||+.||++||+ ++|++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1233445567889999999999999997 8888885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.82 Aligned_cols=257 Identities=21% Similarity=0.298 Sum_probs=204.2
Q ss_pred hhhhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
..|+..+.||+|+||.||+|.+. ..+..||+|.+.........+.|.+|+.++++++||||++++|++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 34667778999999999999875 346789999986554333446789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999764 24689999999999999999999998 99999999999999999999999999876432
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
.. .........++..|+|||.+ ....++.++|||||||++||+++ |..||....... ..+. +..+..
T Consensus 159 ~~-~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~----~~~~~~---- 226 (266)
T cd05064 159 SE-AIYTTMSGKSPVLWAAPEAI-QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKA----VEDGFR---- 226 (266)
T ss_pred cc-chhcccCCCCceeecCHHHH-hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHH----HHCCCC----
Confidence 21 11111223456789999987 55678999999999999999775 999996543211 1111 111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
...+...+..+.+++.+||+.+|++|||++|+.+.|.++
T Consensus 227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 112344566789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.80 Aligned_cols=260 Identities=24% Similarity=0.416 Sum_probs=209.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCC-----eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQG-----RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
+.++..+.||+|+||.||+|.....+ ..||+|.+.........+.|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 34667789999999999999986544 6799999865443334567899999999999999999999999888899
Q ss_pred EEEecCCCCCHHHHHhhcCCC------------CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC
Q 002717 674 LVSDYAPNGSLQAKLHERLPS------------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 741 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 741 (888)
++|||+++|+|.+++...... ...+++..++.++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999764221 14578899999999999999999998 999999999999999999
Q ss_pred CcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHH
Q 002717 742 NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 820 (888)
Q Consensus 742 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~ 820 (888)
.++|+|||+++.....+.........+++.|+|||.+ ....++.++|||||||++|||++ |..||...... ....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI-LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIE- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHh-ccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH-
Confidence 9999999999865443333333444567889999987 44568999999999999999998 99998654321 1111
Q ss_pred HHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 821 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 821 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.+..+. ....+...+..+.+++.+||+.||++|||+.|++++|+.
T Consensus 238 ---~i~~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 ---MIRSRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 112345566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.10 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=209.7
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCC
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQ 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 670 (888)
+.+.|+..+.||+|+||.||+|++.. .+..||||++.........+.+.+|+++++++. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45567788899999999999998743 235799999865544444567899999999996 999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhcCC---------------------------------------------------------
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLP--------------------------------------------------------- 693 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 693 (888)
..++||||+++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999875311
Q ss_pred -----------------------------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec
Q 002717 694 -----------------------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 738 (888)
Q Consensus 694 -----------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 738 (888)
....+++..+..++.|+++|++|||+. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 013478888999999999999999998 999999999999999
Q ss_pred CCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhH
Q 002717 739 DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVIL 817 (888)
Q Consensus 739 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l 817 (888)
+++.+||+|||+++...............++..|+|||.+ .+..++.++|||||||++|||++ |..||.....+....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI-FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999999865433222222334567889999988 45568999999999999999997 899987543222111
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 818 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
. ....+.. ...+...+..+.+++.+||+.+|++|||+.++.+.|+++.+
T Consensus 351 -~----~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 -N----KIKSGYR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -H----HHhcCCC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1 1111111 11233455678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=333.69 Aligned_cols=264 Identities=23% Similarity=0.276 Sum_probs=203.0
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.|+..+.||+|+||.||+|....+++.||+|++...........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 36677899999999999999988999999999865544444567889999999999999999999999988999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 86 DS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred Cc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 74 899988754 34578899999999999999999998 999999999999999999999999999975432211
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHh-----------cC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE-----------EG 828 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~-----------~~ 828 (888)
......+++.|+|||.+.....++.++||||+||++|||++|+.||...... ..+....+.... ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhccccch
Confidence 1233467889999998866567899999999999999999999999654322 112111111000 00
Q ss_pred CcccccCCCCCC-----CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 NVLDCVDPSMGD-----YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ~~~~~~d~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.......+.... .......+..+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000111000 111234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=338.97 Aligned_cols=265 Identities=23% Similarity=0.316 Sum_probs=206.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+.|+..+.||+|+||.||++++..++..||+|.+.........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 45677789999999999999999899999999986543333446789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 85 MDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999764 35888999999999999999999852 69999999999999999999999999997653221
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC---Ccc----
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG---NVL---- 831 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~---~~~---- 831 (888)
.....|+..|+|||++ .+..++.++|||||||++|||++|+.||....... +..........+ ...
T Consensus 159 ----~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 159 ----ANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ----cccCCCCcCcCCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCc
Confidence 2345688999999988 45578999999999999999999999996543211 111110000000 000
Q ss_pred ---------------------------cccCCCCCCC-ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 832 ---------------------------DCVDPSMGDY-PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 832 ---------------------------~~~d~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.......... ......++.+++.+||+.||++|||+.|++++-+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0000000000 11245578999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.03 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=205.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
..|+..+.||+|+||.||+|.+..+++ .||+|.+.........+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 446777899999999999999865554 48999986544334456788999999999999999999999765 5679
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999864 24578899999999999999999998 9999999999999999999999999999876
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.............++..|+|||.+ ....++.++|||||||++|||++ |..||...... ... .....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~-- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EIS----SILEKGERL-- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHhCCCCC--
Confidence 543332222333456789999988 55578999999999999999998 99998653221 111 111211111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
..+..+..++.+++.+||..+|++|||+.+++..+..+..
T Consensus 231 ------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1133445678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=327.57 Aligned_cols=261 Identities=25% Similarity=0.347 Sum_probs=203.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
+.++..+.||+|+||.||+|.+..+++ .+|+|.+..........++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 345667789999999999999976665 4677776433322334567788889999999999999998864 45678
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999764 24689999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.............++..|+|||.+ ....++.++|||||||++||+++ |..||..... ....+ .+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~~- 231 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESI-LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPD----LLEKGERLA- 231 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH----HHHCCCcCC-
Confidence 543332223345577889999988 44568999999999999999998 9999865422 11112 222222111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCC
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 881 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 881 (888)
.+..+..++.+++.+||..+|++|||+.|+++.|..+...-
T Consensus 232 -------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 232 -------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 12233456788999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=312.80 Aligned_cols=273 Identities=23% Similarity=0.273 Sum_probs=211.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCC-cceeeeEEEcCC-----
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPN-LISLEGYYWTPQ----- 670 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 670 (888)
-..|+..++||+|+||+||+|+...+|+.||+|++..... +..+....+|+.++++++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456777789999999999999999999999999976644 345677789999999999999 999999998877
Q ss_pred -eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 671 -LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 671 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
..++|+||++ -+|..++....+....++...+..++.|+++||+|+|++ +|+||||||.||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 7789999995 489999988643324566688999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
+|+...-.... -....+|.+|+|||++.+...|+...||||+||+++||++++.-|.... +..++....+.+-....
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s-e~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS-EIDQLFRIFRLLGTPNE 242 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHHHcCCCCc
Confidence 99865422221 2445788999999999888789999999999999999999887776443 34444444443322110
Q ss_pred c-----cc--ccCCCCCCC--C-------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhh
Q 002717 830 V-----LD--CVDPSMGDY--P-------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVI 877 (888)
Q Consensus 830 ~-----~~--~~d~~~~~~--~-------~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~ 877 (888)
. .. ..+...... + .....+..+++..|++.+|.+|.|++.++++ +..+
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0 00 011111111 0 1111357899999999999999999999997 4444
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.48 Aligned_cols=261 Identities=23% Similarity=0.285 Sum_probs=209.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeee-EEEc------CCee
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEG-YYWT------PQLK 672 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~~~ 672 (888)
+++.+.|.+|||+.||.|.+...|..||+|++... .+.......+|+++|++++ |+|||.+++ .... ..++
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 45677899999999999999877799999999766 3445677899999999996 999999999 3321 1356
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
++.||||.+|.|.+++..+.. ..+++.++++|+.|+++|+++||.. +|+|||||||-+|||++.++..||||||.|.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 899999999999999998743 3499999999999999999999986 8899999999999999999999999999986
Q ss_pred ccccccc-c------cccccccccccccCccccc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHH
Q 002717 753 LLTRLDK-H------VMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV 823 (888)
Q Consensus 753 ~~~~~~~-~------~~~~~~~g~~~y~aPE~~~--~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~ 823 (888)
....... . ...-....|+.|+|||.+. .+...++|+||||+||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 4432211 0 0012346789999999753 456789999999999999999999999975422
Q ss_pred HHhcCCcccccCCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002717 824 LLEEGNVLDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883 (888)
Q Consensus 824 ~~~~~~~~~~~d~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 883 (888)
..+++....- ..+.+...+..||+.|+++||++||++.||++.+..+...-++
T Consensus 264 -------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 -------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred -------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 1122221111 1256788899999999999999999999999999888654443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=340.98 Aligned_cols=244 Identities=25% Similarity=0.299 Sum_probs=199.1
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 682 (888)
+.||+|+||.||+|+...+|+.||+|++..... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999999988999999999865422 122356778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccc
Q 002717 683 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 762 (888)
Q Consensus 683 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 762 (888)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 999998764 4688999999999999999999998 99999999999999999999999999987532211 11
Q ss_pred cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCC
Q 002717 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 842 (888)
Q Consensus 763 ~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 842 (888)
.....||+.|+|||++ .+..++.++||||+||++|||++|+.||...... ... ... ..+. ..++
T Consensus 152 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~---~~~-~~~~---------~~~p 215 (323)
T cd05571 152 MKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF---ELI-LMEE---------IRFP 215 (323)
T ss_pred ccceecCccccChhhh-cCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHH---HHH-HcCC---------CCCC
Confidence 2345689999999988 5557899999999999999999999999653221 111 111 1111 1234
Q ss_pred hhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 843 EDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 843 ~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
......+.+++.+||+.||++|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 44566788999999999999999 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=316.50 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=213.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCCh--HHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
..-.|+..+.+|+|.||.|-+|.....|+.||||.+++..+.... -.+.+|++||+.++||||+.++.+|...+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345688888999999999999999889999999999777655433 357899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
||||..+|.|++|+.++ ..+++.++..+++||.+|+.|.|.+ +++|||+|.+|||+|.++++||+|||++..+
T Consensus 131 vMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999999986 5799999999999999999999998 9999999999999999999999999999877
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
.+. ....+++|++-|.+||+..+..+..+..|.||+||++|-++.|..||+..+. . ..++++ ..|...
T Consensus 204 ~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--k---~lvrQI-s~GaYr--- 271 (668)
T KOG0611|consen 204 ADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--K---RLVRQI-SRGAYR--- 271 (668)
T ss_pred ccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--H---HHHHHh-hccccc---
Confidence 642 2336789999999999997777778999999999999999999999975322 1 122222 222221
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.+..+.+..-||++|+..+|++|.|+.+|..+-|
T Consensus 272 -------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 272 -------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1222334567999999999999999999998864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=297.89 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=214.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.++.++.+|+|.||.||.|+.+.++-.||+|++.+++.. +...++.+|+++-+.++||||+++++++.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 4467888999999999999999999999999999776543 34567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||.++|.+...++.. ...++++...+.+..|+|.|+.|+|.. +|+||||||+|+|++..+..|++|||-+-..+
T Consensus 102 Eya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999965 245688999999999999999999988 99999999999999999999999999886433
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.....+.+||..|.+||.. .+...+...|+|++|++.||++.|.+||.....+ ....+ ++. .+.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv-~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkr-I~k-------~~~--- 239 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMV-EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKR-IRK-------VDL--- 239 (281)
T ss_pred ---CCCceeeecccccCCHhhc-CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHH-HHH-------ccc---
Confidence 2233678999999999988 6667899999999999999999999999765422 11111 111 111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.+|+.....+.++|.+|+..+|.+|.+..|++++-+-
T Consensus 240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred ---cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 2345666678899999999999999999999988653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=335.38 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=201.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 55677899999999999999888999999998644321 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 83 VPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999764 4588899999999999999999998 9999999999999999999999999999765421
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
.....|++.|+|||++ .+..++.++||||+||++|||++|+.||...... . ..+.... +.
T Consensus 155 ----~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~----~~~~i~~-~~--------- 214 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-G----IYEKILA-GK--------- 214 (291)
T ss_pred ----cccccCChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H----HHHHHHh-CC---------
Confidence 1234688999999988 5556889999999999999999999999654321 1 1111111 11
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQIL 874 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L 874 (888)
..++......+.+++.+||+.||.+||+ ++|++++-
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 1223334556889999999999999995 99988875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=325.03 Aligned_cols=262 Identities=21% Similarity=0.348 Sum_probs=209.8
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.|+..+.||+|+||.||+|++..+++.||||.+...... .....+.+|+++++.++||||+++++++...+..++|+|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 356677899999999999999889999999987543322 223568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+++.........+++..++.++.|+++||+|||+. +++||||||+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999999876443445688899999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.. ......++..|+|||.+ .+..++.++||||||+++|||++|+.||.....+.......+ .... .+.
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----~~~~-----~~~ 227 (267)
T cd08228 160 TT--AAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI----EQCD-----YPP 227 (267)
T ss_pred hH--HHhcCCCCccccChhhh-ccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH----hcCC-----CCC
Confidence 21 11334678889999987 445678999999999999999999999865433322222211 1111 111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
.........+.+++.+||+.+|++|||+.|+++.+++++
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 112344567899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=335.79 Aligned_cols=266 Identities=27% Similarity=0.398 Sum_probs=207.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcC-
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP- 669 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 669 (888)
+.+.|+..+.||+|+||.||+|.+.. +++.||+|++.........+.+.+|+.+++++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 45678889999999999999997532 35789999986443333345678899999999 799999999988654
Q ss_pred CeeeEEEecCCCCCHHHHHhhcCCC-------------------------------------------------------
Q 002717 670 QLKLLVSDYAPNGSLQAKLHERLPS------------------------------------------------------- 694 (888)
Q Consensus 670 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 694 (888)
...++++||+++|+|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 4578999999999999998653210
Q ss_pred --CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccccccccccc
Q 002717 695 --TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772 (888)
Q Consensus 695 --~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y 772 (888)
..+++|..+.+++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++.+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 13689999999999999999999998 9999999999999999999999999999876443333333344567789
Q ss_pred cCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHH
Q 002717 773 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLK 851 (888)
Q Consensus 773 ~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~ 851 (888)
+|||++ .+..++.++|||||||++|||++ |..||........ +.. .+..+... ..+......+.+
T Consensus 242 ~aPE~~-~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~----~~~~~~~~--------~~~~~~~~~~~~ 307 (337)
T cd05054 242 MAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCR----RLKEGTRM--------RAPEYATPEIYS 307 (337)
T ss_pred cCcHHh-cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHH----HHhccCCC--------CCCccCCHHHHH
Confidence 999988 45578999999999999999998 9999965432221 111 11211111 112334457889
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 852 LALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 852 li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
++.+||+.+|++|||+.|++++|+++.+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.92 Aligned_cols=264 Identities=24% Similarity=0.315 Sum_probs=205.1
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC-------------ChHHHHHHHHHHhhcCCCCccee
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------------YPEDFEREVRVLGKARHPNLISL 662 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l 662 (888)
.+-+.|+..+.||+|.||.|-+|+...+++.||||++.+..... ..+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34566888889999999999999999999999999985543211 12578899999999999999999
Q ss_pred eeEEEcC--CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC
Q 002717 663 EGYYWTP--QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN 740 (888)
Q Consensus 663 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 740 (888)
+.+..++ +..|+|+|||..|.+... ....+.+++.++++++.++..||+|||.+ +||||||||+|+|++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9998765 467999999998875322 22334489999999999999999999999 99999999999999999
Q ss_pred CCcEEecccccccccccc---cccccccccccccccCcccccCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCch
Q 002717 741 YNPRISDFGLARLLTRLD---KHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814 (888)
Q Consensus 741 ~~~kl~Dfgla~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~ 814 (888)
|+|||+|||.+.....+. ....-....||+.|+|||....+ ...+.+.||||+||++|.|+.|+.||-....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 999999999997663321 11122347899999999987552 2346789999999999999999999954211
Q ss_pred hhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 815 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 815 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
..+.+ ++ ....+. ++. .++...++..||.+++.+||+.|.+..+|..+.+....
T Consensus 325 ~~l~~---KI-vn~pL~------fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 325 LELFD---KI-VNDPLE------FPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHH---HH-hcCccc------CCC-cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11111 11 111110 011 12456778899999999999999999999999877654
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.43 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=206.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
+.|+..+.||+|+||.||+|.+... ...||+|.+...........|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 3456677999999999999998643 4579999886554444456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|||+++++|.+++... ...+++..++.++.|++.|++|||+. +|+||||||+||++++++.++++|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999764 23689999999999999999999998 99999999999999999999999999998765
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
............++..|+|||.. ....++.++||||||+++|||++ |..||...... .... .+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~----~~~~~~~~--- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIK----AVEDGYRL--- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhh-ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHH----HHHcCCCC---
Confidence 22222222233456789999987 45578999999999999999998 99998643321 1111 11111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
..+...+..+.+++.+||+.+|++||++.|++++|+++
T Consensus 228 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.93 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=202.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.|+..+.||+|+||.||+|++..+++.||+|.+..... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 346777899999999999999998999999999865432 223467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999864 4578888999999999999999998 999999999999999999999999999976543
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.. ....|++.|+|||++ ....++.++|||||||++|||++|+.||...... +..+. +..+.
T Consensus 171 ~~-----~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~-i~~~~------- 231 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RIYEK-ILAGR------- 231 (329)
T ss_pred Cc-----ceecCChhhcCHHHH-cCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HHHHH-HhcCC-------
Confidence 21 235689999999988 4556789999999999999999999999643221 11111 11111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQIL 874 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L 874 (888)
..++......+.+++.+||+.||++||+ ++|++.+-
T Consensus 232 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 232 --LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred --cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 1123334556889999999999999997 78888663
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=326.42 Aligned_cols=261 Identities=21% Similarity=0.352 Sum_probs=204.5
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCee
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 672 (888)
.+.|+..+.||+|+||.||+|.+.. .+..||+|++..........++.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 4567788899999999999998742 35679999885443333345788999999999999999999999988899
Q ss_pred eEEEecCCCCCHHHHHhhcCCC------CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEe
Q 002717 673 LLVSDYAPNGSLQAKLHERLPS------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 746 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 746 (888)
++||||+++|+|.+++...... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.++++
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999764221 23467888999999999999999998 99999999999999999999999
Q ss_pred cccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHH
Q 002717 747 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 747 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
|||+++...............++..|+|||.+ ....++.++|||||||++|||++ |..||...... . ..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-~----~~~~~- 234 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-Q----VLRFV- 234 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHh-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-H----HHHHH-
Confidence 99999765433322222233456789999988 45568999999999999999999 67888643221 1 11111
Q ss_pred hcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..+. ....+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111 112234455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.00 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=203.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecC-CccCChHHHHHHHHHHhhcCCCCcceeeeEEEc-----CCeeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS-DIIQYPEDFEREVRVLGKARHPNLISLEGYYWT-----PQLKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~l 674 (888)
|...+.||+|+||.|+.+.++.+|+.||||++... +.....++..+|+.+++.++|+||+.+.+++.. -...|+
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 34456899999999999999999999999998633 222345678899999999999999999998865 245799
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
|+|+| ..+|...++.. +.++..++.-+++|+++|+.|+|+. +|+|||+||+|++++.+...||+|||+|+..
T Consensus 104 V~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 104 VFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeec
Confidence 99999 55888888764 4599999999999999999999999 9999999999999999999999999999987
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHH---------------
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE--------------- 819 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~--------------- 819 (888)
.........+....|.+|.|||++.....|+.+.||||.||++.||++|+.-|.+... ..++..
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~-v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY-VHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch-HHHHHHHHHhcCCCCHHHHHH
Confidence 5431222224456789999999998888999999999999999999999988865322 111111
Q ss_pred ----HHHHHHhcCCcccccCCCCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 820 ----HVRVLLEEGNVLDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 820 ----~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.++..++.-...... .+.. ++ ......++|+.+|+..||.+|+|++|++++-
T Consensus 255 i~s~~ar~yi~slp~~p~~--~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQ--PFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred hccHHHHHHHHhCCCCCCC--CHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 112222211111000 0001 22 3444578999999999999999999999975
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=351.68 Aligned_cols=255 Identities=20% Similarity=0.298 Sum_probs=205.4
Q ss_pred hhhhcCeeccccceEEEEEEECCC-CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQ-GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~-~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
.|...+.||+|+||.||+|....+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 367778999999999999998766 7888998764332 22335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++........++++..+..++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999876544456789999999999999999999998 99999999999999999999999999998765433
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
.........||+.|+|||++ ....++.++|||||||++|||++|+.||..... . ........ +..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-~----~~~~~~~~-~~~-------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-R----EIMQQVLY-GKY-------- 288 (478)
T ss_pred ccccccccCCCccccCHhHh-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-H----HHHHHHHh-CCC--------
Confidence 22223456789999999988 455789999999999999999999999964322 1 11111111 111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
...+......+.+++.+||..||++|||+++++.+
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11233445678999999999999999999998753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=339.45 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=200.3
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.+.++..+.||+|+||.||+|++..+++.||||++.........+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 34567778999999999999999888999999998654433345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+. ....+..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 153 ~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999998542 2345677889999999999999998 9999999999999999999999999999865432
Q ss_pred ccccccccccccccccCcccccC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.. ......|+..|+|||.+.. +...+.++|||||||++|||++|+.||....... +..........
T Consensus 222 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~------ 291 (353)
T PLN00034 222 MD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMS------ 291 (353)
T ss_pred cc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhcc------
Confidence 11 1234568999999998732 2234568999999999999999999997432211 11111111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.....+......+.+++.+||+.||++|||+.|++++-+-
T Consensus 292 ---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~ 331 (353)
T PLN00034 292 ---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331 (353)
T ss_pred ---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 0111233455678999999999999999999999997543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=331.66 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=216.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCe-eeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQL-KLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 676 (888)
+.|+..+.+|+|+||.++.++++.+++.+++|.+.-.... .......+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4577888999999999999999999999999998654322 233467899999999999999999999999888 89999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
+|++||++.+.+.+.. +.-++++.++.|+.|++.|+.|||+. .|+|||||+.||+++.+..|||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999999874 56789999999999999999999988 999999999999999999999999999998875
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.+ .......||+.||.||++ .+..|..|+||||+||++|||++-+++|.......- +....+.
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil-~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----i~ki~~~--------- 221 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEIL-SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----ILKINRG--------- 221 (426)
T ss_pred ch--hhhheecCCCcccCHHHh-CCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----HHHHhhc---------
Confidence 43 234678999999999988 788999999999999999999999999976533221 1111111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.....+..+..++..+|..|++.+|..||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1223567777889999999999999999999999986
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=320.75 Aligned_cols=251 Identities=26% Similarity=0.340 Sum_probs=199.5
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCH
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 684 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 684 (888)
+.||+|+||.||+|++..+++.||+|........+....+.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999998889999999875443333446789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccc
Q 002717 685 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764 (888)
Q Consensus 685 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 764 (888)
.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+|++|||+++............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999754 34588999999999999999999998 99999999999999999999999999987544221111111
Q ss_pred cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCCh
Q 002717 765 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 843 (888)
Q Consensus 765 ~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 843 (888)
....+..|+|||.+ ....++.++|||||||++|||++ |..||....... .......... ...+.
T Consensus 155 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~~~~~~~~~--------~~~~~ 219 (252)
T cd05084 155 MKQIPVKWTAPEAL-NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQGVR--------LPCPE 219 (252)
T ss_pred CCCCceeecCchhh-cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HHHHHHcCCC--------CCCcc
Confidence 12234579999988 45568899999999999999998 888886432211 1111111110 11233
Q ss_pred hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 844 DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 844 ~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..+..+.+++.+||+.+|++|||+.|+.+.|+.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 445678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.56 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=204.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.+.|+..++||+|+||.||+|.+..++..+|+|.+.........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 35677888999999999999999988999999988654333334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+++... ..+++..+..++.|++.|+.|||+.. +|+||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999764 35788899999999999999999742 7999999999999999999999999998755321
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccc-----
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD----- 832 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~----- 832 (888)
......++..|+|||.+ .+..++.++|||||||++|||++|+.||........ ...............
T Consensus 158 ----~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 ----MANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL--ELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred ----ccccCCCCccccCHHHh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH--HHHhcCcccCCccccccCcc
Confidence 11345688999999988 555788999999999999999999999975432111 110000000000000
Q ss_pred ---------------------------ccCCCCCCCC-hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 833 ---------------------------CVDPSMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 833 ---------------------------~~d~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.+.......+ .....++.+++.+||+.||++|||+.|++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 0000000000 112356889999999999999999999988654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=336.22 Aligned_cols=244 Identities=25% Similarity=0.314 Sum_probs=198.3
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 682 (888)
+.||+|+||.||+++...+|+.||+|++..... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 369999999999999988999999999865421 123356778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccc
Q 002717 683 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 762 (888)
Q Consensus 683 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 762 (888)
+|..++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 999888764 4689999999999999999999998 99999999999999999999999999987532211 11
Q ss_pred cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCC
Q 002717 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 842 (888)
Q Consensus 763 ~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 842 (888)
.....|++.|+|||++ .+..++.++|||||||++|||++|+.||....... . .+...... ..++
T Consensus 152 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~----~~~~~~~~----------~~~p 215 (323)
T cd05595 152 MKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-L----FELILMEE----------IRFP 215 (323)
T ss_pred cccccCCcCcCCcccc-cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-H----HHHHhcCC----------CCCC
Confidence 2345689999999988 55578999999999999999999999996543211 1 11111110 1233
Q ss_pred hhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 843 EDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 843 ~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
......+.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 44556788999999999999998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=326.10 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=207.7
Q ss_pred hhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
+.|...+.||+|+||.||+|.+.. +++.||+|.+......+..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 346677799999999999998742 357899999865544334578999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCC----------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCc
Q 002717 674 LVSDYAPNGSLQAKLHERLP----------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 743 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 743 (888)
+||||+++|+|.+++..... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 99999999999999976421 234578899999999999999999998 99999999999999999999
Q ss_pred EEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHH
Q 002717 744 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 822 (888)
Q Consensus 744 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~ 822 (888)
|++|||+++...............+++.|+|||++ ....++.++|||||||++|||++ |..||....... ....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~-- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIEC-- 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhh-ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHH--
Confidence 99999999765433322222334457889999988 55578999999999999999998 999986543221 1111
Q ss_pred HHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 823 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
+..+. ....+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 237 --~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 --ITQGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --HHcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111 111233455678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.85 Aligned_cols=263 Identities=21% Similarity=0.255 Sum_probs=200.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 5667789999999999999998999999999865432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
+++.+..+... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 98877655432 24588899999999999999999998 999999999999999999999999999986543221
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHH-----------HHHHhcC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV-----------RVLLEEG 828 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~-----------~~~~~~~ 828 (888)
. ......|++.|+|||++ .+..++.++||||+||++|||++|+.||....... .+.... +......
T Consensus 156 ~-~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 156 A-NYTEYVATRWYRSPELL-LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred c-cccccccccccCCcHHH-cCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHHHhhhccc
Confidence 1 11345688999999988 44568999999999999999999999997543211 111111 1000000
Q ss_pred CcccccCCCCC-------CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 NVLDCVDPSMG-------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ~~~~~~d~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.......+... ......+..+.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 0112234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=325.96 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=200.7
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCH
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 684 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 684 (888)
||+|+||+||++.+..+++.||+|.+....... ..+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999999899999999986543221 235677899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccc
Q 002717 685 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764 (888)
Q Consensus 685 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 764 (888)
..++.........+++..++.++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++....... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 998866444456789999999999999999999998 999999999999999999999999999976543222 123
Q ss_pred cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChh
Q 002717 765 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844 (888)
Q Consensus 765 ~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 844 (888)
...|++.|+|||.+ .+..++.++|||||||++|||++|+.||........ .......... ....++..
T Consensus 156 ~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~----------~~~~~~~~ 223 (280)
T cd05608 156 GYAGTPGFMAPELL-QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILN----------DSVTYPDK 223 (280)
T ss_pred ccCCCcCccCHHHh-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhcc----------cCCCCccc
Confidence 45688999999998 455788999999999999999999999975432211 1111111100 01123445
Q ss_pred hHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 845 EVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 845 ~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
.+..+.+++.+||+.||++|| |++|++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 566788999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=350.03 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=207.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-----
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ----- 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 670 (888)
..+.|+..+.||+|+||.||+|++..+|+.||||++...... .....+.+|+.++..++|+||++++..+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 345677888999999999999999889999999998654322 23356788999999999999999988765432
Q ss_pred ---eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEec
Q 002717 671 ---LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD 747 (888)
Q Consensus 671 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 747 (888)
..++||||+++|+|.+++.........+++..+..++.|++.||.|+|+. +|+||||||+||++++++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 25799999999999999987655556789999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc
Q 002717 748 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827 (888)
Q Consensus 748 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 827 (888)
||+++.+.............||+.|+|||++ ....++.++|||||||++|||++|+.||...... ..+.....
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~~~~~~~- 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIW-RRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EVMHKTLA- 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHhc-
Confidence 9999866433222223456789999999998 4557899999999999999999999999653221 11221111
Q ss_pred CCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 828 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 828 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+. ....+...+..+.+++.+||+.||++|||+.+++.+
T Consensus 260 ~~--------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GR--------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC--------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 112344455678899999999999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.98 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=199.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.++..+.||+|+||.||+|.++ ++..+|+|.+.... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 3556678999999999999986 56789999875433 23567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||.++.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999997642 3588999999999999999999998 999999999999999999999999999986543222
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
.......++..|+|||.+ ....++.++||||||+++|||++ |+.||...... .. +... ..+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~----~~~i-~~~~~~------- 220 (256)
T cd05114 156 -TSSSGAKFPVKWSPPEVF-NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EV----VEMI-SRGFRL------- 220 (256)
T ss_pred -eccCCCCCchhhCChhhc-ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HH----HHHH-HCCCCC-------
Confidence 111233456689999988 45568899999999999999999 88898644221 11 1111 111110
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..+......+.+++.+||+.+|++|||++|+++.|
T Consensus 221 -~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 -YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11223345688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=335.11 Aligned_cols=242 Identities=26% Similarity=0.342 Sum_probs=196.7
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCH
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 684 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 684 (888)
||+|+||.||+|++..+++.||+|++..... ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999988899999999865321 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccc
Q 002717 685 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764 (888)
Q Consensus 685 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 764 (888)
.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 9999764 4589999999999999999999998 99999999999999999999999999997543211 1223
Q ss_pred cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChh
Q 002717 765 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844 (888)
Q Consensus 765 ~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 844 (888)
...||+.|+|||.+ .+..++.++||||+||++|||++|+.||...... +..+...... ..++..
T Consensus 152 ~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~~~----------~~~~~~ 215 (312)
T cd05585 152 TFCGTPEYLAPELL-LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQEP----------LRFPDG 215 (312)
T ss_pred cccCCcccCCHHHH-cCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCC----------CCCCCc
Confidence 45689999999988 4557899999999999999999999999653221 1122221111 123344
Q ss_pred hHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002717 845 EVLPVLKLALVCTCHIPSSRPS---MAEVVQI 873 (888)
Q Consensus 845 ~~~~l~~li~~cl~~dp~~RPs---~~evl~~ 873 (888)
....+.+++.+||+.||++||+ +.|++.+
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 5567889999999999999975 6666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.30 Aligned_cols=265 Identities=22% Similarity=0.323 Sum_probs=207.7
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCC
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQ 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 670 (888)
+.+.+...+.||+|+||.||+|++. ..++.||+|++.........+.+.+|+.++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3455667789999999999999974 2456899999975543334457889999999997 999999999999988
Q ss_pred eeeEEEecCCCCCHHHHHhhcCC---------------------------------------------------------
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLP--------------------------------------------------------- 693 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 693 (888)
..++|+||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999975321
Q ss_pred -------------------------------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEE
Q 002717 694 -------------------------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 736 (888)
Q Consensus 694 -------------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 736 (888)
....+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 113467888899999999999999988 9999999999999
Q ss_pred ecCCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchh
Q 002717 737 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVV 815 (888)
Q Consensus 737 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~ 815 (888)
+++++.+|++|||+++...............++..|+|||.+ ....++.++|||||||++|||++ |+.||........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI-FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh-cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999865432222222334567889999988 44568899999999999999998 8889865432221
Q ss_pred hHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 816 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 816 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
... .+..+.. ...+......+.+++.+||..+|++||+++|+++.|+++.
T Consensus 351 -~~~----~~~~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -FYN----AIKRGYR--------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHH----HHHcCCC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111 1111111 1123345567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.10 Aligned_cols=263 Identities=27% Similarity=0.385 Sum_probs=208.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQL 671 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 671 (888)
.+.|+..+.||+|+||.||++.+.. ....+|+|.+......+....+.+|+.+++++ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3456777899999999999999853 33789999886543333345688999999999 79999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhcC------------CCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC
Q 002717 672 KLLVSDYAPNGSLQAKLHERL------------PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD 739 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 739 (888)
.++||||+++|+|.++++... .....+++..++.++.|++.|++|||+. +|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 999999999999999997642 2345689999999999999999999998 9999999999999999
Q ss_pred CCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHH
Q 002717 740 NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILS 818 (888)
Q Consensus 740 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~ 818 (888)
++.+|++|||+++.+.............++..|+|||.. ....++.++|||||||++||+++ |..||....... ..
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 244 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF 244 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHh-ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HH
Confidence 999999999999876543322222333456789999987 55578899999999999999998 888986432211 11
Q ss_pred HHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 819 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 819 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
. ....+.. ...+......+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 245 ~----~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 K----LLKEGYR--------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H----HHHcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 1111111 1223445567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.20 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=217.2
Q ss_pred cccCChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCe
Q 002717 592 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 671 (888)
Q Consensus 592 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 671 (888)
.+...|++.+.+.+++|+|+||.||+|.++.+|..||+|+..- ....+++.+|+.++++++.|+||+++|.|.....
T Consensus 26 sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 26 ALNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred hhcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 4556789999999999999999999999999999999998742 2356788999999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 751 (888)
.++|||||..|++.+.++-+ ..++++.++..++.+.++||+|||.. .-+|||||+.|||++.+|.+|++|||.|
T Consensus 103 LWIVMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVA 176 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVA 176 (502)
T ss_pred eEeehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcccc
Confidence 99999999999999999876 46799999999999999999999998 8899999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcc
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (888)
-.+.+ ......+..||+.|||||++ ....|+.++||||+|++..||..|++||.+...-..+. ++.-
T Consensus 177 GQLTD--TMAKRNTVIGTPFWMAPEVI-~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------MIPT---- 243 (502)
T KOG0574|consen 177 GQLTD--TMAKRNTVIGTPFWMAPEVI-EEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------MIPT---- 243 (502)
T ss_pred chhhh--hHHhhCccccCcccccHHHH-HHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------eccC----
Confidence 76542 33334678899999999998 66678999999999999999999999997643211100 0000
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 832 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.-.|.+ ..|+.-..++-++++.|+-..|++|-|+-+++++-
T Consensus 244 -~PPPTF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 244 -KPPPTF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred -CCCCCC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 001111 13455566788999999999999999999998864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=333.37 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=199.1
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 682 (888)
+.||+|+||.||++....+++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999999998999999999865422 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccc
Q 002717 683 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 762 (888)
Q Consensus 683 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 762 (888)
+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 999888764 4689999999999999999999998 99999999999999999999999999987532211 11
Q ss_pred cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCC
Q 002717 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 842 (888)
Q Consensus 763 ~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 842 (888)
.....||+.|+|||.+ ....++.++||||+||++|||++|+.||...... ...+..... ...++
T Consensus 152 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~----------~~~~p 215 (328)
T cd05593 152 MKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILME----------DIKFP 215 (328)
T ss_pred cccccCCcCccChhhh-cCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccC----------CccCC
Confidence 2345689999999988 4557899999999999999999999999653221 111111110 01234
Q ss_pred hhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 843 EDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 843 ~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
.....++.+++.+|++.||++|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 44556788999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.57 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=204.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
++..+.||+|+||.||+|.+...++.||+|.+.... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 455668999999999999998889999999985432 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+++|.+++.... ...+++..++.++.|+++|++|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 86 ~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999997642 34589999999999999999999998 9999999999999999999999999999765432211
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
.......+..|+|||.+ ....++.++|||||||++|||++ |..||...... +..+. ...+. . .
T Consensus 161 -~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~-~~~~~-----~---~ 224 (263)
T cd05052 161 -AHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYEL-LEKGY-----R---M 224 (263)
T ss_pred -ccCCCCCccccCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHH-HHCCC-----C---C
Confidence 11223345679999987 55678899999999999999998 88888643221 11111 11111 0 1
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
..+...+..+.+++.+||+.+|++|||+.|+.+.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 22344556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=346.20 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=199.4
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC-------
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP------- 669 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 669 (888)
+...|+..+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3455788889999999999999998889999999885332 3345799999999999999999886432
Q ss_pred -CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC-CCcEEec
Q 002717 670 -QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISD 747 (888)
Q Consensus 670 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~D 747 (888)
...++||||+++ ++.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 135689999975 78777765433456789999999999999999999998 99999999999999965 4799999
Q ss_pred ccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc
Q 002717 748 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827 (888)
Q Consensus 748 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 827 (888)
||+++.+..... .....+|+.|+|||++.....++.++||||+||++|||++|..||..... ...+...++.....
T Consensus 215 FGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~p 290 (440)
T PTZ00036 215 FGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQLVRIIQVLGTP 290 (440)
T ss_pred cccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence 999986543222 13356789999999875666789999999999999999999999965432 22222222211000
Q ss_pred ---------CCcccccCCCCC------CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 828 ---------GNVLDCVDPSMG------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 828 ---------~~~~~~~d~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
....+..-+... .++...+.++.+++.+||..||.+|||+.|++++-
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 000000000000 12334556788999999999999999999999764
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.92 Aligned_cols=264 Identities=23% Similarity=0.403 Sum_probs=208.9
Q ss_pred hhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
|...+.||+|+||.||+|.+. .++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 555678999999999999863 245678999875432 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCC------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCc
Q 002717 676 SDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 743 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 743 (888)
|||+++++|.+++..... ....+++..++.++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999976432 123588999999999999999999998 99999999999999999999
Q ss_pred EEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHH
Q 002717 744 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 822 (888)
Q Consensus 744 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~ 822 (888)
+|+|||+++...............++..|+|||.+ ....++.++|||||||++|||+| |..||....... . ++
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~----~~ 236 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-V----IE 236 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-H----HH
Confidence 99999999765443322223344567889999987 45578899999999999999999 999986543211 1 11
Q ss_pred HHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002717 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883 (888)
Q Consensus 823 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 883 (888)
. ...+... ..+...+..+.+++.+||+.+|++|||+.++++.|+++.++.|.
T Consensus 237 ~-~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 237 C-ITQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred H-HhCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 1 1111111 12233456788999999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=334.96 Aligned_cols=254 Identities=20% Similarity=0.286 Sum_probs=203.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|++..+++.||+|++...... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 56677999999999999999888999999998654321 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 83 VPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999764 4588899999999999999999998 999999999999999999999999999975543
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
......|++.|+|||++ .+..++.++||||+||++|||++|..||....... .. ..+. ....... .+..
T Consensus 154 ---~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~-~~i~---~~~~~~~--~~~~ 222 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVL-RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TW-ENLK---YWKETLQ--RPVY 222 (333)
T ss_pred ---ccCCcccCccccChhHh-cCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HH-HHHH---hcccccc--CCCC
Confidence 22445789999999988 44578999999999999999999999997543221 11 1111 1110000 0111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..........+.+++.+|+..+|++|||++|++++-
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 111123355688999999999999999999999763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.73 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=207.9
Q ss_pred hhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
..+...+.||+|+||.||++... .++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 34566778999999999999862 245678999885432 223467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCC---------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcE
Q 002717 674 LVSDYAPNGSLQAKLHERLP---------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 744 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 744 (888)
+|+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999999976431 223589999999999999999999998 999999999999999999999
Q ss_pred EecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHH
Q 002717 745 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRV 823 (888)
Q Consensus 745 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~ 823 (888)
++|||+++...............++..|+|||.+ ....++.++|||||||++|||++ |..||...... .... .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-~~~~----~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIE----C 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH----H
Confidence 9999999865433332222334457789999988 55678999999999999999998 88888654321 1111 1
Q ss_pred HHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 824 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 824 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
+..+... ..+...+..+.+++.+||+.+|.+|||+.|+.+.|+++.+.
T Consensus 235 -i~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 -ITQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111 11223445689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=334.30 Aligned_cols=242 Identities=26% Similarity=0.372 Sum_probs=203.8
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEE
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 676 (888)
.+...+.+|+|.||.|+++..+.+++.+|||.+++..+.+ ..+..+.|..|+... +||.++.++.++...++.|+||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 3556678999999999999999999999999998876543 456788899998887 5999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+.||++..+.+ ...+++.++.-+|+.|+.||.|||++ +||+||||-+|||+|.+|.+||+|||+++..-
T Consensus 449 ey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 449 EYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred EecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC-
Confidence 9999999544443 35699999999999999999999999 99999999999999999999999999998543
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.....+++++||+.|||||++ .+..|+.+.|.|||||++|||++|..||.....+ +.... +...
T Consensus 520 -~~g~~TsTfCGTpey~aPEil-~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-e~Fds----I~~d--------- 583 (694)
T KOG0694|consen 520 -GQGDRTSTFCGTPEFLAPEVL-TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-EVFDS----IVND--------- 583 (694)
T ss_pred -CCCCccccccCChhhcChhhh-ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH----HhcC---------
Confidence 122345889999999999998 7778999999999999999999999999754332 21111 1111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSM 867 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 867 (888)
-..+|...+.+...+|++++..+|++|.-+
T Consensus 584 -~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 123677778889999999999999999866
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=334.81 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=200.7
Q ss_pred hhhhhcCeeccccceEEEEEEECCCC-eEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQG-RMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
+.|+..+.||+|+||.||+|.+...+ ..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 34677789999999999999976544 6899999864422 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999764 4588999999999999999999998 99999999999999999999999999997653
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.. .....||+.|+|||++ .+..++.++|||||||++|||++|..||...... .. .+... .+.
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~---~~~i~-~~~------ 244 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEIL-LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LI---YQKIL-EGI------ 244 (340)
T ss_pred CC-----cceecCChhhcCHHHH-hCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HH---HHHHh-cCC------
Confidence 21 1345789999999998 4556789999999999999999999999754221 11 11111 111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
..++......+.+++.+|++.||++|+ |++|++++
T Consensus 245 ---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 112334445678999999999999995 89999886
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.66 Aligned_cols=254 Identities=27% Similarity=0.352 Sum_probs=206.8
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc---C----ChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeee
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII---Q----YPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~---~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 673 (888)
+-.+.+|.|..++|-++.++.+|..+|+|++...... + ..++-.+|+.+++++ .||+|+++.++|..+...+
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 3345799999999999999999999999998533221 1 124556899999999 6999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+|.|+.|.|.+++... ..+++.+..+|+.|+..|++|||.. .|||||+||+|||+|++.++||+|||+++.
T Consensus 100 lVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeec
Confidence 999999999999999875 5789999999999999999999999 999999999999999999999999999998
Q ss_pred ccccccccccccccccccccCcccccC-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQ-----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 828 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 828 (888)
+.+++.. ...+||++|.|||.+.. ...|+...|+||+||++|-++.|.+||..-. .. .+-..+.+|
T Consensus 173 l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-Qm-----lMLR~ImeG 243 (411)
T KOG0599|consen 173 LEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-QM-----LMLRMIMEG 243 (411)
T ss_pred cCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-HH-----HHHHHHHhc
Confidence 8776553 56799999999998743 3457889999999999999999999995321 11 111223333
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 829 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 829 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.. +.- .....+....+.+||.+|++.||.+|.|++|++++-..
T Consensus 244 ky-qF~----speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 244 KY-QFR----SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred cc-ccC----CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 21 111 12234555668899999999999999999999987543
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.30 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=204.3
Q ss_pred hhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
.|+..+.||+|+||.||+|.+.. .++.||+|++.........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 36667789999999999998743 3578999998644332334668899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCC------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCC
Q 002717 675 VSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN 742 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 742 (888)
++||+++++|.+++..... ....+++..++.++.|++.||+|+|+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 9999999999999864321 123578888999999999999999998 9999999999999999999
Q ss_pred cEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHH
Q 002717 743 PRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHV 821 (888)
Q Consensus 743 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~ 821 (888)
+||+|||+++...............+++.|+|||.+ ....++.++||||+||++|||++ |..||..... . ...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~----~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-Q----DVI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHH-hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-H----HHH
Confidence 999999998866443332222334567789999987 44568899999999999999998 7778754322 1 111
Q ss_pred HHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 822 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 822 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.. +..+. ....+...+..+.+++..||+.+|++||++.|++..|+.
T Consensus 237 ~~-i~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EM-IRNRQ--------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-HHcCC--------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 11111 112345566678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.13 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=201.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.|+..+.||+|+||+||.|+-+.+|..+|+|++++.... ...+....|-.+|...++|.||+++-.|.+.+..|+||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 4467777999999999999999999999999999876543 34567888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||++||++..+|... ..+++..+..++.+++.|++-+|+. |+|||||||+|+|+|..|.+||+|||++.-+..
T Consensus 221 EylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999875 5799999999999999999999998 999999999999999999999999999853321
Q ss_pred c----------------------cccc----c-------------------cccccccccccCcccccCcCCCCCcchHH
Q 002717 757 L----------------------DKHV----M-------------------SNRFQSALGYVAPELTCQSLRVNEKCDIY 791 (888)
Q Consensus 757 ~----------------------~~~~----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~sDvw 791 (888)
. +... . .-...|||.|||||++. +..|+..+|.|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-~kgY~~~cDwW 372 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-GKGYGKECDWW 372 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-cCCCCccccHH
Confidence 0 0000 0 01246899999999994 44699999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC---CHH
Q 002717 792 GFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP---SMA 868 (888)
Q Consensus 792 S~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~ 868 (888)
|+|||+|||+.|.+||...... ....+.+ ........ | .......+..+||.+|+. ||++|. .+.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~-~T~rkI~----nwr~~l~f--P----~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQ-ETYRKIV----NWRETLKF--P----EEVDLSDEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHH-HHHHHHH----HHhhhccC--C----CcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence 9999999999999999764332 1122211 11100000 0 012223567899999998 999996 466
Q ss_pred HHHHH
Q 002717 869 EVVQI 873 (888)
Q Consensus 869 evl~~ 873 (888)
||.++
T Consensus 441 EIK~H 445 (550)
T KOG0605|consen 441 EIKKH 445 (550)
T ss_pred HHhcC
Confidence 76654
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.22 Aligned_cols=261 Identities=24% Similarity=0.347 Sum_probs=207.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCC-----CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCee
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQ-----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 672 (888)
.+.|+..+.||+|+||.||+|.+... +..||+|.+...........+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 34567778999999999999998643 4789999986544333446788999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhcCCC------CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEe
Q 002717 673 LLVSDYAPNGSLQAKLHERLPS------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 746 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 746 (888)
++||||+++|+|.+++...... ...+++..++.++.|++.|+.|||+. +|+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999999764321 23478899999999999999999988 99999999999999999999999
Q ss_pred cccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHH
Q 002717 747 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 747 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
|||+++.+...+.........++..|+|||.+ ....++.++|||||||++||+++ |..||..... ....+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~---- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFV---- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHH-hcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHH----
Confidence 99999866543322222334567889999987 44568999999999999999998 8888864322 1111111
Q ss_pred hcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..+. ....+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGG--------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111 112344456778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.35 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=204.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCee
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 672 (888)
.+.|+..+.||+|+||.||+|.+.. .+..||+|.............|.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3556777899999999999999976 57889999875443333346789999999999999999999999998889
Q ss_pred eEEEecCCCCCHHHHHhhcCC---CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC---CcEEe
Q 002717 673 LLVSDYAPNGSLQAKLHERLP---STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY---NPRIS 746 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~ 746 (888)
++||||+++|+|.+++..... ....+++..+.+++.|++.|++|||+. +++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999977532 123589999999999999999999998 999999999999998654 58999
Q ss_pred cccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHH
Q 002717 747 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 747 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
|||+++................+..|+|||++ .+..++.++|||||||++|||++ |..||....... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAF-LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----VMEFVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHH-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHH
Confidence 99999876432221111222345679999988 45568999999999999999997 999986533211 111111
Q ss_pred hcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.... ...+...+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 236 ~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 1223445567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=317.24 Aligned_cols=256 Identities=21% Similarity=0.337 Sum_probs=204.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.+.|+..++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++|+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 455777889999999999999976 66789999875433 235788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.++++.. ....+++..++.++.|+++|++|||+. +++||||||+||++++++.++++|||+++.....
T Consensus 82 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 82 YMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred cCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999764 234578899999999999999999998 9999999999999999999999999999865432
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... ......++..|+|||.. ....++.++|||||||++|||++ |..||...... . ....+ ..+...
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~-~~~~~----~~~~~~----- 223 (261)
T cd05072 157 EYT-AREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-D-VMSAL----QRGYRM----- 223 (261)
T ss_pred cee-ccCCCccceecCCHHHh-ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-H-HHHHH----HcCCCC-----
Confidence 211 11233456789999987 44568899999999999999998 89998643221 1 11111 111110
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
......+.++.+++.+||+.+|++|||++++.+.|+.+
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 ---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11223455688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.98 Aligned_cols=269 Identities=24% Similarity=0.333 Sum_probs=203.4
Q ss_pred hhhcCeeccccceEEEEEEE----CCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC--CeeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 674 (888)
++..+.||+|+||.||++.+ ..+++.||+|.+.........+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 46777999999999988654 3467889999986544333456788999999999999999999988654 35789
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
||||+++|+|.+++... .+++..++.++.|++.|+.|||+. +|+||||||+||++++++.++++|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999763 489999999999999999999998 9999999999999999999999999999866
Q ss_pred ccccccc-ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 755 TRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 755 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
....... ......++..|+|||.. ....++.++|||||||++|||+||..||........................+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECL-KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHh-cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 5432211 11223456679999987 455688999999999999999999999865432111111000000000001111
Q ss_pred cCCCC-CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 834 VDPSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 834 ~d~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
++... ...+...+..+.+++..||+.+|++|||++++++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111 1134455678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.38 Aligned_cols=262 Identities=21% Similarity=0.364 Sum_probs=210.0
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.|+..+.||+|+||.||+|.+..+++.+|||.+...... ...+++.+|+.+++.++||||+++++++..++..++|||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 356677899999999999999889999999987643322 223578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++++|.+++.........+++..++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999976444456789999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.. ......++..|+|||.. ....++.++||||||+++|||++|..||.....+.....+.+. . ...+.
T Consensus 160 ~~--~~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~-----~~~~~ 227 (267)
T cd08229 160 TT--AAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE----Q-----CDYPP 227 (267)
T ss_pred Cc--ccccccCCcCccCHHHh-cCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh----c-----CCCCC
Confidence 21 11334678899999988 4556889999999999999999999999654332222211111 0 11111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
. .+......+.+++.+||..+|++|||+.+|++.++++.
T Consensus 228 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 L--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 12234567889999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=321.69 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=203.9
Q ss_pred hhhhcCeeccccceEEEEEEEC----CCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFG----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
.++..+.||+|+||.||+|.+. ..++.||+|.+......+..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 3556678999999999999862 356789999986544333446788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCC-------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCC
Q 002717 676 SDYAPNGSLQAKLHERLP-------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN 742 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 742 (888)
|||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence 999999999999964321 123478889999999999999999998 9999999999999999999
Q ss_pred cEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHH
Q 002717 743 PRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHV 821 (888)
Q Consensus 743 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~ 821 (888)
+|++|||+++...............++..|+|||.+ .+..++.++|||||||++|||++ |..||..... ....+.+
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~ 239 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI-MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV 239 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 999999999865433322222334456789999988 44568999999999999999998 8888864322 1111111
Q ss_pred HHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 822 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 822 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..... ...+...+..+.+++.+||+.||++||++.++.++|+.
T Consensus 240 ----~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111 11234455678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=315.33 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=197.9
Q ss_pred eeccccceEEEEEEEC--CCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCC
Q 002717 606 EVGEGVFGTVYKVSFG--TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 683 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 683 (888)
.||+|+||.||+|.+. ..+..||+|.+.........+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999875 34567999998655433345678999999999999999999998854 46789999999999
Q ss_pred HHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccc-
Q 002717 684 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM- 762 (888)
Q Consensus 684 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~- 762 (888)
|.+++... ...+++..+++++.|++.|+.|||+. +++||||||+||+++.++.+|++|||+++..........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998753 34689999999999999999999998 999999999999999999999999999976543322111
Q ss_pred cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 763 ~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
.....++..|+|||.+ ....++.++|||||||++||+++ |..||....... .. ..+..+.. ...
T Consensus 155 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~-~~~~~~~~--------~~~ 219 (257)
T cd05115 155 RSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----VM-SFIEQGKR--------LDC 219 (257)
T ss_pred cCCCCCCcccCCHHHH-ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----HH-HHHHCCCC--------CCC
Confidence 1122335789999987 44568899999999999999996 999997543221 11 11122211 123
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 445567888999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=323.01 Aligned_cols=268 Identities=23% Similarity=0.344 Sum_probs=203.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCC--------------CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceee
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQ--------------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~--------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 663 (888)
...|+..+.||+|+||.||++..... ...||+|.+.........+.|.+|++++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 45677888999999999999987432 2358999986543333345788999999999999999999
Q ss_pred eEEEcCCeeeEEEecCCCCCHHHHHhhcCC--------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcE
Q 002717 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLP--------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNI 735 (888)
Q Consensus 664 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 735 (888)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999965321 113478899999999999999999998 999999999999
Q ss_pred EecCCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCc
Q 002717 736 LLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GRRPVEYGEDN 813 (888)
Q Consensus 736 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt--g~~p~~~~~~~ 813 (888)
++++++.+|++|||+++...............++..|+|||.. ....++.++|||||||++|||++ +..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI-LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh-ccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 9999999999999999765433322222334456789999987 44568999999999999999998 5567654322
Q ss_pred hhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 814 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
...... ........... .....+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 239 ~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 EQVIEN-TGEFFRNQGRQ-----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHH-HHHhhhhcccc-----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111 11111111000 0011123345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=322.88 Aligned_cols=269 Identities=24% Similarity=0.347 Sum_probs=204.8
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC----------------CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcc
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGT----------------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~----------------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv 660 (888)
+.+.|+..+.||+|+||.||++.+.. ++..||+|++.........+.+.+|+.+++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 34567888899999999999986532 34578999986543333456789999999999999999
Q ss_pred eeeeEEEcCCeeeEEEecCCCCCHHHHHhhcCCC-------CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCC
Q 002717 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPS-------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPS 733 (888)
Q Consensus 661 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~ 733 (888)
++++++...+..++||||+++|+|.+++...... ...+++..++.++.|++.|++|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 9999999999999999999999999999874321 23477889999999999999999998 9999999999
Q ss_pred cEEecCCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh--CCCCCCCCC
Q 002717 734 NILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GRRPVEYGE 811 (888)
Q Consensus 734 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt--g~~p~~~~~ 811 (888)
||++++++.++++|||+++.+.............++..|+|||.. ....++.++|||||||++|||++ |..||....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI-LLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH-hcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999865433222222333446789999976 44568999999999999999998 667875432
Q ss_pred CchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 812 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 812 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.. .... ........... .... ..+..++..+.+++.+||+.||++|||+.|+++.|++
T Consensus 239 ~~-~~~~-~~~~~~~~~~~-~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DE-QVIE-NTGEFFRDQGR-QVYL----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hH-HHHH-HHHHHHhhccc-cccC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 21 1111 11111111110 0000 1123345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=320.03 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=204.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
..++..+.||+|+||+||+|++..+++ .||+|.+.........+.+.+|+.+++.+.||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 446677799999999999999876665 48999886544434456788999999999999999999999754 4679
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999764 24689999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.............++..|+|||.. ....++.++|||||||++|||++ |..||...... ..... +..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~----~~~~~~~-- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESI-LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDL----LEKGERL-- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH----HHCCCcC--
Confidence 432222222223456789999987 45578999999999999999998 88888643221 11121 1221111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
..+......+.+++.+||+.||++||++.|+++.++.+..
T Consensus 231 ------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 ------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1123345678899999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=319.00 Aligned_cols=258 Identities=23% Similarity=0.340 Sum_probs=202.4
Q ss_pred hhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCe------
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQL------ 671 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 671 (888)
+..+.||+|+||.||+|.+..+ +..||+|++...... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 4567899999999999998643 378999998643322 223578899999999999999999999876554
Q ss_pred eeEEEecCCCCCHHHHHhhcCC--CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLP--STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
.++|+||+++|+|..++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 6899999999999999865422 234689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcC
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEG 828 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 828 (888)
+++.+..............+..|+|||.+ ....++.++|||||||++|||++ |..||...... . ..... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-~----~~~~~-~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-E----IYDYL-RHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-H----HHHHH-HcC
Confidence 99876543332222233456789999987 55678999999999999999999 88888543321 1 11111 111
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 829 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 829 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
. ....+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 232 ~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1123445566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.59 Aligned_cols=243 Identities=24% Similarity=0.330 Sum_probs=193.7
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|++..+++.||+|++..... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999988899999999865321 22334566677777655 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 9999998764 4588899999999999999999998 99999999999999999999999999997543222 2
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......||+.|+|||.+ .+..++.++|||||||++|||++|+.||...... .. ...... . ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-~~----~~~i~~-~---------~~~~ 215 (316)
T cd05592 152 KASTFCGTPDYIAPEIL-KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-EL----FDSILN-D---------RPHF 215 (316)
T ss_pred ccccccCCccccCHHHH-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-HH----HHHHHc-C---------CCCC
Confidence 22445789999999988 4556899999999999999999999999754321 11 111111 1 1123
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMA-EVVQ 872 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~ 872 (888)
+......+.+++.+||+.||++||++. ++.+
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 444556688999999999999999876 4544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=333.16 Aligned_cols=269 Identities=16% Similarity=0.196 Sum_probs=201.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
..|++.+.||+|+||.||+|.+..+++.||+|... .+.+.+|++++++++||||+++++++......++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 34778889999999999999999899999999642 24577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+. ++|..++... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 6888888654 4578999999999999999999998 99999999999999999999999999997543221
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC------chhhHHHHHHHHHhcC----
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED------NVVILSEHVRVLLEEG---- 828 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~------~~~~l~~~~~~~~~~~---- 828 (888)
. .......||+.|+|||++ .+..++.++||||+||++|||++|+.||..... ....+...++......
T Consensus 237 ~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 237 A-NKYYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred c-cccccccCccCCCChhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1 112345789999999988 455789999999999999999999988743211 1111111111100000
Q ss_pred --------------CcccccCCCCCC---CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh--hcCCCCCC
Q 002717 829 --------------NVLDCVDPSMGD---YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV--IKTPLPQR 884 (888)
Q Consensus 829 --------------~~~~~~d~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~--~~~~~~~~ 884 (888)
.......+.... .....+.++.+++.+|++.||++|||++|++++-.- +.++.+.+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~ 389 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNP 389 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCCC
Confidence 000000000000 001234568899999999999999999999986543 33444433
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=322.82 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=206.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEE-----CCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCC
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 670 (888)
..+.++..+.||+|+||.||+|.+ ...+..||+|.+.........+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 345677788999999999999986 2345689999886544333446789999999999 7999999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
..++|+||+++|+|.++++... ...+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.++++|||+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999997642 23489999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
++...............++..|+|||.+ ....++.++||||+||++|||++ |..||......... .+ ....+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~-~~----~~~~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF-YK----LIKEGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhh-ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH-HH----HHHcCC
Confidence 9865432222222233456789999987 44568899999999999999998 99998654332211 11 111111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
.. ..+......+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 262 ~~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RM--------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cC--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 10 11223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=322.34 Aligned_cols=261 Identities=27% Similarity=0.366 Sum_probs=204.6
Q ss_pred hhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
|+..+.||+|+||.||+|.... ....+|+|.+.........+.+.+|+.+++.++||||+++++.+...+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 4556789999999999998742 23578888875443333346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCC--------------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcE
Q 002717 676 SDYAPNGSLQAKLHERLP--------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNI 735 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 735 (888)
+||+++|+|.+++..... ....+++..++.++.|++.|+.|||+. +++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence 999999999999875321 124578999999999999999999998 999999999999
Q ss_pred EecCCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCch
Q 002717 736 LLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNV 814 (888)
Q Consensus 736 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~ 814 (888)
++++++.+||+|||+++...............++..|+|||.. ....++.++||||||+++|||++ |..||.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH-ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999865433322222334556789999987 45568999999999999999999 9989864322
Q ss_pred hhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 815 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 815 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
..+.. ....... ...+......+.+++.+||+.+|++||+++|+++.|+++..
T Consensus 236 ~~~~~----~~~~~~~--------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFN----LLKTGYR--------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHH----HHhCCCC--------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111 1111110 11234455678899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.69 Aligned_cols=266 Identities=26% Similarity=0.365 Sum_probs=208.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-------CCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcC
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP 669 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 669 (888)
.+.|.+.+.||+|+||.||+|.+.. ++..+|+|.+...........+.+|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3567888899999999999998742 23569999986543333345688899999999 799999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhcCC------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEe
Q 002717 670 QLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 737 (888)
Q Consensus 670 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 737 (888)
+..++|+||+++|+|.+++....+ ....+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999987532 123588999999999999999999998 99999999999999
Q ss_pred cCCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhh
Q 002717 738 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVI 816 (888)
Q Consensus 738 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~ 816 (888)
++++.+||+|||.++...............++..|+|||.+ .+..++.++|||||||++|||++ |..||..... ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHh-ccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HH
Confidence 99999999999999765432222111222345689999987 44568899999999999999998 8888854321 11
Q ss_pred HHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCC
Q 002717 817 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 881 (888)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 881 (888)
+.. ....+.. ...+......+.+++.+||+.+|++|||+.|+++.|+++.+..
T Consensus 251 ~~~----~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 LFK----LLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHH----HHHcCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 111 1111111 1223445567889999999999999999999999999886653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=329.74 Aligned_cols=266 Identities=26% Similarity=0.356 Sum_probs=205.1
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcC-
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP- 669 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 669 (888)
+.+.|+..+.||+|+||.||+|.+. .+++.||||++...........+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 4567888999999999999999852 357889999986543333345688999999999 689999999988654
Q ss_pred CeeeEEEecCCCCCHHHHHhhcCC--------------------------------------------------------
Q 002717 670 QLKLLVSDYAPNGSLQAKLHERLP-------------------------------------------------------- 693 (888)
Q Consensus 670 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 693 (888)
...++||||+++|+|.++++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 457899999999999999875321
Q ss_pred -------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccccc
Q 002717 694 -------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 766 (888)
Q Consensus 694 -------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 766 (888)
....+++..+..++.|+++|++|||+. +|+||||||+||++++++.+|++|||+++..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 012468888999999999999999998 9999999999999999999999999999865432222222334
Q ss_pred cccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhh
Q 002717 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 845 (888)
Q Consensus 767 ~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 845 (888)
.++..|+|||.+ ....++.++|||||||++|||++ |..||......... .. ....+... ..+...
T Consensus 242 ~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~----~~~~~~~~--------~~~~~~ 307 (343)
T cd05103 242 RLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CR----RLKEGTRM--------RAPDYT 307 (343)
T ss_pred CCCcceECcHHh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-HH----HHhccCCC--------CCCCCC
Confidence 456789999987 45568899999999999999997 88998654322211 11 11111111 112223
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 846 VLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 846 ~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
..++.+++..||+.+|++|||+.|++++|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.52 Aligned_cols=261 Identities=22% Similarity=0.360 Sum_probs=210.6
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.|+..+.||+|+||.||+|....+|+.||+|.+..... ....+.+.+|++++++++|++|+++++++...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 35667789999999999999988899999998864322 2235678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+++.........+++..++.++.|++.|++|||+. +|+||||+|+||+++.++.++++|||+++.....
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999976544456689999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.. ......++..|+|||.+ .+..++.++|||||||++|||++|+.||.........+.+ .. ..+.
T Consensus 160 ~~--~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~-~~~~-------- 224 (267)
T cd08224 160 TT--AAHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---KI-EKCD-------- 224 (267)
T ss_pred Cc--ccceecCCccccCHHHh-ccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh---hh-hcCC--------
Confidence 11 11334578889999987 4556889999999999999999999998654322211111 11 1111
Q ss_pred CCCCCh-hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 838 MGDYPE-DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 838 ~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
....+. .....+.+++.+||..+|++|||+.++++.++.++
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111222 44557889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=323.34 Aligned_cols=266 Identities=26% Similarity=0.381 Sum_probs=209.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-------CCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEc
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFG-------TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT 668 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 668 (888)
..+.|+..+.||+|+||.||+|++. .++..||+|.+.........+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3556777889999999999999752 234579999886443333456788999999999 89999999999999
Q ss_pred CCeeeEEEecCCCCCHHHHHhhcCC------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEE
Q 002717 669 PQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 736 (888)
Q Consensus 669 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 736 (888)
....++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999987432 124578889999999999999999998 9999999999999
Q ss_pred ecCCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchh
Q 002717 737 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVV 815 (888)
Q Consensus 737 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~ 815 (888)
+++++.+||+|||+++.+.............++..|+|||.+ .+..++.++|||||||++|||++ |..||.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 999999999999999876543332222334456789999988 45568899999999999999998 7777753321
Q ss_pred hHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 816 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 816 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
.+.... ...+.. ...+......+.+++.+||+.+|++|||+.|+++.|+++..-
T Consensus 246 --~~~~~~-~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 --EELFKL-LKEGHR--------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred --HHHHHH-HHcCCc--------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 111111 111111 112344566788999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.68 Aligned_cols=253 Identities=27% Similarity=0.336 Sum_probs=202.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||++.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 45667899999999999999888999999998654322 2234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 82 MNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988754 234589999999999999999999998 99999999999999999999999999997654222
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. .....|++.|+|||.+ ....++.++||||+||++|||++|+.||....... .. +.+...+.. ..
T Consensus 157 ~---~~~~~~~~~y~aPE~~-~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~-~~~~~~~~~---------~~ 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KR-EEVERRVKE---------DQ 221 (285)
T ss_pred c---cccccCCCCccCcHHh-cCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HH-HHHHHHhhh---------cc
Confidence 1 1334688999999988 45568899999999999999999999997543211 11 111111111 11
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
..++......+.+++.+||+.||++|| ++++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 123344556788999999999999999 88899775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=333.87 Aligned_cols=244 Identities=25% Similarity=0.309 Sum_probs=197.8
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 682 (888)
+.||+|+||.||++....+|+.||+|.+..... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999999988999999999865422 123356778999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 683 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 683 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
+|..++... ..+++..+..++.|++.||.|||+ . +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 151 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 151 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence 999888764 468999999999999999999997 6 899999999999999999999999999875322111
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... ...+.... . ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~-~---------~~~~ 215 (325)
T cd05594 152 TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILM-E---------EIRF 215 (325)
T ss_pred ccccccCCcccCCHHHH-ccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhc-C---------CCCC
Confidence 12345689999999988 4557899999999999999999999999653221 11111111 1 0123
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
+.....++.+++.+|++.||++|+ ++.+++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 344556788999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.27 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=197.4
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|++..+++.||+|++..... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 369999999999999998999999999875432 22335577899888877 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 9999888764 4689999999999999999999998 99999999999999999999999999987532211 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCc---hhhHHHHHHHHHhcCCcccccCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN---VVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... ......++...+....
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------- 221 (329)
T cd05618 152 TTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------- 221 (329)
T ss_pred ccccccCCccccCHHHH-cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------
Confidence 12345789999999988 4557889999999999999999999999632111 1111111111111111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPS------MAEVVQI 873 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~evl~~ 873 (888)
..+|......+.+++.+||+.||++||| +.+++++
T Consensus 222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1234455667889999999999999998 5677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=316.68 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=209.0
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
.+...|+..+.||+|+||.||+|.+.. ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 345668888899999999999999985 8899999985443 22356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +|+||||||+||++++++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 81 TELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred EeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999999998742 34689999999999999999999998 99999999999999999999999999997654
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
.... ......++..|+|||.. ....++.++||||||+++|+|++ |+.||...... ... .. .. .+..
T Consensus 156 ~~~~--~~~~~~~~~~~~~PE~~-~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~-~~---~~-~~~~---- 222 (261)
T cd05148 156 EDVY--LSSDKKIPYKWTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVY-DQ---IT-AGYR---- 222 (261)
T ss_pred Cccc--cccCCCCceEecCHHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHH-HH---HH-hCCc----
Confidence 3211 11234456789999987 45578899999999999999998 88998654321 111 11 11 1111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
...+...+..+.+++.+||+.||++|||++++++.|+.+
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 112345556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=322.44 Aligned_cols=266 Identities=25% Similarity=0.357 Sum_probs=205.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCC----------------CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCccee
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQ----------------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~----------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 662 (888)
+.|+..+.||+|+||.||+|.+... +..||+|.+.........+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 4567788999999999999887542 356899998655444445678999999999999999999
Q ss_pred eeEEEcCCeeeEEEecCCCCCHHHHHhhcCC-------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcE
Q 002717 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLP-------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNI 735 (888)
Q Consensus 663 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 735 (888)
++++..++..++|+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 9999998999999999999999999987531 123689999999999999999999998 999999999999
Q ss_pred EecCCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCc
Q 002717 736 LLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT--GRRPVEYGEDN 813 (888)
Q Consensus 736 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt--g~~p~~~~~~~ 813 (888)
++++++.++++|||+++.....+.........++..|+|||.+ ....++.++|||||||++|||++ +..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV-LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh-hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999765443332223344567789999987 44568999999999999999998 6677754322
Q ss_pred hhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 814 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
...+ ............... ...+...+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQVI-ENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHH-HHHHhcccccccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111 111111111111100 1123344567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=317.18 Aligned_cols=258 Identities=27% Similarity=0.353 Sum_probs=195.9
Q ss_pred CeeccccceEEEEEEECC--CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCC
Q 002717 605 AEVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~--~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 682 (888)
+.||+|+||.||+|.+.. .+..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998753 456799998865443333457889999999999999999999999988899999999999
Q ss_pred CHHHHHhhcCC-CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 683 SLQAKLHERLP-STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 683 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
+|.++++.... .....++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 223567778889999999999999998 99999999999999999999999999997544333222
Q ss_pred ccccccccccccCcccccCc------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 762 MSNRFQSALGYVAPELTCQS------LRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~------~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
......++..|+|||++... ..++.++|||||||++|||++ |+.||........ ....+ .. ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~----~~-~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTV----RE-QQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHh----hc-ccCCCC
Confidence 22345567889999987422 235789999999999999996 9999975433221 11111 11 111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
++. ........+.+++..|| .+|++|||++||++.|+
T Consensus 232 ~~~---~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPR---LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCc---cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111 12223445778999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=318.94 Aligned_cols=264 Identities=20% Similarity=0.284 Sum_probs=207.9
Q ss_pred hhhhhcCeeccccceEEEEEEECC----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEc-CCeee
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGT----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT-PQLKL 673 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 673 (888)
+.|+..+.||+|+||.||+|.+.. .+..||+|++.........+.+.+|+.++++++||||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 445667799999999999999864 2688999988644333345678899999999999999999998876 46679
Q ss_pred EEEecCCCCCHHHHHhhcCCC----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPS----TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
+++||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+|++|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999999764322 25689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcC
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEG 828 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 828 (888)
+++.+...+.........++..|+|||.+ ....++.++|||||||++||+++ |+.||..... ..+..++ ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~----~~~ 235 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESL-VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYL----KDG 235 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHH-hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHH----HcC
Confidence 99866443332222334556789999988 45568999999999999999999 9999865322 1122211 111
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 829 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 829 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
... ..+...+..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 236 ~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 236 YRL--------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCC--------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 110 11223445688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=328.20 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=198.5
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|++..+++.||+|++...... ...+.+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999999989999999999754322 2335678899999998 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 9999888753 4689999999999999999999998 99999999999999999999999999987432111 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCc---hhhHHHHHHHHHhcCCcccccCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN---VVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... ......+....+....
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------- 221 (329)
T cd05588 152 TTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------- 221 (329)
T ss_pred ccccccCCccccCHHHH-cCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC---------
Confidence 22345789999999988 4557889999999999999999999999642111 1111122222222111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPS------MAEVVQI 873 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~evl~~ 873 (888)
...+......+.+++.+|++.||++||| ++|++++
T Consensus 222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1234445567889999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=324.97 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=204.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.|+..+.||+|+||.||+|++..+++.||+|++...........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 46677899999999999999988899999999875544444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++ ++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 87 DK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 75 888888664 34578899999999999999999998 999999999999999999999999999875432211
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH-----------hcC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL-----------EEG 828 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~-----------~~~ 828 (888)
......+++.|+|||.+.....++.++||||+||++|||+||+.||...... ..+....+... ...
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhhcchh
Confidence 1123457889999998866667889999999999999999999999754322 11111111100 000
Q ss_pred CcccccCCCCC-----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 829 NVLDCVDPSMG-----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 829 ~~~~~~d~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.....-.+... .........+.+++.+|++.||++|||++|++++-+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 00000000000 0112234567899999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.92 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=196.4
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|++..+++.||+|++..... ....+.+..|..+++.. +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 368999999999999998899999999865321 23345677888888877 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 9999988764 4588999999999999999999998 99999999999999999999999999987532211 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......||+.|+|||.+ .+..++.++||||+||++|||++|+.||...... ...+.... +. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~-~~---------~~~ 215 (320)
T cd05590 152 TTSTFCGTPDYIAPEIL-QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILN-DE---------VVY 215 (320)
T ss_pred cccccccCccccCHHHH-cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhc-CC---------CCC
Confidence 22345789999999988 5557889999999999999999999999754321 11111111 11 112
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSM------AEVVQI 873 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~ 873 (888)
+......+.+++.+|++.||++||++ ++++.+
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 33445678899999999999999998 666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=296.76 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=206.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
.+.|+.-+.||+|+|+.||++.+..+|+.+|+|.+...... ...+++.+|+.|-+.++|||||++...+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45577777899999999999999999999999987544322 24567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC---CCCcEEeccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDFGLARL 753 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgla~~ 753 (888)
|+|.|++|..-|-.+ ...++..+-..++||++++.|.|.+ +|||||+||+|+++.+ ..-+|++|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998766543 3578888889999999999999999 9999999999999963 34589999999988
Q ss_pred ccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
+.. ........|||+|||||++ ...+++..+|||+.||++|-++.|+.||.+.... ..... + ..+.. .
T Consensus 163 l~~---g~~~~G~~GtP~fmaPEvv-rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~----I-~~g~y--d 230 (355)
T KOG0033|consen 163 VND---GEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQ----I-KAGAY--D 230 (355)
T ss_pred eCC---ccccccccCCCcccCHHHh-hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHH----H-hcccc--C
Confidence 762 2334678899999999998 5557999999999999999999999999753221 11111 1 11111 1
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
+++ .+.+........|+++|+..||++|.|+.|++.+-+-
T Consensus 231 ~~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 231 YPS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred CCC---cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 111 1234445567889999999999999999999887654
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.42 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=205.2
Q ss_pred CChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 595 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
..+...|+..+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 355667888999999999999999998899999999985443 2234567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
|+||+++++|.++++.. ..+++..+..++.|++.|+.|||+. +|+|||++|+||++++++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceee
Confidence 99999999999998753 4578999999999999999999998 9999999999999999999999999999865
Q ss_pred cccccccccccccccccccCcccccC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (888)
.... .......++..|+|||.+.. ...++.++|||||||++|||++|+.||.......... . ......
T Consensus 157 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~-----~~~~~~-- 226 (267)
T cd06646 157 TATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-L-----MSKSNF-- 226 (267)
T ss_pred cccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-e-----eecCCC--
Confidence 4221 11233467889999998632 3446789999999999999999999986432211100 0 000000
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 833 ~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..+.. .........+.+++.+||+.+|++|||++++++++
T Consensus 227 -~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 -QPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -CCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00111 11223345788999999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=331.86 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=196.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-----eeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 674 (888)
|+..+.||+|+||.||+|++..+++.||||++..... ......+.+|+.++++++||||+++++++.... ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 5567789999999999999988999999999864321 223456889999999999999999999886432 4699
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
||||++ ++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 v~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999995 6898888753 4589999999999999999999998 9999999999999999999999999999754
Q ss_pred ccccc-ccccccccccccccCcccccC-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH-------
Q 002717 755 TRLDK-HVMSNRFQSALGYVAPELTCQ-SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL------- 825 (888)
Q Consensus 755 ~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~------- 825 (888)
..... ........|++.|+|||++.. ...++.++|||||||++|||++|+.||....... .+. .+....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~-~~~~~~~~~~~~~ 231 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLD-LITDLLGTPSPET 231 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHH-HHHHHhCCCCHHH
Confidence 32211 111234568899999998743 2567899999999999999999999996542211 110 000000
Q ss_pred ----hcCC---cccccCC----CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 826 ----EEGN---VLDCVDP----SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 826 ----~~~~---~~~~~d~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.... ....+.. ............+.+++.+||+.||++|||++|++++-
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 0000 0000000 00000112344578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=321.82 Aligned_cols=261 Identities=29% Similarity=0.464 Sum_probs=205.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCee
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 672 (888)
.+.|+..+.||+|+||.||+|.+.. ++..||+|.+.........+.+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3456777899999999999998742 57889999986544333456789999999999999999999999998899
Q ss_pred eEEEecCCCCCHHHHHhhcCC------------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCc
Q 002717 673 LLVSDYAPNGSLQAKLHERLP------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSN 734 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~N 734 (888)
++|+||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999975421 123578889999999999999999998 99999999999
Q ss_pred EEecCCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCc
Q 002717 735 ILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDN 813 (888)
Q Consensus 735 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~ 813 (888)
|++++++.++++|||+++.+..............+..|+|||.. ....++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH-hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998765433222222233446779999987 45578999999999999999998 77888543221
Q ss_pred hhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 814 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
+.... +..+... ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 -----~~~~~-~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIYY-VRDGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHH-HhcCCCC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 1122111 1233455678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.23 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=203.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+.++..+.||+|+||.||+|.+. +++.||+|.+.... ...+++.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 44667789999999999999986 56789999986443 2357789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999997652 34689999999999999999999998 99999999999999999999999999998665321
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.. .......+..|+|||.. ....++.++||||||+++|||++ |+.||..... ...+ .. +......
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~-~~----~~~~~~~------ 223 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVL-QQ----VDQGYRM------ 223 (261)
T ss_pred cc-ccCCCcCceeccCcccc-ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHH-HH----HHcCCCC------
Confidence 11 11222334679999987 55678999999999999999999 9989864321 1111 11 1111110
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1233445678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=314.36 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=199.7
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.|+..+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 3556678999999999999886 45569999886433 23467999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++|+|.+++... ...+++..++.++.|++.|++|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999764 23589999999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
.......++..|+|||.. ....++.++|||||||++|||++ |..||....... ... .. ..+...
T Consensus 156 -~~~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~---~~-~~~~~~------- 220 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVL-LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVE---KV-SQGLRL------- 220 (256)
T ss_pred -eecCCCccChhhCCHHHH-hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH---HH-hcCCCC-------
Confidence 111223456789999988 44568899999999999999998 999986543211 111 11 111110
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
..+......+.+++.+||+.+|++|||+.++++.++
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112233567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.48 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=208.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEEC-------CCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEc
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFG-------TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT 668 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 668 (888)
+.+.+...+.||+|+||.||+|.+. .....||+|.+.........+.+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4566778889999999999999863 234579999886543333346788999999999 69999999999998
Q ss_pred CCeeeEEEecCCCCCHHHHHhhcCC------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEE
Q 002717 669 PQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 736 (888)
Q Consensus 669 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 736 (888)
.+..++|+||+++|+|.+++..... ....+++..+..++.|++.|+.|||+. +++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 8889999999999999999976432 124588999999999999999999998 9999999999999
Q ss_pred ecCCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchh
Q 002717 737 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVV 815 (888)
Q Consensus 737 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~ 815 (888)
+++++.+|++|||+++...............++..|+|||.+ ....++.++|||||||++|||++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-- 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-- 243 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHH-ccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999866533222211222344679999987 45578999999999999999999 88888543221
Q ss_pred hHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 816 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 816 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
.... ....+.. ...+...+.++.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 244 ~~~~----~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 ELFK----LLREGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHH----HHHcCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1111 1111111 122344556788999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.29 Aligned_cols=257 Identities=24% Similarity=0.322 Sum_probs=198.3
Q ss_pred hcCeeccccceEEEEEEECCCCe--EEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcC------Ceee
Q 002717 603 KAAEVGEGVFGTVYKVSFGTQGR--MLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QLKL 673 (888)
Q Consensus 603 ~~~~ig~G~~g~V~~~~~~~~~~--~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 673 (888)
.++.||+|+||.||+|.+...+. .||+|.+..... ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45689999999999999976654 689998754321 22346788999999999999999999987532 2458
Q ss_pred EEEecCCCCCHHHHHhhcC--CCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccc
Q 002717 674 LVSDYAPNGSLQAKLHERL--PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 751 (888)
+|+||+++|+|.+++.... .....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999999885422 1234589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCc
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
+.+.............+++.|+|||.. ....++.++|||||||++|||++ |+.||..... .. ..+ . ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~-~~~---~-~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SE-IYD---Y-LRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHc-cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HH-HHH---H-HHcCCC
Confidence 876543322222233456789999988 45578999999999999999999 7888864322 11 111 1 111111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 831 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
...+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 --------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112334456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=322.01 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=195.6
Q ss_pred hhhhcCeeccccceEEEEEEECC-CCeEEEEEEeecCCcc-CChHHHHHHHHHHhhc---CCCCcceeeeEEEc-----C
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDII-QYPEDFEREVRVLGKA---RHPNLISLEGYYWT-----P 669 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~ 669 (888)
.|+..+.||+|+||.||+|++.. +++.||+|++...... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 35667789999999999999854 4688999998654322 2335667788887766 69999999999852 3
Q ss_pred CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 670 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 670 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
...++|+||++ ++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 45789999996 68999987642 34588999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC-
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG- 828 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~- 828 (888)
+++..... .......|++.|+|||.+ ....++.++|||||||++|||++|+.||...... ..+...+.......
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC---cccccccccccccChHHH-hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCCh
Confidence 99765432 122445688999999988 4556889999999999999999999999764332 22222221110000
Q ss_pred -Cc-------ccccCCCCC----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 -NV-------LDCVDPSMG----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 -~~-------~~~~d~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.. ...+.+... .........+.+++.+|++.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 000111000 0112344567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=318.65 Aligned_cols=249 Identities=25% Similarity=0.303 Sum_probs=194.9
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCH
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 684 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 684 (888)
||+|+||.||+++...+|+.||+|++...... .....+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999889999999998643322 1234456799999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccc
Q 002717 685 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764 (888)
Q Consensus 685 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 764 (888)
.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++........ ..
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence 9988654 234588899999999999999999998 999999999999999999999999999876543221 13
Q ss_pred cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChh
Q 002717 765 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844 (888)
Q Consensus 765 ~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 844 (888)
...++..|+|||++. ...++.++||||+||++|||++|+.||........ .....+..... . .......
T Consensus 153 ~~~~~~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~-~--------~~~~~~~ 221 (277)
T cd05607 153 QRAGTNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLED-E--------VKFEHQN 221 (277)
T ss_pred ccCCCCCccCHHHHc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhcc-c--------ccccccc
Confidence 346888999999884 44589999999999999999999999965432111 11111111111 0 0001123
Q ss_pred hHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 845 EVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 845 ~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
...++.+++.+||+.||++||+++|+++..
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 345688999999999999999997765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.33 Aligned_cols=265 Identities=23% Similarity=0.368 Sum_probs=205.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCee
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 672 (888)
.+.|++.+.||+|+||.||+|..+. .+..||+|.+...........+.+|+.+++.++||||+++++++.++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3567778899999999999997642 35689999875444333345688899999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhcCC------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEe
Q 002717 673 LLVSDYAPNGSLQAKLHERLP------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 746 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 746 (888)
++||||+++|+|.+++..... .....++..+..++.|++.|+.|||+. +|+||||||+||++++++.++++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999976421 134567778899999999999999998 99999999999999999999999
Q ss_pred cccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHH
Q 002717 747 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 747 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
|||+++...............++..|+|||.+ ....++.++|||||||++|||++ |..||...... . ..+...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-~----~~~~~~ 235 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-Q----VLKFVM 235 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHh-ccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-H----HHHHHH
Confidence 99999865433322222223456789999987 45568999999999999999998 77888543221 1 111111
Q ss_pred hcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
. + .....+...+..+.+++.+||+.+|++|||+.|+++.++...-+
T Consensus 236 ~-~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 236 D-G--------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred c-C--------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 1 1 11122334456799999999999999999999999999875433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.20 Aligned_cols=255 Identities=26% Similarity=0.343 Sum_probs=200.2
Q ss_pred hhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCc---cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeee
Q 002717 601 LEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 673 (888)
|+..+.||+|+||.||+++.. .+++.||+|++.+... ....+.+..|+.+++.+ +||+|+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 456778999999999998874 3688999999864322 12345678899999999 5999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999764 4588999999999999999999998 999999999999999999999999999976
Q ss_pred ccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
....... ......||+.|+|||++.....++.++|||||||++|||++|+.||........ .....+....
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~------- 225 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK------- 225 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc-------
Confidence 5432221 123457899999999885444578899999999999999999999964322111 1111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQIL 874 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L 874 (888)
.++ .++......+.+++.+||+.||++|| +++|++++-
T Consensus 226 ~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 226 CDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred CCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 111 22334456688999999999999999 788888753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.90 Aligned_cols=243 Identities=26% Similarity=0.352 Sum_probs=194.1
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|.+..+++.||+|++..... ....+.+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999998899999999865421 22345567788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 9999999763 4588899999999999999999998 999999999999999999999999999874322111
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......||+.|+|||++ .+..++.++||||+||++|||++|+.||..... ..+.+.+ .... + .+
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i----~~~~------~---~~ 215 (316)
T cd05619 152 KTCTFCGTPDYIAPEIL-LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSI----RMDN------P---CY 215 (316)
T ss_pred ceeeecCCccccCHHHH-cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCC------C---CC
Confidence 12345689999999988 455789999999999999999999999965432 1111111 1110 1 12
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMA-EVVQ 872 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~ 872 (888)
+.....++.+++.+||+.||++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 333445678999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.31 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=195.4
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHH---hhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVL---GKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+..+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++ +.++||||+++++++...+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 456689999999999999998999999999865431 12335566676655 4567999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|..+++. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 82 E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 82 EYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred cCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988864 3589999999999999999999998 999999999999999999999999999875322
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.. .......|++.|+|||.+ .+..++.++|||||||++|||++|+.||...... .. ........
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~----~~~i~~~~-------- 217 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EV----FDSIVNDE-------- 217 (324)
T ss_pred CC--CcccccccCccccCHhHh-cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HH----HHHHHhCC--------
Confidence 11 122346789999999988 4557899999999999999999999999654321 11 11111111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
..++......+.+++.+||+.||++|| ++.+++++
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 113344556788999999999999999 57777664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=326.42 Aligned_cols=242 Identities=25% Similarity=0.329 Sum_probs=193.9
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|++..+|+.||+|.+..... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 369999999999999998999999999865421 22345567788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|..++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 9999998764 4588899999999999999999998 999999999999999999999999999874322111
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......||+.|+|||++ .+..++.++||||+||++|||++|+.||..... ..+.+ .. ... ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~~~---~~-~~~---------~~~~ 215 (316)
T cd05620 152 RASTFCGTPDYIAPEIL-QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DELFE---SI-RVD---------TPHY 215 (316)
T ss_pred ceeccCCCcCccCHHHH-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHH---HH-HhC---------CCCC
Confidence 22446789999999988 555789999999999999999999999964322 11111 11 111 1122
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMA-EVV 871 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~-evl 871 (888)
+.....++.+++.+||+.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 334456788999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=326.93 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=196.0
Q ss_pred CeeccccceEEEEEEEC---CCCeEEEEEEeecCCc---cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 605 AEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~---~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+.||+|+||.||+++.. ..++.||+|.+..... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 47999999999999873 3678999999865322 12234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+.+..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999999764 4577888899999999999999998 99999999999999999999999999987533211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
.......|++.|+|||++ ....++.++|||||||++|||++|+.||...... ........ +.
T Consensus 155 --~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~-~~--------- 216 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEIL-MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILK-GK--------- 216 (323)
T ss_pred --CcccccCCCccccChhhc-cCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHc-CC---------
Confidence 112345689999999988 4556789999999999999999999999754321 11111111 11
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
...+......+.+++.+||+.||++|| ++.+++++
T Consensus 217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 122344456788999999999999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=321.79 Aligned_cols=258 Identities=28% Similarity=0.426 Sum_probs=210.6
Q ss_pred cCChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCCh--HHHHHHHHHHhhcCCCCcceeeeEEEcCCe
Q 002717 594 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPNLISLEGYYWTPQL 671 (888)
Q Consensus 594 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 671 (888)
..+|+..|...+.||.|+||.||-|++..+.+.||||++......... .++.+|+.++++++|||++.+-|+|....+
T Consensus 21 k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 21 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT 100 (948)
T ss_pred cCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence 457899999999999999999999999999999999999655432211 468899999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 751 (888)
.|+|||||- |+-.+.+.-. ..++.+.++..|..+.+.||+|||+. +.||||||+.|||+++.|.||++|||.|
T Consensus 101 aWLVMEYCl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 101 AWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred HHHHHHHHh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence 999999994 5777777654 35688899999999999999999999 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCccccc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
..+.+ ...+.|||.|||||++. ..+.|+-++||||+|+++.|+.-+++|+..+.. ...+..+++
T Consensus 174 si~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQ------- 239 (948)
T KOG0577|consen 174 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQ------- 239 (948)
T ss_pred hhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHh-------
Confidence 76654 25678999999999863 346799999999999999999999999865432 222211111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
.-.|.+. ..+-...+..++..|+++-|.+|||.++++.+---.
T Consensus 240 ---NesPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 240 ---NESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL 282 (948)
T ss_pred ---cCCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence 1112222 223344577899999999999999999998875443
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.17 Aligned_cols=256 Identities=25% Similarity=0.316 Sum_probs=193.2
Q ss_pred eeccccceEEEEEEECC--CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCC
Q 002717 606 EVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 683 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~--~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 683 (888)
.||+|+||.||+|.... ....+|+|.+...........+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 68999999999997632 3457888887544333344678899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccc
Q 002717 684 LQAKLHERLPS-TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 762 (888)
Q Consensus 684 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 762 (888)
|.+++...... ....++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999875322 23356778889999999999999998 999999999999999999999999999875433222222
Q ss_pred cccccccccccCcccccC------cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 763 SNRFQSALGYVAPELTCQ------SLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 763 ~~~~~g~~~y~aPE~~~~------~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.....++..|+|||+... ...++.++|||||||++|||++ |..||...... ..+... ..... ....+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~----~~~~~-~~~~~ 232 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQV----VREQD-IKLPK 232 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHH----hhccC-ccCCC
Confidence 233445678999998632 2356789999999999999999 77787644321 111111 11111 11111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
+ ..+......+.+++..|| .||++|||++||++.|
T Consensus 233 ~---~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 233 P---QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred C---cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1 223344556778999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=326.63 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=205.7
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCHH
Q 002717 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 685 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 685 (888)
.+|+|.||+||.|++..+...+|||.+...+ .+..+-...|+..-++++|.|||+++|.+.+.+..-+.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 6999999999999999889999999985544 334566889999999999999999999999999989999999999999
Q ss_pred HHHhhcCCCCCCC--ChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec-CCCCcEEecccccccccccccccc
Q 002717 686 AKLHERLPSTPPL--SWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVM 762 (888)
Q Consensus 686 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~ 762 (888)
+.++... +++ .+.++-.+..||++||.|||+. .|||||||.+|||++ -.|.+||+|||-++.+.... -.
T Consensus 661 sLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~ 732 (1226)
T KOG4279|consen 661 SLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PC 732 (1226)
T ss_pred HHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC--cc
Confidence 9999864 234 6677778899999999999999 999999999999997 57899999999998765322 23
Q ss_pred cccccccccccCcccccCcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 763 SNRFQSALGYVAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 763 ~~~~~g~~~y~aPE~~~~~~-~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
+.++.||..|||||++.++. .|..++|||||||++.||.||++||.........+. +. | +-..-+.+
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF---kV----G-----myKvHP~i 800 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF---KV----G-----MYKVHPPI 800 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh---hh----c-----ceecCCCC
Confidence 46788999999999997654 578999999999999999999999965433222111 10 1 11112346
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
|++.......+|.+|+.+||.+||++.++++.
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 78888889999999999999999999999874
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.17 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=206.8
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
.++++|+..+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 2 ~~~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred CHHHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence 36788999999999999999999998889999999985433 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
+||+++|+|..++... ..++++..+..++.|+++||.|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 81 IEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999999999988753 34689999999999999999999998 99999999999999999999999999987543
Q ss_pred ccccccccccccccccccCccccc----CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (888)
... .......++..|+|||++. ....++.++|||||||++|||++|+.||....... ..... .....
T Consensus 155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~----~~~~~-- 225 (282)
T cd06643 155 RTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKI----AKSEP-- 225 (282)
T ss_pred ccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHH----hhcCC--
Confidence 221 1123456788999999873 23456789999999999999999999986533211 11111 11100
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 832 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
+.. ..+...+..+.+++.+||+.+|++|||+.+++++-.
T Consensus 226 ----~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 226 ----PTL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ----CCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 010 123334567889999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.34 Aligned_cols=260 Identities=26% Similarity=0.380 Sum_probs=206.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
...|+..+.||+|+||.||+|.+..+|+ .||+|.+...........+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3456777899999999999999865554 5899987655433344678899999999999999999999987 6789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||.++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999864 23589999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccc
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (888)
..............++..|+|||.. ....++.++|+|||||++||+++ |+.||...... .+.. .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~~-- 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESI-LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPD----LLEKGER-- 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHh-hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHH----HHhCCCC--
Confidence 6543332222223345789999987 45578899999999999999999 99998654321 1111 1111111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 833 ~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
...+..+..++.+++.+||..+|++|||+.++++.|+.+..
T Consensus 230 ------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11233345678899999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.82 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=200.2
Q ss_pred CeeccccceEEEEEEECCCC---eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQG---RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
++||+|+||.||+|.+...+ ..+|+|.+.........+++.+|+++++.+.||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 46999999999999885544 78999998655543345678999999999999999999998764 457899999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|.+++... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999864 3689999999999999999999998 99999999999999999999999999998765433221
Q ss_pred c-cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 762 M-SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 762 ~-~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
. .....++..|+|||.. ....++.++|||||||++|||++ |..||..... ......+ ......
T Consensus 153 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~----~~~~~~-------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECI-NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML----ESGERL-------- 217 (257)
T ss_pred ccccCccccccccCHHHh-cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----HcCCcC--------
Confidence 1 1122345679999988 55568999999999999999998 9999865432 1122221 111111
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
..+...+..+.+++.+||..+|++|||+.++++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 123445567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=327.61 Aligned_cols=244 Identities=24% Similarity=0.335 Sum_probs=196.9
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|++..+++.||+|++..... ....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 368999999999999988899999999865322 22345677899998876 799999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 9999988764 4588999999999999999999998 99999999999999999999999999987533211 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......|++.|+|||++ ....++.++||||+||++|||++|+.||...... .. .+...... ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~----~~~i~~~~----------~~~ 215 (321)
T cd05591 152 TTTTFCGTPDYIAPEIL-QELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-DL----FESILHDD----------VLY 215 (321)
T ss_pred cccccccCccccCHHHH-cCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-HH----HHHHHcCC----------CCC
Confidence 22445689999999988 5557899999999999999999999999754321 11 11111111 012
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRP-------SMAEVVQI 873 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RP-------s~~evl~~ 873 (888)
+......+.+++.+|++.||++|| ++.+++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 333455788999999999999999 88888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=325.80 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=197.3
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|.+..+++.||+|++..... ....+.+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999998899999999875422 22345677899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 9999988764 4689999999999999999999998 99999999999999999999999999987532211 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......|++.|+|||++ .+..++.++|||||||++|||++|+.||...... . ..... .... ..+
T Consensus 152 ~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-~----~~~~i-~~~~---------~~~ 215 (318)
T cd05570 152 TTSTFCGTPDYIAPEIL-SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-E----LFQSI-LEDE---------VRY 215 (318)
T ss_pred cccceecCccccCHHHh-cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-H----HHHHH-HcCC---------CCC
Confidence 12345688999999988 5567899999999999999999999999644321 1 11111 1111 112
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSM-----AEVVQI 873 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~ 873 (888)
+......+.+++.+||+.||++|||+ .+++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 33445678899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=347.63 Aligned_cols=265 Identities=19% Similarity=0.219 Sum_probs=204.5
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.|+..+.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 366778999999999999999888999999998643221 224578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCC-------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 678 YAPNGSLQAKLHERLP-------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
|+++|+|.+++..... .....++..++.++.|+++||+|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999875311 123466778899999999999999998 999999999999999999999999999
Q ss_pred ccccccccc----------------ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCch
Q 002717 751 ARLLTRLDK----------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814 (888)
Q Consensus 751 a~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~ 814 (888)
++....... ........||+.|+|||.+ .+..++.++|||||||++|||+||+.||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l-~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh-cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 986521110 0011234689999999988 55578999999999999999999999996532211
Q ss_pred hhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhcCC
Q 002717 815 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-SMAEVVQILQVIKTP 880 (888)
Q Consensus 815 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~~~~ 880 (888)
.... ... .++.........+..+.+++.+|++.||++|| +++++.+.|+.....
T Consensus 239 i~~~---------~~i---~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYR---------DVI---LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhh---------hhc---cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1110 000 01100001123445688999999999999995 677777888776543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=332.62 Aligned_cols=264 Identities=23% Similarity=0.272 Sum_probs=199.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-----eeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 674 (888)
++..+.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++...+ ..++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 3456789999999999999988999999999854321 123456889999999999999999999998776 7899
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
|+||+. ++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 82 v~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 82 VTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred Eeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 999996 5787777543 4689999999999999999999998 9999999999999999999999999999765
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHH------------
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR------------ 822 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~------------ 822 (888)
..... .......++..|+|||.+.....++.++||||+||++|||++|+.||...... ..+....+
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHH
Confidence 43221 11233457889999998855556789999999999999999999999654321 11111110
Q ss_pred ------HHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 823 ------VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 823 ------~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..+.......................+.+++.+|++.||++|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 0000000000000000011223355688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.36 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=197.0
Q ss_pred eeccccceEEEEEEE--CCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCC
Q 002717 606 EVGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~--~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 682 (888)
+||+|+||.||+|.+ ..++..+|+|++...... ...+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999976 346788999988544322 23467889999999999999999999885 45678999999999
Q ss_pred CHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc-
Q 002717 683 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV- 761 (888)
Q Consensus 683 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~- 761 (888)
+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999753 3588999999999999999999998 99999999999999999999999999998664332211
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 840 (888)
......++..|+|||.+ ....++.++|||||||++|||++ |..||...... ..... +..+.. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~----i~~~~~--------~~ 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQM----IESGER--------ME 218 (257)
T ss_pred ecCCCCCCccccCHhHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHCCCC--------CC
Confidence 11223345789999987 45568889999999999999998 99999654321 11111 222211 12
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 841 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
.+...+..+.+++.+||+.||++||++++|++.|+..
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2344556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=334.21 Aligned_cols=255 Identities=20% Similarity=0.293 Sum_probs=197.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 56677999999999999999989999999998654322 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 83 IPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999764 3578888999999999999999998 99999999999999999999999999975431100
Q ss_pred c---------------------------------------------ccccccccccccccCcccccCcCCCCCcchHHHH
Q 002717 759 K---------------------------------------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGF 793 (888)
Q Consensus 759 ~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~ 793 (888)
. ........||+.|+|||++ ....++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSl 234 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL-LRKGYTQLCDWWSV 234 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH-cCCCCCCccceeeh
Confidence 0 0001234689999999988 45568899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHH--ccCCCCCCCCCHHHHH
Q 002717 794 GVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALV--CTCHIPSSRPSMAEVV 871 (888)
Q Consensus 794 Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~--cl~~dp~~RPs~~evl 871 (888)
||++|||++|+.||.......... ......... ..+ .......++.+++.+ |+..+|..||+++|++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~-----~i~~~~~~~-----~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQL-----KVINWENTL-----HIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHH-----HHHcccccc-----CCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999997643322111 111100000 000 011233456677777 5566777799999999
Q ss_pred HHH
Q 002717 872 QIL 874 (888)
Q Consensus 872 ~~L 874 (888)
.+-
T Consensus 304 ~hp 306 (381)
T cd05626 304 AHP 306 (381)
T ss_pred cCc
Confidence 864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=330.95 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=202.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|....+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 5567789999999999999998999999999875432 22345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999874 24689999999999999999999998 99999999999999999999999999998654322
Q ss_pred cccccccccccccccCcccccC-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 759 KHVMSNRFQSALGYVAPELTCQ-----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.. ......||+.|+|||++.. ...++.++|||||||++|||++|+.||...... ..............
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~~- 229 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQRFLK- 229 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCCCccC-
Confidence 21 2234568899999998742 445788999999999999999999999654321 11112211111110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.+. .......+.+++..|++ +|++|||+.+++.+
T Consensus 230 ----~~~-~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 ----FPE-DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----CCC-CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 001 12344568889999997 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.35 Aligned_cols=260 Identities=28% Similarity=0.366 Sum_probs=201.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe--EEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGR--MLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 675 (888)
+.|+..+.||+|+||.||+|.+..++. .+|+|.+.........+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 345667789999999999999876665 45777765433333446788999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCC------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCc
Q 002717 676 SDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 743 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 743 (888)
+||+++|+|.++++.... ....+++..++.++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999976421 124688999999999999999999998 99999999999999999999
Q ss_pred EEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHH
Q 002717 744 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 822 (888)
Q Consensus 744 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~ 822 (888)
||+|||+++..... ........+..|+|||.+ ....++.++|||||||++|||+| |..||....... . .+
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~---~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--L---YE 234 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHH-hccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--H---HH
Confidence 99999998643211 111122345679999987 45568899999999999999998 999986432211 1 11
Q ss_pred HHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 823 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
. ...+.. ...+......+.+++.+||+.+|++||++.++++.++++..
T Consensus 235 ~-~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 235 K-LPQGYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred H-HhcCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 111100 01122344568899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.73 Aligned_cols=264 Identities=26% Similarity=0.379 Sum_probs=207.0
Q ss_pred hhhhhcCeeccccceEEEEEEECC-------CCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCC
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 670 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 670 (888)
..|++.+.||+|+||.||+|.+.. .+..||+|.+.........+++.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 457788899999999999998632 23468999876443333456789999999999 7999999999999998
Q ss_pred eeeEEEecCCCCCHHHHHhhcCC------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD 738 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~ 738 (888)
..++|+||+++|+|.+++....+ ....+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 99999999999999999976431 234588899999999999999999998 999999999999999
Q ss_pred CCCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhH
Q 002717 739 DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVIL 817 (888)
Q Consensus 739 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l 817 (888)
+++.+||+|||+++...............++..|+|||.+ ....++.++|||||||++|||++ |..||......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---- 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHh-ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 9999999999999865433222222223345679999988 45568899999999999999998 78888543221
Q ss_pred HHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 818 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
+..+.. ..+.. ...+......+.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus 244 -~~~~~~-~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 244 -ELFKLL-KEGHR--------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -HHHHHH-HcCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111111 11111 122334456788999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.61 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=203.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
|+..+.||+|+||.||++.+..+++.+|+|.+.........+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 45567899999999999999989999999998654444455778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+|+|.+++... ....+++..++.++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.++.......
T Consensus 82 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 82 GGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 99999988754 234578899999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 840 (888)
......++..|+|||++ ....++.++||||||+++|+|++|..||...... ...... ..+.. ..
T Consensus 156 -~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~--------~~ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIW-ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----NLILKV-CQGSY--------KP 219 (255)
T ss_pred -ccccccCCccccCHHHH-ccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----HHHHHH-hcCCC--------CC
Confidence 12345678889999988 5556889999999999999999999999643211 111111 11111 11
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 841 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.+......+.+++.+||+.||++|||+.|++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 233445568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=326.06 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=197.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCC-CCcceeeeEEEcCCeeeEEEe
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARH-PNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 677 (888)
|+..+.||+|+||.||+|.+..+++.||+|++..... ....+.+..|..++..++| ++|+++++++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 4556789999999999999988899999999865321 2234567889999999976 568889999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 82 YVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999998764 4578899999999999999999998 9999999999999999999999999998643211
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
. .......||+.|+|||++ .+..++.++||||+||++|||+||+.||...... . ....... .
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~----~~~~i~~-~--------- 216 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-E----LFQSIME-H--------- 216 (324)
T ss_pred C--CceeeecCCccccChhhh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-H----HHHHHHc-C---------
Confidence 1 112345689999999988 4556889999999999999999999999754321 1 1111111 1
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSM-----AEVVQI 873 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~ 873 (888)
...++......+.+++.+||..||++|++. +++.++
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112334455678899999999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.51 Aligned_cols=253 Identities=29% Similarity=0.406 Sum_probs=206.7
Q ss_pred CeeccccceEEEEEEECCC---CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~---~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|.+... +..||+|.+.........+.+.+|+++++.++|+||+++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 3689999999999999765 8899999986654433467889999999999999999999999998899999999999
Q ss_pred CCHHHHHhhcCCC-----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 682 GSLQAKLHERLPS-----TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 682 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
++|.+++...... ...+++..++.++.|+++|++|||+. +++||||+|+||++++++.+|++|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875322 36789999999999999999999998 999999999999999999999999999987654
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
...........++..|+|||.+. ...++.++||||+||++|||++ |..||..... ..+ .+.. ..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~---~~~~-~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLK-DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEV---LEYL-RKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhc-cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHH---HHHH-HcC-------
Confidence 33223334556788999999884 4478999999999999999999 5889875522 111 1111 111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.....+...+.++.+++.+||+.+|++|||+.|++++|+
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 -YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111234445667899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.98 Aligned_cols=256 Identities=23% Similarity=0.421 Sum_probs=202.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCe---EEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
++..+.||+|+||.||+|.+..+++ .||+|.+.........++|..|+.+++.++||||+++++++..+...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 5667789999999999999976554 6999998654333345689999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 86 FMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred cCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999764 24589999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccc-cccc--cccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 758 DKHVM-SNRF--QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 758 ~~~~~-~~~~--~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
..... .... ..+..|+|||.+ ....++.++|||||||++||+++ |..||...... ....++ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i----~~~~~--- 229 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI----EQDYR--- 229 (269)
T ss_pred ccccccccccCCCcceeecCHhHh-ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH----HcCCc---
Confidence 22111 0111 124579999988 55678999999999999999887 99998643221 111111 11110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
...+.+.+..+.+++.+||+.+|++||++.+++..|+++
T Consensus 230 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 -----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011234456688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.66 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=206.1
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.+.|+..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|+.++++++||||+++++++..+...++|+
T Consensus 2 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred hHHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 45678888899999999999999988899999998864443344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++++|.+++.. ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 82 EYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999999998864 3578899999999999999999998 999999999999999999999999999976543
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... ......++..|+|||.+ .+..++.++|||||||++|||++|+.|+......... . ....+
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~----~~~~~-------- 216 (277)
T cd06642 154 TQI--KRNTFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--F----LIPKN-------- 216 (277)
T ss_pred cch--hhhcccCcccccCHHHh-CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--h----hhhcC--------
Confidence 221 11234578889999988 4556889999999999999999999998643221110 0 01111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.....+...+..+.+++.+||+.+|++|||+.|++++-
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 01122334556788999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.29 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=203.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCe---EEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
.|+..+.||+|+||.||+|+...+++ .+|+|.+.........+.+..|+.++++++||||+++++++...+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 45667789999999999999865443 799998865433334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||++.....
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 86 EYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999764 24689999999999999999999998 999999999999999999999999999976543
Q ss_pred cccccc-cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 757 LDKHVM-SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 757 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
...... ......+..|+|||.+ ....++.++|||||||++|||++ |+.||...... +..+.. ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i-~~~~~---- 228 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAI-NDGFR---- 228 (268)
T ss_pred ccccceeccCCCcCceecCHHHh-hcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHH-hcCCC----
Confidence 222111 1112234579999988 44568899999999999999998 99998654321 111111 11110
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 229 ----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111234456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.54 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=202.6
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.+.|+..+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++|++++++++++. ....++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 3456788889999999999999886 667799999865432 3567999999999999999999999875 45678999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++++|.++++.. ....+++..++.++.|++.|++|||+. +++||||||+||++++++.++++|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 80 EYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999764 234589999999999999999999998 999999999999999999999999999976543
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
..... .....++..|+|||.. ....++.++||||||+++|||++ |..||..... .... ... ..+..
T Consensus 155 ~~~~~-~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~----~~~-~~~~~----- 221 (260)
T cd05070 155 NEYTA-RQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVL----EQV-ERGYR----- 221 (260)
T ss_pred ccccc-ccCCCCCccccChHHH-hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHH----HHH-HcCCC-----
Confidence 22211 1223456679999987 45578899999999999999999 8888865322 1111 111 11110
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
...+...+..+.+++.+||..+|++|||++++.+.|+.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 ---MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11234455678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.49 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=203.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCe----EEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
+.++..+.||+|+||.||+|.+..+|+ .||+|.+...........+.+|+.+++.++||||++++|++..+ ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 345667789999999999999876665 47888875544333345788999999999999999999998764 4678
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998764 23578899999999999999999998 9999999999999999999999999999866
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.............++..|+|||.+ .+..++.++|||||||++||+++ |+.||..... ..... ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~-- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECI-HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPD----LLEKGERL-- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHh-ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH----HHHCCCCC--
Confidence 433322222334456789999987 55678999999999999999997 8899864321 11112 22221111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
..+.....++.+++.+||..+|++||+++|+++.++.+...
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11233456788999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.57 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=202.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
|+..+.||+|++|.||+|....+++.||+|.+...... ...+.+.+|++++++++||||+++++++...+..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 56677999999999999999888999999998644221 12356888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||+|+||++++++.++|+|||+++....
T Consensus 84 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999764 3578889999999999999999998 999999999999999999999999999976543
Q ss_pred cccccc-cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 757 LDKHVM-SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 757 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
...... .....++..|+|||.. .+..++.++||||+||++|||++|+.||......... ......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~-------- 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-----FKIATQ-------- 222 (263)
T ss_pred cccccccccCCCcCccccCccee-ccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-----HHHhcc--------
Confidence 221111 0234567889999988 4456889999999999999999999998654221111 111111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
......+......+.+++.+||..+|++|||+.|++++.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 111123445566788999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.44 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=203.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|++|.||+|.+..+++.||+|.+..... ....+.+.+|++++++++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 3445689999999999999988999999999864322 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++++|.++++.. ....+++..++.++.|++.|+.|||+. +++||||||+||++++++.++++|||+++.......
T Consensus 82 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 82 ENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 999999999874 235688999999999999999999998 999999999999999999999999999886553222
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
. .....+++.|+|||+. ....++.++|||||||++|||++|+.||..... ... .+.. ..+. ..
T Consensus 157 ~--~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~----~~~~-~~~~--------~~ 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-GAL----ILKI-IRGV--------FP 219 (256)
T ss_pred h--hhccccCccccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHH----HHHH-HcCC--------CC
Confidence 1 1334678899999988 445688999999999999999999999965431 111 1111 1111 11
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
..+......+.+++.+||+.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 2233455678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.82 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=198.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
++..+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++|+||++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 556778999999999999986 56789999875433 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+|++|||+++.......
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 999999997642 3689999999999999999999998 999999999999999999999999999976543211
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
.......++..|+|||.+ ....++.++|||||||++||+++ |..||...... ... ..+ ..+. ..
T Consensus 156 ~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~-~~~----~~~~-----~~--- 220 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVF-DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVV-ESV----SAGY-----RL--- 220 (256)
T ss_pred cccCCCCCCccccCHHHh-ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-HHH-HHH----HcCC-----cC---
Confidence 111222344679999988 45578899999999999999999 78888643221 111 111 1110 11
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12334566799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=319.70 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=204.9
Q ss_pred hhhhhcCeeccccceEEEEEEE----CCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC--Cee
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLK 672 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 672 (888)
.+|++.+.||+|+||.||.+.+ ..+++.||+|.+.........+.+.+|+++++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578888999999999999985 3467889999986554344456799999999999999999999998775 567
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999999764 23589999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccc-cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC----------chhhHHHHH
Q 002717 753 LLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED----------NVVILSEHV 821 (888)
Q Consensus 753 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~----------~~~~l~~~~ 821 (888)
........ .......++..|+|||.. .+..++.++|||||||++|||++++.|...... ........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECL-IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHh-ccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 66432221 112234566789999987 445688999999999999999998776532111 001111111
Q ss_pred HHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 822 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 822 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
.. ...+.. ...+...+..+.+++.+||+.+|++|||+.++++.++++
T Consensus 237 ~~-~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RV-LEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 111111 112334566799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=310.50 Aligned_cols=257 Identities=20% Similarity=0.300 Sum_probs=192.5
Q ss_pred eeccccceEEEEEEECCC--CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCC
Q 002717 606 EVGEGVFGTVYKVSFGTQ--GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 683 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~--~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 683 (888)
.||+|+||.||+|..... ...+++|.+.........+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 689999999999986432 235677776544433445789999999999999999999999999989999999999999
Q ss_pred HHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccccc
Q 002717 684 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS 763 (888)
Q Consensus 684 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 763 (888)
|.++++.........++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999987533344567777889999999999999998 9999999999999999999999999998643221111122
Q ss_pred ccccccccccCcccccC------cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 764 NRFQSALGYVAPELTCQ------SLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 764 ~~~~g~~~y~aPE~~~~------~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
....++..|+|||+... ...++.++|||||||++|||++ |..||..... ...+.. .... ......++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~----~~~~-~~~~~~~~ 232 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNH----VIKD-QQVKLFKP 232 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH----HHhh-cccccCCC
Confidence 34567889999998632 1235789999999999999997 4667754322 122221 1111 11222222
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.. +......+.+++..|| .+|++|||++|+++.|.
T Consensus 233 ~~---~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 233 QL---ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cc---CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22 2234456788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.13 Aligned_cols=258 Identities=23% Similarity=0.352 Sum_probs=201.6
Q ss_pred hhhhcCeeccccceEEEEEEEC-----CCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
.+...++||+|+||.||+|... .++..+|+|.+.... ....+.+.+|+++++.++|+||+++++++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 3455678999999999999752 246789999875432 2334678999999999999999999999999889999
Q ss_pred EEecCCCCCHHHHHhhcCCC-----------CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCc
Q 002717 675 VSDYAPNGSLQAKLHERLPS-----------TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 743 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 743 (888)
|+||+++|+|.+++....+. ...+++..++.++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 99999999999999864321 13588999999999999999999998 99999999999999999999
Q ss_pred EEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHH
Q 002717 744 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 822 (888)
Q Consensus 744 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~ 822 (888)
||+|||+++...............+++.|+|||.+ ....++.++|||||||++|||++ |..||........ ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-----~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-----IE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-----HH
Confidence 99999999765432222222333456789999987 45568999999999999999998 8888854322111 11
Q ss_pred HHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 823 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.. ..+.. ...+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus 236 ~~-~~~~~--------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CI-TQGRE--------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HH-HcCcc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11 11110 01123445568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.17 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=202.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.+.|+..++||+|+||.||+|.+.. +..||+|++.... ...+.+.+|++++++++||||+++++++.+ ...++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecC-CceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 34567888899999999999999864 4569999986433 234678999999999999999999998754 4578999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++.... ...+++..+..++.|++.||+|+|+. +++||||||+||++++++.++|+|||.++....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 80 EYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 9999999999998642 34578999999999999999999998 999999999999999999999999999976643
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.... ......++..|+|||.. ....++.++|||||||++|||+| |..||...... ... .. ...+..
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~~----~~-~~~~~~----- 221 (262)
T cd05071 155 NEYT-ARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVL----DQ-VERGYR----- 221 (262)
T ss_pred cccc-cccCCcccceecCHhHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HHH----HH-HhcCCC-----
Confidence 3221 11234456789999987 45568999999999999999999 78788654321 111 11 111110
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
...+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 222 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 012334556788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=308.05 Aligned_cols=247 Identities=27% Similarity=0.352 Sum_probs=197.6
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCHH
Q 002717 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 685 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 685 (888)
.||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 6899999999999975 788999998865433333457889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccccccc
Q 002717 686 AKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 765 (888)
Q Consensus 686 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 765 (888)
+++... ...+++..+..++.|++.|+.|+|+. +++||||||+||++++++.+|++|||++........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 153 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL 153 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence 998764 24578999999999999999999988 999999999999999999999999999875432211 11122
Q ss_pred ccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChh
Q 002717 766 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844 (888)
Q Consensus 766 ~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 844 (888)
..++..|+|||++ ....++.++|||||||++||+++ |..||....... ... ....+.. ...+..
T Consensus 154 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~----~~~~~~~--------~~~~~~ 218 (250)
T cd05085 154 KQIPIKWTAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--ARE----QVEKGYR--------MSCPQK 218 (250)
T ss_pred CCCcccccCHHHh-ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHH----HHHcCCC--------CCCCCC
Confidence 2345679999988 55578999999999999999998 899986542211 111 1111111 112334
Q ss_pred hHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 845 EVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 845 ~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.+.++.+++.+||+.+|++|||+.|++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 5567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.37 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=202.9
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcC-----
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP----- 669 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----- 669 (888)
++.+.|+..+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 46677888889999999999999998889999999986443 3456788999999999 699999999998753
Q ss_pred -CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecc
Q 002717 670 -QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 748 (888)
Q Consensus 670 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 748 (888)
...++||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 3578999999999999999864 234688999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcccccC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH
Q 002717 749 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824 (888)
Q Consensus 749 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~ 824 (888)
|++....... .......|+..|+|||++.. ...++.++|||||||++|||++|+.||.......... .
T Consensus 156 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~ 227 (272)
T cd06637 156 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------L 227 (272)
T ss_pred CCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------H
Confidence 9997653321 12234568889999998742 3357889999999999999999999996432211110 0
Q ss_pred HhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 825 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
..... .+. ......+..+.+++.+||..+|.+|||+.|++++
T Consensus 228 ~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 IPRNP-----APR--LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HhcCC-----CCC--CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 01110 011 1122334568899999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.62 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=215.6
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCee
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLK 672 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 672 (888)
.....|+..+.||+|.||.||+++.+.+|+.+|+|.+.+..... ..+.+.+|+.+|+++. |||||.+.+++.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34566788889999999999999999899999999997665433 3468899999999998 99999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC----CCcEEecc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN----YNPRISDF 748 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~~~kl~Df 748 (888)
++|||++.||.|.+.+... .+++.++..++.|++.++.|+|+. +|+|||+||+|+|+... +.+|++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999876 289999999999999999999998 99999999999999633 47999999
Q ss_pred cccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC
Q 002717 749 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 828 (888)
Q Consensus 749 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 828 (888)
|++..... .......+||+.|+|||++ ....++..+||||+||++|.|++|..||.......... .+..+
T Consensus 184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl-~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~ 253 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGTPEYVAPEVL-GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRG 253 (382)
T ss_pred CCceEccC---CceEeeecCCccccCchhh-cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcC
Confidence 99988765 2234678999999999998 55689999999999999999999999997654433222 11112
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 829 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 829 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.. +. ..+..+.....+.+++..|+..||.+|+|+.+++++-|-
T Consensus 254 ~~-~f----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 254 DF-DF----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred CC-CC----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 11 11 112344556678899999999999999999999998653
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.49 Aligned_cols=252 Identities=29% Similarity=0.390 Sum_probs=197.2
Q ss_pred eeccccceEEEEEEECCCCe--EEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCCC
Q 002717 606 EVGEGVFGTVYKVSFGTQGR--MLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 682 (888)
.||+|+||.||+|.+..++. .+|+|.+.........+.+.+|+++++++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 68999999999999976665 46888875433333446788999999999 7999999999999998999999999999
Q ss_pred CHHHHHhhcCC------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 683 SLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 683 sL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
+|.+++..... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence 99999976421 123578999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
++.... .........+..|+|||++ ....++.++|||||||++|||++ |..||...... ...+.. ..+.
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~-~~~~ 228 (270)
T cd05047 159 SRGQEV---YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKL-PQGY 228 (270)
T ss_pred ccccch---hhhccCCCCccccCChHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHH-hCCC
Confidence 863221 1111222345679999987 55578899999999999999997 99998643221 111111 1111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
.. ..+.....++.+++.+||+.+|.+|||+.|++..|+.+.
T Consensus 229 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RL--------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC--------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 10 122334456889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.64 Aligned_cols=253 Identities=28% Similarity=0.378 Sum_probs=193.0
Q ss_pred CeeccccceEEEEEEECC---CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEc-CCeeeEEEecCC
Q 002717 605 AEVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT-PQLKLLVSDYAP 680 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 680 (888)
+.||+|+||.||+|.+.. .+..||+|++.........+.+.+|+.+++.++||||+++++++.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998742 3467999987543333345678899999999999999999998764 445789999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+|+|.+++... ....++..+..++.|+++|++|||+. +++||||||+||++++++.+|++|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999764 23467778889999999999999998 9999999999999999999999999999755332111
Q ss_pred --cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 761 --VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR-PVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 761 --~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~-p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.......++..|+|||.+ ....++.++|||||||++|||++|+. ||... .. ... ...... +..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~-~~~---~~~~~~-~~~------- 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DS-FDI---TVYLLQ-GRR------- 220 (262)
T ss_pred eecccccCcCCccccChhHh-ccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CH-HHH---HHHHhc-CCC-------
Confidence 111233456789999987 45578899999999999999999655 55432 21 111 111111 110
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
...+...+..+.+++..||+.+|++||++.|+++.|+++.
T Consensus 221 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 -LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1112333457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.76 Aligned_cols=259 Identities=26% Similarity=0.338 Sum_probs=201.3
Q ss_pred hhhhcCeeccccceEEEEEEECCCCe--EEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEE
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGR--MLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 676 (888)
.|+..+.||+|+||.||+|....++. .+|+|.++........+.+.+|+++++++ +||||+++++++...+..++|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35667789999999999999876654 46888875433233346788999999999 7999999999999988899999
Q ss_pred ecCCCCCHHHHHhhcCC------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcE
Q 002717 677 DYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 744 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 744 (888)
||+++|+|.+++..... ....+++..++.++.|++.|++|||+. +|+||||||+||++++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEE
Confidence 99999999999976421 123588899999999999999999998 999999999999999999999
Q ss_pred EecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHH
Q 002717 745 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRV 823 (888)
Q Consensus 745 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~ 823 (888)
|+|||++...... ........+..|+|||.. ....++.++|||||||++|||++ |..||....... ....
T Consensus 160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~~ 230 (297)
T cd05089 160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYEK 230 (297)
T ss_pred ECCcCCCccccce---eccCCCCcCccccCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence 9999998643211 111122335679999987 45568899999999999999997 999996543211 1111
Q ss_pred HHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 824 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 824 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
. ..+. ....+......+.+++.+||+.+|.+|||++++++.|+.+..
T Consensus 231 ~-~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 L-PQGY--------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred H-hcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 1111 011233455678899999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.25 Aligned_cols=265 Identities=23% Similarity=0.278 Sum_probs=203.0
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.|+..+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 46677899999999999999988899999999865544444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
+ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 87 ~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 87 D-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred c-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 7 5898888764 34578899999999999999999998 999999999999999999999999999875432111
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH-----------HhcC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL-----------LEEG 828 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~-----------~~~~ 828 (888)
......+++.|+|||.+.....++.++||||+||++|||++|+.||...... ..+....+.. ....
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhccc
Confidence 1123456788999998755566789999999999999999999999754321 1111111100 0000
Q ss_pred CcccccCCCC-----CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 829 NVLDCVDPSM-----GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 829 ~~~~~~d~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.....-.+.. ..........+.+++.+|++.||.+|||++|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000000000 001123345678999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.37 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=200.0
Q ss_pred eeccccceEEEEEEECCCC------eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 606 EVGEGVFGTVYKVSFGTQG------RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~~------~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.||+|+||.||+|++.... +.+|+|.+...........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 6899999999999985333 6899998865443344577899999999999999999999999988999999999
Q ss_pred CCCCHHHHHhhcCC---CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC-----CcEEeccccc
Q 002717 680 PNGSLQAKLHERLP---STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-----NPRISDFGLA 751 (888)
Q Consensus 680 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-----~~kl~Dfgla 751 (888)
++|+|.+++..... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999976422 224578899999999999999999988 999999999999999877 8999999999
Q ss_pred ccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCc
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
+.....+.........++..|+|||.+ ....++.++|||||||++|||++ |+.||...... .....+ ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~----~~~~- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESL-LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHV----TAGG- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHH-ccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHH----hcCC-
Confidence 765433322222233456789999988 55578999999999999999998 99998643221 111111 1111
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 831 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
....+...+..+.+++.+||..+|++||++.++++.|++
T Consensus 231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 -------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 112234456678899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=331.23 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=203.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|++..+++.||+|++...... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 56677999999999999999989999999998654321 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 83 MPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 9999999999874 4688999999999999999999998 99999999999999999999999999997654322
Q ss_pred ---------------------------cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 002717 759 ---------------------------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 811 (888)
Q Consensus 759 ---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~ 811 (888)
.........||+.|+|||++ ....++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHH-cCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 00112345689999999988 45578999999999999999999999997543
Q ss_pred CchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC-HHHHHHHH
Q 002717 812 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS-MAEVVQIL 874 (888)
Q Consensus 812 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~L 874 (888)
... ........... . ..+. ....+..+.+++.+|+. ||++||+ ++|++++-
T Consensus 235 ~~~-----~~~~i~~~~~~--~---~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQE-----TYNKIINWKES--L---RFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHH-----HHHHHhccCCc--c---cCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 211 11111110000 0 0001 11135678899999997 9999999 99999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.98 Aligned_cols=256 Identities=19% Similarity=0.260 Sum_probs=202.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.|+..+.||+|+||.||+|+...+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 456777899999999999999998999999999864321 123345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 123 EYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred cCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999998763 477888889999999999999998 999999999999999999999999999976543
Q ss_pred cccccccccccccccccCcccccCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.. ........||+.|+|||++... ..++.++|||||||++|||++|+.||...... .............
T Consensus 195 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~~~~~-- 266 (370)
T cd05596 195 NG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMDHKNSL-- 266 (370)
T ss_pred CC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCCcC--
Confidence 21 1122345789999999987432 24788999999999999999999999754321 1111111111000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQIL 874 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L 874 (888)
..+. ....+..+.+++.+|+..+|++ |||+.|++++-
T Consensus 267 ---~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 267 ---TFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred ---CCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0011 1134567889999999999988 99999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=311.74 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=202.7
Q ss_pred hhhhcCeeccccceEEEEEEECCCC---eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQG---RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
.|+..+.||+|+||.||+|.+..++ ..+|+|.+.........+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 4566779999999999999985433 4799998865433334467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++++|.+++... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 85 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 85 EYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999764 24589999999999999999999998 999999999999999999999999999987653
Q ss_pred cccccc-cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 757 LDKHVM-SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 757 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
...... .....++..|+|||.+ ....++.++|||||||++||+++ |..||....... ... . +..+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~---~-~~~~~~---- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIK---A-IEEGYR---- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHh-ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHH---H-HhCCCc----
Confidence 322111 1122335679999988 45568999999999999999887 999986543211 111 1 111110
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011233455688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=308.54 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=203.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.+.|+..++||+|+||.||+|... +++.||+|.+.... ...+++.+|+.++++++|+||+++++++. .+..++|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3456778889999999999999976 67889999986443 34578999999999999999999999874 45679999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... .+..+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999998764 234688999999999999999999988 999999999999999999999999999976542
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
... .......++..|+|||.+ ....++.++|||||||++||+++ |+.||...... . .... . ..+...
T Consensus 155 ~~~-~~~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~-~~~~---~-~~~~~~---- 222 (260)
T cd05067 155 NEY-TAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-E-VIQN---L-ERGYRM---- 222 (260)
T ss_pred CCc-ccccCCcccccccCHHHh-ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-H-HHHH---H-HcCCCC----
Confidence 221 111233456789999987 45568899999999999999999 99999654321 1 1111 1 111110
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..+...+..+.+++.+||+.+|++|||+++++..|+.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1223345578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=331.03 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=198.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|++..+++.||||++..... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 5667799999999999999998999999999965422 12335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 83 ~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 83 LPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999764 3589999999999999999999998 99999999999999999999999999987543211
Q ss_pred cc------------------------------------cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh
Q 002717 759 KH------------------------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT 802 (888)
Q Consensus 759 ~~------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt 802 (888)
.. .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-LQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH-cCCCCCCeeeeecchhHHHHhhc
Confidence 00 001124589999999988 55578999999999999999999
Q ss_pred CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002717 803 GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS---MAEVVQI 873 (888)
Q Consensus 803 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~ 873 (888)
|..||....... .............. + . .......+.+++.+|+. +|.+|++ ++|++++
T Consensus 235 G~~Pf~~~~~~~-----~~~~i~~~~~~~~~--~---~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQE-----TYRKIINWKETLQF--P---D-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHH-----HHHHHHcCCCccCC--C---C-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999997543211 11111111110000 0 0 11234467789999996 9999998 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=316.19 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=203.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
...|+..+.||+|+||.||+|....+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3456777789999999999999988899999999865443 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++++|.+++... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999998653 478899999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.. ......+++.|+|||.+ ....++.++|||||||++|||++|+.||........ ... ....+. +.
T Consensus 170 ~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~----~~~~~~------~~ 235 (296)
T cd06654 170 QS--KRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYL----IATNGT------PE 235 (296)
T ss_pred cc--ccCcccCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHH----HhcCCC------CC
Confidence 21 11334678899999987 455678999999999999999999999965432111 111 111110 00
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
...+......+.+++.+||..+|++|||+.|++++-
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred -CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 012334456688999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.16 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=197.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEe
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 677 (888)
|+..+.||+|+||.||+|++..+++.||+|.+...... ...+.+..|..++..+ .|++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 44567899999999999999988999999998654321 2234567788888877 58999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 82 YVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999998764 3588999999999999999999998 9999999999999999999999999998753321
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
. .......||+.|+|||++ ....++.++|||||||++|||++|+.||...... . + .+.... ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~-~---~~~i~~-~~-------- 217 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-E-L---FQSIME-HN-------- 217 (323)
T ss_pred C--CccccCCCChhhcCHHHh-cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-H-H---HHHHHh-CC--------
Confidence 1 122345789999999988 5557899999999999999999999999754321 1 1 111111 11
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSM-----AEVVQI 873 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~ 873 (888)
..++......+.+++.+|++.||++|++. .++.++
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 12334455678899999999999999984 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=324.88 Aligned_cols=239 Identities=23% Similarity=0.305 Sum_probs=189.9
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHH-HHhhcCCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVR-VLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|.+..+|+.||+|++...... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999999989999999998654221 22234555554 56778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 9999998763 4688899999999999999999998 99999999999999999999999999987532211 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... +..+...... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~----------~~~ 215 (323)
T cd05575 152 TTSTFCGTPEYLAPEVL-RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNKP----------LRL 215 (323)
T ss_pred ccccccCChhhcChhhh-cCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcCC----------CCC
Confidence 22345689999999988 5557899999999999999999999999653221 1111111110 012
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMA 868 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~ 868 (888)
+......+.+++.+|++.||++||+++
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 233455688999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=313.75 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=198.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
|+..+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.++++++||||+++++++..++..++|+||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 45667899999999999999889999999998654333344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+++|..+. .+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 83 GGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 99986542 367788899999999999999998 99999999999999999999999999997654321
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhh--HHHHHHHHHhcCCcccccCCCC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI--LSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
.....++..|+|||.+ ....++.++|||||||++|||++|+.||......... .....+...... .+..
T Consensus 150 --~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 220 (279)
T cd06619 150 --AKTYVGTNAYMAPERI-SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL 220 (279)
T ss_pred --ccCCCCChhhcCceee-cCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC
Confidence 1345688899999988 4556899999999999999999999999653221111 111111111110 1111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.......++.+++.+||+.+|++||+++|++++-+
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 11223456889999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=313.28 Aligned_cols=262 Identities=22% Similarity=0.361 Sum_probs=209.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+.|+..+.||+|+||+||+|.+..+|+.||+|++.........+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777889999999999999998889999999886554444567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++... ..+++..+..++.+++.|+.|||+.. +++||||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999998764 35889999999999999999999732 89999999999999999999999999986543211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCch------hhHHHHHHHHHhcCCccc
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV------VILSEHVRVLLEEGNVLD 832 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~------~~l~~~~~~~~~~~~~~~ 832 (888)
.....++..|+|||.+ ....++.++|||||||++||+++|+.||....... .......+......
T Consensus 159 ----~~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 159 ----ADTFVGTSTYMSPERI-QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred ----cCccccCcccCCHHHH-ccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 1345688999999987 44578899999999999999999999997543211 11112222221111
Q ss_pred ccCCCCCCCC-hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 833 CVDPSMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 833 ~~d~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
....+ ...+..+.+++.+||+.||++|||+.|++++..-++..
T Consensus 230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 230 -----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred -----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 11111 12445688999999999999999999999986555443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=312.02 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=208.5
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.+.|+..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|+.++++++||||+++++++.++...++||
T Consensus 2 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred hHHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45678888899999999999999988899999999865543444567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... ++++..+..++.|++.|++|+|+. +++|+||+|+||++++++.++++|||++.....
T Consensus 82 e~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 82 EYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999999998642 478889999999999999999998 999999999999999999999999999976543
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... ......++..|+|||.+ .+..++.++|||||||++|||++|..||......... . .....
T Consensus 154 ~~~--~~~~~~~~~~y~apE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~----~~~~~-------- 216 (277)
T cd06640 154 TQI--KRNTFVGTPFWMAPEVI-QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--F----LIPKN-------- 216 (277)
T ss_pred Ccc--ccccccCcccccCHhHh-ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--h----hhhcC--------
Confidence 221 11334577889999987 4556899999999999999999999998654321110 0 00110
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.....+...+..+.+++.+||+.+|++||++.+++.+-.-
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence 0112345566788999999999999999999999887543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.04 Aligned_cols=250 Identities=20% Similarity=0.275 Sum_probs=197.0
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|....+++.||+|++...... ...+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999999989999999999754322 2335678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 9999888754 4589999999999999999999998 99999999999999999999999999987532211 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchh-hHHHHHHHHHhcCCcccccCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV-ILSEHVRVLLEEGNVLDCVDPSMGD 840 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~~~~ 840 (888)
......||+.|+|||++ .+..++.++|||||||++|||++|+.||........ .............. ..
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~ 221 (327)
T cd05617 152 TTSTFCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---------IR 221 (327)
T ss_pred ceecccCCcccCCHHHH-CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---------CC
Confidence 12345789999999988 455789999999999999999999999964322111 11111111111111 11
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 002717 841 YPEDEVLPVLKLALVCTCHIPSSRPSM------AEVVQI 873 (888)
Q Consensus 841 ~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~ 873 (888)
.+......+.+++.+|++.||++|+++ .+++++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 234445667899999999999999984 576654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=307.50 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=200.4
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.+.|+..+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWN-GTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEc-CCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 345777789999999999999986 44569999875433 23467899999999999999999999875 455789999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.++++.. ....+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 81 FMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999764 234578999999999999999999998 9999999999999999999999999999765432
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... ......++..|+|||.. ....++.++|||||||++|||++ |..||...... ... .+. ..+..
T Consensus 156 ~~~-~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~-~~~----~~~~~------ 221 (260)
T cd05069 156 EYT-ARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVL-EQV----ERGYR------ 221 (260)
T ss_pred ccc-ccCCCccchhhCCHHHh-ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHH-HHH----HcCCC------
Confidence 211 11223456789999987 45568999999999999999999 88898653321 111 111 11110
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
...+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01233445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.38 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=193.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||+||+|....+++.||+|++..... ......+.+|+.++++++||+|+++++++.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 5667799999999999999988899999999865322 12235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 83 ~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 83 LPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999764 4689999999999999999999998 99999999999999999999999999987543211
Q ss_pred cc---------------------------------cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCC
Q 002717 759 KH---------------------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR 805 (888)
Q Consensus 759 ~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~ 805 (888)
.. .......||+.|+|||++ .+..++.++|||||||++|||++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF-MQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH-cCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 00 001234689999999998 45578899999999999999999999
Q ss_pred CCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 002717 806 PVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTC--HIPSSRPSMAEVVQI 873 (888)
Q Consensus 806 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~--~dp~~RPs~~evl~~ 873 (888)
||....... ..+......... .+.+. .....++.+++.+++. .++..||+++|++++
T Consensus 235 Pf~~~~~~~-----~~~~i~~~~~~~-~~p~~-----~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQE-----TYKKVMNWKETL-IFPPE-----VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHH-----HHHHHHcCcCcc-cCCCc-----CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 996543211 111111110000 01110 1123345566666433 334457999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.36 Aligned_cols=254 Identities=27% Similarity=0.337 Sum_probs=201.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||++.+..+++.||+|.+....... ..+.+.+|+.++++++|++|+++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345568999999999999999999999999986543222 234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999986542 24588999999999999999999988 99999999999999999999999999987544222
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. .....|+..|+|||.+ ....++.++||||+||++|||++|+.||........ ........... .
T Consensus 157 ~---~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~~---------~ 221 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEV---------Q 221 (285)
T ss_pred c---ccCCCCCccccChHHH-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhhh---------h
Confidence 1 1234688999999998 455689999999999999999999999975432110 01111111100 0
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQIL 874 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L 874 (888)
..++......+.+++..||+.||++||| ++|++++-
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 0123334456889999999999999999 88988854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=308.97 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=204.5
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
++.|+..+.||+|+||.||+|.+..+++.||+|.+..... .+++.+|++++++++||||+++++++......++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 4557778899999999999999987789999999854432 5789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++++|.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999999764 35689999999999999999999998 9999999999999999999999999999865432
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.. ......++..|+|||.+ .+..++.++|||||||++|||++|+.||........... ... ....
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~~------~~~~ 217 (256)
T cd06612 153 MA--KRNTVIGTPFWMAPEVI-QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IPN------KPPP 217 (256)
T ss_pred cc--ccccccCCccccCHHHH-hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hcc------CCCC
Confidence 21 12334578899999987 555788999999999999999999999975422211100 000 0000
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
....+......+.+++.+||+.+|++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 111233344578899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=316.70 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=203.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
|+..+.||+|+||.||++.+..++..+|+|.+.........+++.+|++++++++||||+++++++..++..++|+||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 56677899999999999999888999999988644333334568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+++|.+++... ..+++..+..++.|+++||.|||+.+ +++||||||+||++++++.+||+|||++......
T Consensus 83 ~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 83 GGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999764 45788999999999999999999732 8999999999999999999999999998754321
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcc---------
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL--------- 831 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~--------- 831 (888)
......++..|+|||.+ .+..++.++|||||||++|||++|+.||...... ................
T Consensus 154 -~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 -MANSFVGTRSYMSPERL-QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred -ccccCCCCcCccChhHh-cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCC
Confidence 12345678899999987 5556889999999999999999999998643211 1111110000000000
Q ss_pred ---------------cccCCCCCCCC-hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 832 ---------------DCVDPSMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 832 ---------------~~~d~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
..+....+..+ ......+.+++.+||+.+|++|||+.|++++..-..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000000011 123456889999999999999999999999875433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=287.46 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=206.0
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCeeeE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 674 (888)
++++. +....+|+|+.|.||+++++.+|..+|||.+......+..+++...++++..-. +|.||+.+|||..+...++
T Consensus 90 dindl-~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 90 DINDL-ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred ChHHh-hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 34443 344489999999999999999999999999988776667778888888877664 8999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
.||.|.. .....+... ..++++.-+-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|+||||++-.+
T Consensus 169 cMelMs~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccccee
Confidence 9999843 556666553 345888888899999999999999876 9999999999999999999999999999766
Q ss_pred cccccccccccccccccccCcccccC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (888)
.+.. ..+...|-+.|||||.+.- ...|+.++||||||++++|+.||+.||.....+-..+.+... ..
T Consensus 243 vdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln----~e---- 311 (391)
T KOG0983|consen 243 VDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN----EE---- 311 (391)
T ss_pred eccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh----cC----
Confidence 5433 2355677788999998743 346788999999999999999999999876666555554332 11
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 833 ~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.|.+.. ......++.+++..|+..|+.+||...+++++
T Consensus 312 --PP~L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 --PPLLPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --CCCCCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 122211 12245678899999999999999999998875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=325.77 Aligned_cols=240 Identities=25% Similarity=0.356 Sum_probs=192.7
Q ss_pred CeeccccceEEEEEEEC---CCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 605 AEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~---~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
+.||+|+||.||+++.. .+|+.||+|++...... .....+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 47999999999998863 46889999998654321 223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 152 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-- 152 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence 99999999764 4589999999999999999999998 99999999999999999999999999987643321
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 840 (888)
.......|++.|+|||.+ ....++.++|||||||++|||++|+.||...... .. ...... .. ..
T Consensus 153 ~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~----~~~i~~-~~---------~~ 216 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ET----MTMILK-AK---------LG 216 (318)
T ss_pred CceecccCChhhcCHHHH-cCCCCCCccceeccceEeeeeccCCCCCCCCCHH-HH----HHHHHc-CC---------CC
Confidence 112345789999999988 4456789999999999999999999999653221 11 111111 10 12
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHH
Q 002717 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAE 869 (888)
Q Consensus 841 ~~~~~~~~l~~li~~cl~~dp~~RPs~~e 869 (888)
++......+.+++.+||+.||++|||+.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 34445567889999999999999999444
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=312.60 Aligned_cols=263 Identities=26% Similarity=0.400 Sum_probs=199.3
Q ss_pred hhhhcCeeccccceEEEEEEE----CCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC--Ceee
Q 002717 600 LLEKAAEVGEGVFGTVYKVSF----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKL 673 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 673 (888)
.++..+.||+|+||.||+|.. ..+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 355667899999999999985 3468899999985443 22346788999999999999999999987543 4578
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999764 24589999999999999999999998 999999999999999999999999999987
Q ss_pred cccccccc-ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCch----------hhHHHHHH
Q 002717 754 LTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV----------VILSEHVR 822 (888)
Q Consensus 754 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~----------~~l~~~~~ 822 (888)
........ ......++..|+|||.. ....++.++|||||||++|||++|..|+....... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHh-ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 64332211 11122334569999987 45568899999999999999999877754321100 00000000
Q ss_pred HHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 823 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
....... ....+...+..+.+++.+||+.+|++|||+.|+++.|+.++
T Consensus 237 ~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 237 ELLKNNG--------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHhcCC--------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 1111110 11123345567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.85 Aligned_cols=254 Identities=30% Similarity=0.494 Sum_probs=202.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCCh-HHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||+++...+++.||+|++......... ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 45677899999999999999999999999999766533222 23356999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++++|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+||++++++.++|+|||.+.... ..
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN 151 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 999999999843 4689999999999999999999998 99999999999999999999999999997541 12
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC--chhhHHHHHHHHHhcCCcccccCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED--NVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
........++..|+|||........+.++||||+|+++|+|++|..||..... .................
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-------- 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--------
Confidence 22234567788999999984367889999999999999999999999976511 11111111110111000
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.........+.+++.+||+.||++|||+.|++++
T Consensus 224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011123679999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=323.54 Aligned_cols=263 Identities=25% Similarity=0.267 Sum_probs=197.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC------
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------ 670 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 670 (888)
.+.|+..+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 3557788899999999999999988899999999864422 223466789999999999999999999986543
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
..++||||+++ ++.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 56666643 378888999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHH----------
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH---------- 820 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~---------- 820 (888)
++..... .......+|+.|+|||.+ .+..++.++||||+||++|||++|+.||...... ..+...
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAE 244 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHH
Confidence 9754321 112345678999999988 5557899999999999999999999999754321 111111
Q ss_pred --------HHHHHhcCCccccc----------CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 821 --------VRVLLEEGNVLDCV----------DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 821 --------~~~~~~~~~~~~~~----------d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
++............ .+............+.+++.+|++.||++|||+.|++++-+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 11111110000000 00000011122356789999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=313.97 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=200.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|++|.||+|+...+++.||+|++..... ....+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 4556789999999999999988899999999854432 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
+ ++|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 82 S-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred C-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 7 68988887542 235689999999999999999999998 999999999999999999999999999875432211
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc-----------C
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE-----------G 828 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~-----------~ 828 (888)
......+++.|+|||.+.....++.++|||||||++|||+||+.||....... ......+..... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhH
Confidence 11233567889999987555567899999999999999999999997542211 111111100000 0
Q ss_pred Ccc----cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 NVL----DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ~~~----~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
... ................++.+++.+||..||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 000000001112244567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=328.23 Aligned_cols=257 Identities=20% Similarity=0.183 Sum_probs=195.9
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.|...+.||+|+||.||+|.+...++.||||... ...+.+|++++++++|+|||++++++...+..++|||++
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 3666778999999999999999889999999632 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
. ++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 5 7888888654 23689999999999999999999998 999999999999999999999999999986543222
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCc------hhhHHHHHHHHHhcCCcccc
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN------VVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~------~~~l~~~~~~~~~~~~~~~~ 833 (888)
........||+.|+|||++ .+..++.++|||||||++|||++|..|+...... ...+...++.. +....-
T Consensus 316 ~~~~~~~~GT~~Y~APE~~-~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~---~~~~~~ 391 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVL-AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA---QVHVDE 391 (461)
T ss_pred cccccccCCCcCCcCHHHH-cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh---cccccc
Confidence 2222345689999999988 5557899999999999999999988765432111 11122222111 000000
Q ss_pred cCC-----------------CCCCCCh-------hhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 834 VDP-----------------SMGDYPE-------DEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 834 ~d~-----------------~~~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
+.+ ....... .....+.+++.+|++.||++|||+.|++++-
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 000 0000000 1223577899999999999999999999863
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=344.47 Aligned_cols=258 Identities=19% Similarity=0.299 Sum_probs=201.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEc--CCeeeEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 675 (888)
..|++.+.||+|+||.||+|.+...+..||+|.+...... .....|..|+.++++++|||||++++++.. ....++|
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 3467788999999999999999989999999998644322 234678899999999999999999998854 3467999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCC----CCeEecCCCCCcEEecC------------
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR----PPIIHYNLKPSNILLDD------------ 739 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivHrdlk~~Nill~~------------ 739 (888)
|||+++|+|.++|.........+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 99999999999998754444579999999999999999999998521 25999999999999964
Q ss_pred -----CCCcEEecccccccccccccccccccccccccccCcccccC-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCc
Q 002717 740 -----NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ-SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN 813 (888)
Q Consensus 740 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~ 813 (888)
...+||+|||+++.+.... ......||+.|+|||++.. ...++.++|||||||++|||+||..||......
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred cccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 2348999999997654221 1234578999999998743 345789999999999999999999999754332
Q ss_pred hhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 814 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.. .+.. +.... ... ....+..+.++|..||..+|++|||+.|++.+
T Consensus 250 ~q----li~~-lk~~p-------~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 250 SQ----LISE-LKRGP-------DLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HH----HHHH-HhcCC-------CCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 21 1111 11111 000 11234568899999999999999999999953
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.40 Aligned_cols=242 Identities=22% Similarity=0.263 Sum_probs=190.3
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHH-HHHhhcCCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREV-RVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|++..+++.||+|++...... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999999988999999998643221 1223444444 456778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|.+++... ..+.+..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~ 151 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--G 151 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--C
Confidence 9999999764 4577888889999999999999998 99999999999999999999999999997533211 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... . ..+...... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~----~~~~i~~~~----------~~~ 215 (325)
T cd05602 152 TTSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-E----MYDNILNKP----------LQL 215 (325)
T ss_pred CcccccCCccccCHHHH-cCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-H----HHHHHHhCC----------cCC
Confidence 22445789999999988 5567889999999999999999999999643221 1 111111110 012
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMAEVV 871 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl 871 (888)
+......+.+++.+|++.||.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 234455688999999999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=307.69 Aligned_cols=240 Identities=20% Similarity=0.280 Sum_probs=188.5
Q ss_pred eeccccceEEEEEEECCC------------CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 606 EVGEGVFGTVYKVSFGTQ------------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
.||+|+||.||+|++..+ ...||+|.+.... ......|.+|+.+++.++||||+++++++..+...+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 689999999999986422 2358888875432 234467889999999999999999999999988999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCC-------cEEe
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN-------PRIS 746 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-------~kl~ 746 (888)
+||||+++|+|..++... ...+++..+++++.|+++||+|||+. +|+||||||+||+++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988754 34589999999999999999999998 9999999999999986654 8999
Q ss_pred cccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCchhhHHHHHHHHH
Q 002717 747 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELV-TGRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 747 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ell-tg~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
|||++...... ....++..|+|||.+.....++.++|||||||++|||+ +|..||....... . ....
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~-~~~~ 222 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----K-ERFY 222 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----H-HHHH
Confidence 99998654321 23456788999998855667899999999999999998 5777775432111 0 1111
Q ss_pred hcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
. +.. .........+.+++.+||+.||++||++.++++++
T Consensus 223 ~-~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 E-GQC---------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred h-cCc---------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 100 01122245688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=307.59 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=200.3
Q ss_pred CeeccccceEEEEEEECC-CC--eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGT-QG--RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~-~~--~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|++|.||+|.+.. .+ ..||+|.+.........+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999864 33 36899998665443445788999999999999999999999988 888999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc-
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH- 760 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 760 (888)
|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987532 4689999999999999999999998 9999999999999999999999999999876543221
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
.......++..|+|||.+ ....++.++|||||||++|||++ |..||....... ..+ ........ .
T Consensus 155 ~~~~~~~~~~~y~~pE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~---~~~~~~~~--------~ 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESL-RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILK---KIDKEGER--------L 220 (257)
T ss_pred ecccCCCCCceecCHHHh-cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHH---HHHhcCCc--------C
Confidence 112234567889999987 55578999999999999999999 999986432211 111 11111110 1
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
..+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 123344567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.32 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=196.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|....+++.||||++..... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 5567799999999999999998999999999864321 12335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 83 ~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 83 LPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999764 4578889999999999999999998 99999999999999999999999999996432110
Q ss_pred cc---------------------------------------------cccccccccccccCcccccCcCCCCCcchHHHH
Q 002717 759 KH---------------------------------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGF 793 (888)
Q Consensus 759 ~~---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~ 793 (888)
.. .......||+.|+|||++ ....++.++|||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSl 234 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF-LQQGYGQECDWWSL 234 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH-ccCCCCCceeeEec
Confidence 00 000124689999999988 55578999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCC---CCHHHH
Q 002717 794 GVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSR---PSMAEV 870 (888)
Q Consensus 794 Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~ev 870 (888)
||++|||++|..||...... ... +.......... .+. .......+.+++.+|+. +|.+| +|+.|+
T Consensus 235 Gvil~elltG~~Pf~~~~~~-~~~----~~i~~~~~~~~-----~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSH-ETY----RKIINWRETLY-----FPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred chhhhhhhcCCCCCCCCCHH-HHH----HHHHccCCccC-----CCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 99999999999999654321 111 11111110000 001 11234567889999997 66665 699999
Q ss_pred HHHH
Q 002717 871 VQIL 874 (888)
Q Consensus 871 l~~L 874 (888)
+.+-
T Consensus 303 l~hp 306 (377)
T cd05629 303 KSHP 306 (377)
T ss_pred hcCC
Confidence 8874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=331.86 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=196.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|++.+.||+|+||.||+|+...+++.||||.+..... ....+.+.+|++++++++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 5677899999999999999998999999999854322 12345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 83 IPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999764 3578888899999999999999998 99999999999999999999999999975321000
Q ss_pred -----------------------------------------cccccccccccccccCcccccCcCCCCCcchHHHHHHHH
Q 002717 759 -----------------------------------------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLI 797 (888)
Q Consensus 759 -----------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l 797 (888)
.........||+.|+|||++ .+..++.++|||||||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-cCCCCCcceeeeecccee
Confidence 00001234689999999988 555789999999999999
Q ss_pred HHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 002717 798 LELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP---SMAEVVQI 873 (888)
Q Consensus 798 ~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~evl~~ 873 (888)
|||++|+.||......... ........... .+ ........+.+++.+|+ .+|.+|+ |+.|++.+
T Consensus 235 yell~G~~Pf~~~~~~~~~-----~~i~~~~~~~~--~~----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQ-----LKVINWETTLH--IP----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHHHHH-----HHHhccCcccc--CC----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999754332111 11111000000 00 11223445667777876 5999999 89999887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=312.57 Aligned_cols=252 Identities=26% Similarity=0.311 Sum_probs=200.1
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
+..+.||+|+||+||+|.+..+++.||+|.+...... ...+.+.+|+++++.++|++|+++.+++..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 4456899999999999999989999999998654322 12345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 83 NGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred cCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999887642 34689999999999999999999998 999999999999999999999999999875432211
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
.....|+..|+|||.+ .+..++.++|+||+||++|||++|..||....... .... +........ .
T Consensus 158 ---~~~~~g~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~-~~~~~~~~~---------~ 222 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVL-NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREE-VDRRVLETE---------E 222 (285)
T ss_pred ---ccCCCCCcCccChHHh-cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhhccc---------c
Confidence 1334688999999988 45578999999999999999999999997543211 1111 111111110 1
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQI 873 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 873 (888)
.++......+.+++.+||+.||++||| +.+++.+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 123334456789999999999999999 7777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.81 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=189.6
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHH-HHhhcCCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVR-VLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|++..+++.||+|++...... .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999989999999998644221 22334555554 57888999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 9999888753 4578888999999999999999998 99999999999999999999999999987532211 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......|++.|+|||.+ ....++.++|||||||++|||++|+.||..... ... ...... .. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~---~~~i~~-~~---------~~~ 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVL-RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQM---YDNILH-KP---------LQL 215 (321)
T ss_pred ccccccCCcccCCHHHh-cCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--HHH---HHHHhc-CC---------CCC
Confidence 22445689999999988 455788999999999999999999999965421 111 111111 10 123
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMA 868 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~ 868 (888)
+......+.+++.+|++.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 344556788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.57 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=198.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEE-cCCeeeEEEec
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW-TPQLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~ 678 (888)
.|+..+.||+|+||.||++.. .|+.||+|.+... ...+.+.+|+.++++++|+|++++++++. .++..++|+||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 456677899999999999987 4888999987533 23567899999999999999999999865 44568999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++.... ...+++..++.++.|++.|++|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999998642 34588999999999999999999998 99999999999999999999999999987543211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
....++..|+|||++ ....++.++|||||||++|||++ |+.||..... ...... +..+...
T Consensus 157 -----~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~~------ 218 (256)
T cd05082 157 -----DTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPR----VEKGYKM------ 218 (256)
T ss_pred -----CCCccceeecCHHHH-ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HhcCCCC------
Confidence 223445689999987 55578899999999999999998 8999864321 111111 1111111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 --DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 12334556788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=312.71 Aligned_cols=260 Identities=25% Similarity=0.368 Sum_probs=203.1
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEE-----cC
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYW-----TP 669 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~ 669 (888)
+..+.|+..+.||+|+||.||+|....+++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++. .+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 45566778889999999999999998889999999875432 2346788999999999 6999999999884 33
Q ss_pred CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 670 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 670 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
+..++||||+++++|.+++.........+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++++|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCC
Confidence 467999999999999999876444456788999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
+++....... ......|+..|+|||++.. ...++.++||||+||++|||++|+.||........ +.. .
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~----~- 241 (286)
T cd06638 170 VSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFK----I- 241 (286)
T ss_pred ceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhh----c-
Confidence 9876543211 1234468899999998742 23478899999999999999999999865432111 100 0
Q ss_pred hcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.... .+.. ..+......+.+++.+||+.||++|||+.|++++.
T Consensus 242 ~~~~-----~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 PRNP-----PPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccC-----CCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000 0000 11223345688999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=318.16 Aligned_cols=200 Identities=27% Similarity=0.382 Sum_probs=162.3
Q ss_pred cCeeccccceEEEEEEEC--CCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEc--CCeeeEEEecC
Q 002717 604 AAEVGEGVFGTVYKVSFG--TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLVSDYA 679 (888)
Q Consensus 604 ~~~ig~G~~g~V~~~~~~--~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 679 (888)
+++||+|+||.||+|++. .+++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 458999999999999975 356889999885432 23567899999999999999999998864 34578999998
Q ss_pred CCCCHHHHHhhcCC-----CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEe----cCCCCcEEecccc
Q 002717 680 PNGSLQAKLHERLP-----STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGL 750 (888)
Q Consensus 680 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfgl 750 (888)
. ++|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 588888764321 123588899999999999999999998 99999999999999 4567899999999
Q ss_pred cccccccccc-cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 002717 751 ARLLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG 810 (888)
Q Consensus 751 a~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~ 810 (888)
++........ .......+|+.|+|||++.....++.++||||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9865432211 11234578899999998866566899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=324.99 Aligned_cols=256 Identities=20% Similarity=0.276 Sum_probs=199.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.|+..+.||+|+||.||+|++..+++.||+|.+.+.... ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4567778999999999999999988999999998643221 22355789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 123 EYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred cCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999753 478888999999999999999998 999999999999999999999999999986543
Q ss_pred cccccccccccccccccCcccccCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.. ........||+.|+|||++... ..++.++||||+||++|||++|+.||...... .. ............
T Consensus 195 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~----~~~i~~~~~~~~- 267 (370)
T cd05621 195 TG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GT----YSKIMDHKNSLN- 267 (370)
T ss_pred CC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HH----HHHHHhCCcccC-
Confidence 22 1122456799999999987432 23788999999999999999999999654221 11 111111111000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQIL 874 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L 874 (888)
.+. .......+.+++..|+..++.+ |+|+.|++++-
T Consensus 268 ----~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 268 ----FPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred ----CCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 000 1123455778888999755543 89999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.98 Aligned_cols=259 Identities=23% Similarity=0.364 Sum_probs=205.6
Q ss_pred CChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 595 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
..+.+.|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 346678999999999999999999998889999999985433 2335678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
||||++++++..++... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 87 MIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999998887653 24589999999999999999999998 9999999999999999999999999998654
Q ss_pred cccccccccccccccccccCcccccC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
... ........+++.|+|||++.. ...++.++|||||||++|||++|..||....... .........
T Consensus 161 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~-- 231 (292)
T cd06644 161 VKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSE-- 231 (292)
T ss_pred ccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HHHHHhcCC--
Confidence 321 111234457788999998742 3346789999999999999999999986533211 111111110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 831 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.+.. ..+.....++.+++.+||+.+|++||+++|++++-
T Consensus 232 ----~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 270 (292)
T cd06644 232 ----PPTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHP 270 (292)
T ss_pred ----CccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111 11334455688999999999999999999998753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.58 Aligned_cols=253 Identities=20% Similarity=0.277 Sum_probs=193.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|+...+++.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 5667799999999999999998999999999865432 12345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 83 IPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999999764 3578888999999999999999998 99999999999999999999999999975321000
Q ss_pred c---------------------------------------------ccccccccccccccCcccccCcCCCCCcchHHHH
Q 002717 759 K---------------------------------------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGF 793 (888)
Q Consensus 759 ~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~ 793 (888)
. ........||+.|+|||++ .+..++.++||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSl 234 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSV 234 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh-cCCCCCCeeeEEec
Confidence 0 0001234689999999988 45578999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC---HHHH
Q 002717 794 GVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS---MAEV 870 (888)
Q Consensus 794 Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~ev 870 (888)
||++|||++|+.||........ ... ........ -.+. .......+.+++.+|+ .+|++|++ +.|+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~-~~~----i~~~~~~~--~~p~----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLET-QMK----VINWQTSL--HIPP----QAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHH-HHH----HHccCCCc--CCCC----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999999975432111 111 11100000 0010 1122345666776665 59999997 8888
Q ss_pred HHH
Q 002717 871 VQI 873 (888)
Q Consensus 871 l~~ 873 (888)
+.+
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.88 Aligned_cols=240 Identities=21% Similarity=0.316 Sum_probs=189.9
Q ss_pred eeccccceEEEEEEECCCCe-------EEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 606 EVGEGVFGTVYKVSFGTQGR-------MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~~~-------~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
.||+|+||.||+|.....+. .||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 68999999999999865443 48888774332 23346788999999999999999999999998889999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCC--------cEEecccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN--------PRISDFGL 750 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--------~kl~Dfgl 750 (888)
+++|+|.++++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999864 23688999999999999999999998 9999999999999987765 59999998
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR-RPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~-~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
+...... ....++..|+|||.+.....++.++|||||||++|||++|. .|+..... ... .. .....
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~----~~-~~~~~- 221 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKK----LQ-FYEDR- 221 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHH----HH-HHHcc-
Confidence 8654321 23456788999999855556789999999999999999985 45433221 111 11 11110
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
...+.....++.+++.+||+.+|++|||++++++.|
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 122334446789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=308.49 Aligned_cols=257 Identities=24% Similarity=0.344 Sum_probs=203.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.+.|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 4456788889999999999999998889999999986443 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++++|.+++... ..+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 86 EFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred eccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 999999999998764 4588999999999999999999998 999999999999999999999999999876542
Q ss_pred cccccccccccccccccCccccc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 757 LDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
. ........|+..|+|||.+. ....++.++||||+||++|||++|..||......... ... ......
T Consensus 159 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~-----~~~~~~--- 227 (267)
T cd06645 159 T--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLM-----TKSNFQ--- 227 (267)
T ss_pred c--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-Hhh-----hccCCC---
Confidence 2 11123456889999999863 2345788999999999999999999998654322111 110 001100
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.+.... ....+..+.+++.+|++.+|++|||+++++++
T Consensus 228 ~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 PPKLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCcccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 011111 11234468899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.83 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=204.6
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.+.|+..+.||+|+||.||+|....+++.+|+|.+..... ...+.+.+|++++++++||||+++++++......+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 3456777899999999999999988889999999865432 245788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++++|.+++... ...+++..++.++.|++.|+.|||+. +++|+||+|+||++++++.+||+|||.+......
T Consensus 81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999998764 24688999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQS--LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.. ......++..|+|||.+... ..++.++|||||||++|||++|+.||.......... .. .... +.
T Consensus 155 ~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-----~~-~~~~----~~ 222 (262)
T cd06613 155 IA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-----LI-SKSN----FP 222 (262)
T ss_pred hh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HH-Hhcc----CC
Confidence 11 11334677889999987332 267889999999999999999999996543221111 11 1110 01
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+.....+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111233445678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.89 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=202.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+.|+..+.||+|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 3456777999999999999998 488999999865432 457889999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999998752 23689999999999999999999998 99999999999999999999999999998653211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.....+..|+|||.+ ....++.++||||||+++||+++ |..||..... ..+...+ ..+..
T Consensus 157 -----~~~~~~~~~~ape~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~----~~~~~------- 217 (256)
T cd05039 157 -----DSGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHV----EKGYR------- 217 (256)
T ss_pred -----ccCCCcccccCchhh-cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH----hcCCC-------
Confidence 123345679999987 44568889999999999999997 9999864422 1111111 11111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
...+...+..+.+++.+||..+|++|||++|+++.|+.+
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 -MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 112334456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=311.54 Aligned_cols=240 Identities=20% Similarity=0.288 Sum_probs=187.5
Q ss_pred eeccccceEEEEEEECCC------------------------CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcce
Q 002717 606 EVGEGVFGTVYKVSFGTQ------------------------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~------------------------~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 661 (888)
.||+|+||.||+|.+..+ ...||+|.+.... ......|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 589999999999986321 2458888875432 223456888999999999999999
Q ss_pred eeeEEEcCCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC
Q 002717 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 741 (888)
Q Consensus 662 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 741 (888)
+++++......++||||+++|+|..++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++.+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 999999999999999999999999998753 34688999999999999999999998 999999999999997643
Q ss_pred -------CcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCc
Q 002717 742 -------NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELV-TGRRPVEYGEDN 813 (888)
Q Consensus 742 -------~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ell-tg~~p~~~~~~~ 813 (888)
.+|++|||.+...... ....++..|+|||.+.....++.++|||||||++||++ +|+.||......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 3799999988643221 22346778999998855566899999999999999995 688888654222
Q ss_pred hhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 814 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.. .. ...... ..+......+.+++.+||+.+|++|||+.++++.|
T Consensus 229 ~~--~~----~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 EK--ER----FYEKKH----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HH--HH----HHHhcc----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11 11 111110 11222234688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=311.80 Aligned_cols=263 Identities=28% Similarity=0.401 Sum_probs=204.1
Q ss_pred hhhhcCeeccccceEEEEEEECC----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEc--CCeee
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGT----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKL 673 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 673 (888)
.++..+.||+|+||.||+|++.. +++.||||.+.........+.|.+|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 35566789999999999999743 4789999998655432235689999999999999999999999877 55789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 85 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999864 23589999999999999999999998 999999999999999999999999999987
Q ss_pred ccccccc-cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhh---------HHHHHHH
Q 002717 754 LTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI---------LSEHVRV 823 (888)
Q Consensus 754 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~---------l~~~~~~ 823 (888)
....... .......++..|+|||.. ....++.++||||||+++|||++|+.|+......... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECL-RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHH-ccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 6532221 111223445679999987 4457889999999999999999999998653221100 0111111
Q ss_pred HHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 824 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 824 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
....... ...+..++..+.+++.+||+.+|++||||.|++++|+.+
T Consensus 238 ~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGER--------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCc--------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111 011233446789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.39 Aligned_cols=265 Identities=17% Similarity=0.246 Sum_probs=196.3
Q ss_pred cCeeccc--cceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 604 AAEVGEG--VFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 604 ~~~ig~G--~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
.++||+| +||+||++..+.+|+.||+|++...... ...+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4578999 7899999999999999999998654322 223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+.........
T Consensus 83 ~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 83 YGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999997642 23588999999999999999999998 9999999999999999999999999865433211110
Q ss_pred -----cccccccccccccCcccccCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHh--------
Q 002717 761 -----VMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE-------- 826 (888)
Q Consensus 761 -----~~~~~~~g~~~y~aPE~~~~~-~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~-------- 826 (888)
.......++..|+|||++... ..++.++|||||||++|||++|+.||............ ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccch
Confidence 011223466779999988543 45789999999999999999999999754322211111 000000
Q ss_pred -cC-----CcccccCCC------------------CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 827 -EG-----NVLDCVDPS------------------MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 827 -~~-----~~~~~~d~~------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.. ......+.. ...........+.+++.+||+.||++|||++|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 00 000000000 0001122345688999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.30 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=199.3
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCH
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 684 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 684 (888)
+.||+|+||.||+|.+.. ++.||+|.+.........+.+.+|++++++++|+||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 368999999999999975 9999999886554333456789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccc
Q 002717 685 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764 (888)
Q Consensus 685 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 764 (888)
.+++... ...+++..+..++.+++.|++|||+. +++||||+|+||+++.++.+||+|||.++............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9999764 23578899999999999999999998 99999999999999999999999999997654222111112
Q ss_pred cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCCh
Q 002717 765 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 843 (888)
Q Consensus 765 ~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 843 (888)
....+..|+|||.+ .+..++.++|||||||++|||+| |..||...... ..... ...... ...+.
T Consensus 154 ~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~----~~~~~~--------~~~~~ 218 (251)
T cd05041 154 LKQIPIKWTAPEAL-NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRER----IESGYR--------MPAPQ 218 (251)
T ss_pred cCcceeccCChHhh-ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHH----HhcCCC--------CCCCc
Confidence 22335679999987 45578999999999999999999 78888654321 11111 111110 01233
Q ss_pred hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 844 DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 844 ~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..+..+.+++.+||..+|++|||+.|+++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 445678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=307.38 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=215.8
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC-ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
..|...+.||+|.|+.|..|++.-+|++||||++.+.+... ....+.+|+..|+.++|||||++|.+...+...|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777888999999999999999999999999996655443 23567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec-CCCCcEEecccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTR 756 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgla~~~~~ 756 (888)
.-++|+|.+||-++ ...+.++...++++||..|+.|.|+. .+||||+||+||.+- +-|-||+.|||++..+.+
T Consensus 98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999876 35689999999999999999999998 899999999999775 678999999999987776
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
+... .+.+|+..|-|||++.+..+..++.||||+||++|-+++|+.||....+.+ .+.. +++|-
T Consensus 172 G~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-TLTm----------ImDCK-- 235 (864)
T KOG4717|consen 172 GKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-TLTM----------IMDCK-- 235 (864)
T ss_pred cchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-hhhh----------hhccc--
Confidence 5543 567899999999999888777899999999999999999999997665432 1211 11221
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
-..|.....+..+||.+|+..||++|.|.+|++..-|
T Consensus 236 --YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 236 --YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred --ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 1247777888999999999999999999999987654
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.17 Aligned_cols=240 Identities=23% Similarity=0.284 Sum_probs=189.9
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHH-HHhhcCCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVR-VLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|+...+|+.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 368999999999999998999999999864421 122344555554 46778999999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 151 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--D 151 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--C
Confidence 9999888753 4688999999999999999999998 99999999999999999999999999987532211 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......|++.|+|||++ .+..++.++|||||||++|||++|+.||...... +..+...... . ..
T Consensus 152 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~~~-~---------~~ 215 (325)
T cd05604 152 TTTTFCGTPEYLAPEVI-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILHKP-L---------VL 215 (325)
T ss_pred CcccccCChhhCCHHHH-cCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHcCC-c---------cC
Confidence 12345689999999988 5557889999999999999999999999754321 1111111111 0 11
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMAE 869 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~e 869 (888)
+......+.+++.+|++.+|++||++++
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2234456789999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.39 Aligned_cols=241 Identities=23% Similarity=0.328 Sum_probs=192.8
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCeeeEEEec
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+..+.||+|+||.||+|....+|+.||+|++..... ....+.+..|..+++.+. |++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 345689999999999999998999999999865321 223356778999998885 57788899999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 83 VNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999998764 4589999999999999999999998 99999999999999999999999999987532211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
.......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... ...+......
T Consensus 156 --~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i~~~~---------- 217 (323)
T cd05615 156 --VTTRTFCGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELFQSIMEHN---------- 217 (323)
T ss_pred --ccccCccCCccccCHHHH-cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC----------
Confidence 122345689999999988 4556899999999999999999999999754321 1111111111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSM 867 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 867 (888)
..++......+.+++.+|++.+|++|++.
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12233445678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.12 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=196.1
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCHH
Q 002717 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 685 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 685 (888)
.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 15 ~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 7999999999999998888999999875443 223467889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCC--ChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC-CCCcEEecccccccccccccccc
Q 002717 686 AKLHERLPSTPPL--SWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLDKHVM 762 (888)
Q Consensus 686 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~ 762 (888)
+++.... ..+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||.+........ .
T Consensus 94 ~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~ 165 (268)
T cd06624 94 ALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--C 165 (268)
T ss_pred HHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--c
Confidence 9998642 234 7788889999999999999998 9999999999999986 67999999999876542221 1
Q ss_pred cccccccccccCcccccCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 763 SNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 763 ~~~~~g~~~y~aPE~~~~~-~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
.....++..|+|||.+... ..++.++|||||||++|||++|+.||............ .. ........
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~--~~----------~~~~~~~~ 233 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--VG----------MFKIHPEI 233 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh--hh----------hhccCCCC
Confidence 1234578899999987433 34788999999999999999999999653322111110 00 00111123
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+......+.+++.+||+.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 44455678899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=311.77 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=206.7
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
.|.+.|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|
T Consensus 2 ~~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred CchhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35677889999999999999999998889999999985442 22346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|||+++++|.+++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 81 IEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999999998764 24689999999999999999999998 99999999999999999999999999986543
Q ss_pred ccccccccccccccccccCccccc----CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (888)
... .......++..|+|||.+. ....++.++|||||||++|||++|+.||....... .. ... ..+..
T Consensus 155 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~----~~~-~~~~~- 225 (280)
T cd06611 155 STL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VL----LKI-LKSEP- 225 (280)
T ss_pred ccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HH----HHH-hcCCC-
Confidence 211 1123446788999999863 23446789999999999999999999996542211 11 111 11100
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 832 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
+.. ..+......+.+++.+||+.+|++||++.+++++-.
T Consensus 226 ----~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 226 ----PTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred ----CCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 011 113334556889999999999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=323.49 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=197.1
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCc---cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCe--eeEEEec
Q 002717 604 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL--KLLVSDY 678 (888)
Q Consensus 604 ~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 678 (888)
..+||+|+|-+||+|.+..+|..||--.++..+. ++..+.|..|+.+|+.++|||||+++.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 4479999999999999988898887654433322 2334689999999999999999999999987665 6799999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC-CCCcEEeccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRL 757 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~~~ 757 (888)
+..|+|..|..+. ...+...+..|++||++||.|||++ +|+|+|||||.+||+++. .|.|||+|.|+|+.....
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999986 4577789999999999999999997 899999999999999984 589999999999876542
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
. .....|||.|||||.+ . ..|++..||||||+++.||+|+.+||.-......++.+ . ..|..-+.+.
T Consensus 200 ~----aksvIGTPEFMAPEmY-E-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK----V-~SGiKP~sl~-- 266 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMY-E-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK----V-TSGIKPAALS-- 266 (632)
T ss_pred c----cceeccCccccChHHH-h-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH----H-HcCCCHHHhh--
Confidence 2 1347899999999987 3 57999999999999999999999999765444333322 1 1111111110
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
... ...+.++|.+|+.. ..+|||+.|++.+
T Consensus 267 --kV~---dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 --KVK---DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred --ccC---CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111 22478999999999 9999999999974
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.86 Aligned_cols=266 Identities=23% Similarity=0.244 Sum_probs=200.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+.|+..+.||+|+||.||+|....+++.||+|++...........+.+|+.+++.++|+||+++++++..++..++|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 34667779999999999999998889999999986554444445778999999999999999999999999899999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+. +++.+++... ...+.+..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 85 MH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred cc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 95 6777777543 23467888899999999999999998 99999999999999999999999999987543211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH-----------hc
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL-----------EE 827 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~-----------~~ 827 (888)
.. .....++..|+|||.+.....++.++|||||||++|||++|+.||.........+.+.+.... ..
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 QT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 11 123356788999998755556788999999999999999999999765443333222211100 00
Q ss_pred CCccccc-----CCCCCCC--ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 828 GNVLDCV-----DPSMGDY--PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 828 ~~~~~~~-----d~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
....... ....... .......+.+++.+|+..||++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000 0000000 00123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=312.55 Aligned_cols=262 Identities=24% Similarity=0.279 Sum_probs=195.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhc---CCCCcceeeeEEEcC-----Ce
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKA---RHPNLISLEGYYWTP-----QL 671 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~~ 671 (888)
|+..+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.+ +||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 45667899999999999999989999999998653322 2234566788777766 699999999988642 34
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 751 (888)
.++|+||++ ++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 689999997 48988887642 34589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc---C
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE---G 828 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~---~ 828 (888)
+...... ......++..|+|||++ .+..++.++||||+||++|||++|+.||..... ...+.+........ .
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVL-LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc---cCCCccccccccCchHh-hCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-HHHHHHHHHHhCCCChhh
Confidence 7654221 11334678899999988 455689999999999999999999999865432 22222222111000 0
Q ss_pred Cc------ccccCCCC----CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 NV------LDCVDPSM----GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ~~------~~~~d~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.. ...+.+.. ..........+.+++.+|++.||++|||+.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00001000 01122345567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.45 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=206.9
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
++++.|+..+.||+|+||.||+|.+..+++.||+|...........+.+.+|+.++++++||||+++++++..+...++|
T Consensus 1 ~~~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred CHHHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 35677888889999999999999998889999999876544434456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
+||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 81 MEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 152 (277)
T ss_pred EEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecc
Confidence 999999999999864 3578999999999999999999998 99999999999999999999999999987654
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.... ......++..|+|||.. ....++.++|||||||++|||++|..||...... ..... .....
T Consensus 153 ~~~~--~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~------ 217 (277)
T cd06641 153 DTQI--KRNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL-IPKNN------ 217 (277)
T ss_pred cchh--hhccccCCccccChhhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH-HhcCC------
Confidence 3221 11234577889999987 4556789999999999999999999998643221 11111 11111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
....+...+..+.+++.+||+.+|++||++.+++++-
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 218 --PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred --CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 1112334556788999999999999999999999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.10 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=203.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
+.+...+.||+|+||.||+|.+... ...||+|........+..+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 3456677999999999999998533 346899987554433445678999999999999999999998875 456899
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|||+++|+|.+++... ...+++..++.++.|++.|+.|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999764 23589999999999999999999998 99999999999999999999999999997654
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
...... .....++..|+|||.+ ....++.++|||||||++||+++ |..||....... .. .. +..+...
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~-~~----~~~~~~~--- 227 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-VI-GR----IENGERL--- 227 (270)
T ss_pred ccccee-cCCCCccccccChhhh-ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-HH-HH----HHcCCcC---
Confidence 332211 1223345679999987 45568899999999999999986 999996543221 11 11 1111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
..+...+..+.+++.+||..+|++|||+.|+++.|+.+...
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 12344556789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=312.05 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=204.2
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.|+..+.||+|+||.||+|.+..+++.||+|.+.........+.+.+|+.++++++||||+++++++..++..++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 36777899999999999999988999999998864432233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++++|.+++.... ....+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999887632 2346899999999999999999999632 89999999999999999999999999987553211
Q ss_pred ccccccccccccccCcccccCc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 760 HVMSNRFQSALGYVAPELTCQS-----LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
.....++..|+|||.+... ..++.++|||||||++|||++|+.||....... .........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~--------- 223 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSAIV--------- 223 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHHHh---------
Confidence 1334577889999987332 235789999999999999999999996532211 111111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
+......+.....++.+++.+||+.+|++||++.+++.+-+
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 11112234446667889999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.59 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=204.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
..|+..+.||.|+||.||+|....+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 34667778999999999999998899999999986443 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|..++... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999988753 488999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
.. .....++..|+|||.+ ....++.++|||||||++|+|++|+.||........ ... ... ... ..
T Consensus 170 ~~--~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~----~~~-~~~------~~ 234 (296)
T cd06655 170 SK--RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL----IAT-NGT------PE 234 (296)
T ss_pred cc--CCCcCCCccccCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH----HHh-cCC------cc
Confidence 21 1334678899999987 455688999999999999999999999965433211 111 111 100 00
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
...+......+.+++.+||..||++|||+.+++.+=
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 112334455688999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.52 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=204.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.+.|+..+.||+|+||.||+|.+. +++.||||.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 345677789999999999999986 56789999986443 245789999999999999999999999998888999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++++|.+++... ....+++..+..++.|++.|++|||+. +++|+||||+||++++++.+|++|||.++.....
T Consensus 82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999874 234689999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.. ........+..|+|||.+ .+..++.++||||+||++||+++ |+.||..... ...+.. .. .+..
T Consensus 157 ~~-~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~----~~-~~~~------ 222 (261)
T cd05034 157 EY-TAREGAKFPIKWTAPEAA-NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQ----VE-RGYR------ 222 (261)
T ss_pred hh-hhhhccCCCccccCHHHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH----HH-cCCC------
Confidence 11 111223345679999988 45568899999999999999999 9999864322 111111 11 1100
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
...+...+..+.+++.+|++.+|++||+++|+++.|+.
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 --MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01123335678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=308.62 Aligned_cols=254 Identities=28% Similarity=0.382 Sum_probs=205.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
|+..+.||+|+||.||+|.+..+++.||+|++.........+++.+|++++++++||||+++++++..+...++|+||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 45566899999999999999988999999998665444445678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
+++|.+++.... ..+++..+..++.|+++|++|||+ . +++||||||+||++++++.++|+|||.+........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 83 GGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999998642 568889999999999999999998 7 999999999999999999999999999875532111
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
....++..|+|||.+ .+..++.++||||||+++|+|++|+.||.............++...... ..
T Consensus 157 ----~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~ 222 (265)
T cd06605 157 ----KTFVGTSSYMAPERI-QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---------PP 222 (265)
T ss_pred ----hcccCChhccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC---------CC
Confidence 125678889999988 5557899999999999999999999999765322222222222222111 11
Q ss_pred CCChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 840 DYPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 840 ~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..+.. ....+.++|.+||..+|++|||+.|++.+-
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 258 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHP 258 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence 11222 455688999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.93 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=203.9
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.|+..+.||.|+||.||+|.+..+++.||+|.+...........+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 35667789999999999999998999999999865544444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++++|.+++... ++++..++.++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++.......
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999998763 689999999999999999999998 999999999999999999999999999987653221
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
......++..|+|||.+ .+..++.++|||||||++|||+||..||....... .... +.... .+.
T Consensus 154 --~~~~~~~~~~y~~PE~~-~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~~-~~~~~-----~~~-- 217 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVI-KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFL-IPKNN-----PPS-- 217 (274)
T ss_pred --ccccccCCccccChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHHH-hhhcC-----CCC--
Confidence 12344677889999988 44458999999999999999999999996533211 1111 11110 111
Q ss_pred CCChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 840 DYPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 840 ~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.+.. .+..+.+++.+||..+|++|||+++++++-
T Consensus 218 -~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 218 -LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred -CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 1111 455688999999999999999999998864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.60 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=200.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--------ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCee
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--------YPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 672 (888)
|...+.||+|+||.||+|....+++.||+|.+....... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 345668999999999999998889999999885443221 124678999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
++|+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999764 4578889999999999999999998 99999999999999999999999999998
Q ss_pred ccccccc----ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC
Q 002717 753 LLTRLDK----HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 828 (888)
Q Consensus 753 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 828 (888)
....... ........++..|+|||.+ ....++.++||||+||++|||++|+.||......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~-- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-----FKIGE-- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHh-ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-----HHHhc--
Confidence 6642111 1111234577889999988 4456788999999999999999999999754321111 11100
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
......+......+.+++.+||+.||++||++.|++++
T Consensus 227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 -------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11112344556678899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.49 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=205.4
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
++...|+..+.||+|+||.||+|....+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 345667788899999999999999988899999999864432 3346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|||+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 95 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 95 MEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred ecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 9999999999998753 478889999999999999999998 99999999999999999999999999987654
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
..... .....+++.|+|||.. .+..++.++|||||||++|++++|+.||........... ....+
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~------- 231 (297)
T cd06656 167 PEQSK--RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG------- 231 (297)
T ss_pred CCccC--cCcccCCccccCHHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC-------
Confidence 32211 1334678889999988 455688999999999999999999999965432111100 00000
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
......+......+.+++.+||..+|++|||+++++++=.
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 0001123344556789999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.76 Aligned_cols=265 Identities=25% Similarity=0.309 Sum_probs=199.9
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.|+..+.||+|++|.||+|....+++.||+|.+...........+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 46677799999999999999988899999999865443333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++ +|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 86 DT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 74 899988764 23688999999999999999999998 999999999999999999999999999865322111
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc--CC--------
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE--GN-------- 829 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~--~~-------- 829 (888)
......++..|+|||.+.....++.++||||+||++|||++|+.||.........+....+..... ..
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 112234578899999875555678999999999999999999999965543222222211110000 00
Q ss_pred -ccc----cc-CCCCCCCChhh--HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 830 -VLD----CV-DPSMGDYPEDE--VLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 830 -~~~----~~-d~~~~~~~~~~--~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
... .. ........... ...+.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 00 00000000011 2567899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=316.82 Aligned_cols=263 Identities=22% Similarity=0.295 Sum_probs=189.7
Q ss_pred cCeeccccceEEEEEEECC--CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEc--CCeeeEEEecC
Q 002717 604 AAEVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLVSDYA 679 (888)
Q Consensus 604 ~~~ig~G~~g~V~~~~~~~--~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 679 (888)
+.+||+|+||.||+|+... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3579999999999999753 56789999885432 23567899999999999999999998854 45678999998
Q ss_pred CCCCHHHHHhhcC-----CCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEe----cCCCCcEEecccc
Q 002717 680 PNGSLQAKLHERL-----PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGL 750 (888)
Q Consensus 680 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfgl 750 (888)
++ ++.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 64 7877775321 1223588899999999999999999998 99999999999999 5667899999999
Q ss_pred cccccccccc-cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCch--------hhHHHHH
Q 002717 751 ARLLTRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV--------VILSEHV 821 (888)
Q Consensus 751 a~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~--------~~l~~~~ 821 (888)
++........ .......+|+.|+|||.+.....++.++|||||||++|||+||+.||.....+. ..+....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 9865432211 112345678999999988555668999999999999999999999996532211 1111111
Q ss_pred HHHH-----------hcCCc---cccc-----C-C----CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 822 RVLL-----------EEGNV---LDCV-----D-P----SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 822 ~~~~-----------~~~~~---~~~~-----d-~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.... ..... .... . . ............+.+++.+|++.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 1000 00000 0000 0 0 0000111223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=312.41 Aligned_cols=264 Identities=24% Similarity=0.289 Sum_probs=200.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||+|++..+|+.||+|++...... ...+.+.+|++++++++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 45567899999999999999989999999998654322 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
+ ++|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 82 D-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 7 5788877653 24589999999999999999999998 999999999999999999999999999975532211
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC-----Cccccc
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG-----NVLDCV 834 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~ 834 (888)
. .....++..|+|||.+.....++.++|||||||++|||+||+.|+.........+....+...... ......
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1 123456788999998755556789999999999999999999997554433322222111110000 000000
Q ss_pred C-CCCC---------CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 835 D-PSMG---------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 835 d-~~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+ .... .........+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 0000 0112334567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=322.24 Aligned_cols=262 Identities=23% Similarity=0.237 Sum_probs=197.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCC------
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------ 670 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 670 (888)
.+.|+..+.||+|+||.||+|.+...++.||||++...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 35577788999999999999999888999999998654322 23456788999999999999999999886432
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999965 67666653 378889999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHH--------
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR-------- 822 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~-------- 822 (888)
++..... .......+|..|+|||++ .+..++.++|||||||++|||++|+.||...... ..+...++
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 9764321 112345688999999988 5557899999999999999999999999653211 11111111
Q ss_pred ----------HHHhcCCc-ccccCCC---------CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 823 ----------VLLEEGNV-LDCVDPS---------MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 823 ----------~~~~~~~~-~~~~d~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
........ .....+. ....+......+.+++.+|++.||++|||+.|++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 11110000 0000000 0011122345678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.28 Aligned_cols=264 Identities=25% Similarity=0.331 Sum_probs=201.6
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
.|+..+.||+|+||.||+|++..+|+.||+|++...... ...+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 356677899999999999999888999999998654322 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
++++++..++... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 82 CDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred cCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9998888776542 3589999999999999999999998 99999999999999999999999999998765432
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH----------hcC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL----------EEG 828 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~----------~~~ 828 (888)
.. .....++..|+|||.+.....++.++|||||||++|||++|+.||....... .......... ...
T Consensus 155 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 155 DD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcccc
Confidence 11 1234567889999987555567899999999999999999999997543221 1111111000 000
Q ss_pred Ccc-cccCCCCCC------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 NVL-DCVDPSMGD------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ~~~-~~~d~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
... ....+.... ........+.+++.+||+.+|++|||+.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 000000000 011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=316.75 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=212.1
Q ss_pred cCChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 594 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 594 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
...|++++++...+|.|+||.||+|..+.++-..|.|++... ..+..++|.-|++|+..+.||+||++++.|...+..+
T Consensus 27 dlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 27 DLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred cCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 346889999999999999999999999866666677877443 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
++.|||.||.++..+-+. +.++.+.++..+++|++.||.|||++ .|||||+|+.|||++-+|.++++|||.+..
T Consensus 106 iliEFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred EEEeecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence 999999999999988775 56799999999999999999999999 999999999999999999999999998854
Q ss_pred ccccccccccccccccccccCccccc----CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
... .......+.||+.|||||+.. ....|+.++||||||+++.||..+.+|-..... ...+.+..+ .
T Consensus 180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-MRVllKiaK----S-- 250 (1187)
T KOG0579|consen 180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAK----S-- 250 (1187)
T ss_pred chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-HHHHHHHhh----c--
Confidence 321 222335788999999999863 346788999999999999999999999754322 111111110 0
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
-.|.+ -.|..-...+.+++.+|+..||+.||++++++++-.
T Consensus 251 ----ePPTL-lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 251 ----EPPTL-LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred ----CCCcc-cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 11222 235555667889999999999999999999998754
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.08 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=204.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC---CCCcceeeeEEEcCCeeeEEE
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR---HPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 676 (888)
.|+..+.||+|+||.||+|.+..+++.||+|.+.........+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 35667789999999999999988999999999865444445567889999999996 999999999999988999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++++|.+++... .+++..++.++.|++.|+.|||+. +|+||||+|+||++++++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998653 588999999999999999999998 999999999999999999999999999986654
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... ......|+..|+|||.+..+..++.++|||||||++|+|++|..||....... ... .....
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~-~~~~~-------- 217 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMM-LIPKS-------- 217 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhh-ccccC--------
Confidence 321 12334678899999988555667899999999999999999999996532211 110 00000
Q ss_pred CCCCCCh-hhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 837 SMGDYPE-DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 837 ~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.....+. .....+.+++.+||+.||++||++.|++.+-.-
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 218 KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 0111111 245678899999999999999999999886433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=322.18 Aligned_cols=256 Identities=20% Similarity=0.264 Sum_probs=199.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.|+..+.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 567778899999999999999998999999999864322 122345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 123 EYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred cCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 999999999999753 378888899999999999999998 999999999999999999999999999986543
Q ss_pred cccccccccccccccccCcccccCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
... .......||+.|+|||++... ..++.++||||+||++|||++|+.||...... . .............
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~----~~~~i~~~~~~~~- 267 (371)
T cd05622 195 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-G----TYSKIMNHKNSLT- 267 (371)
T ss_pred CCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-H----HHHHHHcCCCccc-
Confidence 221 122356789999999987432 23788999999999999999999999753221 1 1111111111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQIL 874 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L 874 (888)
.. ........+.+++..|+...+.+ ||+++|++++.
T Consensus 268 ----~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 ----FP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ----CC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 01 11234556788999999744433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.05 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=201.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.+.|+..+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.++++++|+||+++++++.. ...++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 3455677889999999999999875 56779999875432 234678999999999999999999999887 6779999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||.++....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999999764 234678899999999999999999988 999999999999999999999999999976543
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.... ......++..|+|||.+ ....++.++|+|||||++||+++ |+.||....... ... .+..+...
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~----~~~~~~~~---- 222 (260)
T cd05073 155 NEYT-AREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIR----ALERGYRM---- 222 (260)
T ss_pred CCcc-cccCCcccccccCHhHh-ccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHhCCCCC----
Confidence 2221 11233456779999988 45568899999999999999999 888986432211 111 11111111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1123445578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.94 Aligned_cols=257 Identities=22% Similarity=0.267 Sum_probs=197.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+++...+++.||+|++..... ....+.+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 5667799999999999999998899999999864321 12345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999763 34588899999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccccccCcccccC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 759 KHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
. .......||+.|+|||++.. ...++.++||||+||++|||++|+.||...... +.............
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~~-- 228 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHKEHFQ-- 228 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----HHHHHHHcCCCccc--
Confidence 1 11123468999999998742 245788999999999999999999999643221 11111111111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCC--CCCCCHHHHHHHH
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIP--SSRPSMAEVVQIL 874 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp--~~RPs~~evl~~L 874 (888)
........+..+.+++++|+..++ ..||++.+++++-
T Consensus 229 ---~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 229 ---FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred ---CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 111112244567788888775543 3488999999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.62 Aligned_cols=258 Identities=25% Similarity=0.353 Sum_probs=206.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
|+..+.||.|+||.||+|.+..++..+|+|++.........+.+.+|+++++.++|+||+++++.+..++..++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 56677899999999999999888999999998655444456788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+++|.++++...+ ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||++.........
T Consensus 83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 83 GGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 9999999987532 24588999999999999999999998 9999999999999999999999999998766543222
Q ss_pred c--ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 761 V--MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 761 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. ......++..|+|||.+.....++.++|||||||++|||++|+.||....... ...+. .... .+..
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~----~~~~------~~~~ 227 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLT----LQND------PPSL 227 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHH----hcCC------CCCc
Confidence 1 12334678899999988555478999999999999999999999996543211 11111 1110 1111
Q ss_pred CCC--ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 839 GDY--PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 839 ~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
... .......+.+++.+||..||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111 12445678899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.06 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=204.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-ccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||.|+||.||.++...+++.+++|.+.... .....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 556778999999999999998899999999986443 2234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++|+|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 82 NGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999998652 35688999999999999999999998 999999999999999999999999999976543221
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
......+++.|+|||.. .+..++.++||||||+++|||++|..||...... +....... +.. .
T Consensus 157 --~~~~~~~~~~y~ape~~-~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~-~~~--------~ 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELC-QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQ-GNY--------T 219 (256)
T ss_pred --cccccCCCccccCHhhc-CCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc-CCC--------C
Confidence 22345678899999987 4446789999999999999999999998653221 11211111 111 1
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..+......+.+++.+||+.+|++|||+.|+++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11234455688999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=330.30 Aligned_cols=373 Identities=29% Similarity=0.378 Sum_probs=213.3
Q ss_pred cccCCcCeEecCCCccc-ccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEcCCccccccccccccCCC
Q 002717 18 VVFRILERLNFSHNSLS-GQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCS 96 (888)
Q Consensus 18 ~~~~~L~~L~ls~n~l~-~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 96 (888)
.-++.++-.|+|+|.++ +..|.....+ +++++|.|...++. .+|..+ +.|.+|++|++++|++..+... ++.++
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qM--t~~~WLkLnrt~L~-~vPeEL-~~lqkLEHLs~~HN~L~~vhGE-Ls~Lp 78 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQM--TQMTWLKLNRTKLE-QVPEEL-SRLQKLEHLSMAHNQLISVHGE-LSDLP 78 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHh--hheeEEEechhhhh-hChHHH-HHHhhhhhhhhhhhhhHhhhhh-hccch
Confidence 34566788888888887 4566666654 67888888888886 777664 6777777788887777765543 55666
Q ss_pred CCCEEECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCE
Q 002717 97 SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTT 176 (888)
Q Consensus 97 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 176 (888)
.|+.+++..|++.... + +..+..+..|+.||||+|+++ ..|..+..-+++..|+|++|+|..+....|.+++.|-.
T Consensus 79 ~LRsv~~R~N~LKnsG--i-P~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLf 154 (1255)
T KOG0444|consen 79 RLRSVIVRDNNLKNSG--I-PTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLF 154 (1255)
T ss_pred hhHHHhhhccccccCC--C-Cchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhh
Confidence 6666666666665321 1 113445566666666666665 45555555555666666666665443344455555555
Q ss_pred EEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccccC-CCCCCCCCCCCCCcEEEeeCCc
Q 002717 177 LDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT-GSLPSSLFNCKKLSVIRLRGNS 255 (888)
Q Consensus 177 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~ 255 (888)
||||+|++. .+|.-++.|..|+.|.|++|.+...--..+..|++|+.|.+++.+=+ ..+|.++..+.+
T Consensus 155 LDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~N---------- 223 (1255)
T KOG0444|consen 155 LDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHN---------- 223 (1255)
T ss_pred hccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhh----------
Confidence 556555555 34444555555555555555544322233334444555555443321 134444444444
Q ss_pred CCCCCCccccccCCceEEcccCcccccCCCCCCCCCCCcccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCcccc
Q 002717 256 LNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS 335 (888)
Q Consensus 256 l~~~~p~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 335 (888)
|..+|||.|.+. ..|..+..+.+|+.|+||+|+|+.
T Consensus 224 -------------------------------------------L~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 224 -------------------------------------------LRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred -------------------------------------------hhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 444444444444 455555555555555555555542
Q ss_pred CCCCCcccCCcceEEEcccCcccccCCccccccCCCceEEccCCcCCC-ccCccccccccccEEEccCCcccccCCcccc
Q 002717 336 RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSGSIPKSIS 414 (888)
Q Consensus 336 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 414 (888)
+.-..+...+|++|+||.|+++ .+|.+++.+++|+.|++.+|+++- -+|..++++.+|+.+..++|++. ..|+.++
T Consensus 260 -L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglc 336 (1255)
T KOG0444|consen 260 -LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLC 336 (1255)
T ss_pred -eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhh
Confidence 2223333445555566666655 556666666666666666665542 25556666666666666666665 5666666
Q ss_pred CCCCCCeEEccCCcceecCCccccccCCCCeeeccCCcceecCC
Q 002717 415 NLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 458 (888)
Q Consensus 415 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 458 (888)
.+.+|+.|.|+.|.|- .+|+.+--|+.|+.|||..|+----+|
T Consensus 337 RC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 337 RCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 6666666666666665 566666666666666666665433333
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.15 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=197.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHH-HhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRV-LGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||+|.+..+|+.||+|++...........+..|+.. ++..+||||+++++++..++..++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 45567899999999999999989999999998654333334456666665 55568999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
+ |+|.+++.........+++..++.++.|++.|++|||+++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-- 157 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-- 157 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc--
Confidence 6 6898888765444567899999999999999999999753 8999999999999999999999999999765321
Q ss_pred ccccccccccccccCcccccCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.......++..|+|||.+... ..++.++|+|||||++|||++|+.||.........+... .... .+
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~------~~ 226 (283)
T cd06617 158 -VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV----VEEP------SP 226 (283)
T ss_pred -cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH----HhcC------CC
Confidence 111234578889999987432 346789999999999999999999996543322222111 1110 11
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.. .....+..+.+++.+||..+|++|||+.+++++-
T Consensus 227 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 227 QL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 11 1122345688999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=293.75 Aligned_cols=256 Identities=23% Similarity=0.296 Sum_probs=206.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
..++..+.||+|.-|+||+++.+.++..+|+|++.+..... ...+...|-+||+.++||.+..+++.++.+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 34667779999999999999999888999999996654332 2345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
|||+||+|....+.+ .+..+++..+.-+|..|+-||+|||.. |||.|||||+|||+.++|.+.++||.++.....
T Consensus 157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999999886 466799999999999999999999998 999999999999999999999999998754311
Q ss_pred ---------------------------------ccc---------------------ccccccccccccccCcccccCcC
Q 002717 757 ---------------------------------LDK---------------------HVMSNRFQSALGYVAPELTCQSL 782 (888)
Q Consensus 757 ---------------------------------~~~---------------------~~~~~~~~g~~~y~aPE~~~~~~ 782 (888)
... ..+...+.||-.|+|||++ .+.
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI-~G~ 310 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI-RGE 310 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee-ecC
Confidence 000 0112235688889999999 565
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCC
Q 002717 783 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPS 862 (888)
Q Consensus 783 ~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~ 862 (888)
..+.+.|.|+|||++|||+.|..||..... ...+...+ .+ +..+++.+ .....+.+||++.+.+||.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~-~~Tl~NIv----~~-------~l~Fp~~~-~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNN-KETLRNIV----GQ-------PLKFPEEP-EVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCc-hhhHHHHh----cC-------CCcCCCCC-cchhHHHHHHHHHhccChh
Confidence 678999999999999999999999976533 22222221 11 12222322 5566788999999999999
Q ss_pred CCCC----HHHHHHH
Q 002717 863 SRPS----MAEVVQI 873 (888)
Q Consensus 863 ~RPs----~~evl~~ 873 (888)
+|.- ++||.++
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9998 8888775
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.61 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=194.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----CChHHHHHHHHHHhhcCCCCcceeeeEEEcC--CeeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 674 (888)
|+..+.||+|+||.||+|....+++.||+|++...... +..+.+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 55677999999999999999888999999988543211 1235688899999999999999999988753 56789
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
++||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||+|+||++++++.+||+|||+++..
T Consensus 84 ~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 84 FMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999999764 3478899999999999999999988 9999999999999999999999999998765
Q ss_pred cccccc-cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 755 TRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 755 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
...... .......++..|+|||.+ .+..++.++||||+||++|||++|+.||....... .+...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~~~~~~~-----~ 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVI-SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AIFKIATQ-----P 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHh-CCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcC-----C
Confidence 321111 111234578899999988 45578899999999999999999999997542211 11111110 0
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.. ...+......+..++ +||..+|++|||++|++++
T Consensus 226 ~~---~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 TN---PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CC---CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11 123333444566666 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.05 Aligned_cols=262 Identities=22% Similarity=0.241 Sum_probs=197.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcC------C
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------Q 670 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 670 (888)
.+.|+..+.||+|+||.||+|.+...++.||||++..... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 3457778899999999999999988899999999864422 22345678999999999999999999987543 3
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 46899999965 67777753 378889999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHH-------
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV------- 823 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~------- 823 (888)
++..... .......++..|+|||++ .+..++.++|||||||++|||++|+.||...... ..+...++.
T Consensus 173 a~~~~~~---~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 173 ARTAGTS---FMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPE 247 (364)
T ss_pred ccccCCC---CcccCCcccCCcCCHHHH-hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHH
Confidence 9765321 112345688999999988 5567899999999999999999999999654321 111111110
Q ss_pred -----------HHhcCCcccc----------cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 824 -----------LLEEGNVLDC----------VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 824 -----------~~~~~~~~~~----------~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.......... .-+............+.+++.+|++.||++|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0000000000 00000011112234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.05 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=203.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||++....+|+.||+|++..... ....+++.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 4566789999999999999988999999999864322 223467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++++|.+++.... ...+++..++.++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999997642 23578899999999999999999998 999999999999999999999999999976543221
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
......+++.|+|||.. ....++.++|||||||++|+|++|+.||...... ..+...... . ..
T Consensus 157 --~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~-~--------~~ 219 (256)
T cd08218 157 --LARTCIGTPYYLSPEIC-ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVLKIIRG-S--------YP 219 (256)
T ss_pred --hhhhccCCccccCHHHh-CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHHHHhcC-C--------CC
Confidence 11234578889999987 4556889999999999999999999998654221 111111111 1 11
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
..+......+.+++.+||+.+|++||++.||+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2234455678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=321.08 Aligned_cols=244 Identities=25% Similarity=0.338 Sum_probs=190.6
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhc---CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA---RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
||+|+||.||+|++..+++.||||++...... .....+..|..++... +||||+++++++..+...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999989999999998643221 1223455667776665 699999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 9999988763 4688999999999999999999998 99999999999999999999999999987533211 1
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
......||+.|+|||.+.....++.++||||+||++|||++|+.||...... +..+.. ..+.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~i-~~~~~------~~~-- 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRNI-AFGKV------RFP-- 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHHH-HcCCC------CCC--
Confidence 2234578999999998855556789999999999999999999999653221 111111 11111 011
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRP----SMAEVVQI 873 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RP----s~~evl~~ 873 (888)
.......+.+++.+||+.||++|| ++.|++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 112345677899999999999998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.73 Aligned_cols=250 Identities=27% Similarity=0.420 Sum_probs=198.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
++..+.||+|+||.||+|.+. +++.+|+|.+.... ...++|.+|++++++++|||++++++++......++|+||++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred eEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 455678999999999999986 57789999875433 234679999999999999999999999999889999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+++|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++...... .
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 155 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-Y 155 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc-c
Confidence 99999998764 24578999999999999999999998 99999999999999999999999999987653221 1
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
.......++.+|+|||.+ ....++.++|||||||++|||++ |..||...... ...+.. ..+. ....
T Consensus 156 ~~~~~~~~~~~~~aPe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~-~~~~--~~~~---- 222 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVF-SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETI-NAGF--RLYK---- 222 (256)
T ss_pred cccCCCccchhhcCHhHh-ccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHH-hCCC--CCCC----
Confidence 111223346789999988 45568899999999999999998 89998643221 111111 1111 0111
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 223 --~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 --PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2223467899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=306.56 Aligned_cols=264 Identities=21% Similarity=0.269 Sum_probs=203.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC--CeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 678 (888)
|+..+.||.|++|.||+|.+..+++.+|+|.+...........+.+|++++++++||||+++++++... ...++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 345568999999999999998889999999986554434456789999999999999999999998653 367999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999998876444456688999999999999999999998 99999999999999999999999999987543211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. ....++..|+|||.. .+..++.++||||+||++|||++|+.||...........+....... .... .+....
T Consensus 160 ~----~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~ 232 (287)
T cd06621 160 A----GTFTGTSFYMAPERI-QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNP-ELKDEP 232 (287)
T ss_pred c----ccccCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCch-hhccCC
Confidence 1 234567889999987 55578899999999999999999999997653211111111111111 1100 010000
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.........+.+++.+||+.+|++|||+.|++++-+
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 001223456889999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=305.66 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=200.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--C-------ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCe
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--Q-------YPEDFEREVRVLGKARHPNLISLEGYYWTPQL 671 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 671 (888)
|...+.||+|+||.||+|....+|+.||+|.+...... . ..+.+.+|+.+++.++|||++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 44567899999999999999888999999987532111 1 12467889999999999999999999999999
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 751 (888)
.++|+||+++|+|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred eEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999864 4688899999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccccCcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCc
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
+...............++..|+|||.+.... .++.++||||+|+++||+++|..||....... ... ..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~-~~~~~-~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA----AMF-KLGNK-RS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH----HHH-Hhhcc-cc
Confidence 7654322222223456788999999874443 47899999999999999999999986432211 111 11111 11
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 831 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
...++. .........+.+++.+||..+|++|||+.|++++
T Consensus 230 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 1222345678899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.00 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=202.2
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcC-----C
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP-----Q 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~ 670 (888)
+.+.|+..+.||+|+||.||+|....+++.+|+|++.... ...+.+.+|+.+++++ +|||++++++++... .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 4566778889999999999999998899999999985432 2346778899999999 799999999998754 3
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
..++|+||+++|+|.++++........+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||+
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 57999999999999999876443456789999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCcC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHh
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSL----RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~ 826 (888)
++........ .....++..|+|||.+.... .++.++|||||||++|||++|+.||...... ..+.. . .
T Consensus 175 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~----~-~ 246 (291)
T cd06639 175 SAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFK----I-P 246 (291)
T ss_pred chhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHH----H-h
Confidence 8765432211 13346788899999874332 3678999999999999999999999654221 11111 1 1
Q ss_pred cCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 827 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
..... .. ..+......+.+++.+||+.+|++||++.|++++
T Consensus 247 ~~~~~-----~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 RNPPP-----TL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cCCCC-----CC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11110 11 1123344568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.29 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=205.0
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
++.+.+.....||+|+||.||++....++..||||.+.... ....+.+.+|+.+++.++||||+++++.+..++..++|
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 45667777778999999999999998889999999885432 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|||+++++|.+++.. ..+++..++.++.|++.|++|||+. +|+||||||+||++++++.++|+|||++....
T Consensus 98 ~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 98 MEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred EeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 999999999998854 2478999999999999999999998 99999999999999999999999999987543
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.... ......++..|+|||.. ....++.++|||||||++|||++|+.||....... .+.. ++ . .+.
T Consensus 170 ~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~-~~---~------~~~ 235 (292)
T cd06658 170 KEVP--KRKSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRR-IR---D------NLP 235 (292)
T ss_pred cccc--cCceeecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HH---h------cCC
Confidence 2211 11334678899999987 45568899999999999999999999997543211 1111 11 0 111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
+.... .......+..++.+||..||++|||++|++++-.-.
T Consensus 236 ~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~ 276 (292)
T cd06658 236 PRVKD-SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276 (292)
T ss_pred Ccccc-ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence 11111 122344678899999999999999999999874443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.88 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=200.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcC-CeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP-QLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 678 (888)
|+..+.||+|++|.||++....+++.||+|++..... ....+.+.+|++++++++|+|++++++.+... ...++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 5567789999999999999988899999999865432 22345688999999999999999999987644 457899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998642 34589999999999999999999998 99999999999999999999999999997654221
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. ......+++.|+|||.. ....++.++||||+||++|||++|+.||...... ....... .+. .
T Consensus 157 ~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~-~~~--------~ 219 (257)
T cd08223 157 D--MASTLIGTPYYMSPELF-SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRII-EGK--------L 219 (257)
T ss_pred C--ccccccCCcCccChhHh-cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHH-hcC--------C
Confidence 1 12345678899999987 5557889999999999999999999998643221 1111111 111 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
...+......+.+++.+||+.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 12234455678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=335.89 Aligned_cols=259 Identities=27% Similarity=0.375 Sum_probs=213.2
Q ss_pred hhcCeeccccceEEEEEEECC-------CCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeee
Q 002717 602 EKAAEVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 673 (888)
+..+.+|+|+||.|++|.... ....||||.++........+.+..|+++++.+ +|+||+.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 566699999999999998631 14579999997766666678899999999999 6999999999999988999
Q ss_pred EEEecCCCCCHHHHHhhcC---C-------CC--CCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC
Q 002717 674 LVSDYAPNGSLQAKLHERL---P-------ST--PPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 741 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 741 (888)
+|+||+..|+|.++++... . .. ..++..+.+.++.|||.||+||++. ++||||+.++|||++++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999998865 0 01 2388899999999999999999999 999999999999999999
Q ss_pred CcEEecccccccccccccccccccc-cccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHH
Q 002717 742 NPRISDFGLARLLTRLDKHVMSNRF-QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSE 819 (888)
Q Consensus 742 ~~kl~Dfgla~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~ 819 (888)
.+||+|||+|+.....+.+...... .-+..|||||.+ ....++.|+|||||||++||++| |..||......... .+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl-~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~ 533 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL-FDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LE 533 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHh-ccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HH
Confidence 9999999999976655544322111 135679999998 55789999999999999999999 88898653322222 11
Q ss_pred HHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 820 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 820 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
.++.|... +.|..+..+++++|+.||+.+|++||++.|+++.++..
T Consensus 534 ----~l~~G~r~--------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 534 ----FLKEGNRM--------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----HHhcCCCC--------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 34445443 34777788899999999999999999999999999874
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=288.36 Aligned_cols=283 Identities=24% Similarity=0.312 Sum_probs=213.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCC----eEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEc-CC
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQG----RMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWT-PQ 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 670 (888)
....|+..+.||+|.||.||+|....+. +.+|+|+++.... ........+|+..++.++||||+.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456788889999999999999664322 3689999865532 2334567899999999999999999999877 77
Q ss_pred eeeEEEecCCCCCHHHHHhhcCC-CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC----CCcEE
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLP-STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN----YNPRI 745 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~~~kl 745 (888)
..++++||.+. +|.+.|+.... ....++...+..|+.||+.|+.|||+. =|+|||+||.|||+..+ |+|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 88999999987 78888876432 235688889999999999999999999 69999999999999877 99999
Q ss_pred eccccccccccccc-ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCch----hhHHHH
Q 002717 746 SDFGLARLLTRLDK-HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV----VILSEH 820 (888)
Q Consensus 746 ~Dfgla~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~----~~l~~~ 820 (888)
+|||+++.+...-. ......+.-|.+|+|||.+.+...||.+.||||.||++.||+|-++-|...+... -+...+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 99999998754322 2233456778999999999899999999999999999999999888775532111 111222
Q ss_pred HHHHHh-cCCcccccCCCCCCCChh--------------------------hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 821 VRVLLE-EGNVLDCVDPSMGDYPED--------------------------EVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 821 ~~~~~~-~~~~~~~~d~~~~~~~~~--------------------------~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+..++. -|...+...|.+..+|+. .....++|+..++..||.+|.|+++++++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 222221 122222233333333321 01125789999999999999999999999
Q ss_pred HHhhcCCCCC
Q 002717 874 LQVIKTPLPQ 883 (888)
Q Consensus 874 L~~~~~~~~~ 883 (888)
.--..+++|+
T Consensus 338 ~yF~~d~lpp 347 (438)
T KOG0666|consen 338 PYFTEDPLPP 347 (438)
T ss_pred cccccCCCCC
Confidence 8887777774
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=317.58 Aligned_cols=256 Identities=20% Similarity=0.216 Sum_probs=190.8
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
.|+..+.||+|+||.||+|++..+++.||+|.... .....|+.++++++||||+++++++......++|+||+
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 47778899999999999999988889999997432 22356999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
. ++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 140 ~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 140 S-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred C-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 5 6888888654 35689999999999999999999998 99999999999999999999999999997532211
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CCchhhH----HHHHHHHHhcCCcc-cc
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG-EDNVVIL----SEHVRVLLEEGNVL-DC 833 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~-~~~~~~l----~~~~~~~~~~~~~~-~~ 833 (888)
......||+.|+|||++ .+..++.++|||||||++|||+++..|+... ....... ...+.......... ..
T Consensus 212 --~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVL-ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred --ccccccccccccCCeec-CCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 11345688999999988 4557899999999999999999966655322 1111100 01111111100000 00
Q ss_pred cC--C------------CCC--CC-------ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 834 VD--P------------SMG--DY-------PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 834 ~d--~------------~~~--~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+. + ... .+ ......++..++.+||+.||++|||+.|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 0 000 00 01123345679999999999999999999976
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.00 Aligned_cols=264 Identities=25% Similarity=0.334 Sum_probs=204.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 4566789999999999999988899999999865543 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
+++|.+++.... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 82 -~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999999987642 5689999999999999999999998 999999999999999999999999999986643221
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC-----------
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG----------- 828 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~----------- 828 (888)
.......++..|+|||.+.....++.++||||+||++|||++|..||.... +...+...........
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 111334678899999988555567899999999999999999977775432 2222222211110000
Q ss_pred CcccccCCC-----CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 NVLDCVDPS-----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ~~~~~~d~~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.......+. +.....+....+.+++.+|++.+|++|||+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 001112334678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.94 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=199.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
|+..+.||+|+||.||+|... +++.+|+|.+...... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 456778999999999999875 7889999988543221 1234688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
+||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++++|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999764 3578899999999999999999998 99999999999999999999999999987653
Q ss_pred cccc----ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcc
Q 002717 756 RLDK----HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 756 ~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (888)
.... ........++..|+|||.+ .+..++.++||||+||++|||++|+.||.......... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~~~-- 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGAHRG-- 225 (265)
T ss_pred hccccccccccccccCCCccccChhhh-cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----HhhhccC--
Confidence 2111 1111234578899999988 55567899999999999999999999996543211111 0000000
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 832 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.....+......+.+++++||+.+|++|||+.|++.+
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 -----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0112234455678899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.70 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=199.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|++|.||+|++..+++.||||++..... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 4556789999999999999988899999998854332 223357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
. ++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||+++.......
T Consensus 82 ~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 82 H-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred c-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 5 68988887642 35689999999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC-----------
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG----------- 828 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~----------- 828 (888)
. .....++..|+|||.+.....++.++|||||||++|||+||+.||...... ....+..+......
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1 123346788999998755555688999999999999999999999654322 11111111100000
Q ss_pred ----CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 ----NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ----~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
....................+.+++.+||+.||++|||++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000001111233457789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.16 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=198.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||++++..+++.||+|.+.+... ......+.+|+.++..++|++|+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 5667789999999999999998899999999854321 12234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999864 24588899999999999999999998 99999999999999999999999999987543222
Q ss_pred cccccccccccccccCcccccC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 759 KHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
. .......||+.|+|||++.. ...++.++|||||||++|||++|+.||...... +............
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~~~~--- 227 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHKERF--- 227 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----HHHHHHhCCCccc---
Confidence 1 12234578999999998742 345788999999999999999999999653221 1111111111100
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQI 873 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~ 873 (888)
..+.........+.+++.+|+..++++ |++++|++++
T Consensus 228 --~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 --QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111112234556788888888654444 7899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.51 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=214.2
Q ss_pred eeccccceEEEEEEECCC-----CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-eeeEEEecC
Q 002717 606 EVGEGVFGTVYKVSFGTQ-----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-LKLLVSDYA 679 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 679 (888)
.+-+|.||.||+|.|+.. .+.|-||.++....+-....+..|...+..+.|||+..+.+++.++. ..+++|.++
T Consensus 291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~ 370 (563)
T KOG1024|consen 291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPAT 370 (563)
T ss_pred hhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEecc
Confidence 467999999999988643 34567777765554445567889999999999999999999987654 568999999
Q ss_pred CCCCHHHHHhhcCC----CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 680 PNGSLQAKLHERLP----STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 680 ~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
..|+|..++...+. ..+.++..+...+|.|++.||+|||.+ +|||.||.++|+++|+.-.+|++|=.++|.+.
T Consensus 371 ~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF 447 (563)
T KOG1024|consen 371 GVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLF 447 (563)
T ss_pred CcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccC
Confidence 99999999984321 235577788899999999999999998 99999999999999999999999999999999
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
+.+++........+..||+||.+ ....++.++|||||||++|||+| |+.||...+. .. +...+.+|...
T Consensus 448 P~DYhcLGDnEnRPvkWMslEal-~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--fE----m~~ylkdGyRl--- 517 (563)
T KOG1024|consen 448 PGDYHCLGDNENRPVKWMSLEAL-QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--FE----MEHYLKDGYRL--- 517 (563)
T ss_pred cccccccCCCCCCcccccCHHHH-hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--HH----HHHHHhcccee---
Confidence 99988877777889999999988 66689999999999999999999 8889864432 22 22233444332
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCC
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 881 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 881 (888)
..|-.++.+++.+|.-||..+|++||+++|++.-|..+...+
T Consensus 518 -----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 518 -----AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 347788899999999999999999999999999998876543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=304.26 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=200.5
Q ss_pred hhhcCeeccccceEEEEEEECC-CCeEEEEEEeecCCc---------cCChHHHHHHHHHHhh-cCCCCcceeeeEEEcC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDI---------IQYPEDFEREVRVLGK-ARHPNLISLEGYYWTP 669 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~ 669 (888)
|+..+.||+|+||.||+|.+.. .++.+|+|.+..... .....++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4566789999999999999976 678899998753221 1123456778888875 6999999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 670 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 670 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
+..++||||+++++|.+++.........+++..++.++.|++.|+.|||+.. +++||||+|+||++++++.+|++|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEeccc
Confidence 9999999999999999998764334567899999999999999999999631 89999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
.+....... ......++..|+|||.+. ...++.++||||||+++|||++|+.||...... ...... ..+.
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-----~~~~~~-~~~~ 229 (269)
T cd08528 160 LAKQKQPES---KLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-----SLATKI-VEAV 229 (269)
T ss_pred ceeeccccc---ccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-----HHHHHH-hhcc
Confidence 997654322 224456788999999884 556899999999999999999999998643221 111111 1111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.... ........+.+++.+||+.||++||++.|+.++++
T Consensus 230 ~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPL-------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcC-------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1100 01133456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.55 Aligned_cols=263 Identities=26% Similarity=0.373 Sum_probs=200.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC-ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 556779999999999999998789999999975543222 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
+++++..+.... ..+++..++.++.|+++|++|||+. +++|||++|+||++++++.++++|||++........
T Consensus 83 ~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 83 DHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999888876543 3489999999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH----------HhcCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL----------LEEGN 829 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~----------~~~~~ 829 (888)
......++..|+|||++.....++.++|||||||++|||++|+.||..... ...+....... .....
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhhHHHhccch
Confidence 112345788899999885555678899999999999999999988864322 11111111100 00000
Q ss_pred cc-cccCCCCC------CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 830 VL-DCVDPSMG------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 830 ~~-~~~d~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.. ....+... ......+..+.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 00000000 0112345668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=308.20 Aligned_cols=273 Identities=23% Similarity=0.305 Sum_probs=205.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
|+..+.||+|+||.||+|.+..+++.||+|++...... .....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 44566899999999999999888999999998655432 12345678999999999999999999999988999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+ +|+|.+++.... ..+++..++.++.|+++||+|||+. +|+||||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999 899999997642 3689999999999999999999998 999999999999999999999999999986643
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc--------C
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE--------G 828 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~--------~ 828 (888)
.... .....+++.|+|||.+.....++.++|||||||++|||++|..||.... ....+....+..... .
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cHHHHHHHHHHcCCCchhhhhhcc
Confidence 2211 1233457789999987555567899999999999999999977665432 222222221110000 0
Q ss_pred Cccccc------CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCCC
Q 002717 829 NVLDCV------DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883 (888)
Q Consensus 829 ~~~~~~------d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~ 883 (888)
...... ..............+.+++.+||+.+|++|||+.|++++=.--..+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 000000 0000011123356788999999999999999999999974443344443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=302.39 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=203.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEc--CCeeeEEEe
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLVSD 677 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 677 (888)
|+..+.||.|+||.||+|.+..+++.||+|.+...... ...+.+..|++++++++||||+++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 45567899999999999999889999999998654332 234568889999999999999999998764 345789999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcC--CCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF--RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|+++++|.+++........++++..++.++.|++.|+.|||..+ +.+++|+||+|+||++++++.+|++|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999999875444567899999999999999999999221 2299999999999999999999999999998765
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
..... .....++..|+|||.+ ....++.++||||||+++|+|++|+.||..... ..+.+. ...+
T Consensus 162 ~~~~~--~~~~~~~~~~~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~~~------- 225 (265)
T cd08217 162 HDSSF--AKTYVGTPYYMSPEQL-NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASK----IKEG------- 225 (265)
T ss_pred CCccc--ccccccCCCccChhhh-cCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHH----HhcC-------
Confidence 43221 1334678899999988 445688999999999999999999999975431 111111 1111
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.....+......+.+++.+|++.+|++|||+.|++++
T Consensus 226 -~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 -KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1122344556678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=321.74 Aligned_cols=265 Identities=20% Similarity=0.207 Sum_probs=201.0
Q ss_pred hhhhhcCeeccccceEEEEEEECC--CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~--~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
..|+..+.||+|+||.||++.... .++.||+|.+... +...+|+.++++++||||+++++++......++||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 347788899999999999998643 4678999987432 23568999999999999999999999989999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
|++. ++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 166 e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9995 688888843 35689999999999999999999998 999999999999999999999999999976654
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC--chhhHHHHHHHHHhcCCcc---
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED--NVVILSEHVRVLLEEGNVL--- 831 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~--~~~~l~~~~~~~~~~~~~~--- 831 (888)
...........||+.|+|||++ ....++.++|||||||++|||++|+.||..... ....+...++.. +.....
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~-~~~~~~~~~ 315 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM-QVHPLEFPQ 315 (392)
T ss_pred ccccccccccccccCccCHhHh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh-ccCccccCC
Confidence 3333233456789999999988 555788999999999999999999999965432 122222222211 000000
Q ss_pred --------------cccCCC--CCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 832 --------------DCVDPS--MGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 832 --------------~~~d~~--~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
....+. ... .......++.+++.+|+..||++|||+.|++.+-.-...
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 000000 000 001223467789999999999999999999998655443
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=302.11 Aligned_cols=240 Identities=21% Similarity=0.321 Sum_probs=190.0
Q ss_pred CeeccccceEEEEEEECCCC----------eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 605 AEVGEGVFGTVYKVSFGTQG----------RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~----------~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
+.||+|+||.||+|.+...+ ..|++|.+...... ...|.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 36899999999999997655 35788876544322 5788999999999999999999999988 77899
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC-------CcEEec
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-------NPRISD 747 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-------~~kl~D 747 (888)
|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++|
T Consensus 78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999998752 2688999999999999999999998 999999999999999887 799999
Q ss_pred ccccccccccccccccccccccccccCcccccCc-CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHH
Q 002717 748 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 748 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
||+++.... .....++..|+|||++... ..++.++|||||||++|||++ |..||...... . +... .
T Consensus 152 fg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~----~~~~-~ 219 (259)
T cd05037 152 PGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-E----KERF-Y 219 (259)
T ss_pred CCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-h----HHHH-H
Confidence 999976543 1233456779999988444 368899999999999999999 56677544211 1 1111 1
Q ss_pred hcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
..... .+......+.+++.+||..+|++|||+.|+++.|+
T Consensus 220 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QDQHR----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hcCCC----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11110 11112267889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=308.33 Aligned_cols=260 Identities=21% Similarity=0.304 Sum_probs=205.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
..++....||+|+||.||+|....+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 34455558999999999999998889999999985443 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++.. ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 100 LQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 999999998764 3478999999999999999999998 99999999999999999999999999987543221
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. ......++..|+|||.+ .+..++.++|||||||++|||++|+.||....... .+ ... .... ...
T Consensus 172 ~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~----~~~-~~~~------~~~ 236 (297)
T cd06659 172 P--KRKSLVGTPYWMAPEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AM----KRL-RDSP------PPK 236 (297)
T ss_pred c--cccceecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH----HHH-hccC------CCC
Confidence 1 11335678899999988 45568899999999999999999999996533211 11 111 1110 000
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCC
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 882 (888)
..........+.+++.+||+.+|++||+++|++++-.-.....+
T Consensus 237 ~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 237 LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 11122334568899999999999999999999997655544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=304.83 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=204.1
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCC----
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ---- 670 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 670 (888)
.+.+.|+..+.||+|+||.||+|.+..+++.+|+|.+.... ...+.+.+|+.+++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 34567888889999999999999998889999999986543 2346789999999999 6999999999997644
Q ss_pred --eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecc
Q 002717 671 --LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 748 (888)
Q Consensus 671 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 748 (888)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+|++||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 37999999999999999876543346789999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcccccC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH
Q 002717 749 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824 (888)
Q Consensus 749 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~ 824 (888)
|.+....... .......++..|+|||.+.. ...++.++|||||||++|||++|+.||...... ..... .
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~----~ 230 (275)
T cd06608 158 GVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFK----I 230 (275)
T ss_pred ccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHH----h
Confidence 9987654221 11234567889999998633 234678999999999999999999999643221 11111 1
Q ss_pred HhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 825 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
. ... .+.. ..+......+.+++.+||..||++|||+.|++++
T Consensus 231 ~-~~~-----~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 P-RNP-----PPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred h-ccC-----CCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 110 1111 1123345678899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.23 Aligned_cols=260 Identities=24% Similarity=0.278 Sum_probs=196.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcC------Ce
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP------QL 671 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 671 (888)
+.|+..+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 5577888999999999999999888999999998643221 2335677899999999999999999987543 34
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 751 (888)
.++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 58999988 7889888764 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHh-----
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE----- 826 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~----- 826 (888)
+..... .....+++.|+|||++.....++.++||||+||++|||++|+.||...... ..+.........
T Consensus 166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPEV 239 (343)
T ss_pred eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 765321 134467899999998855567889999999999999999999999653221 111111110000
Q ss_pred -----cCCcccccCCCCCCCC--------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 827 -----EGNVLDCVDPSMGDYP--------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 827 -----~~~~~~~~d~~~~~~~--------~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
...... ....+...+ ......+.+++.+|++.||++|||+.|++++-
T Consensus 240 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 240 LKKISSEHARK-YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HHhcchhhHHH-HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000000 000000111 11223467999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=301.29 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=201.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
|+..+.||+|+||.||+|....+++.||+|.+...... +..+.+.+|+++++.++|+||+++++++..+...++|+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 44567899999999999999888999999998654321 23467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 82 ELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999764 3578999999999999999999998 999999999999999999999999999876543
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.. ......++..|+|||.+.....++.++|+|||||++|+|++|+.||...... ..... .....
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-~~~~~----~~~~~-------- 218 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-AAVFK----IGRSK-------- 218 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-HHHHH----HHhcc--------
Confidence 22 1234567888999998744434889999999999999999999999654311 11111 11100
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.....+......+.+++.+||+.+|++|||+.|++.+
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1112334455678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=304.30 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=201.7
Q ss_pred hhhhhcCeeccccceEEEEEEECC-----CCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
+.|+..+.||+|+||.||+|+... +.+.||+|.+.........+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 456677789999999999999753 346789998754432223467899999999999999999999999888899
Q ss_pred EEEecCCCCCHHHHHhhcCCC-----CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecc
Q 002717 674 LVSDYAPNGSLQAKLHERLPS-----TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 748 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 748 (888)
+||||+++|+|.+++...... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999865321 12689999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhc
Q 002717 749 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEE 827 (888)
Q Consensus 749 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 827 (888)
|+++....... .......++..|+|||.+ .....+.++|||||||++|||++ |..||...... ..+. . ...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~-~----~~~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAV-QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLN-R----LQA 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHH-H----HHc
Confidence 99875432211 111233556789999987 44467899999999999999999 77888543221 1111 1 111
Q ss_pred CCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 828 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 828 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
+... ...+...+..+.+++.+||+.+|++|||+.|++++|+
T Consensus 234 ~~~~-------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLE-------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcC-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111 0112344567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=300.39 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=200.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||+|....+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 4556789999999999999988999999999865432 223467889999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC-CCcEEecccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGLARLLTRLD 758 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgla~~~~~~~ 758 (888)
++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++++ +.+|++|||.+.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 82 PGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998742 34588999999999999999999998 99999999999999854 468999999998654322
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. .....++..|+|||.. ....++.++||||||+++|+|++|+.||....... .+..... .. .
T Consensus 157 ~---~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~-~~--------~ 218 (256)
T cd08220 157 K---AYTVVGTPCYISPELC-EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVLKIMS-GT--------F 218 (256)
T ss_pred c---ccccccCCcccCchhc-cCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHHHHHh-cC--------C
Confidence 1 1234678899999988 45567899999999999999999999986543211 1111111 11 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
...+......+.+++.+||+.+|++|||+.|++++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11233445678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.20 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=195.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|....+++.||+|++..... ....+.+.+|+.++..++||+|+++++++.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 5566789999999999999998999999999864321 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 83 LPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999764 4588999999999999999999998 99999999999999999999999999987543211
Q ss_pred c---------------------------------ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCC
Q 002717 759 K---------------------------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR 805 (888)
Q Consensus 759 ~---------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~ 805 (888)
. ........||+.|+|||++ .+..++.++||||+||++|||++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF-MQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH-cCCCCCCcceeccccceeeecccCCC
Confidence 0 0001234689999999988 55678999999999999999999999
Q ss_pred CCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002717 806 PVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS---MAEVVQI 873 (888)
Q Consensus 806 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~ 873 (888)
||....... ............ .+.+ .......+.+++.+|+ .||.+|++ +.|++++
T Consensus 235 Pf~~~~~~~-----~~~~i~~~~~~~-~~p~-----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQE-----TYRKVMNWKETL-VFPP-----EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHH-----HHHHHHcCCCce-ecCC-----CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 996543211 111111111000 0111 0113345677777766 49999985 6777776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.19 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=198.5
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.|+..+.||+|+||.||++++..+++.||+|.+..... ......+.+|..++..++|++|+++++++.+.+..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 35667799999999999999998999999999864321 1223457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 y~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 82 YYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred CCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999864 24588899999999999999999998 9999999999999999999999999999765432
Q ss_pred ccccccccccccccccCcccccCc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQS----LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.. .......|++.|+|||++... ..++.++|||||||++|||++|+.||...... +............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~~~~-- 227 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHEERF-- 227 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----HHHHHHHcCCCcc--
Confidence 22 112335689999999987431 35788999999999999999999999653221 1111111111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSS--RPSMAEVVQI 873 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~ 873 (888)
..+.........+.+++.+|+..++++ |+++++++++
T Consensus 228 ---~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 ---QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 011112234556888999998866554 5689888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.71 Aligned_cols=258 Identities=29% Similarity=0.438 Sum_probs=203.3
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
++...|+..+.||+|+||.||+|....+++.||+|++...... +..+.+.+|+.+++.++||||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 4556688888999999999999999888999999998544322 22356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||++ |++.+.+... ...+++..+..++.|++.|+.|||+. +|+||||+|+||++++++.++|+|||++..
T Consensus 92 lv~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 92 LVMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 9999996 5777777543 23589999999999999999999998 999999999999999999999999999875
Q ss_pred ccccccccccccccccccccCccccc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcc
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (888)
.... ....++..|+|||.+. ....++.++|||||||++|||++|+.||......... . .. ....
T Consensus 165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~--~---~~-~~~~-- 230 (307)
T cd06607 165 VSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--Y---HI-AQND-- 230 (307)
T ss_pred cCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH--H---HH-hcCC--
Confidence 4321 2345778899999873 2356788999999999999999999998654321110 0 01 0000
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 832 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
.+.. .+......+.+++.+||+.+|++||++.+++.+..-...
T Consensus 231 ---~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 231 ---SPTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ---CCCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0111 122345578999999999999999999999987654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=300.57 Aligned_cols=251 Identities=31% Similarity=0.451 Sum_probs=201.3
Q ss_pred hcCeeccccceEEEEEEECCCC----eEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 603 KAAEVGEGVFGTVYKVSFGTQG----RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 603 ~~~~ig~G~~g~V~~~~~~~~~----~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
..+.||+|+||.||++.+...+ ..||+|.+.........+.+..|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4568999999999999997655 889999986554333567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||+++......
T Consensus 83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 83 MEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred cCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999998642 11289999999999999999999998 99999999999999999999999999998765432
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.... ....++..|+|||.. ....++.++||||+|+++|||++ |..||..... . ...+. . ..+..
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~-~~~~~---~-~~~~~------- 222 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-E-EVLEY---L-KKGYR------- 222 (258)
T ss_pred cccc-ccCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-H-HHHHH---H-hcCCC-------
Confidence 2221 123367889999988 55678999999999999999998 7777754211 1 11111 1 11111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
...+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112333566789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=300.17 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=196.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc----CChHHHHHHHHHHhhcCCCCcceeeeEEEcC--CeeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 674 (888)
|+..+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.++++++||||+++++++.++ ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 45677899999999999999888999999987533211 1235678899999999999999999988764 45679
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
|+||+++++|.+++... ..+++..+.+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 84 FMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 99999999999998764 3478888999999999999999998 9999999999999999999999999998765
Q ss_pred cccccc-cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 755 TRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 755 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
...... .......++..|+|||.+ ....++.++|||||||++|||++|+.||........ . ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~----~~~~~~------ 224 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-I----FKIATQ------ 224 (265)
T ss_pred ccccccccccccCCCCccccChhhh-cCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-H----HHHhcC------
Confidence 322111 111234578899999988 445688999999999999999999999964322111 1 111110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+.....+......+..++.+||. +|++||+++|++++
T Consensus 225 --~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 --PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11112344555667889999994 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=305.61 Aligned_cols=260 Identities=21% Similarity=0.243 Sum_probs=196.3
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcC--CeeeEEEec
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTP--QLKLLVSDY 678 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~ 678 (888)
+..+.||+|+||.||+|....+++.||+|++.............+|+.++.++. |+||+++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 455689999999999999988899999999865432223334567899999885 99999999999987 788999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
++ |++.+.+... ...+++..++.++.|++.||+|||+. +++||||+|+||++++ +.+||+|||+++......
T Consensus 82 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 82 MD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred CC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 97 5888887764 24689999999999999999999998 9999999999999999 999999999997654322
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHH----------HHHhcC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR----------VLLEEG 828 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~----------~~~~~~ 828 (888)
.. ....++..|+|||.+.....++.++||||+||++|||++|..||....... ....... ......
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHcCCCCHHHHHhhccc
Confidence 11 234577889999976555667899999999999999999999996543211 1111100 000000
Q ss_pred CcccccCCC-----CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 NVLDCVDPS-----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ~~~~~~d~~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.......+. ........+..+.+++.+||+.+|++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 001122446778999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=298.19 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=197.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+.|+..+.||+|+||.||++.. .++.||+|...... ..+.+.+|+.++++++|||++++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4577788999999999999976 68889999885432 346789999999999999999999998654 46899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++... ....+++..++.++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 80 MSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 9999999999764 234578999999999999999999988 99999999999999999999999999987543211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.....+..|+|||.+ ....++.++|||||||++|||++ |+.||....... . ......+...
T Consensus 155 -----~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~------ 216 (254)
T cd05083 155 -----DNSKLPVKWTAPEAL-KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--V----KECVEKGYRM------ 216 (254)
T ss_pred -----CCCCCCceecCHHHh-ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--H----HHHHhCCCCC------
Confidence 122345679999987 45578899999999999999998 888886442211 1 1111221111
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 217 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 --EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1123445678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=302.21 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=197.1
Q ss_pred hhcCeeccccceEEEEEEECC---CCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC------e
Q 002717 602 EKAAEVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------L 671 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 671 (888)
+..+.||+|+||.||+|.+.. +++.||+|++..... ....+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 345689999999999998743 468999999854322 223467889999999999999999999886542 2
Q ss_pred eeEEEecCCCCCHHHHHhhcCC--CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLP--STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
.++++||+++|+|.+++..... ....+++..++.++.|++.|++|||+. +|+||||||+||++++++.+|++|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 3688999999999988764321 223578889999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHHHhcC
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEG 828 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 828 (888)
+++...............++..|++||.. ....++.++|||||||++|||++ |+.||..... .....++ ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~----~~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYL----IKG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHH-hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHH----HcC
Confidence 99865433222222233456789999987 44567889999999999999999 7888764322 1111111 111
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 829 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 829 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
.. ...+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 232 ~~--------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR--------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 011233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=303.46 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=192.9
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhc---CCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKA---RHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
.||+|+||.||++....+++.||+|.+....... ....+.+|..+++.+ +||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999998889999999986543321 123344555444443 69999999999999899999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999998764 4589999999999999999999998 99999999999999999999999999987543221
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 840 (888)
.....|+..|+|||....+..++.++||||+||++|||++|..||......... ........ .. ..
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~------~~---~~ 217 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLT------VN---VE 217 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHhhc------CC---cC
Confidence 123468899999998754556789999999999999999999999654322111 11111000 01 12
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002717 841 YPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQIL 874 (888)
Q Consensus 841 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L 874 (888)
.+...+.++.+++.+||+.||++|| |++|++++-
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 3444566788999999999999999 699998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=304.92 Aligned_cols=263 Identities=23% Similarity=0.278 Sum_probs=200.7
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
+..+.||+|++|.||+|.+..+|+.||+|++...... ...+.+.+|+++++.++|||++++++++.+++..++|+||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 4566899999999999999889999999998654322 234678899999999999999999999999999999999995
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
++|.+++.... ...+++..++.++.|+++||+|||+. +++||||+|+||++++++.++++|||+++........
T Consensus 82 -~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 82 -LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred -cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 68999987652 24689999999999999999999998 9999999999999999999999999999755322111
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC-----------C
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG-----------N 829 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~-----------~ 829 (888)
.....++..|+|||++.....++.++|||||||++|||++|+.||...... ..+.+..+...... .
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhhhhhchh
Confidence 122345788999998755556789999999999999999999999654322 11212111100000 0
Q ss_pred ----cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 830 ----VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 830 ----~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
...................+.+++.+||+.+|++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000011111223344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=304.16 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=199.8
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEc------C
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT------P 669 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~ 669 (888)
+.+.|+..+.||+|+||.||+|.+..+++.||+|.+.... ....++..|+.+++++ +||||+++++++.. .
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 5567888889999999999999998889999999875432 2345688899999999 69999999999853 3
Q ss_pred CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 670 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 670 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
...++||||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +|+||||+|+||++++++.++|+|||
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCc
Confidence 56799999999999999997642 34578888899999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
++........ ......+++.|+|||.+.. ...++.++|||||||++|||++|..||.......... ..
T Consensus 167 ~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-----~~- 238 (282)
T cd06636 167 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-----LI- 238 (282)
T ss_pred chhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-----hH-
Confidence 9875432111 1234567889999998742 3457889999999999999999999996543211110 00
Q ss_pred hcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
... ..+. ......+..+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~-----~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 PRN-----PPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhC-----CCCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000 0011 0122345578999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=311.01 Aligned_cols=269 Identities=23% Similarity=0.278 Sum_probs=199.6
Q ss_pred hhhcCeeccccceEEEEEEECC--CCeEEEEEEeecCC--ccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC--CeeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~--~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 674 (888)
|+..+.||+|+||.||+|.+.. .++.||+|.+.... .....+.+.+|+.++++++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4456689999999999999987 78999999986532 123346678899999999999999999999988 77899
Q ss_pred EEecCCCCCHHHHHhhcCCC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC----CCCcEEeccc
Q 002717 675 VSDYAPNGSLQAKLHERLPS-TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD----NYNPRISDFG 749 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~----~~~~kl~Dfg 749 (888)
||||+++ ++.+.+...... ...+++..++.++.|++.|++|||+. +|+||||||+||+++. ++.+|++|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 677777543322 23688999999999999999999998 9999999999999999 9999999999
Q ss_pred cccccccccc-ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCch--------hhHHHH
Q 002717 750 LARLLTRLDK-HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV--------VILSEH 820 (888)
Q Consensus 750 la~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~--------~~l~~~ 820 (888)
+++....... ........++..|+|||.+.....++.++|||||||++|||++|+.||....... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986543222 1122344678889999987555567899999999999999999999997543321 011111
Q ss_pred HHHHHh-----------cCCccccc-CCCCCCCC---------h--hhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 821 VRVLLE-----------EGNVLDCV-DPSMGDYP---------E--DEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 821 ~~~~~~-----------~~~~~~~~-d~~~~~~~---------~--~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+..+.. ........ ......++ . ....++.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111000 00000000 00000011 1 334568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=305.25 Aligned_cols=265 Identities=23% Similarity=0.287 Sum_probs=202.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
|+..+.||.|++|.||+|++..+|+.||+|++.........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 45667899999999999999888999999998765444445678889999999999999999999999999999999998
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+ +|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||+++.......
T Consensus 82 ~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 82 K-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred c-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 5 8888887642 234689999999999999999999998 999999999999999999999999999975432111
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc-------CCcccc
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE-------GNVLDC 833 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~-------~~~~~~ 833 (888)
......++..|+|||.+.....++.++|||||||++|||++|+.||..... ........+..... ......
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-EDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 112345678899999875555678999999999999999999999975432 22222211110000 000000
Q ss_pred cCCCCCC--------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 834 VDPSMGD--------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 834 ~d~~~~~--------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
....... ..+.....+.+++.+|++.||++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011000 112234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.29 Aligned_cols=369 Identities=28% Similarity=0.392 Sum_probs=268.7
Q ss_pred ccEEEcCCCCCc-CCCchhhhccCCCCcEEEcCCccccccccccccCCCCCCEEECcCcccccccCccccccccccccCc
Q 002717 49 MKFLDLSNNLLS-GPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 127 (888)
Q Consensus 49 L~~L~Ls~N~l~-~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~ 127 (888)
.+-.|+++|.++ +..|..+ ..++++++|.|...++..++.. ++.+.+|+.|.+++|++.++.. .+..|+.|+
T Consensus 9 VrGvDfsgNDFsg~~FP~~v-~qMt~~~WLkLnrt~L~~vPeE-L~~lqkLEHLs~~HN~L~~vhG-----ELs~Lp~LR 81 (1255)
T KOG0444|consen 9 VRGVDFSGNDFSGDRFPHDV-EQMTQMTWLKLNRTKLEQVPEE-LSRLQKLEHLSMAHNQLISVHG-----ELSDLPRLR 81 (1255)
T ss_pred eecccccCCcCCCCcCchhH-HHhhheeEEEechhhhhhChHH-HHHHhhhhhhhhhhhhhHhhhh-----hhccchhhH
Confidence 456778888887 3566554 6777888888877777766654 5667777777777777664432 345566666
Q ss_pred EEEcCCccccccCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCc
Q 002717 128 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 207 (888)
Q Consensus 128 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 207 (888)
.+.+.+|++... -+|..+..+..|+.||||+|+++ ..|..+..-+++..|+||+|+
T Consensus 82 sv~~R~N~LKns-----------------------GiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~ 137 (1255)
T KOG0444|consen 82 SVIVRDNNLKNS-----------------------GIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNN 137 (1255)
T ss_pred HHhhhccccccC-----------------------CCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCc
Confidence 666666666521 23334444455555555555554 344555555555555555555
Q ss_pred ccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCcccccCCCCC
Q 002717 208 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGS 287 (888)
Q Consensus 208 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~~p~~~ 287 (888)
|..++...|.+++.|-.||||+|++. .+|..+..+..|++|.|++|++.. +++ + .+|
T Consensus 138 IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~h------fQL--r-----------QLP--- 194 (1255)
T KOG0444|consen 138 IETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNH------FQL--R-----------QLP--- 194 (1255)
T ss_pred cccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhH------HHH--h-----------cCc---
Confidence 55444444555666666666666665 445555566666666666665541 110 0 011
Q ss_pred CCCCCCcccCCCCEEeCCCCcCc-ccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCcccc
Q 002717 288 SSSSSSTLFQTLRILDLSSNNLV-GDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC 366 (888)
Q Consensus 288 ~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 366 (888)
.+++|+.|.+++.+-+ ..+|.++..+.||..+|+|.|.+. ..|+.+-.+.+|+.|+||+|+|+ .+.....
T Consensus 195 -------smtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~ 265 (1255)
T KOG0444|consen 195 -------SMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEG 265 (1255)
T ss_pred -------cchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHH
Confidence 1455666666665433 257899999999999999999997 78999999999999999999999 6677777
Q ss_pred ccCCCceEEccCCcCCCccCccccccccccEEEccCCcccc-cCCccccCCCCCCeEEccCCcceecCCccccccCCCCe
Q 002717 367 ESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG-SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLA 445 (888)
Q Consensus 367 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 445 (888)
...+|+.|+||.|+++ .+|.++.++++|+.|++.+|+++- -+|..++.|.+|+.+..++|.|. .+|+.++.+.+|+.
T Consensus 266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~k 343 (1255)
T KOG0444|consen 266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQK 343 (1255)
T ss_pred HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHH
Confidence 8889999999999999 899999999999999999999973 48999999999999999999998 89999999999999
Q ss_pred eeccCCcceecCCCCCCCCCCCCCCcCCCcCCCCCCC
Q 002717 446 VNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLL 482 (888)
Q Consensus 446 l~ls~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~~ 482 (888)
|+|+.|+|...+...-.++.+..+++..||.+--||-
T Consensus 344 L~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 344 LKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred hcccccceeechhhhhhcCCcceeeccCCcCccCCCC
Confidence 9999999987666556788999999999999887764
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.97 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=201.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||+|....+++.||+|.+...... ...+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 45667899999999999999888999999998655432 24567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++++|.+++... ..+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999763 3578899999999999999999998 999999999999999999999999999987643322
Q ss_pred ccc--cccccccccccCcccccCcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 760 HVM--SNRFQSALGYVAPELTCQSL--RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 760 ~~~--~~~~~g~~~y~aPE~~~~~~--~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
... .....++..|+|||.+.... ..+.++||||||+++||+++|+.||......... .... ..+ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-~~~~----~~~-----~~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-MFHV----GAG-----HK 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-HHHH----hcC-----CC
Confidence 111 11345778999999884332 3788999999999999999999999654322111 1111 111 11
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+..+. .......+.+++.+||+.+|++|||+.|++.+
T Consensus 225 ~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 225 PPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111 11225567899999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=324.58 Aligned_cols=264 Identities=21% Similarity=0.273 Sum_probs=192.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCC------CcceeeeEEEcC-C
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHP------NLISLEGYYWTP-Q 670 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~-~ 670 (888)
...|+..+.||+|+||.||+|.+...++.||||++.... .....+..|+++++.++|. +++++++++... .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 355778889999999999999998889999999985432 2334567788888877654 588888888765 4
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC---------
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY--------- 741 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~--------- 741 (888)
..++|||++ +++|.+++... ..+++..+..++.|++.||.|||+++ +|+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccccc
Confidence 678999988 77898888764 46899999999999999999999732 899999999999998665
Q ss_pred -------CcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCch
Q 002717 742 -------NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814 (888)
Q Consensus 742 -------~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~ 814 (888)
.+||+|||.+..... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||..... .
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~ 351 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVV-LGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN-L 351 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHh-hcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-H
Confidence 499999998864221 12346789999999998 555789999999999999999999999975432 1
Q ss_pred hhHHHHHHH-------------------HHh-cCCcccccCCCC-----C-C-C-ChhhHHHHHHHHHHccCCCCCCCCC
Q 002717 815 VILSEHVRV-------------------LLE-EGNVLDCVDPSM-----G-D-Y-PEDEVLPVLKLALVCTCHIPSSRPS 866 (888)
Q Consensus 815 ~~l~~~~~~-------------------~~~-~~~~~~~~d~~~-----~-~-~-~~~~~~~l~~li~~cl~~dp~~RPs 866 (888)
..+....+. .+. .+....+.++.. . . . .......+.+|+.+|++.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 111111110 000 000001111100 0 0 0 0011245679999999999999999
Q ss_pred HHHHHHHHHhh
Q 002717 867 MAEVVQILQVI 877 (888)
Q Consensus 867 ~~evl~~L~~~ 877 (888)
++|++++-+-.
T Consensus 432 a~e~L~Hp~~~ 442 (467)
T PTZ00284 432 ARQMTTHPYVL 442 (467)
T ss_pred HHHHhcCcccc
Confidence 99999876543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.82 Aligned_cols=255 Identities=26% Similarity=0.305 Sum_probs=206.2
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
+.+...+.||+|+||.||.+..+.+|+.+|.|++.+.... +.......|-.|+++++.+.||.+--.|...+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 3355667899999999999999999999999998554332 23345678999999999999999988899999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
..|.||+|.-+|.... .+.+++.++.-+|.+|+.||++||.+ +||.||+||+|||+|+.|.++|+|.|+|..+.+
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999998863 46799999999999999999999999 999999999999999999999999999998876
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
+... ....||.+|||||++ ....|+...|.||+||++|||+.|+.||..-..-. -.+.+..... .
T Consensus 340 g~~~---~~rvGT~GYMAPEvl-~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--k~eEvdrr~~---------~ 404 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVL-QNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--KREEVDRRTL---------E 404 (591)
T ss_pred CCcc---ccccCcccccCHHHH-cCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--hHHHHHHHHh---------c
Confidence 5443 445899999999999 55569999999999999999999999996532110 0011111111 1
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
.-.++++....+...+.+..+..||.+|. .+.||.++
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 11135666667788899999999999996 44566553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=288.86 Aligned_cols=257 Identities=22% Similarity=0.335 Sum_probs=199.7
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEec
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
..+....||.|+||+|++..++..|+.+|||+++........+++..|.+...+- ++||||+++|.+..++..|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3455568999999999999999999999999998776656677888898886655 699999999999999999999999
Q ss_pred CCCCCHHHHHhh-cCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 679 APNGSLQAKLHE-RLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 679 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|. -++..+-.. .......+++.-.-.|......||.||.+.. .|+|||+||+|||+|..|.+|+||||++-.+..
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~- 220 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD- 220 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence 94 355443222 1113456888888889999999999999875 899999999999999999999999999865432
Q ss_pred ccccccccccccccccCcccccCcCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLR-VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
....+...|-..|||||.+..... ++.+|||||+|+++||+.||..||.....- .+++....... +
T Consensus 221 --SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----feql~~Vv~gd-------p 287 (361)
T KOG1006|consen 221 --SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----FEQLCQVVIGD-------P 287 (361)
T ss_pred --HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----HHHHHHHHcCC-------C
Confidence 223344566678999998855544 889999999999999999999999755332 23333332222 1
Q ss_pred CCCCCC---hhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 837 SMGDYP---EDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 837 ~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.....+ .+....+..++..|+.+|-..||...++.++
T Consensus 288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111112 2355678899999999999999999988763
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.03 Aligned_cols=264 Identities=25% Similarity=0.337 Sum_probs=201.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 5667789999999999999988899999998864432 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
+++.+..+.... ..+++..++.++.|++.|+.|||+. +++|||++|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 83 ERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 987776655432 4488999999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH----------HhcCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL----------LEEGN 829 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~----------~~~~~ 829 (888)
. ......++..|+|||++.....++.++||||||+++|+|++|+.||...... ..+....... .....
T Consensus 156 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 S-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHhhhcccCc
Confidence 1 1133457788999999855447889999999999999999999998653221 1111110000 00000
Q ss_pred cc------cccCCCC--CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 830 VL------DCVDPSM--GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 830 ~~------~~~d~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.. +..++.. ..++...+..+.+++++||..+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 0000000 01223346778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.55 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=203.8
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-C-----CCcceeeeEEEcCCeee
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-H-----PNLISLEGYYWTPQLKL 673 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 673 (888)
.|++.+.||+|+||.|.+|.+..+++.||||+++... ....+-..|+.+|..++ | -|+|++++++...++.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 6788889999999999999999999999999996543 33456678999999996 4 38999999999999999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC--CCCcEEeccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD--NYNPRISDFGLA 751 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfgla 751 (888)
+|+|.+. -+|.++++... -..++...+..|+.||+.||.+||+. +|||+||||+|||+.+ ...+||+|||.+
T Consensus 265 iVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999995 59999999864 34588999999999999999999998 9999999999999974 347999999999
Q ss_pred ccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHh-----
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE----- 826 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~----- 826 (888)
....+.-. ...-+..|+|||++ -+.+|+.+.||||||||+.||++|.+-| .+....+++...++....
T Consensus 339 c~~~q~vy-----tYiQSRfYRAPEVI-LGlpY~~~IDmWSLGCIlAEL~tG~PLf-pG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 339 CFESQRVY-----TYIQSRFYRAPEVI-LGLPYDTAIDMWSLGCILAELFTGEPLF-PGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccCCcce-----eeeeccccccchhh-ccCCCCCccceeehhhhHHhHhcCcccc-CCCCHHHHHHHHHHHhCCCCHHH
Confidence 87654222 34456779999999 5668999999999999999999995555 455555555544332110
Q ss_pred --cC-CcccccCC---------------------------------CCC----C----CChhhHHHHHHHHHHccCCCCC
Q 002717 827 --EG-NVLDCVDP---------------------------------SMG----D----YPEDEVLPVLKLALVCTCHIPS 862 (888)
Q Consensus 827 --~~-~~~~~~d~---------------------------------~~~----~----~~~~~~~~l~~li~~cl~~dp~ 862 (888)
.+ +....++. ..+ + .+......+.+++.+|+..||+
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 00 00000000 000 0 1123445688999999999999
Q ss_pred CCCCHHHHHHHHHh
Q 002717 863 SRPSMAEVVQILQV 876 (888)
Q Consensus 863 ~RPs~~evl~~L~~ 876 (888)
+|+|+.|++++-.-
T Consensus 492 ~R~tp~qal~Hpfl 505 (586)
T KOG0667|consen 492 ERITPAQALNHPFL 505 (586)
T ss_pred hcCCHHHHhcCccc
Confidence 99999999987543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=304.28 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=197.8
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCeeeEEEec
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
.++..+.||+|+||.||++.+..+++.||+|.+...........+.+|+.++.++. ||||+++++++..+...++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 34556689999999999999998999999999865443334567889999999996 99999999999988889999999
Q ss_pred CCCCCHHHHHhhc-CCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 679 APNGSLQAKLHER-LPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 679 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
+.. ++.++.... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 555443221 112356899999999999999999999742 8999999999999999999999999999765422
Q ss_pred ccccccccccccccccCcccccCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQS--LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.. .....++..|+|||.+... ..++.++||||+||++|||++|+.||...... .......... ..
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~------~~ 228 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQLTQVVKG------DP 228 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHHHhhhcCC------CC
Confidence 11 1334578889999988544 36889999999999999999999999654311 1111111111 01
Q ss_pred CCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 836 PSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 836 ~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
+.+. ..+......+.+++.+||+.+|++|||+.|++++-
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1111 12234566789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.01 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=205.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
|+..+.||+|++|.||+|....+++.||+|++.........+.+.+|+.++++++|+|++++++++..+...++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 45567899999999999999988999999998655433445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
+++|.+++... ..+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.+........
T Consensus 83 ~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 83 GGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 99999999864 468999999999999999999999 8 999999999999999999999999999976543222
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC-chhhHHHHHHHHHhcCCcccccCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED-NVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. .....++..|+|||.+ ....++.++||||||+++|||++|+.||..... ..... .+.... . ..
T Consensus 156 ~--~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~-~--------~~ 220 (264)
T cd06623 156 Q--CNTFVGTVTYMSPERI-QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICD-G--------PP 220 (264)
T ss_pred c--ccceeecccccCHhhh-CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HHHHhc-C--------CC
Confidence 1 1234577889999987 455788999999999999999999999976532 11111 111111 1 11
Q ss_pred CCCChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 839 GDYPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 839 ~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
...+.. .+..+.+++..||+.+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 122333 55678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.13 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=204.5
Q ss_pred CChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCee
Q 002717 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 595 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 672 (888)
.+++..|+..+.||+|+||.||+|++..++..||+|++...... ...+.+.+|++++++++|||++++++++.+++..
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 45666688888999999999999999888999999998644322 2335688999999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
++||||++ |++.+.+... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++.
T Consensus 101 ~lv~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~ 173 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS 173 (317)
T ss_pred EEEEeCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCcc
Confidence 99999997 5787777643 34589999999999999999999998 99999999999999999999999999986
Q ss_pred cccccccccccccccccccccCccccc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCc
Q 002717 753 LLTRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 753 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
..... ....++..|+|||.+. ....++.++|||||||++|||++|+.||...... ..... ....+.
T Consensus 174 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~----~~~~~~- 241 (317)
T cd06635 174 IASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYH----IAQNES- 241 (317)
T ss_pred ccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHH----HHhccC-
Confidence 54321 2346778899999863 2346789999999999999999999998653221 11111 111110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 831 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
+ ..........+.+++.+||+.+|.+||++.+++++.....
T Consensus 242 -----~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 -----P--TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----C--CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0 0112234456889999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=311.32 Aligned_cols=270 Identities=22% Similarity=0.316 Sum_probs=201.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-----eee
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKL 673 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 673 (888)
+.|+..+.||+|+||.||+|.+..+|+.||+|++...........+.+|+.++++++||||+++++++.... ..+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 346778899999999999999988999999999864433344567889999999999999999999876543 468
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||++ +++.+.+.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 85 IVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 9999996 478777754 3589999999999999999999998 999999999999999999999999999976
Q ss_pred cccccccc-ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC---
Q 002717 754 LTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN--- 829 (888)
Q Consensus 754 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~--- 829 (888)
........ ......++..|+|||.+.....++.++||||+||++|||++|+.||...... ...... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~-~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLI-LGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-HHHcCCCCHHH
Confidence 54322111 1123467889999998755556889999999999999999999999653221 111111 11000000
Q ss_pred ccccc-------------CCCCC--CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhcC
Q 002717 830 VLDCV-------------DPSMG--DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKT 879 (888)
Q Consensus 830 ~~~~~-------------d~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~ 879 (888)
...+. .+... .........+.+++.+||+.+|++|||+.|++++ ++...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000 00000 0011234568899999999999999999999997 554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.09 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=201.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||++.+..+++.||+|.+..... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 5566789999999999999988899999999865432 12346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 83 VPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999764 4688999999999999999999998 9999999999999999999999999999765432
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
.....+++.|+|||.+ .....+.++||||||+++|+|++|..||..... ... .+... .+.
T Consensus 155 ----~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~---~~~~~-~~~--------- 214 (290)
T cd05580 155 ----TYTLCGTPEYLAPEII-LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQI---YEKIL-EGK--------- 214 (290)
T ss_pred ----CCCCCCCccccChhhh-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHHh-cCC---------
Confidence 2345678899999987 444678999999999999999999999965431 111 11111 111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQIL 874 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L 874 (888)
...+......+.+++.+||..+|++|+ +++|++++-
T Consensus 215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 112334456788999999999999999 778877643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=302.27 Aligned_cols=264 Identities=25% Similarity=0.324 Sum_probs=201.1
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcC--CeeeEEE
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLVS 676 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 676 (888)
.|+..+.||+|+||.||+|.+..+++.+|+|.+...... .....+.+|+.++++++||||+++++++..+ ...++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 467778999999999999999888999999998654322 2234677899999999999999999998877 7889999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 86 e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 86 EYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred hhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 9997 59999887642 3689999999999999999999998 999999999999999999999999999986543
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH-----------
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL----------- 825 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~----------- 825 (888)
... ......++..|+|||.+.....++.++|+||+||++|||++|..||..... .....+......
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchHHHHHhh
Confidence 221 113345678899999885555578999999999999999999999965322 111111111000
Q ss_pred h-----cCCcccccCCCCC-CCChh-hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 826 E-----EGNVLDCVDPSMG-DYPED-EVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 826 ~-----~~~~~~~~d~~~~-~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
. ............. .++.. ....+.+++.+||+.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000000000111 12222 35668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.80 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=202.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
...|+..+.||+|+||.||+|....+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 355677789999999999999988788999999985332 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 97 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999999753 478899999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.. ......+++.|+|||.+ ....++.++|||||||++||+++|+.||........... ....+. +.
T Consensus 169 ~~--~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-----~~~~~~------~~ 234 (293)
T cd06647 169 QS--KRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGT------PE 234 (293)
T ss_pred cc--ccccccCChhhcCchhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-----hhcCCC------CC
Confidence 22 11334678889999987 445688999999999999999999999965432211110 000000 00
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
. ..+......+.+++.+||..+|++||++.+++.+-
T Consensus 235 ~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 235 L-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred C-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0 11233445688999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.25 Aligned_cols=254 Identities=19% Similarity=0.261 Sum_probs=196.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||++.+...++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 4556789999999999999998999999999865432 22345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++......
T Consensus 83 ~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 83 VEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999764 3588899999999999999999998 99999999999999999999999999986421100
Q ss_pred -------------cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH
Q 002717 759 -------------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 759 -------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
.........++..|+|||.+ ....++.++|+|||||++|||++|..||..... .. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-~~----~~~~~~ 229 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI-LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EE----LFGQVI 229 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HH----HHHHHH
Confidence 00011123567889999987 445689999999999999999999999964322 11 111111
Q ss_pred hcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
... . ..+ ......+..+.+++.+||+.+|++||++.++.+.+
T Consensus 230 ~~~-~---~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 230 SDD-I---EWP---EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred hcc-c---CCC---CccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 111 0 011 11123455688999999999999999854444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.51 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=200.5
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||+|....+|..||+|.+...... ...+.+.+|+++++.++|+||+++++++...+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 44566899999999999999988999999998654221 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC-CcEEecccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTRLD 758 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~~~~~ 758 (888)
++++|.+++... ....+++..+..++.|+++|++|||+. +++|+||||+||++++++ .+|++|||.+.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 82 DGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999764 234579999999999999999999998 999999999999999875 46999999987654322
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. ......|++.|+|||.. ....++.++|||||||++|||++|+.||...... +.+..... +. .
T Consensus 157 ~--~~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~--------~ 219 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEIC-QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKICQ-GY--------F 219 (257)
T ss_pred c--cccccCCCccccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhc-cc--------C
Confidence 1 11234578899999987 4456889999999999999999999998643221 12221111 11 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.........++.+++.+||..+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223344578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=304.23 Aligned_cols=275 Identities=27% Similarity=0.325 Sum_probs=206.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcC--CeeeEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 675 (888)
+.|+..+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.++++++|+||+++++++... +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 4467778999999999999999989999999998644322 2234567899999999999999999998755 457999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|||++ ++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||++....
T Consensus 87 ~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 87 MEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 99996 4888888764 25689999999999999999999998 99999999999999999999999999998664
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC--Ccc--
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--NVL-- 831 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--~~~-- 831 (888)
..... .....++..|+|||.+.....++.++||||+||++|||++|+.||...... ..+..... ..... ...
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~-~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQ-LLGTPNESIWPG 235 (309)
T ss_pred CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH-hcCCCChhhchh
Confidence 32211 122345778999998755566789999999999999999999999754322 11211111 10000 000
Q ss_pred -------cccC--CC-CC---CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCCCC
Q 002717 832 -------DCVD--PS-MG---DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQR 884 (888)
Q Consensus 832 -------~~~d--~~-~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~ 884 (888)
..+. .. .. .........+.+++.+|++.||++|||+.|++++-+-...++|.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 0000 00 00 000112456778999999999999999999999887776666654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=298.54 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=204.8
Q ss_pred cccCChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecC-CccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcC
Q 002717 592 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS-DIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP 669 (888)
Q Consensus 592 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 669 (888)
++..-....|++.++||+||.+.||++... +.+.||+|++... ...+....|..|+..|.++ .|.+||.+++|-..+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 334445667899999999999999999986 5677888776433 3334567899999999999 599999999999999
Q ss_pred CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 670 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 670 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
+..|+||||- ..+|.++|..+. ....+| .+..+..|++.++.+.|++ ||||.||||.|+|+-+ |.+||+|||
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFG 504 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFG 504 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeec
Confidence 9999999986 459999998863 223344 6778889999999999999 9999999999999864 689999999
Q ss_pred ccccccccccccccccccccccccCcccccCc----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHH
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQS----------LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~ 819 (888)
+|..+......+......||+.||+||.+... .+.+.++||||+||++|+|+.|+.||..... .
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~ 578 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------Q 578 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------H
Confidence 99988877777777888999999999987322 1256899999999999999999999964211 1
Q ss_pred HHHHHHhcCCcccccCCCC-CCCChhhH-HHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 820 HVRVLLEEGNVLDCVDPSM-GDYPEDEV-LPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 820 ~~~~~~~~~~~~~~~d~~~-~~~~~~~~-~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
|. ++..+.||.- -+||.-.. .+++++|..|+..||++|||+.|++++-
T Consensus 579 ~a-------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 579 IA-------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred HH-------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 11 1223444422 12222111 2289999999999999999999999853
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.62 Aligned_cols=255 Identities=22% Similarity=0.383 Sum_probs=201.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
|+..+.||+|+||.||+|....+++.||+|.+...... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 45567899999999999999889999999998643311 1235788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC-CcEEecccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLL 754 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~ 754 (888)
+||+++++|.+++... .++++..+..++.|++.|+.|||+. +++||||+|+||+++.++ .++|+|||.+...
T Consensus 82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 82 VEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999764 3578899999999999999999998 999999999999998775 5999999998766
Q ss_pred cccccc--cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccc
Q 002717 755 TRLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832 (888)
Q Consensus 755 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (888)
...... .......++..|+|||.+ ....++.++||||+|+++|+|++|..||........ . .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~-~~~~~~~~~----- 226 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVL-RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-L-ALIFKIASA----- 226 (268)
T ss_pred ccccccCCccccccccccceeCHhHh-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-H-HHHHHHhcc-----
Confidence 432111 111234578899999987 455688999999999999999999999964322111 1 111111000
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 833 ~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
......+.....++.+++.+|+..+|++|||+.|++.+
T Consensus 227 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 ---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00122344556678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.80 Aligned_cols=262 Identities=25% Similarity=0.352 Sum_probs=199.8
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-ccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC--CeeeEEEec
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLVSDY 678 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 678 (888)
+..+.||+|+||.||+|.+..+++.+|+|++.... .......+.+|+++++.++|||++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45568999999999999998889999999997653 223446788999999999999999999999888 789999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++ +|.+++... ...+++..++.++.|++.|++|||+. +++|+||+|+||++++++.+|++|||++.......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 82 MDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 974 888888654 24689999999999999999999998 99999999999999999999999999998665432
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC---c---cc
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN---V---LD 832 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~---~---~~ 832 (888)
. .......++..|+|||.+.....++.++||||||+++|||++|+.||..... ...+....+ ...... . .+
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFE-LCGSPTDENWPGVSK 231 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH-HhCCCchhhcccccc
Confidence 1 1112335577899999775555678999999999999999999999965432 221211111 100000 0 00
Q ss_pred -----ccCC------CCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 833 -----CVDP------SMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 833 -----~~d~------~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
...+ .+.+ +...+...+.+++.+||+.+|++|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 0000 111125678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.90 Aligned_cols=266 Identities=23% Similarity=0.258 Sum_probs=197.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCe-----ee
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQL-----KL 673 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~~ 673 (888)
|+..+.||+|+||.||+|.+..+++.||+|+....... .....+.+|+.+++.++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 55667899999999999999889999999987543222 23467888999999995 6999999999887665 79
Q ss_pred EEEecCCCCCHHHHHhhcCCC-CCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC-CCCcEEeccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPS-TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLA 751 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla 751 (888)
+||||+++ ++.+++...... ...+++..++.++.|++.||.|||+. +|+||||+|+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 898888764322 35689999999999999999999998 9999999999999998 899999999998
Q ss_pred ccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC-c
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN-V 830 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~-~ 830 (888)
+........ .....+++.|+|||.+.....++.++|||||||++|||++|..||...... ..+.+..+....... .
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 159 RAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQLLHIFKLLGTPTEQV 235 (295)
T ss_pred eecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHhCCCChhh
Confidence 754321111 122345778999998755556789999999999999999999999653221 111111111000000 0
Q ss_pred c-cc---c----CCC-----CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 831 L-DC---V----DPS-----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 831 ~-~~---~----d~~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
. .. . -+. .....+.....+.+++.+||..||++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00 0 000 000112345568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.40 Aligned_cols=270 Identities=24% Similarity=0.326 Sum_probs=204.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC------eeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------LKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 674 (888)
++..+.+|+|+||.||+|+.+.+|+.||||.+.........+...+|++++++++|||||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445579999999999999999999999999977665666788999999999999999999999765443 4589
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec--CCC--CcEEecccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNY--NPRISDFGL 750 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~--~~kl~Dfgl 750 (888)
|||||.+|+|...+..-. ....+++.+.+.+..+++.||.|||++ +||||||||.||++- ++| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999998642 345699999999999999999999998 999999999999984 223 479999999
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC-
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN- 829 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~- 829 (888)
|+.+.+.. ......||..|.+||.+-....++..+|.|||||++||++||..||.............+....+...
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99877544 34678999999999998435788999999999999999999999997653332211111111111111
Q ss_pred cccccCCCCCC-------------CChhhHHHHHHHHHHccCCCCCCCC--CHHHHHHHHHhh
Q 002717 830 VLDCVDPSMGD-------------YPEDEVLPVLKLALVCTCHIPSSRP--SMAEVVQILQVI 877 (888)
Q Consensus 830 ~~~~~d~~~~~-------------~~~~~~~~l~~li~~cl~~dp~~RP--s~~evl~~L~~~ 877 (888)
......+...+ .......++-+....++..+|++|. .+.+....+..|
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11111111110 1123334566778888888899998 666666555544
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=296.30 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=199.3
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCH
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 684 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 684 (888)
||.|+||.||+|+...+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999888999999998654322 3346789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccc
Q 002717 685 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764 (888)
Q Consensus 685 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 764 (888)
.+++... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||+++...... ...
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 9999864 3478899999999999999999998 99999999999999999999999999998664322 113
Q ss_pred cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChh
Q 002717 765 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844 (888)
Q Consensus 765 ~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 844 (888)
...++..|+|||.+ ....++.++|+||+|+++|||++|..||.....+.. +..+..... .....++..
T Consensus 151 ~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~--------~~~~~~~~~ 218 (262)
T cd05572 151 TFCGTPEYVAPEII-LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EIYNDILKG--------NGKLEFPNY 218 (262)
T ss_pred cccCCcCccChhHh-cCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HHHHHHhcc--------CCCCCCCcc
Confidence 34678889999987 455688999999999999999999999976543221 111111110 011123334
Q ss_pred hHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 002717 845 EVLPVLKLALVCTCHIPSSRPS-----MAEVVQIL 874 (888)
Q Consensus 845 ~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L 874 (888)
....+.+++.+||+.+|++||+ ++|++++-
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHK 253 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcCh
Confidence 4567899999999999999999 78877743
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.87 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=202.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||.|+||.||+|.+..+++.||+|.+...... ...+.+.+|++++++++||||+++++++..+...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 45667899999999999999888999999998654322 3457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++... .++++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||.+.......
T Consensus 82 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 82 LLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999764 4688999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
......++..|+|||.+ ....++.++|+||+|+++|+|++|..||....... .......... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~---------~~ 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVL-CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIRAKQET---------AD 218 (258)
T ss_pred ---cccccCCChhhcCHHHH-cccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHHHHhcc---------cc
Confidence 12345677889999988 44558999999999999999999999997654321 1111111110 11
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCH--HHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSM--AEVVQ 872 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~evl~ 872 (888)
...+...+..+.+++.+||+.||++||++ +|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 12344455778899999999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.43 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=201.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
..+...+.||+|++|.||++.+..+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 34555668999999999999998889999999885432 22345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||.+.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 98 LEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 999999999876 2478899999999999999999998 99999999999999999999999999887543211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. ......|+..|+|||.. .+..++.++|||||||++|||++|+.||...... ...+.... .. .+..
T Consensus 170 ~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~~~~~-~~-----~~~~ 235 (285)
T cd06648 170 P--RRKSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMKRIRD-NL-----PPKL 235 (285)
T ss_pred c--ccccccCCccccCHHHh-cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHh-cC-----CCCC
Confidence 1 11334578899999987 4456889999999999999999999998643221 11111111 10 0111
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
..+......+.+++.+||+.+|++|||+.+++++-.
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred -cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 112234567899999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.26 Aligned_cols=254 Identities=26% Similarity=0.325 Sum_probs=201.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
|+..+.||+|+||.||+|....+++.||+|.+....... ..+.+..|+++++.++||||+++++++......++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 556678999999999999998889999999987654332 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+.+++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 83 CPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred cCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999998754 235689999999999999999999998 99999999999999999999999999987543221
Q ss_pred ccc---------------------------ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 002717 759 KHV---------------------------MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 811 (888)
Q Consensus 759 ~~~---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~ 811 (888)
... ......|+..|+|||++ .+..++.++|||||||++|+|++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI-SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH-cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 11123578889999988 45567899999999999999999999996543
Q ss_pred CchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 002717 812 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS----MAEVVQI 873 (888)
Q Consensus 812 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~evl~~ 873 (888)
.... +.. ...... .... .......+.+++.+||+.||++||| ++|++.+
T Consensus 237 ~~~~-~~~----~~~~~~-------~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDET-FSN----ILKKEV-------TFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHH-HHH----HhcCCc-------cCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 3211 111 111100 0001 1114567899999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=326.50 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=193.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC---------
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--------- 669 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 669 (888)
..++..+.+|+||||.||+++.+-+|+.||||++...........+.+|+..+++++|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 44566678999999999999999999999999997665444456788999999999999999997632110
Q ss_pred --------------------------------------------------------------------------------
Q 002717 670 -------------------------------------------------------------------------------- 669 (888)
Q Consensus 670 -------------------------------------------------------------------------------- 669 (888)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhh
Q 002717 670 ------------------------------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719 (888)
Q Consensus 670 ------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~ 719 (888)
...|+=||||+..++.++++...... .....|+++++|+.||+|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHh
Confidence 01267788998888888887652111 457789999999999999999
Q ss_pred cCCCCeEecCCCCCcEEecCCCCcEEeccccccccc----c------------cccccccccccccccccCcccccCcC-
Q 002717 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT----R------------LDKHVMSNRFQSALGYVAPELTCQSL- 782 (888)
Q Consensus 720 ~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~----~------------~~~~~~~~~~~g~~~y~aPE~~~~~~- 782 (888)
+ |||||||||.||++|++..|||+|||+|+... . +......+...||--|+|||++....
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998722 0 01111234567899999999986665
Q ss_pred -CCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCC
Q 002717 783 -RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIP 861 (888)
Q Consensus 783 -~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp 861 (888)
.|+.|+|+||+|||+|||+ +||....++...+.. ++.+.+ |.-.++.......-.++|+++++.||
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~-----LR~g~i-----P~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTN-----LRKGSI-----PEPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred ccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHh-----cccCCC-----CCCcccccccchHHHHHHHHHhcCCC
Confidence 6999999999999999997 467654332222211 112211 11123344444455689999999999
Q ss_pred CCCCCHHHHHH
Q 002717 862 SSRPSMAEVVQ 872 (888)
Q Consensus 862 ~~RPs~~evl~ 872 (888)
++||||.|++.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999986
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=298.56 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=206.1
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
++.+.|+..+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+++++.++|+||+++++++...+..++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345557777899999999999999988899999999865432 456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999998752 4689999999999999999999998 99999999999999999999999999886544
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.... ......++..|+|||.+ ....++.++|||||||++|+|++|+.||....... .... ... .....
T Consensus 168 ~~~~--~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~----~~~-~~~~~--- 235 (286)
T cd06614 168 KEKS--KRNSVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFL----ITT-KGIPP--- 235 (286)
T ss_pred cchh--hhccccCCcccCCHhHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHH----HHh-cCCCC---
Confidence 3211 11334577889999987 45568899999999999999999999986432211 1111 111 11100
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
. ..+...+..+.+++.+||+.+|.+|||+.+++++-.
T Consensus 236 --~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 236 --L-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred --C-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 0 112224567889999999999999999999997553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=292.76 Aligned_cols=253 Identities=27% Similarity=0.406 Sum_probs=206.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||++.+..+++.||+|++...... ...+.+.+|+++++.++|||++++.+.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 44566899999999999999888999999998654322 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++++|.+++.........+++..+..++.+++.|++|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99999999987644456799999999999999999999998 99999999999999999999999999997654322
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
.......+++.|+|||.. ....++.++||||+|+++|+|++|+.||..... .......... ...
T Consensus 158 -~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~---------~~~ 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELC-QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKG---------QYP 221 (258)
T ss_pred -ceecceeeeecccChhHh-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcC---------CCC
Confidence 122345678889999987 455688999999999999999999999865431 1111111111 112
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
..+......+.+++.+||..+|++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2344555678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=297.37 Aligned_cols=247 Identities=27% Similarity=0.313 Sum_probs=195.6
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCH
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 684 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 684 (888)
||+|+||+||+|....+|+.||+|.+..... ......+..|++++++++||||+++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999988999999999865332 12344567899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccc
Q 002717 685 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764 (888)
Q Consensus 685 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 764 (888)
.+++.... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||.+...... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 99998652 24689999999999999999999998 9999999999999999999999999998765431 1113
Q ss_pred cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChh
Q 002717 765 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844 (888)
Q Consensus 765 ~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 844 (888)
...++..|+|||.+. +..++.++||||+||++|+|++|+.||........ .....+ .. .......+..
T Consensus 153 ~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-----~~-----~~~~~~~~~~ 220 (277)
T cd05577 153 GRAGTPGYMAPEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKR-----RT-----LEMAVEYPDK 220 (277)
T ss_pred cccCCCCcCCHHHhc-CCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHh-----cc-----ccccccCCcc
Confidence 345678899999874 44588999999999999999999999965432111 011110 00 0011123344
Q ss_pred hHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 845 EVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 845 ~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
....+.+++.+||+.+|++|| ++.+++.+
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 456788999999999999999 67777664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.95 Aligned_cols=262 Identities=25% Similarity=0.321 Sum_probs=199.3
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCeeeEEEecCC
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
+..+.||+|+||.||+|....+++.||+|++.............+|+..+++++ ||||+++++++..++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 455689999999999999988899999999865433222334567999999998 999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+|++.+++.... ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889999887652 34689999999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHH------------HHHHhcC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV------------RVLLEEG 828 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~------------~~~~~~~ 828 (888)
.....++..|+|||.+.....++.++||||||+++|||++|+.||........ ..+.. .......
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCChhhhhhHhhhhc
Confidence 12345778899999875666688999999999999999999999865432211 11100 0000000
Q ss_pred CcccccC----CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 NVLDCVD----PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ~~~~~~d----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.....+. ............++.+++++||+.+|++|||++|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00011111224678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=304.48 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=194.4
Q ss_pred eeccc--cceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCC
Q 002717 606 EVGEG--VFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 606 ~ig~G--~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 682 (888)
.||+| +||+||++.+..+|+.||+|.+...... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999999889999999998644322 23467889999999999999999999999999999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc--
Q 002717 683 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-- 760 (888)
Q Consensus 683 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-- 760 (888)
++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+.........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999988753 23588899999999999999999988 9999999999999999999999999865433211110
Q ss_pred ---cccccccccccccCcccccCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH------------
Q 002717 761 ---VMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------------ 824 (888)
Q Consensus 761 ---~~~~~~~g~~~y~aPE~~~~~-~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~------------ 824 (888)
.......++..|+|||++... ..++.++|||||||++|||++|+.||............ ....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK-LKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH-hcCCCCCCccccccch
Confidence 001112345679999988443 34789999999999999999999999754322211110 0000
Q ss_pred --------------------HhcCCcccccCCCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 825 --------------------LEEGNVLDCVDPSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 825 --------------------~~~~~~~~~~d~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..........+..+. ..+......+.+++++||+.||++|||+.|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 000000000000000 11233456789999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=300.27 Aligned_cols=264 Identities=22% Similarity=0.260 Sum_probs=196.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|++|.||+|.+..+|+.||+|.+...... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 56667899999999999999888999999988544322 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC-CCCcEEecccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~~~~ 758 (888)
+ +++.+++.... ...+++..+..++.|++.||+|||+. +++||||+|+||++++ ++.+||+|||+++......
T Consensus 84 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 84 D-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred c-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 6 57888776532 23467888889999999999999998 9999999999999985 5679999999997543211
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc-CCcc----cc
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE-GNVL----DC 833 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~-~~~~----~~ 833 (888)
. ......+++.|+|||.+.....++.++||||+||++|+|+||+.||....... ...+........ .... ..
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhccccccc
Confidence 1 11233567889999987555567899999999999999999999997543221 111111110000 0000 00
Q ss_pred ------c----CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 834 ------V----DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 834 ------~----d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
. ..............+.+++.+|++.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000122334567899999999999999999999975
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=294.34 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=205.1
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|++++++++|+||+++++++......++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 45567899999999999999889999999998654322 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++++|.+++.........+++..++.++.|++.|++|||+. +++|+||+|+||++++++.+|++|||+++.....
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99999999987544456789999999999999999999998 9999999999999999999999999999766543
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
......++..|+|||.. .+..++.++|+||+|+++|||++|+.||...... .+.. ....+ ...
T Consensus 157 --~~~~~~~~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~----~~~~~--------~~~ 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRY----KVQRG--------KYP 219 (256)
T ss_pred --CcccccCCccccCHHHH-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHhcC--------CCC
Confidence 12334578899999988 5557888999999999999999999999654321 1111 11111 111
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
..+.....++.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2233455678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=303.23 Aligned_cols=271 Identities=23% Similarity=0.336 Sum_probs=202.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-ccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcC--Ceee
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP--QLKL 673 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~ 673 (888)
.+.|+..+.||+|+||.||+|.+..+++.+|+|++.... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456778889999999999999998889999999885432 122335677899999999 999999999998654 3579
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||++ ++|..++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 5898888653 578899999999999999999998 999999999999999999999999999986
Q ss_pred ccccccc---cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH------
Q 002717 754 LTRLDKH---VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------ 824 (888)
Q Consensus 754 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~------ 824 (888)
....... .......++..|+|||.+.....++.++|||||||++|||++|+.||...... ....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHH
Confidence 6433221 11233457889999998756566789999999999999999999999643221 1111111000
Q ss_pred ----Hh---cCCcccccC----CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhc
Q 002717 825 ----LE---EGNVLDCVD----PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIK 878 (888)
Q Consensus 825 ----~~---~~~~~~~~d----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~ 878 (888)
.. .....+.+. ..........+..+.+++.+||+.+|++|||+.+++++ ++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 00 000000000 00111112245678999999999999999999999986 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=333.60 Aligned_cols=254 Identities=26% Similarity=0.327 Sum_probs=205.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
++.+..||.|.||.||-|....+|+..|+|.+.-... ....+...+|..++..++|||+|+++|+-...+..++.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 4556689999999999999999999999998753322 233456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++|+|.+.+... .-.++.....+-.|++.|++|||++ |||||||||.||+++.+|.+|.+|||.|..+.....
T Consensus 1317 ~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1317 EGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred ccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999864 3456666667889999999999999 999999999999999999999999999987754321
Q ss_pred c--cccccccccccccCcccccCcC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 760 H--VMSNRFQSALGYVAPELTCQSL--RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 760 ~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
. .......||+.|||||++.+.. ....++||||+|||+.||+||++||...+.+-.++.+ |. .|
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~-V~----~g------- 1457 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH-VA----AG------- 1457 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH-Hh----cc-------
Confidence 1 1123567999999999985432 2346899999999999999999999876655444322 11 11
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..+.+|......-.+++..|+..||++|.++.|++++=
T Consensus 1458 -h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1458 -HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred -CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 12345666666778999999999999999999998864
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=299.15 Aligned_cols=259 Identities=28% Similarity=0.408 Sum_probs=203.7
Q ss_pred CChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc--cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCee
Q 002717 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 595 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 672 (888)
.++...|+..+.||+|+||.||+|++..+++.+|+|.+..... .....++.+|+.+++.++|+|++++.+++......
T Consensus 11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (308)
T cd06634 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (308)
T ss_pred CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence 3466678888899999999999999988899999999864322 12235678899999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
++|+||+. |++.+.+... ...+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++.
T Consensus 91 ~lv~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred EEEEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccce
Confidence 99999996 6888777643 24578999999999999999999998 99999999999999999999999999987
Q ss_pred cccccccccccccccccccccCccccc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCc
Q 002717 753 LLTRLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 753 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
..... ....++..|+|||.+. ....++.++|||||||++|||++|+.||....... .... ... +..
T Consensus 164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~-~~~ 231 (308)
T cd06634 164 IMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYH----IAQ-NES 231 (308)
T ss_pred eecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHH----Hhh-cCC
Confidence 54321 2345778899999863 23457889999999999999999999986532211 1111 111 110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 831 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
+. .........+.+++.+||+.+|++||++.+++.+.+....
T Consensus 232 -----~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 232 -----PA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -----CC--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00 0122344568899999999999999999999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=298.51 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=198.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCeeeEEEe
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 677 (888)
+.|+..+.||+|+||.||+|.+..+++.||||++...........+..|+.++.+.. ||||+++++++.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 446777899999999999999987899999999875543334456777887777774 9999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|++ +++.+.+... ...+++..+..++.|++.|++|||+.. +|+||||+|+||++++++.+||+|||++......
T Consensus 95 ~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 4777776653 236899999999999999999999732 8999999999999999999999999998765432
Q ss_pred ccccccccccccccccCcccccCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
... ....++..|+|||.+... ..++.++||||||+++|||++|+.||.........+... .....
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~----- 236 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI----LQEEP----- 236 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH----hcCCC-----
Confidence 211 233567889999987433 247889999999999999999999996543322222111 11110
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
+... .......++.+++.+||+.||++||++.+++++-.
T Consensus 237 -~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 237 -PSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred -CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0111 11134567899999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=294.92 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=191.9
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHH---HhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRV---LGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
.||+|+||.||+|....+++.||+|.+....... ....+..|..+ ++...||+|+++.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3799999999999998889999999986543221 12234444443 444579999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+|+|..++... ..+++..+..++.|+++|+.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999988653 4689999999999999999999998 99999999999999999999999999987543221
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 840 (888)
.....|+..|+|||.+..+..++.++||||+||++|||++|+.||.......... ....... ... .
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~------~~~---~ 217 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLT------MAV---E 217 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---HHHHhhc------cCC---C
Confidence 1334688999999998555568899999999999999999999997643221111 0000000 011 2
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002717 841 YPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQIL 874 (888)
Q Consensus 841 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L 874 (888)
.+......+.+++.+|+..+|++|| ++.|++++-
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 2334456788999999999999999 999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=300.87 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=196.0
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCe------
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQL------ 671 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 671 (888)
+.|+..+.||+|+||.||+|....+++.||||.+...... .....+.+|+.++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 3467788999999999999999989999999998644322 223456789999999999999999999876543
Q ss_pred --eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 672 --KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 672 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
.++|+||+. +++.+.+... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 489999996 4788887653 24589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccc--cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc
Q 002717 750 LARLLTRLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827 (888)
Q Consensus 750 la~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 827 (888)
++......... .......++..|+|||.+.....++.++||||||+++|||++|+.||...... ... ..+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~-~~~~~~~~~ 242 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQL-TLISQLCGS 242 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHH-HHHHHHhCC
Confidence 99765432211 11123456788999998755555788999999999999999999998654321 111 111111100
Q ss_pred --------CCcccccCC-CCCC-----C-----ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 828 --------GNVLDCVDP-SMGD-----Y-----PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 828 --------~~~~~~~d~-~~~~-----~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
....+..+. .... . +......+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000 0000 0 00122456789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=299.69 Aligned_cols=265 Identities=25% Similarity=0.307 Sum_probs=199.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-------
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------- 670 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 670 (888)
+.|+..+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 456777899999999999999988899999999865432 233456788999999999999999999987654
Q ss_pred ---eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEec
Q 002717 671 ---LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD 747 (888)
Q Consensus 671 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 747 (888)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 67999999976 677776653 34689999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc
Q 002717 748 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827 (888)
Q Consensus 748 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 827 (888)
||++........ .......++..|+|||.+......+.++|||||||++|||++|+.||..... ...+....+ ....
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~-~~~~ 236 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISR-LCGS 236 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH-HhCC
Confidence 999986643221 1112234567899999875555678999999999999999999999965432 222221111 1110
Q ss_pred CC---ccc--------ccCC------CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 828 GN---VLD--------CVDP------SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 828 ~~---~~~--------~~d~------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.. ..+ ..++ .........+..+.+++.+||+.+|++|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000 0000 0000112235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=301.68 Aligned_cols=259 Identities=20% Similarity=0.254 Sum_probs=191.6
Q ss_pred cceEEEEEEECCCCeEEEEEEeecCC-ccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCHHHHHh
Q 002717 611 VFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLH 689 (888)
Q Consensus 611 ~~g~V~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 689 (888)
++|.||.++...+++.||||++.... .....+.+.+|+++++.++||||+++++++...+..+++|||+++|++.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44555555555589999999986542 23345678999999999999999999999999999999999999999999998
Q ss_pred hcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc-----ccccc
Q 002717 690 ERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK-----HVMSN 764 (888)
Q Consensus 690 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-----~~~~~ 764 (888)
... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+........ .....
T Consensus 92 ~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 THF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 752 23578889999999999999999998 999999999999999999999999998875532211 11112
Q ss_pred cccccccccCcccccCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHh----cC-------Cccc
Q 002717 765 RFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE----EG-------NVLD 832 (888)
Q Consensus 765 ~~~g~~~y~aPE~~~~~-~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~----~~-------~~~~ 832 (888)
...++..|+|||++... ..++.++|||||||++|||++|+.||............ ...... .. ....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhcCCcCc
Confidence 34567789999987443 35788999999999999999999999765332222111 110000 00 0000
Q ss_pred ----ccCCCCC-----CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 833 ----CVDPSMG-----DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 833 ----~~d~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
..++... ........++.+++.+||+.||++|||+.|++++-.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0000000 012233456889999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.35 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=202.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
|+..+.||+|++|.||++.+..+++.+++|++..... ...+.+.+|+.++++++|++|+++++++..+...++++||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4456789999999999999988899999999865443 345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987742 4689999999999999999999998 999999999999999999999999999976654321
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCC
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 840 (888)
.....++..|+|||.. ....++.++||||||+++|+|++|+.||.......... . ... .... .. .
T Consensus 154 --~~~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~----~~~-~~~~-----~~-~ 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVI-NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-K----IAT-NGPP-----GL-R 218 (253)
T ss_pred --ccceecCCcccCHHHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-H----HHh-cCCC-----Cc-C
Confidence 2345678889999988 44458899999999999999999999986542211111 0 000 0000 00 1
Q ss_pred CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 841 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.+......+.+++.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111224568899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.69 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=205.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcC--CeeeEEEe
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLLVSD 677 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 677 (888)
|+..+.||+|++|.||+|....+++.|++|++..... ....+.+.+|++++++++||||+++++.+... ...++|+|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 3455689999999999999988899999999865432 12356789999999999999999999999988 78899999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++++|.+++... ..+++..++.++.|++.|++|||+. +++|+|++|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 82 YVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999875 2789999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
..........++..|+|||.. .....+.++||||||+++|+|++|..||............ ... ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~--------~~~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVI-RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK----IGS--------SGE 221 (260)
T ss_pred cccccccCCCCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh----ccc--------cCC
Confidence 321112345678899999988 4445899999999999999999999999765422111111 000 011
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
....+......+.+++.+|+..+|++||++.|++.+
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 122444556779999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=304.62 Aligned_cols=270 Identities=21% Similarity=0.276 Sum_probs=201.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEc----CCeee
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWT----PQLKL 673 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 673 (888)
+.|+..+.||+|+||.||+|....+|+.||+|++..... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 456677789999999999999998999999999865432 2344667889999999999999999998753 34578
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||+. |+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 6888888653 3489999999999999999999998 999999999999999999999999999976
Q ss_pred ccccccc--cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH------
Q 002717 754 LTRLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL------ 825 (888)
Q Consensus 754 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~------ 825 (888)
....... .......++..|+|||.+.....++.++|||||||++|||++|+.||...... ..+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSPSEEV 235 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCChhHh
Confidence 5432211 11123467889999998755556889999999999999999999999654221 11111110000
Q ss_pred ----hcCCccc---ccCCC----CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 826 ----EEGNVLD---CVDPS----MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 826 ----~~~~~~~---~~d~~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
....... ..... ..........++.+++.+||+.+|++|||+++++.+-+--
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 0000000 00000 0011123456789999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.47 Aligned_cols=260 Identities=15% Similarity=0.140 Sum_probs=184.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCC---CeEEEEEEeecCCccCChH----------HHHHHHHHHhhcCCCCcceeeeE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPE----------DFEREVRVLGKARHPNLISLEGY 665 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~l~~~~~~~~~~----------~~~~E~~~l~~l~h~niv~l~~~ 665 (888)
..|+..+.||+|+||.||+|.+..+ +..+|+|...........+ ....+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4577888999999999999999766 5667777542222111011 12233344556689999999998
Q ss_pred EEcCC----eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC
Q 002717 666 YWTPQ----LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 741 (888)
Q Consensus 666 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 741 (888)
+.... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 76543 3367888764 3566666543 2356788899999999999999998 999999999999999999
Q ss_pred CcEEecccccccccccccc-----cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhh
Q 002717 742 NPRISDFGLARLLTRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 816 (888)
Q Consensus 742 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~ 816 (888)
.++|+|||+++.+...... .......||+.|+|||+. .+..++.++|||||||++|||++|+.||.........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~-~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH-NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 9999999999866432211 111234689999999988 5667899999999999999999999999765333222
Q ss_pred HHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 817 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
...........-. .... .....+..+.+++..||..+|++||++.++++.+
T Consensus 243 ~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLH-----EGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhh-----hhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 2111111111100 0000 1123346688999999999999999999999876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.86 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=200.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
....++....||+|+||.||++....+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 18 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 18 PRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred hHHHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 3344555568999999999999998899999999874332 233466889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||++.....
T Consensus 97 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 97 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred ecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 99999999998754 2478899999999999999999998 999999999999999999999999999875532
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... ......++..|+|||.. ....++.++||||+||++|||++|..||....... .. .... . ...+
T Consensus 169 ~~~--~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-~~-~~~~----~-----~~~~ 234 (292)
T cd06657 169 EVP--RRKSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AM-KMIR----D-----NLPP 234 (292)
T ss_pred ccc--cccccccCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHH----h-----hCCc
Confidence 211 11334678899999987 45567899999999999999999999986532211 11 1111 1 0111
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.... .......+.+++.+||+.+|.+||++.+++++=.
T Consensus 235 ~~~~-~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 235 KLKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred ccCC-cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence 1111 1223446788999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=304.75 Aligned_cols=268 Identities=21% Similarity=0.262 Sum_probs=201.2
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-ccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC-----Ceee
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-----QLKL 673 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 673 (888)
.|+..+.||+|+||.||+|....+++.||||++.... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 4667779999999999999998899999999986432 222345677899999999999999999988654 2469
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 86 IVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 9999996 6888888653 4589999999999999999999998 999999999999999999999999999986
Q ss_pred ccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc------
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE------ 827 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~------ 827 (888)
...... ......++..|+|||.+.....++.++|||||||++|+|++|+.||...... ......... ...
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~~~~~~~~~ 233 (337)
T cd07858 158 TSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITEL-LGSPSEEDL 233 (337)
T ss_pred cCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHH-hCCCChHHh
Confidence 543221 1133456788999998755456889999999999999999999999643211 111111100 000
Q ss_pred -----CC-------cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhcC
Q 002717 828 -----GN-------VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKT 879 (888)
Q Consensus 828 -----~~-------~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~ 879 (888)
.. .....++......+....++.+++.+||+.+|++|||++|++++ ++.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00 00000011111123445678899999999999999999999998 555433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.13 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=197.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC----ccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC--CeeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD----IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--QLKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 674 (888)
|+..+.||+|+||.||+|.+..+++.||+|.+.... ..+....+.+|++++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 566779999999999999998889999999875321 122335788999999999999999999998764 45789
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
|+||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 99999999999999764 3478889999999999999999998 9999999999999999999999999999765
Q ss_pred ccccc-ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 755 TRLDK-HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 755 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
..... ........++..|+|||.+ .+..++.++|||||||++||+++|+.||........ +......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~------ 224 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVI-SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-----IFKIATQ------ 224 (264)
T ss_pred ccccccCccccccCCcccccCHhhh-cCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-----HHHHHcC------
Confidence 32111 1111234578899999988 445688999999999999999999999965322111 1111111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+.....+......+.+++.+||. +|.+|||+.+++.+
T Consensus 225 --~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 225 --PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11122455566678899999998 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=294.76 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=200.2
Q ss_pred CChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCee
Q 002717 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 595 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 672 (888)
.+..+++...++||+|+||.||+|+...+++.||+|++...... ...+.+.+|+++++.++|||++++++++.+....
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 45677788888899999999999999888999999998644322 1234678899999999999999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
++||||+. |++.+++... ..++++..+..++.|++.|+.|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 97 ~lv~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred EEEEecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCc
Confidence 99999996 5787777653 34588999999999999999999998 99999999999999999999999999986
Q ss_pred cccccccccccccccccccccCcccccC--cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCc
Q 002717 753 LLTRLDKHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 753 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
.... .....++..|+|||.+.. ...++.++|||||||++|||++|..||......... ........
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-----~~~~~~~~- 237 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNDS- 237 (313)
T ss_pred ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHhcCC-
Confidence 4321 133467888999998732 345788999999999999999999998654321111 11111110
Q ss_pred ccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 831 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+.. ........+.+++.+||+.+|++||++.+++.+
T Consensus 238 -----~~~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -----PTL--QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 112233457899999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=296.75 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=200.9
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
+..+.||+|++|.||+|....+++.+|+|++...... .....+.+|++++++++|+||+++++++..+...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 4456899999999999999888999999998654332 234678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+ ++.+++... ...+++..+..++.|++.|+.|||+. +|+|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 82 T-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred C-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 5 888888764 24689999999999999999999998 999999999999999999999999999976654321
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC-----Ccc----
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG-----NVL---- 831 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~-----~~~---- 831 (888)
......++..|+|||.+.....++.++||||+|+++|+|++|+.||..... ............... ...
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112345678899999885554789999999999999999999999865432 111111111100000 000
Q ss_pred -------cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 832 -------DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 832 -------~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
...+.............+.+++.+||+.||.+||+++|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000011122345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=300.66 Aligned_cols=268 Identities=23% Similarity=0.272 Sum_probs=201.0
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC-------------ChHHHHHHHHHHhhcCCCCcceeeeEEEc
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------------YPEDFEREVRVLGKARHPNLISLEGYYWT 668 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 668 (888)
.+.+.||+|+||.||+|.+..+++.||||.+....... ....+.+|+++++.++||||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 34567999999999999998889999999986543221 11247789999999999999999999999
Q ss_pred CCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecc
Q 002717 669 PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 748 (888)
Q Consensus 669 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 748 (888)
.+..++||||++ |+|.+++... ..+++.....++.|++.||.|||+. +|+||||+|+||+++.++.++++||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 999999999996 6899888653 4588999999999999999999998 9999999999999999999999999
Q ss_pred cccccccccc------------cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhh
Q 002717 749 GLARLLTRLD------------KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 816 (888)
Q Consensus 749 gla~~~~~~~------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~ 816 (888)
|.++...... .........++..|+|||.+.....++.++||||+||++|||++|+.||...... ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~~ 242 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-DQ 242 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 9997654110 0001122345778999998855556789999999999999999999999754332 22
Q ss_pred HHHHHHHHHhcCCc---c--------cccC----CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 817 LSEHVRVLLEEGNV---L--------DCVD----PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 817 l~~~~~~~~~~~~~---~--------~~~d----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
+...... ...... . .... +............+.+++.+||+.+|++|||++|++.+-+-...
T Consensus 243 ~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 243 LGRIFEL-LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHH-hCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 2221111 110000 0 0000 00011112335568899999999999999999999987755433
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=307.35 Aligned_cols=262 Identities=22% Similarity=0.249 Sum_probs=197.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-ccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC------C
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTP------Q 670 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 670 (888)
...|+..+.||+|+||.||+|....+++.||+|++.... .....+.+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 345777789999999999999998899999999985432 122345677899999999999999999988643 2
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
..++||||+. ++|.+.+... +++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 4689999996 5888877642 78889999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHH--------
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR-------- 822 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~-------- 822 (888)
++...... ......++..|+|||.+ .+..++.++|||||||++|+|++|+.||...... ..+.....
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDE 239 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHH-hCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHH
Confidence 97654321 12334578899999988 5567899999999999999999999999654221 11111110
Q ss_pred ----------HHHhcCCcc------cccCCC----CCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 823 ----------VLLEEGNVL------DCVDPS----MGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 823 ----------~~~~~~~~~------~~~d~~----~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
......... +.+... ... .+......+.+++.+|++.||++|||+.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 000000000 000000 000 1123455688999999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=332.84 Aligned_cols=438 Identities=27% Similarity=0.334 Sum_probs=266.3
Q ss_pred CccccccccccccCc-ccccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEcC
Q 002717 2 TTPLVHGNSYNAIPS-MVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLA 80 (888)
Q Consensus 2 ~~l~l~~n~~~~ip~-~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~ 80 (888)
++||+++|.+.+-|. +..+.+|++|+++.|-|. .+|.+...+ .+|++|.|..|++. .+|.. +..+.+|+.|+++
T Consensus 48 ~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~--~~l~~lnL~~n~l~-~lP~~-~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 48 KSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNM--RNLQYLNLKNNRLQ-SLPAS-ISELKNLQYLDLS 122 (1081)
T ss_pred EEeeccccccccCCchhhhHHHHhhcccchhhHh-hCchhhhhh--hcchhheeccchhh-cCchh-HHhhhcccccccc
Confidence 344444444444442 334444444444444444 344333332 34444555444444 44433 2444444445555
Q ss_pred CccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCCEEEccCccc
Q 002717 81 GNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF 160 (888)
Q Consensus 81 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 160 (888)
.|++..++. .+..+..++++..++|..... ++. ..++.++|..|.+.+.++..+..++. .|+|+.|.+
T Consensus 123 ~N~f~~~Pl-~i~~lt~~~~~~~s~N~~~~~--------lg~-~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~ 190 (1081)
T KOG0618|consen 123 FNHFGPIPL-VIEVLTAEEELAASNNEKIQR--------LGQ-TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEM 190 (1081)
T ss_pred hhccCCCch-hHHhhhHHHHHhhhcchhhhh--------hcc-ccchhhhhhhhhcccchhcchhhhhe--eeecccchh
Confidence 444444332 233344444444444411100 111 12555566666666555555555555 577777766
Q ss_pred cccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCCCCC
Q 002717 161 SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSL 240 (888)
Q Consensus 161 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 240 (888)
.. ..+..+.+|+.|....|+++... -..++|+.|+.+.|.++...+.. --.+|+++++++|+++ .+|+++
T Consensus 191 ~~---~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi 260 (1081)
T KOG0618|consen 191 EV---LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWI 260 (1081)
T ss_pred hh---hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecccc--ccccceeeecchhhhh-cchHHH
Confidence 51 23555666666666666665221 23356777777777777333221 2246888888888888 466888
Q ss_pred CCCCCCcEEEeeCCcCCCCCCcccccc-CCceEEcccCcccccCCCCCCCCCCCcccCCCCEEeCCCCcCcccCChhhhh
Q 002717 241 FNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL 319 (888)
Q Consensus 241 ~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~l~~N~l~~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 319 (888)
..+.+|+.|+..+|++. .+|..++.. .|+.|++..|.+... |+. ...++.|+.|+|..|+|....+..+..
T Consensus 261 ~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yi-p~~------le~~~sL~tLdL~~N~L~~lp~~~l~v 332 (1081)
T KOG0618|consen 261 GACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYI-PPF------LEGLKSLRTLDLQSNNLPSLPDNFLAV 332 (1081)
T ss_pred HhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhC-CCc------ccccceeeeeeehhccccccchHHHhh
Confidence 88888888888888886 666666654 688888888887633 332 233677888888888887433333333
Q ss_pred ccC-CcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceEEccCCcCCCccCccccccccccEE
Q 002717 320 FAN-LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLL 398 (888)
Q Consensus 320 l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 398 (888)
+.. |..|+.+.|++....--.=..+..|+.|+|.+|.+++..-..+.+...|+.|+|++|+|.......+.++..|+.|
T Consensus 333 ~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL 412 (1081)
T KOG0618|consen 333 LNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEEL 412 (1081)
T ss_pred hhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHH
Confidence 333 6777777777764332222234567788888888877666667777788888888888874444567777888888
Q ss_pred EccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeeccCCccee-cCCCCCCCCCCCCCCcCCCcCC
Q 002717 399 SLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG-RLPVGGVFPTLDQSSLQGNLGI 477 (888)
Q Consensus 399 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~-~~p~~~~~~~l~~~~~~~n~~~ 477 (888)
+||+|+++ .+|..+..++.|++|...+|+|. ..| ++.+++.|+.+|+|.|+|+- .+|.....++++-+++.||.++
T Consensus 413 ~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 413 NLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 88888887 67777888888888888888887 566 77788888888888888754 4444444467777778888753
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=286.95 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=202.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|+..+.||+|++|.||+|....+++.||+|.+...... ...+.+.+|++++++++|||++++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 45567899999999999999888999999998655432 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++++|.+++... ..+++..++.++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 82 ENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998764 4689999999999999999999998 999999999999999999999999999987654322
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
. .....++..|+|||... +..++.++||||+|+++|+|++|+.||...... ..... . .. . ...
T Consensus 155 ~--~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-~~~~~---~-~~-~--------~~~ 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIE-MSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-AALFR---I-VQ-D--------DHP 217 (254)
T ss_pred c--ccccccchhhcCHhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-HHHHH---H-hc-c--------CCC
Confidence 1 23346788899999874 445889999999999999999999998654321 11111 1 00 0 111
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
..+......+.+++.+||..+|++|||+.|++.+
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 2234445678899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=291.74 Aligned_cols=261 Identities=26% Similarity=0.309 Sum_probs=195.2
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhc---CCCCcceeeeEEEcCCe-----e
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKA---RHPNLISLEGYYWTPQL-----K 672 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----~ 672 (888)
+..+.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++++ +||||+++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 4556899999999999999878999999998644322 2234567788877766 59999999999988776 8
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
+++|||+. ++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||.+.
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred EEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 99999997 48998887642 23589999999999999999999998 99999999999999999999999999997
Q ss_pred cccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCc--
Q 002717 753 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV-- 830 (888)
Q Consensus 753 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~-- 830 (888)
....... .....++..|+|||.+ ....++.++|||||||++|||++|..||.... .........+........
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~-~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVL-LQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc---cccccccccccChHHh-ccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHhc
Confidence 6543221 1233467889999988 44568899999999999999999988886432 222222222211000000
Q ss_pred -------ccccCCCC----CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 831 -------LDCVDPSM----GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 831 -------~~~~d~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
........ ..........+.+++.+||+.||++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 01112334567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=288.45 Aligned_cols=236 Identities=22% Similarity=0.300 Sum_probs=186.5
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCCCCHH
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQ 685 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 685 (888)
+|+|+||.||++....+++.+|+|......... .|+.....+ +||||+++++++...+..++||||+++|+|.
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 599999999999998899999999985433211 122222223 6999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC-CcEEecccccccccccccccccc
Q 002717 686 AKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTRLDKHVMSN 764 (888)
Q Consensus 686 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~~~~~~~~~~~ 764 (888)
+++... ..+++..+..++.|+++|+.|||+. +++||||||+||+++.++ .++++|||+++..... .
T Consensus 98 ~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~ 164 (267)
T PHA03390 98 DLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------S 164 (267)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------c
Confidence 999864 3689999999999999999999998 999999999999999888 9999999998754321 2
Q ss_pred cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChh
Q 002717 765 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844 (888)
Q Consensus 765 ~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 844 (888)
...++..|+|||++ .+..++.++||||+||++|||++|+.||............+.... . .....+..
T Consensus 165 ~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----------~~~~~~~~ 232 (267)
T PHA03390 165 CYDGTLDYFSPEKI-KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q----------KKLPFIKN 232 (267)
T ss_pred cCCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c----------ccCCcccc
Confidence 34578899999988 455688999999999999999999999975433322222222211 1 00112234
Q ss_pred hHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 002717 845 EVLPVLKLALVCTCHIPSSRPS-MAEVVQI 873 (888)
Q Consensus 845 ~~~~l~~li~~cl~~dp~~RPs-~~evl~~ 873 (888)
....+.+++.+||+.+|.+||+ ++|++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 5567889999999999999996 6988864
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.10 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=197.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc----cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI----IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 676 (888)
|...+.||+|+||.||++.+...+..+++|.++.... ......+..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4566789999999999999976666666666543221 122345778999999999999999999999888899999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++++|.+++.........+++..++.++.|++.|+.|||+. +++|+||+|+||++++ +.++++|||.++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999999986544556799999999999999999999998 9999999999999975 5699999999876543
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... ......++..|+|||.. ....++.++||||||+++|+|++|..||..... . ........ +
T Consensus 158 ~~~--~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-~----~~~~~~~~-~-------- 220 (260)
T cd08222 158 SCD--LATTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-L----SVVLRIVE-G-------- 220 (260)
T ss_pred Ccc--cccCCCCCcCccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-H----HHHHHHHc-C--------
Confidence 221 12345578889999987 455678899999999999999999999864321 1 11111111 1
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.....+......+.+++.+||+.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1112344555678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=301.10 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=196.6
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC------ee
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------LK 672 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 672 (888)
.|+..+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 45666789999999999999988899999999864322 223456889999999999999999999986543 45
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
++|+||+.. ++..+.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++
T Consensus 96 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 96 YLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred EEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 899999964 6666542 2488999999999999999999998 99999999999999999999999999987
Q ss_pred cccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH--------
Q 002717 753 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL-------- 824 (888)
Q Consensus 753 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~-------- 824 (888)
..... .....++..|+|||.+.....++.++|||||||++|||++|+.||..... ...+.......
T Consensus 166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence 54321 12345678899999875555688999999999999999999999975322 11111111100
Q ss_pred --HhcC---Cccccc----CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhcCC
Q 002717 825 --LEEG---NVLDCV----DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTP 880 (888)
Q Consensus 825 --~~~~---~~~~~~----d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~~ 880 (888)
.... ...... ..............+.+++.+||+.||++||+++|++.+ ++..++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000 000000 000000011234567899999999999999999999976 6666553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.12 Aligned_cols=253 Identities=25% Similarity=0.289 Sum_probs=207.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC-ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
..|...+.||+|.|+.|..|++..++..||+|.+.+..... ....+.+|+++|+.++|||||+++++...+...|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 34566778999999999999999999999999986654332 22458899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+.+|.+.+++... ....+..+..++.|+.+|++|+|++ .|||||||++|++++.++++||+|||++..+...
T Consensus 136 ya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 136 YASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999885 3455578889999999999999999 9999999999999999999999999999887632
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCC
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
......+|++.|.|||++.+..+..+++|+||+|+++|-|+.|..||+...- ..+...+ +..
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--k~Lr~rv---l~g---------- 270 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--KELRPRV---LRG---------- 270 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--ccccchh---eee----------
Confidence 3346789999999999997777778999999999999999999999975311 0000000 000
Q ss_pred CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
.-..+.....+..+++++++-.+|.+|++++++.++-+.
T Consensus 271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred eecccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 001233344456789999999999999999999987654
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=292.43 Aligned_cols=245 Identities=24% Similarity=0.390 Sum_probs=194.3
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCH
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 684 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 684 (888)
||+|+||.||++++..+|+.||+|.+...... ...+.+.+|++++++++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999888999999998544321 2346788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc-----
Q 002717 685 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK----- 759 (888)
Q Consensus 685 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~----- 759 (888)
.+++... ..+++..++.++.|++.||+|||+. +++||||+|+||++++++.++++|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999864 3689999999999999999999998 999999999999999999999999999875432211
Q ss_pred -ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 760 -HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 760 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
........++..|+|||... ....+.++||||||+++||+++|..||...... ........ +..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~-------- 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILN-GKI-------- 218 (265)
T ss_pred ccccccCcccCccccCHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhc-CCc--------
Confidence 11123345678899999884 445889999999999999999999999654321 11111111 110
Q ss_pred CCCChh--hHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 839 GDYPED--EVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 839 ~~~~~~--~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
..+.. ....+.+++.+||+.+|++|||+.++.+.|
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 11112 256788999999999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=274.50 Aligned_cols=255 Identities=21% Similarity=0.285 Sum_probs=201.9
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEc----CCeeeEEEecC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT----PQLKLLVSDYA 679 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~ 679 (888)
++||-|-.|.|..+.++.+|+++|+|++... ....+|++.--.. .|||||.++++|.. .....+|||.|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 4799999999999999999999999998543 2345777765444 69999999999864 23457999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec---CCCCcEEecccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARLLTR 756 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfgla~~~~~ 756 (888)
+||.|.+.++++ ....+++.++..|+.||+.|+.|||+. +|+||||||+|+|++ .+..+|++|||+|+.-.+
T Consensus 142 eGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 142 EGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999999987 356799999999999999999999999 999999999999997 456789999999986432
Q ss_pred cccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.....+.+-|+.|.|||++ +..+|+..+|+||+||++|-|++|.+||..... ..++-.++..++.+...
T Consensus 217 ---~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~gqy~----- 285 (400)
T KOG0604|consen 217 ---PGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTGQYE----- 285 (400)
T ss_pred ---CccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhccCcc-----
Confidence 2223556778999999998 777899999999999999999999999976543 22223333333333221
Q ss_pred CCCC-CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCCC
Q 002717 837 SMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882 (888)
Q Consensus 837 ~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 882 (888)
++. .....+++..++|+..+..+|.+|.|+.|++.+-+-.+...-
T Consensus 286 -FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~v 331 (400)
T KOG0604|consen 286 -FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAV 331 (400)
T ss_pred -CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccC
Confidence 111 223455667889999999999999999999998766554433
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=273.88 Aligned_cols=252 Identities=25% Similarity=0.291 Sum_probs=204.7
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
+-+.++..+.+|+|.||.|..++-+.+|+.+|+|++++.-... ..+.-..|-.+++..+||.+..+--.+...+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3445666778999999999999999999999999997664432 23445679999999999999999888889999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
||||+.||.|..++... ..+++.+..-+-..|.+||.|||++ +||.||+|.+|.++|.+|.+||+|||+++.-
T Consensus 246 VMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999998888763 5688888888999999999999998 9999999999999999999999999999743
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
- .......+++||+.|.|||++ ....|..+.|.|.+||++|||++|+.||...+.+. +.+.+ --
T Consensus 319 I--~~g~t~kTFCGTPEYLAPEVl-eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--LFeLI----l~------- 382 (516)
T KOG0690|consen 319 I--KYGDTTKTFCGTPEYLAPEVL-EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--LFELI----LM------- 382 (516)
T ss_pred c--cccceeccccCChhhcCchhh-ccccccceeehhhhhHHHHHHHhccCcccccchhH--HHHHH----Hh-------
Confidence 2 233344778999999999999 77789999999999999999999999997543321 11110 00
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
.-..+|.....+...|+.-.+..||.+|. .+.||.++
T Consensus 383 --ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 383 --EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred --hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 01134556666778899999999999996 45666553
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=303.94 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=195.6
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC---------
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP--------- 669 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 669 (888)
..|+..+.||+|+||.||+|....+|+.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 456777899999999999999988999999999865543 3456788999999999999999999876543
Q ss_pred -----CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec-CCCCc
Q 002717 670 -----QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNP 743 (888)
Q Consensus 670 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~ 743 (888)
...++|+||++ ++|.+++.. ..+++..++.++.|+++|+.|||+. +|+||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 34689999997 588888754 2488999999999999999999998 999999999999998 55678
Q ss_pred EEeccccccccccccccc-ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHH
Q 002717 744 RISDFGLARLLTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822 (888)
Q Consensus 744 kl~Dfgla~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~ 822 (888)
|++|||.++......... ......++..|+|||.+.....++.++|||||||++|||++|+.||......... .....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~~~ 233 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLILE 233 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHH
Confidence 999999997653221111 1122356788999998755566889999999999999999999999654322111 11100
Q ss_pred HH-----------HhcC--Ccc-cccCCC--CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 823 VL-----------LEEG--NVL-DCVDPS--MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 823 ~~-----------~~~~--~~~-~~~d~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.. .... ... ....+. ...........+.+++.+|++.||++|||+.|++.+=
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~ 301 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCC
Confidence 00 0000 000 000000 0001122345678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=296.21 Aligned_cols=267 Identities=24% Similarity=0.327 Sum_probs=195.9
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC-ChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-------
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQ------- 670 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 670 (888)
+.|+..+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+++++.++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 45677789999999999999999899999999986543222 2356788999999999999999999875443
Q ss_pred -eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 671 -LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 671 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
..++|+||+.+ ++...+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.++++|||
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999965 677766543 34689999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccccccc---------cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHH
Q 002717 750 LARLLTRLDKHVM---------SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 820 (888)
Q Consensus 750 la~~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~ 820 (888)
+++.......... .....+++.|+|||.+.....++.++|||||||++|||++|+.||..... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~~~~ 239 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLI 239 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence 9976543221111 11234577899999875555688999999999999999999999864332 1111111
Q ss_pred HHHHHhcC--------Ccccc--------cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 821 VRVLLEEG--------NVLDC--------VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 821 ~~~~~~~~--------~~~~~--------~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
........ ..... ..+............+.+++.+|+..||++|||+.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11100000 00000 0000000001222467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=288.88 Aligned_cols=243 Identities=22% Similarity=0.335 Sum_probs=187.0
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHH-hhcCCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVL-GKARHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+.||+|+||.||+|....+++.||+|.+...... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999999888999999998544321 1122344555544 344899999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++++|||+++....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999999764 3578899999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
.....++..|+|||... +..++.++||||+|+++|||++|..||...... ... ... ..+... .. ...
T Consensus 150 -~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~----~~~-~~~~~~--~~---~~~ 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-AVF----DNI-LSRRIN--WP---EEV 216 (260)
T ss_pred -cccCCCCcCccChhhhc-CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-HHH----HHH-HhcccC--CC---Ccc
Confidence 13345778899999874 445889999999999999999999999654321 111 111 111110 00 011
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 872 (888)
....+..+.+++.+||+.+|++|||+.++.+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 2234567889999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=315.59 Aligned_cols=271 Identities=15% Similarity=0.182 Sum_probs=186.5
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCC-eEEEEEEe--------------ecC--CccCChHHHHHHHHHHhhcCCCCcc
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQG-RMLAVKKL--------------VTS--DIIQYPEDFEREVRVLGKARHPNLI 660 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~l--------------~~~--~~~~~~~~~~~E~~~l~~l~h~niv 660 (888)
.+.|++.+.||+|+||.||++.++... ..++.|.+ .+. ........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 356788889999999999998875322 22222211 000 0111234678999999999999999
Q ss_pred eeeeEEEcCCeeeEEEecCCCCCHHHHHhhcC-CCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC
Q 002717 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERL-PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD 739 (888)
Q Consensus 661 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~ 739 (888)
++++++...+..++|+|++. +++.+++.... ..........+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 57777765432 1122334566778999999999999998 9999999999999999
Q ss_pred CCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCC-chhhH
Q 002717 740 NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP-VEYGED-NVVIL 817 (888)
Q Consensus 740 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p-~~~~~~-~~~~l 817 (888)
++.+||+|||+++.+..... .......||+.|+|||++ .+..++.++|||||||++|||++|..+ +..... ....+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEIL-AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999987643222 122345789999999998 455789999999999999999998754 433222 12222
Q ss_pred HHHHHHHHh-cCCc-------cccc-----CCCCCCCC-----hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 818 SEHVRVLLE-EGNV-------LDCV-----DPSMGDYP-----EDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 818 ~~~~~~~~~-~~~~-------~~~~-----d~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.+.+..... .... .+.+ +......+ .....++.+++.+|++.||++|||+.|++++-
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 222111000 0000 0000 00000000 11233567789999999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=256.11 Aligned_cols=216 Identities=21% Similarity=0.301 Sum_probs=180.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEE
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 676 (888)
.+.......||+|++|.|-+.++..+|...|+|++...-..+..++..+|+++..+. .+|.+|.++|.+......++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344455568999999999999999999999999997655555667788999987776 6999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
|.|. .+|..+-.+....+..+++.-+-+||..+..||.|||++. .++|||+||+|||++.+|.+|+||||++-.+.+
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9994 5788877776666788999999999999999999999986 899999999999999999999999999976643
Q ss_pred cccccccccccccccccCcccccCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHH
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~ 819 (888)
. ...+...|-..|||||.+... ..|+.|+||||+|+++.||.+++.||+.....-.++.+
T Consensus 202 S---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 202 S---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred h---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 2 222334566679999987432 35789999999999999999999999877665544443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=297.83 Aligned_cols=270 Identities=24% Similarity=0.328 Sum_probs=204.4
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-----eeeE
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 674 (888)
|+..+.||+|+||.||+|....+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 4567789999999999999988899999999865432 334567889999999999999999999988775 6799
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
||||++ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 82 v~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 999997 5788888753 3789999999999999999999998 9999999999999999999999999999876
Q ss_pred cccccc-cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC-----
Q 002717 755 TRLDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG----- 828 (888)
Q Consensus 755 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~----- 828 (888)
...... .......++..|+|||.+.....++.++||||+|+++|+|++|..||....... ....... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~-~~~~~~~~~~ 231 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVE-VLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHH-hcCCCChhHh
Confidence 543210 112334578889999998554478999999999999999999999996543211 1111110 00000
Q ss_pred ------CcccccC-------CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhcCC
Q 002717 829 ------NVLDCVD-------PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTP 880 (888)
Q Consensus 829 ------~~~~~~d-------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~~ 880 (888)
.....+. .............+.+++.+||+.+|++|||+++++.+ ++.+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000 00001122345668899999999999999999999996 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=290.93 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=197.2
Q ss_pred hhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCc---cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeee
Q 002717 601 LEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 673 (888)
|+..+.||+|+||.||+|... .+|+.||+|++..... ....+.+.+|+.+++++ +|++|+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 455678999999999999874 3688999999865322 12346678899999999 5999999999999888899
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++.
T Consensus 82 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 82 LILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999764 4578889999999999999999998 999999999999999999999999999976
Q ss_pred ccccccccccccccccccccCcccccCc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccc
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (888)
...... .......++..|+|||..... ...+.++||||||+++|+|++|..||...... .......+.....
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~----- 227 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKS----- 227 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhcc-----
Confidence 543221 111234578899999987432 34678999999999999999999999643221 1111222211111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002717 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 833 ~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 873 (888)
...++......+.+++.+||+.||++|| ++.+++.+
T Consensus 228 -----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1123344556788999999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=268.83 Aligned_cols=275 Identities=25% Similarity=0.355 Sum_probs=209.0
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEee-cCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC------
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLV-TSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP------ 669 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 669 (888)
....|++..+||+|.||+||+|+.+.+|++||+|+.. ..+.+.......+|+++++.++|+|++.++..|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 3455777789999999999999999999999998753 334455667788999999999999999999887532
Q ss_pred --CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEec
Q 002717 670 --QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD 747 (888)
Q Consensus 670 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 747 (888)
...|+|+++|+. +|.-.+... ...++..++.+++.++..||.|+|.. .|+|||+|+.|+|++.++.+||+|
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 346899999976 788888764 36789999999999999999999998 999999999999999999999999
Q ss_pred ccccccccccccccccc--cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH
Q 002717 748 FGLARLLTRLDKHVMSN--RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 748 fgla~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
||+++.+...+...... ....|.+|.+||.+.+...++++.|||+-||++.||+||.+-+.... +...+. .+..+.
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt-eqqql~-~Is~Lc 245 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT-EQQQLH-LISQLC 245 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh-HHHHHH-HHHHHh
Confidence 99998765444332222 23458899999999899999999999999999999999887765432 222221 111111
Q ss_pred hcCCcccccCCCCCCC-----------C-------hhh------HHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCCC
Q 002717 826 EEGNVLDCVDPSMGDY-----------P-------EDE------VLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 881 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~-----------~-------~~~------~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 881 (888)
. ....-+.|....+ + .+. .....+|+..++..||++|+++.+++.+-.-.+++.
T Consensus 246 G--s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 246 G--SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred c--cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 1 1111111111000 0 011 114568889999999999999999999988777776
Q ss_pred C
Q 002717 882 P 882 (888)
Q Consensus 882 ~ 882 (888)
|
T Consensus 324 p 324 (376)
T KOG0669|consen 324 P 324 (376)
T ss_pred c
Confidence 6
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=294.07 Aligned_cols=270 Identities=25% Similarity=0.320 Sum_probs=200.9
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEc-CCeeeE
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWT-PQLKLL 674 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 674 (888)
..+.|+..+.||+|+||.||+|....+++.||+|++..... ....+.+.+|++++++++||||+++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 34557778899999999999999988999999998754322 2234678899999999999999999999876 456789
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
|+||+ +++|.+++... .+++..+..++.|+++||.|||+. +|+||||+|+||++++++.++++|||.++..
T Consensus 88 v~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 88 VTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred Eeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 99998 56898888642 478888889999999999999998 9999999999999999999999999998754
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH----------
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL---------- 824 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~---------- 824 (888)
... .....++..|+|||.+.....++.++|||||||++|||++|+.||...... .......+..
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 321 123456788999998755567899999999999999999999999654321 1111110000
Q ss_pred HhcCCcccccCC--CCCC-----CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH--HHhhcCCC
Q 002717 825 LEEGNVLDCVDP--SMGD-----YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTPL 881 (888)
Q Consensus 825 ~~~~~~~~~~d~--~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~~~ 881 (888)
.......+.+.. .... ........+.+++.+|++.+|++|||++|++.+ ++..+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 000000000000 0000 112234678899999999999999999999987 44444443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=290.56 Aligned_cols=262 Identities=27% Similarity=0.350 Sum_probs=199.6
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCC-ccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
+..+.||+|+||.||+|+...+++.||+|.+.... .....+.+..|+.++++++|+|++++++++.+.+..++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34567999999999999999889999999986543 22344678899999999999999999999999999999999997
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
++|.+++.... ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+|||.++.......
T Consensus 82 -~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 82 -MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred -cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 58999998742 4689999999999999999999998 999999999999999999999999999976543221
Q ss_pred cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH-------HhcCCcccc
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL-------LEEGNVLDC 833 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~-------~~~~~~~~~ 833 (888)
......++..|+|||.+.....++.++|||||||++||+++|+.||..... ...+....+.. +........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-IDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 112334567899999885555789999999999999999999999865332 11111111100 000000000
Q ss_pred cCCCCCCC--------ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 834 VDPSMGDY--------PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 834 ~d~~~~~~--------~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.+.....+ .......+.+++.+||..+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 01111110 11224578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=292.35 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=201.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCeeeEEEe
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 677 (888)
|+..+.||+|+||.||+|....+++.||+|++...... ...+.+.+|++++++++ ||||+++++++..++..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 55667899999999999999889999999998653221 22356889999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 83 YAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999864 3689999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccc------------------cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHH
Q 002717 758 DKH------------------VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819 (888)
Q Consensus 758 ~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~ 819 (888)
... .......++..|+|||.. ....++.++||||+|+++|++++|+.||...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~--- 230 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LT--- 230 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHh-CCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HH---
Confidence 210 112334567889999987 4456889999999999999999999999754321 11
Q ss_pred HHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 002717 820 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSM----AEVVQI 873 (888)
Q Consensus 820 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~evl~~ 873 (888)
.+..... ...++...+..+.+++.+||+.+|++|||+ +|++.+
T Consensus 231 -~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 -FQKILKL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -HHHHHhc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111110 112334445678899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=289.47 Aligned_cols=256 Identities=26% Similarity=0.345 Sum_probs=197.3
Q ss_pred hhhcCeeccccceEEEEEEEC---CCCeEEEEEEeecCCc---cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeee
Q 002717 601 LEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSDI---IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~l~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 673 (888)
|+..+.||+|+||.||++... .+++.||||.+..... ....+.+.+|+++++++ +||||+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 445668999999999999864 3568899999864322 12345688999999999 5999999999999888999
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+||||+++|+|.+++... ..+++..+..++.|+++||.|||+. +++||||+|+||++++++.++++|||+++.
T Consensus 82 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 82 LILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998753 3588899999999999999999988 999999999999999999999999999876
Q ss_pred ccccccccccccccccccccCcccccCcC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccc
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (888)
....... ......++..|+|||...... ..+.++||||||+++|||++|..||....... ......+.....
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~----- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS----- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc-----
Confidence 5432211 112345788999999874332 36889999999999999999999996432111 111111211111
Q ss_pred ccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 833 ~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
....+......+.+++.+||+.+|++|||+.++.+.|+
T Consensus 228 -----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 228 -----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred -----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 01123334456889999999999999999887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=296.83 Aligned_cols=261 Identities=23% Similarity=0.291 Sum_probs=196.5
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC------
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ------ 670 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 670 (888)
.+.|+..+.||+|+||.||+|....+++.||||++..... ....+.+.+|+.++++++||||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 3447777899999999999999988999999999854321 223456789999999999999999999987543
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
..++|+||+ +++|.+++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||+
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 348999999 7789888764 3588999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH------
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------ 824 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~------ 824 (888)
+...... .....+++.|+|||.+.....++.++||||+||++|++++|+.||....... ...+..+..
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 238 (343)
T cd07880 165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHH
Confidence 9764321 1234567889999987554568899999999999999999999997543211 111111100
Q ss_pred ----HhcCCc------ccccC-CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 825 ----LEEGNV------LDCVD-PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 825 ----~~~~~~------~~~~d-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
+..... ...+. .............+.+++.+|++.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000 00011122344568899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=266.10 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=200.9
Q ss_pred hhhhhhhc-CeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeE
Q 002717 597 PETLLEKA-AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 597 ~~~~~~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 674 (888)
..+.|+.. +.+|+|+|+.|--++...+|..||||++.+. .-.......+|++++.+. .|+||+.++.+|+++...|+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 34555443 4699999999999999889999999998543 223456788999999999 59999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCC---cEEeccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN---PRISDFGLA 751 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgla 751 (888)
|||-|.||.|.+.|+++ ..+++.++.++..+||.||.|||.+ ||.|||+||+|||-.+... +|||||.++
T Consensus 154 VfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccc
Confidence 99999999999999886 4689999999999999999999999 9999999999999975443 799999987
Q ss_pred ccccccccccc-----cccccccccccCcccc----cCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCc---------
Q 002717 752 RLLTRLDKHVM-----SNRFQSALGYVAPELT----CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN--------- 813 (888)
Q Consensus 752 ~~~~~~~~~~~-----~~~~~g~~~y~aPE~~----~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~--------- 813 (888)
.-+.....-.. -.+..|+..|||||+. .....|+.++|.||+|||+|-|++|..||...-+.
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 64322111111 1234677789999975 23446889999999999999999999999653111
Q ss_pred hhhHHHHHHHHHhcCCcccccCCCCCCCChhhH----HHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 814 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEV----LPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~----~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
........-..+++|.. ++|+.++ ....+++...+..|+..|.++.+++.+-
T Consensus 307 Cr~CQ~~LFesIQEGkY---------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 307 CRVCQNKLFESIQEGKY---------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred cHHHHHHHHHHHhccCC---------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 11112222223334332 3444443 3456788889999999999999998854
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=295.98 Aligned_cols=262 Identities=24% Similarity=0.286 Sum_probs=195.3
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcC------Ce
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QL 671 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 671 (888)
+.|+..+.||+|+||.||+|....+++.||+|++..... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 446677789999999999999988899999999864321 22345678899999999999999999988643 23
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 751 (888)
.+++++++ +++|.+++... .+++..++.++.|+++|++|||+. +|+||||||+||++++++.+||+|||++
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred EEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccc
Confidence 57788876 78998887642 489999999999999999999998 9999999999999999999999999998
Q ss_pred ccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhc----
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE---- 827 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~---- 827 (888)
+..... .....++..|+|||.+.....++.++|||||||++|||++|+.||...... ..+....+.....
T Consensus 168 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 168 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAEL 241 (345)
T ss_pred cccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHH
Confidence 754321 133467888999998755456789999999999999999999999643221 1111111110000
Q ss_pred ------C---CcccccC----CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 828 ------G---NVLDCVD----PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 828 ------~---~~~~~~d----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
. .....+. .............+.+++.+|++.||++|||+.+++.+-.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0 0000000 0000111123456789999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=243.71 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=202.9
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
|.+.++||+|.||+||+|+...+++.||+|+.+-.+. ...+....+|+-+++.++|.|||+++++...+....+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 5566789999999999999999999999999865543 345678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
.. +|..+.... ...++.+....++.|+.+|+.|.|++ ++.|||+||.|.+++.+|+.|++|||+++-++-...
T Consensus 84 dq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 84 DQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 54 677777654 35688899999999999999999999 999999999999999999999999999986642211
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC--C---ccccc
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--N---VLDCV 834 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--~---~~~~~ 834 (888)
.-+...-|.+|.+|.++.+..-|+...|+||-||++.|+.....|...+.+-.+++.+..+.+.... . ....-
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 1133456889999999878888999999999999999999877776666555555555544332111 0 11111
Q ss_pred CCCC-CCCChh---------hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 835 DPSM-GDYPED---------EVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 835 d~~~-~~~~~~---------~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
|... +-+|.. ....=.++++..+.-+|..|.++++++++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111 011211 11112466777777789999999998875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=280.35 Aligned_cols=238 Identities=29% Similarity=0.370 Sum_probs=194.0
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCH
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL 684 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 684 (888)
||+|+||.||++.+..+++.+|+|.+....... ..+.+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999998889999999986554322 345788999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccc
Q 002717 685 QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764 (888)
Q Consensus 685 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~ 764 (888)
.+++... ..+++..+..++.|+++|+.|+|+. +++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 9999864 3589999999999999999999998 99999999999999999999999999997654321 1123
Q ss_pred cccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChh
Q 002717 765 RFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844 (888)
Q Consensus 765 ~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 844 (888)
...++..|+|||.. .+...+.++|+||||+++||+++|..||..... . ...+.... . ...++..
T Consensus 152 ~~~~~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~---~~~~~~~~-~---------~~~~~~~ 215 (250)
T cd05123 152 TFCGTPEYLAPEVL-LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--K---EIYEKILK-D---------PLRFPEF 215 (250)
T ss_pred CCcCCccccChHHh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--H---HHHHHHhc-C---------CCCCCCC
Confidence 45678889999987 445678899999999999999999999964432 1 11111111 1 0122334
Q ss_pred hHHHHHHHHHHccCCCCCCCCCHHH
Q 002717 845 EVLPVLKLALVCTCHIPSSRPSMAE 869 (888)
Q Consensus 845 ~~~~l~~li~~cl~~dp~~RPs~~e 869 (888)
.+..+.+++.+||..||++|||+++
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 4567889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=297.36 Aligned_cols=260 Identities=24% Similarity=0.305 Sum_probs=197.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCe------
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL------ 671 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 671 (888)
+.|+..+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.++++++|||++++.+++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 346677899999999999999988899999998854321 2233567789999999999999999998866554
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccc
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla 751 (888)
.++|+||+ +++|.+++.. ..+++..++.++.|+++|++|||+. +|+||||||+||++++++.++|+|||++
T Consensus 95 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 79999998 6799998875 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC---
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--- 828 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--- 828 (888)
...... .....++..|+|||.......++.++||||+||++||+++|+.||...... ..+....... ...
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~-~~~~~~ 238 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLV-GTPDEE 238 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhc-CCCCHH
Confidence 765422 133456788999998755456789999999999999999999999654321 1111111100 000
Q ss_pred -----------CcccccCC----CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 829 -----------NVLDCVDP----SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 829 -----------~~~~~~d~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.....+.. ............+.+++.+|++.+|++|||+.|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 00000000 00001112356788999999999999999999998854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=291.36 Aligned_cols=265 Identities=20% Similarity=0.258 Sum_probs=194.1
Q ss_pred hhhcCeeccccceEEEEEEECCC--CeEEEEEEeecCCc-cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcC----Cee
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQ--GRMLAVKKLVTSDI-IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTP----QLK 672 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~--~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~ 672 (888)
|+..+.||+|+||.||++.+... +..||+|++..... ....+.+.+|+++++++ .||||+++++++... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 44566899999999999999877 88999999854321 12345678899999999 599999999875432 346
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
++++||+. ++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 82 ~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 82 YLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 78888885 6898888653 4689999999999999999999998 99999999999999999999999999998
Q ss_pred cccccccc--cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHH------
Q 002717 753 LLTRLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------ 824 (888)
Q Consensus 753 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~------ 824 (888)
........ .......|+..|+|||.......++.++||||+||++|+|++|..||..... ...+...++..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQVLGTPDEE 232 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHHhCCCCHH
Confidence 65432211 1112346788999999875555688999999999999999999999865432 11111111100
Q ss_pred -----HhcC------CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 825 -----LEEG------NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 825 -----~~~~------~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.... .....-...+..........+.+++.+|++.||++|||+.|++.+=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000 0000000000111122345688999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=278.67 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=203.9
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC------ChHHHHHHHHHHhhcCCCCcceeeeEEEc-CC
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ------YPEDFEREVRVLGKARHPNLISLEGYYWT-PQ 670 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 670 (888)
.+.|-....+|+|||+.||+|.+....+.||||+-.-...+. ..+...+|..|-+.+.||.||++++|+.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 456667778999999999999999899999999864333222 23456789999999999999999999975 45
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec---CCCCcEEec
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISD 747 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~D 747 (888)
..+-|+|||+|.+|+.|++.. ..+++.++..|+.||+.||.||.+. +|+|||-|+||.|||+- .-|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 678999999999999999875 4688999999999999999999987 88999999999999995 347799999
Q ss_pred ccccccccccccc-----cccccccccccccCcccccCc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHH
Q 002717 748 FGLARLLTRLDKH-----VMSNRFQSALGYVAPELTCQS---LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819 (888)
Q Consensus 748 fgla~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~---~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~ 819 (888)
||+++.+....+. ..++...||.+|.+||.+.-+ .+.+.|.||||+||++|.++.|+.||........++.+
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999988654332 223557899999999987433 46788999999999999999999999765444433332
Q ss_pred HHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002717 820 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872 (888)
Q Consensus 820 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 872 (888)
..+.......++. .+....+...+|++|++..-++|....++..
T Consensus 697 --------NTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 --------NTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --------hchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 2222221111111 1233445778999999999999988777654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=289.81 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=199.1
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEE
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 676 (888)
.+.|+....+|.|+|+.|-.+.+..+++..+||++.+.. .+-.+|+.++... .||||+++.+.+.+..+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 345666667999999999999999999999999986552 3344677776666 6999999999999999999999
Q ss_pred ecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEe-cCCCCcEEeccccccccc
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL-DDNYNPRISDFGLARLLT 755 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill-~~~~~~kl~Dfgla~~~~ 755 (888)
|++.+|-+.+.+... +.+. ..+..|+++++.|+.|||++ ||||||+||+|||+ ++.+.++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999888877664 1222 66778999999999999998 99999999999999 588999999999998765
Q ss_pred ccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.. ..+.+-|..|.|||+. ....+++++|+||+|++||+|++|+.||.....+.+.. ..+..+
T Consensus 468 ~~-----~~tp~~t~~y~APEvl-~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~-----~~i~~~------- 529 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVL-AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH-----TRIQMP------- 529 (612)
T ss_pred hh-----hcccchhhcccChhhh-ccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH-----HhhcCC-------
Confidence 43 2344567889999998 47789999999999999999999999998765542211 111211
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
.+....+....+|+..|++.||.+||+|.|+..+-+..
T Consensus 530 ----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 530 ----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred ----ccccccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence 12245556788999999999999999999999887663
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=293.12 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=212.7
Q ss_pred cccCChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEc--
Q 002717 592 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT-- 668 (888)
Q Consensus 592 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 668 (888)
+...++.+.++..+.||.|.+|.||+++...+++.+|+|++.... ...+++..|..|++.. .|||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 334566777788889999999999999999999999999986544 3347788899999988 69999999999863
Q ss_pred ---CCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEE
Q 002717 669 ---PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRI 745 (888)
Q Consensus 669 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 745 (888)
++..++|||||.+|+..++++... +..+.|+.+..|++.++.|+.|||.. .++|||||-.|||++.++.||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 567899999999999999999875 67899999999999999999999998 9999999999999999999999
Q ss_pred ecccccccccccccccccccccccccccCcccccCc----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHH
Q 002717 746 SDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS----LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV 821 (888)
Q Consensus 746 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~ 821 (888)
+|||.+..+.. ......+..||+.|||||++... ..|+.++|+||+|++..||.-|.+|+.++..-.
T Consensus 165 vDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------- 235 (953)
T KOG0587|consen 165 VDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------- 235 (953)
T ss_pred eeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------
Confidence 99999987653 23334677899999999998543 346779999999999999999999997763311
Q ss_pred HHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 822 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 822 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.++...+ .-.|++. -+..-..++.++|..|+..|-.+||++.+++++
T Consensus 236 -aLF~IpR---NPPPkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 -ALFLIPR---NPPPKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -hhccCCC---CCCcccc-chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111100 0011111 245556778899999999999999999998875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=274.07 Aligned_cols=220 Identities=23% Similarity=0.257 Sum_probs=177.4
Q ss_pred ccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCHHHHHh
Q 002717 610 GVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLH 689 (888)
Q Consensus 610 G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 689 (888)
|.+|.||++.+..+++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999985432 23445555556679999999999999999999999999999999997
Q ss_pred hcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccccccccccc
Q 002717 690 ERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 769 (888)
Q Consensus 690 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~ 769 (888)
.. ..+++..+..++.|+++||.|+|+. +|+||||||+||++++++.++++|||.+....... ....++
T Consensus 78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~ 145 (237)
T cd05576 78 KF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVE 145 (237)
T ss_pred Hh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcC
Confidence 64 3489999999999999999999998 99999999999999999999999999886554311 223456
Q ss_pred ccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHH
Q 002717 770 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPV 849 (888)
Q Consensus 770 ~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l 849 (888)
..|+|||.. ....++.++||||+||++|||++|+.|+....... .. . .....+......+
T Consensus 146 ~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~-----~---~~~~~~~~~~~~~ 205 (237)
T cd05576 146 NMYCAPEVG-GISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NT-----H---TTLNIPEWVSEEA 205 (237)
T ss_pred ccccCCccc-CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cc-----c---cccCCcccCCHHH
Confidence 679999987 45567899999999999999999998875321110 00 0 0001233445678
Q ss_pred HHHHHHccCCCCCCCCCH
Q 002717 850 LKLALVCTCHIPSSRPSM 867 (888)
Q Consensus 850 ~~li~~cl~~dp~~RPs~ 867 (888)
.+++.+|++.||++|||+
T Consensus 206 ~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 206 RSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHccCCHHHhcCC
Confidence 899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-33 Score=314.43 Aligned_cols=420 Identities=26% Similarity=0.312 Sum_probs=268.8
Q ss_pred CCccccccccccccCc-ccccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEc
Q 002717 1 MTTPLVHGNSYNAIPS-MVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSL 79 (888)
Q Consensus 1 ~~~l~l~~n~~~~ip~-~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L 79 (888)
|..|.++.|-|.++|. .....+|+.|+|..|.+. ..|.++..+ ++|++||+|.|++. .+|.-+ ..++.+.++..
T Consensus 70 L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~l--knl~~LdlS~N~f~-~~Pl~i-~~lt~~~~~~~ 144 (1081)
T KOG0618|consen 70 LRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISEL--KNLQYLDLSFNHFG-PIPLVI-EVLTAEEELAA 144 (1081)
T ss_pred HhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhh--hcccccccchhccC-CCchhH-HhhhHHHHHhh
Confidence 4578999999999995 447899999999999998 699999987 89999999999997 888765 56888888888
Q ss_pred CCc-ccccccc---------------ccccCCCCCCE-EECcCcccccccCccccccccccccCcEEEcCCccccccCCc
Q 002717 80 AGN-ILQGPIG---------------KIFNYCSSLNT-LNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142 (888)
Q Consensus 80 ~~N-~l~~~~~---------------~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 142 (888)
++| ++..... .......+|+. |||.+|.+. ..+ +..+.+|+.|....|++....
T Consensus 145 s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~-~~d------ls~~~~l~~l~c~rn~ls~l~-- 215 (1081)
T KOG0618|consen 145 SNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEME-VLD------LSNLANLEVLHCERNQLSELE-- 215 (1081)
T ss_pred hcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhh-hhh------hhhccchhhhhhhhcccceEE--
Confidence 888 2222111 11111122222 555555544 111 234455555555555554211
Q ss_pred cccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCCcc
Q 002717 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTL 222 (888)
Q Consensus 143 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 222 (888)
-.-++|+.|+.++|.++...+. ....+|++++++.|++++ +|+.+..+.+|+.|...+|+++ .+|..+..+.+|
T Consensus 216 --~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L 289 (1081)
T KOG0618|consen 216 --ISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSL 289 (1081)
T ss_pred --ecCcchheeeeccCcceeeccc--cccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhH
Confidence 1234556666666666532222 123466777777777764 3466677777777777777775 566666666777
Q ss_pred cEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCcccccc---CCceEEcccCcccccCCCCCCCCCCCcccCCC
Q 002717 223 EFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL---GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 299 (888)
Q Consensus 223 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~---~L~~L~l~~N~l~~~~p~~~~~~~~~~~l~~L 299 (888)
+.|.+.+|.+. -+|.....++.|++|+|..|.|. .+|+.++.. .++.|+.+.|.+... | ......++.|
T Consensus 290 ~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~l-p-----~~~e~~~~~L 361 (1081)
T KOG0618|consen 290 VSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTL-P-----SYEENNHAAL 361 (1081)
T ss_pred HHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccccc-c-----cccchhhHHH
Confidence 77777777776 45666666777777777777776 555554443 255555555555421 1 1111234567
Q ss_pred CEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceEEccCC
Q 002717 300 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGN 379 (888)
Q Consensus 300 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N 379 (888)
+.|.+.+|.+++..-..+.++.+|+.|+|++|+|.......+.++..|++|+||+|+++ .+|.++.++..|+.|...+|
T Consensus 362 q~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN 440 (1081)
T KOG0618|consen 362 QELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSN 440 (1081)
T ss_pred HHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCC
Confidence 77777777777666556667777777777777776655566677777777777777776 66677777777777777777
Q ss_pred cCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeeccCC
Q 002717 380 SLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYN 451 (888)
Q Consensus 380 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N 451 (888)
+|. ..| .+..++.|+.+|+|.|+|+...-..-...++|++|||++|.-....-+.|..+..+..++++-|
T Consensus 441 ~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 441 QLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 776 566 6777777777777777776433322223367777777777644344555666666666666655
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=308.85 Aligned_cols=146 Identities=26% Similarity=0.374 Sum_probs=130.4
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
.|++.+.||+|+||.||+|.+..+++.||||++...... .....+..|+.+++.++||||+++++++......++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 356677999999999999999988999999998654322 123568889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
|+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999764 3578889999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=302.96 Aligned_cols=255 Identities=21% Similarity=0.283 Sum_probs=204.8
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
.+.|++.+.||+|+||.|..++++.+++.||.|++.+-... .....|..|-++|..-+.+=|+.++-.|.++.+.|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 34577888999999999999999999999999998653322 2346688999999888899999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
||||+||+|-..+... .++++.-+..++..|+-||.-+|+. |+|||||||+|||+|..|.+|++|||.+-.+.
T Consensus 154 MdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 9999999999999986 2688888889999999999999999 99999999999999999999999999987765
Q ss_pred ccccccccccccccccccCcccccC---c-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTCQ---S-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~~---~-~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (888)
. +.........|||.|++||++.. + +.|+..+|.||+||++|||+.|..||+.. .+......+..-..
T Consensus 227 ~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~hk~-- 298 (1317)
T KOG0612|consen 227 A-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNHKE-- 298 (1317)
T ss_pred C-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhchhh--
Confidence 3 34455677899999999998732 2 56889999999999999999999999642 11221111111111
Q ss_pred cccCCCCCCCC--hhhHHHHHHHHHHccCCCCCCCCC---HHHHHHHH
Q 002717 832 DCVDPSMGDYP--EDEVLPVLKLALVCTCHIPSSRPS---MAEVVQIL 874 (888)
Q Consensus 832 ~~~d~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~L 874 (888)
.-.+| .+.+.....||++.+ -+|+.|.. ++++..|.
T Consensus 299 ------~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 299 ------SLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred ------hcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCc
Confidence 11233 345666778888877 45888887 88887764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=278.62 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=197.0
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCccC-ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCC
Q 002717 604 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 604 ~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 682 (888)
.+.+|+|.||+||-|+++.+|+.||||++.+..... ......+|+.|++++.||.||.+.-.|+.++..++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 458999999999999999999999999997655443 34678899999999999999999999999999999999994 5
Q ss_pred CHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC---CCcEEeccccccccccccc
Q 002717 683 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN---YNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 683 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfgla~~~~~~~~ 759 (888)
+..++|-.. ...++++....-+..||+.||.|||.+ +|+|+|+||+|||+.+. -.+||||||+|+.+++..
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 666665443 245688888888999999999999998 99999999999999743 469999999999887522
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
......||+.|.|||++ ....|...-|+||.||++|--++|..||..+++-.+ ++ +...++ ..+
T Consensus 722 --FRrsVVGTPAYLaPEVL-rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd----QI----QNAaFM--yPp--- 785 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVL-RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND----QI----QNAAFM--YPP--- 785 (888)
T ss_pred --hhhhhcCCccccCHHHH-hhccccccccceeeeEEEEEEecccccCCCccchhH----Hh----hccccc--cCC---
Confidence 23567899999999998 556789999999999999999999999965433221 11 111111 111
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
....+.....+++|...++..=.+|-|..+.+.+-
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 12334455678899999999999999988766543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=270.54 Aligned_cols=238 Identities=25% Similarity=0.339 Sum_probs=194.7
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCC--hHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecC
Q 002717 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 603 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
....||+|+||.|..|..+.+.+.+|||++++.-..+. .+--..|-.++..- +.|.++.++.++...+..|+||||+
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyv 432 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYV 432 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEe
Confidence 34579999999999999999999999999976654432 23345677777766 5789999999999999999999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
.||+|--.++.. ..+.+..+.-+|..||-||-+||++ +|+.||+|.+||++|.+|.+||+|||+++.-- -.
T Consensus 433 nGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~ 503 (683)
T KOG0696|consen 433 NGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FD 503 (683)
T ss_pred cCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc--cC
Confidence 999998888875 4678888899999999999999999 99999999999999999999999999997422 22
Q ss_pred ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCC
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
..++.+.+||+.|+|||++ ....|+..+|.|||||++|||+.|+.||+....+ ....... +. -.
T Consensus 504 ~~TTkTFCGTPdYiAPEIi-~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-elF~aI~----eh----------nv 567 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQAIM----EH----------NV 567 (683)
T ss_pred CcceeeecCCCcccccceE-EecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHH----Hc----------cC
Confidence 3345778999999999988 7778999999999999999999999999754332 2221111 11 11
Q ss_pred CCChhhHHHHHHHHHHccCCCCCCCC
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRP 865 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~cl~~dp~~RP 865 (888)
.+|...+.+...+....+...|.+|.
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCcccc
Confidence 35666677788888888999999885
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=264.16 Aligned_cols=240 Identities=28% Similarity=0.377 Sum_probs=193.7
Q ss_pred cceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCHHHHHhh
Q 002717 611 VFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE 690 (888)
Q Consensus 611 ~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 690 (888)
+||.||+|.+..+++.+|+|++.........+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999998789999999986554333267899999999999999999999999998999999999999999999976
Q ss_pred cCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccccccccc
Q 002717 691 RLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770 (888)
Q Consensus 691 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~ 770 (888)
.. .+++..++.++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 42 288999999999999999999998 99999999999999999999999999998765432 223456778
Q ss_pred cccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHH
Q 002717 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVL 850 (888)
Q Consensus 771 ~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~ 850 (888)
.|++||.. ....++.++||||+|+++|++++|..||........ ..+. . ...... ..........++.
T Consensus 151 ~~~~pE~~-~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~---~-~~~~~~------~~~~~~~~~~~~~ 218 (244)
T smart00220 151 EYMAPEVL-LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-LFKK---I-GKPKPP------FPPPEWKISPEAK 218 (244)
T ss_pred CCCCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHH---H-hccCCC------CccccccCCHHHH
Confidence 89999988 455678899999999999999999999965322211 1111 1 111100 0000111456788
Q ss_pred HHHHHccCCCCCCCCCHHHHHH
Q 002717 851 KLALVCTCHIPSSRPSMAEVVQ 872 (888)
Q Consensus 851 ~li~~cl~~dp~~RPs~~evl~ 872 (888)
+++.+||..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=266.43 Aligned_cols=262 Identities=23% Similarity=0.277 Sum_probs=200.7
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-C-C----CcceeeeEEEcCCe
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-H-P----NLISLEGYYWTPQL 671 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~ 671 (888)
...|++...+|+|.||.|.++.+...+..||||+++... ...++..-|+++++++. + | -+|.+.+++.-.++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 456777889999999999999999889999999985433 44567788999999993 2 2 36777788888899
Q ss_pred eeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC------------
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD------------ 739 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~------------ 739 (888)
.++|+|.+ |.++.+++... .-.+++..++..|+.|++++++|||+. +++|-|+||+||++.+
T Consensus 166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 99999998 66999999885 345688899999999999999999999 9999999999999821
Q ss_pred --------CCCcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 002717 740 --------NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 811 (888)
Q Consensus 740 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~ 811 (888)
...+|+.|||.|+...+.. .....|..|+|||++ -+..++.++||||+|||++|++||..-|..-+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEVi-LgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVI-LGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchhe-eccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 3358999999998654322 456678899999998 66789999999999999999999999886544
Q ss_pred CchhhHHHH----------------HHHHHhcCCcc-----------cccCCCCC-----CCChhhHHHHHHHHHHccCC
Q 002717 812 DNVVILSEH----------------VRVLLEEGNVL-----------DCVDPSMG-----DYPEDEVLPVLKLALVCTCH 859 (888)
Q Consensus 812 ~~~~~l~~~----------------~~~~~~~~~~~-----------~~~d~~~~-----~~~~~~~~~l~~li~~cl~~ 859 (888)
+.+.++-. .++....+.+. ...++-.+ ...+.+..++.+|+++|+..
T Consensus 314 -n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 314 -NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred -cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 33322111 11111111100 00000000 02345667799999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 002717 860 IPSSRPSMAEVVQIL 874 (888)
Q Consensus 860 dp~~RPs~~evl~~L 874 (888)
||.+|+|++|++.+-
T Consensus 393 DP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 393 DPARRITLREALSHP 407 (415)
T ss_pred CccccccHHHHhcCH
Confidence 999999999999763
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=244.69 Aligned_cols=261 Identities=21% Similarity=0.249 Sum_probs=209.3
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCC--eee
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQ--LKL 673 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~ 673 (888)
..+.|+..+++|+|.|++||.|....+.++++||.+++.. .+.+.+|+.+++.++ ||||++++++..++. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 3456888899999999999999998899999999996554 467899999999996 999999999998765 457
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec-CCCCcEEecccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLAR 752 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgla~ 752 (888)
+|+||+++.+....-. .++..++...+.++++||.|.|+. ||.|||+||.|+++| +....+++|||+|.
T Consensus 112 LiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 9999999877655443 377788999999999999999999 999999999999999 55679999999999
Q ss_pred cccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC----
Q 002717 753 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG---- 828 (888)
Q Consensus 753 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~---- 828 (888)
++.++..... ...+..|.-||.+.....++..-|+|||||++..|+..+.||-.+.++.+++.+.++.+....
T Consensus 182 FYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 182 FYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 8876554422 234566888999878888899999999999999999999999999999888888776543221
Q ss_pred --CcccccCCCCCC----CC-------------hhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 829 --NVLDCVDPSMGD----YP-------------EDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 829 --~~~~~~d~~~~~----~~-------------~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
...-.+||...+ .. .-...+..+++.+.+..|-++|||++|++.+-
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 000112322211 00 01124567899999999999999999998753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-31 Score=290.89 Aligned_cols=245 Identities=27% Similarity=0.370 Sum_probs=186.9
Q ss_pred cCeeccccceE-EEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 604 AAEVGEGVFGT-VYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 604 ~~~ig~G~~g~-V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
.+.+|.|+.|+ ||+|.+ +|+.||||++... ..+-..+|++.++.- +|||||++++.-.+++..|+..|.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 34688999887 799999 7999999998543 235567999999988 69999999999888999999999995
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC---C--CCcEEecccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---N--YNPRISDFGLARLLTR 756 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~--~~~kl~Dfgla~~~~~ 756 (888)
.+|.+++...............+.+..|+++|++|||+. +|||||+||.|||++. + .+++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 599999987411222222255678899999999999997 9999999999999975 2 5799999999998865
Q ss_pred ccc-ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 757 LDK-HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTG-RRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 757 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
+.. ........||-+|+|||.+ .....+.++|+||+||++|+.++| .+||.+........ .........+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L-~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-------l~~~~~L~~L 735 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQL-REDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-------LTGNYTLVHL 735 (903)
T ss_pred CcchhhcccCCCCcccccCHHHH-hccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-------hcCccceeee
Confidence 443 2334567899999999998 444567799999999999999996 89997643221111 1111111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
. +.... ...+||.+|++++|..||++.+|+.+
T Consensus 736 ----~--~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 ----E--PLPDC-EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ----c--cCchH-HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 11111 67789999999999999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=292.31 Aligned_cols=261 Identities=18% Similarity=0.175 Sum_probs=169.5
Q ss_pred hhhhhcCeeccccceEEEEEEECCC----CeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeE------EEc
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQ----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY------YWT 668 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~----~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~ 668 (888)
+.|+..+.||+|+||.||+|++..+ +..||+|++.... ..+.+..| .++...+.++..+... +..
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4567788999999999999999877 8999999875322 11111111 1112222233322221 234
Q ss_pred CCeeeEEEecCCCCCHHHHHhhcCC----------------CCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCC
Q 002717 669 PQLKLLVSDYAPNGSLQAKLHERLP----------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 732 (888)
Q Consensus 669 ~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~ 732 (888)
....++|+||+++++|.+++..... .........+..++.|++.||.|||+. +|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCH
Confidence 5678999999999999999875310 011112344668999999999999998 999999999
Q ss_pred CcEEecC-CCCcEEecccccccccccccccccccccccccccCcccccCcC---------------------CCCCcchH
Q 002717 733 SNILLDD-NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL---------------------RVNEKCDI 790 (888)
Q Consensus 733 ~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---------------------~~~~~sDv 790 (888)
+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+.... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 679999999999865433222 224567889999999642211 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC----cccccCCCC----C---CCChhhHHHHHHHHHHccCC
Q 002717 791 YGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN----VLDCVDPSM----G---DYPEDEVLPVLKLALVCTCH 859 (888)
Q Consensus 791 wS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~----~~~~~d~~~----~---~~~~~~~~~l~~li~~cl~~ 859 (888)
|||||++|||+++..|++.. ...+...+. ..+. ....+.+.. . +..........+|+.+|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~---~~~~~~~l~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN---LIQFNRQLK---RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH---HHHHHHHHH---hcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999876654321 111111110 0000 000000100 0 01111223456899999999
Q ss_pred CCCCCCCHHHHHHHH
Q 002717 860 IPSSRPSMAEVVQIL 874 (888)
Q Consensus 860 dp~~RPs~~evl~~L 874 (888)
||++|||++|++++-
T Consensus 437 dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 437 KGRQRISAKAALAHP 451 (566)
T ss_pred CcccCCCHHHHhCCc
Confidence 999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=277.15 Aligned_cols=266 Identities=18% Similarity=0.172 Sum_probs=181.3
Q ss_pred hhhhhhcCeeccccceEEEEEEEC----------------CCCeEEEEEEeecCCcc-------------CChHHHHHHH
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFG----------------TQGRMLAVKKLVTSDII-------------QYPEDFEREV 648 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~----------------~~~~~vavK~l~~~~~~-------------~~~~~~~~E~ 648 (888)
.+.|+..++||+|+||.||+|.+. ..++.||||++...... ...+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 345777889999999999999752 24568999998543211 1112344577
Q ss_pred HHHhhcCCCCc-----ceeeeEEEc--------CCeeeEEEecCCCCCHHHHHhhcCC--------------------CC
Q 002717 649 RVLGKARHPNL-----ISLEGYYWT--------PQLKLLVSDYAPNGSLQAKLHERLP--------------------ST 695 (888)
Q Consensus 649 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~ 695 (888)
.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++.... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 78888866554 677887753 3457999999999999999975321 11
Q ss_pred CCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccccccccccccCc
Q 002717 696 PPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 775 (888)
Q Consensus 696 ~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aP 775 (888)
..+++..+..++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||+++....... .......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 2356788899999999999999998 999999999999999999999999999976543221 111223447899999
Q ss_pred ccccCcCC---------------------CCCcchHHHHHHHHHHHHhCCC-CCCCCCCchhhHHH------HHHHHHhc
Q 002717 776 ELTCQSLR---------------------VNEKCDIYGFGVLILELVTGRR-PVEYGEDNVVILSE------HVRVLLEE 827 (888)
Q Consensus 776 E~~~~~~~---------------------~~~~sDvwS~Gv~l~elltg~~-p~~~~~~~~~~l~~------~~~~~~~~ 827 (888)
|.+..... ...+.||||+||++|||++|.. |+.........+.. .++. ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~ 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKG 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hcc
Confidence 98743211 1235799999999999999875 66432111111110 0111 010
Q ss_pred CCcccccCCCCCCCChhhHHHHHHHHHHccCCCC---CCCCCHHHHHHHHH
Q 002717 828 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIP---SSRPSMAEVVQILQ 875 (888)
Q Consensus 828 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~evl~~L~ 875 (888)
.. .+ .. ..........+++.+++..+| .+|+|++|+++|-+
T Consensus 459 ~~----~~--~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 459 QK----YD--FS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred cC----CC--cc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 00 11 11 122334567789999998765 68999999998744
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=266.29 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=206.3
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
.++...+|-|+||.|-.+..+.+...+|+|.+++..... ..+....|-.+|...+.|.||++|..|.+....|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 455557999999999999997655568999987765543 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
|-||.+-..++++ ..++.....-++.-+.+|++|||.+ +||.||+||+|.++|.+|-+|+.|||+|+.+..+.
T Consensus 502 ClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 502 CLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999886 5688888899999999999999999 99999999999999999999999999999887654
Q ss_pred cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCC
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
.. -+++||+.|+|||++... ..+.++|.||+|+++||+++|.+||..... ...+....+. +| .
T Consensus 575 KT---wTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dp-mktYn~ILkG----------id--~ 637 (732)
T KOG0614|consen 575 KT---WTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDP-MKTYNLILKG----------ID--K 637 (732)
T ss_pred ce---eeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHhh----------hh--h
Confidence 43 468999999999998544 468899999999999999999999975422 2111111111 11 1
Q ss_pred CCCChhhHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHH
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQILQ 875 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L~ 875 (888)
..+|........++|++.+..+|.+|.- +.++.++-+
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 1356677777889999999999999975 777777653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=247.70 Aligned_cols=242 Identities=21% Similarity=0.306 Sum_probs=194.2
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEe
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 677 (888)
+...+.||+|+|+.|..++++.+.+.+|+|++++.-.. +..+=.+.|-.+..+- +||.+|.++.++......++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 45567899999999999999999999999998654221 2223355677777777 69999999999999999999999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|++||+|--.++.+ ..++++.+.-+...|..||.|||++ ||+.||+|.+||++|..|.+|++|+|+++.--.
T Consensus 332 yv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~- 403 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG- 403 (593)
T ss_pred EecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC-
Confidence 99999997777764 5689999999999999999999999 999999999999999999999999999975322
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCC--CC----chhhHHHHHHHHHhcCCcc
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYG--ED----NVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~--~~----~~~~l~~~~~~~~~~~~~~ 831 (888)
..-.+++++||+.|+|||++ .+..|....|.|++||+++||+.|+.||+.- .. .++++.+ .+++..
T Consensus 404 -~gd~tstfcgtpnyiapeil-rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq---vilekq--- 475 (593)
T KOG0695|consen 404 -PGDTTSTFCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ---VILEKQ--- 475 (593)
T ss_pred -CCcccccccCCCcccchhhh-cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH---HHhhhc---
Confidence 22234788999999999998 6778999999999999999999999999752 11 1222222 112211
Q ss_pred cccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC
Q 002717 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 865 (888)
Q Consensus 832 ~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 865 (888)
...|.....+...++..-+.+||.+|.
T Consensus 476 -------iriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 -------IRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -------ccccceeehhhHHHHHHhhcCCcHHhc
Confidence 123445555667788889999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=246.81 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=190.4
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCC-----eeeEEEe
Q 002717 604 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ-----LKLLVSD 677 (888)
Q Consensus 604 ~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 677 (888)
.+.||-|+||.||.+++..+|+.||+|++..... -...+.+.+|++++..++|.||+..++...-+. +.|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 4579999999999999999999999999853321 123467889999999999999999988775443 4578888
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
.|. .+|...|- +.+.++...+.-+.+||++||.|||+. +|.||||||.|.+++++...||||||+++..+..
T Consensus 138 LmQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 873 34544443 456788899999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHH-----------------
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH----------------- 820 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~----------------- 820 (888)
+...+ ....-|-.|+|||++.+...|+.+.||||.||++.|++.++.-|..... .+++.-.
T Consensus 210 ~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-iqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 210 DRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-IEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-HHHHHHHHHHhCCCcHHHHHHHhh
Confidence 33222 3344577899999998889999999999999999999988877754321 1111110
Q ss_pred -HHHHHhcCCcccccCCCCCC--CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 002717 821 -VRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 821 -~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 875 (888)
.+.-+-.+.....--+.+-. -+.........+...++..||++|.+.++++.++.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11000001111000000100 11222334556778889999999999999887663
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-30 Score=264.51 Aligned_cols=396 Identities=21% Similarity=0.221 Sum_probs=241.0
Q ss_pred ccccccccccccCcccccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEcCC-
Q 002717 3 TPLVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG- 81 (888)
Q Consensus 3 ~l~l~~n~~~~ip~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~~- 81 (888)
++++++.++++||+ .-...-..++|..|+|+.+.|.+|..+ ++|++||||+|+|+ .|.+++|+++++|.+|-+.+
T Consensus 50 ~VdCr~~GL~eVP~-~LP~~tveirLdqN~I~~iP~~aF~~l--~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~ 125 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPA-NLPPETVEIRLDQNQISSIPPGAFKTL--HRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGN 125 (498)
T ss_pred eEEccCCCcccCcc-cCCCcceEEEeccCCcccCChhhccch--hhhceecccccchh-hcChHhhhhhHhhhHHHhhcC
Confidence 57888999999996 346678889999999998888888877 78999999999998 88888899999988887766
Q ss_pred ccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCCEEEccCccc-
Q 002717 82 NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF- 160 (888)
Q Consensus 82 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l- 160 (888)
|+|++++.++|.+|..|+.|.+.-|++.-+. ..+|+.+++|..|.|-+|.+..+-...|..+..++.+.+..|.+
T Consensus 126 NkI~~l~k~~F~gL~slqrLllNan~i~Cir----~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i 201 (498)
T KOG4237|consen 126 NKITDLPKGAFGGLSSLQRLLLNANHINCIR----QDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI 201 (498)
T ss_pred CchhhhhhhHhhhHHHHHHHhcChhhhcchh----HHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc
Confidence 8999999999999999999999999987543 35788899999999999999854445889999999999888872
Q ss_pred -----------cccCCCCCCCCCCCCEEEccCCccCcCC--------------------------ChhhhcCCCCcEEEe
Q 002717 161 -----------SGPLPADIGFCPHLTTLDLSNNLFTGQL--------------------------PVSLRLLNSMIFISV 203 (888)
Q Consensus 161 -----------~~~~~~~~~~l~~L~~L~L~~N~l~~~~--------------------------~~~~~~l~~L~~L~L 203 (888)
....|..++......-..+.++++..+. ...|..|++|+.|+|
T Consensus 202 cdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnl 281 (498)
T KOG4237|consen 202 CDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNL 281 (498)
T ss_pred cccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEecc
Confidence 1222333333333333333333333222 233555555555555
Q ss_pred ecCcccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCcccccC
Q 002717 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 283 (888)
Q Consensus 204 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~~ 283 (888)
++|+|+++-+.+|.++..+++|.|..|+|..+....|.++..|+.|+|.+|+|+..-|..|..
T Consensus 282 snN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~----------------- 344 (498)
T KOG4237|consen 282 SNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQT----------------- 344 (498)
T ss_pred CCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccc-----------------
Confidence 555555555555555555555555555555444445555555555555555555333322222
Q ss_pred CCCCCCCCCCcccCCCCEEeCCCCcCccc-CChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCccccc--
Q 002717 284 PPGSSSSSSSTLFQTLRILDLSSNNLVGD-IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGS-- 360 (888)
Q Consensus 284 p~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-- 360 (888)
+..|..|+|-.|.+.-. --.+++.+ |..+.-.+. .....-..++.+.++.+.+...
T Consensus 345 ------------~~~l~~l~l~~Np~~CnC~l~wl~~W-------lr~~~~~~~--~~Cq~p~~~~~~~~~dv~~~~~~c 403 (498)
T KOG4237|consen 345 ------------LFSLSTLNLLSNPFNCNCRLAWLGEW-------LRKKSVVGN--PRCQSPGFVRQIPISDVAFGDFRC 403 (498)
T ss_pred ------------cceeeeeehccCcccCccchHHHHHH-------HhhCCCCCC--CCCCCCchhccccchhcccccccc
Confidence 22233333333322210 00111111 000110000 1122223444555554444311
Q ss_pred -CCcccc---------ccCCCceE-EccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcc
Q 002717 361 -IPQEVC---------ESRSLGIL-QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 429 (888)
Q Consensus 361 -~~~~~~---------~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 429 (888)
.|++.+ ..+-+..+ ..|++.++ .+|..+. ..-.+|++.+|.++ .+|.+ .+.+| .+|+++|++
T Consensus 404 ~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i 476 (498)
T KOG4237|consen 404 GGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRI 476 (498)
T ss_pred CCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCce
Confidence 111111 12223322 33444444 5555443 34567788888887 67776 66677 888888888
Q ss_pred eecCCccccccCCCCeeeccCC
Q 002717 430 SGEIPQELGKLASLLAVNVSYN 451 (888)
Q Consensus 430 ~~~~p~~~~~l~~L~~l~ls~N 451 (888)
+..--..|.+|+.|.+|-+|+|
T Consensus 477 ~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 477 SSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred ehhhcccccchhhhheeEEecC
Confidence 7666677888888888888876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=259.87 Aligned_cols=197 Identities=20% Similarity=0.350 Sum_probs=170.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--Ch-----HHHHHHHHHHhhcC---CCCcceeeeEEEcCC
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YP-----EDFEREVRVLGKAR---HPNLISLEGYYWTPQ 670 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~-----~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 670 (888)
|...+.+|+|+||.|+.|.++.+...|+||.+.++..-. +. -..-.|++||..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 777789999999999999999888999999986654321 11 12457999999997 999999999999999
Q ss_pred eeeEEEecC-CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 671 LKLLVSDYA-PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 671 ~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
.+|++||-. ++-+|.++|... +.+++.++..|+.||+-|+++||+. +|||||||-+||.++.+|-+|++|||
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred eeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 999999976 455899999875 6799999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 808 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~ 808 (888)
.|.....+. -..+.||.+|.|||++.+..+....-|||++|+++|-++....||.
T Consensus 716 saa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 987654322 2457899999999999666666788999999999999999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=258.54 Aligned_cols=202 Identities=23% Similarity=0.379 Sum_probs=169.6
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+.+.+.||-|+||+|.++.-..+...||.|.+.+.+.. ......+.|-+||..-..+=||+++-.|.+.+..|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 44566899999999999988767788999998766542 2345577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc----
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL---- 754 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~---- 754 (888)
++||++-++|-.. .-+.+..+..++..++.|+++.|.. |+|||||||+|||+|.+|.+||+|||++.-+
T Consensus 711 IPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999988775 4578888888999999999999998 9999999999999999999999999998532
Q ss_pred -----ccccc-------------------------------ccccccccccccccCcccccCcCCCCCcchHHHHHHHHH
Q 002717 755 -----TRLDK-------------------------------HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLIL 798 (888)
Q Consensus 755 -----~~~~~-------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ 798 (888)
..++. ........||+.|+|||++ ....++..+|.||.|||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl-~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL-ARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh-cccCccccchhhHhhHHHH
Confidence 11110 0011234689999999998 4456899999999999999
Q ss_pred HHHhCCCCCCCC
Q 002717 799 ELVTGRRPVEYG 810 (888)
Q Consensus 799 elltg~~p~~~~ 810 (888)
||+.|+.||...
T Consensus 863 em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 863 EMLVGQPPFLAD 874 (1034)
T ss_pred HHhhCCCCccCC
Confidence 999999999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=236.39 Aligned_cols=213 Identities=35% Similarity=0.524 Sum_probs=183.4
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCHHH
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQA 686 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 686 (888)
||+|++|.||++....+++.+++|++.........+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999877999999998655432234779999999999999999999999999889999999999999999
Q ss_pred HHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC-CCCcEEeccccccccccccccccccc
Q 002717 687 KLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLDKHVMSNR 765 (888)
Q Consensus 687 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 765 (888)
++.... ..+++..++.++.++++++.|||+. +++|+||+|.||+++. ++.++++|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 998642 4588999999999999999999998 9999999999999998 89999999999976543221 1233
Q ss_pred ccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhh
Q 002717 766 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 845 (888)
Q Consensus 766 ~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 845 (888)
..+...|++||........+.++|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 45677899999884433778999999999999999
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 846 VLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 846 ~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246789999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=232.90 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=189.6
Q ss_pred CChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeE-EEcCCee
Q 002717 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGY-YWTPQLK 672 (888)
Q Consensus 595 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~ 672 (888)
.+-.+.|.+.+.+|+|.||.+-+++++++.+.+++|.+..... ..++|.+|..---.+ .|.||+.-+++ |...+.+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3456788999999999999999999999999999998865543 358899998876556 48999987665 5667778
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec--CCCCcEEecccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNYNPRISDFGL 750 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~~~kl~Dfgl 750 (888)
++++||++.|+|.+-+... .+.+....+++.|+++|+.|||++ .+||||||.+|||+- +..++|+||||.
T Consensus 98 vF~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEeeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence 8999999999999888763 477788899999999999999999 999999999999994 445899999999
Q ss_pred cccccccccccccccccccccccCcccccC----cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHh
Q 002717 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQ----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826 (888)
Q Consensus 751 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~ 826 (888)
++..+.. ......+..|.|||.... .....+.+|||.||+++|.++||..||...-..+....+|.+ +.
T Consensus 170 t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~--w~ 242 (378)
T KOG1345|consen 170 TRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ--WL 242 (378)
T ss_pred ccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH--Hh
Confidence 9754421 123344567999996522 234567899999999999999999999754222222223222 11
Q ss_pred cCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHH
Q 002717 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAE 869 (888)
Q Consensus 827 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 869 (888)
.+ ..+.+++.-......+.++.++-+.++|++|=-..+
T Consensus 243 ~r-----k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 243 KR-----KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred cc-----cCccCchhhcccCHHHHHHHHHhcCCcccccchhHH
Confidence 11 112333322233445778889999999999933333
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=244.48 Aligned_cols=132 Identities=23% Similarity=0.277 Sum_probs=113.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-----C---CCcceeeeEEEc--
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-----H---PNLISLEGYYWT-- 668 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 668 (888)
..|.+.++||.|.|++||++.+.+..+.||+|+.+... ...+....||+++++++ | .+||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 45778889999999999999999999999999986443 34567789999999994 3 379999999864
Q ss_pred --CCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEe
Q 002717 669 --PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 737 (888)
Q Consensus 669 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 737 (888)
+.+.++|+|++ |.+|..+|.... -..++...+.+|++||+.||.|||.+| +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999999 668888888753 345788899999999999999999998 99999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=263.57 Aligned_cols=257 Identities=26% Similarity=0.355 Sum_probs=202.8
Q ss_pred ChhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEE
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 675 (888)
+|.+.|+....+|+|.||.||++++..+++..|+|.++-... ...+..++|+-+++..+|||||.++|-+...+..+++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 577788889999999999999999999999999999865432 2345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
||||.+|+|.+.-+-. .++++.++..+.+...+|+.|||+. +-+|||||-.||++++.|.+|++|||.+..+.
T Consensus 91 MEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 9999999998876653 5789999999999999999999998 88999999999999999999999999987654
Q ss_pred ccccccccccccccccccCccccc--CcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccc
Q 002717 756 RLDKHVMSNRFQSALGYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 756 ~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
. .-.....+.||+.|||||+.. ....|..++|||+.|++..|+---+.|..+... ..+-.+... ..
T Consensus 164 a--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~LmTk----S~ 231 (829)
T KOG0576|consen 164 A--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFLMTK----SG 231 (829)
T ss_pred h--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHHhhc----cC
Confidence 2 222235678999999999753 234678999999999999999877777533211 111111111 11
Q ss_pred cCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 872 (888)
+++-..+-...-..-+.++++.|+..+|++|||++.++.
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 222111112223345789999999999999999987665
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=235.73 Aligned_cols=258 Identities=24% Similarity=0.280 Sum_probs=193.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecC-CccCChHHHHHHHHHHhhcCCCCcceeeeEEEcC------Ceee
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTS-DIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QLKL 673 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 673 (888)
|...+.+|.|.- .|..|.+.-.++.||+|++... ......+...+|...+..+.|+||++++.++.-. .+.|
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 444557888888 7888888778999999987544 2233456778999999999999999999998643 3458
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+||||| .++|...+... ++-.++..+..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+.
T Consensus 98 ~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 98 LVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 999999 55888888853 66688899999999999999999 999999999999999999999999999985
Q ss_pred ccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHH-------------
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH------------- 820 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~------------- 820 (888)
... ..+.+....|..|.|||++.+.+ +.+.+||||.||++.||++|+.-|.+ ++.-+++-+.
T Consensus 168 e~~---~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g-~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 168 EDT---DFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPG-KDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cCc---ccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecC-chHHHHHHHHHHHhcCCCHHHHH
Confidence 432 22335566788899999986655 89999999999999999999988863 2222222221
Q ss_pred -----HHHHHhcCCccc--ccCCCCCC--------CChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 821 -----VRVLLEEGNVLD--CVDPSMGD--------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 821 -----~~~~~~~~~~~~--~~d~~~~~--------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
++...+...... .+...+++ .+.-....+..++.+|+-.+|++|.|+++++++-
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 111111110000 01111111 1223345577899999999999999999999864
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-30 Score=257.66 Aligned_cols=385 Identities=24% Similarity=0.271 Sum_probs=276.7
Q ss_pred CccccccccccccCc--ccccCCcCeEecCCCcccccCCchhhccCCCCccEE-EcCCCCCcCCCchhhhccCCCCcEEE
Q 002717 2 TTPLVHGNSYNAIPS--MVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFL-DLSNNLLSGPVPYQLFENCASLRYLS 78 (888)
Q Consensus 2 ~~l~l~~n~~~~ip~--~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L-~Ls~N~l~~~~~~~~f~~l~~L~~L~ 78 (888)
+.++|.-|+|++||. |..+.+|++||||+|+|+.+-|.+|.+| .+|..| ++++|+|+ .+|.++|+++.+|+.|.
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL--~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGL--ASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLL 146 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhh--HhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHh
Confidence 568899999999995 7789999999999999999999999998 565554 55559998 99999999999999999
Q ss_pred cCCccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccc------------cccCCccccC
Q 002717 79 LAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLF------------SGSIPQGVAA 146 (888)
Q Consensus 79 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l------------~~~~~~~~~~ 146 (888)
+.-|++.-+..++|..+++|..|.|..|.+..+.. .+|..+..++.+.+..|.+ ....|..+++
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~----~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsg 222 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICK----GTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSG 222 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhcc----ccccchhccchHhhhcCccccccccchhhhHHhhchhhccc
Confidence 99999999999999999999999999999985433 4788999999999999882 2233333444
Q ss_pred CCCCCEEEccCcccc-------------------------ccCC-CCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcE
Q 002717 147 LHYLKELLLQGNQFS-------------------------GPLP-ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200 (888)
Q Consensus 147 l~~L~~L~L~~n~l~-------------------------~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 200 (888)
..-..-..+..+++. .+-| ..|..+++|+.|+|++|+|+.+-+.+|.++..++.
T Consensus 223 arc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~e 302 (498)
T KOG4237|consen 223 ARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQE 302 (498)
T ss_pred ceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhh
Confidence 332222222222221 1222 34778999999999999999999999999999999
Q ss_pred EEeecCcccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCccc
Q 002717 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFM 280 (888)
Q Consensus 201 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~ 280 (888)
|.|..|+|..+....|.++..|+.|+|.+|+|+..-|.+|..+..|.+|+|-.|++....--.+..- .|..++-.
T Consensus 303 L~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-----Wlr~~~~~ 377 (498)
T KOG4237|consen 303 LYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-----WLRKKSVV 377 (498)
T ss_pred hhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-----HHhhCCCC
Confidence 9999999998888899999999999999999999999999999999999999999874322111110 11222212
Q ss_pred ccCCCCCCCCCCCcccCCCCEEeCCCCcCccc---CChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcc
Q 002717 281 GSIPPGSSSSSSSTLFQTLRILDLSSNNLVGD---IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 357 (888)
Q Consensus 281 ~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 357 (888)
| .|+... ...++.+.++++.+... .|.+.+. .-.+.-|+....+. +....|+..+
T Consensus 378 ~-~~~Cq~-------p~~~~~~~~~dv~~~~~~c~~~ee~~~------------~~s~~cP~~c~c~~--tVvRcSnk~l 435 (498)
T KOG4237|consen 378 G-NPRCQS-------PGFVRQIPISDVAFGDFRCGGPEELGC------------LTSSPCPPPCTCLD--TVVRCSNKLL 435 (498)
T ss_pred C-CCCCCC-------CchhccccchhccccccccCCccccCC------------CCCCCCCCCcchhh--hhHhhcccch
Confidence 2 222111 12456666666554321 1221111 11112222222221 1223444444
Q ss_pred cccCCccccccCCCceEEccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCC
Q 002717 358 YGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 427 (888)
Q Consensus 358 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 427 (888)
+ .+|..+ ...-++|++.+|.++ .+|.. .+..| .+|||+|+++..---.|.+|++|.+|-|++|
T Consensus 436 k-~lp~~i--P~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 436 K-LLPRGI--PVDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred h-hcCCCC--CchhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 4 455443 234567788888888 66665 56677 7888888887656667888888888888776
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=242.04 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=205.4
Q ss_pred hhhhhhhcCeeccccceEEEEEEECC---CCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCee
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGT---QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 672 (888)
..+.|....+||+|.|++||++.+.. ..+.||+|.+... ..+..+..|++++..+ .+.||+++.+++...+..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t---s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT---SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc---cCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34557778899999999999999976 6789999988544 3567899999999999 599999999999999999
Q ss_pred eEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec-CCCCcEEeccccc
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLA 751 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfgla 751 (888)
.+|+||+++....++... ++...+..+++.+..||.|+|.. |||||||||.|++++ ..+.-.|.|||+|
T Consensus 111 ~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred EEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 999999999998888876 56788899999999999999999 999999999999998 5577899999999
Q ss_pred ccccccc---------------------------------cccc---------cccccccccccCcccccCcCCCCCcch
Q 002717 752 RLLTRLD---------------------------------KHVM---------SNRFQSALGYVAPELTCQSLRVNEKCD 789 (888)
Q Consensus 752 ~~~~~~~---------------------------------~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~sD 789 (888)
....... .+.. .-...||+||.|||++......+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7321000 0000 012468999999999988888899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHh---------cCC--ccc---------------ccC-----C--
Q 002717 790 IYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE---------EGN--VLD---------------CVD-----P-- 836 (888)
Q Consensus 790 vwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~---------~~~--~~~---------------~~d-----~-- 836 (888)
|||.||++.-+++++.||....++...+.+.+..... .+. +.+ -++ +
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999998777666655554322111 111 000 000 0
Q ss_pred ----CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 837 ----SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 837 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
......+..+..++.++.+|+..||.+|.|++|++++-
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 00001122233578999999999999999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=230.41 Aligned_cols=200 Identities=33% Similarity=0.478 Sum_probs=170.1
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCC
Q 002717 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 603 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 682 (888)
..+.||+|++|.||+|....+++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45689999999999999987789999999865433224578899999999999999999999999988999999999999
Q ss_pred CHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccc
Q 002717 683 SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 762 (888)
Q Consensus 683 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~ 762 (888)
+|.+++.... ..+++..+..++.+++.++.|||+. +++|+|++|.||+++.++.++++|||.+......... .
T Consensus 83 ~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 83 DLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 9999998752 1178899999999999999999998 9999999999999999999999999999876543210 1
Q ss_pred cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 002717 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEY 809 (888)
Q Consensus 763 ~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~ 809 (888)
.....++..|++||.......++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 13345677899999874445677799999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-27 Score=243.79 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=200.3
Q ss_pred hhhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC------CCCcceeeeEEEcCC
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR------HPNLISLEGYYWTPQ 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~ 670 (888)
-...|.+....|+|-|++|.+|.+...|..||||++..... ..+.=++|+++|+++. --|+++++..|...+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34557777788999999999999998899999999976543 3455678999999995 348999999999999
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC-CCcEEeccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFG 749 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg 749 (888)
+.|+|+|-+ .-+|.+.+.... ....+...++..++.|+.-||.+|... +|+|.||||+||||++. ...||||||
T Consensus 508 HLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence 999999988 458999998863 345688899999999999999999987 99999999999999965 568999999
Q ss_pred ccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHH-------H
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV-------R 822 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~-------~ 822 (888)
.|....+.+. .....+..|.|||++ -+..|+...|+||.||++||+.||+.-|.....+.. +...+ .
T Consensus 583 SA~~~~enei----tPYLVSRFYRaPEIi-LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M-Lrl~me~KGk~p~ 656 (752)
T KOG0670|consen 583 SASFASENEI----TPYLVSRFYRAPEII-LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM-LRLFMELKGKFPN 656 (752)
T ss_pred cccccccccc----cHHHHHHhccCccee-ecCcccCCccceeeceeeEEeeccceecCCCCcHHH-HHHHHHhcCCCcH
Confidence 9987654332 222334569999998 566899999999999999999999999976433321 11111 1
Q ss_pred HHHhcCCc---------------------------ccccCCC------C---CCCChh---hHHHHHHHHHHccCCCCCC
Q 002717 823 VLLEEGNV---------------------------LDCVDPS------M---GDYPED---EVLPVLKLALVCTCHIPSS 863 (888)
Q Consensus 823 ~~~~~~~~---------------------------~~~~d~~------~---~~~~~~---~~~~l~~li~~cl~~dp~~ 863 (888)
.+++.+.+ +..+.|. + +.++.+ ....+..|+..|+..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 11111111 1111110 0 002223 3345778999999999999
Q ss_pred CCCHHHHHHH
Q 002717 864 RPSMAEVVQI 873 (888)
Q Consensus 864 RPs~~evl~~ 873 (888)
|.|..|++.+
T Consensus 737 Rit~nqAL~H 746 (752)
T KOG0670|consen 737 RITVNQALKH 746 (752)
T ss_pred cCCHHHHhcC
Confidence 9999999875
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=268.02 Aligned_cols=349 Identities=22% Similarity=0.262 Sum_probs=175.1
Q ss_pred CchhhhccCCCCcEEEcCCcccc------ccccccccCC-CCCCEEECcCcccccccCccccccccccccCcEEEcCCcc
Q 002717 63 VPYQLFENCASLRYLSLAGNILQ------GPIGKIFNYC-SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNL 135 (888)
Q Consensus 63 ~~~~~f~~l~~L~~L~L~~N~l~------~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~ 135 (888)
+...+|.++++|+.|.+..+... ...+..|..+ .+|+.|++.+|.++..|.. | ...+|+.|+|++|+
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~-----f-~~~~L~~L~L~~s~ 622 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSN-----F-RPENLVKLQMQGSK 622 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCc-----C-CccCCcEEECcCcc
Confidence 34455666666666666544321 1111223333 2466666666655544331 1 24556666666666
Q ss_pred ccccCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcC
Q 002717 136 FSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHW 215 (888)
Q Consensus 136 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 215 (888)
+. .++.++..+++|++|+|++|.....+|. +..+++|++|+|++|.....+|..+..+++|+.|++++|..-..+|..
T Consensus 623 l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~ 700 (1153)
T PLN03210 623 LE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG 700 (1153)
T ss_pred cc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc
Confidence 55 3455555566666666655543323442 555566666666655444455555555666666666554322234433
Q ss_pred cccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCcccccCCCCCCCCCCCcc
Q 002717 216 IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTL 295 (888)
Q Consensus 216 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~ 295 (888)
+ ++++|+.|++++|.....+|.. .++|+.|++++|.+. .+|..+.-.+|..|++.++.... +.
T Consensus 701 i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~-l~----------- 763 (1153)
T PLN03210 701 I-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEK-LW----------- 763 (1153)
T ss_pred C-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhh-cc-----------
Confidence 3 4555566665555433333322 234555555555554 34433322233333333321100 00
Q ss_pred cCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceEE
Q 002717 296 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 375 (888)
Q Consensus 296 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 375 (888)
+.+....+..+...++|+.|+|++|.....+|..++++++|+.|+|++|..-+.+|..+ .+++|+.|+
T Consensus 764 -----------~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~ 831 (1153)
T PLN03210 764 -----------ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLD 831 (1153)
T ss_pred -----------ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEE
Confidence 00111111122233456666666665555555556666666666666553333455444 456666666
Q ss_pred ccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeeccCCc
Q 002717 376 LDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNR 452 (888)
Q Consensus 376 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~ 452 (888)
|++|.....+|.. .++|+.|+|++|.|+ .+|.++..+++|+.|+|++|+-...+|..+..++.|+.++++++.
T Consensus 832 Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 832 LSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 6665443344432 245666666666666 566666666666666666633222466666666666666666653
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=217.61 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=190.0
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGS 683 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 683 (888)
.+|.+...|+.|+|+|. |..+++|++.-.+.. ....+|..|.-.++-+.||||+.++|.|..+....++..||+.|+
T Consensus 196 tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 36889999999999994 666777877433322 234679999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccccc
Q 002717 684 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS 763 (888)
Q Consensus 684 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~ 763 (888)
|+..+++. .+...+-.++.++|.++|+|++|||+. .|-|.---+.+..|++|++.+++|+- +-+++.. ..
T Consensus 274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf------qe 343 (448)
T KOG0195|consen 274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF------QE 343 (448)
T ss_pred HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee------ec
Confidence 99999986 455678889999999999999999986 55566667999999999999988751 1111111 11
Q ss_pred ccccccccccCcccccCcCCC--CCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 764 NRFQSALGYVAPELTCQSLRV--NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 764 ~~~~g~~~y~aPE~~~~~~~~--~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
....-.+.||+||.+...... -.++|+|||++++||+.|+..||.....-+ -.++..++ .+ ....
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme----cgmkiale------gl---rv~i 410 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME----CGMKIALE------GL---RVHI 410 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh----hhhhhhhc------cc---cccC
Confidence 233446789999988443222 258999999999999999999997642211 11111111 11 1134
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
|+.....+.++|.-|+..||.+||.+..++-.|+++.
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 5666667889999999999999999999999998864
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=266.61 Aligned_cols=338 Identities=20% Similarity=0.200 Sum_probs=224.5
Q ss_pred cccccccCcEEEcCCcc------ccccCCccccCCC-CCCEEEccCccccccCCCCCCCCCCCCEEEccCCccCcCCChh
Q 002717 119 GIWSLKRLRTLDLSHNL------FSGSIPQGVAALH-YLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVS 191 (888)
Q Consensus 119 ~~~~l~~L~~L~Ls~n~------l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 191 (888)
+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| .+.+|+.|+|.+|++. .++..
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence 34455555555554332 1222344444442 4666666666655 444444 3456666666666665 34455
Q ss_pred hhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCce
Q 002717 192 LRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEE 271 (888)
Q Consensus 192 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~ 271 (888)
+..+++|+.|+|++|.....+|. +..+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|..+...+|+.
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~ 708 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYR 708 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCE
Confidence 55666666666665543334443 55566666666666554445666666666666666666544445555543335666
Q ss_pred EEcccCcccccCCCCCCCCCCCcccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccc-------cCCCCCcccC
Q 002717 272 IDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR-------SRIPPELGYF 344 (888)
Q Consensus 272 L~l~~N~l~~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------~~~~~~~~~l 344 (888)
|++++|...+.+|.. ..+|+.|++++|.+. .+|..+ .+++|++|++.++... ...+..+...
T Consensus 709 L~Lsgc~~L~~~p~~---------~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~ 777 (1153)
T PLN03210 709 LNLSGCSRLKSFPDI---------STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLS 777 (1153)
T ss_pred EeCCCCCCccccccc---------cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcc
Confidence 666666555555432 356788888888876 566554 5778888888774322 1122233445
Q ss_pred CcceEEEcccCcccccCCccccccCCCceEEccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEc
Q 002717 345 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL 424 (888)
Q Consensus 345 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 424 (888)
++|+.|+|++|...+.+|..+.++++|+.|++++|..-+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 789999999998887899999999999999999986545788766 7999999999998665566653 468999999
Q ss_pred cCCcceecCCccccccCCCCeeeccC-CcceecCCCCCCCCCCCCCCcCCCcC
Q 002717 425 EFNELSGEIPQELGKLASLLAVNVSY-NRLIGRLPVGGVFPTLDQSSLQGNLG 476 (888)
Q Consensus 425 ~~N~l~~~~p~~~~~l~~L~~l~ls~-N~l~~~~p~~~~~~~l~~~~~~~n~~ 476 (888)
++|.++ .+|.++..+++|+.|++++ |+|++.++....+..+..+.+.+...
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~ 905 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGA 905 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCcc
Confidence 999998 7899999999999999999 67776555566677777777765543
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=246.88 Aligned_cols=265 Identities=27% Similarity=0.276 Sum_probs=136.8
Q ss_pred ccEEEcCCCCCcCCCchhhhccCCCCcEEEcCCccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcE
Q 002717 49 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 128 (888)
Q Consensus 49 L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~ 128 (888)
-..|+|++|.++ .+|..+. ++|+.|++++|+|+.++. ..++|++|+|++|+|+.++. ..++|+.
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt~LP~----lp~~Lk~LdLs~N~LtsLP~--------lp~sL~~ 266 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSLPV--------LPPGLLE 266 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCCCCCC----CCCCCcEEEecCCccCcccC--------cccccce
Confidence 456666666666 5665432 356666666666665543 13566666666666664432 1245566
Q ss_pred EEcCCccccccCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcc
Q 002717 129 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 208 (888)
Q Consensus 129 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 208 (888)
|+|++|.++. +|.. ..+|+.|++++|+|+. +|.. +++|+.|+|++|+|+++ |.. ..+
T Consensus 267 L~Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~L-p~l---p~~----------- 323 (788)
T PRK15387 267 LSIFSNPLTH-LPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PAL---PSE----------- 323 (788)
T ss_pred eeccCCchhh-hhhc---hhhcCEEECcCCcccc-cccc---ccccceeECCCCccccC-CCC---ccc-----------
Confidence 6666666652 3322 1345555566665552 2321 24555555555555532 211 122
Q ss_pred cccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCcccccCCCCCC
Q 002717 209 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSS 288 (888)
Q Consensus 209 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~~p~~~~ 288 (888)
|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|..
T Consensus 324 -------------L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l------------------------- 360 (788)
T PRK15387 324 -------------LCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL------------------------- 360 (788)
T ss_pred -------------ccccccccCcccc-cccc---ccccceEecCCCccC-CCCCC-------------------------
Confidence 3444444444442 2221 123444444444444 12210
Q ss_pred CCCCCcccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCcccccc
Q 002717 289 SSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES 368 (888)
Q Consensus 289 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 368 (888)
..+|+.|++++|+|+ .+|.. ..+|+.|++++|+|++ +|.. .++|+.|++++|+|+ .+|.. .
T Consensus 361 -------p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l---~ 421 (788)
T PRK15387 361 -------PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPML---P 421 (788)
T ss_pred -------Ccccceehhhccccc-cCccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcc---h
Confidence 012333344444443 22321 1345555555555543 2221 235666677777766 34543 2
Q ss_pred CCCceEEccCCcCCCccCccccccccccEEEccCCcccccCCccccC
Q 002717 369 RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISN 415 (888)
Q Consensus 369 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 415 (888)
.+|+.|++++|+|+ .+|..|.++++|+.|+|++|+|++..|..+..
T Consensus 422 ~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 422 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 35667778888877 67777777888888888888888776666643
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=247.12 Aligned_cols=260 Identities=31% Similarity=0.365 Sum_probs=144.3
Q ss_pred CcEEEcCCccccccCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeec
Q 002717 126 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 205 (888)
Q Consensus 126 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 205 (888)
-..|+|++|.++ .+|..+. .+|+.|++.+|+|+. +|.. +++|++|+|++|+|+.+ |. ..++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~LtsL-P~---lp~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTSL-PV---LPPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCcc-cC---cccccceeeccC
Confidence 455666666665 3444443 256666666666653 3321 35566666666666533 22 124555555555
Q ss_pred CcccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCcccccCCC
Q 002717 206 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPP 285 (888)
Q Consensus 206 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~~p~ 285 (888)
|.++. +|.. .++|+.|++++|+|+. +|.. .++|+.|+|++|+|++ +|..
T Consensus 272 N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~l---------------------- 320 (788)
T PRK15387 272 NPLTH-LPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL---------------------- 320 (788)
T ss_pred Cchhh-hhhc---hhhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCC----------------------
Confidence 55552 3322 1345555555555552 3321 2445555555555552 2321
Q ss_pred CCCCCCCCcccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccc
Q 002717 286 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 365 (888)
Q Consensus 286 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 365 (888)
..+|+.|++++|++++ +|.. ..+|++|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|..
T Consensus 321 ----------p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l- 380 (788)
T PRK15387 321 ----------PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL- 380 (788)
T ss_pred ----------cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc-
Confidence 1234555555555552 3321 1356666666666654 2322 234566666666666 34432
Q ss_pred cccCCCceEEccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCe
Q 002717 366 CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLA 445 (888)
Q Consensus 366 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 445 (888)
..+|+.|+|++|+|++ +|... ++|+.|++++|+|+ .+|..+ .+|+.|++++|+|+ .+|..++++++|+.
T Consensus 381 --~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~ 449 (788)
T PRK15387 381 --PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETT 449 (788)
T ss_pred --ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCe
Confidence 2456777777777763 44332 46777777777777 355432 35667777777776 67777777777777
Q ss_pred eeccCCcceecCC
Q 002717 446 VNVSYNRLIGRLP 458 (888)
Q Consensus 446 l~ls~N~l~~~~p 458 (888)
|+|++|+|+|.+|
T Consensus 450 LdLs~N~Ls~~~~ 462 (788)
T PRK15387 450 VNLEGNPLSERTL 462 (788)
T ss_pred EECCCCCCCchHH
Confidence 7777777777666
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=211.27 Aligned_cols=168 Identities=23% Similarity=0.272 Sum_probs=127.4
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|+|.++++.. +..+++.+++.++.|+++||.|||+. + ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc----
Confidence 6899999864 34699999999999999999999988 5 999999999999999 9998765431
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
...|++.|||||++ .+..++.++|||||||++|||+||+.||.........+....... .. .++.....
T Consensus 63 ---~~~g~~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~ 131 (176)
T smart00750 63 ---QSRVDPYFMAPEVI-QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM----PA---DDPRDRSN 131 (176)
T ss_pred ---cCCCcccccChHHh-cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh----cc---CCcccccc
Confidence 22578999999998 556789999999999999999999999965433222222222111 10 11111111
Q ss_pred ChhhHH--HHHHHHHHccCCCCCCCCCHHHHHHHHHhhc
Q 002717 842 PEDEVL--PVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 842 ~~~~~~--~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 878 (888)
+..... .+.+++.+||..+|++|||+.|+++++..+.
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 222222 5889999999999999999999999997764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-24 Score=262.83 Aligned_cols=198 Identities=20% Similarity=0.185 Sum_probs=138.5
Q ss_pred cCC-CCcceeeeEE-------EcCCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCe
Q 002717 654 ARH-PNLISLEGYY-------WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725 (888)
Q Consensus 654 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 725 (888)
++| +||+++++++ ......+.++||+ +++|.+++... ...+++.+++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 455 5777888876 2334567788887 66999999753 34589999999999999999999998 99
Q ss_pred EecCCCCCcEEecC-------------------CCCcEEeccccccccccccc--------c------cccccccccccc
Q 002717 726 IHYNLKPSNILLDD-------------------NYNPRISDFGLARLLTRLDK--------H------VMSNRFQSALGY 772 (888)
Q Consensus 726 vHrdlk~~Nill~~-------------------~~~~kl~Dfgla~~~~~~~~--------~------~~~~~~~g~~~y 772 (888)
+||||||+|||++. ++.+|++|||+++....... . .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45566777777654221000 0 000123578889
Q ss_pred cCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHH
Q 002717 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKL 852 (888)
Q Consensus 773 ~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l 852 (888)
||||++ .+..++.++|||||||++|||++|..|+..... ........ ...+. ..........+
T Consensus 182 ~APE~~-~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~---------~~~~~----~~~~~~~~~~~ 244 (793)
T PLN00181 182 TSPEED-NGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHR---------VLPPQ----ILLNWPKEASF 244 (793)
T ss_pred EChhhh-ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHh---------hcChh----hhhcCHHHHHH
Confidence 999988 455689999999999999999998887642111 11111000 01110 01112345678
Q ss_pred HHHccCCCCCCCCCHHHHHHHHH
Q 002717 853 ALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 853 i~~cl~~dp~~RPs~~evl~~L~ 875 (888)
+.+||+++|.+||||.|++++-.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHhCCCChhhCcChHHHhhchh
Confidence 89999999999999999988653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=214.54 Aligned_cols=164 Identities=21% Similarity=0.209 Sum_probs=125.8
Q ss_pred hhhhhcCeeccccceEEEEEEECC-CCeEEEEEEeecCCc----cCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeee
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDI----IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 673 (888)
..|+..+.||+|+||+||+|.+.. +++.||||++..... ....+.|.+|++++++++|+|+++.+.. .+..+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 447778899999999999999875 678889998753211 1224568999999999999999853322 24579
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCC-CCCcEEecCCCCcEEecccccc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNL-KPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdl-k~~Nill~~~~~~kl~Dfgla~ 752 (888)
+||||+++++|.. +... . ...++.++++||.|+|+. +|+|||| ||+||+++.++.+||+|||+|+
T Consensus 95 LVmE~~~G~~L~~-~~~~-------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 95 LVRGWTEGVPLHL-ARPH-------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred EEEEccCCCCHHH-hCcc-------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 9999999999962 2110 1 146788999999999998 9999999 9999999999999999999998
Q ss_pred cccccccccc------cccccccccccCccccc
Q 002717 753 LLTRLDKHVM------SNRFQSALGYVAPELTC 779 (888)
Q Consensus 753 ~~~~~~~~~~------~~~~~g~~~y~aPE~~~ 779 (888)
.+.+...... -....+++.|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 7654321111 13456788899999873
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-20 Score=200.36 Aligned_cols=263 Identities=19% Similarity=0.211 Sum_probs=194.7
Q ss_pred hhhhcCeeccccceEEEEEEECCCC-eEEEEEEeecCCccCChHHHHHHHHHHhhcCC----CCcceeeeEE-EcCCeee
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQG-RMLAVKKLVTSDIIQYPEDFEREVRVLGKARH----PNLISLEGYY-WTPQLKL 673 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~ 673 (888)
.|++.+.||+|+||.||.|....++ ..+|+|........... .+..|..++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 5778889999999999999987554 67888877554333222 67889999998862 6888999888 4677789
Q ss_pred EEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC-----CCcEEecc
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-----YNPRISDF 748 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-----~~~kl~Df 748 (888)
+||+.+ |.+|.++..... ...++..+..+++.|++.+|.++|+. |++||||||.|+.+... ..+.+.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999988 779999776653 56799999999999999999999998 99999999999999854 46899999
Q ss_pred ccccccc--cccc----ccc--cccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHH
Q 002717 749 GLARLLT--RLDK----HVM--SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 820 (888)
Q Consensus 749 gla~~~~--~~~~----~~~--~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~ 820 (888)
|+++... .... ..+ .....||..|.++... .+...+.+.|+||++.++.|+..|..||......... ..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H-~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~--~~ 248 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH-LGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK--SK 248 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHh-CCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH--HH
Confidence 9998332 1111 111 1345699999999987 6667899999999999999999999999665432221 11
Q ss_pred HHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 821 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 821 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
+........ ... .....+..+.++...+-..+..++|....+...++.....
T Consensus 249 ~~~~~~~~~----~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 249 FEKDPRKLL----TDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHhhhhc----ccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 111111100 000 1222334456666666668999999999999988766443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-22 Score=230.06 Aligned_cols=260 Identities=16% Similarity=0.165 Sum_probs=192.6
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEee----cCCcc-CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLV----TSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 603 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~----~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
..+.+|.|++|.|+.+......+..+.|... ..... .....+..|+.+-..+.|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3457999999988888876666666666543 11111 111225668888888899999988888777776666799
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
||++ +|..++... ..+...++..++.|+..|+.|+|+. ||.|||+|++|++++.++.+||+|||.+....-.
T Consensus 402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 999998764 3578888999999999999999999 9999999999999999999999999998765433
Q ss_pred ccc--cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccC
Q 002717 758 DKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 758 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
... .......|+-.|+|||+......-....||||.|+++..|.+|+.||............. ....+.. +.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----~~~~~~~--~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----NYSDQRN--IF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----ccccccc--cc
Confidence 332 444677889999999998555555678899999999999999999998764443321000 0000000 00
Q ss_pred CCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
..........+.....+|.++++.||.+|.|+.+|++.=|.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 11111233445567789999999999999999999986554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=228.47 Aligned_cols=286 Identities=23% Similarity=0.316 Sum_probs=140.3
Q ss_pred ccEEEcCCCCCcCCCchhhhccCCCCcEEEcCCccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcE
Q 002717 49 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 128 (888)
Q Consensus 49 L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~ 128 (888)
...|+|++++++ .+|..+ .++|+.|+|++|+|+.++...+ ++|++|+|++|++++++.. + ..+|+.
T Consensus 180 ~~~L~L~~~~Lt-sLP~~I---p~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~LtsLP~~-----l--~~~L~~ 245 (754)
T PRK15370 180 KTELRLKILGLT-TIPACI---PEQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLTSIPAT-----L--PDTIQE 245 (754)
T ss_pred ceEEEeCCCCcC-cCCccc---ccCCcEEEecCCCCCcCChhhc---cCCCEEECCCCccccCChh-----h--hccccE
Confidence 344444444444 344322 1334444444444444443322 2444445554444433221 1 124555
Q ss_pred EEcCCccccccCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcc
Q 002717 129 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 208 (888)
Q Consensus 129 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 208 (888)
|+|++|+++ .+|..+. .+|+.|++++|+|+ .+|..+. ++|+.|+|++|+++.. |..+. .+|+.|++++|++
T Consensus 246 L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~L 316 (754)
T PRK15370 246 MELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSL 316 (754)
T ss_pred EECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccC-cccch--hhHHHHHhcCCcc
Confidence 555555554 3333332 24555555555555 2343332 3566666666666532 22221 3566666666666
Q ss_pred cccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCcccccCCCCCC
Q 002717 209 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSS 288 (888)
Q Consensus 209 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~~p~~~~ 288 (888)
+. +|..+ .++|+.|++++|.++. +|..+. ++|+.|++++|+|+ .+|..+.
T Consensus 317 t~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp----------------------- 366 (754)
T PRK15370 317 TA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP----------------------- 366 (754)
T ss_pred cc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc-----------------------
Confidence 63 33322 2467777777777774 455443 57777777777776 3443221
Q ss_pred CCCCCcccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCC----cccCCcceEEEcccCcccccCCcc
Q 002717 289 SSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE----LGYFHSLIHLDLRNNALYGSIPQE 364 (888)
Q Consensus 289 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~ 364 (888)
++|+.|+|++|+++ .+|..+. ..|+.|++++|+|++ +|.. ++.++++..|+|.+|.++.
T Consensus 367 --------~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~----- 429 (754)
T PRK15370 367 --------PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE----- 429 (754)
T ss_pred --------CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH-----
Confidence 23555555555555 3344332 246666666666653 3332 2334567777777777752
Q ss_pred ccccCCCceEEccCCcCCC-ccCccccccccccEEEccCCccc
Q 002717 365 VCESRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLS 406 (888)
Q Consensus 365 ~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~ 406 (888)
..+.+|+.| ++.+.+.| .++..++.+.+++....-++.+.
T Consensus 430 -~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~ 470 (754)
T PRK15370 430 -RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQ 470 (754)
T ss_pred -HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHh
Confidence 233444444 34444443 23334444455554443444444
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=227.61 Aligned_cols=291 Identities=23% Similarity=0.341 Sum_probs=216.9
Q ss_pred CCCcEEEcCCccccccccccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCC
Q 002717 72 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLK 151 (888)
Q Consensus 72 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 151 (888)
.+...|++++++++.++... .++|+.|+|++|+|++++... .++|+.|+|++|+++ .+|..+. .+|+
T Consensus 178 ~~~~~L~L~~~~LtsLP~~I---p~~L~~L~Ls~N~LtsLP~~l-------~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~ 244 (754)
T PRK15370 178 NNKTELRLKILGLTTIPACI---PEQITTLILDNNELKSLPENL-------QGNIKTLYANSNQLT-SIPATLP--DTIQ 244 (754)
T ss_pred cCceEEEeCCCCcCcCCccc---ccCCcEEEecCCCCCcCChhh-------ccCCCEEECCCCccc-cCChhhh--cccc
Confidence 45789999999999988654 357999999999999765421 258999999999998 4566554 4799
Q ss_pred EEEccCccccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccc
Q 002717 152 ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 231 (888)
Q Consensus 152 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 231 (888)
.|+|++|++. .+|..+. .+|+.|++++|+|+. +|..+. .+|+.|+|++|++++ +|..+. ++|+.|++++|.
T Consensus 245 ~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~ 315 (754)
T PRK15370 245 EMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNS 315 (754)
T ss_pred EEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCc
Confidence 9999999998 5666553 589999999999995 565553 589999999999995 554443 479999999999
Q ss_pred cCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCcccccCCCCCCCCCCCcccCCCCEEeCCCCcCcc
Q 002717 232 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 311 (888)
Q Consensus 232 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~ 311 (888)
++. +|..+. ++|+.|++++|.+++ +|..+ .++|+.|++++|+|+
T Consensus 316 Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l-------------------------------~~sL~~L~Ls~N~L~- 359 (754)
T PRK15370 316 LTA-LPETLP--PGLKTLEAGENALTS-LPASL-------------------------------PPELQVLDVSKNQIT- 359 (754)
T ss_pred ccc-CCcccc--ccceeccccCCcccc-CChhh-------------------------------cCcccEEECCCCCCC-
Confidence 994 555443 689999999998873 44321 246889999999988
Q ss_pred cCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCcccc----ccCCCceEEccCCcCCCccCc
Q 002717 312 DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC----ESRSLGILQLDGNSLTGPIPQ 387 (888)
Q Consensus 312 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~Ls~N~l~~~~p~ 387 (888)
.+|..+ .++|++|++++|+|+.+ |..+. .+|+.|++++|+|+ .+|..+. .++++..|+|.+|.++.
T Consensus 360 ~LP~~l--p~~L~~LdLs~N~Lt~L-P~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~---- 429 (754)
T PRK15370 360 VLPETL--PPTITTLDVSRNALTNL-PENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE---- 429 (754)
T ss_pred cCChhh--cCCcCEEECCCCcCCCC-CHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH----
Confidence 567655 36899999999999854 54443 37999999999998 5666543 45788999999999982
Q ss_pred cccccccccEEEccCCcccc-cCCccccCCCCCCeEEccCCcceecC
Q 002717 388 VIRNCTSLYLLSLSHNHLSG-SIPKSISNLNKLKILKLEFNELSGEI 433 (888)
Q Consensus 388 ~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~ 433 (888)
..+.+|+.| ++.+.+.| .++..++.+.+++....-.+.+.+.+
T Consensus 430 --~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~~Wl 473 (754)
T PRK15370 430 --RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQGWL 473 (754)
T ss_pred --HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHhccC
Confidence 345566666 44455543 34445556666665554455554433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-19 Score=197.50 Aligned_cols=261 Identities=27% Similarity=0.375 Sum_probs=197.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCC-CcceeeeEEEcCCeeeEEEe
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHP-NLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e 677 (888)
|+..+.+|.|+||.||++.+. ..+|+|.+....... ....+.+|+.+++.+.|+ +++++.+++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 345568999999999999986 778999987665444 367899999999999988 79999999977777899999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC-CcEEecccccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTR 756 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla~~~~~ 756 (888)
|+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777654211 3688889999999999999999998 899999999999999888 799999999985544
Q ss_pred ccccc----ccccccccccccCcccccCc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCc--hhhHHHHHHHHHhcC
Q 002717 757 LDKHV----MSNRFQSALGYVAPELTCQS--LRVNEKCDIYGFGVLILELVTGRRPVEYGEDN--VVILSEHVRVLLEEG 828 (888)
Q Consensus 757 ~~~~~----~~~~~~g~~~y~aPE~~~~~--~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~--~~~l~~~~~~~~~~~ 828 (888)
..... ......++..|+|||..... ...+...|+||+|++++++++|..||...... .......+. ...
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL---ELP 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH---hcC
Confidence 33221 23567889999999988443 57889999999999999999999997654331 111111111 111
Q ss_pred CcccccCCCCC-CCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002717 829 NVLDCVDPSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 829 ~~~~~~d~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 873 (888)
.. ....... .........+.+++..|+..+|..|.++.+....
T Consensus 232 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP--SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc--ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 0000000 0011223567789999999999999999987765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=176.44 Aligned_cols=261 Identities=15% Similarity=0.179 Sum_probs=189.4
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCC-CCcceeeeEEEcCCeeeEEEe
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH-PNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 677 (888)
..|.+.++||+|+||.+|.|....+|+.||||.-.... ..-+...|..+++.++| ..|..+..|..+.....+|||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 44677889999999999999999999999999753322 22457789999999975 667777778888888899999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC---CCCcEEecccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDFGLARLL 754 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfgla~~~ 754 (888)
.+ |.+|.+...-. ...++..+++..|-|+..-++|+|.+ +++||||||+|+|..- -..+.++|||+|+.+
T Consensus 92 LL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 98 77999988765 35689999999999999999999998 9999999999999963 345889999999877
Q ss_pred cccccc-----cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 755 TRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 755 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
.+.... .......||.+|.+--.. -+...+.+-|+=|+|.++..+--|..||.......... ..+. +.+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh-~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q--KyEk-I~EkK 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAH-LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ--KYEK-ISEKK 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhh-hhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH--HHHH-HHHhh
Confidence 543321 122345688888776544 23345778899999999999999999998764432211 1111 11111
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
..-.+..-..++ +.++.-.+.-|-..--++-|...-+.+.++.+
T Consensus 241 ~s~~ie~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 241 MSTPIEVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred cCCCHHHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 111111112223 34456677778777777788777666655443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=180.45 Aligned_cols=263 Identities=13% Similarity=0.112 Sum_probs=194.5
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCeeeEEEec
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
.|.++++||+|.||.++.|+.--+++.||||.-.... ..-++..|...++.+. .+.|...+-+..++-+..+|+|.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3678999999999999999998899999999743222 2346778899998884 68898888777777778899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC-----CCcEEeccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-----YNPRISDFGLARL 753 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-----~~~kl~Dfgla~~ 753 (888)
+ |.+|.++..-. +..++..++..+|.|+..-++|+|++ .+|.|||||+|+|+... ..+.+.|||+|+.
T Consensus 106 L-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 77999988765 46799999999999999999999999 99999999999999633 3589999999998
Q ss_pred ccccccc-----cccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcC
Q 002717 754 LTRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG 828 (888)
Q Consensus 754 ~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 828 (888)
+.+.++. .......||.+||+--.. -+..-+.+-|.=|+|-++++.+-|..||..-..+.. .+..+ .+.+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTH-lGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn--K~kYe-KIGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN--KEKYE-KIGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeecc-ccchhhhhhhHHHhhhhhhhhccCCCccccccCcch--HHHHH-Hhccc
Confidence 8655432 123456789999998766 344568899999999999999999999987543221 01111 11111
Q ss_pred CcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 829 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 829 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
...-.+. ......+.++..-+.-.-+.+-.+-|..+-+...+..+.+.
T Consensus 255 Kr~T~i~----~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 255 KRSTPIE----VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred cccCCHH----HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 1111111 12223344555666666667778888887777666555443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=203.53 Aligned_cols=220 Identities=28% Similarity=0.376 Sum_probs=165.5
Q ss_pred HhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCe-EecC
Q 002717 651 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI-IHYN 729 (888)
Q Consensus 651 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i-vHrd 729 (888)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...++|.....+.++++.||+|+|.. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 35678999999999999999999999999999999999884 56799999999999999999999986 44 9999
Q ss_pred CCCCcEEecCCCCcEEecccccccccccccccccccccccccccCcccccCc--CC----CCCcchHHHHHHHHHHHHhC
Q 002717 730 LKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS--LR----VNEKCDIYGFGVLILELVTG 803 (888)
Q Consensus 730 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~----~~~~sDvwS~Gv~l~elltg 803 (888)
++++|+++|....+|++|||+.....+..............-|.|||.+... .. .+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998766431111111222334569999987442 11 46789999999999999999
Q ss_pred CCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcCC
Q 002717 804 RRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 804 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
+.||+........ .+.+... .. .....+-|.+.... +....+..+++.||..+|.+||+++++-..++.+...
T Consensus 155 ~~~~~~~~~~~~~-~eii~~~-~~-~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 155 SGPFDLRNLVEDP-DEIILRV-KK-GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cCccccccccCCh-HHHHHHH-Hh-cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9999874332221 1222211 11 11111222222111 3333688999999999999999999999988876553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=179.00 Aligned_cols=139 Identities=19% Similarity=0.184 Sum_probs=107.9
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccC-C-------hH-----------------HHHHHHHHHhhcCCCCc
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-Y-------PE-----------------DFEREVRVLGKARHPNL 659 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-~-------~~-----------------~~~~E~~~l~~l~h~ni 659 (888)
+.||+|+||.||+|... +|+.||||+++...... . .. ....|++.++++.++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 57999999999999997 89999999996542211 1 01 12349999999988877
Q ss_pred ceeeeEEEcCCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHh-hhcCCCCeEecCCCCCcEEec
Q 002717 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLD 738 (888)
Q Consensus 660 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrdlk~~Nill~ 738 (888)
.....+.. ...++||||++++++....... ..+++..+..++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54433322 2238999999988776543221 3578899999999999999999 677 999999999999998
Q ss_pred CCCCcEEecccccccc
Q 002717 739 DNYNPRISDFGLARLL 754 (888)
Q Consensus 739 ~~~~~kl~Dfgla~~~ 754 (888)
++.++++|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.2e-20 Score=209.01 Aligned_cols=249 Identities=23% Similarity=0.290 Sum_probs=175.1
Q ss_pred hcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHH--HhhcCCCCcceeeeEEEcCCeeeEEEecCC
Q 002717 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRV--LGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 603 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 680 (888)
..+.+|++.|=.|.+|++. +|. |+||++.+.+..-..+.|.+++.- ...++|||++++--+-..+...|+|-+|..
T Consensus 27 ~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 3457999999999999996 555 999999776644344455443333 444589999998877666666788888875
Q ss_pred CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc-ccccc
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL-TRLDK 759 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~-~~~~~ 759 (888)
+ +|++.+..+ +-+...+...||.|++.|+...|.. +|+|||||.+|||+++..-+.|+||.--+-. -+.|.
T Consensus 105 h-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 105 H-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 4 788888764 6678888899999999999999998 9999999999999999999999999765422 11111
Q ss_pred cccccccc----ccccccCcccccCcC----------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCchhhHHHHHHHH
Q 002717 760 HVMSNRFQ----SALGYVAPELTCQSL----------RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 824 (888)
Q Consensus 760 ~~~~~~~~----g~~~y~aPE~~~~~~----------~~~~~sDvwS~Gv~l~ellt-g~~p~~~~~~~~~~l~~~~~~~ 824 (888)
...-..+. .-.+|.|||.+.... ..+++.||||.||+++|+++ |++||... ++..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~a----- 246 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLA----- 246 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHh-----
Confidence 11111122 224699999875422 14678999999999999998 56666421 1100
Q ss_pred HhcCCcccccCCC--CCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 002717 825 LEEGNVLDCVDPS--MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 825 ~~~~~~~~~~d~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 877 (888)
++.+. ..|+. +.++++ ..+.+++..|++.||++|.++++.++.-+.+
T Consensus 247 Yr~~~---~~~~e~~Le~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 YRSGN---ADDPEQLLEKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HhccC---ccCHHHHHHhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 01110 00000 001111 1477899999999999999999999986554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-21 Score=175.18 Aligned_cols=176 Identities=27% Similarity=0.399 Sum_probs=157.7
Q ss_pred cCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceEE
Q 002717 296 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 375 (888)
Q Consensus 296 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 375 (888)
+.+.+.|.||+|+++ .+|..+..+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. +.|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 456788999999998 67778899999999999999998 67889999999999999999998 8999999999999999
Q ss_pred ccCCcCCC-ccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeeccCCcce
Q 002717 376 LDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 454 (888)
Q Consensus 376 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~ 454 (888)
|.+|++.. .+|..|..++.|+.|+|+.|.+. .+|..+++|++|+.|.+.+|.+- ++|.+++.|+.|++|.+.+|+|+
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 99999964 68999999999999999999998 89999999999999999999998 89999999999999999999999
Q ss_pred ecCCCCCCCCCC---CCCCcCCCcC
Q 002717 455 GRLPVGGVFPTL---DQSSLQGNLG 476 (888)
Q Consensus 455 ~~~p~~~~~~~l---~~~~~~~n~~ 476 (888)
-.+|+.+++.-. .....+.|||
T Consensus 187 vlppel~~l~l~~~k~v~r~E~NPw 211 (264)
T KOG0617|consen 187 VLPPELANLDLVGNKQVMRMEENPW 211 (264)
T ss_pred ecChhhhhhhhhhhHHHHhhhhCCC
Confidence 999987665433 2233566666
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.9e-19 Score=180.27 Aligned_cols=235 Identities=20% Similarity=0.259 Sum_probs=149.7
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc--CChHHHHHHHHHHhhcC----------CCCcceeeeEEEc-
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKAR----------HPNLISLEGYYWT- 668 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~~- 668 (888)
.+++.||.|+++.||.+++..+|+.+|||.+...... ...+++.+|.-....+. |-.++..++....
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 4566899999999999999999999999998655422 22356777766665532 2223322332221
Q ss_pred --------C---C-----eeeEEEecCCCCCHHHHHhh---cCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecC
Q 002717 669 --------P---Q-----LKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYN 729 (888)
Q Consensus 669 --------~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrd 729 (888)
. . ..+++|+-+ .++|.+++.. .......+....+..+..|+.+.+++||+. |++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 1 1 125677776 5688877653 221122234445567779999999999999 999999
Q ss_pred CCCCcEEecCCCCcEEecccccccccccccccccccccccccccCcccccCc-------CCCCCcchHHHHHHHHHHHHh
Q 002717 730 LKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS-------LRVNEKCDIYGFGVLILELVT 802 (888)
Q Consensus 730 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~sDvwS~Gv~l~ellt 802 (888)
|+|+|++++.+|.++++||+.....+. ... . ...+..|.+||..... ..++.+.|.|++|+++|.|++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~--~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT--RYR--C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE--EEE--G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc--eee--c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999987765432 111 1 3344779999975332 347889999999999999999
Q ss_pred CCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCC
Q 002717 803 GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSR 864 (888)
Q Consensus 803 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~R 864 (888)
+..||.......... + .+.... +.++.+..||..+++.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~--~----------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE--W----------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG--G----------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccc--c----------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999997542211100 0 112223 667789999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=171.50 Aligned_cols=139 Identities=24% Similarity=0.244 Sum_probs=110.3
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccC--------------------C-----hHHHHHHHHHHhhcCCCCc
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--------------------Y-----PEDFEREVRVLGKARHPNL 659 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--------------------~-----~~~~~~E~~~l~~l~h~ni 659 (888)
+.||+|+||.||+|... +|+.||||++....... . ...+..|.+.+.++.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57999999999999987 89999999987542110 0 1123578999999999987
Q ss_pred ceeeeEEEcCCeeeEEEecCCCCCHHHH-HhhcCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeEecCCCCCcEEe
Q 002717 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAK-LHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILL 737 (888)
Q Consensus 660 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill 737 (888)
.....+... ..++||||++++++... +.. ..++..+...++.|++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 655444433 24899999998865443 332 346778899999999999999999 7 99999999999999
Q ss_pred cCCCCcEEeccccccccc
Q 002717 738 DDNYNPRISDFGLARLLT 755 (888)
Q Consensus 738 ~~~~~~kl~Dfgla~~~~ 755 (888)
+ ++.++++|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.7e-19 Score=176.59 Aligned_cols=171 Identities=14% Similarity=0.107 Sum_probs=128.2
Q ss_pred hhhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCC--hH------HHHHHHHHHhhcCCCCcceeeeEEEcC
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PE------DFEREVRVLGKARHPNLISLEGYYWTP 669 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~--~~------~~~~E~~~l~~l~h~niv~l~~~~~~~ 669 (888)
...|...+.+|.|+||.||.+.. ++..+|+|.+........ .. .+.+|+..+.+++||+|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 34567778899999999999766 466899999865432211 11 267999999999999999999886643
Q ss_pred --------CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCC
Q 002717 670 --------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY 741 (888)
Q Consensus 670 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 741 (888)
...++||||++|.+|.++.. ++. ....+++.++..+|.. +++|||++|+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 34789999999999987732 222 2456899999999998 999999999999999888
Q ss_pred CcEEecccccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHH
Q 002717 742 NPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELV 801 (888)
Q Consensus 742 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ell 801 (888)
++++|||.......... .. .+. ....+..++|+||||+++....
T Consensus 173 -i~liDfg~~~~~~e~~a-~d-------------~~v-ler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKA-KD-------------RID-LERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhh-HH-------------HHH-HHhHhcccccccceeEeehHHH
Confidence 99999998865432110 00 012 2234557999999999987553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=166.83 Aligned_cols=186 Identities=17% Similarity=0.140 Sum_probs=137.7
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCccCC---hHHHHHHHHHHhhcC-CCCcceeeeEEEcCCeeeEEEecC
Q 002717 604 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY---PEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 604 ~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
...+++|+||+||.+.. .+.+++.+.+........ ...+.+|+++++++. |++|.+++++ +..+++|||+
T Consensus 7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 34799999999997765 688888777754433211 125789999999995 5889999886 3468999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCC-CCCcEEecCCCCcEEecccccccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNL-KPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdl-k~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
.|.+|...+.. ....++.|+++++.++|+. ||+|||| ||.||+++.++.++|+|||++....+..
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998654321 1135778999999999999 9999999 7999999999999999999998554322
Q ss_pred cc----c-------ccccccccccccCcccccCcCCCC-CcchHHHHHHHHHHHHhCCCCCCC
Q 002717 759 KH----V-------MSNRFQSALGYVAPELTCQSLRVN-EKCDIYGFGVLILELVTGRRPVEY 809 (888)
Q Consensus 759 ~~----~-------~~~~~~g~~~y~aPE~~~~~~~~~-~~sDvwS~Gv~l~elltg~~p~~~ 809 (888)
.. . .......++.|++|+....-...+ ...+.++-|.-+|.++|++.+...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 0 012234567788887542222333 567888999999999999988643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-20 Score=203.01 Aligned_cols=89 Identities=25% Similarity=0.305 Sum_probs=46.4
Q ss_pred ccccCCCceEEccCCcCCCccCccccc-----cccccEEEccCCccc----ccCCccccCCCCCCeEEccCCcceec---
Q 002717 365 VCESRSLGILQLDGNSLTGPIPQVIRN-----CTSLYLLSLSHNHLS----GSIPKSISNLNKLKILKLEFNELSGE--- 432 (888)
Q Consensus 365 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~--- 432 (888)
+..+++|+.|++++|.+++.....+.. .+.|+.|++++|.++ ..+...+..+++|+++++++|.++..
T Consensus 217 ~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~ 296 (319)
T cd00116 217 LASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQ 296 (319)
T ss_pred hcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHH
Confidence 334455555555555555322222211 256666666666664 12333444556666666666666643
Q ss_pred -CCcccccc-CCCCeeeccCCcc
Q 002717 433 -IPQELGKL-ASLLAVNVSYNRL 453 (888)
Q Consensus 433 -~p~~~~~l-~~L~~l~ls~N~l 453 (888)
+...+... +.|+++++.+|++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 297 LLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHHhhcCCchhhcccCCCCC
Confidence 33333334 5666777766653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-18 Score=174.79 Aligned_cols=198 Identities=22% Similarity=0.291 Sum_probs=136.6
Q ss_pred CCCCcceeeeEEEcC---------------------------CeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHH
Q 002717 655 RHPNLISLEGYYWTP---------------------------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVI 707 (888)
Q Consensus 655 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 707 (888)
+|||||++.++|.+. .+.|+||...+. +|..++..+ ..+.-...-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 599999998876432 344889987754 888888764 24445566788
Q ss_pred HHHHHHHHHhhhcCCCCeEecCCCCCcEEec--CCCC--cEEecccccccccc----cccccccccccccccccCccccc
Q 002717 708 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNYN--PRISDFGLARLLTR----LDKHVMSNRFQSALGYVAPELTC 779 (888)
Q Consensus 708 ~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~~--~kl~Dfgla~~~~~----~~~~~~~~~~~g~~~y~aPE~~~ 779 (888)
.|+++|+.|||.+ +|.|||+|++|||+. +|+. ..|+|||++---.. ...........|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999998 999999999999994 4443 57899998732111 01111112234556789999874
Q ss_pred CcCC-----CCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHH
Q 002717 780 QSLR-----VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLAL 854 (888)
Q Consensus 780 ~~~~-----~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~ 854 (888)
.... -..|+|.|+.|.+.||+++..-||..-.+- .+.. +. +++ ..++..++.++..+.+++.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem--~L~~--r~-Yqe--------~qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM--LLDT--RT-YQE--------SQLPALPSRVPPVARQLVF 491 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh--eech--hh-hhh--------hhCCCCcccCChHHHHHHH
Confidence 3221 136899999999999999999999752110 0000 00 111 1233456777778899999
Q ss_pred HccCCCCCCCCCHHHHHHHH
Q 002717 855 VCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 855 ~cl~~dp~~RPs~~evl~~L 874 (888)
..++.||.+|++..=+...+
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876554443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-20 Score=202.81 Aligned_cols=277 Identities=25% Similarity=0.261 Sum_probs=152.4
Q ss_pred EEEcCCcccc-ccCCccccCCCCCCEEEccCccccc----cCCCCCCCCCCCCEEEccCCccCc------CCChhhhcCC
Q 002717 128 TLDLSHNLFS-GSIPQGVAALHYLKELLLQGNQFSG----PLPADIGFCPHLTTLDLSNNLFTG------QLPVSLRLLN 196 (888)
Q Consensus 128 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~l~ 196 (888)
.|+|+.+.++ ......+..+.+|++|+++++.++. .++..+...++|++|+++++.+.+ ..+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677777776 3344556677778888888888743 234445566778888888877662 1233455566
Q ss_pred CCcEEEeecCcccccCCcCcccCCc---ccEEEeeccccCC----CCCCCCCCC-CCCcEEEeeCCcCCCCCCccccccC
Q 002717 197 SMIFISVSNNTLTGDIPHWIGNIST---LEFLDFSNNHLTG----SLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFDLG 268 (888)
Q Consensus 197 ~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~~~ 268 (888)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++.....+..
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~-- 159 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK-- 159 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH--
Confidence 6666666666665444444444444 6666666666552 122233344 55566666666555321111100
Q ss_pred CceEEcccCcccccCCCCCCCCCCCcccCCCCEEeCCCCcCccc----CChhhhhccCCcEeeccCCccccCC----CCC
Q 002717 269 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGD----IPAEMGLFANLRYLNLSSNHLRSRI----PPE 340 (888)
Q Consensus 269 L~~L~l~~N~l~~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----~~~ 340 (888)
.+..+++|+.|++++|.+++. ++..+..+++|+.|++++|.+++.. ...
T Consensus 160 -----------------------~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 216 (319)
T cd00116 160 -----------------------ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAET 216 (319)
T ss_pred -----------------------HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHH
Confidence 011234566777777766632 2223334456777777766665322 223
Q ss_pred cccCCcceEEEcccCcccccCCccccc-----cCCCceEEccCCcCCC----ccCccccccccccEEEccCCccccc---
Q 002717 341 LGYFHSLIHLDLRNNALYGSIPQEVCE-----SRSLGILQLDGNSLTG----PIPQVIRNCTSLYLLSLSHNHLSGS--- 408 (888)
Q Consensus 341 ~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~--- 408 (888)
+..+++|++|++++|.+++.....+.. .+.|+.|++++|.+++ .+...+..+++|+.+++++|.++..
T Consensus 217 ~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~ 296 (319)
T cd00116 217 LASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQ 296 (319)
T ss_pred hcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHH
Confidence 445566677777776665422222222 2566677777776652 2233445556666777777766633
Q ss_pred -CCccccCC-CCCCeEEccCCcc
Q 002717 409 -IPKSISNL-NKLKILKLEFNEL 429 (888)
Q Consensus 409 -~p~~~~~l-~~L~~L~L~~N~l 429 (888)
....+... +.|++|++.+|++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 297 LLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHHhhcCCchhhcccCCCCC
Confidence 33334344 5666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-19 Score=192.66 Aligned_cols=226 Identities=23% Similarity=0.295 Sum_probs=178.9
Q ss_pred eccccceEEEEEEE---CCCCeEEEEEEeecCCccCC-hHHHHHHHHHHhhcC-CCCcceeeeEEEcCCeeeEEEecCCC
Q 002717 607 VGEGVFGTVYKVSF---GTQGRMLAVKKLVTSDIIQY-PEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 607 ig~G~~g~V~~~~~---~~~~~~vavK~l~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
+|+|+||.|+.++- ...|..+|.|.+++...... ......|-.++..++ ||.+|++.-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999987543 22567789998865543321 124556888888886 99999999999999999999999999
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~ 761 (888)
|.+...+... ..+++.........+|-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-+...
T Consensus 82 g~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 82 GDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred chhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 9998888764 4577777788888999999999998 999999999999999999999999999986543222
Q ss_pred ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCC
Q 002717 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDY 841 (888)
Q Consensus 762 ~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 841 (888)
.+||..|||||+.. ....++|.||||++++||+||..||.. +.++.+.+. -..+
T Consensus 153 ----~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~---------~~~~~Il~~----------~~~~ 206 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG---------DTMKRILKA----------ELEM 206 (612)
T ss_pred ----cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch---------HHHHHHhhh----------ccCC
Confidence 28999999999984 357899999999999999999999965 112222111 1235
Q ss_pred ChhhHHHHHHHHHHccCCCCCCCCCH
Q 002717 842 PEDEVLPVLKLALVCTCHIPSSRPSM 867 (888)
Q Consensus 842 ~~~~~~~l~~li~~cl~~dp~~RPs~ 867 (888)
|.+.......++..+...+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 66667777788888899999988654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.3e-20 Score=166.06 Aligned_cols=158 Identities=31% Similarity=0.508 Sum_probs=126.9
Q ss_pred cCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCccc-ccCCccccccCCCceE
Q 002717 296 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY-GSIPQEVCESRSLGIL 374 (888)
Q Consensus 296 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L 374 (888)
+.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. +.|..|+.++.|+.|||++|++. ..+|+.|..++.|+.|
T Consensus 55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 456666666666666 67777788888888888888875 67788888888888888888875 3688889999999999
Q ss_pred EccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCC---CeeeccCC
Q 002717 375 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL---LAVNVSYN 451 (888)
Q Consensus 375 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L---~~l~ls~N 451 (888)
+|++|.+. .+|..++++++|+.|.+..|.+- .+|.+++.|++|++|++.+|+++ .+|.+++++.-+ +.+.+.+|
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~N 209 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEEN 209 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhC
Confidence 99999998 88888999999999999999988 78999999999999999999998 788888776432 34556677
Q ss_pred cceecCC
Q 002717 452 RLIGRLP 458 (888)
Q Consensus 452 ~l~~~~p 458 (888)
++...|.
T Consensus 210 Pwv~pIa 216 (264)
T KOG0617|consen 210 PWVNPIA 216 (264)
T ss_pred CCCChHH
Confidence 7655444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-17 Score=190.62 Aligned_cols=195 Identities=19% Similarity=0.293 Sum_probs=156.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcC---CCCcceeeeEEEcCCeeeEE
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR---HPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 675 (888)
+.|.+.+.||+|+||.||+|.... |+.||+|+-+....++.. -=.+++.+++ -+.|+.+...+.-.+..++|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY----I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY----ICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee----ehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 445566789999999999999984 999999998766655422 1223334443 35566666666677778999
Q ss_pred EecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEec-------CCCCcEEecc
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-------DNYNPRISDF 748 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~-------~~~~~kl~Df 748 (888)
+||.+.|||.+++.. ...++|.-.+.++.|+++.+++||.. +|||+||||+|+++. +...++|+||
T Consensus 773 ~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999984 45789999999999999999999998 999999999999994 3445899999
Q ss_pred cccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCC
Q 002717 749 GLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806 (888)
Q Consensus 749 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p 806 (888)
|.+-.+.-......-...++|-.+-.+|.. .+..++.++|.|.++.+++-|+.|++-
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~-~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMR-EGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHh-cCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999776543333333556778889999987 777899999999999999999998753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.2e-17 Score=160.22 Aligned_cols=135 Identities=17% Similarity=0.184 Sum_probs=105.2
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-----CCCCcceeeeEEEcCC---eee-E
Q 002717 604 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-----RHPNLISLEGYYWTPQ---LKL-L 674 (888)
Q Consensus 604 ~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l 674 (888)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ .||||++++|++.++. ..+ +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 45899999999995 6545554 799886543 23457799999999999 5799999999998864 323 7
Q ss_pred EEec--CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHH-HHhhhcCCCCeEecCCCCCcEEecC----CCCcEEec
Q 002717 675 VSDY--APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL-AHLHHSFRPPIIHYNLKPSNILLDD----NYNPRISD 747 (888)
Q Consensus 675 v~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivHrdlk~~Nill~~----~~~~kl~D 747 (888)
|+|| +.+|+|.+++... .+++. ..++.+++.++ +|||+. +|+||||||+||+++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5579999999653 24444 35677888777 999999 9999999999999974 34799999
Q ss_pred ccccc
Q 002717 748 FGLAR 752 (888)
Q Consensus 748 fgla~ 752 (888)
|+.++
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=161.28 Aligned_cols=143 Identities=20% Similarity=0.177 Sum_probs=110.1
Q ss_pred hhhhcCeeccccceEEEEEE-ECCCCeEEEEEEeecCCccC-----------------------ChHHHHHHHHHHhhcC
Q 002717 600 LLEKAAEVGEGVFGTVYKVS-FGTQGRMLAVKKLVTSDIIQ-----------------------YPEDFEREVRVLGKAR 655 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~-~~~~~~~vavK~l~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 655 (888)
.|+..+.||+|+||.||+|. ...+|+.||+|++....... ....+.+|+..++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46677899999999999998 55689999999986542110 0123568999999997
Q ss_pred CC--CcceeeeEEEcCCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCC-eEecCCCC
Q 002717 656 HP--NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP-IIHYNLKP 732 (888)
Q Consensus 656 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivHrdlk~ 732 (888)
+. .+.+++++ ...++||||++++++....... ......+...++.|++.++.+||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 53 33444432 2358999999998886654221 2355566788999999999999998 8 99999999
Q ss_pred CcEEecCCCCcEEecccccccc
Q 002717 733 SNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 733 ~Nill~~~~~~kl~Dfgla~~~ 754 (888)
+||+++ ++.++++|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.4e-16 Score=156.16 Aligned_cols=135 Identities=22% Similarity=0.349 Sum_probs=113.5
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccC-------ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
+.||+|++|.||+|.+ .|..|++|+........ ....+.+|+.++..++|++|.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 4689999999999998 67789999865332111 12357789999999999999888878777778899999
Q ss_pred cCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
|++|++|.+++... .+ .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998753 11 7889999999999999998 999999999999999 78899999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=154.08 Aligned_cols=130 Identities=24% Similarity=0.364 Sum_probs=106.9
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecCCccC-------ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecC
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-------YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 679 (888)
||+|+||.||+|.+ +|..|++|+........ ..+.+.+|+++++.++|+++.....++...+..++||||+
T Consensus 2 ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 79999999999996 57889999864432111 1245678999999999887666666666667779999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|++|.+.+.... . .++.+++.++.++|+. +++|||++|.||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998876531 0 7899999999999998 999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=151.26 Aligned_cols=137 Identities=18% Similarity=0.075 Sum_probs=106.8
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc---------------------CChHHHHHHHHHHhhcCCCC-
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII---------------------QYPEDFEREVRVLGKARHPN- 658 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~---------------------~~~~~~~~E~~~l~~l~h~n- 658 (888)
|...+.||+|+||.||++... +|+.||||++...... .....+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 556678999999999999886 7999999987543210 01123667899999997774
Q ss_pred -cceeeeEEEcCCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEe
Q 002717 659 -LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 737 (888)
Q Consensus 659 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill 737 (888)
+...++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||||+||++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 444443 2345899999999998665321 34567889999999999998 99999999999999
Q ss_pred cCCCCcEEeccccccccc
Q 002717 738 DDNYNPRISDFGLARLLT 755 (888)
Q Consensus 738 ~~~~~~kl~Dfgla~~~~ 755 (888)
++++.++|+|||.+....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=174.57 Aligned_cols=134 Identities=24% Similarity=0.319 Sum_probs=109.3
Q ss_pred hhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-------CChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeE
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-------QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 674 (888)
...+.||+|+||.||+|.+. +..+++|+....... ...+.+.+|+++++.++|++++....++......++
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred CccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 44678999999999999985 344455543221111 112467899999999999999988888877777899
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ +++.++|+|||+++.
T Consensus 414 v~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999998886 2467899999999999998 99999999999999 677999999999975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.8e-16 Score=169.22 Aligned_cols=177 Identities=25% Similarity=0.411 Sum_probs=129.7
Q ss_pred eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccc
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgl 750 (888)
..|+.|++|.-.+|.+|+..+. .....++...+.++.|++.|+.| + +.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 4589999999999999998653 23456888899999999999999 5 899999999999999999999999999
Q ss_pred cccccccc----cccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHh
Q 002717 751 ARLLTRLD----KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826 (888)
Q Consensus 751 a~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~ 826 (888)
........ .........||..||+||.+ .+..|+.|+||||+|++++|+++ +|.........+.. ++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi-~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d-----~r 473 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQI-RGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTD-----IR 473 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHH-hhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhh-----hh
Confidence 97765443 22234567899999999998 66789999999999999999986 22221111111111 11
Q ss_pred cCCcccccCCCC-CCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002717 827 EGNVLDCVDPSM-GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872 (888)
Q Consensus 827 ~~~~~~~~d~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 872 (888)
.+ .+++.. .++|. =+.++.+++++.|.+||++.++..
T Consensus 474 ~g----~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~~~ 511 (516)
T KOG1033|consen 474 DG----IIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEVAL 511 (516)
T ss_pred cC----CCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHHhh
Confidence 11 111111 11222 246888999999999996665543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-15 Score=173.68 Aligned_cols=209 Identities=21% Similarity=0.286 Sum_probs=139.1
Q ss_pred hhhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
..++..+.|..|+||.||.++++...+++|.|.= +.. -+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~------lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN------LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-ccc------hhhhc--cccccCCccee------------------
Confidence 3456677899999999999999888888998532 211 11111 22222333333
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc-
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL- 757 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~- 757 (888)
|+=...++.. ++++.. .+.+++|+|+. +|+|||+||+|.+++.-|.+|++|||+++.....
T Consensus 136 ---gDc~tllk~~----g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccC----CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 3333334332 222222 27799999998 9999999999999999999999999998653211
Q ss_pred -----------cc-ccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHH
Q 002717 758 -----------DK-HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 758 -----------~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~ 825 (888)
+. .......+||+.|+|||++ ....|....|.|++|+++||.+.|+.||..... ++.+...+...+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi-lrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i 275 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI-LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDI 275 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhh-hhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhc
Confidence 01 1112356899999999998 555689999999999999999999999965422 222222222111
Q ss_pred hcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCC
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 865 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 865 (888)
. ..+-.+....++..++.+.++.+|..|-
T Consensus 276 ~-----------wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 E-----------WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred c-----------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1 1111233344677889999999999995
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.7e-16 Score=179.75 Aligned_cols=263 Identities=21% Similarity=0.213 Sum_probs=196.0
Q ss_pred hhhhhhcCeeccccceEEEEEEECC-CCeEEEEEEeecCC-ccCChHHHHHHHHHHhhcC-CCCcceeeeEEEcCCeeeE
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSD-IIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 674 (888)
...|+..+.||+|+|+.|-...... ....+|+|.+.... .....+....|..+-+.+. |+|++.+++....++..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4446666779999999999877743 34567777765443 2223344556787777776 9999999999999999999
Q ss_pred EEecCCCCCHHHHH-hhcCCCCCCCChhhHHHHHHHHHHHHHHhh-hcCCCCeEecCCCCCcEEecCCC-CcEEeccccc
Q 002717 675 VSDYAPNGSLQAKL-HERLPSTPPLSWTNRFKVILGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLA 751 (888)
Q Consensus 675 v~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfgla 751 (888)
+.+|..+|++.+.+ +.. ....+.......+.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|
T Consensus 99 ~~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred ccCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence 99999999998888 332 224556677789999999999999 76 999999999999999999 9999999999
Q ss_pred ccccc-cccccccccccc-cccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCC
Q 002717 752 RLLTR-LDKHVMSNRFQS-ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 752 ~~~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
..+.. ...........| ++.|+|||...+.....+..|+||.|+++.-+++|..|+............|....
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~----- 247 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK----- 247 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-----
Confidence 87766 344444455667 99999999885555668899999999999999999999987644433222222110
Q ss_pred cccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 002717 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 876 (888)
+...............++...++..+|..|.+.+++...-+.
T Consensus 248 -----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~ 289 (601)
T KOG0590|consen 248 -----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWL 289 (601)
T ss_pred -----cccccCccccCChhhhhcccccccCCchhccccccccccccc
Confidence 000011223334456778888898999999999987665433
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.3e-15 Score=173.05 Aligned_cols=117 Identities=33% Similarity=0.560 Sum_probs=98.7
Q ss_pred CCceEEccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeecc
Q 002717 370 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 449 (888)
Q Consensus 370 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls 449 (888)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36788999999998899889999999999999999998899889999999999999999999999999999999999999
Q ss_pred CCcceecCCCC--CCCCCCCCCCcCCCcCCCCCCCCCCC
Q 002717 450 YNRLIGRLPVG--GVFPTLDQSSLQGNLGICSPLLKGPC 486 (888)
Q Consensus 450 ~N~l~~~~p~~--~~~~~l~~~~~~~n~~~c~~~~~~~c 486 (888)
+|+++|.+|.. ..+..+..+++.+|+++|+.|....|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence 99999998842 12234456788999999997755556
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-13 Score=142.30 Aligned_cols=144 Identities=22% Similarity=0.199 Sum_probs=109.9
Q ss_pred ChhhhhhhcCeec-cccceEEEEEEECCCCeEEEEEEeecCCc------------cCChHHHHHHHHHHhhcCCCCc--c
Q 002717 596 DPETLLEKAAEVG-EGVFGTVYKVSFGTQGRMLAVKKLVTSDI------------IQYPEDFEREVRVLGKARHPNL--I 660 (888)
Q Consensus 596 ~~~~~~~~~~~ig-~G~~g~V~~~~~~~~~~~vavK~l~~~~~------------~~~~~~~~~E~~~l~~l~h~ni--v 660 (888)
++.........|| .|+.|+||.+.. .+..++||++..... ......+.+|+.++.+++|++| +
T Consensus 28 ~~~~~~~~~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 28 DPDFWQQQARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred CHHHHhhcCceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4444445556798 999999999988 478899998854221 0123467889999999988774 6
Q ss_pred eeeeEEEcCCe----eeEEEecCCC-CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcE
Q 002717 661 SLEGYYWTPQL----KLLVSDYAPN-GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNI 735 (888)
Q Consensus 661 ~l~~~~~~~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Ni 735 (888)
+.+++...... .++|+||+++ .+|.+++... .++.. .+.+++.++.+||+. ||+||||||.||
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NI 173 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNI 173 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhE
Confidence 67776543322 2599999997 6998888642 23433 357899999999998 999999999999
Q ss_pred EecCCCCcEEeccccccc
Q 002717 736 LLDDNYNPRISDFGLARL 753 (888)
Q Consensus 736 ll~~~~~~kl~Dfgla~~ 753 (888)
|++.++.++++|||.++.
T Consensus 174 Lv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 174 LLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEcCCCCEEEEECCCccc
Confidence 999888999999998864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.9e-14 Score=134.16 Aligned_cols=134 Identities=22% Similarity=0.174 Sum_probs=112.2
Q ss_pred cCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCC--CCcceeeeEEEcCCeeeEEEecCCC
Q 002717 604 AAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH--PNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 604 ~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 681 (888)
.+.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| ..+.+++++...++..++++||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 357999999999999984 47899998754432 4678999999999976 5899999888877888999999988
Q ss_pred CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+.+..+ +......++.+++++++++|....++++|+|++|+||++++.+.+++.|||.++.
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766433 4466678899999999999986445799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.5e-14 Score=139.18 Aligned_cols=136 Identities=21% Similarity=0.210 Sum_probs=97.6
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccC-ChHH----------------------HHHHHHHHhhcCCC--Cc
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPED----------------------FEREVRVLGKARHP--NL 659 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~-~~~~----------------------~~~E~~~l~~l~h~--ni 659 (888)
+.||+|+||.||+|... +|+.||||++....... .... ...|...+.++.+. .+
T Consensus 3 ~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 3 GPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred cccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 57999999999999987 79999999986532111 0011 13566666666433 24
Q ss_pred ceeeeEEEcCCeeeEEEecCCCCCHHH-HHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhh-cCCCCeEecCCCCCcEEe
Q 002717 660 ISLEGYYWTPQLKLLVSDYAPNGSLQA-KLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH-SFRPPIIHYNLKPSNILL 737 (888)
Q Consensus 660 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrdlk~~Nill 737 (888)
.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|. . +|+|||+||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444443 23589999999964321 122210 11 5678899999999999998 6 99999999999999
Q ss_pred cCCCCcEEeccccccccc
Q 002717 738 DDNYNPRISDFGLARLLT 755 (888)
Q Consensus 738 ~~~~~~kl~Dfgla~~~~ 755 (888)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.2e-14 Score=143.42 Aligned_cols=209 Identities=22% Similarity=0.257 Sum_probs=144.6
Q ss_pred HHHHHHhhcCCCCcceeeeEEEcCC-----eeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhc
Q 002717 646 REVRVLGKARHPNLISLEGYYWTPQ-----LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720 (888)
Q Consensus 646 ~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~ 720 (888)
.-.+-+-++.|.|+|+++.|+.+.. ...+++|||..|++.++|++.......+......+|+-||..||.|||+.
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 3344455667999999999986543 45799999999999999998766667788888889999999999999984
Q ss_pred CCCCeEecCCCCCcEEecCCCCcEEeccc--ccccccccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHH
Q 002717 721 FRPPIIHYNLKPSNILLDDNYNPRISDFG--LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLIL 798 (888)
Q Consensus 721 ~~~~ivHrdlk~~Nill~~~~~~kl~Dfg--la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~ 798 (888)
+|+|+|+++..+-|++..++-+|++--- ..................+-++|.|||.- .....+.++|||+||+...
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHH
Confidence 9999999999999999999888875211 10000000001111234456889999965 4445678999999999999
Q ss_pred HHHhCCCCCCCCCCchhhHHHHHH-HHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 799 ELVTGRRPVEYGEDNVVILSEHVR-VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 799 elltg~~p~~~~~~~~~~l~~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
||..+..--....... ....... ..+... ++. =...+..|+...|..||+|++++.+.
T Consensus 274 emailEiq~tnseS~~-~~ee~ia~~i~~le------n~l-----------qr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKV-EVEENIANVIIGLE------NGL-----------QRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHHheeccCCCccee-ehhhhhhhheeecc------Ccc-----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence 9988776422221111 1111111 111000 000 12477889999999999999988764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3e-15 Score=159.75 Aligned_cols=178 Identities=30% Similarity=0.525 Sum_probs=99.1
Q ss_pred cEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCc
Q 002717 199 IFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENG 278 (888)
Q Consensus 199 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~ 278 (888)
...+|+.|++. .+|..+..+-.|+.|.|..|.|. .+|..+.++..|+.|+|+.|+++ .+|..++.+.
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp---------- 144 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP---------- 144 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc----------
Confidence 44556666665 56666666666677777777666 56666666666666666666665 4555554432
Q ss_pred ccccCCCCCCCCCCCcccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCccc
Q 002717 279 FMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY 358 (888)
Q Consensus 279 l~~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 358 (888)
|+.|-+++|+++ .+|+.++.+..|..||.+.|.|.
T Consensus 145 --------------------------------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~ 179 (722)
T KOG0532|consen 145 --------------------------------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ 179 (722)
T ss_pred --------------------------------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh
Confidence 333333333333 23334444444555555555554
Q ss_pred ccCCccccccCCCceEEccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCcccc
Q 002717 359 GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELG 438 (888)
Q Consensus 359 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 438 (888)
.+|..++++.+|+.|.+..|++. .+|.++..| .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|+|. ..|..++
T Consensus 180 -slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 180 -SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred -hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 45555555555555555555555 444455533 2555666666665 55666666666666666666665 4555544
Q ss_pred c
Q 002717 439 K 439 (888)
Q Consensus 439 ~ 439 (888)
-
T Consensus 255 ~ 255 (722)
T KOG0532|consen 255 E 255 (722)
T ss_pred h
Confidence 3
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-14 Score=154.95 Aligned_cols=194 Identities=35% Similarity=0.441 Sum_probs=145.0
Q ss_pred EEECcCcccccccCccccccccccccCcEEEcCCccccccCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEc
Q 002717 100 TLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDL 179 (888)
Q Consensus 100 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 179 (888)
+|.|++-++...+... .. ..+.--...||+.|++. .+|..++.+..|+.+.|..|.|. .+|..+.++..|+.|||
T Consensus 54 ~l~Ls~rrlk~fpr~a--~~-~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~l 128 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGA--AS-YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDL 128 (722)
T ss_pred ccccccchhhcCCCcc--cc-ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhh
Confidence 3455555555433211 11 34556667788888887 67778888888888888888888 77888888888899999
Q ss_pred cCCccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCC
Q 002717 180 SNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN 259 (888)
Q Consensus 180 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 259 (888)
+.|+++ .+|..+..|+ |+.|.+++|+++ .+|+.++.+..|..||.+.|.|. .+|..+.++.+|+.|.+..|++. .
T Consensus 129 s~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~ 203 (722)
T KOG0532|consen 129 SSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-D 203 (722)
T ss_pred ccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-h
Confidence 999888 5677676664 888999999998 68888888999999999999998 67888999999999999999998 6
Q ss_pred CCccccccCCceEEcccCcccccCCCCCCCCCCCcccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccc
Q 002717 260 IPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR 334 (888)
Q Consensus 260 ~p~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 334 (888)
+|+.+..+.|..||+|.|++ + .+|..|..|+.|++|-|.+|.+.
T Consensus 204 lp~El~~LpLi~lDfScNki------------------------------s-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 204 LPEELCSLPLIRLDFSCNKI------------------------------S-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred CCHHHhCCceeeeecccCce------------------------------e-ecchhhhhhhhheeeeeccCCCC
Confidence 77777666555555555544 3 55666666666666666666665
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.5e-13 Score=149.64 Aligned_cols=155 Identities=35% Similarity=0.526 Sum_probs=106.0
Q ss_pred CCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceEEcc
Q 002717 298 TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 377 (888)
Q Consensus 298 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 377 (888)
+|+.|++++|++. .+|..++.+++|+.|++++|+++. +|...+.++.|+.|++++|+++ .+|.....+..|+.|+++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~-l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhhh-hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 4566666666665 455556666667777777776663 3333336667777777777776 556555555667777777
Q ss_pred CCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeeccCCcceecC
Q 002717 378 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRL 457 (888)
Q Consensus 378 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~ 457 (888)
+|++. ..+..+.++.++..|.+++|++. .++..++.++.|++|++++|+++ .++. ++.+.+++.|++++|.++..+
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~ 293 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNAL 293 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccc
Confidence 77544 45666777777777777888776 44777777777888888888887 4444 777788888888888887776
Q ss_pred CC
Q 002717 458 PV 459 (888)
Q Consensus 458 p~ 459 (888)
|.
T Consensus 294 ~~ 295 (394)
T COG4886 294 PL 295 (394)
T ss_pred hh
Confidence 64
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.1e-12 Score=147.27 Aligned_cols=79 Identities=37% Similarity=0.478 Sum_probs=38.0
Q ss_pred EEEccCCccCcCCChhhhcCCCCcEEEeecCcccccCCcCcccCC-cccEEEeeccccCCCCCCCCCCCCCCcEEEeeCC
Q 002717 176 TLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIS-TLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 254 (888)
Q Consensus 176 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 254 (888)
.|+++.|.+. .....+..++.+..|++.+|.++ .++.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4555555543 12223333344555555555555 2333334442 5555555555555 33344555555555555555
Q ss_pred cCC
Q 002717 255 SLN 257 (888)
Q Consensus 255 ~l~ 257 (888)
+++
T Consensus 174 ~l~ 176 (394)
T COG4886 174 DLS 176 (394)
T ss_pred hhh
Confidence 554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.1e-13 Score=127.86 Aligned_cols=142 Identities=25% Similarity=0.208 Sum_probs=51.0
Q ss_pred ccccccccccCcccccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEcCCccc
Q 002717 5 LVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNIL 84 (888)
Q Consensus 5 ~l~~n~~~~ip~~~~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~~N~l 84 (888)
.+..+.|+.+|...+..++++|+|++|+|+.+ ..++. .+.+|+.|||++|+|+ .++. |..++.|++|++++|+|
T Consensus 3 ~lt~~~i~~~~~~~n~~~~~~L~L~~n~I~~I--e~L~~-~l~~L~~L~Ls~N~I~-~l~~--l~~L~~L~~L~L~~N~I 76 (175)
T PF14580_consen 3 RLTANMIEQIAQYNNPVKLRELNLRGNQISTI--ENLGA-TLDKLEVLDLSNNQIT-KLEG--LPGLPRLKTLDLSNNRI 76 (175)
T ss_dssp -----------------------------------S--T-T-TT--EEE-TTS--S---TT------TT--EEE--SS--
T ss_pred cccccccccccccccccccccccccccccccc--cchhh-hhcCCCEEECCCCCCc-cccC--ccChhhhhhcccCCCCC
Confidence 46778899999888888999999999999853 23432 1368999999999998 6653 67899999999999999
Q ss_pred cccccccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccccccCC---ccccCCCCCCEEEc
Q 002717 85 QGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP---QGVAALHYLKELLL 155 (888)
Q Consensus 85 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~~~l~~L~~L~L 155 (888)
+.+.......+++|++|+|++|+|.+..+. ..+..+++|+.|+|.+|.++...- ..+..+++|+.||-
T Consensus 77 ~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l---~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 77 SSISEGLDKNLPNLQELYLSNNKISDLNEL---EPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -S-CHHHHHH-TT--EEE-TTS---SCCCC---GGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CccccchHHhCCcCCEEECcCCcCCChHHh---HHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 988665445789999999999999865442 356678889999999988874321 13456677776654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.8e-12 Score=139.91 Aligned_cols=142 Identities=18% Similarity=0.217 Sum_probs=100.3
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccCC---------------------------------------hHHHH
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY---------------------------------------PEDFE 645 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~---------------------------------------~~~~~ 645 (888)
+.||+|++|.||+|+.. +|+.||||+.++.-.... .-+|.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46999999999999987 899999999854311000 00245
Q ss_pred HHHHHHhhcC----CCCcceeeeEEE-cCCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHH-HHHHhhh
Q 002717 646 REVRVLGKAR----HPNLISLEGYYW-TPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK-GLAHLHH 719 (888)
Q Consensus 646 ~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~ 719 (888)
+|+..+.+++ |.+-+.+-.++. .....++||||++|+++.+...... ... .+.+++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 5666666652 333333333332 2345689999999999988765421 111 34566766666 4678888
Q ss_pred cCCCCeEecCCCCCcEEecCCCCcEEecccccccccc
Q 002717 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 720 ~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
. |++|+|++|.||++++++.++++|||++..+.+
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-12 Score=122.60 Aligned_cols=126 Identities=26% Similarity=0.310 Sum_probs=59.3
Q ss_pred CCccccccccccccCccc-ccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEc
Q 002717 1 MTTPLVHGNSYNAIPSMV-VFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSL 79 (888)
Q Consensus 1 ~~~l~l~~n~~~~ip~~~-~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L 79 (888)
++.|++++|.|+.|..+. .+++|+.||||+|.|+.+ ..+..+ ++|+.|+|++|+|+ .++......+++|++|+|
T Consensus 21 ~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L--~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 21 LRELNLRGNQISTIENLGATLDKLEVLDLSNNQITKL--EGLPGL--PRLKTLDLSNNRIS-SISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ---------------S--TT-TT--EEE-TTS--S----TT------TT--EEE--SS----S-CHHHHHH-TT--EEE-
T ss_pred cccccccccccccccchhhhhcCCCEEECCCCCCccc--cCccCh--hhhhhcccCCCCCC-ccccchHHhCCcCCEEEC
Confidence 367999999999999876 589999999999999854 346665 89999999999998 776655567999999999
Q ss_pred CCcccccccc-ccccCCCCCCEEECcCcccccccCccccccccccccCcEEEcC
Q 002717 80 AGNILQGPIG-KIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 132 (888)
Q Consensus 80 ~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls 132 (888)
++|+|.++.. ..+..+++|+.|+|.+|.++.... -....+..+++|+.||-.
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~-YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKN-YRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTT-HHHHHHHH-TT-SEETTE
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCcccchhh-HHHHHHHHcChhheeCCE
Confidence 9999988654 557889999999999999986543 233467789999998754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.2e-11 Score=129.96 Aligned_cols=171 Identities=19% Similarity=0.220 Sum_probs=131.1
Q ss_pred EEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEecCCCCCHHHHHhhcCCCCC
Q 002717 617 KVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP 696 (888)
Q Consensus 617 ~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~ 696 (888)
.|..+.++.+|.|........ ...+...+.++.++.+|||||++++..+..++..|+|+|.+. -|..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----
Confidence 466667888999988865554 344567788999999999999999999999999999999974 477777764
Q ss_pred CCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccccccccccccccCcc
Q 002717 697 PLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776 (888)
Q Consensus 697 ~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE 776 (888)
.......-+.||+.||.|||+.| +++|+++.-..|+|++.|+.||++|.++........ ......---.|..|+
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPE 175 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChh
Confidence 35666778899999999999776 999999999999999999999999998865432221 111111122366676
Q ss_pred cccCcCCCCCcchHHHHHHHHHHHHhCC
Q 002717 777 LTCQSLRVNEKCDIYGFGVLILELVTGR 804 (888)
Q Consensus 777 ~~~~~~~~~~~sDvwS~Gv~l~elltg~ 804 (888)
..... .-..|.|.|||++||++.|.
T Consensus 176 ~~~~s---~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 176 EIDPS---EWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hcCcc---ccchhhhhHHHHHHHHhCcc
Confidence 54111 13569999999999999983
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.2e-11 Score=135.53 Aligned_cols=249 Identities=21% Similarity=0.217 Sum_probs=180.2
Q ss_pred hhhcCeecc--ccceEEEEEEE--CCCCeEEEEEEeecCCc-cCChHHHHHHHHHHhhc-CCCCcceeeeEEEcCCeeeE
Q 002717 601 LEKAAEVGE--GVFGTVYKVSF--GTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 601 ~~~~~~ig~--G~~g~V~~~~~--~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 674 (888)
+...+.+|. |.+|.||.+.. ..++..+|+|+-+.... ......-.+|+..-+.+ .|++.++.+..+...+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 344557899 99999999999 77899999998533322 12233445677777777 49999999999999999999
Q ss_pred EEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHH----HHHHhhhcCCCCeEecCCCCCcEEecCC-CCcEEeccc
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK----GLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFG 749 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg 749 (888)
-+|++. .++.++.+.. ...++....+....+..+ |+.++|+. .++|-|+||.||+..++ ..++++|||
T Consensus 196 qtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 999985 6777777664 233566677778888888 99999998 99999999999999988 899999999
Q ss_pred cccccccccccc---ccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHh
Q 002717 750 LARLLTRLDKHV---MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826 (888)
Q Consensus 750 la~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~ 826 (888)
+...+....-.. ......|...|++||.. ...++.++|+||+|.+..+..++..+...+.... |.+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~--~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~---- 337 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL--NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQ---- 337 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh--ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----ccc----
Confidence 998876544211 11122566779999986 3357899999999999999999888765542211 100
Q ss_pred cCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002717 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872 (888)
Q Consensus 827 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 872 (888)
..... .+ .++.+....++...+..+++.+|..|++.+.+..
T Consensus 338 ~r~~~---ip--~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 LRQGY---IP--LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccc---Cc--hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000 00 0122222334556888999999999999886654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-12 Score=136.42 Aligned_cols=208 Identities=22% Similarity=0.216 Sum_probs=140.5
Q ss_pred CCCccEEEcCCCCCcCCCch-hhhccCCCCcEEEcCCcccccc--ccccccCCCCCCEEECcCcccccccCccccccccc
Q 002717 46 MMNMKFLDLSNNLLSGPVPY-QLFENCASLRYLSLAGNILQGP--IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWS 122 (888)
Q Consensus 46 ~~~L~~L~Ls~N~l~~~~~~-~~f~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 122 (888)
+++|+...|.+.... .++. .....|++++.|||++|-+... ...+.+.|++|+.|+|+.|++...... ..-..
T Consensus 120 ~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s---~~~~~ 195 (505)
T KOG3207|consen 120 LKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISS---NTTLL 195 (505)
T ss_pred HHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccc---cchhh
Confidence 366888888888886 4442 4557889999999999988763 335567889999999999988643221 12225
Q ss_pred cccCcEEEcCCcccccc-CCccccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEccCCccCcCC-ChhhhcCCCCcE
Q 002717 123 LKRLRTLDLSHNLFSGS-IPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL-PVSLRLLNSMIF 200 (888)
Q Consensus 123 l~~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~ 200 (888)
+++|+.|.|+.|.++.. +......+++|+.|+|..|............+..|+.|||++|++-... -.....++.|..
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhh
Confidence 78888888888888732 2233466788888888888533344444556778888888888876432 234567777888
Q ss_pred EEeecCccccc-CCcC-----cccCCcccEEEeeccccCCC-CCCCCCCCCCCcEEEeeCCcCC
Q 002717 201 ISVSNNTLTGD-IPHW-----IGNISTLEFLDFSNNHLTGS-LPSSLFNCKKLSVIRLRGNSLN 257 (888)
Q Consensus 201 L~L~~N~l~~~-~~~~-----~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~ 257 (888)
|+++.+.+..+ .|+. ...+++|++|+++.|+|... .-..+..+.+|+.|.+..|.++
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 88888877643 2332 34567788888888887531 1234445667777777777776
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.5e-12 Score=145.84 Aligned_cols=113 Identities=38% Similarity=0.563 Sum_probs=105.7
Q ss_pred cceEEEcccCcccccCCccccccCCCceEEccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEcc
Q 002717 346 SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLE 425 (888)
Q Consensus 346 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 425 (888)
.++.|+|++|.+.|.+|..+..+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 48899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcceecCCcccccc-CCCCeeeccCCcceecCC
Q 002717 426 FNELSGEIPQELGKL-ASLLAVNVSYNRLIGRLP 458 (888)
Q Consensus 426 ~N~l~~~~p~~~~~l-~~L~~l~ls~N~l~~~~p 458 (888)
+|+++|.+|..++.+ ..+..+++++|...+.+|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999999874 467899999998665555
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-13 Score=139.02 Aligned_cols=236 Identities=23% Similarity=0.330 Sum_probs=139.9
Q ss_pred ccCCcCeEecCCCccccc----CCchhhccCCCCccEEEcCCC---CCcCCCchhh------hccCCCCcEEEcCCcccc
Q 002717 19 VFRILERLNFSHNSLSGQ----IPPSLLNLNMMNMKFLDLSNN---LLSGPVPYQL------FENCASLRYLSLAGNILQ 85 (888)
Q Consensus 19 ~~~~L~~L~ls~n~l~~~----~p~~~~~l~~~~L~~L~Ls~N---~l~~~~~~~~------f~~l~~L~~L~L~~N~l~ 85 (888)
.+..+++++||+|.+... +-..+... ++|++-++|+= ++...+|..+ +.+++.|++|+||+|.+.
T Consensus 28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~--~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 28 PMDSLTKLDLSGNTFGTEAARAIAKVLASK--KELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred ccCceEEEeccCCchhHHHHHHHHHHHhhc--ccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 567788888888888532 33444444 56777777752 2222344322 456778888888888776
Q ss_pred cccc----ccccCCCCCCEEECcCcccccccCcc---------ccccccccccCcEEEcCCcccccc----CCccccCCC
Q 002717 86 GPIG----KIFNYCSSLNTLNLSNNHFSGDLDFA---------SGYGIWSLKRLRTLDLSHNLFSGS----IPQGVAALH 148 (888)
Q Consensus 86 ~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~---------~~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~ 148 (888)
.-.. ..+..+..|++|.|.+|.+....... .......-++|+++..++|++..- +...|...+
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~ 185 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHP 185 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcc
Confidence 4222 33455778888888888775322111 111233456677777777777632 233455566
Q ss_pred CCCEEEccCccccc----cCCCCCCCCCCCCEEEccCCccCcC----CChhhhcCCCCcEEEeecCcccccCCcCcc---
Q 002717 149 YLKELLLQGNQFSG----PLPADIGFCPHLTTLDLSNNLFTGQ----LPVSLRLLNSMIFISVSNNTLTGDIPHWIG--- 217 (888)
Q Consensus 149 ~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--- 217 (888)
.|+++.++.|.|.. .....|..+++|+.|||.+|-++.. +...++.+++|+.|++++|.+......+|.
T Consensus 186 ~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al 265 (382)
T KOG1909|consen 186 TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDAL 265 (382)
T ss_pred ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHH
Confidence 77777777777651 1223456677777777777777632 234456666677777777766644333322
Q ss_pred --cCCcccEEEeeccccCC----CCCCCCCCCCCCcEEEeeCCcC
Q 002717 218 --NISTLEFLDFSNNHLTG----SLPSSLFNCKKLSVIRLRGNSL 256 (888)
Q Consensus 218 --~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l 256 (888)
..++|+.|.|.+|.|+. .+...+...+.|..|+|++|.+
T Consensus 266 ~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 266 KESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred hccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 34667777777776663 2222334456666666666666
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.2e-12 Score=126.19 Aligned_cols=133 Identities=24% Similarity=0.289 Sum_probs=82.6
Q ss_pred ccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceEEccCCcCCCccCccccccccccEEE
Q 002717 320 FANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 399 (888)
Q Consensus 320 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 399 (888)
+..|++|||++|.|+ .+.++..-++.++.|++|+|.|..+ +.+..+++|+.||||+|.++ .+..+-..+-+.++|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 344555555555554 2334444555666666666666522 22566666666666666666 4445555666777777
Q ss_pred ccCCcccccCCccccCCCCCCeEEccCCcceec-CCccccccCCCCeeeccCCcceecCC
Q 002717 400 LSHNHLSGSIPKSISNLNKLKILKLEFNELSGE-IPQELGKLASLLAVNVSYNRLIGRLP 458 (888)
Q Consensus 400 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~l~ls~N~l~~~~p 458 (888)
|+.|.|.. -..++.|-+|..||+++|+|... --..+++|+.|+.+.|.+|++.+.+-
T Consensus 359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 77777652 23466677777777777777632 13457788888888888888876544
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.4e-13 Score=134.65 Aligned_cols=232 Identities=22% Similarity=0.278 Sum_probs=176.6
Q ss_pred CccccccccccccCc------ccccCCcCeEecCCC---cccccCCchhhcc-----CCCCccEEEcCCCCCcCCCch--
Q 002717 2 TTPLVHGNSYNAIPS------MVVFRILERLNFSHN---SLSGQIPPSLLNL-----NMMNMKFLDLSNNLLSGPVPY-- 65 (888)
Q Consensus 2 ~~l~l~~n~~~~ip~------~~~~~~L~~L~ls~n---~l~~~~p~~~~~l-----~~~~L~~L~Ls~N~l~~~~~~-- 65 (888)
|-+++++|.+..-.+ +..-++|++.++|+- ++...+|.++.-| ..++|++||||+|-+.-.-+.
T Consensus 33 ~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l 112 (382)
T KOG1909|consen 33 TKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGL 112 (382)
T ss_pred EEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHH
Confidence 567888888876653 335678999999874 3444566555432 235799999999999733222
Q ss_pred -hhhccCCCCcEEEcCCcccccccccc-------------ccCCCCCCEEECcCcccccccCccccccccccccCcEEEc
Q 002717 66 -QLFENCASLRYLSLAGNILQGPIGKI-------------FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDL 131 (888)
Q Consensus 66 -~~f~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L 131 (888)
..+..+.+|++|+|.+|.+.....+. ...-++|++++.++|++.+.+....+..|...+.|+.+.+
T Consensus 113 ~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~ 192 (382)
T KOG1909|consen 113 EELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRL 192 (382)
T ss_pred HHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEE
Confidence 33678899999999999997543333 2345789999999999988776666778888999999999
Q ss_pred CCccccc----cCCccccCCCCCCEEEccCccccc----cCCCCCCCCCCCCEEEccCCccCcCCChhh-----hcCCCC
Q 002717 132 SHNLFSG----SIPQGVAALHYLKELLLQGNQFSG----PLPADIGFCPHLTTLDLSNNLFTGQLPVSL-----RLLNSM 198 (888)
Q Consensus 132 s~n~l~~----~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L 198 (888)
+.|.|.. .....|..+++|+.|||++|.++. .+...+..+++|+.|++++|.+.......| ...++|
T Consensus 193 ~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L 272 (382)
T KOG1909|consen 193 SQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSL 272 (382)
T ss_pred ecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCC
Confidence 9999872 234568889999999999999873 234566778899999999999986554444 347899
Q ss_pred cEEEeecCccccc----CCcCcccCCcccEEEeeccccC
Q 002717 199 IFISVSNNTLTGD----IPHWIGNISTLEFLDFSNNHLT 233 (888)
Q Consensus 199 ~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 233 (888)
+.|.+.+|.|+.. +...+...+.|+.|+|+.|++.
T Consensus 273 ~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 273 EVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9999999999742 3334556889999999999994
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.6e-12 Score=125.81 Aligned_cols=132 Identities=32% Similarity=0.327 Sum_probs=109.0
Q ss_pred ccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceE
Q 002717 295 LFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGIL 374 (888)
Q Consensus 295 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 374 (888)
.++.|+.+|||+|.|+ .+..++.-.+.++.|++++|.|+.+ ..+..+++|+.||||+|.++ .+.++-..+.+++.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 4678999999999998 6777888889999999999999855 34888999999999999998 556666678899999
Q ss_pred EccCCcCCCccCccccccccccEEEccCCccccc-CCccccCCCCCCeEEccCCcceec
Q 002717 375 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGS-IPKSISNLNKLKILKLEFNELSGE 432 (888)
Q Consensus 375 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~ 432 (888)
.|++|.|.. -..++.+-+|..||+++|+|... --..+++|+.|+.|.|.+|++.+.
T Consensus 358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 999999873 24578888899999999999732 224689999999999999999853
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.2e-11 Score=115.17 Aligned_cols=129 Identities=20% Similarity=0.210 Sum_probs=95.1
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcc-eeeeEEEcCCeeeEEEecCCCCC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI-SLEGYYWTPQLKLLVSDYAPNGS 683 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs 683 (888)
+.++.|.++.||+++. .++.|++|....... ....+.+|+.+++.+.+..++ +++.+. ....++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEE--CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 3688999999999997 478899998744321 224567899999998655544 444433 334589999999987
Q ss_pred HHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcC--CCCeEecCCCCCcEEecCCCCcEEecccccc
Q 002717 684 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF--RPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 684 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
+.+. . .....++.+++++++.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 78 l~~~--~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE--D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6532 0 111345678999999999872 12369999999999999 6689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.8e-11 Score=138.09 Aligned_cols=142 Identities=15% Similarity=0.212 Sum_probs=92.7
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCcc---------------------------------CChH------HHH
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII---------------------------------QYPE------DFE 645 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~---------------------------------~~~~------~~~ 645 (888)
+.||+|++|.||+|+++.+|+.||||+.++.-.. +..+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 4799999999999999866999999998643100 0001 244
Q ss_pred HHHHHHhhcC----CCCcceeeeEEEc-CCeeeEEEecCCCCCHHHHH--hhcCCCCCCCChhhHHHHHHHHHHHHHHhh
Q 002717 646 REVRVLGKAR----HPNLISLEGYYWT-PQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLH 718 (888)
Q Consensus 646 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH 718 (888)
+|+..+.+++ +...+.+-.++++ ....++||||++|+.+.+.- .........+....+..++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 5555555552 4444444444433 34568999999999998743 2211001112222223333333 3
Q ss_pred hcCCCCeEecCCCCCcEEecCCC----CcEEecccccccccc
Q 002717 719 HSFRPPIIHYNLKPSNILLDDNY----NPRISDFGLARLLTR 756 (888)
Q Consensus 719 ~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfgla~~~~~ 756 (888)
.. |++|+|+||.||+++.++ .+++.|||++..+.+
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 999999999999999887 999999999987754
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.9e-12 Score=132.39 Aligned_cols=216 Identities=22% Similarity=0.199 Sum_probs=114.6
Q ss_pred CCCCCCEEECcCcccccccCccccccccccccCcEEEcCCccccccC--CccccCCCCCCEEEccCccccccCCCC-CCC
Q 002717 94 YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI--PQGVAALHYLKELLLQGNQFSGPLPAD-IGF 170 (888)
Q Consensus 94 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~ 170 (888)
++++|++..|.+..+...+.. .....+++++.||||+|-+.... -.....|++|+.|+|+.|++....... -..
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~---~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIE---EYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hHHhhhheeecCccccccchh---hhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence 344455555555544322110 12334555555555555554221 223345555666666666554211111 113
Q ss_pred CCCCCEEEccCCccCc-CCChhhhcCCCCcEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCC--CCCCCCCCCc
Q 002717 171 CPHLTTLDLSNNLFTG-QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLP--SSLFNCKKLS 247 (888)
Q Consensus 171 l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~ 247 (888)
+++|+.|.|+.|.++. ........+++|+.|+|..|............+..|++|||++|++-. .+ .....++.|.
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchh
Confidence 5666677777776662 112234556677777777774332333444556677777777777653 22 3455677777
Q ss_pred EEEeeCCcCCCCCCccccccCCceEEcccCcccccCCCCCCCCCCCcccCCCCEEeCCCCcCcccC-ChhhhhccCCcEe
Q 002717 248 VIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDI-PAEMGLFANLRYL 326 (888)
Q Consensus 248 ~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~~p~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L 326 (888)
.|+++.+.+... . +|+..+ ..-...+++|++|++..|+|.... -..+..+++|+.|
T Consensus 275 ~Lnls~tgi~si-~---------------------~~d~~s-~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l 331 (505)
T KOG3207|consen 275 QLNLSSTGIASI-A---------------------EPDVES-LDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHL 331 (505)
T ss_pred hhhccccCcchh-c---------------------CCCccc-hhhhcccccceeeecccCccccccccchhhccchhhhh
Confidence 777777766521 0 011000 000134677888888888886321 2335567788888
Q ss_pred eccCCccccC
Q 002717 327 NLSSNHLRSR 336 (888)
Q Consensus 327 ~L~~N~l~~~ 336 (888)
....|.+...
T Consensus 332 ~~~~n~ln~e 341 (505)
T KOG3207|consen 332 RITLNYLNKE 341 (505)
T ss_pred hccccccccc
Confidence 8888888753
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.2e-12 Score=141.81 Aligned_cols=242 Identities=27% Similarity=0.273 Sum_probs=136.9
Q ss_pred ccCCcCeEecCCCcccccCCchhhccCCCCccEEEcCCCCCcCCCchhhhccCCCCcEEEcCCccccccccccccCCCCC
Q 002717 19 VFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSL 98 (888)
Q Consensus 19 ~~~~L~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 98 (888)
.+..++.+++..|.+.. +-..+..+ ++|+.|+|.+|+|. .+... +..+++|++|+|++|.|+.+.. +..++.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~--~~l~~l~l~~n~i~-~i~~~-l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L 142 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKL--KSLEALDLYDNKIE-KIENL-LSSLVNLQVLDLSFNKITKLEG--LSTLTLL 142 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccc--cceeeeeccccchh-hcccc-hhhhhcchheeccccccccccc--hhhccch
Confidence 45566666677776653 22334433 56777777777776 33321 3556777777777777776655 5556667
Q ss_pred CEEECcCcccccccCccccccccccccCcEEEcCCccccccCC-ccccCCCCCCEEEccCccccccCCCCCCCCCCCCEE
Q 002717 99 NTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP-QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTL 177 (888)
Q Consensus 99 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 177 (888)
+.|++++|.|+.... +..+++|+.+++++|+++...+ . ...+.+++.+++.+|.+..+ ..+..+..+..+
T Consensus 143 ~~L~l~~N~i~~~~~------~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~ 213 (414)
T KOG0531|consen 143 KELNLSGNLISDISG------LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLL 213 (414)
T ss_pred hhheeccCcchhccC------CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHh
Confidence 777777777765432 3446777777777777764333 2 46666677777777776532 334444555555
Q ss_pred EccCCccCcCCChhhhcCC--CCcEEEeecCcccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCc
Q 002717 178 DLSNNLFTGQLPVSLRLLN--SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNS 255 (888)
Q Consensus 178 ~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 255 (888)
++..|.++..-+ +..+. .|+.+++++|++.. .+..+..+..+..|++.+|++... ..+.....+..+.+..|.
T Consensus 214 ~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~ 288 (414)
T KOG0531|consen 214 SLLDNKISKLEG--LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNK 288 (414)
T ss_pred hcccccceeccC--cccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcch
Confidence 666676663222 11222 26667777777662 334455666677777777776632 224445555666666666
Q ss_pred CCCC---CCcc-cc-ccCCceEEcccCcccc
Q 002717 256 LNGN---IPEG-LF-DLGLEEIDLSENGFMG 281 (888)
Q Consensus 256 l~~~---~p~~-~~-~~~L~~L~l~~N~l~~ 281 (888)
+... .... .. ...+..+.+..|....
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 289 LALSEAISQEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred hcchhhhhccccccccccccccccccCcccc
Confidence 5421 1110 11 1145556666665544
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.6e-12 Score=142.23 Aligned_cols=266 Identities=27% Similarity=0.318 Sum_probs=126.3
Q ss_pred ccCcEEEcCCccccccCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEEEe
Q 002717 124 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 203 (888)
Q Consensus 124 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 203 (888)
+.++.++..++.+....-. ...+..++.+++..|.|.. .-..+..+.+|+.|++.+|+|..+
T Consensus 49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i---------------- 110 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI---------------- 110 (414)
T ss_pred chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc----------------
Confidence 3455555555544321111 1344455555555555552 222244445555555555555422
Q ss_pred ecCcccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCCCCCccccccCCceEEcccCcccccC
Q 002717 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 283 (888)
Q Consensus 204 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~l~~N~l~~~~ 283 (888)
...+..+++|++|++++|.|+.+ ..+..++.|+.|++++|.|+. +..
T Consensus 111 ---------~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~-~~~--------------------- 157 (414)
T KOG0531|consen 111 ---------ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISD-ISG--------------------- 157 (414)
T ss_pred ---------ccchhhhhcchheeccccccccc--cchhhccchhhheeccCcchh-ccC---------------------
Confidence 11144455555555555555533 223444445555555555541 111
Q ss_pred CCCCCCCCCCcccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCc
Q 002717 284 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 363 (888)
Q Consensus 284 p~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 363 (888)
+..+..|+.+++++|++...-+.....+.+++.+.+.+|.+..+ ..+..+..+..+++..|+++..-+
T Consensus 158 ---------~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~- 225 (414)
T KOG0531|consen 158 ---------LESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG- 225 (414)
T ss_pred ---------CccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC-
Confidence 01134455555555555532220034555666666666666432 334444444455666666652211
Q ss_pred cccccCC--CceEEccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceec---CCcc-c
Q 002717 364 EVCESRS--LGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE---IPQE-L 437 (888)
Q Consensus 364 ~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p~~-~ 437 (888)
+..+.. |+.+++++|.+. ..+..+..+..+..|++++|++... ..+.....+..+.+..|++... .... .
T Consensus 226 -l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (414)
T KOG0531|consen 226 -LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYIT 301 (414)
T ss_pred -cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccc
Confidence 112222 566666666665 3334555666666666666666522 2244445555556666655411 1111 3
Q ss_pred cccCCCCeeeccCCcceec
Q 002717 438 GKLASLLAVNVSYNRLIGR 456 (888)
Q Consensus 438 ~~l~~L~~l~ls~N~l~~~ 456 (888)
+....+..+.+..|.....
T Consensus 302 ~~~~~~~~~~~~~~~~~~~ 320 (414)
T KOG0531|consen 302 SAAPTLVTLTLELNPIRKI 320 (414)
T ss_pred cccccccccccccCccccc
Confidence 4444555555555554443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.8e-09 Score=105.75 Aligned_cols=137 Identities=15% Similarity=0.111 Sum_probs=97.5
Q ss_pred CeeccccceEEEEEEECC------CCeEEEEEEeecCCcc---------------------CChHHHH----HHHHHHhh
Q 002717 605 AEVGEGVFGTVYKVSFGT------QGRMLAVKKLVTSDII---------------------QYPEDFE----REVRVLGK 653 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~------~~~~vavK~l~~~~~~---------------------~~~~~~~----~E~~~l~~ 653 (888)
..||.|--+.||.|.... .+..+|||..+..... ...+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999998643 3578999987432110 0012233 79999999
Q ss_pred cCC--CCcceeeeEEEcCCeeeEEEecCCCCCHH-HHHhhcCCCCCCCChhhHHHHHHHHHHHHHHh-hhcCCCCeEecC
Q 002717 654 ARH--PNLISLEGYYWTPQLKLLVSDYAPNGSLQ-AKLHERLPSTPPLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYN 729 (888)
Q Consensus 654 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrd 729 (888)
+.. -++.+.+++ ...++||||+.++.+. ..+.. ..++......+..+++.+|..+ |.. ++||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 952 455566654 4568999999765432 22332 1244455667889999999999 776 999999
Q ss_pred CCCCcEEecCCCCcEEecccccccc
Q 002717 730 LKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 730 lk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
+++.||++++ +.+.++|||.+-..
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 67999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.3e-10 Score=125.66 Aligned_cols=248 Identities=21% Similarity=0.256 Sum_probs=174.0
Q ss_pred hhcCeeccccceEEEEEEEC-CCCeEEEEEEeecCCccCChHHH-HHHHHHHhhc-CCCCcceeeeEEEcCCeeeEEEec
Q 002717 602 EKAAEVGEGVFGTVYKVSFG-TQGRMLAVKKLVTSDIIQYPEDF-EREVRVLGKA-RHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 602 ~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~l~~~~~~~~~~~~-~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
.....||.|.|+.|+....+ .++..|++|...........+.+ ..|+.+...+ .|.++++++..+..-+..|+=.||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 34458999999999998876 57788999987554322222222 4577777666 588999888877777777899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCC-CCcEEeccccccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFGLARLLTRL 757 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfgla~~~~~~ 757 (888)
+++++....+.- ...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||++..+.-.
T Consensus 348 ~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 348 CEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred hcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee
Confidence 999988776633 23477788899999999999999988 99999999999999875 88999999998642210
Q ss_pred cccccccccccccccc-CcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCC
Q 002717 758 DKHVMSNRFQSALGYV-APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~-aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.......-+++ ..|++.....+-.++|+||||..+.|..++..--..+.. . .. ++.+ .
T Consensus 421 -----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-~---~~-----i~~~-----~-- 479 (524)
T KOG0601|consen 421 -----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-S---LT-----IRSG-----D-- 479 (524)
T ss_pred -----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-c---ee-----eecc-----c--
Confidence 01122233444 355555666778899999999999999987543221111 0 00 0000 0
Q ss_pred CCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhcC
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 879 (888)
....+.. ...+..+...+..+++..||.+.+...+.+..++
T Consensus 480 -~p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 480 -TPNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred -ccCCCch-HHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 1111222 2566778888999999999999998876655443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.4e-10 Score=90.09 Aligned_cols=61 Identities=38% Similarity=0.481 Sum_probs=48.4
Q ss_pred CCccEEEcCCCCCcCCCchhhhccCCCCcEEEcCCccccccccccccCCCCCCEEECcCccc
Q 002717 47 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHF 108 (888)
Q Consensus 47 ~~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 108 (888)
++|++|+|++|+|+ .+|..+|.++++|++|++++|.|+.+++++|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 35778888888887 77777788888888888888888888888888888888888888764
|
... |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.4e-09 Score=98.14 Aligned_cols=131 Identities=27% Similarity=0.360 Sum_probs=100.1
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeec-CCccCC------hHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVT-SDIIQY------PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~~~~vavK~l~~-~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
.+++|+-+.+|.+.+ -|..+++|.-.+ ...... .+...+|+.++.+++--.|.-..-+..+++...++|||
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 578999999999988 455566665322 221111 13456799999998755555555566678888999999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccc
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
++|..|.+.+... ...++..+-.-+.-||.. +|+|+|+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888764 245667777888889998 999999999999998764 99999999964
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=7e-09 Score=96.65 Aligned_cols=142 Identities=20% Similarity=0.252 Sum_probs=104.8
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCc-cC------ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEe
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQ------YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~-~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 677 (888)
..+-+|+-+.|+++.+ .|+...||.-..... .. ..+...+|+..+.+++--.|.-..-++.+.....++||
T Consensus 13 ~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4788999999999999 688888875322211 11 12456789999999865455444445667777789999
Q ss_pred cCCC-CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCC---cEEeccccccc
Q 002717 678 YAPN-GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN---PRISDFGLARL 753 (888)
Q Consensus 678 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfgla~~ 753 (888)
|+++ .++.+++.... ...........++..|-+.+.-||.. +|+|+|+..+||++.+++. +.+.|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9976 48888888753 22223333367889999999999998 9999999999999975543 58999999853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=3e-09 Score=109.20 Aligned_cols=143 Identities=24% Similarity=0.311 Sum_probs=106.5
Q ss_pred CeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCC--CCcceeeeEEEcCC---eeeEEEecC
Q 002717 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARH--PNLISLEGYYWTPQ---LKLLVSDYA 679 (888)
Q Consensus 605 ~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~ 679 (888)
+.++.|.++.||+++.. +|+.+++|.............+..|+++++.+++ ..+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 36899999999999885 4688999987544322234678899999999965 34567777766542 568999999
Q ss_pred CCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF-------------------------------------- 721 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------- 721 (888)
+++++.+.+.. ..++..+...++.++++++.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99877664421 23566666777777777777777421
Q ss_pred ---------------CCCeEecCCCCCcEEecC--CCCcEEeccccccc
Q 002717 722 ---------------RPPIIHYNLKPSNILLDD--NYNPRISDFGLARL 753 (888)
Q Consensus 722 ---------------~~~ivHrdlk~~Nill~~--~~~~kl~Dfgla~~ 753 (888)
...++|+|+++.||+++. ++.+.+.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 56689999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.3e-08 Score=104.47 Aligned_cols=219 Identities=19% Similarity=0.203 Sum_probs=151.2
Q ss_pred cceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhcCCCCcceeeeEEE----cCCeeeEEEecCCC-CCHH
Q 002717 611 VFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW----TPQLKLLVSDYAPN-GSLQ 685 (888)
Q Consensus 611 ~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~ 685 (888)
...+.|++....+|..|++|+++ ....+.......-+++++++.|+|||++..++. .+...++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlh-g~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLH-GDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeec-cccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 44578999999999999999993 333333434456688999999999999998876 34567899999886 5777
Q ss_pred HHHhhcC-----------CCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccc
Q 002717 686 AKLHERL-----------PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 686 ~~l~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
+.--... ..+...++..+|.++.|++.||.++|+. |..-+-+.+.+|+++.+.+++|+..|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 6543211 1245578899999999999999999999 9999999999999999999999988876544
Q ss_pred cccccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCccccc
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
.... . |.+ .--.+-|.=.+|.+++.+.||..--..... . .....+.
T Consensus 444 ~~d~--------------~--~~l----e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-~--~~s~~~~----------- 489 (655)
T KOG3741|consen 444 QEDP--------------T--EPL----ESQQQNDLRDLGLLLLALATGTENSNRTDS-T--QSSHLTR----------- 489 (655)
T ss_pred cCCC--------------C--cch----hHHhhhhHHHHHHHHHHHhhcccccccccc-h--HHHHHHH-----------
Confidence 3211 0 111 112366888999999999998543111111 1 1111111
Q ss_pred CCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 874 (888)
.......++.+++.-....++++ -++.+++.++
T Consensus 490 ------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 490 ------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 12233445566666666666666 4666666554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.3e-08 Score=102.30 Aligned_cols=265 Identities=17% Similarity=0.176 Sum_probs=161.0
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccCChHHHHHHHHHHhhc-CCCCcceeeeE----EE--c-CCee
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGY----YW--T-PQLK 672 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~~--~-~~~~ 672 (888)
...++.+|+|+-+.+|-.-.- +..+.|+....... .-.+.+.+|... .||-+-.=+.+ .+ . ....
T Consensus 13 i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa----~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPA----AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred cCCCccccCCccceeeecchh---hchhheeecCCCch----HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 344668999999999964331 12344666444321 112233444444 56644331111 11 1 1225
Q ss_pred eEEEecCCCCCHHHHHhh---cCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccc
Q 002717 673 LLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 749 (888)
.++|..+++.-=-..+.. +..+-+...|...+++++.+|.+.+.||.. |.+-+|+.++|+|+.+++.|.+.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 677877766522222221 233456789999999999999999999998 99999999999999999999998754
Q ss_pred ccccccccccccccccccccccccCccccc----CcCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCC---chhhHHHHH
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTG-RRPVEYGED---NVVILSEHV 821 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~sDvwS~Gv~l~elltg-~~p~~~~~~---~~~~l~~~~ 821 (888)
.-..... + .......|...|.+||... .+..-+...|-|.+||++|+++.| ++||..... ...-+...
T Consensus 163 sfqi~~n-g--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~- 238 (637)
T COG4248 163 SFQINAN-G--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD- 238 (637)
T ss_pred ceeeccC-C--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh-
Confidence 3322211 1 1112335677899999642 123446789999999999999886 999976321 11111100
Q ss_pred HHHHhcCCcccccCCCC------CCCC-hhhHHHHHHHHHHccCC--CCCCCCCHHHHHHHHHhhcCCCC
Q 002717 822 RVLLEEGNVLDCVDPSM------GDYP-EDEVLPVLKLALVCTCH--IPSSRPSMAEVVQILQVIKTPLP 882 (888)
Q Consensus 822 ~~~~~~~~~~~~~d~~~------~~~~-~~~~~~l~~li~~cl~~--dp~~RPs~~evl~~L~~~~~~~~ 882 (888)
+..+.+...-|... ...| .-.+.++..+..+|+.. .+.-|||++-++..|..+.+.+-
T Consensus 239 ---Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 239 ---IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred ---hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 11112211111111 1111 22234577888999855 36789999999999988766543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-09 Score=129.86 Aligned_cols=199 Identities=24% Similarity=0.216 Sum_probs=123.6
Q ss_pred CccEEEcCCCCCcCCCchhhhccCCCCcEEEcCCcc--ccccccccccCCCCCCEEECcCccc-ccccCccccccccccc
Q 002717 48 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNI--LQGPIGKIFNYCSSLNTLNLSNNHF-SGDLDFASGYGIWSLK 124 (888)
Q Consensus 48 ~L~~L~Ls~N~l~~~~~~~~f~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~~~~~l~ 124 (888)
..+...+-+|.+. .++.. ..++.|++|-+.+|. +..+..+.|..++.|++|||++|.= ...| ..++.|-
T Consensus 524 ~~rr~s~~~~~~~-~~~~~--~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP-----~~I~~Li 595 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGS--SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLP-----SSIGELV 595 (889)
T ss_pred heeEEEEeccchh-hccCC--CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCC-----hHHhhhh
Confidence 4667777777775 45543 345677777777775 6667777777777777777776642 2222 2466777
Q ss_pred cCcEEEcCCccccccCCccccCCCCCCEEEccCccccccCCCCCCCCCCCCEEEccCCcc--CcCCChhhhcCCCCcEEE
Q 002717 125 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLF--TGQLPVSLRLLNSMIFIS 202 (888)
Q Consensus 125 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l--~~~~~~~~~~l~~L~~L~ 202 (888)
+|++|+|++..++ .+|.++.+|+.|.+|++..+.-...+|.....+++|++|.+..-.. +...-..+..+.+|+.+.
T Consensus 596 ~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls 674 (889)
T KOG4658|consen 596 HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLS 674 (889)
T ss_pred hhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhe
Confidence 8888888888887 6777888888888888887765555566666688888887766542 222333445555566555
Q ss_pred eecCcccccCCcCcccCCccc----EEEeeccccCCCCCCCCCCCCCCcEEEeeCCcCCC
Q 002717 203 VSNNTLTGDIPHWIGNISTLE----FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 258 (888)
Q Consensus 203 L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 258 (888)
....... +-..+..++.|. .+.+..+... ..+..+..+.+|+.|.+.++.+..
T Consensus 675 ~~~~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 675 ITISSVL--LLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred eecchhH--hHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 5433321 111123333333 3333333333 456677788888888888887763
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.7e-09 Score=84.05 Aligned_cols=59 Identities=36% Similarity=0.456 Sum_probs=28.7
Q ss_pred cccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccCCCCeeeccCCc
Q 002717 394 SLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNR 452 (888)
Q Consensus 394 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~ls~N~ 452 (888)
+|+.|++++|+|+...+..|..+++|++|++++|+++...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444555554443333444445555555555555544444445555555555555544
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.5e-09 Score=125.20 Aligned_cols=248 Identities=22% Similarity=0.244 Sum_probs=167.7
Q ss_pred hhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCccC--ChHHHHHHHHHHhhcCCCCcceeeeEEEcCCeeeEEEec
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 601 ~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 678 (888)
+...+-+-+|+++.++.+.-...|...+.|......... ..+....+-.+.-..+||-++....-+.-....++|++|
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~ 885 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY 885 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence 344447889999999988877777555666543322111 122223333333333456666655544445667899999
Q ss_pred CCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEeccccccccccc-
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL- 757 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~- 757 (888)
..++++...++.. +..+.+........+..+.+|||.. .+.|||++|.+.+...++..+++|||......-.
T Consensus 886 ~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 886 LNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999999875 2455555556667788899999987 7999999999999999999999999843322100
Q ss_pred ----------------------------ccccccccccccccccCcccccCcCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 002717 758 ----------------------------DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEY 809 (888)
Q Consensus 758 ----------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDvwS~Gv~l~elltg~~p~~~ 809 (888)
+.........+|+.|.|||.. .+......+|.|+.|++++|.++|..||..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~-lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL-LGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccc-ccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 000112345688999999988 555678889999999999999999999976
Q ss_pred CCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCCCCCCCCHH
Q 002717 810 GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA 868 (888)
Q Consensus 810 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 868 (888)
..... .++.+.. -+...+..+.........++.+.+..+|.+|-.|.
T Consensus 1038 ~tpq~-----~f~ni~~-------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQ-----IFENILN-------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhh-----hhhcccc-------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 43321 1111110 11222234455555677888888999999997776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=8.1e-08 Score=99.82 Aligned_cols=141 Identities=13% Similarity=0.082 Sum_probs=100.2
Q ss_pred eeccccceEEEEEEECCCCeEEEEEEeecCCccC---------C-hHHHHHHHHHHhhcCC--CCcceeeeEEEc-----
Q 002717 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ---------Y-PEDFEREVRVLGKARH--PNLISLEGYYWT----- 668 (888)
Q Consensus 606 ~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~~---------~-~~~~~~E~~~l~~l~h--~niv~l~~~~~~----- 668 (888)
.+-+.....|+++.+ +|+.|.||+........ . ...+.+|...+.++.. -.+...+++...
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 444444445777777 68899999774332111 1 1247889999888843 233445555543
Q ss_pred CCeeeEEEecCCCC-CHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecC-------C
Q 002717 669 PQLKLLVSDYAPNG-SLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-------N 740 (888)
Q Consensus 669 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~-------~ 740 (888)
....++|+|++++. +|.+++.... ..+.+......++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 8998886421 12345566778999999999999999 9999999999999975 4
Q ss_pred CCcEEeccccccc
Q 002717 741 YNPRISDFGLARL 753 (888)
Q Consensus 741 ~~~kl~Dfgla~~ 753 (888)
..+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6789999998853
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.4e-09 Score=123.59 Aligned_cols=128 Identities=27% Similarity=0.376 Sum_probs=72.2
Q ss_pred ccCcEEEcCCccccccCCccccCCCCCCEEEccCcc--ccccCCCCCCCCCCCCEEEccCCccCcCCChhhhcCCCCcEE
Q 002717 124 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQ--FSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFI 201 (888)
Q Consensus 124 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 201 (888)
...+.+.+-+|.+. .++.... .++|+.|-+..|. +.....+.|..++.|+.|||++|.=-+.+|..++.|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 45555666666654 2222222 2256666666664 443334445556666666666655445566666666666666
Q ss_pred EeecCcccccCCcCcccCCcccEEEeeccccCCCCCCCCCCCCCCcEEEeeCC
Q 002717 202 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 254 (888)
Q Consensus 202 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 254 (888)
+|+...++ .+|..+.+++.|.+|++..+.-...+|.....+++|++|.+..-
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence 66666666 45666666666666666665544344555555666666665443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.2e-10 Score=123.86 Aligned_cols=178 Identities=26% Similarity=0.277 Sum_probs=114.4
Q ss_pred CCcccCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccc----------cCCCCCcccCCcceEEEcccCcccccC
Q 002717 292 SSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR----------SRIPPELGYFHSLIHLDLRNNALYGSI 361 (888)
Q Consensus 292 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~----------~~~~~~~~~l~~L~~L~L~~N~l~~~~ 361 (888)
.+-.|.+|+.|.|.++.|.. .-....--..|+.|-- .|.+. +.+-.++.+ ..|...+.++|++. .+
T Consensus 104 ~ifpF~sLr~LElrg~~L~~-~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~W-n~L~~a~fsyN~L~-~m 179 (1096)
T KOG1859|consen 104 SIFPFRSLRVLELRGCDLST-AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVW-NKLATASFSYNRLV-LM 179 (1096)
T ss_pred eeccccceeeEEecCcchhh-hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhh-hhHhhhhcchhhHH-hH
Confidence 34557789999999988863 1111111123333321 12111 111112222 25777888888887 66
Q ss_pred CccccccCCCceEEccCCcCCCccCccccccccccEEEccCCcccccCCc-cccCCCCCCeEEccCCcceecCCcccccc
Q 002717 362 PQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPK-SISNLNKLKILKLEFNELSGEIPQELGKL 440 (888)
Q Consensus 362 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 440 (888)
..++.-++.|+.|||++|+++... .+..|++|+.|||+.|++. .+|. ...... |+.|.|++|.++. -..+.+|
T Consensus 180 D~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~t--L~gie~L 253 (1096)
T KOG1859|consen 180 DESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTT--LRGIENL 253 (1096)
T ss_pred HHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHh--hhhHHhh
Confidence 677777888888888888887432 7788888888888888887 4553 334444 8888888888873 2357788
Q ss_pred CCCCeeeccCCcceecCC--CCCCCCCCCCCCcCCCcCCCC
Q 002717 441 ASLLAVNVSYNRLIGRLP--VGGVFPTLDQSSLQGNLGICS 479 (888)
Q Consensus 441 ~~L~~l~ls~N~l~~~~p--~~~~~~~l~~~~~~~n~~~c~ 479 (888)
.+|+.|||++|-|.+--. ....+..+..+-++|||.-|.
T Consensus 254 ksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 254 KSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 888888888888876322 223445566677888888776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.3e-07 Score=92.53 Aligned_cols=125 Identities=25% Similarity=0.263 Sum_probs=81.0
Q ss_pred EEEEEEECCCCeEEEEEEeecCCcc------------C---------C----hHHHHHHHHHHhhcCCC--CcceeeeEE
Q 002717 614 TVYKVSFGTQGRMLAVKKLVTSDII------------Q---------Y----PEDFEREVRVLGKARHP--NLISLEGYY 666 (888)
Q Consensus 614 ~V~~~~~~~~~~~vavK~l~~~~~~------------~---------~----~~~~~~E~~~l~~l~h~--niv~l~~~~ 666 (888)
.||.|... +|..+|||..+..... . . .....+|...|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999885 7889999987432110 0 0 12456899999999755 455555442
Q ss_pred EcCCeeeEEEecCC--CCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHh-hhcCCCCeEecCCCCCcEEecCCCCc
Q 002717 667 WTPQLKLLVSDYAP--NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNP 743 (888)
Q Consensus 667 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrdlk~~Nill~~~~~~ 743 (888)
...+||||++ |..+..+.... ++.+....++.++...+..+ |.. ||+|+|+.+.||+++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eE
Confidence 3479999998 54443333221 22455667888888866665 566 99999999999999988 99
Q ss_pred EEeccccccc
Q 002717 744 RISDFGLARL 753 (888)
Q Consensus 744 kl~Dfgla~~ 753 (888)
.++|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998854
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.7e-10 Score=124.29 Aligned_cols=129 Identities=36% Similarity=0.387 Sum_probs=88.3
Q ss_pred cCCCCEEeCCCCcCcccCChhhhhccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceEE
Q 002717 296 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQ 375 (888)
Q Consensus 296 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 375 (888)
+..|...+.++|.+. .....+.-++.|+.|+|++|+++... .+.+++.|++|||++|.++ .+|.--..--.|+.|.
T Consensus 163 Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~ 238 (1096)
T KOG1859|consen 163 WNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLN 238 (1096)
T ss_pred hhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeee
Confidence 446777788888887 56667777788888888888887553 6777888888888888887 4443221122377788
Q ss_pred ccCCcCCCccCccccccccccEEEccCCcccccCC-ccccCCCCCCeEEccCCcce
Q 002717 376 LDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP-KSISNLNKLKILKLEFNELS 430 (888)
Q Consensus 376 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 430 (888)
+++|.++.. ..+.+|++|+.||++.|-|.+.-- ..++.|..|+.|+|.+|++-
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 888877632 346777778888888887764322 12455667777777777774
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.2e-06 Score=84.07 Aligned_cols=139 Identities=17% Similarity=0.084 Sum_probs=102.5
Q ss_pred eccccceEEEEEEECCCCeEEEEEEeecC--Cc---cCChHHHHHHHHHHhhcC--CCCcceeeeEEE-c--C--CeeeE
Q 002717 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTS--DI---IQYPEDFEREVRVLGKAR--HPNLISLEGYYW-T--P--QLKLL 674 (888)
Q Consensus 607 ig~G~~g~V~~~~~~~~~~~vavK~l~~~--~~---~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~-~--~--~~~~l 674 (888)
-|+||.+-|++..+ +|..+-+|+.... .. +-....|.+|+..++++. .-.+.+.. ++. . + ..-++
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 37799999999887 4667999986311 00 223467999999999994 22344444 332 1 1 23479
Q ss_pred EEecCCC-CCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCC--cEEeccccc
Q 002717 675 VSDYAPN-GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN--PRISDFGLA 751 (888)
Q Consensus 675 v~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfgla 751 (888)
|+|-+++ -+|.+++.... ..+.+...+..+..+++..++-||+. ++.|+|+.+.||+++.++. ++++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9997764 58888886531 23456677789999999999999999 9999999999999986666 999999876
Q ss_pred cc
Q 002717 752 RL 753 (888)
Q Consensus 752 ~~ 753 (888)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 53
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.2e-09 Score=93.44 Aligned_cols=110 Identities=22% Similarity=0.268 Sum_probs=69.0
Q ss_pred CcceEEEcccCcccccCCccccc-cCCCceEEccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEE
Q 002717 345 HSLIHLDLRNNALYGSIPQEVCE-SRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILK 423 (888)
Q Consensus 345 ~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 423 (888)
..|+..+|++|.+. ..|..|.. .+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|..||
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 34556677777776 45555543 346777777777777 56666777777777777777777 6677777777777777
Q ss_pred ccCCcceecCCccccccCCCCeeeccCCcceecCC
Q 002717 424 LEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 458 (888)
Q Consensus 424 L~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p 458 (888)
..+|.+. .+|-.+---+.....++.++.+.+.-|
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 7777776 444443322233334445555555444
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.4e-07 Score=88.75 Aligned_cols=136 Identities=19% Similarity=0.153 Sum_probs=94.6
Q ss_pred hhhhcCeeccccceEEEEEEECCCCeEEEEEEeecCCcc-----------------C----ChHHHHHHHHHHhhcCCC-
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----------------Q----YPEDFEREVRVLGKARHP- 657 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~V~~~~~~~~~~~vavK~l~~~~~~-----------------~----~~~~~~~E~~~l~~l~h~- 657 (888)
....+..||.|--+.||.|... +|.++|||.-+..... . .....++|.++|+++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3455678999999999999986 7999999975322110 0 123467899999998543
Q ss_pred -CcceeeeEEEcCCeeeEEEecCCCCCHHHHHhhcCCCCCCCChhhHHHHHHHHHHHHHHhhhcCCCCeEecCCCCCcEE
Q 002717 658 -NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 736 (888)
Q Consensus 658 -niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrdlk~~Nil 736 (888)
.|.+.+++ +...+||||++|--|...- ++.+..-.++..|.+-+...-.. ||||+|+.+-||+
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIl 234 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNIL 234 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEE
Confidence 56666543 4458999999885442211 12333344455555554444445 9999999999999
Q ss_pred ecCCCCcEEecccccc
Q 002717 737 LDDNYNPRISDFGLAR 752 (888)
Q Consensus 737 l~~~~~~kl~Dfgla~ 752 (888)
++++|.+.++||--+.
T Consensus 235 V~~dg~~~vIDwPQ~v 250 (304)
T COG0478 235 VTEDGDIVVIDWPQAV 250 (304)
T ss_pred EecCCCEEEEeCcccc
Confidence 9999999999997654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=8.2e-09 Score=90.90 Aligned_cols=140 Identities=26% Similarity=0.267 Sum_probs=101.2
Q ss_pred CCCEEeCCCCcCcccCChhhh---hccCCcEeeccCCccccCCCCCcccCCcceEEEcccCcccccCCccccccCCCceE
Q 002717 298 TLRILDLSSNNLVGDIPAEMG---LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGIL 374 (888)
Q Consensus 298 ~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 374 (888)
.+-.++|+++++- .+++... ....|+..+|++|.+....+..-...+.++.|+|++|+|+ .+|..+..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 3556777777764 4555443 3445667788888887544433344557888999999998 688889999999999
Q ss_pred EccCCcCCCccCccccccccccEEEccCCcccccCCccccCCCCCCeEEccCCcceecCCccccccC
Q 002717 375 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 441 (888)
Q Consensus 375 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 441 (888)
+++.|.+. ..|..|..|.+|-.|+..+|.+. .+|-.+-.-...-..++.++++.+.-|..+..+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~k 170 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQALK 170 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccccccC
Confidence 99999998 77888888999999999999887 5665544444455556688888877776655543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.3e-08 Score=98.32 Aligned_cols=63 Identities=17% Similarity=0.150 Sum_probs=36.3
Q ss_pred CCCceEEccCCcCCCcc-CccccccccccEEEccCCccccc-CCccccCCCCCCeEEccCCccee
Q 002717 369 RSLGILQLDGNSLTGPI-PQVIRNCTSLYLLSLSHNHLSGS-IPKSISNLNKLKILKLEFNELSG 431 (888)
Q Consensus 369 ~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~ 431 (888)
+++..+-+..|.|.... -+.+..++.+-.|+|+.|+|..- .-+.+.+++.|.-|.+++|+|..
T Consensus 199 pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 199 PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred ccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 35555666666554322 23344556666777777777521 12345666777777777777653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.2e-08 Score=106.75 Aligned_cols=152 Identities=19% Similarity=0.282 Sum_probs=103.3
Q ss_pred HHHHHHHHHhhhcCCCCeEecCCCCCcEEecCCCCcEEecccccccccccccccc-------cccccccccccCcccccC
Q 002717 708 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM-------SNRFQSALGYVAPELTCQ 780 (888)
Q Consensus 708 ~~ia~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~ 780 (888)
.+++.|+.|+|.. +++||++|.|++|.++.++..||+.|+.+........+-. +.-......|.|||++.
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~- 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL- 182 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc-
Confidence 4455899999965 5999999999999999999999999998765443111110 01112235699999984
Q ss_pred cCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCchhhHHHHHHHHHhcCCcccccCCCCCCCChhhHHHHHHHHHHccCCC
Q 002717 781 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHI 860 (888)
Q Consensus 781 ~~~~~~~sDvwS~Gv~l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~d 860 (888)
....+.++|+||+||++|-+..|+.+.-.......+... .+. ..+.....+....+.++.+=+.+++..+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~~---------~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SRN---------LLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hhc---------ccccccccccccCcHHHHHHHHHHhcCC
Confidence 467889999999999999998655554333222221111 000 1111222344566667888888999999
Q ss_pred CCCCCCHHHHHH
Q 002717 861 PSSRPSMAEVVQ 872 (888)
Q Consensus 861 p~~RPs~~evl~ 872 (888)
+..||++.++..
T Consensus 253 ~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 253 SAVRPTLDLLLS 264 (700)
T ss_pred cccCcchhhhhc
Confidence 999997777554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.6e-06 Score=85.78 Aligned_cols=105 Identities=26% Similarity=0.293 Sum_probs=82.9
Q ss_pred HHHHHHHHHHhhcC--CCCcceeeeEEEcCC----eeeEEEecCCCC-CHHHHHhhcCCCCCCCChhhHHHHHHHHHHHH
Q 002717 642 EDFEREVRVLGKAR--HPNLISLEGYYWTPQ----LKLLVSDYAPNG-SLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714 (888)
Q Consensus 642 ~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l 714 (888)
....+|...+..+. .=.+.+.+++..... ..++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 45778888888884 333556666665432 348999999874 8999888632 155566788999999999
Q ss_pred HHhhhcCCCCeEecCCCCCcEEecCCC---CcEEeccccccc
Q 002717 715 AHLHHSFRPPIIHYNLKPSNILLDDNY---NPRISDFGLARL 753 (888)
Q Consensus 715 ~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfgla~~ 753 (888)
+-||+. ||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 999999999999999876 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 888 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-48 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-48 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-36 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-19 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-05 | ||
| 3a79_B | 562 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 1e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 422 bits (1088), Expect = e-136
Identities = 141/503 (28%), Positives = 228/503 (45%), Gaps = 34/503 (6%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L L+ S N G +PP + + ++ L LS+N SG +P L+ L L+ N
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCS--LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 83 ILQGPIGK-IFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 141
G + + + N +SL TL+LS+N+FSG + L+ L L +N F+G IP
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPIL--PNLCQNPKNTLQELYLQNNGFTGKIP 411
Query: 142 QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFI 201
++ L L L N SG +P+ +G L L L N+ G++P L + ++ +
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETL 471
Query: 202 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 261
+ N LTG+IP + N + L ++ SNN LTG +P + + L++++L NS +GNIP
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531
Query: 262 EGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 320
L D L +DL+ N F G+IP S +++N + G +
Sbjct: 532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----------GKIAANFIAGKRYVYIKND 581
Query: 321 ANLRYLNLSSN--HLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDG 378
+ + + N + +L + ++ + G + S+ L +
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 379 NSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELG 438
N L+G IP+ I + L++L+L HN +SGSIP + +L L IL L N+L G IPQ +
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 701
Query: 439 KLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPCKMNVPKPLVLDP 498
L L +++S N L G +P G F T + N G+C L
Sbjct: 702 ALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCD------------ 749
Query: 499 DAYNSNQMDGHIHSHSFSSNHHH 521
+ DG+ H +HHH
Sbjct: 750 ----PSNADGYAHHQRSHHHHHH 768
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 401 bits (1032), Expect = e-127
Identities = 159/442 (35%), Positives = 233/442 (52%), Gaps = 20/442 (4%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVP--YQLFENCASLRYLSLA 80
L+ LN S N+L S L + +++ LDLS N +SG + L + C L++L+++
Sbjct: 128 LKFLNVSSNTLDFPGKVSGG-LKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 81 GNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
GN + G + + C +L L++S+N+FS + F + L+ LD+S N SG
Sbjct: 187 GNKISGDVD-VSR-CVNLEFLDVSSNNFSTGIPF-----LGDCSALQHLDISGNKLSGDF 239
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR-LLNSMI 199
+ ++ LK L + NQF GP+P L L L+ N FTG++P L +++
Sbjct: 240 SRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 200 FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLP-SSLFNCKKLSVIRLRGNSLNG 258
+ +S N G +P + G+ S LE L S+N+ +G LP +L + L V+ L N +G
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357
Query: 259 NIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAE 316
+PE L +L L +DLS N F G I P + +TL + L L +N G IP
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL----QELYLQNNGFTGKIPPT 413
Query: 317 MGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQL 376
+ + L L+LS N+L IP LG L L L N L G IPQE+ ++L L L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473
Query: 377 DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE 436
D N LTG IP + NCT+L +SLS+N L+G IPK I L L ILKL N SG IP E
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533
Query: 437 LGKLASLLAVNVSYNRLIGRLP 458
LG SL+ ++++ N G +P
Sbjct: 534 LGDCRSLIWLDLNTNLFNGTIP 555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 375 bits (964), Expect = e-117
Identities = 147/453 (32%), Positives = 212/453 (46%), Gaps = 27/453 (5%)
Query: 14 IPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCAS 73
IP + L+ L+ S N LSG ++ +K L++S+N GP+P S
Sbjct: 216 IPFLGDCSALQHLDISGNKLSGDFSRAISTCT--ELKLLNISSNQFVGPIPP---LPLKS 270
Query: 74 LRYLSLAGNILQGPI-GKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 132
L+YLSLA N G I + C +L L+LS NHF G + S L +L LS
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP----FFGSCSLLESLALS 326
Query: 133 HNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFC-PHLTTLDLSNNLFTGQLPV 190
N FSG +P + LK L L N+FSG LP + L TLDLS+N F+G +
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
Query: 191 SL--RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV 248
+L N++ + + NN TG IP + N S L L S N+L+G++PSSL + KL
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 249 IRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 307
++L N L G IP+ L + LE + L N G IP G S+ ++ L + LS+N
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN------LNWISLSNN 500
Query: 308 NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCE 367
L G+IP +G NL L LS+N IP ELG SLI LDL N G+IP + +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 368 SRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN--HLSGSIPKSISNLNKLKILKLE 425
+ N + G I+N + N G + ++ L+ +
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616
Query: 426 FNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 458
G S++ +++SYN L G +P
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-117
Identities = 139/451 (30%), Positives = 214/451 (47%), Gaps = 21/451 (4%)
Query: 15 PSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQL-FENCAS 73
S++ LE L S++ ++G + ++ LDLS N LSGPV +C+
Sbjct: 71 SSLLSLTGLESLFLSNSHINGSVSGF---KCSASLTSLDLSRNSLSGPVTTLTSLGSCSG 127
Query: 74 LRYLSLAGNILQGPI-GKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 132
L++L+++ N L P +SL L+LS N SG L+ L +S
Sbjct: 128 LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN-VVGWVLSDGCGELKHLAIS 186
Query: 133 HNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSL 192
N SG + V+ L+ L + N FS +P +G C L LD+S N +G ++
Sbjct: 187 GNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAI 243
Query: 193 RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRL 251
+ +++S+N G IP + +L++L + N TG +P L C L+ + L
Sbjct: 244 STCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL 301
Query: 252 RGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLV 310
GN G +P LE + LS N F G +P + L++LDLS N
Sbjct: 302 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG-----LKVLDLSFNEFS 356
Query: 311 GDIPAEMG-LFANLRYLNLSSNHLRSRIPPELG--YFHSLIHLDLRNNALYGSIPQEVCE 367
G++P + L A+L L+LSSN+ I P L ++L L L+NN G IP +
Sbjct: 357 GELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN 416
Query: 368 SRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 427
L L L N L+G IP + + + L L L N L G IP+ + + L+ L L+FN
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476
Query: 428 ELSGEIPQELGKLASLLAVNVSYNRLIGRLP 458
+L+GEIP L +L +++S NRL G +P
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-112
Identities = 153/450 (34%), Positives = 222/450 (49%), Gaps = 32/450 (7%)
Query: 23 LERLNFSHNSLS---GQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSL 79
+ ++ S L+ + SLL+L ++ L LSN+ ++G V F+ ASL L L
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLT--GLESLFLSNSHINGSVS--GFKCSASLTSLDL 107
Query: 80 AGNILQGPI--GKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS 137
+ N L GP+ CS L LN+S+N + G L L LDLS N S
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGL---KLNSLEVLDLSANSIS 164
Query: 138 GSIPQGVAA---LHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL 194
G+ G LK L + GN+ SG + + C +L LD+S+N F+ +P L
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGD 221
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 254
+++ + +S N L+GD I + L+ L+ S+N G +P K L + L N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 279
Query: 255 SLNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGD 312
G IP+ L L +DLS N F G++PP S S L L LSSNN G+
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL------LESLALSSNNFSGE 333
Query: 313 IPAEM-GLFANLRYLNLSSNHLRSRIPPELGYFH-SLIHLDLRNNALYGSIPQEVCES-- 368
+P + L+ L+LS N +P L SL+ LDL +N G I +C++
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393
Query: 369 RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNE 428
+L L L N TG IP + NC+ L L LS N+LSG+IP S+ +L+KL+ LKL N
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453
Query: 429 LSGEIPQELGKLASLLAVNVSYNRLIGRLP 458
L GEIPQEL + +L + + +N L G +P
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIP 483
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 5e-93
Identities = 116/401 (28%), Positives = 185/401 (46%), Gaps = 31/401 (7%)
Query: 73 SLRYLSLAGNILQGPIGKI---FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 129
+ + L+ L + + L +L LSN+H +G + G L +L
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-----GFKCSASLTSL 105
Query: 130 DLSHNLFSGSIP--QGVAALHYLKELLLQGNQFSGPLPADIGF-CPHLTTLDLSNNLFTG 186
DLS N SG + + + LK L + N P G L LDLS N +G
Sbjct: 106 DLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISG 165
Query: 187 QLPVSLRLLNSM---IFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC 243
V L + +++S N ++GD+ + LEFLD S+N+ + +P L +C
Sbjct: 166 ANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDC 222
Query: 244 KKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRIL 302
L + + GN L+G+ + L+ +++S N F+G IPP S L+ L
Sbjct: 223 SALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS--------LQYL 274
Query: 303 DLSSNNLVGDIPAEM-GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSI 361
L+ N G+IP + G L L+LS NH +PP G L L L +N G +
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 362 PQEV-CESRSLGILQLDGNSLTGPIPQVIRNCT-SLYLLSLSHNHLSGSIPKSISN--LN 417
P + + R L +L L N +G +P+ + N + SL L LS N+ SG I ++ N
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394
Query: 418 KLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 458
L+ L L+ N +G+IP L + L+++++S+N L G +P
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP 435
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-50
Identities = 73/273 (26%), Positives = 120/273 (43%), Gaps = 21/273 (7%)
Query: 214 HWIG---NISTLEFLDFSNNHLT---GSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL 267
+ G + +D S+ L ++ SSL + L + L + +NG++
Sbjct: 41 TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSA 100
Query: 268 GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL-FANLRYL 326
L +DLS N G + +S S S L+ L++SSN L GL +L L
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCS----GLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156
Query: 327 NLSSNHLRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 383
+LS+N + L HL + N + G + V +L L + N+ +
Sbjct: 157 DLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFST 214
Query: 384 PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL 443
IP + +C++L L +S N LSG ++IS +LK+L + N+ G IP L SL
Sbjct: 215 GIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSL 271
Query: 444 LAVNVSYNRLIGRLP--VGGVFPTLDQSSLQGN 474
++++ N+ G +P + G TL L GN
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-07
Identities = 20/44 (45%), Positives = 27/44 (61%), Gaps = 2/44 (4%)
Query: 21 RILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVP 64
R L L+ S N L G+IP ++ L + +DLSNN LSGP+P
Sbjct: 680 RGLNILDLSSNKLDGRIPQAMSALT--MLTEIDLSNNNLSGPIP 721
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = 1e-99
Identities = 108/274 (39%), Positives = 167/274 (60%), Gaps = 11/274 (4%)
Query: 607 VGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEG 664
+G G FG VYK G G ++AVK+L F+ EV ++ A H NL+ L G
Sbjct: 38 LGRGGFGKVYK---GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ TP +LLV Y NGS+ + L ER S PPL W R ++ LG+A+GLA+LH P
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 784
IIH ++K +NILLD+ + + DFGLA+L+ D HV + + +G++APE + +
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPE-YLSTGKS 212
Query: 785 NEKCDIYGFGVLILELVTGRRPVEYG---EDNVVILSEHVRVLLEEGNVLDCVDPSM-GD 840
+EK D++G+GV++LEL+TG+R + D+ V+L + V+ LL+E + VD + G+
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 272
Query: 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874
Y ++EV ++++AL+CT P RP M+EVV++L
Sbjct: 273 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 1e-89
Identities = 99/292 (33%), Positives = 147/292 (50%), Gaps = 25/292 (8%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDII---QYPEDFEREVRVL 651
D + ++GEG FG VYK G +AVKKL I + + F++E++V+
Sbjct: 28 DERPISVGGNKMGEGGFGVVYK---GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
K +H NL+ L G+ LV Y PNGSL +L TPPLSW R K+ G A
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAA 143
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
G+ LH IH ++K +NILLD+ + +ISDFGLAR + + VM++R
Sbjct: 144 NGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 772 YVAPE-----LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL- 825
Y+APE +T K DIY FGV++LE++TG V+ + ++L + +
Sbjct: 201 YMAPEALRGEIT-------PKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-DIKEEIED 252
Query: 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
EE + D +D M D V + +A C + RP + +V Q+LQ +
Sbjct: 253 EEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 4e-79
Identities = 92/275 (33%), Positives = 143/275 (52%), Gaps = 16/275 (5%)
Query: 607 VGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEG 664
+G GVFG VYK G G +A+K+ T + Q E+FE E+ L RHP+L+SL G
Sbjct: 47 IGHGVFGKVYK---GVLRDGAKVALKRR-TPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ +L+ Y NG+L+ L+ T +SW R ++ +G A+GL +LH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RA 159
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK-HVMSNRFQSALGYVAPE-LTCQSL 782
IIH ++K NILLD+N+ P+I+DFG+++ T LD+ H+ S + LGY+ PE L
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL-STVVKGTLGYIDPEYFIKGRL 218
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEYG-EDNVVILSEHVRVLLEEGNVLDCVDPSM-GD 840
EK D+Y FGV++ E++ R + +V L+E G + VDP++
Sbjct: 219 --TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276
Query: 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ + A+ C RPSM +V+ L+
Sbjct: 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 253 bits (650), Expect = 1e-77
Identities = 80/331 (24%), Positives = 128/331 (38%), Gaps = 40/331 (12%)
Query: 164 LPADIGFCPHL----TTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG--DIPHWIG 217
+ D+G L T D N + G L + + + +S L IP +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 218 NISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSE 276
N+ L FL N+L G +P ++ +L + + +++G IP+ L +
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI--------- 124
Query: 277 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 336
+TL LD S N L G +P + NL + N +
Sbjct: 125 --------------------KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 337 IPPELGYFHSLI-HLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSL 395
IP G F L + + N L G IP + +L + L N L G + + +
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 396 YLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 455
+ L+ N L+ + + L L L N + G +PQ L +L L ++NVS+N L G
Sbjct: 224 QKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 456 RLPVGGVFPTLDQSSLQGNLGICSPLLKGPC 486
+P GG D S+ N +C L C
Sbjct: 283 EIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 6e-62
Identities = 75/309 (24%), Positives = 116/309 (37%), Gaps = 41/309 (13%)
Query: 26 LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85
+ + + G + + + LDLS L
Sbjct: 31 TDCCNRTWLGVLCDTDTQTY--RVNNLDLSGLNLPK-----------------------P 65
Query: 86 GPIGKIFNYCSSLNTLNLSN-NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV 144
PI LN L + N+ G + I L +L L ++H SG+IP +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPI----PPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 145 AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSL-RLLNSMIFISV 203
+ + L L N SG LP I P+L + N +G +P S +++
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 263
S N LTG IP N++ L F+D S N L G + K I L NSL ++ +
Sbjct: 182 SRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK- 239
Query: 264 LFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN 322
+ L +DL N G++P G + + L L++S NNL G+IP G
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQ------LKFLHSLNVSFNNLCGEIPQG-GNLQR 292
Query: 323 LRYLNLSSN 331
++N
Sbjct: 293 FDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 4e-58
Identities = 73/269 (27%), Positives = 113/269 (42%), Gaps = 13/269 (4%)
Query: 23 LERLNFSHNSLSGQ--IPPSLLNLNMMNMKFLDLSN-NLLSGPVPYQLFENCASLRYLSL 79
+ L+ S +L IP SL NL + FL + N L GP+P + L YL +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLP--YLNFLYIGGINNLVGPIPPAIA-KLTQLHYLYI 108
Query: 80 AGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS 139
+ G I + +L TL+ S N SG L + I SL L + N SG+
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS----ISSLPNLVGITFDGNRISGA 164
Query: 140 IPQGVAALHYLKELL-LQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM 198
IP + L + + N+ +G +P +L +DLS N+ G V +
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 199 IFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 258
I ++ N+L D+ +G L LD NN + G+LP L K L + + N+L G
Sbjct: 224 QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 259 NIPEGLFDLGLEEIDLSENGFMGSIPPGS 287
IP+G + + N + P +
Sbjct: 283 EIPQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 16/69 (23%), Positives = 29/69 (42%), Gaps = 4/69 (5%)
Query: 14 IPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCAS 73
+ + + + L L+ +N + G +P L L + L++S N L G +P N
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK--FLHSLNVSFNNLCGEIPQGG--NLQR 292
Query: 74 LRYLSLAGN 82
+ A N
Sbjct: 293 FDVSAYANN 301
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 8e-75
Identities = 66/463 (14%), Positives = 134/463 (28%), Gaps = 51/463 (11%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
E+ + ++ ++++ + + + N
Sbjct: 135 DEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK-KSSRITLKDTQIGQLSN 193
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+ + + L + N+ F + + + + +
Sbjct: 194 NITFVSKAVMR-LTKLRQFYMGNSPFVAENICEA---------WENENSEYAQQYKTEDL 243
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT--------GQLPVSLRL 194
L L ++ + LP + P + ++++ N Q +
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPV 303
Query: 195 LNSMIFISVSNNTL-TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRG 253
+ I + N L T + + + L L+ N L G LP + + KL+ + L
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362
Query: 254 NSLNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 311
N + IP +E + + N IP + S + +D S N +
Sbjct: 363 NQITE-IPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKS----VSVMSAIDFSYNEIGS 416
Query: 312 -------DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL------- 357
+ N+ +NLS+N + L ++L N L
Sbjct: 417 VDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476
Query: 358 YGSIPQEVCESRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL 416
+ + L + L N LT L + LS+N S P N
Sbjct: 477 LKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535
Query: 417 NKLKILKLE------FNELSGEIPQELGKLASLLAVNVSYNRL 453
+ LK + N E P+ + SL + + N +
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 6e-73
Identities = 72/450 (16%), Positives = 140/450 (31%), Gaps = 53/450 (11%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L + ++ + + ++N L + +
Sbjct: 208 LRQFYMGNSPFVAENICEAWEN-------ENSEYAQQYKTED-LKWDNLKDLTDVEVYNC 259
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWS----LKRLRTLDLSHN-LFS 137
+ + +N++ N + + ++++ + + +N L +
Sbjct: 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319
Query: 138 GSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNS 197
+ + + L L NQ G LPA G L +L+L+ N T
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 198 MIFISVSNNTLTGDIPHW--IGNISTLEFLDFSNNHLTG-------SLPSSLFNCKKLSV 248
+ +S ++N L IP+ ++S + +DFS N + L + F +S
Sbjct: 379 VENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437
Query: 249 IRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQ--TLRILDLS 305
I L N ++ E L I+L N IP S + L +DL
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSINLMGNML-TEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 306 SNNLVGDIPAEMGL--FANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 363
N L + + L ++LS N S+ P + +L +RN
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQ-------- 546
Query: 364 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILK 423
GN P+ I C SL L + N + + + I + +L
Sbjct: 547 ----------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLD 593
Query: 424 LEFNELSGEIPQELGKLASLLAVNVSYNRL 453
++ N + + Y++
Sbjct: 594 IKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-66
Identities = 64/456 (14%), Positives = 138/456 (30%), Gaps = 30/456 (6%)
Query: 15 PSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASL 74
+ + I + LN + S G N N + G P + +
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWN-------FNKELDMWGAQPGVSLNSNGRV 83
Query: 75 RYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
LSL G G + + L L L ++ + GI +
Sbjct: 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143
Query: 135 LFSGSIPQGVAALHY--LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSL 192
+ + + L + + + + T + +N T + ++
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAV 202
Query: 193 RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 252
L + + N+ + E + N K L+ + +
Sbjct: 203 MRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKDLTDVEVY 257
Query: 253 GNSLNGNIPEGLFDLG-LEEIDLSENGFMG--SIPPGSSSSSSSTLFQTLRILDLSSNNL 309
+P L L ++ I+++ N + + + + + + + ++I+ + NNL
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317
Query: 310 -VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCE- 367
+ + L L N L P G L L+L N + IP C
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQI-TEIPANFCGF 375
Query: 368 SRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSG-------SIPKSISNLNKL 419
+ + L N L P ++ + + + S+N + + + +
Sbjct: 376 TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 420 KILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 455
+ L N++S + + L ++N+ N L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 9e-66
Identities = 75/401 (18%), Positives = 139/401 (34%), Gaps = 43/401 (10%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLS-NNLLSGPVPYQLFE------NCASLR 75
L + + ++P L L M+ ++++ N +SG ++ ++
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALP--EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQ 308
Query: 76 YLSLAGN-ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
+ + N + P+ L L N G L S +L +L+L++N
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-----AFGSEIKLASLNLAYN 363
Query: 135 LFSGSIPQGVAALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTG------- 186
+ ++ L N+ P D ++ +D S N
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
Query: 187 QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG-------SLPSS 239
L + ++ I++SNN ++ S L ++ N LT +
Sbjct: 424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483
Query: 240 LFNCKKLSVIRLRGNSLNGNIPEGLFDLG---LEEIDLSENGFMGSIPPGSSSSSSSTLF 296
N L+ I LR N L + + L IDLS N F P +SS+ F
Sbjct: 484 FKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGF 541
Query: 297 QTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNA 356
D N + + P + L +L L + SN + ++ ++ ++ LD+++N
Sbjct: 542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNP 598
Query: 357 LYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYL 397
VC G+ L + Q IR C +L +
Sbjct: 599 NISIDLSYVCPYIEAGMYMLFYDK-----TQDIRGCDALDI 634
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-41
Identities = 41/299 (13%), Positives = 97/299 (32%), Gaps = 28/299 (9%)
Query: 176 TLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG- 234
+ +++ Q VSL + +S+ +G +P IG ++ LE L ++
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 235 ---SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD---LGLEEIDLSENGFMGSIPPGSS 288
P + + + L + ++ + SI S
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 289 SSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLI 348
+ + SNN+ + + LR + ++ + E
Sbjct: 181 ITLK------DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA-----WE 228
Query: 349 HLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHL--- 405
+ + Y + + + L +++ +P ++ + L++++ N
Sbjct: 229 NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 406 -----SGSIPKSISNLNKLKILKLEFNEL-SGEIPQELGKLASLLAVNVSYNRLIGRLP 458
K++I+ + +N L + + L K+ L + YN+L G+LP
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-33
Identities = 31/266 (11%), Positives = 75/266 (28%), Gaps = 39/266 (14%)
Query: 215 WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN----IPEGLFDL-GL 269
+ + + L +G +P ++ +L V+ L + N P+G+
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 270 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 329
E+ + + S L + ++S+ I + +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIK----DCINSDPQQKSIKKSSRITLKDTQIGQL 191
Query: 330 SNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI 389
SN++ + + L + N+
Sbjct: 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI--------------------------- 223
Query: 390 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 449
C + + + + NL L +++ ++P L L + +NV+
Sbjct: 224 --CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281
Query: 450 YNRLIGRLPVGGVFPTLDQSSLQGNL 475
NR I + + L + + +
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKI 307
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 1e-74
Identities = 104/449 (23%), Positives = 165/449 (36%), Gaps = 25/449 (5%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L L+ N++S P L +K L+L +N LS + + F C +L L L N
Sbjct: 51 LTSLDVGFNTISKLEPELCQKLP--MLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSN 107
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+Q F +L TL+LS+N S L+ L+ L LS+N +
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT----QVQLENLQELLLSNNKIQALKSE 163
Query: 143 GVAALH--YLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL---LNS 197
+ LK+L L NQ P L L L+N L L L S
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223
Query: 198 MIFISVSNNTLTGDIPHWIGN--ISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNS 255
+ +S+SN+ L+ + L LD S N+L S +L L N+
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNN 283
Query: 256 LNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQ---TLRILDLSSNNLVG 311
+ L L + ++L + SI S FQ L L++ N++ G
Sbjct: 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
Query: 312 DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH----SLIHLDLRNNALYGSIPQEVCE 367
NL+YL+LS++ R + L L+L N +
Sbjct: 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403
Query: 368 SRSLGILQLDGNSLTGPIP-QVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEF 426
L +L L N + + Q R +++ + LS+N S + + L+ L L
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463
Query: 427 NELSG--EIPQELGKLASLLAVNVSYNRL 453
L P L +L +++S N +
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNI 492
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-68
Identities = 91/455 (20%), Positives = 148/455 (32%), Gaps = 53/455 (11%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
E + SH L+ Q+P L N+ L+L++N L +P F + L L + N
Sbjct: 6 HEVADCSHLKLT-QVPDDLPT----NITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFN 59
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+ ++ L LNL +N S D L L L N
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKT----FAFCTNLTELHLMSNSIQKIKNN 115
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
L L L N S +L L LSNN L + +
Sbjct: 116 PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFAN----- 170
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
S+L+ L+ S+N + P +L + L L ++ E
Sbjct: 171 -----------------SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213
Query: 263 GLFD----LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG 318
L + + LS + + T L +LDLS NNL
Sbjct: 214 KLCLELANTSIRNLSLSNSQLST-TSNTTFLGLKWT---NLTMLDLSYNNLNVVGNDSFA 269
Query: 319 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES---------R 369
L Y L N+++ L ++ +L+L+ + SI +
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329
Query: 370 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSIS----NLNKLKILKLE 425
L L ++ N + G + +L LSLS++ S + + + L IL L
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLT 389
Query: 426 FNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG 460
N++S L L +++ N + L
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 1e-67
Identities = 94/446 (21%), Positives = 159/446 (35%), Gaps = 59/446 (13%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
+ L+ S++ LS + L L N+ LDLS N L+ V F L Y L N
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFFLEYN 282
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+Q + ++ LNL + +S
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRS-------------------FTKQSISLASLPKIDDF 323
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
L L+ L ++ N G +L L LSN+ SLR L + F+S
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT------SLRTLTNETFVS 377
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
+++ S L L+ + N ++ + L V+ L N + +
Sbjct: 378 LAH--------------SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 263 GLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL--VGDIPAEMG 318
+ + EI LS N ++ +S L +L+ L L L V P+
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTR------NSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477
Query: 319 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN--------ALYGSIPQEVCESRS 370
NL L+LS+N++ + L L LDL++N A G +
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537
Query: 371 LGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 430
L IL L+ N +V ++ L ++ L N+L+ +N LK L L+ N ++
Sbjct: 538 LHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT 597
Query: 431 GEIPQELGK-LASLLAVNVSYNRLIG 455
+ G +L +++ +N
Sbjct: 598 SVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-58
Identities = 73/396 (18%), Positives = 133/396 (33%), Gaps = 36/396 (9%)
Query: 97 SLNTLNLSNNHFS---GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 153
S + S+ + DL + L+L+HN L L
Sbjct: 5 SHEVADCSHLKLTQVPDDL----------PTNITVLNLTHNQLRRLPAANFTRYSQLTSL 54
Query: 154 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP 213
+ N S P P L L+L +N + + ++ + + +N++
Sbjct: 55 DVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
Query: 214 HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG---LE 270
+ L LD S+N L+ + + + L + L N + E L L+
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174
Query: 271 EIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN---LRYLN 327
+++LS N PG + L L L++ L + ++ L +R L+
Sbjct: 175 KLELSSNQIKE-FSPGCFHAIGR-----LFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 328 LSSNHLRSRIPPELGYFH--SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPI 385
LS++ L + +L LDL N L L L+ N++
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 386 PQVIRNCTSLYLLSLSHN---------HLSGSIPKSISNLNKLKILKLEFNELSGEIPQE 436
+ ++ L+L + L S L L+ L +E N++ G
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
Query: 437 LGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQ 472
L +L +++S + R F +L S L
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-45
Identities = 71/350 (20%), Positives = 123/350 (35%), Gaps = 29/350 (8%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLS-GPVPYQLFENCA--SLRYLSL 79
LE LN N + G L N+K+L LSN+ S + + F + A L L+L
Sbjct: 331 LEHLNMEDNDIPGIKSNMFTGLI--NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 80 AGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS 139
N + F++ L L+L N +L L+ + + LS+N +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE---WRGLENIFEIYLSYNKYLQL 445
Query: 140 IPQGVAALHYLKELLLQGNQFSG--PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNS 197
A + L+ L+L+ P+ +LT LDLSNN L L
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505
Query: 198 MIFISVSNNTLT--------GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 249
+ + + +N L G +++ +S L L+ +N + +L +I
Sbjct: 506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565
Query: 250 RLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNN 308
L N+LN + L+ ++L +N F+ L LD+ N
Sbjct: 566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK-----KVFGPAFRNLTELDMRFNP 620
Query: 309 LVGDIPAEMGLFANLRYLNLSSNHLRSRI----PPELGYFHSLIHLDLRN 354
+ + + + L S PP + + D +
Sbjct: 621 FDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHY-HGFPVRLFDTSS 669
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 6e-69
Identities = 98/483 (20%), Positives = 181/483 (37%), Gaps = 47/483 (9%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
++ IP + + L+ S N L S + ++ LDLS +
Sbjct: 15 MELNFYKIPD-NLPFSTKNLDLSFNPLRHLGSYSFFSFP--ELQVLDLSRCEIQTIED-G 70
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
+++ + L L L GN +Q F+ SSL L + + +F I LK L
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP----IGHLKTL 126
Query: 127 RTLDLSHNLF-SGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLT----TLDLSN 181
+ L+++HNL S +P+ + L L+ L L N+ D+ + +LDLS
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP-HWIGNISTLEFLD------FSNNHLTG 234
N P + + + + +++ NN + ++ I ++ LE + +L
Sbjct: 187 NPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 235 SLPSSLFNCKKLSVIRLRGNSLN---GNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSS 290
S+L L++ R L+ +I + L + L + S +
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI-ERVKDFSYNF 304
Query: 291 SSSTL--------------FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 336
L ++L+ L +SN +E+ L +L +L+LS N L +
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-AFSEVDL-PSLEFLDLSRNGLSFK 362
Query: 337 --IPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQ-VIRNCT 393
SL +LDL N + + L L ++L V +
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 394 SLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEI-PQELGKLASLLAVNVSYNR 452
+L L +SH H + + L+ L++LK+ N P +L +L +++S +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 453 LIG 455
L
Sbjct: 482 LEQ 484
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 1e-68
Identities = 94/472 (19%), Positives = 161/472 (34%), Gaps = 55/472 (11%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L++L +L+ + +L +K L++++NL+ + F N +L +L L+ N
Sbjct: 102 LQKLVAVETNLASLENFPIGHLK--TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 83 ILQGPIGKIFNYCSSL----NTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG 138
+Q + +L+LS N + G + RL L L +N S
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-----GAFKEIRLHKLTLRNNFDSL 214
Query: 139 SIPQGV-AALHYLKELLLQGNQFSG---PLPADIGFCPHLTTLDLSNN------LFTGQL 188
++ + L L+ L +F D L L + + +
Sbjct: 215 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDI 274
Query: 189 PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT--------------- 233
L ++ S+ + T+ + L+ N
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF 332
Query: 234 ----GSLPSSLFNCKKLSVIRLRGNSLN--GNIPEGLFDLG-LEEIDLSENGFMGSIPPG 286
G S + L + L N L+ G + F L+ +DLS NG + +
Sbjct: 333 TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 391
Query: 287 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEM-GLFANLRYLNLSSNHLRSRIPPELGYFH 345
L LD +NL + NL YL++S H R
Sbjct: 392 FLGLEQ------LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 346 SLIHLDLRNNALYGSIPQEV-CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 404
SL L + N+ + ++ E R+L L L L P + +SL +L++SHN+
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 505
Query: 405 LSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAV-NVSYNRLIG 455
LN L++L N + QEL S LA N++ N
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-57
Identities = 73/400 (18%), Positives = 128/400 (32%), Gaps = 47/400 (11%)
Query: 96 SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLL 155
S L+LS N ++ +S L+ LDLS +L +L L+L
Sbjct: 28 FSTKNLDLSFNPLRHLGSYS----FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 156 QGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG-DIPH 214
GN L L + L ++ ++V++N + +P
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 215 WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV----IRLRGNSLNGNIPEGLFDLGLE 270
+ N++ LE LD S+N + + L ++ + + L N +N P ++ L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 203
Query: 271 EIDLSENGFMGSIPPGSSSSSSST----------------------LFQTLRILDLSSNN 308
++ L N ++ + + L L +
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 309 L------VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 362
L + DI N+ +L S + + Y HL+L N
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKF----- 316
Query: 363 QEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS--GSIPKSISNLNKLK 420
+ + + +L S G + SL L LS N LS G +S LK
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 421 ILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG 460
L L FN + + L L ++ ++ L
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 8e-52
Identities = 80/454 (17%), Positives = 143/454 (31%), Gaps = 73/454 (16%)
Query: 3 TPLVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGP 62
+ V + + V R++ + +L +L L + ++ L+
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD 272
Query: 63 VPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWS 122
LF ++ SL ++ F+Y L L N F
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPT-------LK 323
Query: 123 LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQ--FSGPLPADIGFCPHLTTLDLS 180
LK L+ L + N G L L+ L L N F G L LDLS
Sbjct: 324 LKSLKRLTFTSN--KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 181 NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSL 240
N + + LE LDF +++L S+
Sbjct: 382 FNGVIT-------------------------MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 241 F-NCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQT 298
F + + L + + L LE + ++ N F + P + +
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN----- 471
Query: 299 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY 358
L LDLS L P ++L+ LN+S N+ S +SL LD
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL---- 527
Query: 359 GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNC-TSLYLLSLSHNHLSGSIPKS--ISN 415
N + Q +++ +SL L+L+ N + + +
Sbjct: 528 --------------------NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 567
Query: 416 LNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 449
+ + L +E + P + + +L++N++
Sbjct: 568 IKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-46
Identities = 62/386 (16%), Positives = 109/386 (28%), Gaps = 46/386 (11%)
Query: 126 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 185
+ LDLS N + L+ L L + HL+TL L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG-SLPSSLFNCK 244
+ L+S+ + L IG++ TL+ L+ ++N + LP N
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 245 KLSVIRLRGNSLNGNIPEGLFDLG----------------------------LEEIDLSE 276
L + L N + L L L ++ L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 209
Query: 277 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS- 335
N ++ + L + + + + L L + L
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK--SALEGLCNLTIEEFRLAYL 267
Query: 336 -----RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIR 390
I ++ L + + L+L ++
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQFPTLKLK 325
Query: 391 NCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS--GEIPQELGKLASLLAVNV 448
+ L L+ G S +L L+ L L N LS G Q SL +++
Sbjct: 326 S-----LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 449 SYNRLIGRLPVGGVFPTLDQSSLQGN 474
S+N +I L+ Q +
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHS 406
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-29
Identities = 43/190 (22%), Positives = 70/190 (36%), Gaps = 14/190 (7%)
Query: 271 EIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSS 330
E F IP L + + LDLS N L F L+ L+LS
Sbjct: 11 TYQCMELNFY-KIPDN--------LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 331 NHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIR 390
+++ L L L N + SL L +L I
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 391 NCTSLYLLSLSHNHL-SGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL----LA 445
+ +L L+++HN + S +P+ SNL L+ L L N++ +L L + L+
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 446 VNVSYNRLIG 455
+++S N +
Sbjct: 182 LDLSLNPMNF 191
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-65
Identities = 84/462 (18%), Positives = 158/462 (34%), Gaps = 40/462 (8%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ L + N L + + L+ +K L +S + + N +L L L N
Sbjct: 83 LDTLVLTANPLIF-MAETALS-GPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSN 139
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSG---------------DLDFAS------GYGIW 121
+ L L+ NN L+ G +
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF 199
Query: 122 SLKRLRTLDLSHNLFSGSIPQGVA--ALHYLKELLLQGNQFSGPLPADIGFCP--HLTTL 177
++L+ I +G+ + L + PA + ++
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259
Query: 178 DLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLP 237
+L + F + + + + ++ L+ ++P + +STL+ L S N
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ 318
Query: 238 SSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTL 295
S N L+ + ++GN+ + G + L E+DLS + S + S L
Sbjct: 319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL 378
Query: 296 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRN 354
+ L+LS N + L L+L+ L+ + H L L+L +
Sbjct: 379 ----QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434
Query: 355 NALYGSIPQEVCESRSLGILQLDGNSLTGPIPQ---VIRNCTSLYLLSLSHNHLSGSIPK 411
+ L S Q +L L L GN Q ++ L +L LS LS
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
Query: 412 SISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
+ ++L + + L N L+ + L L + +N++ N +
Sbjct: 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHL-KGIYLNLASNHI 535
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-63
Identities = 92/439 (20%), Positives = 166/439 (37%), Gaps = 29/439 (6%)
Query: 26 LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85
N + L+ +IP +L N + + L+ S N+L + F +L +L L +
Sbjct: 17 YNCENLGLN-EIPGTLPN----STECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIY 70
Query: 86 GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVA 145
F L+TL L+ N + A + K L+ L S +
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETA----LSGPKALKHLFFIQTGISSIDFIPLH 126
Query: 146 ALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNS--MIFISV 203
L+ L L N S L LD NN + L + +++
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186
Query: 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCK--KLSVIRLRGNSLNG--- 258
+ N + G I + + + L+F + L N L +
Sbjct: 187 NGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
Query: 259 NIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG 318
+ EGL ++ +E I+L ++ F +I + S L+ LDL++ +L ++P+ +
Sbjct: 246 AVFEGLCEMSVESINLQKHYF-FNISSNTFHCFSG-----LQELDLTATHL-SELPSGLV 298
Query: 319 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLD 377
+ L+ L LS+N + F SL HL ++ N + E+ +L L L
Sbjct: 299 GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358
Query: 378 GNSLT--GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQ 435
+ + +RN + L L+LS+N ++ +L++L L F L + Q
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
Query: 436 E-LGKLASLLAVNVSYNRL 453
L L +N+S++ L
Sbjct: 419 SPFQNLHLLKVLNLSHSLL 437
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-63
Identities = 88/467 (18%), Positives = 153/467 (32%), Gaps = 49/467 (10%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L L+ + + + + + + L L+ N L + +L++L
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQH--RLDTLVLTANPLIF-MAETALSGPKALKHLFFIQT 115
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG---- 138
+ + +L +L L +NH S + + ++L+ LD +N
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISS-IKLPK---GFPTEKLKVLDFQNNAIHYLSKE 171
Query: 139 ---------------------SIPQGVAALHYLKELLLQGNQFSGPLPADIGFC--PHLT 175
I G + L G Q + + L
Sbjct: 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231
Query: 176 TLDLSNNLFTGQLPVSLRLL--NSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT 233
+ P L S+ I++ + + S L+ LD + HL+
Sbjct: 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
Query: 234 GSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSS 292
LPS L L + L N + L + + N + G +
Sbjct: 292 -ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 293 STLFQTLRILDLSSNNL--VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL 350
+ LR LDLS +++ ++ ++L+ LNLS N S L L
Sbjct: 351 N-----LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 351 DLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI 409
DL L Q ++ L +L L + L Q+ +L L+L NH
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN 465
Query: 410 ---PKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
S+ L +L+IL L F +LS L + V++S+NRL
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 6e-63
Identities = 90/463 (19%), Positives = 163/463 (35%), Gaps = 42/463 (9%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ L F +S L N ++ L L +N +S + L+ L N
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQK--TLESLYLGSNHISS-IKLPKGFPTEKLKVLDFQNN 163
Query: 83 ILQGPIGKIFNYCSSLN--TLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
+ + + +LNL+ N +G G + ++L+ I
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEP-----GAFDSAVFQSLNFGGTQNLLVI 218
Query: 141 PQGVA--ALHYLKELLLQGNQFSGPLPADIGFCP--HLTTLDLSNNLFTGQLPVSLRLLN 196
+G+ + L + PA + +++L + F + +
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278
Query: 197 SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSL 256
+ + ++ L+ ++P + +STL+ L S N S N L+ + ++GN+
Sbjct: 279 GLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK 337
Query: 257 NGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTL------------------- 295
+ G + L E+DLS + S + S L
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 296 -FQTLRILDLSSNNLVG-DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 353
L +LDL+ L D + L+ LNLS + L +L HL+L+
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 354 NNALYGSIPQEV---CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP 410
N Q+ L IL L L+ + + + LSHN L+ S
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
Query: 411 KSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
+++S+L + L L N +S +P L L+ +N+ N L
Sbjct: 518 EALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-54
Identities = 73/394 (18%), Positives = 139/394 (35%), Gaps = 26/394 (6%)
Query: 26 LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQL-FENCASLRYLSLAGNIL 84
LN + N ++G I P + + L+ + L SL +
Sbjct: 184 LNLNGNDIAG-IEPGAFDS--AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 85 QGPIGKIFNYCSSLN--TLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+ +F ++ ++NL ++F L+ LDL+ S +P
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNT----FHCFSGLQELDLTATHLS-ELPS 295
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLS-NNLFTGQLPVSLRLLNSMIFI 201
G+ L LK+L+L N+F P LT L + N L L ++ +
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL 355
Query: 202 SVSNNTLT--GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN 259
+S++ + + N+S L+ L+ S N + C +L ++ L L
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415
Query: 260 IPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM 317
+ F L+ ++LS + + + L+ L+L N+ +
Sbjct: 416 DAQSPFQNLHLLKVLNLSHS-LLDISSEQLFDGLPA-----LQHLNLQGNHFPKGNIQKT 469
Query: 318 GLFAN---LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGIL 374
L L LS L S + H+DL +N L S + + + + L
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL 528
Query: 375 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGS 408
L N ++ +P ++ + ++L N L +
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-45
Identities = 72/391 (18%), Positives = 126/391 (32%), Gaps = 32/391 (8%)
Query: 94 YCSSLN-TLNLSNNHFS---GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHY 149
+N T N N + G L L+ S N+ + L
Sbjct: 9 IEKEVNKTYNCENLGLNEIPGTL----------PNSTECLEFSFNVLPTIQNTTFSRLIN 58
Query: 150 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 209
L L L Q L TL L+ N +L ++ + ++
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 210 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE---GLFD 266
+ N TLE L +NH++ F +KL V+ + N+++ E L
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178
Query: 267 LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL--FANLR 324
++L+ N + I PG+ S+ + L+ + I + +L
Sbjct: 179 ATNLSLNLNGN-DIAGIEPGAFDSAV------FQSLNFGGTQNLLVIFKGLKNSTIQSLW 231
Query: 325 YLNLSSNHLR--SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLT 382
S E S+ ++L+ + + L L L L+
Sbjct: 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
Query: 383 GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEI-PQELGKLA 441
+P + ++L L LS N S SN L L ++ N E+ L L
Sbjct: 292 E-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350
Query: 442 SLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQ 472
+L +++S++ + L S LQ
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNL--SHLQ 379
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-40
Identities = 67/340 (19%), Positives = 123/340 (36%), Gaps = 21/340 (6%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ L+ + LS ++P L+ L+ +K L LS N + N SL +LS+ GN
Sbjct: 280 LQELDLTATHLS-ELPSGLVGLS--TLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGN 335
Query: 83 ILQGPIGK-IFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 141
+ +G +L L+LS++ D + + +L L++L+LS+N
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIET-SDCCNL-QLRNLSHLQSLNLSYNEPLSLKT 393
Query: 142 QGVAALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200
+ L+ L L + + L L+LS++L L ++
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH 453
Query: 201 ISVSNNTLTGDI---PHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 257
+++ N + + + LE L S L+ + + K ++ + L N L
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513
Query: 258 GNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM 317
+ E L L ++L+ N + I P S R ++L N L
Sbjct: 514 SSSIEALSHLKGIYLNLASN-HISIILPSLLPILSQ-----QRTINLRQNPLDCTC---- 563
Query: 318 GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 357
L + + L L + L + L
Sbjct: 564 SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 39/207 (18%), Positives = 67/207 (32%), Gaps = 11/207 (5%)
Query: 270 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 329
+ + G IP L + L+ S N L NL +L+L+
Sbjct: 15 KTYNCENLGL-NEIPGT--------LPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLT 65
Query: 330 SNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI 389
+ H L L L N L + ++L L ++ +
Sbjct: 66 RCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 390 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL--LAVN 447
N +L L L NH+S KLK+L + N + +++ L L++N
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN 185
Query: 448 VSYNRLIGRLPVGGVFPTLDQSSLQGN 474
++ N + G P + G
Sbjct: 186 LNGNDIAGIEPGAFDSAVFQSLNFGGT 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-24
Identities = 31/167 (18%), Positives = 51/167 (30%), Gaps = 3/167 (1%)
Query: 287 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 346
+SS + + + + L +IP L + L S N L + +
Sbjct: 2 TSSDQKCIEKEVNKTYNCENLGLN-EIPG--TLPNSTECLEFSFNVLPTIQNTTFSRLIN 58
Query: 347 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 406
L LDL +Y L L L N L + +L L +S
Sbjct: 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118
Query: 407 GSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
+ N L+ L L N +S + L ++ N +
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 7e-63
Identities = 66/320 (20%), Positives = 119/320 (37%), Gaps = 36/320 (11%)
Query: 585 DSRSSSLDCSID----PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY 640
SS +D + L+ G FG V+K +AVK D +
Sbjct: 6 HHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSW 63
Query: 641 PEDFEREVRVLGKARHPNLISLEGY----YWTPQLKLLVSDYAPNGSLQAKLHERLPSTP 696
E EV L +H N++ G L++ + GSL L
Sbjct: 64 --QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----- 116
Query: 697 PLSWTNRFKVILGTAKGLAHLHH-------SFRPPIIHYNLKPSNILLDDNYNPRISDFG 749
+SW + A+GLA+LH +P I H ++K N+LL +N I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN----EKCDIYGFGVLILELVTGRR 805
LA ++ Y+APE+ ++ + D+Y G+++ EL +
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 806 PVEY-GEDNVVILSEHVRVLLEEGNVLDCV-----DPSMGD-YPEDEVLPVL-KLALVCT 857
+ ++ ++ E + ++ + V P + D + + + +L + C
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 858 CHIPSSRPSMAEVVQILQVI 877
H +R S V + + +
Sbjct: 297 DHDAEARLSAGCVGERITQM 316
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 1e-60
Identities = 68/486 (13%), Positives = 147/486 (30%), Gaps = 69/486 (14%)
Query: 9 NSYNAIPSMVVFRILERLNFSHNSLSG------QIPPSLLNLNMMNMKFLDLSNNLLSGP 62
++ N P M + R++ + I ++ L ++ + +N+ +
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLT--KLQIIYFANSPFTYD 463
Query: 63 VPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWS 122
+ ++ L + L N L ++
Sbjct: 464 NI------AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF----LYD 513
Query: 123 LKRLRTLDLSHNLFSG---------SIPQGVAALHYLKELLLQGNQFSG-PLPADIGFCP 172
L L++L+++ N + ++ + N P A +
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV 573
Query: 173 HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST-LEFLDFSNNH 231
L LD +N L + + + + N + IP + +E L FS+N
Sbjct: 574 KLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNK 630
Query: 232 LTGSLPSSLF--NCKKLSVIRLRGNSLNGNIPEGLFDLG------LEEIDLSENGFMGSI 283
L +P+ + + + N + + + LS N
Sbjct: 631 LK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-F 688
Query: 284 PPGSSSSSSSTLFQTLRILDLSSNNL-------VGDIPAEMGLFANLRYLNLSSNHLRSR 336
P ++ S + + LS+N + + L ++L N L +
Sbjct: 689 PTELFATGSP-----ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TS 742
Query: 337 IPPEL--GYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQL------DGNSLTGPIPQV 388
+ + L ++D+ N S P + S L + +GN + P
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801
Query: 389 IRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL-SGEIPQELGKLASLLAVN 447
I C SL L + N + + + + +L IL + N S ++ +
Sbjct: 802 ITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYI-EAGMYV 857
Query: 448 VSYNRL 453
+ Y++
Sbjct: 858 LLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-58
Identities = 57/456 (12%), Positives = 131/456 (28%), Gaps = 65/456 (14%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
+ L+ + G++P ++ L +K L + + E
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLT--ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHR 382
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
I +Y LN +L + + + + + +K+ + L
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRNPE------MKPIKKDSRISLKDT-------- 428
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
++ N+ + + I L + +N+ FT +++ + +
Sbjct: 429 ---------QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-DNIAVDWED----AN 473
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG---- 258
+ N+ L ++ N LP L++ +L + + N
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 259 -----NIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGD 312
+ + ++ + N S L +LD N +
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVK-----LGLLDCVHNKVR-H 587
Query: 313 IPAEMGLFANLRYLNLSSNHLRSRIPPELGYF-HSLIHLDLRNNALYGSIPQ--EVCESR 369
+ G L L L N + IP + F + L +N L IP
Sbjct: 588 LE-AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVY 644
Query: 370 SLGILQLDGNSLTG-----PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL 424
+G + N + + ++LS+N + + + + + + L
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704
Query: 425 EFNELS-------GEIPQELGKLASLLAVNVSYNRL 453
N ++ L +++ +N+L
Sbjct: 705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-58
Identities = 66/472 (13%), Positives = 142/472 (30%), Gaps = 49/472 (10%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ L+F +S + L + + + + + L L +
Sbjct: 349 LKVLSFGTHSETV--SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASG--YGIWSLKRLRTLDLSHNLFSGSI 140
+ + ++L + + + I L +L+ + +++ F+
Sbjct: 407 AINR--NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDN 464
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200
++ + LT ++L N QLP L L +
Sbjct: 465 IAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519
Query: 201 ISVSNNTLTG---------DIPHWIGNISTLEFLDFSNNHLTGSLPS-SLFNCKKLSVIR 250
++++ N + ++ N+L S SL KL ++
Sbjct: 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLD 579
Query: 251 LRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLV 310
N + ++ ++ L ++ L N IP + + + L S N L
Sbjct: 580 CVHNKVR-HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQ-----VEGLGFSHNKLK 632
Query: 311 GDIPAEMGL--FANLRYLNLSSNHLRSRIPPELG------YFHSLIHLDLRNNALYGSIP 362
IP + ++ S N + S + + + L N +
Sbjct: 633 Y-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPT 690
Query: 363 QEVCESRSLGILQLDGNSLT-------GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-- 413
+ + + L N +T P +N L + L N L+ S+
Sbjct: 691 ELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRA 749
Query: 414 SNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPT 465
+ L L + + +N S P + + L A + + R + +PT
Sbjct: 750 TTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-55
Identities = 73/401 (18%), Positives = 133/401 (33%), Gaps = 45/401 (11%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPY--------QLFENCASL 74
L + + Q+P L +L ++ L+++ N + +
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLP--ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 75 RYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSH 133
+ + N L+ P L L+ +N L+ + +L L L +
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-----FGTNVKLTDLKLDY 604
Query: 134 NLFSGSIPQGV-AALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTG---QL 188
N IP+ A ++ L N+ P + + ++D S N +
Sbjct: 605 NQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNI 663
Query: 189 PVSLRLLN--SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT-------GSLPSS 239
S+ + +++S N + S + + SNN +T +
Sbjct: 664 SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723
Query: 240 LFNCKKLSVIRLRGNSLNGNIPEGLFDLG---LEEIDLSENGFMGSIPPGSSSSSSSTLF 296
N L+ I LR N L + + L +D+S N F S P +SS F
Sbjct: 724 YKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAF 781
Query: 297 QTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNA 356
D N ++ P + +L L + SN + ++ +L L LD+ +N
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNP 838
Query: 357 LYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYL 397
VC G+ L + Q IR C +L +
Sbjct: 839 NISIDVTSVCPYIEAGMYVLLYDKT-----QDIRGCDALGI 874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-47
Identities = 56/385 (14%), Positives = 123/385 (31%), Gaps = 39/385 (10%)
Query: 92 FNYCSSLNTLNLSNNHFSGDLDF---ASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALH 148
+ + NT++ N +F+ +LD G + + R+ L L+ G +P + L
Sbjct: 288 YYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLT 347
Query: 149 YLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL-PVSLRLLNSMIFISVSNNT 207
LK L + + + + + L + + +
Sbjct: 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407
Query: 208 LT-----GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
+ I + N +T + ++ KL +I + +
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIA 466
Query: 263 GLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN 322
+ E+ + + S+ L ++L + + +P +
Sbjct: 467 ----VDWEDANSDYAKQYENEELSWSNLKD------LTDVELYNCPNMTQLPDFLYDLPE 516
Query: 323 LRYLNLSSNHLRS---------RIPPELGYFHSLIHLDLRNNALYGSIPQEV--CESRSL 371
L+ LN++ N S R+ + + + N L P + L
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKL 575
Query: 372 GILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFNELS 430
G+L N + + L L L +N + IP+ + ++++ L N+L
Sbjct: 576 GLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK 632
Query: 431 GEIPQ--ELGKLASLLAVNVSYNRL 453
IP + + +V+ SYN++
Sbjct: 633 -YIPNIFNAKSVYVMGSVDFSYNKI 656
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-37
Identities = 45/348 (12%), Positives = 104/348 (29%), Gaps = 36/348 (10%)
Query: 137 SGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLN 196
+ I A + L + ++ + + +++ Q V L
Sbjct: 265 AEYIKDYKALKAIWEALDGKNWRYYSGTI-NNTIHSLNWNFNKELDMWGDQPGVDLDNNG 323
Query: 197 SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSL 256
+ +S++ G +P IG ++ L+ L F + T S + R + +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 257 NGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP 314
+ + D L DL ++ + S + +I +L N + I
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL--TNRITFIS 441
Query: 315 AEMGLFANLRYLNLSSNHLRS-------------------RIPPELGYFHSLIHLDLRNN 355
+ L+ + +++ L ++L N
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501
Query: 356 ALYGSIPQEVCESRSLGILQLDGNSLTGP---------IPQVIRNCTSLYLLSLSHNHLS 406
+P + + L L + N + + + + +N+L
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561
Query: 407 G-SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
S+ + KL +L N++ + G L + + YN++
Sbjct: 562 EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQI 607
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-28
Identities = 35/291 (12%), Positives = 79/291 (27%), Gaps = 32/291 (10%)
Query: 177 LDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSL 236
LD N + + + F + + + N + L + G +
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339
Query: 237 PSSLFNCKKLSVIRLRGNSLNGNIPE-GLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTL 295
P ++ +L V+ +S + G +L + + ++
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399
Query: 296 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN 355
L ++ N + I + + + +N + I + L + N+
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANS 458
Query: 356 ALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISN 415
+ + + S SN
Sbjct: 459 PFTYDNI-----------------------------AVDWEDANSDYAKQYENEELSWSN 489
Query: 416 LNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTL 466
L L ++L ++P L L L ++N++ NR I + + L
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 22/173 (12%), Positives = 48/173 (27%), Gaps = 1/173 (0%)
Query: 302 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSI 361
+ + I L A L+ + S + + + + +
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQP 315
Query: 362 PQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKI 421
++ + + L L G G +P I T L +LS + + S +
Sbjct: 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 422 LKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 474
+ + + + L ++ I R P + SL+
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 16/102 (15%), Positives = 33/102 (32%), Gaps = 8/102 (7%)
Query: 15 PSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASL 74
+ F I + + N + Q P + ++ L + +N + V +L L
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCP--SLIQLQIGSNDIRK-VDEKLTPQ---L 829
Query: 75 RYLSLAGN-ILQGPIGKIFNYCSS-LNTLNLSNNHFSGDLDF 114
L +A N + + + Y + + L D
Sbjct: 830 YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 9e-59
Identities = 79/488 (16%), Positives = 144/488 (29%), Gaps = 62/488 (12%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
+ +P + + ++ S N L S N + +++LDLS + + +
Sbjct: 19 MDQKLSKVPDDI-PSSTKNIDLSFNPLKILKSYSFSNFS--ELQWLDLSRCEIET-IEDK 74
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
+ L L L GN +Q F+ +SL L + F I L L
Sbjct: 75 AWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP----IGQLITL 130
Query: 127 RTLDLSHNLFSG-SIPQGVAALHYLKELLLQGNQFSGPLPADIGF--------------- 170
+ L+++HN +P + L L + L N D+ F
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 171 ------------CPHLTTLDLSNNLFTGQLP-------VSLRLLNSMIFISVSNNTLTGD 211
L L L N + + L + ++ L
Sbjct: 191 NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250
Query: 212 IPHWIGNISTL--EFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGL 269
P + + + + + + +S + L G S+ + +
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKW 309
Query: 270 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 329
+ + + P L+ L L+ N ++ L +L YL+LS
Sbjct: 310 QSLSIIRCQL-KQFPTLD--------LPFLKSLTLTMNKG-SISFKKVAL-PSLSYLDLS 358
Query: 330 SNHLR--SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIP- 386
N L +SL HLDL N + L L ++L
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEF 417
Query: 387 QVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLA 445
+ L L +S+ + L L LK+ N +L
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477
Query: 446 VNVSYNRL 453
+++S +L
Sbjct: 478 LDLSKCQL 485
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-56
Identities = 87/475 (18%), Positives = 146/475 (30%), Gaps = 67/475 (14%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
LE L L+ + L +K L++++N + F N +L ++ L+ N
Sbjct: 106 LENLVAVETKLASLESFPIGQLI--TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 83 ILQGPIGKIF----NYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG 138
+Q +L++S N + +L L L N S
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-----IQDQAFQGIKLHELTLRGNFNSS 218
Query: 139 SIP----QGVAALHYLK-----------------------------ELLLQGNQFSGPLP 165
+I Q +A LH + E L
Sbjct: 219 NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278
Query: 166 ADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 225
+++ + L+ + +S+ L P ++ L+ L
Sbjct: 279 VKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSL 333
Query: 226 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG---LEEIDLSENGFMGS 282
+ N S+ LS + L N+L+ + DLG L +DLS NG
Sbjct: 334 TLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA--I 389
Query: 283 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPP 339
I + L+ LD + L F L YL++S + +
Sbjct: 390 IMSANFMGLEE-----LQHLDFQHSTLKRVTEF--SAFLSLEKLLYLDISYTNTKIDFDG 442
Query: 340 ELGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLL 398
SL L + N+ + V + +L L L L V L LL
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502
Query: 399 SLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
++SHN+L + L L L FN + SL N++ N +
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-54
Identities = 91/470 (19%), Positives = 143/470 (30%), Gaps = 53/470 (11%)
Query: 26 LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85
LS ++P + + + K +DLS N L + F N + L++L L+ ++
Sbjct: 16 YQCMDQKLS-KVPDDIPS----STKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIE 69
Query: 86 GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVA 145
K ++ L+ L L+ N + L L L + +
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGS----FSGLTSLENLVAVETKLASLESFPIG 125
Query: 146 ALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF---- 200
L LK+L + N LPA +L +DLS N L+ L
Sbjct: 126 QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLS 185
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGN 259
+ +S N + I L L N + ++ + N L V RL
Sbjct: 186 LDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244
Query: 260 ---------IPEGLFDLGLEEIDLSENGFMGSIPPGS-----------------SSSSSS 293
I EGL D+ ++E L+ S
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYT-NDFSDDIVKFHCLANVSAMSLAGVSIKYLEDV 303
Query: 294 TLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 353
+ L + L P L+ L L+ N I + SL +LDL
Sbjct: 304 PKHFKWQSLSIIRCQL-KQFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLS 358
Query: 354 NNALYGSIPQ--EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPK 411
NAL S + SL L L N + L L H+ L
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEF 417
Query: 412 S-ISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG 460
S +L KL L + + + L SL + ++ N
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-50
Identities = 76/419 (18%), Positives = 127/419 (30%), Gaps = 26/419 (6%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKF--LDLSNNLLSGPVPYQLFENCASLRYLSLA 80
L ++ S+N + L L LD+S N + + Q F+ L L+L
Sbjct: 155 LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGI-KLHELTLR 212
Query: 81 GNILQGPIGK-IFNYCSSLNTLNLSNNHFSG--DLDFASGYGIWSLKRLRT--LDLSHNL 135
GN I K + L+ L F +L+ + L + L++
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 136 FSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLL 195
L + + L G D+ +L + + L L
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQFPTLDLPFL 330
Query: 196 NSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFN--CKKLSVIRLRG 253
S ++++ N + I + +L +LD S N L+ S S + L + L
Sbjct: 331 KS---LTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 254 NSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGD 312
N + L L+ +D + + S L LD+S N D
Sbjct: 386 NGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK-----LLYLDISYTNTKID 439
Query: 313 IPAEMGLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGSIPQEVCESRSL 371
+L L ++ N + +L LDL L L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499
Query: 372 GILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 430
+L + N+L SL L S N + S L L N ++
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-44
Identities = 80/407 (19%), Positives = 130/407 (31%), Gaps = 51/407 (12%)
Query: 96 SSLNTLNLSNNHFSG--DLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 153
SS ++LS N F++ L+ LDLS + LH+L L
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSN------FSELQWLDLSRCEIETIEDKAWHGLHHLSNL 85
Query: 154 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG-DI 212
+L GN P L L + L ++ ++V++N + +
Sbjct: 86 ILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKL 145
Query: 213 PHWIGNISTLEFLDFSNNHLTG---------------------------SLPSSLFNCKK 245
P + N++ L +D S N++ + F K
Sbjct: 146 PAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK 205
Query: 246 LSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI-- 301
L + LRGN + NI + GL L F S + I
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE 265
Query: 302 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSI 361
L+ N D + AN+ ++L+ ++ ++ L + L
Sbjct: 266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL-KQF 322
Query: 362 PQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLN--KL 419
P L L L N + SL L LS N LS S S S+L L
Sbjct: 323 PTLDL--PFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378
Query: 420 KILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTL 466
+ L L FN + L L ++ ++ + R+ F +L
Sbjct: 379 RHLDLSFNGAI-IMSANFMGLEELQHLDFQHST-LKRVTEFSAFLSL 423
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-43
Identities = 71/384 (18%), Positives = 121/384 (31%), Gaps = 46/384 (11%)
Query: 3 TPLVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGP 62
+ + + + V R++ +L P + L + + L+
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 63 VPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWS 122
+ F A++ +SLAG ++ +L++
Sbjct: 277 DIVK-FHCLANVSAMSLAGVSIKYLEDVPK--HFKWQSLSIIRCQLK-QFPTL------D 326
Query: 123 LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFS--GPLPADIGFCPHLTTLDLS 180
L L++L L+ N GSI AL L L L N S G L LDLS
Sbjct: 327 LPFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 181 NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSL 240
N + + L+ LDF ++ L S
Sbjct: 385 FNGAI-------------------------IMSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 241 F-NCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQT 298
F + +KL + + + + L L + ++ N F + +++++
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN----- 474
Query: 299 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY 358
L LDLS L L+ LN+S N+L +SL LD N +
Sbjct: 475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534
Query: 359 GSIPQEVCESRSLGILQLDGNSLT 382
S +SL L NS+
Sbjct: 535 TSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-40
Identities = 59/319 (18%), Positives = 108/319 (33%), Gaps = 28/319 (8%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
++ ++ + L N+ + L+ + + LS+
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLA--NVSAMSLAGVSIKYLED---VPKHFKWQSLSIIRC 317
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
L+ L +L L+ N S +L L LDLS N S S
Sbjct: 318 QLKQFP---TLDLPFLKSLTLTMNKGSISFKK------VALPSLSYLDLSRNALSFSGCC 368
Query: 143 GVAALHY--LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVS-LRLLNSMI 199
+ L L+ L L N + A+ L LD ++ S L ++
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 200 FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNG 258
++ +S D +++L L + N + S++F N L+ + L L
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 259 NIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAE 316
I G+FD L+ +++S N + + + S L LD S N +
Sbjct: 488 -ISWGVFDTLHRLQLLNMSHNNLL-FLDSSHYNQLYS-----LSTLDCSFNRIETSKGIL 540
Query: 317 MGLFANLRYLNLSSNHLRS 335
+L + NL++N +
Sbjct: 541 QHFPKSLAFFNLTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-38
Identities = 58/358 (16%), Positives = 100/358 (27%), Gaps = 23/358 (6%)
Query: 128 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ 187
T S +P + K + L N L LDLS
Sbjct: 15 TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 188 LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLS 247
+ L+ + + ++ N + P +++LE L L + L
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 248 VIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 305
+ + N ++ F L +DLS N +I Q LD+S
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ-TITVNDLQFLRE-NPQVNLSLDMS 189
Query: 306 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY-FHSLIHLDLRNNALYGSIPQE 364
N + I + L L L N S I L L E
Sbjct: 190 LNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 365 VCESRSLG--------ILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL 416
+ E + +L + ++ +SL+ + + +
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKH 306
Query: 417 NKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 474
K + L + +L +L L SL ++ N+ P+L L N
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPFLKSL---TLTMNKGSISFKKVA-LPSLSYLDLSRN 360
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-23
Identities = 38/170 (22%), Positives = 61/170 (35%), Gaps = 6/170 (3%)
Query: 285 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 344
PGS + + L +P + ++ + ++LS N L+ F
Sbjct: 1 PGSLNPCIEVVPNI--TYQCMDQKLS-KVPD--DIPSSTKNIDLSFNPLKILKSYSFSNF 55
Query: 345 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 404
L LDL + + L L L GN + P TSL L
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 405 LSGSIPKSISNLNKLKILKLEFNELSG-EIPQELGKLASLLAVNVSYNRL 453
L+ I L LK L + N + ++P L +L+ V++SYN +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI 165
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-55
Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 34/296 (11%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
ID + +E VG G FG V K + + + +A+K++ + + F E+R L +
Sbjct: 5 IDYK-EIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESER---KAFIVELRQLSRV 58
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
HPN++ L G P LV +YA GSL LH P P + + L ++G+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGV 115
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYN-PRISDFGLARLLTRLDKHVMSNRFQSALG-- 771
A+LH +IH +LKP N+LL +I DFG A + + G
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--------DIQTHMTNNKGSA 167
Query: 772 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830
++APE+ + +EKCD++ +G+++ E++T R+P + D + + + + G
Sbjct: 168 AWMAPEV-FEGSNYSEKCDVFSWGIILWEVITRRKP--F--DEIGGPAFRIMWAVHNGTR 222
Query: 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRME 886
P + + P+ P+ L C PS RPSM E+V+I+ + P E
Sbjct: 223 P----PLIKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 4e-55
Identities = 87/324 (26%), Positives = 139/324 (42%), Gaps = 33/324 (10%)
Query: 569 SSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGT-QGRML 627
++ + + F D I L K ++G G FGTV++ G +
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKE-KIGAGSFGTVHR---AEWHGSDV 63
Query: 628 AVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQA 686
AVK L+ D +F REV ++ + RHPN++ G P +V++Y GSL
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 687 KLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 746
LH+ L R + AKG+ +LH + PPI+H NLK N+L+D Y ++
Sbjct: 124 LLHKSGAR-EQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVC 181
Query: 747 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
DFGL+RL S ++APE+ + NEK D+Y FGV++ EL T ++P
Sbjct: 182 DFGLSRLKASTFLSSKSAAG--TPEWMAPEVL-RDEPSNEKSDVYSFGVILWELATLQQP 238
Query: 807 ---VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSS 863
+ + + + R + P + V + C + P
Sbjct: 239 WGNLNPAQVVAAVGFKCKR-------------LEI---PRNLNPQVAAIIEGCWTNEPWK 282
Query: 864 RPSMAEVVQILQVIKT---PLPQR 884
RPS A ++ +L+ + P P R
Sbjct: 283 RPSFATIMDLLRPLIKSAVPPPNR 306
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-54
Identities = 70/309 (22%), Positives = 137/309 (44%), Gaps = 35/309 (11%)
Query: 581 VILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--- 637
+ S ++ + + ++G+G FG V+K ++A+K L+ D
Sbjct: 2 AMGGSEFPKSRLPTLADNEIEYEK-QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 638 ---IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPS 694
I+ ++F+REV ++ HPN++ L G P +V ++ P G L +L ++
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDK--- 115
Query: 695 TPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-----DNYNPRISDFG 749
P+ W+ + +++L A G+ ++ + PPI+H +L+ NI L +++DFG
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 750 LARLLTRLDKHVMSNRFQSALGYVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 808
L++ H +S + ++APE + + EK D Y F +++ ++TG P
Sbjct: 175 LSQQSV----HSVSGLLGN-FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-- 227
Query: 809 YGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA 868
+ E + + + EEG PED + + +C P RP +
Sbjct: 228 FDEYSYGKIKFINMI-REEGLRPTI--------PEDCPPRLRNVIELCWSGDPKKRPHFS 278
Query: 869 EVVQILQVI 877
+V+ L +
Sbjct: 279 YIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-53
Identities = 71/293 (24%), Positives = 116/293 (39%), Gaps = 39/293 (13%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDII-QYPEDFEREVRVLG 652
ID + L ++ E G ++K G QG + VK L D + DF E L
Sbjct: 7 IDFKQLNFLT-KLNENHSGELWK---GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 653 KARHPNLISLEGYYWTPQLKLL--VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
HPN++ + G +P ++ + P GSL LHE + + + K L
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDM 120
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
A+G+A LH + P I + L ++++D++ RIS + M
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--SPGRMYA-----P 172
Query: 771 GYVAPELTC--QSLRVNEKCDIYGFGVLILELVTGRRP---VEYGEDNVVILSEHVRVLL 825
+VAPE D++ F VL+ ELVT P + E + + E +R +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878
G + P + KL +C P+ RP +V IL+ ++
Sbjct: 233 PPG-----ISPHVS-----------KLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-52
Identities = 86/463 (18%), Positives = 156/463 (33%), Gaps = 42/463 (9%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ L+ S + I ++ ++ L L+ N + + F +SL+ L
Sbjct: 54 LQVLDLSRCEIQ-TIEDGAYQ-SLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVET 110
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
L + +L LN+++N F +L L LDLS N
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQ---SFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
Query: 143 GVAALHYLK----ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLP-------VS 191
+ LH + L L N + + L L L NN + +
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG 226
Query: 192 LRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGS---LPSSLFNCKKLSV 248
L + ++ + L + + L +F +L + +S
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286
Query: 249 IRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGS--------------SSSSSST 294
L ++ + + ++ G + ++L F P ++ S
Sbjct: 287 FSLVSVTIE-RVKDFSYNFGWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAFSEV 344
Query: 295 LFQTLRILDLSSNNL--VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDL 352
+L LDLS N L G +L+YL+LS N + + + L HLD
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDF 403
Query: 353 RNNALYGSIPQEV-CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPK 411
+++ L V R+L L + + +SL +L ++ N +
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
Query: 412 SI-SNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
I + L L L L +L P L+SL +N++ N+L
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-45
Identities = 87/466 (18%), Positives = 163/466 (34%), Gaps = 48/466 (10%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L L + N + + + + +++ L L+ + + +L+ L++A N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFS-GLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHN 134
Query: 83 ILQ-GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 141
++Q + + F+ ++L L+LS+N +LDLS N + I
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193
Query: 142 QGVAALHYLKELLLQGNQFSGPLPAD-IGFCPHLTTLDLSNNLFTGQ---LPVSLRLLNS 197
G L +L L+ N S + I L L F + L
Sbjct: 194 PGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
Query: 198 MIFISVSNNTLTG------DIPHWIGNISTLEFLDFSNNHLTGSLPSSLF---------- 241
+ +++ L DI ++ + + + S
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVN 313
Query: 242 ---------NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSS 292
K L + N N + LE +DLS NG + S S
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNG-LSFKGCCSQSDFG 371
Query: 293 STLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH---SLIH 349
+T +L+ LDLS N ++ + + L +L+ ++L+ E F +LI+
Sbjct: 372 TT---SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ--MSEFSVFLSLRNLIY 425
Query: 350 LDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQ-VIRNCTSLYLLSLSHNHLSG 407
LD+ + + SL +L++ GNS + +L L LS L
Sbjct: 426 LDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 408 SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
P + ++L+ L++L + N+L +L SL + + N
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-41
Identities = 101/448 (22%), Positives = 155/448 (34%), Gaps = 48/448 (10%)
Query: 27 NFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG 86
+ +IP +L + K LDLS N L + F + L+ L L+ +Q
Sbjct: 13 QCMELNFY-KIPDNL----PFSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQT 66
Query: 87 PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA 146
+ S L+TL L+ N + + L L+ L + +
Sbjct: 67 IEDGAYQSLSHLSTLILTGNP----IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 147 LHYLKELLLQGNQF-SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 205
L LKEL + N S LP +L LDLS+N LR+L+ M +++S
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS- 181
Query: 206 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLF 265
LD S N + + F +L + LR N + N+ +
Sbjct: 182 -------------------LDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
Query: 266 D--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF--- 320
GLE L F S+ L I + L + + LF
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 321 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 380
N+ +L S + + Y HL+L N P +SL L N
Sbjct: 282 TNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFG-QFPTLKL--KSLKRLTFTSNK 336
Query: 381 LTGPIPQVIRNCTSLYLLSLSHNHLS--GSIPKSISNLNKLKILKLEFNELSGEIPQELG 438
+V + SL L LS N LS G +S LK L L FN + +
Sbjct: 337 GGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL 393
Query: 439 KLASLLAVNVSYNRLIGRLPVGGVFPTL 466
L L ++ ++ L ++ VF +L
Sbjct: 394 GLEQLEHLDFQHSNLK-QMSEFSVFLSL 420
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 80/402 (19%), Positives = 131/402 (32%), Gaps = 31/402 (7%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKF--LDLSNNLLSGPVPYQLFENCASLRYLSLA 80
LE L+ S N + L L+ M + LDLS N ++ + F+ L L+L
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI-RLHKLTLR 208
Query: 81 GNILQGPI-GKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN----- 134
N + + L L F + + + +L+ L L +
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK-FDKSALEGLCNLTIEEFRLAYL 267
Query: 135 -LFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR 193
+ I L + L + L+L N F + L+
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLK 325
Query: 194 LLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT--GSLPSSLFNCKKLSVIRL 251
L ++ ++N ++ +LEFLD S N L+ G S F L + L
Sbjct: 326 SLKR---LTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 252 RGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLV 310
N + + L LE +D + + S S L LD+S +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNL----IYLDISHTHTR 434
Query: 311 GDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGSIPQEVCES- 368
++L L ++ N + P+ +L LDL L + S
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSL 493
Query: 369 RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP 410
SL +L + N L + TSL + L N S P
Sbjct: 494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 72/369 (19%), Positives = 120/369 (32%), Gaps = 55/369 (14%)
Query: 3 TPLVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGP 62
+ V + + V R++ + +L +L L + ++ L+
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD 272
Query: 63 VPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWS 122
LF ++ SL ++ +N L L N F +
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKF-------GQFPTLK 323
Query: 123 LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQ--FSGPLPADIGFCPHLTTLDLS 180
LK L+ L + N + V L L+ L L N F G L LDLS
Sbjct: 324 LKSLKRLTFTSNKGG-NAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 181 NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSL 240
N + + LE LDF +++L S+
Sbjct: 382 FNGVI-------------------------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 241 F-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQ 297
F + + L + + G+F+ LE + ++ N F + P + +
Sbjct: 417 FLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN---- 471
Query: 298 TLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLR 353
L LDLS L + F +L+ LN++SN L+S +P SL + L
Sbjct: 472 -LTFLDLSQCQLEQ-LSP--TAFNSLSSLQVLNMASNQLKS-VPDGIFDRLTSLQKIWLH 526
Query: 354 NNALYGSIP 362
N S P
Sbjct: 527 TNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 66/360 (18%), Positives = 109/360 (30%), Gaps = 26/360 (7%)
Query: 128 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ 187
T F IP + K L L N P L LDLS
Sbjct: 11 TYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 188 LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLS 247
+ + L+ + + ++ N + +S+L+ L +L + + K L
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 248 VIRLRGNSLN-GNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 305
+ + N + +PE +L LE +DLS N SI L LDLS
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS-LDLS 185
Query: 306 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYG----- 359
N + I L L L +N + + L L
Sbjct: 186 LNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 360 SIPQEVCES-RSLGILQLDGNSLTG---PIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-S 414
+ E +L I + L I + T++ SL + S
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 415 NLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 474
L+++ +F + + L +L + N+ G P+L+ L N
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRL------TFTSNK-GGNAFSEVDLPSLEFLDLSRN 357
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 50/264 (18%), Positives = 88/264 (33%), Gaps = 19/264 (7%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
+ + + L + L + ++K L ++N
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFG-----QFPTLKLKSLKRLTFTSNKGGNAFS-- 342
Query: 67 LFENCASLRYLSLAGNILQ--GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLK 124
+ SL +L L+ N L G + +SL L+LS N L+
Sbjct: 343 -EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-----TMSSNFLGLE 396
Query: 125 RLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL 183
+L LD H+ V +L L L + L L ++ N
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456
Query: 184 FTGQL-PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF- 241
F P L ++ F+ +S L P ++S+L+ L+ ++N L S+P +F
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFD 515
Query: 242 NCKKLSVIRLRGNSLNGNIPEGLF 265
L I L N + + P +
Sbjct: 516 RLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-50
Identities = 66/306 (21%), Positives = 124/306 (40%), Gaps = 35/306 (11%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 653
P L + +G+G FG KV+ G ++ +K+L+ D F +EV+V+
Sbjct: 7 FRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-QRTFLKEVKVMRC 63
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
HPN++ G + + +++Y G+L+ + W+ R A G
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASG 120
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL---------TRLDKHVMSN 764
+A+LH IIH +L N L+ +N N ++DFGLARL+ R K
Sbjct: 121 MAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 765 RFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV 821
+ + +G ++APE+ +EK D++ FG+++ E++ +
Sbjct: 178 KRYTVVGNPYWMAPEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD----F 232
Query: 822 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 881
+ + C P + + + C P RPS ++ L+ ++ L
Sbjct: 233 GLNVRGFLDRYC--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
Query: 882 PQRMEV 887
+ +
Sbjct: 285 AGHLPL 290
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 77/295 (26%), Positives = 130/295 (44%), Gaps = 23/295 (7%)
Query: 586 SRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDF 644
SR ++ D I + +G G FGTVYK G +AVK L + + F
Sbjct: 12 SRDAADDWEIPDGQITVGQ-RIGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAF 67
Query: 645 EREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF 704
+ EV VL K RH N++ GY PQL +V+ + SL LH
Sbjct: 68 KNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHAS---ETKFEMKKLI 123
Query: 705 KVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764
+ TA+G+ +LH IIH +LK +NI L ++ +I DFGLA +R
Sbjct: 124 DIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 765 RFQSALGYVAPEL--TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
+ ++ ++APE+ S + + D+Y FG+++ EL+TG+ P +N + +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNR----DQII 235
Query: 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
++ G++ P + + + +L C RPS ++ ++ +
Sbjct: 236 EMVGRGSLS----PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-49
Identities = 70/338 (20%), Positives = 128/338 (37%), Gaps = 54/338 (15%)
Query: 589 SSLDCSIDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER 646
++ + S+D + LLE +G G +G VYK S R +AVK ++ ++F
Sbjct: 4 AASEPSLDLDNLKLLEL---IGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFIN 54
Query: 647 EVRV--LGKARHPNLISLEGY------YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPL 698
E + + H N+ + LLV +Y PNGSL L
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEY-LLVMEYYPNGSLXKYLSLH-----TS 108
Query: 699 SWTNRFKVILGTAKGLAHLH------HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752
W + ++ +GLA+LH ++P I H +L N+L+ ++ ISDFGL+
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 753 LLTR------LDKHVMSNRFQSALGYVAPEL------TCQSLRVNEKCDIYGFGVLILEL 800
LT ++ + + Y+APE+ ++ D+Y G++ E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 801 V---TGRRPVEYGEDNVVILSEHV--RVLLEEGNVLDCVD---PSMGD-YPEDEVLP--V 849
T P E + + V E+ VL + P + + E+ + +
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288
Query: 850 LKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEV 887
+ C +R + + + + + V
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-49
Identities = 81/295 (27%), Positives = 122/295 (41%), Gaps = 39/295 (13%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKL---VTSDIIQYPEDFEREVRV 650
ID L + +G G FG VY+ G +AVK DI Q E+ +E ++
Sbjct: 4 IDFAELTLEE-IIGIGGFGKVYR---AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 651 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
+HPN+I+L G LV ++A G L L + + +
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQI 114
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR--------ISDFGLARLLTRLDKHVM 762
A+G+ +LH PIIH +LK SNIL+ I+DFGLAR R K M
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--M 172
Query: 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
S ++APE+ ++ ++ D++ +GVL+ EL+TG P + + + ++ V
Sbjct: 173 SAAGA--YAWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVP--FRGIDGLAVAYGV- 226
Query: 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
L P P KL C P SRPS ++ L I
Sbjct: 227 --AMNKLALPI--------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 8e-48
Identities = 77/323 (23%), Positives = 131/323 (40%), Gaps = 39/323 (12%)
Query: 585 DSRSSSLDCSIDPETL---LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP 641
S S S + T+ ++ ++G+G +G V+ + +G +AVK T++ +
Sbjct: 20 SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASW- 76
Query: 642 EDFEREVRVLGKARHPNLI-----SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP 696
E E+ RH N++ ++G QL L++DY NGSL L
Sbjct: 77 -FRETEIYQTVLMRHENILGFIAADIKGTGSWTQL-YLITDYHENGSLYDYLKST----- 129
Query: 697 PLSWTNRFKVILGTAKGLAHLH-----HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751
L + K+ + GL HLH +P I H +LK NIL+ N I+D GLA
Sbjct: 130 TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 752 RLLTRLDKHVMSNRFQSALG---YVAPEL-----TCQSLRVNEKCDIYGFGVLILELVTG 803
D + + + +G Y+ PE+ + D+Y FG+++ E+
Sbjct: 190 VKFIS-DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
Query: 804 RRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD-----PSMGD-YPEDEVLPVL-KLALVC 856
E+ + + V ++ + V PS + + DE L + KL C
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308
Query: 857 TCHIPSSRPSMAEVVQILQVIKT 879
H P+SR + V + L +
Sbjct: 309 WAHNPASRLTALRVKKTLAKMSE 331
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-47
Identities = 84/440 (19%), Positives = 149/440 (33%), Gaps = 47/440 (10%)
Query: 5 LVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVP 64
+ N I + + +++ + + L+ + L +
Sbjct: 8 ITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLD----QVTTLQADRLGIKSIDG 63
Query: 65 YQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLK 124
E +L ++ + N L + L + ++NN + A +L
Sbjct: 64 ---VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA------NLT 112
Query: 125 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLF 184
L L L +N + P + L L L L N S + L L N +
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVT 168
Query: 185 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCK 244
L L ++ + +S+N ++ DI + ++ LE L +NN ++ + L
Sbjct: 169 D---LKPLANLTTLERLDISSNKVS-DISV-LAKLTNLESLIATNNQISDI--TPLGILT 221
Query: 245 KLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILD 303
L + L GN L L L L ++DL+ N P L L
Sbjct: 222 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSG--------LTKLTELK 271
Query: 304 LSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 363
L +N + +I GL L L L+ N L + +L +L L N + P
Sbjct: 272 LGANQIS-NISPLAGL-TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP- 326
Query: 364 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILK 423
V L L N ++ + N T++ LS HN +S P ++NL ++ L
Sbjct: 327 -VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381
Query: 424 LEFNELSGEIPQELGKLASL 443
L + ++
Sbjct: 382 LNDQAWTNAPVNYKANVSIP 401
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-41
Identities = 88/439 (20%), Positives = 164/439 (37%), Gaps = 68/439 (15%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L ++NFS+N L+ P N+ + + ++NN ++ P N +L L+L N
Sbjct: 70 LTQINFSNNQLTDITPLK----NLTKLVDILMNNNQIADITP---LANLTNLTGLTLFNN 122
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+ ++LN L LS+N S + L L+ L + + + +
Sbjct: 123 QITDIDP--LKNLTNLNRLELSSNTISDISALSG------LTSLQQLSFGNQV---TDLK 171
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
+A L L+ L + N+ S + +L +L +NN + P+ + L ++ +S
Sbjct: 172 PLANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITPLGI--LTNLDELS 227
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
++ N L DI + +++ L LD +NN ++ P L KL+ ++L N ++ P
Sbjct: 228 LNGNQLK-DIGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP- 282
Query: 263 GLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 321
L L L ++L+EN S + + L L L NN+ P +
Sbjct: 283 -LAGLTALTNLELNENQL--------EDISPISNLKNLTYLTLYFNNISDISP--VSSLT 331
Query: 322 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 381
L+ L +N + L ++ L +N + P + + L L+ +
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 382 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL------------ 429
T N + + L P +IS+ + +N
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQ 445
Query: 430 -----------SGEIPQEL 437
SG + Q L
Sbjct: 446 PVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-36
Identities = 80/379 (21%), Positives = 139/379 (36%), Gaps = 40/379 (10%)
Query: 97 SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQ 156
L + ++ + + +L L + ++ Q L + L
Sbjct: 2 PLGSATITQDTPINQIF-----TDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQAD 54
Query: 157 GNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWI 216
+ + +LT ++ SNN T P L+ L ++ I ++NN + P +
Sbjct: 55 RLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--L 108
Query: 217 GNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLS 275
N++ L L NN +T L N L+ + L N+++ L L L+++
Sbjct: 109 ANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG 164
Query: 276 ENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS 335
+ TL LD+SSN + + + NL L ++N + S
Sbjct: 165 NQ---------VTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQI-S 212
Query: 336 RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSL 395
I P LG +L L L N L + +L L L N ++ P + T L
Sbjct: 213 DITP-LGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKL 267
Query: 396 YLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 455
L L N +S P ++ L L L+L N+L P + L +L + + +N +
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323
Query: 456 RLPVGGVFPTLDQSSLQGN 474
PV L + N
Sbjct: 324 ISPVSS-LTKLQRLFFYNN 341
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 76/301 (25%), Positives = 123/301 (40%), Gaps = 34/301 (11%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+ VG+G +G V++ S+ QG +AVK + D + E E+ RH N++
Sbjct: 10 ITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSW--FRETELYNTVMLRHENIL 65
Query: 661 SLEGYYWTPQLK----LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
T + L++ Y GSL L L + +++L A GLAH
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAH 120
Query: 717 LH-----HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
LH +P I H +LK NIL+ N I+D GLA + ++ + +G
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ-LDVGNNPRVG 179
Query: 772 ---YVAPEL-----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV-- 821
Y+APE+ ++ DI+ FG+++ E+ ED + V
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 822 RVLLEEGNVLDCVD---PSM-GDYPEDEVLPVL-KLALVCTCHIPSSRPSMAEVVQILQV 876
E+ + CVD P++ + D L L KL C PS+R + + + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 877 I 877
I
Sbjct: 300 I 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-46
Identities = 75/323 (23%), Positives = 124/323 (38%), Gaps = 39/323 (12%)
Query: 585 DSRSSSLDCSIDPETL---LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP 641
S S S + T+ + +G+G FG V++ + +G +AVK + + +
Sbjct: 25 TSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSW- 81
Query: 642 EDFEREVRVLGKARHPNLISLEGY-----YWTPQLKLLVSDYAPNGSLQAKLHERLPSTP 696
E E+ RH N++ QL LVSDY +GSL L+
Sbjct: 82 -FREAEIYQTVMLRHENILGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY----- 134
Query: 697 PLSWTNRFKVILGTAKGLAHLH-----HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751
++ K+ L TA GLAHLH +P I H +LK NIL+ N I+D GLA
Sbjct: 135 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194
Query: 752 RLLTRLDKHVMSNRFQSALG---YVAPEL-----TCQSLRVNEKCDIYGFGVLILELVTG 803
+ +G Y+APE+ + ++ DIY G++ E+
Sbjct: 195 VRHDS-ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
Query: 804 RRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD-----PSM-GDYPEDEVLPVL-KLALVC 856
ED + + V + V P++ + E L V+ K+ C
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 313
Query: 857 TCHIPSSRPSMAEVVQILQVIKT 879
++R + + + L +
Sbjct: 314 WYANGAARLTALRIKKTLSQLSQ 336
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-46
Identities = 79/453 (17%), Positives = 153/453 (33%), Gaps = 28/453 (6%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
S+ +IPS + ++ L+ S N ++ I L N++ L L ++ ++ +
Sbjct: 13 RSRSFTSIPS-GLTAAMKSLDLSFNKIT-YIGHGDLR-ACANLQVLILKSSRINT-IEGD 68
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
F + SL +L L+ N L F SSL LNL N + +L L
Sbjct: 69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ---TLGVTSLFPNLTNL 125
Query: 127 RTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 185
+TL + + I + A L L EL ++ + + L L +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 245
L + +L+S+ ++ + + L + + + S K
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 246 LSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 305
L L + + D L + + + + +R L +
Sbjct: 246 LLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVT-----IRRLHIP 294
Query: 306 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEV 365
L D+ L ++ + + ++ + + SL LDL N + +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 366 CESRSLGILQ---LDGNSLT--GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLK 420
+ LQ L N L +++ +L L +S N +P S K++
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMR 413
Query: 421 ILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
L L + + + +L ++VS N L
Sbjct: 414 FLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-42
Identities = 75/437 (17%), Positives = 150/437 (34%), Gaps = 31/437 (7%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ LN N + + L N+ N++ L + N + F SL L +
Sbjct: 100 LKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
L+ + ++ L L + + L+ L +R L+L +
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF----ADILSSVRYLELRDTNLARFQFS 214
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
+ + + S L L + ++ LN + +
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS----EVEFDDCTLNGLGDFN 270
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
S + + ++ T+ L +L L + +K+ I + + + +P
Sbjct: 271 PSESDVVSELGKV--ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPC 327
Query: 263 GLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 320
LE +DLSEN + +S+ + +L+ L LS N+L + +
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLK---NSACKGAWPSLQTLVLSQNHLR-SMQKTGEIL 383
Query: 321 A---NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 377
NL L++S N +P + + L+L + + + + ++L +L +
Sbjct: 384 LTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVS 439
Query: 378 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQEL 437
N+L L L +S N L ++P S L ++K+ N+L
Sbjct: 440 NNNLD----SFSLFLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIF 493
Query: 438 GKLASLLAVNVSYNRLI 454
+L SL + + N
Sbjct: 494 DRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-30
Identities = 66/399 (16%), Positives = 132/399 (33%), Gaps = 43/399 (10%)
Query: 95 CSSLNTLNLSNNHFSG------------DLDF-----ASGYGIWSLKRLRTLDLSHNLFS 137
C + + + F+ DL F + + L+ L L + +
Sbjct: 4 CDASGVCDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 138 GSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG-QLPVSLRLL 195
+I +L L+ L L N S + G L L+L N + + L
Sbjct: 64 -TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 196 NSMIFISVSNNTLTGDIP-HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 254
++ + + N +I +++L L+ L SL + + + + L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 255 SLNGNIPEGLFD-------LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 307
+ E D L L + +L+ F SS F+ + D S N
Sbjct: 183 ESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 308 NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH--------SLIHLDLRNNALYG 359
L+ + + L + + + + N L P E ++ L + L+
Sbjct: 242 ELLKLLRYILELS-EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300
Query: 360 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKS---ISNL 416
+ + + ++ + + ++ SL L LS N + K+
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360
Query: 417 NKLKILKLEFNELS--GEIPQELGKLASLLAVNVSYNRL 453
L+ L L N L + + L L +L ++++S N
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 65/304 (21%), Positives = 110/304 (36%), Gaps = 32/304 (10%)
Query: 20 FRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCA-----SL 74
FR + S N L ++ +L L+ + L+ P + ++
Sbjct: 230 FRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288
Query: 75 RYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
R L + L + +++ + + + N+ S LK L LDLS N
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQ----HLKSLEFLDLSEN 344
Query: 135 LFSGSI---PQGVAALHYLKELLLQGNQFSGPLPADIGFC---PHLTTLDLSNNLFTGQL 188
L A L+ L+L N + +LT+LD+S N F +
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRS-MQKTGEILLTLKNLTSLDISRNTFH-PM 402
Query: 189 PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV 248
P S + M F+++S+ + + TLE LD SNN+L S L L
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFLPR---LQE 455
Query: 249 IRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNN 308
+ + N L +P+ L + +S N S+P G +S L+ + L +N
Sbjct: 456 LYISRNKLK-TLPDASLFPVLLVMKISRNQL-KSVPDGIFDRLTS-----LQKIWLHTNP 508
Query: 309 LVGD 312
Sbjct: 509 WDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-18
Identities = 43/214 (20%), Positives = 77/214 (35%), Gaps = 32/214 (14%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLS--GPVPYQLFENCASLRYLSLA 80
++R+ ++ + +P S ++ +++FLDLS NL+ SL+ L L+
Sbjct: 312 VKRITVENSKVF-LVPCSFSQ-HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 81 GNILQ--GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG 138
N L+ G+I +L +L++S N F +++R L+LS
Sbjct: 370 QNHLRSMQKTGEILLTLKNLTSLDISRNTFH-----PMPDSCQWPEKMRFLNLSSTGIR- 423
Query: 139 SIPQGV------------------AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLS 180
+ + L L+EL + N+ LP P L + +S
Sbjct: 424 VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT-LPDA-SLFPVLLVMKIS 481
Query: 181 NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPH 214
N L S+ I + N P
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 32/119 (26%), Positives = 52/119 (43%), Gaps = 4/119 (3%)
Query: 350 LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI 409
D R+ + SIP + + ++ L L N +T +R C +L +L L + ++
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 410 PKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQ 468
+ +L L+ L L N LS G L+SL +N+ N L V +FP L
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTN 124
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 25/107 (23%), Positives = 41/107 (38%), Gaps = 11/107 (10%)
Query: 10 SYNAIPSM--VVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQL 67
S I + + + LE L+ S+N+L L L + L +S N L L
Sbjct: 418 SSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSLFLPRL-----QELYISRNKLKTLPDASL 471
Query: 68 FENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDF 114
F L + ++ N L+ IF+ +SL + L N +
Sbjct: 472 FPV---LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 56/301 (18%), Positives = 116/301 (38%), Gaps = 40/301 (13%)
Query: 592 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDIIQYP-EDFEREVR 649
+ I E L +G+G FG VY G G +A++ + + + F+REV
Sbjct: 27 EWDIPFEQLEIGE-LIGKGRFGQVYH---GRWHGE-VAIRLIDIERDNEDQLKAFKREVM 81
Query: 650 VLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 709
+ RH N++ G +P +++ +L + + + L ++
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQE 138
Query: 710 TAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 769
KG+ +LH I+H +LK N+ D+ I+DFGL + L ++ +
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 770 LG---YVAPEL--------TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 818
G ++APE+ L ++ D++ G + EL P + + I+
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAII- 252
Query: 819 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLK-LALVCTCHIPSSRPSMAEVVQILQVI 877
+ + P++ + + + + L C RP+ +++ +L+ +
Sbjct: 253 ---------WQMGTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
Query: 878 K 878
Sbjct: 301 P 301
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-45
Identities = 88/474 (18%), Positives = 164/474 (34%), Gaps = 49/474 (10%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
+ +P V ERL S N + + S + ++ L+L + + +
Sbjct: 12 RFCNLTQVPQ--VLNTTERLLLSFNYIR-TVTASSFP-FLEQLQLLELGSQYTPLTIDKE 67
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
F N +LR L L + + F L L L S + +LK L
Sbjct: 68 AFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV--LKDGYFRNLKAL 125
Query: 127 RTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLSNNL 183
LDLS N L+ LK + NQ ++ L+ L+ N
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS 185
Query: 184 FTGQLP------------VSLRLLN------SMIFISVSNNTLTGDIPHWIGNISTLEFL 225
++ + L +L+ ++ +N ++ + +
Sbjct: 186 LYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA 245
Query: 226 DFSNNHLTGSLPSSLFNCKKLSV--IRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMG 281
F +++ ++ + SV + L + ++ +F+ L+ ++L+ N +
Sbjct: 246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYN-KIN 303
Query: 282 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL 341
I + L++L+LS N L + + Y++L NH+
Sbjct: 304 KIADEAFYG-----LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTF 358
Query: 342 GYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLS 401
+ L LDLR+NAL + S+ + L GN L + + + L+ LS
Sbjct: 359 KFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV----TLPKINLTANLIHLS 409
Query: 402 HNHLSG-SIPKSISNLNKLKILKLEFNELSGEIPQEL-GKLASLLAVNVSYNRL 453
N L I + + L+IL L N S + + SL + + N L
Sbjct: 410 ENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-45
Identities = 93/469 (19%), Positives = 168/469 (35%), Gaps = 44/469 (9%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L L LS + N+ + LDLS N + + F SL+ + + N
Sbjct: 99 LFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158
Query: 83 ILQGPIGKIFN--YCSSLNTLNLSNNHFSG--DLDFASGYGIWSLKRLRTLDLSHNLFS- 137
+ +L+ +L+ N +D+ + L LD+S N ++
Sbjct: 159 QIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTV 218
Query: 138 -----------GSIPQGVAALHYLKELLLQGNQFSGPLPADIG--FCPHLTTLDLSNNLF 184
S + H++ + P + LDLS+
Sbjct: 219 DITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFV 278
Query: 185 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCK 244
L + ++++ N + + L+ L+ S N L S+ +
Sbjct: 279 FSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLP 338
Query: 245 KLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSS----------SSS 292
K++ I L+ N + I + F L+ +DL +N + +I S +
Sbjct: 339 KVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNA-LTTIHFIPSIPDIFLSGNKLVTL 396
Query: 293 STLFQTLRILDLSSNNLVG-DIPAEMGLFANLRYLNLSSNHLRSRIPPEL-GYFHSLIHL 350
+ T ++ LS N L DI + +L+ L L+ N S + SL L
Sbjct: 397 PKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456
Query: 351 DLRNNALYGSIPQEVCES-----RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHL 405
L N L + E+C L +L L+ N L P V + T+L LSL+ N L
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
Query: 406 SGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 454
+ + + L+IL + N+L P L+ +++++N+ I
Sbjct: 517 T-VLSHN-DLPANLEILDISRNQLLAPNPDVFVSLSV---LDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 3e-38
Identities = 93/414 (22%), Positives = 161/414 (38%), Gaps = 42/414 (10%)
Query: 5 LVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVP 64
+ S + S+++ + F +++ + L +++ LDLS+ + +
Sbjct: 224 FSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LN 282
Query: 65 YQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLK 124
++FE L+ L+LA N + + F +L LNLS N +L ++ YG L
Sbjct: 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYG---LP 338
Query: 125 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLF 184
++ +DL N + Q L L+ L L+ N + I F P + + LS N
Sbjct: 339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL 393
Query: 185 TG--QLPVSLRLLNSMIFISVSNNTLTG-DIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 241
++ ++ L++ +S N L DI +++ + L+ L + N +
Sbjct: 394 VTLPKINLTANLIH------LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP 447
Query: 242 -NCKKLSVIRLRGNSLNG----NIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSST 294
L + L N L + +F+ L+ + L+ N S+PPG S ++
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTA- 505
Query: 295 LFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRN 354
LR L L+SN L + L ANL L++S N L + P F SL LD+ +
Sbjct: 506 ----LRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLA---PNPDVFVSLSVLDITH 556
Query: 355 NALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGS 408
N CE + N P I +S LS
Sbjct: 557 NKFICE-----CELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTE 605
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 61/348 (17%), Positives = 113/348 (32%), Gaps = 41/348 (11%)
Query: 94 YCSSLNTLNLSN-NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKE 152
+ S L D + +R D + + + +
Sbjct: 10 HSSGRENLYFQGSTALRPYHD-----VLSQWQRHYNADRNRWHSAWRQAN----SNNPQI 60
Query: 153 LLLQGNQFSGPLPADIGFC--PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG 210
G + P L+L + Q P L+ + +++ L
Sbjct: 61 ETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117
Query: 211 DIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLE 270
++P + + LE L + N L +LP+S+ + +L + +R +PE L
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST--- 173
Query: 271 EIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSS 330
+S L+ L L + +PA + NL+ L + +
Sbjct: 174 -----------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215
Query: 331 NHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQL-DGNSLTGPIPQVI 389
+ L + + P + + L LDLR + P L L L D ++L +P I
Sbjct: 216 SPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDI 273
Query: 390 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQEL 437
T L L L +P I+ L I+ + + L ++ Q
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 52/301 (17%), Positives = 97/301 (32%), Gaps = 30/301 (9%)
Query: 171 CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNN 230
L + L + N + + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGR 66
Query: 231 HLTGSLPSSLFNCK--KLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGS 287
L + L + + LR L P+ F L L+ + + G M +P
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPD-- 121
Query: 288 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELG----- 342
+ F L L L+ N L +PA + LR L++ + + +P L
Sbjct: 122 ----TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 343 ----YFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLL 398
+L L L + S+P + ++L L++ + L+ + I + L L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234
Query: 399 SLSHNHLSGSIPKSISNLNKLKILKL-EFNELSGEIPQELGKLASLLAVNVSYNRLIGRL 457
L + P LK L L + + L +P ++ +L L +++ + RL
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 458 P 458
P
Sbjct: 294 P 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 43/255 (16%), Positives = 84/255 (32%), Gaps = 22/255 (8%)
Query: 213 PHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEI 272
H + S E L F + L ++ +I
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQI 60
Query: 273 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH 332
+ + + ++ L+L S L P + ++L+++ + +
Sbjct: 61 ETRTGRALKATADLLEDATQ----PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 333 LRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNC 392
L +P + F L L L N L ++P + L L + +P+ + +
Sbjct: 116 LME-LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 393 ---------TSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL 443
+L L L + S+P SI+NL LK LK+ + LS + + L L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231
Query: 444 LAVNVSYNRLIGRLP 458
+++ + P
Sbjct: 232 EELDLRGCTALRNYP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 51/330 (15%), Positives = 104/330 (31%), Gaps = 34/330 (10%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
E L F ++ L N + N + + + G
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQR-------HYNADRNRWHSAWRQANSNNPQIETRTGR 66
Query: 83 ILQGPIGKIFNYCS-SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 141
L+ + + L L + D + L L+ + + +P
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVPLPQFPD-----QAFRLSHLQHMTIDAAGLM-ELP 120
Query: 142 QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNN---------LFTGQLPVSL 192
+ L+ L L N LPA I L L + L +
Sbjct: 121 DTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 193 RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 252
+ L ++ + + + +P I N+ L+ L N+ L+ +L ++ + KL + LR
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237
Query: 253 GNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 311
G + N P L+ + L + + ++P + L LDL +
Sbjct: 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ------LEKLDLRGCVNLS 291
Query: 312 DIPAEMGLFANLRYLNLSSNHLRSRIPPEL 341
+P+ + + + HL++++
Sbjct: 292 RLPSLIAQLPANCIILV-PPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 50/256 (19%), Positives = 85/256 (33%), Gaps = 19/256 (7%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L L Q P L+ +++ + + L +P + + A L L+LA N
Sbjct: 83 RVALELRSVPLP-QFPDQAFRLS--HLQHMTIDAAGLME-LPDTM-QQFAGLETLTLARN 137
Query: 83 ILQG-P--IGKIFNYCSSLNTLNLSNNHFSGDL-----DFASGYGIWSLKRLRTLDLSHN 134
L+ P I + L L++ +L + L L++L L
Sbjct: 138 PLRALPASIAS----LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 135 LFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL 194
S+P +A L LK L ++ + S L I P L LDL P
Sbjct: 194 GIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGG 251
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 254
+ + + + + +P I ++ LE LD LPS + +I + +
Sbjct: 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
Query: 255 SLNGNIPEGLFDLGLE 270
E
Sbjct: 312 LQAQLDQHRPVARPAE 327
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 67/380 (17%), Positives = 133/380 (35%), Gaps = 39/380 (10%)
Query: 52 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 111
L ++ P + A L + + S+ L ++ +
Sbjct: 5 LATLPAPINQIFP---DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-S 58
Query: 112 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC 171
+ GI L L L+L+ N + P ++ L L L + N+ + +
Sbjct: 59 IQ-----GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNL 109
Query: 172 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 231
+L L L+ + + L L M +++ N D+ + N++ L +L + +
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESK 166
Query: 232 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSS 290
+ + + N L + L N + L L L N P + +
Sbjct: 167 VKDV--TPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITPVANMTR 222
Query: 291 SSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL 350
L L + +N + D+ L + L +L + +N + + L L
Sbjct: 223 --------LNSLKIGNNKIT-DLSPLANL-SQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 351 DLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP 410
++ +N + S + L L L+ N L +VI T+L L LS NH++ P
Sbjct: 271 NVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
Query: 411 KSISNLNKLKILKLEFNELS 430
+++L+K+ +
Sbjct: 329 --LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-42
Identities = 76/375 (20%), Positives = 139/375 (37%), Gaps = 38/375 (10%)
Query: 82 NILQGPIGKIFN--YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS 139
L PI +IF + L + + L+ + L ++ + S
Sbjct: 6 ATLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQEE------LESITKLVVAGEKVA-S 58
Query: 140 IPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMI 199
I G+ L L+ L L GNQ + P + LT L + N T +L+ L ++
Sbjct: 59 IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLR 113
Query: 200 FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN 259
+ ++ + ++ P + N++ + L+ NH S S L N L+ + + + +
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDV 170
Query: 260 IP-EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMG 318
P L DL + L+ N P S +S L N + DI
Sbjct: 171 TPIANLTDL--YSLSLNYNQIEDISPLASLTS--------LHYFTAYVNQIT-DITPVAN 219
Query: 319 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDG 378
+ L L + +N + L L L++ N + S V + L +L +
Sbjct: 220 M-TRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGS 274
Query: 379 NSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELG 438
N ++ + N + L L L++N L + I L L L L N ++ P L
Sbjct: 275 NQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330
Query: 439 KLASLLAVNVSYNRL 453
L+ + + + + +
Sbjct: 331 SLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-34
Identities = 71/351 (20%), Positives = 125/351 (35%), Gaps = 57/351 (16%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
G +I + LE LN + N ++ P L NL + L + N ++
Sbjct: 52 AGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLV--KLTNLYIGTNKITDISA-- 105
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
+N +LR L L + + + + +LNL NH DL + ++ L
Sbjct: 106 -LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-----PLSNMTGL 157
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 186
L ++ + P +A L L L L NQ P + L N T
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213
Query: 187 QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKL 246
+ + + + + NN +T P + N+S L +L+ N ++ +++ + KL
Sbjct: 214 --ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKL 267
Query: 247 SVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSS 306
++ + N ++ D+S + L L L++
Sbjct: 268 KMLNVGSNQIS---------------DISVLNNLSQ----------------LNSLFLNN 296
Query: 307 NNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 357
N L + +G NL L LS NH+ I P L + D N +
Sbjct: 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRP-LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 33/176 (18%), Positives = 61/176 (34%), Gaps = 12/176 (6%)
Query: 299 LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALY 358
L + I + L A L + S+ L + +
Sbjct: 2 AATLATLPAPI-NQIFPDADL-AEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV- 56
Query: 359 GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 418
SI + +L L L+GN +T P + N L L + N ++ ++ NL
Sbjct: 57 ASIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 419 LKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 474
L+ L L + +S P L L + ++N+ N + L L+ ++ +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTES 165
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-41
Identities = 65/412 (15%), Positives = 120/412 (29%), Gaps = 36/412 (8%)
Query: 42 LNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTL 101
+ N K ++++ L L ++ +++ L L+GN L + L L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 102 NLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFS 161
NLS+N LD SL LRTLDL++N + ++ L N S
Sbjct: 64 NLSSNVLYETLDLE------SLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNIS 112
Query: 162 GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG-DIPHWIGNIS 220
+ G + L+NN T + + + ++ + N + + +
Sbjct: 113 R-VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 221 TLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGF 279
TLE L+ N + + + KL + L N L + + I L N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 280 MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPP 339
+ I S + L DL N N R ++ ++
Sbjct: 227 V-LIEKALRFSQN------LEHFDLRGNGFHCGTL-RDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 340 ELGYFHSLIHLDLRNNALYGSIPQEVCE------SRSLGILQLDGNSLTGPIPQVIRNCT 393
+P + + +L G+ + N
Sbjct: 279 NEEECTVPTLGHYGAYCC-EDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQA 336
Query: 394 SLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLA 445
+ I + L+ + L ++ A L
Sbjct: 337 RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-37
Identities = 63/353 (17%), Positives = 135/353 (38%), Gaps = 23/353 (6%)
Query: 122 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181
+ R + ++ + ++ + +KEL L GN S AD+ L L+LS+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 241
N+ + L L+++ + ++NN + + ++E L +NN+++ + S
Sbjct: 68 NVLY-ETL-DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 242 NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 299
+ I L N + + + ++ +DL N ++ ++SS TL
Sbjct: 120 --QGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASS----DTL 171
Query: 300 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 359
L+L N + D+ ++ A L+ L+LSSN L + + PE + + LRNN L
Sbjct: 172 EHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKL-V 227
Query: 360 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKL 419
I + + S++L L GN + + + + +++ + ++
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 420 KILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQ 472
+ +L +L + G +Q+ +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-36
Identities = 63/441 (14%), Positives = 141/441 (31%), Gaps = 42/441 (9%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
++ L+ S N LS L ++ L+LS+N+L + E+ ++LR L L N
Sbjct: 36 VKELDLSGNPLSQISAADLAPFT--KLELLNLSSNVLYETLD---LESLSTLRTLDLNNN 90
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+Q S+ TL+ +NN+ S + + G G + + L++N +
Sbjct: 91 YVQE-----LLVGPSIETLHAANNNIS-RVSCSRGQG------KKNIYLANNKITMLRDL 138
Query: 143 GVAALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFI 201
++ L L+ N+ L L+L N + + + + +
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTL 196
Query: 202 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 261
+S+N L + + + + ++ NN L + +L + L LRGN +
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254
Query: 262 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 321
F +++ + + +
Sbjct: 255 RDFFSKNQRVQTVAKQTVKKLTGQNEEECTV------PTLGHYGAYCC---EDLPAPFAD 305
Query: 322 NLRYLNLSSNHLRS-------RIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGI 373
L L + L S R+ E +D ++ +V ++
Sbjct: 306 RLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY-RTVIDQVTLRKQAKIT 364
Query: 374 LQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS-GE 432
L+ +L + R L + + + L++L+
Sbjct: 365 LEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMY 423
Query: 433 IPQELGKLASLLAVNVSYNRL 453
+ Q+ + ++ ++ ++
Sbjct: 424 VEQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-36
Identities = 68/457 (14%), Positives = 139/457 (30%), Gaps = 45/457 (9%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
+ + +SL Q SL + N+K LDLS N LS + L L+L+ N
Sbjct: 12 YKIEKVTDSSLK-QALASLRQ-SAWNVKELDLSGNPLSQ-ISAADLAPFTKLELLNLSSN 68
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSG--------DLDFA----SGYGIWSLKRLRTLD 130
+L + S+L TL+L+NN+ L A S + + +
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIY 126
Query: 131 LSHNLFSGSIPQGVAALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTGQLP 189
L++N + ++ L L+ N+ L L+L N +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185
Query: 190 VSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 249
+ + + + +S+N L + + + + ++ NN L + +L + L
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 250 RLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSS---------------SSSSST 294
LRGN + F +++ +
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
Query: 295 LFQTLRILDLSSN-------NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 347
L L + + + E A R ++ R+ I +
Sbjct: 303 FADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAK 362
Query: 348 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG 407
I L+ + AL + L L ++ +
Sbjct: 363 ITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEM 422
Query: 408 SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLL 444
+ + N ++ + ++ + ++ +E +L L
Sbjct: 423 YVEQQSVQNNAIRDWDMYQHKET-QLAEENARLKKLN 458
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-33
Identities = 56/308 (18%), Positives = 114/308 (37%), Gaps = 22/308 (7%)
Query: 139 SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM 198
+I + + K + + L + ++ LDLS N + L +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 199 IFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 258
+++S+N L + + ++STL LD +NN++ L + + N+++
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 259 NIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG-DIPAEM 317
+ G + I L+ N + S ++ LDL N + +
Sbjct: 113 RVSCSRGQ-GKKNIYLANNKI-TMLRDLDEGCRSR-----VQYLDLKLNEIDTVNFAELA 165
Query: 318 GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 377
L +LNL N + + ++ F L LDL +N L + E + + + L
Sbjct: 166 ASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLR 222
Query: 378 GNSLTGPIPQVIRNCTSLYLLSLSHNHLS-GSIPKSISNLNKLKILKLE-FNELSGEIPQ 435
N L I + +R +L L N G++ S +++ + + +L+G+ +
Sbjct: 223 NNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 436 ELGKLASL 443
E
Sbjct: 282 ECTVPTLG 289
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 9e-12
Identities = 34/276 (12%), Positives = 67/276 (24%), Gaps = 32/276 (11%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
N + VVF L+ L+ S N L+ + P + + ++ L NN L + +
Sbjct: 177 QYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAA--GVTWISLRNNKLVL-IE-K 231
Query: 67 LFENCASLRYLSLAGNILQGPI-----------------------GKIFNYCSSLNTLNL 103
+L + L GN G+ C+ +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
Query: 104 SNNHFSG-DLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG 162
FA K L + + +E+ Q+
Sbjct: 292 GAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRT 350
Query: 163 PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTL 222
+ TL+ Q+ R + ++ H S L
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSPL 409
Query: 223 EFLDFS-NNHLTGSLPSSLFNCKKLSVIRLRGNSLN 257
+ L + + + + +
Sbjct: 410 QLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 20/94 (21%), Positives = 43/94 (45%), Gaps = 2/94 (2%)
Query: 360 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKL 419
+I + I ++ +SL + + ++ ++ L LS N LS ++ KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 420 KILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
++L L N L +L L++L ++++ N +
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV 92
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 16/77 (20%), Positives = 31/77 (40%)
Query: 385 IPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLL 444
I ++ +N + ++ + L ++ + +K L L N LS +L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 445 AVNVSYNRLIGRLPVGG 461
+N+S N L L +
Sbjct: 62 LLNLSSNVLYETLDLES 78
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-40
Identities = 79/384 (20%), Positives = 142/384 (36%), Gaps = 39/384 (10%)
Query: 26 LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85
+ + + + ++ + N K + N+ + +P L ++ + L+L ++
Sbjct: 24 YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE 82
Query: 86 GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV- 144
F Y ++ L + N L + L L L N S S+P+G+
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN---VPLLTVLVLERNDLS-SLPRGIF 137
Query: 145 AALHYLKELLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 203
L L + N + D L L LS+N T V L L+ S+ +V
Sbjct: 138 HNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANV 193
Query: 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 263
S N L+ + +E LD S+N + + + +L++++L+ N+L +
Sbjct: 194 SYNLLST-----LAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT-DTAWL 244
Query: 264 LFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANL 323
L GL E+DLS N I L L +S+N LV + L
Sbjct: 245 LNYPGLVEVDLSYNELE-KIMYHPFVKMQR-----LERLYISNNRLV-ALNLYGQPIPTL 297
Query: 324 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 383
+ L+LS NHL + F L +L L +N++ ++ +L L L N
Sbjct: 298 KVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI-VTLKLSTH--HTLKNLTLSHNDWDC 353
Query: 384 PIPQVIRNCTSLYLLSLSHNHLSG 407
N +++ +
Sbjct: 354 -------NSLRALFRNVARPAVDD 370
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 72/389 (18%), Positives = 135/389 (34%), Gaps = 42/389 (10%)
Query: 134 NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR 193
I + ++ + + + + N+ L
Sbjct: 7 QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLD 66
Query: 194 LLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLR 252
+ +++++ + + T++ L N + LP +F N L+V+ L
Sbjct: 67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLE 125
Query: 253 GNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLV 310
N L+ ++P G+F L + +S N I + +++S L+ L LSSN L
Sbjct: 126 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTS-----LQNLQLSSNRLT 178
Query: 311 GDIPAEMGLFANLRYLNLSSNHLRS------------------RIPPELGYFHSLIHLDL 352
+ L +L + N+S N L + + + L L L
Sbjct: 179 -HVDL--SLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPV--NVELTILKL 233
Query: 353 RNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKS 412
++N L + + L + L N L + L L +S+N L ++
Sbjct: 234 QHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY 290
Query: 413 ISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQ 472
+ LK+L L N L + + + L + + +N I L + TL +L
Sbjct: 291 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS-IVTLKL-STHHTLKNLTLS 347
Query: 473 GNLGICSPLLKGPCKMNVPKPLVLDPDAY 501
N C+ L NV +P V D D +
Sbjct: 348 HNDWDCNSLRALF--RNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 42/173 (24%), Positives = 67/173 (38%), Gaps = 17/173 (9%)
Query: 10 SYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFE 69
SYN + ++ + +E L+ SHNS++ + + + L L +N L+
Sbjct: 194 SYNLLSTLAIPIAVEELDASHNSIN-VVRGPVNV----ELTILKLQHNNLTDT---AWLL 245
Query: 70 NCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 129
N L + L+ N L+ + F L L +SNN L+ + L+ L
Sbjct: 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY----GQPIPTLKVL 300
Query: 130 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNN 182
DLSHN + + L+ L L N L L L LS+N
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 29/155 (18%), Positives = 55/155 (35%), Gaps = 14/155 (9%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
N+ ++ + L ++ S+N L +I M ++ L +SNN L +
Sbjct: 234 QHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFV-KMQRLERLYISNNRLVA-LN-L 289
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
+ +L+ L L+ N L + + L L L +N L + + L
Sbjct: 290 YGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLS------THHTL 341
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFS 161
+ L LSHN + + A + +
Sbjct: 342 KNLTLSHNDWDCN--SLRALFRNVARPAVDDADQH 374
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-38
Identities = 90/443 (20%), Positives = 162/443 (36%), Gaps = 74/443 (16%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L ++ LS +P +L + L S N L+ +P +L ++ SL +
Sbjct: 73 AHELELNNLGLS-SLPELPPHL-----ESLVASCNSLT-ELP-ELPQSLKSLLVDNNNLK 124
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+ + L L +SNN L + + L+ +D+ +N +P
Sbjct: 125 -------ALSDLPPLLEYLGVSNNQLE-KLP-----ELQNSSFLKIIDVDNNSLK-KLPD 170
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
L+ + NQ LP ++ P LT + NN +LP L S I
Sbjct: 171 L---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLES---IV 221
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
NN L ++P + N+ L + NN L +LP + + L+V L
Sbjct: 222 AGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQ- 277
Query: 263 GLFDLGLEEIDLSENGFMGSIPPGSSS-----------SSSSTLFQTLRILDLSSNNLVG 311
L +D+SEN F + + S L +L L++S+N L+
Sbjct: 278 -----SLTFLDVSENIFS-GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI- 330
Query: 312 DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSL 371
++PA L L S NHL +P +L L + N L P S+
Sbjct: 331 ELPALPP---RLERLIASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPE---SV 379
Query: 372 GILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSG 431
L+++ + +P++ +N L++ N L P ++ + L++ +
Sbjct: 380 EDLRMNSHLAE--VPELPQNLKQLHV---ETNPLR-EFPDIPESV---EDLRMNSERVV- 429
Query: 432 EIPQELGKLASLLAVNVSYNRLI 454
+ + + L +V +
Sbjct: 430 DPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-36
Identities = 92/426 (21%), Positives = 146/426 (34%), Gaps = 76/426 (17%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
+ + PP M L + L L L
Sbjct: 36 KTEYYNAWSEWERNAPPGNGEQ--REMAVSRLRDCLDR------------QAHELELNNL 81
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
L + L +L S N + +L SLK L + + S P
Sbjct: 82 GLS----SLPELPPHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKALSDLPPL 132
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
L+ L + NQ LP ++ L +D+ NN +LP L I+
Sbjct: 133 -------LEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEF---IA 179
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
NN L ++P + N+ L + NN L LP + + + N L +PE
Sbjct: 180 AGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE-ELPE 232
Query: 263 GLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 321
L +L L I N + ++P S L L++ N L D+P
Sbjct: 233 -LQNLPFLTTIYADNN-LLKTLPDLPPS---------LEALNVRDNYLT-DLPELPQ--- 277
Query: 322 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 381
+L +L++S N S + +L +L+ +N + S+ SL L + N L
Sbjct: 278 SLTFLDVSENIF-SGLSELPP---NLYYLNASSNEI-RSLCDLP---PSLEELNVSNNKL 329
Query: 382 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 441
+P + L S NHL+ +P+ N LK L +E+N L E P +
Sbjct: 330 IE-LPALPPRLERLIA---SFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVE 380
Query: 442 SLLAVN 447
L +
Sbjct: 381 DLRMNS 386
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-35
Identities = 87/402 (21%), Positives = 143/402 (35%), Gaps = 78/402 (19%)
Query: 21 RILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLA 80
+ L N + +LS +PP L ++L +SNN L +P +N + L+ + +
Sbjct: 114 KSLLVDNNNLKALS-DLPPLL--------EYLGVSNNQLEK-LP--ELQNSSFLKIIDVD 161
Query: 81 GNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
N + K+ + SL + NN +L + +L L + +N +
Sbjct: 162 NN----SLKKLPDLPPSLEFIAAGNNQLE-ELPE-----LQNLPFLTAIYADNNSLK-KL 210
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200
P L+ ++ N ++ P LTT+ NNL LP L +
Sbjct: 211 PDL---PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA--- 261
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 260
++V +N LT D+P + L FLD S N + L N L+ SL
Sbjct: 262 LNVRDNYLT-DLPELPQS---LTFLDVSENIFS-GLSELPPNLYYLNASSNEIRSLCDLP 316
Query: 261 PEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 320
P LEE+++S N + +P L L L S N+L ++P
Sbjct: 317 P------SLEELNVSNNKLI-ELPA---------LPPRLERLIASFNHLA-EVPELPQ-- 357
Query: 321 ANLRYLNLSSNHLRSRIPPELGY----------------FHSLIHLDLRNNALYGSIPQE 364
NL+ L++ N LR P +L L + N L P
Sbjct: 358 -NLKQLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDI 414
Query: 365 VCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 406
S+ L+++ + P L H+H
Sbjct: 415 P---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 65/325 (20%), Positives = 114/325 (35%), Gaps = 50/325 (15%)
Query: 147 LHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF------ 200
+L+E L + + +P + T + + + P M
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 201 -------ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRG 253
+ ++N L+ +P + LE L S N LT LP + K L V
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 254 NSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDI 313
+L+ P LE + +S N + +P +SS L+I+D+ +N+L +
Sbjct: 124 KALSDLPP------LLEYLGVSNN-QLEKLPELQNSSF-------LKIIDVDNNSLK-KL 168
Query: 314 PAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGI 373
P +L ++ +N L PEL L + NN+L +P SL
Sbjct: 169 PDLPP---SLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSL-KKLPDLPL---SLES 219
Query: 374 LQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEI 433
+ N L ++N L + +N L ++P +L L + +L
Sbjct: 220 IVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL---- 272
Query: 434 PQELGKLASLLAVNVSYNRLIGRLP 458
P+ L L ++ L P
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-33
Identities = 80/347 (23%), Positives = 123/347 (35%), Gaps = 60/347 (17%)
Query: 120 IWSLKRLRTLDLSHNLFSGSIPQGVAALHY-------------LKELLLQGNQFSGPLPA 166
++K + + + + P G EL L S LP
Sbjct: 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE 88
Query: 167 DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 226
HL +L S N T +LP + L S++ + + L+ LE+L
Sbjct: 89 LPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-------DLPPLLEYLG 137
Query: 227 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPG 286
SNN L LP L N L +I + NSL +P+ LE I N + +P
Sbjct: 138 VSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS--LEFIAAGNN-QLEELPEL 191
Query: 287 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 346
+ L + +N+L +P +L + +N L PEL
Sbjct: 192 QNLPF-------LTAIYADNNSLK-KLPDLPL---SLESIVAGNNILEE--LPELQNLPF 238
Query: 347 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 406
L + NN L ++P SL L + N LT +P++ ++ T L + + LS
Sbjct: 239 LTTIYADNNLL-KTLPDLPP---SLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLS 293
Query: 407 GSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
P L L NE+ + L L NVS N+L
Sbjct: 294 ELPP-------NLYYLNASSNEIR-SLCDLPPSLEEL---NVSNNKL 329
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 71/353 (20%), Positives = 120/353 (33%), Gaps = 69/353 (19%)
Query: 120 IWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDL 179
S L+ + + +P + E +++ P G + L
Sbjct: 7 NVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRL 65
Query: 180 SNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS 239
+ L L ++N L+ +P + LE L S N LT LP
Sbjct: 66 RDCLDR-----QAHELE------LNNLGLS-SLPELPPH---LESLVASCNSLT-ELPEL 109
Query: 240 LFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 299
+ K L V +L+ P LE + +S N + +P +SS L
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPP------LLEYLGVSNN-QLEKLPELQNSSF-------L 155
Query: 300 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 359
+I+D+ +N+L +P +L ++ +N L PEL L + NN+L
Sbjct: 156 KIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSL-K 208
Query: 360 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG------------ 407
+P SL + N L ++N L + +N L
Sbjct: 209 KLPDLPL---SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALN 263
Query: 408 -------SIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
+P+ +L L + + F+ LS E+P L L N S N +
Sbjct: 264 VRDNYLTDLPELPQSLTFLDVSENIFSGLS-ELPPNLYYL------NASSNEI 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 62/271 (22%), Positives = 103/271 (38%), Gaps = 42/271 (15%)
Query: 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 263
++ LT ++P N+ + + + + P ++++V RLR
Sbjct: 19 HSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR------ 71
Query: 264 LFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANL 323
E++L+ G S+P L L L S N+L ++P +L
Sbjct: 72 ----QAHELELNNLGL-SSLPE---------LPPHLESLVASCNSLT-ELPELPQSLKSL 116
Query: 324 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 383
N + L S +PP L +L + NN L +P E+ S L I+ +D NSL
Sbjct: 117 LVDNNNLKAL-SDLPP------LLEYLGVSNNQL-EKLP-ELQNSSFLKIIDVDNNSLKK 167
Query: 384 PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL 443
+P + SL ++ +N L +P + NL L + + N L ++P L S+
Sbjct: 168 -LPDLP---PSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESI 220
Query: 444 LAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN 474
N L LP P L N
Sbjct: 221 ---VAGNNIL-EELPELQNLPFLTTIYADNN 247
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-38
Identities = 79/385 (20%), Positives = 143/385 (37%), Gaps = 41/385 (10%)
Query: 26 LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85
+ + + + ++ + N K + N+ + +P L ++ + L+L ++
Sbjct: 30 YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE 88
Query: 86 GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV- 144
F Y ++ L + N L + L L L N S S+P+G+
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN---VPLLTVLVLERNDLS-SLPRGIF 143
Query: 145 AALHYLKELLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 203
L L + N + D L L LS+N T V L L+ S+ +V
Sbjct: 144 HNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANV 199
Query: 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 263
S N L+ + +E LD S+N + + + +L++++L+ N+L +
Sbjct: 200 SYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLT-DTA-W 249
Query: 264 LFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN 322
L + GL E+DLS N I L L +S+N LV +
Sbjct: 250 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQR-----LERLYISNNRLV-ALNLYGQPIPT 302
Query: 323 LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLT 382
L+ L+LS NHL + F L +L L +N++ ++ +L L L N
Sbjct: 303 LKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI-VTLKLSTH--HTLKNLTLSHNDWD 358
Query: 383 GPIPQVIRNCTSLYLLSLSHNHLSG 407
N +++ +
Sbjct: 359 C-------NSLRALFRNVARPAVDD 376
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-36
Identities = 81/475 (17%), Positives = 161/475 (33%), Gaps = 87/475 (18%)
Query: 29 SHNSLSGQIPPSLLNLNM-MNMKFLDLSNNLLSGPVPYQLFE-NCASLRYLSLAGNILQG 86
+N Q ++ N+ + F D+ ++ + V + + + + ++ + ++
Sbjct: 6 RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65
Query: 87 PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA 146
+ + + LNL++ ++ F+
Sbjct: 66 LPAALLDSFRQVELLNLNDLQIE--------------------EIDTYAFAY-------- 97
Query: 147 LHYLKELLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 205
H +++L + N LP + P LT L L N + S+
Sbjct: 98 AHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS----------------SLPR 140
Query: 206 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGL 264
N L L SNN+L + F L ++L N L ++ L
Sbjct: 141 GIF--------HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 190
Query: 265 FDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLR 324
L ++S N + ++ + + LD S N++ + + L
Sbjct: 191 IP-SLFHANVSYN-LLSTLAIPIA----------VEELDASHNSIN-VVRG--PVNVELT 235
Query: 325 YLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTG 383
L L N+L L + L+ +DL N L I + L L + N L
Sbjct: 236 ILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLVA 292
Query: 384 PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASL 443
+ + +L +L LSHNHL + ++ ++L+ L L+ N + + L +L
Sbjct: 293 -LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 347
Query: 444 LAVNVSYNRLIGRLPVGGVFPTLDQSSLQGN---LGICSPLLKGPCKMNVPKPLV 495
+ +S+N + +F + + ++ I L G C KP +
Sbjct: 348 KNLTLSHNDWDC-NSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYL 401
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 6e-19
Identities = 60/329 (18%), Positives = 106/329 (32%), Gaps = 32/329 (9%)
Query: 10 SYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFE 69
SYN + ++ + +E L+ SHNS++ + + + + L L +N L+
Sbjct: 200 SYNLLSTLAIPIAVEELDASHNSIN-VVRGPVN----VELTILKLQHNNLTDT---AWLL 251
Query: 70 NCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTL 129
N L + L+ N L+ + F L L +SNN L+ + L+ L
Sbjct: 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY----GQPIPTLKVL 306
Query: 130 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLP 189
DLSHN + + L+ L L N L L L LS+N +
Sbjct: 307 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDW--DCN 360
Query: 190 VSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 249
L ++ +V + I + + + L + + L I
Sbjct: 361 SLRALFRNVARPAVDDADQHCKIDYQL------------EHGLCCKESDKPYLDRLLQYI 408
Query: 250 RLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL 309
L +G + + G + L + L L
Sbjct: 409 ALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQL 468
Query: 310 VGDIPAEMGLFANLRYLNLSSNHLRSRIP 338
+ + L L + +N R R+P
Sbjct: 469 TNEQIQQEQLLQGLH-AEIDTNLRRYRLP 496
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 28/128 (21%), Positives = 50/128 (39%), Gaps = 12/128 (9%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
N+ ++ + L ++ S+N L +I M ++ L +SNN L +
Sbjct: 240 QHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFV-KMQRLERLYISNNRLVA-LN-L 295
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
+ +L+ L L+ N L + + L L L +N L + + L
Sbjct: 296 YGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLS------THHTL 347
Query: 127 RTLDLSHN 134
+ L LSHN
Sbjct: 348 KNLTLSHN 355
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 57/328 (17%), Positives = 114/328 (34%), Gaps = 45/328 (13%)
Query: 122 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181
+ R + ++ + ++ + +KEL L GN S AD+ L L+LS+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 241
N+ + + ++STL LD +NN++ L
Sbjct: 68 NVLY-------------------------ETLD-LESLSTLRTLDLNNNYVQ-----ELL 96
Query: 242 NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 301
+ + N+++ + G + I L+ N + ++
Sbjct: 97 VGPSIETLHAANNNIS-RVSCSRGQ-GKKNIYLANNKI-TMLRDLDEGC-----RSRVQY 148
Query: 302 LDLSSNNLVG-DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGS 360
LDL N + + L +LNL N + + ++ F L LDL +N L
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKL-AF 205
Query: 361 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS-GSIPKSISNLNKL 419
+ E + + + L N L I + +R +L L N G++ S ++
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 420 KILKLEFNELSGEIPQELGKLASLLAVN 447
+ + + + +E + +L
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 59/342 (17%), Positives = 111/342 (32%), Gaps = 33/342 (9%)
Query: 42 LNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTL 101
+ N K ++++ L L ++ +++ L L+GN L + L L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 102 NLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFS 161
NLS+N LD SL LRTLDL++N + ++ L N S
Sbjct: 64 NLSSNVLYETLDLE------SLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNIS 112
Query: 162 GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG-DIPHWIGNIS 220
+ G + L+NN T + + + ++ + N + + +
Sbjct: 113 R-VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 221 TLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGF 279
TLE L+ N + + + KL + L N L + + I L N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 280 MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPP 339
+ I S + L DL N N R ++ ++ +
Sbjct: 227 V-LIEKALRFSQN------LEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK-LTG 277
Query: 340 ELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 381
+ ++ L +P + ++ L +
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLP----APFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 50/263 (19%), Positives = 100/263 (38%), Gaps = 22/263 (8%)
Query: 193 RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 252
+ N V++++L + + ++ LD S N L+ + L KL ++ L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 253 GNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 311
N L + L L L +DL+ N ++ + G S + L ++NN+
Sbjct: 67 SNVLY-ETLD-LESLSTLRTLDLNNN-YVQELLVGPS----------IETLHAANNNI-S 112
Query: 312 DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG-SIPQEVCESRS 370
+ + + L++N + + G + +LDL+ N + + + S +
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 371 LGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 430
L L L N + + + L L LS N L+ + + + + L N+L
Sbjct: 171 LEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 431 GEIPQELGKLASLLAVNVSYNRL 453
I + L +L ++ N
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 56/312 (17%), Positives = 114/312 (36%), Gaps = 33/312 (10%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
++ L+ S N LS QI + L ++ L+LS+N+L + E+ ++LR L L N
Sbjct: 36 VKELDLSGNPLS-QISAADLA-PFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNN 90
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+Q ++ S+ TL+ +NN+ S + + + + + L++N +
Sbjct: 91 YVQ----ELLV-GPSIETLHAANNNIS-RVSCS------RGQGKKNIYLANNKITMLRDL 138
Query: 143 GVAALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFI 201
++ L L+ N+ L L+L N + + + +
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTL 196
Query: 202 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 261
+S+N L + + + + ++ NN L + +L + L LRGN +
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254
Query: 262 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 321
F +++ + + T+ L D+PA
Sbjct: 255 RDFFSKNQRVQTVAKQTV-------KKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA--- 304
Query: 322 NLRYLNLSSNHL 333
R + L +H
Sbjct: 305 -DRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 51/277 (18%), Positives = 102/277 (36%), Gaps = 37/277 (13%)
Query: 235 SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSS 292
++ N + + ++ +SL L ++E+DLS N I + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPL-SQISAADLAPFT 58
Query: 293 STLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS----------------- 335
L +L+LSSN L ++ + LR L+L++N+++
Sbjct: 59 K-----LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI 111
Query: 336 -RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG-PIPQVIRNCT 393
R+ ++ L NN + + + L L N + ++ +
Sbjct: 112 SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 394 SLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
+L L+L +N + + + KLK L L N+L+ + E A + +++ N+L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 454 IGRLPVG-GVFPTLDQSSLQGNLGICSPLLKGPCKMN 489
+ + L+ L+GN C L K
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 42/234 (17%), Positives = 86/234 (36%), Gaps = 19/234 (8%)
Query: 10 SYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFE 69
+ N + ++V +E L+ ++N++S ++ S K + L+NN ++ +
Sbjct: 88 NNNYVQELLVGPSIETLHAANNNIS-RVSCSRGQ----GKKNIYLANNKITM-LRDLDEG 141
Query: 70 NCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 128
+ ++YL L N + ++ +L LNL N D+ G +L+T
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-----GQVVFAKLKT 195
Query: 129 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNN-LFTGQ 187
LDLS N + + + + + L+ N+ + + F +L DL N G
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGT 253
Query: 188 LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 241
L + ++ + T+ L + LP+
Sbjct: 254 LRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 40/274 (14%), Positives = 81/274 (29%), Gaps = 25/274 (9%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
N + L L+ ++N + ++ +++ L +NN +S V
Sbjct: 66 SSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLV------GPSIETLHAANNNISR-VSCS 117
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
+ + + LA N + S + L+L N ++FA S L
Sbjct: 118 RGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAA--SSDTL 171
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 186
L+L +N + LK L L N+ + + + +T + L NN
Sbjct: 172 EHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV- 227
Query: 187 QLPVSLRLLNSMIFISVSNNTLTGD-IPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 245
+ +LR ++ + N + + ++ +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 246 LSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGF 279
L + F L I L +
Sbjct: 288 L----GHYGAYCCEDLPAPFADRL--IALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 24/145 (16%), Positives = 44/145 (30%), Gaps = 19/145 (13%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
N + VVF L+ L+ S N L+ + P + + ++ L NN L + +
Sbjct: 177 QYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAA--GVTWISLRNNKLVL-IE-K 231
Query: 67 LFENCASLRYLSLAGNILQ-GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 125
+L + L GN G + F+ + T+ +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
Query: 126 -------------LRTLDLSHNLFS 137
R + L H+
Sbjct: 292 GAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-35
Identities = 81/358 (22%), Positives = 126/358 (35%), Gaps = 54/358 (15%)
Query: 94 YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 153
+ LN+ + + L + TL + N + S+P A L+ L
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLP------AHITTLVIPDNNLT-SLP---ALPPELRTL 86
Query: 154 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP 213
+ GNQ + LP L+ LP L L + N LT +P
Sbjct: 87 EVSGNQLTS-LPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLW------IFGNQLT-SLP 137
Query: 214 HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEID 273
L+ L S+N L SLP+ KL N L ++P GL+E+
Sbjct: 138 VLPPG---LQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPS--GLQELS 187
Query: 274 LSENGFMGSIPPGSSS-----------SSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN 322
+S+N S+P S +S L L+ L +S N L +P
Sbjct: 188 VSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRL-TSLPVLPS---E 242
Query: 323 LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLT 382
L+ L +S N L S +P L+ L + N L +P+ + S + L+GN L+
Sbjct: 243 LKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQL-TRLPESLIHLSSETTVNLEGNPLS 297
Query: 383 GPIPQVIRNCTSLYLLS---LSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQEL 437
Q +R TS S + + S P+ L+ L P +
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADR 355
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-35
Identities = 87/411 (21%), Positives = 141/411 (34%), Gaps = 53/411 (12%)
Query: 120 IWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDL 179
L++ + + ++P + A + L++ N + LPA L TL++
Sbjct: 36 ACLNNGNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLTS-LPALPP---ELRTLEV 88
Query: 180 SNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS 239
S N T LPV L + S L S L L N LT SLP
Sbjct: 89 SGNQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPVL 139
Query: 240 LFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 299
++LS + N L ++P + L ++ N S+P L L
Sbjct: 140 PPGLQELS---VSDNQLA-SLPALPSE--LCKLWAYNNQL-TSLPM---------LPSGL 183
Query: 300 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 359
+ L +S N L +P L L +N L S +P L L + N L
Sbjct: 184 QELSVSDNQLA-SLPTLPS---ELYKLWAYNNRLTS-LPALPS---GLKELIVSGNRL-T 234
Query: 360 SIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKL 419
S+P L L + GN LT +P + SL + N L+ +P+S+ +L+
Sbjct: 235 SLPVLPS---ELKELMVSGNRLTS-LPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSE 286
Query: 420 KILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICS 479
+ LE N LS Q L ++ S +I G P ++
Sbjct: 287 TTVNLEGNPLSERTLQALREITSA---PGYSGPIIRFDMAGASAPRETRALHLAAADWLV 343
Query: 480 PLLKG-PCKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAI 529
P +G P + + +A + + +S+
Sbjct: 344 PAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSW 394
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 82/376 (21%), Positives = 129/376 (34%), Gaps = 58/376 (15%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
LN + L+ +P L ++ L + +N L+ L LR L ++GN
Sbjct: 42 NAVLNVGESGLT-TLPDCLPA----HITTLVIPDNNLT-----SLPALPPELRTLEVSGN 91
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
L + + L+ + H L L + N + S+P
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLPA-----------LPSGLCKLWIFGNQLT-SLP- 137
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
L+EL + NQ + LPA L L NN T LP+ L +S
Sbjct: 138 --VLPPGLQELSVSDNQLAS-LPALPS---ELCKLWAYNNQLT-SLPMLPSGLQE---LS 187
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE 262
VS+N L +P L L NN LT SLP+ K+L + GN L ++P
Sbjct: 188 VSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLKELI---VSGNRLT-SLPV 238
Query: 263 GLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFAN 322
+L +E+ +S N + S+P L L L + N L +P + ++
Sbjct: 239 LPSEL--KELMVSGN-RLTSLPM---------LPSGLLSLSVYRNQLT-RLPESLIHLSS 285
Query: 323 LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLT 382
+NL N L R L S + E+R+L + L
Sbjct: 286 ETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL--HLAAADWLV 343
Query: 383 GPIPQVIRNCTSLYLL 398
++
Sbjct: 344 PAREGEPAPADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 18/90 (20%), Positives = 36/90 (40%), Gaps = 8/90 (8%)
Query: 364 EVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILK 423
C + +L + + LT +P + + L + N+L+ S+P L+ L+
Sbjct: 35 RACLNNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLPALPPE---LRTLE 87
Query: 424 LEFNELSGEIPQELGKLASLLAVNVSYNRL 453
+ N+L+ +P L L + L
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHL 116
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 70/337 (20%), Positives = 128/337 (37%), Gaps = 31/337 (9%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
H + A+P + L+ N + + + +++ L+L+ N++S V
Sbjct: 19 HRKRFVAVPE-GIPTETRLLDLGKNRIK-TLNQDEFA-SFPHLEELELNENIVSA-VEPG 74
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS--GDLDFASGYGIWSLK 124
F N +LR L L N L+ +F S+L L++S N D F L
Sbjct: 75 AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQ------DLY 128
Query: 125 RLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL 183
L++L++ N I + L+ L++L L+ + + L L L +
Sbjct: 129 NLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187
Query: 184 FTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-N 242
S + L + + +S+ + L L ++ +LT ++P +
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
Query: 243 CKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLR 300
L + L N ++ I + L L+EI L + + P + + LR
Sbjct: 247 LVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQ-LAVVEPYAFRGLNY-----LR 299
Query: 301 ILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLR 334
+L++S N L + +F NL L L SN L
Sbjct: 300 VLNVSGNQLT-TLEE--SVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-31
Identities = 80/345 (23%), Positives = 138/345 (40%), Gaps = 53/345 (15%)
Query: 96 SSLNTLNLSNNHFS--GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKE 152
+ L+L N +FAS L L+L+ N+ S ++ G L L+
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFAS------FPHLEELELNENIVS-AVEPGAFNNLFNLRT 84
Query: 153 LLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 211
L L+ N+ +P + +LT LD+S N L + L ++ + V +N L
Sbjct: 85 LGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI 143
Query: 212 IPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GL 269
+++LE L +LT +L + L V+RLR ++N I + F L
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRL 202
Query: 270 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYL 326
+ +++S ++ ++ P + L L ++ NL +P LR+L
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLN------LTSLSITHCNLT-AVPY--LAVRHLVYLRFL 253
Query: 327 NLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIP 386
NLS N + S I H L L +QL G L P
Sbjct: 254 NLSYNPI-STIEG--SMLHEL---------------------LRLQEIQLVGGQLAVVEP 289
Query: 387 QVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFNELS 430
R L +L++S N L+ ++ +S+ ++ L+ L L+ N L+
Sbjct: 290 YAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-31
Identities = 67/358 (18%), Positives = 129/358 (36%), Gaps = 51/358 (14%)
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 186
R + F ++P+G+ + L L N+ + PHL L+L+ N+ +
Sbjct: 14 RAVLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69
Query: 187 QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKK 245
+V + L L +N L +P +F
Sbjct: 70 ---------------AVEPGAFNN--------LFNLRTLGLRSNRLK-LIPLGVFTGLSN 105
Query: 246 LSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILD 303
L+ + + N + + + +F L+ +++ +N + I + S +S L L
Sbjct: 106 LTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNS-----LEQLT 158
Query: 304 LSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGS 360
L NL IP + L L L ++ + + L L++ + +
Sbjct: 159 LEKCNLT-SIPT--EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215
Query: 361 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLK 420
+ +L L + +LT +R+ L L+LS+N +S + L +L+
Sbjct: 216 MTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ 275
Query: 421 ILKLEFNELSGEIPQE-LGKLASLLAVNVSYNRLIGRLPVGGVF---PTLDQSSLQGN 474
++L +L+ + L L +NVS N+ + L VF L+ L N
Sbjct: 276 EIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQ-LTTLE-ESVFHSVGNLETLILDSN 330
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 84/427 (19%), Positives = 142/427 (33%), Gaps = 75/427 (17%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
+ ++ S NS++ ++ + + + +++FL + + F +SL L L N
Sbjct: 32 VNYVDLSLNSIA-ELNETSFS-RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN-LFSGSIP 141
L F+G L L L L+ L +
Sbjct: 90 QFL----------------QLETGAFNG------------LANLEVLTLTQCNLDGAVLS 121
Query: 142 QGV-AALHYLKELLLQGNQFSGPLPADIGFC--PHLTTLDLSNN--------LFTGQLPV 190
L L+ L+L+ N PA F LDL+ N
Sbjct: 122 GNFFKPLTSLEMLVLRDNNIKKIQPASF-FLNMRRFHVLDLTFNKVKSICEEDLLNFQGK 180
Query: 191 SLRLLN--SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV 248
LL S+ ++ L + +++ LD S N S+ F+ +
Sbjct: 181 HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK 240
Query: 249 IRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNN 308
I+ S + N+ + D F G G ++ DLS +
Sbjct: 241 IQSLILSNSYNMGSSFGHTNFK--DPDNFTFKGLEASG------------VKTCDLSKSK 286
Query: 309 LVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFH---SLIHLDLRNNALYGSIP 362
+ + +F+ +L L L+ N + I F L+ L+L N L GSI
Sbjct: 287 I-FALLK--SVFSHFTDLEQLTLAQNEINK-IDD--NAFWGLTHLLKLNLSQNFL-GSID 339
Query: 363 QEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLK 420
+ E+ L +L L N + Q +L L+L N L S+P I L L+
Sbjct: 340 SRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQ 398
Query: 421 ILKLEFN 427
+ L N
Sbjct: 399 KIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 68/356 (19%), Positives = 127/356 (35%), Gaps = 52/356 (14%)
Query: 126 LRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADI-GFCPHLTTLDLSNNL 183
+ +DLS N + + + + L L+ L ++ + + L L L N
Sbjct: 32 VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN- 89
Query: 184 FTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGS-LPSSLF- 241
L + F ++N LE L + +L G+ L + F
Sbjct: 90 -------QFLQLETGAFNGLAN----------------LEVLTLTQCNLDGAVLSGNFFK 126
Query: 242 NCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 299
L ++ LR N++ P F +DL+ N SI + F L
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLL 185
Query: 300 R-----ILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRN 354
R + D++ L + ++ L+LS N + + +F ++ +++
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE-SMAK-RFFDAIAGTKIQS 243
Query: 355 NALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI- 413
L S + D + G + + LS + + ++ KS+
Sbjct: 244 LILSNSYNMGSSFGHTN-FKDPDNFTFKGL------EASGVKTCDLSKSKIF-ALLKSVF 295
Query: 414 SNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQ 468
S+ L+ L L NE++ +I L LL +N+S N L G + +F LD+
Sbjct: 296 SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSID-SRMFENLDK 348
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 54/294 (18%), Positives = 98/294 (33%), Gaps = 53/294 (18%)
Query: 220 STLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSE 276
+ + ++D S N + L + F + L +++ + I F L + L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 277 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL-VGDIPAEMGLFA---NLRYLNLSSNH 332
N F + G+ + ++ L +L L+ NL + F +L L L N+
Sbjct: 89 NQF-LQLETGAFNGLAN-----LEVLTLTQCNLDGAVLSG--NFFKPLTSLEMLVLRDNN 140
Query: 333 LRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEV---CESRSLGILQLDGNSLT---- 382
++ I P +F LDL N + SI +E + + +L+L +L
Sbjct: 141 IKK-IQPA-SFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197
Query: 383 ----GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL-------------NKLKILKLE 425
TS+ L LS N S+ K + +
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257
Query: 426 FNELSGEIPQELGKL--ASLLAVNVSYNRLIGRLPVGGVF---PTLDQSSLQGN 474
L + + ++S ++ I L VF L+Q +L N
Sbjct: 258 HTNFKDPDNFTFKGLEASGVKTCDLSKSK-IFALLK-SVFSHFTDLEQLTLAQN 309
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 30/143 (20%), Positives = 58/143 (40%), Gaps = 17/143 (11%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
++ + S + + + S+ + + +++ L L+ N ++ + F L L+L+ N
Sbjct: 277 VKTCDLSKSKIF-ALLKSVFS-HFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFS----GDLDFASGYGIWSLKRLRTLDLSHNLFSG 138
L ++F L L+LS NH L L+ L L N
Sbjct: 334 FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL--------GLPNLKELALDTNQLK- 384
Query: 139 SIPQGV-AALHYLKELLLQGNQF 160
S+P G+ L L+++ L N +
Sbjct: 385 SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 66/336 (19%), Positives = 126/336 (37%), Gaps = 53/336 (15%)
Query: 568 SSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRML 627
SS R G +++ D++ ++GEG F V V G
Sbjct: 10 HSSGRENLYFQGHMVIIDNKH------------YLFIQKLGEGGFSYVDLVEGLHDGHFY 57
Query: 628 AVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK----LLVSDYAPNGS 683
A+K+++ + E+ +RE + HPN++ L Y + L+ + G+
Sbjct: 58 ALKRILCHEQQDR-EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116
Query: 684 LQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 743
L ++ L+ ++LG +GL +H H +LKP+NILL D P
Sbjct: 117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQP 173
Query: 744 RISDFGLARLLTR-LDKHVMSNRFQSALG------YVAPEL-TCQS-LRVNEKCDIYGFG 794
+ D G ++ + Q Y APEL + QS ++E+ D++ G
Sbjct: 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233
Query: 795 VLILELVTGRRPVEY----GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVL 850
++ ++ G P + G+ + + + + P + L
Sbjct: 234 CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI------------PQSPRHSSA-----L 276
Query: 851 KLALVCTC--HIPSSRPSMAEVVQILQVIKTPLPQR 884
L+ + P RP + ++ L+ ++ P P +
Sbjct: 277 W-QLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-34
Identities = 98/495 (19%), Positives = 177/495 (35%), Gaps = 74/495 (14%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
N +P + + LN S N +S +L+L+ ++ L +S+N + +
Sbjct: 8 SKNGLIHVPK-DLSQKTTILNISQNYISELWTSDILSLS--KLRILIISHNRIQY-LDIS 63
Query: 67 LFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 125
+F+ L YL L+ N L +L L+LS N F ++ +
Sbjct: 64 VFKFNQELEYLDLSHNKLVKISCHPT----VNLKHLDLSFNAFD---ALPICKEFGNMSQ 116
Query: 126 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGN--------------------------- 158
L+ L LS S +A L+ K LL+ G
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 159 QFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF------ISVSNNTLTGDI 212
+F L + +L ++ L + L +L + ++++N T +
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 213 PHWIGNI---STLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI----PEGLF 265
I + +T+ + SN L G L F+ S+ L + + ++ ++
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 266 D----LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 321
+ + ++ +S + S S LD S+N L + G
Sbjct: 297 EIFSNMNIKNFTVSGTRM---VHMLCPSKISP-----FLHLDFSNNLLTDTVFENCGHLT 348
Query: 322 NLRYLNLSSNHLRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEVCES-RSLGILQLD 377
L L L N L+ + SL LD+ N++ + C +SL L +
Sbjct: 349 ELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 378 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE- 436
N LT I + + + +L L N + SIPK + L L+ L + N+L +P
Sbjct: 408 SNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGI 463
Query: 437 LGKLASLLAVNVSYN 451
+L SL + + N
Sbjct: 464 FDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 7e-22
Identities = 60/441 (13%), Positives = 130/441 (29%), Gaps = 72/441 (16%)
Query: 26 LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85
++ S N L +P L L++S N +S + + + LR L ++ N +Q
Sbjct: 5 VDRSKNGLI-HVPKDLSQ----KTTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQ 58
Query: 86 GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVA 145
+F + L L+LS+N + L+ LDLS N F
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLVK-ISC------HPTVNLKHLDLSFNAFD-------- 103
Query: 146 ALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 205
+ P+ + G L L LS + + LN + V
Sbjct: 104 ---------------ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148
Query: 206 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLF 265
T + T + + +V L +++ + +
Sbjct: 149 ETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 266 DLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRY 325
L ++ TL ++ + N+ + + + +
Sbjct: 207 SYFLSI-------------LAKLQTNPKLSNLTLNNIETTWNSFIR-------ILQLVWH 246
Query: 326 LNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPI 385
+ + + F D +L ++L I Q+ + P
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDF---DYSGTSL-----------KALSIHQVVSDVFGFPQ 292
Query: 386 PQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLA 445
+ +++ + + + + S ++ L N L+ + + G L L
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 446 VNVSYNRLIGRLPVGGVFPTL 466
+ + N+L + + +
Sbjct: 353 LILQMNQLKELSKIAEMTTQM 373
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-18
Identities = 48/262 (18%), Positives = 99/262 (37%), Gaps = 26/262 (9%)
Query: 8 GNSYNAIPSMVVFRILERLNFSHNSLSGQI---PPSLLNLNMMNMKFLDLSNNLLSGPVP 64
NS+ I +V + + S+ L GQ+ ++ + + +++ P
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP-Q 292
Query: 65 YQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLK 124
++E +++ + + + + S L+ SNN + + G L
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG----HLT 348
Query: 125 RLRTLDLSHNLFSGSIPQGVAALHYLKELL---LQGNQFSGPLPADI-GFCPHLTTLDLS 180
L TL L N + + +K L + N S + L +L++S
Sbjct: 349 ELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 181 NNLFT----GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSL 236
+N+ T LP +++L+ + +N + IP + + L+ L+ ++N L S+
Sbjct: 408 SNILTDTIFRCLPPRIKVLD------LHSNKIK-SIPKQVVKLEALQELNVASNQLK-SV 459
Query: 237 PSSLF-NCKKLSVIRLRGNSLN 257
P +F L I L N +
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPWD 481
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 72/297 (24%), Positives = 123/297 (41%), Gaps = 48/297 (16%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
E+ A +G+G FG V K R A+KK+ ++ EV +L H ++
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL--STILSEVMLLASLNHQYVVR 66
Query: 662 LEGYYWTPQLKL-------------LVSDYAPNGSLQAKLHER-LPSTPPLSWTNRFKVI 707
+ + + + +Y NG+L +H L W F+ I
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-RLFRQI 125
Query: 708 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR---------LD 758
L + L+++H IIH +LKP NI +D++ N +I DFGLA+ + R +
Sbjct: 126 L---EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 759 KHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV 815
S+ SA+G YVA E+ + NEK D+Y G++ E++ P G + V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236
Query: 816 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
IL + L ++ + + + E K+ + H P+ RP ++
Sbjct: 237 ILKK-----LRSVSI-EFPPDFDDNKMKVEK----KIIRLLIDHDPNKRPGARTLLN 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEG 664
+G G +G K+ + G++L K+L + + + EV +L + +HPN++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 665 YYWTPQLKLL--VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH--HS 720
L V +Y G L + + + L +V+ L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 777
++H +LKP+N+ LD N ++ DFGLAR+L ++ +G Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-----KTFVGTPYYMSPEQ 187
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ NEK DI+ G L+ EL P
Sbjct: 188 -MNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 76/447 (17%), Positives = 143/447 (31%), Gaps = 82/447 (18%)
Query: 9 NSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLF 68
S+N F F + ++ + + LD N+ ++
Sbjct: 9 QSFNDWFPDDNFASEVAAAFEMQATD-----TISEEQLATLTSLDCHNSSITDMTG---I 60
Query: 69 ENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 127
E L L N + + + ++L L +N + +LD L +L
Sbjct: 61 EKLTGLTKLICTSNNITTLDLSQ----NTNLTYLACDSNKLT-NLDVT------PLTKLT 109
Query: 128 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ 187
L+ N + + V+ L L N + D+ LT LD N +
Sbjct: 110 YLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITK 163
Query: 188 LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLS 247
L V+ + + S N +T ++ + L L+ N++T L L +L+
Sbjct: 164 LDVT--PQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLT 215
Query: 248 VIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 307
+ N L EID++ L D S N
Sbjct: 216 FLDCSSNK-------------LTEIDVTPL-------------------TQLTYFDCSVN 243
Query: 308 NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCE 367
L ++ + + L L+ L I L + LI+ + +V
Sbjct: 244 PL-TELD--VSTLSKLTTLHCIQTDLLE-ID--LTHNTQLIYFQAEGCRKIKEL--DVTH 295
Query: 368 SRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 427
+ L +L +T + + L L L++ L+ + +S+ KLK L
Sbjct: 296 NTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNA 349
Query: 428 ELSGEIPQELGKLASLLAVNVSYNRLI 454
+ + +GK+ +L + + I
Sbjct: 350 HIQ-DFS-SVGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 68/438 (15%), Positives = 142/438 (32%), Gaps = 60/438 (13%)
Query: 23 LERLNFSHNSLSGQIPPSLLNL-NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG 81
L L+ ++S++ + + + + L ++N ++ + +L YL+
Sbjct: 44 LTSLDCHNSSIT-----DMTGIEKLTGLTKLICTSNNITT-LD---LSQNTNLTYLACDS 94
Query: 82 NILQG-PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
N L + + L LN N + LD + L L+ + N + I
Sbjct: 95 NKLTNLDVTP----LTKLTYLNCDTNKLT-KLDVSQ------NPLLTYLNCARNTLT-EI 142
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200
V+ L EL N+ L D+ LTTLD S N T + + +
Sbjct: 143 D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE---LDVSQNKLLNR 195
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 260
++ N +T + + L FLD S+N LT + + +L+ N L +
Sbjct: 196 LNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVNPLT-EL 248
Query: 261 PEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 320
L + + + I ++ L + ++ ++
Sbjct: 249 DVSTLS-KLTTLHCIQTDLL-EIDLTHNTQ--------LIYFQAEGCRKIKEL--DVTHN 296
Query: 321 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 380
L L+ + + +L L++L L N L + V + L L
Sbjct: 297 TQLYLLDCQAAGITE---LDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAH 350
Query: 381 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSG---EIPQEL 437
+ + +L + ++++N + + + + G I
Sbjct: 351 IQD-FS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGD 408
Query: 438 GKLASLLAVNVSYNRLIG 455
G + +++ L
Sbjct: 409 GGVYDQATNTITWENLST 426
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 58/312 (18%), Positives = 103/312 (33%), Gaps = 36/312 (11%)
Query: 150 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 209
+ + LT+LD N+ T + L + + ++N +T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEK--LTGLTKLICTSNNIT 77
Query: 210 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGL 269
+ + + L +L +N LT +L + KL+ + N L + L L
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPL-L 129
Query: 270 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 329
++ + N + + L LD N + + + L L+ S
Sbjct: 130 TYLNCARNTL---------TEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCS 178
Query: 330 SNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI 389
N + ++ L L+ N + + + ++ L L N LT I +
Sbjct: 179 FNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE-ID--V 229
Query: 390 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 449
T L S N L+ + +S L+KL L +L EI L L+
Sbjct: 230 TPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAE 283
Query: 450 YNRLIGRLPVGG 461
R I L V
Sbjct: 284 GCRKIKELDVTH 295
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 41/293 (13%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLG 652
ET +K +G G FGTVYK + +G + A+K+L + + ++ E V+
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVILG 709
+P++ L G T + L++ P G L + E + L+W +
Sbjct: 73 SVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 125
Query: 710 TAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
AKG+ +L +H +L N+L+ + +I+DFGLA+LL +K + +
Sbjct: 126 IAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 769 ALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 824
+ ++A E S+ + D++ +GV + EL+T G +P Y I + + +
Sbjct: 182 PIKWMALE----SILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDG----IPASEISSI 231
Query: 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
LE+G L P + V + C SRP E++ +
Sbjct: 232 LEKGERLPQ--------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 64/341 (18%), Positives = 119/341 (34%), Gaps = 57/341 (16%)
Query: 126 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 185
LR + S +P+ + L LQ N+ + D +L TL L NN +
Sbjct: 33 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 245
+S + LE L S N L LP + K
Sbjct: 90 ----------------KISPGAFAP--------LVKLERLYLSKNQLK-ELPEKMP--KT 122
Query: 246 LSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGF-MGSIPPGSSSSSSSTLFQTLRIL 302
L +R+ N + + + +F+ + ++L N I G+ L +
Sbjct: 123 LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK-----LSYI 176
Query: 303 DLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGSI 361
++ N+ IP GL +L L+L N + + L ++L L L N++ ++
Sbjct: 177 RIADTNIT-TIPQ--GLPPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSI-SAV 231
Query: 362 PQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKS-------I 413
+ L L L+ N L +P + + + ++ L +N++S +I +
Sbjct: 232 DNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN 289
Query: 414 SNLNKLKILKLEFNELS-GEIPQEL-GKLASLLAVNVSYNR 452
+ + L N + EI + AV + +
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 66/319 (20%), Positives = 109/319 (34%), Gaps = 53/319 (16%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ +N ++ +I N+ N+ L L NN +S + F L L L+ N
Sbjct: 54 TALLDLQNNKIT-EIKDGDFK-NLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKN 110
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSG--DLDFASGYGIWSLKRLRTLDLSHN-LFSGS 139
L+ K+ +L L + N + F L ++ ++L N L S
Sbjct: 111 QLKELPEKMP---KTLQELRVHENEITKVRKSVFN------GLNQMIVVELGTNPLKSSG 161
Query: 140 IPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM 198
I G + L + + + +P G P LT L L N T
Sbjct: 162 IENGAFQGMKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKIT------------- 205
Query: 199 IFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 258
V +L G ++ L L S N ++ SL N L + L N L
Sbjct: 206 ---KVDAASLKG--------LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 253
Query: 259 NIPEGLFDL-GLEEIDLSENGFMGSIPPGS-SSSSSSTLFQTLRILDLSSNNL-VGDIPA 315
+P GL D ++ + L N + +I +T + + L SN + +I
Sbjct: 254 KVPGGLADHKYIQVVYLHNN-NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312
Query: 316 EMGLFA---NLRYLNLSSN 331
F + L +
Sbjct: 313 --STFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 64/322 (19%), Positives = 110/322 (34%), Gaps = 57/322 (17%)
Query: 162 GPLPADIGFCP-----HLTTLDLSNNLFT---GQLPVSLRLLNSMIFISVSNNTLTGDIP 213
+ CP HL + S+ LP LL+ + NN +T
Sbjct: 16 PEIEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLD------LQNNKITEIKD 69
Query: 214 HWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEI 272
N+ L L NN ++ + F KL + L N L +PE + L+E+
Sbjct: 70 GDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK-TLQEL 126
Query: 273 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLS 329
+ EN + + + + +++L +N L E G F L Y+ ++
Sbjct: 127 RVHENEI-TKVRKSVFNGLNQ-----MIVVELGTNPL-KSSGIENGAFQGMKKLSYIRIA 179
Query: 330 SNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI 389
++ + IP L SL L L N + + +
Sbjct: 180 DTNITT-IPQGL--PPSLTELHLDGNKI-TKVD-----------------------AASL 212
Query: 390 RNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 449
+ +L L LS N +S S++N L+ L L N+L ++P L + V +
Sbjct: 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271
Query: 450 YNRLIGRLPVGGVFPTLDQSSL 471
N I + P +
Sbjct: 272 NNN-ISAIGSNDFCPPGYNTKK 292
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 44/242 (18%), Positives = 87/242 (35%), Gaps = 37/242 (15%)
Query: 19 VFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLL-SGPVPYQLFENCASLRYL 77
+ + L+ L N ++ ++ S+ N + M ++L N L S + F+ L Y+
Sbjct: 119 MPKTLQELRVHENEIT-KVRKSVFN-GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 176
Query: 78 SLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS--GDLDFASGYGIWSLKRLRTLDLSHNL 135
+A + + SL L+L N + L L L LS N
Sbjct: 177 RIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLK------GLNNLAKLGLSFNS 227
Query: 136 FSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL 194
S ++ G A +L+EL L N+ +P + ++ + L NN +
Sbjct: 228 IS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS--------- 276
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT-GSLPSSLFNC-KKLSVIRLR 252
++ +N P + ++ + +N + + S F C + ++L
Sbjct: 277 -------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG 327
Query: 253 GN 254
Sbjct: 328 NY 329
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 53/308 (17%), Positives = 100/308 (32%), Gaps = 55/308 (17%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
E +G G FG V++ A+K++ + E REV+ L K HP ++
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 662 LEGYYWTPQLKL------------LVSDYAPNGSLQAKLHERLPSTPP-----LSWTNRF 704
+ + +L+ ++ R L F
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI---F 124
Query: 705 KVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764
I + + LH ++H +LKPSNI + ++ DFGL + + ++
Sbjct: 125 LQIA---EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 765 RFQSALG----------YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNV 814
A Y++PE + K DI+ G+++ EL+ P + V
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234
Query: 815 VILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ-- 872
L++ + P E + P RP +++
Sbjct: 235 RTLTD-----VRNLK----FPPLFTQKYPCEY----VMVQDMLSPSPMERPEAINIIENA 281
Query: 873 ILQVIKTP 880
+ + + P
Sbjct: 282 VFEDLDFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 61/319 (19%), Positives = 115/319 (36%), Gaps = 39/319 (12%)
Query: 128 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF--SGPLPADIGFCPHLTTLDLSNNLFT 185
+ + +N SG+ +A ++ L G + L + + L L+ +
Sbjct: 14 SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLI-NQFSELQLNRLNLS 72
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 245
LP + L + + ++ N L +P + LE+LD +N L+ +LP + K
Sbjct: 73 -SLPDN--LPPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKH 124
Query: 246 LSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 305
L + N L +PE LE I+ N +P L +L +L +
Sbjct: 125 L---DVDNNQLT-MLPELP--ALLEYINADNNQL-TMLPE---------LPTSLEVLSVR 168
Query: 306 SNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL----IHLDLRNNALYGSI 361
+N L +P +L L++S+N L S +P H I R N + I
Sbjct: 169 NNQL-TFLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI-THI 222
Query: 362 PQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKI 421
P+ + + L+ N L+ I + + T+ + S S + N +
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ--QNTLHRPL 280
Query: 422 LKLEFNELSGEIPQELGKL 440
++ ++
Sbjct: 281 ADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 63/316 (19%), Positives = 110/316 (34%), Gaps = 43/316 (13%)
Query: 171 CPHLTTLDLSNNLFTGQLPV-------SLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 223
P LS N F + + + N + I+
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFS 62
Query: 224 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 283
L + +L+ SLP +L +++V+ + N+L ++PE L E +D +N ++
Sbjct: 63 ELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASL--EYLDACDNRLS-TL 115
Query: 284 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY 343
P L +L+ LD+ +N L +P L Y+N +N L +P
Sbjct: 116 PE---------LPASLKHLDVDNNQLT-MLPELPA---LLEYINADNNQLTM-LPELPT- 160
Query: 344 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSL----YLLS 399
SL L +RNN L +P+ SL L + N L +P V
Sbjct: 161 --SLEVLSVRNNQL-TFLPELP---ESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 400 LSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPV 459
N ++ IP++I +L+ + LE N LS I + L + + +
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
Query: 460 GGVFPTLDQSSLQGNL 475
++
Sbjct: 273 QNTLHRPLADAVTAWF 288
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-26
Identities = 65/325 (20%), Positives = 101/325 (31%), Gaps = 31/325 (9%)
Query: 82 NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 141
N + G F+ L + + + + + L L+ S S+P
Sbjct: 20 NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK---ECLINQFSELQLNRLNLS-SLP 75
Query: 142 QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFI 201
+ + L + N LP L LD +N + LP L +
Sbjct: 76 DNLPPQ--ITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLKHL--- 125
Query: 202 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 261
V NN LT +P LE+++ NN LT LP + L V+ +R N L +P
Sbjct: 126 DVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LP 176
Query: 262 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA 321
E LE +D+S N + S+P + +T N + IP +
Sbjct: 177 ELPE--SLEALDVSTN-LLESLPAVPVRNHH--SEETEIFFRCRENRIT-HIPENILSLD 230
Query: 322 NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSL 381
+ L N L SRI L + S Q+ R L
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT--AWF 288
Query: 382 TGPIPQVIRNCTSLYLLSLSHNHLS 406
+ + N S
Sbjct: 289 PENKQSDVSQIWHAFEHEEHANTFS 313
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 2e-21
Identities = 63/387 (16%), Positives = 114/387 (29%), Gaps = 76/387 (19%)
Query: 14 IPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCAS 73
+ + L + +LS +P +L + L+++ N L
Sbjct: 52 LLKECLINQFSELQLNRLNLS-SLPDNLPP----QITVLEITQNALI------------- 93
Query: 74 LRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSH 133
SL +SL L+ +N S + L+ LD+ +
Sbjct: 94 ----SLPELP------------ASLEYLDACDNRLSTLPE--------LPASLKHLDVDN 129
Query: 134 NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG--QLPVS 191
N + +P+ A L+ + NQ + LP L L + NN T +LP S
Sbjct: 130 NQLT-MLPELPAL---LEYINADNNQLTM-LPELPT---SLEVLSVRNNQLTFLPELPES 181
Query: 192 LRLLNSMIFISVSNNTLTGDIPHWIGNISTLE----FLDFSNNHLTGSLPSSLFNCKKLS 247
L L+ VS N L +P E F N +T +P ++ +
Sbjct: 182 LEALD------VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTC 233
Query: 248 VIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 307
I L N L+ I E L + + ++ +
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQ 293
Query: 308 -------NLVGDIPAEMGLFANLRYLNLSSNH-----LRSRIPPELGYFHSLIHLDLRNN 355
+ A L L+ + + R ++ L + L ++
Sbjct: 294 SDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSF 353
Query: 356 ALYGSIPQEVCESRSLGILQLDGNSLT 382
A+ + + +L L L
Sbjct: 354 AVAADATESCEDRVALTWNNLRKTLLV 380
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 5e-20
Identities = 42/232 (18%), Positives = 82/232 (35%), Gaps = 34/232 (14%)
Query: 6 VHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPY 65
++ + +++P + + L + N+L +P +L ++LD +N LS
Sbjct: 66 LNRLNLSSLPDNL-PPQITVLEITQNALI-SLPELPASL-----EYLDACDNRLS----- 113
Query: 66 QLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 125
L E ASL++L + N L + + L +N NN + +
Sbjct: 114 TLPELPASLKHLDVDNNQLT----MLPELPALLEYINADNNQLTMLPE--------LPTS 161
Query: 126 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTT----LDLSN 181
L L + +N + +P L+ L + N LPA H
Sbjct: 162 LEVLSVRNNQLT-FLP---ELPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRE 216
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT 233
N T +P ++ L+ I + +N L+ I + + + +
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 34/230 (14%), Positives = 67/230 (29%), Gaps = 18/230 (7%)
Query: 6 VHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMM--NMKFLDLSNNLLSGPV 63
V N +P + LE L+ S N L +P + + F N ++ +
Sbjct: 167 VRNNQLTFLPELP--ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-I 222
Query: 64 PYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSL 123
P + + + L N L I + + ++ + +FS G +
Sbjct: 223 PENIL-SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMS------DGQQNT 275
Query: 124 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL 183
D F + V+ + + E N FS L +
Sbjct: 276 LHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL-DRLSDTVSARNTSGFRE- 333
Query: 184 FTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT 233
Q+ L L++ + + + D + L + + L
Sbjct: 334 ---QVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 61/297 (20%), Positives = 109/297 (36%), Gaps = 39/297 (13%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNL 659
++G G F VY+ + G +A+KK+ D++ D +E+ +L + HPN+
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
I + +V + A G L + + +K + L H+H
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH- 153
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 776
++H ++KP+N+ + ++ D GL R + S +G Y++PE
Sbjct: 154 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-----HSLVGTPYYMSPE 206
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836
N K DI+ G L+ E+ + P + N+ L + +
Sbjct: 207 R-IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-------------- 251
Query: 837 SMGDYPEDEVLPVLKL-----ALVCTC--HIPSSRPSMAEVVQILQVIKTPLPQRME 886
DYP LP LV C P RP + V + + + +E
Sbjct: 252 -QCDYPP---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 65/311 (20%), Positives = 117/311 (37%), Gaps = 67/311 (21%)
Query: 594 SIDPETLL--EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRV 650
++D + ++ +G G FG V+K G+ +K+ ++Y E EREV+
Sbjct: 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR------VKYNNEKAEREVKA 57
Query: 651 LGKARHPNLISLEGYYWTPQLKL----------------LVSDYAPNGSLQAKLHERLPS 694
L K H N++ G + + ++ G+L+ + +R
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 695 TPP----LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750
L F+ I KG+ ++H +I+ +LKPSNI L D +I DFGL
Sbjct: 118 KLDKVLALEL---FEQIT---KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGL 168
Query: 751 ARLLTRLDKHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPV 807
L K + G Y++PE S ++ D+Y G+++ EL+
Sbjct: 169 VTSLKNDGKR------TRSKGTLRYMSPEQ-ISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 808 EYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSM 867
++ D + + + + E L P RP+
Sbjct: 222 FETSKFFT-------------DLRDGIISDI--FDKKEK----TLLQKLLSKKPEDRPNT 262
Query: 868 AEVVQILQVIK 878
+E+++ L V K
Sbjct: 263 SEILRTLTVWK 273
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 71/287 (24%), Positives = 115/287 (40%), Gaps = 27/287 (9%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 653
++ E L L + ++G G FG V+ ++AVK + F +E R+L +
Sbjct: 111 LNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQ 168
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
HPN++ L G Q +V + G L L +++ A G
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAG 225
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
+ +L IH +L N L+ + +ISDFG++R Q + +
Sbjct: 226 MEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLEEGNVL 831
APE R + + D++ FG+L+ E + G P Y N + R +E+G L
Sbjct: 283 APE-ALNYGRYSSESDVWSFGILLWETFSLGASP--YPNLSN-----QQTREFVEKGGRL 334
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878
C PE V +L C + P RPS + + Q LQ I+
Sbjct: 335 PC--------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 69/293 (23%), Positives = 125/293 (42%), Gaps = 41/293 (13%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLG 652
ET +K +G G FGTVYK + +G + A+K+L + + ++ E V+
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVILG 709
+P++ L G T + L++ P G L + E + L+W +
Sbjct: 73 SVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQ 125
Query: 710 TAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
AKG+ +L +H +L N+L+ + +I+DFGLA+LL +K + +
Sbjct: 126 IAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 769 ALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 824
+ ++A E S+ + D++ +GV + EL+T G +P Y I + + +
Sbjct: 182 PIKWMALE----SILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDG----IPASEISSI 231
Query: 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
LE+G L P + V + + C SRP E++ +
Sbjct: 232 LEKGERLPQ--------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 594 SIDPETLLEKAAE-VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVL 651
+ + K +G G F TVYK +A +L + + + F+ E +L
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEML 79
Query: 652 GKARHPNLISLEGYYWTPQLK----LLVSDYAPNGSLQAKLHERLPSTPPL--SWTNRFK 705
+HPN++ + + +LV++ +G+L+ L + SW +
Sbjct: 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWC---R 136
Query: 706 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTRLDKHVMSN 764
IL KGL LH + PPIIH +LK NI + + +I D GLA L +
Sbjct: 137 QIL---KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-------S 185
Query: 765 RFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++ +G ++APE+ + +E D+Y FG+ +LE+ T P
Sbjct: 186 FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYP 228
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 71/308 (23%), Positives = 120/308 (38%), Gaps = 48/308 (15%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGY 665
+ EG F VY+ GR A+K+L++++ + +EV + K HPN++
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-RAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 666 YW-------TPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
T Q + L+ G L L + P LS K+ T + + H+H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMH 153
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG------- 771
+PPIIH +LK N+LL + ++ DFG A ++ + S + ++ +
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 772 ---YVAPEL--TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826
Y PE+ + + EK DI+ G ++ L + P E + I++ +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-DGAKLRIVNGKYSI--- 268
Query: 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI--------K 878
P L P R S+AEVV LQ I K
Sbjct: 269 ---------PPHDTQYTV----FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315
Query: 879 TPLPQRME 886
+P+ + +E
Sbjct: 316 SPITELLE 323
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-28
Identities = 98/497 (19%), Positives = 180/497 (36%), Gaps = 63/497 (12%)
Query: 26 LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85
+++S+ +L+ +P L K L LS N +S + + LR L L+ N ++
Sbjct: 36 VDYSNRNLT-HVPKDLPP----RTKALSLSQNSISE-LRMPDISFLSELRVLRLSHNRIR 89
Query: 86 G-PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV 144
+F + L L++S+N + + LR LDLS N F +P
Sbjct: 90 SLDFH-VFLFNQDLEYLDVSHNRLQN-ISCC------PMASLRHLDLSFNDFD-VLPVCK 140
Query: 145 A--ALHYLKELLLQGNQF-SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFI 201
L L L L +F L LDL + G SL++ N+ + +
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV-L 199
Query: 202 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFN-----CKKLSVIRLRGNSL 256
+ + + +++ L L SN L L + +++ + +
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259
Query: 257 NGN------IPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLV 310
+ + + +E +++ I + S + L ++L I + + +
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL-KSLMIEHVKNQVFL 318
Query: 311 GDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-R 369
A +FA + LS + S L+ N + C + +
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF-TDSVFQGCSTLK 377
Query: 370 SLGILQLDGNSLT--GPIPQVIRNCTSLYLLSLSHNHLSG-------SIPKSISNLN--- 417
L L L N L + + +N +SL L +S N L+ + +SI LN
Sbjct: 378 RLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSS 437
Query: 418 -------------KLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVG--GV 462
K+K+L L N + IP+++ L +L +NV+ N+L +P G
Sbjct: 438 NMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL-KSVPDGVFDR 495
Query: 463 FPTLDQSSLQGNLGICS 479
+L L N C+
Sbjct: 496 LTSLQYIWLHDNPWDCT 512
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-25
Identities = 78/418 (18%), Positives = 151/418 (36%), Gaps = 45/418 (10%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
LE L+ SHN L I + +++ LDLS N + F N L +L L+
Sbjct: 102 LEYLDVSHNRLQN-ISCCPMA----SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAA 156
Query: 83 ILQ-GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 141
+ + + + S L+L + H G + + L + ++LFS +
Sbjct: 157 KFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP--NTTVLHLVFHPNSLFSVQVN 214
Query: 142 QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFI 201
V AL +L+ ++ N + + L G +++ L + I
Sbjct: 215 MSVNALGHLQLSNIKLNDE-----------NCQRLMTFLSELTRGPTLLNVTLQH----I 259
Query: 202 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN-- 259
+ +E+L+ N +T + F + ++ L +
Sbjct: 260 ETTWKCSVKLFQ--FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF 317
Query: 260 --IPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPA 315
E L+ + + LS + I S SS L+ + N +
Sbjct: 318 LFSKEALYSVFAEMNIKMLSISD-TPFIHMVCPPSPSS-----FTFLNFTQNVFTDSVFQ 371
Query: 316 EMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL----YGSIPQEVCESRSL 371
L+ L L N L++ ++ L+ + +L + + + S+
Sbjct: 372 GCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430
Query: 372 GILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 429
+L L N LTG + + + + +L L +N + SIPK +++L L+ L + N+L
Sbjct: 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 44/191 (23%), Positives = 74/191 (38%), Gaps = 19/191 (9%)
Query: 1 MTTPLVHGNSYNAIPSMVVFRI---LERLNFSHN---SLSGQIPPSLLNLNMMNMKFLDL 54
M ++ + I MV LNF+ N Q +L L + ++
Sbjct: 331 MNIKMLSISDTPFIH-MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ---- 385
Query: 55 SNNLLSGPVPYQLFENCASLRYLSLAGNILQ-GPIGKIFNYCSSLNTLNLSNNHFSGDLD 113
N L + + +N +SL L ++ N L + + S+ LNLS+N +G +
Sbjct: 386 RNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV- 444
Query: 114 FASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPH 173
F +++ LDL +N SIP+ V L L+EL + NQ
Sbjct: 445 FRCL-----PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTS 498
Query: 174 LTTLDLSNNLF 184
L + L +N +
Sbjct: 499 LQYIWLHDNPW 509
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 26/217 (11%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+G+G V++ G + A+K ++ + RE VL K H N++ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 666 YW--TPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
T + K+L+ ++ P GSL L E + L + V+ G+ HL +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 724 PIIHYNLKPSNILL----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 776
I+H N+KP NI+ D +++DFG AR L +F S G Y+ P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED------DEQFVSLYGTEEYLHPD 185
Query: 777 L-------TCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ + D++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNLISLEG 664
++GEG FG V GR +K++ S + E+ REV VL +HPN++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP----LSWTNRFKVILGTAKGLAHLHHS 720
+ +V DY G L +++ + L W F I L H+H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW---FVQIC---LALKHVH-- 142
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 777
I+H ++K NI L + ++ DFG+AR+L + ++ +G Y++PE+
Sbjct: 143 -DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-----RACIGTPYYLSPEI 196
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRP 806
C++ N K DI+ G ++ EL T +
Sbjct: 197 -CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 32/210 (15%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEGY 665
G+G FG VY +LA+K L + + + REV + RHPN++ L GY
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------KVILGTAKGLAHLHH 719
+ L+ +YAP G++ +L + ++F I A L++ H
Sbjct: 78 FHDATRVYLILEYAPLGTVYRELQKL----------SKFDEQRTATYITELANALSYCH- 126
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 776
+IH ++KP N+LL +I+DFG + H S+R G Y+ PE
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPE 177
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ + +EK D++ GVL E + G+ P
Sbjct: 178 M-IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 77/316 (24%), Positives = 126/316 (39%), Gaps = 47/316 (14%)
Query: 597 PETLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
E L+ +++G+G FG+V G ++AVK+L DF+RE+++L
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILK 79
Query: 653 KARHPNLISLEGYYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVI 707
++ G + P + LV +Y P+G L+ L L ++
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS------ 133
Query: 708 LGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNR 765
KG+ +L +H +L NIL++ + +I+DFGLA+LL + V+
Sbjct: 134 SQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 766 FQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRP--------VEYGEDN 813
QS + + APE SL N + D++ FGV++ EL T + G +
Sbjct: 190 GQSPIFWYAPE----SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 814 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873
V + LLEEG L P V +L +C P RPS + +
Sbjct: 246 DVPALSRLLELLEEGQRLPA--------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297
Query: 874 LQ-VIKTPLPQRMEVF 888
L + F
Sbjct: 298 LDMLWSGSRGCETHAF 313
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 41/293 (13%)
Query: 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLG 652
ET L K +G GVFGTV+K + +G + +K + Q + + +G
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVILG 709
H +++ L G L LV+ Y P GSL + + + P L+W +
Sbjct: 71 SLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQ 123
Query: 710 TAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
AKG+ +L H +H NL N+LL +++DFG+A LL DK ++ + ++
Sbjct: 124 IAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 769 ALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVL 824
+ ++A E S+ + + D++ +GV + EL+T G P Y + V L
Sbjct: 180 PIKWMALE----SIHFGKYTHQSDVWSYGVTVWELMTFGAEP--YAG----LRLAEVPDL 229
Query: 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
LE+G L P+ + V + + C + RP+ E+ +
Sbjct: 230 LEKGERLAQ--------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 42/234 (17%), Positives = 92/234 (39%), Gaps = 36/234 (15%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY----------------PEDFEREVRVL 651
+G F + + A+KK S + + +DF+ E++++
Sbjct: 40 NQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRF--KVI 707
++ ++ EG ++ +Y N S+ L + +I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 708 LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 767
+++H+ I H ++KPSNIL+D N ++SDFG + ++++ + +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGES-------EYMVDKKIK 208
Query: 768 SALG---YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
+ G ++ PE + +S K DI+ G+ + + P + ++V L
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-LKISLVEL 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 14/256 (5%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLS-GPVPY 65
+ ++P+ + RL N L +P + + + + L LS+N LS
Sbjct: 15 NSKGLTSVPT-GIPSSATRLELESNKLQ-SLPHGVFD-KLTQLTKLSLSSNGLSFKGCCS 71
Query: 66 QLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 125
Q SL+YL L+ N + + F L L+ +++ +F+ SL+
Sbjct: 72 QSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV---FLSLRN 127
Query: 126 LRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADI-GFCPHLTTLDLSNNL 183
L LD+SH G+ L L+ L + GN F DI +LT LDLS
Sbjct: 128 LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 184 FTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFN- 242
P + L+S+ +++S+N +++L+ LD+S NH+ +
Sbjct: 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQH 245
Query: 243 -CKKLSVIRLRGNSLN 257
L+ + L N
Sbjct: 246 FPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 55/266 (20%), Positives = 100/266 (37%), Gaps = 26/266 (9%)
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 186
+ + + S+P G+ L L+ N+ LT L LS+N +
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 187 Q--LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NC 243
+ S S+ ++ +S N + + + LE LDF +++L S+F +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 244 KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 301
+ L + + G+F+ LE + ++ N F + P + + L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN-----LTF 179
Query: 302 LDLSSNNLVGDIPAEMGLFAN---LRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNAL 357
LDLS L + F + L+ LN+S N+ S + +SL LD N +
Sbjct: 180 LDLSQCQLE-QLSP--TAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHI 235
Query: 358 YGSIPQEVCES--RSLGILQLDGNSL 381
+ ++ + SL L L N
Sbjct: 236 -MTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 60/292 (20%), Positives = 109/292 (37%), Gaps = 47/292 (16%)
Query: 50 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS 109
+ ++ L+ VP + +S L L N LQ +F+ + L L+LS+N S
Sbjct: 10 TEIRCNSKGLTS-VPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 110 GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIG 169
+ L+ LDLS N ++ L L+ L Q + +
Sbjct: 66 --FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSV 121
Query: 170 F--CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 227
F +L LD+S+ R+ + IF +S+ LE L
Sbjct: 122 FLSLRNLIYLDISHT--------HTRVAFNGIFNGLSS----------------LEVLKM 157
Query: 228 SNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIP 284
+ N + +F + L+ + L L + F+ L+ +++S N F S+
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLD 215
Query: 285 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLR 334
+S L++LD S N+++ + ++L +LNL+ N
Sbjct: 216 TFPYKCLNS-----LQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/261 (23%), Positives = 103/261 (39%), Gaps = 26/261 (9%)
Query: 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLN-GNIP 261
++ LT +P I S+ L+ +N L SLP +F +L+ + L N L+
Sbjct: 15 NSKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70
Query: 262 EGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL 319
L+ +DLS NG + ++ L LD +NL + E +
Sbjct: 71 SQSDFGTTSLKYLDLSFNG-VITMSSNFLGLEQ------LEHLDFQHSNLK-QMS-EFSV 121
Query: 320 FA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGIL 374
F NL YL++S H R SL L + N+ + ++ R+L L
Sbjct: 122 FLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180
Query: 375 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIP 434
L L P + +SL +L++SHN+ LN L++L N +
Sbjct: 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSK 239
Query: 435 QEL--GKLASLLAVNVSYNRL 453
++ +SL +N++ N
Sbjct: 240 KQELQHFPSSLAFLNLTQNDF 260
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 64/322 (19%), Positives = 130/322 (40%), Gaps = 45/322 (13%)
Query: 579 GKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVT 634
G ++ ++ +D + + L++ ++GEG FG V G +AVK L
Sbjct: 1 GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP 60
Query: 635 SDIIQYPEDFEREVRVLGKARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLH--- 689
+ D ++E+ +L H N++ +G L+ ++ P+GSL+ L
Sbjct: 61 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
Query: 690 ERLPSTPPLSWTNRFKVILGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDF 748
++ L + + KG+ +L + +H +L N+L++ + +I DF
Sbjct: 121 NKINLKQQLKYA------VQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDF 170
Query: 749 GLARLLTR-LDKHVMSNRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-G 803
GL + + + + + + S + + APE L ++ D++ FGV + EL+T
Sbjct: 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPE----CLMQSKFYIASDVWSFGVTLHELLTYC 226
Query: 804 RRPVEYGEDNVVILS--------EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALV 855
+ ++ + L+EG L C P + V +L
Sbjct: 227 DSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC--------PPNCPDEVYQLMRK 278
Query: 856 CTCHIPSSRPSMAEVVQILQVI 877
C PS+R S +++ + +
Sbjct: 279 CWEFQPSNRTSFQNLIEGFEAL 300
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-27
Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 29/288 (10%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 653
++ + ++ ++G G +G VY+ + +AVK L + E+F +E V+ +
Sbjct: 217 MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKE 272
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
+HPNL+ L G +++++ G+L L E +
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM--ATQISSA 330
Query: 714 LAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
+ +L +F IH NL N L+ +N+ +++DFGL+RL+T D + + + +
Sbjct: 331 MEYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKW 385
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
APE + + + K D++ FGVL+ E+ T G P G D V LLE+ +
Sbjct: 386 TAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYP-GIDL-----SQVYELLEKDYRM 438
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
+ PE V +L C PS RPS AE+ Q + +
Sbjct: 439 ER--------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 39/302 (12%)
Query: 597 PETLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
+ L+K ++GEG FG V + G M+AVK L Q+ +++E+ +L
Sbjct: 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILR 88
Query: 653 KARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
H ++I +G LV +Y P GSL+ L L
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQI 143
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNRFQSA 769
+G+A+L H+ IH +L N+LLD++ +I DFGLA+ + + + + S
Sbjct: 144 CEGMAYL-HAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 770 LGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILS------- 818
+ + APE L+ + D++ FGV + EL+T + ++
Sbjct: 201 VFWYAPE----CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
Query: 819 -EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
+ LLE G L P+ V L C S RP+ ++ IL+ +
Sbjct: 257 VLRLTELLERGERLPR--------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
Query: 878 KT 879
Sbjct: 309 HE 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 1e-26
Identities = 39/335 (11%), Positives = 79/335 (23%), Gaps = 45/335 (13%)
Query: 569 SSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLA 628
+ V V ++ ++ E L+ + G V+ V + A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 629 VKKLVTSDIIQYP--EDFEREVRVLGKARHPN---------------LISLEGYYWTPQL 671
+K E + + ++++ QL
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 672 KLLVSDYAPN-------------GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
DYA L + L + + A+L
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 777
++H + P N+ + + + D + + Y E L
Sbjct: 212 SK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFL 263
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837
+ + + G+ I + P +G I R L S
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPGIKGSWKRPSLRVPGTDSLAFGS 321
Query: 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
P+ V ++ L R E ++
Sbjct: 322 CTPLPD-FVKTLIGRFLNFD---RRRRLLPLEAME 352
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/295 (19%), Positives = 118/295 (40%), Gaps = 37/295 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNL--ISLE 663
+G G V++V + ++ A+K + + + + E+ L K + + I L
Sbjct: 36 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
Y T Q +V + N L + L ++ P + +K +L + + +H
Sbjct: 95 DYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER-KSYWKNML---EAVHTIHQH--- 146
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL------ 777
I+H +LKP+N L+ D ++ DFG+A + V+ + + Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 778 ----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833
+++ K D++ G ++ + G+ P + + + L +
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------PN 256
Query: 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ--ILQVIKTPLPQRME 886
+ D PE ++ VLK C P R S+ E++ +Q+ P+ Q +
Sbjct: 257 HEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 63/263 (23%), Positives = 97/263 (36%), Gaps = 29/263 (11%)
Query: 560 ETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLL----EKAAEVGEGVFGTV 615
+SM R V+ S PE+ ++ + +G G +G V
Sbjct: 17 NLYFQSMHQLQPRRVSFRGEASETLQSPGYD---PSRPESFFQQSFQRLSRLGHGSYGEV 73
Query: 616 YKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGK-ARHPNLISLEGYYWTPQLKL 673
+KV GR+ AVK+ ++ + EV K +HP + LE + +
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133
Query: 674 LVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 732
L ++ SLQ S P W + T LAHLH ++H ++KP
Sbjct: 134 LQTELC-GPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLHSQG---LVHLDVKP 185
Query: 733 SNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTCQSLRVNEKCD 789
+NI L ++ DFGL L + G Y+APEL Q D
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELGTAGAG------EVQEGDPRYMAPEL-LQG-SYGTAAD 237
Query: 790 IYGFGVLILELVTGRRPVEYGED 812
++ G+ ILE+ GE
Sbjct: 238 VFSLGLTILEVACNMELPHGGEG 260
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 18/220 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
++G G FG V+ V + G +K + E E E+ VL HPN+I +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---WTNRFKVILGTAKGLAHLHHSFR 722
+ +V + G L ++ LS K ++ LA+ H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---ALAYFHSQ-- 143
Query: 723 PPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
++H +LKP NIL + +I DFGLA L +N +A Y+APE+
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAAGTA-LYMAPEVFK 199
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
+ + KCDI+ GV++ L+TG P G + +
Sbjct: 200 RDV--TFKCDIWSAGVVMYFLLTGCLPF-TGTSLEEVQQK 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 26/216 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G+G V++ G + A+K ++ + RE VL K H N++ L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 667 --WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
T + K+L+ ++ P GSL L E + L + V+ G+ HL +
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 725 IIHYNLKPSNILL----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 777
I+H N+KP NI+ D +++DFG AR L +F S G Y+ P++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED------DEQFVSLYGTEEYLHPDM 186
Query: 778 -------TCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ D++ GV TG P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 36/278 (12%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLEG 664
+G G GT+ R +AVK+++ +REV++L + HPN+I
Sbjct: 31 VLGHGAEGTIVYRGMFD-NRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFC 85
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
Q + + + +LQ + ++ + L ++ T GLAHLH
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSLN--- 138
Query: 725 IIHYNLKPSNILL-----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSA--LGYVAPEL 777
I+H +LKP NIL+ ISDFGL + L +H S R G++APE+
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV-GRHSFSRRSGVPGTEGWIAPEM 197
Query: 778 TCQSL--RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
+ DI+ G + +++ G P +G+ +LL + LDC+
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHP--FGKSL----QRQANILLGACS-LDCL 250
Query: 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
P + L + K P RPS V++
Sbjct: 251 HPEKHEDVIAREL-IEK----MIAMDPQKRPSAKHVLK 283
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 65/301 (21%), Positives = 130/301 (43%), Gaps = 36/301 (11%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLG 652
+ + LL E+G G FG+V + + + + + A+K L E+ RE +++
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 65
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
+ +P ++ L G L +LV + A G L L + + +N +++ +
Sbjct: 66 QLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSM 121
Query: 713 GLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNRFQSAL 770
G+ +L +F +H +L N+LL + + +ISDFGL++ L D + + + L
Sbjct: 122 GMKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 771 GYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGE-DNVVILSEHVRVLL 825
+ APE + + + D++ +GV + E ++ G++P Y + V +
Sbjct: 178 KWYAPE----CINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKG-----PEVMAFI 226
Query: 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRM 885
E+G ++C P + + L C + RP V Q ++ L ++
Sbjct: 227 EQGKRMEC--------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
Query: 886 E 886
E
Sbjct: 279 E 279
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 90/485 (18%), Positives = 154/485 (31%), Gaps = 95/485 (19%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ----LFENCASLRYLS 78
++ L+ LS LL L + + L + L + +L L+
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQ-QCQVVRLDDCGL-TEARCKDISSALRVNPALAELN 62
Query: 79 LAGNILQGP----IGKIFNYCS-SLNTLNLSNNHFS--GDLDFASGYGIWSLKRLRTLDL 131
L N L + + S + L+L N + G +S + +L L+ L L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST--LRTLPTLQELHL 120
Query: 132 SHNLFSGSIPQGVAALH--------YLKELLLQGNQFSGPLPADIGF----CPHLTTLDL 179
S NL + G+ L L++L L+ S + P L +
Sbjct: 121 SDNLLGDA---GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTV 177
Query: 180 SNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT----GS 235
SNN +R+L + ++ LE L + +T
Sbjct: 178 SNNDINEA---GVRVLCQGL----KDSPCQ------------LEALKLESCGVTSDNCRD 218
Query: 236 LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG---------LEEIDLSENGFMGSIPPG 286
L + + L + L N L G+ +L L + + E G +
Sbjct: 219 LCGIVASKASLRELALGSNKLGD---VGMAELCPGLLHPSSRLRTLWIWECGI--TAKGC 273
Query: 287 SSSSSSSTLFQTLRILDLSSNNLVGD----IPAEMGLFAN--LRYLNLSSNHLRSR---- 336
++L+ L L+ N L GD + E L L L + S +
Sbjct: 274 GDLCRVLRAKESLKELSLAGNEL-GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH 332
Query: 337 IPPELGYFHSLIHLDLRNNALYGSIPQEVCES-----RSLGILQLDGNSLT----GPIPQ 387
L L+ L + NN L + +E+C+ L +L L ++ +
Sbjct: 333 FSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392
Query: 388 VIRNCTSLYLLSLSHNHLSGSIPKSIS-----NLNKLKILKLEFNELSGEIPQELGKLAS 442
+ SL L LS+N L + + L+ L L S E+ L +
Sbjct: 393 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR---LQA 449
Query: 443 LLAVN 447
L
Sbjct: 450 LEKDK 454
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 74/373 (19%), Positives = 131/373 (35%), Gaps = 69/373 (18%)
Query: 126 LRTLDLSHNLFS-GSIPQGVAALHYLKELLLQGNQFS----GPLPADIGFCPHLTTLDLS 180
+++LD+ S + + L + + L + + + + P L L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 181 NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT----GSL 236
+N V + + + + + ++ L N LT G L
Sbjct: 65 SNELG---DVGVHCVLQGL---QTPSC-------------KIQKLSLQNCCLTGAGCGVL 105
Query: 237 PSSLFNCKKLSVIRLRGNSLNG----NIPEGLFDLG--LEEIDLSENGFMGSIPPGSSSS 290
S+L L + L N L + EGL D LE++ L S+ S
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYC----SLSAASCEP 161
Query: 291 SSSTLF--QTLRILDLSSNNLVGDIPAEM---GLFAN---LRYLNLSSNHLRSR----IP 338
+S L + L +S+N++ + + GL + L L L S + S +
Sbjct: 162 LASVLRAKPDFKELTVSNNDI-NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220
Query: 339 PELGYFHSLIHLDLRNNALYGSIPQEVCE-----SRSLGILQLDGNSLTGP----IPQVI 389
+ SL L L +N L E+C S L L + +T + +V+
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280
Query: 390 RNCTSLYLLSLSHNHLSGSIPKSISNL-----NKLKILKLEFNELSGE----IPQELGKL 440
R SL LSL+ N L + + +L+ L ++ + L +
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 441 ASLLAVNVSYNRL 453
LL + +S NRL
Sbjct: 341 RFLLELQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 53/302 (17%), Positives = 99/302 (32%), Gaps = 76/302 (25%)
Query: 220 STLEFLDFSNNHLTGS-----------------------------LPSSLFNCKKLSVIR 250
++ LD L+ + + S+L L+ +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 251 LRGNSLNGNIPEGLFDLG---------LEEIDLSENGFMGSIPPGSSSSSSSTLF--QTL 299
LR N L G+ + ++++ L + SSTL TL
Sbjct: 63 LRSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNC----CLTGAGCGVLSSTLRTLPTL 115
Query: 300 RILDLSSNNLVGDIPA----EMGLFAN--LRYLNLSSNHLRSR----IPPELGYFHSLIH 349
+ L LS N L GD E L L L L L + + L
Sbjct: 116 QELHLSDNLL-GDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKE 174
Query: 350 LDLRNNALYGSIPQEVCES-----RSLGILQLDGNSLT----GPIPQVIRNCTSLYLLSL 400
L + NN + + + +C+ L L+L+ +T + ++ + SL L+L
Sbjct: 175 LTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELAL 234
Query: 401 SHNHLSGSIPKSISN-----LNKLKILKLEFNELSGE----IPQELGKLASLLAVNVSYN 451
N L + ++L+ L + ++ + + + L SL ++++ N
Sbjct: 235 GSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 294
Query: 452 RL 453
L
Sbjct: 295 EL 296
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEGY 665
G+G FG VY ++A+K L S + + RE+ + RHPN++ + Y
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82
Query: 666 YWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
+ + L+ ++AP G L +L H R + + A L + H
Sbjct: 83 FHDRKRIYLMLEFAPRGELYKELQKHGRFDE-----QRSATF-MEELADALHYCH---ER 133
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTCQ 780
+IH ++KP N+L+ +I+DFG + H S R ++ G Y+ PE+ +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRTMCGTLDYLPPEMI-E 185
Query: 781 SLRVNEKCDIYGFGVLILELVTGRRP 806
+EK D++ GVL E + G P
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 78/310 (25%), Positives = 128/310 (41%), Gaps = 39/310 (12%)
Query: 585 DSRSSSLDCSIDPETL-LEKAAEVGEGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQY 640
+ + I P +L + +G G FG VY + + AVK L I
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 641 PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL-VSDYAPNGSLQAKLHERLPSTPPLS 699
F E ++ HPN++SL G + L V Y +G L+ + T +
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPT 126
Query: 700 WTNRFKVILGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758
+ L AKG+ +L F +H +L N +LD+ + +++DFGLAR + +
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
Query: 759 KHVMSNRFQSAL--GYVAPELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEY-GE 811
+ + N+ + L ++A E SL + K D++ FGVL+ EL+T G P Y
Sbjct: 183 YYSVHNKTGAKLPVKWMALE----SLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDV 236
Query: 812 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVV 871
+ + V L +G L PE P+ ++ L C RPS +E+V
Sbjct: 237 NT-----FDITVYLLQGRRLLQ--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELV 283
Query: 872 QILQVIKTPL 881
+ I +
Sbjct: 284 SRISAIFSTF 293
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 70/318 (22%), Positives = 116/318 (36%), Gaps = 38/318 (11%)
Query: 126 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 185
LR + S ++P+ ++ L LQ N S D HL L L NN +
Sbjct: 35 LRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCK 244
+ L + + +S N L +IP S+L L +N + +P +F +
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIP--PNLPSSLVELRIHDNRIR-KVPKGVFSGLR 147
Query: 245 KLSVIRLRGNSL-NGNIPEGLFD-LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRIL 302
++ I + GN L N G FD L L + +SE + IP L +TL L
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA-KLTGIPKD--------LPETLNEL 198
Query: 303 DLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALY 358
L N + I L L L N +R I L + +L L L NN L
Sbjct: 199 HLDHNKIQ-AIEL--EDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS 254
Query: 359 GSIPQEVCESRSLGILQLDGNSLTGPIP-------QVIRNCTSLYLLSLSHNHLS-GSIP 410
+P + + + L ++ L N++T + +SL +N + +
Sbjct: 255 -RVPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQ 312
Query: 411 KSI-SNLNKLKILKLEFN 427
+ + ++
Sbjct: 313 PATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 50/265 (18%), Positives = 96/265 (36%), Gaps = 24/265 (9%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L L +N +S +I + + ++ L +S N L +P L +SL L + N
Sbjct: 80 LYALVLVNNKIS-KIHEKAFS-PLRKLQKLYISKNHLVE-IPPNLP---SSLVELRIHDN 133
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
++ +F+ ++N + + N + G + +L L +S + IP+
Sbjct: 134 RIRKVPKGVFSGLRNMNCIEMGGNPLE---NSGFEPGAFDGLKLNYLRISEAKLT-GIPK 189
Query: 143 GVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFIS 202
L EL L N+ D+ L L L +N SL L ++ +
Sbjct: 190 D--LPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247
Query: 203 VSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-------NCKKLSVIRLRGNS 255
+ NN L+ +P + ++ L+ + N++T + + F + I L N
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNP 305
Query: 256 L-NGNIPEGLFD--LGLEEIDLSEN 277
+ + F I
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 70/327 (21%), Positives = 114/327 (34%), Gaps = 60/327 (18%)
Query: 165 PADIGFCP-----HLTTLDLSNNLFT---GQLPVSLRLLNSMIFISVSNNTLTGDIPHWI 216
P CP HL + S+ ++ LL+ + NN ++
Sbjct: 21 PTYSAMCPFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLD------LQNNDISELRKDDF 74
Query: 217 GNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSE 276
+ L L NN ++ + +KL + + N L IP L L E+ + +
Sbjct: 75 KGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS-SLVELRIHD 132
Query: 277 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA--NLRYLNLSSNHLR 334
N +P G S + + +++ N L + E G F L YL +S L
Sbjct: 133 NRI-RKVPKGVFSGLRN-----MNCIEMGGNPL-ENSGFEPGAFDGLKLNYLRISEAKLT 185
Query: 335 SRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTS 394
IP +L +L L L +N + +I + + +
Sbjct: 186 G-IPKDL--PETLNELHLDHNKI-QAIE-----------------------LEDLLRYSK 218
Query: 395 LYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL- 453
LY L L HN + S+S L L+ L L+ N+LS +P L L L V + N +
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
Query: 454 ------IGRLPVGGVFPTLDQSSLQGN 474
+ G + SL N
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNN 304
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 52/319 (16%), Positives = 103/319 (32%), Gaps = 54/319 (16%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ +N +S ++ + ++ L L NN +S + + F L+ L ++ N
Sbjct: 56 TTLLDLQNNDIS-ELRKDDFK-GLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKN 112
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFS--GDLDFASGYGIWSLKRLRTLDLSHN-LFSGS 139
L + SSL L + +N F+ L+ + +++ N L +
Sbjct: 113 HLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFS------GLRNMNCIEMGGNPLENSG 163
Query: 140 IPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMI 199
G L L + + +G +P D+ L L L +N
Sbjct: 164 FEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQ-------------- 206
Query: 200 FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNG 258
++ L S L L +N + + + L + L N L+
Sbjct: 207 --AIELEDLLR--------YSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS- 254
Query: 259 NIPEGLFDL-GLEEIDLSENGFMGSIPPGS-SSSSSSTLFQTLRILDLSSNNL-VGDIPA 315
+P GL DL L+ + L N + + + L +N + ++
Sbjct: 255 RVPAGLPDLKLLQVVYLHTN-NITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 316 EMGLFA---NLRYLNLSSN 331
F + + +
Sbjct: 314 --ATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 47/242 (19%), Positives = 79/242 (32%), Gaps = 38/242 (15%)
Query: 19 VFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLL-SGPVPYQLFENCASLRYL 77
+ L L N + ++P + + + NM +++ N L + F+ L YL
Sbjct: 121 LPSSLVELRIHDNRIR-KVPKGVFS-GLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYL 177
Query: 78 SLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS--GDLDFASGYGIWSLKRLRTLDLSHNL 135
++ L G + +LN L+L +N D +L L L HN
Sbjct: 178 RISEAKLTGIPKDLP---ETLNELHLDHNKIQAIELEDLL------RYSKLYRLGLGHNQ 228
Query: 136 FSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRL 194
I G + L L+EL L N+ S +PA + L + L N T
Sbjct: 229 IR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT--------- 277
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT-GSLPSSLFNC-KKLSVIRLR 252
V N + + + NN + + + F C I+
Sbjct: 278 -------KVGVNDFCP--VGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
Query: 253 GN 254
Sbjct: 329 NY 330
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 58/295 (19%), Positives = 118/295 (40%), Gaps = 37/295 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNL--ISLE 663
+G G V++V + ++ A+K + + + + E+ L K + + I L
Sbjct: 17 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
Y T Q +V + N L + L ++ P + +K +L + + +H
Sbjct: 76 DYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER-KSYWKNML---EAVHTIHQH--- 127
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL------ 777
I+H +LKP+N L+ D ++ DFG+A + V+ + + Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 778 ----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833
+++ K D++ G ++ + G+ P + + + L +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------PN 237
Query: 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ--ILQVIKTPLPQRME 886
+ D PE ++ VLK L P R S+ E++ +Q+ P+ Q +
Sbjct: 238 HEIEFPDIPEKDLQDVLKCCLK---RDPKQRISIPELLAHPYVQIQTHPVNQMAK 289
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+G G F V K + G A K + S E+ EREV +L + H N+I
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---WTNRFKVILGTAKGLAHL 717
+L Y +L+ + G +L + L LS T+ K IL G+ +L
Sbjct: 79 TLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQILD---GVNYL 131
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNP----RISDFGLARLLTRLDKHVMSNRFQSALGYV 773
H I H++LKP NI+L D P ++ DFGLA + D N F + +V
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTP-EFV 185
Query: 774 APE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 818
APE + + + + D++ GV+ L++G P G+ L+
Sbjct: 186 APEIVNYEP--LGLEADMWSIGVITYILLSGASPF-LGDTKQETLA 228
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 33/235 (14%), Positives = 74/235 (31%), Gaps = 24/235 (10%)
Query: 606 EVGEGVFGTVYKVSFGTQ-----GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+GEG F VY+ + G + +K ++ ++ + + L + +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF-YIGTQLMERLKPSMQHMFM 130
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHE-RLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
+ +LV + G+L ++ + + + + +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH- 189
Query: 720 SFRPPIIHYNLKPSNILLDDNYNP-----------RISDFGLARLLTRLDKHVMSNRFQS 768
IIH ++KP N +L + + + D G + + K +
Sbjct: 190 --DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 769 ALGYVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
G+ E L+ + N + D +G + ++ G E R
Sbjct: 248 TSGFQCVEMLSNKPW--NYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 31/288 (10%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 653
I E+L LE ++G+G FG V+ ++ R +A+K L + PE F +E +V+ K
Sbjct: 181 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM--SPEAFLQEAQVMKK 235
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
RH L+ L + + +V++Y GSL L L A G
Sbjct: 236 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASG 292
Query: 714 LAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
+A++ ++ +H +L+ +NIL+ +N +++DFGLARL+ +++ + + +
Sbjct: 293 MAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 347
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
APE R K D++ FG+L+ EL T GR P G N V +E G +
Sbjct: 348 TAPE-AALYGRFTIKSDVWSFGILLTELTTKGRVPYP-GMVN-----REVLDQVERGYRM 400
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
C P + + L C P RP+ + L+ T
Sbjct: 401 PC--------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 55/298 (18%), Positives = 89/298 (29%), Gaps = 62/298 (20%)
Query: 44 LNMMNMKFLDLSNNLLSGPVPYQLFE--NCASLRYLSLAGNILQG--PIGKIFNYCSSLN 99
+ +++K L + + + + + L+ L+L + G P + LN
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124
Query: 100 TLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQ 159
LNL N ++ + + W L+ L ++ + V L L L N
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 160 FSGPLPADIGFC----PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHW 215
G C P L L L N T +G
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGM---------------------ETPSGVCSAL 223
Query: 216 IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLS 275
L+ LD S+N L + + + L ++LS
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ----------------------LNSLNLS 261
Query: 276 ENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHL 333
G +P G L L +LDLS N L P+ L + L+L N
Sbjct: 262 FTGL-KQVPKG--------LPAKLSVLDLSYNRL-DRNPSPDEL-PQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 66/321 (20%), Positives = 100/321 (31%), Gaps = 48/321 (14%)
Query: 78 SLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS 137
S A N L +++ SL L + + F I L+ L +
Sbjct: 25 SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTD---IIKSLSLKRLTVRAARIP 81
Query: 138 GSIPQGVAALH---YLKELLLQGNQFSGPLPADIGFCPH--LTTLDLSNNLFTGQLPVSL 192
I G + L+EL L+ + +G P + L L+L N + +
Sbjct: 82 SRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLA 141
Query: 193 RLLN----SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC----K 244
L + +S++ + L LD S+N G C
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201
Query: 245 KLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 304
L V+ LR + + S+ + L+ LDL
Sbjct: 202 TLQVLALRNAGME------------------------TPSG--VCSALAAARVQLQGLDL 235
Query: 305 SSNNLVGDIPAEMGLF-ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQ 363
S N+L A + + L LNLS L+ +P L L LDL N L P
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRL-DRNPS 291
Query: 364 EVCESRSLGILQLDGNSLTGP 384
E +G L L GN
Sbjct: 292 P-DELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 51/298 (17%), Positives = 91/298 (30%), Gaps = 21/298 (7%)
Query: 172 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 231
P N L + + + + + I +L+ L
Sbjct: 20 PKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAAR 79
Query: 232 LTGSLPSS---LFNCKKLSVIRLRGNSLNGNIPEGLFDL---GLEEIDLSENGFMGSIPP 285
+ + + L + L + G P L + L ++L + +
Sbjct: 80 IPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW--ATRD 137
Query: 286 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE----L 341
+ L L++L ++ + + ++ +F L L+LS N
Sbjct: 138 AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197
Query: 342 GYFHSLIHLDLRNN---ALYGSIPQEVCESRSLGILQLDGNSLTG-PIPQVIRNCTSLYL 397
F +L L LRN G L L L NSL + L
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
Query: 398 LSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 455
L+LS L +PK + KL +L L +N L P L + +++ N +
Sbjct: 258 LNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 37/190 (19%), Positives = 51/190 (26%), Gaps = 28/190 (14%)
Query: 23 LERLNFSHNSLSG--QIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLA 80
L LN + S + L +K L ++ + +L L L+
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN-FSCEQVRVFPALSTLDLS 181
Query: 81 GNILQGPIGKIFNYC----SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLF 136
N G G I C +L L L N + +L+ LDLSHN
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGME-TPSGVCSALAAARVQLQGLDLSHNSL 240
Query: 137 SGSI-PQGVAALHYLKELLLQGNQFS---GPLPA----------------DIGFCPHLTT 176
+ L L L LPA P +
Sbjct: 241 RDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDRNPSPDELPQVGN 300
Query: 177 LDLSNNLFTG 186
L L N F
Sbjct: 301 LSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 39/165 (23%), Positives = 57/165 (34%), Gaps = 16/165 (9%)
Query: 6 VHGNSYNAIP--SMVVFRILERLNFSHNSLSGQIP--PSLLNLNMMNMKFLDLSNNLLS- 60
+ + VF L L+ S N G+ +L L ++ L L N +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 61 -GPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGY 118
V L L+ L L+ N L+ ++ S LN+LNLS
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK----- 270
Query: 119 GIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP 163
+L LDLS+N P L + L L+GN F
Sbjct: 271 --GLPAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 37/232 (15%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK--------KLVTSDIIQYPEDFEREVRVLGK-ARH 656
+G GV V + + AVK ++ + E +EV +L K + H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGT 710
PN+I L+ Y T LV D G L + L E+ + +L
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-------KIMRALL-- 134
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
+ + LH I+H +LKP NILLDD+ N +++DFG + L + +
Sbjct: 135 -EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP- 187
Query: 771 GYVAPE-LTCQSLRV----NEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
Y+APE + C ++ D++ GV++ L+ G P + +++L
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLML 238
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+G G F V K G+ A K +L +S E+ EREV +L + RHPN+I
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-----FKVILGTAKGLA 715
+L + +L+ + G L L E+ S T K IL G+
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEK------ESLTEDEATQFLKQILD---GVH 122
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNP----RISDFGLARLLTRLDKHVMSNRFQSALG 771
+LH I H++LKP NI+L D P ++ DFG+A + + N F +
Sbjct: 123 YLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--AGNEFKNIFGTP-E 176
Query: 772 YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 818
+VAPE + + + + D++ GV+ L++G P GE L+
Sbjct: 177 FVAPEIVNYEP--LGLEADMWSIGVITYILLSGASPF-LGETKQETLT 221
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 56/258 (21%), Positives = 98/258 (37%), Gaps = 51/258 (19%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP----EDFEREVRVLGKARHPNLIS 661
+G+G +G V + A+K + + I Q E + EVR++ K HPN+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK--------- 712
L Y Q LV + G L KL+ + + + K +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 713 ---------------------------GLAHLHHSFRPPIIHYNLKPSNILL--DDNYNP 743
L +LH+ I H ++KP N L + ++
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 744 RISDFGLARLLTRL---DKHVMSNRFQSALGYVAPE-LTCQSLRVNEKCDIYGFGVLILE 799
++ DFGL++ +L + + M+ + + +VAPE L + KCD + GVL+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTP-YFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 800 LVTGRRPVEYGEDNVVIL 817
L+ G P G ++ +
Sbjct: 269 LLMGAVPF-PGVNDADTI 285
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 71/319 (22%), Positives = 127/319 (39%), Gaps = 56/319 (17%)
Query: 586 SRSSSL-DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF 644
SR +++ + + L+ +G G GTV GR +AVK+++ I + +
Sbjct: 1 SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRML----IDFCDIA 55
Query: 645 EREVRVLGK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR 703
E+++L + HPN+I T + + + N +LQ + + S L
Sbjct: 56 LMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKE 114
Query: 704 F---KVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-------------DNYNPRISD 747
+ ++ A G+AHLH IIH +LKP NIL+ +N ISD
Sbjct: 115 YNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 748 FGLARLLTRLDKHVMSNRFQSALG---YVAPEL------TCQSLRVNEKCDIYGFGVLIL 798
FGL + L + + G + APEL R+ DI+ G +
Sbjct: 172 FGLCKKLDS-GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 799 ELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLA--LV 855
+++ G+ P +G+ E N++ + S+ + ++ A L+
Sbjct: 231 YILSKGKHP--FGDKY-----------SRESNIIRGI-FSLDEMKCLHDRSLIAEATDLI 276
Query: 856 --CTCHIPSSRPSMAEVVQ 872
H P RP+ +V++
Sbjct: 277 SQMIDHDPLKRPTAMKVLR 295
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 64/286 (22%), Positives = 127/286 (44%), Gaps = 38/286 (13%)
Query: 606 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+G+G FG VY+ V +A+K + + ++ +F E V+ + +++
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------PPLSWTNRFKVILGTAKGL 714
L G Q L++ + G L++ L P+ P S + ++ A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 715 AHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
A+L+ + F +H +L N ++ +++ +I DFG+ R + D + + + ++
Sbjct: 152 AYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 774 APELTCQSLRVN---EKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 829
+PE SL+ D++ FGV++ E+ T +P G N E V + EG
Sbjct: 208 SPE----SLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSN-----EQVLRFVMEGG 257
Query: 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+LD P++ + +L +C + P RPS E++ ++
Sbjct: 258 LLDK--------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+G G F V K + G A K + S E+ EREV +L + HPN+I
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---WTNRFKVILGTAKGLAHL 717
+L Y +L+ + G +L + L LS T+ K IL G+ +L
Sbjct: 79 TLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQILD---GVNYL 131
Query: 718 HHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
H I H++LKP NI+L + ++ DFGLA + D N F + +V
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTP-EFV 185
Query: 774 APE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 818
APE + + + + D++ GV+ L++G P G+ L+
Sbjct: 186 APEIVNYEP--LGLEADMWSIGVITYILLSGASPF-LGDTKQETLA 228
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 72/306 (23%), Positives = 123/306 (40%), Gaps = 43/306 (14%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK---VSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVR 649
ID L L K +GEG FG+V + +AVK + + + + E+F E
Sbjct: 31 IDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAA 88
Query: 650 VLGKARHPNLISLEG-----YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR- 703
+ HPN+I L G +++ + G L L T P +
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 704 -FKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761
K ++ A G+ +L + +F +H +L N +L D+ ++DFGL++ + D +
Sbjct: 149 LLKFMVDIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204
Query: 762 MSNRFQSALGYVAPELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVI 816
+ + ++A E SL K D++ FGV + E+ T G P Y G N
Sbjct: 205 QGRIAKMPVKWIAIE----SLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPGVQN--- 255
Query: 817 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876
+ L G+ L PED + + ++ C P RP+ + + L+
Sbjct: 256 --HEMYDYLLHGHRLKQ--------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305
Query: 877 IKTPLP 882
+ LP
Sbjct: 306 LLESLP 311
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 36/293 (12%)
Query: 592 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRML--AVKKL-VTSDIIQYPEDFEREV 648
+ +D + L + E+G G FGTV K + + + AVK L ++ ++ E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 649 RVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL 708
V+ + +P ++ + G +LV + A G L L + + N +++
Sbjct: 70 NVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVH 124
Query: 709 GTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNRF 766
+ G+ +L +F +H +L N+LL + +ISDFGL++ L + +
Sbjct: 125 QVSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 767 QSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVR 822
+ + + APE + + K D++ FGVL+ E + G++P Y + SE V
Sbjct: 181 KWPVKWYAPE----CINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRG---MKGSE-VT 230
Query: 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+LE+G + C P + L +C + +RP A V L+
Sbjct: 231 AMLEKGERMGC--------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 71/307 (23%), Positives = 131/307 (42%), Gaps = 47/307 (15%)
Query: 597 PETLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
E L+ ++G+G FG+V G ++AVKKL ++ DFERE+ +L
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILK 66
Query: 653 KARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHE---RLPSTPPLSWTNRFKVI 707
+H N++ +G Y + L+ +Y P GSL+ L + R+ L +T
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT------ 120
Query: 708 LGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNR 765
KG+ +L + IH +L NIL+++ +I DFGL ++L + + +
Sbjct: 121 SQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 766 FQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVIL---- 817
+S + + APE SL ++ D++ FGV++ EL T + + + ++
Sbjct: 177 GESPIFWYAPE----SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 818 -----SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
H+ LL+ L P+ + + C + + RPS ++
Sbjct: 233 QGQMIVFHLIELLKNNGRLPR--------PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284
Query: 873 ILQVIKT 879
+ I+
Sbjct: 285 RVDQIRD 291
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+G G F V K + G A K + +S ED EREV +L + +HPN+I
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---WTNRFKVILGTAKGLAHL 717
+L Y +L+ + G +L + L L+ T K IL G+ +L
Sbjct: 78 TLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN---GVYYL 130
Query: 718 HHSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
H I H++LKP NI+L +I DFGLA + + N F + +V
Sbjct: 131 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTP-EFV 184
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
APE+ + + D++ GV+ L++G P G+ L+
Sbjct: 185 APEIVNYE-PLGLEADMWSIGVITYILLSGASPF-LGDTKQETLAN 228
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 70/307 (22%), Positives = 129/307 (42%), Gaps = 47/307 (15%)
Query: 597 PETLLEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
E L+ ++G+G FG+V G ++AVKKL ++ DFERE+ +L
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILK 97
Query: 653 KARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LSWTNRFKVI 707
+H N++ +G Y + L+ +Y P GSL+ L + L +T
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT------ 151
Query: 708 LGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNR 765
KG+ +L + IH +L NIL+++ +I DFGL ++L + + + +
Sbjct: 152 SQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 766 FQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVTGRRPVEYGEDNVV------- 815
+S + + APE SL ++ D++ FGV++ EL T + +
Sbjct: 208 GESPIFWYAPE----SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
Query: 816 ---ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
++ H+ LL+ L P+ + + C + + RPS ++
Sbjct: 264 QGQMIVFHLIELLKNNGRLPR--------PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315
Query: 873 ILQVIKT 879
+ I+
Sbjct: 316 RVDQIRD 322
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 70/301 (23%), Positives = 116/301 (38%), Gaps = 45/301 (14%)
Query: 606 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+G G FG VY+ + +AVK L Q DF E ++ K H N++
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST---PPLSWTNRFKVILGTAKGLAHL 717
G + ++ + G L++ L E P L+ + V A G +L
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 718 -HHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
+ F IH ++ N LL +I DFG+AR + R + + ++
Sbjct: 157 EENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 774 APELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGN 829
PE + K D + FGVL+ E+ + G P + N + V + G
Sbjct: 213 PPE----AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSN-----QEVLEFVTSGG 262
Query: 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ-------VIKTPLP 882
+D P++ PV ++ C H P RP+ A +++ ++ VI T LP
Sbjct: 263 RMDP--------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 314
Query: 883 Q 883
Sbjct: 315 I 315
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 81/347 (23%), Positives = 135/347 (38%), Gaps = 44/347 (12%)
Query: 555 RLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSID------PETLLEKAAEVG 608
+ + T+L S + A I + + L ++ ++ +G
Sbjct: 39 SIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIG 98
Query: 609 EGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
G FG VY + + AVK L I F E ++ HPN++SL G
Sbjct: 99 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158
Query: 666 YWTPQLKLL-VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL-HHSFRP 723
+ L V Y +G L+ + T + + L AKG+ L F
Sbjct: 159 CLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKKF-- 213
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--GYVAPELTCQS 781
+H +L N +LD+ + +++DFGLAR + + + N+ + L ++A E S
Sbjct: 214 --VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE----S 267
Query: 782 L---RVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLEEGNVLDCVDP 836
L + K D++ FGVL+ EL+T G P Y + + V L +G L
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNT-----FDITVYLLQGRRLLQ--- 317
Query: 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883
PE P+ ++ L C RPS +E+V + I +
Sbjct: 318 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 38/295 (12%)
Query: 601 LEKAAEVGEGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHP 657
+G+G FG VY + A+K L +Q E F RE ++ HP
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 658 NLISLEGYYWTPQ-LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
N+++L G P+ L ++ Y +G L + + + L A+G+ +
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEY 139
Query: 717 L-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--GYV 773
L F +H +L N +LD+++ +++DFGLAR + + + + + L +
Sbjct: 140 LAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 774 APELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLEEG 828
A E SL R K D++ FGVL+ EL+T G P Y D + L +G
Sbjct: 196 ALE----SLQTYRFTTKSDVWSFGVLLWELLTRGAPP--YRHIDP-----FDLTHFLAQG 244
Query: 829 NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883
L PE + ++ C P+ RP+ +V ++ I + L
Sbjct: 245 RRLPQ--------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 109 bits (272), Expect = 1e-24
Identities = 59/229 (25%), Positives = 85/229 (37%), Gaps = 28/229 (12%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL----- 662
G G FG V + G +A+K+ + E + E++++ K HPN++S
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 663 -EGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
L LL +Y G L+ L E I L +LH
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS---SALRYLHE 139
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPR---ISDFGLARLLTRLDKHVMSNRFQSALG---YV 773
+ IIH +LKP NI+L I D G A+ L + +G Y+
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ------GELCTEFVGTLQYL 190
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
APEL + + D + FG L E +TG RP V VR
Sbjct: 191 APELL-EQKKYTVTVDYWSFGTLAFECITGFRPF-LPNWQPVQWHGKVR 237
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 31/288 (10%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 653
I E+L LE ++G+G FG V+ ++ R +A+K L + PE F +E +V+ K
Sbjct: 264 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM--SPEAFLQEAQVMKK 318
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
RH L+ L + + +V++Y GSL L L A G
Sbjct: 319 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASG 375
Query: 714 LAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
+A++ ++ +H +L+ +NIL+ +N +++DFGLARL+ +++ + + +
Sbjct: 376 MAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 430
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
APE R K D++ FG+L+ EL T GR P G N V +E G +
Sbjct: 431 TAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYP-GMVN-----REVLDQVERGYRM 483
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
C P + + L C P RP+ + L+ T
Sbjct: 484 PC--------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+G+G F V + G+ AVK K +S + ED +RE + +HP+++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS-TEDLKREASICHMLKHPHIV 89
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS---WTNRFKVILGTAKGLAHL 717
L Y + + +V ++ L ++ +R + S ++ + IL + L +
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EALRYC 146
Query: 718 HHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
H + IIH ++KP +LL +++ ++ FG+A L V R + ++A
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTP-HFMA 201
Query: 775 PE-LTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
PE + + + D++G GV++ L++G P
Sbjct: 202 PEVVKREPY--GKPVDVWGCGVILFILLSGCLP 232
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 36/231 (15%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-------KLVTSDIIQYPEDFEREVRVLGK-ARHP 657
+G GV V + G AVK +L + + E RE +L + A HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTA 711
++I+L Y + LV D G L + L E+ + + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-------SIMRSLL--- 210
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+ ++ LH + I+H +LKP NILLDDN R+SDFG + L + + G
Sbjct: 211 EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLRELCGTP-G 264
Query: 772 YVAPE-LTCQSLRV----NEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
Y+APE L C ++ D++ GV++ L+ G P + +++L
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF-WHRRQILML 314
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 82/302 (27%), Positives = 125/302 (41%), Gaps = 45/302 (14%)
Query: 589 SSLDCSIDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRML---AVK--KLVTSDIIQYPE 642
SL C I + L L + ++G+G FG V + + AVK K + +
Sbjct: 9 QSLTCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66
Query: 643 DFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPP---LS 699
DF REV + H NLI L G TP + +V++ AP GSL +L +
Sbjct: 67 DFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125
Query: 700 WTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758
+ + A+G+ +L F IH +L N+LL +I DFGL R L + D
Sbjct: 126 YA------VQVAEGMGYLESKRF----IHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 759 KH-VMSNRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDN 813
H VM + + APE SL+ D + FGV + E+ T G+ P +
Sbjct: 176 DHYVMQEHRKVPFAWCAPE----SLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIG-- 227
Query: 814 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873
+ S+ + + +EG L PED + + + C H P RP+ +
Sbjct: 228 -LNGSQILHKIDKEGERLPR--------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278
Query: 874 LQ 875
L
Sbjct: 279 LL 280
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 39/308 (12%), Positives = 82/308 (26%), Gaps = 58/308 (18%)
Query: 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREV---RVLGKA 654
L + +G+ + + G V ++ + + EV R+L
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 655 RHPNLISLEGYYWTPQLKLLVSD--------------------------YAPNGSLQAKL 688
++ + + P + + + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 689 HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 748
+ L R ++ L + LA LHH ++H L+P +I+LD ++ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 749 GLARLLTRLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGR 804
R + A + + D + G+ I +
Sbjct: 256 EHLVRDGA-SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 805 RPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSR 864
P +D + SE + C + V +L+ L R
Sbjct: 315 LP--NTDDAALGGSEWI--------FRSCKNIP------QPVRALLEGFLRYP---KEDR 355
Query: 865 PSMAEVVQ 872
+ ++
Sbjct: 356 LLPLQAME 363
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 77/371 (20%), Positives = 133/371 (35%), Gaps = 63/371 (16%)
Query: 553 RRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAA------- 605
+ T E++ + L + + L R+S++ +P
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK 66
Query: 606 -----------EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR 649
+G G FG VY+ + +AVK L Q DF E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 650 VLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST---PPLSWTNRFKV 706
++ K H N++ G + ++ + G L++ L E P L+ + V
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 707 ILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARLLTRLDKHVM 762
A G +L + F IH ++ N LL +I DFG+AR + R +
Sbjct: 187 ARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 763 SNRFQSALGYVAPELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILS 818
+ ++ PE + K D + FGVL+ E+ + G P + N
Sbjct: 243 GGCAMLPVKWMPPE----AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSN----- 292
Query: 819 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ--- 875
+ V + G +D P++ PV ++ C H P RP+ A +++ ++
Sbjct: 293 QEVLEFVTSGGRMDP--------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344
Query: 876 ----VIKTPLP 882
VI T LP
Sbjct: 345 QDPDVINTALP 355
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 43/296 (14%)
Query: 606 EVGEGVFGTVYK---VSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLIS 661
+G+G FG+V + +AVK L E+F RE + + HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 662 LEG------YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR--FKVILGTAKG 713
L G + +++ + +G L A L P + + + ++ A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 714 LAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+ +L + IH +L N +L ++ ++DFGL+R + D + + +
Sbjct: 150 MEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 772 YVAPELTCQSL---RVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLE 826
++A E SL D++ FGV + E++T G+ P Y G +N + L
Sbjct: 205 WLALE----SLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAGIEN-----AEIYNYLI 253
Query: 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882
GN L P + + V L C P RPS + L+ I L
Sbjct: 254 GGNRLKQ--------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 25/222 (11%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
++G G +G V A+K + TS EV VL HPN++
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN----SKLLEEVAVLKLLDHPNIM 99
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
L ++ + LV + G L + + + + +I G+ +LH
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELF----DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 721 FRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
I+H +LKP N+LL + + +I DFGL+ + ++ M R +A Y+APE+
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTA-YYIAPEV 209
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
+ +EKCD++ GV++ L+ G P G+ + IL +
Sbjct: 210 LRKK--YDEKCDVWSIGVILFILLAGYPPF-GGQTDQEILRK 248
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 38/227 (16%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+G+G F V + T G A K KL D + ERE R+ K +HPN++
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF----QKLEREARICRKLQHPNIV 68
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
L LV D G L + E S + + IL + +
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL---ESI 118
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNP---RISDFGLARLLTRLDKHVMSNRFQSALG 771
A+ H + I+H NLKP N+LL +++DFGLA + D + G
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP-G 172
Query: 772 YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
Y++PE L ++ DI+ GV++ L+ G P + ED +
Sbjct: 173 YLSPEVLKKDPY--SKPVDIWACGVILYILLVGYPPF-WDEDQHRLY 216
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 18/219 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLE 663
+G+G FG V G+ AVK + + Q E REV++L + HPN++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
++ LV + G L + + S S + ++I G+ ++H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELF----DEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 724 PIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
I+H +LKP N+LL + N RI DFGL+ M ++ +A Y+APE+
Sbjct: 147 -IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTA-YYIAPEVLHG 202
Query: 781 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
+ +EKCD++ GV++ L++G P G + IL +
Sbjct: 203 T--YDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKK 238
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 59/295 (20%), Positives = 119/295 (40%), Gaps = 37/295 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP-EDFEREVRVLGKARHPNL--ISLE 663
+G G V++V + ++ A+K + + + + E+ L K + + I L
Sbjct: 64 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
Y T Q +V + N L + L ++ P + +K +L + + +H
Sbjct: 123 DYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER-KSYWKNML---EAVHTIHQH--- 174
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL------ 777
I+H +LKP+N L+ D ++ DFG+A + V+ + A+ Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 778 ----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833
+++ K D++ G ++ + G+ P + + + L +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------PN 284
Query: 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ--ILQVIKTPLPQRME 886
+ D PE ++ VLK L P R S+ E++ +Q+ P+ Q +
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLK---RDPKQRISIPELLAHPYVQIQTHPVNQMAK 336
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 47/217 (21%), Positives = 80/217 (36%), Gaps = 22/217 (10%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
+ + VG G FG V+++ G AVKK ++ E+
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVACAGLS 108
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHE--RLPSTPPLSWTNRFKVILGTAKG 713
P ++ L G + + GSL + + LP L + L +G
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYL---GQAL---EG 162
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSALG- 771
L +LH I+H ++K N+LL + + + DFG A L G
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 772 --YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++APE+ + K DI+ ++L ++ G P
Sbjct: 220 ETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+G+G FG V K + AVK D REV +L K HPN++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT----STILREVELLKKLDHPNIM 84
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
L +V + G L + + E + K + G+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFS---GI 134
Query: 715 AHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
++H I+H +LKP NILL + + + +I DFGL+ M +R +A
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTA-Y 188
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
Y+APE+ + +EKCD++ GV++ L++G P YG++ IL
Sbjct: 189 YIAPEVLRGTY--DEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKR 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 33/226 (14%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARH-PNL 659
E+G G F V + + G+ A K + + E+ VL A+ P +
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR----AEILHEIAVLELAKSCPRV 91
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-----FKVILGTAKGL 714
I+L Y +L+ +YA G ++ + K IL G+
Sbjct: 92 INLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILE---GV 144
Query: 715 AHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+LH + I+H +LKP NILL + +I DFG++R + + +
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HACELREIMGTP-E 198
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
Y+APE+ + D++ G++ L+T P GEDN
Sbjct: 199 YLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPF-VGEDNQETY 242
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 45/223 (20%), Positives = 83/223 (37%), Gaps = 29/223 (13%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+G G +G V A KK+ + + F++E+ ++ HPN+I L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 666 YWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
+ LV + G L + E + K +L +A+ H
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------RIMKDVL---SAVAYCHK 124
Query: 720 SFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
+ H +LKP N L + ++ DFGLA +M + + YV+P+
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTP-YYVSPQ 178
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
+ +CD + GV++ L+ G P + ++ +
Sbjct: 179 VLEGLY--GPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLK 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 53/296 (17%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVL 651
++ + ++ ++G G +G VY+ + +AVK K T + E+F +E V+
Sbjct: 10 MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 63
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
+ +HPNL+ L G +++++ G+L L E +
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM--ATQIS 121
Query: 712 KGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
+ +L +F IH +L N L+ +N+ +++DFGL+RL+T + + +
Sbjct: 122 SAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHA 170
Query: 771 G------YVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSE 819
G + APE SL N+ K D++ FGVL+ E+ T G P Y G D
Sbjct: 171 GAKFPIKWTAPE----SLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDL-----S 219
Query: 820 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
V LLE+ ++ PE V +L C PS RPS AE+ Q +
Sbjct: 220 QVYELLEKDYRMER--------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 65/292 (22%), Positives = 128/292 (43%), Gaps = 34/292 (11%)
Query: 592 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVR 649
+ + LL E+G G FG+V + + + + + A+K L E+ RE +
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 650 VLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 709
++ + +P ++ L G L +LV + A G L L + + +N +++
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQ 444
Query: 710 TAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNRFQ 767
+ G+ +L +F +H NL N+LL + + +ISDFGL++ L D + + +
Sbjct: 445 VSMGMKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 768 SALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRV 823
L + APE + + + D++ +GV + E ++ G++P Y + + E V
Sbjct: 501 WPLKWYAPE----CINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKK---MKGPE-VMA 550
Query: 824 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+E+G ++C P + + L C + RP V Q ++
Sbjct: 551 FIEQGKRMEC--------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 60/311 (19%), Positives = 106/311 (34%), Gaps = 64/311 (20%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK------VSFGTQGRML-AVKKLVTSDIIQYPEDFER 646
I E L + +G+G F ++K +G +K L Y E F
Sbjct: 5 IRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-DKAHRNYSESFFE 61
Query: 647 EVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV 706
++ K H +L+ G +LV ++ GSL L + ++ + +V
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEV 118
Query: 707 ILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPR--------ISDFGLARLLTRL 757
A + L ++ IH N+ NILL + + +SD G++ +
Sbjct: 119 AKQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 758 DKHVMSNRFQSALGY------VAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEY- 809
D V PE +N D + FG + E+ + G +P
Sbjct: 175 D------------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LS 220
Query: 810 GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAE 869
D+ + E+ + L P+ + L C + P RPS
Sbjct: 221 ALDS-----QRKLQFYEDRHQLPA--------PKAA--ELANLINNCMDYEPDHRPSFRA 265
Query: 870 VVQILQVIKTP 880
+++ L + TP
Sbjct: 266 IIRDLNSLFTP 276
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-24
Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 28/229 (12%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYP-------EDFEREVRVLGK 653
++G G +G V A+K + E+ E+ +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
HPN+I L + + LV+++ G L E++ + + ++ G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF----EQIINRHKFDECDAANIMKQILSG 158
Query: 714 LAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
+ +LH I+H ++KP NILL + N +I DFGL+ + + + +R +A
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS--KDYKLRDRLGTA- 212
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
Y+APE+ + NEKCD++ GV++ L+ G P G+++ I+ +
Sbjct: 213 YYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKK 258
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 39/292 (13%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK 653
I E+L LEK ++G G FG V+ ++ + +AVK + + E F E V+
Sbjct: 185 IPRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSV--EAFLAEANVMKT 239
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
+H L+ L T + +++++ GSL L S PL F A+G
Sbjct: 240 LQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEG 296
Query: 714 LAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
+A + ++ IH +L+ +NIL+ + +I+DFGLAR++ +++ + + +
Sbjct: 297 MAFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKW 351
Query: 773 VAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLEE 827
APE ++ K D++ FG+L++E+VT GR P Y G N V LE
Sbjct: 352 TAPE----AINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSN-----PEVIRALER 400
Query: 828 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
G + PE+ + + + C + P RP+ + +L T
Sbjct: 401 GYRMPR--------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 55/215 (25%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
PE + + ++GEG +G+VYK G+++A+K++ + ++ +E+ ++ +
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCD 82
Query: 656 HPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
P+++ G Y+ L +V +Y GS+ + R L+ ++ T KGL
Sbjct: 83 SPHVVKYYGSYFKNTDL-WIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGL 138
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 771
+LH IH ++K NILL+ + +++DFG+A LT M+ R + +G
Sbjct: 139 EYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT----DTMAKR-NTVIGTPF 190
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++APE+ + N DI+ G+ +E+ G+ P
Sbjct: 191 WMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPP 224
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+G+G FG V K + AVK D REV +L K HPN++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT----STILREVELLKKLDHPNIM 84
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
L +V + G L + + S + ++I G+ ++H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELF----DEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 721 FRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
I+H +LKP NILL + + + +I DFGL+ M +R +A Y+APE+
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTA-YYIAPEV 194
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
+ +EKCD++ GV++ L++G P YG++ IL
Sbjct: 195 LRGT--YDEKCDVWSAGVILYILLSGTPPF-YGKNEYDIL 231
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 69/307 (22%), Positives = 125/307 (40%), Gaps = 41/307 (13%)
Query: 588 SSSLDCSIDPETL-LEKAAEVGEGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQYPED 643
SS+ D I E + L + +GEG FG V++ +S +A+K E
Sbjct: 5 SSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 62
Query: 644 FEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR 703
F +E + + HP+++ L G T ++ + G L++ L R S L +
Sbjct: 63 FLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASL 118
Query: 704 FKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVM 762
+ LA+L F +H ++ N+L+ N ++ DFGL+R + +
Sbjct: 119 ILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYK 173
Query: 763 SNRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVIL 817
+++ + + ++APE S+ D++ FGV + E++ G +P + G N
Sbjct: 174 ASKGKLPIKWMAPE----SINFRRFTSASDVWMFGVCMWEILMHGVKP--FQGVKN---- 223
Query: 818 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL-QV 876
V +E G L P + + L C + PS RP E+ L +
Sbjct: 224 -NDVIGRIENGERLPM--------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
Query: 877 IKTPLPQ 883
++ Q
Sbjct: 275 LEEEKAQ 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVL 651
IDP L + E+G G FG V+ + + + +A+K + EDF E V+
Sbjct: 5 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMS----EEDFIEEAEVM 57
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
K HP L+ L G LV+++ +G L L + + + L
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVC 114
Query: 712 KGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
+G+A+L IH +L N L+ +N ++SDFG+ R V+ +++ S+
Sbjct: 115 EGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRF-------VLDDQYTSST 163
Query: 771 G------YVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSE 819
G + +PE + K D++ FGVL+ E+ + G+ P Y N
Sbjct: 164 GTKFPVKWASPE----VFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSN-----S 212
Query: 820 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ-VIK 878
V + G L P V ++ C P RP+ + +++ L + +
Sbjct: 213 EVVEDISTGFRLYK--------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
Query: 879 TPL 881
+ L
Sbjct: 265 SGL 267
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 63/297 (21%), Positives = 122/297 (41%), Gaps = 44/297 (14%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK---VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRV 650
I E + L + +GEG FG VY+ + + +AVK + E F E +
Sbjct: 9 IAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI 66
Query: 651 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVIL 708
+ HP+++ L G + ++ + P G L L ++ L L
Sbjct: 67 MKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSL 120
Query: 709 GTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 767
K +A+L + +H ++ NIL+ ++ DFGL+R + + + ++ +
Sbjct: 121 QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTR 175
Query: 768 SALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVR 822
+ +++PE S+ D++ F V + E+++ G++P + +N + V
Sbjct: 176 LPIKWMSPE----SINFRRFTTASDVWMFAVCMWEILSFGKQP--FFWLEN-----KDVI 224
Query: 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
+LE+G+ L P+ + L C + PS RP E+V L +
Sbjct: 225 GVLEKGDRLPK--------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 39/233 (16%)
Query: 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED------FEREVRVLGKARHPN 658
VG G G VY+ + R++A+K + D +RE R G+ + P+
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSE----TLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 659 LISL------EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
++ + +G + + L A L + P PP + ++
Sbjct: 96 VVPIHDFGEIDGQLY------VDMRLINGVDLAAMLRRQGPLAPPRA----VAIVRQIGS 145
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 771
L H H ++KP NIL+ + + DFG+A T D+ + + +G
Sbjct: 146 ALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQL--GNTVGT 198
Query: 772 --YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
Y+APE + DIY ++ E +TG P Y D + ++ H+
Sbjct: 199 LYYMAPER-FSESHATYRADIYALTCVLYECLTGSPP--YQGDQLSVMGAHIN 248
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 61/253 (24%), Positives = 95/253 (37%), Gaps = 13/253 (5%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
+ +P + LN N++ I ++ +++ L L N + +
Sbjct: 62 TRRGLSEVPQ-GIPSNTRYLNLMENNIQ-MIQADTFR-HLHHLEVLQLGRNSIRQ-IEVG 117
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
F ASL L L N L F Y S L L L NN Y + L
Sbjct: 118 AFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE----SIPSYAFNRVPSL 173
Query: 127 RTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 185
LDL I +G L LK L L +P L L++S N F
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTP-LVGLEELEMSGNHFP 231
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCK 244
P S L+S+ + V N+ ++ + +++L L+ ++N+L+ SLP LF +
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLR 290
Query: 245 KLSVIRLRGNSLN 257
L + L N N
Sbjct: 291 YLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-23
Identities = 58/265 (21%), Positives = 95/265 (35%), Gaps = 25/265 (9%)
Query: 125 RLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLF 184
+ + + S +PQG+ + L L N HL L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 185 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NC 243
+ L S+ + + +N LT +S L L NN + S+PS F
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRV 170
Query: 244 KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 301
L + L I EG F+ L+ ++L +P + L
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVG-------LEE 222
Query: 302 LDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNAL 357
L++S N+ +I G F +L+ L + ++ + I SL+ L+L +N L
Sbjct: 223 LEMSGNHFP-EIRP--GSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNNL 278
Query: 358 YGSIPQEVCES-RSLGILQLDGNSL 381
S+P ++ R L L L N
Sbjct: 279 -SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 60/289 (20%), Positives = 99/289 (34%), Gaps = 51/289 (17%)
Query: 172 PHLTTLDLSNNLFT---GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 228
+ + + + +P + R LN + N + ++ LE L
Sbjct: 54 NQFSKVVCTRRGLSEVPQGIPSNTRYLN------LMENNIQMIQADTFRHLHHLEVLQLG 107
Query: 229 NNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPP 285
N + + F L+ + L N L IP G F+ L E+ L N SIP
Sbjct: 108 RNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPS 164
Query: 286 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSRIPPELGY 343
+ + S L LDL + I GL NL+YLNL +++ +
Sbjct: 165 YAFNRVPS-----LMRLDLGELKKLEYISEGAFEGL-FNLKYLNLGMCNIKD-----MPN 213
Query: 344 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 403
L L L++ GN P +SL L + ++
Sbjct: 214 LTPL---------------------VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 404 HLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSYN 451
+S + L L L L N LS +P + L L+ +++ +N
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 62/269 (23%), Positives = 99/269 (36%), Gaps = 26/269 (9%)
Query: 48 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 107
+ + LS VP + N RYL+L N +Q F + L L L N
Sbjct: 55 QFSKVVCTRRGLSE-VPQGIPSN---TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 108 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPA 166
A L L TL+L N + IP G L L+EL L+ N +P+
Sbjct: 111 IRQIEVGA----FNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPS 164
Query: 167 DI-GFCPHLTTLDLSNNLFTGQLPV-SLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 224
P L LDL + + L ++ ++++ + D+P+ + LE
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNL-TPLVGLEE 222
Query: 225 LDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMG 281
L+ S NH + F L + + + ++ I FD L E++L+ N +
Sbjct: 223 LEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHN-NLS 279
Query: 282 SIPPGSSSSSSSTLFQTLRILDLSSNNLV 310
S+P + L L L N
Sbjct: 280 SLPHDLFTPLRY-----LVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 51/216 (23%), Positives = 82/216 (37%), Gaps = 23/216 (10%)
Query: 245 KLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 304
+ S + L+ +P+G+ ++L EN I + L +L L
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIPS-NTRYLNLMENNIQ-MIQADTFRHLHH-----LEVLQL 106
Query: 305 SSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGS 360
N++ I G F +L L L N L IP Y L L LRNN + S
Sbjct: 107 GRNSI-RQIEV--GAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPI-ES 161
Query: 361 IPQEVCES-RSLGILQL-DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 418
IP SL L L + L +L L+L ++ +P +++ L
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVG 219
Query: 419 LKILKLEFNELSGEIPQE-LGKLASLLAVNVSYNRL 453
L+ L++ N EI L+SL + V +++
Sbjct: 220 LEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQV 254
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 60/253 (23%), Positives = 93/253 (36%), Gaps = 13/253 (5%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
+ +P + LN N + I + ++ +++ L LS N + +
Sbjct: 51 VRKNLREVPD-GISTNTRLLNLHENQIQ-IIKVNSFK-HLRHLEILQLSRNHIRT-IEIG 106
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
F A+L L L N L F Y S L L L NN Y + L
Sbjct: 107 AFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE----SIPSYAFNRIPSL 162
Query: 127 RTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 185
R LDL I +G L L+ L L +P + L LDLS N +
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLS 220
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCK 244
P S + L + + + + + + N+ +L ++ ++N+LT LP LF
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLH 279
Query: 245 KLSVIRLRGNSLN 257
L I L N N
Sbjct: 280 HLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 60/264 (22%), Positives = 106/264 (40%), Gaps = 28/264 (10%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
++ +L ++P + N + L+L N + + F++ L L L+ N
Sbjct: 45 FSKVICVRKNLR-EVPDGIST----NTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRN 98
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSG--DLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
++ FN ++LNTL L +N + + F L +L+ L L +N SI
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFV------YLSKLKELWLRNNPIE-SI 151
Query: 141 PQGV-AALHYLKELLLQG-NQFSGPLPADIGF--CPHLTTLDLSNNLFTGQLPVSLRLLN 196
P + L+ L L + S + F +L L+L+ ++P +L L
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSY-ISEGA-FEGLSNLRYLNLAMCNLR-EIP-NLTPLI 207
Query: 197 SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNS 255
+ + +S N L+ P + L+ L + + + + F N + L I L N+
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNN 266
Query: 256 LNGNIPEGLFDL--GLEEIDLSEN 277
L +P LF LE I L N
Sbjct: 267 LT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-21
Identities = 64/288 (22%), Positives = 100/288 (34%), Gaps = 49/288 (17%)
Query: 172 PHLTTLDLSNNLFT---GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 228
+ + + + RLLN + N + + ++ LE L S
Sbjct: 43 NQFSKVICVRKNLREVPDGISTNTRLLN------LHENQIQIIKVNSFKHLRHLEILQLS 96
Query: 229 NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPG 286
NH+ + L+ + L N L IP G F L+E+ L N SIP
Sbjct: 97 RNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSY 154
Query: 287 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSRIPPELGYF 344
+ + S LR LDL + I GL +NLRYLNL+ +LR +
Sbjct: 155 AFNRIPS-----LRRLDLGELKRLSYISEGAFEGL-SNLRYLNLAMCNLRE-----IPNL 203
Query: 345 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 404
L L L L GN L+ P + L L + +
Sbjct: 204 TPL---------------------IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ 242
Query: 405 LSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSYN 451
+ + NL L + L N L+ +P + L L +++ +N
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 70/315 (22%), Positives = 111/315 (35%), Gaps = 72/315 (22%)
Query: 48 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 107
+ L VP + N R L+L N +Q F + L L LS NH
Sbjct: 44 QFSKVICVRKNLRE-VPDGISTN---TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 108 FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPA 166
+ L L TL+L N + +IP G L LKEL L+ N +P+
Sbjct: 100 ----IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPS 153
Query: 167 DI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFL 225
P L LDL L ++ F +SN L +L
Sbjct: 154 YAFNRIPSLRRLDLGEL-------KRLSYISEGAFEGLSN----------------LRYL 190
Query: 226 DFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSI 283
+ + +L +P+ L KL + L GN L+ I G F + L+++ + ++ + I
Sbjct: 191 NLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQ-IQVI 246
Query: 284 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LG 342
+ F L+ +L +NL+ N+L +P +
Sbjct: 247 ERNA--------FDNLQ---------------------SLVEINLAHNNLTL-LPHDLFT 276
Query: 343 YFHSLIHLDLRNNAL 357
H L + L +N
Sbjct: 277 PLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 58/215 (26%), Positives = 85/215 (39%), Gaps = 21/215 (9%)
Query: 245 KLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 304
+ S + +L +P+G+ ++L EN I S L IL L
Sbjct: 44 QFSKVICVRKNLR-EVPDGIST-NTRLLNLHENQIQ-IIKVNSFKHLRH-----LEILQL 95
Query: 305 SSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGS 360
S N++ I G F NL L L N L + IP Y L L LRNN + S
Sbjct: 96 SRNHI-RTIEI--GAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPI-ES 150
Query: 361 IPQEVCES-RSLGILQL-DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 418
IP SL L L + L+ ++L L+L+ +L IP +++ L K
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIK 208
Query: 419 LKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
L L L N LS P L L + + +++
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 39/292 (13%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRV 650
I+ + +EK +G G G V G+ +A+K L + DF E +
Sbjct: 46 IEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 651 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
+G+ HPN+I LEG +L ++V++Y NGSL L + ++ G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGV 160
Query: 711 AKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQS 768
G+ +L + +H +L N+L+D N ++SDFGL+R+L D + +
Sbjct: 161 GAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 769 ALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRV 823
+ + APE ++ D++ FGV++ E++ G RP Y N V
Sbjct: 217 PIRWTAPE----AIAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTN-----RDVIS 265
Query: 824 LLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+EEG L P + +L L C + RP +++V +L
Sbjct: 266 SVEEGYRLPA--------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+G G F V+ V G++ A+K + S + E E+ VL K +H N+++LE
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-DSSLENEIAVLKKIKHENIVTLEDI 74
Query: 666 YWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
Y + LV G L + E+ S + +L + +LH
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLS---AVKYLHE 124
Query: 720 SFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
+ I+H +LKP N+L ++N I+DFGL+++ +MS + GYVAPE
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTP-GYVAPE 177
Query: 777 -LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
L + ++ D + GV+ L+ G P Y E + +
Sbjct: 178 VLAQKPY--SKAVDCWSIGVITYILLCGYPPF-YEETESKLFEK 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 72/370 (19%), Positives = 138/370 (37%), Gaps = 46/370 (12%)
Query: 527 SAIVAIIAAILIAGGVLVISLLNVST----RRRLTFVETTLESMCSSSSRSVNLAAGKVI 582
S +A A LI G +++ S ++ ++ + ++ + V V
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 583 LFDSRSSSLDCSIDPETLLEKAAEV-----------GEGVFGTVYK---VSFGTQGRMLA 628
D + +D + E+ GEG FG V++ +S +A
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422
Query: 629 VKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL 688
+K E F +E + + HP+++ L G + ++ + G L++ L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL 481
Query: 689 HERLPSTPPLSWTNRFKVILGTAKGLAHLH-HSFRPPIIHYNLKPSNILLDDNYNPRISD 747
R L + + LA+L F +H ++ N+L+ N ++ D
Sbjct: 482 QVR---KFSLDLASLILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGD 534
Query: 748 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRP 806
FGL+R + + +++ + + ++APE + R D++ FGV + E++ G +P
Sbjct: 535 FGLSRYMED-STYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP 592
Query: 807 VEY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 865
+ G N V +E G L P + + L C + PS RP
Sbjct: 593 --FQGVKN-----NDVIGRIENGERLPM--------PPNCPPTLYSLMTKCWAYDPSRRP 637
Query: 866 SMAEVVQILQ 875
E+ L
Sbjct: 638 RFTELKAQLS 647
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 36/226 (15%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK---KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
E+G G FG V++V+ G A K SD E +E++ + RHP L++L
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK----ETVRKEIQTMSVLRHPTLVNL 219
Query: 663 EGYYWTPQLKLLVSDYAPNGSL-------QAKLHERLPSTPPLSWTNRFKVILGTAKGLA 715
+ +++ ++ G L K+ E + + KGL
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-------EAVEYMRQVC---KGLC 269
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRI--SDFGLARLLTRLDKHVMSNRFQSALGYV 773
H+H + +H +LKP NI+ + + DFGL L K + +A +
Sbjct: 270 HMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTA-EFA 323
Query: 774 APE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 818
APE + V D++ GVL L++G P GE++ L
Sbjct: 324 APEVAEGKP--VGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLR 366
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 72/295 (24%), Positives = 128/295 (43%), Gaps = 49/295 (16%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
++ + L L + +G+G FG V G +G +AVK + + F E V+
Sbjct: 18 LNMKELKLLQ--TIGKGEFGDVML---GDYRGNKVAVKCIKNDAT---AQAFLAEASVMT 69
Query: 653 KARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
+ RH NL+ L G L +V++Y GSL L R S +F L
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF--SLDV 126
Query: 711 AKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 769
+ + +L ++F +H +L N+L+ ++ ++SDFGL + + + +
Sbjct: 127 CEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLP 177
Query: 770 LGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVL 824
+ + APE +LR + K D++ FG+L+ E+ + GR P Y + V
Sbjct: 178 VKWTAPE----ALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPL-----KDVVPR 226
Query: 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
+E+G +D P+ V ++ C + RPS ++ + L+ IKT
Sbjct: 227 VEKGYKMDA--------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 69/316 (21%), Positives = 122/316 (38%), Gaps = 58/316 (18%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 648
I + L++ E+GEG FG V+ +S ++AVK L + +DF+RE
Sbjct: 12 IKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREA 68
Query: 649 RVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------P 696
+L +H +++ G ++V +Y +G L L P
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 697 PLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755
L + + A G+ +L F +H +L N L+ N +I DFG++R +
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 756 RLDKHVMSNRFQSALGYV-----APELTCQSLRVN---EKCDIYGFGVLILELVT-GRRP 806
D + + + PE S+ + D++ FGV++ E+ T G++P
Sbjct: 185 STDYYRVGGH-----TMLPIRWMPPE----SIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 807 VEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS 866
+ N V + +G VL+ P V + L C P R +
Sbjct: 236 W-FQLSN-----TEVIECITQGRVLER--------PRVCPKEVYDVMLGCWQREPQQRLN 281
Query: 867 MAEVVQILQVIKTPLP 882
+ E+ +IL + P
Sbjct: 282 IKEIYKILHALGKATP 297
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 5e-23
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEGY 665
G+G F VY+ G +A+K + + + + + EV++ + +HP+++ L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------KVILGTAKGLAHLHH 719
+ LV + NG + L R F + G+ +LH
Sbjct: 80 FEDSNYVYLVLEMCHNGEMNRYLKNR---------VKPFSENEARHFMHQIITGMLYLH- 129
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPE 776
S I+H +L SN+LL N N +I+DFGLA L + + G Y++PE
Sbjct: 130 SHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-----EKHYTLCGTPNYISPE 182
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ +S + D++ G + L+ GR P
Sbjct: 183 IATRSAH-GLESDVWSLGCMFYTLLIGRPP 211
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 43/216 (19%), Positives = 87/216 (40%), Gaps = 17/216 (7%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
++G G FG V++ + + K + Q ++E+ +L ARH N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--VLVKKEISILNIARHRNILHLHES 69
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
+ + + +++ ++ + +++ + + + L LH I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFLHSH---NI 123
Query: 726 IHYNLKPSNILLDDNYNP--RISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-LTCQSL 782
H++++P NI+ + +I +FG AR L F + Y APE
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAP-EYYAPEVHQHDV- 179
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 818
V+ D++ G L+ L++G P E N I+
Sbjct: 180 -VSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIE 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
DPE L K ++G+G FG V+K +++A+K + + ED ++E+ VL +
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 656 HPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
P + G Y +L ++ +Y GS L ++ ++ KGL
Sbjct: 79 SPYVTKYYGSYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIAT-----ILREILKGL 132
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 771
+LH IH ++K +N+LL ++ +++DFG+A LT R + +G
Sbjct: 133 DYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT----DTQIKR-NTFVGTPF 184
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++APE+ QS + K DI+ G+ +EL G P
Sbjct: 185 WMAPEVIKQS-AYDSKADIWSLGITAIELARGEPP 218
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 14/215 (6%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
E+G G FG V++ GR+ K + T + + E+ ++ + HP LI+L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDA 116
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
+ +L+ ++ G L ++ N + GL H+H I
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEH---SI 170
Query: 726 IHYNLKPSNILL--DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
+H ++KP NI+ + +I DFGLA L ++ +A + APE+ +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATA-EFAAPEIVDRE-P 226
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 818
V D++ GVL L++G P GED++ L
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQ 260
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 41/234 (17%), Positives = 85/234 (36%), Gaps = 36/234 (15%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGK-ARHPNL 659
+ ++G G FG+V+K G + A+K+ ++ REV +H ++
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 660 ISLEGYY--WTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
+ Y+ W + + ++Y GSL + E ++L +GL +
Sbjct: 74 VR---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNP-------------------RISDFGLARLLTRL 757
+H ++H ++KPSNI + P +I D G ++
Sbjct: 131 IHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGE 811
+R ++A E+ ++ K DI+ + ++ G+
Sbjct: 188 QVEEGDSR------FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 39/226 (17%)
Query: 594 SIDPETLLEK---AAEVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQY--PED 643
S+ P+ L ++ + +G G G V + +A+K K + +
Sbjct: 2 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 644 FEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPP 697
E E+ +L K HP +I ++ ++ +V + G L +L E
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK--- 117
Query: 698 LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLL 754
F +L + +LH + IIH +LKP N+LL +++ +I+DFG +++L
Sbjct: 118 ----LYFYQMLL---AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRV--NEKCDIYGFGVLIL 798
+ +M + Y+APE+ N D + GV IL
Sbjct: 168 G--ETSLMRTLCGTP-TYLAPEVLVSVGTAGYNRAVDCWSLGV-IL 209
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 74/310 (23%), Positives = 122/310 (39%), Gaps = 59/310 (19%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 648
I + + E+GE FG VYK + G Q + +A+K L E+F E
Sbjct: 6 ISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 649 RVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------P 696
+ + +HPN++ L G Q ++ Y +G L L R P +
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 697 PLSWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755
L + ++ A G+ +L H +H +L N+L+ D N +ISD GL R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 756 RLDKHVMSNRFQSALGYV-----APELTCQSLRVN---EKCDIYGFGVLILELVT-GRRP 806
D + + + APE ++ DI+ +GV++ E+ + G +P
Sbjct: 180 AADYYKLLGN-----SLLPIRWMAPE----AIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
Query: 807 VEY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 865
Y G N + V ++ VL C P+D V L + C PS RP
Sbjct: 231 --YCGYSN-----QDVVEMIRNRQVLPC--------PDDCPAWVYALMIECWNEFPSRRP 275
Query: 866 SMAEVVQILQ 875
++ L+
Sbjct: 276 RFKDIHSRLR 285
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 70/295 (23%), Positives = 128/295 (43%), Gaps = 49/295 (16%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
++ + L L + +G+G FG V G +G +AVK + + F E V+
Sbjct: 190 LNMKELKLLQ--TIGKGEFGDVML---GDYRGNKVAVKCIKNDAT---AQAFLAEASVMT 241
Query: 653 KARHPNLISLEG--YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
+ RH NL+ L G L +V++Y GSL L R S +F L
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGL-YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF--SLDV 298
Query: 711 AKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 769
+ + +L ++F +H +L N+L+ ++ ++SDFGL + + + +
Sbjct: 299 CEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKL--P 349
Query: 770 LGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVL 824
+ + APE +LR + K D++ FG+L+ E+ + GR P Y + V
Sbjct: 350 VKWTAPE----ALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPL-----KDVVPR 398
Query: 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
+E+G +D P+ V + C ++RP+ ++ + L+ I+T
Sbjct: 399 VEKGYKMDA--------PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 26/227 (11%)
Query: 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED------FEREVRVLGKARHPN 658
++G G TVY +A+K + E FEREV + H N
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFI----PPREKEETLKRFEREVHNSSQLSHQN 72
Query: 659 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
++S+ LV +Y +L + PLS G+ H H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAH 128
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAP 775
I+H ++KP NIL+D N +I DFG+A+ L+ + + LG Y +P
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQT--NHVLGTVQYFSP 181
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
E + +E DIY G+++ E++ G P GE V I +H++
Sbjct: 182 EQA-KGEATDECTDIYSIGIVLYEMLVGEPPFN-GETAVSIAIKHIQ 226
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G+G +G VY + +A+K+ + +Y + E+ + +H N++ G +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKE-IPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 667 WTPQLKLLVSDYAPNGSLQAKL---HERLPSTPPL--SWTNRFKVILGTAKGLAHLHHSF 721
+ + P GSL A L L +T K IL +GL +LH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT---KQIL---EGLKYLHDN- 141
Query: 722 RPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
I+H ++K N+L++ + +ISDFG ++ L ++ + F L Y+APE+ +
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 781 SLR-VNEKCDIYGFGVLILELVTGRRP 806
R + DI+ G I+E+ TG+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREV-------RVLGKARHPNL 659
+GEG F TV R A+K L II+ E +V V+ + HP
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTRERDVMSRLDHPFF 92
Query: 660 ISLEGYYWTPQLKL-LVSDYAPNGSLQAKL-HERLPSTPPLSWTNRF---KVILGTAKGL 714
+ L + + KL YA NG L + RF +++ L
Sbjct: 93 VKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDET----CTRFYTAEIVSA----L 143
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 771
+LH IIH +LKP NILL+++ + +I+DFG A++L+ K +N F +G
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF---VGTAQ 197
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
YV+PEL + D++ G +I +LV G P
Sbjct: 198 YVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 54/229 (23%), Positives = 89/229 (38%), Gaps = 37/229 (16%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+G+G F V + G+ A KL D + ERE R+ +HPN++
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH----QKLEREARICRLLKHPNIV 73
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
L L+ D G L + E S + + IL +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILE---AV 123
Query: 715 AHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
H H ++H NLKP N+LL +++DFGLA + ++ + G
Sbjct: 124 LHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTP-G 178
Query: 772 YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
Y++PE L + D++ GV++ L+ G P + ED + +
Sbjct: 179 YLSPEVLRKDPY--GKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQ 224
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 33/289 (11%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRV 650
+D + ++K VG G FG V + +A+K L + DF E +
Sbjct: 42 LDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 651 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
+G+ HPN+I LEG + ++V++Y NGSL + L + + ++ G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGI 156
Query: 711 AKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQS 768
A G+ +L + +H +L NIL++ N ++SDFGL R+L + + +
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 769 ALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVRVLLE 826
+ + +PE + D++ +G+++ E+++ G RP Y N + V ++
Sbjct: 213 PIRWTSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERP--YWEMSN-----QDVIKAVD 264
Query: 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
EG L P D + +L L C ++RP ++V IL
Sbjct: 265 EGYRLPP--------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 38/229 (16%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
E+G+G F V + T G A K KL D + ERE R+ K +HPN++
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF----QKLEREARICRKLQHPNIV 91
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
L LV D G L + E S + + IL + +
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL---ESI 141
Query: 715 AHLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
A+ H + I+H NLKP N+LL +++DFGLA + D + G
Sbjct: 142 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP-G 195
Query: 772 YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
Y++PE L ++ DI+ GV++ L+ G P + ED + ++
Sbjct: 196 YLSPEVLKKDPY--SKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQ 241
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 55/255 (21%), Positives = 107/255 (41%), Gaps = 39/255 (15%)
Query: 573 SVNLAAGKVILFDSRSSSLDCSIDPETLLEK---AAEVGEGVFGTVYKVSFGTQGRMLAV 629
+++L+ KV +F + D S+ P+ L ++ + +G G G V + +A+
Sbjct: 107 ALSLSRNKVFVFFDLTVD-DQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165
Query: 630 K-----KLVTSDIIQY--PEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNG 682
+ K + + E E+ +L K HP +I ++ ++ +V + G
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG 224
Query: 683 SL------QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 736
L +L E F +L + +LH + IIH +LKP N+L
Sbjct: 225 ELFDKVVGNKRLKEATCK-------LYFYQML---LAVQYLHEN---GIIHRDLKPENVL 271
Query: 737 L---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV--NEKCDIY 791
L +++ +I+DFG +++L + +M + Y+APE+ N D +
Sbjct: 272 LSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP-TYLAPEVLVSVGTAGYNRAVDCW 328
Query: 792 GFGVLILELVTGRRP 806
GV++ ++G P
Sbjct: 329 SLGVILFICLSGYPP 343
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 69/305 (22%), Positives = 119/305 (39%), Gaps = 48/305 (15%)
Query: 606 EVGEGVFGTVYK-----VSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNL 659
E+GEG FG V+ + ++AVK L S+ +DF+RE +L +H ++
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTMLQHQHI 105
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST-----------PPLSWTNRFKVIL 708
+ G + L+V +Y +G L L P PL V
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 709 GTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQ 767
A G+ +L F +H +L N L+ +I DFG++R + D + + R
Sbjct: 166 QVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 768 SALGYVAPELTCQSLRVN---EKCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVR 822
+ ++ PE S+ + D++ FGV++ E+ T G++P + N
Sbjct: 222 LPIRWMPPE----SILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSN-----TEAI 270
Query: 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882
+ +G L+ P V + C P R S+ +V LQ + P
Sbjct: 271 DCITQGRELER--------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322
Query: 883 QRMEV 887
++V
Sbjct: 323 VYLDV 327
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 2e-22
Identities = 48/350 (13%), Positives = 93/350 (26%), Gaps = 70/350 (20%)
Query: 511 HSHSFSSNHHHMFFSVSAIVAIIAAILIAGGVLVISLLNVSTRRRLTFVETTLESMCSSS 570
H H SS +++F V V+ + T E + S
Sbjct: 3 HHHHHSSGRENLYFQGPGDV-----------VIEELFNRIPQANVRTTSEYMQSAADSLV 51
Query: 571 SRSVNLAAGKVILFDSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVK 630
S S+ G+ +S L + +G+ + + G V
Sbjct: 52 STSL-WNTGQPFRVESELGE------RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVH 104
Query: 631 ---------------------------KLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
+ + F ++ + +I +
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164
Query: 664 GYYWTPQLKLLVSDY----APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
+ Y + + L + L R ++ L + LA LHH
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
++H L+P +I+LD ++ F + G+ PEL
Sbjct: 225 Y---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR------VVSSVSRGFEPPELEA 275
Query: 780 QS----------LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSE 819
+ + D + G++I + P +D + SE
Sbjct: 276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--ITKDAALGGSE 323
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 69/301 (22%), Positives = 126/301 (41%), Gaps = 59/301 (19%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGT-QGRML-AVK--KLVTSDIIQYPEDFEREVR 649
+ E + L K E+G G FG V G +G+ AVK K + ++F +E +
Sbjct: 5 LKREEITLLK--ELGSGQFGVVKL---GKWKGQYDVAVKMIKEGSMS----EDEFFQEAQ 55
Query: 650 VLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 709
+ K HP L+ G +V++Y NG L L L + ++
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYD 112
Query: 710 TAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
+G+A L H F IH +L N L+D + ++SDFG+ R V+ +++ S
Sbjct: 113 VCEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRY-------VLDDQYVS 161
Query: 769 ALG------YVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVIL 817
++G + APE + K D++ FG+L+ E+ + G+ P Y N
Sbjct: 162 SVGTKFPVKWSAPE----VFHYFKYSSKSDVWAFGILMWEVFSLGKMP--YDLYTN---- 211
Query: 818 SEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
V + + +G+ L P + ++ C +P RP+ +++ ++ +
Sbjct: 212 -SEVVLKVSQGHRLYR--------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
Query: 878 K 878
+
Sbjct: 263 R 263
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 24/207 (11%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
G+G F +++S + A K L+ E E+ + H +++
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR---EKMSMEISIHRSLAHQHVVGF 80
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
G++ +V + SL R T P + + G +LH R
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQIVLGCQYLH---R 133
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTC 779
+IH +LK N+ L+++ +I DFGLA + R + G Y+APE+
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVLCGTPNYIAPEVLS 188
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRP 806
+ + + D++ G ++ L+ G+ P
Sbjct: 189 KKGH-SFEVDVWSIGCIMYTLLVGKPP 214
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 62/314 (19%), Positives = 110/314 (35%), Gaps = 55/314 (17%)
Query: 130 DLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLP 189
S + SIP G+ +K L L N+ + +D+ C +L L L++N
Sbjct: 37 KGSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG------ 87
Query: 190 VSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSV 248
+ + F S+ + LE LD S N+L+ +L SS F L+
Sbjct: 88 --INTIEEDSFSSLGS----------------LEHLDLSYNYLS-NLSSSWFKPLSSLTF 128
Query: 249 IRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSS 306
+ L GN LF L+ + + I + + L L++ +
Sbjct: 129 LNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF-----LEELEIDA 183
Query: 307 NNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPEL-GYFHSLIHLDLRNNALYGSIP 362
++L N+ +L L + S+ L+LR+ L
Sbjct: 184 SDLQ-SYEP--KSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHF 239
Query: 363 QEVCE--------SRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI- 413
E+ + +++ SL + +++ + L L S N L S+P I
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIF 297
Query: 414 SNLNKLKILKLEFN 427
L L+ + L N
Sbjct: 298 DRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 52/301 (17%), Positives = 106/301 (35%), Gaps = 39/301 (12%)
Query: 171 CPHLTTLDLSNNLFT---GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDF 227
C S+ L +++ L+ +SNN +T + L+ L
Sbjct: 30 CDRNGICKGSSGSLNSIPSGLTEAVKSLD------LSNNRITYISNSDLQRCVNLQALVL 83
Query: 228 SNNHLTGSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIP 284
++N + ++ F+ L + L N L N+ F L ++L N + ++
Sbjct: 84 TSNGIN-TIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLG 140
Query: 285 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE- 340
S S + L L + + + I FA L L + ++ L+S P+
Sbjct: 141 ETSLFSHLTKLQI----LRVGNMDTFTKIQR--KDFAGLTFLEELEIDASDLQS-YEPKS 193
Query: 341 LGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVI--------RN 391
L ++ HL L + + + S+ L+L L +
Sbjct: 194 LKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 392 CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSY 450
+ + ++ L + K ++ ++ L L+ N+L +P +L SL + +
Sbjct: 253 KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHT 310
Query: 451 N 451
N
Sbjct: 311 N 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 54/316 (17%), Positives = 95/316 (30%), Gaps = 65/316 (20%)
Query: 48 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 107
+K LDLSNN ++ + + C +L+ L L N + F+ SL L+LS N+
Sbjct: 53 AVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 108 FS----GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSG 162
S L L L+L N + + + L L+ L +
Sbjct: 112 LSNLSSSWFK--------PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT 163
Query: 163 PLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST 221
+ L L++ + S +L +I
Sbjct: 164 KIQRKDFAGLTFLEELEIDASDLQ----------------SYEPKSLK--------SIQN 199
Query: 222 LEFLDFSNNHLTGSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFM 280
+ L L + + + LR L+
Sbjct: 200 VSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFH-------------------F 239
Query: 281 GSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE 340
+ G ++S T R + ++ +L + + + L L S N L+S +P
Sbjct: 240 SELSTGETNSLIKKF--TFRNVKITDESLFQVMKLLNQI-SGLLELEFSRNQLKS-VPDG 295
Query: 341 -LGYFHSLIHLDLRNN 355
SL + L N
Sbjct: 296 IFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 52/264 (19%), Positives = 99/264 (37%), Gaps = 32/264 (12%)
Query: 228 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPP 285
S+ L S+PS L + + + L N + I + L+ + L+ NG + +I
Sbjct: 39 SSGSLN-SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNG-INTIEE 93
Query: 286 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-- 340
S SS S L LDLS N L ++ + F +L +LNL N ++ +
Sbjct: 94 DSFSSLGS-----LEHLDLSYNYLS-NLSS--SWFKPLSSLTFLNLLGNPYKT-LGETSL 144
Query: 341 LGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLS 399
+ L L + N + I ++ L L++D + L P+ +++ ++ L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204
Query: 400 LSHNHLSGSIPKSI-SNLNKLKILKLEFNELSGEIPQEL--------GKLASLLAVNVSY 450
L + + + ++ L+L +L EL K + V ++
Sbjct: 205 LHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 451 NRLIGRLPVGGVFPTLDQSSLQGN 474
L + + L + N
Sbjct: 264 ESLFQVMKLLNQISGLLELEFSRN 287
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 28/185 (15%), Positives = 60/185 (32%), Gaps = 14/185 (7%)
Query: 7 HGNSYNAIPSMVVFRILERLNF---SHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPV 63
GN Y + +F L +L + +I + ++ L++ + L
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA-GLTFLEELEIDASDLQS-Y 189
Query: 64 PYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSG----DLDFASGYG 119
+ ++ ++ +L L + + SS+ L L + +L
Sbjct: 190 EPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNS 249
Query: 120 IWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC--PHLTTL 177
+ R + ++ + + + + L EL NQ +P I F L +
Sbjct: 250 LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGI-FDRLTSLQKI 306
Query: 178 DLSNN 182
L N
Sbjct: 307 WLHTN 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 25/232 (10%)
Query: 585 DSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKK--LVTSDIIQYPE 642
+ +DP + E E+G+G FG VYK G + A K + + + E
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---E 61
Query: 643 DFEREVRVLGKARHPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 701
D+ E+ +L HP ++ L G YY +L ++ ++ P G++ A + E L+
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKL-WIMIEFCPGGAVDAIMLEL---DRGLTEP 117
Query: 702 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761
V + L LH IIH +LK N+L+ + R++DFG++
Sbjct: 118 QIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL----KT 170
Query: 762 MSNRFQSALG---YVAPEL-TCQSLRV---NEKCDIYGFGVLILELVTGRRP 806
+ R S +G ++APE+ C++++ + K DI+ G+ ++E+ P
Sbjct: 171 LQKR-DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 14/220 (6%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+ K +G G FG V+K G LA K + T + E+ + E+ V+ + H NLI
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANLI 149
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
L + + +LV +Y G L ++ + + L K I G+ H+H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQM 206
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRI--SDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 778
I+H +LKP NIL + +I DFGLAR + + F + ++APE+
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--PREKLKVNFGTP-EFLAPEVV 260
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILS 818
V+ D++ GV+ L++G P G+++ L+
Sbjct: 261 NYD-FVSFPTDMWSVGVIAYMLLSGLSPF-LGDNDAETLN 298
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 24/207 (11%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
G+G F +++S + A K L+ E E+ + H +++
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR---EKMSMEISIHRSLAHQHVVGF 106
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
G++ +V + SL R T P + + G +LH R
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQIVLGCQYLH---R 159
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELTC 779
+IH +LK N+ L+++ +I DFGLA + R + G Y+APE+
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-----EYDGERKKVLCGTPNYIAPEVLS 214
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRP 806
+ + + D++ G ++ L+ G+ P
Sbjct: 215 KKGH-SFEVDVWSIGCIMYTLLVGKPP 240
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 23/232 (9%)
Query: 228 SNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPP 285
L ++P + I L GN ++ ++P F L + L N I
Sbjct: 19 PQQGLQ-AVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDA 73
Query: 286 GSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-L 341
+ + + L LDLS N + + F L L+L L+ + P
Sbjct: 74 AAFTGLAL-----LEQLDLSDNAQLRSVDP--ATFHGLGRLHTLHLDRCGLQE-LGPGLF 125
Query: 342 GYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSL 400
+L +L L++NAL ++P + +L L L GN ++ + R SL L L
Sbjct: 126 RGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 401 SHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSYN 451
N ++ P + +L +L L L N LS +P E L L +L + ++ N
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 58/254 (22%), Positives = 90/254 (35%), Gaps = 42/254 (16%)
Query: 29 SHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPI 88
L +P + + + L N +S VP F C +L L L N+L
Sbjct: 19 PQQGLQ-AVPVGIPA----ASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARID 72
Query: 89 GKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AAL 147
F + L L+LS+N +D A+ L RL TL L + G+ L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPAT---FHGLGRLHTLHLDRCGLQ-ELGPGLFRGL 128
Query: 148 HYLKELLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 206
L+ L LQ N LP D +LT L L N + SV
Sbjct: 129 AALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS----------------SVPER 171
Query: 207 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLF 265
G + +L+ L N + + F + +L + L N+L+ +P
Sbjct: 172 AFRG--------LHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEAL 221
Query: 266 DL--GLEEIDLSEN 277
L+ + L++N
Sbjct: 222 APLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 58/268 (21%), Positives = 96/268 (35%), Gaps = 47/268 (17%)
Query: 122 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181
+ T ++P G+ A + + L GN+ S A C +LT L L +
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 241
N+ + TG ++ LE LD S+N S+ + F
Sbjct: 66 NVLA----------------RIDAAAFTG--------LALLEQLDLSDNAQLRSVDPATF 101
Query: 242 -NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQT 298
+L + L L + GLF L+ + L +N + ++P + +
Sbjct: 102 HGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA-LQALPDDTFRDLGN----- 154
Query: 299 LRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRN 354
L L L N + +P F +L L L N + + P L+ L L
Sbjct: 155 LTHLFLHGNRIS-SVPE--RAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 355 NALYGSIPQEVCES-RSLGILQLDGNSL 381
N L ++P E R+L L+L+ N
Sbjct: 211 NNL-SALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 48/189 (25%), Positives = 73/189 (38%), Gaps = 16/189 (8%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L L N L+ +I + + ++ LDLS+N V F L L L
Sbjct: 58 LTILWLHSNVLA-RIDAAAFT-GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSG--DLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
LQ +F ++L L L +N D F L L L L N S S+
Sbjct: 116 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR------DLGNLTHLFLHGNRIS-SV 168
Query: 141 PQGV-AALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLSNNLFTGQLPVSLRLLNS 197
P+ LH L LLL N+ + + F L TL L N + +L L +
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAH-VHPHA-FRDLGRLMTLYLFANNLSALPTEALAPLRA 226
Query: 198 MIFISVSNN 206
+ ++ +++N
Sbjct: 227 LQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 50/249 (20%), Positives = 84/249 (33%), Gaps = 52/249 (20%)
Query: 96 SSLNTLNLSNNHFS--GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKE 152
++ + L N S F + + L L L N+ + I L L++
Sbjct: 32 AASQRIFLHGNRISHVPAASF------RACRNLTILWLHSNVLA-RIDAAAFTGLALLEQ 84
Query: 153 LLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 211
L L N + L TL L + G
Sbjct: 85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ----------------ELGPGLFRG- 127
Query: 212 IPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LG 268
++ L++L +N L +LP F + L+ + L GN ++ ++PE F
Sbjct: 128 -------LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHS 178
Query: 269 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRY 325
L+ + L +N + + P + L L L +NNL +P A L+Y
Sbjct: 179 LDRLLLHQNR-VAHVHPHAFRDLGR-----LMTLYLFANNLS-ALPT--EALAPLRALQY 229
Query: 326 LNLSSNHLR 334
L L+ N
Sbjct: 230 LRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 9/139 (6%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L L+ L ++ P L + +++L L +N L +P F + +L +L L GN
Sbjct: 107 LHTLHLDRCGLQ-ELGPGLFR-GLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGN 163
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+ + F SL+ L L N + + L RL TL L N S ++P
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNR----VAHVHPHAFRDLGRLMTLYLFANNLS-ALPT 218
Query: 143 GV-AALHYLKELLLQGNQF 160
A L L+ L L N +
Sbjct: 219 EALAPLRALQYLRLNDNPW 237
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-22
Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 16/273 (5%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
+ EK +E+G G G V+KVS G ++A K + RE++VL +
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQA--KLHERLPSTPPLSWTNRFKVILGTAKG 713
P ++ G +++ + ++ GSL K R+P L KV + KG
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-QILG-----KVSIAVIKG 143
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
L +L + I+H ++KPSNIL++ ++ DFG++ L M+N F Y+
Sbjct: 144 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 197
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP-VEYGEDNVVILSEHVRVLLEEGNVLD 832
+PE Q + + DI+ G+ ++E+ GR P + ++
Sbjct: 198 SPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 865
P +I + P
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 28/231 (12%)
Query: 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED------FEREVRVLGKARHPN 658
+G G V+ R +AVK L D F RE + HP
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRA----DLARDPSFYLRFRREAQNAAALNHPA 73
Query: 659 LISL----EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
++++ E L +V +Y +L+ +H P++ +VI + L
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQAL 129
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 771
H + IIH ++KP+NI++ ++ DFG+AR + V + +G
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT--AAVIGTAQ 184
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
Y++PE + V+ + D+Y G ++ E++TG P G+ V + +HVR
Sbjct: 185 YLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVR 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 653
DP LL+ ++GEG G V GR +AVK + D+ + E EV ++
Sbjct: 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRD 98
Query: 654 ARHPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
+H N++ + Y +L ++ ++ G+L + + L+ V +
Sbjct: 99 YQHFNVVEMYKSYLVGEEL-WVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQ 152
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 771
LA+LH +IH ++K +ILL + ++SDFG ++ + R +S +G
Sbjct: 153 ALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS----KDVPKR-KSLVGT 204
Query: 772 --YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++APE+ +S + DI+ G++++E+V G P
Sbjct: 205 PYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 74/296 (25%), Positives = 128/296 (43%), Gaps = 55/296 (18%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVL 651
+ ETL L + +G G FG V+ + + +AVK K + P+ F E ++
Sbjct: 10 VPRETLKLVE--RLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS----PDAFLAEANLM 62
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
+ +H L+ L T + ++++Y NGSL L ++ A
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM--AAQIA 119
Query: 712 KGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
+G+A + ++ IH +L+ +NIL+ D + +I+DFGLARL + N + +
Sbjct: 120 EGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARL-------IEDNEYTARE 168
Query: 771 G------YVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSE 819
G + APE ++ K D++ FG+L+ E+VT GR P Y G N
Sbjct: 169 GAKFPIKWTAPE----AINYGTFTIKSDVWSFGILLTEIVTHGRIP--YPGMTN-----P 217
Query: 820 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
V LE G + P++ + +L +C P RP+ + +L+
Sbjct: 218 EVIQNLERGYRMVR--------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 57/238 (23%), Positives = 106/238 (44%), Gaps = 29/238 (12%)
Query: 585 DSRSSSLDCSIDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL----VTSDII 638
SS+L SI+ + L E +G G V + +A+K++ + +
Sbjct: 2 SEDSSALPWSINRDDYELQEV---IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM- 57
Query: 639 QYPEDFEREVRVLGKARHPNLISLEGYY--WTPQLKL-LVSDYAPNGSLQAKLHERLPST 695
++ +E++ + + HPN++S YY + + +L LV GS+ + +
Sbjct: 58 ---DELLKEIQAMSQCHHPNIVS---YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKG 111
Query: 696 PPLSWTNRFKVI----LGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751
S I +GL +LH + IH ++K NILL ++ + +I+DFG++
Sbjct: 112 EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168
Query: 752 RLLTRLDKHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
L + ++ +G ++APE+ Q + K DI+ FG+ +EL TG P
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 66/296 (22%), Positives = 114/296 (38%), Gaps = 55/296 (18%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYKVSFGTQGRMLAVK--KLVTSDIIQYPEDFEREVRVL 651
IDP+ L K E+G G FG V + Q +A+K K + ++F E +V+
Sbjct: 21 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS----EDEFIEEAKVM 73
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
H L+ L G + ++++Y NG L L E ++
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVC 130
Query: 712 KGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
+ + +L F +H +L N L++D ++SDFGL+R V+ + + S++
Sbjct: 131 EAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSV 179
Query: 771 G------YVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSE 819
G + PE L ++ K DI+ FGVL+ E+ + G+ P Y N
Sbjct: 180 GSKFPVRWSPPE----VLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTN-----S 228
Query: 820 HVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ +G L P V + C RP+ ++ +
Sbjct: 229 ETAEHIAQGLRLYR--------PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 75/293 (25%), Positives = 133/293 (45%), Gaps = 40/293 (13%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR 649
I P + +K +G G FG VYK S G + +A+K L + DF E
Sbjct: 41 IHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 98
Query: 650 VLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 709
++G+ H N+I LEG + +++++Y NG+L L E+ S ++ G
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRG 155
Query: 710 TAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQ 767
A G+ +L + ++ +H +L NIL++ N ++SDFGL+R+L + ++ +
Sbjct: 156 IAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 768 SALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILSEHVR 822
+ + APE ++ + D++ FG+++ E++T G RP Y N V
Sbjct: 212 IPIRWTAPE----AISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSN-----HEVM 260
Query: 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ +G L P D + +L + C + RP A++V IL
Sbjct: 261 KAINDGFRLPT--------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 53/217 (24%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGK 653
DP+ + ++G+G GTVY G+ +A++++ ++ Q P E E+ V+ +
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRE 73
Query: 654 ARHPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
++PN+++ Y +L +V +Y GSL + E + V +
Sbjct: 74 NKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQ 127
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 771
L LH + +IH ++K NILL + + +++DFG +T S R + +G
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKR-STMVGT 179
Query: 772 --YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
++APE+ + K DI+ G++ +E++ G P
Sbjct: 180 PYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 1e-21
Identities = 45/237 (18%), Positives = 89/237 (37%), Gaps = 22/237 (9%)
Query: 583 LFDSRSSSLDCSIDPETLLEKAAEVGEGV--FGTVYKVSFGTQGRMLAVKKL-VTSDIIQ 639
+ + + + E +G+G TV + G + V+++ + + +
Sbjct: 9 MENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE 68
Query: 640 YPEDFEREVRVLGKARHPNLISLEGYY--WTPQLKL-LVSDYAPNGSLQAKLHERLPSTP 696
+ E+ V HPN++ Y + +L +V+ + GS + +
Sbjct: 69 MVTFLQGELHVSKLFNHPNIVP---YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM 125
Query: 697 PLSWTNRFKVIL-GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755
IL G K L ++HH +H ++K S+IL+ + +S +
Sbjct: 126 NELAI---AYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 756 -----RLDKHVMSNRFQSALGYVAPELTCQSLR-VNEKCDIYGFGVLILELVTGRRP 806
+ H L +++PE+ Q+L+ + K DIY G+ EL G P
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 590 SLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREV 648
L DP + E VG G +G VYK G++ A+K + VT D E+ ++E+
Sbjct: 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEI 71
Query: 649 RVLGKA-RHPNLISLEGYY-----WTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWT 701
+L K H N+ + G + +L LV ++ GS+ + +T W
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 131
Query: 702 NRFKVIL-GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760
I +GL+HLH +IH ++K N+LL +N ++ DFG++ L R
Sbjct: 132 ---AYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR---- 181
Query: 761 VMSNRFQSALG---YVAPE-LTCQSLRV---NEKCDIYGFGVLILELVTGRRP 806
R + +G ++APE + C + K D++ G+ +E+ G P
Sbjct: 182 -TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 33/219 (15%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEG 664
+GEG F K + AVK + + ++E+ L HPN++ L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRME----ANTQKEITALKLCEGHPNIVKLHE 73
Query: 665 YYWTPQLKLLVSDYAPNGSL----QAKLH--ERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
+ LV + G L + K H E S ++ ++H+H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRKLVSAVSHMH 123
Query: 719 HSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 775
++H +LKP N+L +DN +I DFG ARL D + + Y AP
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTL-HYAAP 178
Query: 776 E-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN 813
E L +E CD++ GV++ +++G+ P D
Sbjct: 179 ELLNQNGY--DESCDLWSLGVILYTMLSGQVPF-QSHDR 214
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 28/231 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 663
+G+G FG V G+M A KKL I + + E ++L K ++SL
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHS 720
Y T LV G L+ ++ + P + F ++ G L LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-VFYAAEICCG----LEDLHRE 305
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL----GYVAPE 776
I++ +LKP NILLDD+ + RISD GLA HV + GY+APE
Sbjct: 306 R---IVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVGTVGYMAPE 355
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827
+ ++ R D + G L+ E++ G+ P + E R++ E
Sbjct: 356 V-VKNERYTFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEV 404
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 77/304 (25%), Positives = 120/304 (39%), Gaps = 52/304 (17%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK--VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 651
+D + + +GEG FG V K + A+K++ DF E+ VL
Sbjct: 22 LDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 79
Query: 652 GK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------PPL 698
K HPN+I+L G L +YAP+G+L L + L
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 699 SWTNRFKVILGTAKGLAHL-HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757
S A+G+ +L F IH +L NIL+ +NY +I+DFGL+R
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR----- 190
Query: 758 DKHVMSNRFQSAL--GYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEYGE 811
+ V + L ++A E SL + D++ +GVL+ E+V+ G P Y
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIE----SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCG 244
Query: 812 DNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVV 871
+ + L +G L+ P + V L C P RPS A+++
Sbjct: 245 ----MTCAELYEKLPQGYRLEK--------PLNCDDEVYDLMRQCWREKPYERPSFAQIL 292
Query: 872 QILQ 875
L
Sbjct: 293 VSLN 296
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 4e-21
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 32/213 (15%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF----EREVRVLGK---ARHPNL 659
+G G FG VY G+M A+K L I + ER +L P +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER--IMLSLVSTGDCPFI 254
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAH 716
+ + + TP + D G L L + + RF ++ILG L H
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM---RFYAAEIILG----LEH 307
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YV 773
+H+ F +++ +LKP+NILLD++ + RISD GLA + +++G Y+
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYM 357
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
APE+ + + + D + G ++ +L+ G P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
E+G G VY+ + A+K L + + E+ VL + HPN+I L+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK---KIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 666 YWTPQLKLLVSDYAPNGSL------QAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
+ TP LV + G L + ER + + K IL +A+LH
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-------DAVKQILE---AVAYLHE 166
Query: 720 SFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
+ I+H +LKP N+L + +I+DFGL++++ + +M + GY APE
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTP-GYCAPE 220
Query: 777 -LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN 813
L + + D++ G++ L+ G P Y E
Sbjct: 221 ILRGCAY--GPEVDMWSVGIITYILLCGFEPF-YDERG 255
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 6e-21
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 19/228 (8%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLISLE 663
+G G FG V+ G++ A KKL + + + ++ E ++L K ++SL
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-KGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLS-WTNRF---KVILGTAKGLAHLHH 719
+ T LV G ++ ++ P F +++ G L HLH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQ 307
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
II+ +LKP N+LLDD+ N RISD GLA L + + G++APEL
Sbjct: 308 RN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELL- 361
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827
+ D + GV + E++ R P V E + +LE+
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPF-RARGEKVENKELKQRVLEQ 408
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 8e-21
Identities = 39/256 (15%), Positives = 76/256 (29%), Gaps = 45/256 (17%)
Query: 634 TSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP 693
+ ++R + N + + +L+ ++ R
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 694 STPP-----LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 748
L F I + + LH ++H +LKPSNI + ++ DF
Sbjct: 158 LEDREHGVCLHI---FIQIA---EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 208
Query: 749 GLARLL-------TRLDKHVMSNRFQSALG---YVAPELTCQSLRVNEKCDIYGFGVLIL 798
GL + T L +G Y++PE + K DI+ G+++
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ-IHGNNYSHKVDIFSLGLILF 267
Query: 799 ELVTGRRPVEYGEDNVVILSEHVRVL--LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVC 856
EL+ E VR++ + E +
Sbjct: 268 ELLYSFSTQ----------MERVRIITDVRNLK----FPLLFTQKYPQEH----MMVQDM 309
Query: 857 TCHIPSSRPSMAEVVQ 872
P+ RP ++++
Sbjct: 310 LSPSPTERPEATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 16/67 (23%), Positives = 27/67 (40%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
E +G G FG V++ A+K++ + E REV+ L K HP ++
Sbjct: 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 68
Query: 662 LEGYYWT 668
+
Sbjct: 69 YFNAWLE 75
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-20
Identities = 54/296 (18%), Positives = 99/296 (33%), Gaps = 63/296 (21%)
Query: 605 AEVGEGVFGTVYKVSFGT----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+ G G +Y GR + +K LV S + E + L + HP+++
Sbjct: 86 GCIAHGGLGWIYL---ALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 661 SL-----EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 715
+ + +V +Y SL+ ++LP ++ +L L+
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA------YLLEILPALS 196
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---Y 772
+LH +++ +LKP NI+L + ++ D G + F G +
Sbjct: 197 YLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN---------SFGYLYGTPGF 243
Query: 773 VAPELTCQSL-RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
APE DIY G + L +V L E+
Sbjct: 244 QAPE---IVRTGPTVATDIYTVGRTLAALTLDLPTRN---------GRYVDGLPED---- 287
Query: 832 DCVDPSMGDYPE-DEVLPVLKLALVCTCHIPSSRPSMAEVV--QILQVIKTPLPQR 884
DP + Y + + + P R + AE + Q+ V++ + Q
Sbjct: 288 ---DPVLKTYDSYGRL--LRR----AIDPDPRQRFTTAEEMSAQLTGVLREVVAQD 334
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 76/307 (24%), Positives = 127/307 (41%), Gaps = 66/307 (21%)
Query: 606 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
++GEG FG V++ + M+AVK L DF+RE ++ + +PN++
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST--------------------PPLSW 700
L G + L+ +Y G L L P T PPLS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 701 TNRFKVILGTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758
+ + A G+A+L +H +L N L+ +N +I+DFGL+R + D
Sbjct: 174 AEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 759 KHVMSNRFQSALGYV-----APELTCQSLRVN---EKCDIYGFGVLILELVT-GRRPVEY 809
+ + PE S+ N + D++ +GV++ E+ + G +P Y
Sbjct: 229 YYKADGN-----DAIPIRWMPPE----SIFYNRYTTESDVWAYGVVLWEIFSYGLQP--Y 277
Query: 810 -GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA 868
G + E V + +GN+L C PE+ L + L +C +P+ RPS
Sbjct: 278 YGMAH-----EEVIYYVRDGNILAC--------PENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 869 EVVQILQ 875
+ +ILQ
Sbjct: 325 SIHRILQ 331
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 36/207 (17%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLEG 664
++G G + + AVK + S D E+ +L + +HPN+I+L+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKS-----KRDPTEEIEILLRYGQHPNIITLKD 83
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------KVILGTAKGLAHLH 718
Y + +V++ G L K+ + F V+ K + +LH
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKILRQ----------KFFSEREASAVLFTITKTVEYLH 133
Query: 719 HSFRPPIIHYNLKPSNILL----DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
++H +LKPSNIL + + RI DFG A+ L R + ++ +A +VA
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCYTA-NFVA 188
Query: 775 PE-LTCQSLRVNEKCDIYGFGVL--IL 798
PE L Q + CDI+ GVL +
Sbjct: 189 PEVLERQGY--DAACDIWSLGVLLYTM 213
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 66/232 (28%), Positives = 93/232 (40%), Gaps = 29/232 (12%)
Query: 585 DSRSSSLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKK--LVTSDIIQYPE 642
D + L DPE L E+G G FG VY ++A+KK + +
Sbjct: 40 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 99
Query: 643 DFEREVRVLGKARHPNLISLEG-YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWT 701
D +EVR L K RHPN I G Y LV +Y GS L PL
Sbjct: 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTA-WLVMEYCL-GSASDLLEVH---KKPLQEV 154
Query: 702 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761
V G +GLA+LH +IH ++K NILL + ++ DFG A ++ + V
Sbjct: 155 EIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 211
Query: 762 -----MSNRFQSALGYVAPELTCQSLRV--NEKCDIYGFGVLILELVTGRRP 806
M APE+ + K D++ G+ +EL + P
Sbjct: 212 GTPYWM-----------APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 68/311 (21%), Positives = 116/311 (37%), Gaps = 57/311 (18%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 648
L K +G G FG V + + +AVK L S + E E+
Sbjct: 20 FPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSEL 77
Query: 649 RVLGK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVI 707
+VL H N+++L G L++++Y G L L + S +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 708 LGT--------------AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751
AKG+A L + IH +L NILL +I DFGLA
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLA 192
Query: 752 RLLTRLDKHVMSNRFQSALGYVAPE------LTCQSLRVNEKCDIYGFGVLILELVT-GR 804
R + +V+ + + ++APE T +S D++ +G+ + EL + G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFES-------DVWSYGIFLWELFSLGS 245
Query: 805 RPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSR 864
P Y + + +++EG + PE + + C P R
Sbjct: 246 SP--YPG---MPVDSKFYKMIKEGFRMLS--------PEHAPAEMYDIMKTCWDADPLKR 292
Query: 865 PSMAEVVQILQ 875
P+ ++VQ+++
Sbjct: 293 PTFKQIVQLIE 303
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW 667
GEG +G V +AVK + + PE+ ++E+ + H N++ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 668 TPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNR--FKVILGTAKGLAHLHHSFRP 723
++ L +Y G L ++ +P + F ++ G+ +LH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPE-----PDAQRFFHQLMA---GVVYLHGIG-- 125
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
I H ++KP N+LLD+ N +ISDFGLA + ++ + N+ L YVAPEL +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
E D++ G+++ ++ G P + D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 49/222 (22%), Positives = 94/222 (42%), Gaps = 15/222 (6%)
Query: 590 SLDCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR 649
S++ D LE E+G G +G V K+ G+++AVK++ + Q + ++
Sbjct: 1 SMEVKAD---DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD 57
Query: 650 VLGKA-RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL 708
+ + P ++ G + + + + SL + + + K+ +
Sbjct: 58 ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVMSNRFQ 767
K L HLH +IH ++KPSN+L++ ++ DFG++ L + K +
Sbjct: 117 SIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDA 170
Query: 768 SALGYVAPE---LTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
Y+APE + K DI+ G+ ++EL R P
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 34/232 (14%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G G FG VY+ G ++A+KK ++Q RE++++ K H N++ L ++
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 667 WTPQLKL------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHH 719
++ K LV DY P ++ + L K+ + + LA++ H
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYI-H 173
Query: 720 SFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSALGYV----- 773
SF I H ++KP N+LLD + ++ DFG A+ L R + +V Y+
Sbjct: 174 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---------SYICSRYY 222
Query: 774 -APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
APEL + D++ G ++ EL+ G +P+ G+ V L E ++VL
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVL 273
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 61/307 (19%)
Query: 606 EVGEGVFGTVYK-------VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHP 657
+GEG FG V + +AVK L + D E+ ++ +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------PPLSWTNRFK 705
N+I+L G ++ +YA G+L+ L R P +++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 706 VILGTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS 763
A+G+ +L IH +L N+L+ +N +I+DFGLAR + +D + +
Sbjct: 208 CTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 764 NRFQSALGYV-----APELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDN 813
G + APE +L + D++ FGVL+ E+ T G P Y G
Sbjct: 263 TN-----GRLPVKWMAPE----ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPV 311
Query: 814 VVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873
E + LL+EG+ +D P + + + C +PS RP+ ++V+
Sbjct: 312 -----EELFKLLKEGHRMDK--------PANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
Query: 874 LQVIKTP 880
L I T
Sbjct: 359 LDRILTL 365
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 79/317 (24%), Positives = 128/317 (40%), Gaps = 65/317 (20%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 648
+ L L K +GEG FG V K + +AVK L + D E
Sbjct: 20 FPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF 77
Query: 649 RVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL 708
VL + HP++I L G LL+ +YA GSL+ L E P + +
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 709 GT--------------------AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRIS 746
++G+ +L ++H +L NIL+ + +IS
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKIS 192
Query: 747 DFGLARLLTRLDKHVMSNRFQSALGYVAPE------LTCQSLRVNEKCDIYGFGVLILEL 800
DFGL+R + D +V ++ + + ++A E T QS D++ FGVL+ E+
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEI 245
Query: 801 VT-GRRPVEY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTC 858
VT G P Y G E + LL+ G+ ++ P++ + +L L C
Sbjct: 246 VTLGGNP--YPGIPP-----ERLFNLLKTGHRMER--------PDNCSEEMYRLMLQCWK 290
Query: 859 HIPSSRPSMAEVVQILQ 875
P RP A++ + L+
Sbjct: 291 QEPDKRPVFADISKDLE 307
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 48/216 (22%), Positives = 88/216 (40%), Gaps = 42/216 (19%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLEGYY 666
G GV G V + G+ A+K ++ +EV + + P+++ + Y
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALK------LLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 667 ----WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-----FKVILGTAKGLAHL 717
+ L++ + G L +++ ER ++T R + I + L
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQ----AFTEREAAEIMRDIG---TAIQFL 144
Query: 718 HHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG--- 771
H I H ++KP N+L + + +++DFG A K N Q+
Sbjct: 145 HSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-------KETTQNALQTPCYTPY 194
Query: 772 YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
YVAPE L + ++ CD++ GV++ L+ G P
Sbjct: 195 YVAPEVLGPEKY--DKSCDMWSLGVIMYILLCGFPP 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 51/218 (23%), Positives = 84/218 (38%), Gaps = 33/218 (15%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYY 666
GEG V + AVK + REV +L + + H N++ L ++
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHI-RSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 667 WTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------KVILGTAKGLAHLHHS 720
LV + GS+ + +H+R F V+ A L LH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKR----------RHFNELEASVVVQDVASALDFLH-- 128
Query: 721 FRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLT--RLDKHVMSNRFQSALG---Y 772
I H +LKP NIL + +I DF L + + + + G Y
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 773 VAPE-LTCQSLRV---NEKCDIYGFGVLILELVTGRRP 806
+APE + S +++CD++ GV++ L++G P
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 51/302 (16%)
Query: 606 EVGEGVFGTVYK-------VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHP 657
+GEG FG V + +AVK L + D E+ ++ +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPST------------PPLSWTNRFK 705
N+I+L G ++ +YA G+L+ L R P +++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 706 VILGTAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS 763
A+G+ +L IH +L N+L+ +N +I+DFGLAR + +D + +
Sbjct: 162 CTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 764 NRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPVEY-GEDNVVILS 818
+ + ++APE +L + D++ FGVL+ E+ T G P Y G
Sbjct: 217 TNGRLPVKWMAPE----ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPV----- 265
Query: 819 EHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878
E + LL+EG+ +D P + + + C +PS RP+ ++V+ L I
Sbjct: 266 EELFKLLKEGHRMDK--------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317
Query: 879 TP 880
T
Sbjct: 318 TL 319
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 27/219 (12%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNL 659
L+ E+G G +G+V K+ G+++AVK++ ++ + + ++ V+ ++ P +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------KVILGTAKG 713
+ G + + + + S + K+ L T K
Sbjct: 84 VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLD-----DVIPEEILGKITLATVKA 137
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-- 771
L HL + + IIH ++KPSNILLD + N ++ DFG++ L ++ G
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRD--AGCR 189
Query: 772 -YVAPELTCQSLRV---NEKCDIYGFGVLILELVTGRRP 806
Y+APE S + + D++ G+ + EL TGR P
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 34/244 (13%), Positives = 84/244 (34%), Gaps = 44/244 (18%)
Query: 96 SSLNTLNLSNNHFSG--DLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKE 152
S TL L H F++ L + + +S ++ + L +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSN------LPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84
Query: 153 LLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 211
+ ++ + + D P L L + N L++ + + ++
Sbjct: 85 IEIRNTRNLTYIDPDALKELPLLKFLGIFNT--------GLKMFPDLTKVYSTDI----- 131
Query: 212 IPHWIGNISTLEFLDFSNNHLTGSLPSSLFN--CKKLSVIRLRGNSLNGNIPEGLFD-LG 268
L+ ++N S+P + F C + ++L N ++ F+
Sbjct: 132 ----------FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTK 180
Query: 269 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNL 328
L+ + L++N ++ I + ++ +LD+S ++ +P+ +L+ L
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGG----VYSGPSLLDVSQTSVT-ALPS--KGLEHLKELIA 233
Query: 329 SSNH 332
+
Sbjct: 234 RNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 42/232 (18%), Positives = 77/232 (33%), Gaps = 23/232 (9%)
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGN 259
V+ + IP + + L HL ++PS F N +S I + +
Sbjct: 16 FRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 260 IPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM 317
+ F + I++ + I P + L+ L + + L P
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPL-----LKFLGIFNTGLK-MFPDLT 124
Query: 318 GLF--ANLRYLNLSSNHLRSRIPPEL--GYFHSLIHLDLRNNALYGSIPQEVCESRSLGI 373
++ L ++ N + IP G + + L L NN S+ L
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDA 183
Query: 374 LQLDGN-SLTGPIPQVIRNCTS-LYLLSLSHNHLSGSIPKSI-SNLNKLKIL 422
+ L+ N LT S LL +S ++ ++P +L +L
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 46/254 (18%), Positives = 81/254 (31%), Gaps = 40/254 (15%)
Query: 6 VHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPY 65
V IPS+ + L L IP + N+ N+ + +S ++ +
Sbjct: 18 VTCKDIQRIPSLPPS--TQTLKLIETHLR-TIPSHAFS-NLPNISRIYVSIDVTLQQLES 73
Query: 66 QLFENCASLRYLSLAGN-ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLK 124
F N + + ++ + L L L + N F ++S
Sbjct: 74 HSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK---MFPDLTKVYSTD 130
Query: 125 RLRTLDLSHNLFSGSIP----QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLS 180
L+++ N + SIP QG+ L L N F+ + L + L+
Sbjct: 131 IFFILEITDNPYMTSIPVNAFQGLCNE--TLTLKLYNNGFTS-VQGYAFNGTKLDAVYLN 187
Query: 181 NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSL 240
N + L +++ F G S LD S +T +LPS
Sbjct: 188 KNKY-------LTVIDKDAF---------------GGVYSGPSLLDVSQTSVT-ALPSKG 224
Query: 241 FNCKKLSVIRLRGN 254
+ L + R
Sbjct: 225 L--EHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 24/180 (13%), Positives = 50/180 (27%), Gaps = 36/180 (20%)
Query: 302 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNNALYGS 360
++ ++ IP L + + L L HLR+ IP ++ + + +
Sbjct: 16 FRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 361 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKL 419
+ N + + + + + I L L
Sbjct: 71 LE-----------------------SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLL 107
Query: 420 KILKLEFNELSGEIPQE--LGKLASLLAVNVSYNRLIGRLPVG---GVFPTLDQSSLQGN 474
K L + L P + + ++ N + +PV G+ L N
Sbjct: 108 KFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW 667
GEG +G V +AVK + + PE+ ++E+ + H N++ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 668 TPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNR--FKVILGTAKGLAHLHHSFRP 723
++ L +Y G L ++ +P + F ++ G+ +LH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPE-----PDAQRFFHQLMA---GVVYLHGIG-- 125
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
I H ++KP N+LLD+ N +ISDFGLA + ++ + N+ L YVAPEL +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
E D++ G+++ ++ G P + D+
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 62/308 (20%), Positives = 119/308 (38%), Gaps = 55/308 (17%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 648
L K +G G FG V + + +AVK L ++ E E+
Sbjct: 43 FPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSEL 100
Query: 649 RVLGK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVI 707
+++ +H N+++L G L++++Y G L L +
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 708 LGT----------AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755
T A+G+A L + IH ++ N+LL + + +I DFGLAR +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 756 RLDKHVMSNRFQSALGYVAPE------LTCQSLRVNEKCDIYGFGVLILELVT-GRRPVE 808
+++ + + ++APE T QS D++ +G+L+ E+ + G P
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQS-------DVWSYGILLWEIFSLGLNP-- 266
Query: 809 Y-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSM 867
Y G ++++ L+++G + P + + C P+ RP+
Sbjct: 267 YPG----ILVNSKFYKLVKDGYQMAQ--------PAFAPKNIYSIMQACWALEPTHRPTF 314
Query: 868 AEVVQILQ 875
++ LQ
Sbjct: 315 QQICSFLQ 322
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNL 659
LE E+G G G V+K+ F G ++AVK++ S + + ++ V+ K+ P +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP-STPPLSWTNRFKVILGTAKGLAHLH 718
+ G + T + + + + K + P L K+ + K L +L
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLK 141
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-- 776
+IH ++KPSNILLD+ ++ DFG++ RL +R Y+APE
Sbjct: 142 EKHG--VIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERI 196
Query: 777 --LTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ + D++ G+ ++EL TG+ P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 663
+G+G FG V V +M A+K + ++ + +E++++ HP L++L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 664 GYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK--------GL 714
+ + + +V D G L + H L FK T K L
Sbjct: 82 YSFQDEE-DMFMVVDLLLGGDL--RYH--------LQQNVHFK--EETVKLFICELVMAL 128
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL---- 770
+L + IIH ++KP NILLD++ + I+DF +A + + +
Sbjct: 129 DYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIA-------AMLPRETQITTMAGTK 178
Query: 771 GYVAPELTCQSLRV--NEKCDIYGFGVLILELVTGRRP 806
Y+APE+ + D + GV EL+ GRRP
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 57/234 (24%), Positives = 82/234 (35%), Gaps = 44/234 (18%)
Query: 126 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 185
++ + ++P + L L N A + LT L+L T
Sbjct: 12 HLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCK 244
+L V L + + +S+N L +P + L LD S N LT SLP
Sbjct: 69 -KLQVDGTLPV-LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124
Query: 245 KLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 304
+L + L+GN L +P GL + L L L
Sbjct: 125 ELQELYLKGNELK-TLPPGLLT------PTPK----------------------LEKLSL 155
Query: 305 SSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN 355
++NNL ++PA GL NL L L N L + IP H L L N
Sbjct: 156 ANNNLT-ELPA--GLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 53/211 (25%), Positives = 80/211 (37%), Gaps = 17/211 (8%)
Query: 243 CKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRIL 302
L V +L +P L + LSEN + + + L L
Sbjct: 10 ASHLEV-NCDKRNL-TALPPDLPK-DTTILHLSENLL-YTFSLATLMPYTR-----LTQL 60
Query: 303 DLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 362
+L L + + L L L+LS N L+S +P +L LD+ N L S+P
Sbjct: 61 NLDRAEL-TKLQVDGTL-PVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRL-TSLP 116
Query: 363 QEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLK 420
L L L GN L P ++ L LSL++N+L+ +P + + L L
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175
Query: 421 ILKLEFNELSGEIPQELGKLASLLAVNVSYN 451
L L+ N L IP+ L + N
Sbjct: 176 TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 56/230 (24%), Positives = 77/230 (33%), Gaps = 43/230 (18%)
Query: 52 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 111
++ L+ +P L L L+ N+L + L LNL +
Sbjct: 15 VNCDKRNLTA-LPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL 70
Query: 112 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC 171
+L L TLDLSHN S+P L L L + N+ + LP
Sbjct: 71 QVD------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGA-LR 121
Query: 172 --PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSN 229
L L L N LP + LE L +N
Sbjct: 122 GLGELQELYLKGNELK-TLPPG-------LLTPTPK----------------LEKLSLAN 157
Query: 230 NHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSEN 277
N+LT LP+ L + L + L+ NSL IP+G F L L N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 50/216 (23%), Positives = 80/216 (37%), Gaps = 24/216 (11%)
Query: 218 NISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLS 275
+++ ++ +LT +LP L K +++ L N L L +++L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLL-YTFSLATLMPYTRLTQLNLD 63
Query: 276 ENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS 335
+ + + L LDLS N L +P L L++S N L S
Sbjct: 64 RAE-LTKLQVDGTLPV-------LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS 114
Query: 336 RIPPELGYFHSLI---HLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRN 391
+P G L L L+ N L ++P + L L L N+LT ++
Sbjct: 115 -LPL--GALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170
Query: 392 CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFN 427
+L L L N L +IPK + L L N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 51/196 (26%), Positives = 79/196 (40%), Gaps = 20/196 (10%)
Query: 284 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY 343
P S +S ++ NL +P L + L+LS N L + L
Sbjct: 2 PICEVSKVAS-----HLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMP 53
Query: 344 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 403
+ L L+L L + + LG L L N L +P + + +L +L +S N
Sbjct: 54 YTRLTQLNLDRAEL-TKLQVDG-TLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFN 110
Query: 404 HLSGSIPKSI-SNLNKLKILKLEFNELSGEIPQEL-GKLASLLAVNVSYNRLIGRLPVGG 461
L+ S+P L +L+ L L+ NEL +P L L ++++ N L LP G
Sbjct: 111 RLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL-TELPA-G 166
Query: 462 VF---PTLDQSSLQGN 474
+ LD LQ N
Sbjct: 167 LLNGLENLDTLLLQEN 182
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 74/310 (23%), Positives = 121/310 (39%), Gaps = 56/310 (18%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 648
+ L L K +G G FG V + + R +AVK L E+
Sbjct: 24 FPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 81
Query: 649 RVLGK-ARHPNLISLEG---YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR- 703
++L H N+++L G P + ++ ++ G+L L + P
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 704 -FKVILGT----------AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGL 750
+K L AKG+ L IH +L NILL + +I DFGL
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGL 194
Query: 751 ARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRP 806
AR + + +V + L ++APE ++ + D++ FGVL+ E+ + G P
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPE----TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 807 VEY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP 865
Y G V + E L+EG + P+ + + L C PS RP
Sbjct: 251 --YPG----VKIDEEFCRRLKEGTRMRA--------PDYTTPEMYQTMLDCWHGEPSQRP 296
Query: 866 SMAEVVQILQ 875
+ +E+V+ L
Sbjct: 297 TFSELVEHLG 306
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVR---VLGKARHPNLISLE 663
G+G FGTV + G +A+KK +IQ P RE++ L HPN++ L+
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKK-----VIQDPRFRNRELQIMQDLAVLHHPNIVQLQ 85
Query: 664 GYYWTPQLK-------LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 715
Y++T + +V +Y P+ +L KV L + +
Sbjct: 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PILIKVFLFQLIRSIG 143
Query: 716 HLH-HSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
LH S + H ++KP N+L++ + ++ DFG A+ L+ + +V Y+
Sbjct: 144 CLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV---------AYI 192
Query: 774 ------APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
APEL + DI+ G + E++ G P+ G+++ L E VRVL
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSAGQLHEIVRVL 248
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 4e-18
Identities = 46/255 (18%), Positives = 91/255 (35%), Gaps = 27/255 (10%)
Query: 5 LVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVP 64
+ I F + N S++ + + + ++ + +N+ +
Sbjct: 5 ITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQN----ELNSIDQIIANNSDIKSVQG 60
Query: 65 YQLFENCASLRYLSLAGNILQGPIGKIFN--YCSSLNTLNLSNNHFSGDLDFASGYGIWS 122
+ ++ L L GN + I +L L L N DL +
Sbjct: 61 ---IQYLPNVTKLFLNGN----KLTDIKPLTNLKNLGWLFLDENKIK-DLS-----SLKD 107
Query: 123 LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNN 182
LK+L++L L HN S I G+ L L+ L L N+ + + L TL L +N
Sbjct: 108 LKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDN 163
Query: 183 LFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFN 242
+ + L L + + +S N ++ D+ + + L+ L+ + + N
Sbjct: 164 QIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSN 219
Query: 243 CKKLSVIRLRGNSLN 257
+ ++ SL
Sbjct: 220 LVVPNTVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 2e-17
Identities = 58/283 (20%), Positives = 86/283 (30%), Gaps = 53/283 (18%)
Query: 150 LKELLLQGNQFS--GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 207
+ E + P A +L T V+ LNS+ I +N+
Sbjct: 1 MGETITVSTPIKQIFPDDA----FAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSD 54
Query: 208 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL 267
+ + I + + L + N LT + L N K L + L N + ++ L DL
Sbjct: 55 IK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDL 108
Query: 268 -GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYL 326
L+ + L NG I L L L +N + DI L L L
Sbjct: 109 KKLKSLSLEHNGIS-DINGLVH-------LPQLESLYLGNNKIT-DITVLSRL-TKLDTL 158
Query: 327 NLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIP 386
+L N + I P L L +L L N I L
Sbjct: 159 SLEDNQISD-IVP-LAGLTKLQNLYLSKN----------------HISDLRA-------- 192
Query: 387 QVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 429
+ +L +L L SNL +K L
Sbjct: 193 --LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 3e-16
Identities = 52/261 (19%), Positives = 98/261 (37%), Gaps = 30/261 (11%)
Query: 79 LAGNILQG-PIGKIFN--YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNL 135
+ I PI +IF + NL + + L + + +++
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNE------LNSIDQIIANNSD 54
Query: 136 FSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLL 195
S+ QG+ L + +L L GN+ + P + +L L L N L SL+ L
Sbjct: 55 IK-SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS-SLKDL 108
Query: 196 NSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNS 255
+ +S+ +N ++ DI + ++ LE L NN +T + L KL + L N
Sbjct: 109 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ 164
Query: 256 LNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP 314
++ +I L L L+ + LS+N + + + L +L+L S +
Sbjct: 165 IS-DI-VPLAGLTKLQNLYLSKNHIS-DLRALAGLKN-------LDVLELFSQECLNKPI 214
Query: 315 AEMGLFANLRYLNLSSNHLRS 335
+ + L +
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVT 235
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 39/172 (22%), Positives = 56/172 (32%), Gaps = 21/172 (12%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ L+ HN +S I L++L ++ L L NN ++ L LSL N
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLP--QLESLYLGNNKITDITV---LSRLTKLDTLSLEDN 163
Query: 83 ILQGPIGKI--FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
I I + L L LS NH S DL + LK L L+L
Sbjct: 164 ----QISDIVPLAGLTKLQNLYLSKNHIS-DLR-----ALAGLKNLDVLELFSQECLNKP 213
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSL 192
+ L + P I ++ +L VS
Sbjct: 214 INHQSNLVVPNTVKNTDGSLVTPEI--ISDDGDYEKPNVKWHLPEFTNEVSF 263
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 62/316 (19%), Positives = 107/316 (33%), Gaps = 62/316 (19%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREV 648
E L K +G G FG V +S +AVK L E E+
Sbjct: 42 FPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSEL 99
Query: 649 RVLGK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVI 707
+++ + H N+++L G L+ +Y G L L + +
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 708 LGT-------------------AKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRIS 746
L AKG+ L +H +L N+L+ +I
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKIC 214
Query: 747 DFGLARLLTRLDKHVMSNRFQSALGYVAPE------LTCQSLRVNEKCDIYGFGVLILEL 800
DFGLAR + +V+ + + ++APE T +S D++ +G+L+ E+
Sbjct: 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS-------DVWSYGILLWEI 267
Query: 801 VT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCH 859
+ G P Y + + + L++ G +D P + + C
Sbjct: 268 FSLGVNP--YPG---IPVDANFYKLIQNGFKMDQ--------PFYATEEIYIIMQSCWAF 314
Query: 860 IPSSRPSMAEVVQILQ 875
RPS + L
Sbjct: 315 DSRKRPSFPNLTSFLG 330
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 74/309 (23%), Positives = 131/309 (42%), Gaps = 54/309 (17%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK-------VSFGTQGRMLAVKKLVTSDIIQYPEDFER 646
+ + L L K +GEG FG V + +AVK L + + D
Sbjct: 66 LPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS 123
Query: 647 EVRVLGK-ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-- 703
E+ ++ +H N+I+L G ++ +YA G+L+ L R P S+
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 704 ------FKVILG----TAKGLAHL--HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751
K ++ A+G+ +L IH +L N+L+ ++ +I+DFGLA
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNE---KCDIYGFGVLILELVT-GRRPV 807
R + +D + + + + ++APE +L + D++ FGVL+ E+ T G P
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWMAPE----ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP- 293
Query: 808 EY-GEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS 866
Y G E + LL+EG+ +D P + + + C +PS RP+
Sbjct: 294 -YPGVPV-----EELFKLLKEGHRMDK--------PSNCTNELYMMMRDCWHAVPSQRPT 339
Query: 867 MAEVVQILQ 875
++V+ L
Sbjct: 340 FKQLVEDLD 348
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED--FEREVRVLGKARHPNLISLEG 664
+G G FG V V + ++ A+K L ++I+ + F E ++ A P ++ L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 665 YYWTPQLKLLVSDYAPNG---SLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 718
+ + +V +Y P G +L + +P RF +V+L L +H
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEK-----WARFYTAEVVLA----LDAIH 185
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 777
IH ++KP N+LLD + + +++DFG + + + V + Y++PE L
Sbjct: 186 SM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVL 241
Query: 778 TCQSLRV--NEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 816
Q +CD + GV + E++ G P Y + V
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGT 281
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 41/218 (18%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLEG 664
+G G+ G V ++ A+K ++Q REV + + ++ P+++ +
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALK------MLQDCPKARREVELHWRASQCPHIVRIVD 122
Query: 665 YYWTPQLK----LLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-----FKVILGTAKGLA 715
Y L+V + G L +++ +R ++T R K I + +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIG---EAIQ 175
Query: 716 HLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG- 771
+LH I H ++KP N+L N +++DFG A+ T N +
Sbjct: 176 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS------HNSLTTPCYT 226
Query: 772 --YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
YVAPE L + ++ CD++ GV++ L+ G P
Sbjct: 227 PYYVAPEVLGPEKY--DKSCDMWSLGVIMYILLCGYPP 262
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-18
Identities = 58/231 (25%), Positives = 94/231 (40%), Gaps = 26/231 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLEG 664
+G G FG V V ++ A+K L ++++ E F E VL + +L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 665 YYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHS 720
+ L LV DY G L L + P RF ++++ + +H
Sbjct: 142 AFQDDN-NLYLVMDYYVGGDLLTLL-SKFEDRLPEEMA-RFYLAEMVIA----IDSVHQL 194
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
+H ++KP NIL+D N + R++DFG L D V S+ Y++PE+
Sbjct: 195 ---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEILQA 250
Query: 781 SLRVNEK----CDIYGFGVLILELVTGRRPVEYGEDNVV----ILSEHVRV 823
+ CD + GV + E++ G P Y E V I++ R
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERF 300
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-17
Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 607 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLI 660
+G+G +G V+ KV+ G++ A+K L + I++ +D E +L + +HP ++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 661 SLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAH 716
L + T KL L+ +Y G L +L + F ++ + L H
Sbjct: 85 DLIYAFQTGG-KLYLILEYLSGGELFMQLEREGIFMEDTA---CFYLAEISMA----LGH 136
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YV 773
LH II+ +LKP NI+L+ + +++DFGL + + +++ F G Y+
Sbjct: 137 LHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTF---CGTIEYM 188
Query: 774 APELTCQSLRVNEK-----CDIYGFGVLILELVTGRRPVEYGED 812
APE+ + D + G L+ +++TG P GE+
Sbjct: 189 APEI------LMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGEN 225
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLISLE 663
+G+G FG V V GR A+K L I+ ++ E RVL +RHP L +L+
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLTENRVLQNSRHPFLTALK 214
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLH-ERLPSTPPLSWTNRF---KVILGTAKGLAHLHH 719
+ T V +YA G L L ER+ S RF +++ L +LH
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGAEIVSA----LDYLHS 266
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
+++ +LK N++LD + + +I+DFGL + + F Y+APE+
Sbjct: 267 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVL- 321
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+ D +G GV++ E++ GR P Y +D
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQD 353
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 57/232 (24%), Positives = 107/232 (46%), Gaps = 35/232 (15%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G G FG V++ + + +A+KK ++Q RE++++ +HPN++ L+ ++
Sbjct: 48 IGNGSFGVVFQ-AKLVESDEVAIKK-----VLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 667 WTPQLKL------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHH 719
++ K LV +Y P ++ + K+ + + LA++H
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIH- 158
Query: 720 SFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSALGYV----- 773
S I H ++KP N+LLD ++ DFG A++L + +V Y+
Sbjct: 159 SIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV---------SYICSRYY 207
Query: 774 -APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
APEL + DI+ G ++ EL+ G +P+ GE + L E ++VL
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLFPGESGIDQLVEIIKVL 258
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 58/243 (23%), Positives = 88/243 (36%), Gaps = 50/243 (20%)
Query: 48 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNN 106
+ K LDLS N L + F + L+ L L+ +Q G + S L+TL L+ N
Sbjct: 29 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDG-AYQSLSHLSTLILTGN 86
Query: 107 H--------FSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA-LHYLKELLLQG 157
FSG L L+ L + S+ L LKEL +
Sbjct: 87 PIQSLALGAFSG------------LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAH 133
Query: 158 NQF-SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWI 216
N S LP +L LDLS+N ++ + + +
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSN--------KIQSIYCTDLRVLHQ--MPLLNLS-- 181
Query: 217 GNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDL 274
LD S N + + F +L + L N L ++P+G+FD L++I L
Sbjct: 182 --------LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 231
Query: 275 SEN 277
N
Sbjct: 232 HTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 52/234 (22%), Positives = 84/234 (35%), Gaps = 31/234 (13%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
+ L+ S N L + + ++ LDLS + + +++ + L L L GN
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFF-SFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGN 86
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
+Q F+ SSL L + + +F G LK L+ L+++HNL
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG----HLKTLKELNVAHNLIQSFKLP 142
Query: 143 GV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFI 201
+ L L+ L L N+ D+ + L+LS +L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL------------------ 184
Query: 202 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGN 254
S N + I L+ L N L S+P +F L I L N
Sbjct: 185 --SLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 54/242 (22%), Positives = 88/242 (36%), Gaps = 45/242 (18%)
Query: 220 STLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSE 276
+ + LD S N L L S F + +L V+ L + I +G + L + L+
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85
Query: 277 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHL 333
N + S+ G+ S SS L+ L NL + L+ LN++ N +
Sbjct: 86 NP-IQSLALGAFSGLSS-----LQKLVAVETNLA-SLEN--FPIGHLKTLKELNVAHNLI 136
Query: 334 RSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCT 393
+S P YF +L +L+ L L N + +R
Sbjct: 137 QSFKLP--EYFSNLTNLE---------------------HLDLSSNKIQSIYCTDLRVLH 173
Query: 394 SL----YLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 449
+ L LS N ++ I +LK L L+ N+L +L SL + +
Sbjct: 174 QMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 232
Query: 450 YN 451
N
Sbjct: 233 TN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 53/229 (23%), Positives = 88/229 (38%), Gaps = 33/229 (14%)
Query: 188 LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NCKKL 246
LP S + L+ +S N L + + L+ LD S + ++ + + L
Sbjct: 26 LPFSTKNLD------LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 247 SVIRLRGNSLNGNIPEGLFD-LG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDL 304
S + L GN + ++ G F L L+++ E S+ +TL+ L++
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH-----LKTLKELNV 131
Query: 305 SSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSL-------IHLDLRN 354
+ N + F+ NL +L+LSSN ++S I L + LDL
Sbjct: 132 AHNLIQ-SFKLP-EYFSNLTNLEHLDLSSNKIQS-IYC--TDLRVLHQMPLLNLSLDLSL 186
Query: 355 NALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 403
N + I + L L LD N L + TSL + L N
Sbjct: 187 NPM-NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 29/207 (14%)
Query: 260 IPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL 319
IP+ L + +DLS N + S S L++LDLS + I G
Sbjct: 22 IPDNLPF-STKNLDLSFNPL-RHLGSYSFFSFPE-----LQVLDLSRCEI-QTIED--GA 71
Query: 320 FA---NLRYLNLSSNHLRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEVCES-RSLG 372
+ +L L L+ N ++S + G F SL L L S+ ++L
Sbjct: 72 YQSLSHLSTLILTGNPIQS-LAL--GAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLK 127
Query: 373 ILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLE----F 426
L + N + +P+ N T+L L LS N + SI + L+++ +L L
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 427 NELSGEIPQELGKLASLLAVNVSYNRL 453
N ++ I K L + + N+L
Sbjct: 187 NPMN-FIQPGAFKEIRLKELALDTNQL 212
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 41/170 (24%), Positives = 65/170 (38%), Gaps = 16/170 (9%)
Query: 305 SSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL---DLRNNALYGSI 361
N IP L + + L+LS N LR + F S L DL + +I
Sbjct: 15 MELNFY-KIPD--NLPFSTKNLDLSFNPLRH-LGS--YSFFSFPELQVLDLSRCEI-QTI 67
Query: 362 PQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKL 419
+S L L L GN + +SL L +L+ S+ +L L
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTL 126
Query: 420 KILKLEFNEL-SGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQ 468
K L + N + S ++P+ L +L +++S N+ I + L Q
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK-IQSIYC-TDLRVLHQ 174
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 11/108 (10%)
Query: 6 VHGNSYNAIPSMVVFRI---LERLNFSHNSLSGQIPP----SLLNLNMMNMKFLDLSNNL 58
V N + F LE L+ S N + I L + ++N+ LDLS N
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS-LDLSLNP 188
Query: 59 LSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNN 106
++ + F+ L+ L+L N L+ IF+ +SL + L N
Sbjct: 189 MNF-IQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 24/213 (11%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 654
EK ++GEG +GTV+K ++A+K+ ++ +D E RE+ +L +
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKR------VRLDDDDEGVPSSALREICLLKEL 58
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG-TAKG 713
+H N++ L + + LV ++ L + S K L KG
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
L H ++H +LKP N+L++ N ++++FGLAR + S L Y
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEV-VTLWYR 168
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
P++ + + D++ G + EL RP
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 55/217 (25%), Positives = 85/217 (39%), Gaps = 22/217 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPE--DFEREVRVLGKARHPNLISLEG 664
+G G F V V G++ A+K + D+++ E F E VL + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHSF 721
+ LV +Y G L L + P RF ++++ + +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMA-RFYLAEIVMA----IDSVH--- 179
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-LTCQ 780
R +H ++KP NILLD + R++DFG L R D V S Y++PE L
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 781 SLRVNEK-----CDIYGFGVLILELVTGRRPVEYGED 812
CD + GV E+ G+ P Y +
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADS 274
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 28/215 (13%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 654
+ ++GEG +G VYK +A+K+ I+ + E REV +L +
Sbjct: 37 RRITKLGEGTYGEVYKAIDTVTNETVAIKR------IRLEHEEEGVPGTAIREVSLLKEL 90
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
+H N+I L+ L+ +Y + L + + P +S + G+
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPR-----ISDFGLARLLTRLDKHVMSNRFQSA 769
H +H +LKP N+LL + I DFGLAR + ++
Sbjct: 146 NFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEII-T 200
Query: 770 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
L Y PE+ S + DI+ + E++
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 24/221 (10%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDF---EREVRVLGKARHPNLISL-E 663
GEG +G V +V AVK L + + P ++E+++L + RH N+I L +
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 664 GYYW-TPQLKLLVSDYAPNGS--LQAKL-HERLPSTPPLSWTNR--FKVILGTAKGLAHL 717
Y Q +V +Y G + + +R P F ++ GL +L
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV-----CQAHGYFCQLID---GLEYL 125
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE- 776
H S I+H ++KP N+LL +IS G+A L Q + + PE
Sbjct: 126 H-SQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
K DI+ GV + + TG P E DN+ L
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE--GDNIYKL 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
G G FG V G +AVK K+ + D++ +RE++ L RHP++I L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVV---GKIKREIQNLKLFRHPHIIKL 76
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
TP +V +Y G L + H R+ F+ IL + + H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR---RLFQQILS---AVDYCH-- 128
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 777
R ++H +LKP N+LLD + N +I+DFGL+ +++ +++ G Y APE+
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD------GEFLRTSCGSPNYAAPEV 181
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
L + DI+ GV++ L+ G P + +++V L
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFD--DEHVPTL 219
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISL 662
+GEG +G V + G ++A+KK+ + P RE+++L +H N+I++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKI---EPFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 663 EGYYWTPQLKL-----LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAH 716
+ ++ + +Q LH R+ ST LS + + + T + +
Sbjct: 75 FNIQRPDSFENFNEVYIIQEL-----MQTDLH-RVISTQMLS-DDHIQYFIYQTLRAVKV 127
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--GYV- 773
LH S +IH +LKPSN+L++ N + ++ DFGLAR++ Q + +V
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 774 -----APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
APE+ S + + D++ G ++ EL R
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 53/308 (17%), Positives = 111/308 (36%), Gaps = 31/308 (10%)
Query: 5 LVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVP 64
+ + N I ++ ++++ + + ++ + L ++
Sbjct: 3 ITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQA----DLDGITTLSAFGTGVTT--- 55
Query: 65 YQLFENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSNNHFSGDLDFASGYGIWS 122
+ + +L L L N I + + + L LS N ++ I
Sbjct: 56 IEGVQYLNNLIGLELKDN----QITDLAPLKNLTKITELELSGNPLK-NVS-----AIAG 105
Query: 123 LKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNN 182
L+ ++TLDL+ + P +A L L+ L L NQ + P + +L L + N
Sbjct: 106 LQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNA 161
Query: 183 LFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFN 242
+ L L L+ + + +N ++ DI + ++ L + NN ++ S L N
Sbjct: 162 QVS-DLT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLAN 215
Query: 243 CKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRIL 302
L ++ L ++ +L + + +G I P + S + + L
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP--IAPATISDNGTYASPNLTWN 273
Query: 303 DLSSNNLV 310
S N V
Sbjct: 274 LTSFINNV 281
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 54/302 (17%), Positives = 110/302 (36%), Gaps = 38/302 (12%)
Query: 45 NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLN 102
+ N + + ++ V + + LS G + I Y ++L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGT----GVTTIEGVQYLNNLIGLE 69
Query: 103 LSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG 162
L +N + DL + +L ++ L+LS N ++ +A L +K L L Q +
Sbjct: 70 LKDNQIT-DLA-----PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD 121
Query: 163 PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTL 222
P + +L L L N T P L L ++ ++S+ N ++ D+ + N+S L
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP-LANLSKL 175
Query: 223 EFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMG 281
L +N ++ S L + L + L+ N ++ L + L + L+
Sbjct: 176 TTLKADDNKISDI--SPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQ---- 227
Query: 282 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL 341
+ ++ L + ++ I + N Y + + + +
Sbjct: 228 -----TITNQPVFYNNNLVVPNVVKGPSGAPIAPA-TISDNGTYASPNLTWNLTSFINNV 281
Query: 342 GY 343
Y
Sbjct: 282 SY 283
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 50/284 (17%), Positives = 105/284 (36%), Gaps = 49/284 (17%)
Query: 172 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 231
+ + + T V+ L+ + +S +T I + ++ L L+ +N
Sbjct: 19 ANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 232 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSS 290
+T + L N K++ + L GN L N+ + L ++ +DL+ + + P +
Sbjct: 75 ITD--LAPLKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQ-ITDVTPLAG-- 127
Query: 291 SSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL 350
L++L L N + +I GL NL+YL++ + + + P L L L
Sbjct: 128 -----LSNLQVLYLDLNQIT-NISPLAGL-TNLQYLSIGNAQVSD-LTP-LANLSKLTTL 178
Query: 351 DLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIP 410
+N + + ++ + + +L + L +N +S P
Sbjct: 179 KADDNKI---------------------SDISP-----LASLPNLIEVHLKNNQISDVSP 212
Query: 411 KSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 454
++N + L I+ L ++ + L V I
Sbjct: 213 --LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 59/297 (19%), Positives = 117/297 (39%), Gaps = 32/297 (10%)
Query: 122 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181
+L + + + ++ Q A L + L G + + + + +L L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKD 72
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 241
N T P L+ L + + +S N L ++ I + +++ LD ++ +T + L
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD--VTPLA 126
Query: 242 NCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLR 300
L V+ L N + NI L L L+ + + + P ++ S L
Sbjct: 127 GLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS-DLTPLANLSK-------LT 176
Query: 301 ILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGS 360
L N + DI L NL ++L +N + + P L +L + L N +
Sbjct: 177 TLKADDNKIS-DISPLASL-PNLIEVHLKNNQISD-VSP-LANTSNLFIVTLTNQTITN- 231
Query: 361 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLN 417
Q V + +L + N + GP I T + + +L+ ++ I+N++
Sbjct: 232 --QPVFYNNNLVVP----NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 18/113 (15%), Positives = 44/113 (38%), Gaps = 8/113 (7%)
Query: 341 LGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSL 400
+ I + + + ++ Q + + L G +T ++ +L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLD--GITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70
Query: 401 SHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRL 453
N ++ + + NL K+ L+L N L + L S+ ++++ ++
Sbjct: 71 KDNQIT-DLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI 119
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 53/263 (20%), Positives = 96/263 (36%), Gaps = 62/263 (23%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+G G FG V +V G+ A+KK ++Q P RE+ ++ H N+I L Y
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKK-----VLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF------------------KVI 707
++T + P+ + + S KV+
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 708 LGTAK-------------------GLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-RISD 747
+ + +H S I H ++KP N+L++ N ++ D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLG--ICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 748 FGLARLLTRLDKHVMSNRFQSALGYV------APELTCQSLRVNEKCDIYGFGVLILELV 801
FG A+ L + V Y+ APEL + D++ G + EL+
Sbjct: 186 FGSAKKLIPSEPSV---------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 802 TGRRPVEYGEDNVVILSEHVRVL 824
G +P+ GE ++ L ++++
Sbjct: 237 LG-KPLFSGETSIDQLVRIIQIM 258
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 51/228 (22%), Positives = 98/228 (42%), Gaps = 46/228 (20%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 654
EK A++G+G FG V+K G+ +A+KK + + E RE+++L
Sbjct: 20 EKLAKIGQGTFGEVFKARHRKTGQKVALKK------VLMENEKEGFPITALREIKILQLL 73
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLH----------ERLPSTPPLSWTNR- 703
+H N+++L + + +P + ++ L S + +T
Sbjct: 74 KHENVVNLIE--------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 704 ----FKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL---TR 756
+++L GL ++H + I+H ++K +N+L+ + +++DFGLAR
Sbjct: 126 IKRVMQMLL---NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
+ +NR L Y PEL D++G G ++ E+ T
Sbjct: 180 SQPNRYTNRV-VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 47/232 (20%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
G+G F V GR +A+K +L + + + REVR++ HPN++ L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK----LFREVRIMKILNHPNIVKL 79
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNR--FKVILGTAKGLAHLH 718
T + L+ +YA G + L H R+ R F+ I+ + + H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EARSKFRQIV---SAVQYCH 131
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS---------A 769
+ I+H +LK N+LLD + N +I+DFG SN F A
Sbjct: 132 ---QKRIVHRDLKAENLLLDADMNIKIADFGF------------SNEFTVGGKLDAFCGA 176
Query: 770 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV 821
Y APEL + D++ GV++ LV+G P + N+ L E V
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD--GQNLKELRERV 226
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 8e-17
Identities = 74/403 (18%), Positives = 121/403 (30%), Gaps = 102/403 (25%)
Query: 73 SLRYLSLAGNILQG----PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 128
S+ SL + + + + S+ + LS N + I S K L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 129 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL 188
+ S + AL L + LL+ CP L T+ LS+N F
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLK--------------CPKLHTVRLSDNAFG--- 107
Query: 189 PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT-------------GS 235
P + L + S +T LE L NN L +
Sbjct: 108 PTAQEPLIDFL----SKHT-------------PLEHLYLHNNGLGPQAGAKIARALQELA 150
Query: 236 LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG--------LEEIDLSENGFMGSIPPGS 287
+ N L I N L + + L + + +NG P G
Sbjct: 151 VNKKAKNAPPLRSIICGRNRLE---NGSMKEWAKTFQSHRLLHTVKMVQNGI---RPEGI 204
Query: 288 SSSSSSTL--FQTLRILDLSSNNLVGDIPAE-----MGLFANLRYLNLSSNHLRSRIPPE 340
L Q L++LDL N + + + + NLR L L+ L +R
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTF-THLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263
Query: 341 LGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVI-----RNCTSL 395
+ +A E+ L L+L N + + + L
Sbjct: 264 VV------------DAF------SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305
Query: 396 YLLSLSHNHLS------GSIPKSISNLNKLKILKLEFNELSGE 432
L L+ N S I + S + ++ +L+ E +
Sbjct: 306 LFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 42/283 (14%), Positives = 85/283 (30%), Gaps = 50/283 (17%)
Query: 23 LERLNFSHNSLSG----------QIPPSLLNLNMMNMKFLDLSNNLLSGPVP-YQLFENC 71
++ + S N++ L ++ + + + Q C
Sbjct: 34 VKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKC 93
Query: 72 ASLRYLSLAGNILQG----PIGKIFNYCSSLNTLNLSNNHFSGD---------LDFASGY 118
L + L+ N P+ + + L L L NN + A
Sbjct: 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153
Query: 119 GIWSLKRLRTLDLSHNLFSG----SIPQGVAALHYLKELLLQGNQF-----SGPLPADIG 169
+ LR++ N + + L + + N L +
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213
Query: 170 FCPHLTTLDLSNNLFTGQ----LPVSLRLLNSMIFISVSNNTLT-------GDIPHWIGN 218
+C L LDL +N FT L ++L+ ++ + +++ L+ D + N
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN 273
Query: 219 ISTLEFLDFSNNHLTG----SLPSSLF-NCKKLSVIRLRGNSL 256
L+ L N + +L + + L + L GN
Sbjct: 274 -IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 41/196 (20%), Positives = 72/196 (36%), Gaps = 36/196 (18%)
Query: 23 LERLNFSHNSLS-----------GQIPPSLLNLNMMNMKFLDLSNNLL-SGPVPY--QLF 68
LE L +N L ++ + N ++ + N L +G + + F
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 69 ENCASLRYLSLAGNIL-----QGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSL 123
++ L + + N + + + + YC L L+L +N F+ A + S
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 124 KRLRTLDLSHNLFSGSIPQGVAAL---------HYLKELLLQGNQFSGPLPADIG----- 169
LR L L+ L S +G AA+ L+ L LQ N+ +
Sbjct: 244 PNLRELGLNDCLLS---ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 300
Query: 170 FCPHLTTLDLSNNLFT 185
P L L+L+ N F+
Sbjct: 301 KMPDLLFLELNGNRFS 316
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 32/228 (14%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYP--EDFEREVRVLGKARHPNLISLEG 664
+G G FG V V G A+K L +++ E E R+L P L+ LE
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHHSF 721
+ +V +Y G + + L + P + RF +++L +LH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA---RFYAAQIVLT----FEYLHSL- 160
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELT 778
+I+ +LKP N+L+D +++DFG A K V R + G +APE+
Sbjct: 161 --DLIYRDLKPENLLIDQQGYIQVTDFGFA-------KRV-KGRTWTLCGTPEALAPEII 210
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV----ILSEHVR 822
S N+ D + GVLI E+ G P + + + I+S VR
Sbjct: 211 -LSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVR 256
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE----REVRVLGKARHP 657
E VGEG +G V K GR++A+KK + SD + + RE+++L + RH
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD---DDKMVKKIAMREIKLLKQLRHE 84
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAKGLAH 716
NL++L + LV ++ + + + L P L + K + G+
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
H IIH ++KP NIL+ + ++ DFG AR L V + + Y APE
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEV-ATRWYRAPE 194
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGR 804
L ++ + D++ G L+ E+ G
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--------REVRVLGK 653
K ++GEG + TVYK ++A+K++ + E REV +L
Sbjct: 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL--------EHEEGAPCTAIREVSLLKD 56
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAK 712
+H N+++L T + LV +Y L L + L ++ N + +
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
GLA+ H ++H +LKP N+L+++ +++DFGLAR + + N L Y
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWY 166
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
P++ S + + D++G G + E+ TGR
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE----REVRVLGKARHP 657
EK ++GEG +G V+K G+++A+KK + S + + RE+R+L + +HP
Sbjct: 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLKQLKHP 62
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAKGLAH 716
NL++L + + LV +Y + L + + T + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
H IH ++KP NIL+ + ++ DFG ARLLT + + Y +PE
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEV-ATRWYRSPE 172
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGR 804
L + D++ G + EL++G
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 51/263 (19%), Positives = 91/263 (34%), Gaps = 25/263 (9%)
Query: 225 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGS 282
+ +T +PS L + +R L I +G F LE+I++S+N +
Sbjct: 14 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 283 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPP 339
I S+ L + + N + I F NL+YL +S+ ++ +P
Sbjct: 70 IEADVFSNLPK-----LHEIRIEKANNLLYINP--EAFQNLPNLQYLLISNTGIKH-LPD 121
Query: 340 ELGYF-HSLIHLDLRNNALYGSIPQEVCE--SRSLGILQLDGNSLTGPIPQVIRNCTSLY 396
+ LD+++N +I + S IL L+ N +
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDE 181
Query: 397 LLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQE-LGKLASLLAVNVSYNRLIG 455
L +N+L + IL + + +P L L L A + +
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK--- 237
Query: 456 RLPVGGVFPTLDQSSLQGNLGIC 478
+LP L ++SL C
Sbjct: 238 KLPTLEKLVALMEASLTYPSHCC 260
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 50/274 (18%), Positives = 87/274 (31%), Gaps = 41/274 (14%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
+ IPS + R L F L I + +++ +++S N + +
Sbjct: 17 QESKVTEIPSDL-PRNAIELRFVLTKLR-VIQKGAFS-GFGDLEKIEISQNDVLEVIEAD 73
Query: 67 LFENCASLRYLSLA-GNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 125
+F N L + + N L + F +L L +SN D +
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH----KIHSLQ 129
Query: 126 LRTLDLSHNLFSGSIPQGV-AALHY-LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNL 183
LD+ N+ +I + L + L L N ++ N+
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ----------------EIHNSA 173
Query: 184 FTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC 243
F G L L ++ + N+ G S LD S + SLPS
Sbjct: 174 FNGTQLDELNLSDNNNLEELPNDVFHG--------ASGPVILDISRTRIH-SLPSYGLE- 223
Query: 244 KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLS 275
++ +LR S + + L E L+
Sbjct: 224 ---NLKKLRARSTYNLKKLPTLEKLVALMEASLT 254
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 42/237 (17%), Positives = 81/237 (34%), Gaps = 23/237 (9%)
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 186
R + + IP + EL + L +++S N
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 187 QLPVS-LRLLNSMIFISVSN-NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NC 243
+ L + I + N L P N+ L++L SN + LP +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 244 KKLSVIRLRGNSLNGNIPEGLFD---LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLR 300
+ ++ ++ N I F + L++NG I + + + L
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQ------LD 180
Query: 301 ILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN 355
L+LS NN + ++P ++ G + L++S + S +P +L L R+
Sbjct: 181 ELNLSDNNNLEELPNDVFHGA-SGPVILDISRTRIHS-LPSYG--LENLKKLRARST 233
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 17/112 (15%), Positives = 31/112 (27%), Gaps = 11/112 (9%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L + N + +I S N + NN L +P +F + L ++
Sbjct: 156 SVILWLNKNGIQ-EIHNSAFNG-TQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRT 212
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
+ L + N L+ L L L++
Sbjct: 213 RIHSLPSYGLENLKKLRARSTYNLKKLPTLE--------KLVALMEASLTYP 256
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 42/215 (19%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 663
VG G +G+V G +A+KKL S Q + RE+ +L +H N+I L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 664 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 715
+ TP L LV + +Q L + + S + + ++ KGL
Sbjct: 90 DVF-TPASSLRNFYDFYLVMPF-----MQTDLQKIMGL--KFS-EEKIQYLVYQMLKGLK 140
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 773
++H + ++H +LKP N+ ++++ +I DFGLAR M+ GYV
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMT-------GYVVT 186
Query: 774 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
APE+ + N+ DI+ G ++ E++TG+
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 52/246 (21%), Positives = 98/246 (39%), Gaps = 51/246 (20%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQY-------------------- 640
E+G+G +G V A+K KL+
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 641 PEDFEREVRVLGKARHPNLISL-EGYYWTPQLKL-LVSDYAPNGSLQAKL-HERLPSTPP 697
E +E+ +L K HPN++ L E + L +V + G + + L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 698 LSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757
+ F+ ++ KG+ +LH + IIH ++KPSN+L+ ++ + +I+DFG++
Sbjct: 140 RFY---FQDLI---KGIEYLH-YQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 758 DKHVMSNRFQSALG---YVAPELTCQSLRVN---EKCDIYGFGVLILELVTGRRPVEYGE 811
D + +G ++APE R + D++ GV + V G+ P +
Sbjct: 191 DAL-----LSNTVGTPAFMAPES-LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM--D 242
Query: 812 DNVVIL 817
+ ++ L
Sbjct: 243 ERIMCL 248
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLISLE 663
+G+G FG V V GR A+K L II ++ E RVL RHP L +L+
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 664 GYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK----------VILGTAK 712
+ T +L V +YA G L H LS F ++
Sbjct: 72 YAFQTHD-RLCFVMEYANGGELF--FH--------LSRERVFTEERARFYGAEIVSA--- 117
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
L +LH +++ ++K N++LD + + +I+DFGL + + F Y
Sbjct: 118 -LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEY 171
Query: 773 VAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+APE L D +G GV++ E++ GR P Y +D
Sbjct: 172 LAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPF-YNQD 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 654
+K +VGEG +G VYK + +QGR++A+K+ I+ + E RE+ +L +
Sbjct: 24 QKLEKVGEGTYGVVYK-AKDSQGRIVALKR------IRLDAEDEGIPSTAIREISLLKEL 76
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-PLSWTNRFKVILGTAKG 713
HPN++SL + + LV ++ ++ L + L L + + +G
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
+AH H I+H +LKP N+L++ + +++DFGLAR + ++ L Y
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYR 186
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
AP++ S + + DI+ G + E++TG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 42/222 (18%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPED-FE---------REVRVLGKAR 655
+ G +G V ++G +A+K++ + + RE+R+L
Sbjct: 29 FISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 656 HPNLISLEGYYWTPQLKL-----LVSDYAPNGSLQAKLHERLPST-PPLSWTNRFKVIL- 708
HPN++ L + + LV++ ++ L + + +S + +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVIS-PQHIQYFMY 141
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQS 768
GL LH + ++H +L P NILL DN + I DF LAR T +
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDT--ADANKT----- 191
Query: 769 ALGYV------APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
YV APEL Q + D++ G ++ E+ +
Sbjct: 192 --HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REVRVLGKA 654
++GEG +G VYK G A+KK I+ ++ E RE+ +L +
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNY-GETFALKK------IRLEKEDEGIPSTTIREISILKEL 57
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG-TAKG 713
+H N++ L T + +LV ++ L L + L + K L G
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
+A+ H ++H +LKP N+L++ +I+DFGLAR + ++ L Y
Sbjct: 113 IAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWYR 167
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
AP++ S + + DI+ G + E+V G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 607 VGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEG 664
VG G +G VYK G + A+K++ + I RE+ +L + +HPN+ISL+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQK 85
Query: 665 YYWTPQLKL--LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV---------ILGTAKG 713
+ + + L+ DYA + L + + ++ + IL G
Sbjct: 86 VFLSHADRKVWLLFDYAEH-DL-WHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---DG 140
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPR----ISDFGLARL-------LTRLDKHVM 762
+ +LH ++ ++H +LKP+NIL+ R I+D G ARL L LD V+
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
Y APEL + + DI+ G + EL+T
Sbjct: 198 ------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 38/231 (16%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARHPNLISLE 663
+G G FG V+ + GR A+K L +++ + E E +L HP +I +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 664 GYYWTPQLKL-LVSDYAPNGSLQAKL-HERLPSTPPLSWTNRF---KVILGTAKGLAHLH 718
G + Q ++ ++ DY G L + L + P +F +V L L +LH
Sbjct: 73 GTFQDAQ-QIFMIMDYIEGGELFSLLRKSQRFPNP----VAKFYAAEVCLA----LEYLH 123
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAP 775
II+ +LKP NILLD N + +I+DFG A K+V + + G Y+AP
Sbjct: 124 SK---DIIYRDLKPENILLDKNGHIKITDFGFA-------KYV-PDVTYTLCGTPDYIAP 172
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVV----ILSEHVR 822
E+ + N+ D + FG+LI E++ G P Y + + IL+ +R
Sbjct: 173 EVV-STKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELR 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 41/215 (19%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 663
VG G +G V G G +A+KKL Q + RE+R+L RH N+I L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 664 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 715
+ TP L LV + + L +L L +R + ++ KGL
Sbjct: 91 DVF-TPDETLDDFTDFYLVMPF-----MGTDLG-KLMKHEKLG-EDRIQFLVYQMLKGLR 142
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 773
++H + IIH +LKP N+ ++++ +I DFGLAR M+ GYV
Sbjct: 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMT-------GYVVT 188
Query: 774 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
APE+ +R + DI+ G ++ E++TG+
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 2e-15
Identities = 51/272 (18%), Positives = 95/272 (34%), Gaps = 24/272 (8%)
Query: 189 PVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV 248
P + L + W G+ S E + + ++L
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRP--ECWCRDSATDEQLFR 353
Query: 249 IRLRGNSLNGNIPEGLFDLGLEEID-------LSENGFMGSIPPGSSSSSSSTLFQTLRI 301
L E L+E++ L+ M ++ P + F TL+
Sbjct: 354 CELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 302 LD--------LSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 353
+D + + + +A++R L+L+ L L + HLDL
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLS 471
Query: 354 NNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG-SIPKS 412
+N L ++P + R L +LQ N+L + + N L L L +N L + +
Sbjct: 472 HNRL-RALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNRLQQSAAIQP 528
Query: 413 ISNLNKLKILKLEFNELSGEIPQELGKLASLL 444
+ + +L +L L+ N L + +LA +L
Sbjct: 529 LVSCPRLVLLNLQGNSLC-QEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 4e-13
Identities = 55/316 (17%), Positives = 98/316 (31%), Gaps = 21/316 (6%)
Query: 73 SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 132
++S L + S + TL L + +++ + G + DL
Sbjct: 246 CCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLP 305
Query: 133 HNLFSGSIPQGVAALHYL-----KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ 187
+ +PQ + + KE +L ++ D L +LS T
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC-WCRDSATDEQLFRCELSVEKST-V 363
Query: 188 LPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLS 247
L L + + N I + + L + + + + ++ +
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL--KAVDPMRAAY 421
Query: 248 VIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 307
+ LR L N + + + L+ + + LDLS N
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQ-------LLLVTHLDLSHN 473
Query: 308 NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG-SIPQEVC 366
L +P + L L S N L + + L L L NN L + Q +
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALEN--VDGVANLPRLQELLLCNNRLQQSAAIQPLV 530
Query: 367 ESRSLGILQLDGNSLT 382
L +L L GNSL
Sbjct: 531 SCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 5e-11
Identities = 73/399 (18%), Positives = 125/399 (31%), Gaps = 35/399 (8%)
Query: 92 FNYCSSLNTLNLSNN-----------HFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
+ SL T N SN D + L+ L+L N F +
Sbjct: 164 LAFTDSLITRNFSNYSSWHYRSCLLPQLHPQPDSGPQGRLPENVLLKELELVQNAFF-TD 222
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200
P +A Y + LL + + ++ S L G +L L+
Sbjct: 223 PNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAP 282
Query: 201 ISVSNNTLTGD---IPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 257
+SV T G W+ ++ D H + + + K+ +++ R
Sbjct: 283 LSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWC 342
Query: 258 GNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM 317
+ D L +LS S S Q L + + + +
Sbjct: 343 RDSAT---DEQLFRCELSVE----KSTVLQSELESCKELQELEPENKWCLLTIILLMRAL 395
Query: 318 GLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLD 377
+ + L++ P Y L L N E + +L L
Sbjct: 396 DPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN------SVLKMEYADVRVLHLA 449
Query: 378 GNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQEL 437
LT + + L LSHN L ++P +++ L L++L+ N L + +
Sbjct: 450 HKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GV 504
Query: 438 GKLASLLAVNVSYNRL--IGRLPVGGVFPTLDQSSLQGN 474
L L + + NRL + P L +LQGN
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 1e-10
Identities = 30/161 (18%), Positives = 61/161 (37%), Gaps = 14/161 (8%)
Query: 22 ILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG 81
+ + S+L + +++ L L++ L+ + + E + +L L+
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSH 472
Query: 82 NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG-SI 140
N L+ + L L S+N ++D G+ +L RL+ L L +N +
Sbjct: 473 NRLRA-LPPALAALRCLEVLQASDNALE-NVD-----GVANLPRLQELLLCNNRLQQSAA 525
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPAD---IGFCPHLTTLD 178
Q + + L L LQGN P ++++
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 25/109 (22%), Positives = 39/109 (35%), Gaps = 7/109 (6%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
+ + ++ L+ SHN L +PP+L L ++ L S+N L
Sbjct: 449 AHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALR--CLEVLQASDNALENVDG-- 503
Query: 67 LFENCASLRYLSLAGN-ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDF 114
N L+ L L N + Q + C L LNL N +
Sbjct: 504 -VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 41/215 (19%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 663
VG G +G+V G +AVKKL S Q + RE+R+L +H N+I L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 664 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 715
+ TP L LV+ + A L+ + L+ + + ++ +GL
Sbjct: 95 DVF-TPARSLEEFNDVYLVTHL-----MGADLN-NIVKCQKLT-DDHVQFLIYQILRGLK 146
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 773
++H + IIH +LKPSN+ ++++ +I DFGLAR M+ GYV
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMT-------GYVAT 192
Query: 774 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
APE+ + N+ DI+ G ++ EL+TGR
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 2e-15
Identities = 65/446 (14%), Positives = 135/446 (30%), Gaps = 65/446 (14%)
Query: 20 FRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSN-NLLSGPVPYQLFENCASLRYLS 78
R L+ ++F +S L +++ L L + + + +C ++ L
Sbjct: 111 LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLL 170
Query: 79 LAGNILQ----GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSH- 133
+ + + ++ + +SL LN F+ + + L ++ +
Sbjct: 171 MEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDF 230
Query: 134 -NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSL 192
L + A L L + ++ F L L LS +P+
Sbjct: 231 EILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILF 289
Query: 193 RLLNSMIFISVSNNTLTGDIPHW-IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRL 251
+ + + L + I LE L+ N L CK+L +R+
Sbjct: 290 PFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRI 349
Query: 252 RGNSLNGNIP--------EGLFDLG-----LEEIDLSENGF----MGSIPPGSSSSSSST 294
+ + GL L LE + + + + SI +
Sbjct: 350 ERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESI------GTYLK 403
Query: 295 LFQTLRILDLSSNNLVGDIPAEMGLFA------NLRYLNLSSN--HLRSRIPPELG-YFH 345
R++ L + D+P + G+ + LR L +G Y
Sbjct: 404 NLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463
Query: 346 SLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHL 405
++ + L G+++ R C +L L +
Sbjct: 464 NVRWMLLGY-----------VGESDEGLMEF------------SRGCPNLQKLEMRGCCF 500
Query: 406 S-GSIPKSISNLNKLKILKLEFNELS 430
S +I +++ L L+ L ++ S
Sbjct: 501 SERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 9e-10
Identities = 43/285 (15%), Positives = 87/285 (30%), Gaps = 37/285 (12%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
+L S G +L ++ LDL LL L + C +L L
Sbjct: 269 PRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNV 328
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGY----GIWSL----KRLRTLDLSHN 134
I + + YC L L + ++ G G+ +L + L + + +
Sbjct: 329 IGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVS 388
Query: 135 LFS----GSIPQGVAALHYLKELLLQGNQFSGPLPADIGF------CPHLTTLDLSNN-- 182
+ SI + L + +LL + LP D G C L
Sbjct: 389 DITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQG 448
Query: 183 -------LFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT-G 234
+ GQ ++R + + + G + + L+ L+ +
Sbjct: 449 GLTDLGLSYIGQYSPNVRWML----LGYVGESDEG-LMEFSRGCPNLQKLEMRGCCFSER 503
Query: 235 SLPSSLFNCKKLSVIRLRGNSLN----GNIPEGLFDLGLEEIDLS 275
++ +++ L + ++G + + +E I
Sbjct: 504 AIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 49/394 (12%), Positives = 107/394 (27%), Gaps = 90/394 (22%)
Query: 54 LSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLD 113
++ L P +L +LR L L G NL ++ G +
Sbjct: 55 VTMALCYTATPDRLSRRFPNLRSLKLKG-------------KPRAAMFNLIPENWGGYVT 101
Query: 114 FASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPH 173
+L++L+++ + S L L +
Sbjct: 102 PWVTEISNNLRQLKSVHFRRMIVSDL------DLDRLAK----------------ARADD 139
Query: 174 LTTLDLSN--NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 231
L TL L T L + + + + ++ + W+ ++
Sbjct: 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ---------- 189
Query: 232 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-----LEEIDLSENGFMGSIPPG 286
+ L V+ P+ L + L + + + + +
Sbjct: 190 ----------HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFF 239
Query: 287 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHS 346
++++ + L+ + + + + L L LS +P +
Sbjct: 240 KAAAN----LEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQ 294
Query: 347 LIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLS 406
+ LDL L T +I+ C +L +L +
Sbjct: 295 IRKLDLLYALL-----------------------ETEDHCTLIQKCPNLEVLETRNVIGD 331
Query: 407 GSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 440
+ +LK L++E + E G +
Sbjct: 332 RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLV 365
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 41/215 (19%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 663
+G G G V R +A+KKL S Q + RE+ ++ H N+I L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 664 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 715
+ TPQ L +V + + A L + + L R +L G+
Sbjct: 91 NVF-TPQKSLEEFQDVYIVMEL-----MDANLCQVIQM--ELD-HERMSYLLYQMLCGIK 141
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 773
HLH + IIH +LKPSNI++ + +I DFGLAR +M+ YV
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT-------PYVVT 189
Query: 774 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
APE+ + E DI+ G ++ E++ G
Sbjct: 190 RYYRAPEV-ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 607 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPED---FEREVRVLGKARHPNLI 660
+G+G FG V+ K+S ++ A+K L + + ER +L + HP ++
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER--DILVEVNHPFIV 89
Query: 661 SLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAH 716
L + T KL L+ D+ G L +L + + T +F ++ L L H
Sbjct: 90 KLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDV---KFYLAELALA----LDH 141
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
LH II+ +LKP NILLD+ + +++DFGL++ +D + F + Y+APE
Sbjct: 142 LHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPE 196
Query: 777 LTCQSLRVNEK-----CDIYGFGVLILELVTGRRPVEYGEDN 813
+ VN + D + FGVL+ E++TG P G+D
Sbjct: 197 V------VNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDR 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
G G FG V G +AVK K+ + D++ RE++ L RHP++I L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVV---GKIRREIQNLKLFRHPHIIKL 81
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
TP +V +Y G L + + RL F+ IL G+ + H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESR---RLFQQILS---GVDYCH-- 133
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 777
R ++H +LKP N+LLD + N +I+DFGL+ +++ +++ G Y APE+
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD------GEFLRTSCGSPNYAAPEV 186
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
L + DI+ GV++ L+ G P + +D+V L
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFD--DDHVPTL 224
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 42/215 (19%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G G G V+ + +A+KK+V +D RE++++ + H N++ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVFEIL 77
Query: 667 WTPQLKLLVSDYAPNGS---------LQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAH 716
+L + ++ L + PL ++ + +GL +
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-NVLEQGPLL-EEHARLFMYQLLRGLKY 135
Query: 717 LHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 773
+H + ++H +LKP+N+ ++ ++ +I DFGLAR+ +D H S +
Sbjct: 136 IHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARI---MDPHYSHKGHLS--EGLVT 187
Query: 774 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
+P L + D++ G + E++TG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 52/241 (21%), Positives = 90/241 (37%), Gaps = 40/241 (16%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISL 662
+G G +G VY + +A+KK+ + + + D + RE+ +L + + +I L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 663 EGYYWTPQLKL-----LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG-TAKGLAH 716
L +V + + L + + L+ K IL G
Sbjct: 91 YDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLT-EEHIKTILYNLLLGENF 144
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL------ 770
+H S IIH +LKP+N LL+ + + ++ DFGLAR + + N +
Sbjct: 145 IHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 771 --------GYV------APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 816
+V APEL + DI+ G + EL+ + N
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
Query: 817 L 817
L
Sbjct: 262 L 262
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 37/224 (16%)
Query: 607 VGEGVFGTVY---KVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKARH-PNL 659
+G G +G V+ K+S G++ A+K L + I+Q + E E +VL R P L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 660 ISLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLA 715
++L + T KL L+ DY G L L +R T + +++L L
Sbjct: 122 VTLHYAFQTET-KLHLILDYINGGELFTHLSQRERFTEHEV---QIYVGEIVL----ALE 173
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA---LG- 771
HLH II+ ++K NILLD N + ++DFGL+ K +++ + A G
Sbjct: 174 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS-------KEFVADETERAYDFCGT 223
Query: 772 --YVAPE-LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
Y+AP+ + ++ D + GVL+ EL+TG P +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDG 266
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE----REVRVLGKARHP 657
EK +GEG F TVYK +++A+KK+ + + RE+++L + HP
Sbjct: 13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKL-HERLPSTPPL--SWTNRFKVILGTAKGL 714
N+I L + LV D+ L+ + L TP ++ +L T +GL
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY------MLMTLQGL 125
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
+LH + I+H +LKP+N+LLD+N +++DFGLA+ +++ Y A
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWYRA 180
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGR 804
PEL + D++ G ++ EL+
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 47/216 (21%), Positives = 86/216 (39%), Gaps = 36/216 (16%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPED--FEREVRVLGKARHPNLI 660
G G FG V+ + + + VK K++ I+ P+ E+ +L + H N+I
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 661 SLEGYYWTPQLKLLVSDYAPNG-------SLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
+ + LV + +G +L E L S F+ ++
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS-------YIFRQLVS---A 142
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG-- 771
+ +L IIH ++K NI++ +++ ++ DFG A L R F + G
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER------GKLFYTFCGTI 193
Query: 772 -YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
Y APE+ + + +++ GV + LV P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL---------VTSDIIQYPEDFEREVRVLG 652
++ ++G G + TVYK T G +A+K++ T+ I RE+ ++
Sbjct: 8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--I-------REISLMK 58
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGT 710
+ +H N++ L T LV ++ N L+ + + L
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
+GLA H + I+H +LKP N+L++ ++ DFGLAR + + S+ L
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-TL 172
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
Y AP++ S + DI+ G ++ E++TG+
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
GEG FG V + + +A+K L SD+ ERE+ L RHP++I L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM---HMRVEREISYLKLLRHPHIIKL 74
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
TP ++V +YA G L + +R+ F+ I+ + + H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGR---RFFQQIIC---AIEYCH-- 125
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG---YVAPEL 777
R I+H +LKP N+LLDDN N +I+DFGL+ ++T N +++ G Y APE+
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD------GNFLKTSCGSPNYAAPEV 178
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL 817
L + D++ G+++ ++ GR P + ++ + L
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFD--DEFIPNL 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 32/289 (11%), Positives = 72/289 (24%), Gaps = 61/289 (21%)
Query: 605 AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISL 662
G ++ R +A+ + ++ ++ L + P + +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 663 ------EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
+V+++ GSLQ P + + + A
Sbjct: 97 LDVVHTRAGGL------VVAEWIRGGSLQEVADTSPS--PVGA----IRAMQSLAAAADA 144
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
H R + PS + + + + ++ +
Sbjct: 145 AH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD- 178
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836
N + DI G G + L+ R P+ L+ R + +D
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNRWPLP-EAGVRSGLAPAERDTAGQPIEPADIDR 230
Query: 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRM 885
D P + +A R + + + Q +
Sbjct: 231 ---DIPFQ----ISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEV 272
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 47/225 (20%), Positives = 81/225 (36%), Gaps = 25/225 (11%)
Query: 45 NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLN 102
+L ++ V S+ + + I + Y ++ L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNS----DIKSVQGIQYLPNVTKLF 74
Query: 103 LSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG 162
L+ N + D+ + +LK L L L N + + L LK L L+ N S
Sbjct: 75 LNGNKLT-DIK-----PLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISD 126
Query: 163 PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTL 222
+ P L +L L NN T L L + +S+ +N ++ DI + ++ L
Sbjct: 127 ING--LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKL 180
Query: 223 EFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL 267
+ L S NH++ L +L K L V+ L +L
Sbjct: 181 QNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNL 223
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 46/238 (19%), Positives = 91/238 (38%), Gaps = 23/238 (9%)
Query: 218 NISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSE 276
+ + +T + + I + + ++ +G+ L + ++ L+
Sbjct: 22 AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 277 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 336
N + I P ++ + L L L N + D+ + L L+ L+L N +
Sbjct: 78 NK-LTDIKPLAN-------LKNLGWLFLDENKVK-DLSSLKDL-KKLKSLSLEHNGISD- 126
Query: 337 IPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLY 396
I L + L L L NN + + + L L L+ N ++ +P + T L
Sbjct: 127 ING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 181
Query: 397 LLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLI 454
L LS NH+S + ++++ L L +L+L E + L V + L+
Sbjct: 182 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 48/210 (22%), Positives = 78/210 (37%), Gaps = 25/210 (11%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
+ +L + N L+ I P L NL N+ +L L N + ++ L+ LSL N
Sbjct: 70 VTKLFLNGNKLT-DIKP-LANLK--NLGWLFLDENKVKDLSS---LKDLKKLKSLSLEHN 122
Query: 83 ILQGPIGKI--FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
I I + L +L L NN + D+ + L +L TL L N S I
Sbjct: 123 ----GISDINGLVHLPQLESLYLGNNKIT-DIT-----VLSRLTKLDTLSLEDNQIS-DI 171
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200
+A L L+ L L N S + +L L+L + + L
Sbjct: 172 V-PLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 228
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNN 230
+ ++ +L P I + E + +
Sbjct: 229 VKNTDGSLVT--PEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 41/214 (19%), Positives = 85/214 (39%), Gaps = 27/214 (12%)
Query: 23 LERLNFSHNSLSGQIPPSLLNL-NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG 81
++++ +++ + S+ + + N+ L L+ N L+ P N +L +L L
Sbjct: 48 IDQIIANNSDIK-----SVQGIQYLPNVTKLFLNGNKLTDIKP---LANLKNLGWLFLDE 99
Query: 82 NILQGPIGKI--FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGS 139
N + + L +L+L +N S D++ G+ L +L +L L +N +
Sbjct: 100 N----KVKDLSSLKDLKKLKSLSLEHNGIS-DIN-----GLVHLPQLESLYLGNNKI--T 147
Query: 140 IPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMI 199
++ L L L L+ NQ S +P + L L LS N + L L ++
Sbjct: 148 DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRA--LAGLKNLD 203
Query: 200 FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT 233
+ + + + N+ + ++ L
Sbjct: 204 VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 42/213 (19%), Positives = 83/213 (38%), Gaps = 27/213 (12%)
Query: 69 ENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 128
+ A +L + + N +S++ + +N+ + GI L +
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-----GIQYLPNVTK 72
Query: 129 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGF---CPHLTTLDLSNNLFT 185
L L+ N + I +A L L L L N+ D+ L +L L +N +
Sbjct: 73 LFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGIS 125
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 245
+ L L + + + NN +T DI + ++ L+ L +N ++ + L K
Sbjct: 126 -DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI-VPLAGLTK 179
Query: 246 LSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSEN 277
L + L N ++ ++ L L L+ ++L
Sbjct: 180 LQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQ 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 7e-15
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 24/214 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 662
+G+G FG V + AVK L +IQ +D E E RVL + P L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQL 407
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLHH 719
+ T V +Y G L + + P + F ++ +G L L
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA---VFYAAEIAIG----LFFLQS 460
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-LT 778
II+ +LK N++LD + +I+DFG+ + + V + F Y+APE +
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEIIA 515
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
Q + D + FGVL+ E++ G+ P GED
Sbjct: 516 YQPY--GKSVDWWAFGVLLYEMLAGQAPF-EGED 546
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 45/219 (20%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---------REVRVLGKARHP 657
+GEG +G V +A+KK+ FE RE+++L + RH
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKI---------SPFEHQTYCQRTLREIKILLRFRHE 85
Query: 658 NLISLEGYYWTPQLKL-----LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTA 711
N+I + P ++ +V D ++ L+ +L T LS + L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDL-----METDLY-KLLKTQHLS-NDHICYFLYQIL 138
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+GL ++H + ++H +LKPSN+LL+ + +I DFGLAR+ D F +
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV---ADPDHDHTGFLT--E 190
Query: 772 YV------APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
YV APE+ S + DI+ G ++ E+++ R
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 27/225 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKAR-HPNLISL 662
+G G + V++ T + VK L P + RE+++L R PN+I+L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITL 96
Query: 663 EGYYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
P + LV ++ N + + IL K L + H S
Sbjct: 97 ADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYDIRFYMYEIL---KALDYCH-S 148
Query: 721 FRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
I+H ++KP N+++D ++ R+ D+GLA + R S + PEL
Sbjct: 149 MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH--PGQEYNVRVAS-RYFKGPELLV 203
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
+ D++ G ++ ++ + P +G DN L +VL
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKARHPNLISLE 663
+G G G V R +A+KKL S Q + RE+ ++ H N+ISL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 664 GYYWTPQLKL-------LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLA 715
+ TPQ L LV + + A L + + L R +L G+
Sbjct: 128 NVF-TPQKTLEEFQDVYLVMEL-----MDANLCQVIQM--ELD-HERMSYLLYQMLCGIK 178
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV-- 773
HLH + IIH +LKPSNI++ + +I DFGLAR +M+ YV
Sbjct: 179 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT-------PYVVT 226
Query: 774 ----APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
APE+ + E DI+ G ++ E+V +
Sbjct: 227 RYYRAPEV-ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 43/214 (20%), Positives = 81/214 (37%), Gaps = 54/214 (25%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISLEG 664
+G G+ G V ++ A+K ++Q REV + + ++ P+++ +
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK------MLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 665 YYWTPQLK----LLVSDYAPNGSLQAKLHERLPSTPPLSWTNR-----FKVILGTAKGLA 715
Y L+V + G +L R+ ++T R K I + +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGG----ELFSRIQDRGDQAFTEREASEIMKSIG---EAIQ 131
Query: 716 HLHHSFRPPIIHYNLKPSNILL---DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
+LH I H ++KP N+L N +++DFG
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------- 166
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
A E T + ++ CD++ GV++ L+ G P
Sbjct: 167 -AKETTGEKY--DKSCDMWSLGVIMYILLCGYPP 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 49/178 (27%), Positives = 73/178 (41%), Gaps = 24/178 (13%)
Query: 282 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL--FANLRYLNLSSNHLRSRIPP 339
++P L +LDLS NNL + AE NL L LS NHL I
Sbjct: 32 NVPQS--------LPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNF-ISS 81
Query: 340 ELGYFH---SLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSL 395
F +L +LDL +N L ++ + + ++L +L L N + + L
Sbjct: 82 --EAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQL 138
Query: 396 YLLSLSHNHLSGSIP----KSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 449
L LS N +S P K + L KL +L L N+L +L KL + + +
Sbjct: 139 QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 51/228 (22%), Positives = 77/228 (33%), Gaps = 33/228 (14%)
Query: 48 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 107
LDLS+N LS +L L L+ N L + F +L L+LS+NH
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 108 F----SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSG 162
L+ L L L +N + + + L++L L NQ S
Sbjct: 100 LHTLDEFLFS--------DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR 150
Query: 163 PLPADI----GFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS--NNTLTGD----- 211
P ++ P L LDLS+N L+ L + + + NN L D
Sbjct: 151 -FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQ 209
Query: 212 -IPHWIG-NISTLEFLD-----FSNNHLTGSLPSSLFNCKKLSVIRLR 252
HW +S++ + L FNC +
Sbjct: 210 LFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKESAWE 257
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 49/196 (25%), Positives = 73/196 (37%), Gaps = 25/196 (12%)
Query: 243 CKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRIL 302
C + L N+P+ L +DLS N + + + + L L
Sbjct: 18 CASNIL-SCSKQQLP-NVPQSL-PSYTALLDLSHN-NLSRLRAEWTPTR----LTNLHSL 69
Query: 303 DLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSLI---HLDLRNNA 356
LS N+L I + F NLRYL+LSSNHL + + F L L L NN
Sbjct: 70 LLSHNHL-NFISS--EAFVPVPNLRYLDLSSNHLHT-LDE--FLFSDLQALEVLLLYNNH 123
Query: 357 LYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNC---TSLYLLSLSHNHLSGSIPKS 412
+ + + E L L L N ++ ++I++ L LL LS N L
Sbjct: 124 I-VVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 413 ISNLNKLKILKLEFNE 428
+ L L +
Sbjct: 183 LQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 60/274 (21%), Positives = 95/274 (34%), Gaps = 47/274 (17%)
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC--PHLTTLDLSNNLF 184
L S ++PQ + + Y L L N S L A+ +L +L LS+N
Sbjct: 21 NILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHN-- 74
Query: 185 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NC 243
L ++S F+ V N L +LD S+NHL +L LF +
Sbjct: 75 ------HLNFISSEAFVPVPN----------------LRYLDLSSNHLH-TLDEFLFSDL 111
Query: 244 KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 301
+ L V+ L N + + F+ L+++ LS+N P + L +
Sbjct: 112 QALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK--LPKLML 167
Query: 302 LDLSSNNLVGDIPAEMGLFANL-----RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNA 356
LDLSSN L +P L L L +N L F + L +
Sbjct: 168 LDLSSNKL-KKLPLTD--LQKLPAWVKNGLYLHNNPLEC-DCKLYQLFSHWQYRQLSSVM 223
Query: 357 LYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIR 390
+ + + I LD + +
Sbjct: 224 DFQEDLYCMHSKKLHNIFSLDFFNCSEYKESAWE 257
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 62/362 (17%), Positives = 106/362 (29%), Gaps = 82/362 (22%)
Query: 23 LERLNFSHNSLSGQIPPSL---LNLNMMNMKFLDLSNNLLSGPVPYQLFE----NCASLR 75
+ L+ S N+L L ++ L+LS N L +L + A++
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83
Query: 76 YLSLAGNILQGPIGKIF-----NYCSSLNTLNLSNNHFS--GDLDFASGYGIWSLKRLRT 128
L+L+GN L ++ L+L N FS +F + + +
Sbjct: 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP-ASITS 142
Query: 129 LDLSHNLFSGSIPQGVAAL--------HYLKELLLQGNQFSGPLPADIG----------F 170
L+L N + L + L L+GN +
Sbjct: 143 LNLRGNDLG---IKSSDELIQILAAIPANVNSLNLRGNNLA-----SKNCAELAKFLASI 194
Query: 171 CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNN 230
+T+LDLS NL S L + S + + L+ N
Sbjct: 195 PASVTSLDLSANLLG---LKSYAELAYIF---SSIP-------------NHVVSLNLCLN 235
Query: 231 HLTGS----LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG--------LEEIDLSENG 278
L G L + K L + L + + E LG + +D +
Sbjct: 236 CLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKE 295
Query: 279 FMGSIPPGSS--SSSSSTLFQTLRILDLSSNNL-----VGDIPAEMGLFANLRYLNLSSN 331
P S S+ L + L + L ++ + LR +
Sbjct: 296 I---HPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCK 352
Query: 332 HL 333
L
Sbjct: 353 PL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 66/331 (19%), Positives = 112/331 (33%), Gaps = 75/331 (22%)
Query: 171 CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNN 230
+T+LDLS N +S L +++ L+ S N
Sbjct: 21 PHGVTSLDLSLNNLY---SISTVELIQAF----------------ANTPASVTSLNLSGN 61
Query: 231 HLT----GSLPSSL-FNCKKLSVIRLRGNSLNGNIPEGLFDLG---------LEEIDLSE 276
L L L ++ + L GN L+ + +L + +DL
Sbjct: 62 SLGFKNSDELVQILAAIPANVTSLNLSGNFLS---YKSSDELVKTLAAIPFTITVLDLGW 118
Query: 277 NGFMGSIPPGSSSSSS-----STLFQTLRILDLSSNNLVGDIPAE------MGLFANLRY 325
N F S SSS S L ++ L+L N+L G ++ + AN+
Sbjct: 119 NDF------SSKSSSEFKQAFSNLPASITSLNLRGNDL-GIKSSDELIQILAAIPANVNS 171
Query: 326 LNLSSNHLRSRIPPELGYF-----HSLIHLDLRNNALYGSIPQEVCE-----SRSLGILQ 375
LNL N+L S+ EL F S+ LDL N L E+ + L
Sbjct: 172 LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLN 231
Query: 376 LDGNSLTGP----IPQVIRNCTSLYLLSLSHNHLSG-------SIPKSISNLNKLKILKL 424
L N L GP + + + L + L ++ + ++ + N+ K+ ++
Sbjct: 232 LCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDK 291
Query: 425 EFNELSGEIPQELGKLASLLAVNVSYNRLIG 455
E+ + L L+ L+
Sbjct: 292 NGKEIHPSHSIPISNLIRELSGKADVPSLLN 322
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 58/394 (14%), Positives = 118/394 (29%), Gaps = 103/394 (26%)
Query: 88 IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSL--------KRLRTLDLSHNLFSGS 139
+ + + + +L+LS N+ L + +L+LS N
Sbjct: 14 VEEFTSIPHGVTSLDLSLNNLYSI-------STVELIQAFANTPASVTSLNLSGNSLG-- 64
Query: 140 IPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMI 199
+ L ++L ++T+L+LS N + + S L +
Sbjct: 65 -FKNSDEL---VQILAAIPA-------------NVTSLNLSGNFLSYK---SSDELVKTL 104
Query: 200 FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGS----LPSSLFNC-KKLSVIRLRGN 254
+ T+ LD N + + N ++ + LRGN
Sbjct: 105 ---AAIPF-------------TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGN 148
Query: 255 SLNGNIPEGLFDLG---------LEEIDLSENGFMGSIPPGSS--SSSSSTLFQTLRILD 303
L + +L + ++L N + + +++ ++ LD
Sbjct: 149 DLG---IKSSDELIQILAAIPANVNSLNLRGNNLA---SKNCAELAKFLASIPASVTSLD 202
Query: 304 LSSNNLVGDIPAEM---GLFAN---LRYLNLSSNHLRSRIPPELGYF----HSLIHLDLR 353
LS+N L G + + LNL N L L L + L
Sbjct: 203 LSANLL-GLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261
Query: 354 NNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI 413
+ + ++ +E C++ + N + L+ + + S I
Sbjct: 262 YDIV-KNMSKEQCKA----------------LGAAFPNIQKIILVDKNGKEIHPSHSIPI 304
Query: 414 SNLNKLKILKLEFNELSGEIPQELGKLASLLAVN 447
SNL + K + L + K + +
Sbjct: 305 SNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDL 338
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 47/213 (22%), Positives = 80/213 (37%), Gaps = 30/213 (14%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKARH--PNLI 660
G G FG+VY + +A+K ++ + EV +L K +I
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 661 SLEGYYWTPQLKLLVSDYA-PNGSLQAKLHERLPSTPPLSWTNR--FKVILGTAKGLAHL 717
L ++ P +L+ + P L + ER L+ R F +L + + H
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA---RSFFWQVL---EAVRHC 165
Query: 718 HHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARLLTRLDKHVMSNRFQSALG---YV 773
H ++H ++K NIL+D N ++ DFG LL + G Y
Sbjct: 166 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-------TVYTDFDGTRVYS 215
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
PE ++ G+L+ ++V G P
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 43/215 (20%)
Query: 220 STLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD-LG-LEEIDLSE 276
+ + LD +N L+ SLPS F KL ++ L N L +P G+F L LE + +++
Sbjct: 37 ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94
Query: 277 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHL 333
N ++P G + L L L N L +P +F L YL+L N L
Sbjct: 95 NKLQ-ALPIGVFDQLVN-----LAELRLDRNQLK-SLPP--RVFDSLTKLTYLSLGYNEL 145
Query: 334 RSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCT 393
+S +P G F L L L+L N L T
Sbjct: 146 QS-LPK--GVFDKLTSLK---------------------ELRLYNNQLKRVPEGAFDKLT 181
Query: 394 SLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 427
L L L +N L +P+ +L KLK+L+L+ N
Sbjct: 182 ELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 64/218 (29%), Positives = 91/218 (41%), Gaps = 25/218 (11%)
Query: 242 NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 301
N K SV L IP + +++DL N S+P + + LR+
Sbjct: 15 NNNKNSV-DCSSKKLTA-IPSNIPA-DTKKLDLQSNKL-SSLPSKAFHRLTK-----LRL 65
Query: 302 LDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIPPELGYFHSLI---HLDLRNN 355
L L+ N L +PA G+F NL L ++ N L++ +P G F L+ L L N
Sbjct: 66 LYLNDNKLQ-TLPA--GIFKELKNLETLWVTDNKLQA-LPI--GVFDQLVNLAELRLDRN 119
Query: 356 ALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI- 413
L S+P V +S L L L N L V TSL L L +N L +P+
Sbjct: 120 QL-KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAF 177
Query: 414 SNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYN 451
L +LK LKL+ N+L L L + + N
Sbjct: 178 DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 55/197 (27%), Positives = 80/197 (40%), Gaps = 32/197 (16%)
Query: 72 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH--------FSGDLDFASGYGIWSL 123
A + L L N L K F+ + L L L++N F L
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKE------------L 84
Query: 124 KRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLS 180
K L TL ++ N ++P GV L L EL L NQ LP + F LT L L
Sbjct: 85 KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRV-FDSLTKLTYLSLG 141
Query: 181 NNLFTGQLPVSL-RLLNSMIFISVSNNTLTGDIPHWI-GNISTLEFLDFSNNHLTGSLPS 238
N LP + L S+ + + NN L +P ++ L+ L NN L +P
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLK-RVPE 198
Query: 239 SLF-NCKKLSVIRLRGN 254
F + +KL +++L+ N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 19/142 (13%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
LE L + N L +P + + ++N+ L L N L +P ++F++ L YLSL N
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFD-QLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYN 143
Query: 83 ILQG-PIGKIFNYCSSLNTLNLSNNHFS----GDLDFASGYGIWSLKRLRTLDLSHNLFS 137
LQ P G +F+ +SL L L NN G D L L+TL L +N
Sbjct: 144 ELQSLPKG-VFDKLTSLKELRLYNNQLKRVPEGAFD--------KLTELKTLKLDNNQLK 194
Query: 138 GSIPQGV-AALHYLKELLLQGN 158
+P+G +L LK L LQ N
Sbjct: 195 -RVPEGAFDSLEKLKMLQLQEN 215
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 34/162 (20%), Positives = 70/162 (43%), Gaps = 32/162 (19%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---------REVRVLGKARH 656
+G G +G V + + R++A+KK+ FE RE+ +L + H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKI--------LRVFEDLIDCKRILREIAILNRLNH 111
Query: 657 PNLISLEGYYWTPQLKL-----LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GT 710
+++ + ++ +V + + + + L+ K +L
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLT-ELHIKTLLYNL 165
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752
G+ ++H S I+H +LKP+N L++ + + ++ DFGLAR
Sbjct: 166 LVGVKYVH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGLAR 204
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 38/224 (16%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE---REVRVLGKAR-HPNLISL 662
+G+G +G V+K G ++AVKK+ D Q D + RE+ +L + H N+++L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 663 EGYYWTPQLK--LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVIL-GTAKGLAHLHH 719
+ LV DY ++ LH + L + ++ K + +LH
Sbjct: 75 LNVLRADNDRDVYLVFDY-----METDLH-AVIRANILE-PVHKQYVVYQLIKVIKYLHS 127
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL--------- 770
++H ++KPSNILL+ + +++DFGL+R + + +
Sbjct: 128 G---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 771 ----GYV------APELTCQSLRVNEKCDIYGFGVLILELVTGR 804
YV APE+ S + + D++ G ++ E++ G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 38/222 (17%)
Query: 602 EKAAEVGEGVFGTVYK-VSFGTQGRMLAVKKLVTSDIIQYPEDFE-------REV---RV 650
E AE+GEG +G V+K GR +A+K+ ++ E REV R
Sbjct: 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKR------VRVQTGEEGMPLSTIREVAVLRH 67
Query: 651 LGKARHPNLISLE----GYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFK 705
L HPN++ L + KL LV ++ L +++P P +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DL-TTYLDKVPE-PGVPTETIKD 124
Query: 706 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT---RLDKHVM 762
++ +GL LH ++H +LKP NIL+ + +++DFGLAR+ + L V+
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
L Y APE+ QS D++ G + E+ +
Sbjct: 182 ------TLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 662
+G+G FG V+ F + A+K L ++ +D E E RVL A HP L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 663 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 718
+ T + L V +Y G L + + F ++ILG L LH
Sbjct: 84 FCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHKFDLSRA---TFYAAEIILG----LQFLH 135
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 777
I++ +LK NILLD + + +I+DFG+ + + +N F Y+APE L
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGTPDYIAPEIL 190
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
Q N D + FGVL+ E++ G+ P +G+D
Sbjct: 191 LGQKY--NHSVDWWSFGVLLYEMLIGQSPF-HGQD 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 662
+G+G FG V + AVK L +IQ +D E E RVL + P L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVEKRVLALPGKPPFLTQL 86
Query: 663 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 718
+ T +L V +Y G L + + P + F ++ +G L L
Sbjct: 87 HSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPHA---VFYAAEIAIG----LFFLQ 138
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 777
II+ +LK N++LD + +I+DFG+ + + V + F Y+APE +
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEII 193
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
Q + D + FGVL+ E++ G+ P GED
Sbjct: 194 AYQPY--GKSVDWWAFGVLLYEMLAGQAPF-EGED 225
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYW 667
G G FG + ++AVK + I E+ +RE+ RHPN++ +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAID--ENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 668 TPQLKLLVSDYAPNGSLQAKL--HERLPSTPPLSWTNR--FKVILGTAKGLAHLHHSFRP 723
TP ++ +YA G L ++ R R F+ +L G+++ H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSED-----EARFFFQQLLS---GVSYCHSMQ-- 136
Query: 724 PIIHYNLKPSNILLDDNYNPR--ISDFGLARLLTRLDKHVMSNRFQSALG---YVAPELT 778
I H +LK N LLD + PR I DFG ++ V+ ++ +S +G Y+APE+
Sbjct: 137 -ICHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVL 189
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRP 806
+ + D++ GV + ++ G P
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE----REV---RVLGKA 654
E AE+G G +GTVYK G +A+K + + REV R L
Sbjct: 12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 655 RHPNLISLE----GYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 709
HPN++ L ++K+ LV ++ L ++ P P L ++
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DL-RTYLDKAP-PPGLPAETIKDLMRQ 128
Query: 710 TAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT---RLDKHVMSNRF 766
+GL LH + I+H +LKP NIL+ +++DFGLAR+ + L V+
Sbjct: 129 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV---- 181
Query: 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
L Y APE+ QS D++ G + E+ +
Sbjct: 182 --TLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRK 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 45/216 (20%), Positives = 79/216 (36%), Gaps = 34/216 (15%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVK-----KLVTSDIIQYPEDFEREVRVLGKAR----HPN 658
G+G FGTV+ T +A+K +++ + EV +L K HP
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 659 LISLEGYYWTPQLKLLVSDYAPNG-------SLQAKLHERLPSTPPLSWTNRFKVILGTA 711
+I L ++ T + +LV + + + L E F ++
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-------CFFGQVV--- 149
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-RISDFGLARLLTRLDKHVMSNRFQSAL 770
+ H H ++H ++K NIL+D ++ DFG LL F
Sbjct: 150 AAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTR 202
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRP 806
Y PE + ++ G+L+ ++V G P
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 29/169 (17%), Positives = 61/169 (36%), Gaps = 15/169 (8%)
Query: 68 FENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKR 125
SL Y++LA + + Y ++ L ++N H + + + I L
Sbjct: 40 EAQMNSLTYITLANI----NVTDLTGIEYAHNIKDLTINNIHAT-NYN-----PISGLSN 89
Query: 126 LRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT 185
L L + + ++ L L L + + + I P + ++DLS N
Sbjct: 90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG 234
+ L+ L + +++ + + D I + L L + + G
Sbjct: 150 TDIM-PLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 33/149 (22%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 306 SNNLVGDI-PAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQE 364
+ +I A+M +L Y+ L++ ++ + + Y H++ L + N +
Sbjct: 31 GQSSTANITEAQM---NSLTYITLANINVTD-LTG-IEYAHNIKDLTINNIHA--TNYNP 83
Query: 365 VCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL 424
+ +L L++ G +T + TSL LL +SH+ SI I+ L K+ + L
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 425 EFNELSGEIPQELGKLASLLAVNVSYNRL 453
+N +I L L L ++N+ ++ +
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 32/165 (19%), Positives = 63/165 (38%), Gaps = 16/165 (9%)
Query: 23 LERLNFSHNSLSGQIPPSLLNL-NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG 81
L + ++ +++ L + N+K L ++N + P ++L L + G
Sbjct: 46 LTYITLANINVT-----DLTGIEYAHNIKDLTINNIHATNYNP---ISGLSNLERLRIMG 97
Query: 82 NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP 141
+ + +SL L++S++ D I +L ++ ++DLS+N I
Sbjct: 98 KDVTSDKIPNLSGLTSLTLLDISHSAHD-DSILT---KINTLPKVNSIDLSYNGAITDI- 152
Query: 142 QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 186
+ L LK L +Q + I P L L + G
Sbjct: 153 MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 32/193 (16%), Positives = 69/193 (35%), Gaps = 18/193 (9%)
Query: 122 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181
+ K L + + A ++ L + L + I + ++ L ++N
Sbjct: 21 TFKAYLNGLLGQSSTANITE---AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 241
T P + L+++ + + +T D + +++L LD S++ S+ + +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 242 NCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLR 300
K++ I L N +I L L L+ +++ +G F L
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV-HDYRGIED-------FPKLN 184
Query: 301 ILDLSSNNLVGDI 313
L S +G
Sbjct: 185 QLYAFSQT-IGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 24/216 (11%), Positives = 63/216 (29%), Gaps = 41/216 (18%)
Query: 218 NISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSE 276
+ + + L+ I L ++ ++ G+ ++++ ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 277 NGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSR 336
++ + S L L L + ++ D + +L L++S +
Sbjct: 76 IHA-------TNYNPISGLSN-LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 337 IPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLY 396
I ++ + +DL N I ++ L
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDI-------------------------MPLKTLPELK 162
Query: 397 LLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE 432
L++ + + I + KL L + G+
Sbjct: 163 SLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 26/215 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 662
+G+G FG V G + AVK L I+Q +D E E R+L A HP L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLTQL 89
Query: 663 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 718
+ TP +L V ++ G L + + + RF ++I L LH
Sbjct: 90 FCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEARA---RFYAAEIISA----LMFLH 141
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 777
II+ +LK N+LLD + +++DFG+ + + V + F Y+APE L
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDYIAPEIL 196
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
D + GVL+ E++ G P E+
Sbjct: 197 QEMLY--GPAVDWWAMGVLLYEMLCGHAPF-EAEN 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 25/229 (10%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 662
+G G + V V R+ A+K + + ED + E V +A HP L+ L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 663 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 718
+ T +L V +Y G L + + + RF ++ L L +LH
Sbjct: 76 HSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAEISLA----LNYLH 127
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 777
II+ +LK N+LLD + +++D+G+ + L ++ F Y+APE L
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEIL 182
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826
+ D + GVL+ E++ GR P + + L +
Sbjct: 183 RGEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 37/237 (15%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 662
+G G + V V R+ A++ + + ED + E V +A HP L+ L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 663 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 718
+ T +L V +Y G L + + + RF ++ L L +LH
Sbjct: 119 HSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAEISLA----LNYLH 170
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE-L 777
II+ +LK N+LLD + +++D+G+ + L ++ F Y+APE L
Sbjct: 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEIL 225
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRP--------VEYGEDNV----VILSEHVR 822
+ D + GVL+ E++ GR P VIL + +R
Sbjct: 226 RGEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER---EVRVLGKA-RHPNLISL 662
+G+G FG V + AVK L I++ ++ + E VL K +HP L+ L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 663 EGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRF---KVILGTAKGLAHLH 718
+ T KL V DY G L L P + RF ++ L +LH
Sbjct: 105 HFSFQTAD-KLYFVLDYINGGELFYHLQRERCFLEPRA---RFYAAEIASA----LGYLH 156
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 778
I++ +LKP NILLD + ++DFGL + ++ + ++ F Y+APE+
Sbjct: 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYLAPEVL 211
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGED 812
+ D + G ++ E++ G P Y +
Sbjct: 212 -HKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRN 243
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 41/213 (19%), Positives = 75/213 (35%), Gaps = 26/213 (12%)
Query: 23 LERLNFSHNSLSGQIPPSLLNL-NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG 81
++ N ++++ SL + N+K L LS+N +S P ++ L LS+
Sbjct: 43 VQNFNGDNSNIQ-----SLAGMQFFTNLKELHLSHNQISDLSP---LKDLTKLEELSVNR 94
Query: 82 NILQGPIGKIFN-YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
N + + + L+ L L NN D D + LK L L + +N SI
Sbjct: 95 N----RLKNLNGIPSACLSRLFLDNNELR-DTD-----SLIHLKNLEILSIRNNKLK-SI 143
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200
+ L L+ L L GN+ + + + +DL+ + L
Sbjct: 144 V-MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNT 200
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT 233
+ + P++I N +
Sbjct: 201 VKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 34/234 (14%), Positives = 81/234 (34%), Gaps = 32/234 (13%)
Query: 45 NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLS 104
+ N +L ++ V + + ++ + + +Q G + ++L L+LS
Sbjct: 17 GLANAVKQNLGKQSVTDLVS---QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLS 71
Query: 105 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPL 164
+N S DL + L +L L ++ N ++ G+ + L L L N+
Sbjct: 72 HNQIS-DLS-----PLKDLTKLEELSVNRNRLK-NLN-GIPSAC-LSRLFLDNNELRDTD 122
Query: 165 PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 224
+ +L L + NN + L L+ + + + N +T + + + + +
Sbjct: 123 S--LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNW 176
Query: 225 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENG 278
+D + + ++ +G + +S G
Sbjct: 177 IDLTGQKCVNEPVKYQPELYITNTVKD----PDGRW--------ISPYYISNGG 218
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 46/192 (23%), Positives = 72/192 (37%), Gaps = 27/192 (14%)
Query: 69 ENCASLRYLSLAGNILQGPIGKI--FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
A+ +L + + S + N N++ L G+ L
Sbjct: 16 PGLANAVKQNLGKQ----SVTDLVSQKELSGVQNFNGDNSNIQ-SLA-----GMQFFTNL 65
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLSNNLF 184
+ L LSHN S + + L L+EL + N+ ++ L+ L L NN
Sbjct: 66 KELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNEL 118
Query: 185 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCK 244
SL L ++ +S+ NN L I +G +S LE LD N +T L K
Sbjct: 119 RD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITN--TGGLTRLK 172
Query: 245 KLSVIRLRGNSL 256
K++ I L G
Sbjct: 173 KVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 41/254 (16%), Positives = 80/254 (31%), Gaps = 47/254 (18%)
Query: 202 SVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIP 261
S+ T + ++ + +T S + +++ ++
Sbjct: 2 SIQRPTPINQVFP-DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL- 56
Query: 262 EGLFDL-GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 320
G+ L+E+ LS N + + P L L ++ N L ++
Sbjct: 57 AGMQFFTNLKELHLSHNQ-ISDLSPLKD-------LTKLEELSVNRNRLK-NLNGIPSA- 106
Query: 321 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNS 380
L L L +N LR L + +L L +RNN L S
Sbjct: 107 -CLSRLFLDNNELRD-TDS-LIHLKNLEILSIRNNKL---------------------KS 142
Query: 381 LTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKL 440
+ + + L +L L N ++ + ++ L K+ + L + E + +L
Sbjct: 143 IVM-----LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPEL 195
Query: 441 ASLLAVNVSYNRLI 454
V R I
Sbjct: 196 YITNTVKDPDGRWI 209
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 64/409 (15%), Positives = 123/409 (30%), Gaps = 47/409 (11%)
Query: 20 FRILERLNFSHNSLSGQIPPSLLNL--NMMNMKFLDLSN--NLLSGPVPYQLFENCASLR 75
R L+ L+ + + L + ++ L++S + +S +L C +L+
Sbjct: 155 CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLK 214
Query: 76 YLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYG--IWSLKRLRTLDLSH 133
L L + + + L L D SG + K LR L
Sbjct: 215 SLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFW 274
Query: 134 NLFSGSIPQGVAALHYLKELLLQGNQFSGP-LPADIGFCPHLTTLDLSNNL-------FT 185
+ +P + L L L L + CP L L + + +
Sbjct: 275 DAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLA 334
Query: 186 GQLP--VSLRLLNSMIFISVSNNTLTGDIPHWIG-NISTLEFLDFSNNHLTG-SLPSSLF 241
LR+ S F+ N LT + LE + + +T +L +
Sbjct: 335 STCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIAR 394
Query: 242 NCKKLSVIRLRGNSLNG--NIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL 299
N ++ RL + D+G I + L
Sbjct: 395 NRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAI--------------------VEHCKDL 434
Query: 300 RILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSR-IPPELGYFHSLIHLDLRNNA 356
R L LS L+ D E + L+++ + L SL L++R+
Sbjct: 435 RRLSLS--GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP 492
Query: 357 LYG-SIPQEVCESRSLGILQLDGNSLTGP-IPQVIRNCTSLYLLSLSHN 403
++ + ++ L + S++ + + L + +
Sbjct: 493 FGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDER 541
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 4e-12
Identities = 68/467 (14%), Positives = 141/467 (30%), Gaps = 49/467 (10%)
Query: 23 LERLNFSHNSLSGQIPPSLLNL--NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLA 80
N + G + P + + + ++ + L +++ + ++ + + L L+
Sbjct: 79 FADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLS 138
Query: 81 G--NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS--HNLF 136
+ I C +L L+L + + + L +L++S +
Sbjct: 139 SCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEV 198
Query: 137 S-GSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLS------NNLFTGQLP 189
S ++ + V LK L L L + P L L L
Sbjct: 199 SFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLS 258
Query: 190 VSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG-SLPSSLFNCKKLSV 248
V+L + +S + + +P S L L+ S + L L C KL
Sbjct: 259 VALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQR 318
Query: 249 IRLRGNSLNGNIPEGLFDLG-----LEEIDLSE-NGFMGSIPPGSSSSSSSTLFQTLRIL 302
+ + + GL L L E+ + F+ + ++ L
Sbjct: 319 LWVLDYIED----AGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKL 374
Query: 303 D--LSSNNLVGDIPAEMGLFA------NLRYLNLSSNHLRSRIPPELG-----------Y 343
+ L + + L N+ L ++ L +
Sbjct: 375 ESVLYFCRQMTN----AALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEH 430
Query: 344 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGP-IPQVIRNCTSLYLLSLSH 402
L L L ++ + +L + + + V+ C SL L +
Sbjct: 431 CKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRD 490
Query: 403 -NHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNV 448
++ + S L ++ L + +S + LG+ L V V
Sbjct: 491 CPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEV 537
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 43/169 (25%), Positives = 65/169 (38%), Gaps = 32/169 (18%)
Query: 25 RLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLS---GPVPYQLFENCASLRYLSLAG 81
L+ + + +L L K L LS N + +LR LSL
Sbjct: 29 ELHGMIPPIEK-MDATLSTLK--ACKHLALSTNNIEKISS------LSGMENLRILSLGR 79
Query: 82 NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS--GS 139
N+++ I + +L L +S N + L GI L LR L +S+N + G
Sbjct: 80 NLIKK-IENLDAVADTLEELWISYNQIA-SLS-----GIEKLVNLRVLYMSNNKITNWGE 132
Query: 140 IPQGVAALHYLKELLLQGNQFSGPLPAD----------IGFCPHLTTLD 178
I +AAL L++LLL GN + + P+L LD
Sbjct: 133 I-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 32/150 (21%), Positives = 55/150 (36%), Gaps = 20/150 (13%)
Query: 88 IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAAL 147
+ + + L LS N+ + + ++ LR L L NL I A
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KIS-----SLSGMENLRILSLGRNLIK-KIENLDAVA 92
Query: 148 HYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVS-LRLLNSMIFISVSNN 206
L+EL + NQ + + I +L L +SNN T + L L+ + + ++ N
Sbjct: 93 DTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
Query: 207 TLTGDIPHW----------IGNISTLEFLD 226
L D + + L+ LD
Sbjct: 151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 30/139 (21%), Positives = 49/139 (35%), Gaps = 15/139 (10%)
Query: 129 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADI---GFCPHLTTLDLSNNLFT 185
L + ++ L K L L N I +L L L NL
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK 83
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT--GSLPSSLFNC 243
++ + +++ + +S N + + I + L L SNN +T G + L
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAAL 139
Query: 244 KKLSVIRLRGNSLNGNIPE 262
KL + L GN L + E
Sbjct: 140 DKLEDLLLAGNPLYNDYKE 158
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 40/179 (22%), Positives = 68/179 (37%), Gaps = 41/179 (22%)
Query: 262 EGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGL-- 319
+ + E+++L G IPP ++ + + + L LS+NN I L
Sbjct: 18 KSVVATEAEKVELH-----GMIPPIEKMDATLSTLKACKHLALSTNN----IEKISSLSG 68
Query: 320 FANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGN 379
NLR L+L N + +I +L L + N I L G
Sbjct: 69 MENLRILSLGRNLI-KKIENLDAVADTLEELWISYNQ----------------IASLSG- 110
Query: 380 SLTGPIPQVIRNCTSLYLLSLSHNHLS--GSIPKSISNLNKLKILKLEFNELSGEIPQE 436
I +L +L +S+N ++ G I ++ L+KL+ L L N L + +
Sbjct: 111 ---------IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 32/134 (23%), Positives = 49/134 (36%), Gaps = 20/134 (14%)
Query: 152 ELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFT-----GQLPVSLRLLNSMIFISVSNN 206
EL + A + L LS N + +LR+L+ + N
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLSGME-NLRILS------LGRN 80
Query: 207 TLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPE--GL 264
+ I + TLE L S N + SL S + L V+ + N + N E L
Sbjct: 81 LIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKL 136
Query: 265 FDL-GLEEIDLSEN 277
L LE++ L+ N
Sbjct: 137 AALDKLEDLLLAGN 150
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 77/355 (21%), Positives = 121/355 (34%), Gaps = 96/355 (27%)
Query: 595 IDPETL-LEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFERE- 647
+ L L K +G G FG V + + R +AVK L E
Sbjct: 19 FPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 76
Query: 648 ------------VRVLG---KARHPNLI--------SLEGYYWT-----PQLKLLVSDYA 679
V +LG K P ++ +L Y + K + +
Sbjct: 77 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR 136
Query: 680 PN----GSLQAKLHERLPSTPP--------------LSWTNRFKVILGT----------- 710
G++ L RL S LS +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 711 ------AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSN 764
AKG+ L + R IH +L NILL + +I DFGLAR + + +V
Sbjct: 197 CYSFQVAKGMEFL--ASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 765 RFQSALGYVAPELTCQSLRVN---EKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEH 820
+ L ++APE ++ + D++ FGVL+ E+ + G P Y V + E
Sbjct: 254 DARLPLKWMAPE----TIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPG---VKIDEE 304
Query: 821 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
L+EG + P+ + + L C PS RP+ +E+V+ L
Sbjct: 305 FCRRLKEGTRMRA--------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 24/154 (15%)
Query: 282 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRSRIP 338
IP L +T+ + L N + IP G F+ LR ++LS+N + +
Sbjct: 25 EIPTN--------LPETITEIRLEQNTIK-VIPP--GAFSPYKKLRRIDLSNNQISE-LA 72
Query: 339 PELGYFHSLIHL---DLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTS 394
P F L L L N + +P+ + E SL +L L+ N + ++ +
Sbjct: 73 P--DAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129
Query: 395 LYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 427
L LLSL N L +I K S L ++ + L N
Sbjct: 130 LNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 35/168 (20%), Positives = 59/168 (35%), Gaps = 45/168 (26%)
Query: 220 STLEFLDFSNNHLTGSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENG 278
T+ + N + +P F+ KKL I L N ++ + F GL
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQ-GLRS------- 81
Query: 279 FMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFA---NLRYLNLSSNHLRS 335
L L L N + ++P LF +L+ L L++N +
Sbjct: 82 --------------------LNSLVLYGNKIT-ELPK--SLFEGLFSLQLLLLNANKINC 118
Query: 336 RIPPELGYF---HSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGN 379
+ F H+L L L +N L +I + R++ + L N
Sbjct: 119 -LRV--DAFQDLHNLNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 34/142 (23%), Positives = 54/142 (38%), Gaps = 17/142 (11%)
Query: 24 ERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNI 83
+ N++ IPP + ++ +DLSNN +S + F+ SL L L GN
Sbjct: 35 TEIRLEQNTIK-VIPPGAFS-PYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNK 91
Query: 84 LQGPIGKIFNYCSSLNTLNLSNNHFS----GDLDFASGYGIWSLKRLRTLDLSHNLFSGS 139
+ +F SL L L+ N + L L L L N +
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQ--------DLHNLNLLSLYDNKLQ-T 142
Query: 140 IPQGV-AALHYLKELLLQGNQF 160
I +G + L ++ + L N F
Sbjct: 143 IAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 30/142 (21%), Positives = 55/142 (38%), Gaps = 18/142 (12%)
Query: 72 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS----GDLDFASGYGIWSLKRLR 127
++ + L N ++ F+ L ++LSNN S L+ L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ--------GLRSLN 83
Query: 128 TLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFC--PHLTTLDLSNNLF 184
+L L N + +P+ + L L+ LLL N+ + L D F +L L L +N
Sbjct: 84 SLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDA-FQDLHNLNLLSLYDNKL 140
Query: 185 TGQLPVSLRLLNSMIFISVSNN 206
+ L ++ + ++ N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 31/164 (18%), Positives = 52/164 (31%), Gaps = 46/164 (28%)
Query: 100 TLNLSNNHFS----GDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELL 154
+ L N G K+LR +DLS+N S + L L L+
Sbjct: 36 EIRLEQNTIKVIPPGAFS--------PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLV 86
Query: 155 LQGNQFSGPLPADIGFC--PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDI 212
L GN+ + LP + F L L L+ N ++ +
Sbjct: 87 LYGNKITE-LPKSL-FEGLFSLQLLLLNAN----KI---------------------NCL 119
Query: 213 PHWI-GNISTLEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGN 254
++ L L +N L ++ F + + + L N
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 36/171 (21%), Positives = 63/171 (36%), Gaps = 33/171 (19%)
Query: 313 IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLG 372
IP L + + L N ++ IPP G F + L
Sbjct: 26 IPT--NLPETITEIRLEQNTIKV-IPP--GAFSPY---------------------KKLR 59
Query: 373 ILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFNELSG 431
+ L N ++ P + SL L L N ++ +PKS+ L L++L L N+++
Sbjct: 60 RIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN- 117
Query: 432 EIPQEL-GKLASLLAVNVSYNRLIGRLPVGGV--FPTLDQSSLQGNLGICS 479
+ + L +L +++ N+L + G + L N IC
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQNPFICD 167
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 35/195 (17%), Positives = 63/195 (32%), Gaps = 65/195 (33%)
Query: 164 LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 223
LP I T + L N +++++ F L
Sbjct: 30 LPETI------TEIRLEQN--------TIKVIPPGAFSPYKK----------------LR 59
Query: 224 FLDFSNNHLTGSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFM 280
+D SNN ++ L F + L+ + L GN + +P+ LF+ L+ + L+ N +
Sbjct: 60 RIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANK-I 116
Query: 281 GSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE 340
+ + FQ L NL L+L N L++
Sbjct: 117 NCLRVDA--------FQDLH---------------------NLNLLSLYDNKLQTIAKGT 147
Query: 341 LGYFHSLIHLDLRNN 355
++ + L N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 3/86 (3%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L L N ++ ++P SL + +++ L L+ N ++ + F++ +L LSL N
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFE-GLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDN 138
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHF 108
LQ F+ ++ T++L+ N F
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 6e-11
Identities = 33/200 (16%), Positives = 58/200 (29%), Gaps = 45/200 (22%)
Query: 594 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-------VTSDIIQYPEDFER 646
P L++ ++GEGVFG V++ +A+K + V + E+
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 647 EVRVL---------GKARHPNLISLEGYY----WTPQLKLLVSDY--APNGSLQAKLHER 691
E+ + R I L + P L L D+ + GS +
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 692 LPSTPPL-------------------SWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKP 732
+ S ++ LA S R H +L
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHW 190
Query: 733 SNILLDDNYNPRISDFGLAR 752
N+LL ++ +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 31/144 (21%), Positives = 53/144 (36%), Gaps = 18/144 (12%)
Query: 48 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNH 107
L L+NN + +F+ LR ++ + N + F S +N + L++N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 108 F----SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSG 162
L+ L+TL L N + + L ++ L L NQ +
Sbjct: 93 LENVQHKMFK--------GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT- 142
Query: 163 PLPADIGF--CPHLTTLDLSNNLF 184
+ F L+TL+L N F
Sbjct: 143 TVAPGA-FDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 31/142 (21%), Positives = 56/142 (39%), Gaps = 16/142 (11%)
Query: 24 ERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNI 83
L ++N + + + + + ++ ++ SNN ++ + FE + + + L N
Sbjct: 35 AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNR 92
Query: 84 LQGPIGKIFNYCSSLNTLNLSNNHFS----GDLDFASGYGIWSLKRLRTLDLSHNLFSGS 139
L+ K+F SL TL L +N + L +R L L N + +
Sbjct: 93 LENVQHKMFKGLESLKTLMLRSNRITCVGNDSFI--------GLSSVRLLSLYDNQIT-T 143
Query: 140 IPQGV-AALHYLKELLLQGNQF 160
+ G LH L L L N F
Sbjct: 144 VAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 27/140 (19%), Positives = 54/140 (38%), Gaps = 16/140 (11%)
Query: 313 IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFH---SLIHLDLRNNALYGSIPQEVCES- 368
IP + L L++N + + G F L ++ NN + I + E
Sbjct: 26 IPE--HIPQYTAELRLNNNEF-TVLEAT-GIFKKLPQLRKINFSNNKI-TDIEEGAFEGA 80
Query: 369 RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 427
+ + L N L ++ + SL L L N ++ + L+ +++L L N
Sbjct: 81 SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139
Query: 428 ELSGEIPQE----LGKLASL 443
+++ + L L++L
Sbjct: 140 QIT-TVAPGAFDTLHSLSTL 158
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-09
Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 40/181 (22%)
Query: 52 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 111
+ L+ L+ Y N R L L G + I + + ++ S+N
Sbjct: 2 VKLTAELIEQAAQY---TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56
Query: 112 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC 171
LD G L+RL+TL +++N + + E L Q
Sbjct: 57 LD-----GFPLLRRLKTLLVNNN-----------RICRIGEGLDQA-------------L 87
Query: 172 PHLTTLDLSNNLFTGQLPVS-LRLLNSMIFISVSNNTLTGDIPHW----IGNISTLEFLD 226
P LT L L+NN + L L S+ ++ + N +T + H+ I + + LD
Sbjct: 88 PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 146
Query: 227 F 227
F
Sbjct: 147 F 147
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 21/112 (18%), Positives = 35/112 (31%), Gaps = 9/112 (8%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L+ + I L + +D S+N + F L+ L + N
Sbjct: 21 DRELDLRGYKIP-VI--ENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVNNN 74
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
+ + L L L+NN + + SLK L L + N
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLV---ELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 25/127 (19%), Positives = 44/127 (34%), Gaps = 13/127 (10%)
Query: 10 SYNAIPSM----VVFRILERLNFSHNSLSGQIPPSLLNL-NMMNMKFLDLSNNLLSGPVP 64
IP + + ++FS N + L + +K L ++NN + +
Sbjct: 27 RGYKIPVIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRLKTLLVNNNRICR-IG 80
Query: 65 YQLFENCASLRYLSLAGNILQGPIG-KIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSL 123
L + L L L N L SL L + N + + Y I+ +
Sbjct: 81 EGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL-YVIYKV 139
Query: 124 KRLRTLD 130
++R LD
Sbjct: 140 PQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 24/134 (17%), Positives = 46/134 (34%), Gaps = 15/134 (11%)
Query: 225 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL--GLEEIDLSENGFMGS 282
+ + + + + N + + LRG + + E L + ID S+N
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDN----- 52
Query: 283 IPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS-RIPPEL 341
L + L+ L +++N + +L L L++N L L
Sbjct: 53 ---EIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL 109
Query: 342 GYFHSLIHLDLRNN 355
SL +L + N
Sbjct: 110 ASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 22/128 (17%), Positives = 39/128 (30%), Gaps = 8/128 (6%)
Query: 326 LNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPI 385
+ L++ + + LDLR + I + N + +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 386 PQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS--GEIPQELGKLASL 443
L L +++N + L L L L N L G++ L L SL
Sbjct: 58 DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSL 115
Query: 444 LAVNVSYN 451
+ + N
Sbjct: 116 TYLCILRN 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 28/115 (24%), Positives = 43/115 (37%), Gaps = 8/115 (6%)
Query: 70 NCASLRYLSLAGN-ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 128
A++R L L G I + +L L+L N + + L +L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-----NLPKLPKLKK 75
Query: 129 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPAD-IGFCPHLTTLDLSNN 182
L+LS N G + L L L L GN+ + + L +LDL N
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 37/157 (23%), Positives = 52/157 (33%), Gaps = 14/157 (8%)
Query: 32 SLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI 91
+ +I L N ++ L L N + L +L +LSL L +
Sbjct: 9 DMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI----SV 64
Query: 92 --FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG-SIPQGVAALH 148
L L LS N G LD + L L L+LS N S + + L
Sbjct: 65 SNLPKLPKLKKLELSENRIFGGLDMLAE----KLPNLTHLNLSGNKLKDISTLEPLKKLE 120
Query: 149 YLKELLLQGN---QFSGPLPADIGFCPHLTTLDLSNN 182
LK L L + + P LT LD +
Sbjct: 121 CLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 9/113 (7%)
Query: 20 FRILERLNFSHNSLSGQIPPSLLNL-NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLS 78
F LE L+ + L S+ NL + +K L+LS N + G L E +L +L+
Sbjct: 48 FVNLEFLSLINVGLI-----SVSNLPKLPKLKKLELSENRIFG-GLDMLAEKLPNLTHLN 101
Query: 79 LAGNILQGPIG-KIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLD 130
L+GN L+ + L +L+L N + D+ L +L LD
Sbjct: 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRE-SVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 29/142 (20%), Positives = 52/142 (36%), Gaps = 11/142 (7%)
Query: 94 YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 153
+++ L L N + L L L + S+ + L LK+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTA---EFVNLEFLSLINVGLI-SV-SNLPKLPKLKKL 76
Query: 154 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVS-LRLLNSMIFISVSNNTLTGDI 212
L N+ G L P+LT L+LS N + L+ L + + + N +T ++
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NL 135
Query: 213 PHW----IGNISTLEFLDFSNN 230
+ + L +LD +
Sbjct: 136 NDYRESVFKLLPQLTYLDGYDR 157
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 6/105 (5%)
Query: 30 HNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIG 89
N S L +N++FL L N L L+ L L+ N + G +
Sbjct: 32 DNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS---VSNLPKLPKLKKLELSENRIFGGLD 88
Query: 90 KIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
+ +L LNLS N D ++ + L+ L++LDL +
Sbjct: 89 MLAEKLPNLTHLNLSGNKLK---DISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 26/132 (19%), Positives = 43/132 (32%), Gaps = 32/132 (24%)
Query: 296 FQTLRILDLSSNNL--VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 353
F L L L + L V ++P L+ L LS N + + +L HL+L
Sbjct: 48 FVNLEFLSLINVGLISVSNLPK----LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLS 103
Query: 354 NNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN---HLSGSIP 410
N L + + L + ++ L L L + +L+
Sbjct: 104 GNKL-----------KDISTL------------EPLKKLECLKSLDLFNCEVTNLNDYRE 140
Query: 411 KSISNLNKLKIL 422
L +L L
Sbjct: 141 SVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 26/110 (23%), Positives = 43/110 (39%), Gaps = 11/110 (10%)
Query: 174 LTTLDLSNNLFT-GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNIST---LEFLDFSN 229
+ L L N G++ ++ F+S+ N L + N+ L+ L+ S
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-----VSNLPKLPKLKKLELSE 80
Query: 230 NHLTGSLPSSLFNCKKLSVIRLRGNSLNG-NIPEGLFDL-GLEEIDLSEN 277
N + G L L+ + L GN L + E L L L+ +DL
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 24/87 (27%), Positives = 37/87 (42%), Gaps = 6/87 (6%)
Query: 299 LRILDLSSNNLVGDIPAEM--GLFANLRYLNLSSNHLRSRIPPE-LGYFHSLIHLDLRNN 355
L L + + + + GL LR L + + LR + P+ + L L+L N
Sbjct: 33 LTELYIENQQHLQHLELRDLRGL-GELRNLTIVKSGLRF-VAPDAFHFTPRLSRLNLSFN 90
Query: 356 ALYGSIPQEVCESRSLGILQLDGNSLT 382
AL S+ + + SL L L GN L
Sbjct: 91 AL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 9e-07
Identities = 21/120 (17%), Positives = 32/120 (26%), Gaps = 26/120 (21%)
Query: 139 SIPQGVAALHYLKELLLQGNQFSGPLPA-DIGFCPHLTTLDLSNNLFTGQLPVSLRLLNS 197
+ L EL ++ Q L D+ L L + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------------ 69
Query: 198 MIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 257
V+ + L L+ S N L SL L + L GN L+
Sbjct: 70 ----FVAPDAFHF--------TPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 4e-06
Identities = 23/118 (19%), Positives = 36/118 (30%), Gaps = 12/118 (10%)
Query: 243 CKKLSVIRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 301
S +R + + L L E+ + + + LR
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGE-----LRN 60
Query: 302 LDLSSNNLVGDIPAE--MGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 357
L + + L + + L LNLS N L S + + SL L L N L
Sbjct: 61 LTIVKSGLR-FVAPDAFHFT-PRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 22/131 (16%), Positives = 38/131 (29%), Gaps = 31/131 (23%)
Query: 30 HNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIG 89
+ L N+ L + N + + LR L++ + L+
Sbjct: 16 TRDGALDSLHHLPGAE--NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR---- 69
Query: 90 KIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHY 149
++ + F RL L+LS N S+
Sbjct: 70 ------------FVAPDAFHF------------TPRLSRLNLSFNALE-SLSWKTVQGLS 104
Query: 150 LKELLLQGNQF 160
L+EL+L GN
Sbjct: 105 LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 20/95 (21%), Positives = 28/95 (29%), Gaps = 2/95 (2%)
Query: 336 RIPPELGYFHSLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTS 394
L +L L + N + L L + + L P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 395 LYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 429
L L+LS N L S+ L+ L L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 18/112 (16%), Positives = 37/112 (33%), Gaps = 6/112 (5%)
Query: 171 CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHW-IGNISTLEFLDFSN 229
+ L + + L ++ + + N + + + L L
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 230 NHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFD-LGLEEIDLSENGF 279
+ L + F +LS + L N+L ++ L L+E+ LS N
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-09
Identities = 37/149 (24%), Positives = 52/149 (34%), Gaps = 14/149 (9%)
Query: 36 QIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKI--FN 93
+I L N ++K L L N+ + L + L +LS L I
Sbjct: 6 RIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT----SIANLP 61
Query: 94 YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG-SIPQGVAALHYLKE 152
+ L L LS+N SG L+ + L L+LS N S + + L LK
Sbjct: 62 KLNKLKKLELSDNRVSGGLEVLAE----KCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117
Query: 153 LLLQGN---QFSGPLPADIGFCPHLTTLD 178
L L + P LT LD
Sbjct: 118 LDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-08
Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 9/113 (7%)
Query: 20 FRILERLNFSHNSLSGQIPPSLLNL-NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLS 78
F LE L+ + L+ S+ NL + +K L+LS+N +SG + L E C +L +L+
Sbjct: 41 FEELEFLSTINVGLT-----SIANLPKLNKLKKLELSDNRVSGGLE-VLAEKCPNLTHLN 94
Query: 79 LAGNILQGPIG-KIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLD 130
L+GN ++ + +L +L+L N + D+ L +L LD
Sbjct: 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRE-NVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 32/141 (22%), Positives = 57/141 (40%), Gaps = 11/141 (7%)
Query: 91 IFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYL 150
S + L L N+ + + + L L + + SI + L+ L
Sbjct: 12 RNRTPSDVKELVLDNSRSN---EGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKL 66
Query: 151 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVS-LRLLNSMIFISVSNNTLT 209
K+L L N+ SG L CP+LT L+LS N + L+ L ++ + + N +T
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
Query: 210 GDIPHW----IGNISTLEFLD 226
++ + + L +LD
Sbjct: 127 -NLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 7e-05
Identities = 29/131 (22%), Positives = 50/131 (38%), Gaps = 29/131 (22%)
Query: 150 LKELLLQGNQFS-GPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 208
+KEL+L ++ + G L L L N T S++N
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT----------------SIAN--- 59
Query: 209 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG-NIPEGLFDL 267
+ ++ L+ L+ S+N ++G L C L+ + L GN + + E L L
Sbjct: 60 -------LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKL 112
Query: 268 -GLEEIDLSEN 277
L+ +DL
Sbjct: 113 ENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 20/90 (22%), Positives = 36/90 (40%), Gaps = 7/90 (7%)
Query: 296 FQTLRILDLSSNNL--VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLR 353
F+ L L + L + ++P L+ L LS N + + +L HL+L
Sbjct: 41 FEELEFLSTINVGLTSIANLPK----LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96
Query: 354 NNALYG-SIPQEVCESRSLGILQLDGNSLT 382
N + S + + + +L L L +T
Sbjct: 97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 27/104 (25%), Positives = 44/104 (42%), Gaps = 5/104 (4%)
Query: 374 LQLDGNSLT-GPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGE 432
L LD + G + + L LS + L+ SI ++ LNKLK L+L N +SG
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGG 79
Query: 433 IPQELGKLASLLAVNVSYNRL--IGRLPVGGVFPTLDQSSLQGN 474
+ K +L +N+S N++ + + L L
Sbjct: 80 LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 48/310 (15%), Positives = 86/310 (27%), Gaps = 57/310 (18%)
Query: 23 LERLNFSHNSLSGQIPPSL---LNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSL 79
L +LN + ++ + L + ++L++ L L R L L
Sbjct: 74 LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGL 133
Query: 80 AGNILQGPIGKIF-----NYCSSLNTLNLSNNHF--SGDLDFASGYGIWSLKRLRTLDLS 132
N L K + + TL LSNN +G G+ + L L
Sbjct: 134 QLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLME--GLAGNTSVTHLSLL 191
Query: 133 HNLFSGSIPQGVAAL-------HYLKELLLQGNQFSGP----LPADIGFCPHLTTLDLSN 181
H +G+ L L+EL + N L P L L L
Sbjct: 192 HTGLG---DEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYF 248
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 241
N + ++L + + + + ++ +
Sbjct: 249 NELS---SEGRQVLRDLGGAAEGG--------------ARVVVSLTEGTAVS------EY 285
Query: 242 NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLF--QTL 299
LS ++ NS + L L DL ++ + + L +
Sbjct: 286 WSVILSEVQRNLNSWDRA--RVQRHLELLLRDLEDS----RGATLNPWRKAQLLRVEGEV 339
Query: 300 RILDLSSNNL 309
R L +
Sbjct: 340 RALLEQLGSS 349
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 56/356 (15%), Positives = 98/356 (27%), Gaps = 93/356 (26%)
Query: 123 LKRLRTLDLSHNLFSGSIPQGVAAL--------HYLKELLLQGNQFSGPLPADIGFCP-- 172
L LR L+L+ + P + H L E+ L Q G
Sbjct: 71 LSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLD-----PAGLRTLL 122
Query: 173 ----HLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS 228
L L N + + + L ++ + + + L S
Sbjct: 123 PVFLRARKLGLQLNSLGPE---ACKDLRDLL----------------LHDQCQITTLRLS 163
Query: 229 NNHLTGS----LPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 284
NN LT + L L ++ + L L D GLE +
Sbjct: 164 NNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG--------DEGLELL------------ 203
Query: 285 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEM---GLFAN--LRYLNLSSNHLRSR--- 336
++ + L+ L+++ N GD A + L L+L N L S
Sbjct: 204 --AAQLDRNR---QLQELNVAYNGA-GDTAALALARAAREHPSLELLHLYFNELSSEGRQ 257
Query: 337 -IPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSL 395
+ G + + G+ E S L +Q + NS ++ L
Sbjct: 258 VLRDLGGAAEGGARVVVSL--TEGTAVSEYW-SVILSEVQRNLNSWD---RARVQRHLEL 311
Query: 396 YLLSLSHNHLSGSIPKSISNL----NKLKILKLEFNELSGEIPQELGKLASLLAVN 447
L L + + P + L +++ L +
Sbjct: 312 LLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG---SPSGSWSHPQFEKG 364
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 48/329 (14%), Positives = 86/329 (26%), Gaps = 92/329 (27%)
Query: 96 SSLNTLNLSNNHFSGDLDFASGYGIWSL--------KRLRTLDLSHNLFSGSIPQGVAAL 147
SSL LNL+ + + L ++L+ P G+ L
Sbjct: 72 SSLRQLNLAGVRMTPV-------KCTVVAAVLGSGRHALDEVNLASCQLD---PAGLRTL 121
Query: 148 ----HYLKELLLQGNQFSGPLPADIGF----------CPHLTTLDLSNNLFTGQLPVSLR 193
++L LQ N +TTL LSNN T +
Sbjct: 122 LPVFLRARKLGLQLNSLG-----PEACKDLRDLLLHDQCQITTLRLSNNPLT---AAGVA 173
Query: 194 LLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT----GSLPSSLFNCKKLSVI 249
+L + + NT ++ L + L L + L ++L +
Sbjct: 174 VLMEGL----AGNT-------------SVTHLSLLHTGLGDEGLELLAAQLDRNRQLQEL 216
Query: 250 RLRGNSLNGNIPEGLFDLG--------LEEIDLSENGF----MGSIPPGSSSSSSSTLFQ 297
+ N L LE + L N + ++
Sbjct: 217 NVAYNGAG---DTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVV 273
Query: 298 TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 357
L+ V + + + ++ S + R + EL DL ++
Sbjct: 274 VS----LTEGTAVSE--YWSVILSEVQRNLNSWDRARVQRHLELL------LRDLEDSRG 321
Query: 358 YGSIPQEVCES----RSLGILQLDGNSLT 382
P + + L S
Sbjct: 322 ATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFER----EVRVLGKARHPNLISL 662
+G+G FG V K + +A+K +++ + F R E+R+L H
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK------MVRNEKRFHRQAAEEIRIL---EHLRKQDK 155
Query: 663 EGYYWTPQLK---------LLVSDYAPNGSLQAKLHERLPSTP----PLSWTNRF-KVIL 708
+ + + + L L+E + L +F IL
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 709 GTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP--RISDFGLARLLTRLDKHVMSNRF 766
+ L LH + IIH +LKP NILL ++ DFG + + + +RF
Sbjct: 211 ---QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF 264
Query: 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
Y APE+ R D++ G ++ EL+TG P+ GED L+ + +L
Sbjct: 265 -----YRAPEVILG-ARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLACMIELL 315
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 52/252 (20%), Positives = 94/252 (37%), Gaps = 13/252 (5%)
Query: 5 LVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVP 64
L N + + ++ + + + + + + + +DLSN+++
Sbjct: 54 LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRV---QHMDLSNSVIEVSTL 110
Query: 65 YQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLK 124
+ + C+ L+ LSL G L PI S+L LNLS + + S
Sbjct: 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ--TLLSSCS 168
Query: 125 RLRTLDLS--HNLFSGSIPQGVA-ALHYLKELLLQGNQFS---GPLPADIGFCPHLTTLD 178
RL L+LS + + VA + +L L G + + L + CP+L LD
Sbjct: 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228
Query: 179 LSN-NLFTGQLPVSLRLLNSMIFISVSNNT-LTGDIPHWIGNISTLEFLDFSNNHLTGSL 236
LS+ + LN + +S+S + + +G I TL+ L G+L
Sbjct: 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 288
Query: 237 PSSLFNCKKLSV 248
L +
Sbjct: 289 QLLKEALPHLQI 300
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 44/223 (19%)
Query: 608 GEGVFGTVYKVSFGTQGRMLAVKKLVTSDII----QYPEDFEREVRVLGKARH--PNLIS 661
G G F TV+ +A+K I+ Y E E E+++L +
Sbjct: 28 GWGHFSTVWLAKDMVNNTHVAMK------IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 662 LEGYYWTPQLKLLVSDY----APNGSLQAKLHERL-PSTPPLSWTNRFKVI-LGTAK--- 712
G +L D+ PNG + E L + L + I L K
Sbjct: 82 SMGANHILKLL----DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 713 -----GLAHLHHSFRPPIIHYNLKPSNILLDDNYNP------RISDFGLARLLTRLDKHV 761
GL ++H IIH ++KP N+L++ +P +I+D G A +
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR 804
+ R Y +PE+ DI+ LI EL+TG
Sbjct: 196 IQTRE-----YRSPEVLLG-APWGCGADIWSTACLIFELITGD 232
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 43/232 (18%)
Query: 139 SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM 198
P A + L+ + + + +N+ + L N +
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVTD-AVTQNEL-NSIDQIIANNSDIKS-VQGIQYLPN-V 65
Query: 199 IFISVSNNTLTGDIPHWIG---NISTLEFLDFSNNHLTGSLPSSLFNC-KKLSVIRLRGN 254
++++ N L I ++ L +L + N L SLP+ +F+ L + L N
Sbjct: 66 RYLALGGNKLHD-----ISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119
Query: 255 SLNGNIPEGLFDL--GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTL---RILDLSSNNL 309
L ++P+G+FD L ++L+ N + S+P G +F L LDLS N L
Sbjct: 120 QLQ-SLPDGVFDKLTNLTYLNLAHNQ-LQSLPKG--------VFDKLTNLTELDLSYNQL 169
Query: 310 VGDIPAEMGLF---ANLRYLNLSSNHLRSRIPPELGYF---HSLIHLDLRNN 355
+P G+F L+ L L N L+S +P G F SL ++ L +N
Sbjct: 170 -QSLPE--GVFDKLTQLKDLRLYQNQLKS-VPD--GVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 46/185 (24%), Positives = 69/185 (37%), Gaps = 29/185 (15%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIP-PSLLNLNMMNMKFLDLSNN-LLSGPVP 64
S + ++++ +++ + L N+ ++L L N L
Sbjct: 27 KKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNV-----RYLALGGNKLHDISA- 80
Query: 65 YQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHF----SGDLDFASGYGI 120
+ +L YL L GN LQ +F+ ++L L L N G D
Sbjct: 81 ---LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFD------- 130
Query: 121 WSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGF--CPHLTTL 177
L L L+L+HN S+P+GV L L EL L NQ LP + F L L
Sbjct: 131 -KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPEGV-FDKLTQLKDL 186
Query: 178 DLSNN 182
L N
Sbjct: 187 RLYQN 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 45/133 (33%), Positives = 54/133 (40%), Gaps = 10/133 (7%)
Query: 302 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLI---HLDLRNNALY 358
LDL S L A L +LNL N L++ + G F L L L NN L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSA--GVFDDLTELGTLGLANNQL- 95
Query: 359 GSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNL 416
S+P V + L L L GN L V T L L L+ N L SIP L
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 417 NKLKILKLEFNEL 429
L+ L L N+L
Sbjct: 155 TNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 51/167 (30%), Positives = 71/167 (42%), Gaps = 24/167 (14%)
Query: 270 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF---ANLRYL 326
E++DL G ++ + + L L+L N L + A G+F L L
Sbjct: 38 EKLDLQSTGLA-TLSDATFRGLTK-----LTWLNLDYNQLQT-LSA--GVFDDLTELGTL 88
Query: 327 NLSSNHLRSRIPPELGYFHSLI---HLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLT 382
L++N L S +P G F L L L N L S+P V + L L+L+ N L
Sbjct: 89 GLANNQLAS-LPL--GVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ 144
Query: 383 GPIPQ-VIRNCTSLYLLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 427
IP T+L LSLS N L S+P L KL+ + L N
Sbjct: 145 S-IPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 50/163 (30%), Positives = 67/163 (41%), Gaps = 21/163 (12%)
Query: 52 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHF-- 108
LDL + L+ + F L +L+L N LQ G +F+ + L TL L+NN
Sbjct: 40 LDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQTLSAG-VFDDLTELGTLGLANNQLAS 97
Query: 109 --SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLP 165
G D L +L L L N S+P GV L LKEL L NQ +P
Sbjct: 98 LPLGVFD--------HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IP 147
Query: 166 ADIGF--CPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNN 206
A F +L TL LS N + L + I++ N
Sbjct: 148 AGA-FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 53/209 (25%), Positives = 75/209 (35%), Gaps = 61/209 (29%)
Query: 151 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG 210
++L LQ + A LT L+L N L +F + LT
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAG-------VF-----DDLT- 83
Query: 211 DIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFDLGL 269
L L +NN L SLP +F+ +L + L GN L +P G+FD L
Sbjct: 84 ----------ELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFD-RL 130
Query: 270 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF---ANLRYL 326
+ L+ L L++N L IPA G F NL+ L
Sbjct: 131 TK---------------------------LKELRLNTNQL-QSIPA--GAFDKLTNLQTL 160
Query: 327 NLSSNHLRSRIPPELGYFHSLIHLDLRNN 355
+LS+N L+S L + L N
Sbjct: 161 SLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 42/157 (26%), Positives = 63/157 (40%), Gaps = 11/157 (7%)
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCP-HLTTLDLSNNLFT 185
LDL + L L L L NQ L A + L TL L+NN
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 186 GQLPVSL-RLLNSMIFISVSNNTLTGDIPHWI-GNISTLEFLDFSNNHLTGSLPSSLFNC 243
LP+ + L + + + N L +P + ++ L+ L + N L S+P+ F+
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 244 -KKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSEN 277
L + L N L ++P G FD L+ I L N
Sbjct: 154 LTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 54/191 (28%), Positives = 67/191 (35%), Gaps = 44/191 (23%)
Query: 72 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS----GDLDFASGYGIWSLKRLR 127
A L L L F + L LNL N G D L L
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD--------DLTELG 86
Query: 128 TLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLSNNLF 184
TL L++N + S+P GV L L +L L GNQ LP+ + F L L L+ N
Sbjct: 87 TLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGV-FDRLTKLKELRLNTNQL 143
Query: 185 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF-NC 243
+P F + LT L+ L S N L S+P F
Sbjct: 144 Q-SIPAG-------AF-----DKLTN-----------LQTLSLSTNQLQ-SVPHGAFDRL 178
Query: 244 KKLSVIRLRGN 254
KL I L GN
Sbjct: 179 GKLQTITLFGN 189
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 56/282 (19%), Positives = 88/282 (31%), Gaps = 75/282 (26%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G G F TV+ + +A+K V Y E E+R+L R+ + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK--VVKSAEHYTETALDEIRLLKSVRNSD-PNDPNRE 101
Query: 667 WTPQLKLLVSDYAPNGS----LQAKLHERLPSTPPLSWTNRF------KVILGTAKGLAH 716
QL NG+ + L L S K+I +GL +
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 717 LHHSFRPPIIHYNLKPSNILL--------------------------------------- 737
LH R IIH ++KP NILL
Sbjct: 162 LHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 738 ----------DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEK 787
+ +I+D G A + KH + Q+ Y + E+ S N
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNAC---WVHKH-FTEDIQT-RQYRSLEVLIGS-GYNTP 273
Query: 788 CDIYGFGVLILELVTGR-----RPVEYGEDNVVILSEHVRVL 824
DI+ + EL TG E + ++ + +L
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP--RISDFGLARLLTRLDKHVMSNRFQSA 769
L L IIH +LKP NILL + +I DFG + L + + +RF
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--- 223
Query: 770 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
Y +PE+ + + D++ G +++E+ TG P+ G + V +++ V VL
Sbjct: 224 --YRSPEV-LLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGANEVDQMNKIVEVL 274
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 38/139 (27%), Positives = 59/139 (42%), Gaps = 22/139 (15%)
Query: 52 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHF-- 108
L L +N ++ + +F++ +L+ L L N L P+G +F+ + L L+L N
Sbjct: 45 LYLHDNQITK-LEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQLTVLDLGTNQLTV 102
Query: 109 --SGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQF-SGPLP 165
S D L L+ L + N + +P+G+ L +L L L NQ S P
Sbjct: 103 LPSAVFD--------RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153
Query: 166 ADIGF--CPHLTTLDLSNN 182
A F LT L N
Sbjct: 154 A---FDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 47/151 (31%), Positives = 63/151 (41%), Gaps = 19/151 (12%)
Query: 282 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL 341
S+P G +++ +IL L N + P NL+ L L SN L + +P
Sbjct: 33 SVPAGIPTNA--------QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPV-- 81
Query: 342 GYFHSLI---HLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQVIRNCTSLYL 397
G F SL LDL N L +P V + L L + N LT +P+ I T L
Sbjct: 82 GVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTH 139
Query: 398 LSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 427
L+L N L SIP L+ L L N
Sbjct: 140 LALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 40/121 (33%), Positives = 56/121 (46%), Gaps = 11/121 (9%)
Query: 313 IPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLI---HLDLRNNALYGSIPQEVCES- 368
+PA G+ N + L L N + + P G F SLI L L +N L G++P V +S
Sbjct: 34 VPA--GIPTNAQILYLHDNQITK-LEP--GVFDSLINLKELYLGSNQL-GALPVGVFDSL 87
Query: 369 RSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNE 428
L +L L N LT V L L + N L+ +P+ I L L L L+ N+
Sbjct: 88 TQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146
Query: 429 L 429
L
Sbjct: 147 L 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 34/116 (29%), Positives = 48/116 (41%), Gaps = 15/116 (12%)
Query: 72 ASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHF----SGDLDFASGYGIWSLKRLR 127
+ + L L N + +F+ +L L L +N G D SL +L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD--------SLTQLT 91
Query: 128 TLDLSHNLFSGSIPQGV-AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNN 182
LDL N + +P V L +LKEL + N+ + LP I HLT L L N
Sbjct: 92 VLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQN 145
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 2e-07
Identities = 26/176 (14%), Positives = 59/176 (33%), Gaps = 25/176 (14%)
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQ 142
I Q + + + LN L + +L L++L++ S+ +
Sbjct: 159 IEQVDLSPVLDAMPLLNNLKIKGT---NNLSIGK----KPRPNLKSLEIISGGLPDSVVE 211
Query: 143 GVAA--LHYLKELLL---QGNQFSGPLPADI------GFCPHLTTLDLSNNLFTGQLPVS 191
+ L L++L+L + P+L L + + +
Sbjct: 212 DILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271
Query: 192 L---RLLNSMIFISVSNNTLTGD----IPHWIGNISTLEFLDFSNNHLTGSLPSSL 240
+L + + +S LT + + + I L+F++ N+L+ + L
Sbjct: 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.1 bits (121), Expect = 9e-07
Identities = 20/136 (14%), Positives = 52/136 (38%), Gaps = 14/136 (10%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLS--------NNLLSGPVPYQLFENCASL 74
L+ L L + +L ++ N++ L L + ++ P + +L
Sbjct: 195 LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNL 254
Query: 75 RYLSLAGNILQGPIGKIF---NYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDL 131
++L + Q + ++F + L T+++S + + + +K L+ +++
Sbjct: 255 KWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINM 314
Query: 132 SHNLFSGSIPQGVAAL 147
+N S + L
Sbjct: 315 KYNYLS---DEMKKEL 327
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.4 bits (114), Expect = 6e-06
Identities = 25/167 (14%), Positives = 56/167 (33%), Gaps = 23/167 (13%)
Query: 303 DLSSNNLVGDIPAEMGLF--ANLRYLNLSSNHLRSRIPPELG--YFHSLIHLDL---RNN 355
L++ + G +G NL+ L + S L + ++ +L L L +
Sbjct: 173 LLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVED 232
Query: 356 ALYGSIPQEVCES------RSLGILQLDGNSLTGPIPQVI---RNCTSLYLLSLSHNHLS 406
+ +L L + + ++ L + +S L+
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 407 GS----IPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVS 449
+ + + LK + +++N LS E+ +E L L + +
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKE---LQKSLPMKID 336
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 2e-04
Identities = 24/185 (12%), Positives = 51/185 (27%), Gaps = 18/185 (9%)
Query: 43 NLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLN 102
+ + +D +S L ++ L+ + +L +L
Sbjct: 140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE 199
Query: 103 LSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALH---------YLKEL 153
+ + L L L L + + LK L
Sbjct: 200 IISGGLPDS--VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWL 257
Query: 154 LLQGNQFSGPLPADIG---FCPHLTTLDLSNNLFTG----QLPVSLRLLNSMIFISVSNN 206
+ + + P L T+D+S + T L + + + FI++ N
Sbjct: 258 GIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317
Query: 207 TLTGD 211
L+ +
Sbjct: 318 YLSDE 322
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 6e-07
Identities = 79/552 (14%), Positives = 161/552 (29%), Gaps = 189/552 (34%)
Query: 15 PSMVVFRILER-LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPY-------- 65
+V + +E L ++ L I +MM +++ + L + +
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL 134
Query: 66 QLFENC-ASLRYLSLAGNI-LQGP--IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGI- 120
Q + +L L A N+ + G GK + + L++ ++ + + I
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGK-----TWV-ALDVCLSY---KVQCKMDFKIF 185
Query: 121 W-SLKRLRTLDLSHNLFSGSIPQGVAALHY-LKELLLQGNQFSGPLPADIGFCPHLTTLD 178
W +LK + + ++ + + L Y + + S + I H +
Sbjct: 186 WLNLKNCNSPE--------TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI----HSIQAE 233
Query: 179 LSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPS 238
L L + L +L ++ N +
Sbjct: 234 LRRLLKSKPYENCLLVLL--------------NV--Q--NAKAWNAFNL----------- 264
Query: 239 SLFNCKKLSVIRLRG--NSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLF 296
+CK L R + + L+ + L+ T
Sbjct: 265 ---SCKILLTTRFKQVTDFLSAATT---THISLDHH---SMTL--------------TPD 301
Query: 297 QTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNA 356
+ L YL+ L
Sbjct: 302 EVK------------------SLLLK--YLDCRPQDL----------------------- 318
Query: 357 LYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRN--CTSLYLLSLSHNHLSGSIPKSIS 414
P+EV + + S+ I + IR+ T ++ + L+ I S++
Sbjct: 319 -----PREVLTTNPRRL------SI---IAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364
Query: 415 NLNKLKILKLEFNELS-----GEIPQELGKLASLLAVNVSY-------NRLIGRLPVGGV 462
L + K+ F+ LS IP L SL+ +V N+L
Sbjct: 365 VLEPAEYRKM-FDRLSVFPPSAHIPT---ILLSLIWFDVIKSDVMVVVNKLHKYS----- 415
Query: 463 FPTLDQSSLQGNLGICSPLLKGPCKMNVPKPL---VLD----PDAYNSN-----QMDGHI 510
+++ + + I S L+ K+ L ++D P ++S+ +D +
Sbjct: 416 --LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF 473
Query: 511 HSHSFSSNHHHM 522
+SH HH+
Sbjct: 474 YSH-IG---HHL 481
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 6e-05
Identities = 68/536 (12%), Positives = 144/536 (26%), Gaps = 185/536 (34%)
Query: 372 GILQLDGNSLTGPIPQVIRNCTSLYLLSLS-HNHLSGS----IPKSISNLNKLKILKLEF 426
+L+++ L PI R + + + + + L ++S L L+
Sbjct: 85 EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL 144
Query: 427 NELSGEIPQEL---------GKLASLLAVNVSYNRLIGRLPVGGVF-------------- 463
EL P + GK + +A++V + + +F
Sbjct: 145 LELR---PAKNVLIDGVLGSGK--TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 464 -------PTLDQSSLQGNLGICSP-------------LLKGP------------------ 485
+D + + + LLK
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 486 ------CKMNVPKPLVLDPDAYNSNQMDGHIHSHSFSSNHHHMFFSVSAIVAIIAAIL-- 537
CK+ L+ ++ + +H S +HH M + + +++ L
Sbjct: 260 NAFNLSCKI-----LLTTRFKQVTDFLSAATTTH-ISLDHHSMTLTPDEVKSLLLKYLDC 313
Query: 538 ---------IAGGVLVISLLNVSTRRRLTFVETTLESMCSSSSRSVNLAAGKVILFDSRS 588
+ +S++ S R L + C + +
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII-------------E 360
Query: 589 SSLDCSIDPE---------TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ 639
SSL+ ++P ++ +A + + ++ M+ V KL +++
Sbjct: 361 SSLNV-LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV-IKSDVMVVVNKLHKYSLVE 418
Query: 640 YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERL------- 692
+ P E P + L + + LH +
Sbjct: 419 ---------------KQPK----ESTISIPSIYL---ELKVKLENEYALHRSIVDHYNIP 456
Query: 693 -----PSTPPLSWTNRFKVILG---TAKGLAHLHHSFRP----------PIIH----YNL 730
P F +G FR I H +N
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516
Query: 731 KPS--NILLD-DNYNPRISD---------FGLARLLTRLDKHVMSNRF----QSAL 770
S N L Y P I D + L +++++++ +++ + AL
Sbjct: 517 SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-04
Identities = 63/438 (14%), Positives = 122/438 (27%), Gaps = 140/438 (31%)
Query: 511 HSHSFSSNHHHMFFSVS---------------AIV-------------AIIAA-----IL 537
H H HHHM F A V +I++ I+
Sbjct: 1 HHH-----HHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHII 55
Query: 538 IAGGV------LVISLLNVSTRRRLTFVETTLES----MCSSSSRSVNLAAGKVILFDSR 587
++ L +LL+ FVE L + S + ++ +
Sbjct: 56 MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 588 SSSLD-----------CSIDPETLLEKA---AEVGEGVFGTVY-KVSFGTQGRMLAVKKL 632
L + P L +A + V + + G +A+
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV--LIDGVLGSGKT--WVALDVC 171
Query: 633 VTSDIIQYPEDFEREVRV----LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL 688
++ + + ++ L P + LE L+ L+ PN + ++
Sbjct: 172 LSYKVQCKMDF-----KIFWLNLKNCNSPETV-LE------MLQKLLYQIDPNWTSRSDH 219
Query: 689 HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISD- 747
+ S + +L + ++L + N + +
Sbjct: 220 SSNIKL-RIHSIQAELRRLL-----------------KSKPYENCLLVLLNVQNAKAWNA 261
Query: 748 FGL-ARLL--TRLDKHVM-----SNRFQSALGYVAPELT---------------CQSLRV 784
F L ++L TR K V + +L + + LT Q L
Sbjct: 262 FNLSCKILLTTR-FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP- 319
Query: 785 NEKCDIYGFGV-LILELVTGR--RPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP----- 836
E + +I E + + N L+ + L NVL+ +
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFD 376
Query: 837 SMGDYPEDEVLP--VLKL 852
+ +P +P +L L
Sbjct: 377 RLSVFPPSAHIPTILLSL 394
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 30/119 (25%), Positives = 48/119 (40%), Gaps = 26/119 (21%)
Query: 248 VIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQ---TLRIL 302
+ L N L +GLF L +++L N + I P F+ ++ L
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ-LTGIEPN--------AFEGASHIQEL 83
Query: 303 DLSSNNLVGDIPAEMGLF---ANLRYLNLSSNHLRSRIPPELGYF---HSLIHLDLRNN 355
L N + +I +F L+ LNL N + + P G F +SL L+L +N
Sbjct: 84 QLGENKI-KEISN--KMFLGLHQLKTLNLYDNQISC-VMP--GSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 31/116 (26%), Positives = 51/116 (43%), Gaps = 17/116 (14%)
Query: 2 TTPLV-HGNSYNAIPSMVVF---RILERLNFSHNSLSGQIPP----SLLNLNMMNMKFLD 53
TT L+ + N I S +F L +L N L+G I P ++ + L
Sbjct: 31 TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHI-----QELQ 84
Query: 54 LSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNNHF 108
L N + + ++F L+ L+L N + G F + +SL +LNL++N F
Sbjct: 85 LGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPG-SFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 30/115 (26%), Positives = 49/115 (42%), Gaps = 14/115 (12%)
Query: 24 ERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNI 83
L + N L +I L + ++ L+L N L+G + FE + ++ L L N
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENK 89
Query: 84 LQGPIGKIFNYCSSLNTLNLSNNHFS----GDLDFASGYGIWSLKRLRTLDLSHN 134
++ K+F L TLNL +N S G + L L +L+L+ N
Sbjct: 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE--------HLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 23/88 (26%), Positives = 34/88 (38%), Gaps = 14/88 (15%)
Query: 299 LRILDLSSNNLVGDIPAEMGLF---ANLRYLNLSSNHLRSRIPPELGYF---HSLIHLDL 352
L L+L N L I F ++++ L L N ++ I F H L L+L
Sbjct: 56 LVKLELKRNQLT-GIEP--NAFEGASHIQELQLGENKIKE-ISN--KMFLGLHQLKTLNL 109
Query: 353 RNNALYGSIPQEVCES-RSLGILQLDGN 379
+N + + E SL L L N
Sbjct: 110 YDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 32/147 (21%), Positives = 56/147 (38%), Gaps = 40/147 (27%)
Query: 139 SIPQGVAALHYLKELLLQGNQFSGPLPADIGF--CPHLTTLDLSNNLFTGQLPVSLRLLN 196
IP+ + + ELLL N+ + +D F PHL L+L N TG + +
Sbjct: 22 EIPRDIPL--HTTELLLNDNELGR-ISSDGLFGRLPHLVKLELKRNQLTG-IEPN----- 72
Query: 197 SMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSL 256
F S+ ++ L N + + + +F L +L+ +L
Sbjct: 73 --AFEGASH----------------IQELQLGENKIK-EISNKMFL--GLH--QLKTLNL 109
Query: 257 NGN----IPEGLFD-LG-LEEIDLSEN 277
N + G F+ L L ++L+ N
Sbjct: 110 YDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 44/152 (28%), Positives = 61/152 (40%), Gaps = 20/152 (13%)
Query: 282 SIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPEL 341
S+P G + + LDL +N+L +L L L N L+S +P
Sbjct: 21 SVPTGIPAQT--------TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPN-- 69
Query: 342 GYFHSLIHLD---LRNNALYGSIPQEVCES-RSLGILQLDGNSLTGPIPQ-VIRNCTSLY 396
G F+ L L L N L S+P V + L L L+ N L +P V T L
Sbjct: 70 GVFNKLTSLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLK 127
Query: 397 LLSLSHNHLSGSIPKSI-SNLNKLKILKLEFN 427
L L N L S+P + L L+ + L N
Sbjct: 128 DLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 35/116 (30%), Positives = 61/116 (52%), Gaps = 8/116 (6%)
Query: 175 TTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGN-ISTLEFLDFSNNHLT 233
T LDL N L S+ + + N L +P+ + N +++L +L+ S N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 234 GSLPSSLFNC-KKLSVIRLRGNSLNGNIPEGLFD-LG-LEEIDLSENGFMGSIPPG 286
SLP+ +F+ +L + L N L ++P+G+FD L L+++ L +N + S+P G
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ-LKSVPDG 142
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 7/108 (6%)
Query: 2 TTPLV-HGNSYNAIPSMV-VFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLL 59
T L GN + +P + ++ L ++ S+N +S + + NM + L LS N L
Sbjct: 33 VTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFS-NMTQLLTLILSYNRL 90
Query: 60 SGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLNLSNN 106
+P + F+ SLR LSL GN + P G FN S+L+ L + N
Sbjct: 91 RC-IPPRTFDGLKSLRLLSLHGNDISVVPEG-AFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 14/100 (14%)
Query: 366 CESRSL-----GI------LQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSIS 414
C ++ L GI L LDGN T +P+ + N L L+ LS+N +S +S S
Sbjct: 17 CSNKGLKVLPKGIPRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFS 75
Query: 415 NLNKLKILKLEFNELSGEIPQEL-GKLASLLAVNVSYNRL 453
N+ +L L L +N L IP L SL +++ N +
Sbjct: 76 NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 29/131 (22%), Positives = 50/131 (38%), Gaps = 27/131 (20%)
Query: 298 TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 357
+ L L N +P E+ + +L ++LS+N + + + F ++ L
Sbjct: 32 DVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIST-LSN--QSFSNMTQLL------ 81
Query: 358 YGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSI-SNL 416
L L N L P+ SL LLSL N +S +P+ ++L
Sbjct: 82 ---------------TLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL 125
Query: 417 NKLKILKLEFN 427
+ L L + N
Sbjct: 126 SALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 37/130 (28%), Positives = 58/130 (44%), Gaps = 30/130 (23%)
Query: 151 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG 210
EL L GNQF+ +P ++ HLT +DLSNN + L++ F +++
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNN--------RISTLSNQSFSNMTQ----- 79
Query: 211 DIPHWIGNISTLEFLDFSNNHLTGSLPSSLFN-CKKLSVIRLRGNSLNGNIPEGLFD-LG 268
L L S N L +P F+ K L ++ L GN ++ +PEG F+ L
Sbjct: 80 -----------LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLS 126
Query: 269 -LEEIDLSEN 277
L + + N
Sbjct: 127 ALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 25/82 (30%), Positives = 38/82 (46%), Gaps = 3/82 (3%)
Query: 350 LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI 409
L L N +P+E+ + L ++ L N ++ Q N T L L LS+N L I
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 410 PKSI-SNLNKLKILKLEFNELS 430
P L L++L L N++S
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS 115
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 31/137 (22%), Positives = 49/137 (35%), Gaps = 39/137 (28%)
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-------------------RISDFGLAR 752
L LH + + H +LKP NIL ++ R++DFG A
Sbjct: 134 HALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 753 LLTRLDKHVM---SNRFQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPV 807
T +H + R Y PE L L + CD++ G ++ E G +
Sbjct: 190 --TFDHEHHTTIVATRH-----YRPPEVIL---ELGWAQPCDVWSIGCILFEYYRG-FTL 238
Query: 808 EYGEDNVVILSEHVRVL 824
+N L ++L
Sbjct: 239 FQTHENREHLVMMEKIL 255
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 34/143 (23%), Positives = 56/143 (39%), Gaps = 45/143 (31%)
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-------------------------RIS 746
K L +L + H +LKP NILLDD Y ++
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 747 DFGLARLLTRLDKH---VMSNRFQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELV 801
DFG A T + +++ R Y APE L +L + D++ FG ++ EL
Sbjct: 205 DFGCA---TFKSDYHGSIINTRQ-----YRAPEVIL---NLGWDVSSDMWSFGCVLAELY 253
Query: 802 TGRRPVEYGEDNVVILSEHVRVL 824
TG + +++ L+ ++
Sbjct: 254 TG-SLLFRTHEHMEHLAMMESII 275
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 46/165 (27%)
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP-------------------RISDFGLAR 752
K + LH + H +LKP NIL + ++ DFG A
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 753 LLTRLDKH---VMSNRFQSALGYVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPV 807
T D+H ++S R Y APE L +L ++ CD++ G +++E G V
Sbjct: 185 --TYDDEHHSTLVSTRH-----YRAPEVIL---ALGWSQPCDVWSIGCILIEYYLG-FTV 233
Query: 808 EYGEDNVVILSEHVRVL-------LEEGNVLDCVDPSMGDYPEDE 845
D+ L+ R+L +++ D+ E
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHS 278
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 888 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-09 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 2e-63
Identities = 78/294 (26%), Positives = 130/294 (44%), Gaps = 27/294 (9%)
Query: 595 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVL 651
I T+ ++ +G G FGTVYK G +AVK L VT+ Q + F+ EV VL
Sbjct: 5 IPDGQITVGQR---IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
K RH N++ GY PQL +V+ + SL LH + TA
Sbjct: 59 RKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTA 114
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+G+ +LH IIH +LK +NI L ++ +I DFGLA + +R + ++
Sbjct: 115 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 772 YVAPE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829
++APE + + D+Y FG+++ EL+TG+ P +N + V
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR------ 224
Query: 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883
+ P + + + +L C RP +++ ++++ LP+
Sbjct: 225 --GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (478), Expect = 3e-54
Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 42/295 (14%)
Query: 606 EVGEGVFGTVYKV-----SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
++GEG FG V++ M+AVK L DF+RE ++ + +PN++
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHER--------------------LPSTPPLSW 700
L G + L+ +Y G L L P PPLS
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 701 TNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760
+ + A G+A+L +H +L N L+ +N +I+DFGL+R + D +
Sbjct: 140 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 820
+ ++ PE R + D++ +GV++ E+ + YG + ++
Sbjct: 197 KADGNDAIPIRWMPPES-IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY-- 253
Query: 821 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ +GN+L C PE+ L + L +C +P+ RPS + +ILQ
Sbjct: 254 ---YVRDGNILAC--------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (463), Expect = 4e-52
Identities = 71/281 (25%), Positives = 113/281 (40%), Gaps = 30/281 (10%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGK 653
DPE L E+G G FG VY ++A+KK+ S + +D +EVR L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
RHPN I G Y LV +Y + + PL V G +G
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQG 127
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
LA+LH +IH ++K NILL + ++ DFG A ++ +N F ++
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWM 178
Query: 774 APE--LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
APE L + + K D++ G+ +EL + P+ + + + L +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQ--------N 229
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
+ G + E C IP RP+ +++
Sbjct: 230 ESPALQSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-51
Identities = 67/303 (22%), Positives = 117/303 (38%), Gaps = 35/303 (11%)
Query: 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPN 658
L E +G+G FG V++ + +G +AVK + + E E+ RH N
Sbjct: 6 VLQES---IGKGRFGEVWRGKW--RGEEVAVKIFSSREERS--WFREAEIYQTVMLRHEN 58
Query: 659 LISLEGYYWTPQLKL----LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
++ LVSDY +GSL L+ ++ K+ L TA GL
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGL 113
Query: 715 AHLHHSF-----RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH--VMSNRFQ 767
AHLH +P I H +LK NIL+ N I+D GLA + N
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 768 SALGYVAPEL-----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN-----VVIL 817
Y+APE+ + ++ DIY G++ E+ ED ++
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 818 SEHVRVLLEEGNVLDCVDPSMGDYPE--DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
S+ + + + P++ + + + + + K+ C ++R + + + L
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
Query: 876 VIK 878
+
Sbjct: 294 QLS 296
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-51
Identities = 66/288 (22%), Positives = 119/288 (41%), Gaps = 35/288 (12%)
Query: 595 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
++ + LL+ +G+G FG V + +G +AVK + Q F E V+
Sbjct: 4 LNMKELKLLQT---IGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ---AFLAEASVMT 55
Query: 653 KARHPNLISLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
+ RH NL+ L G + L +V++Y GSL L R L K L
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVC 113
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
+ + +L +H +L N+L+ ++ ++SDFGL + + +
Sbjct: 114 EAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VK 165
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
+ APE + + + K D++ FG+L+ E+ + R ++ +E+G +
Sbjct: 166 WTAPEA-LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----RVEKGYKM 219
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879
D D P V ++ C + RPS ++ + L+ IKT
Sbjct: 220 DAPD----GCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (454), Expect = 5e-51
Identities = 64/281 (22%), Positives = 123/281 (43%), Gaps = 27/281 (9%)
Query: 607 VGEGVFGTVYKVSF---GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLE 663
+G G FG V G + +A+K L + + DF E ++G+ HPN+I LE
Sbjct: 34 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 93
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
G ++++++ NGSL + L + + ++ G A G+ +L
Sbjct: 94 GVVTKSTPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLAD---M 147
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLL---TRLDKHVMSNRFQSALGYVAPELTCQ 780
+H +L NIL++ N ++SDFGL+R L T + + + + + APE Q
Sbjct: 148 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA-IQ 206
Query: 781 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840
+ D++ +G+++ E+++ + N +++ +E+ L
Sbjct: 207 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN-----AIEQDYRL--------P 253
Query: 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL-QVIKTP 880
P D + +L L C + RP ++V L ++I+ P
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 6e-51
Identities = 67/283 (23%), Positives = 121/283 (42%), Gaps = 29/283 (10%)
Query: 595 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
+ E L+E+ +G G FG V+ + +AVK L P+ F E ++
Sbjct: 10 VPRETLKLVER---LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS--MSPDAFLAEANLMK 63
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
+ +H L+ L + ++++Y NGSL L PS L+ + A+
Sbjct: 64 QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAE 120
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
G+A + IH +L+ +NIL+ D + +I+DFGLARL+ +++ + + +
Sbjct: 121 GMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKW 176
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832
APE K D++ FG+L+ E+VT R G N ++ N+
Sbjct: 177 TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ----------NLER 225
Query: 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
P++ + +L +C P RP+ + +L+
Sbjct: 226 GYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 7e-51
Identities = 63/285 (22%), Positives = 117/285 (41%), Gaps = 29/285 (10%)
Query: 595 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
IDP T +++ +G G FG V+ + +A+K + + + EDF E V+
Sbjct: 2 IDPSELTFVQE---IGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE--EDFIEEAEVMM 55
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
K HP L+ L G LV ++ +G L L + + + L +
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCE 112
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
G+A+L +IH +L N L+ +N ++SDFG+ R + D++ S + + +
Sbjct: 113 GMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKW 168
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832
+PE+ R + K D++ FGVL+ E+ + + N ++ +
Sbjct: 169 ASPEV-FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----- 222
Query: 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
P V ++ C P RP+ + +++ L I
Sbjct: 223 --------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (448), Expect = 2e-50
Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 27/285 (9%)
Query: 595 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
++ T+ K +G G +G VY+ + +AVK L + E+F +E V+
Sbjct: 14 MERTDITMKHK---LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMK 68
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
+ +HPNL+ L G +++++ G+L L E + +S + +
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISS 126
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
+ +L + IH +L N L+ +N+ +++DFGL+RL+T D + + + +
Sbjct: 127 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKW 182
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832
APE + + K D++ FGVL+ E+ T G D V LLE+ +
Sbjct: 183 TAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDYRM- 235
Query: 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
+ PE V +L C PS RPS AE+ Q + +
Sbjct: 236 -------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 9e-50
Identities = 61/282 (21%), Positives = 119/282 (42%), Gaps = 25/282 (8%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
++PE E E+G+G FG VYK + A K + T + ED+ E+ +L
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASC 66
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
HPN++ L ++ ++ ++ G++ A + E PL+ + V T L
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDAL 123
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
+LH IIH +LK NIL + + +++DFG++ TR + + F ++A
Sbjct: 124 NYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMA 178
Query: 775 PEL----TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830
PE+ T + + K D++ G+ ++E+ P + + + +L + +
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH-HELNPMRVLLKIAK-------- 229
Query: 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
+P P C +R + ++++Q
Sbjct: 230 ---SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-49
Identities = 57/272 (20%), Positives = 102/272 (37%), Gaps = 22/272 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEG 664
+G G +G K+ + G++L K+L + + + EV +L + +HPN++
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 665 YYW--TPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH--HS 720
T +V +Y G L + + + L +V+ L H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
++H +LKP+N+ LD N ++ DFGLAR+L + F Y++PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMSPEQ-MN 187
Query: 781 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840
+ NEK DI+ G L+ EL P + +
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREGKFRR------------- 233
Query: 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
P + ++ RPS+ E+++
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-49
Identities = 60/295 (20%), Positives = 124/295 (42%), Gaps = 24/295 (8%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSF--GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
+ + LL E+G G FG+V + + + +A+K L E+ RE +++
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 64
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
+ +P ++ L G L +LV + A G L L + + +N +++ +
Sbjct: 65 QLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSM 120
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH-VMSNRFQSALG 771
G+ +L +H +L N+LL + + +ISDFGL++ L D + + + L
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
+ APE + + + D++ +GV + E ++ + +++ +E+G +
Sbjct: 178 WYAPEC-INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-----FIEQGKRM 231
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRME 886
+C P + + L C + RP V Q ++ L ++E
Sbjct: 232 EC--------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-49
Identities = 55/283 (19%), Positives = 109/283 (38%), Gaps = 29/283 (10%)
Query: 595 IDPE--TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLG 652
IDP+ T L++ +G G FG V + +A+K + + + ++F E +V+
Sbjct: 1 IDPKDLTFLKE---LGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE--DEFIEEAKVMM 54
Query: 653 KARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
H L+ L G + ++++Y NG L L E ++ +
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCE 111
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
+ +L +H +L N L++D ++SDFGL+R + D++ S + + +
Sbjct: 112 AMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRW 167
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832
PE+ + + K DI+ FGVL+ E+ + + N ++
Sbjct: 168 SPPEV-LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----------HIAQ 216
Query: 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ P V + C RP+ ++ +
Sbjct: 217 GLRL---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 11/223 (4%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLIS 661
EK +E+G G G V+KVS G ++A K + RE++VL + P ++
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 662 LEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF 721
G +++ + ++ GSL L + + KV + KGL +L
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 722 RPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
+ I+H ++KPSNIL++ ++ DFG++ L M+N F Y++PE Q
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPER-LQG 177
Query: 782 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
+ + DI+ G+ ++E+ GR P+ + + L +V
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-49
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 26/290 (8%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA 654
I E+L ++G+G FG V+ ++ +A+K L + PE F +E +V+ K
Sbjct: 14 IPRESL-RLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKL 69
Query: 655 RHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGL 714
RH L+ L + +V++Y GSL + + L + A G+
Sbjct: 70 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL--DFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
A++ +H +L+ +NIL+ +N +++DFGLARL+ +++ + + + A
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 182
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
PE R K D++ FG+L+ EL T R G N +L + R
Sbjct: 183 PEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP------- 234
Query: 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ-VIKTPLPQ 883
P + + L C P RP+ + L+ + PQ
Sbjct: 235 ------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-49
Identities = 60/279 (21%), Positives = 116/279 (41%), Gaps = 22/279 (7%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+GEG +G V +AVK + + PE+ ++E+ + H N++ G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
++ L +Y G L ++ + + + + G+ +LH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHG---IGI 124
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
H ++KP N+LLD+ N +ISDFGLA + ++ + N+ L YVAPEL +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 786 EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 845
E D++ G+++ ++ G P + D+ E+ L+ P +
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----SDWKEKKTYLN---------PWKK 231
Query: 846 VLPVLK-LALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883
+ L PS+R ++ ++ + + PL +
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKK-DRWYNKPLKK 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 4e-49
Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 31/293 (10%)
Query: 591 LDCSIDPE--TLLEKAAEVGEGVFGTVYKVSF---GTQGRMLAVKKLVTSDII--QYPED 643
L C I + LLEK +G+G FG V + + + +AVK L + + +D
Sbjct: 1 LTCLIGEKDLRLLEK---LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 57
Query: 644 FEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNR 703
F REV + H NLI L G TP +K+ V++ AP GSL +L +
Sbjct: 58 FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTL 113
Query: 704 FKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR-LDKHVM 762
+ + A+G+ +L IH +L N+LL +I DFGL R L + D +VM
Sbjct: 114 SRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 763 SNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
+ + APE ++ + D + FGV + E+ T + G + IL + +
Sbjct: 171 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ PED + + + C H P RP+ + L
Sbjct: 230 ------------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-49
Identities = 70/292 (23%), Positives = 129/292 (44%), Gaps = 27/292 (9%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKV----SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRV 650
I P + + +G G FG VYK S G + +A+K L + DF E +
Sbjct: 4 IHPSCV-TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 651 LGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGT 710
+G+ H N+I LEG + +++++Y NG+L L E+ S ++ G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGI 119
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMS-NRFQSA 769
A G+ +L +H +L NIL++ N ++SDFGL+R+L + + + +
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 770 LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829
+ + APE + D++ FG+++ E++T + N ++ + +
Sbjct: 177 IRWTAPE-AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KAIN------- 227
Query: 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL-QVIKTP 880
D P D + +L + C + RP A++V IL ++I+ P
Sbjct: 228 -----DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-49
Identities = 59/273 (21%), Positives = 106/273 (38%), Gaps = 29/273 (10%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEG 664
E+G G F TVYK +A +L + + F+ E +L +HPN++
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 665 YYWTP----QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
+ + + +LV++ +G+L+ L + KGL LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 721 FRPPIIHYNLKPSNILLDD-NYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
PPIIH +LK NI + + +I D GLA L + + ++APE+
Sbjct: 132 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYE 186
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839
+ + +E D+Y FG+ +LE+ T P N + V ++ + P +
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPY-SECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
+ + C R S+ +++
Sbjct: 244 E-----------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 63/285 (22%), Positives = 120/285 (42%), Gaps = 26/285 (9%)
Query: 595 IDPETLLEKAAEVGEGVFGTVYKVSF--GTQGRMLAVKKL-VTSDIIQYPEDFEREVRVL 651
+D + L + E+G G FGTV K + + +AVK L ++ ++ E V+
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
+ +P ++ + G +LV + A G L ++ L + N +++ +
Sbjct: 63 QQLDNPYIVRMIGICEAESW-MLVMEMAELGPL----NKYLQQNRHVKDKNIIELVHQVS 117
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQSAL 770
G+ +L S +H +L N+LL + +ISDFGL++ L + + + +
Sbjct: 118 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830
+ APE + + K D++ FGVL+ E + + G + + +LE+G
Sbjct: 175 KWYAPEC-INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-----MLEKGER 228
Query: 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ C P + L +C + +RP A V L+
Sbjct: 229 MGC--------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-48
Identities = 61/290 (21%), Positives = 107/290 (36%), Gaps = 36/290 (12%)
Query: 606 EVGEGVFGTVYKVSF-----GTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNL 659
+G G FG V + + +AVK L S + E E++VL H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP--------------PLSWTNRFK 705
++L G L++++Y G L L + S L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 706 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 765
AKG+A L IH +L NILL +I DFGLAR + +V+
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 766 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 825
+ + ++APE + + D++ +G+ + EL + G + ++
Sbjct: 207 ARLPVKWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK--- 262
Query: 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+ PE + + C P RP+ ++VQ+++
Sbjct: 263 ---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-48
Identities = 53/295 (17%), Positives = 99/295 (33%), Gaps = 41/295 (13%)
Query: 606 EVGEGVFGTVYKVSFGTQGR-----MLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNL 659
+G G FG V + + +AVK L E E++++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP-------------------PLSW 700
++L G L+ +Y G L L + L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 701 TNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760
+ AKG+ L +H +L N+L+ +I DFGLAR + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEH 820
V+ + + ++APE + K D++ +G+L+ E+ + G +
Sbjct: 221 VVRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279
Query: 821 VRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
++ + D P + + C RPS + L
Sbjct: 280 IQ------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 58/299 (19%), Positives = 124/299 (41%), Gaps = 33/299 (11%)
Query: 595 IDPE--TLLEKAAEVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFERE 647
+ E T+ + +G+G FG VY+ V +A+K + + ++ +F E
Sbjct: 17 VAREKITMSRE---LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 648 VRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLH------ERLPSTPPLSWT 701
V+ + +++ L G Q L++ + G L++ L P P S +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 702 NRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV 761
++ A G+A+L+ + +H +L N ++ +++ +I DFG+ R + D +
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 762 MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHV 821
+ + +++PE + D++ FGV++ E+ T G N +L
Sbjct: 191 KGGKGLLPVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 248
Query: 822 RVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880
++ + D P++ + +L +C + P RPS E++ ++ P
Sbjct: 249 ------------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-47
Identities = 74/296 (25%), Positives = 123/296 (41%), Gaps = 27/296 (9%)
Query: 595 IDPETLLEKAAEV-GEGVFGTVYKVSF---GTQGRMLAVKKLVTSDIIQYPEDFEREVRV 650
I P +L+ EV G G FG VY + + AVK L I F E +
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 81
Query: 651 LGKARHPNLISLEGYYWTPQLK-LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILG 709
+ HPN++SL G + L+V Y +G L+ + T + + L
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQ 138
Query: 710 TAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA 769
AKG+ L +H +L N +LD+ + +++DFGLAR + + + N+ +
Sbjct: 139 VAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 770 --LGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827
+ ++A E Q+ + K D++ FGVL+ EL+T P + + LL+
Sbjct: 196 LPVKWMALES-LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLLQG 250
Query: 828 GNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883
+L PE P+ ++ L C RPS +E+V + I +
Sbjct: 251 RRLLQ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-46
Identities = 69/295 (23%), Positives = 121/295 (41%), Gaps = 26/295 (8%)
Query: 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRML----AVKKLVTSDIIQYPEDFEREVRVLGK 653
ET +K +G G FGTVYK + +G + A+K+L + + ++ E V+
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 654 ARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKG 713
+P++ L G T ++L+ P G L + E + + AKG
Sbjct: 68 VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 123
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYV 773
+ +L ++H +L N+L+ + +I+DFGLA+LL +K + + + ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 774 APELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833
A E + D++ +GV + EL+T G I S +LE+G L
Sbjct: 181 ALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERL-- 232
Query: 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRMEVF 888
P + V + + C SRP E++ + PQR V
Sbjct: 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD-PQRYLVI 280
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-45
Identities = 66/269 (24%), Positives = 104/269 (38%), Gaps = 29/269 (10%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLE 663
+G+G FG VY +LA+K L + + REV + RHPN++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
GY+ L+ +YAP G++ +L + I A L++ H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCH---SK 125
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
+IH ++KP N+LL +I+DFG + L Y+ PE+ +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEM-IEGRM 180
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 843
+EK D++ GVL E + G+ P E RV +P+
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEF--------------TFPD 225
Query: 844 DEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
L H PS RP + EV++
Sbjct: 226 FVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 3e-45
Identities = 71/287 (24%), Positives = 114/287 (39%), Gaps = 35/287 (12%)
Query: 606 EVGEGVFGTVYKVSFGTQGRML--AVKKLVTSDIIQYPEDFEREVRVLGK-ARHPNLISL 662
+GEG FG V K G + A+K++ DF E+ VL K HPN+I+L
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGT 710
G L +YAP+G+L L + + LS
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 711 AKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSAL 770
A+G+ +L IH +L NIL+ +NY +I+DFGL+R + +V + +
Sbjct: 137 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPV 190
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830
++A E + D++ +GVL+ E+V+ G + L +G
Sbjct: 191 RWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-----KLPQGYR 244
Query: 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
L + P + V L C P RPS A+++ L +
Sbjct: 245 L--------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-44
Identities = 56/277 (20%), Positives = 106/277 (38%), Gaps = 24/277 (8%)
Query: 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR 655
DP+ + ++G+G GTVY G+ +A++++ E E+ V+ + +
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENK 75
Query: 656 HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLA 715
+PN+++ Y +V +Y GSL + E + V + L
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALE 130
Query: 716 HLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAP 775
LH + +IH ++K NILL + + +++DFG +T + + ++AP
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAP 185
Query: 776 ELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835
E K DI+ G++ +E++ G P E+ + L E + +
Sbjct: 186 E-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLS 243
Query: 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
D C R S E++Q
Sbjct: 244 AIFRD-----------FLNRCLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 9e-44
Identities = 67/292 (22%), Positives = 119/292 (40%), Gaps = 37/292 (12%)
Query: 606 EVGEGVFGTVYKV-------SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGK-ARHP 657
+GEG FG V + +AVK L + + D E+ ++ +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTP------------PLSWTNRFK 705
N+I+L G ++ +YA G+L+ L R P LS +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 706 VILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNR 765
A+G+ +L IH +L N+L+ ++ +I+DFGLAR + +D + +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 766 FQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL 825
+ + ++APE + D++ FGVL+ E+ T G + LL
Sbjct: 197 GRLPVKWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-----LL 250
Query: 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
+EG+ + D P + + + C +PS RP+ ++V+ L I
Sbjct: 251 KEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-43
Identities = 57/275 (20%), Positives = 106/275 (38%), Gaps = 25/275 (9%)
Query: 606 EVGEGVFGTVYKV---SFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL 662
+GEG FG V++ S +A+K E F +E + + HP+++ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
G + ++ + G L++ L R L + + LA+L
Sbjct: 74 IGVITENPV-WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLE---S 126
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
+H ++ N+L+ N ++ DFGL+R + + +++ + + ++APE
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPES-INFR 184
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 842
R D++ FGV + E++ G N ++ +E G L + P
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-----RIENGERLPMPP----NCP 235
Query: 843 EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877
+ L C + PS RP E+ L I
Sbjct: 236 PT----LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-43
Identities = 66/277 (23%), Positives = 103/277 (37%), Gaps = 25/277 (9%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLE 663
+GEG F TV R A+K L II RE V+ + HP + L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
+ + YA NG L + + T L +LH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAEIVSALEYLH---GK 127
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
IIH +LKP NILL+++ + +I+DFG A++L+ K +N F YV+PEL
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-LTEKS 186
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 843
+ D++ G +I +LV G P + +I + +++ D+PE
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEY--------------DFPE 231
Query: 844 DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880
L + R E+ + P
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 154 bits (390), Expect = 8e-42
Identities = 57/269 (21%), Positives = 106/269 (39%), Gaps = 24/269 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
E+G G FG V++V+ G A K ++T E +E++ + RHP L++L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
+ +++ ++ G L K+ + +S + + KGL H+H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMH---ENNY 145
Query: 726 IHYNLKPSNILLDDNYNPRI--SDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
+H +LKP NI+ + + DFGL L ++ + APE+ +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT---AEFAAPEV-AEGKP 201
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 843
V D++ GVL L++G P GE++ L + D + E
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCD------WNMDDSAFSGISE 254
Query: 844 DEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
D P++R ++ + ++
Sbjct: 255 D----GKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 7e-40
Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 23/285 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+GEG +G V +A+KK+ + Y + RE+++L + RH N+I +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
P ++ + Y + A L++ L T LS + + +GL ++H +
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLT-RLDKHVMSNRFQSALGYVAPELTCQSLRV 784
+H +LKPSN+LL+ + +I DFGLAR+ D + + Y APE+ S
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 785 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL------------LEEGNVLD 832
+ DI+ G ++ E+++ R G+ + L+ + +L +
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 833 CVDPSMGDYPEDEVLP-----VLKLALVCTCHIPSSRPSMAEVVQ 872
P P + + P L L P R + + +
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-40
Identities = 65/289 (22%), Positives = 108/289 (37%), Gaps = 35/289 (12%)
Query: 606 EVGEGVFGTVYK-----VSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI 660
+G G FG V + + R +AVK L E+++L H +
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 661 -SLEGYYWTPQLKL-LVSDYAPNGSLQAKLHERLPSTPP------------LSWTNRFKV 706
+L G P L ++ ++ G+L L + P L+ +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 707 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 766
AKG+ L IH +L NILL + +I DFGLAR + + +V
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826
+ L ++APE T + D++ FGVL+ E+ + G ++
Sbjct: 197 RLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---- 251
Query: 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
EG + P+ + + L C PS RP+ +E+V+ L
Sbjct: 252 EGTRMRA--------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 50/289 (17%), Positives = 111/289 (38%), Gaps = 31/289 (10%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
++G G FG V++ + + K + ++E+ +L ARH N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHES 69
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
+ + + +++ ++ + +++ L+ + + L LH I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 726 IHYNLKPSNILLD--DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
H++++P NI+ + +I +FG AR L D +A Y APE+ Q
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEV-HQHDV 179
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPE 843
V+ D++ G L+ L++G P E N I+ + + + +
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAE------YTFDEEAFKEISI 232
Query: 844 DEVLPVLKLALVCTCHIPSSRPSMAEVV------QILQVIKTPLPQRME 886
+ + SR + +E + Q ++ + T + + ++
Sbjct: 233 E----AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLK 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (368), Expect = 2e-39
Identities = 52/267 (19%), Positives = 100/267 (37%), Gaps = 19/267 (7%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
+G G F V +++A+K + + E E+ VL K +HPN+++L+
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
Y + L+ G L ++ E+ + + ++I + +LH
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 726 IHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVN 785
LD++ ISDFGL+++ D + + GYVAPE+ Q +
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK-PYS 187
Query: 786 EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDE 845
+ D + GV+ L+ G P Y E++ + + ++ + P D +
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILK------AEYEFDSPYWDDISDS- 239
Query: 846 VLPVLKLALVCTCHIPSSRPSMAEVVQ 872
P R + + +Q
Sbjct: 240 ---AKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 143 bits (361), Expect = 1e-38
Identities = 70/281 (24%), Positives = 114/281 (40%), Gaps = 35/281 (12%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKL--------VTSDIIQYPEDFEREVRVLGKAR-H 656
+G GV V + + AVK + ++ + E +EV +L K H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
PN+I L+ Y T LV D G L L E+ LS K++ + +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICA 125
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
LH + I+H +LKP NILLDD+ N +++DFG + +LD Y+APE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPE 179
Query: 777 LTCQSLRVN-----EKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831
+ S+ N ++ D++ GV++ L+ G P + +++L + + G
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLMLRMIMSGNYQFG--- 235
Query: 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
P DY + V L P R + E +
Sbjct: 236 ---SPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 145 bits (367), Expect = 1e-38
Identities = 58/270 (21%), Positives = 106/270 (39%), Gaps = 26/270 (9%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
E+G G FG V++ GR+ K + T + + E+ ++ + HP LI+L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDA 94
Query: 666 YWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPI 725
+ +L+ ++ G L ++ +S + +GL H+H I
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMH---EHSI 148
Query: 726 IHYNLKPSNILLDDNYNPRI--SDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
+H ++KP NI+ + + DFGLA +L+ + + + APE+
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEI-VDREP 204
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE-EGNVLDCVDPSMGDYP 842
V D++ GVL L++G P GED++ L R E + + V P D
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD-- 261
Query: 843 EDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
P R ++ + ++
Sbjct: 262 ---------FIKNLLQKEPRKRLTVHDALE 282
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 5e-38
Identities = 69/300 (23%), Positives = 117/300 (39%), Gaps = 27/300 (9%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLI 660
+K ++GEG +G VYK G ++A+KK+ + ++ P RE+ +L + HPN++
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
L T LV ++ + + + + +GLA H
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
++H +LKP N+L++ +++DFGLAR + L Y APE+
Sbjct: 121 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLG 176
Query: 781 SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840
+ DI+ G + E+VT R G+ + L R L V+ SM D
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 841 Y----------PEDEVLPVLKLALV-----CTCHIPSSRPSMAEVVQ--ILQVIKTPLPQ 883
Y +V+P L + P+ R S + Q + P+P
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (352), Expect = 2e-37
Identities = 61/283 (21%), Positives = 108/283 (38%), Gaps = 27/283 (9%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKL-VTSDIIQYPEDFEREVRVLGKARHPNLISLEG 664
++GEG +G VYK G A+KK+ + + P RE+ +L + +H N++ L
Sbjct: 9 KIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
T + +LV ++ + L +L G+A+ H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 784
++H +LKP N+L++ +I+DFGLAR + L Y AP++ S +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMGSKKY 178
Query: 785 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL----------LEEGNVLDCV 834
+ DI+ G + E+V G G L R+L + E D
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 835 DPSMGDYPEDEVLPVLKLALV-----CTCHIPSSRPSMAEVVQ 872
P + L L + + P+ R + + ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-36
Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 28/289 (9%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ----YPEDFEREVRVLGKARHP 657
EK +GEG F TVYK +++A+KK+ + RE+++L + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 658 NLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHL 717
N+I L + LV D+ L+ ++ +L T +GL +L
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYL 116
Query: 718 HHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
H + I+H +LKP+N+LLD+N +++DFGLA+ + Y APEL
Sbjct: 117 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPEL 171
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837
+ D++ G ++ EL+ + G+ ++ L+ L S
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 838 MGDYPEDEVLPVLKLALV--------------CTCHIPSSRPSMAEVVQ 872
+ DY + P + L + P +R + + ++
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 8e-36
Identities = 55/297 (18%), Positives = 114/297 (38%), Gaps = 29/297 (9%)
Query: 592 DCSIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVL 651
+ ID + + +G G+ G V ++ A+K ++Q REV +
Sbjct: 7 NAIIDDYKVTSQ--VLGLGINGKVLQIFNKRTQEKFALK------MLQDCPKARREVELH 58
Query: 652 GKA-RHPNLISLEGYYWTPQLK----LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKV 706
+A + P+++ + Y L+V + G L +++ +R + ++
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEI 116
Query: 707 ILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRF 766
+ + + +LH I H ++KP N+L I H
Sbjct: 117 MKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173
Query: 767 QSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826
YVAPE+ + ++ CD++ GV++ L+ G P + ++ + +S ++ +
Sbjct: 174 CYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIR 230
Query: 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ---ILQVIKTP 880
G + +P + E+ V L P+ R ++ E + I+Q K P
Sbjct: 231 MGQ-YEFPNPEWSEVSEE----VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 135 bits (340), Expect = 2e-35
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 19/231 (8%)
Query: 594 SIDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVL 651
S+ +L +G G FG V+ + GR A+K L ++ + E E +L
Sbjct: 2 SLQDFQILRT---LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 652 GKARHPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTA 711
HP +I + G + Q ++ DY G L + L + P++ +V
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----- 113
Query: 712 KGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALG 771
L + II+ +LKP NILLD N + +I+DFG A+ + + +
Sbjct: 114 --CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP-----D 166
Query: 772 YVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
Y+APE+ + N+ D + FG+LI E++ G P Y + + + +
Sbjct: 167 YIAPEV-VSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILN 215
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 68/288 (23%), Positives = 119/288 (41%), Gaps = 35/288 (12%)
Query: 607 VGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYY 666
+G G FG VY+ G ++A+KK ++Q RE++++ K H N++ L ++
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 667 WTPQLK------LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
++ K LV DY P + H + L + + LA++H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 721 FRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
I H ++KP N+LLD D ++ DFG A+ L R + +V + Y APEL
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIF 195
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG---------NV 830
+ D++ G ++ EL+ G+ G+ V L E ++VL N
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 831 LDCVDPSMGDYPEDEVLP------VLKLALVCTCHIPSSRPSMAEVVQ 872
+ P + +P +V + L + P++R + E
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (334), Expect = 4e-35
Identities = 59/275 (21%), Positives = 107/275 (38%), Gaps = 28/275 (10%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLE 663
+G G V+ R +AVK L + F RE + HP ++++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 664 GYYWTP----QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
L +V +Y +L+ +H P++ +VI + L H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH- 128
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHV-MSNRFQSALGYVAPELT 778
+ IIH ++KP+NI++ ++ DFG+AR + V + Y++PE
Sbjct: 129 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ- 185
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838
+ V+ + D+Y G ++ E++TG P G+ V + +HVR DP
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVR-----------EDPIP 233
Query: 839 GDYPEDEVLPVLK-LALVCTCHIPSSRPSMAEVVQ 872
+ + L + L P +R A ++
Sbjct: 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 58/283 (20%), Positives = 105/283 (37%), Gaps = 25/283 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEG 664
++GEG +GTV+K ++A+K++ D + P RE+ +L + +H N++ L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ + LV ++ + L + KGL H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---RN 121
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 784
++H +LKP N+L++ N ++++FGLAR + L Y P++ +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 785 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844
+ D++ G + EL RP+ G D L R+L + DY
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 845 EVLPVLKLALVCTCHI---------------PSSRPSMAEVVQ 872
+ P + + P R S E +Q
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (334), Expect = 3e-34
Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKARHPNLI 660
+G G FG VY G+M A+K L I + + ++ P ++
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
+ + TP + D G L L + + GL H+H+
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR----FYAAEIILGLEHMHN- 125
Query: 721 FRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQ 780
+++ +LKP+NILLD++ + RISD GLA ++ + GY+APE+ +
Sbjct: 126 --RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQK 179
Query: 781 SLRVNEKCDIYGFGVLILELVTGRRP 806
+ + D + G ++ +L+ G P
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 66/276 (23%), Positives = 106/276 (38%), Gaps = 31/276 (11%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-----YPEDFEREVRVLGKARHPNLI 660
E+G G F V K + G A K + ED EREV +L + +HPN+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 661 SLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHS 720
+L Y +L+ + G L L E+ L+ + + G+ +LH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLH-- 130
Query: 721 FRPPIIHYNLKPSNILLDDNYNPR----ISDFGLARLLTRLDKHVMSNRFQSALGYVAPE 776
I H++LKP NI+L D P+ I DFGLA ++D +VAPE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPE 186
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836
+ + + D++ GV+ L++G P G+ L+ NV
Sbjct: 187 I-VNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLA----------NVSAVNYE 234
Query: 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
+Y + P R ++ + +Q
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-34
Identities = 65/273 (23%), Positives = 103/273 (37%), Gaps = 30/273 (10%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKA-RHPNLISL 662
+G+G FG V+ F + A+K L ++ E E RVL A HP L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 663 EGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
+ T + V +Y G L + + GL LH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHS--- 121
Query: 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSL 782
I++ +LK NILLD + + +I+DFG+ + +N F Y+APE+
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM--LGDAKTNTFCGTPDYIAPEI-LLGQ 178
Query: 783 RVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYP 842
+ N D + FGVL+ E++ G+ P + + L +R +P +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEELFHSIR----------MDNPFYPRWL 226
Query: 843 EDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
E E +L V P R + I Q
Sbjct: 227 EKEAKDLLVKLFVRE---PEKRLGVRG--DIRQ 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-34
Identities = 62/303 (20%), Positives = 121/303 (39%), Gaps = 43/303 (14%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLI 660
EK A++G+G FG V+K G+ +A+KK++ + + +P RE+++L +H N++
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 661 SLEGYYWTPQLK--------LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAK 712
+L T LV D+ + + + + +V+
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLN 128
Query: 713 GLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA--L 770
GL ++H R I+H ++K +N+L+ + +++DFGLAR + + L
Sbjct: 129 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 771 GYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830
Y PEL D++G G ++ E+ T + G L+ ++ G++
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLC---GSI 241
Query: 831 LDCVDPSMGDYPEDEVLPVLK---------------------LALVCTCHIPSSRPSMAE 869
V P++ +Y E L ++K L P+ R +
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 870 VVQ 872
+
Sbjct: 302 ALN 304
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (322), Expect = 2e-33
Identities = 38/279 (13%), Positives = 80/279 (28%), Gaps = 27/279 (9%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
++G G FG +Y + G +A+K E ++ + I +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 666 YWT-PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
++V + S + + ++H
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKN 123
Query: 725 IIHYNLKPSNIL---LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSA-----LGYVAPE 776
IH ++KP N L I DFGLA+ H ++ Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 777 LTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836
T + + + D+ G +++ G P + + + E + ++
Sbjct: 184 -THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR---QKYERISEKKMSTPIEV 239
Query: 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
YP + C +P + + Q+ +
Sbjct: 240 LCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-33
Identities = 64/285 (22%), Positives = 109/285 (38%), Gaps = 27/285 (9%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEG 664
VG G +G V G G +A+KKL + + + RE+R+L RH N+I L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ + +D+ +L L ++ KGL ++H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 784
IIH +LKP N+ ++++ +I DFGLAR + R+ Y APE+ +R
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAPEVILNWMRY 196
Query: 785 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLL------------EEGNVLD 832
+ DI+ G ++ E++TG+ G D++ L E ++V +E
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 833 CVDPSMGDYPEDEVLPVLKLALV-----CTCHIPSSRPSMAEVVQ 872
P + +L V R + E +
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 62/291 (21%), Positives = 102/291 (35%), Gaps = 28/291 (9%)
Query: 602 EKAAEVGEGVFGTVYKV-SFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRV---LGKARH 656
E AE+GEG +G V+K GR +A+K++ + P REV V L H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLP--STPPLSWTNRFKVILGTAKGL 714
PN++ L + + L L P + ++ +GL
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 715 AHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVA 774
LH ++H +LKP NIL+ + +++DFGLAR+ + L Y A
Sbjct: 130 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRA 183
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
PE+ D++ G + E+ + G +V L + + V+ G
Sbjct: 184 PEV-LLQSSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 835 DPSMGDYPEDEVLPVLKLALV-------------CTCHIPSSRPSMAEVVQ 872
D ++ V C P+ R S +
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-32
Identities = 53/275 (19%), Positives = 94/275 (34%), Gaps = 39/275 (14%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-----IQYPEDFEREVRVLGKAR--HPN 658
+G G FG+VY + +A+K + I + EV +L K
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 659 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
+I L ++ P +L+ + L + + L + + H H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 719 HSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPEL 777
+ ++H ++K NIL+D + ++ DFG LL K + F Y PE
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEW 180
Query: 778 TCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837
++ G+L+ ++V G P E+ E+ I+ V
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---IIRGQV---------------- 221
Query: 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQ 872
+ + L C PS RP+ E+
Sbjct: 222 --FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 4e-31
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 13/219 (5%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLE 663
+G+G FG V V GR A+K L II E RVL RHP L +L+
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 664 GYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRP 723
+ T V +YA G L L T + +++ L +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA-------LEYLHSR 124
Query: 724 PIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLR 783
+++ ++K N++LD + + +I+DFGL + + F Y+APE+ +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLEDN-D 181
Query: 784 VNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
D +G GV++ E++ GR P Y +D+ + +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILM 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (306), Expect = 9e-31
Identities = 51/223 (22%), Positives = 86/223 (38%), Gaps = 16/223 (7%)
Query: 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNL 659
++ +G G FG V V G A+K L ++ + E E R+L P L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 660 ISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHH 719
+ LE + +V +Y G + + L S + +LH
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLH- 158
Query: 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTC 779
+I+ +LKP N+L+D +++DFG A+ + +APE+
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI-I 210
Query: 780 QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVR 822
S N+ D + GVLI E+ G P + + + I + V
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVS 252
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 63/281 (22%), Positives = 108/281 (38%), Gaps = 31/281 (11%)
Query: 606 EVGEGVFGTVYKV---SFGTQGRMLAVKKLVTSDIIQYP---EDFEREVRVLGKARH-PN 658
+G G +G V+ V S G++ A+K L + I+Q E E +VL R P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 659 LISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
L++L + T L+ DY G L L +R T +++L L
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA-------LE 143
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 778
H + II+ ++K NILLD N + ++DFGL++ + + + +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838
++ D + GVL+ EL+TG P + +E R +L+
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILK------------ 250
Query: 839 GDYPEDEVLPVLKLALV--CTCHIPSSRPSMAE--VVQILQ 875
+ P + + L L+ P R +I +
Sbjct: 251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (295), Expect = 7e-30
Identities = 37/281 (13%), Positives = 82/281 (29%), Gaps = 29/281 (10%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLI-SLEG 664
+GEG FG +++ + + +A+K E R I ++
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE---PRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ +LV D S + +H
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 725 IIHYNLKPSNILLDDNYNP-----RISDFGLARLL--TRLDKHVMSNRFQSALG---YVA 774
+++ ++KP N L+ + + DFG+ + +H+ ++ G Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 775 PELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834
T + + D+ G + + + G P + G ++ R+ E +
Sbjct: 182 IN-THLGREQSRRDDLEALGHVFMYFLRGSLPWQ-GLKAATNKQKYERIG--EKKQSTPL 237
Query: 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875
+PE K + P + +
Sbjct: 238 RELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-28
Identities = 67/285 (23%), Positives = 113/285 (39%), Gaps = 27/285 (9%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEG 664
VG G +G+V G +AVKKL I + + RE+R+L +H N+I L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPP 724
+ + +D L + L+ + +I +GL ++H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141
Query: 725 IIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRV 784
IIH +LKPSN+ ++++ +I DFGLAR ++ R+ Y APE+ +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YRAPEIMLNWMHY 196
Query: 785 NEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPED 844
N+ DI+ G ++ EL+TGR G D++ L +R++ G L S
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 845 EVLPVLK-----------------LALVCTCHIPSSRPSMAEVVQ 872
+ L + L R + A+ +
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (287), Expect = 2e-28
Identities = 47/223 (21%), Positives = 93/223 (41%), Gaps = 21/223 (9%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEG 664
++G G + V++ T + VK L + +RE+++L R PN+I+L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKK----KKIKREIKILENLRGGPNIITLAD 97
Query: 665 YYWTPQLKL--LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFR 722
P + LV ++ N + L+ + + K L + H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM-- 148
Query: 723 PPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQS 781
I+H ++KP N+++D ++ R+ D+GLA ++ N ++ + PEL
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDY 204
Query: 782 LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
+ D++ G ++ ++ + P +G DN L +VL
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (261), Expect = 8e-25
Identities = 56/226 (24%), Positives = 86/226 (38%), Gaps = 22/226 (9%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEG 664
+G G G V R +A+KKL Q + + RE+ ++ H N+ISL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 665 YYWTP------QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLH 718
+ Q LV + Q E ++ G+ HLH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLH 136
Query: 719 HSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELT 778
IIH +LKPSNI++ + +I DFGLAR M + Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPE-V 189
Query: 779 CQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824
+ E DI+ G ++ E+V + G D + ++ + L
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQL 234
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.8 bits (242), Expect = 2e-22
Identities = 45/216 (20%), Positives = 77/216 (35%), Gaps = 18/216 (8%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGY 665
++G G F TV+ +A+K + + Y E E E+++L + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 666 YWTPQLKLL--VSDYAPNGSLQAKLHE----------RLPSTPPLSWTNRFKVILGTAKG 713
LKLL + PNG + E + + ++ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 714 LAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLLTRLDKHVMSNRFQSALGY 772
L ++H R IIH ++KP N+L++ + + +A L Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 773 VAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVE 808
+PE DI+ LI EL+TG E
Sbjct: 196 RSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.5 bits (231), Expect = 7e-21
Identities = 63/355 (17%), Positives = 116/355 (32%), Gaps = 25/355 (7%)
Query: 6 VHGNSYNAIPSMVVFRILERLNFSHNSLSGQIP----PSLLNLNMMNMKFLDLSNNLLSG 61
+I + L ++NFS+N L+ P L+++ M N + D++
Sbjct: 51 ADRLGIKSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLT 110
Query: 62 PVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIW 121
+ N L + N S ++ L+ +
Sbjct: 111 NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKP 170
Query: 122 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181
L + S +A L L+ L+ NQ S P +G +L L L+
Sbjct: 171 LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNG 228
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 241
N +L L ++ + ++NN ++ P + ++ L L N ++ P L
Sbjct: 229 NQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LA 282
Query: 242 NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 301
L+ + L N L P L + L N P S L+
Sbjct: 283 GLTALTNLELNENQLEDISPISNLK-NLTYLTLYFNNISDISPVSS--------LTKLQR 333
Query: 302 LDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNA 356
L ++N + + + N+ +L+ N + P L + L L + A
Sbjct: 334 LFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.6 bits (226), Expect = 3e-20
Identities = 66/376 (17%), Positives = 115/376 (30%), Gaps = 56/376 (14%)
Query: 96 SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLL 155
+ TL +D G+ L L ++ S+N + P L L +L+
Sbjct: 44 DQVTTLQADRLGIK-SID-----GVEYLNNLTQINFSNNQLTDITP-----LKNLTKLVD 92
Query: 156 QGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHW 215
+ T N + L N SN
Sbjct: 93 ILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNT------ISD 146
Query: 216 IGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLS 275
I +S L L + + L N L + + N ++ E + +
Sbjct: 147 ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL-ESLIAT 205
Query: 276 ENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS 335
N P G ++ L L L+ N L + NL L+L++N + +
Sbjct: 206 NNQISDITPLGILTN--------LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255
Query: 336 RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRS--------------------LGILQ 375
P L L L L N + P + + L L
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 313
Query: 376 LDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQ 435
L N+++ P + + T L L ++N +S S++NL + L N++S P
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP- 368
Query: 436 ELGKLASLLAVNVSYN 451
L L + + ++
Sbjct: 369 -LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 59.2 bits (142), Expect = 9e-10
Identities = 19/106 (17%), Positives = 40/106 (37%), Gaps = 9/106 (8%)
Query: 1 MTTPLVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLS 60
+T ++ N I + + L L N++S P S ++ ++ L +NN +S
Sbjct: 287 LTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS----SLTKLQRLFFANNKVS 342
Query: 61 GPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNN 106
N ++ +LS N + + + L L++
Sbjct: 343 DVSS---LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.1 bits (222), Expect = 3e-20
Identities = 52/273 (19%), Positives = 97/273 (35%), Gaps = 18/273 (6%)
Query: 164 LPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLE 223
+P D+ P LDL NN T + L ++ + + NN ++ P + LE
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 224 FLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSI 283
L S N L ++L V + ++ GL + + E+ + G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 284 PPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGY 343
L + ++ N+ IP GL +L L+L N + L
Sbjct: 143 NGAFQGMKK------LSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAASLKG 193
Query: 344 FHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 403
++L L L N++ + + L L L+ N L +P + + + ++ L +N
Sbjct: 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 252
Query: 404 HLSG------SIPKSISNLNKLKILKLEFNELS 430
++S P + + L N +
Sbjct: 253 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.7 bits (208), Expect = 2e-18
Identities = 52/286 (18%), Positives = 93/286 (32%), Gaps = 18/286 (6%)
Query: 26 LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85
+ S L ++P L + LDL NN ++ + F+N +L L L N +
Sbjct: 15 VQCSDLGLE-KVPKDLPP----DTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKIS 68
Query: 86 GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVA 145
F L L LS N + K L+ L + N +
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPE-------KMPKTLQELRVHENEITKVRKSVFN 121
Query: 146 ALHYLKELLLQG--NQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISV 203
L+ + + L + SG L+ + +++ T + L S+ + +
Sbjct: 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHL 178
Query: 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 263
N +T + ++ L L S N ++ SL N L + L N L
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGL 238
Query: 264 LFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL 309
++ + L N +T + + L SN +
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.2 bits (199), Expect = 3e-17
Identities = 58/271 (21%), Positives = 93/271 (34%), Gaps = 26/271 (9%)
Query: 96 SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLL 155
L+L NN + D +LK L TL L +N S P A L L+ L L
Sbjct: 31 PDTALLDLQNNKITEIKDGD----FKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 156 QGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN--NTLTGDIP 213
NQ L L + N T LN MI + + +G
Sbjct: 87 SKNQLKELPE---KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 214 HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG-LEEI 272
+ L ++ ++ ++T ++P L L+ + L GN + L L L ++
Sbjct: 144 GAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKL 200
Query: 273 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH 332
LS N S LR L L++N LV ++ + L +N+
Sbjct: 201 GLSFNSISAVDN------GSLANTPHLRELHLNNNKLVKVPGGLADHK-YIQVVYLHNNN 253
Query: 333 LRS------RIPPELGYFHSLIHLDLRNNAL 357
+ + P S + L +N +
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.8 bits (164), Expect = 9e-13
Identities = 29/166 (17%), Positives = 58/166 (34%), Gaps = 4/166 (2%)
Query: 293 STLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDL 352
L +LDL +N + + NL L L +N + P L L L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 353 RNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKS 412
N L + + L + + + + + + + L + + SG +
Sbjct: 87 SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGA 145
Query: 413 ISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 458
+ KL +++ ++ IPQ L SL +++ N++
Sbjct: 146 FQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDA 188
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (213), Expect = 3e-19
Identities = 62/287 (21%), Positives = 99/287 (34%), Gaps = 18/287 (6%)
Query: 25 RLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNIL 84
+ L +P + + + L N +S VP F C +L L L N+L
Sbjct: 15 TTSCPQQGLQ-AVPVGIPA----ASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVL 68
Query: 85 QGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGV 144
F + L L+LS+N +D L RL TL L P
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDP---ATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 145 AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS 204
L L+ L LQ N +LT L L N + + R L+S+ + +
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 205 NNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGL 264
N + PH ++ L L N+L+ +L + L +RL N +
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP 245
Query: 265 FDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 311
L++ S + S+P + L++N+L G
Sbjct: 246 LWAWLQKFRGSSSEVPCSLPQR---------LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (191), Expect = 2e-16
Identities = 45/275 (16%), Positives = 81/275 (29%), Gaps = 10/275 (3%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQ 66
A+P + +R+ N +S S + + +L + +
Sbjct: 19 PQQGLQAVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL--ARIDAAA 75
Query: 67 LFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRL 126
+ L+ F+ L+TL+L L L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL----QELGPGLFRGLAAL 131
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 186
+ L L N L L L L GN+ S L L L N
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 187 QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKL 246
P + R L ++ + + N L+ + + L++L ++N + L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWL 250
Query: 247 SVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMG 281
R + + ++P+ L L L+ N G
Sbjct: 251 QKFRGSSSEVPCSLPQRLAGRDL--KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (185), Expect = 1e-15
Identities = 52/265 (19%), Positives = 89/265 (33%), Gaps = 14/265 (5%)
Query: 96 SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLL 155
++ + L N S + + + L L L N+ + L L++L L
Sbjct: 32 AASQRIFLHGNRISHVPAAS----FRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87
Query: 156 QGNQFSGPL-PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPH 214
N + PA L TL L P R L ++ ++ + +N L
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 215 WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDL 274
++ L L N ++ + L + L N + P DLG
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 275 SENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLR 334
+ ++P + + + L+ L L+ N V D A L+A L+ SS+ +
Sbjct: 208 LFANNLSALPTEALAP-----LRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVP 261
Query: 335 SRIPPELGYFHSLIHLDLRNNALYG 359
+P L L N L G
Sbjct: 262 CSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (178), Expect = 1e-14
Identities = 55/305 (18%), Positives = 93/305 (30%), Gaps = 37/305 (12%)
Query: 128 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQ 187
T ++P G+ A + + L GN+ S A C +LT L L +N+
Sbjct: 15 TTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 188 LPVSLRLLNSMIFISVSNNTLTGDI-PHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKL 246
+ L + + +S+N + P + L L L P L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 247 SVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSS 306
+ L+ N+L + D L L L
Sbjct: 132 QYLYLQDNALQALPDDTFRD-----------------------------LGNLTHLFLHG 162
Query: 307 NNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC 366
N + +L L L N + P L+ L L N L + +
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222
Query: 367 ESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEF 426
R+L L+L+ N L S + + S+P+ ++ + +L
Sbjct: 223 PLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAA 278
Query: 427 NELSG 431
N+L G
Sbjct: 279 NDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (176), Expect = 2e-14
Identities = 51/286 (17%), Positives = 85/286 (29%), Gaps = 21/286 (7%)
Query: 175 TTLDLSNNLFT---GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 231
T +P + + + + N ++ L L +N
Sbjct: 14 VTTSCPQQGLQAVPVGIPAASQRIF------LHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 232 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFD--LGLEEIDLSENGFMGSIPPGSSS 289
L ++ L + L N+ ++ F L + L G P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP----- 122
Query: 290 SSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIH 349
L+ L L N L NL +L L N + S HSL
Sbjct: 123 -GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 350 LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSI 409
L L N + P + L L L N+L+ + + +L L L+ N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 410 PKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIG 455
+ L+ + +E+ +PQ L L ++ N L G
Sbjct: 242 R-ARPLWAWLQKFRGSSSEVPCSLPQRLAGR-DLK--RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (163), Expect = 8e-13
Identities = 48/255 (18%), Positives = 90/255 (35%), Gaps = 7/255 (2%)
Query: 225 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 284
L ++P + I L GN ++ +L+ ++
Sbjct: 16 TSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACR----NLTILWLHSNVL 68
Query: 285 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 344
+++ + L ++ + L PA L L+L L+ P
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128
Query: 345 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNH 404
+L +L L++NAL + +L L L GN ++ + R SL L L N
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188
Query: 405 LSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLPVGGVFP 464
++ P + +L +L L L N LS + L L +L + ++ N + ++
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA 248
Query: 465 TLDQSSLQGNLGICS 479
L + + CS
Sbjct: 249 WLQKFRGSSSEVPCS 263
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 83.6 bits (205), Expect = 6e-18
Identities = 73/291 (25%), Positives = 115/291 (39%), Gaps = 27/291 (9%)
Query: 102 NLSNNHFSGDLDFASGYGIW-----SLKRLRTLDLSHNLFSG--SIPQGVAALHYLKELL 154
LS+ + D + G+ R+ LDLS IP +A L YL L
Sbjct: 23 TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82
Query: 155 LQGN-QFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP 213
+ G GP+P I L L +++ +G +P L + +++ + S N L+G +P
Sbjct: 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
Query: 214 HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV-IRLRGNSLNGNIPEGLFDLGLEEI 272
I ++ L + F N ++G++P S + KL + + N L G IP +L L +
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFV 202
Query: 273 DLSENGFMGSIPPGSSSSSSSTL-----------------FQTLRILDLSSNNLVGDIPA 315
DLS N G S ++ + L LDL +N + G +P
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ 262
Query: 316 EMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC 366
+ L LN+S N+L I P+ G NN P C
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 81.7 bits (200), Expect = 2e-17
Identities = 65/275 (23%), Positives = 98/275 (35%), Gaps = 14/275 (5%)
Query: 217 GNISTLEFLDFSNNHLTG--SLPSSLFNCKKLSVIRLRG--NSLNGNIPEGLFDLGLEEI 272
+ LD S +L +PSSL N L+ + + G N + P L +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 273 DLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNH 332
++ G+IP + +TL LD S N L G +P + NL + N
Sbjct: 107 YITHTNVSGAIPD------FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 333 LRSRIPPELGYFHSLIH-LDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRN 391
+ IP G F L + + N L G IP ++ V+
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDASVLFG 218
Query: 392 CTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYN 451
+ + L L L N + G +PQ L +L L ++NVS+N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 452 RLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPC 486
L G +P GG D S+ N +C L C
Sbjct: 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.2 bits (183), Expect = 4e-15
Identities = 60/269 (22%), Positives = 91/269 (33%), Gaps = 9/269 (3%)
Query: 23 LERLNFSHNSLSG--QIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLA 80
+ L+ S +L IP SL NL +N ++ NNL+ P L YL +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ--LHYLYIT 109
Query: 81 GNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSI 140
+ G I + +L TL+ S N I SL L + N SG+I
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNAL----SGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 141 PQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIF 200
P + L + +L +DLS N L +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRN-MLEGDASVLFGSDKNTQ 224
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 260
+G L LD NN + G+LP L K L + + N+L G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 261 PEGLFDLGLEEIDLSENGFMGSIPPGSSS 289
P+G + + N + P + +
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 3/132 (2%)
Query: 291 SSSTLFQTLRILDLSSNNLVGD--IPAEMGLFANLRYLNLSSNH-LRSRIPPELGYFHSL 347
+ T + LDLS NL IP+ + L +L + + L IPP + L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 348 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG 407
+L + + + G+IP + + ++L L N+L+G +P I + +L ++ N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 408 SIPKSISNLNKL 419
+IP S + +KL
Sbjct: 164 AIPDSYGSFSKL 175
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 73.7 bits (180), Expect = 2e-15
Identities = 28/187 (14%), Positives = 51/187 (27%), Gaps = 31/187 (16%)
Query: 606 EVGEGVFGTVYKVSFGTQGRMLAVKKL---------VTSDIIQYPEDFEREVRVLGKARH 656
+GEG V+ + + VK V F +
Sbjct: 7 LMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 657 PNLISLEGYYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAH 716
L L+G + N L + + + + V+ + +A
Sbjct: 66 RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 717 LHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR---------LLTRLDKHVMSNRFQ 767
+H I+H +L N+L+ + I DF + +L R D + F
Sbjct: 119 FYH---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILER-DVRNIITYFS 173
Query: 768 SALGYVA 774
Sbjct: 174 RTYRTEK 180
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.5 bits (158), Expect = 4e-12
Identities = 46/272 (16%), Positives = 97/272 (35%), Gaps = 11/272 (4%)
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 186
+TLDL+ + + + + + PL + + +DLSN++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60
Query: 187 -QLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFS--NNHLTGSLPSSLFNC 243
L L + + +S+ L+ I + + S L L+ S + +L + L +C
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 244 KKLSVI--RLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 301
+L + + ++ + + L+ +G+ ++ S+ + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 302 LDLSSNNLVGDIPAEMGLFANLRYLNLSS-NHLRSRIPPELGYFHSLIHLDLRNNALYGS 360
S L D E L++L+LS + ELG +L L + G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 361 IPQEVCESRSLGILQLDGNSLTGPIPQVIRNC 392
+ +L LQ++ + T I N
Sbjct: 241 LQLLK---EALPHLQINCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (154), Expect = 1e-11
Identities = 38/283 (13%), Positives = 89/283 (31%), Gaps = 22/283 (7%)
Query: 25 RLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN-I 83
L+ + +L + LL+ ++ + + P+ + ++++ L+ + I
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIA---FRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVI 58
Query: 84 LQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS--HNLFSGSIP 141
+ I + CS L L+L S + + L L+LS ++
Sbjct: 59 EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT----LAKNSNLVRLNLSGCSGFSEFALQ 114
Query: 142 QGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLD-------LSNNLFTGQLPVSLRL 194
+++ L EL L + T+ N + + R
Sbjct: 115 TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC 174
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLRG 253
N + + L D ++ L+ L S + L L +++ G
Sbjct: 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234
Query: 254 NSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLF 296
+G + L + ++ + F P + + ++
Sbjct: 235 IVPDGTLQL--LKEALPHLQINCSHFTTIARPTIGNKKNQEIW 275
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 48/262 (18%), Positives = 88/262 (33%), Gaps = 8/262 (3%)
Query: 175 TTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTG 234
TLDL+ + L L +I + + + ++ +D SN+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 235 -SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL-GLEEIDLSENGFMGSIPPGSSSSSS 292
+L L C KL + L G L+ I L L ++LS + SS
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 293 STLFQT--LRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHL 350
S L + D + ++ + L N +S + + +L+HL
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 351 DLRNNALY-GSIPQEVCESRSLGILQLDG-NSLTGPIPQVIRNCTSLYLLSLSHNHLSGS 408
DL ++ + QE + L L L + + +L L + G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 409 IPKSISNLNKLKILKLEFNELS 430
+ L L+I F ++
Sbjct: 241 LQLLKEALPHLQINCSHFTTIA 262
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 44/293 (15%), Positives = 84/293 (28%), Gaps = 32/293 (10%)
Query: 52 LDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGD 111
LDL+ L V +L + + + P+ + F+ + ++LSN+
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVS 61
Query: 112 LDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFC 171
+ +L+ L L S I +A L L
Sbjct: 62 TLHGI---LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL----------------NL 102
Query: 172 PHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNH 231
+ L LN + + + H I+ L + N
Sbjct: 103 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNL 162
Query: 232 LTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLF--DLGLEEIDLSENGFMGSIPPGSSS 289
L + + C L + L + + N F L+ + LS +
Sbjct: 163 QKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222
Query: 290 SSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELG 342
+ L+ L + G + L L +L ++ +H + P +G
Sbjct: 223 EIPT-----LKTLQVFGIVPDGTLQL---LKEALPHLQINCSHFTTIARPTIG 267
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 2e-10
Identities = 45/213 (21%), Positives = 71/213 (33%), Gaps = 12/213 (5%)
Query: 45 NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLS 104
+ + ++ L+ +P L ++ L L+ N+L + L LNL
Sbjct: 8 KVASHLEVNCDKRNLTA-LPPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 105 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPL 164
+ +L L TLDLSHN G L L + N+ +
Sbjct: 64 RAELTKL------QVDGTLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLP 116
Query: 165 PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 224
+ L L L N P L + +S++NN LT + + L+
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 225 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 257
L N L ++P F L L GN
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 8e-09
Identities = 44/208 (21%), Positives = 69/208 (33%), Gaps = 31/208 (14%)
Query: 268 GLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLN 327
E++ + ++PP L + IL LS N L A + + L LN
Sbjct: 11 SHLEVNCDKRNLT-ALPPD--------LPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 328 LSSN---------------------HLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC 366
L + +P +L LD+ N L +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 367 ESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEF 426
L L L GN L P ++ L LSL++N+L+ ++ L L L L+
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 427 NELSGEIPQELGKLASLLAVNVSYNRLI 454
N L IP+ L + N +
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 2e-08
Identities = 42/211 (19%), Positives = 67/211 (31%), Gaps = 14/211 (6%)
Query: 122 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181
+ ++ + ++P + L L N A + LT L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 182 -NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSL 240
L Q+ +L +L ++ +L LD S N LT +L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALT----VLDVSFNRLTSLPLGAL 120
Query: 241 FNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLR 300
+L + L+GN L P L E N + +P G + + L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN-----LD 175
Query: 301 ILDLSSNNLVGDIPAEMGLFANLRYLNLSSN 331
L L N+L IP L + L N
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.6 bits (128), Expect = 3e-09
Identities = 32/127 (25%), Positives = 48/127 (37%), Gaps = 9/127 (7%)
Query: 300 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYG 359
R+L L+ +L + + + +L+LS N LR+ PP L L L +N
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDN--AL 55
Query: 360 SIPQEVCESRSLGILQLDGNSLTG-PIPQVIRNCTSLYLLSLSHNHLS---GSIPKSISN 415
V L L L N L Q + +C L LL+L N L G +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 416 LNKLKIL 422
L + +
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 5e-08
Identities = 30/122 (24%), Positives = 48/122 (39%), Gaps = 7/122 (5%)
Query: 324 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 383
R L+L+ L L + HLDL +N L P + R L +LQ N+L
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 384 PIPQVIRNCTSLYLLSLSHNHL-SGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLAS 442
L L +N L + + + + +L +L L+ N L + +LA
Sbjct: 58 VDGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114
Query: 443 LL 444
+L
Sbjct: 115 ML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 6e-07
Identities = 32/125 (25%), Positives = 45/125 (36%), Gaps = 10/125 (8%)
Query: 75 RYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHN 134
R L LA L + L+LS+N + +L+ L L S N
Sbjct: 1 RVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDN 53
Query: 135 LFSGSIPQGVAALHYLKELLLQGNQF-SGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLR 193
GVA L L+ELLL N+ + CP L L+L N + + R
Sbjct: 54 ALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111
Query: 194 LLNSM 198
L +
Sbjct: 112 LAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 23/132 (17%), Positives = 45/132 (34%), Gaps = 14/132 (10%)
Query: 50 KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFS 109
+ L L++ L+ E + +L L+ N L+ + L + +
Sbjct: 1 RVLHLAHKDLTVLCH---LEQLLLVTHLDLSHNRLRALPPALAALRC----LEVLQASDN 53
Query: 110 GDLDFASGYGIWSLKRLRTLDLSHN-LFSGSIPQGVAALHYLKELLLQGNQFSGP---LP 165
+ + RL+ L L +N L + Q + + L L LQGN
Sbjct: 54 ALENVDGVANLP---RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110
Query: 166 ADIGFCPHLTTL 177
P ++++
Sbjct: 111 RLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 4e-06
Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 6/109 (5%)
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTG 186
R L L+H + + + L + L L N+ PA + L L S+N
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 187 QLPVSLRLLNSMIFISVSNNTLTG-DIPHWIGNISTLEFLDFSNNHLTG 234
V+ + + + NN L + + L L+ N L
Sbjct: 58 VDGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 6e-06
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 151 KELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTG 210
+ L L + + +T LDLS+N P L + + N
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 211 DIPHWIGNISTLEFLDFSNNHLTG-SLPSSLFNCKKLSVIRLRGNSLNG 258
D + + + L NN L + L +C +L ++ L+GNSL
Sbjct: 59 DGVANLPRL---QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 6e-05
Identities = 26/127 (20%), Positives = 50/127 (39%), Gaps = 9/127 (7%)
Query: 201 ISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 260
+ +++ LT + + + + LD S+N L P +L + L V++ N+ N+
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA-LENV 58
Query: 261 PEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLF 320
L+E+ L N S S L +L+L N+L + + L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR-----LVLLNLQGNSLCQEEGIQERLA 113
Query: 321 ANLRYLN 327
L ++
Sbjct: 114 EMLPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 23/117 (19%), Positives = 41/117 (35%), Gaps = 22/117 (18%)
Query: 7 HGNSYNAIPSMVVFRILERLNFSHNSLSGQIP--PSLLNLNMMNM--------------- 49
+ + ++ L+ SHN L P +L L ++
Sbjct: 6 AHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLP 65
Query: 50 --KFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNIL---QGPIGKIFNYCSSLNTL 101
+ L L NN L Q +C L L+L GN L +G ++ S++++
Sbjct: 66 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 55.2 bits (131), Expect = 4e-09
Identities = 38/193 (19%), Positives = 68/193 (35%), Gaps = 13/193 (6%)
Query: 127 RTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADI-GFCPHLTTLDLSNNLFT 185
T+D + IP+ + + ELLL N+ + G PHL L+L N T
Sbjct: 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 186 GQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKK 245
G P + + + + + N + + L+ L+ +N ++ +P S +
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 246 LSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 305
L+ + L N N N F L + L+ P + ++I DL
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---------VRDVQIKDLP 178
Query: 306 SNNLVGDIPAEMG 318
+ G
Sbjct: 179 HSEFKCSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 30/121 (24%), Positives = 48/121 (39%), Gaps = 4/121 (3%)
Query: 300 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRI-PPELGYFHSLIHLDLRNNALY 358
+D + L +IP + + L L+ N L G L+ L+L+ N L
Sbjct: 11 TTVDCTGRGLK-EIPR--DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 359 GSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNK 418
G P + + LQL N + ++ L L+L N +S +P S +LN
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 419 L 419
L
Sbjct: 128 L 128
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 7e-08
Identities = 53/347 (15%), Positives = 105/347 (30%), Gaps = 48/347 (13%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGN 82
L ++ LS +P +L + L S N L+ +L E SL+ L + N
Sbjct: 40 AHELELNNLGLS-SLPELPPHL-----ESLVASCNSLT-----ELPELPQSLKSLLVDNN 88
Query: 83 ILQGPIGKIFNYCSSLNTLNLSNNHFSGD----------LDFASGYGIWSLKRLRTLDLS 132
L+ + + L L +SNN + + L L
Sbjct: 89 NLKA----LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEF 144
Query: 133 HNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSL 192
+ + + + + + S D+ + +L
Sbjct: 145 IAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLP 204
Query: 193 RL----LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSV 248
L ++ + ++ + + + + N T + + +L
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264
Query: 249 IRLRGNSLNGNIPEGLFDLG-LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSN 307
N+ + I LEE+++S N + +P L L S N
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---------LERLIASFN 314
Query: 308 NLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRN 354
+L ++P NL+ L++ N LR P S+ L + +
Sbjct: 315 HL-AEVPELPQ---NLKQLHVEYNPLRE-FPDIPE---SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 21/82 (25%), Positives = 36/82 (43%), Gaps = 12/82 (14%)
Query: 296 FQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNN 355
+L L++S+N L+ ++PA L L S NHL + +P +L L + N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELPQ---NLKQLHVEYN 334
Query: 356 ALYGSIPQEVCESRSLGILQLD 377
L P S+ L+++
Sbjct: 335 PLR-EFPDIP---ESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 3e-07
Identities = 48/333 (14%), Positives = 90/333 (27%), Gaps = 24/333 (7%)
Query: 95 CSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELL 154
+ L L+N S + L +L S N + +P+ +L L
Sbjct: 37 DRQAHELELNNLGLSSLPE--------LPPHLESLVASCNSLT-ELPELPQSLKSLLVDN 87
Query: 155 LQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT------L 208
S P L+ L + + N+ +
Sbjct: 88 NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147
Query: 209 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLG 268
+ + + L FL S++ + L L
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207
Query: 269 LEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNL 328
D + + +PP + + + T S + + L
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLY 267
Query: 329 SSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQV 388
N + I SL L++ NN L +P L L N L +P++
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPP---RLERLIASFNHLAE-VPEL 322
Query: 389 IRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKI 421
+N L+ + +N L P ++ L++
Sbjct: 323 PQNLKQLH---VEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 53/312 (16%), Positives = 98/312 (31%), Gaps = 23/312 (7%)
Query: 150 LKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLT 209
EL L S LP PHL +L S N T +LP + L S++ + + L+
Sbjct: 40 AHELELNNLGLSS-LPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94
Query: 210 GDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGL 269
P + + + ++ + + L
Sbjct: 95 DLPPLL--EYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 270 EEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 329
EE+ +N + ++S L + + + N + + E+ L +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 330 SNHLRSRIPPELGYFHSLIHLDLRNNAL--------YGSIPQEVCESRSLGILQLDGNSL 381
+N L++ + + + L N+
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 382 TGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLA 441
+ I + SL L++S+N L +P L+ L FN L+ E+P+ L
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLK 327
Query: 442 SLLAVNVSYNRL 453
L +V YN L
Sbjct: 328 QL---HVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 16/78 (20%), Positives = 28/78 (35%), Gaps = 5/78 (6%)
Query: 319 LFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDG 378
L L L++ L S +P L L N+L +P+ +SL + +
Sbjct: 36 LDRQAHELELNNLGLSS-LPELPP---HLESLVASCNSL-TELPELPQSLKSLLVDNNNL 90
Query: 379 NSLTGPIPQVIRNCTSLY 396
+L+ P + S
Sbjct: 91 KALSDLPPLLEYLGVSNN 108
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 1e-07
Identities = 16/93 (17%), Positives = 32/93 (34%), Gaps = 5/93 (5%)
Query: 47 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG----PIGKIFNYCSSLNTLN 102
++++ LD+ LS +L + + L L I +L LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 103 LSNNHFSGDLDFASGYGIWSLK-RLRTLDLSHN 134
L +N G+ + +++ L L +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 1e-07
Identities = 17/80 (21%), Positives = 27/80 (33%), Gaps = 9/80 (11%)
Query: 370 SLGILQLDGNSLTG----PIPQVIRNCTSLYLLSLSHNHLSGSIPKSIS-----NLNKLK 420
L +L L ++ + + SL L LS+N L + + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 421 ILKLEFNELSGEIPQELGKL 440
L L S E+ L L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 5/91 (5%)
Query: 346 SLIHLDLRNNALYGSIPQEVCES-RSLGILQLDGNSLTG----PIPQVIRNCTSLYLLSL 400
+ LD++ L + E+ + +++LD LT I +R +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 401 SHNHLSGSIPKSISNLNKLKILKLEFNELSG 431
N L + + K++ L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 2e-07
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 9/95 (9%)
Query: 92 FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA----- 146
S L L L++ S + + + LR LDLS+N + +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 147 LHYLKELLLQGNQFSGPLPADIGF----CPHLTTL 177
L++L+L +S + + P L +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 4e-07
Identities = 10/72 (13%), Positives = 26/72 (36%), Gaps = 5/72 (6%)
Query: 126 LRTLDLSHNLFSGS-IPQGVAALHYLKELLLQGNQFSG----PLPADIGFCPHLTTLDLS 180
+++LD+ S + + + L + + L + + + + P L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 181 NNLFTGQLPVSL 192
+N +
Sbjct: 64 SNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 23/117 (19%), Positives = 37/117 (31%), Gaps = 27/117 (23%)
Query: 314 PAEMGLFANLRYLNLSSNHLRSR----IPPELGYFHSLIHLDLRNNALYGSIPQEVCESR 369
+ LR L L+ + + L HSL LDL NN L + ++ ES
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES- 420
Query: 370 SLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNL----NKLKIL 422
V + L L L + S + + L L+++
Sbjct: 421 ------------------VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 6e-06
Identities = 14/82 (17%), Positives = 27/82 (32%), Gaps = 10/82 (12%)
Query: 213 PHWIGNISTLEFLDFSNNHLTG----SLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDL- 267
S L L ++ ++ SL ++L L + L N L L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 268 -----GLEEIDLSENGFMGSIP 284
LE++ L + + +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 17/83 (20%), Positives = 29/83 (34%), Gaps = 5/83 (6%)
Query: 299 LRILDLSSNNLVGDIPAEM-GLFANLRYLNLSSNHLRSR----IPPELGYFHSLIHLDLR 353
++ LD+ L AE+ L + + L L I L +L L+LR
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 354 NNALYGSIPQEVCESRSLGILQL 376
+N L V + ++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 9e-06
Identities = 18/85 (21%), Positives = 27/85 (31%), Gaps = 5/85 (5%)
Query: 68 FENCASLRYLSLAGNILQG----PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGI-WS 122
+ + LR L LA + + SL L+LSNN +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 123 LKRLRTLDLSHNLFSGSIPQGVAAL 147
L L L +S + + AL
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 15/95 (15%), Positives = 30/95 (31%), Gaps = 12/95 (12%)
Query: 97 SLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG----SIPQGVAALHYLKE 152
+ +L++ S D +A L++ + + L + I + L E
Sbjct: 3 DIQSLDIQCEELS-DARWAELLP--LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 153 LLLQGNQFSGPLPADIG-----FCPHLTTLDLSNN 182
L L+ N+ + + L L N
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 10/94 (10%), Positives = 24/94 (25%), Gaps = 6/94 (6%)
Query: 73 SLRYLSLAGN-ILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDL 131
++ L + + ++ + L + + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 132 SHNLFSGSIPQGVAAL-----HYLKELLLQGNQF 160
N V +++L LQ
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 5/91 (5%)
Query: 174 LTTLDLSNNLFT-GQLPVSLRLLNSMIFISVSNNTLTGD----IPHWIGNISTLEFLDFS 228
+ +LD+ + + L LL + + + LT I + L L+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 229 NNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN 259
+N L + + +++ SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 19/95 (20%), Positives = 32/95 (33%), Gaps = 15/95 (15%)
Query: 148 HYLKELLLQGNQFSG----PLPADIGFCPHLTTLDLSNNLFTGQ----LPVSLRLLNSMI 199
L+ L L S L A + L LDLSNN L S+R ++
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 200 -FISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLT 233
+ + + + ++ L+ L+ L
Sbjct: 429 EQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 15/76 (19%), Positives = 27/76 (35%), Gaps = 8/76 (10%)
Query: 45 NMMNMKFLDLSNNLLSGPVPYQL---FENCASLRYLSLAGNILQGPIGK-----IFNYCS 96
++ L L++ +S L SLR L L+ N L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 97 SLNTLNLSNNHFSGDL 112
L L L + ++S ++
Sbjct: 427 LLEQLVLYDIYWSEEM 442
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 14/93 (15%), Positives = 30/93 (32%), Gaps = 7/93 (7%)
Query: 222 LEFLDFSNNHLTGSLPSSLF-NCKKLSVIRLRGNSLNGNIPEGLFDL-----GLEEIDLS 275
++ LD L+ + + L ++ V+RL L + + L E++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 276 ENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNN 308
N + ++ L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPS-CKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 16/104 (15%), Positives = 32/104 (30%), Gaps = 9/104 (8%)
Query: 267 LGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNL----VGDIPAEMGLFAN 322
L ++ +D+ + + L Q +++ L L DI + + +
Sbjct: 2 LDIQSLDIQCEEL-----SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPA 56
Query: 323 LRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVC 366
L LNL SN L + ++ +L
Sbjct: 57 LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 17/108 (15%), Positives = 27/108 (25%), Gaps = 25/108 (23%)
Query: 165 PADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 224
L L L++ + SL + +L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSL--------------------AATLLANHSLRE 401
Query: 225 LDFSNNHLTGSLPSSLF-----NCKKLSVIRLRGNSLNGNIPEGLFDL 267
LD SNN L + L L + L + + + L L
Sbjct: 402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 6/62 (9%)
Query: 23 LERLNFSHNSLSGQIPPSL---LNLNMMNMKFLDLSNNLLSGPVPYQL---FENCASLRY 76
L L+ S+N L L + ++ L L + S + +L ++ SLR
Sbjct: 399 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
Query: 77 LS 78
+S
Sbjct: 459 IS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 16/79 (20%), Positives = 29/79 (36%), Gaps = 9/79 (11%)
Query: 296 FQTLRILDLSSNNL----VGDIPAEMGLFANLRYLNLSSNHLRSRIPPELG-----YFHS 346
LR+L L+ ++ + A + +LR L+LS+N L +L
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 347 LIHLDLRNNALYGSIPQEV 365
L L L + + +
Sbjct: 428 LEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 10/94 (10%), Positives = 28/94 (29%), Gaps = 6/94 (6%)
Query: 19 VFRILERLNFSHNSLSGQIPPSLLNL--NMMNMKFLDLSNNLLSGPVPYQLFE----NCA 72
+ + + + L+ + + + L+L +N L + + +
Sbjct: 25 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC 84
Query: 73 SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNN 106
++ LSL L G + + +
Sbjct: 85 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 118
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 12/61 (19%), Positives = 26/61 (42%), Gaps = 5/61 (8%)
Query: 398 LSLSHNHLSGS-IPKSISNLNKLKILKLEFNELSGE----IPQELGKLASLLAVNVSYNR 452
L + LS + + + L + ++++L+ L+ I L +L +N+ N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 453 L 453
L
Sbjct: 67 L 67
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.9 bits (117), Expect = 7e-07
Identities = 45/367 (12%), Positives = 94/367 (25%), Gaps = 44/367 (11%)
Query: 73 SLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLS 132
SL+ ++ + + + S+ + LS N + I S K L + S
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 133 HNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSL 192
+ + + + L + CP L T+ LS+N F L
Sbjct: 68 DI--------------FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPL 113
Query: 193 RLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 252
S + G + + N + P + +
Sbjct: 114 IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 173
Query: 253 GNSLNGNIPEGLFDLGLEEIDLSENGF-MGSIPPGSSSSSSSTLFQTLRILDLSSNNLVG 311
+ L ++ + + L + ++
Sbjct: 174 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 233
Query: 312 DIPAEMGLFANLRYLNLSSNHLRSRIPPELG------YFHSLIHLDLRNNALYGSIPQEV 365
+ + + NLR L L+ L +R + L L L+ N + + +
Sbjct: 234 ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 293
Query: 366 CESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL- 424
+ L L L+ N + + ++ +
Sbjct: 294 KTV-------------------IDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGR 333
Query: 425 -EFNELS 430
E +EL
Sbjct: 334 GELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.6 bits (111), Expect = 4e-06
Identities = 35/338 (10%), Positives = 83/338 (24%), Gaps = 34/338 (10%)
Query: 124 KRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGP----LPADIGFCPHLTTLDL 179
K L+ ++ S+ + +KE++L GN L +I L +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 180 SNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS 239
S+ L ++ + L T + L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 240 LFNCKKLSVIRLRGNSLNGNIPEGLFDLG--LEEIDLSENGFMGSIPPGSSSSSSSTLFQ 297
+ L + + + + +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 298 TLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNAL 357
L + + N + + + L L + + +
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD---------------LQDNTFTHLG 231
Query: 358 YGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNC------TSLYLLSLSHNHLSGSIPK 411
++ + +L L L+ L+ + + L L L +N + +
Sbjct: 232 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 291
Query: 412 SI-----SNLNKLKILKLEFNELSGEIPQELGKLASLL 444
++ + L L+L N S E + ++ +
Sbjct: 292 TLKTVIDEKMPDLLFLELNGNRFSEE-DDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 39/320 (12%), Positives = 72/320 (22%), Gaps = 24/320 (7%)
Query: 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQL---FENCASLRYLSL 79
L+ + + LL + ++K + LS N + L + L
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDD--SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 80 AGNILQGPIGKIFNYCSSLNTLNLSN-NHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSG 138
+ +I L L + L + + L L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 139 SIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSM 198
+ + + + P L ++ N
Sbjct: 127 YLHNNGLGPQAGAK--IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 199 IFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNG 258
+ + + I LE L + L + F S + + S
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 259 NIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP---- 314
GL D + S L+ L L N + D
Sbjct: 245 LRELGLND----------CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294
Query: 315 -AEMGLFANLRYLNLSSNHL 333
+L +L L+ N
Sbjct: 295 TVIDEKMPDLLFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 16/84 (19%), Positives = 33/84 (39%), Gaps = 8/84 (9%)
Query: 367 ESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSG----SIPKSISNLNKLKIL 422
E +SL + + + V+ S+ + LS N + + ++I++ L+I
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 423 KLEFN---ELSGEIPQELGKLASL 443
+ + EIP+ L L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQA 88
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 10/77 (12%)
Query: 45 NMMNMKFLDLSNNLLSGPVPYQLFENCA-----SLRYLSLAGNILQGPIGK-----IFNY 94
+ N++ L L++ LLS + + + L+ L L N ++ + I
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 95 CSSLNTLNLSNNHFSGD 111
L L L+ N FS +
Sbjct: 301 MPDLLFLELNGNRFSEE 317
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 37/209 (17%), Positives = 72/209 (34%), Gaps = 21/209 (10%)
Query: 122 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181
+ +L + ++ Q L+ + +++ + I + P++T L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLF 241
N T P++ +F+ + + S H S + L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLK------SLSLEHNGISDINGLV 131
Query: 242 NCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRI 301
+ +L + L N + L + E+ + I P + + L+
Sbjct: 132 HLPQLESLYLGNNKITDITVL--SRLTKLDTLSLEDNQISDIVPLAGLTK-------LQN 182
Query: 302 LDLSSNNLVGDIPAEMGLFANLRYLNLSS 330
L LS N++ D+ A GL NL L L S
Sbjct: 183 LYLSKNHI-SDLRALAGL-KNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 36/206 (17%), Positives = 64/206 (31%), Gaps = 47/206 (22%)
Query: 12 NAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENC 71
I S F + N S++ + + LN ++ + +N+ + +
Sbjct: 15 KQIFSDDAFAETIKDNLKKKSVTDAVTQNELN----SIDQIIANNSDIKSVQG---IQYL 67
Query: 72 ASLRYLSLAGNILQG------------------------------------PIGKIFNYC 95
++ L L GN L +
Sbjct: 68 PNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI 127
Query: 96 SSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLL 155
+ L L + + G+ + L +L TL L N S +P +A L L+ L L
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185
Query: 156 QGNQFSGPLPADIGFCPHLTTLDLSN 181
N S L A + +L L+L +
Sbjct: 186 SKNHISD-LRA-LAGLKNLDVLELFS 209
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (109), Expect = 4e-06
Identities = 28/230 (12%), Positives = 53/230 (23%), Gaps = 6/230 (2%)
Query: 26 LNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85
+ ++ +IP L N L L + F L + ++ N +
Sbjct: 13 FLCQESKVT-EIPSDLPR----NAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVL 66
Query: 86 GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVA 145
I + + + + + + + +
Sbjct: 67 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 126
Query: 146 ALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSN 205
L ++ N + + +G L L+ N + N
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186
Query: 206 NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNS 255
N L S LD S + L N KKL
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (101), Expect = 4e-05
Identities = 31/221 (14%), Positives = 62/221 (28%), Gaps = 4/221 (1%)
Query: 204 SNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEG 263
+ +T +IP + L F L + L I + N + I
Sbjct: 16 QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 264 LFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANL 323
+F + ++ + + + Q L I + +L L
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 324 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG 383
+ + N +G + L L N + ++ + D N+L
Sbjct: 133 DIQD-NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191
Query: 384 PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL 424
V + +L +S + + NL KL+
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 30/239 (12%), Positives = 58/239 (24%), Gaps = 10/239 (4%)
Query: 171 CPH------LTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEF 224
C H + T ++P L + I + L LE
Sbjct: 1 CHHRICHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 225 LDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIP 284
++ S N + + + +F+ + N I
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINP-EAFQNLPNLQYLLISNTGIK 116
Query: 285 PGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 344
+L + L + + N + + +GL L L+ N ++
Sbjct: 117 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT 176
Query: 345 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 403
NN L + IL + + + N L S +
Sbjct: 177 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 8e-06
Identities = 37/231 (16%), Positives = 70/231 (30%), Gaps = 23/231 (9%)
Query: 195 LNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGN 254
L + I I+ + +T + ++ + L +T + L + L+ N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 255 SLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIP 314
+ P E S G S + L T
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT------------- 120
Query: 315 AEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGIL 374
L L + + L +L +L + N S + L L
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA--QVSDLTPLANLSKLTTL 178
Query: 375 QLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLE 425
+ D N ++ P + + +L + L +N +S P ++N + L I+ L
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 29/218 (13%), Positives = 63/218 (28%), Gaps = 19/218 (8%)
Query: 45 NMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLS 104
+ N + + ++ V + + LS G + G Y ++L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELK 71
Query: 105 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQG------- 157
+N + + I L+ + + +G L + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 158 ---NQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPH 214
+ LS L L+ + + +N ++ P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 215 WIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 252
+ ++ L + NN ++ P L N L ++ L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 4e-05
Identities = 31/183 (16%), Positives = 55/183 (30%), Gaps = 11/183 (6%)
Query: 6 VHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPY 65
G I + L L N ++ P L + N+ +
Sbjct: 48 AFGTGVTTIEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQ 107
Query: 66 QLFENCASLRYLSLAGNILQG-------PIGKIFNYCSSLNTLNLSNNHFSGDLDFASGY 118
+ + ++ + S L L G+ +
Sbjct: 108 SIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT 167
Query: 119 GIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLD 178
+ +L +L TL N S P +A+L L E+ L+ NQ S P + +L +
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 179 LSN 181
L+N
Sbjct: 224 LTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 28/220 (12%), Positives = 63/220 (28%), Gaps = 21/220 (9%)
Query: 20 FRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSL 79
++ ++++ + + L+ + L ++ + + +L L L
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLD----GITTLSAFGTGVTT---IEGVQYLNNLIGLEL 70
Query: 80 AGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSH------ 133
N + + L+ + + L + D++
Sbjct: 71 KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 134 ----NLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLP 189
L I L + LTTL +N + P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190
Query: 190 VSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSN 229
L L ++I + + NN ++ P + N S L + +N
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 31/219 (14%), Positives = 64/219 (29%), Gaps = 17/219 (7%)
Query: 145 AALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVS 204
AL ++ + + + +TTL T + ++ LN++I + +
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71
Query: 205 NNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGL 264
+N +T P T L + ++ + L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 265 FDLGLEEIDLSENGFMGSIPPGSSSSSSSTLF---------QTLRILDLSSNNLVGDIPA 315
L L+ ++ + + S + L L N + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 316 EMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRN 354
+ NL ++L +N + P L +L + L N
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 31/223 (13%), Positives = 64/223 (28%), Gaps = 29/223 (13%)
Query: 122 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181
+L + + + ++ Q A L + L G + + + +L L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGN---------------ISTLEFLD 226
N T P+ + + +S + I ++ L L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 227 FSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPG 286
L S GN+ ++ L + +N P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192
Query: 287 SSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLS 329
S + L + L +N + P + +NL + L+
Sbjct: 193 SLPN--------LIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 1e-05
Identities = 28/126 (22%), Positives = 45/126 (35%), Gaps = 7/126 (5%)
Query: 9 NSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSG-PVPYQL 67
+ P +V I LN + + ++ N+ + L+LSNN L +
Sbjct: 30 KGLRSDPDLVAQNIDVVLNRRSSMAAT---LRIIEENIPELLSLNLSNNRLYRLDDMSSI 86
Query: 68 FENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYG---IWSLK 124
+ +L+ L+L+GN L+ L L L N S S Y
Sbjct: 87 VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFP 146
Query: 125 RLRTLD 130
+L LD
Sbjct: 147 KLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 2e-05
Identities = 21/131 (16%), Positives = 44/131 (33%), Gaps = 11/131 (8%)
Query: 94 YCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKEL 153
Y S L+L DL + L+ ++ + ++ + L L
Sbjct: 20 YDGSQQALDLKGLRSDPDL--------VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSL 70
Query: 154 LLQGNQFSG--PLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGD 211
L N+ + + + P+L L+LS N + + + + + N+L+
Sbjct: 71 NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130
Query: 212 IPHWIGNISTL 222
IS +
Sbjct: 131 FRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 9e-05
Identities = 28/145 (19%), Positives = 55/145 (37%), Gaps = 6/145 (4%)
Query: 303 DLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIP 362
+L + + M + L LRS P+L + + L+ R++ + ++
Sbjct: 3 ELKPEQV-EQLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSS-MAATLR 58
Query: 363 QEVCESRSLGILQLDGNSLTG--PIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLK 420
L L L N L + +++ +L +L+LS N L KL+
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 421 ILKLEFNELSGEIPQELGKLASLLA 445
L L+ N LS + ++++
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRE 143
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 21/154 (13%), Positives = 41/154 (26%), Gaps = 6/154 (3%)
Query: 95 CSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAA-LHYLKEL 153
+ L + + L + + L L + + + L L+ L
Sbjct: 7 PHGSSGLRCTRDGALDSLH-----HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 154 LLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIP 213
+ + P F P L+ L+LS N +++ L+ + N
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
Query: 214 HWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLS 247
W+ L L + S
Sbjct: 122 RWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 2e-05
Identities = 24/139 (17%), Positives = 42/139 (30%), Gaps = 7/139 (5%)
Query: 288 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL 347
++ T R LDL + I ++ S N + R L
Sbjct: 9 EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRL 65
Query: 348 IHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTG----PIPQVIRNCTSLYLLSLSHN 403
L + NN + L L L NSL +++ T L +L
Sbjct: 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125
Query: 404 HLSGSIPKSISNLNKLKIL 422
+ I + ++++L
Sbjct: 126 NKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 29/132 (21%), Positives = 48/132 (36%), Gaps = 8/132 (6%)
Query: 68 FENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 127
+ N R L L G + I + + ++ S+N LD L+RL+
Sbjct: 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDGFPL-----LRRLK 66
Query: 128 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSG-PLPADIGFCPHLTTLDLSNNLFTG 186
TL +++N AL L EL+L N + LT L + N T
Sbjct: 67 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126
Query: 187 QLPVSLRLLNSM 198
+ L ++ +
Sbjct: 127 KKHYRLYVIYKV 138
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 28/195 (14%), Positives = 53/195 (27%), Gaps = 24/195 (12%)
Query: 69 ENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 128
A L + + + + TL +D G+ L L
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SID-----GVEYLNNLTQ 66
Query: 129 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQL 188
++ S+N + P + PL + ++ +
Sbjct: 67 INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126
Query: 189 PVSLRLLNSMIFISVSNNTLTGDIPHW--------------IGNISTLEFLDFSNNHLTG 234
+L L + L+G + N++TLE LD S+N ++
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD 186
Query: 235 SLPSSLFNCKKLSVI 249
S L L +
Sbjct: 187 --ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 888 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.98 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.98 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.96 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.96 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.92 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.91 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.84 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.83 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.82 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.82 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.79 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.73 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.7 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.7 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.67 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.61 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 99.03 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.99 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.98 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.78 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.75 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.69 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.68 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 98.38 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 98.36 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.09 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.91 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.48 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.42 Aligned_cols=267 Identities=27% Similarity=0.427 Sum_probs=216.4
Q ss_pred HHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 4565413711112660899999899992999999332886-679689999999996248998330333898289016999
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
.+.|+..+.||+|+||+||+|++. ..||||++..... ....+.|.+|+.++++++||||++++|++.. +..++|+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEE
T ss_conf 451899889830788589999999---989999997346998999999999999984799878645679715-5899999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866999908920235531234
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... ...+++..+..++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ECCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCC
T ss_conf 658998889998523---57899999999999999998887509---995161478997981899788750022133355
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 4643102533544554674355585--78898201898999999998099989789873453899999998509745556
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQS--LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
...........||+.|||||++... ..++.++|||||||++|||+||+.||......... ...+ ..+. .
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~-~~~~----~~~~----~ 227 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-IFMV----GRGY----L 227 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHH----HHTS----C
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHH----HCCC----C
T ss_conf 67763125665574317999995056899995315163599999999788998998969999-9999----6588----8
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 9999999924399999999980179999999999999999830189998
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~~~~ 883 (888)
.+.....+..++..+.+++.+||+.||++||||+|++++|+.+..+.|+
T Consensus 228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred CCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCC
T ss_conf 9860003655549999999997588976892999999999999970989
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.00 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=216.8
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECCCC-----EEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEECCC
Q ss_conf 1456541371111266089999989999-----299999933288667968999999999624-8998330333898289
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQG-----RMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 670 (888)
+.+.|+..+.||+|+||.||+|++...+ ..||+|.+...........+.+|+.++.++ +|||||+++|++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 78993970198307881999999857885542049999996633587899999999999997158996868778886299
Q ss_pred EEEEEEECCCCCCHHHHHHHCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 01699962799998999932099-------------------99999945599999999999997430599993736789
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLP-------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLK 731 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 731 (888)
..++||||+++|+|.++++.... ....+++..++.++.|+++||+|||++ +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCC
T ss_conf 589999727999599999862577751022100001222001257789999999999999999999739---90505270
Q ss_pred CCCEEECCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCC
Q ss_conf 99678669999089202355312344643102533544554674355585788982018989999999980-99989789
Q 002717 732 PSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYG 810 (888)
Q Consensus 732 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~ 810 (888)
|+||+++.++.+||+|||+|+...............||+.|||||++ ....++.++|||||||++|||+| |+.||...
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHH-CCCCCCCCEECCCHHHHHHHHHHCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887-27999963303000399999983899999998
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 873453899999998509745556999999992439999999998017999999999999999983
Q 002717 811 EDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 811 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~ 876 (888)
.... .+...+ ..+.. ...|...+..+.+++.+||+.||++||||+|++++|..
T Consensus 271 ~~~~-~~~~~~----~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 271 PVDA-NFYKLI----QNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCSH-HHHHHH----HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHH-HHHHHH----HCCCC--------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9899-999998----56998--------99887678999999999758896689399999999748
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=375.21 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=212.1
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCE---EEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEE
Q ss_conf 565413711112660899999899992---99999933288667968999999999624899833033389828901699
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGR---MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 675 (888)
+.|+..+.||+|+||+||+|.+..+++ .||||.+.........+.|.+|+.++++++|||||+++|++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCC
Q ss_conf 96279999899993209999999945599999999999997430599993736789996786699990892023553123
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLT 755 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~ 755 (888)
|||+++|+|.+++... ...+++.++..++.|+|+||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 106 ~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCEEEECCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf 9722798530021045---67999999999999999988988527---98357615044898899919988844315756
Q ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 446431---02533544554674355585788982018989999999980-99989789873453899999998509745
Q 002717 756 RLDKHV---MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 756 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (888)
...... ......||+.|+|||.+ ....++.++|||||||++|||+| |+.||...... .+... +..+..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~----i~~~~~- 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINA----IEQDYR- 251 (299)
T ss_dssp ----------------CGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH----HHTTCC-
T ss_pred CCCCCCEEEECCCCCCCCCCCCHHHH-HCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHCCCC-
T ss_conf 77776536502566688300387888-36997861214453578999986799999999999--99999----973788-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 556999999992439999999998017999999999999999983018
Q 002717 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 832 ~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~ 879 (888)
...+...+..+.+++.+||+.||++||||.|+++.|+.+.+
T Consensus 252 -------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 -------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf -------99974226999999999758797689299999999999841
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=373.71 Aligned_cols=261 Identities=26% Similarity=0.352 Sum_probs=215.9
Q ss_pred HHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 45654137111126608999998999929999993328866796899999999962489983303338982890169996
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 677 (888)
.+.|+..+.||+|+||+||+|.+..+++.||||++.... ...+.|.+|+.++++++|||||+++|++.+.+..++|+|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf 799398659820888089999999999699999977761--039999999999986799988267752745785478763
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 27999989999320999999994559999999999999743059999373678999678669999089202355312344
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+++... ....+++..+..++.|+|+||.|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 94 ~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred CCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCCC
T ss_conf 14676067775303--554157999999999999978889878---9305760457689989992898324454653788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 64310253354455467435558578898201898999999998099989789873453899999998509745556999
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
. ........|++.|+|||++ ....++.++|||||||++|||++++.|+........ +.+ ....+..
T Consensus 169 ~-~~~~~~~~g~~~y~aPE~~-~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~----~i~~~~~------- 234 (287)
T d1opja_ 169 T-YTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYE----LLEKDYR------- 234 (287)
T ss_dssp S-SEEETTEEECGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH----HHHTTCC-------
T ss_pred C-CEEECCCCCCCCCCCHHHH-CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHH----HHHCCCC-------
T ss_conf 7-2210355665466692787-279998104302178999999867998877425999-999----9855888-------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 9999924399999999980179999999999999999830189
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
...+...+..+.+++.+||+.||++||||+|+++.|+.+.+.
T Consensus 235 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 235 -MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf -888743309999999997577976893999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.96 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=212.9
Q ss_pred HHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEECC
Q ss_conf 65413711112660899999899992999999332886679689999999996248998330333898289016999627
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 679 (888)
.|+..+.||+|+||+||+|++..+++.||+|++......+..+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECC
T ss_conf 60899897217480999999999997999999845664127999999999998579988846965404674367988645
Q ss_pred CCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf 99998999932099999999455999999999999974305999937367899967866999908920235531234464
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++|+|.+++... ..+++..+..++.|+++|+.|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 86 ~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 86 SGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp TTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 898089997537----9999999999999999999999975---983575468997887899879832314224046886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 31025335445546743555857889820189899999999809998978987345389999999850974555699999
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
........||+.|||||++.....++.++||||+||++|||+||+.||.............. .... ..
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~----~~~~--------~~ 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKT--------YL 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH----TTCT--------TS
T ss_pred CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH----CCCC--------CC
T ss_conf 53111325574742872861899999710161737999999829978888985999999986----3888--------78
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 999243999999999801799999999999999998
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~ 875 (888)
.........+.+++.+||+.||++|||++|++++-+
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 864469999999999976799668909999961984
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.12 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=210.5
Q ss_pred HHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEECCC
Q ss_conf 54137111126608999998999929999993328866796899999999962489983303338982890169996279
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAP 680 (888)
Q Consensus 601 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 680 (888)
|+..+.||+|+||.||+|.+. ++..||||++.... ...++|.+|+.++++++||||++++|++..++..++|+||++
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred CEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 588889820888299999988-99999999987886--768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 99989999320999999994559999999999999743059999373678999678669999089202355312344643
Q 002717 681 NGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH 760 (888)
Q Consensus 681 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~ 760 (888)
+|+|.+++... ...+++..+..++.|+|.||.|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE
T ss_conf 99189975201---34788999999999999987765316---4310443153266668877686553210023688733
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 10253354455467435558578898201898999999998099989789873453899999998509745556999999
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMGD 840 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 840 (888)
......||+.|+|||++ ....++.++|||||||++|||+|++.|+.........+ ..+ ..+.. ..
T Consensus 158 -~~~~~~gt~~y~aPE~l-~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~-~~i----~~~~~--------~~ 222 (263)
T d1sm2a_ 158 -SSTGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDI----STGFR--------LY 222 (263)
T ss_dssp --------CTTSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-HHH----HHTCC--------CC
T ss_pred -EECCEECCCCCCCHHHH-CCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHH-HHH----HHCCC--------CC
T ss_conf -50430017666785786-07999840332105999999987898887789999999-999----80688--------89
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 9924399999999980179999999999999999830189
Q 002717 841 YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 841 ~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
.|..++..+.+++.+||+.||++||||+|++++|+.+.++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9543679999999997657976891999999999999857
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.87 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=209.6
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 14565413711112660899999899992999999332886679689999999996248998330333898289016999
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
+.+.|+..+.||+|+||.||+|.++ ++..||||++.... ...+.|.+|+.++++++|||||+++|++.+ +..++||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEE
T ss_conf 8899388679810798289999999-99999999986476--888999999999986799988578731045-9769999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866999908920235531234
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++.... ...+++..++.++.|+|+||.|||+. +|+||||||+||++++++.+||+|||+|+.+..
T Consensus 87 Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp ECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EECCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCC
T ss_conf 9578982888875147--89887889999999999999999748---954675642251562024404234101477358
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... .......|++.|+|||++ ....++.++|||||||++|||+||+.|+.........+ .. +..+..
T Consensus 162 ~~~-~~~~~~~gt~~y~APE~~-~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~-~~----i~~~~~------ 228 (272)
T d1qpca_ 162 NEY-TAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-QN----LERGYR------ 228 (272)
T ss_dssp SCE-ECCTTCCCCTTTSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HH----HHTTCC------
T ss_pred CCC-CCCCCCCCCCCCCCHHHH-HCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HH----HHHCCC------
T ss_conf 864-420356774444582898-37999824564525799999996898888888999999-99----970688------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 999999243999999999801799999999999999998301
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~ 878 (888)
...+...+..+.+++.+||+.||++||||.|+++.|+.+-
T Consensus 229 --~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf --8896557199999999975889768939999999861132
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.10 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=214.2
Q ss_pred CCHHHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEE
Q ss_conf 78145654137111126608999998999929999993328866796899999999962489983303338982890169
Q 002717 595 IDPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 595 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 674 (888)
.+++++|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 8 ~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCCCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
T ss_conf 991037598479930778199999999999399999987289-9999999999999986799998849889800995899
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99627999989999320999999994559999999999999743059999373678999678669999089202355312
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
||||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 87 vmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCC
T ss_conf 99627998188999862---89999999999999999999999988---9887140700314878999899716123035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 3446431025335445546743555----857889820189899999999809998978987345389999999850974
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTC----QSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
.... .......||+.|+|||++. ....++.++||||+||++|||+||+.||....... .+.... ...
T Consensus 161 ~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~----~~~-- 231 (288)
T d2jfla1 161 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIA----KSE-- 231 (288)
T ss_dssp HHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHH----HSC--
T ss_pred CCCC--CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHH----CCC--
T ss_conf 7786--4100102562647999983202578888806657878999999820889999989999-999997----079--
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 555699999999243999999999801799999999999999998
Q 002717 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 831 ~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~ 875 (888)
+.....+...+..+.+++.+||+.||++|||+.|++++-+
T Consensus 232 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 232 -----PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp -----CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf -----9877765669999999999976699668919999962923
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.57 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=209.9
Q ss_pred HHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 45654137111126608999998999929999993328866796899999999962489983303338982890169996
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 677 (888)
++.|+..+.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.+++.++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 56888978971277809999999899969999998754097899999999999986799999949999998999999997
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 27999989999320999999994559999999999999743059999373678999678669999089202355312344
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+++... ..+++..+..++.|++.|+.|||+.+ +|+||||||+|||+++++.+||+|||+|+.+.+.
T Consensus 85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 67998689987424----99999999999999999999999859--9971445779946878998999548776256788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC---------
Q ss_conf 64310253354455467435558578898201898999999998099989789873453899999998509---------
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--------- 828 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--------- 828 (888)
. .....||+.|+|||++ .+..++.++||||+||++|||++|+.||.....................
T Consensus 159 ~----~~~~~GT~~Y~APEvl-~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 159 M----ANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp T----C---CCSSCCCCHHHH-HCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred C----CCCCCCCCCCCCCHHH-CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 6----2111377141194687-5899894888998999999999888998998878999999887517754577421233
Q ss_pred -CCC--C----------------CCCCCCCCCC-HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf -745--5----------------5699999999-24399999999980179999999999999999
Q 002717 829 -NVL--D----------------CVDPSMGDYP-EDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 829 -~~~--~----------------~~d~~~~~~~-~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L 874 (888)
... . .........+ .....++.+++.+|+..||++|||++|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCH
T ss_conf 322111122235413477887665026876676444899999999998689946790899996098
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.87 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=208.4
Q ss_pred HHHCC-EECCCCCEEEEEEEECC--CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 54137-11112660899999899--9929999993328866796899999999962489983303338982890169996
Q 002717 601 LEKAA-EVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 601 ~~~~~-~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 677 (888)
+.... +||+|+||.||+|.++. ++..||||++.........+.|.+|+.++++++|||||+++|++.. +..++|||
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE 88 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 88 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred EEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEEE
T ss_conf 18878487306080999999960897689999998820397899999999999986799888068656036-80799998
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 27999989999320999999994559999999999999743059999373678999678669999089202355312344
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|.+++... ...+++..+..++.|+|+||+|||++ +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 89 ~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 89 MAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp CCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred ECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 07899689975212---56999999999999999987899868---8105767646604546885420331342115543
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 643-102533544554674355585788982018989999999980-999897898734538999999985097455569
Q 002717 758 DKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 758 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
... .......||+.|+|||++ ....++.++|||||||++|||+| |+.||...... . +.. .+..+..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~-~~~----~i~~~~~----- 230 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-E-VMA----FIEQGKR----- 230 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-H-HHH----HHHTTCC-----
T ss_pred CCCCCCCCCCCCCCCCCCHHHH-HCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH-H-HHH----HHHCCCC-----
T ss_conf 4321135621137433586887-27999954123220178999993899999997999-9-999----9981899-----
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 999999924399999999980179999999999999999830189
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
...|...+..+.+++.+||+.||++||||.++++.|+.+...
T Consensus 231 ---~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ---999976789999999997577976890999999999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.80 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=212.4
Q ss_pred HHHCCEECCCCCEEEEEEEECCCC----EEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 541371111266089999989999----2999999332886679689999999996248998330333898289016999
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQG----RMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 601 ~~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
|+..+.||+|+||.||+|.++.++ ..||||++...........|.+|+.++++++|||||+++|++.+.+..++|+
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEE
T ss_conf 68615981177909999999689987879999999884459689999999999998568987832367783388038999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866999908920235531234
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+.+|++.+.+... ...+++..+..++.|++.|+.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 89 e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 89 EYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp ECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EECCCCCCHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf 721357402221023---45420899999999999854121212---342576564427888998499845510300357
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 4643-102533544554674355585788982018989999999980999897898734538999999985097455569
Q 002717 757 LDKH-VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVD 835 (888)
Q Consensus 757 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (888)
.... .......||+.|+|||++ ....++.++|||||||++|||++++.|+.........+ .. +..+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~-~~----i~~~~------ 230 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KA----INDGF------ 230 (283)
T ss_dssp -----------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HH----HHTTC------
T ss_pred CCCCCEEECCCCCCCCCCCHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHH-HH----HHCCC------
T ss_conf 87652674267777343488887-04999973556344898999996798865568999999-99----86357------
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 999999924399999999980179999999999999999830189
Q 002717 836 PSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 836 ~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
....+...+..+.+++.+||+.||++||||.|+++.|+.+.+.
T Consensus 231 --~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 --RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf --8998504579999999997767976893999999999998669
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.24 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=211.6
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 14565413711112660899999899992999999332886679689999999996248998330333898289016999
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
+.+.|+..+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 51053887898128582999999989998999999843017-27999999999998679998805857798899989999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866999908920235531234
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 97 Ey~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp ECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EECCCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECC
T ss_conf 703798089886415-----999999999999999999999987---972267768886887899686425156413213
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... ..+... ...+..
T Consensus 169 ~~~--~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~----~~~~~~------ 234 (293)
T d1yhwa1 169 EQS--KRSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLI----ATNGTP------ 234 (293)
T ss_dssp TTC--CBCCCCSCGGGCCHHHH-SSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHH----HHHCSC------
T ss_pred CCC--CCCCCCCCCCCCCHHHH-CCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHH-HHHHHH----HHCCCC------
T ss_conf 666--44444447773682664-4799880120313729999980488998997999-999999----857999------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 999999243999999999801799999999999999998
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~ 875 (888)
. ...+......+.+++.+||+.||++|||+.|++++-+
T Consensus 235 ~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 235 E-LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp C-CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred C-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 8-8885537999999999986699668909999964996
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=368.51 Aligned_cols=265 Identities=26% Similarity=0.423 Sum_probs=217.4
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCE
Q ss_conf 14565413711112660899999899-----9929999993328866796899999999962489983303338982890
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 671 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 671 (888)
|.+.|+..+.||+|+||.||+|++.. +++.||||++......+..+.|.+|+.+++.++||||+++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf 98893886798207883999999888765778829999998821085799999999999996689976552466605980
Q ss_pred EEEEEECCCCCCHHHHHHHCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 1699962799998999932099--------------------99999945599999999999997430599993736789
Q 002717 672 KLLVSDYAPNGSLQAKLHERLP--------------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLK 731 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk 731 (888)
.++|+||+++|+|.+++..... ....+++..++.++.|+|.||+|||+. +++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEEC
T ss_conf 389998158992999998527554210000111001210346788989999999999999985541357---86854884
Q ss_pred CCCEEECCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCC
Q ss_conf 99678669999089202355312344643102533544554674355585788982018989999999980999-89789
Q 002717 732 PSNILLDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR-PVEYG 810 (888)
Q Consensus 732 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~-p~~~~ 810 (888)
|+|||++.++.+||+|||+|+.+.............+++.|+|||.+ ....++.++|||||||++|||+++.. ||...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHH-CCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCC
T ss_conf 01168989992898331442113677641115777767676798997-26889805630252362999980689999998
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 873453899999998509745556999999992439999999998017999999999999999983018
Q 002717 811 EDNVVILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 811 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~ 879 (888)
...... .. +..+.. ...+...+.++.+++.+||+.+|++||||.||+++|+++++
T Consensus 247 -~~~e~~-~~----v~~~~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 247 -AHEEVI-YY----VRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp -CHHHHH-HH----HHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -CHHHHH-HH----HHCCCC--------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf -999999-99----973997--------88873252999999999748896579399999999998429
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.37 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=213.1
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCE----EEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEE
Q ss_conf 565413711112660899999899992----9999993328866796899999999962489983303338982890169
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGR----MLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLL 674 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 674 (888)
+.|+..+.||+|+||+||+|.+..+++ .||+|++......+..+.|.+|+.++++++|||||+++|+|.+++ .++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC-EEE
T ss_conf 9997831982089929999999589988989999999651349799999999999998679988815899996198-369
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99627999989999320999999994559999999999999743059999373678999678669999089202355312
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
++||+.+|+|.+++... ...+++..+..++.|+|.||.|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEECCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf 99842687401011133---45799999999999999999999876---9504762120311679987586025522233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 344643102533544554674355585788982018989999999980-9998978987345389999999850974555
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
.............||+.|+|||++ .+..++.++|||||||++|||+| |..||...... .+...+ ..+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l-~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i----~~~~~--- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL----EKGER--- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHH----HHTCC---
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHH-HCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HCCCC---
T ss_conf 544453223651058644670887-46999835654407999999997799999999989--999999----75998---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 699999999243999999999801799999999999999998301
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~ 878 (888)
...+...+..+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf -----9998556899999999847899346919999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=362.80 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=211.1
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 14565413711112660899999899992999999332886679689999999996248998330333898289016999
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
..+.|+..+.||+|+||.||+|++..+++.||+|++.........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCCEEECCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866---999908920235531
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARL 753 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~ 753 (888)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||+|||+|+.
T Consensus 87 E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ECCCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 526898488865303----6788789999999999998752413---055687046300110468882499831543587
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 23446431025335445546743555857889820189899999999809998978987345389999999850974555
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
...... .....||+.|+|||++ .+..++.++||||+||++|||++|+.||...... ... ..........
T Consensus 160 ~~~~~~---~~~~~GT~~y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~----~~i~~~~~~~-- 228 (307)
T d1a06a_ 160 EDPGSV---LSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLF----EQILKAEYEF-- 228 (307)
T ss_dssp ----------------CTTSCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHH----HHHHTTCCCC--
T ss_pred CCCCCE---EEEEEECCCCCCCHHH-CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHH----HHHHCCCCCC--
T ss_conf 258970---4400328422591887-3799980787345159999998597999998999-999----9986168777--
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 699999999243999999999801799999999999999998
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~ 875 (888)
....+...+..+.+++.+|+..||++|||++|++++-+
T Consensus 229 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 229 ----DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred ----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf ----87666678999999999976089757918999862984
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=361.12 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=208.4
Q ss_pred CHHHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEE
Q ss_conf 81456541371111266089999989999299999933288667--9689999999996248998330333898289016
Q 002717 596 DPETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ--YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 596 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 673 (888)
++++.|+..+.||+|+||.||+|++..+++.||||++....... ..+.+.+|+.++++++|||||++++++.+++..+
T Consensus 12 dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp CHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
T ss_conf 90785676279701888099999998999399999984444358899999999999999778999823899999899889
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 99962799998999932099999999455999999999999974305999937367899967866999908920235531
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||+++|++..++... .++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 92 iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEEECCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCC
T ss_conf 999806999457899737----9999999999999999999999868---976667884217987999789844365334
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 234464310253354455467435558--578898201898999999998099989789873453899999998509745
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQ--SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (888)
... .....||+.|||||++.. ...++.++||||+||++|||++|+.||...... ..+. .......
T Consensus 165 ~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~----~i~~~~~-- 231 (309)
T d1u5ra_ 165 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALY----HIAQNES-- 231 (309)
T ss_dssp SSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHH----HHHHSCC--
T ss_pred CCC------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHH----HHHHCCC--
T ss_conf 677------87313476636889983467888672145455899999998788999997999-9999----9982899--
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 556999999992439999999998017999999999999999983
Q 002717 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 832 ~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~ 876 (888)
+.. .+...+..+.+++.+||..||++|||++|++++-+-
T Consensus 232 ----~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 232 ----PAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp ----CCC--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred ----CCC--CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHH
T ss_conf ----988--878889999999999773796579189999719975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.02 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=208.5
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEC--CCEEEEE
Q ss_conf 5654137111126608999998999929999993328866-796899999999962489983303338982--8901699
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT--PQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 675 (888)
+.|+..+.||+|+||.||+|+...+|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 9627999989999320999999994559999999999999743059--99937367899967866999908920235531
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF--RPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
|||+++|+|.+++.........+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 23446431025335445546743555857889820189899999999809998978987345389999999850974555
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
+..... ......||+.|+|||++ .+..++.++||||+||++|||+||+.||..... ..+... +..+..
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~----i~~~~~--- 231 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGK----IREGKF--- 231 (269)
T ss_dssp C-------------CCCSCCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH----HHHTCC---
T ss_pred CCCCCC--CCCCCCCCCCCCCHHHH-CCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH--HHHHHH----HHCCCC---
T ss_conf 245777--55667788232799998-399999389887527899998018899899899--999999----971899---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 6999999992439999999998017999999999999999
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~ 873 (888)
...+...+..+.+++.+||+.||++|||+.|++++
T Consensus 232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -----88974359999999999767995579189999729
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.67 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=209.6
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 56541371111266089999989999299999933288--6679689999999996248998330333898289016999
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
+.|+..+.||+|+||.||+|++..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866999908920235531234
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EECCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf 504798589887504----8999999999999999999999988---946522023441466899871155563354488
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.. .....||+.|+|||++ .+..++.++||||+||++|||++|+.||..... ...+ +.... ..
T Consensus 159 ~~----~~~~~Gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~----~~i~~-~~------- 220 (263)
T d2j4za1 159 SR----RTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETY----KRISR-VE------- 220 (263)
T ss_dssp CC----CEETTEEGGGCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHH----HHHHT-TC-------
T ss_pred CC----CCCCCCCCCCCCHHHH-CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHH----HHHHC-CC-------
T ss_conf 85----2355788763499997-589989314404675999998329999888999-9999----99971-89-------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 9999992439999999998017999999999999999983
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~ 876 (888)
..+|...+..+.+++.+||+.||++|||++|++++-+-
T Consensus 221 --~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 221 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred --CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf --99986689999999999764797689099999719070
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.80 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=210.9
Q ss_pred HHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEECC
Q ss_conf 65413711112660899999899992999999332886679689999999996248998330333898289016999627
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYA 679 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 679 (888)
.|+..++||+|+||+||+|+++ ++..||||++.... ...++|.+|+.++++++||||++++|++.+++..++|+||+
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 9799689820788399999988-99899999987475--77899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf 99998999932099999999455999999999999974305999937367899967866999908920235531234464
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++|++.+++... ...+++..+++++.|+|+||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC
T ss_conf 899388864102---46776899999999999999987546---843466541358876998479886144202357872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 3102533544554674355585788982018989999999980-999897898734538999999985097455569999
Q 002717 760 HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSM 838 (888)
Q Consensus 760 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 838 (888)
. ......+|+.|+|||++ ....++.++|||||||++|||+| |+.||...... .+... +..+..
T Consensus 156 ~-~~~~~~~t~~y~aPE~~-~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~----i~~~~~-------- 219 (258)
T d1k2pa_ 156 T-SSVGSKFPVRWSPPEVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEH----IAQGLR-------- 219 (258)
T ss_dssp C-CCCCSCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHH----HHTTCC--------
T ss_pred E-EECCCCCCCCCCCCHHH-CCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHH--HHHHH----HHHCCC--------
T ss_conf 2-52465788775780786-37998852103364324673975599998899999--99999----980797--------
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 999924399999999980179999999999999999830
Q 002717 839 GDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 839 ~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~ 877 (888)
...|...+..+.+++.+||+.||++||||.|++++|..+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 899654659999999997668976893999999874188
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.58 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=210.3
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 565413711112660899999899992999999332886--679689999999996248998330333898289016999
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
+.|+..+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866999908920235531234
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ECCCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCC
T ss_conf 704898777765315----9999999999999999999762165---088476774123668885388603210242256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
...........||+.|+|||++ .+..++.++||||+||++|||++|+.||..... ...+ . .... +.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~-~---~i~~-~~------- 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-YLIF-Q---KIIK-LE------- 226 (288)
T ss_dssp ---------CCCCGGGCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH-H---HHHT-TC-------
T ss_pred CCCCCCCCCCCCCCCCCCCEEE-CCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCH-HHHH-H---HHHC-CC-------
T ss_conf 7764333555677552584400-268989666230456999998038899899599-9999-9---9971-89-------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 9999992439999999998017999999999999999
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~ 873 (888)
..++.....++.+++.+||..||++|||++|++.+
T Consensus 227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf --99985479999999999855797689197897377
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.42 Aligned_cols=262 Identities=26% Similarity=0.372 Sum_probs=213.4
Q ss_pred HHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 45654137111126608999998999929999993328866796899999999962489983303338982890169996
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 677 (888)
.+.|+..+.||+|+||.||+|.++ ++..||||++.... ...+.|.+|+.++++++|||||+++|++.+ +..++|+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEE
T ss_conf 799798469930798099999999-99999999988044--888999999999986666788689999823-97599999
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 27999989999320999999994559999999999999743059999373678999678669999089202355312344
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
|+++|+|..++.... ...++|..++.++.|+|.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 y~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 92 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ECCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCC
T ss_conf 447994354200003--55305999999999999999987541---1433531230799989992998442555425688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 64310253354455467435558578898201898999999998099989789873453899999998509745556999
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.. .......|++.|+|||++ ....++.++||||||+++|||++|+.|+.........+. .+ ..+..
T Consensus 167 ~~-~~~~~~~gt~~y~aPE~~-~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~-~i----~~~~~------- 232 (285)
T d1fmka3 167 EY-TARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QV----ERGYR------- 232 (285)
T ss_dssp ----------CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HH----HTTCC-------
T ss_pred CC-EEECCCCCCCCCCCHHHH-HCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHH-HH----HHCCC-------
T ss_conf 73-352454556654580898-379989177413235899999868999998888999999-99----82689-------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 9999924399999999980179999999999999999830189998
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~~~~ 883 (888)
...+...+..+.+++.+||+.||++||||.+|++.|+.......+
T Consensus 233 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 233 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCC
T ss_conf -999832379999999997566975891999999987666238999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.95 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=203.2
Q ss_pred CEECCCCCEEEEEEEECC--CCEEEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEECCCC
Q ss_conf 711112660899999899--9929999993328866-7968999999999624899833033389828901699962799
Q 002717 605 AEVGEGVFGTVYKVSFGT--QGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDYAPN 681 (888)
Q Consensus 605 ~~ig~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 681 (888)
++||+|+||.||+|.+.. .++.||||++...... ...+.|.+|+.++++++|||||+++|+|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEEEEECCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059-77999974788
Q ss_pred CCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCC-
Q ss_conf 9989999320999999994559999999999999743059999373678999678669999089202355312344643-
Q 002717 682 GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDKH- 760 (888)
Q Consensus 682 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 760 (888)
|+|.+++... ..+++..++.++.|+|.||+|||+. +|+||||||+||+++.++.+|++|||+++.+......
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 9689997522----5789999999999999997668747---95567776113102356751234134533134323443
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 102533544554674355585788982018989999999980-9998978987345389999999850974555699999
Q 002717 761 VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPSMG 839 (888)
Q Consensus 761 ~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 839 (888)
.......||+.|+|||.+ ....++.++|||||||++|||+| |+.||...... .+.. .+..+.. .
T Consensus 165 ~~~~~~~gt~~y~APE~l-~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~----~i~~~~~--------~ 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTA----MLEKGER--------M 229 (277)
T ss_dssp EC----CCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHTTCC--------C
T ss_pred CCCCCCCCCCEECCCHHH-CCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHH--HHHH----HHHCCCC--------C
T ss_conf 224456778420391665-37999843443034031328965899999998999--9999----9982899--------9
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 99924399999999980179999999999999999830
Q 002717 840 DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 840 ~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~ 877 (888)
..|...+..+.+++.+||+.||++||||+++++.|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf 99865679999999997588976890989999985288
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=358.64 Aligned_cols=255 Identities=21% Similarity=0.315 Sum_probs=207.8
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEEC
Q ss_conf 56541371111266089999989999299999933288667968999999999624899833033389828901699962
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 678 (888)
+.|+..+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 575898898407681999999889998999999845243-1699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCCEEECCCCCCCCCC
Q ss_conf 799998999932099999999455999999999999974305999937367899967866--999908920235531234
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNYNPRISDFGLARLLTR 756 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~~~~ 756 (888)
+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++.+..
T Consensus 105 ~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECCC
T ss_conf 7998899999762---37899999999999999999999756---97600015467364168898699954521044256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... .....||+.|||||++ .+..++.++||||+||++|||++|+.||.... ....+.. ........ .
T Consensus 179 ~~~---~~~~~gT~~Y~aPEv~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~----i~~~~~~~---~- 245 (350)
T d1koaa2 179 KQS---VKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-DDETLRN----VKSCDWNM---D- 245 (350)
T ss_dssp TSC---EEEECSCTTTCCHHHH-HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHH----HHHTCCCS---C-
T ss_pred CCC---CCEECCCCCCCCHHHH-CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHH----HHHCCCCC---C-
T ss_conf 543---2000686242188997-58998726765546599999985989989979-9999999----98478898---9-
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 999999243999999999801799999999999999998
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~ 875 (888)
..........+.+++.+||..||++|||++|++++-+
T Consensus 246 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 246 --DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp --CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred --CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf --4223589999999999975689667908999862913
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=357.35 Aligned_cols=254 Identities=21% Similarity=0.299 Sum_probs=208.0
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEEC
Q ss_conf 56541371111266089999989999299999933288667968999999999624899833033389828901699962
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 678 (888)
+.|+..+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 035998999317782999999989997999999887264-6799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCCEEECCCCCCCCCC
Q ss_conf 799998999932099999999455999999999999974305999937367899967866--999908920235531234
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD--DNYNPRISDFGLARLLTR 756 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfgla~~~~~ 756 (888)
+++|+|.+++... ..++++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 108 ~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC
T ss_conf 8998088889863---89989999999999999999999977---92651314455311346788489952563034378
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... .....|++.|+|||++ .+..++.++||||+||++|||+||+.||..... ...+. ........ .
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~----~i~~~~~~---~-- 247 (352)
T d1koba_ 182 DEI---VKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQ----NVKRCDWE---F-- 247 (352)
T ss_dssp TSC---EEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHH----HHHHCCCC---C--
T ss_pred CCC---EEECCCCCCCCCHHHH-CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH-HHHHH----HHHHCCCC---C--
T ss_conf 872---0100476453489997-479989763338989999999968899899799-99999----99847889---8--
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 99999924399999999980179999999999999999
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L 874 (888)
........+..+.+++.+||..||++|||+.|++++-
T Consensus 248 -~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 248 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf -9300247999999999997569966891899996097
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.91 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=212.5
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEECCC
Q ss_conf 14565413711112660899999899-----99299999933288667968999999999624-8998330333898289
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 670 (888)
+.+.|+..+.||+|+||.||+|.+.. +++.||+|++.........+.+..|..++.++ +|+||+.+++++...+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCC
T ss_conf 67997984498416783999999867775557839999998600171789999999999886149984997411540479
Q ss_pred -EEEEEEECCCCCCHHHHHHHCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf -01699962799998999932099------------99999945599999999999997430599993736789996786
Q 002717 671 -LKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILL 737 (888)
Q Consensus 671 -~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill 737 (888)
..++||||+++|+|.++++.... ....+++..+..++.|+++||.|||++ +|+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEE
T ss_conf 757999984589929999985366666532220233214689999999999999999988737---97178677310657
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCHHH
Q ss_conf 6999908920235531234464310253354455467435558578898201898999999998099-989789873453
Q 002717 738 DDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR-RPVEYGEDNVVI 816 (888)
Q Consensus 738 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~-~p~~~~~~~~~~ 816 (888)
++++.+||+|||+|+...............||+.|+|||++ .+..++.++|||||||++|||+|+. .||........
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l-~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~- 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred CCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHH-HCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHH-
T ss_conf 79982898457520011356652224751667210203686-4688996632213678999998688999989998999-
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 899999998509745556999999992439999999998017999999999999999983018
Q 002717 817 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~ 879 (888)
+... ...+... ..+...+..+.+++.+||+.||++||||.|++++|+.+.+
T Consensus 246 ~~~~----~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 FCRR----LKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHH----HHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH----HHCCCCC--------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9999----9638988--------8886578999999999767796679199999999979986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.34 Aligned_cols=270 Identities=22% Similarity=0.338 Sum_probs=219.1
Q ss_pred HHHHHHCCEECCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEE
Q ss_conf 4565413711112660899999899-----99299999933288667968999999999624899833033389828901
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGT-----QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLK 672 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 672 (888)
.+.++..+.||+|+||+||+|.+.. .+..||||++......+....|.+|+.++++++||||++++|++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 89918835982078818999998786447789689999987012868999999999999976999884125478428810
Q ss_pred EEEEECCCCCCHHHHHHHCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEE
Q ss_conf 69996279999899993209------999999945599999999999997430599993736789996786699990892
Q 002717 673 LLVSDYAPNGSLQAKLHERL------PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 746 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 746 (888)
++|+||+++|+|.+++.... .....+++..+.+++.|+|+||.|||+. +|+||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEEEE
T ss_conf 677760489988999875033211344468879999999999999999987647---96543286775403599649994
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCHHHHHHHHHHHH
Q ss_conf 0235531234464310253354455467435558578898201898999999998099-989789873453899999998
Q 002717 747 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGR-RPVEYGEDNVVILSEHVRVLL 825 (888)
Q Consensus 747 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~-~p~~~~~~~~~~l~~~~~~~~ 825 (888)
|||+++...............+++.|+|||.+ .+..++.++||||||+++|||+||. .||... .....+ ...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l-~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~~~~~----~~i- 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVL----RFV- 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHHHH----HHH-
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-CHHHHH----HHH-
T ss_conf 24542023577630313402316323788887-36998833344437899999996899999998-999999----999-
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf 509745556999999992439999999998017999999999999999983018999888
Q 002717 826 EEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQRM 885 (888)
Q Consensus 826 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~~~~~~ 885 (888)
..+. ....+...+..+.+++.+||+.+|++||||.|++++|+...++..+..
T Consensus 249 ~~~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 249 MEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HHCC--------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCCCCCC
T ss_conf 8088--------888863353999999999757796589399999999787617787577
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.42 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=199.6
Q ss_pred HHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEC----CCEEEEE
Q ss_conf 54137111126608999998999929999993328866-796899999999962489983303338982----8901699
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWT----PQLKLLV 675 (888)
Q Consensus 601 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 675 (888)
++..++||+|+||+||+|.+..+++.||+|.+...... ...+.+.+|++++++++||||+++++++.. ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCCEEECCCCCCCC
Q ss_conf 962799998999932099999999455999999999999974305999937367899967866-9999089202355312
Q 002717 676 SDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD-DNYNPRISDFGLARLL 754 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfgla~~~ 754 (888)
|||+++|+|.+++... ..+++..+..++.|+++||+|||++ .++|+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EECCCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf 9578989489997513----5546999999999999999999978-9979968767435116679998898005765423
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 34464310253354455467435558578898201898999999998099989789873453899999998509745556
Q 002717 755 TRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCV 834 (888)
Q Consensus 755 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (888)
... ......||+.|+|||++. . .++.++||||+||++|||++|+.||.......... .. +..+...
T Consensus 166 ~~~----~~~~~~GT~~Y~aPE~~~-~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~-~~----i~~~~~~--- 231 (270)
T d1t4ha_ 166 RAS----FAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-RR----VTSGVKP--- 231 (270)
T ss_dssp CTT----SBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-HH----HTTTCCC---
T ss_pred CCC----CCCCCCCCCCCCCHHHHC-C-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HH----HHCCCCC---
T ss_conf 687----667755381300898847-8-99986711007999999987889998765599999-99----9738998---
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999999992439999999998017999999999999999
Q 002717 835 DPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 835 d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~ 873 (888)
..++.....++.+++.+||+.||++|||+.|++++
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 ----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----65675578999999999763797589299999677
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.72 Aligned_cols=266 Identities=24% Similarity=0.320 Sum_probs=217.6
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEECCC
Q ss_conf 1456541371111266089999989-----999299999933288667968999999999624-8998330333898289
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFG-----TQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQ 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 670 (888)
+.+.|+..+.||+|+||.||+|++. .+++.||||++...........|.+|+.+++.+ +|||||+++|++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 78996985498206882999999806644778869999998742487799999999999876269998878998983199
Q ss_pred EEEEEEECCCCCCHHHHHHHCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 01699962799998999932099--------------9999994559999999999999743059999373678999678
Q 002717 671 LKLLVSDYAPNGSLQAKLHERLP--------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 736 (888)
Q Consensus 671 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 736 (888)
..++||||+++|+|.++++.... ....+++..+..++.|++.||+|||++ +++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCC
T ss_conf 7899997379987999998535665444445332223345889999999999999999988757---9266624102100
Q ss_pred ECCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 66999908920235531234464310253354455467435558578898201898999999998099989789873453
Q 002717 737 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVI 816 (888)
Q Consensus 737 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~ 816 (888)
++.++.+|++|||.++...............||+.|+|||.+ ....++.++|||||||++|||+|++.|+.........
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 002575210234010233678861586201359687677886-1799997400102589999998589988778998999
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 89999999850974555699999999243999999999801799999999999999998301
Q 002717 817 LSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~ 878 (888)
+...++ .+.. ...+...+..+.+|+.+||+.||++||||+|+++.|+++.
T Consensus 257 ~~~~i~----~~~~--------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 FYKMIK----EGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHH----HTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH----CCCC--------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 999986----6898--------8985436599999999975779657929999999998765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.94 Aligned_cols=260 Identities=26% Similarity=0.334 Sum_probs=208.6
Q ss_pred CCEECCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEC-CCEEEEEEECC
Q ss_conf 37111126608999998999---929999993328866796899999999962489983303338982-89016999627
Q 002717 604 AAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWT-PQLKLLVSDYA 679 (888)
Q Consensus 604 ~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~~ 679 (888)
.+.||+|+||+||+|.+..+ ...||||++.........+.|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf 99998999932099999999455999999999999974305999937367899967866999908920235531234464
Q 002717 680 PNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLDK 759 (888)
Q Consensus 680 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~ 759 (888)
++|+|.+++... ....++..+++++.|+|.||.|+|+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ECCCHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCC
T ss_conf 067414421013---45404899999999988765200336---762577668757677999889910652322556655
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 31--0253354455467435558578898201898999999998099989789873453899999998509745556999
Q 002717 760 HV--MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 760 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
.. ......||+.|+|||.+ ....++.++||||||+++|||+||+.||.......... ..+ ..+..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~-~~i----~~g~~------- 252 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-VYL----LQGRR------- 252 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH-HHH----HTTCC-------
T ss_pred CCCEECCCCCCCCCCCCHHHH-HCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHH----HCCCC-------
T ss_conf 531002565556455676887-43799974574661999999997899998889999999-999----80898-------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 9999924399999999980179999999999999999830189998
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~~~~ 883 (888)
...|...+..+.+++.+||+.||++||||.||+++|+.+......
T Consensus 253 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 253 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf -899644759999999997688976893999999999999975201
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.99 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=209.0
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-----CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCE
Q ss_conf 145654137111126608999998999929999993328866-----796899999999962489983303338982890
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----QYPEDFEREVRVLGKARHPNLISLEGYYWTPQL 671 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 671 (888)
-++.|+..+.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|+.++++++||||+++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CCEEEC
Q ss_conf 1699962799998999932099999999455999999999999974305999937367899967866999----908920
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY----NPRISD 747 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~D 747 (888)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+|++|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEECCCCCCCCCHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECC
T ss_conf 99999867786431001035----6421557899999999998766625---4221133301279825898666469643
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 23553123446431025335445546743555857889820189899999999809998978987345389999999850
Q 002717 748 FGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE 827 (888)
Q Consensus 748 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 827 (888)
||+|+....... .....|++.|+|||++ .+..++.++||||+||++|||++|+.||...... ..+. ....
T Consensus 161 fG~a~~~~~~~~---~~~~~~t~~y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~----~i~~- 230 (293)
T d1jksa_ 161 FGLAHKIDFGNE---FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLA----NVSA- 230 (293)
T ss_dssp CTTCEECTTSCB---CSCCCCCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHH----HHHT-
T ss_pred HHHHHHCCCCCC---CCCCCCCCCCCCHHHH-CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH-HHHH----HHHH-
T ss_conf 344210577763---1224777743099998-1899997665221409999997088998899999-9999----9981-
Q ss_pred CCCCCCCCCCCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 974555699999-99924399999999980179999999999999999
Q 002717 828 GNVLDCVDPSMG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 828 ~~~~~~~d~~~~-~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L 874 (888)
.. .... ..+...+..+.+++.+||+.||++|||++|++++-
T Consensus 231 ~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 272 (293)
T d1jksa_ 231 VN------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 272 (293)
T ss_dssp TC------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CC------CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf 68------8887010478899999999998638966891999996190
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.16 Aligned_cols=261 Identities=27% Similarity=0.353 Sum_probs=211.4
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCE--EEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEECCCEEEEE
Q ss_conf 565413711112660899999899992--99999933288667968999999999624-899833033389828901699
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGR--MLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWTPQLKLLV 675 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 675 (888)
+.|+..+.||+|+||.||+|.++.++. .||||++.........+.|.+|+.+++++ +||||++++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EECCCCCCHHHHHHHCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCC
Q ss_conf 96279999899993209------------999999945599999999999997430599993736789996786699990
Q 002717 676 SDYAPNGSLQAKLHERL------------PSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNP 743 (888)
Q Consensus 676 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 743 (888)
+||+++|+|.++++... .....+++..++.++.|+|.||.|+|+. +++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCCE
T ss_conf 980289869999864035555512310123457899999999999999998766308---95455505204898688763
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCCHHHHHHHHH
Q ss_conf 89202355312344643102533544554674355585788982018989999999980999-89789873453899999
Q 002717 744 RISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRR-PVEYGEDNVVILSEHVR 822 (888)
Q Consensus 744 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~-p~~~~~~~~~~l~~~~~ 822 (888)
||+|||+++...... ......||..|+|||.+ ....++.++|||||||++|||++|.. ||... .... +...
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l-~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~~~-~~~~-- 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAE-LYEK-- 238 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHH-HHHH--
T ss_pred EECCCCCCCCCCCCC---CCCCEECCCCCCCHHHH-CCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC-CHHH-HHHH--
T ss_conf 874344322444223---45530137755553875-26999962215313889999983689999999-9999-9999--
Q ss_pred HHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 9985097455569999999924399999999980179999999999999999830189
Q 002717 823 VLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTP 880 (888)
Q Consensus 823 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~ 880 (888)
+..+. ....+...+..+.+++.+||+.||++||||.|++++|+.+...
T Consensus 239 --i~~~~--------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 239 --LPQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp --GGGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --HHHCC--------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf --98268--------8888766789999999997678966894999999999999861
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=352.19 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=203.7
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCC--CCCHHHHHHH---HHHHHHCCCCCCCEEEEEEECCCEEE
Q ss_conf 565413711112660899999899992999999332886--6796899999---99996248998330333898289016
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFERE---VRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E---~~~l~~l~h~niv~l~g~~~~~~~~~ 673 (888)
+.|+..+.||+|+||.||+|++..+|+.||+|++..... ......+.+| +.+++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 99962799998999932099999999455999999999999974305999937367899967866999908920235531
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEECCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf 999914898389998732----5532789999999999999999977---962204442216785889679822010233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 23446431025335445546743555857889820189899999999809998978987345389999999850974555
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDC 833 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (888)
+.... .....||+.|+|||++..+..++.++||||+||++|||+||+.||......... ...+.
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~---------- 220 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRM---------- 220 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHH----------
T ss_pred CCCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHH----------
T ss_conf 37886----433113455421687603899984410467789999998599988889989999--99986----------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHH
Q ss_conf 699999999243999999999801799999999-----99999999
Q 002717 834 VDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQIL 874 (888)
Q Consensus 834 ~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs-----~~evl~~L 874 (888)
........+...+..+.+++.+||..||++||| ++|++++-
T Consensus 221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp 266 (364)
T d1omwa3 221 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 266 (364)
T ss_dssp SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCC
T ss_conf 0468887887789999999999856698880887435799997491
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.04 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=211.1
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEE
Q ss_conf 145654137111126608999998999---92999999332886679689999999996248998330333898289016
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 673 (888)
+.+.|+..+.||+|+||.||+|.+..+ +..||+|.+.........+.|.+|+.++++++||||++++|++. ++..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEE
T ss_conf 88996987799307882999999936996449999999365668799999999999998689999856988995-37479
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 99962799998999932099999999455999999999999974305999937367899967866999908920235531
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||+++|++.+++... ...+++..++.++.|+++||.|||+. +++||||||+||++++++.+||+|||+|+.
T Consensus 84 iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 999840698077654224---78999999999999998775230226---744141026553206789678765034213
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCCCCC
Q ss_conf 2344643102533544554674355585788982018989999999980-999897898734538999999985097455
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLD 832 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (888)
...... .......||+.|+|||++ ....++.++|||||||++|||+| |..||....... +...+ ..+..
T Consensus 158 ~~~~~~-~~~~~~~gt~~y~apE~l-~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i----~~~~~-- 227 (273)
T d1mp8a_ 158 MEDSTY-YKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI----ENGER-- 227 (273)
T ss_dssp --------------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH----HTTCC--
T ss_pred CCCCCC-EECCCEECCCCCCHHHHH-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HCCCC--
T ss_conf 367762-330540058310326675-169988745244424789999826999988899999--99999----81899--
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 56999999992439999999998017999999999999999983018
Q 002717 833 CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 833 ~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~ 879 (888)
...+...+..+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 228 ------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 228 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------98987779999999999768797689299999999999977
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.64 Aligned_cols=251 Identities=24% Similarity=0.288 Sum_probs=209.3
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 565413711112660899999899992999999332886--679689999999996248998330333898289016999
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI--IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
+.|+..+.||+|+||.||+|+...+++.||+|++.+... ....+.+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866999908920235531234
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... ..+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred ECCCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 035798605555325----6775999999999996521134315---962246477784765899888820565200356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.. .......||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .+.. .. ..+.
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~-~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~---~i-~~~~------- 221 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFE---LI-LMEE------- 221 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HH-HHCC-------
T ss_pred CC--CCCCCCEECHHHHHHHHC-CCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHH--HHHH---HH-HCCC-------
T ss_conf 78--620551008899666650-4898883331022306788998789999996999--9999---98-5289-------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHH
Q ss_conf 999999243999999999801799999999-----99999999
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPS-----MAEVVQIL 874 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RPs-----~~evl~~L 874 (888)
..+|......+.+++..|++.||.+|++ +.|+++|-
T Consensus 222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp 262 (337)
T d1o6la_ 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred --CCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCC
T ss_conf --98986689999999986663893442256523499997291
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.66 Aligned_cols=265 Identities=27% Similarity=0.369 Sum_probs=216.2
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECCC-------CEEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEEC
Q ss_conf 145654137111126608999998999-------9299999933288667968999999999624-89983303338982
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQ-------GRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT 668 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 668 (888)
+.+.|+..+.||+|+||.||+|+.... +..||||++...........+.+|...+.++ +||||++++|++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 58996970098516782899999857875556675499999988112868899999999999981399969734652201
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 8901699962799998999932099------------9999994559999999999999743059999373678999678
Q 002717 669 PQLKLLVSDYAPNGSLQAKLHERLP------------STPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNIL 736 (888)
Q Consensus 669 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil 736 (888)
++..++||||+++|+|.+++..... ....+++..++.++.|+|.||+|||+. +|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEE
T ss_conf 8868999973699909999986067764322233457434679999999999999999876637---9786302210224
Q ss_pred ECCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCHH
Q ss_conf 669999089202355312344643102533544554674355585788982018989999999980-9998978987345
Q 002717 737 LDDNYNPRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVV 815 (888)
Q Consensus 737 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~ 815 (888)
++.++.+||+|||+++...............+++.|+|||.+ ....++.++||||||+++|||++ |..||......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l-~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHH-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH--
T ss_conf 547897676221110113555554314667888466326675-17988825554775888887401798989999999--
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 3899999998509745556999999992439999999998017999999999999999983018
Q 002717 816 ILSEHVRVLLEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 816 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~ 879 (888)
.+. ..+..+.. ...+...+..+.+++.+||+.||.+||||.|+++.|+++.+
T Consensus 245 ~~~----~~i~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ELF----KLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHH----HHHHTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----HHHHCCCC--------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999----99972888--------89874352999999999766797679399999999988860
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=345.08 Aligned_cols=247 Identities=25% Similarity=0.316 Sum_probs=206.4
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 56541371111266089999989999299999933288--6679689999999996248998330333898289016999
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
+.|+..+.||+|+||+||+|+++.+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866999908920235531234
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|++..++... ..+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EECCCCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf 503786322343222----2111007999999998765541247---677055681050386899889831752167124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.. ....||+.|+|||++ .+..++.++||||+||++|||++|+.||...... .. ........
T Consensus 157 ~~-----~~~~Gt~~Y~APE~l-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~----~~~i~~~~-------- 217 (316)
T d1fota_ 157 VT-----YTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KT----YEKILNAE-------- 217 (316)
T ss_dssp CB-----CCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HH----HHHHHHCC--------
T ss_pred CC-----CCCCCCCCCCCHHHH-CCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHH-HH----HHHHHCCC--------
T ss_conf 56-----434576343599998-3899980430465333689997598999996999-99----99997089--------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 99999924399999999980179999999-----99999999
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RP-----s~~evl~~ 873 (888)
..++...+..+.+++.+|+..||.+|+ |++|++++
T Consensus 218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf --8899778999999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=345.10 Aligned_cols=248 Identities=22% Similarity=0.277 Sum_probs=207.1
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCC--CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 56541371111266089999989999299999933288--6679689999999996248998330333898289016999
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
+.|+..+.||+|+||.||+|.++.+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866999908920235531234
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCC
T ss_conf 233466226667515----8989999999999999989999859---986176799993607789788610103332256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
. .....||+.|||||++ .+..++.++||||+||++|||+||+.||..... ...+ ..... +.
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~----~~i~~-~~------- 254 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIY----EKIVS-GK------- 254 (350)
T ss_dssp C-----BCCCEECGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH----HHHHH-CC-------
T ss_pred C-----CCCCCCCCCCCCHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH-HHHH----HHHHC-CC-------
T ss_conf 6-----6433676356788997-179988533114500789999758899899599-9999----99861-79-------
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHH
Q ss_conf 99999924399999999980179999999-----999999999
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQIL 874 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RP-----s~~evl~~L 874 (888)
...+.....++.+++.+|+..||.+|+ |++|+++|-
T Consensus 255 --~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCC
T ss_conf --88976689999999999834099860655345499997190
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.19 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=205.2
Q ss_pred HHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECC-CEEEEEEEC
Q ss_conf 6541371111266089999989999299999933288667968999999999624899833033389828-901699962
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP-QLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~ 678 (888)
.++..+.||+|+||.||+|.+ .+..||||+++... ..+.|.+|++++++++||||++++|++.+. +..++|+||
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HEEEEEEEECCCCEEEEEEEE--CCEEEEEEEECCHH---HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 948857982079808999999--99099999988577---7999999999998678989854987887238928999963
Q ss_pred CCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 79999899993209999999945599999999999997430599993736789996786699990892023553123446
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+++|+|.+++.... ...+++..++.++.|+|.||.|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 83 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC
T ss_conf 69998999987457--88889999999999998523211337---65536665676014689977632456003447877
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 43102533544554674355585788982018989999999980-99989789873453899999998509745556999
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDPS 837 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (888)
....++..|+|||++ .+..++.++||||||+++|||+| |+.||...... .+...+ ..+ .
T Consensus 158 -----~~~~~~~~y~aPE~l-~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i----~~~--------~ 217 (262)
T d1byga_ 158 -----DTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRV----EKG--------Y 217 (262)
T ss_dssp ---------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHH----TTT--------C
T ss_pred -----CCCCCCCCCCCHHHH-HCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HCC--------C
T ss_conf -----655666467781787-27988858877757999999997899999999999--999999----808--------9
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 999992439999999998017999999999999999983018
Q 002717 838 MGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 838 ~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~ 879 (888)
....+...+..+.+++.+||+.||++||||.|++++|+.++.
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999976579999999999756697689399999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.15 Aligned_cols=265 Identities=25% Similarity=0.354 Sum_probs=200.4
Q ss_pred HHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHH--HHHHHHHHCCCCCCCEEEEEEECCC----EEEE
Q ss_conf 541371111266089999989999299999933288667968999--9999996248998330333898289----0169
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFE--REVRVLGKARHPNLISLEGYYWTPQ----LKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 674 (888)
|...+.||+|+||.||+|++ +|+.||||++.... ...+. .|+..+..++||||++++|++...+ ..++
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCC----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 99988982078819999999--99899999987200----4679999999999627998683268899837986048999
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCCEEECCC
Q ss_conf 99627999989999320999999994559999999999999743059-----9993736789996786699990892023
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF-----RPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfg 749 (888)
||||+++|+|.++++.. .++|..++.++.|+|.||+|+|+.. +++|+||||||+|||++.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEECCCCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf 99646698989998658-----9998999999999999999988766520468986615317313578688776887638
Q ss_pred CCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCH--------
Q ss_conf 55312344643--1025335445546743555857-----88982018989999999980999897898734--------
Q 002717 750 LARLLTRLDKH--VMSNRFQSALGYVAPELTCQSL-----RVNEKCDIYGFGVLILELVTGRRPVEYGEDNV-------- 814 (888)
Q Consensus 750 la~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~-----~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~-------- 814 (888)
+++........ .......||+.|+|||++.... .++.++|||||||++|||+||..|+.......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf 66234677762001355250354767822105654546777675012201599999996289988766311241012255
Q ss_pred --HHHHHHHHHHHHCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf --53899999998509745556999999--99243999999999801799999999999999998301899
Q 002717 815 --VILSEHVRVLLEEGNVLDCVDPSMGD--YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPL 881 (888)
Q Consensus 815 --~~l~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~~ 881 (888)
... ......... ...+|.+.. .+......+.+++.+||+.||++||||.|++++|+++....
T Consensus 234 ~~~~~-~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 234 SDPSV-EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCH-HHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHH-HHHHHHHHC----CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 64309-999998750----2468887765577689999999999976069858959999999999888865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.92 Aligned_cols=270 Identities=23% Similarity=0.246 Sum_probs=205.7
Q ss_pred HCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCC----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEEC
Q ss_conf 1371111266089999989999299999933288667----968999999999624899833033389828901699962
Q 002717 603 KAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ----YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 603 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 678 (888)
..+.||+|+||+||+|.+..+++.||+|++....... ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 79999899993209999999945599999999999997430599993736789996786699990892023553123446
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
++++++...... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred HCCHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 345077655412----66778999999999999999886316---35503577625885377841146576100057875
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCC--CC---CC
Q ss_conf 43102533544554674355585788982018989999999980999897898734538999999985097--45---55
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN--VL---DC 833 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~--~~---~~ 833 (888)
.......||+.|+|||++.....++.++||||+||++|||++|..||.... ....+....+....... .. ..
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred --CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCC-HHHHHHHHHHHCCCCCHHHCCCHHCC
T ss_conf --543302047333639997267788805643630428999985969999999-99999999985189972545210002
Q ss_pred -CC---CCCCCC-----CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf -69---999999-----92439999999998017999999999999999983018999
Q 002717 834 -VD---PSMGDY-----PEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLP 882 (888)
Q Consensus 834 -~d---~~~~~~-----~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~~~ 882 (888)
.. ...... .......+.+++.+|+..||++|||++|++++-+--..+.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCC
T ss_conf 1344303478988678565689999999999763894569089999679965789999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.52 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=206.6
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCC---CEEEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEE
Q ss_conf 5654137111126608999998999---929999993328866--79689999999996248998330333898289016
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQ---GRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKL 673 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 673 (888)
+.|+..+.||+|+||.||+|++... ...||||++...... +..+.|.+|+.++++++||||++++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHH
T ss_conf 8919978980388839999999889990799999999835557989999999999999868999987898777401-001
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 99962799998999932099999999455999999999999974305999937367899967866999908920235531
Q 002717 674 LVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 674 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
+|+||+++|++.+++... ...+++..+..++.|+|.||.|||++ +|+||||||+||+++.++.+|++|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEECCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHH
T ss_conf 146542386125444212---68999999999999999999875217---875205668881565565433256115553
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 23446431-02533544554674355585788982018989999999980-99989789873453899999998509745
Q 002717 754 LTRLDKHV-MSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVT-GRRPVEYGEDNVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 754 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (888)
........ ......|+..|+|||.+ ....++.++||||||+++|||+| |+.||....... ........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-----~~~~i~~~~~~- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDKEGER- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTSCCC-
T ss_pred CCCCCCCCEECCCCCCCCCCCCHHHH-HCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHHCCCC-
T ss_conf 03588752654763257310799998-379999421566148999999968999999969999-----99999847999-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 55699999999243999999999801799999999999999998301
Q 002717 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIK 878 (888)
Q Consensus 832 ~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~ 878 (888)
...+...+..+.+++.+||+.||++||||.|+.+.|++.+
T Consensus 234 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 234 -------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf -------9985445399999999976889667929999999999649
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.89 Aligned_cols=275 Identities=24% Similarity=0.305 Sum_probs=211.9
Q ss_pred HHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEEC
Q ss_conf 654137111126608999998999929999993328866-7968999999999624899833033389828901699962
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 678 (888)
.|+..+.||+|+||+||+|.+..+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEE
T ss_conf 97765177237680999999999997999999802225758999999999999867998388744533224320378862
Q ss_pred CCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 79999899993209999999945599999999999997430599993736789996786699990892023553123446
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+.++ +.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||.|+......
T Consensus 83 ~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 83 LHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred CCCC-HHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 3774-45554420--256888899999999999999986528---89921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCC-------
Q ss_conf 4310253354455467435558578898201898999999998099989789873453899999998509745-------
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL------- 831 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~------- 831 (888)
.......|++.|+|||........+.++||||+||++|+|++|+.||.... ....+....+.........
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCC-HHHHHHHHHHHCCCCCHHHCCCCCCC
T ss_conf --410010365215411221366577742210333313427966879989889-99999999983289833314442224
Q ss_pred CCCCCCCCC--------CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHCCCCCC
Q ss_conf 556999999--------992439999999998017999999999999999--9830189998
Q 002717 832 DCVDPSMGD--------YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKTPLPQ 883 (888)
Q Consensus 832 ~~~d~~~~~--------~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~--L~~~~~~~~~ 883 (888)
......... ........+.+++.+|+..||++|||+.|++++ ++.+.++.|.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p~ 295 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCCC
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCCC
T ss_conf 21243454322220444166789999999999763995579189999678701469999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.89 Aligned_cols=254 Identities=19% Similarity=0.285 Sum_probs=205.1
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEEC
Q ss_conf 56541371111266089999989999299999933288667968999999999624899833033389828901699962
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 678 (888)
+.|+..+.||+|+||+||+|.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 105887898317783999999989996999999757866--599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCCEEECCCCCCCCCC
Q ss_conf 7999989999320999999994559999999999999743059999373678999678669--99908920235531234
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD--NYNPRISDFGLARLLTR 756 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfgla~~~~~ 756 (888)
+++|+|.+++... ...+++.++..++.|++.||.|||+. +|+||||||+|||++. ...+|++|||+++....
T Consensus 83 ~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf 8998088998753---89999999999999999999999876---99751355444344378851899764411100346
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
... .....+++.|+|||.. ....++.++||||+||++|||++|..||...... ..+.. ........ +
T Consensus 157 ~~~---~~~~~~t~~y~ape~~-~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~----i~~~~~~~---~- 223 (321)
T d1tkia_ 157 GDN---FRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIEN----IMNAEYTF---D- 223 (321)
T ss_dssp TCE---EEEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHH----HHHTCCCC---C-
T ss_pred CCC---CCCCCCCCCCCCCHHC-CCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHH-HHHHH----HHHCCCCC---C-
T ss_conf 775---3212233222340210-4877784011302799999998289999998999-99999----98389998---8-
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 999999243999999999801799999999999999998
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~ 875 (888)
..........+.+++.+|+..||++|||+.|++++-+
T Consensus 224 --~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 224 --EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp --HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred --HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf --0223678999999999986699668909999963996
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.70 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=202.8
Q ss_pred HHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCC--CCCCHHHHHHHHHHHH-HCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 6541371111266089999989999299999933288--6679689999999996-248998330333898289016999
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSD--IIQYPEDFEREVRVLG-KARHPNLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lv~ 676 (888)
.|+..+.||+|+||+||+|++..+++.||+|++.+.. .....+.+..|..++. .++||||+++++++.+++..++||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 71886589408782899999999998999999805553384899999999999998479996878988970498316777
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866999908920235531234
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTR 756 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~ 756 (888)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+|++|||+++....
T Consensus 83 Ey~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EECCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 503798089986404----7899999999999999999999868---934034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 46431025335445546743555857889820189899999999809998978987345389999999850974555699
Q 002717 757 LDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVLDCVDP 836 (888)
Q Consensus 757 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (888)
.. .......||+.|+|||++ .+..++.++||||+||++|||++|+.||..... . .+...+ ..+. +
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-~-~~~~~i----~~~~------~ 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-E-ELFHSI----RMDN------P 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-H-HHHHHH----HHCC------C
T ss_pred CC--CCCCCCCCCCCCCCHHHH-CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-H-HHHHHH----HCCC------C
T ss_conf 65--334545787776899998-279988323201122789898738899999899-9-999999----7189------9
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 99999924399999999980179999999999-9999
Q 002717 837 SMGDYPEDEVLPVLKLALVCTCHIPSSRPSMA-EVVQ 872 (888)
Q Consensus 837 ~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~-evl~ 872 (888)
.+|...+.++.+++.+||..||++|||+. |+++
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf ---8975679999999999654489878388999980
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=337.66 Aligned_cols=255 Identities=27% Similarity=0.343 Sum_probs=207.5
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCC--------HHHHHHHHHHHHHCC-CCCCCEEEEEEECC
Q ss_conf 565413711112660899999899992999999332886679--------689999999996248-99833033389828
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQY--------PEDFEREVRVLGKAR-HPNLISLEGYYWTP 669 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 669 (888)
+.|+..+.||+|+||+||+|+...+++.||||++........ .+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCC
Q ss_conf 90169996279999899993209999999945599999999999997430599993736789996786699990892023
Q 002717 670 QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 670 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 749 (888)
+..++||||+++|+|.+++... ..+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEECCCCCHHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCH
T ss_conf 6059999768986689999865----9999999999999999999999875---99432346254898689983871240
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 5531234464310253354455467435558-----57889820189899999999809998978987345389999999
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQ-----SLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL 824 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~ 824 (888)
+++...+... .....||..|+|||.+.. ...++.++||||+||++|||++|+.||...... ... +..
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-~~~----~~i 227 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LML----RMI 227 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHH----HHH
T ss_pred HEEECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHH-HHH----HHH
T ss_conf 3167268872---13452467888988860534456788992331856560231032288898899999-999----999
Q ss_pred HHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 85097455569999999924399999999980179999999999999999
Q 002717 825 LEEGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 825 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L 874 (888)
.. +... .. .......+.++.+++.+||+.||++|||+.|++++-
T Consensus 228 ~~-~~~~-~~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~ 271 (277)
T d1phka_ 228 MS-GNYQ-FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 271 (277)
T ss_dssp HH-TCCC-CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HH-CCCC-CC----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 81-8988-89----854346899999999997658966891999997397
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=339.39 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=210.6
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCC----EE
Q ss_conf 5654137111126608999998999929999993328866--79689999999996248998330333898289----01
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII--QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ----LK 672 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~ 672 (888)
+.|+..+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEE
T ss_conf 20698689960899299999999999899999985566469899999999999998569998873114354326887669
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf 69996279999899993209999999945599999999999997430599993736789996786699990892023553
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
++||||+++|+|.+++... ..+++.++..++.|++.|+.|||+. +|+||||||+||+++.++..+++|||.+.
T Consensus 87 ~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEEHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 9999778898710112035----8999999999999999999999857---95276346755665754320100344432
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 123446-4310253354455467435558578898201898999999998099989789873453899999998509745
Q 002717 753 LLTRLD-KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL 831 (888)
Q Consensus 753 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (888)
...... .........||+.|+|||++ .+..++.++||||+||++|||+||+.||..... ...+. .........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~----~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-VSVAY----QHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHH----HHHHCCCCC
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHH-CCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCH-HHHHH----HHHHCCCCC
T ss_conf 212354433334642576243699998-399999663202652899999769799899699-99999----998469999
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHCC
Q ss_conf 5569999999924399999999980179999999-99999999983018
Q 002717 832 DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-SMAEVVQILQVIKT 879 (888)
Q Consensus 832 ~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RP-s~~evl~~L~~~~~ 879 (888)
. .......+..+.+++.+|+..||++|| |++++.+.|.++..
T Consensus 234 ~------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 P------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp G------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred C------CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf 7------100347899999999998667976777399999999999758
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.00 Aligned_cols=255 Identities=19% Similarity=0.279 Sum_probs=198.7
Q ss_pred HHHHHC-CEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEEC----CCEE
Q ss_conf 565413-71111266089999989999299999933288667968999999999624-89983303338982----8901
Q 002717 599 TLLEKA-AEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKA-RHPNLISLEGYYWT----PQLK 672 (888)
Q Consensus 599 ~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~ 672 (888)
+.|++. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++.++ +||||+++++++.+ ....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 4879810796545486999999889998999999897------4779999999998669999782989995034689789
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCCEEECCC
Q ss_conf 6999627999989999320999999994559999999999999743059999373678999678669---9990892023
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD---NYNPRISDFG 749 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg 749 (888)
++|||||++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 9999778998499999862--787757999999999999999999976---98644410022011355556631135455
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 55312344643102533544554674355585788982018989999999980999897898734538999999985097
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
+|+....... .....||+.|+|||++ .+..++.++||||+||++|||+||+.||......... .. .. ..
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~-~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-~~-~~---~~-- 228 (335)
T d2ozaa1 160 FAKETTSHNS---LTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PG-MK---TR-- 228 (335)
T ss_dssp TCEECCCCCC---CCCCSCCCSSCCCCCC-CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------C--
T ss_pred EEEECCCCCC---CCCCCCCCCCCCCHHH-CCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHH-HH-HH---HH--
T ss_conf 1233368886---4322677563792777-4898888888876451677886588998898877889-99-99---99--
Q ss_pred CCCCCCCCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 45556999999-992439999999998017999999999999999983
Q 002717 830 VLDCVDPSMGD-YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 830 ~~~~~d~~~~~-~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~ 876 (888)
. .......+. .....+..+.+++.+|+..||++|||+.|++++-+-
T Consensus 229 i-~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 229 I-RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275 (335)
T ss_dssp C-CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred H-HCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 8-5388888985434699999999999756996579099999709876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.30 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=203.8
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCC----EEEE
Q ss_conf 565413711112660899999899992999999332886679689999999996248998330333898289----0169
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTPQ----LKLL 674 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 674 (888)
+.|+..+.||+|+||+||+|.+..+++.||||++.........+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 98599789940648099999999999499999980310958999999999999976898988588899505645541499
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99627999989999320999999994559999999999999743059999373678999678669999089202355312
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLL 754 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~ 754 (888)
+++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 99962598656644058-----999999999999999999999978---9867778764378879997787545705650
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCC---
Q ss_conf 34464-31025335445546743555857889820189899999999809998978987345389999999850974---
Q 002717 755 TRLDK-HVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV--- 830 (888)
Q Consensus 755 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~--- 830 (888)
..... ........|++.|+|||++.....++.++||||+||++|||++|+.||...... ................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHH
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHH-HHHHHHHHHCCCCCHHHHH
T ss_conf 477764101011026520003878604788874101004670133776697997888889-9999876520699756642
Q ss_pred ---------CCCCCCCCCC-----CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf ---------5556999999-----9924399999999980179999999999999999
Q 002717 831 ---------LDCVDPSMGD-----YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 831 ---------~~~~d~~~~~-----~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L 874 (888)
.....+.... .......++.+++.+|+..||++|||+.|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 3433222202446775577877783789999999999997648956790899986198
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.92 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=200.0
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCC-----CHHHHHHHHHHHHHCC--CCCCCEEEEEEECCCE
Q ss_conf 56541371111266089999989999299999933288667-----9689999999996248--9983303338982890
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-----YPEDFEREVRVLGKAR--HPNLISLEGYYWTPQL 671 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~ 671 (888)
+.|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEECCCC-CCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCCEEECCC
Q ss_conf 1699962799-99899993209999999945599999999999997430599993736789996786699-990892023
Q 002717 672 KLLVSDYAPN-GSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDN-YNPRISDFG 749 (888)
Q Consensus 672 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg 749 (888)
.++|+||+.+ +++.+++... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.+ +.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEECCCCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 899998336862289998615----8999999999999999999999877---975566761114774478848977546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 55312344643102533544554674355585788982018989999999980999897898734538999999985097
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGN 829 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 829 (888)
+|+..... ......||+.|+|||++.....++.++||||+||++|||++|+.||.... . .....
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~----i~~~~- 220 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E----IIRGQ- 220 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H----HHHCC-
T ss_pred CCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-------H----HHHCC-
T ss_conf 53532444----55665658774799998489978865332554034536756889988736-------7----76154-
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 4555699999999243999999999801799999999999999998
Q 002717 830 VLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 830 ~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~ 875 (888)
..++...+.++.+++.+||..||++|||++|++++-+
T Consensus 221 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 221 ---------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp ---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ---------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf ---------4778779999999999976089758939999853986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.60 Aligned_cols=267 Identities=23% Similarity=0.278 Sum_probs=201.0
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECC-CCEEEEEEEEECCCCC-CCHHHHHHHHHHHHHC---CCCCCCEEEEEEEC---
Q ss_conf 14565413711112660899999899-9929999993328866-7968999999999624---89983303338982---
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGT-QGRMLAVKKLVTSDII-QYPEDFEREVRVLGKA---RHPNLISLEGYYWT--- 668 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~--- 668 (888)
.++.|++.+.||+|+||+||+|++.. +++.||+|++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred --CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEE
Q ss_conf --890169996279999899993209999999945599999999999997430599993736789996786699990892
Q 002717 669 --PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRIS 746 (888)
Q Consensus 669 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 746 (888)
....++++||++++.+....... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCCEEEEEEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEEC
T ss_conf 6674699999740587144444303---78999899999999999999999758---89835798627898589975421
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 02355312344643102533544554674355585788982018989999999980999897898734538999999985
Q 002717 747 DFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826 (888)
Q Consensus 747 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 826 (888)
|||.++...... ......||+.|+|||++ .+..++.++||||+||++|||++|+.||.... ....+....+....
T Consensus 159 dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~-~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 159 DFGLARIYSFQM---ALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGL 233 (305)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCC
T ss_pred CHHHHHHHCCCC---CCCCCCCCHHHCCCCHH-CCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHHCC
T ss_conf 000101100234---57776548511483100-17988811100032899999987879989989-89999999984079
Q ss_pred CCCCC-------------CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 09745-------------5569999999924399999999980179999999999999999
Q 002717 827 EGNVL-------------DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 827 ~~~~~-------------~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L 874 (888)
..... .........+.......+.+|+.+|+..||++|||+.|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp 294 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 9611053211110333022345645440445899999999998748966791899996696
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.32 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=198.7
Q ss_pred HHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECC------CEEEE
Q ss_conf 541371111266089999989999299999933288667968999999999624899833033389828------90169
Q 002717 601 LEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISLEGYYWTP------QLKLL 674 (888)
Q Consensus 601 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 674 (888)
|+..+.||+|+||+||+|++..+++.||||++..... ...+|+.++++++||||+++++++... ...++
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 6751698217683999999999997999999881606-----89999999986689898738789974476577318999
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CCEEECCCCCCC
Q ss_conf 9962799998999932099999999455999999999999974305999937367899967866999-908920235531
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARL 753 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~ 753 (888)
||||+++|. .+.+.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEECCCCCC-HHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 984168860-788886310368999999999999999999999866---8764578860378735897116733660544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH-------
Q ss_conf 2344643102533544554674355585788982018989999999980999897898734538999999985-------
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE------- 826 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~------- 826 (888)
+..... .....|+..|+|||.......++.++||||+||++|||++|+.||..... ...+....+....
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCHHHHH
T ss_pred CCCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCH-HHHHHHHHHHHCCCHHHHHH
T ss_conf 047765---32002555556827764046888210002465277855028799898799-99999999974898177654
Q ss_pred --CCCCCCCCCCCCC------CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHCC
Q ss_conf --0974555699999------9992439999999998017999999999999999--983018
Q 002717 827 --EGNVLDCVDPSMG------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIKT 879 (888)
Q Consensus 827 --~~~~~~~~d~~~~------~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~--L~~~~~ 879 (888)
........-+... ........++.+|+.+|+..||++|||+.|++++ ++.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 306210110355445674444315689999999999976589557929999966984524667
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=328.36 Aligned_cols=264 Identities=23% Similarity=0.280 Sum_probs=205.4
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEE
Q ss_conf 565413711112660899999899992999999332886-6796899999999962489983303338982890169996
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 677 (888)
+.|+..+.||+|+||+||+|+++ +++.||||++..... ....+.+.+|+.++++++||||+++++++...+..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf 99634318722778189999968-99999999981232685899999999999986799868766012046773158997
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 27999989999320999999994559999999999999743059999373678999678669999089202355312344
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRL 757 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~ 757 (888)
++.++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.+......
T Consensus 81 ~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EEHHHHHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCC
T ss_conf 40045678998604----7751445689999999999986057---4882678775056868997873236643011467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCC--C-----C
Q ss_conf 64310253354455467435558578898201898999999998099989789873453899999998509--7-----4
Q 002717 758 DKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEG--N-----V 830 (888)
Q Consensus 758 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--~-----~ 830 (888)
.. ......+++.|+|||.+.....++.++||||+||++|||++|+.||..... ...+....+...... . .
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 154 VR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CC--CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCH-HHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 65--410102431101378871788888410021117589999779799898898-999999998638997110421233
Q ss_pred CCCCCCCCC--------CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 555699999--------9992439999999998017999999999999999
Q 002717 831 LDCVDPSMG--------DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI 873 (888)
Q Consensus 831 ~~~~d~~~~--------~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~ 873 (888)
....+.... .........+.+++.+|+..||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 322143333356764666512589999999999866896689099998569
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.67 Aligned_cols=278 Identities=21% Similarity=0.254 Sum_probs=207.9
Q ss_pred HHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECC-------
Q ss_conf 4565413711112660899999899992999999332886-67968999999999624899833033389828-------
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDI-IQYPEDFEREVRVLGKARHPNLISLEGYYWTP------- 669 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 669 (888)
-+.|++.+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|+.+++.++|||++++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred -CEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECC
Q ss_conf -9016999627999989999320999999994559999999999999743059999373678999678669999089202
Q 002717 670 -QLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDF 748 (888)
Q Consensus 670 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 748 (888)
+..++|+||+.++.+...... ...++...+..++.|++.||.|||+. +|+||||||+|||++.++.+|++||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEECCCCCCCCHHHHC----CCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEEC
T ss_conf 7638999853578741012220----34433089999999999999885229---9885676722203668996876313
Q ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 355312344643--102533544554674355585788982018989999999980999897898734538999999985
Q 002717 749 GLARLLTRLDKH--VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLE 826 (888)
Q Consensus 749 gla~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~ 826 (888)
|+++........ .......||+.|+|||++.....++.++||||+||++|||++|+.||.... ....+....+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-~~~~~~~i~~~~~~ 240 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQLCGS 240 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCC
T ss_pred CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCC-HHHHHHHHHHHCCC
T ss_conf 50022355444321135660249787428997079998917870067864661744879989989-99999999984189
Q ss_pred CC-CCCCCCCCC--------CCCCC--H-------HHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 09-745556999--------99999--2-------4399999999980179999999999999999830189998
Q 002717 827 EG-NVLDCVDPS--------MGDYP--E-------DEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKTPLPQ 883 (888)
Q Consensus 827 ~~-~~~~~~d~~--------~~~~~--~-------~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~~~~~ 883 (888)
.. ......+.. ..... . .....+.+|+.+|+..||++|||+.|++++-.--..+.|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred CCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCC
T ss_conf 982553443203444332013344555033404445998999999998738965890999997495015699997
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.48 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=205.2
Q ss_pred HHHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCC-----
Q ss_conf 145654137111126608999998999929999993328866-79689999999996248998330333898289-----
Q 002717 597 PETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTPQ----- 670 (888)
Q Consensus 597 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 670 (888)
..+.|++.+.||+|+||+||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -EEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCC
Q ss_conf -0169996279999899993209999999945599999999999997430599993736789996786699990892023
Q 002717 671 -LKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFG 749 (888)
Q Consensus 671 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 749 (888)
..++||||+ +++|...... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEECC-CCCHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCC
T ss_conf 1599998405-5218999874-----0226999999999999999998737---87645668511112100122113431
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC--
Q ss_conf 553123446431025335445546743555857889820189899999999809998978987345389999999850--
Q 002717 750 LARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEE-- 827 (888)
Q Consensus 750 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~-- 827 (888)
+|+..... .....|++.|+|||++.....++.++||||+||++|||++|+.||..... ...+....+.....
T Consensus 167 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 167 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPA 240 (346)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCH
T ss_pred CEECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCH-HHHHHHHHHCCCCCCH
T ss_conf 02206876-----31024553335889981787899650103003899999978699888976-8999999850378848
Q ss_pred -----C----------CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHHC
Q ss_conf -----9----------745556999999992439999999998017999999999999999--98301
Q 002717 828 -----G----------NVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQI--LQVIK 878 (888)
Q Consensus 828 -----~----------~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~--L~~~~ 878 (888)
. ....................+.+|+.+|+..||++|||+.|++++ ++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 88865300034433115786665566775568999999999997729955792999996396237587
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.98 Aligned_cols=266 Identities=22% Similarity=0.251 Sum_probs=210.4
Q ss_pred HHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCEEEEEEEC
Q ss_conf 6541371111266089999989999299999933288667-968999999999624899833033389828901699962
Q 002717 600 LLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQ-YPEDFEREVRVLGKARHPNLISLEGYYWTPQLKLLVSDY 678 (888)
Q Consensus 600 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 678 (888)
.|++.+.||+|+||+||+|++..+++.||||++....... ....+.+|+.+++.++||||+++++++......++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEE
T ss_conf 97862697128681999999999996999999803217868999999999999856757888213544444311588630
Q ss_pred CCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 79999899993209999999945599999999999997430599993736789996786699990892023553123446
Q 002717 679 APNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLARLLTRLD 758 (888)
Q Consensus 679 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~~~~~~ 758 (888)
+.++++..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.++......
T Consensus 83 ~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 83 CDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred CCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 2332221121235----6540367899999999998774339---98600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCC-----CC-
Q ss_conf 431025335445546743555857889820189899999999809998978987345389999999850974-----55-
Q 002717 759 KHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV-----LD- 832 (888)
Q Consensus 759 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~-----~~- 832 (888)
. ......++..|+|||.+.....++.++||||+||++|||++|+.||.........+............. ..
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred C--CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 5--10010344310146675069888804440265418899851899998899999999999861189973551344322
Q ss_pred ---------CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf ---------569999999924399999999980179999999999999999
Q 002717 833 ---------CVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 833 ---------~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L 874 (888)
................+.+++.+|++.||.+|||++|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp 284 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 211334445443104330656899999999998649966890999996495
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=317.78 Aligned_cols=260 Identities=20% Similarity=0.260 Sum_probs=201.6
Q ss_pred HHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCCEEEEEEECC--CEEEE
Q ss_conf 4565413711112660899999899992999999332886679689999999996248-99833033389828--90169
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTP--QLKLL 674 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~l 674 (888)
.+.|++.++||+|+||+||+|++..+++.||+|++... ..+.+.+|+.+++.++ ||||+++++++... ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEE
T ss_conf 86718978983174819999998899979999998889----99999999999985157998767999998168771268
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CCEEECCCCCCC
Q ss_conf 9962799998999932099999999455999999999999974305999937367899967866999-908920235531
Q 002717 675 VSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNY-NPRISDFGLARL 753 (888)
Q Consensus 675 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfgla~~ 753 (888)
||||+++|+|.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+|++|||+|+.
T Consensus 110 v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEECCCCCHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEE
T ss_conf 88631798589974-------6899999999999999999887643---3443456441237748998366415654266
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH--------H
Q ss_conf 23446431025335445546743555857889820189899999999809998978987345389999999--------8
Q 002717 754 LTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVL--------L 825 (888)
Q Consensus 754 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~--------~ 825 (888)
...... .....+|..|+|||.+.....++.++||||+||++|||++|+.||..............+.. .
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 180 YHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHH
T ss_conf 468874---44322486424761026888888452323354555876048899988760189999999987884155555
Q ss_pred HCCCC------CCCCCCC--------CC-CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 50974------5556999--------99-99924399999999980179999999999999999
Q 002717 826 EEGNV------LDCVDPS--------MG-DYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQIL 874 (888)
Q Consensus 826 ~~~~~------~~~~d~~--------~~-~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L 874 (888)
..... ....... .. ........++.+|+.+|+..||++|||++|++++-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf 4225444743000003334331121155211244899999999998669956890899996493
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=316.31 Aligned_cols=260 Identities=14% Similarity=0.151 Sum_probs=199.1
Q ss_pred HHHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEE-EEEEECCCEEEEEE
Q ss_conf 45654137111126608999998999929999993328866796899999999962489983303-33898289016999
Q 002717 598 ETLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHPNLISL-EGYYWTPQLKLLVS 676 (888)
Q Consensus 598 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~g~~~~~~~~~lv~ 676 (888)
.+.|+..+.||+|+||.||+|++..+++.||||.+..... ...+..|+++++.++|++++.. .++....+..++|+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC---CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEE
T ss_conf 8889996898507880999999988998999999721005---8889999999997038996017999995198778999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCCEEECCCCCCC
Q ss_conf 62799998999932099999999455999999999999974305999937367899967866---999908920235531
Q 002717 677 DYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLD---DNYNPRISDFGLARL 753 (888)
Q Consensus 677 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfgla~~ 753 (888)
||+ +|++.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+||+++ .+..+|++|||+|+.
T Consensus 83 e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEC-CCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEE
T ss_conf 873-87133324430---68876899999999999999999979---944266787660643357776156504675134
Q ss_pred CCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHH--HHHHHHHHH
Q ss_conf 2344643-----102533544554674355585788982018989999999980999897898734538--999999985
Q 002717 754 LTRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVIL--SEHVRVLLE 826 (888)
Q Consensus 754 ~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l--~~~~~~~~~ 826 (888)
+...... .......||+.|+|||.+ .+..++.++|||||||++|||+||+.||.......... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHH-TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred CCCCCCCCCEECCCCCCCCCCCCCCCHHHH-HCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 255445541000135776787353299999-1899898321886177899998498766553057799999985235678
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 097455569999999924399999999980179999999999999999830
Q 002717 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVI 877 (888)
Q Consensus 827 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~ 877 (888)
. ... ......+..+.+++..||+.+|++||+++++.+.|+.+
T Consensus 235 ~-~~~--------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 235 T-PIE--------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp S-CHH--------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred C-CHH--------HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 9-835--------75347889999999998439955791999999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.11 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=205.7
Q ss_pred HHHHHCCEECCCCCEEEEEEEEC---CCCEEEEEEEEECCC---CCCCHHHHHHHHHHHHHCCC-CCCCEEEEEEECCCE
Q ss_conf 56541371111266089999989---999299999933288---66796899999999962489-983303338982890
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFG---TQGRMLAVKKLVTSD---IIQYPEDFEREVRVLGKARH-PNLISLEGYYWTPQL 671 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~ 671 (888)
+.|+..+.||+|+||.||+|... .+|+.||+|.+.... .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCC
Q ss_conf 16999627999989999320999999994559999999999999743059999373678999678669999089202355
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 751 (888)
.++|+||+.+|+|.+++... ..+.......++.|++.|+.|+|+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEEECCCCCHHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf 00123123411799998730----4543788888899999999885149---9896547732012469998887413202
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 312344643102533544554674355585-7889820189899999999809998978987345389999999850974
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQS-LRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNV 830 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 830 (888)
+.+..... .......|++.|+|||.+... ..++.++||||+||++|||++|+.||....... ......+......
T Consensus 177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~i~~~~~~~~-- 252 (322)
T d1vzoa_ 177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE-- 252 (322)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCC--
T ss_pred HHHCCCCC-CCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCC--
T ss_conf 22034444-3221222333331068760577688713251777799999976899988887777-9999998335689--
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 55569999999924399999999980179999999-----99999999
Q 002717 831 LDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRP-----SMAEVVQI 873 (888)
Q Consensus 831 ~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RP-----s~~evl~~ 873 (888)
..++......+.+++.+||.+||++|| |++|++++
T Consensus 253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf --------9886547999999999974458988199974509999749
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=311.83 Aligned_cols=262 Identities=12% Similarity=0.112 Sum_probs=205.9
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCCEEEEEEECCCEEEEEEE
Q ss_conf 565413711112660899999899992999999332886679689999999996248-9983303338982890169996
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 677 (888)
+.|++.+.||+|+||.||+|++..+++.||+|.+..... ...+.+|++.++.+. |+|++.+++++......++|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 806997998417882999999988997999999750258---29999999999996489998779999601881179999
Q ss_pred CCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCCEEECCCCCC
Q ss_conf 27999989999320999999994559999999999999743059999373678999678669-----9990892023553
Q 002717 678 YAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDD-----NYNPRISDFGLAR 752 (888)
Q Consensus 678 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfgla~ 752 (888)
|+ +|+|.+++... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++. ++.+|++|||+|+
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EC-CCCHHHHHHHH---CCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 64-88879999752---03110689999999999999999977---9662667713152347543447956872366057
Q ss_pred CCCCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC-HHHHHHHHHHHHH
Q ss_conf 12344643-----10253354455467435558578898201898999999998099989789873-4538999999985
Q 002717 753 LLTRLDKH-----VMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN-VVILSEHVRVLLE 826 (888)
Q Consensus 753 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~-~~~l~~~~~~~~~ 826 (888)
........ .......||+.|||||.+ .+..++.++||||+|+++|||+||+.||...... .......+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~-~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ECCCCCCCCCEEECCCCCEEECHHHCCHHHH-CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCC
T ss_conf 7146766541110246762775102679896-488888699989831999999869876788530219999999970567
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 09745556999999992439999999998017999999999999999983018
Q 002717 827 EGNVLDCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQVIKT 879 (888)
Q Consensus 827 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~~~~ 879 (888)
..... +.....+..+.+++..||..+|++||+++.+.+.++.+..
T Consensus 234 ~~~~~--------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 234 STPLR--------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HSCHH--------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCHH--------HHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 99958--------9657998999999999843993008599999999999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=312.80 Aligned_cols=262 Identities=23% Similarity=0.254 Sum_probs=200.0
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEECC------CE
Q ss_conf 5654137111126608999998999929999993328866-7968999999999624899833033389828------90
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP------QL 671 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 671 (888)
+.|++.++||+|+||+||+|.+..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCC
Q ss_conf 16999627999989999320999999994559999999999999743059999373678999678669999089202355
Q 002717 672 KLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLA 751 (888)
Q Consensus 672 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla 751 (888)
.|+|+||+.++ +.+.+.. .+++..+..++.|++.|+.|||+. ||+||||||+|||++.++.++++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEEECCCHH-HHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 69998414467-7876503------899999999999999999886522---1124567763211365443132010232
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH--------
Q ss_conf 312344643102533544554674355585788982018989999999980999897898734538999999--------
Q 002717 752 RLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRV-------- 823 (888)
Q Consensus 752 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~-------- 823 (888)
+...... ......+|..|+|||++ .+..++.++||||+||++|||++|+.||..... ...+....+.
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l-~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp -----------------CCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHH
T ss_pred HCCCCCC---CCCCCCCCCCCCCHHHH-CCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCH-HHHHHHHHHHCCCCCHHH
T ss_conf 1146665---53322146555581331-477778774333566257898659899888977-889999997205898799
Q ss_pred ----------HHHCCCCC----------CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf ----------98509745----------55699999999243999999999801799999999999999998
Q 002717 824 ----------LLEEGNVL----------DCVDPSMGDYPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQ 875 (888)
Q Consensus 824 ----------~~~~~~~~----------~~~d~~~~~~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~ 875 (888)
........ ....+............+.+|+.+|+..||++|||++|++++-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf 987656677776417543566642126433354321013337999999999987699457908999966942
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.39 Aligned_cols=264 Identities=23% Similarity=0.264 Sum_probs=201.7
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEECC-----CEE
Q ss_conf 5654137111126608999998999929999993328866-7968999999999624899833033389828-----901
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-QYPEDFEREVRVLGKARHPNLISLEGYYWTP-----QLK 672 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 672 (888)
+.|++.+.||+|+||+||+|.+..+++.||||++...... ...+.+.+|+.+++.++|||++++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCE
T ss_conf 87188889831788399999999999799999988200286899999999999986689874259999963464566864
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf 69996279999899993209999999945599999999999997430599993736789996786699990892023553
Q 002717 673 LLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 673 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
+++++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+.
T Consensus 98 ~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEECCCCHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 9999962588623200224-----530999999999999999999738---87651667763345543220013210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCC-
Q ss_conf 1234464310253354455467435558578898201898999999998099989789873453899999998509745-
Q 002717 753 LLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDNVVILSEHVRVLLEEGNVL- 831 (888)
Q Consensus 753 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~- 831 (888)
.... ......|+..|+|||.......++.++||||+||++|+|++|+.||..... ........+.........
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred CCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHCCCCCHHHH
T ss_conf 2575-----444434543555835533775678551243205899999768899788988-9999999973079975773
Q ss_pred C-----------CCCCCCCC-----CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 5-----------56999999-----992439999999998017999999999999999983
Q 002717 832 D-----------CVDPSMGD-----YPEDEVLPVLKLALVCTCHIPSSRPSMAEVVQILQV 876 (888)
Q Consensus 832 ~-----------~~d~~~~~-----~~~~~~~~l~~li~~c~~~dp~~RPs~~evl~~L~~ 876 (888)
. ........ ........+.+|+.+|+..||++|||+.|++++-+-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f 304 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 2001024454443035578755566267899999999999775883459389998559954
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=277.90 Aligned_cols=266 Identities=20% Similarity=0.222 Sum_probs=191.7
Q ss_pred HHHHHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-----------CCCCCEEEEEEE
Q ss_conf 565413711112660899999899992999999332886679689999999996248-----------998330333898
Q 002717 599 TLLEKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-----------HPNLISLEGYYW 667 (888)
Q Consensus 599 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~ 667 (888)
..|++.++||+|+||+||+|+...+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC--CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431--3368999999999984014555554227676478998763
Q ss_pred C--CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCC---
Q ss_conf 2--89016999627999989999320999999994559999999999999743059999373678999678669999---
Q 002717 668 T--PQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYN--- 742 (888)
Q Consensus 668 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--- 742 (888)
. ....+.+++++..+......... .....+++..+..++.|++.|+.|||+.. +|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred ECCCCCEEEEEEECCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCCHHHEEEECCCCCCC
T ss_conf 12565202343200035420000012-23467868999999999999988876405--8646567705705630576564
Q ss_pred ---CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC-----H
Q ss_conf ---08920235531234464310253354455467435558578898201898999999998099989789873-----4
Q 002717 743 ---PRISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLILELVTGRRPVEYGEDN-----V 814 (888)
Q Consensus 743 ---~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~elltg~~p~~~~~~~-----~ 814 (888)
++++|||.+..... ......|++.|+|||+.. ...++.++||||+||+++||++|+.||...... .
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCEEEEEECCCCCCCCC-----CCCCCCCCCCCCCHHHCC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHH
T ss_conf 43056753144212344-----542236652105713214-667776432012378999998788998987554321026
Q ss_pred HHHHHHHHHHHH-------CC----------CCCCCCCC-----------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 538999999985-------09----------74555699-----------999999243999999999801799999999
Q 002717 815 VILSEHVRVLLE-------EG----------NVLDCVDP-----------SMGDYPEDEVLPVLKLALVCTCHIPSSRPS 866 (888)
Q Consensus 815 ~~l~~~~~~~~~-------~~----------~~~~~~d~-----------~~~~~~~~~~~~l~~li~~c~~~dp~~RPs 866 (888)
..+...+..... .. .....+.. ............+.+++.+|+..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 89999999837998788624532200013201220243235776444210001567435899999999987799457908
Q ss_pred HHHHHHHHH
Q ss_conf 999999998
Q 002717 867 MAEVVQILQ 875 (888)
Q Consensus 867 ~~evl~~L~ 875 (888)
++|++++-+
T Consensus 322 a~e~L~Hp~ 330 (362)
T d1q8ya_ 322 AGGLVNHPW 330 (362)
T ss_dssp HHHHHTCGG
T ss_pred HHHHHCCCC
T ss_conf 999966934
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=7.6e-42 Score=232.92 Aligned_cols=358 Identities=20% Similarity=0.237 Sum_probs=210.1
Q ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 67518995521378000016989933997589988677861222049889689867711244446235689999999875
Q 002717 25 RLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLS 104 (888)
Q Consensus 25 ~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 104 (888)
+..++.+.+.+.+. ...+ .++++|+++++.|. .+. + ++.+++|++|++++|+|+.++. +..+++|++|+++
T Consensus 26 ~~~l~~~~~~~~~~--~~~l--~~l~~L~l~~~~I~-~l~-g-l~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~ 96 (384)
T d2omza2 26 KTVLGKTNVTDTVS--QTDL--DQVTTLQADRLGIK-SID-G-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 96 (384)
T ss_dssp HHHTTCSSTTSEEC--HHHH--TTCCEEECCSSCCC-CCT-T-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHCCCCCCCCCC--HHHH--CCCCEEECCCCCCC-CCC-C-CCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf 99867777788639--8895--78789989998987-762-4-2458999989681881798863--3477110103013
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 76461235866453444666676897478514000780133888888997568625310797989999998997648736
Q 002717 105 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLF 184 (888)
Q Consensus 105 ~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 184 (888)
+|+++..+ .+..+++|+.|+++++.+++... ......+..+....|.+.....................
T Consensus 97 ~n~i~~i~------~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~--- 165 (384)
T d2omza2 97 NNQIADIT------PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV--- 165 (384)
T ss_dssp SSCCCCCG------GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESC---
T ss_pred CCCCCCCC------CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---
T ss_conf 43332222------11123343334433222222222--22222221121346631310023222211222221232---
Q ss_pred CCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCC
Q ss_conf 76789001147998699903385645689674267766578944355677799778899998499950786777789200
Q 002717 185 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGL 264 (888)
Q Consensus 185 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~ 264 (888)
.....+.............|... ....+..+++++.+++++|.++...+ +..+++|+.|++++|.+.. ++
T Consensus 166 --~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~--- 235 (384)
T d2omza2 166 --TDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG--- 235 (384)
T ss_dssp --CCCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG---
T ss_pred --CHHHHHCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-CC---
T ss_conf --20111124542110112224333--21100223532333035774478786--4445778788887777789-61---
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 02699648755686401489999999877336877999678991745587544402679576616984566899985567
Q 002717 265 FDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYF 344 (888)
Q Consensus 265 ~~~~L~~L~l~~n~~~~~~p~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 344 (888)
.+..+++|+.+++++|.+++.. .+..+++|+.|++++|.++.. ..+..+
T Consensus 236 ---------------------------~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~--~~~~~~ 284 (384)
T d2omza2 236 ---------------------------TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNI--SPLAGL 284 (384)
T ss_dssp ---------------------------GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTC
T ss_pred ---------------------------HHHCCCCCCHHCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCC--CCCCCC
T ss_conf ---------------------------3432565341004467447877--535546687754567445787--732356
Q ss_pred CCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 85429992168330137911004589964874587687866701226665657983387032457824529799996983
Q 002717 345 HSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKL 424 (888)
Q Consensus 345 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 424 (888)
+.+..+.+..|++.+ ...+..+++++.|++++|++++.. .+..+++|+.|++++|+++ .++ .++.+++|++|++
T Consensus 285 ~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l 358 (384)
T d2omza2 285 TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSA 358 (384)
T ss_dssp TTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEEC
T ss_conf 522223323233333--221000024676777788778984--5366898898989899899-974-6708999998989
Q ss_pred CCCCCEECCCCCCCCCCCCCEEECCCC
Q ss_conf 388100027946215378992641588
Q 002717 425 EFNELSGEIPQELGKLASLLAVNVSYN 451 (888)
Q Consensus 425 ~~N~l~~~~p~~l~~l~~L~~l~l~~N 451 (888)
++|++++..| +.++++|+.|++++|
T Consensus 359 ~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 359 GHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 7995899800--003999999639789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=3.8e-41 Score=229.28 Aligned_cols=165 Identities=25% Similarity=0.325 Sum_probs=70.8
Q ss_pred CCCCEEECCCCCCCCCCCHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 87799967899174558754440267957661698456689998556785429992168330137911004589964874
Q 002717 297 QTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQL 376 (888)
Q Consensus 297 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 376 (888)
++|+.|++++|.++. + ..+..+++|+.|++.+|.+++. ..+..+++|+.|++++|++.+.. .+..++.++.+++
T Consensus 219 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~ 292 (384)
T d2omza2 219 TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNIS--PLAGLTALTNLEL 292 (384)
T ss_dssp TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCC-C-CHHHCCCCCCHHCCCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf 778788887777789-6-1343256534100446744787--75355466877545674457877--3235652222332
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCEECCCCCCCCCCCCCEEECCCCCCEEC
Q ss_conf 58768786670122666565798338703245782452979999698338810002794621537899264158844111
Q 002717 377 DGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGR 456 (888)
Q Consensus 377 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~ 456 (888)
+.|.+++ ...+..+++++.|++++|++++. + .+..+++|+.|++++|+++ .++ .+..+++|+.|++++|++++.
T Consensus 293 ~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 293 NENQLED--ISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CSSCCSC--CGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBC
T ss_pred CCCCCCC--CCCCCHHCCCCEEECCCCCCCCC-C-CCCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCCCCCCCC
T ss_conf 3233333--22100002467677778877898-4-5366898898989899899-974-670899999898979958998
Q ss_pred CCCCCCCCCCCCCCCCCC
Q ss_conf 899998999897776898
Q 002717 457 LPVGGVFPTLDQSSLQGN 474 (888)
Q Consensus 457 ~p~~~~~~~l~~~~~~~n 474 (888)
+| ...+.++..+.+.+|
T Consensus 367 ~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 367 TP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp GG-GTTCTTCSEEECCCE
T ss_pred HH-HCCCCCCCEEECCCC
T ss_conf 00-003999999639789
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.8e-43 Score=239.72 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=188.0
Q ss_pred CCEEEEECCCCCC--CCCCCCCCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 8699903385645--6896742677665789443-556777997788999984999507867777892000269964875
Q 002717 198 MIFISVSNNTLTG--DIPHWIGNISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDL 274 (888)
Q Consensus 198 L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~l 274 (888)
++.|+|++|.+.+ .+|..++++++|++|+|++ |.+++.+|..+.++++|+.|++++|.+.+..+..+.
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~--------- 122 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS--------- 122 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGG---------
T ss_pred EEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC---------
T ss_conf 88998989988888879847846753352020265433300243114542001102035643443322222---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCC-EEEECC
Q ss_conf 5686401489999999877336877999678991745587544402679576616984566899985567854-299921
Q 002717 275 SENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSL-IHLDLR 353 (888)
Q Consensus 275 ~~n~~~~~~p~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~ 353 (888)
.+..|+.+++++|.+...+|..+..++.++.+++++|.+.+..|..+..+..+ +.++++
T Consensus 123 --------------------~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~ 182 (313)
T d1ogqa_ 123 --------------------QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182 (313)
T ss_dssp --------------------GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECC
T ss_pred --------------------CHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf --------------------011100111122455556851220674000000235533562031214431123231022
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCEECC
Q ss_conf 68330137911004589964874587687866701226665657983387032457824529799996983388100027
Q 002717 354 NNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEI 433 (888)
Q Consensus 354 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 433 (888)
+|++.+..+..+..+.. ..++++++...+.+|..+..+++++.+++++|.+.+.+| .++.+++|+.|++++|+++|.+
T Consensus 183 ~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~i 260 (313)
T d1ogqa_ 183 RNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTL 260 (313)
T ss_dssp SSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECC
T ss_pred CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCC
T ss_conf 46435332433222222-233333343322222222222221112222222222222-2224554444447657066608
Q ss_pred CCCCCCCCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 94621537899264158844111899998999897776898699899988998
Q 002717 434 PQELGKLASLLAVNVSYNRLIGRLPVGGVFPTLDQSSLQGNLGICSPLLKGPC 486 (888)
Q Consensus 434 p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~~~~~c 486 (888)
|..+.++++|+.|+|++|+++|.+|..+.+..+..+++.||+.+||.|+. +|
T Consensus 261 P~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 261 PQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC-CC
T ss_conf 76884799999897958835166898666799897886889500198988-98
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.6e-40 Score=224.17 Aligned_cols=252 Identities=28% Similarity=0.475 Sum_probs=160.7
Q ss_pred CCCEEECCCCCCCC--CCCHHHHCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEE
Q ss_conf 99899764873676--7890011479986999033-85645689674267766578944355677799778899998499
Q 002717 173 HLTTLDLSNNLFTG--QLPVSLRLLNSMIFISVSN-NTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 249 (888)
Q Consensus 173 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 249 (888)
+++.|+|++|.+.+ ..|..+..+++|++|+|++ |.+.+.+|..|+++++|++|++++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 98899898998888887984784675335202026543330024311454200110203564344332222201110011
Q ss_pred EEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCC-CEEEC
Q ss_conf 95078677778920002699648755686401489999999877336877999678991745587544402679-57661
Q 002717 250 RLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANL-RYLNL 328 (888)
Q Consensus 250 ~l~~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~l 328 (888)
+++.|.+.+.+|..+.. ++.++.+++++|.+.+.+|..+..+..+ +.+++
T Consensus 131 ~l~~N~~~~~~p~~l~~-----------------------------l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~ 181 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISS-----------------------------LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181 (313)
T ss_dssp ECCSSEEESCCCGGGGG-----------------------------CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEEC
T ss_pred CCCCCCCCCCCCHHHCC-----------------------------CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 11224555568512206-----------------------------7400000023553356203121443112323102
Q ss_pred CCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 69845668999855678542999216833013791100458996487458768786670122666565798338703245
Q 002717 329 SSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGS 408 (888)
Q Consensus 329 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 408 (888)
++|++++..+..+..+.. ..++++.+...+.+|..+..+++++.+++++|.+.+.+ ..++.+++|+.|+|++|++++.
T Consensus 182 ~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~ 259 (313)
T d1ogqa_ 182 SRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGT 259 (313)
T ss_dssp CSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEEC
T ss_pred CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCEECCC
T ss_conf 246435332433222222-23333334332222222222222111222222222222-2222455444444765706660
Q ss_pred CCCCCCCCCCCCEEECCCCCCEECCCCCCCCCCCCCEEECCCCC-CEEC
Q ss_conf 78245297999969833881000279462153789926415884-4111
Q 002717 409 IPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNR-LIGR 456 (888)
Q Consensus 409 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~-l~~~ 456 (888)
+|..++.+++|++|+|++|+++|.+|. +..+.+|+.+++++|+ ++|.
T Consensus 260 iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred CCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCCHHHHCCCCCCCCC
T ss_conf 876884799999897958835166898-666799897886889500198
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-37 Score=207.84 Aligned_cols=241 Identities=22% Similarity=0.257 Sum_probs=104.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCC
Q ss_conf 76642365343457410148868675189955213780000169899339975899886778612220498896898677
Q 002717 2 TTPLVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG 81 (888)
Q Consensus 2 ~~~~~~~n~~~~~p~~~~~~~l~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~ 81 (888)
+++|++++.++.+|+. .+++++.|+|++|+++...+.+|.++ ++|+.|++++|.+. .+++..|.++++|+.|++++
T Consensus 13 ~~~~C~~~~L~~lP~~-l~~~l~~L~Ls~N~i~~l~~~~f~~l--~~L~~L~l~~n~~~-~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 13 RVVQCSDLGLEKVPKD-LPPDTALLDLQNNKITEIKDGDFKNL--KNLHTLILINNKIS-KISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TEEECTTSCCCSCCCS-CCTTCCEEECCSSCCCCBCTTTTTTC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCS
T ss_pred CEEEECCCCCCCCCCC-CCCCCCEEECCCCCCCCCCHHHHHCC--CCCCCCCCCCCCCC-CCCHHHHHCCCCCCEECCCC
T ss_conf 9998559998851988-89997989784991898696576046--56523112344344-52356652798557831568
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC--CCCCCCCCCCCCCCEEECCCCC
Q ss_conf 11244446235689999999875764612358664534446666768974785140--0078013388888899756862
Q 002717 82 NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS--GSIPQGVAALHYLKELLLQGNQ 159 (888)
Q Consensus 82 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~--~~~~~~~~~l~~L~~L~l~~n~ 159 (888)
|.|+.++... ...++.|++++|.+...+. ..+.....+..++...|... ......+..+++|+.+++++|.
T Consensus 89 n~l~~l~~~~---~~~l~~L~~~~n~l~~l~~----~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~ 161 (305)
T d1xkua_ 89 NQLKELPEKM---PKTLQELRVHENEITKVRK----SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161 (305)
T ss_dssp SCCSBCCSSC---CTTCCEEECCSSCCCBBCH----HHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCCH---HHHHHHHHCCCCCHHHHHH----HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 7567676400---1113232102461023444----45401331100001233333467776422345656712034677
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCC
Q ss_conf 53107979899999989976487367678900114799869990338564568967426776657894435567779977
Q 002717 160 FSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSS 239 (888)
Q Consensus 160 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 239 (888)
+.. .+..+ +++|+.|++++|.+....+..|..++.++.|++++|.+.+..+..+.++++|+.|+|++|+++ .+|.+
T Consensus 162 l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~ 237 (305)
T d1xkua_ 162 ITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237 (305)
T ss_dssp CCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred CCC-CCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCC
T ss_conf 451-67101--776678989788677888267641341330154455332223454334433224302554002-46311
Q ss_pred CCCCCCCCEEEEECCCCC
Q ss_conf 889999849995078677
Q 002717 240 LFNCKKLSVIRLRGNSLN 257 (888)
Q Consensus 240 l~~l~~L~~L~l~~N~l~ 257 (888)
+.++++|+.|++++|+|+
T Consensus 238 l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 238 LADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TTTCSSCCEEECCSSCCC
T ss_pred CCCCCCCCEEECCCCCCC
T ss_conf 033467898989898657
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-36 Score=203.77 Aligned_cols=61 Identities=23% Similarity=0.313 Sum_probs=19.2
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 58996487458768786670122666565798338703245782452979999698338810
Q 002717 368 SRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNEL 429 (888)
Q Consensus 368 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 429 (888)
++.++.|++++|.+.+..+..|.++++|++|+|++|+|+ .+|..+..+++|++|++++|+|
T Consensus 194 ~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i 254 (305)
T d1xkua_ 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 254 (305)
T ss_dssp CTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCC
T ss_conf 341330154455332223454334433224302554002-4631103346789898989865
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-36 Score=204.17 Aligned_cols=226 Identities=23% Similarity=0.223 Sum_probs=139.4
Q ss_pred CEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 86751899552137800001698993399758998867786122204988968986771124444623568999999987
Q 002717 24 ERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNL 103 (888)
Q Consensus 24 ~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 103 (888)
..++.++++++ .+|..+. .++++|+|++|+|+ .++...|.++++|+.|++++|.+..+....+..+..++.+..
T Consensus 14 ~~v~c~~~~L~-~iP~~ip----~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~ 87 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP----AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC----TTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred EEEECCCCCCC-CCCCCCC----CCCCEEECCCCCCC-CCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 69984799989-4497889----99888977488179-879778641421300001344543321112122222222222
Q ss_pred C-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 5-764612358664534446666768974785140007801338888889975686253107979899999989976487
Q 002717 104 S-NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNN 182 (888)
Q Consensus 104 ~-~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 182 (888)
. .|.+...+. ..|.++++|++|++++|.+....+..+....+|+.+++++|.++.+.+..|..+++|+.|++++|
T Consensus 88 ~~~~~~~~l~~----~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N 163 (284)
T d1ozna_ 88 SDNAQLRSVDP----ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (284)
T ss_dssp CSCTTCCCCCT----TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCCCCCCCCC----HHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCC
T ss_conf 21022354462----01010102778756885443201353320001211020014314458057404340502231417
Q ss_pred CCCCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf 36767890011479986999033856456896742677665789443556777997788999984999507867777
Q 002717 183 LFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGN 259 (888)
Q Consensus 183 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~ 259 (888)
.++.+.+..|..+++|+.+++++|++++..|..|.++++|+.|++++|.+....+..|.++++|+.|++++|++...
T Consensus 164 ~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred CCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
T ss_conf 65662566654656341314211434662816766532000233333522100000235546568898119988787
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=203.23 Aligned_cols=85 Identities=26% Similarity=0.221 Sum_probs=27.7
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 67957661698456689998556785429992168330137911004589964874587687866701226665657983
Q 002717 321 ANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSL 400 (888)
Q Consensus 321 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 400 (888)
++|+.|++++|.+..+.+..|.++++|+.+++++|++.+..|..|..+++|+.|++++|.+.+..+..|..+++|++|++
T Consensus 153 ~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l 232 (284)
T d1ozna_ 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232 (284)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEEC
T ss_pred CCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEE
T ss_conf 40502231417656625666546563413142114346628167665320002333335221000002355465688981
Q ss_pred CCCCC
Q ss_conf 38703
Q 002717 401 SHNHL 405 (888)
Q Consensus 401 s~N~l 405 (888)
++|.+
T Consensus 233 ~~N~l 237 (284)
T d1ozna_ 233 NDNPW 237 (284)
T ss_dssp CSSCE
T ss_pred CCCCC
T ss_conf 19988
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-32 Score=183.53 Aligned_cols=197 Identities=24% Similarity=0.199 Sum_probs=95.2
Q ss_pred CCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 33997589988677861222049889689867711244446235689999999875764612358664534446666768
Q 002717 49 MKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRT 128 (888)
Q Consensus 49 L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~l~~L~~ 128 (888)
+.+.+.++++++ .+|..+. +++++|+|++|.|..++.+.|..+++|++|+|++|+|+..+. +..+++|++
T Consensus 12 ~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~------~~~l~~L~~ 81 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV------DGTLPVLGT 81 (266)
T ss_dssp CCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC------CSCCTTCCE
T ss_pred CEEEECCCCCCC-EECCCCC---CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCC------CCCCCCCCC
T ss_conf 869980699988-6196757---688989884992898597786345655221356654444311------111223211
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEECCCC
Q ss_conf 97478514000780133888888997568625310797989999998997648736767890011479986999033856
Q 002717 129 LDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNTL 208 (888)
Q Consensus 129 L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l 208 (888)
|+|++|++. ..+..+..+++|++|++++|.+....+..+..+.+++.|++++|.++.+.+..+..++.++.+++++|++
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred CCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCC
T ss_conf 111222221-1111212222222222222311011001122221111221243421022123332211100000001565
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf 4568967426776657894435567779977889999849995078677
Q 002717 209 TGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLN 257 (888)
Q Consensus 209 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~ 257 (888)
+...+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCC
T ss_conf 2237200134212423430139785-56866777888999983699987
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-32 Score=183.12 Aligned_cols=197 Identities=26% Similarity=0.240 Sum_probs=85.7
Q ss_pred CCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 86867518995521378000016989933997589988677861222049889689867711244446235689999999
Q 002717 22 ILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTL 101 (888)
Q Consensus 22 ~l~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 101 (888)
.+.+++.+++.++ .+|..+. +++++|+|++|+|. .++.+.|.++++|++|+|++|.|+.++. +..+++|+.|
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp----~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L~~L 82 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP----KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTL 82 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC----TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEE
T ss_pred CCEEEECCCCCCC-EECCCCC----CCCCEEECCCCCCC-CCCHHHHHCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf 9869980699988-6196757----68898988499289-8597786345655221356654444311--1112232111
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 87576461235866453444666676897478514000780133888888997568625310797989999998997648
Q 002717 102 NLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSN 181 (888)
Q Consensus 102 ~L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 181 (888)
+|++|+++..+. .+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++.+.+..+..+++++.+++++
T Consensus 83 ~Ls~N~l~~~~~-----~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~ 157 (266)
T d1p9ag_ 83 DLSHNQLQSLPL-----LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (266)
T ss_dssp ECCSSCCSSCCC-----CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CCCCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCC
T ss_conf 112222211111-----212222222222222311011001122221111221243421022123332211100000001
Q ss_pred CCCCCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCC
Q ss_conf 736767890011479986999033856456896742677665789443556
Q 002717 182 NLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHL 232 (888)
Q Consensus 182 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 232 (888)
|+++.+.+..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+
T Consensus 158 N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCC
T ss_conf 5652237200134212423430139785-5686677788899998369998
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.98 E-value=4.4e-29 Score=166.00 Aligned_cols=303 Identities=28% Similarity=0.305 Sum_probs=130.8
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 93399758998867786122204988968986771124444623568999999987576461235866453444666676
Q 002717 48 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 127 (888)
Q Consensus 48 ~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~l~~L~ 127 (888)
++++|||++++++ .+|. ..++|++|++++|+|+.++.. ..+|++|++++|+++..... .+.|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~l~~n~l~~l~~l--------p~~L~ 101 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE----LPPHLESLVASCNSLTELPEL----PQSLKSLLVDNNNLKALSDL--------PPLLE 101 (353)
T ss_dssp TCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCSSCCCC----CTTCCEEECCSSCCSCCCSC--------CTTCC
T ss_pred CCCEEEECCCCCC-CCCC----CCCCCCEEECCCCCCCCCCCC----HHHHHHHHHHHCCCCHHHHH--------CCCCC
T ss_conf 9989993799988-7889----878988898999979633620----33203326655143203210--------22111
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEECCC
Q ss_conf 89747851400078013388888899756862531079798999999899764873676789001147998699903385
Q 002717 128 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 207 (888)
Q Consensus 128 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~ 207 (888)
+|++++|.+.. .| .+..+++|+.|++++|.+.. .+. ....+..+.+..+... ....+..++.++.+.+..|.
T Consensus 102 ~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~~~~~~-~~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 102 YLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNS 173 (353)
T ss_dssp EEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSC
T ss_pred CCCCCCCCCCC-CC-CHHHHCCCEEECCCCCCCCC-CCC---CCCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCC
T ss_conf 11334554322-21-00110131231135651001-322---3333210000122222--33320001222001112334
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 64568967426776657894435567779977889999849995078677778920002699648755686401489999
Q 002717 208 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGS 287 (888)
Q Consensus 208 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~p~~~ 287 (888)
+... +. .....+.+...++.+. ..+ .+..++.|+.++++.|... .++..
T Consensus 174 ~~~~-~~---~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~~------------------------ 222 (353)
T d1jl5a_ 174 LKKL-PD---LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDL------------------------ 222 (353)
T ss_dssp CSSC-CC---CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCSC------------------------
T ss_pred CCCC-CC---CCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCC-CCCCC------------------------
T ss_conf 4322-22---1222222334443222-212-2345553331222542223-45532------------------------
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 99987733687799967899174558754440267957661698456689998556785429992168330137911004
Q 002717 288 SSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCE 367 (888)
Q Consensus 288 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 367 (888)
..++..+.+..+.+.. .+.. ...+...++..+.+..... ........++..+.+.+. + ..
T Consensus 223 --------~~~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~-~---~~ 282 (353)
T d1jl5a_ 223 --------PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSL-C---DL 282 (353)
T ss_dssp --------CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEE-C---CC
T ss_pred --------CCCCCCCCCCCCCCCC-CCCC---CCCCCCCCCCCCCCCCCCC----CCCHHCCCCCCCCCCCCC-C---CC
T ss_conf --------3343332223333344-4333---4432222222233322234----530001233335753234-5---66
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCEECCCC
Q ss_conf 58996487458768786670122666565798338703245782452979999698338810002794
Q 002717 368 SRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQ 435 (888)
Q Consensus 368 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 435 (888)
+++|+.|++++|+++ .+|. .+++|+.|+|++|+|+ .+|.. +++|++|++++|+++ .+|.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCCEEECCCCCCC-CCCC---CCCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCC
T ss_conf 898898979799168-3566---5487998989999687-54532---288898987699189-7776
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.98 E-value=1.2e-28 Score=163.79 Aligned_cols=315 Identities=28% Similarity=0.292 Sum_probs=149.2
Q ss_pred CCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 88686751899552137800001698993399758998867786122204988968986771124444623568999999
Q 002717 21 RILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNT 100 (888)
Q Consensus 21 ~~l~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 100 (888)
.++++|+|++|.++ .+|+.+ ++|++|+|++|+|+ .+|. ...+|+.|++++|.+..+.. -.+.|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~~-----~~L~~L~Ls~N~l~-~lp~----~~~~L~~L~l~~n~l~~l~~----lp~~L~~ 102 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPELP-----PHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKALSD----LPPLLEY 102 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSCC-----TTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSCCCS----CCTTCCE
T ss_pred CCCCEEEECCCCCC-CCCCCC-----CCCCEEECCCCCCC-CCCC----CHHHHHHHHHHHCCCCHHHH----HCCCCCC
T ss_conf 69989993799988-788987-----89888989999796-3362----03320332665514320321----0221111
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 98757646123586645344466667689747851400078013388888899756862531079798999999899764
Q 002717 101 LNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLS 180 (888)
Q Consensus 101 L~L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 180 (888)
|++++|.+...+. +..+++|+.|++++|.+.. .+ .....+..+.+..+... ....+..++.++.++++
T Consensus 103 L~L~~n~l~~lp~------~~~l~~L~~L~l~~~~~~~-~~---~~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~ 170 (353)
T d1jl5a_ 103 LGVSNNQLEKLPE------LQNSSFLKIIDVDNNSLKK-LP---DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYAD 170 (353)
T ss_dssp EECCSSCCSSCCC------CTTCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECC
T ss_pred CCCCCCCCCCCCC------HHHHCCCEEECCCCCCCCC-CC---CCCCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCC
T ss_conf 1334554322210------0110131231135651001-32---23333210000122222--33320001222001112
Q ss_pred CCCCCCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCC
Q ss_conf 87367678900114799869990338564568967426776657894435567779977889999849995078677778
Q 002717 181 NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLRGNSLNGNI 260 (888)
Q Consensus 181 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~ 260 (888)
+|.+..... .......+...++.+.. .+ .+..++.|+.+++++|.... .+ ....++..+.+..+.+.. .
T Consensus 171 ~n~~~~~~~----~~~~~~~l~~~~~~~~~-~~-~~~~l~~L~~l~l~~n~~~~-~~---~~~~~l~~~~~~~~~~~~-~ 239 (353)
T d1jl5a_ 171 NNSLKKLPD----LPLSLESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLTD-L 239 (353)
T ss_dssp SSCCSSCCC----CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CC---SCCTTCCEEECCSSCCSC-C
T ss_pred CCCCCCCCC----CCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CC---CCCCCCCCCCCCCCCCCC-C
T ss_conf 334432222----12222223344432222-12-23455533312225422234-55---323343332223333344-4
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCEEECCCCCCCCCCCCC
Q ss_conf 92000269964875568640148999999987733687799967899174558754440267957661698456689998
Q 002717 261 PEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRSRIPPE 340 (888)
Q Consensus 261 p~~~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 340 (888)
+.. ...+...++..+.+.+.. .. .......++..+.+.+.
T Consensus 240 ~~~--------------------------------~~~l~~~~~~~~~~~~l~-~l---~~~~~~~~~~~~~~~~~---- 279 (353)
T d1jl5a_ 240 PEL--------------------------------PQSLTFLDVSENIFSGLS-EL---PPNLYYLNASSNEIRSL---- 279 (353)
T ss_dssp CCC--------------------------------CTTCCEEECCSSCCSEES-CC---CTTCCEEECCSSCCSEE----
T ss_pred CCC--------------------------------CCCCCCCCCCCCCCCCCC-CC---CCHHCCCCCCCCCCCCC----
T ss_conf 333--------------------------------443222222223332223-45---30001233335753234----
Q ss_pred CCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 55678542999216833013791100458996487458768786670122666565798338703245782452979999
Q 002717 341 LGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLK 420 (888)
Q Consensus 341 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 420 (888)
...+++|++|++++|++. .+|.. +++|+.|++++|+|+ .+|.. +.+|+.|++++|+++ .+|... ..|+
T Consensus 280 ~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~ 347 (353)
T d1jl5a_ 280 CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVE 347 (353)
T ss_dssp CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCC
T ss_pred CCCCCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCC---CCCC
T ss_conf 566898898979799168-35665---487998989999687-54532---288898987699189-777652---6567
Q ss_pred EEECC
Q ss_conf 69833
Q 002717 421 ILKLE 425 (888)
Q Consensus 421 ~L~l~ 425 (888)
.|.+.
T Consensus 348 ~L~~~ 352 (353)
T d1jl5a_ 348 DLRMN 352 (353)
T ss_dssp EEECC
T ss_pred EEECC
T ss_conf 12896
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.4e-33 Score=188.30 Aligned_cols=113 Identities=20% Similarity=0.190 Sum_probs=50.5
Q ss_pred CCCEEECCCCCCCCCC-CCHHHCCCCCCCCEEECCCCCCCCCCC----HHHHCCCCCCCEEECCCCCCCCC-----CCCC
Q ss_conf 8686751899552137-800001698993399758998867786----12220498896898677112444-----4623
Q 002717 22 ILERLNFSHNSLSGQI-PPSLLNLNMMNMKFLDLSNNLLSGPVP----YQLFENCASLRYLSLAGNILQGP-----IGKI 91 (888)
Q Consensus 22 ~l~~L~ls~n~l~~~~-p~~~~~l~~~~L~~L~L~~n~i~~~l~----~~~~~~l~~L~~L~L~~n~i~~~-----~~~~ 91 (888)
+|+.|+++.|++.+.. ...+..+ ++++.|+|++|.++. .. ..++..+++|++|+|++|.|+.. ....
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l--~~l~~L~L~~~~i~~-~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l 79 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLL--QQCQVVRLDDCGLTE-ARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGL 79 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHH--TTCSEEEEESSCCCH-HHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred CCCEEEEECCCCCHHHHHHHHHHC--CCCCEEEECCCCCCH-HHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHH
T ss_conf 877798208958868999999767--799999828999988-99999999985399988897959859728999999998
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 5689999999875764612358664534446666768974785140
Q 002717 92 FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFS 137 (888)
Q Consensus 92 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~ 137 (888)
.....+|+.|+|++|++++......+..+..+++|++|+|++|.+.
T Consensus 80 ~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 80 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred HCCCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 4378877887788877543221012110000343200244433202
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.2e-33 Score=186.60 Aligned_cols=384 Identities=19% Similarity=0.110 Sum_probs=178.1
Q ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC-
Q ss_conf 99339975899886778612220498896898677112444----4623568999999987576461235866453444-
Q 002717 47 MNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGP----IGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIW- 121 (888)
Q Consensus 47 ~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~- 121 (888)
.+|+.||++.|++++..-..++..++++++|+|++|.|+.. ...++..+++|++|+|++|.|++.........+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHC
T ss_conf 98777982089588689999997677999998289999889999999998539998889795985972899999999843
Q ss_pred CCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCC----C-CCCCCCCEEECCCCCCCCCC----
Q ss_conf 666676897478514000----7801338888889975686253107979----8-99999989976487367678----
Q 002717 122 SLKRLRTLDLSHNLFSGS----IPQGVAALHYLKELLLQGNQFSGPLPAD----I-GFCPHLTTLDLSNNLFTGQL---- 188 (888)
Q Consensus 122 ~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~----~-~~l~~L~~L~L~~N~l~~~~---- 188 (888)
...+|++|+|++|++++. .+..+..+++|++|++++|.+....... + ...............+....
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 78877887788877543221012110000343200244433202345555443013554333222222322200110011
Q ss_pred CHHHHCCCCCCEEEEECCCCCCCCCCCC-----CCCCCCCEEEEECCCCCCC----CCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf 9001147998699903385645689674-----2677665789443556777----997788999984999507867777
Q 002717 189 PVSLRLLNSMIFISVSNNTLTGDIPHWI-----GNISTLEFLDFSNNHLTGS----LPSSLFNCKKLSVIRLRGNSLNGN 259 (888)
Q Consensus 189 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~l~~N~l~~~ 259 (888)
...+.....++.+.++.+.+.......+ ..-.....+.+..+.+... ....+...+.++.+.+..|.+...
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 22233332222233222212455554323433211221001241124542101101223322222210010021122334
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC----CHHHHHCCCCCEEECCCCCCCC
Q ss_conf 892000269964875568640148999999987733687799967899174558----7544402679576616984566
Q 002717 260 IPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLSSNNLVGDI----PAEMGLFANLRYLNLSSNHLRS 335 (888)
Q Consensus 260 ~p~~~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~ 335 (888)
....... ........++.+++++|.+.... ...+...+.++.+++++|.++.
T Consensus 242 ~~~~~~~------------------------~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~ 297 (460)
T d1z7xw1 242 GMAELCP------------------------GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 297 (460)
T ss_dssp HHHHHHH------------------------HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHH
T ss_pred CCCHHHC------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 4201100------------------------0111111100001345433212334332211123433344444333224
Q ss_pred CCCCC-----CCCCCCCEEEECCCCCCCCCCCCCC----CCCCCCCEEECCCCCCCCCC----CCCCC-CCCCCCEEECC
Q ss_conf 89998-----5567854299921683301379110----04589964874587687866----70122-66656579833
Q 002717 336 RIPPE-----LGYFHSLIHLDLRNNALYGSIPQEV----CESRSLGILQLDGNSLTGPI----PQVIR-NCTSLYLLSLS 401 (888)
Q Consensus 336 ~~~~~-----~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~n~l~~~~----~~~~~-~l~~L~~L~Ls 401 (888)
..... ......|+.+++++|.+.......+ ...++|+.|+|++|.+++.. ...+. ..+.|+.|+|+
T Consensus 298 ~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls 377 (460)
T d1z7xw1 298 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA 377 (460)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred CCCCHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECC
T ss_conf 56421110123334443333233341023344321332211011113201210135766400111220456777889897
Q ss_pred CCCCCCC----CCCCCCCCCCCCEEECCCCCCEECCCCCCC-----CCCCCCEEECCCCCCE
Q ss_conf 8703245----782452979999698338810002794621-----5378992641588441
Q 002717 402 HNHLSGS----IPKSISNLNKLKILKLEFNELSGEIPQELG-----KLASLLAVNVSYNRLI 454 (888)
Q Consensus 402 ~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~-----~l~~L~~l~l~~N~l~ 454 (888)
+|.++.. ++..+..+++|++|+|++|.++......+. ....|+.+++.+|.+.
T Consensus 378 ~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 378 DCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp TSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred CCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 99797599999999996299889898999969879999999999747886678989898789
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.5e-28 Score=162.02 Aligned_cols=217 Identities=16% Similarity=0.074 Sum_probs=86.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCC-
Q ss_conf 6642365343457410148868675189955213780000169899339975899886778612220498896898677-
Q 002717 3 TPLVHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAG- 81 (888)
Q Consensus 3 ~~~~~~n~~~~~p~~~~~~~l~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~- 81 (888)
++++.+++++.+|+. .+++++.|++++|++....+.+|.++ ++|++|++++|.+.+.++...|..+++++++.+..
T Consensus 12 ~i~c~~~~l~~iP~~-l~~~l~~L~Ls~n~i~~l~~~~f~~l--~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVTEIPSD-LPRNAIELRFVLTKLRVIQKGAFSGF--GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCSSCCSC-SCSCCSEEEEESCCCCEECTTTTTTC--TTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEECCCCCCCCCC-CCCCCCEEECCCCCCCCCCHHHHHCC--CHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCC
T ss_conf 999818998876888-89988999876991896496686146--432321102211242010011222222222111112
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC-CCCEEECCCCCC
Q ss_conf 1124444623568999999987576461235866453444666676897478514000780133888-888997568625
Q 002717 82 NILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALH-YLKELLLQGNQF 160 (888)
Q Consensus 82 n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~l~~n~l 160 (888)
|.+.....+.|..+++|++|++++|.+...+.. ..+..++.+..+..+++.+..+.+..+.++. .++.|++.+|.+
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~---~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l 165 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV---HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCCC---TTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 343222222122222222223421111255433---32221111222222212111222222222233100122001233
Q ss_pred CCCCCCCCCCCCCCCEE-ECCCCCCCCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 31079798999999899-7648736767890011479986999033856456896742677665789
Q 002717 161 SGPLPADIGFCPHLTTL-DLSNNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLD 226 (888)
Q Consensus 161 ~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 226 (888)
+.+.+..+ ..+++..+ ++++|.++.+.+..|.++++|+.|++++|+++.+.+..|.++++|+.++
T Consensus 166 ~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~ 231 (242)
T d1xwdc1 166 QEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 231 (242)
T ss_dssp CEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred CCCCCCCC-CCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCCCC
T ss_conf 33222222-2011101212354324642478866899999898979928945977973771341476
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.5e-27 Score=154.98 Aligned_cols=13 Identities=15% Similarity=0.325 Sum_probs=4.0
Q ss_pred CCCCCCEEECCCC
Q ss_conf 4988968986771
Q 002717 70 NCASLRYLSLAGN 82 (888)
Q Consensus 70 ~l~~L~~L~L~~n 82 (888)
++++|++|++++|
T Consensus 51 ~l~~L~~L~ls~n 63 (242)
T d1xwdc1 51 GFGDLEKIEISQN 63 (242)
T ss_dssp TCTTCCEEEEESC
T ss_pred CCCHHHHHHHCCC
T ss_conf 4643232110221
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.1e-27 Score=158.61 Aligned_cols=171 Identities=16% Similarity=0.082 Sum_probs=118.8
Q ss_pred HHCCEECCCCCEEEEEEEECCCCEEEEEEEEECCCCC-----C------------CHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf 4137111126608999998999929999993328866-----7------------9689999999996248998330333
Q 002717 602 EKAAEVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDII-----Q------------YPEDFEREVRVLGKARHPNLISLEG 664 (888)
Q Consensus 602 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~------------~~~~~~~E~~~l~~l~h~niv~l~g 664 (888)
.++++||+|+||.||+|... +|+.||||.+...... . .......|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred HHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 22778024856599999979-99999999986044346665565630008889999997789999999816999144998
Q ss_pred EEECCCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCE
Q ss_conf 89828901699962799998999932099999999455999999999999974305999937367899967866999908
Q 002717 665 YYWTPQLKLLVSDYAPNGSLQAKLHERLPSTPPLSWTNRFKVILGTAKGLAHLHHSFRPPIIHYNLKPSNILLDDNYNPR 744 (888)
Q Consensus 665 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 744 (888)
+. ..+++|||++++.+. .++......++.|++.++.|||+. +|+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred EC----CCEEEEEEECCCCCC-----------CHHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEE
T ss_conf 62----888999950456542-----------001578999999999999998268---88983689036114289-899
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 920235531234464310253354455467435558578898201898999999
Q 002717 745 ISDFGLARLLTRLDKHVMSNRFQSALGYVAPELTCQSLRVNEKCDIYGFGVLIL 798 (888)
Q Consensus 745 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~sDv~S~Gvil~ 798 (888)
++|||.|........... ....... -.+.+ ...++.++|+||..--+.
T Consensus 143 liDFG~a~~~~~~~~~~~---l~rd~~~-~~~~f--~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREI---LERDVRN-IITYF--SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHHHH---HHHHHHH-HHHHH--HHHHCCCCCHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCHHH---HHHHHHH-HHHHH--CCCCCCCCCHHHHHHHHH
T ss_conf 987788430899870999---9877999-99997--578998446899999874
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=2.7e-25 Score=146.09 Aligned_cols=207 Identities=17% Similarity=0.230 Sum_probs=84.2
Q ss_pred CCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 88686751899552137800001698993399758998867786122204988968986771124444623568999999
Q 002717 21 RILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNT 100 (888)
Q Consensus 21 ~~l~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 100 (888)
.++.+.+++.+++.+.+ .+.++ .+|+.|++.+|+|. .++ + +..+++|++|++++|.|..+.. |..+++|+.
T Consensus 19 ~~~~~~~l~~~~~~d~~--~~~~l--~~L~~L~l~~~~i~-~l~-~-l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~ 89 (227)
T d1h6ua2 19 ANAIKIAAGKSNVTDTV--TQADL--DGITTLSAFGTGVT-TIE-G-VQYLNNLIGLELKDNQITDLAP--LKNLTKITE 89 (227)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHH--HTCCEEECTTSCCC-CCT-T-GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCE
T ss_pred HHHHHHHHCCCCCCCCC--CHHHC--CCCCEEECCCCCCC-CCH-H-HHCCCCCCEEECCCCEEECCCC--CCCCCCCCC
T ss_conf 99999984888767757--98784--88689977799997-664-5-7448888376357853202543--112334320
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 98757646123586645344466667689747851400078013388888899756862531079798999999899764
Q 002717 101 LNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLS 180 (888)
Q Consensus 101 L~L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 180 (888)
+++++|.+++.. .+..+++|+.++++++..... ..+...+.+..+.+..+.+... ..+..+++|+.|+++
T Consensus 90 l~~~~n~~~~i~------~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~ 159 (227)
T d1h6ua2 90 LELSGNPLKNVS------AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIG 159 (227)
T ss_dssp EECCSCCCSCCG------GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECC
T ss_pred CCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCC--CHHCCCCCHHHHHCHHHHHCHH--HHHCCCCCCCCCCCC
T ss_conf 121112222222------222222221221222443311--0000023012220000000000--000102111002333
Q ss_pred CCCCCCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf 873676789001147998699903385645689674267766578944355677799778899998499950
Q 002717 181 NNLFTGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 252 (888)
Q Consensus 181 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 252 (888)
+|.+... ..+..+++|+.|++++|++++. + .+.++++|++|++++|+++.+ + .+.++++|+.|+++
T Consensus 160 ~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 160 NAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp SSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred CCCCCCC--HHHCCCCCCEECCCCCCCCCCC-H-HHCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCEEEEE
T ss_conf 3333310--0105646335644588841778-5-344799999897959968998-0-20369998989712
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.92 E-value=5.9e-25 Score=144.35 Aligned_cols=176 Identities=22% Similarity=0.219 Sum_probs=84.9
Q ss_pred CEEECCCCCCCCCCCHHHHHCCCCCEEECCCCCCCC-CCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 999678991745587544402679576616984566-8999855678542999216833013791100458996487458
Q 002717 300 RILDLSSNNLVGDIPAEMGLFANLRYLNLSSNHLRS-RIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDG 378 (888)
Q Consensus 300 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 378 (888)
+.++.+++.++ .+|..+ .+++++|+|++|+|+. .....|..+++|+.|+|++|++....+..+..+++|+.|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEECCCCC-CCCCCC--CCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECC
T ss_conf 99997089967-029898--978788984898775530200257876272130136322121212221122221010035
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCEECCCCCCCCCCCCCEEECCCCCCEECCC
Q ss_conf 76878667012266656579833870324578245297999969833881000279462153789926415884411189
Q 002717 379 NSLTGPIPQVIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELSGEIPQELGKLASLLAVNVSYNRLIGRLP 458 (888)
Q Consensus 379 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p 458 (888)
|+++...+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|.+...... ..-...+..+.+..|.+.+..|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCH-HHHHHHHHHHCCCCCCEEECCC
T ss_conf 534434979980797465524577453535977856875334200036443435302-7776423540356898276898
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99989998977768986998999
Q 002717 459 VGGVFPTLDQSSLQGNLGICSPL 481 (888)
Q Consensus 459 ~~~~~~~l~~~~~~~n~~~c~~~ 481 (888)
..+.++...++..|...|.++
T Consensus 167 --~~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 167 --SKVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp --TTTTTSBGGGSCTTTCCCCCC
T ss_pred --HHHCCCEEEECCHHHCCCCCC
T ss_conf --433698861448755758998
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=1.5e-23 Score=136.94 Aligned_cols=181 Identities=24% Similarity=0.317 Sum_probs=76.5
Q ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 67518995521378000016989933997589988677861222049889689867711244446235689999999875
Q 002717 25 RLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLS 104 (888)
Q Consensus 25 ~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 104 (888)
+.+++.+.+.+.++.. .+ .++++|++++|.+. .++. ++.+++|++|++++|.|..+.. +..+++|+.|+++
T Consensus 28 ~~~l~~~~~~~~~~~~--~L--~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQN--EL--NSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD 98 (210)
T ss_dssp HHHTTCSCTTSEECHH--HH--HTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHCCCCCCCCCCHH--HH--CCCCEEECCCCCCC-CCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCC
T ss_conf 9985757657751887--95--48458978279888-7444--7648998987698960258601--1358621201433
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 76461235866453444666676897478514000780133888888997568625310797989999998997648736
Q 002717 105 NNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLF 184 (888)
Q Consensus 105 ~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 184 (888)
+|+|+..+ .+..+++|+.|++++|.+.. . ..+..+++++.++++.|.++
T Consensus 99 ~n~i~~l~------~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~----------------------- 147 (210)
T d1h6ta2 99 ENKVKDLS------SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT----------------------- 147 (210)
T ss_dssp SSCCCCGG------GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCC-----------------------
T ss_pred CCCCCCCC------CCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCC-----------------------
T ss_conf 33321222------12122211122345653221-1-22011111222112223334-----------------------
Q ss_pred CCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf 76789001147998699903385645689674267766578944355677799778899998499950
Q 002717 185 TGQLPVSLRLLNSMIFISVSNNTLTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVIRLR 252 (888)
Q Consensus 185 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~ 252 (888)
. ...+..+++|+.+++++|++++.. .+.++++|+.|++++|+++. ++ .+.++++|+.|+++
T Consensus 148 -~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 148 -D--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp -C--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred -C--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECC
T ss_conf -5--431000133210013464302564--53678989999897998998-72-11699998999711
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=5.5e-24 Score=139.28 Aligned_cols=168 Identities=17% Similarity=0.201 Sum_probs=71.9
Q ss_pred CCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 88686751899552137800001698993399758998867786122204988968986771124444623568999999
Q 002717 21 RILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNT 100 (888)
Q Consensus 21 ~~l~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 100 (888)
.++.++.++.+.+.+.+.. ..+ .+++.|++++|++. .+.. ++.+++|++|++++|.+..+.. +..+++|+.
T Consensus 18 ~~~i~~~l~~~~~~~~~~~--~~l--~~l~~L~l~~~~i~-~l~~--l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~ 88 (199)
T d2omxa2 18 AEKMKTVLGKTNVTDTVSQ--TDL--DQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 88 (199)
T ss_dssp HHHHHHHTTCSSTTSEECH--HHH--TTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred HHHHHHHHCCCCCCCCCCH--HHH--CCCCEEECCCCCCC-CCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCC
T ss_conf 9999999677877885598--794--68789989999997-7520--2137886757545655667640--167752231
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 98757646123586645344466667689747851400078013388888899756862531079798999999899764
Q 002717 101 LNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLS 180 (888)
Q Consensus 101 L~L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 180 (888)
|++++|.+...+ .+..++.|+.|++++|.+... ..+..+++|+.|++++|.+.. .+ .+..+++|+.|++.
T Consensus 89 L~l~~n~~~~~~------~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~ 158 (199)
T d2omxa2 89 ILMNNNQIADIT------PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFS 158 (199)
T ss_dssp EECCSSCCCCCG------GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECC
T ss_pred CCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCC-CC-CCCCCCCCCCCCCC
T ss_conf 111222222221------111122322211122222232--100012236776431111002-34-33321111112234
Q ss_pred CCCCCCCCCHHHHCCCCCCEEEEECCCCC
Q ss_conf 87367678900114799869990338564
Q 002717 181 NNLFTGQLPVSLRLLNSMIFISVSNNTLT 209 (888)
Q Consensus 181 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 209 (888)
+|+++.+. .+..+++|+.|++++|+++
T Consensus 159 ~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 159 SNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp SSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCC--CCCCCCCCCEEECCCCCCC
T ss_conf 55556770--1167998999978799799
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=3.6e-23 Score=134.99 Aligned_cols=181 Identities=23% Similarity=0.233 Sum_probs=113.2
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 93399758998867786122204988968986771124444623568999999987576461235866453444666676
Q 002717 48 NMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLR 127 (888)
Q Consensus 48 ~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~l~~L~ 127 (888)
+.....++.+.+.+.+.. ..+++++.|++++|.|..+. .++.+++|++|+|++|++++.++ +..+++|+
T Consensus 19 ~~i~~~l~~~~~~~~~~~---~~l~~l~~L~l~~~~i~~l~--~l~~l~nL~~L~Ls~N~l~~~~~------l~~l~~L~ 87 (199)
T d2omxa2 19 EKMKTVLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDITP------LKNLTKLV 87 (199)
T ss_dssp HHHHHHTTCSSTTSEECH---HHHTTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG------GTTCTTCC
T ss_pred HHHHHHHCCCCCCCCCCH---HHHCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCC
T ss_conf 999999677877885598---79468789989999997752--02137886757545655667640------16775223
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEECCC
Q ss_conf 89747851400078013388888899756862531079798999999899764873676789001147998699903385
Q 002717 128 TLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFSGPLPADIGFCPHLTTLDLSNNLFTGQLPVSLRLLNSMIFISVSNNT 207 (888)
Q Consensus 128 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~ 207 (888)
.|++++|.+... + .+..+++|+.|++++|.+... ..+..+++|+.|++++|++... ..+..+++++.|++.+|+
T Consensus 88 ~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 88 DILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp EEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSC
T ss_pred CCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCC--CCCCCCCCCCCCCCCCCC
T ss_conf 111122222222-1-111122322211122222232--1000122367764311110023--433321111112234555
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEE
Q ss_conf 645689674267766578944355677799778899998499
Q 002717 208 LTGDIPHWIGNISTLEFLDFSNNHLTGSLPSSLFNCKKLSVI 249 (888)
Q Consensus 208 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 249 (888)
+++.. .+.++++|+.|++++|+++++ +.+..+++|+.|
T Consensus 162 l~~l~--~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 162 VTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred CCCCC--CCCCCCCCCEEECCCCCCCCC--CCCCCCCCCCCC
T ss_conf 56770--116799899997879979988--101278998949
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.91 E-value=8.1e-25 Score=143.61 Aligned_cols=13 Identities=38% Similarity=0.547 Sum_probs=4.1
Q ss_pred CCCCCCEEECCCC
Q ss_conf 9999989976487
Q 002717 170 FCPHLTTLDLSNN 182 (888)
Q Consensus 170 ~l~~L~~L~L~~N 182 (888)
.+++|++|+|++|
T Consensus 124 ~l~~L~~l~L~~N 136 (192)
T d1w8aa_ 124 HLNSLTSLNLASN 136 (192)
T ss_dssp TCTTCCEEECTTC
T ss_pred CCCCCCCCCCCCC
T ss_conf 8753342000364
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.84 E-value=9.3e-23 Score=132.81 Aligned_cols=13 Identities=31% Similarity=0.442 Sum_probs=4.2
Q ss_pred CCCCCEEECCCCC
Q ss_conf 9889689867711
Q 002717 71 CASLRYLSLAGNI 83 (888)
Q Consensus 71 l~~L~~L~L~~n~ 83 (888)
...|+.|+|++|.
T Consensus 30 ~~~l~~L~Ls~n~ 42 (344)
T d2ca6a1 30 DDSVKEIVLSGNT 42 (344)
T ss_dssp CSCCCEEECTTSE
T ss_pred CCCCCEEECCCCC
T ss_conf 8997889784983
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=3.7e-21 Score=124.40 Aligned_cols=271 Identities=17% Similarity=0.153 Sum_probs=0.0
Q ss_pred CEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEEE
Q ss_conf 867518995521378000016989933997589988677861222049889689867711244-4462356899999998
Q 002717 24 ERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQG-PIGKIFNYCSSLNTLN 102 (888)
Q Consensus 24 ~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~ 102 (888)
++++|+++.+.......+... ....+.++...+. ...... ....+|++||+++|.+.. ....++..+++|++|+
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~~---~~~~lrl~~~~~~-~~~~~~-~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~ 77 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLSQ---GVIAFRCPRSFMD-QPLAEH-FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 77 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHHT---TCSEEECTTCEEC-SCCCSC-CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred CEEECCCCCCCCHHHHHHHHC---CCEEEECCCCCCC-CCHHHH-CCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 779789997881479998745---5427465233345-522442-56787887889898457779999997487765145
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCC-CCCCCCCEEECCCCCC---CCCCCCCCCCCCCCCEE
Q ss_conf 7576461235866453444666676897478-51400078013-3888888997568625---31079798999999899
Q 002717 103 LSNNHFSGDLDFASGYGIWSLKRLRTLDLSH-NLFSGSIPQGV-AALHYLKELLLQGNQF---SGPLPADIGFCPHLTTL 177 (888)
Q Consensus 103 L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~-n~l~~~~~~~~-~~l~~L~~L~l~~n~l---~~~~~~~~~~l~~L~~L 177 (888)
|++|.++ ......+..+++|+.|++++ +.+++.....+ ..+++|++|+++++.. ...........++|+.|
T Consensus 78 L~~~~l~----~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L 153 (284)
T d2astb2 78 LEGLRLS----DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQL 153 (284)
T ss_dssp CTTCBCC----HHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEE
T ss_pred CCCCCCC----CHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHH
T ss_conf 2346798----678999851899757151001341235540365788743565224533233322000100011111012
Q ss_pred ECCCC--CCCCCCCHHH-HCCCCCCEEEEECCC-CCCCCCCCCCCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf 76487--3676789001-147998699903385-6456896742677665789443-55677799778899998499950
Q 002717 178 DLSNN--LFTGQLPVSL-RLLNSMIFISVSNNT-LTGDIPHWIGNISTLEFLDFSN-NHLTGSLPSSLFNCKKLSVIRLR 252 (888)
Q Consensus 178 ~L~~N--~l~~~~~~~~-~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~l~ 252 (888)
+++++ .++......+ ..+++|+.|++++|. +++.....+..+++|++|++++ +.+++.....+..+++|+.|++.
T Consensus 154 ~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~ 233 (284)
T d2astb2 154 NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233 (284)
T ss_dssp ECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEE
T ss_conf 21355424444434342323222123553223477830333321357687798999997873789997269998989644
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 78677778920002699648755686401489999999877336877999678
Q 002717 253 GNSLNGNIPEGLFDLGLEEIDLSENGFMGSIPPGSSSSSSSTLFQTLRILDLS 305 (888)
Q Consensus 253 ~N~l~~~~p~~~~~~~L~~L~l~~n~~~~~~p~~~~~~~~~~~l~~L~~L~Ls 305 (888)
++ +. ...-......+..|.+..+.++...++..+.......+..=..+.|.
T Consensus 234 ~~-~~-d~~l~~l~~~lp~L~i~~~~ls~~~~~~~~~~~~~~iw~~~~~~~~~ 284 (284)
T d2astb2 234 GI-VP-DGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIKCRLTLQ 284 (284)
T ss_dssp TS-SC-TTCHHHHHHHSTTSEESCCCSCCTTCSSCSSTTCCCBTTBCCSEECC
T ss_pred CC-CC-HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCEEEECCC
T ss_conf 88-89-89999999768436616865877778854766640010510553149
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=9.5e-21 Score=122.28 Aligned_cols=140 Identities=16% Similarity=0.061 Sum_probs=77.0
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
Q ss_conf 23653434574101488686751899552137800001698993399758998867786122204988968986771124
Q 002717 6 VHGNSYNAIPSMVVFRILERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNLLSGPVPYQLFENCASLRYLSLAGNILQ 85 (888)
Q Consensus 6 ~~~n~~~~~p~~~~~~~l~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~i~~~l~~~~~~~l~~L~~L~L~~n~i~ 85 (888)
+..+.+...|.+.++..+++|+|++|++.. ++..+..+ .+|+.|+|++|.|. .++. |..+++|++|++++|.|.
T Consensus 3 Lt~~~i~~~~~~~n~~~lr~L~L~~n~I~~-i~~~~~~l--~~L~~L~Ls~N~i~-~l~~--~~~l~~L~~L~ls~N~i~ 76 (162)
T d1a9na_ 3 LTAELIEQAAQYTNAVRDRELDLRGYKIPV-IENLGATL--DQFDAIDFSDNEIR-KLDG--FPLLRRLKTLLVNNNRIC 76 (162)
T ss_dssp CCHHHHHTSCEEECTTSCEEEECTTSCCCS-CCCGGGGT--TCCSEEECCSSCCC-EECC--CCCCSSCCEEECCSSCCC
T ss_pred CCHHHHHHHHHCCCCCCCCEEECCCCCCCC-CCCCCCCC--CCCCEEECCCCCCC-CCCC--CCCCCCHHHHHCCCCCCC
T ss_conf 889999611751685748489788997886-57620041--45998989799787-6477--445761306431021345
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC---CCCCCCCCCCEEE
Q ss_conf 44462356899999998757646123586645344466667689747851400078---0133888888997
Q 002717 86 GPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIP---QGVAALHYLKELL 154 (888)
Q Consensus 86 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~~~l~~L~~L~ 154 (888)
.++...+..+++|+.|+|++|+|++..+. ..+..+++|++|++++|.+..... ..+..+++|++|+
T Consensus 77 ~l~~~~~~~l~~L~~L~L~~N~i~~~~~l---~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 77 RIGEGLDQALPDLTELILTNNSLVELGDL---DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECSCHHHHCTTCCEEECCSCCCCCGGGG---GGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCCCCCCCCCCCCEECCCCCCCCCCC---CCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEEC
T ss_conf 77763223345344342030001665421---1001365320664079963456106999998789958337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.82 E-value=2.2e-22 Score=130.81 Aligned_cols=14 Identities=50% Similarity=0.781 Sum_probs=5.0
Q ss_pred CCCCEEECCCCCCC
Q ss_conf 99989976487367
Q 002717 172 PHLTTLDLSNNLFT 185 (888)
Q Consensus 172 ~~L~~L~L~~N~l~ 185 (888)
++|+.|+|++|.++
T Consensus 93 ~~L~~L~L~~n~i~ 106 (344)
T d2ca6a1 93 PKLHTVRLSDNAFG 106 (344)
T ss_dssp TTCCEEECCSCCCC
T ss_pred CCCCCCCCCCCCCC
T ss_conf 77563300001345
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=1.6e-19 Score=115.82 Aligned_cols=40 Identities=33% Similarity=0.295 Sum_probs=13.4
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 6666768974785140007801338888889975686253
Q 002717 122 SLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFS 161 (888)
Q Consensus 122 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 161 (888)
.+++|++|++++|+++...+..+..+++|+.|++++|.++
T Consensus 61 ~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~ 100 (162)
T d1a9na_ 61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100 (162)
T ss_dssp CCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC
T ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEECCCCCC
T ss_conf 5761306431021345777632233453443420300016
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.73 E-value=1.4e-19 Score=116.08 Aligned_cols=130 Identities=22% Similarity=0.281 Sum_probs=72.9
Q ss_pred CCCHHHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 58754440267957661698456689998556785429992168330137911004589964874587687866701226
Q 002717 312 DIPAEMGLFANLRYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRN 391 (888)
Q Consensus 312 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 391 (888)
..+..+..+++|++|++++|.|+.+ +.+..+++|+.|+|++|++. .++..+..+++|+.|++++|.++. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred HHHHHHHCCCCCCEEECCCCCCCCC--CCCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCC
T ss_conf 0246776260461519944689986--44247825357341353432-100003322123333333322222-2-22222
Q ss_pred CCCCCEEECCCCCCCCCCC--CCCCCCCCCCEEECCCCCCEECCCCC----------CCCCCCCCEEE
Q ss_conf 6656579833870324578--24529799996983388100027946----------21537899264
Q 002717 392 CTSLYLLSLSHNHLSGSIP--KSISNLNKLKILKLEFNELSGEIPQE----------LGKLASLLAVN 447 (888)
Q Consensus 392 l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~----------l~~l~~L~~l~ 447 (888)
+++|+.|++++|+++. ++ ..+..+++|+.|++++|++....+.. +..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred CCCCCCCCCCCCHHCC-CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCEEC
T ss_conf 2234111234102125-542212367776302342798434676322220558999998788958769
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.70 E-value=1.9e-19 Score=115.45 Aligned_cols=108 Identities=19% Similarity=0.132 Sum_probs=38.9
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 04988968986771124444623568999999987576461235866453444666676897478514000780133888
Q 002717 69 ENCASLRYLSLAGNILQGPIGKIFNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALH 148 (888)
Q Consensus 69 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 148 (888)
..+++|+.|+|++|.|..+. .+..+++|+.|+|++|+|++.+. .+..+++|+.|++++|+++++ ..+..++
T Consensus 45 ~~L~~L~~L~Ls~n~I~~i~--~l~~l~~L~~L~Ls~N~i~~i~~-----~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 45 STLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIKKIEN-----LDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHTTTCCEEECSEEEESCCC--CHHHHTTCCEEECCEEEECSCSS-----HHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred HCCCCCCEEECCCCCCCCCC--CCCCCCCCCCHHHCCCCCCCCCC-----CCCCCCCCCCCCCCCCCCCCC--CCCCCCC
T ss_conf 62604615199446899864--42478253573413534321000-----033221233333333222222--2222222
Q ss_pred CCCEEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCC
Q ss_conf 88899756862531079-79899999989976487367
Q 002717 149 YLKELLLQGNQFSGPLP-ADIGFCPHLTTLDLSNNLFT 185 (888)
Q Consensus 149 ~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 185 (888)
+|+.|++++|.|+.... ..+..+++|+.|++++|++.
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred CCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf 34111234102125542212367776302342798434
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.70 E-value=8.7e-17 Score=101.51 Aligned_cols=118 Identities=28% Similarity=0.358 Sum_probs=0.0
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 57661698456689998556785429992168330137911004589964874587687866701226665657983387
Q 002717 324 RYLNLSSNHLRSRIPPELGYFHSLIHLDLRNNALYGSIPQEVCESRSLGILQLDGNSLTGPIPQVIRNCTSLYLLSLSHN 403 (888)
Q Consensus 324 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 403 (888)
+.|++++|.++.... +..++.|++|++++|+++ .+|..+..+++|+.|++++|.++ .++. ++.+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSS
T ss_pred CEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCCC-CCCCCCCCEEECCCC
T ss_conf 989868998988710--105898898979787168-65215655431354532432112-3574-123355576888898
Q ss_pred CCCCCCC-CCCCCCCCCCEEECCCCCCEECC---CCCCCCCCCCCEE
Q ss_conf 0324578-24529799996983388100027---9462153789926
Q 002717 404 HLSGSIP-KSISNLNKLKILKLEFNELSGEI---PQELGKLASLLAV 446 (888)
Q Consensus 404 ~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~---p~~l~~l~~L~~l 446 (888)
+++.... ..+..+++|+.|++++|+++... ......+++|+.+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf 65888882565379999999897996886826799999989673138
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=1.6e-16 Score=100.09 Aligned_cols=43 Identities=26% Similarity=0.305 Sum_probs=14.9
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCE
Q ss_conf 1226665657983387032457824529799996983388100
Q 002717 388 VIRNCTSLYLLSLSHNHLSGSIPKSISNLNKLKILKLEFNELS 430 (888)
Q Consensus 388 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 430 (888)
.|.++++|+.|+|++|+|+...+..|..+++|++|+|++|+|+
T Consensus 51 ~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 51 DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp GSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred HHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf 2256666672162021247742011124554333322678785
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=3.1e-15 Score=93.38 Aligned_cols=83 Identities=20% Similarity=0.206 Sum_probs=31.6
Q ss_pred CCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCC-CCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 686751899552137800001698993399758998-8677861222049889689867711244446235689999999
Q 002717 23 LERLNFSHNSLSGQIPPSLLNLNMMNMKFLDLSNNL-LSGPVPYQLFENCASLRYLSLAGNILQGPIGKIFNYCSSLNTL 101 (888)
Q Consensus 23 l~~L~ls~n~l~~~~p~~~~~l~~~~L~~L~L~~n~-i~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 101 (888)
.+.++++++.+. ..|..+..+ +++++|++++|+ +. .++...|.++++|+.|++++|+|+.+..++|..+++|++|
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l--~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGA--ENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSC--SCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred CCEEEECCCCCC-CCCCCCCCC--CCCCEEECCCCCCCC-CCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCE
T ss_conf 996985289976-586002576--565743168986644-3692122566666721620212477420111245543333
Q ss_pred ECCCCCCC
Q ss_conf 87576461
Q 002717 102 NLSNNHFS 109 (888)
Q Consensus 102 ~L~~n~l~ 109 (888)
+|++|+|+
T Consensus 86 ~Ls~N~l~ 93 (156)
T d2ifga3 86 NLSFNALE 93 (156)
T ss_dssp ECCSSCCS
T ss_pred ECCCCCCC
T ss_conf 22678785
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=6.4e-12 Score=75.98 Aligned_cols=16 Identities=38% Similarity=0.521 Sum_probs=5.9
Q ss_pred CCCCCCEEECCCCCCC
Q ss_conf 6665657983387032
Q 002717 391 NCTSLYLLSLSHNHLS 406 (888)
Q Consensus 391 ~l~~L~~L~Ls~N~l~ 406 (888)
.+++|+.|+|++|+++
T Consensus 89 ~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 89 KAPNLKILNLSGNELK 104 (162)
T ss_dssp HSTTCCCCCCTTSCCC
T ss_pred HCCCCCCCCCCCCCCC
T ss_conf 5885610004357213
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=1.2e-11 Score=74.54 Aligned_cols=68 Identities=29% Similarity=0.236 Sum_probs=23.2
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 5689999999875764612358664534446666768974785140007801338888889975686253
Q 002717 92 FNYCSSLNTLNLSNNHFSGDLDFASGYGIWSLKRLRTLDLSHNLFSGSIPQGVAALHYLKELLLQGNQFS 161 (888)
Q Consensus 92 ~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 161 (888)
+..+++|++|+|++|+|++..+.. ..+..+++|+.|+|++|+|++...-.+....+|+.|++++|.+.
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~--~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMS--SIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGG--THHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred HHHCCCCCEEECCCCCCCCCCHHH--HHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCC
T ss_conf 974878788637776666773158--89865885610004357213423442220331042664899767
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.98 E-value=3.4e-09 Score=61.71 Aligned_cols=132 Identities=17% Similarity=0.058 Sum_probs=84.8
Q ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCCEEEEEEECCCEEEEEEECCCCCCHHHHH
Q ss_conf 2660899999899992999999332886679689999999996248-998330333898289016999627999989999
Q 002717 610 GVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSDYAPNGSLQAKL 688 (888)
Q Consensus 610 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l 688 (888)
++.+.||+... ++..+.+|+...... .....+.+|..+++.+. +--+.+++.+...++..++|+++++|.++.+..
T Consensus 25 ~s~~~v~rv~~--~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 25 MSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCCEEEEEE--CCCEEEEEECCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCCCCCC
T ss_conf 98771899990--898699998488765-325569999999998760699872899975089649999860433435433
Q ss_pred HHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------------------
Q ss_conf 320999999994559999999999999743059-----------------------------------------------
Q 002717 689 HERLPSTPPLSWTNRFKVILGTAKGLAHLHHSF----------------------------------------------- 721 (888)
Q Consensus 689 ~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------------- 721 (888)
... .....++.+++..++.||+..
T Consensus 102 ~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (263)
T d1j7la_ 102 EDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp TTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred CCC---------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHH
T ss_conf 440---------26999999899999998556842143576446565557789987765555430332320057999999
Q ss_pred ---------CCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf ---------99937367899967866999908920235531
Q 002717 722 ---------RPPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 722 ---------~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
.+.++|+|+.+.||+++++..+-+.||+.+..
T Consensus 173 ~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 99844986781789860047642364996599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.78 E-value=1.6e-07 Score=52.84 Aligned_cols=77 Identities=17% Similarity=0.179 Sum_probs=49.9
Q ss_pred EECCCCCEEEEEEEECCCCEEEEEEEEECC------CCCCCHHHHHHHHHHHHHCC-C-C-CCCEEEEEEECCCEEEEEE
Q ss_conf 111126608999998999929999993328------86679689999999996248-9-9-8330333898289016999
Q 002717 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTS------DIIQYPEDFEREVRVLGKAR-H-P-NLISLEGYYWTPQLKLLVS 676 (888)
Q Consensus 606 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~-h-~-niv~l~g~~~~~~~~~lv~ 676 (888)
.||.|....||++....+++.+++|.-... ......+....|...++.+. + | .+.+++.+ +++..++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred EECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEEE
T ss_conf 807985276899995799848999617713034677788877899999999998650579885528998--598877987
Q ss_pred ECCCCCCH
Q ss_conf 62799998
Q 002717 677 DYAPNGSL 684 (888)
Q Consensus 677 e~~~~gsL 684 (888)
|++++..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred ECCCCCCC
T ss_conf 13577653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.75 E-value=1.2e-09 Score=64.09 Aligned_cols=13 Identities=15% Similarity=0.416 Sum_probs=4.4
Q ss_pred CCCCEEECCCCCC
Q ss_conf 9999998757646
Q 002717 96 SSLNTLNLSNNHF 108 (888)
Q Consensus 96 ~~L~~L~L~~n~l 108 (888)
+.|++|+|++|.+
T Consensus 44 ~~L~~L~Ls~n~l 56 (167)
T d1pgva_ 44 KHIEKFSLANTAI 56 (167)
T ss_dssp SCCCEEECTTSCC
T ss_pred CCCCEEECCCCCC
T ss_conf 7645401201562
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.69 E-value=1.5e-09 Score=63.48 Aligned_cols=10 Identities=30% Similarity=0.394 Sum_probs=3.2
Q ss_pred CCEEECCCCC
Q ss_conf 9689867711
Q 002717 74 LRYLSLAGNI 83 (888)
Q Consensus 74 L~~L~L~~n~ 83 (888)
|++|+|++|.
T Consensus 46 L~~L~Ls~n~ 55 (167)
T d1pgva_ 46 IEKFSLANTA 55 (167)
T ss_dssp CCEEECTTSC
T ss_pred CCEEECCCCC
T ss_conf 4540120156
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.68 E-value=2e-07 Score=52.41 Aligned_cols=142 Identities=16% Similarity=0.138 Sum_probs=79.7
Q ss_pred EECCCCC-EEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC--CCCCCEEEEEEECCCEEEEEEECCCCC
Q ss_conf 1111266-0899999899992999999332886679689999999996248--998330333898289016999627999
Q 002717 606 EVGEGVF-GTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR--HPNLISLEGYYWTPQLKLLVSDYAPNG 682 (888)
Q Consensus 606 ~ig~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~g 682 (888)
.+..|.. +.||+.... ++..+.+|...... ...+..|...++.+. .-.+.+++++..+++..++|+++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred ECCCCCCCCEEEEEEEC-CCCEEEEEECCCCC----HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECC
T ss_conf 76786547758999938-98789999589667----76899999999999865999886132224566159998744135
Q ss_pred CHHH--------------HHHHC---CCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHHC---
Q ss_conf 9899--------------99320---9999999945--5999999--------------------999999974305---
Q 002717 683 SLQA--------------KLHER---LPSTPPLSWT--NRFKVIL--------------------GTAKGLAHLHHS--- 720 (888)
Q Consensus 683 sL~~--------------~l~~~---~~~~~~l~~~--~~~~i~~--------------------~ia~~l~~LH~~--- 720 (888)
++.+ .+... .....++.+. ....-.. .....+..+...
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCC
T ss_conf 54322126899999999999987368854488755412468899999987541101134011213799999999871876
Q ss_pred -CCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf -99993736789996786699990892023553
Q 002717 721 -FRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 721 -~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
..+.++|+|+.+.||+++++..+.+.||+.+.
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 579567867888763577379658999853326
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.38 E-value=2e-08 Score=57.62 Aligned_cols=13 Identities=0% Similarity=0.148 Sum_probs=4.4
Q ss_pred CCCCEEECCCCCC
Q ss_conf 9999998757646
Q 002717 96 SSLNTLNLSNNHF 108 (888)
Q Consensus 96 ~~L~~L~L~~n~l 108 (888)
++|++|+|++|.+
T Consensus 46 ~~L~~L~Ls~n~l 58 (166)
T d1io0a_ 46 TYVKKFSIVGTRS 58 (166)
T ss_dssp CSCCEEECTTSCC
T ss_pred CCCCEEECCCCCC
T ss_conf 8257430158961
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.36 E-value=1.3e-08 Score=58.69 Aligned_cols=15 Identities=13% Similarity=0.213 Sum_probs=5.4
Q ss_pred CCCCCCEEECCCCCC
Q ss_conf 498896898677112
Q 002717 70 NCASLRYLSLAGNIL 84 (888)
Q Consensus 70 ~l~~L~~L~L~~n~i 84 (888)
.+++|++|++++|.+
T Consensus 44 ~n~~L~~L~Ls~n~l 58 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRS 58 (166)
T ss_dssp TCCSCCEEECTTSCC
T ss_pred CCCCCCEEECCCCCC
T ss_conf 198257430158961
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.09 E-value=3.5e-05 Score=40.67 Aligned_cols=137 Identities=15% Similarity=0.147 Sum_probs=73.6
Q ss_pred CEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCC-----CCCEEE--EEEECCCEEEEEEECCCCCCH
Q ss_conf 6089999989999299999933288667968999999999624899-----833033--389828901699962799998
Q 002717 612 FGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKARHP-----NLISLE--GYYWTPQLKLLVSDYAPNGSL 684 (888)
Q Consensus 612 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-----niv~l~--g~~~~~~~~~lv~e~~~~gsL 684 (888)
--.||++... +|..+++|...... ...+++..|...+..+... ..+..- ......+..+.++++++|..+
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCEEEEEECC-CCCEEEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 2026999838-99979999847877--88999999999999998559987875206898056653479999865277688
Q ss_pred -----H---------HHHHHC----C-CCCCCCC-------------------HHHH---HHHHHHHHHHHHH-HHHCCC
Q ss_conf -----9---------999320----9-9999999-------------------4559---9999999999997-430599
Q 002717 685 -----Q---------AKLHER----L-PSTPPLS-------------------WTNR---FKVILGTAKGLAH-LHHSFR 722 (888)
Q Consensus 685 -----~---------~~l~~~----~-~~~~~l~-------------------~~~~---~~i~~~ia~~l~~-LH~~~~ 722 (888)
. ..++.. . ......+ ...+ ...+..+...+.. ..+...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 9937367899967866999908920235531
Q 002717 723 PPIIHYNLKPSNILLDDNYNPRISDFGLARL 753 (888)
Q Consensus 723 ~~ivH~dlk~~Nill~~~~~~kl~Dfgla~~ 753 (888)
.+++|+|+.+.||+++++ ..+.||+.+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.91 E-value=0.00014 Score=37.54 Aligned_cols=71 Identities=8% Similarity=0.122 Sum_probs=46.4
Q ss_pred EECCCCCEEEEEEEECC-------CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCCEEEEEEECCCEEEEEEE
Q ss_conf 11112660899999899-------992999999332886679689999999996248-9983303338982890169996
Q 002717 606 EVGEGVFGTVYKVSFGT-------QGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-HPNLISLEGYYWTPQLKLLVSD 677 (888)
Q Consensus 606 ~ig~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 677 (888)
.++.|-.-.+|++.... ....|.++..- . ........+|..+++.+. +.-..++++++.. ..|+|
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred ECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf 91785334348999688775445789817999659-9--61165899999999999757999808998189----56999
Q ss_pred CCCCCC
Q ss_conf 279999
Q 002717 678 YAPNGS 683 (888)
Q Consensus 678 ~~~~gs 683 (888)
|+++.+
T Consensus 122 fi~g~~ 127 (395)
T d1nw1a_ 122 YIPSRP 127 (395)
T ss_dssp CCCEEE
T ss_pred EECCCC
T ss_conf 734554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.48 E-value=0.00094 Score=33.14 Aligned_cols=142 Identities=15% Similarity=0.062 Sum_probs=70.9
Q ss_pred EECCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-----CCCCCEEE-E--EEECCCEEEEEEE
Q ss_conf 11112660899999899992999999332886679689999999996248-----99833033-3--8982890169996
Q 002717 606 EVGEGVFGTVYKVSFGTQGRMLAVKKLVTSDIIQYPEDFEREVRVLGKAR-----HPNLISLE-G--YYWTPQLKLLVSD 677 (888)
Q Consensus 606 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-g--~~~~~~~~~lv~e 677 (888)
.|..|.--+.|+.... +..+++|....... .+....|..++..+. .|..+... | +.........++.
T Consensus 25 ~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~ 99 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTT--KDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 99 (316)
T ss_dssp EECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred CCCCCCCCCEEEEEEC--CCCEEEEECCCCCC---HHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEE
T ss_conf 3788852673899978--97289998078999---889999999987543025554556410489762134125502453
Q ss_pred CCCCCCH--------------HHHHHHCCC---CCCC--------------------CCHHHHHHHHHHHHHHHHHHH-H
Q ss_conf 2799998--------------999932099---9999--------------------994559999999999999743-0
Q 002717 678 YAPNGSL--------------QAKLHERLP---STPP--------------------LSWTNRFKVILGTAKGLAHLH-H 719 (888)
Q Consensus 678 ~~~~gsL--------------~~~l~~~~~---~~~~--------------------l~~~~~~~i~~~ia~~l~~LH-~ 719 (888)
+..+... ...++.... .... .........+......+.... .
T Consensus 100 ~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (316)
T d2ppqa1 100 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 179 (316)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred ECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCCCC
T ss_conf 11465533320467888889987645444320245310111012002456777765311412799999998764204855
Q ss_pred CCCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf 599993736789996786699990892023553
Q 002717 720 SFRPPIIHYNLKPSNILLDDNYNPRISDFGLAR 752 (888)
Q Consensus 720 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfgla~ 752 (888)
....+++|+|+.+.|++++.+...-+.||+.+.
T Consensus 180 ~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 180 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 454503337863656402045412674222123
|